-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TqLwwqHmDi5Kg/M1LFw1Kz4xiWxK9luQnt3ZqKhR6QMS5xpVxs741Upmn6S5Y8xM jE/tS0YkST60rjbzrMmH+A== 0000950123-10-024450.txt : 20100315 0000950123-10-024450.hdr.sgml : 20100315 20100315083507 ACCESSION NUMBER: 0000950123-10-024450 CONFORMED SUBMISSION TYPE: SC 14D9 PUBLIC DOCUMENT COUNT: 61 FILED AS OF DATE: 20100315 DATE AS OF CHANGE: 20100315 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 14D9 SEC ACT: 1934 Act SEC FILE NUMBER: 005-37954 FILM NUMBER: 10679702 BUSINESS ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 14D9 BUSINESS ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 SC 14D9 1 y83222sc14d9.htm SC 14D9 sc14d9
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
SCHEDULE 14D-9
 
Solicitation/Recommendation Statement under Section 14(d)(4)
of the Securities Exchange Act of 1934
 
OSI Pharmaceuticals, Inc.
(Name of Subject Company)
 
OSI Pharmaceuticals, Inc.
(Name of Person Filing Statement)
 
Common Stock, $0.01 par value per share
(Title of Class of Securities)
 
671040103
(CUSIP Number of Class of Securities)
 
Barbara A. Wood, Esq.
Senior Vice President, General Counsel and Secretary
41 Pinelawn Road
Melville, New York 11747
(631) 962-2000
 
(Name, address and telephone number of person authorized to receive notices
and communications on behalf of the persons filing statement)
 
With copies to:
 
Roger S. Aaron, Esq.
Robert B. Pincus, Esq.
Steven J. Daniels, Esq.
Skadden, Arps, Slate, Meagher & Flom LLP
Four Times Square
New York, New York 10036
(212) 735-3000
 
 
o  Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
 
 

TABLE OF CONTENTS

Item 1. Subject Company Information
Item 2. Identity and Background of Filing Person
Item 3. Past Contacts, Transactions, Negotiations, and Agreements
Item 4.The Solicitation or Recommendation
Item 5. Persons/Assets, Retained, Employed, Compensated or Used
Item 6. Interest in Securities of the Subject Company.
Item 7. Purposes of the Transaction and Plans or Proposals
Item 8. Additional Information
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
Item 9. Exhibits
SIGNATURE
EX-99.A.1
EX-99.A.2
EX-99.A.3
EX-99.A.4
EX-99.A.5
EX-99.E.2
EX-99.E.24
EX-99.E.25
EX-99.E.26
EX-99.E.27

Table of Contents

 
Item 1.  Subject Company Information
 
(a) Name and Address
 
The name of the subject company to which this Solicitation/Recommendation Statement on Schedule 14D-9 (together with any exhibits attached hereto, this “Statement”) relates is OSI Pharmaceuticals, Inc., a Delaware corporation (“OSI” or the “Company”). The Company’s principal executive offices are located at 41 Pinelawn Road, Melville, New York 11747. The Company’s telephone number at this address is (631) 962-2000.
 
(b) Securities
 
The title of the class of equity securities to which this Statement relates is the Company’s common stock, par value $0.01 per share (the “Common Stock”), including the associated rights to purchase shares of Series SRP Junior Participating Preferred Stock, par value $0.01 (the “Rights,” and together with the Common Stock, the “Shares”), issued pursuant to the Rights Agreement, dated as of September 27, 2000, by and between the Company and The Bank of New York, as Rights Agent (the “Rights Agreement”). As of March 11, 2010, there were 59,584,137 Shares outstanding.
 
Item 2.  Identity and Background of Filing Person
 
(a) Name and Address
 
The name, business address and business telephone of the Company, which is the subject company and the person filing this Statement, are set forth in Item 1 above. The Company’s website address is www.osip.com. The information on the Company’s website should not be considered a part of this Statement or incorporated herein by reference.
 
(b) Tender Offer
 
This Statement relates to the unsolicited tender offer by Ruby Acquisition, Inc. (“Purchaser”), a Delaware corporation and a wholly-owned subsidiary of Astellas US Holding, Inc. (“Parent”), a Delaware corporation and a wholly-owned subsidiary of Astellas Pharma Inc. (“Astellas”), a corporation formed under the laws of Japan, pursuant to which Purchaser has offered to purchase all of the issued and outstanding Shares, at a price of $52.00 net per Share in cash (subject to applicable withholding taxes), without interest, upon the terms and subject to the conditions set forth in the Offer to Purchase dated March 2, 2010 (the “Offer to Purchase”) and in the related Letter of Transmittal, (which, together with any amendments or supplements thereto, collectively constitute the “Offer”). The Offer is described in the Tender Offer Statement on Schedule TO (together with exhibits thereto, as amended, the “Schedule TO”), filed with the Securities and Exchange Commission (the “SEC”) on March 2, 2010 by Purchaser, Parent and Astellas.
 
The Schedule TO indicates that the purpose of the Offer is to acquire control of, and ultimately the entire equity interest in, the Company. The Offer, as the first step in the acquisition of the Company, is intended to facilitate the acquisition of all issued and outstanding Shares. If the Offer is consummated, Astellas and Purchaser intend, as soon as practicable after consummation of the Offer, to have Astellas and Purchaser, or another direct or indirect wholly-owned subsidiary of Astellas, consummate a second-step merger (the “Proposed Merger”). At the effective time of the Proposed Merger, each then outstanding Share (other than Shares held by Astellas and its subsidiaries, Shares held in the treasury of the Company, Shares held by subsidiaries of the Company, if any, and Shares held by the Company’s stockholders who have perfected their appraisal rights in accordance with Section 262 of the General Corporation Law of the State of Delaware (“DGCL”)) would be canceled and converted automatically into the right to receive an amount in cash per Share equal to the highest price per Share paid by Purchaser pursuant to the Offer, without interest (and less any applicable withholding taxes). Upon consummation of the Proposed Merger, the Company would be a direct or indirect wholly-owned subsidiary of Astellas.


2

Table of Contents

The Schedule TO provides that the Offer is conditioned upon fifteen conditions including, among other conditions, (i) there having been validly tendered and not properly withdrawn before the expiration of the Offer at least the number of Shares which, together with the Shares then owned by Astellas and its subsidiaries (including Purchaser), represents at least a majority of the total number of Shares outstanding calculated on a fully-diluted basis, (ii) the Company’s Board of Directors (the “Board” or the “OSI Board”) having redeemed the Rights or Purchaser being satisfied, in its reasonable discretion, that the Rights have been invalidated or are otherwise inapplicable to the Offer and the Proposed Merger, (iii) the OSI Board having approved the Offer and the Proposed Merger such that, or Purchaser otherwise being satisfied, in its reasonable discretion, that, the restrictions on business combinations with interested stockholders set forth in Section 203 of the DGCL are inapplicable to the Offer and the Proposed Merger, (iv) the Company not having directly or indirectly sold, licensed or otherwise transferred or encumbered in whole or in part (and not having agreed directly or indirectly to sell, license or otherwise transfer or encumber in whole or in part) any rights or assets related to or in connection with its flagship oncology product, Tarceva® (erlotinib) other than as provided in, and only to the extent (if any) required by, agreements to which the Company is a party and which have been filed by the Company with the SEC on or prior to February 26, 2010 and (v) any applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, having expired or been terminated.
 
According to the Schedule TO, Astellas’ principal executive office is located at 3-11, Nihonbashi-Honcho, 2-chome, Chuo-ku Tokyo 103-8411, Japan and its telephone number at such address is (81) 3-3244-3000, and the executive offices of Parent and Purchaser are located at Three Parkway North, Deerfield, IL 60015. The telephone number of Parent and Purchaser at such address is (847) 317-8800.
 
With respect to all information described in this Statement or the annexes and exhibits to this Statement contained in the Offer to Purchase, the related Letter of Transmittal, the Schedule TO, and any exhibits, amendments or supplements thereto, including information concerning Astellas, Parent and Purchaser or their respective affiliates, officers or directors, or actions or events with respect to any of them, the Company takes no responsibility for the accuracy or completeness of such information or for any failure by Astellas, Parent or Purchaser to disclose events or circumstances that may have occurred and may affect the significance, completeness or accuracy of any such information.
 
Item 3.  Past Contacts, Transactions, Negotiations, and Agreements
 
Except as described in this Statement or in the excerpts from the Company’s Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 29, 2009 (the “2009 Proxy Statement”), relating to the Company’s 2009 Annual Meeting of Stockholders, which excerpts are filed as Exhibit (e)(1) to this Statement and incorporated herein by reference, or as otherwise incorporated herein by reference, to the knowledge of the Company, as of the date of this Statement, there are no material agreements, arrangements, or understandings, nor any actual or potential conflicts of interest between the Company or any of its affiliates, on the one hand, and (i) the Company or any of its executive officers, directors or affiliates, or (ii) Astellas, Parent, Purchaser or any of their respective executive officers, directors or affiliates, on the other hand.
 
Any information incorporated herein by reference shall be deemed modified or superseded for purposes of this Statement to the extent that any information contained herein modifies or supersedes such information.
 
The information contained in Item 4 below is incorporated by reference into this Item 3. In addition, Exhibit (e)(1) includes the following sections of the 2009 Proxy Statement: “Voting Securities and Principal Stockholders”, “Executive Compensation” and “Director Compensation”, which are incorporated herein by reference.


3

Table of Contents

Fujisawa License Agreement
 
In December 2003, the Company entered into a license agreement (the “Fujisawa License Agreement”) with Fujisawa Pharmaceutical Co., Ltd. (“Fujisawa”), in order to obtain from Fujisawa an exclusive license to certain Fujisawa patents implicated in the Company’s use of its clinical candidate, OSI-930, in the field of oncology. The current party to the Fujisawa License Agreement with the Company is Astellas, the successor-in-interest to Fujisawa. Under the terms of the Fujisawa License Agreement, the Company made an initial payment of $300,000 to Fujisawa and a $400,000 milestone payment upon the approval of the Investigational New Drug Application for a licensed product containing OSI-930, any of its derivatives or any c-kit inhibitor (a “Licensed Product”). The Company currently pays an annual $50,000 maintenance fee, which the Company is obligated to pay Astellas (until the launch of the first Licensed Product). Pursuant to the terms of the Fujisawa License Agreement, the Company is also required to pay $3,000,000 upon the first approval of a New Drug Application on a Licensed Product in the United States and royalties equal to 3.5% of the net sales of a Licensed Product in any country where Fujisawa has a valid patent claim. Each party has agreed to indemnify and hold harmless the other party and its representatives and affiliates for certain losses in connection with the transactions contemplated by the Fujisawa License Agreement. Each party may terminate the Fujisawa License Agreement upon sixty-days’ prior written notice to the other party in the event that the other party has committed certain breaches set forth in the Fujisawa License Agreement or has filed a petition for bankruptcy, corporate reorganization, civil rehabilitation or other insolvency proceedings. Unless earlier terminated, the term of the Fujisawa License Agreement will continue until the last to expire of the valid patent claims or published patent applications of the patent rights licensed under the Fujisawa License Agreement.
 
The foregoing summary of the Fujisawa License Agreement is qualified in its entirety by reference to the text of the Fujisawa License Agreement, a copy of which is filed as Exhibit (e)(2) to this Statement and incorporated by reference into this Item 3.
 
Mr. Kenneth B. Lee’s Former Role as Consultant to Astellas Venture Capital an Affiliate of Astellas
 
From November 2003 to November 2005, Mr. Kenneth B. Lee, Jr., a member of the Company’s Board, served as a consultant to Astellas Venture Capital (“AVM,” formerly Yamanouchi Venture Capital), a wholly-owned venture fund of Astellas (formerly Yamanouchi). In connection with his service as a consultant, Mr. Lee received annual compensation from AVM of $22,500 in 2004 and $15,000 in 2005, when his engagement was terminated.
 
Beneficial Ownership of Shares
 
According to the Schedule TO, Parent owned 1,000 Shares as of March 2, 2010. The 1,000 Shares owned by Parent represent less than 1% of the issued and outstanding Shares as of March 15, 2010.
 
Cash Consideration Payable to Directors and Executive Officers Pursuant to the Offer and Proposed Merger
 
As a group, the directors and executive officers of the Company held an aggregate of 324,263 Shares as of March 15, 2010. In the event that the directors or executive officers were to tender any Shares they own for purchase pursuant to the Offer, or if the Proposed Merger were to occur, the directors and executive officers would receive the same cash consideration per Share (on the same terms and conditions) as the other stockholders of the Company. If the directors and executive officers were to tender all of the 324,263 Shares owned by them for purchase pursuant to the Offer and those Shares were purchased by Purchaser for $52.00 per Share, the directors and executive officers would receive an aggregate of approximately $16.9 million in cash, less applicable withholding taxes. The foregoing amount does not include Shares subject to restricted stock units and options to purchase Shares, which are addressed in the following paragraph and in the section entitled “Potential Severance and Change of Control Benefits.” As discussed below under “Item 4 – The Solicitation or Recommendation,”


4

Table of Contents

to the knowledge of the Company, none of the Company’s directors or executive officers currently intends to tender any of their Shares pursuant to the Offer.
 
The Company’s directors and executive officers have outstanding equity awards under the Company’s three Equity Incentive Plans (collectively, the “Company Equity Incentive Plans”): the 1997 Incentive and Non-Qualified Stock Option Plan, the 1999 Incentive and Non-Qualified Stock Option Plan and the Amended and Restated Stock Incentive Plan. As of March 15, 2010, the directors and executive officers of the Company beneficially held vested and exercisable options to purchase 1,250,447 Shares, with exercise prices ranging from $15.02 to $82.88 and an aggregate weighted average exercise price of $42.01 per Share for the options that were vested and exercisable as of that date. If the directors and executive officers were to exercise all vested options and tender all of the Shares subject thereto for purchase pursuant to the Offer, the directors and executive officers would receive an aggregate of approximately $63.8 million in cash with respect to such options (net of the exercise price necessary to purchase the Shares pursuant to the option exercise). See below under the section entitled “Potential Severance and Change of Control Benefits of Executive Officers” for information about unvested equity awards held by executive officers and directors. If the Proposed Merger is consummated following the Offer, the directors and executive officers would receive cash consideration equal to the product of the number of vested options they own and the difference between $52.00 and the exercise price of the options and the same cash consideration for each Share underlying a restricted stock award as the other stockholders of the Company would receive per Share, less any applicable withholding taxes.
 
The foregoing summary is qualified in its entirety by reference to the Company Equity Incentive Plans, copies of each of which are filed as Exhibits (e)(3) through (e)(5) to this Statement and incorporated herein by reference.
 
Potential Severance and Change of Control Benefits of Executive Officers
 
The Company’s executive officers have entered into, or participate in, as applicable, the various agreements and arrangements discussed below, which provide for severance and other benefits in connection with termination upon a change in control of the Company.
 
Colin Goddard, Ph.D. and Mr. Pierre Legault
 
The employment agreement, dated as of June 14, 2006, between the Company and Dr. Colin Goddard, the Company’s Chief Executive Officer, as amended on June 21, 2006, provides that if Dr. Goddard is terminated by the Company without cause, or terminates his employment for good reason, then he will be entitled to receive his accrued but unpaid salary and benefits, a continuation of health and disability benefits for a period of three years, three years of base salary and the pro-rata bonus he would have been entitled to receive for the fiscal year in which the termination occurs. The definition of “good reason” under Dr. Goddard’s agreement includes a change of control of the Company.
 
The employment agreement, dated as of December 16, 2008, between the Company and Mr. Pierre Legault, the Company’s Executive Vice President, Chief Financial Officer and Treasurer, provides that if Mr. Legault is terminated by the Company without cause, terminates his employment for good reason, or resigns within 60 days following a change of control, he will be entitled to receive his accrued but unpaid salary and benefits, a continuation of health benefits for a period of two years, and a lump sum equal to two years of base salary plus two years of his target bonus and his pro-rated target bonus for the year of termination through the date of termination. As used in Mr. Legault’s employment agreement, “good reason” means a material reduction in duties, responsibilities or reporting responsibilities; a reduction in base salary or target bonus; or a requirement of relocation whereby Mr. Legault is based more than 35 miles from the Company’s headquarters or his average commute from residence exceeds 45 minutes.
 
The employment agreements between the Company and each of Dr. Goddard and Mr. Legault also provide for a reimbursement (or “gross-up”) in respect of any “golden parachute” excise taxes imposed on their severance payments and any other payments and benefits under Section 4999 of the


5

Table of Contents

Internal Revenue Code, provided that Mr. Legault’s excise tax gross-up will not be made if the total amount of change of control protection benefits exceeds the threshold by which such excise tax is triggered by less than 10%. If this threshold is not met, Mr. Legault’s severance payments and benefits would be reduced to the extent necessary to avoid the application of such excise tax.
 
Mr. Gabriel Leung
 
The employment agreement, dated as of May 16, 2003, between the Company and Mr. Gabriel Leung, the Company’s Executive Vice President and President, Pharmaceutical Business, as amended on January 5, 2004, provides that if Mr. Leung is terminated by the Company without cause, or terminates his employment for good reason, he will be entitled to receive his accrued but unpaid salary and benefits, a continuation of health benefits for a period of one year, payment of base salary for one year following and a pro-rata amount of the bonus he would have been entitled to receive for the fiscal year in which the termination occurs, based on the portion of such year during which he was employed. The definition of “good reason” under Mr. Leung’s employment agreement includes a change of control of the Company, which is defined as the sale of all or substantially all of the assets of the Company, or a merger or consolidation where the existing stockholders of the Company cease to hold a majority of the voting power of the Company, which would occur if the Proposed Merger is consummated.
 
Anker Lundemose, M.D., Ph.D., D. Sc.
 
The service contract, dated as of September 20, 2005, between Prosidion Limited, a wholly-owned subsidiary of the Company (“Prosidion”), and Dr. Anker Lundemose, the Company’s Executive Vice President, Corporate Development and Strategic Planning, provides that if he is terminated by the Company without cause, or terminates his employment for good reason, then he will be entitled to receive his accrued but unpaid salary and benefits and a lump sum payment equal to (a) one year of base salary and (b) the pro-rata bonus he would have been entitled to receive for the fiscal year in which the termination occurs, based on the portion of such year during which he was employed. The definition of “good reason” under Dr. Lundemose’s agreement includes a change of control of the Company or Prosidion.
 
Mr. Robert L. Simon
 
The employment letter agreement, dated as of November 15, 2001, between the Company and Mr. Robert Simon, the Company’s Executive Vice President, Pharmaceutical and Technical Operations, as amended on September 20, 2005, provides that if Mr. Simon is terminated by the Company without cause or terminates his employment within six months of a change in control of the Company for good reason, he will be entitled to receive a continuation of health benefits for a period of one year, payment of his base salary for a period of one year and a pro-rata bonus for the year of termination. Under Mr. Simon’s employment letter agreement, “good reason” includes a reduction in his total compensation package, duties or responsibilities, or the requirement that he relocate more than forty (40) miles from his present location or home.
 
Linda E. Amper, Ph.D. and Barbara A. Wood, Esq.
 
The change of control agreement, dated October 4, 2001, as amended and restated on December 4, 2007, between the Company and Dr. Linda Amper, the Company’s Senior Vice President, Human Resources and the change of control agreement, dated as of October 4, 2001, between the Company and Ms. Barbara Wood, Esq., the Company’s Senior Vice President, General Counsel and Secretary, as amended on September 20, 2005, each provide that if the officer’s employment with the Company is terminated without cause or if the officer voluntarily terminates for good reason at any time within six months following a change of control, then the officer will receive a lump sum severance payment equal to the officer’s annual salary for a period of one year, a pro-rated bonus for the year of termination, and one year of health benefits. “Good reason” under the terms of the change of control agreements for Dr. Amper and Ms. Wood includes (i) a decrease in total compensation package, (ii) the assignment of duties or responsibilities which are not commensurate with the officer’s position immediately prior to the


6

Table of Contents

sale or change of control, or (iii) the requirement to relocate to an office or facility more than forty (40) miles from the officer’s present location or forty (40) miles from the officer’s home.
 
The aggregate value of the cash severance payments and medical benefits which would be received by the executive officers referred to above, if the employment of each of them was terminated on March 15, 2010 in connection with the consummation of the Offer would be approximately $11.1 million.
 
Jonathan Rachman, M.D., Ph.D.
 
The employment agreement, dated as of March 2, 2005, between Prosidion and Dr. Jonathan Rachman, the Company’s Senior Vice President, Research and Development, Diabetes and Obesity, provides for a six month notice of termination or a payment of salary and benefits in lieu thereof.
 
The above summaries and descriptions of the employment or other agreements entered into with the executive officers are qualified in their entirety by reference to the agreements and the amendments and addenda thereto, copies of each of which are filed as Exhibits (e)(6) through (e)(20) to this Statement and are incorporated herein by reference.
 
Vesting of Equity upon a Change of Control
 
As of March 15, 2010, the executive officers of the Company as a group hold an aggregate of 944,813 unvested stock options and 193,557 unvested restricted stock and restricted stock units. The employment agreements or other arrangements described above for each of the Company’s executive officers, other than Dr. Rachman, provide that upon a change of control of the Company, all of their outstanding unvested equity grants vest and/or become immediately exercisable. Dr. Rachman’s most recent stock option agreement and restricted stock unit agreement, a copy of each of which is attached as Exhibits (e)(21) and (e)(22) and incorporated herein by reference, each provide for the acceleration of equity upon his termination following a change of control, unless the termination is for cause or a resignation without “good reason.” For purposes of these agreements, “good reason” includes (i) a decrease in total compensation package, (ii) the assignment of duties or responsibilities which are not commensurate with the officer’s position immediately prior to the sale or change of control, or (iii) the requirement to relocate to an office or facility more than forty (40) miles from the officer’s present location or forty (40) miles from the officer’s home. In the event that all such awards were to vest as of March 15, 2010 in connection with the Offer or the Proposed Merger, as applicable, the executive officers of the Company would receive an aggregate amount of approximately $24.2 million in respect of such awards (net, in the case of options, of the exercise price applicable to the option).


7

Table of Contents

The following table describes for each executive officer the potential payments due upon the acceleration of vesting of awards as of March 15, 2010 (net, in the case of options, of the exercise price applicable to the options):
 
                                         
      Acceleration
       Acceleration
                  
      of Vesting
       of Vesting
                  
      Restricted
       Restricted
       Acceleration of
          
      Stock
       Stock Unit
       Vesting of
          
 Name     Awards (1)       Awards (1)       Options (2)       Total  
Colin Goddard, Ph.D.
                                       
Chief Executive Officer
    $ 217,100       $ 5,281,050       $ 3,503,864       $ 9,002,014  
                                         
Pierre Legault
                                       
Executive Vice President, Chief
Financial Officer and Treasurer
      -       $ 2,076,550       $ 1,059,500       $ 3,136,050  
                                         
Robert L. Simon
                                       
Executive Vice President,
Pharmaceutical and Technical
Operations
    $ 65,000       $ 1,676,486       $ 1,045,460       $ 2,786,946  
                                         
Gabriel Leung
                                       
Executive Vice President and
President, Pharmaceutical Business
    $ 87,100       $ 1,439,080       $ 895,700       $ 2,421,880  
                                         
Anker Lundemose, M.D. Ph.D., D. Sc.
                                       
Executive Vice President, Corporate
Development and Strategic Planning
    $ 87,100       $ 1,448,500       $ 930,384       $ 2,465,984  
                                         
Barbara Wood, Esq.
                                       
Senior Vice President, General
Counsel and Secretary
    $ 65,000       $ 1,086,375       $ 702,000       $ 1,853,375  
                                         
Linda E. Amper, Ph.D.
                                       
Senior Vice President, Human
Resources
      -       $ 1,068,188       $ 768,300       $ 1,836,488  
                                         
Jonathan Rachman, M.D., Ph.D.
                                       
Senior Vice President, R&D Diabetes
and Obesity, UK 
      -       $ 332,000       $ 348,400       $ 680,400  
                                         
 
  (1)        Assumes a purchase price of $52.00 per Share, and 100% acceleration of all unvested restricted stock and restricted stock unit awards.
 
  (2)        Represents the net proceeds for 100% of unvested options, assuming options are exercised and Shares sold at $52.00 per Share.
 
Benefits Related to Ardsley Site Relocation
 
In 2009, the Compensation Committee of the Board approved the award of commitment bonuses to all of its U.S.-based employees who agreed to relocate to the Company’s new facility in Ardsley, New York. Of the Company’s executive officers, Messrs. Legault, Simon and Leung and Ms. Wood and Dr. Amper received these commitment bonuses. Dr. Goddard elected to forgo such commitment bonus. Certain relocation benefits were also provided to Messrs. Leung and Simon and Dr. Amper.


8

Table of Contents

Summary of Potential Change of Control Benefits
 
The following table summarizes, as of March 15, 2010 (unless specified otherwise below), the aforementioned potential severance and other benefits which may be payable in connection with a change of control of the Company as defined under, and in accordance with, the respective employment agreements or other arrangements described above (excluding the amount of any applicable withholding taxes), assuming termination of the executive on March 15, 2010 and an Offer price of $52.00:
 
                                         
                      Value of
          
      Cash
               Accelerated
          
      Severance
       Medical
       Equity
          
Name     Payment       Continuation       Awards       Total  
Colin Goddard, Ph.D.
                                       
Chief Executive Officer(a)
    $ 5,488,414 (c)     $ 59,436       $ 9,002,014       $ 14,549,864  
                                         
Pierre Legault
                                       
Executive Vice President, Chief
Financial Officer and Treasurer(b)
    $ 3,074,605 (d)     $ 31,488       $ 3,136,050       $ 6,242,143  
                                         
Robert L. Simon
                                       
Executive Vice President,
Pharmaceutical and Technical
Operations
    $ 477,747 (e)     $ 19,812       $ 2,786,946       $ 3,284,505  
                                         
Gabriel Leung
                                       
Executive Vice President and
President, Pharmaceutical
Business
    $ 527,792 (e)     $ 19,812       $ 2,421,880       $ 2,969,484  
                                         
Anker Lundemose, M.D. Ph.D., D. Sc. (f)
                                       
Executive Vice President,
Corporate Development and
Strategic Planning
    $ 421,915 (e)       -       $ 2,465,984       $ 2,887,899  
                                         
Barbara Wood, Esq.
                                       
Senior Vice President, General
Counsel and Secretary
    $ 426,800 (e)     $ 15,744       $ 1,853,375       $ 2,295,919  
                                         
Linda E. Amper, Ph.D.
                                       
Senior Vice President, Human
Resources
    $ 357,676 (e)     $ 5,820       $ 1,836,488       $ 2,199,984  
                                         
Jonathan Rachman, M.D., Ph.D.
                                       
Senior Vice President, R&D Diabetes
and Obesity, UK (f) 
    $ 158,955 (g)       -       $ 680,400       $ 839,355  
                                         
 
(a) Dr. Goddard is entitled to receive tax gross-up payments in the event that his receipt of termination payments and other benefits following a change of control subjects him to an excise tax under Section 4999 of the U.S. Internal Revenue Code. Based on calculated severance amounts, Dr. Goddard would be subject to such excise tax, amounting to $3,219,274, assuming a March 15, 2010 termination date. This amount does not reflect the value that may be attributable to Dr. Goddard’s six-month non-competition and non-solicitation agreement with the Company. Such value may be offset from the parachute payments attributed to the executive in connection with a change in control.
 
(b) Mr. Legault is entitled to receive tax gross-up payments in the event that his receipt of termination payments and other benefits following a change of control subjects him to an excise tax under Section 4999 of the U.S. Internal Revenue Code. Based on calculated severance amounts, Mr. Legault would be subject to such excise tax, amounting to $1,542,542, assuming a March 15, 2010 termination date. This amount does not reflect the value that may be attributable to Mr. Legault’s one-year non-competition and non-solicitation agreement with the Company. Such value may be offset from the parachute payments attributed to the executive in connection with a change in control.


9

Table of Contents

 
(c) Represents three years of 2010 base salary, pro-rated target bonus through March 15, 2010 and tax gross-ups in the amount referenced in footnote (a) above for payment of excise tax.
 
(d) Represents two years of 2010 base salary, two years of Mr. Legault’s 2010 annual target bonus, pro-rated target bonus through March 15, 2010, and tax gross-ups in the amount referenced in footnote (b) above for payment of excise tax.
 
(e) Represents one year of 2010 base salary and a pro-rated target bonus for the year of termination.
 
(f) Compensation amounts have been converted from British Pounds Sterling to U.S. dollars using the average exchange rate for the period ended February 28, 2010 of $1.59.
 
(g) Represents six months of 2010 base salary.
 
Indemnification of Directors and Officers
 
The Company’s Restated Certificate of Incorporation, a copy of which is attached as Exhibit (e)(23) and incorporated herein by reference, provides that the Company shall, to the fullest extent authorized by the DGCL, indemnify any person, or the legal representative of any person, who is or was a director, officer, employee or agent of the Company or is or was serving at the request of the Company as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust or other enterprise against liabilities incurred in his or her capacity as such. The Company’s Restated Certificate of Incorporation also provides that any amendment to the DGCL shall only be applicable to the extent any such amendment permits the Company to provide broader indemnification rights than such law permitted the Company to provide prior to such amendment. The Company’s Restated Certificate of Incorporation further provides that in the case of an action, suit or proceeding initiated by the indemnified person, the Company shall indemnify the person only if such action, suit or proceeding was authorized by the OSI Board. Additionally, the Company’s Restated Certificate of Incorporation provides that, to the fullest extent permitted by the DGCL, the Company shall advance expenses to such directors and officers in connection with defending a proceeding brought against such directors or officers by reason of the fact that he is or was serving in such capacity at the request of the Company. The Company’s Restated Certificate of Incorporation also contains a provision eliminating the liability of its directors to the Company or its stockholders for monetary damages for breach of fiduciary duty except under certain specified circumstances. The Company’s Restated Certificate of Incorporation also permits the Company to maintain insurance to protect itself and any of its directors, officers, employees or agents against any liability with respect to which the Company would have the power to indemnify such persons under the DGCL. The Company maintains officers’ and directors’ liability insurance which insures against certain liabilities that officers and directors of the Company may incur.
 
Item 4. The Solicitation or Recommendation
 
(a)     Solicitation Recommendation.  The Board has reviewed the Offer with the assistance of the Company’s management and legal and financial advisors and, after careful consideration, the Board has unanimously determined that the Offer is inadequate, substantially undervalues the Company and is not in the best interests of the Company and its stockholders. Accordingly, and for the reasons described in more detail below, the Board of Directors of the Company unanimously recommends that you REJECT the Offer and NOT TENDER your Shares pursuant to the Offer.
 
A copy of a letter to stockholders communicating the Board’s recommendation and a form of press release announcing such recommendation are filed as Exhibits (a)(1) and (a)(2) hereto, respectively, and are incorporated herein by reference.
 
(b)     Background of the Offer; Reasons for Recommendation.
 
1.      Background.
 
On January 14, 2009, Dr. Colin Goddard, OSI’s Chief Executive Officer, met with Dr. Masaki Doi, then Vice President, Business Development of Astellas, and Dr. Kaori Maeda, then Associate Director, Business Development of Astellas, in San Francisco, California. In the course of the meeting,


10

Table of Contents

Dr. Doi indicated that Astellas was interested in acquiring OSI. Dr. Goddard responded that OSI had an established strategy for the creation of long-term stockholder value, but that the OSI Board took its fiduciary responsibilities seriously and would certainly consider the near-term merits of any indication of interest in the Company against the longer term stockholder value creation potential of its ongoing strategic plan. Dr. Goddard noted, however, that in light of the pursuit of the Company’s strategic plan, he did not believe that it was the right time to sell the Company.
 
On February 2, 2009, Dr. Goddard received a letter from Mr. Masafumi Nogimori, President and CEO of Astellas (the text of this letter is attached as Exhibit (e)(24) to this Statement) containing a nonbinding indication of interest to acquire OSI at a price between $55.00 — $57.00 per Share in cash. The February 2nd Astellas indication of interest was nonbinding and preliminary in nature and subject to numerous conditions. In connection with its indication of interest, Astellas indicated that it would need approximately two months to complete its due diligence investigation of OSI and that it would require OSI to negotiate exclusively with Astellas until March 31, 2009, if OSI wished to pursue the indication of interest.
 
On February 5, 2009, the OSI Board met by teleconference with the Company’s management and advisors to discuss the nonbinding indication of interest received from Astellas. At the direction of the OSI Board, Dr. Goddard sent a letter to Mr. Nogimori (the text of this letter is attached as Exhibit (e)(25) to this Statement) indicating that the OSI Board would respond to Astellas’ indication of interest following a careful and thorough review.
 
On February 18, 2009, OSI’s Board met formally to consider the nonbinding indication of interest received from Astellas. Also present at the meeting were members of the Company’s management and advisors. The Board, along with the Company’s management and advisors, discussed Astellas’ nonbinding indication of interest, the M&A market in general and the Company’s strategic plan and future prospects. After deliberation, the Board unanimously determined that the $55.00 — $57.00 price reflected in Astellas’ nonbinding indication of interest was inadequate and substantially undervalued the Company based on a number of factors, including: the momentum of global Tarceva sales; the positive recent clinical results relating to Tarceva; the multiple future label and market expansion opportunities inherent in the Tarceva lifecycle plan; and the strength and long-term value creation potential of OSI’s research and development pipeline in oncology and diabetes and obesity. In reaching its determination, the Board also considered a number of other factors, including:
 
  •    Astellas’ request for a two-month due diligence period and almost two months of exclusivity;
 
  •    the highly conditional nature of Astellas’ indication of interest;
 
  •    Astellas’ limited experience in consummating acquisitions together with the fact that Astellas was then actively engaged in an unsolicited takeover attempt for CV Therapeutics; and
 
  •    the fact that a number of large pharmaceutical companies that might have been interested in a transaction with OSI were engaged in major transactions at that time, including Roche, the Company’s partner in the Tarceva franchise.
 
On February 19, 2009, Dr. Goddard sent a letter to Mr. Nogimori (the text of this letter is attached as Exhibit (e)(26) to this Statement) informing him of the Board’s decision.
 
On a number of occasions after the February 18, 2009 Board meeting through June 15, 2009, representatives of Astellas contacted representatives of OSI reiterating Astellas’ interest in OSI and requesting that OSI’s Board reconsider Astellas’ nonbinding indication of interest on the same terms and conditions that were determined by the Board to be inadequate and too conditional in February 2009. Although the OSI Board met on a number of occasions to consider these overtures, given that the terms and conditions of Astellas’ nonbinding indication of interest had not improved at all and that Astellas had


11

Table of Contents

not eliminated any of the conditionality of its nonbinding indication of interest or its request for exclusivity, the Board determined not to pursue these indications of interest.
 
There were no communications between OSI and Astellas or their representatives from July 1, 2009 until late December 2009.
 
On January 13, 2010, Dr. Anker Lundemose, OSI’s Executive Vice President of Corporate Development and Strategic Planning, met with Dr. Maeda and Mr. Chihiro Yokota, Vice President, Licensing & Alliances of Astellas, in San Francisco, California. Mr. Yokota indicated that Astellas continued to be interested in OSI. At the January 13th meeting, Dr. Lundemose gave a slide presentation to Dr. Maeda and Mr. Yokota regarding OSI’s business and indicated that OSI would be willing to consider alternative relationships with Astellas.
 
On January 29, 2010, Dr. Lundemose emailed Mr. Yokota informing him that Dr. Goddard would be available to travel to Japan in the next one to two months to meet with Mr. Nogimori should Astellas still be interested in a top-level interaction between the two companies. On February 3, 2010, Mr. Yokota called Dr. Lundemose to request a face-to-face meeting between Dr. Goddard and Mr. Nogimori during the week of February 8, 2010 and again expressed Astellas’ interest in a transaction with OSI.
 
On February 12, 2010, Dr. Goddard and Mr. Nogimori met in New York City. Mr. Nogimori told Dr. Goddard that Astellas would be willing to acquire OSI for $52.00 per Share. Dr. Goddard told Mr. Nogimori that this price would likely be too low for OSI to consider. Dr. Goddard assured Mr. Nogimori that he would convey Astellas’ proposal to the Board and that he would recommend to the Board that Astellas be permitted to review certain confidential information that Dr. Goddard believed would allow Astellas to better understand the value of the Company, subject to Astellas entering into a mutually acceptable nondisclosure agreement.
 
On February 19, 2010, members of the OSI Board met with members of Company management and representatives from Centerview Partners LLC (“Centerview Partners”), the Company’s lead financial advisor, and Skadden, Arps, Slate, Meagher & Flom LLP (“Skadden”) and Saul Ewing LLP, the Company’s legal advisors. Dr. Goddard described the Company’s recent discussions with Astellas. Members of OSI’s management reported on OSI’s past and current business operations, financial condition and future prospects. Representatives of Centerview Partners reviewed with the Board, among other matters, the M&A market in general, certain financial projections prepared by the Company’s management and related financial matters. Representatives of Skadden discussed certain legal matters relating to the Board’s consideration of Astellas’ proposal and provided the directors with an overview of their fiduciary duties in connection therewith. The Board extensively discussed the recent communications with Astellas, including Astellas’ most recent oral indication of interest. After deliberation, the Board determined that the $52.00 price at which Astellas said it was interested in acquiring the Company very significantly undervalued the Company. Among the factors considered by the Board were the strong financial performance, continued growth in revenue and net income, increases in the Company’s cash position and advances in the Company’s pipeline, as well as other positive trends and developments in OSI’s business. At that meeting, however, the Board determined to offer Astellas access to certain OSI confidential information that was fundamental to the Board’s valuation of the Company, subject to Astellas entering into a mutually acceptable nondisclosure agreement.
 
On February 22, 2010, Dr. Goddard sent a letter to Mr. Nogimori (the text of this letter is attached as Exhibit (e)(27) to this Statement) stating that the Company’s Board was not interested in pursuing a sale of the Company to Astellas at the price at which Astellas had expressed interest in a transaction, given the OSI Board’s belief that the price very significantly undervalued the Company. The letter also stated that the Company would provide Astellas with certain non-public information that the Company believed was fundamental to understanding the value of OSI, subject to Astellas entering into a nondisclosure agreement, a proposed draft form of which was included with Dr. Goddard’s letter. Astellas never responded to the Company’s proposal, never asked to review any of the Company’s confidential information and never made any attempt to negotiate the terms of the draft nondisclosure agreement.


12

Table of Contents

 
On March 1, 2010, Astellas responded to the Company’s offer to provide confidential information by issuing a press release announcing that it would commence its unsolicited tender offer at $52.00 per Share and sending a letter to the Company notifying it of the unsolicited Offer. Later on March 1st, the Company’s Board met with members of management and the Company’s legal and financial advisors to discuss Astellas’ March 1st letter and its intention to commence an unsolicited tender offer.
 
On March 2, 2010, Astellas and Purchaser commenced the Offer.
 
  2.   Reasons for the Recommendation.
 
The Board has reviewed the Offer with the assistance of the Company’s management and legal and financial advisors and, after careful consideration, the Board has unanimously determined that the Offer is inadequate, substantially undervalues the Company and is not in the best interests of the Company and its stockholders. Accordingly, the Board recommends that stockholders REJECT THE OFFER and NOT TENDER their Shares pursuant to the Offer.
 
In reaching its determination to recommend that stockholders reject the Offer, the Board considered numerous factors, including, but not limited to, the following:
 
The Offer Does Not Fully Reflect OSI’s Fundamental, Intrinsic Value.
 
  •  The OSI Board believes that the Offer substantially undervalues the Company relative to its fundamental, intrinsic value. OSI’s flagship oncology drug, Tarceva, with approximately $1.2 billion of worldwide revenue in 2009, is one of the few blockbuster oncology drugs. As of March 12, 2010, Tarceva was approved for sale in 109 countries for the treatment of advanced non-small cell lung cancer, or NSCLC. The Company co-promotes Tarceva in the United States with Genentech, Inc., a wholly-owned member of the Roche Group, where the Company shares profits equally, and the Company receives substantial royalties on sales outside of the United States from its international collaborator, Roche. The exclusivity period for Tarceva (which is expected to range from 2019 to 2020 in the major U.S., European and Japanese markets) provides the Company with strategically valuable long-term cash flows.
 
  •  The Company’s overall financial performance has been extremely strong. OSI’s revenues were approximately $428 million for the fiscal year ended December 31, 2009, an increase of nearly 13% from the prior year, and non-GAAP net income from continuing operations increased to $181 million (or $2.89 per Share) in 2009, an increase of approximately 15% over the prior year. OSI also generates strong cash flow from operations, with $160 million of cash flow from operations generated in fiscal year 2009, resulting in approximately $540 million in cash, investments and marketable securities at fiscal year end. The Company’s overall revenue growth, derived from its share of global Tarceva sales, as well as from the Company’s dipeptyl peptidase IV inhibitor, or DPIV, patent estate, is projected to remain very strong. For a reconciliation of non-GAAP net income from continuing operations to net income from continuing operations and non-GAAP earnings per share to earnings per share for the period ended December 31, 2009, see the Company’s website, www.osip.com, or Exhibit 99.1 to the Company’s Current Report on Form 8-K filed with the SEC on February 23, 2010.
 
  •  In addition to its unique collection of highly attractive strategic assets, OSI has substantial financial assets, which at December 31, 2009, consisted of (i) significant DPIV patent royalties, (ii) approximately $540 million of cash, investments and marketable securities and (iii) substantial net operating loss carryforwards, that together the Company estimates are worth approximately $1.3 billion. This implies that Astellas’ Offer values the Company’s strategic assets at only $2.3 billion. The Board believes that the $2.3 billion value for the Company’s strategic assets implied by Astellas’ Offer significantly undervalues the Company’s highly desirable and scarce oncology and diabetes and obesity franchises.


13

Table of Contents

 
  •  As discussed in greater detail below, the Board also believes that fundamental aspects of the Company’s intrinsic value are not reflected in the Astellas Offer, including:
 
  °  the Company’s highly differentiated oncology and diabetes and obesity new product and line extension pipeline;
 
  °  the scarcity value of OSI’s growing, high quality, and profitable oncology franchise along with its proven track-record in discovering, developing and commercializing oncology products and the Company’s recognized leadership position in cancer biology and EMT research; and
 
  °  the value of OSI’s second profitable and high quality disease area franchise in diabetes and obesity, which has a proven track-record of success.
 
The Offer Does Not Appropriately Value the Company’s Highly Differentiated Oncology and Diabetes and Obesity New Product and Line Extension Pipeline.
 
  •  OSI’s clinical pipeline targets two of the highest growth and most attractive therapeutic areas where major unmet clinical need remains: (i) oncology and (ii) diabetes and obesity. The OSI Board believes that the Offer is valued nearly exclusively on the strength of OSI’s existing Tarceva franchise and the Company’s DPIV patent estate royalty stream and financial assets and offers no consideration to stockholders for the value of the Company’s new product pipeline or label expansion opportunities for Tarceva.
 
  •  OSI – together with its partner Roche – is committed to advancing a comprehensive development plan for Tarceva, which is expected to yield data and label expansion opportunities that will provide the basis for continued growth of the Company’s Tarceva related revenues throughout the patent exclusivity period. In addition to the Tarceva lifecycle plan, OSI focuses its development resources on advancing high quality and differentiated development assets. The Company’s leading development candidates are the IGF-1R/IR inhibitor, OSI-906, and the GPR119 agonist, PSN821. Both of these products have the potential to be blockbusters, “first-in-class” and/or “best-in-class” and are highly competitive in these much sought after target areas. In both cases the Company has invested heavily in a programmatic approach to drug discovery and development.
 
  °  Tarceva Lifecycle Plan: The Board expects that the Tarceva franchise will benefit from multiple label expansion opportunities over the next several years, starting with the pending FDA PDUFA date for the review of the SATURN study in support of a NSCLC first-line maintenance indication, which is expected on or about April 18, 2010. The Board believes, based on the Company’s ongoing dialogue with the FDA, that Tarceva will receive a label derived from the results of the SATURN study, which was conducted under the auspices of a Special Protocol Assessment agreement, or SPA, with the FDA. Over the next 18 months, the Company also expects to see interim and/or final results of the Phase III EURTAC study comparing the efficacy of Tarceva with chemotherapy in first-line NSCLC patients whose tumors harbor a mutation in the EGFR gene. Another key feature of the Tarceva lifecycle plan is the OSI-sponsored RADIANT study, which tests the use of Tarceva for NSCLC patients in the adjuvant setting and provides a key component of value in the latter stages of the Tarceva lifecycle plan. The Company also expects results from a series of other Phase III studies over the coming years that will demonstrate the add-on benefits of combining other molecular targeted therapies, or MTTs, in combination with Tarceva as compared to Tarceva alone. The Board expects that these studies will demonstrate further utility and extended duration of therapy for Tarceva use in NSCLC. In addition, Phase III data validating the potential utility of Tarceva in the treatment of ovarian cancer and hepatocellular carcinoma, or HCC, is expected over the next few years.


14

Table of Contents

 
  °  OSI-906: OSI-906 is a highly selective, small molecule inhibitor of both the Insulin-like Growth Factor Receptor 1, or IGF-1R, and the Insulin Receptor, or IR, that is currently undergoing Phase III trials in Adrenocorticoid Carcinoma, or ACC, and a Phase I/II trial in ovarian cancer. MTTs targeting IGF-1R signaling have been amongst the most sought after in oncology R&D. The Company expects, based upon its in-depth understanding of the cancer biology surrounding compensatory signaling mechanisms in cancer cells, that the co-inhibitory properties of OSI-906 in blocking both IGF-1R and IR signaling will result in superior anti-tumor activity for OSI-906 compared with competitor IGF-1R specific antibody products that have undergone clinical evaluation. A comprehensive development plan is being implemented for OSI-906 that will include the initiation of multiple Phase II and Phase III programs over the next 12 months, including trials in NSCLC, breast cancer, HCC and prostate cancer. The Phase III ACC trial and the HCC program are being pursued along with the proposed development of companion diagnostics measuring the IGF-2 ligand as a means to increase the probability of technical success for these programs by allowing the targeting of those patients whose tumors overexpress the IGF-2 ligand. Subsequent studies in colorectal cancer are also planned. OSI is also undertaking a number of studies intended to demonstrate the effectiveness of OSI-906 in combination with Tarceva in NSCLC including a Phase III trial for the first-line treatment of advanced NSCLC patients whose tumors harbor an EGFR mutation. The Company’s translational research efforts have identified a compensatory signaling connection between the IGF-1R/IR/EGFR receptors in NSCLC tumor models and the combination of Tarceva and OSI-906 has been shown to be particularly effective against epithelial-like tumors using the Company’s proprietary EMT models. The IGF-1R/OSI-906 development program is protected by an intellectual property estate comprising 56 issued and over 100 pending patents. The OSI Board believes that the OSI-906 program has a broad-based commercial potential that could exceed that of Tarceva.
 
  °  PSN821: The Company’s GPR119 agonist, PSN821, has the potential to be a break-through therapy in the treatment of type II diabetes. GPR119 agonists provide the possibility of combining substantial glucose lowering with meaningful weight loss in an oral agent and represent one of the most exciting new target areas in the field of type 2 diabetes. Oral GPR119 agonists represent a next generation approach to GLP-1 modulation which is currently addressed clinically by the use of exogenous GLP-1 peptide analogs (which provide effective glucose lowering and some weight loss, but are associated with nausea and vomiting) and DPIV inhibitors (which provide modest glucose lowering and no weight loss but are oral and well tolerated). Market research testing a target product profile of “effective glucose lowering and meaningful weight loss in an oral agent” indicates that this class has significant commercial potential and a premier, oral GPR119 agonist can reasonably be expected to have blockbuster potential. Preclinical data strongly supports the dual glycemic control/weight loss activity of PSN821. The agent is currently undergoing Phase IIa clinical trials and the clinical program to date has produced promising early proof-of-concept data demonstrating the ability to lower blood glucose in diabetic patients and, separately, the ability to impact accepted surrogates of weight loss in the form of standardized meal intake and visual analog scale measures of appetite in overweight and obese subjects. The Company has 5 granted and 175 pending patent cases protecting its GPR119 development program. The program is on-schedule to complete definitive Phase IIb studies in late 2011/early 2012 which are designed to provide 3-month HbA1c and weight loss data. The Board believes there is the potential for a significant increase in value at the time Phase IIb data is received on PSN821, as well as a subsequent opportunity – likely exploited in collaboration with a major pharmaceutical industry partner – arising from successful Phase III development and global commercialization.


15

Table of Contents

 
The Board believes that the Astellas Offer fails to appropriately recognize the significant value of the Tarceva lifecycle plan and the Company’s OSI-906 and PSN821 assets.
 
  •  Beyond OSI-906 and PSN821, the Company also has additional agents in clinical development, including:
 
  °  OSI-027: OSI-027’s ability to target both mTOR signaling complexes (TORC1 and TORC2) potentially allows it to supersede first generation mTOR inhibitors that only block signaling through the TORC1 complex. The agent’s mechanism of action may allow the Company to broadly target EMT mechanisms by blocking signaling in both epithelial-like and mesenchymal-like tumors cells. OSI-027 is currently progressing successfully through Phase I clinical trials and, if successful, is expected to have a broad-based spectrum of utility (including major tumor types). The Board believes that OSI-027 represents a valuable and differentiated pipeline asset, albeit at an earlier stage of development.
 
  °  PSN010: The Company’s second diabetes and obesity clinical pipeline asset is PSN010, an oral glucokinase activator, or GKA, discovered and developed by the Company’s diabetes and obesity team. GKAs have the potential to lower glucose concentrations to a greater extent than current oral agents for type 2 diabetes. The substantially greater glucose lowering potential of PSN010 is expected to represent a substantial commercial opportunity. OSI entered into a license agreement with Eli Lilly in January 2007, granting Eli Lilly exclusive rights to its GKA program. Under the terms of the license agreement, OSI could receive up to $360 million in potential development and commercial milestones, plus additional low-double digit percentage royalties, on sales of any compounds successfully commercialized from the program. Eli Lilly is currently at the Phase IIb development stage with PSN010 (LY2599506).
 
The Offer Does Not Recognize the Scarcity Value of OSI’s Growing, High Quality, and Profitable Oncology Franchise Along With Its Proven Track-Record in Discovering, Developing and Commercializing Oncology Products and the Company’s Recognized Leadership Position in Cancer Biology and EMT Research.
 
  •  The OSI Board believes that the Company’s integrated oncology franchise, which is currently being consolidated into a single wholly owned campus in Ardsley, New York, represents a unique asset in the mid-cap biotechnology arena based on the following factors:
 
  °  A profitable and growing oncology franchise anchored around Tarceva: OSI has a profitable and growing oncology business anchored around Tarceva, a product with global sales in excess of $1.2 billion annually and anticipated exclusivity in the major U.S., EU and Japanese markets through 2019-2020. These long-term projected cash flows provide an extraordinarily valuable anchoring asset around which to base a long-term strategy to build a leading oncology franchise.
 
  °  An experienced and capable commercial/business organization: The Company has built a high quality and scalable oncology commercial/business organization in the U.S. that includes experienced leadership, a nationwide sales force and a widely networked, state-of-the-art medical affairs organization. The Company’s sales and medical affairs organizations interface with the vast majority of key prescribers and Key Opinion Leaders (KOL’s) in the U.S. market. Achieved together with the Company’s partner Genentech, the Tarceva launch remains the most successful oncology product launch in U.S. history in terms of the number of patients treated in the first twelve months. Since that time, the Company has continued to invest in improving the infrastructure and capabilities of the business team.
 
  °  A pipeline approach that drives the development of differentiated MTTs: The Company has focused on a strategic personalized medicine approach to developing only


16

Table of Contents

  the most differentiated oncology assets and invests significantly in its prioritized drug development programs providing a framework of cancer biology/EMT knowledge and expertise, translational research, and diagnostic array technologies designed to enhance the probability of technical success of the Company’s programs. OSI has utilized its EMT platform to develop a unique set of gene-transcript based biomarkers that accurately predicts tumors that are sensitive or insensitive to a variety of MTTs, including Tarceva, OSI-906 and OSI-027, and has also developed multi-gene biomarkers, or gene signatures, that it intends to develop as companion diagnostics associated with OSI pipeline products. The OSI team believes that defining drug-response biomarkers early in the development of OSI pipeline programs affords a uniquely competitive advantage. The Company is also advancing a series of pre-clinical programs which target EMT related signaling biology directly (for example through co-inhibition of the cMet and Ron axes) and has partnered OSI-930, its c-kit/VEGFR inhibitor with the Chinese company Simcere for further development. The Board believes that OSI’s programmatic approach to oncology drug development emphasizes the value of the Company’s expansive cancer biology capabilities.
 
  °  Industry leading expertise in EMT: OSI has established a leadership position in understanding the biology of Epithelial-Mesenchymal Transition, or EMT. OSI has demonstrated the importance of EMT to the therapeutic activity of Tarceva and other MTTs (including OSI-906 and OSI-027) and has focused its oncology discovery efforts on exploiting its understanding of the signaling pathways and drug targets that drive EMT. The Company’s EMT Platform is comprised of proprietary in vitro and in vivo tumor models which undergo EMT and provide a contextual tumor/stromal cell environment for drug discovery; proprietary bioinformatics and biomarker discovery systems which are used to delineate response biomarkers for OSI’s clinical assets; and, specialized assays, biomarkers and tumor models. This EMT platform enables: (i) the discovery and validation of EMT-related targets as tumor growth and EMT drivers; (ii) the development of novel therapies and combinations of therapies against EMT-related targets; (iii) the delineation of pathways and combination strategies that address compensatory signaling as an EMT-associated drug-resistance mechanism; and (iv) the discovery and development of genomic, protein and transcript-based drug response biomarkers to support these programs. The Board believes that OSI’s EMT-focused oncology R&D program is a valuable and uniquely differentiated technology platform that cannot be readily reconstituted elsewhere. The Board further believes that these assets, along with the associated intellectual property, would be of appreciable value to any potential acquirer committed to developing a leadership position in oncology.
 
  °  A proven track-record of success based on an established high quality drug discovery infrastructure and know-how: The Company has a long-term, established and proven track-record of success in pioneering technological innovation and in conducting successful drug discovery, development, registration, and commercialization projects for oncology products. Tarceva was discovered as part of the Company’s targeted therapy cancer research collaboration with Pfizer and four other MTTs were advanced to clinical development from that collaboration. Since the termination of that alliance in 2000 when OSI’s independent drug discovery programs were initiated, the Company has advanced three high quality clinical development assets while simultaneously establishing its EMT, cancer biology and translational research platforms.
 
  •  The Board believes that OSI’s oncology organization is currently the only profitable franchise of its kind in mid-cap biotech. The oncology organization is built on a long-term foundation of strong science and that offers potential acquirers and strategic partners a full array of high quality and differentiated capabilities and know-how from discovery and cancer cell biology research through commercialization in the U.S. oncology market. As such, the Board believes that the


17

Table of Contents

  Offer does not provide adequate consideration to stockholders given the uniqueness and scarcity of OSI’s fully integrated and commercially successful oncology franchise.
 
The Offer Does Not Recognize the Value of OSI’s Second Profitable and High Quality Disease Area Franchise in Diabetes and Obesity, Which Has a Proven Track-Record of Success.
 
  •  Based within one of the United Kingdom’s established biotechnology hubs and occupying a wholly owned, state-of-the-art research and development facility, the Company’s diabetes and obesity franchise is a profitable business anchored around the Company’s DPIV patent estate revenue stream which was acquired from Probiodrug in 2004 as part of a $35 million assets acquisition. Twelve companies have acquired licenses to this estate which generated 2009 revenues of $67 million in milestones and royalties and provides a rapidly growing revenue source that is expected to increase by more than 30% in 2010. The Company’s estimated average royalty rate for 2010 and beyond accruing from the DPIV patent estate is likely to be approximately 2.5% and is estimated to produce greater than $1 billion of future cash flows.
 
  •  The DPIV revenue stream underpins a diabetes and obesity R&D strategic framework built around an integrated scientific platform focused on the neuroendocrine control of body weight and glycemia. The scientific platform is comprised of technologies providing specific biological readouts (including tissue expression profiling, neuroendocrine cell line functionality and ex vivo tissue applications) coupled with proprietary computational platforms utilizing, amongst others, the SD3 platform acquired from 7TM pharmaceuticals. The scientific platform is geared towards the identification, validation and discovery of Designed Multiple Ligands, or DMLs. These proprietary non-linker based “merged pharmacophore” agents derived from this unique platform are designed to have the ability to overcome the efficacy issues seen with many single target approaches. Consistent with both this platform approach and the Company’s programmatic approach to key development programs, a prototypical DML approach has currently advanced molecules comprising the features of a dual DPIV Inhibitor and GPR119 agonist into late-stage candidate seeking efforts.
 
  •  Beyond the platform focus of OSI’s discovery efforts, the Company’s diabetes and obesity group has a consistent track record of success over the last several years having advanced five drug candidates into clinical development, which included GPR119 agonists, GKAs, Serotonin Noradrenalin Receptor inhibitors and glycogen phosphorylase inhibitors. In addition, a dual adenosine A1/A2b receptor inhibitor, with potential utility in non-alcoholic fatty liver disease, is currently in late-stage preclinical evaluation. Each of these drug candidates was discovered and developed entirely in-house. The Board believes that the Astellas Offer assigns minimal, if any, value to the Company’s profitable and successful diabetes and obesity franchise.
 
Despite the Growth of the Company, Astellas’ Offer is Lower Than the Price Range in its Previous Inadequate Nonbinding Indication of Interest.
 
  •  Since February 2009, when Astellas first submitted a conditional nonbinding indication of interest to acquire the Company, OSI has had stronger financial performance, revenue and net income growth, an increased net cash position and advances in its pipeline. Other positive trends and developments in OSI’s business since the submission of Astellas’ prior nonbinding indication of interest, include:
 
  °  the continued momentum of global Tarceva sales and the positive recent clinical results relating to Tarceva, particularly in the context of first line NSCLC maintenance for patients with EGFR mutation;
 
  °  developments supporting the multiple future label and market expansion opportunities inherent in the Tarceva lifecycle plan, including the first line NSCLC maintenance label expansion expected for Tarceva;


18

Table of Contents

 
  °  the approval of OSI’s application to reissue the patent for Tarceva, which will help the Company manage generic challenges to the Tarceva patent estate, and the anticipated grant of pediatric patent term extensions for Tarceva that extend the Company’s U.S. patent for erlotinib to May 2019; and
 
  °  developments demonstrating the strength and long-term value creation potential of OSI’s research and development pipelines in oncology and diabetes and obesity, including the initiation of Phase III trials for OSI-906 in ACC and the demonstration of preliminary proof-of-concept data for PSN821 in man as a dual glucose lowering and weight loss inducing agent.
 
Despite this growth and positive performance, in the Offer, Astellas proposes to pay OSI stockholders even less for their Shares than the price range reflected in Astellas’ prior nonbinding indication of interest, which the OSI Board determined was inadequate and not in the best interests of OSI and its stockholders.
 
The Offer Represents a Low Revenue Multiple Compared to Recent, Precedent Oncology Transactions.
 
  •  Revenue multiples paid in recent oncology transactions were substantially higher than the revenue multiple implied by Astellas’ $52.00 per Share Offer. The forward year revenue multiple paid by Takeda Pharmaceutical Company Limited for Millennium Pharmaceuticals, Inc. was 13.5x, and the forward year revenue multiple paid by Eli Lilly and Company for ImClone Systems Incorporated was 7.8x. The revenue multiple implied by Astellas’ Offer for OSI is 6.3x, based on Wall Street estimates of OSI’s projected 2010 revenue, and the multiple implied by Astellas’ Offer for the Company’s strategic assets is 5.75x, based on an estimated value of the Company’s financial assets of approximately $1.3 billion. In addition, OSI has very high margin revenue that is composed of Tarceva profit share in the United States, Tarceva royalties from outside the United States and DPIV patent estate royalties. Oncology companies have historically commanded higher implied multiples than biotechnology companies and substantially higher multiples than pharmaceutical companies.
 
The Offer Values OSI at a Price Below Current Trading Levels.
 
  •  The market price of OSI common stock has remained above the Offer price of $52.00 per Share since the public announcement of the Offer on March 1, 2010. The closing price per Share on the NASDAQ Global Select Market on March 12, 2010, the last trading day prior to the date of this Statement, was $57.68 and the 10-day trailing average closing price per Share on the NASDAQ Global Select Market since the March 1st announcement of Astellas’ intention to commence the Offer was $56.92 per Share.
 
The Offer is Highly Conditional and Creates Substantial Uncertainty as to Whether Astellas Would be Required to Consummate the Offer.
 
  •  The Board considered the fact that the Offer is subject to numerous and subjective conditions. Many of these conditions are completely within the control, judgment, interpretation or discretion of Astellas. The effect of these conditions is that the Company’s stockholders cannot be assured that Astellas would consummate the Offer even if OSI’s Board of Directors recommended that stockholders accept the Offer and the Company satisfied all the conditions within its control. The Offer is subject to the satisfaction of each of the following conditions, in addition to numerous other conditions listed in its tender offer materials:
 
  °  Material Adverse Effect, or MAE, Condition. There has not been any event, condition, circumstance, change or effect that, in Astellas’ reasonable judgment, is or may be materially adverse with respect to the (a) value of the Company, its subsidiaries or its Shares to Astellas or (b) the business, assets, condition (financial or otherwise), results of operations or prospects of the Company.


19

Table of Contents

 
  °  Market MAE Condition. There has not been (a) any general suspension in trading in securities on any national securities exchange, (b) any decline in the Dow Jones Industrial Average, S&P or NASDAQ by an amount in excess of 15% measured from the close of business on March 1, 2010, (c) any change in the general political, market or economic conditions in the United States or abroad that, in Astellas’ reasonable judgment, could have a material adverse effect on the business, assets, liabilities, condition (financial or otherwise), results of operations or prospects of the Company, or in the trading or value of the Shares, (d) the declaration of a banking moratorium or any suspension of payments in respect of banks in the United States or Japan, (e) in Astellas’ reasonable judgment, any material adverse change (or development or threatened development involving a prospective material adverse change) in U.S., Japanese or any other currency exchange rates or a suspension of, or a limitation on, the markets therefor, (f) the commencement of a war, armed hostilities or other international or national calamity directly or indirectly involving the United States or Japan or any attack on, outbreak or act of terrorism involving the United States or Japan, (g) any limitation (whether or not mandatory) by any governmental authority on, or any other event that, in Astellas’ reasonable judgment, may adversely affect, the extension of credit by banks or other financial institutions or (h) in the case of any of the foregoing existing on March 2, 2010, a material acceleration or worsening thereof in Astellas’ reasonable judgment.
 
  °  No Impairment Condition. Astellas has not become aware of, as a result of the Offer or the consummation of the Proposed Merger, (a) any material contractual right of the Company that will be adversely affected or (b) any covenant, term or condition in any agreement or license, that in Astellas’ reasonable judgment, has or may have material adverse significance with respect to the value of the Company or the Shares to Astellas.
 
  °  Litigation Condition. No litigation has been publicly announced, instituted or is pending, and the Company has not received written notice of any person’s intent to commence various types of litigation, including litigation that, in the reasonable judgment of Astellas, is likely to delay or otherwise, directly or indirectly, to restrain or prohibit or make more costly the Offer, the acceptance for payment of any of the Shares or the consummation of the Proposed Merger or any other business combination involving the Company or litigation that, in the reasonable judgment of Astellas, has or may have material adverse significance with respect to the value of the Company, the value of the Shares to Astellas, Parent and the Purchaser or materially adversely affecting the business, assets, liabilities, condition, capitalization, operations, licenses, franchises, revenues, results of operations or prospects of the Company.
 
  •  Highly Conditional Offer. The effect of these, and other numerous conditions, is that the Company’s stockholders cannot be assured that Astellas will be required to consummate its Offer. A number of the conditions are broad, are of questionable relevance and are solely for the benefit of the Purchaser, Parent and Astellas. Compliance with some of these conditions could restrict the Company’s ability to manage its business in the ordinary course and may not be capable of being satisfied in the event that the Company continues to operate its business consistent with past practice. The litigation condition is sufficiently broad that Astellas may argue that the litigation currently pending against the Company as described in Item 8 under the heading “Litigation” may have already triggered the failure of this condition. Although the MAE condition and no impairment condition might be capable of being satisfied, they are drafted in extremely broad and general terms and Astellas has the sole discretion to decide whether those conditions, as well as all other conditions, have been met. Accordingly, even assuming that the numerous other conditions to the Offer could be satisfied, these conditions create significant uncertainty regarding whether Astellas would be required to consummate the Offer given that any number of otherwise insignificant events or circumstances could be deemed by Astellas to cause the condition not to be satisfied. Uncertainty as to the likelihood of consummation of the


20

Table of Contents

  Offer is of particular concern because pursuing a transaction would likely disrupt the Company’s business by causing uncertainty in current and potential employees, physicians and their patients, suppliers and other constituencies important to the Company’s success.
 
The Offer Is Financially Inadequate.
 
  •     The OSI Board has received separate oral opinions, confirmed by delivery of written opinions, dated March 12, 2010, from the Company’s financial advisors, Centerview Partners and Lazard Frères & Co. LLC (“Lazard”), as to the inadequacy, from a financial point of view and as of the date of such opinions, of the $52.00 per Share Offer price to holders of OSI common stock (other than Astellas, Parent, Purchaser and their respective affiliates). Please see the full text of each financial advisor’s written opinion, which are included as Annex A and Annex B, respectively, to this Statement. The opinions were provided to the Board (solely in its capacity as such) for its information in its evaluation of the Offer from a financial perspective and were based on and subject to certain assumptions, qualifications, limitations and other considerations. The opinions do not address any other aspect of the Offer or any related transactions and are not intended to constitute, and do not constitute, recommendations as to whether any stockholder should tender Shares in the Offer or as to any other matters.
 
The OSI Board of Directors has Instructed OSI’s Management, with the Assistance of OSI’s Financial Advisors, to Contact Other Parties.
 
In its efforts to maximize value for OSI stockholders, the Company has been actively exploring potential strategic transactions with third parties. The Company has been engaged in preliminary discussions with a number of other parties, including major pharmaceutical companies, regarding potential transactions that could provide significant long- or short-term value to OSI stockholders. At the Board’s meeting on March 12, 2010, the Board instructed OSI management, with the assistance of the Company’s financial advisors, Centerview Partners and Lazard, to contact appropriate third parties in order to explore the availability of a transaction that reflects the full intrinsic value of the Company. Third parties expressing legitimate interest in a transaction with OSI will be afforded an opportunity to engage in a due diligence review of certain OSI confidential information, subject to their entering into an appropriate nondisclosure agreement with the Company.
 
No assurance can be given as to whether any of these contacts will result in a proposed transaction, whether any transaction that may be proposed as a result of such process would be acceptable to the Company and its Board or whether any such proposed transaction will be announced or consummated. While the OSI Board has not made any decision to sell the Company, the OSI Board believes that the Offer must be evaluated against the Company’s well established long-term strategy for stockholder value creation and the prospect of other potential transactions which, if consummated, could yield greater long- or short-term value to stockholders than the Offer. Given that the Board believes that premature disclosure would jeopardize the Company’s ability to continue negotiations with respect to such a transaction, the Board has instructed management not to disclose the parties, nature or terms of any potential transaction, unless and until an agreement in principle or definitive agreement is signed, except as otherwise required by law.
 
Even Though OSI Offered Astellas Access to Confidential Due Diligence Information, Astellas Chose to Bypass Due Diligence and Commenced the Unsolicited Offer.
 
In his February 22, 2010 letter to Mr. Nogimori, Dr. Goddard, at the direction of the OSI Board, offered to provide Astellas with certain non-public information that the Company believed was fundamental to understanding the value of OSI. Despite the fact that in its prior nonbinding indication of interest Astellas had always insisted on a period of approximately two months to complete its due diligence investigation of OSI, Astellas never responded to Dr. Goddard’s February 22nd letter, nor did Astellas make any effort to negotiate the terms of the nondisclosure agreement included with Dr. Goddard’s letter. Rather, on March 1, 2010, Astellas publicly announced its intention to commence


21

Table of Contents

the unsolicited Offer. The Company remains willing to share confidential information with Astellas, as with other interested parties, subject to it entering into an appropriate nondisclosure agreement with the Company.
 
ACCORDINGLY, BASED ON THE FOREGOING, THE OSI BOARD UNANIMOUSLY RECOMMENDS THAT HOLDERS OF SHARES REJECT THE OFFER AND NOT TENDER THEIR SHARES PURSUANT TO THE OFFER.
 
The Board reserves the right to revise this recommendation in the event of changed circumstances, if any. Any such change in the recommendation of the Board will be communicated to stockholders as promptly as practicable in the event that such a determination is reached.
 
The foregoing discussion of the material factors considered by the Board is not intended to be exhaustive. In view of the variety of factors considered in connection with its evaluation of the Offer, the Board did not find it practicable to, and did not, quantify or otherwise assign relative weights to the factors summarized above in reaching its recommendation. In addition, individual members of the Board may have assigned different weights to different factors. After weighing all of these considerations, the Board unanimously rejected the terms of the Offer and recommended that holders of the Shares not tender their Shares pursuant to the Offer.
 
(c)     Intent to Tender.
 
To the Company’s knowledge, after making reasonable inquiry, none of the Company’s executive officers or directors currently intends to tender Shares into the Offer, or sell any Shares held of record or beneficially owned by them. As of the date of this Statement, none of the Company’s subsidiaries held of record or beneficially owned any Shares.
 
Item 5.  Persons/Assets, Retained, Employed, Compensated or Used
 
The Company has retained Centerview Partners and Lazard as the Company’s financial advisors in connection with the Offer and related matters. The Company has agreed to pay Centerview Partners a customary fee for its services, portions of which are payable upon its engagement and during the course thereof, a portion of which is payable in the event the Company remains independent and a significant portion of which is payable upon consummation of a sale of OSI, either as a result of the Offer or otherwise, based on the consideration payable in any such sale. The Company also has agreed to pay Lazard a customary fee for its services, portions of which are payable during the course of its engagement, a portion of which is payable in connection with the delivery of its opinion regarding the Offer price, a portion of which is payable upon any withdrawal of the Offer and a substantial portion of which is contingent upon the consummation of a sale of OSI, including as a result of the Offer or otherwise, based on the consideration payable in any such sale. In addition, the Company has agreed to reimburse Centerview Partners and Lazard for all reasonable expenses incurred by them, including fees and expenses of legal counsel, and to indemnify Centerview Partners, Lazard and related parties against certain liabilities arising out of such engagements, including certain liabilities under U.S. federal securities laws.
 
The Company has also hired MacKenzie Partners, Inc. (“MacKenzie Partners”) to assist it in connection with the Company’s communications with its stockholders with respect to the Offer. The Company has agreed to pay customary compensation to MacKenzie Partners for such services. In addition, the Company has agreed to reimburse MacKenzie Partners for its reasonable out-of-pocket expenses and to indemnify it and certain related persons against certain liabilities relating to or arising out of its engagement.
 
The Company has retained Joele Frank, Wilkinson Brimmer Katcher (“Joele Frank”) as its public relations advisor in connection with the Offer. The Company has agreed to pay Joele Frank customary compensation for such services. In addition, the Company has agreed to reimburse Joele Frank


22

Table of Contents

for its out-of-pocket expenses and to indemnify it against certain liabilities relating to or arising out of its engagement.
 
Except for MacKenzie Partners as set forth above, neither the Company nor any person acting on its behalf has or currently intends to employ, retain or compensate any person to make solicitations or recommendations to the Company’s stockholders with respect to the Offer.
 
Item 6.  Interest in Securities of the Subject Company.
 
Other than in the ordinary course of business in connection with the Company’s employee benefit plans, no transactions with respect to the Shares have been effected by the Company or, to the knowledge of the Company, by any of its executive officers, directors, affiliates or subsidiaries during the past 60 days, except for the following transactions:
 
                         
            Number
 		    Price Per
 		     
Name of Person
   
Transaction Date
   
of Shares
   
Share
   
Nature of Transaction
Joseph Klein
    1/21/10     1,000     $34.00     Acquisition of Shares pursuant to Company’s 10b5-1 trading plan adopted on November 25, 2009
                         
      1/25/10     1,000     $34.00     Acquisition of Shares pursuant to Company’s 10b5-1 trading plan adopted on November 25, 2009
                         
      2/1/10     1,000     $34.00     Acquisition of Shares pursuant to Company’s 10b5-1 trading plan adopted on November 25, 2009
                         
Colin Goddard
    3/1/10     66,000     $23.25     Acquisition in connection with exercise of options (scheduled to expire June 2010) pursuant to Company’s 10b5-1 trading plan adopted on November 7, 2009
                         
      3/1/10     66,000     $55.17(1)     Disposition pursuant to the Company’s 10b5-1 trading plan adopted on November 7, 2009
                         
Linda E. Amper
    3/1/10     7,370     $38.01     Acquisition in connection with exercise of options (scheduled to expire June 2012) pursuant to Company’s 10b5-1 trading plan adopted on November 24, 2008
                         
      3/1/10     8,499     $23.83     Acquisition in connection with exercise of options (scheduled to expire November 2012) pursuant to Company’s 10b5-1 trading plan adopted on November 24, 2008
                         
      3/1/10     15,869     $55.20(1)     Disposition pursuant to the Company’s 10b5-1 trading plan adopted on November 24, 2008
                         


23

Table of Contents

                         
                         
Gabriel Leung
    3/1/10     24,761     $23.85     Acquisition in connection with exercise of options (scheduled to expire May 2013) pursuant to Company’s 10b5-1 trading plan adopted on November 21, 2008
                         
      3/1/10     18,472     $30.74     Acquisition in connection with exercise of options (scheduled to expire June 2013) pursuant to Company’s 10b5-1 trading plan adopted on November 21, 2008
                         
      3/1/10     43,233     $55.37(1)     Disposition pursuant to the Company’s 10b5-1 trading plan adopted on November 21, 2008
                         
Anker Lundemose
    3/1/10     15,200     $35.10     Acquisition in connection with exercise of options (scheduled to expire February 2014) pursuant to Company’s 10b5-1 trading plan adopted on November 3, 2009
                         
      3/1/10     13,000     $29.77     Acquisition in connection with exercise of options (scheduled to expire June 2013) pursuant to Company’s 10b5-1 trading plan adopted on November 3, 2009
                         
      3/1/10     29,200     $55.20(1)     Disposition pursuant to the Company’s 10b5-1 trading plan adopted on November 3, 2009
                         
Barbara A. Wood
    3/1/10     20,000     $35.875     Acquisition in connection with exercise of options (scheduled to expire April 2011) pursuant to Company’s 10b5-1 trading plan adopted on November 20, 2008
                         
      3/1/10     20,000     $55.11(1)     Disposition pursuant to the Company’s 10b5-1 trading plan adopted on November 20, 2008
                         
 
 
(1) Price per Share represents the weighted average sale price with respect to such transaction.
 
Item 7.  Purposes of the Transaction and Plans or Proposals
 
For the reasons discussed in Item 4 “—Reasons for the Recommendation,” the Board has unanimously concluded that the Offer is inadequate, significantly undervalues the Company and is not in the best interests of the Company and its stockholders. Accordingly, and for the reasons described in more detail in Item 4, the Board unanimously recommends that holders of Shares reject the Offer and not tender their Shares pursuant to the Offer.
 
In its efforts to maximize value for OSI stockholders, the Company has been actively exploring potential strategic transactions with third parties. The Company has been engaged in preliminary discussions with a number of other parties, including major pharmaceutical companies, regarding potential transactions that could provide significant long- or short-term value to OSI shareholders. At the Board’s meeting on March 12, 2010, the Board instructed OSI management, with the assistance of the Company’s financial advisors, Centerview Partners and Lazard, to contact appropriate third parties in order to explore the availability of a transaction that reflects the full intrinsic value of the Company. Third parties expressing legitimate interest in a transaction with OSI will be afforded an opportunity to engage


24

Table of Contents

in a due diligence review of certain OSI confidential information, subject to their entering into an appropriate nondisclosure agreement with the Company.
 
Accordingly, the Board may engage in negotiations in response to the Offer that could have one of the effects specified in the paragraph below. The Company has determined that disclosure with respect to the parties to, and the possible terms of, any transactions or proposals of the type referred to in the preceding paragraph might jeopardize the discussions or negotiations that the Company may conduct. Therefore, the Company does not intend to disclose such negotiations in the future unless an agreement in principle has been reached or except where otherwise required by law.
 
Except as described above and as otherwise set forth in this Statement, the Company does not have any knowledge of any negotiations being undertaken or engaged in by the Company in response to the Offer that relate to or would result in (a) a tender offer for or other acquisition of the Company’s Shares by the Astellas, any subsidiary of the Astellas, or any other person; (b) any extraordinary transaction, such as a merger, reorganization, or liquidation, involving the Company or any subsidiary of the Company; (c) any purchase, sale, or transfer of a material amount of assets of the Company or any subsidiary of the Company; or (d) any material change in the present dividend rate or policy, indebtedness, or capitalization of the Company. Except as described above, to the knowledge of the Company, there are no transactions, resolutions of the Board, agreements in principle, or signed contracts in response to the Offer that relate to one or more of the events referred to in this paragraph.
 
Item 8.  Additional Information
 
State Anti-Takeover Laws – Delaware
 
As a Delaware corporation, the Company is subject to DGCL Section 203. Under DGCL Section 203, certain “business combinations” between a Delaware corporation whose stock is publicly traded or held of record by more than 2,000 stockholders and an “interested stockholder” are prohibited for a three-year period following the date that such a stockholder became an interested stockholder, unless (i) the corporation has elected in its original certificate of incorporation not to be governed by DGCL Section 203, (ii) the transaction in which the stockholder became an interested stockholder or the business combination was approved by the board of directors of the corporation before the other party to the business combination became an interested stockholder, (iii) upon consummation of the transaction that made it an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the commencement of the transaction (excluding voting stock owned by directors who are also officers or held in employee benefit plans in which the employees do not have a confidential right to tender or vote stock held by the plan) or (iv) the business combination was approved by the board of directors of the corporation and ratified by 662/3% of the outstanding voting stock which the interested stockholder did not own. The term “business combination” is defined generally to include mergers or consolidations between a Delaware corporation and an “interested stockholder,” transactions with an “interested stockholder” involving the assets or stock of the corporation or its majority owned subsidiaries and transactions which increase an “interested stockholder’s” percentage ownership of stock. The term “interested stockholder” is defined generally as a stockholder who, together with affiliates and associates, owns (or, within three years prior, did own) 15% or more of a Delaware corporation’s outstanding voting stock. It is a condition to the Offer that Purchaser is satisfied, in its reasonable judgment, that the provisions of DGCL Section 203 do not apply to the Offer.
 
State Anti-Takeover Laws-Other
 
A number of states have adopted laws and regulations that purport to apply to attempts to acquire corporations that are incorporated in such states, or whose business operations have substantial economic effects in such states, or which have substantial assets, security holders, employees, principal executive offices or principal places of business in such states. Purchaser has stated, in the section entitled “Certain Legal Matters; Regulatory Approvals” in its Offer to Purchase, that it has not attempted to comply with state takeover statutes in connection with the Offer. In the event that it is asserted that one or more state


25

Table of Contents

takeover statutes apply to the Offer, and it is not determined by an appropriate court that such statute or statutes do not apply or are invalid as applied to the Offer, as applicable, Purchaser may be required to file certain documents with, or receive approvals from, the relevant state authorities, and according to the Offer to Purchase, Purchaser might be unable to accept for payment or pay for Shares tendered pursuant to the Offer or be delayed in consummating the Offer. In such case, according to the Offer to Purchase, Purchaser may not be obligated to accept for payment, or pay for, any Shares tendered in the Offer.
 
Appraisal Rights
 
Holders of the Shares do not have appraisal rights in connection with the Offer because such holders are entitled to receive cash in exchange for any Shares tendered by them in the Offer. However, if a merger of the Company is consummated in which stockholders receive cash consideration for their Shares, stockholders who have neither voted in favor of the merger nor consented thereto in writing, who timely submit a demand for appraisal in accordance with Section 262 of the DGCL and who otherwise comply with the applicable statutory procedures under the DGCL will be entitled to receive a judicial determination of the fair value of the Shares (exclusive of any element of value arising from the accomplishment or expectation of such merger) and to receive payment of such fair value in cash (all such Shares, the “Dissenting Shares”). Any such judicial determination of the fair value of the Dissenting Shares could be based upon considerations other than or in addition to the price paid in the Offer and the market value of the Shares. The value so determined could be higher or lower than, or the same as, the price per Share paid pursuant to the Offer or the consideration paid in such a merger. Investment banking opinions as to the adequacy or fairness from a financial point of view of the consideration payable in a sale transaction, such as the Offer or the Proposed Merger, are not opinions as to fair value under Section 262 of the DGCL. Moreover, Astellas, Parent and Purchaser could argue in an appraisal proceeding that, for purposes of such a proceeding, the fair value of the Dissenting Shares is less than the price paid in the Offer. In the event that any holder of Shares who demands appraisal under Section 262 of the DGCL fails to perfect, or effectively withdraws or loses his rights to appraisal as provided in the DGCL, the Shares of such stockholder will be converted into the right to receive the Offer price. Failure to follow the steps required by Section 262 of the DGCL for perfecting appraisal rights may result in the loss of such rights.
 
The foregoing summary of the rights of stockholders seeking appraisal rights under Delaware law does not purport to be a complete statement of the procedures to be followed by stockholders desiring to exercise any appraisal rights available thereunder and is qualified in its entirety by reference to Section 262 of the DGCL. The perfection of appraisal rights requires strict adherence to the applicable provisions of the DGCL. If a stockholder withdraws or loses his right to appraisal, such stockholder will only be entitled to receive the price per Share paid in the Offer.
 
Rights Agreement
 
The Company is a party to the Rights Agreement, the purpose of which is to protect the Company’s stockholders against unsolicited attempts to acquire control of the Company that do not offer a fair price to its stockholders as determined by the OSI Board. On September 27, 2000, the OSI Board declared a dividend distribution of one Series SRPA Junior Participating Preferred Stock Purchase Right on each outstanding share of Common Stock. The Company distributed Rights to all shareholders of record at the close of business on September 27, 2000, the record date. The Rights entitle the holder to buy one one-thousandth of a share of Series SRPA Junior Participating Preferred Stock (the “Preferred Stock”) upon a triggering event as discussed below. The Rights are not exercisable until the “Distribution Date,” which is the earlier of (i) the date which is 10 days (or such later date as the OSI Board may determine) after the commencement of, or first public announcement of an intention to make, a tender or exchange offer by any person the consummation of which would result in such person becoming an Acquiring Person (defined below) or (ii) the date of the first public announcement that a person has acquired, or obtained the right to acquire, otherwise than pursuant to a Permitted Offer (as defined below), beneficial ownership of 17.5% or more of the outstanding shares of Common Stock. A person


26

Table of Contents

whose acquisition of shares of Common Stock causes a Distribution Date to occur pursuant to the foregoing clause (ii) is an “Acquiring Person.” The Rights will expire at the close of business on August 31, 2010, unless earlier redeemed by the Company as described below.
 
In the event that any person becomes an Acquiring Person (otherwise than pursuant to a Permitted Offer), the Rights will be modified automatically so that each holder of a Right will thereafter have, in lieu of the right to purchase shares of Preferred Stock, the right (the “Flip-In Right”) to receive upon exercise of the Right the number of shares of Common Stock which, immediately before such Acquiring Person became an Acquiring Person, had a market value equal to twice the amount of the exercise price of the Right. Notwithstanding the foregoing, after such person shall have become an Acquiring Person, all Rights that are, or under certain circumstances specified in the Rights Agreement were, beneficially owned by any Acquiring Person or any affiliate or associate thereof will be null and void. A “Permitted Offer” is a tender or exchange offer which is for all outstanding shares of Common Stock at a price and on terms which the OSI Board determines to be adequate and in the best interests of the Company, its stockholders and other relevant constituencies, other than such Acquiring Person, its affiliates and associates.
 
In the event that, at any time after a person has become an Acquiring Person, (i) the Company is acquired in a merger or other business combination in which the holders of all of the outstanding shares of Common Stock immediately prior to the consummation of the transaction are not the holders of all of the surviving corporation’s voting power or (ii) more than 50% of the Company’s assets or earning power is sold or transferred, in either case with or to an Acquiring Person or any affiliate or associate thereof or any other person in which such Acquiring Person, affiliate or associate has an interest or any person acting on behalf of or in concert with such Acquiring Person (or, if in such transaction all holders of shares of Common Stock are not treated alike, any other person), then each holder of a Right (except Rights which previously have become null and void as set forth above) shall thereafter have the right (the “Flip-Over Right”) to receive, upon exercise of the Right, shares of Common Stock of the acquiring company having a value equal to twice the amount of the exercise price of the Right. Each such holder of a Right will continue to have a Flip-Over Right whether or not such holder exercises or surrenders the Flip-In Right, and such holder will have a successive Flip-Over Right on each occurrence of a transaction specified in the first sentence of this paragraph.
 
At any time before a person becomes an Acquiring Person, the Company may redeem the Rights in whole, but not in part, at a price of $.001 per Right (the “Redemption Price”). Immediately upon the action of the OSI Board ordering redemption of the Rights, the right to exercise the Rights will terminate and the only right of the holders of Rights will be to receive the Redemption Price. Each share of Preferred Stock will have 1,000 votes, voting together with the Common Stock. In the event of any merger, consolidation or other transaction in which shares of Common Stock are exchanged for or converted into other stock or securities, cash or other property, each share of Preferred Stock will be entitled to receive 1,000 times the amount received per share of Common Stock.
 
On March 10, 2010, the OSI Board determined, as permitted by the Rights Agreement, to postpone the Distribution Date until such later date as the OSI Board shall determine.
 
The foregoing summary description of the Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the Rights Agreement, including Terms of Series SRP Junior Participating Preferred Stock (Exhibit A thereto), Summary of Rights to Purchase Preferred Stock (Exhibit B thereto) and Form of Right Certificate (Exhibit C thereto), a copy of which was previously filed as Exhibits 1, 2, 3 and 4 to the Company’s Registration Statement on Form 8-A filed on September 27, 2000, and is incorporated herein by reference.
 
Antitrust
 
Under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”) and the rules that have been promulgated thereunder by the Federal Trade Commission (the “FTC”) and the Antitrust Division of the Department of Justice (“DOJ”), certain acquisition transactions may not be


27

Table of Contents

consummated unless certain information has been furnished to the DOJ and the FTC and certain waiting period requirements have been satisfied. The purchase of Shares pursuant to the Offer is subject to such requirements.
 
Under the provisions of the HSR Act applicable to the purchase of Shares pursuant to the Offer, such purchase may not be made until the expiration of a 15-calendar day waiting period following the required filing of a Notification Report Form under the HSR Act by Purchaser.
 
As a result, the waiting period applicable to the purchase of Shares pursuant to the Offer will expire at 11:59 p.m., New York City time, 15-calendar days following Purchaser’s HSR filing, unless early termination of the waiting period is granted by the FTC and the DOJ or Astellas receives a request for additional information or documentary material prior thereto. If such a request is made to Astellas, the waiting period will be extended until 11:59 p.m., New York City time, 10 calendar days after Astellas’ substantial compliance with such request unless terminated earlier by the FTC and the DOJ. If such a request is issued, the purchase of and payment for Shares pursuant to the Offer will be deferred until the additional waiting period expires or is terminated. Thereafter, such waiting period can be extended only by court order or by Astellas’ voluntary agreement.
 
Astellas indicated in its Schedule TO that, as permitted under the HSR Act, it expects to request early termination of the initial waiting period applicable to the Offer. There can be no assurance, however, that the 15-calendar day HSR Act waiting period will be terminated early. Shares will not be accepted for payment or paid for pursuant to the Offer until the expiration or earlier termination of the applicable waiting period under the HSR Act. Subject to certain circumstances described in the Offer, any extension of the waiting period will not give rise to any withdrawal rights not otherwise provided for by applicable law. If Purchaser’s acquisition of Shares is delayed pursuant to a formal request by the DOJ or the FTC for additional information and documentary material pursuant to the HSR Act, the Offer may, but need not, be extended.
 
The DOJ and the FTC frequently scrutinize the legality under the antitrust laws of transactions such as Purchaser’s acquisition of Shares pursuant to the Offer. At any time before or after the consummation of any such transactions, the DOJ or the FTC could take such action under the antitrust laws as it deems necessary or desirable in the public interest, including seeking to enjoin the purchase of Shares pursuant to the Offer or seeking actions under the antitrust laws to enjoin consummation of the Offer. Private parties who may be adversely affected by the proposed transaction and individual states may also bring legal actions under the antitrust laws. There can be no assurance that a challenge to the Offer on antitrust grounds will not be made, or if such a challenge is made, what the result will be.
 
Litigation
 
On March 1, 2010, Parent filed a lawsuit against the Company and each of the members of the OSI Board (the “Director Defendants”) in the Delaware Court of Chancery captioned Astellas US Holding, Inc. v. OSI Pharmaceuticals, Inc., et al. The complaint alleges that the Director Defendants breached and are breaching their fiduciary duties by failing to adequately consider the Offer.
 
Specifically, the lawsuit alleges that the Director Defendants did not undertake sufficient investigation of Parent’s acquisition proposals and refused to engage in a meaningful dialogue with Parent concerning those proposals. The lawsuit further alleges that the Director Defendants took these actions in order to protect their positions with OSI. The complaint seeks declaratory and injunctive relief to prevent the Director Defendants from using the Rights Agreement and Section 203 of the DGCL to preclude or deter the Offer.
 
Subsequently, three purported stockholders of the Company filed suits against the Director Defendants captioned Chazen v. OSI Pharmaceuticals, Inc., et al., filed March 5, 2010, Louisiana Municipal Police Employee’ Retirement System v. Ingram et al., filed March 8, 2010, and Southeastern Pennsylvania Transportation Authority v. Ingram et al., filed March 12, 2010. The Chazen and Southeastern Pennsylvania Transportation Authority suits also named OSI as a defendant, but do not


28

Table of Contents

expressly state any claim against the Company. The stockholder suits make similar allegations to Parent’s suit and seek similar declaratory and injunctive relief. In addition, the stockholder suits seek monetary damages. On March 10, 2010, the plaintiff in the Chazen suit filed a Motion for Expedited Trial on the Merits requesting a trial within 90 days. A hearing was held on March 12, 2010 in which the Delaware Court of Chancery deferred consideration of the motion and ordered that status reports be submitted on March 19, 2010.
 
The Company believes the claims asserted are without merit and intends to vigorously defend against these suits.
 
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
 
This Solicitation/Recommendation Statement on Schedule 14D-9 contains forward-looking statements (as defined in Section 21E of the Exchange Act) that involve risks and uncertainties that could cause actual results to differ materially from projected results. Accordingly, investors should not place undue reliance on forward-looking statements as a prediction of actual results. The forward-looking statements may include projections and estimates concerning the timing and success of specific projects and the Company’s future production, revenues, income and capital spending. When this Statement uses the words “believe,” “intend,” “expect,” “may,” “should,” “anticipate,” “could,” “estimate,” “plan,” “predict,” “project,” or their negatives, or other similar expressions, the statements which include those words are usually forward-looking statements. When strategy that involves risks or uncertainties is described, forward-looking statements are being made. The forward-looking statements in this Solicitation/Recommendation Statement on Schedule 14D-9 speak only as of the date of this Solicitation/Recommendation Statement on Schedule 14D-9; the Company disclaims any obligation to update these statements unless required by securities law, and the Company cautions you not to rely on them unduly. The Company based these forward-looking statements on its current expectations and assumptions about future events. While the Company’s management considers these expectations and assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory and other risks, contingencies, and uncertainties, most of which are difficult to predict and many of which are beyond the Company’s control. These risks, contingencies and uncertainties relate to, among other matters, the following:
 
  •     risks and uncertainties associated with the Offer;
  •     the outcome of any litigation related to the Offer or any other offer or proposal;
  •     the Board’s recommendation to the stockholders concerning the Offer or any other offer or proposal;
  •     OSI’s and its collaborators’ abilities to effectively market and sell Tarceva and to expand the approved indications for Tarceva;
  •     OSI’s ability to protect its intellectual property rights;
  •     safety concerns regarding Tarceva;
  •     competition to Tarceva and OSI’s drug candidates from other biotechnology and pharmaceutical companies;
  •     the completion of clinical trials;
  •     the effects of FDA and other governmental regulation, including pricing controls; and
  •     OSI’s ability to successfully develop and commercialize drug candidates.
 
These and other factors are discussed on the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009, under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in such Form 10-K.
 
Additional information concerning factors that could cause results to differ materially from those in the forward-looking statements are contained in the Company’s filings with the United States Securities and Exchange Commission and especially in the sections therein entitled “Risk Factors,” including, but not limited to, the Company’s Annual Report on Form 10-K, for the fiscal year ended December 31, 2009.


29

Table of Contents

 
Item 9.  Exhibits
 
The following exhibits are filed with this Statement:
 
     
Exhibit
 		   
No.   Description
 
     
(a)(1)
  Letter to the Company’s stockholders dated March 15, 2010.
     
(a)(2)
  Press Release issued by the Company on March 15, 2010.
     
(a)(3)
  Letter to Company’s employees dated March 15, 2010.
     
(a)(4)
  Employee Frequently Asked Questions Information distributed on March 15, 2010.
     
(a)(5)
  Slide presentation dated March 2010 to be used in connection with investor meetings.
     
(e)(1)
  Excerpts from the Company’s Definitive Proxy Statement on Schedule 14A, filed by the Company on April 29, 2009 (file no. 005-37954), and incorporated herein by reference.
     
(e)(2)
  License Agreement, dated as of December 25, 2003, between Fujisawa Pharmaceutical Co., Ltd. and the Company.
     
(e)(3)
  1997 Incentive and Non-Qualified Stock Option Plan, filed by the Company as an exhibit to the registration statement on Form S-8, filed on November 4, 1997 (file no. 333-39509), and incorporated herein by reference.
     
(e)(4)
  1999 Incentive and Non-Qualified Stock Option Plan, as amended, filed by the Company as an exhibit to the Form 10-Q for the quarter ended September 30, 2006 (file no. 000-15190), and incorporated herein by reference.
     
(e)(5)
  Amended and Restated Stock Incentive Plan, as amended, filed by the Company as an exhibit to the Form 10-Q for the quarter ended September 30, 2007 (file no. 000-15190), and incorporated herein by reference.
     
(e)(6)
  Employment Agreement, dated June 14, 2006, by and between OSI Pharmaceuticals, Inc. and Colin Goddard, Ph.D., as amended on June 21, 2006, filed by the Company as an exhibit to the Form 8-K filed on June 22, 2006 (file no. 000-15190), and incorporated herein by reference.
     
(e)(7)
  Amendment to Employment Agreement, dated December 18, 2008, by and between OSI Pharmaceuticals, Inc. and Colin Goddard, Ph.D., filed by the Company as an exhibit to the Form 10-K for the fiscal year ended December 31, 2008 (file no. 000-15190), and incorporated herein by reference.
     
(e)(8)
  Employment Agreement, dated December 16, 2008, by and between OSI Pharmaceuticals, Inc. and Pierre Legault, filed by the Company as an exhibit to the Form 8-K filed on December 16, 2008 (file no. 000-15190), and incorporated herein by reference.
     
(e)(9)
  Employment Agreement, dated May 16, 2003, by and between OSI Pharmaceuticals, Inc. and Gabriel Leung, filed by the Company as an exhibit to the Form 10-K for the fiscal year ended September 30, 2003 (file no. 000-15190), and incorporated herein by reference.
     
(e)(10)
  Addendum to Employment Agreement, dated January 5, 2004, by and between OSI Pharmaceuticals, Inc. and Gabriel Leung, filed by the Company as an exhibit to the Form 10-QT for the transition period ended December 31, 2004 (file no. 000-15190), and incorporated herein by reference.


30

Table of Contents

     
     
(e)(11)
  Amendment to Employment Agreement, dated December 18, 2008, by and between OSI Pharmaceuticals, Inc. and Gabriel Leung, filed by the Company as an exhibit to the Form 10-K for the fiscal year ended December 31, 2008 (file no. 000-15190), and incorporated herein by reference.
     
(e)(12)
  Service Contract, dated September 20, 2005, by and between OSI Pharmaceuticals, Inc. and Dr. Anker Lundemose, filed by the Company as an exhibit to the Form 8-K filed on September 26, 2005 (file no. 000-15190), and incorporated herein by reference.
     
(e)(13)
  Letter Agreement, dated November 15, 2001, by and between OSI Pharmaceuticals, Inc. and Mr. Robert L. Simon filed by the Company as an exhibit to the Form 10-Q for the quarter ended March 31, 2005 (file no. 000-15190), and incorporated herein by reference.
     
(e)(14)
  Amended Letter Agreement, dated September 20, 2005, by and between OSI Pharmaceuticals, Inc. and Robert L. Simon, filed by the Company as an exhibit to the Form 8-K filed on September 26, 2005 (file no. 000-15190), and incorporated herein by reference.
     
(e)(15)
  Amendment to Letter Agreement, dated December 18, 2008, by and between OSI Pharmaceuticals, Inc. and Robert L. Simon, filed by the Company as an exhibit to the Form 10-K for the fiscal year ended December 31, 2008 (file no. 000-15190), and incorporated herein by reference.
     
(e)(16)
  Change in Control Arrangement, dated October 4, 2001, as amended and restated on December 4, 2007, by and between OSI Pharmaceuticals, Inc. and Linda E. Amper, filed by the Company as an exhibit to the Form 10-K for the fiscal year ended December 31, 2007 (file no. 000-15190), and incorporated herein by reference.
     
(e)(17)
  Amendment to Change in Control Arrangement, dated December 18, 2008, by and between OSI Pharmaceuticals, Inc. and Linda E. Amper, filed by the Company as an exhibit to the Form 10-K for the fiscal year ended December 31, 2008 (file no. 000-15190), and incorporated herein by reference.
     
(e)(18)
  Change of Control Arrangement, dated on October 4, 2001, as amended on September 20, 2005, by and between OSI Pharmaceuticals, Inc. and Barbara A. Wood, Esq. filed by the Company as an exhibit to the Form 8-K filed on September 26, 2005 (file no. 000-15190), and incorporated herein by reference.
     
(e)(19)
  Amendment to Change of Control Arrangement, dated December 18, 2008, by and between OSI Pharmaceuticals, Inc. and Barbara A. Wood, Esq., filed by the Company as an exhibit to the Form 10-K for the fiscal year ended December 31, 2008 (file no. 000-15190), and incorporated herein by reference.
     
(e)(20)
  Employment Agreement, dated March 2, 2005, between Prosidion Limited and Dr. Jonathan Rachman, filed by the Company as an exhibit to the Form 10-K for the fiscal year ended December 31, 2009 (file no. 000-15190), and incorporated herein by reference.
     
(e)(21)
  Stock Option Agreement, dated January 22, 2010, between the Company and Dr. Jonathan Rachman, filed by the Company as an exhibit to the Form 10-K for the fiscal year ended December 31, 2009 (file no. 000-15190), and incorporated herein by reference.

31

Table of Contents

     
     
(e)(22)
  Restricted Stock Unit Agreement, dated January 22, 2010, between the Company and Dr. Jonathan Rachman, filed by the Company as an exhibit to the Form 10-K for the fiscal year ended December 31, 2009 (file no. 000-15190), and incorporated herein by reference.
     
(e)(23)
  Restated Certificate of Incorporation of OSI Pharmaceuticals, Inc., filed by the Company as an exhibit to the Form 10-K for the fiscal year ended September 30, 2001 (file no. 000-15190), and incorporated herein by reference.
     
(e)(24)
  Letter to Dr. Colin Goddard from Mr. Masafumi Nogimori dated February 2, 2009.
     
(e)(25)
  Letter to Mr. Masafumi Nogimori from Dr. Colin Goddard dated February 5, 2009.
     
(e)(26)
  Letter to Mr. Masafumi Nogimori from Dr. Colin Goddard dated February 19, 2009.
     
(e)(27)
  Letter to Mr. Masafumi Nogimori from Dr. Colin Goddard dated February 22, 2010.

32

Table of Contents

 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
OSI PHARMACEUTICALS, INC.
 
  By: 
/s/  Barbara A. Wood
Name: Barbara A. Wood
Title: Senior Vice President, General
Counsel and Secretary
 
Dated: March 15, 2010

Table of Contents

Annex A
 
[LETTERHEAD OF CENTERVIEW PARTNERS LLC]
 
March 12, 2010
Board of Directors
OSI Pharmaceuticals, Inc.
41 Pinelawn Road
Melville, New York 11747
 
Members of the Board:
 
 
You have asked us to advise you with respect to the adequacy, from a financial point of view, of the consideration proposed to be paid in the Offer (as defined below) to the holders of shares of the common stock, par value $0.01 per share, of OSI Pharmaceuticals, Inc. (“OSI” and, such common stock, “OSI Common Stock”), other than Astellas Pharma Inc. (“Astellas”), Astellas US Holding, Inc., a wholly owned subsidiary of Astellas (“Astellas Holding”), Ruby Acquisition, Inc., a wholly owned subsidiary of Astellas Holding (“Offeror”), and their respective affiliates (collectively, the “Astellas Parties”). Subject to the satisfaction of certain conditions as set forth in the offer to purchase and related letter of transmittal, each attached as exhibits to the Tender Offer Statement on Schedule TO filed on March 2, 2010, as amended to date, by Astellas, Astellas Holding and Offeror with respect to the Offer (collectively, the “Offer Documents”), Offeror has commenced an offer to purchase all outstanding shares of OSI Common Stock at a price of $52.00 per share in cash (the “Consideration” and, such offer, the “Offer”) and, subsequent to completion of the Offer, Astellas intends to cause the Offeror or another of its subsidiaries to consummate a merger with OSI in which each outstanding share of OSI Common Stock not previously tendered in the Offer would be converted into the right to receive the Consideration (the “Merger” and, together with the Offer, the “Transaction”). The terms and conditions of the Transaction are set forth in more detail in the Offer Documents.
 
 
In connection with rendering our opinion, we have reviewed, among other things, the Offer Documents and drafts of the Solicitation/Recommendation Statement on Schedule 14D-9 to be filed by OSI relating to the Offer (the “Schedule 14D-9”). We also have reviewed and analyzed certain publicly available business and financial information relating to OSI, including OSI’s audited financial statements as of and for the year ended December 31, 2009, certain publicly available research analysts’ estimates, and certain internal financial and operating information relating to OSI, including financial forecasts, analyses and projections prepared by or on behalf of OSI and provided to us for purposes of our analysis, and we have met with management of OSI to review and discuss such information and, among other matters, OSI’s business, operations, assets, financial condition and future prospects.
 
 
We also have reviewed and considered certain financial and stock market data relating to OSI, and we have compared that data with similar data for certain other companies, the securities of which are publicly traded, that we believe may be relevant or comparable in certain respects to OSI or one or more of its businesses or assets, and we have reviewed and considered the financial terms of certain business combinations in the biotechnology and specialty pharmaceuticals industries. We further have reviewed historical stock prices and trading volumes of OSI Common Stock. In addition, we have performed such other financial studies, analyses, and investigations and reviewed such other information as we considered appropriate for purposes of this opinion.
 
 
In our review and analysis and in formulating our opinion, we have assumed and relied upon the accuracy and completeness of all of the historical financial and other information provided to or discussed with us or publicly available, and we have not assumed any responsibility for independent verification of any of such information. We also have assumed that the internal projections, forecasts and analyses relating to

Table of Contents

Board of Directors
OSI Pharmaceuticals, Inc.
March 12, 2010
Page 2
 
 
OSI were reasonably prepared in good faith and on bases reflecting the best currently available judgments and estimates of OSI’s management. We express no opinion with respect to any projections, forecasts, analyses and estimates reviewed by us or the assumptions upon which they are based. We also have relied, with OSI’s consent, on the assessments of OSI’s management as to the validity of, and risks associated with, the products, product candidates and technology of OSI (including, without limitation, the timing and probability of successful development, testing and marketing of such products, product candidates and technology, approval thereof by appropriate governmental authorities and the validity and life of patents relating thereto). In addition, we have not reviewed any of the books and records of OSI, or assumed any responsibility for conducting a physical inspection of the properties or facilities of OSI or for making or obtaining an independent valuation or appraisal of the assets or liabilities (contingent or otherwise) of OSI or concerning the solvency or fair value of OSI and no such independent valuation or appraisal was provided to us. We have assumed that the Transaction, if consummated, would be completed as described in the Offer Documents. We also have assumed, with OSI’s consent, that the Schedule 14D-9, when filed, will conform to the last draft reviewed by us in all material respects. In addition, we have assumed, with OSI’s consent, that obtaining the necessary governmental, regulatory or third party approvals and consents for the Transaction would not have an adverse effect on OSI or the Transaction. We do not express any opinion as to any tax or other consequences that might result from the Transaction, nor does our opinion address any legal, tax, regulatory or accounting matters, as to which we understand that OSI obtained such advice as it deemed necessary from qualified professionals.
 
 
Centerview Partners LLC (“Centerview”) is acting as financial advisor to OSI in connection with the Transaction. OSI has agreed to pay us certain fees for our services, portions of which are payable during the course of our engagement, a portion of which is payable in the event OSI remains independent and a significant portion of which is payable upon consummation of a sale of OSI, either as a result of the Transaction or otherwise. In addition, OSI has agreed to reimburse our expenses and indemnify us against certain liabilities arising out of our engagement. We may provide investment banking and other financial services to OSI, Astellas or their respective affiliates in the future, for which we may receive compensation. Centerview has not been engaged to act as an agent or a fiduciary of OSI, any of its affiliates or its stockholders. In the ordinary course of our business, Centerview or its affiliates may, from time to time, make a market in, have a long or short position in, buy and sell or otherwise effect transactions for customer accounts and for our own accounts in securities or loans of, or perform investment banking, commercial lending or other services for, OSI, Astellas and other entities which are or may be involved in the Transaction. The issuance of this opinion was approved by an authorized internal committee.
 
 
In connection with our engagement and prior to the date hereof, we were not authorized to, and we did not, solicit indications of interest from Astellas or other third parties regarding a potential transaction with OSI. We also were not requested to consider, and our opinion does not address, the relative merits of the Transaction as compared to any strategic alternatives that may be available to OSI or the underlying business decision of OSI with respect to the Offer. This opinion addresses only the adequacy from a financial point of view, as of the date hereof, of the Consideration proposed to be paid to the holders of OSI Common Stock (other than the Astellas Parties) pursuant to the Offer and no view or opinion is expressed as to any other terms or any aspects or implications of the Transaction, including, without limitation, the form or structure of the Transaction. We express no opinion as to the fairness of the amount or nature of, or any other aspects relating to, the compensation to any officers, directors or employees of any parties to the Transaction, or class of such persons, relative to the Consideration or otherwise. We also are not expressing any opinion as to the prices at which the OSI Common Stock will trade at any time. Our opinion is necessarily based

Table of Contents

Board of Directors
OSI Pharmaceuticals, Inc.
March 12, 2010
Page 3
 
 
on economic, monetary, market and other conditions as in effect on, and the information made available to us as of, the date hereof and we assume no responsibility for updating, revising or reaffirming this opinion based on circumstances, developments or events occurring after the date hereof.
 
 
It is understood that our advisory services and the opinion expressed herein are provided for the information and benefit of the Board of Directors of OSI (solely in its capacity as such) in connection with its evaluation of the Offer. This opinion is not intended to and does not constitute a recommendation as to whether or not any holders of OSI Common Stock should tender such OSI Common Stock in the Offer or how to vote or act with respect to the Transaction or any other matter.
 
 
Based upon and subject to the foregoing, including the various assumptions and limitations set forth herein, it is our opinion that, as of the date hereof, the Consideration proposed to be paid in the Offer to the holders of OSI Common Stock (other than the Astellas Parties) is inadequate to such holders from a financial point of view.
 
Very truly yours,
 
/s/  Centerview Partners LLC
Centerview Partners LLC

Table of Contents

Annex B
 
[LETTERHEAD OF LAZARD FRÈRES & CO. LLC]
 
March 12, 2010
The Board of Directors
OSI Pharmaceuticals, Inc.
41 Pinelawn Road
Melville, New York 11747
 
Dear Members of the Board:
 
 
We understand that Astellas Pharma Inc., a corporation formed under the laws of Japan (“Astellas”), Astellas US Holding, Inc., a Delaware corporation and wholly owned subsidiary of Astellas (“Astellas Holding”), and Ruby Acquisition, Inc., a Delaware corporation and wholly owned subsidiary of Astellas Holding (“Offeror”), have commenced an offer to acquire OSI Pharmaceuticals, Inc., a Delaware corporation (“OSI”). Subject to the terms and conditions set forth in the Offer Documents (as defined below), Offeror has commenced a tender offer (the “Offer”) to purchase all outstanding shares of the common stock, par value $0.01 per share, of OSI (“OSI Common Stock”) at a purchase price of $52.00 per share in cash (the “Consideration”) and, subsequent to the consummation of the Offer, Astellas intends to cause Offeror or another of its subsidiaries to be merged with OSI (the “Merger” and, together with the Offer, the “Transaction”) pursuant to which each outstanding share of OSI Common Stock not previously tendered would be converted into the right to receive the Consideration. The terms and conditions of the Transaction are more fully set forth in the Offer Documents.
 
 
You have requested our opinion as of the date hereof as to the adequacy, from a financial point of view, to holders of OSI Common Stock (other than Astellas, Astellas Holding, Offeror and their respective affiliates (collectively, the “Astellas Parties”)) of the Consideration proposed to be paid to such holders in the Offer.
 
 
In connection with this opinion, we have:
 
(i) Reviewed the financial terms and conditions of the Transaction as set forth in the offer to purchase and related letter of transmittal, each attached as exhibits to the Tender Offer Statement on Schedule TO filed on March 2, 2010, as amended to date, by Astellas, Astellas Holding and Offeror with respect to the Offer (collectively, the “Offer Documents”), and drafts of the Solicitation/Recommendation Statement on Schedule 14D-9 of OSI relating to the Offer (the “Schedule 14D-9”);
 
(ii) Reviewed certain publicly available historical business and other financial information relating to OSI, including certain publicly available financial forecasts;
 
(iii) Reviewed various financial forecasts and other data and information provided to us by the management of OSI relating to the business of OSI;
 
(iv) Held discussions with members of the senior management of OSI with respect to the business and prospects of OSI;
 
(v) Reviewed public information with respect to certain other companies in lines of business we believe to be generally relevant in evaluating the business of OSI;
 
(vi) Reviewed the financial terms of certain business combinations involving companies in lines of business we believe to be generally relevant in evaluating the business of OSI;
 
(vii) Reviewed historical stock prices and trading volumes of OSI Common Stock; and
 
(viii) Conducted such other financial studies, analyses and investigations as we deemed appropriate.

Table of Contents

The Board of Directors
OSI Pharmaceuticals, Inc.
March 12, 2010
Page 2
 
 
We have assumed and relied upon the accuracy and completeness of the foregoing information, without independent verification of such information. We have not conducted any independent valuation or appraisal of any of the assets or liabilities (contingent or otherwise) of OSI or concerning the solvency or fair value of OSI, and we have not been furnished with any such valuation or appraisal. With respect to the financial forecasts relating to OSI utilized in our analyses, we have assumed, with the consent of OSI, that they have been reasonably prepared on bases reflecting the best currently available estimates and judgments as to the future financial performance of OSI. We assume no responsibility for and express no view as to any such forecasts or the assumptions on which they are based. We also have relied, with the consent of OSI, on the assessments of the management of OSI as to the validity of, and risks associated with, the products, product candidates and technology of OSI (including, without limitation, the timing and probability of successful development, testing and marketing of such products, product candidates and technology, approval thereof by appropriate governmental authorities and the validity and life of patents relating thereto).
 
 
Further, our opinion is necessarily based on economic, monetary, market and other conditions as in effect on, and the information made available to us as of, the date hereof. We assume no responsibility for updating or revising our opinion based on circumstances or events occurring after the date hereof. We do not express any opinion as to the price at which shares of OSI Common Stock may trade at any time.
 
 
In rendering our opinion, we have assumed, with the consent of OSI, that the Transaction, if consummated, would be completed on the terms described in the Offer Documents. We also have assumed, with the consent of OSI, that the Schedule 14D-9, when filed, will conform to the last draft reviewed by us in all material respects. We further have assumed, with the consent of OSI, that obtaining the necessary governmental, regulatory or third party approvals and consents for the Transaction would not have an adverse effect on OSI or the Transaction. We do not express any opinion as to any tax or other consequences that might result from the Transaction, nor does our opinion address any legal, tax, regulatory or accounting matters, as to which we understand that OSI obtained such advice as it deemed necessary from qualified professionals. We express no view or opinion as to any terms or other aspects or implications of the Transaction (other than the Consideration to the extent expressly specified herein), including, without limitation, the form or structure of the Transaction. In addition, we express no view or opinion as to the fairness of the amount or nature of, or any other aspects relating to, the compensation to any officers, directors or employees of any parties to the Transaction, or class of such persons, relative to the Consideration or otherwise.
 
 
Lazard Frères & Co. LLC (“Lazard”) is acting as financial advisor to OSI in connection with the Transaction and will receive a fee for such services, portions of which are payable during the course of our engagement, a portion of which is payable in connection with this opinion, a portion of which is payable upon any withdrawal of the Offer and a substantial portion of which is contingent upon the consummation of a sale of OSI, including as a result of the Transaction or otherwise. In addition, we in the past have provided and in the future may provide investment banking services to OSI, Astellas and their respective affiliates unrelated to the Transaction, for which we have received and may receive compensation, including having acted as financial advisor to Astellas in connection with its proposed acquisition of CV Therapeutics, Inc. in 2009. In the ordinary course of their respective businesses, Lazard, LFCM Holdings LLC (an entity indirectly owned in large part by managing directors of Lazard) and our respective affiliates may actively trade securities of OSI, Astellas and their respective affiliates for their own accounts and for the accounts of their customers and, accordingly, may at any time hold a

Table of Contents

The Board of Directors
OSI Pharmaceuticals, Inc.
March 12, 2010
Page 3
 
 
long or short position in such securities. The issuance of this opinion was approved by the Opinion Committee of Lazard.
 
 
In connection with our engagement and prior to the date hereof, we were not authorized to, and we did not, solicit indications of interest from Astellas or other third parties regarding a potential transaction with OSI. We also were not requested to consider, and our opinion does not address, the relative merits of the Transaction as compared to any other transaction or business strategy in which OSI might engage or the merits of the underlying decision by OSI with respect to the Offer.
 
 
Our engagement and the opinion expressed herein are for the benefit of the Board of Directors of OSI (solely in its capacity as such) and our opinion is rendered to the Board of Directors of OSI in connection with its evaluation of the Offer. Our opinion is not intended to and does not constitute a recommendation to any stockholder as to whether such stockholder should tender shares of OSI Common Stock in the Offer or how such stockholder should vote or act with respect to the Transaction or any matter relating thereto.
 
 
Based on and subject to the foregoing, we are of the opinion that, as of the date hereof, the Consideration proposed to be paid in the Offer to holders of OSI Common Stock (other than the Astellas Parties) is inadequate, from a financial point of view, to such holders.
 
Very truly yours,
 
LAZARD FRÈRES & CO. LLC
 
  By 
/s/  Stephen Sands
Managing Director

EX-99.A.1 2 y83222exv99waw1.htm EX-99.A.1 exv99waw1
Exhibit (a)(1)
 
OSI Pharmaceuticals, Inc.
41 Pinelawn Road
Melville, NY 11747
T 631.962.2051 F 631.752.3869
www.osip.com
 
(OSI LOGO)
 
March 15, 2010
 
Dear Fellow Stockholders:
 
On March 2, 2010, Astellas Pharma Inc. (“Astellas”) launched an unsolicited, conditional tender offer (the “Offer”) to acquire your shares of common stock of OSI Pharmaceuticals, Inc. (“OSI” or the “Company”) for $52.00 per share in cash.
 
Your Board of Directors has reviewed the Offer with the assistance of the Company’s management and legal and financial advisors and, after careful consideration, the OSI Board has unanimously determined that the Offer is inadequate, substantially undervalues the Company and is not in the best interests of OSI stockholders.
 
Your Board of Directors unanimously recommends that you REJECT THE OFFER and NOT TENDER your shares to Astellas.
 
The Board’s conclusion is based on numerous factors that are detailed in the enclosed Schedule 14D-9, including:
 
  •     The Offer Substantially Undervalues OSI Relative to its Fundamental, Intrinsic Value.
 
  °       OSI’s flagship oncology drug, Tarceva® (erlotinib), with approximately $1.2 billion of worldwide revenue in 2009, is one of the few blockbuster oncology drugs. As of March 12, 2010, Tarceva was approved for sale in 109 countries for the treatment of advanced non-small cell lung cancer, or NSCLC. The exclusivity period for Tarceva (which is expected to range from 2019 to 2020 in the major U.S., European and Japanese markets) provides the Company with strategically valuable long-term cash flows.
 
  °       OSI’s financial assets, which include significant DPIV patent royalties, substantial cash, investments and marketable securities, and net operating loss carryforwards of over $700 million as of December 31, 2009, are estimated to be worth approximately $1.3 billion, which implies that Astellas’ Offer values OSI’s strategic assets at only $2.3 billion.
 
  °       OSI’s revenues were approximately $428 million for the fiscal year ended December 31, 2009, an increase of nearly 13% from the prior year, and non-GAAP net income from continuing operations increased to $181 million (or $2.89 per share) in 2009, an increase of approximately 15% over the prior year. OSI also generates strong cash flow from operations, with $160 million of cash flow from operations generated in fiscal year 2009 resulting in approximately $540 million in cash, investments and marketable securities at fiscal year end.
 
  •     The Offer Does Not Appropriately Value OSI’s Highly Differentiated Oncology and Diabetes and Obesity New Product and Line Extension Pipeline. OSI’s clinical pipeline targets two of the highest growth and most attractive therapeutic areas where major unmet clinical need remains: (i) oncology and (ii) diabetes and obesity. OSI – together with its partner Roche – is committed to advancing a comprehensive development plan for Tarceva, which is expected to yield data and label expansion opportunities that will provide the basis for continued growth of the Company’s Tarceva related revenues throughout the patent exclusivity period. In

 

  addition, OSI focuses its development resources on advancing high quality and differentiated development assets, including OSI’s IGF-1R/IR inhibitor, OSI-906, and its GPR119 agonist, PSN821, both of which have the potential to be blockbusters, “first-in-class” and/or “best-in-class” and are highly competitive in these much sought after target areas. OSI also has additional agents in clinical development, including OSI-027 and PSN010, which together represent valuable and differentiated pipeline assets and substantial commercial opportunities.
 
  •     The Offer Does Not Recognize the Scarcity Value of OSI’s Growing, High Quality, and Profitable Oncology Franchise. OSI’s profitable, growing and integrated oncology business (anchored around its blockbuster drug, Tarceva) represents a unique asset in the mid-cap biotechnology arena. The Board believes that OSI’s oncology organization offers potential acquirers and strategic partners a full array of high quality and differentiated capabilities and know-how from discovery and cancer cell biology research through commercialization in the U.S. oncology market.
 
  •     The Offer Does Not Recognize the Value of OSI’s Second Profitable and High Quality Disease Area Franchise in Diabetes and Obesity, Which Has a Proven Track-Record of Success. OSI’s diabetes and obesity franchise, based in our wholly owned, state-of-the-art R&D facility in the UK, is a profitable business anchored around OSI’s DPIV patent estate revenue stream. Twelve companies have acquired licenses to this estate which generated 2009 revenues of $67 million in milestones and royalties and provides a rapidly growing revenue source that is expected to increase by more than 30% in 2010.
 
  •     Despite the Growth of the Company, Astellas’ Offer is Lower Than the Price Range in its Previous Inadequate Nonbinding Indication of Interest. Since February 2009, when Astellas first submitted a conditional nonbinding indication of interest to acquire the Company, OSI has had strong financial performance, revenue and net income growth, an increased net cash position, secured the re-issue of a key Tarceva patent and made advances in its pipeline. Despite this growth and positive performance, in its Offer, Astellas proposes to pay OSI stockholders even less for their shares than the price range reflected in Astellas’ prior nonbinding indication of interest, which the OSI Board determined was inadequate and not in the best interests of OSI and its stockholders.
 
  •     The Offer Represents a Low Revenue Multiple Compared to Recent, Precedent Oncology Transactions. Revenue multiples paid in recent oncology transactions were substantially higher than the revenue multiple implied by Astellas’ $52.00 per share Offer. For example, the forward year revenue multiple paid by Takeda Pharmaceutical for Millennium Pharmaceuticals was 13.5x, and the forward year revenue multiple paid by Eli Lilly for ImClone Systems was 7.8x. Based on Wall Street research estimates, the 2010 revenue multiple implied by Astellas’ Offer for all of OSI is only 6.3x, and is even lower – below 5.8x – for the strategic assets of OSI (based on a value of approximately $1.3 billion for OSI’s financial assets).
 
  •     The Offer Values OSI at a Price Below Current Trading Levels. OSI’s stock price has remained above Astellas’ Offer price of $52.00 per share since the public announcement of the Offer on March 1, 2010. The closing price per share on the NASDAQ Global Select Market on March 12, 2010, the last trading day prior to the date of the enclosed Schedule 14D-9, was $57.68 and the 10-day trailing average closing price per share on the NASDAQ Global Select Market since the March 1st announcement of Astellas’ intention to commence the Offer was $56.92 per share.
 
  •     Astellas’ Offer is Highly Conditional and Creates Substantial Uncertainty as to Whether Astellas Would be Required to Consummate the Offer. The Board considered the fact that the Offer is subject to numerous and subjective conditions. Many of these conditions are completely within the control, judgment, interpretation or discretion of Astellas.


2

 

 
  •     The Offer Is Financially Inadequate. The OSI Board has received separate oral opinions, confirmed by delivery of written opinions, dated March 12, 2010, from the Company’s financial advisors, Centerview Partners LLC (“Centerview Partners”) and Lazard Frères & Co. LLC (“Lazard”), as to the inadequacy, from a financial point of view and as of the date of such opinions, of the $52.00 per share Offer price to holders of OSI common stock (other than Astellas and its affiliates). The opinions were provided to the Board (solely in its capacity as such) for its information in its evaluation of the Offer from a financial perspective and were based on and subject to certain assumptions, qualifications, limitations and other considerations. The opinions do not address any other aspect of the Offer or any related transactions and are not intended to constitute, and do not constitute, recommendations as to whether any stockholder should tender shares in the Offer or as to any other matters.
 
OSI’s Board of Directors has Instructed OSI’s Management, With the Assistance of OSI’s Financial Advisors, to Contact Other Parties. In its efforts to maximize value for OSI stockholders, the Board instructed OSI management, with the assistance of the Company’s financial advisors, Centerview Partners and Lazard, to contact appropriate third parties in order to explore the availability of a transaction that reflects the full intrinsic value of the Company. Third parties expressing legitimate interest in a transaction with OSI will be afforded an opportunity to engage in a due diligence review of certain OSI confidential information, subject to their entering into an appropriate nondisclosure agreement with the Company. No assurance can be given as to whether any of these contacts will result in any transaction.
 
Prior to Astellas launching its unsolicited Offer, OSI offered to provide Astellas with certain non-public information that the Company believed was fundamental to understanding the value of OSI, subject to it entering into a nondisclosure agreement, a proposed draft of which OSI provided to Astellas. Astellas NEVER responded to the Company’s proposal, NEVER asked to review any of the Company’s confidential information and NEVER made any attempt to negotiate the terms of the draft nondisclosure agreement. OSI remains willing to share confidential information with Astellas, as with other interested parties, subject to their entering into an appropriate nondisclosure agreement with the Company.
 
Accordingly, and for the reasons described both above and in the enclosed Schedule 14D-9, the Board of Directors of the Company unanimously recommends that you REJECT the Offer and NOT TENDER your shares pursuant to the Offer.
 
We urge you to read the enclosed Schedule 14D-9 so you will be fully informed before you make your decision. If you have questions or need assistance, please call our information agent, MacKenzie Partners, Inc. by calling 800-322-2885 toll free or by calling 212-929-5500 or by emailing osipharma@mackenziepartners.com.
 
Sincerely,
 
     
(-s-Robert A. Ingram)   (-s-Colin Goddard)
Robert A. Ingram
  Colin Goddard, Ph.D.
Chairman of the Board
  Chief Executive Officer
OSI Pharmaceuticals
  OSI Pharmaceuticals
 
 
This letter contains both GAAP and non-GAAP financial measures. A reconciliation of the non-GAAP financial measures to their GAAP equivalents can be found in OSI’s earnings release for the year ended December 31, 2009, which is available via the investor relations section of OSI’s website (www.osip.com).


3

EX-99.A.2 3 y83222exv99waw2.htm EX-99.A.2 exv99waw2
Exhibit (a)(2)
 
FOR IMMEDIATE RELEASE
 
OSI PHARMACEUTICALS’ BOARD OF DIRECTORS UNANIMOUSLY REJECTS
ASTELLAS’ UNSOLICITED TENDER OFFER
 
Board Concludes Offer Does Not Fully Reflect OSI’s Fundamental, Intrinsic Value
 
Board Recommends Stockholders Not Tender Shares at $52.00 per Share
 
Company, With Assistance of Financial Advisors, to Contact Third Parties
 
Melville, NY – March 15, 2010 – OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) today announced that its Board of Directors, after careful review and consideration with the assistance of OSI’s management and outside legal and financial advisors, has unanimously rejected the unsolicited, conditional tender offer from Astellas US Holding, Inc., a wholly-owned subsidiary of Astellas Pharma Inc., to acquire all outstanding shares of OSI common stock for $52.00 per share in cash. The OSI Board unanimously recommends that OSI stockholders reject the offer and not tender their shares into the offer.
 
Robert A. Ingram, Chairman of the Board of Directors of OSI, commented, “After carefully analyzing and considering Astellas’ offer, the Board has unanimously concluded that the offer does not fully reflect OSI’s fundamental, intrinsic value. We believe that OSI is a unique asset – the only profitable, mid-cap biotech company with a growing, high quality and fully integrated oncology franchise and a strong diabetes and obesity franchise which also has a proven track-record of success. The OSI Board takes its fiduciary duties seriously and will continue to do what’s right for OSI stockholders. In that regard, the Board of Directors has instructed OSI management, with the assistance of the Company’s financial advisors, to contact appropriate third parties in order to explore the availability of a transaction that reflects the full intrinsic value of the Company.”
 
OSI Chief Executive Colin Goddard, PhD, added, “OSI is well positioned and we continue to successfully execute on our strategic plan. In addition to our blockbuster oncology drug, Tarceva, and our highly differentiated pipeline in two of the highest growth and most attractive therapeutic areas, we have substantial financial assets, including significant DPIV patent royalties, substantial cash balances and net operating loss carryforwards. Our business remains strong, as exemplified by our 13% revenue growth in 2009, which we accomplished while solidifying our patent position and advancing our pipeline. We expect 2010 to be another year of strategic and financial growth.”
 
Centerview Partners LLC is acting as lead financial advisor to OSI. Lazard also recently was retained as a financial advisor to OSI. Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates is acting as legal advisor.
 
The basis for the Board’s recommendation is set forth in a Solicitation/Recommendation Statement on Schedule 14D-9, which was filed by OSI today with the Securities and Exchange Commission, accompanied by a letter to stockholders. The full text of the letter appears below.
 
March 15, 2010
 
Dear Fellow Stockholders:
 
On March 2, 2010, Astellas Pharma Inc. (“Astellas”) launched an unsolicited, conditional tender offer (the “Offer”) to acquire your shares of common stock of OSI Pharmaceuticals, Inc. (“OSI” or the “Company”) for $52.00 per share in cash.
 
Your Board of Directors has reviewed the Offer with the assistance of the Company’s management and legal and financial advisors and, after careful consideration, the OSI Board has unanimously determined that the Offer is inadequate, substantially undervalues the Company and is not in the best interests of OSI stockholders.

 

Your Board of Directors unanimously recommends that you REJECT THE OFFER and NOT TENDER your shares to Astellas.
 
The Board’s conclusion is based on numerous factors that are detailed in the enclosed Schedule 14D-9, including:
 
  •     The Offer Substantially Undervalues OSI Relative to its Fundamental, Intrinsic Value.
 
  °       OSI’s flagship oncology drug, Tarceva® (erlotinib), with approximately $1.2 billion of worldwide revenue in 2009, is one of the few blockbuster oncology drugs. As of March 12, 2010, Tarceva was approved for sale in 109 countries for the treatment of advanced non-small cell lung cancer, or NSCLC. The exclusivity period for Tarceva (which is expected to range from 2019 to 2020 in the major U.S., European and Japanese markets) provides the Company with strategically valuable long-term cash flows.
 
  °       OSI’s financial assets, which include significant DPIV patent royalties, substantial cash, investments and marketable securities, and net operating loss carryforwards of over $700 million as of December 31, 2009, are estimated to be worth approximately $1.3 billion, which implies that Astellas’ Offer values OSI’s strategic assets at only $2.3 billion.
 
  °       OSI’s revenues were approximately $428 million for the fiscal year ended December 31, 2009, an increase of nearly 13% from the prior year, and non-GAAP net income from continuing operations increased to $181 million (or $2.89 per share) in 2009, an increase of approximately 15% over the prior year. OSI also generates strong cash flow from operations, with $160 million of cash flow from operations generated in fiscal year 2009 resulting in approximately $540 million in cash, investments and marketable securities at fiscal year end.
 
  •     The Offer Does Not Appropriately Value OSI’s Highly Differentiated Oncology and Diabetes and Obesity New Product and Line Extension Pipeline. OSI’s clinical pipeline targets two of the highest growth and most attractive therapeutic areas where major unmet clinical need remains: (i) oncology and (ii) diabetes and obesity. OSI – together with its partner Roche – is committed to advancing a comprehensive development plan for Tarceva, which is expected to yield data and label expansion opportunities that will provide the basis for continued growth of the Company’s Tarceva related revenues throughout the patent exclusivity period. In addition, OSI focuses its development resources on advancing high quality and differentiated development assets, including OSI’s IGF-1R/IR inhibitor, OSI-906, and its GPR119 agonist, PSN821, both of which have the potential to be blockbusters, “first-in-class” and/or “best-in-class” and are highly competitive in these much sought after target areas. OSI also has additional agents in clinical development, including OSI-027 and PSN010, which together represent valuable and differentiated pipeline assets and substantial commercial opportunities.
 
  •     The Offer Does Not Recognize the Scarcity Value of OSI’s Growing, High Quality, and Profitable Oncology Franchise. OSI’s profitable, growing and integrated oncology business (anchored around its blockbuster drug, Tarceva) represents a unique asset in the mid-cap biotechnology arena. The Board believes that OSI’s oncology organization offers potential acquirers and strategic partners a full array of high quality and differentiated capabilities and know-how from discovery and cancer cell biology research through commercialization in the U.S. oncology market.
 
  •     The Offer Does Not Recognize the Value of OSI’s Second Profitable and High Quality Disease Area Franchise in Diabetes and Obesity, Which Has a Proven Track-Record of Success. OSI’s diabetes and obesity franchise, based in our wholly owned, state-of-the-art R&D facility in the UK, is a profitable business anchored around OSI’s DPIV patent estate revenue stream. Twelve companies have acquired licenses to this estate which generated 2009 revenues of $67 million in milestones and royalties and provides a rapidly growing revenue source that is expected to increase by more than 30% in 2010.

 

 
  •     Despite the Growth of the Company, Astellas’ Offer is Lower Than the Price Range in its Previous Inadequate Nonbinding Indication of Interest. Since February 2009, when Astellas first submitted a conditional nonbinding indication of interest to acquire the Company, OSI has had strong financial performance, revenue and net income growth, an increased net cash position, secured the re-issue of a key Tarceva patent and made advances in its pipeline. Despite this growth and positive performance, in its Offer Astellas proposes to pay OSI stockholders even less for their shares than the price range reflected in Astellas’ prior nonbinding indication of interest, which the OSI Board determined was inadequate and not in the best interests of OSI and its stockholders.
 
  •     The Offer Represents a Low Revenue Multiple Compared to Recent, Precedent Oncology Transactions. Revenue multiples paid in recent oncology transactions were substantially higher than the revenue multiple implied by Astellas’ $52.00 per share Offer. For example, the forward year revenue multiple paid by Takeda Pharmaceutical for Millennium Pharmaceuticals was 13.5x, and the forward year revenue multiple paid by Eli Lilly for ImClone Systems was 7.8x. Based on Wall Street research estimates, the 2010 revenue multiple implied by Astellas’ Offer for all of OSI is only 6.3x, and is even lower - below 5.8x — for the strategic assets of OSI, (based on a value of approximately $1.3 billion for OSI’s financial assets).
 
  •     The Offer Values OSI at a Price Below Current Trading Levels. OSI’s stock price has remained above Astellas’ Offer price of $52.00 per share since the public announcement of the Offer on March 1, 2010. The closing price per share on the NASDAQ Global Select Market on March 12, 2010, the last trading day prior to the date of the enclosed Schedule 14D-9, was $57.68 and the 10-day trailing average closing price per share on the NASDAQ Global Select Market since the March 1st announcement of Astellas’ intention to commence the Offer was $56.92 per share.
 
  •     Astellas’ Offer is Highly Conditional and Creates Substantial Uncertainty as to Whether Astellas Would be Required to Consummate the Offer. The Board considered the fact that the Offer is subject to numerous and subjective conditions. Many of these conditions are completely within the control, judgment, interpretation or discretion of Astellas.
 
  •     The Offer Is Financially Inadequate. The OSI Board has received separate oral opinions, confirmed by delivery of written opinions, dated March 12, 2010, from the Company’s financial advisors, Centerview Partners LLC (“Centerview Partners”) and Lazard Frères & Co. LLC (“Lazard”), as to the inadequacy, from a financial point of view and as of the date of such opinions, of the $52.00 per share Offer price to holders of OSI common stock (other than Astellas and its affiliates). The opinions were provided to the Board (solely in its capacity as such) for its information in its evaluation of the Offer from a financial perspective and were based on and subject to certain assumptions, qualifications, limitations and other considerations. The opinions do not address any other aspect of the Offer or any related transactions and are not intended to constitute, and do not constitute, recommendations as to whether any stockholder should tender shares in the Offer or as to any other matters.
 
OSI’s Board of Directors has Instructed OSI’s Management, With the Assistance of OSI’s Financial Advisors, to Contact Other Parties. In its efforts to maximize value for OSI stockholders, the Board instructed OSI management, with the assistance of the Company’s financial advisors, Centerview Partners and Lazard, to contact appropriate third parties in order to explore the availability of a transaction that reflects the full intrinsic value of the Company. Third parties expressing legitimate interest in a transaction with OSI will be afforded an opportunity to engage in a due diligence review of certain OSI confidential information, subject to their entering into an appropriate nondisclosure agreement with the Company. No assurance can be given as to whether any of these contacts will result in any transaction.
 
Prior to Astellas launching its unsolicited Offer, OSI offered to provide Astellas with certain non-public information that the Company believed was fundamental to understanding the value of OSI, subject to it entering into a nondisclosure agreement, a proposed draft of which OSI provided to Astellas. Astellas NEVER responded to the Company’s proposal, NEVER asked to review any of the

 

Company’s confidential information and NEVER made any attempt to negotiate the terms of the draft nondisclosure agreement. OSI remains willing to share confidential information with Astellas, as with other interested parties, subject to their entering into an appropriate nondisclosure agreement with the Company.
 
Accordingly, and for the reasons described both above and in the enclosed Schedule 14D-9, the Board of Directors of the Company unanimously recommends that you REJECT the Offer and NOT TENDER your shares pursuant to the Offer.
 
We urge you to read the enclosed Schedule 14D-9 so you will be fully informed before you make your decision. If you have questions or need assistance, please call our information agent, MacKenzie Partners, Inc. by calling 800-322-2885 toll free or by calling 212-929-5500 or by emailing osipharma@mackenziepartners.com.
 
Sincerely,
 
         
/s/ Robert A. Ingram
  /s/ Colin Goddard, Ph.D.    
         
Robert A. Ingram
  Colin Goddard, Ph.D.    
Chairman of the Board
  Chief Executive Officer    
OSI Pharmaceuticals
  OSI Pharmaceuticals    
 
This letter contains both GAAP and non-GAAP financial measures. A reconciliation of the non-GAAP financial measures to their GAAP equivalents can be found in OSI’s earnings release for the year ended December 31, 2009, which is available via the investor relations section of OSI’s website (www.osip.com).
 
About OSI Pharmaceuticals
 
OSI Pharmaceuticals is a biotechnology company committed to building a scientifically strong and financially successful top tier biopharmaceutical organization that discovers, develops and commercializes innovative molecular targeted therapies, or MTTs, addressing major unmet medical needs in oncology, diabetes and obesity. OSI’s largest area of focus is oncology where its business is anchored by Tarceva, a small molecule inhibitor of the epidermal growth factor receptor, or EGFR, which achieved global sales of over $1.2 billion in 2009.
 
As of March 12, 2010, Tarceva was approved for sale in 109 countries for the treatment of advanced non-small cell lung cancer, or NSCLC, in patients who have failed at least one prior chemotherapy regimen and 80 countries for the treatment of patients with advanced pancreatic cancer in combination with the chemotherapy agent, gemcitabine.
 
Additional Information
 
In connection with the unsolicited tender offer commenced by Astellas, OSI is filing a Solicitation/Recommendation Statement on Schedule 14D-9 with the U.S. Securities and Exchange Commission (“SEC”). STOCKHOLDERS OF OSI ARE URGED TO READ THE SCHEDULE 14D-9 AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION. Stockholders may obtain a free copy of the Schedule 14D-9 (when available) and other documents filed by OSI with the SEC through the web site maintained by the SEC at http://www.sec.gov. Stockholders may also obtain, without charge, a copy of the Schedule 14D-9 from MacKenzie Partners, Inc., OSI’s information agent, by calling 800-322-2885 toll free or by calling 212-929-5500 or by emailing osipharma@mackenziepartners.com.
 
Forward Looking Statements
 
This news release contains forward-looking statements. These statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. Various factors may cause differences between current expectations and actual

 

results, including risks and uncertainties associated with Astellas’ offer. Other Factors that might cause such a difference include, among others, OSI’s and its collaborators’ abilities to effectively market and sell Tarceva and to expand the approved indications for Tarceva, OSI’s ability to protect its intellectual property rights, safety concerns regarding Tarceva, competition to Tarceva and OSI’s drug candidates from other biotechnology and pharmaceutical companies, the completion of clinical trials, the effects of FDA and other governmental regulation, including pricing controls, OSI’s ability to successfully develop and commercialize drug candidates, and other factors described in OSI’s filings with the SEC. This news release also contains both GAAP and non-GAAP financial measures. A reconciliation of the non-GAAP financial measures to their GAAP equivalents can be found in OSI’s earnings release for the year ended December 31, 2009, which is available via the investor relations section of OSI’s website (www.osip.com).
 
Contacts:
 
Investors
 
Kathy Galante (investors/media)
OSI, Senior Director
631-962-2043
 
Mark Harnett / Amy Bilbija
MacKenzie Partners, Inc.
212-929-5500
 
Media
 
Joele Frank / Andy Brimmer / Eric Brielmann
Joele Frank, Wilkinson Brimmer Katcher
212-355-4449

EX-99.A.3 4 y83222exv99waw3.htm EX-99.A.3 exv99waw3
 
Exhibit (a)(3)
 
March 15, 2010
 
Dear OSI Employee,
 
This morning OSI announced that our Board of Directors, after careful review and consideration with the assistance of OSI’s management and outside legal and financial advisors, has unanimously rejected Astellas Pharma’s unsolicited, conditional tender offer to acquire OSI for $52.00 per share in cash. The OSI Board unanimously recommends that OSI stockholders reject the offer and not tender their shares into the offer.
 
The Board’s recommendation is based on the conclusion that Astellas’ offer substantially undervalues OSI relative to its fundamental, intrinsic value and is not in the best interests of stockholders. The press release we issued this morning detailing the reasons for the Board’s recommendation is attached.
 
While the OSI Board has not made any decision to sell the Company, it believes that Astellas’ offer must be evaluated against the Company’s well established long-term strategy for stockholder value creation and the prospect of other potential transactions which, if consummated, could yield greater long- or short-term value to stockholders than the offer. Accordingly, the Board instructed OSI management, with the assistance of the Company’s financial advisors, to contact appropriate third parties in order to explore the availability of a transaction that reflects the full intrinsic value of the Company. No assurance can be given as to whether any of these contacts will result in any transaction.
 
It is important to note that Astellas’ offer and the process we’ve established to explore interest have no effect on our day-to-day operations, and it remains business as usual at OSI. Many of you have asked what you can do — we ask that you all maintain your focus on your everyday activities. The best way you can help is by continuing to demonstrate what a tremendous company we have all built together by executing against our business plan to the best of your ability. Remember that “Shaping Medicine and Changing Lives” remains our most important and compelling mission.
 
We expect this announcement may lead to inquiries from external parties, and as always it is important for us to speak with one voice. Consistent with our existing policy, please forward any inquiries from the media, investors, or other outside parties to Kathy Galante at (631) 962-2043 or kgalante@osip.com.
 
We have attached a frequently asked questions (FAQ) document to provide you with further information.
 
Thanks to your efforts and dedication to serving our customers, OSI is well positioned today. We have confidence in OSI’s growth potential and in our ability to continue to create value for our stockholders. On behalf of the Board and management team, I want to thank each and every one of you for your support and commitment to OSI.
 
Sincerely,
 
Colin Goddard, Ph.D.
Chief Executive Officer

 

Additional Information
 
In connection with the unsolicited tender offer commenced by Astellas, OSI is filing a Solicitation/Recommendation Statement on Schedule 14D-9 with the U.S. Securities and Exchange Commission (“SEC”). STOCKHOLDERS OF OSI ARE URGED TO READ THE SCHEDULE 14D-9 AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION. Stockholders may obtain a free copy of the Schedule 14D-9 (when available) and other documents filed by OSI with the SEC through the web site maintained by the SEC at http://www.sec.gov. Stockholders may also obtain, without charge, a copy of the Schedule 14D-9 from MacKenzie Partners, Inc., OSI’s information agent, by calling 800-322-2885 toll free or by calling 212-929-5500 or by emailing osipharma@mackenziepartners.com.

EX-99.A.4 5 y83222exv99waw4.htm EX-99.A.4 exv99waw4
 
Exhibit (a)(4)
 
OSI Employee Frequently Asked Questions (FAQs)
 
1.   What has happened? What has OSI announced?
 
On March 2, 2010, Astellas Pharma announced that it had commenced a cash tender offer for all the outstanding shares of common stock of OSI for $52.00 per share in cash.
 
On March 15, 2010, OSI announced that its Board of Directors, after careful review and consideration with the assistance of OSI’s management and outside legal and financial advisors, has unanimously rejected Astellas’ unsolicited, conditional tender offer because it does not fully reflect OSI’s fundamental, intrinsic value. The OSI Board unanimously recommends that OSI stockholders reject the offer and not tender their shares into the offer.
 
2.   How did the Board go about making its decision?
 
The Board rejected Astellas’ unsolicited, conditional tender offer after carefully reviewing it with the assistance of the Company’s management and outside legal and financial advisors. Centerview Partners LLC is acting as lead financial advisor to OSI. Lazard also recently was retained as a financial advisor to OSI. Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates is acting as legal advisor.
 
3.   What will Astellas do next?
 
We are at the early stages of this journey and it is not productive to speculate on what Astellas may or may not do next. Rather, we ask that you all maintain your focus on your everyday activities.
 
4.   Is there anything employees can be doing to help?
 
The best way you can help is by continuing to demonstrate what a tremendous company we have all built together by executing against our business plan to the best of your ability. Remember that “Shaping Medicine and Changing Lives” remains our most important and compelling mission.
 
5.   What effect does this announcement have on my job?
 
Employees should expect no change in their positions or responsibilities as a result of this announcement. We are counting on you to continue to perform your job with the same dedication, focus and excellence as always.
 
6.   What should I say to customers, business partners and other stakeholders?
 
You should assure all of our company’s stakeholders that it is business as usual for OSI. Your Board and management team remain focused on achieving our business objectives.
 
7.   Where can I get more information?
 
We will do our best to keep you updated throughout this process. For your reference, any publicly disclosed materials will be posted to our website as well as to the Securities and Exchange Commission’s website (www.sec.gov).

 

GLOSSARY OF TERMS
 
Tender Offer: A tender offer is a public offer to all of the stockholders of a company asking those stockholders to sell their stock to the party making the tender offer. Typically, a tender offer is commenced when the offeror places a summary advertisement in a major national newspaper, and the offer to purchase is printed and mailed to the target company’s stockholders. A tender offer must comply with the rules and regulations of the Securities and Exchange Commission (SEC), which are quite technical. Astellas’ tender offer is conditioned amongst other matters, on our Board’s withdrawal of our “poison pill” defense. As such, the tender offer will not proceed unless our Board withdraws this defense or Astellas determines to waive this condition.
 
Schedule 14D-9 Filing: A Schedule 14D-9 filing is a Securities and Exchange Commission filing in response to a tender offer in which the target company makes a recommendation to its stockholders. It is, in effect, a description of the Board’s recommendation concerning the offer. The Schedule 14D-9 filing is often accompanied by a letter to stockholders letting them know of the Board’s decision and providing the background of the offer and rationale for the decision.
 
Expiration Date: The expiration date of a tender offer is the last date that the potential acquirer will accept tendered shares. The SEC’s Williams Act of 1969 requires a 20-business day minimum period for acceptance. However, hostile tender offers are not completed within 20 business days and this process could take several months before it is concluded.
 
Additional Information
 
In connection with the unsolicited tender offer commenced by Astellas, OSI is filing a Solicitation/Recommendation Statement on Schedule 14D-9 with the U.S. Securities and Exchange Commission (“SEC”). STOCKHOLDERS OF OSI ARE URGED TO READ THE SCHEDULE 14D-9 AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION. Stockholders may obtain a free copy of the Schedule 14D-9 (when available) and other documents filed by OSI with the SEC through the web site maintained by the SEC at http://www.sec.gov. Stockholders may also obtain, without charge, a copy of the Schedule 14D-9 from MacKenzie Partners, Inc., OSI’s information agent, by calling 800-322-2885 toll free or by calling 212-929-5500 or by emailing osipharma@mackenziepartners.com.

EX-99.A.5 6 y83222exv99waw5.htm EX-99.A.5 exv99waw5
Exhibit (a)(5)

Shaping Medicine, Changing Lives OSI: A Focus on Fundamental Intrinsic Value Colin Goddard, Ph.D. Chief Executive Officer CEO Gold Standard Founding Member March 2010

 

OSI Pharmaceuticals (OSIP) Forward-looking Statements OSI's presentation today contains forward-looking statements. These statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made Factors that might cause such a difference include, among others, the ability to effectively market products, competition from other pharmaceutical companies, the FDA review process and other governmental regulation, OSI's and its collaborators' abilities to successfully develop and commercialize drug candidates, and other factors described in OSI Pharmaceuticals' filings with the Securities and Exchange Commission. OSI's presentation also contains both GAAP and non-GAAP financial measures. For a reconciliation of the non-GAAP financial measures to their GAAP equivalents, please see our earnings release for the year ended December 31, 2009 available via the investor relations section of OSI's website (www.osip.com). OSI is a Biotechnology Company that Discovers, Develops and Commercializes Innovative Molecular Targeted Therapies Addressing Major Unmet Medical Needs in Oncology, Diabetes & Obesity

 

Focusing on OSI's Strategic and Financial Value Proposition Long Term Factors Affecting Strategic Value Proposition U.S. sales trends and recent data sets (e.g. SATURN) Management projects >$7 billion in Tarceva related revenues through 2020 Life cycle plan with multiple label expansion opportunities ahead Lack of focus on financial assets No anticipated acquirer on near-term horizon Long-term revenue/earnings potential ~$1.3bn value in cash/investments/DP- IV/NOLs Unique, profitable & fully integrated franchise with significant scarcity value Blockbuster potential of differentiated IGF-1R/IR inhibitor, OSI-906 Current stage of '906 & '027 programs Capabilities & technology platforms discounted in current biotech market Profitable second disease area franchise with quality assets Blockbuster potential of GPR119 agonist, PSN821 Lack of investor focus on diabetes and obesity assets Financial Performance & Financial Assets Oncology Franchise Diabetes Franchise Factors Affecting Pre-offer Day-to-Day Stock Price

 

OSI's Unique Portfolio of Assets and Characteristics Provide Compelling Value Tarceva: A Blockbuster with Additional Upside and Extensions Promising Diabetes / Obesity Franchise Strong Financial Performance Significant Financial Assets Any Third-Party Offer Should Provide Value for All of the Above Scarcity Value of a Unique Fully Integrated Oncology Franchise

 

EGFR-mutation, first-line maintenance, and ovarian cancer milestones expected over the next 15 months Life cycle plan expected to yield multiple data and label expansion opportunities Additional opportunities in liver cancer and multiple molecular targeted therapy combination trials Achieved ~$1.2 billion of worldwide revenue in 2009 Approved for sale in 109 countries for treatment of advanced non-small cell lung cancer (NSCLC) Strategically valuable long-term cash flows throughout exclusivity period Tarceva A Blockbuster Oncology Drug Tarceva Life Cycle Plan Has Robust Potential Tarceva Remains the Most Successful Oncology Product Launch in Terms of Patients Treated in U.S. History Expected Patent Exclusivity Through 2019-2020 in Major Markets Ensures Strong Cash Flow Generator for Many Years to Come

 

2004 2005 2006 2007 2008 2009 2010 2011 2013 2014 2012 NSCLC 2L/3L Approval (BR21) Pancreatic Cancer 1L Approval (PA3) NSCLC 1L Maintenance/ EGFR Mutation (SATURN)/CALGB data NSCLC 1L EGFR-Mt (EURTAC) Phase III data Ovarian Cancer 1LM (EORTC) Phase III data HCC 1L (SEARCH) Phase III data NSCLC Adjuvant (RADIANT) Phase III data NSCLC T+OSI-906 Phase III data A New Era for Tarceva No New Indications Timeline is based on latest estimate, which may change over time. Tarceva Life Cycle Plan Has Robust Potential Multiple Data Points Over the Next Several Years

 

A profitable and growing oncology business anchored around a blockbuster product with considerable remaining exclusivity (Tarceva) An experienced and capable commercial/business organization A pipeline approach that drives the development of differentiated Molecular Targeted Therapies (MTTs) Comprehensive OSI-906 development program differentiated from competitor antibody agents Industry leading platform & expertise in Epithelial-Mesenchymal Transition (EMT) A proven track record of success based on an established high quality drug discovery infrastructure and know-how OSI's Oncology Franchise Has Scarcity Value A Unique, Profitable and Fully-integrated Operation Integrated Oncology Franchise Represents a Unique Asset The Only Profitable Franchise of its Kind in Mid-Cap Biotech Space

 

Only Profitable, Mid-cap Company with a Blockbuster Product, Fully-integrated Oncology Franchise, an Exciting Pipeline and a Proven Platform/Technology = Unique Scarcity Value Source: Public filings and FactSet. Dollars in millions. Market value as of March 12, 2010. (1) Reflects 2009 actuals. OSI is the only fully integrated oncology company with high quality differentiated capabilities from discovery to commercialization Limited number of profitable mid-cap companies in the Biotech industry

 

In house discovery of "first-in-class" and potentially "best-in-class" drug candidates PSN821 and PSN010 Oral GLP-1 modulator franchise headed up by blockbuster potential of GPR119 agonist, PSN821 Consistent track record of success with 5 drug candidates advanced into clinical development over the last several years Acquired from ProBiodrug in 2004 for $35 million 12 companies have acquired licenses to this estate Has generated over $180 million in both revenue and pre-tax profit to date Average royalty rate of ~2.5% on a go- forward basis Diabetes and Obesity Franchise A Profitable and Cutting-edge Operation with Enormous Potential Promising Pipeline DP-IV Patent Estate Revenue Stream Diabetes/Obesity Organization is Profitable and Provides Phase II Assets in a Highly Attractive Area with a Huge Unmet Need

 

DP-IV royalty stream (>$1 billion in future cash flows) Cash, marketable securities and investments of ~$540 million, including investments in HBM and AVEO Net operating loss carry forwards of >$700 million at fiscal year end 2009 revenues up 13% YOY to ~$428 million 2009 Tarceva related revenues of $359 million Non-GAAP net income from continuing operations up 15% YOY to $181 million ($2.89 per share) $160mm of cash flow from operations Strong Financial Profile and Financial Assets Financial Assets = Significant Component of Value Considerable Financial Assets Strong Financial Performance in 2009 Financial Assets Valued at ~$1.3bn Implies Valuation of Strategic Assets of < $2.3bn in Astellas Offer

 

Financial assets worth ~$1.3 billion DP-IV patent estate royalties Cash, marketable securities and investments, including investments in HBM and AVEO Net operating loss carry forwards Remaining ~$2.3 billion valuation implies a low 5.75x revenue multiple for strategic assets based on Wall Street consensus 2010 estimates Implies no value for pipeline or technology platform assets Astellas' Offer in Perspective $52.00 per share Astellas' Offer Ascribes Inadequate Value to Strategic Assets OSI Board Response to the Astellas Offer Reflects Commitment to Realizing Full Intrinsic Value for Our Shareholders

 

Astellas' Offer of $52 Per Share is Inadequate Does not appropriately value our highly differentiated new product and Tarceva line extension pipeline Does not recognize value of diabetes and obesity franchise Does not recognize scarcity value of unique, profitable and fully integrated oncology franchise Low revenue multiple compared to recent precedent oncology transactions Offer below current trading levels The OSI Board Unanimously Recommends that OSI Shareholders REJECT the Offer and NOT TENDER Their Shares

 

We have engaged an outstanding team of advisors in order to explore the availability of a transaction that reflects the full intrinsic value of OSI Financial Advisors: Centerview Partners & Lazard Legal Counsel: Skadden Arps Path to Achieve Full Intrinsic Value The OSI Board takes its fiduciary duties very seriously The OSI Board Has Instructed OSI Management, with the Assistance of the Company's Financial Advisors, to Contact Appropriate Third Parties in Order to Explore the Availability of a Transaction that Reflects the Full Intrinsic Value of the Company

 

Shaping Medicine, Changing Lives Supplemental Information Colin Goddard, Ph.D. Chief Executive Officer CEO Gold Standard Founding Member March 2010

 

15 Tarceva: A Blockbuster Oncology Drug

 

16 Tarceva(r): Oral EGFR Tyrosine Kinase Inhibitor Tarceva: Regulatory Approvals First EGFr TK inhibitor to show survival in NSCLC and in 1st line pancreatic in combination with Gemcitabine Approved as a monotherapy treatment for advanced NSCLC patients after a first-line platinum containing chemotherapy regimen FDA approval in November, 2004 Full FDA Approval 3.5 months following submission (Fastest full FDA approval in oncology history) EU Approval in September, 2005 Japan Approval in October, 2007 Approved by the FDA as a first-line treatment in combination with gemcitabine for Pancreatic Cancer patients in November, 2005 EU Approval in January, 2007 Tarceva is now approved for sale in 109 countries for advanced NSCLC and in 80 countries for pancreatic cancer

 

Tarceva Franchise: SATURN A Surprising & Disappointing ODAC The SATURN study design and results have satisfied the customary regulatory hurdles for approval and the negative ODAC outcome (December 16th) was both surprising and disappointing SATURN is a large, multi-centered, well-controlled, well-balanced and randomized Phase III study comparing Tarceva with placebo in the 1st-line NSCLC maintenance setting which met both its primary PFS endpoints and the key overall survival secondary endpoint SATURN was conducted under a Special Protocol Assessment (SPA) procedure with FDA who accepted the study design The PDUFA date is April 18th, 2010 We believe, based on the exchange of information with FDA, that Tarceva will receive a label derived from the results of the SATURN study

 

Tarceva 4Q'09 Sales Exhibited Robust Growth Near Term Tactical Drivers Are Solid Tarceva Had a Strong Quarter to Finish 2009 4Q2009 U.S. Tarceva Sales were ~$137MM (up from $118MM in 3Q2009) Full Year Sales ~$479MM 4Q2009 ROW Tarceva Sales were ~$196MM (up from $183MM in 3Q2009) Full Year Sales ~$724MM Potential Underlying Near-term Growth Drivers in NSCLC Include Progression of Alimta to Earlier Lines of Therapy & Increased EGFR-mutation Awareness Yearly Tarceva Net Sales 2009 Worldwide Tarceva Net Sales of $1.2 Billion OSI Co-promotes with Genentech in US (equal profit share economics) Roche Commercializes ex-US (OSI: 21% Royalty) U.S. Sales - ROW Sales -

 

Robust Tarceva Life Cycle Clinical Program Major Milestones Expected Near-term Moving to 1st-line in patients with EGFR mutation EURTAC Phase III trial with high probability for a positive study (possible interim in 2010) CALGB Never Smokers Study (significant number of EGFR mutation patients) scheduled for ASCO data presentation Phase III combination with OSI-906 in planning for 4Q2010 Start Several other cooperative group trials under way Branching into other disease settings Ovarian maintenance results in 2010 1st-line HCC in combination with Nexavar on track Pediatric study in patients with Ependymoma 6 months patent term extension expected (extends to May 2019) Pancreatic cancer post-approval trials on-track

 

20 Scarcity Value of a Unique Fully Integrated Oncology Franchise

 

21 OSI 2010: A Strong Portfolio Solid Pipeline & Portfolio Progress PRODUCT PRODUCT IND TRACK PHASE I PHASE II PHASE III Marketed Oncology Tarceva - NSCLC Oncology Tarceva - Pancreatic Cancer Oncology Tarceva - Adjuvant NSCLC Oncology Tarceva - 1st line Maintenance Oncology Tarceva - Other Indications Oncology OSI-906 (IGF1R) ACC Ovarian Oncology OSI-027 (TORC1/TORC2) Oncology OSI-930 (c-kit/KDR) Diabetes PSN821(GPR119 Agonist) Diabetes PSN010 (GK activator) Diabetes OSI-541(Fatty Liver)

 

OSI-906: A Differentiated IGF-1R/IR Inhibitor Competitive Positioning Based on Cancer Biology Insights Strategic/Tactical Positioning Comprehensive first-in-class oral IGF-1R/IR inhibitor program protected by 56 issued and over 100 pending patents (Composition of Matter expires: 2027) Proprietary biomarkers linked to OSI-906 to be assessed early in clinical program OSI-906 biomarker IP derived from EMT-platform IGF-1/IGF-2 mediated signaling & Gene signature and indexing methodology Differentiation First small molecule to clinic, flexibility to dose with other agents Rapid cessation of drug exposure in case of adverse effects (unlike MAb's) Dual Inhibitor (IGF-1R and IR) Differentiates from MAb's Compensatory signaling and signaling driven by hybrid IGF-1R/IR receptors Blocks signaling pathways activated by both IGF-1 and IGF-2 ligands Broader spectrum of pre-clinical activity drives superior efficacy in model systems Superior to representative MAb's in pre-clinical setting Speed to Proof of Concept and Registration PoC in ACC with potential accelerated approval opportunity Phase III combination w/Tarceva in 1st-line NSCLC mutation pts scheduled for 2H2010 start 22

 

Speed to POC and registration strategy; orphan drug status Preclinical data indicates ACC is IGF-2 and IR/IGR-1R driven Opportunity to validate IGF-2/compensatory signaling thesis 80% power to detect approximately 70% improvement in OS (primary endpoint) and PFS (secondary endpoint) OSI-906 Registration Strategy in ACC Phase III Trial Currently Enrolling 135 ACC Patients Placebo (45) OSI-906 (90) Interim Analysis: PFS 2:1 randomization Follow patients to Overall Survival 23

 

On-going Phase I/II Combination trial w/paclitaxel in Ovarian Cancer OSI-906 + Tarceva in NSCLC Strong scientific rationale for OSI-906 + Tarceva in NSCLC based on IGF-1R, IR and EGFR compensatory signaling biology Significant clinical opportunity in NSCLC mutation (will also solidify Tarceva in front-line mutation +) Evaluate E-cadherin/vimentin biomarkers to test EMT thesis Planned clinical trials: Phase II maintenance setting, Tarceva vs. Tarceva + 906 Phase III front-line EGFR mutation +, Tarceva vs. Tarceva + 906 Hepatocellular carcinoma (HCC) HCC is associated with IGF-2 over-expression High unmet medical need, no approved agents in 2nd line setting Planned clinical trial: Phase II randomized placebo-controlled trial in 2nd line HCC Future Planned development programs in breast, prostate, and colorectal cancers are expected to initiate 2011-2012 OSI-906 Development Strategy Comprehensive Clinical Development Program 24

 

OSI-906 Clinical Development Plan Translational Medicine: Competitive Positioning Differentiation vs. Competitor Antibody and Small Molecule Products First small molecule to clinic, flexibility to dose with other agents Rapid cessation of drug exposure in case of adverse effects (unlike MAb's) Dual Inhibitor: IGF-1R and IR Compensatory signaling and signaling driven by hybrid IGF-1R/IR receptors Blocks signaling pathways activated by both IGF-1 and IGF-2 ligands Broader spectrum of pre-clinical activity drives superior efficacy in model systems OSI-906 MAB-391 Ctrl ACC (H295R) p-IR p-IGF-1R IGF-1R p-AKT Superior Activity versus IGF-1R Specific Monoclonals

 

pIRS-1Y612 b-actin H295R (ACC) pPRAS40 pAktS437 IGF-1R IR Competitive Positioning vs IGF-1R Monoclonals Dual inhibition of IR and IGF-1R achieves enhanced inhibition of the IRS- AKT pathway OSI-906 MAB-391 Ctrl p-IR p-IGF-1R OSI-906 co-inhibits both IR and IGF-1R, and achieves robust inhibition of the IRS-AKT pathway Compensatory increase in pIR evoked by the IGF-1R Ab MAB391 associated with inability to fully inhibit the IRS-AKT pathway Observations extend to a broad group of tumor types (EwS, ACC, NSCLC, OvCa, CRC,...)

 

Bi-directional IGF-1R/IR Compensatory Signaling is Observed In Vivo Inhibition of either IGF-1R (MAB391 neutralizing antibody) or IR (shRNA) confers a compensatory increase in phosphorylation of the reciprocal receptor. Conclusion: Inhibition of IGF-1R signaling only is Required but Not Sufficient ctrl IR-KD pIR pIGF-1R pIR pIGF-1R ctrl MAB391 GEO (CRC tumors) IGF-1R IR b-actin b-actin

 

hrs post dose hrs post dose GEO SKNAS OSI-906 MAB391 GEO SK-N-AS SK-N-AS GEO pIR pIGF-1R pIR pIGF-1R IR/IR-A IGF-1R IR/IR-A IGF-1R IGF-1 IGF-2 IGF1 IGF-2 Dual Inhibition of IR and IGF-1R Required for Optimal Efficacy in Xenograft Tumors Where Both Receptors are Present and Activated

 

TORC1/TORC2 Dual Kinase Inhibitor OSI-027 Differentiation Strategy PDK1 TSC1/2 TORC1 TORC2 AKT 4E-BP1 S6K S6 AKT PI3K OSI-027 OSI-027 Dual TORC1/TORC2 Inhibitor Strong IP position. Composition of matter coverage to 2026, excluding patent term adjustments / extensions OSI-027 "response" biomarkers now emerging Attenuates AKT activation by inhibiting TORC2 Induces tumor apoptosis; including those tumors resistant to rapamycin Potentiates chemotherapy-induced apoptosis More pronounced reduction of VEGF production in tumors Pronounced effect on tumor vessel re-growth 29

 

OSI Oncology R&D EMT Platform: Leadership in Emerging Field EMT Platform Enables: The discovery and validation of EMT-related targets as tumor growth and EMT drivers The development of novel therapies and combination therapies against EMT-related targets The delineation of pathways and combination strategies that address compensatory signaling as an EMT- associated drug-resistance mechanism The discovery and development of genomic, protein and transcript-based drug response biomarkers to support our oncology programs

 

Strategic Intent Inhibit Pathways in Epithelial-like & Mesenchymal-like Tumor Cells Epithelial, E-Cad+ erlotinib sensitive Mesenchymal, Vim+ erlotinib refractory

 

OSI Pharmaceuticals EMT Biomarker Research EMT Cell Models EMT RNA Signature EMT Biomarker Index Identify pathways that drive EMT Test inhibitors of EMT-associated targets Identify EMT Pathway Biomarkers ? ? ? 88 genes regulated during EMT 44 E- & 44 M-genes Derived iteratively across several model systems Assesses coordinately regulated expression of EMT genes in the novel signature Converts to an integer value for use in defining cut-points EMT 32

 

33 Diabetes / Obesity Franchise

 

34 OSI 2009: A Strong Portfolio Solid Pipeline & Portfolio Progress PRODUCT PRODUCT IND TRACK PHASE I PHASE II PHASE III Marketed Oncology Tarceva - NSCLC Oncology Tarceva - Pancreatic Cancer Oncology Tarceva - Adjuvant NSCLC Oncology Tarceva - 1st line Maintenance Oncology Tarceva - Other Indications Oncology OSI-906 (IGF1R) ACC Ovarian Oncology OSI-027 (TORC1/TORC2) Oncology OSI-930 (c-kit/KDR) Diabetes PSN821(GPR119 Agonist) Diabetes PSN010 (GK activator) Diabetes OSI-541(Fatty Liver)

 

OSI's Diabetes & Obesity Franchise A Profitable & Cutting-edge Operation DP-IV patent estate revenue stream Oral GLP-1 modulator franchise headed up by blockbuster potential of GPR119 agonist, PSN821 In-house discovery of first-in-class and potentially best-in-class drug candidates PSN821 and PSN010* in Phase II clinical trials Advanced molecules with dual DP-IV inhibitor and GRP119 agonist activities into late-stage candidates utilizing expertise in neurocrine biology and computational technology We believe that the Company's Second Profitable and High Quality Disease Area Franchise in Diabetes/Obesity Has Enormous Potential Our diabetes/obesity organization is not only profitable but also provides Phase II assets in a highly attractive area with a huge unmet medical need *Licensed to Lilly

 

DP-IV Patent Estate & License Portfolio A Major Revenue Stream for OSI Including additional DP-IV License Fees and Milestones - Total Revenues exceeded $180 million since 2006. DP-IV Royalties to OSI - -Januvia (Sitagliptin)/Janumet: Sales Since 4Q2006 - -Onglyza (Saxagliptin): Approved August 2009 * *Januvia & Janumet royalties are tiered based on annual sales and therefore average royalty rate re-sets in 1Q * Growth Rate of > 50% We believe that our DP-IV patent estate revenues will continue to grow at >25% year over year for the next several years.

 

Upside Opportunity: Diabetes Value Creation Building a Leading GPR119 Agonist Franchise GLP-1 modulation - glucose dependent improvement in beta-cell function Current GLP-1 modulators GLP-1 peptide agonists DP-IV inhibitors First-Generation GPR119 Agonist (PSN821) Entering Phase II in 2010 Second-Generation GPR119 Agonist (DIVA) Expected to Enter Development in Early 2011 OSI Strategy: Owning Key Space in GLP-1 Modulation Injectable Nausea/vomiting Glucose lowering ++ Meaningful weight loss Oral Well tolerated Glucose lowering + No weight loss Oral Well tolerated Glucose lowering + Meaningful weight loss Oral Well tolerated Glucose lowering ++ Meaningful weight loss

 

38 GPR119 Agonist Program: PSN821 in Phase IIa A Strategic Focus for OSI Highly attractive therapeutic class for treatment of type 2 diabetes Potential for meaningful weight loss in addition to substantial glucose lowering in an oral agent Highly competitive area We have a potential first-and best-in-class opportunity with our first- generation GPR119 agonist, PSN821 We are building a leading GPR119 agonist franchise: Second-generation GPR119 agonist approaches; Dual DP-IV Inhibitor and GPR119 Agonist (DIVA) Translational Research expertise Strong IP position (5 granted and 175 pending patents)

 

PSN821: GPR119 Agonist Preliminary POC From Ongoing Clinical Program Linear PK; twice daily dosing The clinical program to date has produced promising early proof-of-concept data demonstrating the ability to lower glucose in diabetic patients and, separately, the ability to impact accepted surrogates of weight loss in overweight and obese subjects Positive data from standardized meal intake and visual analogue scale measures PSN821 was well tolerated at single doses up to 3000 mg in healthy volunteers and 1000 mg (highest dose tested) in patients 39

 

40 Astellas - OSI Interactions 2009-10

 

Astellas - OSI Interactions 2009-10 February 2009: OSI receives non-binding indication of interest from Astellas to acquire 100% of OSI common shares outstanding for $55-57/share in cash BOD unanimously determined the indication of interest was inadequate and substantially undervalued OSI due to the following reasons: Solid performance of the business Nature of offer and timing Highly conditional including two months exclusivity and due diligence periods Astellas' lack of M&A experience and its CV Therapeutics interaction Other major pharmaceuticals, including OSI's partner, engaged in major transactions On a number of occasions between February 2009 and June 2009, Astellas reiterated interest in OSI BOD decided not to pursue as the terms and conditions of the non-binding indication of interest had not improved at all

 

In early 2010 Astellas reiterated its interest in OSI OSI provided Astellas with a business update at the JPMorgan healthcare conference in San Francisco in January 2010 OSI's CEO met with Astellas' CEO February 12, 2010 Astellas indicated it would be willing to acquire OSI at $52 per share BOD determined $52 price at which Astellas said it was interested in acquiring the company was inadequate due to the following reasons: Strong financial performance, continued growth in revenue and net income, increase in cash position, advances in pipeline and other positive trends However, BOD offered Astellas access to confidential information (under appropriate NDA) fundamental to the BOD's valuation of the company March 1, 2010, Astellas went public with their offer without addressing OSI BOD offer to get additional confidential information Astellas - OSI Interactions 2009-10 (Cont'd)

 

Shaping Medicine, Changing Lives Colin Goddard, Ph.D. Chief Executive Officer CEO Gold Standard Founding Member March 2010 OSI: A Focus on Fundamental Intrinsic Value
EX-99.E.2 7 y83222exv99wew2.htm EX-99.E.2 exv99wew2
Exhibit (e)(2)
LICENSE AGREEMENT
                    This License Agreement (this “Agreement”) is made as of the 25th day of December, 2003 (hereinafter referred to as “Effective Date”) by and between FUJISAWA PHARMACEUTICAL CO., LTD., a corporation organized and existing pursuant to the laws of Japan and having its registered office at 4-7, Doshomachi 3-chome, Chuo-ku, Osaka 541- 8514, Japan (hereinafter referred to as “FUJISAWA”) and OSI PHARMACEUTICALS, INC., a corporation organized and existing pursuant to the laws of the State of Delaware, U.S.A. and having executive offices at 58 South Service Road, Melville, New York 11747, U.S.A. (hereinafter referred to as “OSIP”).
                    WHEREAS, OSIP has been developing through its research activities new anti-cancer agents, including without limitation OSIP’s compound with internal code number, OSIP443930 and its derivatives for anti-cancer applications.
                    WHEREAS, FUJISAWA owns a certain patent rights whose claims may cover these compounds; and
                    WHEREAS, OSIP desires to obtain from FUJISAWA, and FUJISAWA is willing to grant to OSIP, an exclusive license in certain fields under such FUJISAWA patent rights;
                    NOW, THEREFORE, in consideration of the mutual promises, covenants and agreements hereinafter set forth, both parties to this Agreement mutually agree as follows:
ARTICLE 1
DEFINITIONS
1.1   “AFFILIATE(S)” shall mean any corporation, partnership or other business entity that is controlled by, controls, or is under common control with a party to this Agreement. For the purpose hereof, “control” shall mean the direct or beneficial ownership of no less than fifty percent (50%) of the voting stock or other ownership interest of such corporation, partnership or other business entity, or the possession, directly or indirectly, of the power to direct or cause direction of the management and policies of such corporation, partnership, or other business entity.
1.2   “FIELD” shall mean the field of oncology, including without limitation benign neoplasm, carcinoma, adenoma, myoma, sarcoma, myeloma, lymphoma, and leukemia.
1.3   “LICENSED PATENT RIGHT(S)” shall mean (a) the patents and patent applications listed in EXHIBIT A attached hereto and any continuations, divisions, reexaminations or reissues thereof, and any registration, revalidation or other equivalents based thereon, and (b) any patent extensions, and supplementary or complementary protection certificates or applications therefor based thereon.
1.4   “TERRITORY” shall mean the country(ies) where the development, manufacture, usage, labeling, promotion, distribution or sale of the LICENSED PRODUCTS would, but for the license granted hereunder, infringe a VALID CLAIM. For the avoidance of

 

 

    any doubt, TERRITORY shall include countries where any LICENSED PATENT RIGHTS do not exist, but where LICENSED PRODUCTS, whose manufacture was in a country where LICENSED PATENT RIGHTS do exist and would, but for the license granted hereunder, so infringe a VALID CLAIM, are sold.
1.5   “LICENSED PRODUCT(S)” shall mean a finished pharmaceutical product(s) which contains OSIP443930, its derivatives and any Kit-inhibitor and which when developed, made, used, labeled, promoted, distributed or sold would, but for the license granted hereunder, infringe a VALID CLAIM. For the avoidance of any doubt, LICENSED PRODUCT(S) shall include such product(s) whose manufacture would, but for the license granted hereunder, so infringe, but whose sale would not.
1.6   “NET SALES” shall mean the gross amounts received by OSIP and/or by AFFILIATE(S) or sub-licensee(s) of OSIP on account of sales of LICENSED PRODUCTS to non-affiliated third parties in the TERRITORY, less (i) quantity or cash discounts actually allowed or taken; (ii) freight, postage and insurance invoiced to the customer; (iii) customs duties and excise, value added and other taxes directly related to the sale to the extent applicable and not reimbursable and not including income tax; (iv) amounts repaid or credited by reason of rejections, return of goods or retroactive price reductions with respect to LICENSED PRODUCTS; (v) charges incurred in connection with the exportation of LICENSED PRODUCTS; and (vi) third-party rebates and allowances on account of the sale of LICENSED PRODUCTS to the extent actually allowed. Notwithstanding anything to the contrary herein, use of LICENSED PRODUCTS for or in clinical trials, preclinical trials, free samples or indigent patient programs shall not be deemed a sale hereunder.
    If OSIP or any of its AFFILIATES or sublicensees sell any combination product (a “COMBINATION PRODUCT”) in a bona fide sale to a non-affiliated third party in the TERRITORY, the parties shall negotiate in good-faith and shall agree no less than six (6) months before the launch of such COMBINATION PRODUCT on the economic contribution of the LICENSED PRODUCT relative to the COMBINATION PRODUCT. NET SALES shall then be calculated in accordance with the definition of NET SALES above as applied to the COMBINATION PRODUCT, and shall be reduced to the amount of the economic contribution of the LICENSED PRODUCT.
1.7   “VALID CLAIM” shall mean a claim of any patent or published patent application within LICENSED PATENT RIGHTS, which has not been withdrawn, cancelled or disclaimed, or finally rejected or held invalid by a court of competent jurisdiction in an unappealed or unappealable decision.
ARTICLE 2
LICENSE GRANT
2.1   FUJISAWA hereby grants to OSIP an exclusive license under the LICENSED PATENT RIGHTS, to develop, make, have made, use, label, promote, distribute and sell LICENSED PRODUCTS in the FIELD in the TERRITORY.

2

 

2.2   OSIP shall be entitled in its sole discretion to grant sub-licenses under such license in the TERRITORY.
2.3   In the countries or jurisdictions within the TERRITORY in which registration of the license is required by APPLICABLE LAW (hereinafter defined) in order for the license to have full effect as contemplated hereunder (including but not limited to the license (sen-yo jisshi-ken) granted in Japan), when OSIP reasonably determines such registration is necessary, it shall so inform FUJISAWA. If FUJISAWA agrees on the necessity of said registration (such agreement not to be unreasonably withheld), FUJISAWA shall, at OSIP’s expense, render all reasonable cooperation to OSIP (including but not limited to executing and delivering appropriate instruments and deeds) for OSIP to register, such license for the FIELD.
ARTICLE 3
CONSIDERATION
3.1   In consideration for the license granted hereunder, OSIP shall pay to FUJISAWA the following milestone payments;
  (a)   The sum of Three Hundred Thousand U.S. Dollars (US$300,000) upon execution of this Agreement;
  (b)   The sum of Four Hundred Thousand U.S. Dollars (US$400,000) upon first approval of Investigational New Drug Application on a LICENSED PRODUCT in U.S.A. or the equivalent thereto in any other country of the TERRITORY; and
  (c)   The sum of Three Million U.S. Dollars (US$3,000,000) upon first approval of the New Drug Application on a LICENSED PRODUCT in U.S.A.
    OSIP shall inform FUJISAWA of the occurrence of such milestone events promptly after the relevant milestone event occurred and shall make each milestone payment within thirty (30) days thereafter. The Parties hereby agree that each of the foregoing milestone payments shall be paid by OSIP to FUJISAWA not more than one time.
3.2   In consideration for the license granted hereunder, OSIP shall also pay to FUJISAWA a license maintenance fee of Fifty Thousand U. S. Dollars (US$50,000) at each anniversary of the Effective Date of this Agreement (each such period, an “AGREEMENT YEAR”) until the earlier of the termination or expiration of this Agreement or the first LICENSED PRODUCT launch in any country of the TERRITORY. Such license maintenance fee shall be due and payable within thirty (30) days after the end of each applicable AGREEMENT YEAR, provided that if the final AGREEMENT YEAR for which the license maintenance fee is payable is less than twelve (12) months, the annual license maintenance fee payment shall be prorated to reflect the actual duration of such period.
3.3   In consideration for the license granted hereunder, OSIP shall, in addition to those payments referred to in Articles 3.1 and 3.2 hereof, pay to FUJISAWA royalties at the rate of three and one-half percent (3.5%) of the NET SALES of LICENSED PRODUCTS sold in the TERRITORY. Such Royalties shall be payable on NET SALES of

3

 

    LICENSED PRODUCTS in each country of the TERRITORY, on a country-by-country basis, so long as the development, manufacture, usage, labeling, promotion, distribution and sale of LICENSED PRODUCTS would, but for the license granted hereunder, infringe a VALID CLAIM in such country or in the country of manufacture.
ARTICLE 4
ACCOUNTING
4.1   OSIP shall, and it shall cause its AFFILIATE(S) or sub-licensee(s) to, keep true and correct records of NET SALES in sufficient detail to enable determination and verification of royalties payable to FUJISAWA hereunder and shall deliver to FUJISAWA written statements thereof in such form as FUJISAWA shall instruct on or before the sixtieth (60th) day following the end of each calendar quarter (or any part thereof in the first or last calendar quarter) for said calendar quarter of this Agreement and at the same time shall pay to FUJISAWA the amount of such royalties shown to be due converted into Japanese Yen or U.S. Dollars, as FUJISAWA directs from time to time but not less than sixty (60) days prior to the date when the subject payment is due and payable, at the rate of exchange prevailing on the last business day of the quarter for which royalty is payable as set forth in The Wall Street Journal, by wire or in such other form and/or manner as FUJISAWA may reasonably request in advance.
4.2   Any income or other tax which OSIP is required to pay or withhold on behalf of FUJISAWA with respect to milestone payments, license maintenance fees and/or royalties payable to FUJISAWA under this Agreement shall be deducted from the amount of such milestone payments, license maintenance fees and/or royalties due; provided, however, that in regard to any such deduction OSIP shall, at FUJISAWA’ s sole expense, give FUJISAWA such assistance as may reasonably be necessary to enable or assist FUJISAWA to claim exemption therefrom and shall upon request give FUJISAWA proper evidence from time to time as to the payment of said taxes.
4.3   Upon FUJISAWA’ s request but not more than once each calendar year, OSIP shall permit such records as referred to in Article 4. 1 hereof to be examined by an independent certified public accountant, appointed by FUJISAWA and reasonably acceptable to OSIP, to verify the amount of royalties payable hereunder for not more than two (2) previous years. The reasonable costs of such examination shall be borne by FUJISAWA except that, if such examination reveals that royalties have been underpaid by more than five percent (5%), the costs shall be borne by OSIP. Said independent certified public accountant shall treat as confidential, and shall not disclose to (i) FUJISAWA any information other than information which shall be given to FUJISAWA pursuant to any provision of this Agreement and (ii) any other party any information disclosed to it or learned by it in the course of its audit.
ARTICLE 5
PATENT PROSECUTION, MAINTENANCE, INFRINGEMENT
5.1   Nothing in this Agreement shall be construed as a warranty or representation by FUJISAWA as to the validity or scope any LICENSED PATENT RIGHTS.

4

 

5.2   In the event that either party shall become aware of infringement of LICENSED PATENT RIGHTS by any third-party in the TERRITORY, it shall immediately so inform the other party. FUJISAWA may, but shall not be obligated to, institute action for any of such infringement of LICENSED PATENT RIGHTS. In this event OSIP shall give all reasonable assistance except for financial assistance to FUJISAWA, and may, if accepted by FUJISAWA, join such suit with its own counsel at its own expense and seek its own damages and other relief. If FUJISAWA does not institute any infringement proceedings against said third party within ninety (90) days (unless a shorter period is reasonably required to protect the intellectual property in question, then such shorter period shall apply) after confirming that said third party appears to be infringing LICENSED PATENT RIGHTS, then OSIP may institute such infringement proceedings against said third party at its expense; provided, however, that if APPLICABLE LAW of the relevant jurisdiction does not allow OSIP to institute such infringement proceedings as the licensee of LICENSED PATENT RIGHTS and OSIP reasonably demonstrates that the suspected infringement would materially adversely affect OSIP’s exploitation of LICENSED PATENT RIGHTS, as contemplated hereunder, FUJISAWA shall, at OSIP’s expense and upon OSIP’s written request, institute such infringement proceedings with counsel acceptable to both OSIP and FUJISAWA. In either event, FUJISAWA shall give all reasonable assistance except for financial assistance to OSIP and may join such suit with its own counsel at its own expense and seek its own damages and other relief. If neither party chooses to join the other, any amounts payable by said third party as a result of such proceedings shall belong to the party, which has instituted such proceedings.
5.3   FUJISAWA shall be responsible at its sole discretion for the prosecution and maintenance of LICENSED PATENT RIGHTS. FUJISAWA shall not abandon any LICENSED PATENT RIGHTS in any country of the TERRITORY, without first offering to assign it to OSIP. Such assignment shall be free of charge, provided, however, that any and all costs incurred or paid in relation to such assignment shall be borne by OSIP.
ARTICLE 6
DEVELOPMENT AND MARKETING
                    OSIP shall use REASONABLE COMMERCIAL EFFORTS to develop and market LICENSED PRODUCTS in the FIELD in all countries of the TERRITORY and on an semiannual basis shall promptly provide written information as to its development and commercial activities pursuant to this Agreement. FUJISAWA shall maintain such information in confidence to the extent it is and remains not publicly available and to the extent it is not required to be disclosed by law or in pursuance of any dispute resolution proceedings under Article 12.4 hereof. “REASONABLE COMMERCIAL EFFORTS” shall mean those efforts that would be employed by a similarly-sized and situated prudent pharmaceutical company with respect to product of similar market, indications and market potential at its given stage of research and development.

5

 

ARTICLE 7
REPRESENTATIONS, WARRANTIES AND CERTAIN COVENANTS
7.1   Each of FUJISAWA and OSIP represents, warrants and covenants that: (i) it has the legal authority to enter into this Agreement, (ii) the terms of this Agreement do not conflict with, and will not conflict with, and would not result in a breach under any agreement to which it is or will be a party that would have a material adverse effect on its ability to perform its obligations under this Agreement, and (iii) it complies with, and will continue to comply with, all applicable laws, rules, regulations, guidelines and industry standards (“APPLICABLE LAW”).
7.2   FUJISAWA represents, warrants and covenants that (i) it has the right to grant, and will throughout the term of this Agreement continue to have the right to grant, to OSIP the licenses and other rights granted to OSIP herein and (ii) it will not charge to or otherwise obligate OSIP to pay any amounts attributable to compensation payable to FUJISAWA’ s employees for inventions or other intellectual property which are part of the LICENSED PATENT RIGHTS.
ARTICLE 8
INDEMNIFICATION
8.1   OSIP agrees to defend, indemnify and hold FUJISAWA, its AFFILIATE(S) and its and their respective officers, employees and agents harmless from all claims, losses, damages or expenses (including reasonable attorneys’ fees and expenses) (“LOSSES”) arising from the claims of third parties as a result of (a) actual or asserted violations of any APPLICABLE LAW by OSIP, its AFFILIATE(S) or sub- licensees, especially, but not limited to those by virtue of which LICENSED PRODUCTS manufactured, distributed or sold shall be alleged or determined to be adulterated, misbranded, mislabeled or otherwise not in compliance with any APPLICABLE LAW; (b) claims for bodily injury, death or property damage (all including compensation for pain and suffering if asserted) attributable to the manufacture, distribution, sale or use of LICENSED PRODUCTS by OSIP its AFFILIATE(S) or sub-licensee(s) or (c) a LICENSED PRODUCT recall ordered by, a governmental agency or required by a confirmed product failure as reasonably determined by the parties hereto, except to the extent any such LOSSES are the result of the negligence or willful misconduct of FUJISAWA or any other party seeking indemnification under this Section 8.1 or the mutual breach of this Agreement by FUJISAWA.
8.2   FUJISAWA agrees to indemnify, defend and hold harmless OSIP and its AFFILIATES and its and their respective officers, employees, sublicensees and agents from all LOSSES arising from (i) a material breach of this Agreement by FUJISAWA or (ii) the negligence or willful misconduct of FUJISAWA or its AFFILIATES or its or their respective officers or employees, except to the extent any such LOSSES are the result of the negligence or willful misconduct of OSIP or any other party seeking indemnification under this Section 8.2 or the mutual breach of this Agreement by OSIP.
8.3   In case of a claim or indemnification under this Article 8, a party seeking indemnification

6

 

    shall promptly notify the other party in writing and the other party shall assume the defense against such claim with counsel mutually satisfactory to the parties; provided, however, that the party seeking indemnification shall have the right to retain its own counsel at its own expense.
ARTICLE 9
CONFIDENTIALITY
9.1   The parties agree that all information received from the other party and all information and intellectual property developed by the other party pursuant to this Agreement are the other party’s “CONFIDENTIAL INFORMATION”, and shall remain the sole and exclusive property of such party during the term of this Agreement and thereafter.
9.2   Each party agrees not to disclose the other party’s CONFIDENTIAL INFORMATION to any person or entity (except any employee or agent who has a need to know the same and who is directly involved in activities pursuant to this Agreement or as otherwise required by APPLICABLE LAW to know such information) without the prior written consent of such other party and further agrees to take all reasonable precautions to prevent the disclosure by any of its employees, officers or agents of such CONFIDENTIAL INFORMATION to any third party or otherwise into the public domain. Each party agrees that neither it, nor any of its employees or agents, will be permitted to make any use of the other party’s CONFIDENTIAL INFORMATION except as permitted or required by this Agreement. A party may disclose the other party’s CONFIDENTIAL INFORMATION to the extent such disclosure is required to comply with applicable governmental regulations or to the extent ordered by a court order, provided that the other party shall be given reasonable notice of such disclosure requirement and the disclosing party will use its reasonable best efforts to secure confidential treatment of the CONFIDENTIAL INFORMATION required to be disclosed.
9.3   The provisions of this Article do not apply to any information that:
  (a)   was known to the receiving party at the time of disclosure, as demonstrated by competent written records;
  (b)   is generally known to the public or which becomes generally known to the public through no act or omission on the part of the receiving party;
  (c)   is disclosed to the receiving party at any time by a third party who had a legal right to disclose it; or
  (d)   is independently developed by the receiving party’s employees who have no knowledge of or access to the CONFIDENTIAL INFORMATION supplied by the other party.
9.4   Any and all CONFIDENTIAL INFORMATION received by either party, or any of its employees, officers or agents, in whatever form, including all copies or duplicates made or retained by such party, or any of its employees, officers or agents, shall be promptly returned upon written request from the party originally disclosing the same or disposed of

7

 

    in accordance with reasonable written instructions, provided one (1) copy of all such CONFIDENTIAL INFORMATION may be retained for archival purposes and such copy shall continue to be subject to the confidentiality provisions of this Section.
9.5   The obligations of this Article shall terminate five (5) years following termination of this Agreement.
ARTICLE 10
TERM AND TERMINATION
10.1   This Agreement shall become effective on the Effective Date and shall, unless terminated earlier in accordance with this Article, continue in force until the last to expire of the VALID CLAIM of the LICENSED PATENT RIGHTS.
10.2   FUJISAWA may terminate this Agreement following sixty (60) days prior written notice (the “NOTICE PERIOD”) to OSIP in the event that (a) OSIP fails to make any payment which is due under Article 3 hereof and is not subject to a bona fide dispute, within the NOTICE PERIOD; or (b) OSIP commits a material breach of any other obligation of this Agreement which is not cured within the NOTICE PERIOD, (c) OSIP goes into liquidation, a receiver or a trustee is appointed for the property or estate of OSIP, files or is filed a petition for bankruptcy, corporate reorganization, civil rehabilitation or other insolvency proceedings, or OSIP makes an assignment for the benefit of creditors, and whether any of the aforesaid events be the outcome of the voluntary act of OSIP, or otherwise or (d) OSIP directly or indirectly contests the validity of any LICENSED PATENT RIGHTS or does not, within 30 days following execution of this Agreement, irrevocably withdraw any and all proceedings previously filed attacking the validity of such LICENSED PATENT RIGHTS.
10.3   OSIP may terminate this Agreement following the NOTICE PERIOD (a) on sixty (60) days prior written notice to FUJISAWA with or without cause, (b) if FUJISAWA commits a material breach of any other obligation of this Agreement which is not cured within the NOTICE PERIOD; or (c) if FUJISAWA goes into liquidation, a receiver or a trustee is appointed for the property or estate of FUJISAWA, files or is filed a petition for bankruptcy, corporate reorganization, civil rehabilitation or other insolvency proceedings, or FUJISAWA makes an assignment for the benefit of creditors, and whether any of the aforesaid events be the outcome of the voluntary act of FUJISAWA, or otherwise.
10.4   Termination of this Agreement shall not affect any rights or obligations accrued prior to the effective date of such termination, specifically OSIP’s obligation to make payments according to the provisions of this Agreement.
ARTICLE 11
NOTICES
             Any notice required by this Agreement shall be sent by registered or certified air mail or delivered by courier or transmitted by facsimile or other electronic means, then confirmed by air mail, to the following:

8

 

to FUJISAWA:
FUJISAWA PHARMACEUTICAL CO., LTD.
4-7, Doshomachi 3-chome, Chuo-ku,
Osaka 541-8514, Japan
Attn. Director, Legal Affairs
Facsimile No.: 81-6-6206-7929
to OSIP:
OSI PHARMACEUTICALS, INC.
58 South Service Road,
Melville, New York 11747, U.S.A.
Attn.:Corporate Counsel
Facsimile No.: (631) 293-2218
with a copy to:
Attn.: Vice President, Corporate Development
Facsimile No.: (631) 962-2021
                    Such notice shall be effective on the third business day following express mailing or on the day following transmission if transmitted by electronic means. The above address may be changed by notice to the other party as provided in this Article.
ARTICLE 12
MISCELLANEOUS
12.1   This Agreement, together with EXHIBIT A hereto, constitutes the entire agreement between the parties relating to the subject matter thereof. It may not be modified except in writing signed by both parties.
12.2   In the event that further lawful performance of this Agreement or any part thereof by either party shall be rendered impossible by or as a consequence of any law, order or act of any government or political subdivision thereof having jurisdiction over such party, or by acts of public enemies, war, strikes or other labor disturbances, fires, floods, acts of Gods or any causes of like or different kind beyond the control of the parties including acts, omissions or delays of the other party, the parties hereto shall be excused from any failure to perform any obligation hereunder to the extent such failure attributable to such causes.
12.3   This Agreement shall be governed by and interpreted in accordance with the laws of Japan.
12.4   In case any dispute arises out of this Agreement, the parties will endeavor to settle such dispute amicably between themselves. In the event that the parties fail to agree, any such

9

 

    dispute shall be finally settled by arbitration administered by and according to the Rules of Arbitration of the International Chamber of Commerce by one or more arbitrators appointed in accordance with said Rules. Such arbitration shall be in the English language and shall take place in New York, New York (U.S.A.) if demanded by FUJISAWA and in Osaka (Japan) if demanded by OSIP.
12.5   Any waiver on the part of either party hereto of any right or interest hereunder shall not imply the waiver of any other right or interest, or subsequent waiver.
12.6   The illegality, invalidity or unenforceability of any clause or part of this Agreement shall not affect the legality, validity or enforceability of the remainder. If any such clause or part is found by any competent court or authority to be illegal, invalid or unenforceable, the parties agree that they will substitute provisions in form as similar to the offending provisions as is possible without thereby rendering them illegal, invalid or unenforceable.
12.7   A party shall not assign, or otherwise transfer any right or obligation under this Agreement without the prior written consent of the other party, provided a party may assign this Agreement (i) to a third party in connection with the sale, transfer or other disposition (including merger) of substantially all of its assets related to this Agreement or (ii) to an AFFILIATE.
12.8   Neither party shall hold itself out to third parties as possessing any power or authority to enter into any contract or commitment on behalf of the other party. It is not intended that this Agreement shall be construed under any circumstance to create any agency, joint venture, partnership or employer/employee relationship. Each party is an independent contractor of the other party.
12.9   Except as required by APPLICABLE LAW or regulations, no public announcement, press release or disclosure to a third party concerning this Agreement or its terms shall be made by either party hereto without the prior written consent and approval of the other party.
12.10   This Agreement may be executed in any number of counterparts, each of which shall be deemed an original but all of such together shall constitute one and the same instrument.
12.11   Termination of this Agreement for any reason will not relieve either party of any obligation that expressly or by implication survives termination nor relieve either party of any obligations or liabilities for loss or damage to the other party arising out of or caused by acts or omissions of such party prior to the effectiveness of such termination or arising out of its obligations already performed or of obligations assumed prior to the date of such termination.
* * * *

10

 

                    IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed in their names by their properly and duly authorized officers or representatives as of the first above written.
                     
FUJISAWA PHARMACEUTICAL CO., LTD       OSI PHARMACEUTICALS, INC.    
 
                    
By:
  /s/ Hatsuo Aoki, Ph.D.       By:   /s/ Geoff Cooper, Ph.D.    
 
                   
 
  Name: Hatsuo Aoki, Ph.D.           Name: Geoff Cooper, Ph.D.    
 
  Title:   President and CEO           Title:   Vice President,
            Business Development		    

11

 

EXHIBIT A
LICENSED PATENT RIGHTS List
                         
    Patent No.              
Country   (Application No. )     Filing Date     Expiration Date  
USA
     6054457     Jun. 6, 1996   Jun. 6, 2016
Japan
     (9-502896 )   Jun. 6, 1996   Jun. 6, 2016
Austria
     0832061     Jun. 6, 1996   Jun. 6, 2016
Belgium
     0832061     Jun. 6, 1996   Jun. 6, 2016
Switzerland
     0832061     Jun. 6, 1996   Jun. 6, 2016
Germany
     69615025.5     Jun. 6, 1996   Jun. 6, 2016
Denmark
     0832061     June. 6, 1996   June. 6, 2016
Spain
     0832061     Jun. 6, 1996   Jun. 6, 2016
Finland
     0832061     Jun. 6, 1996   Jun. 6, 2016
France
     0832061     Jun. 6, 1996   Jun. 6, 2016
Great Britain
     0832061     Jun. 6, 1996   Jun. 6, 2016
Greece
     3036881     Jun. 6, 1996   Jun. 6, 2016
Ireland
     0832061     Jun. 6, 1996   Jun. 6, 2016
Italy
     0832061     Jun. 6, 1996   Jun. 6, 2016
Luxembourg
     0832061     Jun. 6, 1996   Jun. 6, 2016
Netherlands
     0832061     Jun. 6, 1996   Jun. 6, 2016
Portugal
     0832061     Jun. 6, 1996   Jun. 6, 2016
Sweden
     0832061     Jun. 6, 1996   Jun. 6, 2016
USA
     6316482     Jul. 11, 2000   Nov. 18, 2017
Japan
     (10-521225 )   Nov. 18, 1997   Nov. 18, 2017
USA
     6207693     Nov. 18, 1997   Nov. 18, 2017

 

EX-99.E.24 8 y83222exv99wew24.htm EX-99.E.24 exv99wew24
 
Exhibit (e)(24)
 
     
(ASTELLAS LOGO)   (LETTERHEAD)
 
 
< Strictly Confidential >
 
February 2, 2009
 
 
VIA EMAIL AND OVERNIGHT COURIER
 
Colin Goddard, Ph.D.
Chief Executive Officer
OSI Pharmaceuticals, Inc.
41 Pinelawn Road
Melville, NY 11747
 
Dear Dr. Goddard:
 
 
We appreciate the time that you spent with my colleagues, Drs. Masaki Doi and Kaori Maeda, on January 14, 2009 in San Francisco. As Dr. Doi expressed, in evaluating the future of our industry and the strategic objectives for Astellas Pharma Inc. (“Astellas”), we have concluded that a combination of OSI Pharmaceuticals, Inc. (“OSI” or “the Company”) with Astellas presents a very compelling proposition for our respective shareholders, employees and other important stakeholders.
 
 
We have actively followed OSI for some time and are extremely impressed with your management team, the Company’s achievement and future prospects. Specifically, we compliment OSI on its progression over the last several years from a research-focused organization to a company able to successfully develop a novel therapeutic, establish a commercial infrastructure, and create a robust pipeline. By bringing our two organizations together, our increased scale and financial strength would enable the combined company to expedite bringing additional products through development and ensure their successful commercialization. The combination would also be complementary from geographical and therapeutic area focus perspectives, leveraging your existing presence in the United States with our global footprint and accelerating our aspiration to become one of the leading players in the oncology area. We believe Astellas could serve as a platform for OSI’s future success and, as we experienced in the past, the larger combined entity would allow us to maximize the goal of discovering, developing and delivering novel medications for patients with unmet medical needs far better than each company could independently.
 
 
Astellas is a leading global pharmaceutical company formed through the merger of Yamanouchi and Fujisawa in 2005, with nearly $10 billion in revenue. We have a history of successfully developing, launching and commercializing new drugs and have a significant product pipeline. Some of our leading products include Prograf (immunosuppressant), Flomax/Harnal (BPH) and VESIcare (OAB). Since our decision to expand our capabilities to biologies and to enter into oncology area, Astellas successfully acquired Agensys in

 

Colin Goddard, Ph.D.
OSI Pharmaceuticals, Inc.
February 2, 2009
Page 2
 
 
December 2007, a Santa Monica-based monoclonal antibody company specialized in oncology, and it has already become an integral part of Astellas global operations.
 
 
Based on publicly available information regarding the Company and our knowledge of the industry, Astellas is prepared to provide this non-binding indication of interest for the acquisition of OSI for between $55.00 - $57.00 per share in cash on a fully diluted basis. This price range represents a 54% - 60% premium to OSI’s closing share price as of January 30, 2009 as well as a substantial premium to OSI’s three month average share price. We believe, and expect that you will agree, that this proposal ascribes significant present value to the current success and future potential of OSI. We also believe such an offer provides a very attractive opportunity for your shareholders to realize liquidity at a substantial premium. Our proposal is not subject to any financing condition and thus delivers significant immediate value to your shareholders, with no execution risk in this very volatile market environment.
 
 
We have received approval from our Global Management Committee to submit this letter, and we have discussed this opportunity with our Board of Directors. They support our submission of this proposal and proceeding with further discussions to complete a potential transaction. Prior to executing a definitive proposal, we will need to obtain formal authorization from our Board. Given that we are financing the transaction from available cash and other available resources, there are no authorizations related to financing that need to be secured.
 
 
Given Astellas’s familiarity with the industry and your company, we are prepared to move expeditiously, on an exclusive basis, towards announcing a successful execution of a definitive agreement by March 31, 2009. The transaction would, of course, be subject to the satisfactory completion of a due diligence review, negotiation of definitive deal documents, Board approvals and standard regulatory approvals. If you agree, we could start the due diligence review immediately after the execution of the enclosed mutual non-disclosure agreement.
 
 
We have engaged Citigroup Global Markets, Inc., Ernst & Young LLP, and Morrison & Foerster LLP as our external financial, accounting and legal advisors, respectively, to assist us with this transaction. Each of these organizations has significant expertise in executing cross-border M&A transactions and will help ensure the successful completion of the proposed transaction.
 
 
We are pleased to provide this non-binding proposal to demonstrate our interest in pursuing a strategic transaction between OSI and Astellas. This letter is being provided for discussion purposes only and does not constitute or create any obligation or commitment to pursue a transaction on the part of either OSI or Astellas. We have no intent to publicly disclose this letter, and would also expect you and the OSI Board to maintain this expression of interest as strictly confidential. Upon any unauthorized disclosure of this letter to any third party (other than our respective external advisors, in each case on a confidential basis), our proposal will be withdrawn in our sole discretion.

 

Colin Goddard, Ph.D.
OSI Pharmaceuticals, Inc.
February 2, 2009
Page 3
 
The key contacts for Astellas and Citigroup are:
 
     
Masaki Doi, Ph.D. 
  Naoki Okamura
Corporate Executive
  Senior Director, Business Development
Vice President, Business Development
   
Astellas Pharma Inc. 
  Astellas Pharma Inc.
2-3-11 Nihonbashi-Honcho
  2-3-11 Nihonbashi-Honcho
Chuo-ku, Tokyo 103-8411, Japan
  Chuo-ku, Tokyo 103-8411, Japan
Phone: (0081) 3 3244 2500
  Phone: (0081) 3 3244 2505
Email: masaki.doi@jp.astellas.com
  Email: naoki.okamura@jp.astellas.com
     
Christopher Hite
  Vikram Bhardwaj
Managing Director
  Managing Director
Global Co-Head of Healthcare
  Mergers & Acquisitions
Investment Banking
   
Citigroup
  Citigroup
388 Greenwich Street
  633 West Fifth Street, Suite 6300
New York, NY 10013
  Los Angeles, CA 90071
Phone: (212) 816 1818
  Phone: (213) 833 2349
Email: christopher.hite@citi.com
  Email: vikram.bhardwaj@citi.com
 
 
We are very enthusiastic about the potential combination of our companies. We will contact you after your receipt of this letter to discuss when we might hear back regarding your Board’s reaction to our proposal and how best to move forward.
 
Very truly yours,
 
-s- Masafumi Nogimori
Masafumi Nogimori
President and CEO

EX-99.E.25 9 y83222exv99wew25.htm EX-99.E.25 exv99wew25
Exhibit (e)(25)
 
     
Colin Goddard, Ph.D. 
Chief Executive Officer 		  OSI Pharmaceuticals, Inc.
41 Pinelawn Road
Melville, NY 11747
T 631.962.2051 F 631.752.3869
www.osip.com
 
 
(OSI LOGO) Strictly Confidential
 
February 5, 2009
 
Via Email and Overnight Courier
 
Mr. Masafumi Nogimori
President and CEO
Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chame
Chuo-Ku, Tokyo 103-8411
Japan
 
Dear Mr. Nogimori:
 
 
In follow-up to my earlier note acknowledging receipt of your letter dated February 2, 2009 with respect to Astellas Pharma’s interest in OSI Pharmaceuticals, I am writing to inform you that I have now communicated Astellas’ interest to the OSI Board of Directors. Our board has committed to a careful and thorough review of your proposal and will respond in due course.
 
 
We at OSI continue to make progress in our mission to build a premier personalized medicine company around our flagship product Tarceva. By now I am sure that you have been made aware of our Monday evening announcement regarding the favorable results of the phase III ATLAS study of the combination of Tarceva and Avastin in the first line maintenance treatment of lung cancer patients. The subsequent market reaction appears to concur with our view that this positive outcome, following on from the earlier SATURN study, substantially improves the overall regulatory and commercial prospects for Tarceva in the maintenance setting. Needless to say, these data further reinforce the confidence of our Board and management in OSI’s future prospects and success.
 
 
We at OSI are committed to handling your proposal in an appropriately confidential manner and trust that Astellas’ interest in OSI, your February 2nd letter, this response and the OSI Board’s review will remain strictly confidential.
 
Very truly yours,
 
-s- Colin Goddard
Colin Goddard
Chief Executive Officer

EX-99.E.26 10 y83222exv99wew26.htm EX-99.E.26 exv99wew26
Exhibit (e)(26)
 
     
Colin Goddard, Ph.D. 
Chief Executive Officer 		  OSI Pharmaceuticals, Inc.
41 Pinelawn Road
Melville, NY 11747
T 631.962.2051 F 631.752.3869
www.osip.com
 
 
(OSI LOGO) Strictly Confidential
 
February 19, 2009
 
Via Email and Overnight Courier
 
Mr. Masafumi Nogimori
President and CEO
Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chame
Chuo-Ku, Tokyo 103-8411
Japan
 
Dear Mr. Nogimori:
 
 
Thank you again for your letter of February 2nd. As indicated in my letter of February 5th our board committed to a careful and thorough review of your proposal. The Board of Directors of OSI Pharmaceuticals, with the assistance of its financial and legal advisors, has now reviewed and considered the proposal contained in your letter. Based upon this review, our Board believes that your proposal is inadequate and significantly undervalues OSI and, accordingly, is not in the best interest of OSI stockholders.
 
 
Our Board takes its fiduciary duties very seriously and remains focused on delivering value to OSI’s stockholders. Given the momentum of Tarceva sales, the positive recent clinical results on Tarceva and the strength of our research and development pipeline in oncology and diabetes, the OSI Board does not believe that pursuing your proposal will further the interests of our stockholders.
 
 
We have handled your proposal in an appropriately confidential manner and trust you will do the same.
 
Very truly yours,
 
-s- Colin Goddard
Colin Goddard
Chief Executive Officer

EX-99.E.27 11 y83222exv99wew27.htm EX-99.E.27 exv99wew27
Exhibit (e)(27)
 
     
Colin Gaddard, Ph.D. 
Chief Executive Officer 		  OSI Pharmaceuticals, Inc. 
41 Pinelawn Road
Melville, NY 11747
T 631.962.2051 F 631.752.3869
www.osip.com
 
 
(OSI LOGO) STRICTLY CONFIDENTIAL
 
February 22, 2010
 
Mr. Masafumi Nogimori
President and Chief Executive Officer
Astellas Pharma Inc. 
2-3-11 Nihonbashi-Honcho
Chuo-Ku, Tokyo 103-8411
 
Dear Nogimori-san:
 
 
I enjoyed meeting you on Friday, February 12th and appreciated our frank and open discussions along with the opportunity to share with you our strategic thinking and the broad range of initiatives we have ongoing to enhance the value of our company for our shareholders. Following our meeting, I briefed my Board of Directors on our discussions, including the $52 per share price at which you said Astellas would be interested in acquiring our Company.
 
 
As I had suggested at our meeting, our Board is not interested in undertaking a sale of OSI at that price, which we believe very significantly undervalues our Company. However, I can confirm that we are prepared to provide you with certain non-public information regarding the Company, which is fundamental to our view of the value of OSI Pharmaceuticals. Inasmuch as this information is confidential, our willingness to make it available to your team is subject to your execution of a Nondisclosure Agreement and we have taken the liberty of attaching the form hereto.
 
 
We have handled our discussions in an appropriately confidential manner and trust you will do the same.
 
Very truly yours,
 
-s- Colin Goddard
Colin Goddard
Chief Executive Officer

GRAPHIC 12 y83222y8322204.gif GRAPHIC begin 644 y83222y8322204.gif M1TE&.#EA^@`<`.8``%%14M?7U[Z^OKJZ MNFYN;K>WMWAX>,_/SYJ:FKR\O#HZ.N_O[[*RLA@8&!45%<;&QM+2TL/#P\K* MRA$1$6)B8H*"@JBHJ`4%!8"`@,C(R&!@8)B8F')R<@D)":2DI*JJJD1$1(Z. MCDI*2L+"PCX^/I24E(2$A(B(B-#0T$!`0!X>'GY^?HN+BSP\/*:FIJ"@H%I: M6FAH:'Q\?*ZNKI:6EJRLK%965C`P,&IJ:KBXN#0T-%Y>7K"PL(:&AE145$)" M0EA86#(R,DA(2$9&1AL;&XR,C`("`O[^_MK:VOO[^_W]_>KJZOS\_/KZ^OCX M^-O;V_?W]^OKZ_7U]?/S\^SL[/GY^>7EY=W=W?'Q\=[>WN?GY^;FYO;V]MS< MW./CX^3DY.#@X.WM[=C8V-_?W^+BXO#P\-G9V0$!`0```/___R'Y!``````` M+`````#Z`!P```?_@']_9`A^?A4*@HJ+C(V.CXQO"X8S)G\=?I@Z?HF0BV)? MH6*>I*6FIZBIJJNLCF"A7Z.F&'T57`!=K;H3,RE^$"%_?G]-?D"=I'`##Q(2 M"\BZT=+3U(NYU7=9S@L@=Z5@"%Q^)!G5J6Q0AGX;?RY_%#<4>:9H&CP+?7X3 MYOS]_HULG*PP4ZT#$!+Y9M@IA8>$.!!P_I%:LT+=$3FMUH`98&B?Q(\@6>GA MV&(@-3%G2FCQT\<+J2Y"_+3P0T!6R$8"2!C24B(:1S\L;@H=^D<,&D8F$/J! MD<:<%R`L77H*@<-0BYZ-NK@I`^?:HRYUN'ZQ\P65&`N&N/3P*?,$T;O@]C4K*RP-#$LY8.V`!BJT1-GAX:W0!1X46)*S,,*`(C8,L6&S8 MR`Q`C2(*ZIH$:_73(]S3U>9HX9"5S5&]4%N2BC%C)@*O?X2L])-B1CX_"SZ, M660"R@R6OU0A!@0R^1&$(EULD4(??2P0@!<3Z-3"%$!"E`X4#_"BV4E(L;._B++0Q`/,>%!340L%(+4)``Q`):Y,-$ MBB0L\&\?6BSTQQ@K:#'"`P[W08((E7E0@1]#$$!`$WT,$`88(HS0`@X6`%"; M"FADL("5+/,1&`]`P!$,C%!! M&&@0L4`%#UCI1P1N"]*L(&44/``$.DP:Q@_77OA.UGZ`$/@!0\M$@R!C6"N. M#`*DX8%[BVQ`[KQA-((62PXTPE$%5&B9PPR^W&`P0/'L0)_\K"W,+`A`D[(@!G%R(`%;/DA=8J(PV,,L98_@.%YR=-`O4)W+=(U8@?.>:'J\J&<+>7( M#U`HSQ_2Y8?+">(,"%$:B!1!!ZC<;1$V@`X4R%`7(_2.`(:H@EJT*$(7",I^9K)`H`6NGQ=84R+B(DA<.$=Z/``7LZI M))0,40-%?.$O4G2$$0Y1NN-!IY$#=)4@P,@%&RSB=+'\0QH1\(@7'`>.?\C` M3$C0.U0*P`Q4$(<$=`"#"BP,>OT;I#;)]#!$*H(#V,(FB#A@",K\X0;.>4!W M!)$&%`Q($)WTPR<5$4+0^*$)!KA/+EB)+5<^S!#A_$,6#8&%!G7!:C.Y5@L8 MT,Y4J6,`B_DF2[@``EXMXB?'5`0>AM8'@P[@.2AP)C2K&1XQP.$)-9!`"ZYX M/$,(=!%I]*8BT-*'<-X@'VO_7,07\+"!&-@"!!#%U@)`N0@[V,(/$G"`"F"P M5AC`0$A/>Y`>#(J\/0+#I5\;@`R2$D:PA;,,(\I$" M&'R@+!R]$!I`D(^J6J,*&>-"3L&"A@`0P!=I.:4B4/!2HDZ5)4+T3CYRBKD' MD,BG,L&`4'T8G@(@H`HD($'6F"H(Y-'$$028"1-DFEI!5,0/Y,1<`8[0A`J< M%9U,,,0#^+,(+[A0"&.`!2QR$4)^UB*1QA6'!>AR7+\Z)["/,(,"5F`$F1GB M!XB-C53$X%5UD&`"7[`!N;@@E3\48";`4<\?X."0I7;B#3I@`D&64+""]C(? MT20N_Q="^@><$L0AP"O.,7Q5$$0`9*" MF*8Q!+N(W(DC!1HPK$3C2Z+^=F$"3R!`1QV.07HIL/"*C.$*S]PR.Y,(-F5AA;3Q`J M%X"PK#^`X!`Y&(1^4XQ%1K;8#T8@KHP-D5P!/&8(+BG#8]#YQYD4X=,)`%6% MK%C(0RJ9`-@:+R,:X.`_!"`?).CO(A2@DP7D`0P1G6@H^?_R!05X)@U)-80* M(-##!H!H`VO3P@I8$%QQ,"&FW&L!$#R`@:J@5=9[D$$:N:"%'V!!P&<8&ATD%XPP M'!3,@`L)&,48S`W?10B`#@)@[+_MQ=V0\2^&MK#K'RQP34:`89I]>/4?TM"M MJFY2#/43AU0[V0Z@`=\S*``8K##&=(5\S:L M00T7T`(7%H"!'@W@6E0(@A.%AL$+1Q`'#.;@!CG4 M`8Q]H,(;TH`&.+QHPB&`0[RN)X,=-`%;%=B`%_;0`0G(1`,E*`,?>B`!%EA& M'`\H`$'.<`(;[*,-^.BK%_P3@6NI_`,DPD$=TE"``JS]>09(`X58H"("S"$. M7O!``KH*G29T(`/F!D(`XC`*/HCRE'N`0@I\D(LTK,0(&%CLB+6TI384X5=R M<@`&%BJ(6QV!`@"08!2@!X0R!DM``2Q@``IH`!/P)!'E!S_0*,LD$PE``"M` M!4N%,'70!`#0'*6T`"S`!%US",R@!PAP<<]!`C`P(C$S-RI@,`%#<`70`P01@`,'$&85,`,5P`!40"(2\`"R8P`+ M`#`W^#3+<@8`(`XCX`(]8`,CL`"6@`8JP!)?"`3MEC4S``$M!<"V`!`3`$.H`#"5`D,'`!"^`"B0,=0$`!93$!SM$' M,D!=;Z$'NU$!4N`(G.('B=8/9B!@-S$&;$`0@O`%;$!E@F`&;_`&#[4E='`! M96"36E4&>*`'9&4>7L`',DD*;H`';T"4-UD&(7`-3WD&1-9_<6`&8_`&%W`! MH/,';_`P>U=I<`$:#">!$_B2G]B6;OF)7^`!US(#U@879:!?T/,!C_!3+OF6 M?OF7<*$'9,D`PB84'I`Q?\-_:,>6@-E4F(Y9#5U``:-S!%GY$0!@%6[1"&80 M!J3H`F?PDX\9FJ*9"F90`S0P`7KY%B4P`1.@`%EI`7AR7BG@8Z-9F[9YFY!0 4`#RP`BO@`B[``].!F\)YFX$``#L_ ` end GRAPHIC 13 y83222y8322207.gif GRAPHIC begin 644 y83222y8322207.gif M1TE&.#EA_@`\`,0```\/#Q\?']_?WS\_/^_O[[^_OW]_?T]/3\_/SR\O+U]? M7Y^?GZ^OKX^/CV]O;P```/___P`````````````````````````````````` M`````````````````````````"'Y!```````+`````#^`#P```7_("2.9&F> M*$HLAG$,`0`,BD&D>*[O?.__P*!P2!0B6+'!P#%HM12#Q\-0K%JOV*QV.Q0T M$H]$$X%;@*G@)`H&Z>Y\M``I\@8$"#G$&9$`&#X""C4$" M``^(CI19!`HSC$**FI6>*G$,GZ-=#0`*##=#!`D)JJ2P$(H*L;4[<`>=0PL/ M#K:D#`"NO\0F`PFZJY%ZQ8[!#\W1D&A78-&4SPO7Q+S)1%&BVX$%4@'BM0(* M!\Q5!%':YVX"!F"2\:3N"J]5"#'P]VL$)`C0(`S`3P0"^,+RS-O!$9<<[//A MYP`"<`\I]0MGY1*``!,]L7ND0,HB(/T>_VB;E=&1P`98"IR))>"`/2&FI"Q` M$!('@P.9(-QY,+)E&U;4JB@*P)%4R9-`&,29`P'!)!(V.PE8$"77")9&`S6Y M(O/!NEH%XUSE4;`7&4@#3L11(`!!`:`/!C2%H#8L'Q=7GL*LY8<@-!\UY3!" M$&EP"5XFY2A(5I*67S=2K0@TV_.36@`'?!B(9!E"P@?F4*1KXI`OU,L!`13] M<4DGL8)+\O`@8!/`/P@VB1(AEP`V&U:M>3#.F[P2@4C]2N/_#$!@-AP"`?1#(0*`*$DAO6(B$5)<>PX M0DHXBI#2@$<*HX-Z*IT010((0(*E#NG(`28$/S5G0@$P#M%`@"*XKJBUVL-R4^QP2:(X*))A#HI@9T);`%3I9%XEO#H").H\P*#_@@40 M&88[QY[0EA3#E("7LB+X$>>%4AC:@P&)%FGA`"``X7>;'6!LLQ(KY$>XO$7R*%8Y.\N#7B=,O8]4(EM13Y?`F86S%,2. M\-1`D`@G04B395I.P@$)E#U;3VS4V_A345RS`:$)AGY8V_PZL?(?AU1B";!)V!!3@9I%S M^(>#`%(,:NRLC0]:%6K:AD9.DV*8)@4[E^9YZ0'^'$A.QT4.X$X`!Y!=D"B7 MHM%/`.1(V2@,8.@>1-C;YSM"D3K_$-P^:6+]YPA1#"]"%!V;@/RE!YM0F0I2 MQ"NN%(2KC5J%(K`)&91P@^5)+!)4(,[@\D4.:I3*<0G@'`2BP(A(B`)"2!/. M"!`7A?*)AG(C:$#_$'8S]MWD>[5[$[A(@*'XO8IQ$(",!T]E$OW):1DHP,T. M2D*#$HH`,BI1A2)"$P55M&E\C8GA#"!`&A]U0P3-6X$<;H8'/22+1V;KX+3` M\*4D!0$.:)N6]D(8,?_)04L(G7K-4YJ2/A*T+VE"B43\9B2%]>40AB8H7FO. M!($SVJ0.X0F.^$QCP1?HX5)86@"^:-$C`F`()/XC0S]D,Q2S$2H`"=`#[9*& M"6T83`^F6-`$R]@#!NBJ%^QPP,'@0\=0(&4`,/#.A3`&H0P0.`(7Z#`PHS?O<3DX"D(&>"F&-")I3( M/<5#LA#&)'@8!9@\B5`V0850Y."K$B"@4P[0!81&4C4P1<%[JHE,MTK%CGJ, M!$-=BL,(2?"409X`/GC#D`;SN#X:61,-66'/R\9#0Y/X;4`VP4XM3>4N"(#_ M82$0$\!0R*9049+0><'1!"]J98)A)D!-`S&&M5`0AR`(,@IHD!4+;5.".$BI M4ZWB8:]RL%+Y61,%4IE(Z^3&LUM^QU@SW2EJ&*#+]8SRA'TTQQ!%L!0&/$47 MP8&D"/(7"3Z^+ZK%0EEKIL!N=J&`2`Q$.%>5.-,K)W!!,@J6@C3J\VU"\T$4V".#*G&Q!V`@0/$< M@$C:;C`2]-I,AIX1G+7X$F,SR4'QRK&`5^A0*%'0!T4FHP5CD2`.7UA5.?PE MA`(H00E?&@(>&2-6&6.2!RNM)*P4@5M\_28G+^N4/E(H@G1$0KLB0.`.MA*W M&=WVHJ_<0QPP%J5#XM,6P5J!.'N`S1W$H3:8,$L=J$PH?$&E-E-0D!Q8-DJ] M$$*.K-+4`.":`R.'X1"PJ,`E(I!$EY98JS;@[('C;#C6*1"D*II(5DY2&L/T M=0H`CJ'15`B=I3YH;0\&&\$97DV,O,@.""51;Y=-,D*%$N2N+7C9(9 GRAPHIC 14 y83222y8322208.gif GRAPHIC begin 644 y83222y8322208.gif M1TE&.#EAR`!+`,0``._O[P\/#Q\?'[^_O]_?WT]/3R\O+S\_/W]_?Z^OKU]? M7Y^?G\_/SX^/CV]O;T!`0%!04````/___P`````````````````````````` M`````````````````````````"'Y!```````+`````#(`$L```7_H"2.9&F> M:*JN;.N^<"S/=&W?^+H,>>__P*!0HH@$ALBDP7H#J3D`NRD$"@<))(4D M:`8D6A&U9Z1I)`W6RB,,\%78W"1%_#>-=A"T[8Y8(3?E$AR78C$$)`(PJ@(E<``@R@ MUG4WWM#(3RY\%(".5&AAH"VZK!53`@``H%-U308Q"Y0MN&-B%YKL9=H!!9!T ME38C?(G5$Y*%V8,<,("VAA8),*`>G0Y=!,4((P7H6`$(`&EG#7S",*``3"Y1 MG!8!.,#`%7C9)((=%592YZ)!C$+F"@[(4\D:3_-W(A MRX0B+O@9P0!VG"J%`2G-21*VVDHAJ@MGF>+-IU5N)D&`CVDQ:[H^`'>O,WU< MJLFQ,]B(0IHJ('`KODB@`3"_$W574K8P++#* M$!4-"LCV;0L"'$S0R1H/\6''E=C51E>3*%22<"A\!/'*.Y?P4!+J MP'(*WBR,-0RS9"PRG"34!S$A'",4DPC)?":O"!^IK)S@)K#Y]@\,*FJA`)5I M028J;8PW%YT2.+%L(_?,DF0+E:[@#96'U_!Y_PKK0,Q7MK4*TLH`1.C@;H:#2:,,YT8SJA!E2MDZ3&/!8KEA=?4(YL_ZX.PX% MA.TS*9CAAV2+>9-RBA$$\$'G=N`RY[8(:*F`"M'3E_DW-5/%)``"L12A#XJQ M5#()Z@&>WRU(*?C(J-H'@U$HJ'+R.,`.PK<``\1%(T/QUIG$(ZX>H.L$R"&@ M#?1%`F^9`P4("``I`$$3`22-8CBX8`G.)&/#V03'"(!K+*@%UR`4%1:GH$+<(D!ME M4(!7X<-3\-!"'$L0#L+MD3VEXHF4>((*>"'MD&'B0YT^PHQIG(_@5-H-'D&/3Q8S7Q-0L3 MM:&"V[23`Y;UNR"&$U2PQ-\Y$4:PE:P386C@@>S>B3!)$$9N]`R3"!F23X0E +``(/`&<_;Q0"`#L_ ` end GRAPHIC 15 y83222y83222z0001.gif GRAPHIC begin 644 y83222y83222z0001.gif M1TE&.#=AT`(<`O<``````-BP6&AP:!A08&B0H``P2%!86'@``"`@*/#P^%A0 M.+BXN)!X.`A`8-C@Z$A(2!`8$-C@X&A@.-C8V,"86&!8.'AP0)@@.*BHJ."X MP-#(J$`X."!8<#@X.)B8F-BHL'!P<*"@H'AH0`@0"(B(D(B(B-C`B%A06,#` MP,"`D+"PL#`P,)`0(("`@)BPN,!X@-#0T`@(""`@&.CP\#!@>%!XD,B8H/#P M**C`R("@J)B0>*A(8(@`$/#HL+A@<.C8P%A(..#0J+!8:+!08#`X.*"XP,C0 MV+#(T.C08)"`8-"X@.C@X.#HZ.#(H.C0V%!(*%A@8-BH8,"H4&"(F*A06(@` M&*"@J+B@2"A8<*`P0.CH\.#`R`!`6+AP>*B82(BHL#AH>/#84/#HD-"P:/CP M\-#`D'AX>'"8H/#@P&!@8!!(8$APB.C(4/#@X,C(R-"@J&AH6-#8X/#HV)@8 M,-C0L/#@B/#@F)``(.C`8/CX^(``$,#0V.CHZ)B(2"!0:'!H:/#80#@P,.#( MT/CPX+B06-"X0.#@Z*A(6%!04"@H(.#`4(``"'AP<#AH@``X6+AX@-BPN/#@ ML/#P\&A@:,B0F,"`B+BPD,B@6+"06(B@L*`P2'B8J%B`D*A`4*BXP/#HT/#8 M>.#`B&!86%!XB*B`4-"HL.#8..#8T.#`P)"HN."X*"8B/C@ M2!A(:&B(F.C0F/CX\-C`N+#`R`A`6*`H0``X4)!X4%!02"`@(.#@X(!X6!@8 M(*"88$!H@.C`6,BP4)@@,,C(P$!`0.C8L)"(@-"H6,B@8)`0*$A`*/#PX'B8 MH"@H**!`2-BP<`A(8/#@8-"X>,C8V"A@/#@Z)!X2$!P@.C@T'AH4/C@0.C0T*`X2.C0B%A86.C8V)"0D/#X^&"` MD!@8&-#@X.#0P-"8H)`((%!(2*"PP)B8H*B(6+C(T'"0H"@H,*B(4,B(D.C( M/($.*'$FRI,F3*%.J7,FRID8P%:6(B5-50 M38RAZ2%G%JA!3,.*'4NVK-FS:-.J+2LGTL)(390DHT#W$J%+=9$A4V4N4H]! M@WJL'4RXL.'#B!,K7CPQ(1H3JU_/OKW[]RTCF1MDXA(F M$80P8;H]QD36'Y]\@D8D09BC#QYL*)*@%^4%PQ4H9,`GX8045FCA@Z`ABSZO*+C-%<'5T4.$%]9HXXTXYFA4))$,`DTR MR8BP7W\_E#C+#S\0@^(T?.3Q21L"?2(+@H5LDR`;=I!A!U@Z=NGEEV"&.5$0 M&A*2RUR7C!'$B7G(XLY`04QS2AXF*)%'.`)Q`PH;@$C11QA8VO&)F(06:NBA MZ^$T2RB7!&F;"8.V0<><;6J0QRKAT&&,!I)H(,LI&@28QRQVA&'*%3<`PL:, M7"+JZJO^L,:ZUE3&-(I,%)>$`I8HHE2>3B11+\:%"B MOWF&,JH8\]ZPZB<%[RORR"3+*HD)D=P:10!XH)&',3_(L80QQD2H@02)R`"` M!<+$8(T,R^@`EC'N1#(&.C^0,8LT\X8A322RE"SUU%1[*8DYFUT23-0+04.' M)'/*88$,[)2=2&U/^&(-!-8L8RE]F#:Y4!@W>`&H8%7GK??^WNQ)$@0W4=P& M6L&T)#!+B`8O,\(N,NS"0!CCF#*.%$]`0+8,KN3!J^&R0"D&(("T6(>`?)=N M^NFFL6M'`-]M[218DA093B+6),*.XPQ(`,@X7E2PS3*UYVS)G;),H^E"T@`" M*!YPH>[\\]"C188^K`>#QZ#&A!W.+`K\S,XR,B0"@`)(5`D`.^'OLDLBB;Q) MBS$FE#%J'6&$@80B>$>O__[\!T7&WZKPCB+,$1'Z(,X5UF!<[]!GC5[H0`'" M0-_W**>^"HS*!.B0!+SJ)PU%U`$-+NN?"$=(PI%(H@F1J)XBW&*B@C$#?.R0 M`@/.)P-K).$<[,"$[600@PJ$X0G^C+,8I:*$A#"\(AAUD`I&)#$##6:DB1:9 MP0Q*PL026O&*%%K==]B0GH*H@`%CL,`KML$`!2QC%Z*@G00"L8ME5.!QAM2#$U.0)$$<$`LPQ&$@,_@"&%Q`$$G$8A-&<,$FJ`&2&60"#$70R!XX M,8J"&,$>4[#'%[X0BUAH\B/MB$4CM!`!+)"2(WQPP11BH06"I((3.8C`1N(P MA48P`8O8[)(:!!/?)@"#6H(0*2:$2C"&B2B#AKT0Y.QP$4[",*):$RQ'M%P@$!PL%*. M<((+,LT(-7!A#X/4H`"ID(0Z:C'2DN(BE)W:;!P?TX[<"T4(U&K#0@4P!%Z\]B!%JD8D&RP,7RZU% M$8K`A0@/9`UJ,&$-=@""XLT0A&,$(LOJ`,']O"$).S1#*]JV`5<,&Y5 M:U&/4=2#"9E8!S7LL5`F?*$>C>``2`>R!UN,U,@#B8`G4A%+I6["$WEP`2>T MP`1E.H`:G*AR'E)1BRG8(@Z-W$3^`AK94T]P@J*I<($+ZK$'X>9!$D4X`RYP MD`2J,5OOU"`3*AC"@4H@@OZ$=,\9((#,^9"5NW1"'6` M`Q=&4`<'L!"+`KA`'7XH@A8T:I`<<&$-7_`#EJO*`0<<`1>+Y$0!%LF!`>1A M!ASPPQ[^"(`+<`@$'+&H;6J-X.L\[`$7-=C#&@K0U%AD&P>XX$1-!;*'6GP! M%ZEPK0/6T(!/:J$1&RY`/>)0@'5X`@RXR(1%LYW0@])@`%/\PAJ8T(_4-D(- M9RC`&39-=M6(E:Q>D((T"I8`8M!"@Q*XW3+,R\,'K*"NWZU`#"R7"`4T+A#H M>)DLP#(+#A!]J`&#ER3"?;@ MP!K:\?*F&GN1:J@E-;A`RC7X8X=0P.#CBU'STU\TI'<5`F8"&I1N!" M+!N!!9=S89%82*T6^K$&3[A`$C4H?BUP@=`/VZ(>IKRF`]3^L-$+DY+X>6B' M+4S+]4;L8:FOW80M))%1TS89RSAH`"<!J28`>*(`Q.,RAT(`N10%`Z<#LRX`N,LP(Z0#;J0U>_\`3HHSZ)L`L* MH#ET0`M14WC((`Z$<"T4\6!-U7!1=WD@U5NV,'%Y`&+\%VEJ@`4@Q6[&96+2 M!`PN50_2E0?.)0E:$`VF-1`.`%*I<&*1Q@6FU6O4('"IM7U*-GV!-@IJD``9 MU5.\EP=&X`@]502.T%@CUH3KP&W^!!$'!"@0(`5@NS4%CA`'3(`+IK4&CB!: MO;91G&`+[3`#:I!_N;50L=``U\0)CD!*')!:ZE`-G#`#?H`%=J8.QN4)M@`& M6-9KC35]+H!(`I%2@48##]4.N#!9F;!_4UA\8*!0,:=4MI!_(_B,I?$)D1`, MPF`WZ?$#YD)0&A`^,B`"@1`#O_`+`%`!Y"@..Q-!J,8^[*`#+U,P(S((!X(' MR&`.>C01O=93E&4N:Q`-G(5N>9!<6=6&A$@08-`/(&5BG^0'2;5PIC4%T7!- M_5!+?P9I>9`##29PME>,HL4)?A!23>@)CA!+G#``6B`)_;!1]L`%]8!PFF@+ M&>>2`N'^<$S`!,]E$(+8#`4!#*R5!QQ@%8-JW0"@KP"@H@`5X0/&\"*DI@#%U#"%*0#'8@"T$P$9(`#J?(?BZP M2'O`!?VE!4BVA+KX<33@C`51#SD6:;C057D`E7DP!4F5`&J@4`96#7L`#FJ0 M"L(%#,[8#DR5!U^'`W%@8K/D"&<0`:/@""79FX]%@$;P=2[^H(B-8`18H`8N MT`Z].1#&)F>.P`G@5F[`@%D$T8<6=4U@P`4628`_9@N-D`U4`"; M<`31``9[L%BQL`?Y67-,!63]D`.>,%OD&7340`,:1`T-4'1Y`&"EN4K]&6CP MEE58T`_,R06U%`LFYP#V&0=%\`6]U0\.:I$SO-@JL MY`+FEPG`D)ZNY`*UL`=G,)5ZRF?^M0`&*@9+KA5HDK`.\U=1>YH#X+!(F[`& M#F`/X$!BL4!@!08..4`-8)`#FE0+-$:BH^]S)Q#T"\Y0`2*`,RMK`7"P`N*`!&YS)_RT M!4TP*J%`"$:(#%C*763G"0+H`DK+M'1+(4=B!WQ2"*8@!A$A!YY2(LR@`^;E M"PBP/HG@"XC[74E`*:>@!"9@#,UD#$"2']#P"1M;MYB;N<@A":'`$,*`#Y(C M&.'`-1J`F7E`![VP##WH"SL8".*P``+!+IL2#G/R"="`#]\`)+(@L)K;N[[+ M''@+"*80M07#*Z<0"OU2(H.@`99P#,?@"AJP5B?$#3.@!+3^0%#T01?T@`G0 M0`9MP":_&[[BNQ@\`@HTZP4W``H%LP33,`M:H`01P0?U6!"#H`X:T+BS0`1 M0`;H`)B",`;<0`P_H`2AD``-\Y<44!VY0`'3P`S@R\),W,1)T1=V@`PH*`QL M@`>R($GN<`HFD`>\8"?$0`>AX`YX$EC&,`:70`HB0`&8,`8HK+!._,9P#!0Q M6G@GZ`4*H@BJ8`SU*`=Z9,%YP"G^I\`,$7(D2D`!^$`*F'!?8\#'(13'COS( M,"$:LE!6K^`%5U`>JB`+X2`)2SPJGQ`$SQP`A(`/R``DH$, MA$`*]7S*32`'/5`'_1S1$GT0-2P&/?#)H0`-8T#/V4'/2G#""3$+@($19+`* M)NVSBU'^TEIPT@I;DJM`!HGEQA,]TV'"#05CT8.0(32STVB0TWSKT!LA!"PP M!RS0!8R!#G.@#$JMU()`$-@P#,.0#T)0#GD@!%F0$I(P`5J]U1-P"G)#TRV1 MU5RMU3#PU6!M$C:=!Q:=!__\%&*`(OF3$1%R"/[``U5`#J6!#77-`SS@#X=` M$&1P")5`!IU0!5N@#,.0$C#P#R#0V([]#[![UBRQV([]V"H@V2JAO(37R1HQ M!(O``SY@&N@`#W9=!57``QE`$$*0#WDP!)UP`8?0"9?;$3#0`K;=`F:0VR`0 MV8\\`=H``TDQ`;>-V[K-VY@M%JC0"8=P",I@UTYP&MBP"*;^706+0-4#(=AY MT`F44`7YD`6SW1%D*`DH``+%#'N;=QOO``,#@*7K10>GN`3OA1"(-T7K@FJ00LL?N'S MU>$(#N).O."Y[=XH`.$UGN)+T0:DO=^4L!H78.&+@`U$<>(V[KO`71$>P-C_ MD`[?[1-*[N-*00DQS@/P,$ZI40E9K@PH'115/KXJX`$7@0(8@`)33N4];N5( M40X6S@-_O1I.,-VFO0AO0.,2'K[^"_`/Z7T88^[F15'G=KX(-H`<<+[?]RT4 M@>Z[(@X"?VX8C2[H0H'E=@X/@7<1DB`(M/`&;P`)@A#F'.$$D/#IF;X%6[#F M&>'ET\T#8,[H;>[HY`WIB#'IE`X4&M[B%U$*0C`'IZT'>L#7RG`(-J#JE)`% MU!WL53`$E<`#>C#C!=$&RSWMU#[MG3`$#EOA=LX#_2T26>T&;E#6%C'IO``# M*"#N&5'NX8XN(,$+;C`!'5'NYSZQ?&#N,,#N&"'O][X1O#`!X#X!7XWN!\$' M_G[N^.X2(J[;D4Y%^CX!3E3O].[O^WX1MEX0Z@[P>0#QM^[M\B3?U`:!#CSPV?1]\R-?\_`@ZM`Q#!Y_ M$1@0`D(_]!Z``1FO`BU0V6:0#@\^$6/."RI0`N[=V&;@`6:]I0N0#E-/WNG0 MY`:Q`!XP]&(O-RK@V.F`+I(0]&(?`AY0XEP<]5O?`FY?;BB@]8Y=]0<_\%F_ M]4L/[Q4AWG8/`HR]]"B``FDP]P,!`QZ0]/\P^"6P`+^D`FO/]D9/$&`_^2'` ML..=XV;0`F+?]@+!"V&_]A[0]!+!"QB`VR`@`(WM^1.0#O^0]W>&`HL_]690 M`J;O]+'^]5(O^"`@]YD0^QL?$H)@Y]1="A3Q`I_=ZLJ@W$7^7MHUC^04(0DB M?^'-?P@=?^$R7Q`T7_+&?]HZS_,#D>NGS>&@:09IT/B/W?4MP-BJK]L@22$`(-3O4Y_ONR/Q`HP/AW/_4`@2+/0()YTJ7Y]P_$PH5\\H0`848BB!9\ M)(%(J'#A/P]Y>(4PLU#BR'\A!DI:T$+DR)!F)A2$B:)%0H830;B!"7-""884 MT_%4&'(!3$D0198H$7)AB9<$6R#4N+`%S(,T:SHLB"+H2(P9TY08"`-JU']# M MH;><)0/I`Z1NM37S>*0;DN%\F%TK\Y88Q8(%:4>V"(EA`I\)SB>V*"QWKX<2 M"DN$\*"2:PE).?EX4-@BA`H5'MZ&;%H0!O,%24?RP?!^9%SZUD&DP\",]$H0 MCR04=DK(C!:@>P\$\LQ#CZ(0F@.,I?BTB\A!-\J39`+W0KJ+($DJ!`$#K#[* MT"6"EFN.);#RH@\ZB2HJ"*4%`IRH!/J8PRD//NCS@*N^8/HP.E[*XT.FM[(K M"B/UV`N2*Q@.TVNB(4^JT`P4D$1AO\J^!#-,,<O"N-`N(`,O&S[3 M;)%\Z?%E0XLL,B0^JQ(%%+*)6@4R?J**<)]GH0IOQ`"'&@3T$P":9I6\"T(/$< M-"Q+&LWCJMK#4-CK2FG+S:G2B++#X*L%L!JHRI#2H1)=F([E"R88X#JS7W__ M!3A@@2$[1,W7\$(''CMY*`7.2VPVPPU,_$$J;X'<9@ MM?"L"2+%("=Y%9P4)IXF2EDN.'#!!R>\<,1NH=@'O'SH^`V\ MMF#TX)S>B=R&@E:AA!+2-N[X3\3(&(;B%T;FBEZ\\F.)Z[R?7CND9!=382^B MJ=*OY1%!X/KL>0U;&@2!SFK]O\90#VGV8Z/#.XUH2735V;>PK5'&2_$B^RS= MJ57.7A%[OQ!KP('?Z_>S5O>+J^Y]--%P]==GOWTR]Z2XDK/@_PV>)0P+%#0> M!H7IC6@F!#^2#<1TYFL05PG60#R4 M+JZ\+E2RPPLOF-68V$TD@U`SH6&*,JGKO2TLX8M>V*CWO+)Y)%S98YM\1HBW M$(@-+W&;R- MA60A:1X.B4@0W?%+,:TSPW="L$A&@N>&(I)>L^PXHQJV4)!Z(PCQL/:/PC.,W2B2M`B":X*,H>,%[Z,8/1JFA,#"BR2V%4C$-#,/ M*X.>8H@7DHR4TRI.BB$@I:F@2CYR7*#,$K3`U,F?X<6;:&F0&4+P/53VTY__ MG`PY@9"]"?&,."\*'`DW$#'0#:%2E.M7#;%%_!2U()SJ64+PL5'_#""-, MN@&GAU;!'YWPX<4HFAB+AF88:?5C2-6FGZM]="#';"!>^`#^`Q6DHR43(>G8 M[GC2#AI&DR>$)$\/L]>^_G60^%2L8I09L\;L5)TSI*3UW&F8X`D5E(W9ZP+" MTR"D:DVI.M1/2%J`6*JVUK6GA!QH](!5@A2L@!)5*,0N8)A'+(*+J5D-YPH8 MS,X8[*W&E"OX4I?4QQ:1C7A$09"Z$BL+8K:CU"QL2ON(1Y:>11(H\.MT9=1< MCH8S,:7(+L MI"G8606'=+SKBG.'E:7Q)-FI6:`B MIK-[@YEC>.&SI:A@`L';KUWO:A3J$G7`5\;ROY;PQ"XZ+B=>)>9ANM$QW!IF M%3[@P6\7$5PWK14QPW2-)C*:UYP$+Y!2QJNRU++:%<'0NC;#+K)BO%VB!/F% M&>+S0(X,MP:=[\,]?I2A!0OB%V_RG?)5)IT1$[3W%(N>4>YO03RTDHDX.LNG M1K68Z-?%.>5$$`.=`USSH-4"BBPG81W(%FBM/PZW>;B*.:AKU-CAYY[%I7O$ M,XGGB^B;1?//+GZOH+6+S1E'5FG,S@H<_RABPRR+*ZP]C#8S),F2#IF#1;ZT MB'GL7L3^_.IJG_ZD?/'2LP:Y,-7WQC=D0$>Q/)VE'!"36$Y6P>70L"`Y,-F" M,BYP<(*D(')SP+5:?WU`BK$Y,7DV3)%>RE]YWY7$UR.IL\_2XD##>-HW6:FU M\^#MD(0+%\2A<2JSQ./4;RWRP!^M+DAQ?M/KLUC8@(C!Y:&H?G%EOVJ\@&;NQD'J MX1>6.B9^'OE@-YW=LQPVY9<-,0BZ=\].WNV0C0;R\^!:O7.;/-UJA_EB6-YS M1B=9Z/(V`V7YJ"!9)]WRED^P:ZJ(EUUKAG\U"MUOE"'`@FS^D0!WJ2M(+[)3EA9YX3NU<;[_&"^^V/*N3I MV7-25&-6Y25QL]Z1(EGX?@Y?R>5$.[3L9]>?:W MGR!:/P[I"[($/FT]]2>QK6MFBQ>K\B`+]\^#4K`3?_`RO'@#-S,,J_H-6E@C MY#&/LRL;W2NVE=N+%F@*2;".XRNW]%LLNLL)E[*^J=DF]7N.IN`#CF(O46N0 M="@;_/@'5_&^38&KN2`:C2.W;VHJ\T(ROS.;$UHT9_D'`,L)&#@(G-@V,WB^ M!?BK97H\$8.^].*X>G*_*42Z1='^'XTYBRU@`8-1ADI`A2V@A`LP&!Z(HK-0 M0![HPB^D!!;H$TV(N#QH@W+(@G((O:V3PT[0@JXR&/MI0*:Y&5[HG0R2A$&$ MLNG#E$'LD-)!1$SI'3/P@/#0E?&B%I[!B46LF0E`1.^RB)-!ED4\"8L8J4R< MFD&L%",2Q49\Q)E8D'#AF999&8I0`1C@!5YP`PQPBSI")`=!`:R0!%Y8`)_Q MJ"#,$3?@F5\,PO'"#E$D")=BP:G1BV1!Q-\S1")9P0/A&?!RDL*H&4?DCF/L MH`F8@`T9Q>\Z*E'`,J4G(JB<:R5J(G`NI4&$8R?(*<6"*R7;`%R$[?K^(D@C(N3N7)#NH3*ET)3_R`[O4XH7Y(6^RY!_H`X%X4F9 MG!+HDPJ*=`,5D)%_T`9W],M[TX2*2XPPO$=\#$C?&H878$@M\@=_4(9#2;/# MY($A8#B8*+#(Q$S,'#V\"+M%B#JRRY&T,*<;ZQX8B(J>Z`G^A^@.U.R)K,&G MGG@J@@B!T^2S"&'-U"0*I;A-C+B+"3C-VXP+V[Q-CEC&TS2#OIC-GDBT5W&/ MV]0G?O(4W=R(]%"!&OJ+WX3%4+I-'5PYMYC.$B@,W]S-C2"E6K`QUM01[H-- M#,`4OX%-@3#-\<2(NE20`!E-BEBQO]3/U](PB%.,#*B$(2B'"[@`3:""1Z"% MRB,(=,`&;!`$)\B'(="$"\B"0ZB$S\.-+=#0#>50#L4+)UBE0RE`GY.C)`F! MGTB']7"T#IE%GIE%=&C1PG!1G@%'<)S%Z1"U$&"+ZKR7G_"`8J&.&(W1"9A% MZR%2&JU1(L51%KU1)572P@C2)+7^49ZY&1C@CG3@45-!BA`HEG01+:1(T5T\ M*10X4:3P`(I44#%U5@])8?\,MF+$ZPC-HV2 MU5[UU5\%5C.)K=_0U"SC5![PU%8-UF5EUF9U5L/(@@2Z-P2*$]=3UF?%UFS5 MUE<]5M1#-4%@E$6@,,3`N&TUUW-%5RI,`K+? MU,V2.-F;Q=F<78Q2&(9;H-`+.`1]C2I)Z(0+\-E;X,?':`NDX$BD()#]TMFH ME=JII=JJM=JKQ=JLU=JMY=JN]=JO!=NP%=NQ)=NR-=NS1=NTO5I*&((Y[((, M6(5*N`U)0(4WZ()R(((%*J(07*$B8((='$-PNJ(2\90PM MR``;\`'8&(AWR`*./0QO.(1#6,Q_:0-*$((LR`(J>`=RR(?^X5@"2,@'*N"J MP2$#(7B&PBT3R`7

V"$24(5=PED">M2#2H`$(?`'>*B"Y%@% MCBG>W9V,-_`'/;B#V#"35:`%>/"'13@`72V-"S@`[#T$F(C;QN2P+=`# M/<@8Q3B$QK16@&F#+CB4(7@#WM`#'M"#O"6' M=Y!>0%D$?^C?WF5@]?DW'DC8?#@K@EB"*M"#!2L3YUT$>*C,,BD'/8"'BLD) MQKF#*L!8Q@!7'NA?<$5?+#R,'6C,IO.7=V`!QW2"@H"<7NL&3'5AP?&,7?(7 MR`EAELT),?2'+&K@)!8<5#".`\[^`V48G3;!5X3-@_"-C!1XAF(E$W28@\<4 MX8+X`!XHX2]^C%F*&()X@V>P73.C@B'8W#(I#AZ8@QN&B4,8-C*8`SWPS\(A M@\AUXC*Q*-B%"2?H!(M1XD,>F`.\`W$M"/DE"*U*UM:R@2$0`M^2,X)H@PN` MWT,9U\00PSG(PW[RJC/.B7S((LA9!`S.M\#D@0!&Y%=6'TA8A$6^Y(&`!.G= MDT6XY,.EL'>XT#:`!%J(C55`APS(!Y%!A4<`(TS>`ANHA#8A`V\`0UM#!V7. M"5KH`E/&4,,X!$I@'!ZHY3S(`DIPV2K83(3+!\25O[]]`W((X1VHXC8@AS=X MA`X&PWS^R(?-T8(V`%`ODP1^EEM;?@1',4@;Z`+"70QRJ(TU^]#4*PX]L+4W M>`$?6H(7T)PMH`6)B694*-U<>P3BDH12R.9*@%TR:`.._M>-%EZ/;J7+$>E* MR`<`1)@N6F#Q/=T7T&A4**C#_>,V>(>#9MP\<`+!+=U2"&I8AF4\7NB:)H@Z M603YJ02KXP$Z'@ATF$-RJ`3]S1@R^``Q/``A\('K/8"$<@(JT(,#**9YY`'^ MS8-W0-\#*,"NQA-TJ`0]D$-5MJ4Y:(.%W6-*P*A3U8/V18=#\`$!/``VTP)L MX(&,'H9#$9DVZ`W'#*LVH((L^(`X'`;2@(1AP-Y_?8,07H3^O+VBXJW,5<"& M0_@`93@`5[:B6>:!'O:W#5Z%-L@"[,5K2JB"-]@"(8`'M!X(5#C5`_B3-%F$ M]!T(2H@P2D`'VNB$89"?+-B.#N_V`.3@`4,Z#`\1;5!@&?Z!JI(;E M*;H3(AX([":'=U"&QR1E.'Q,TB#O7ML!3,V"=W@#/EG(R?4MVFN3*^(!GU:& M.3@40ZX3U1B();#?\$[`W0*SV"`'99#GA>;8#ZB"6IH#72:()BS\Y#SH!C4/ M82]+@>O]UP^H1UXRC$HV9Z$]53:I8L2!AX(T\\V;1Q?/@RNZ@]DVJ_YU@A,& M<$0>JQ+F@9:&[T6X`$@8@EM"U@,^A`-HU[8N[H0B`SYQ]$?'C((<)JH60TW( M@*"MY$5H:2DGY3#F@5/'BVY0(*^*WCRX`-JSV,P(Z@S8X#ST'RI&\P,8MER& MR(7"]8'P!A;0`SK.A_M&WAJOY459A!00W#Q0&"H?B#;8PKP5A!`V9,20Y45N M=\.8HG#^KUU97@0?!^'-09PJ8%PM%X)W4*!;P-2\56IXD%Y\)2B"T`3W)@@0 MO?=W4)S\X8Q51];-,6."QHM3701X_M`05J`VL=B$SP-(\`?%607[3A1T4`82 MSP!,Y??COO28A_0T"VJ!"NP7(`.%U@-6O8Q$'P@A0%\O0^75:)-*-O@JKO%> M@QP>.(0AT`**YV"D1\/-`7HR/@M-:*786@1!2(%BZH0T"^"3/^*!X-Y:VJ)% M\#)P7^!_._H\P(;#)@@RH`3&G?<-O$?/2A`9;B-(?#M/!""^QYF)K\%:(YY M1)9IK5IDB0I]S+@`SICB,O>'6BKX@_>MA.V$F,VU>U0<*<:,.3P"=]W_"!A2'IX;/$F9-&050@G4JS895$5AA4WYKG`H\J+/*OF M\)@C,.%"2`C?+5KD8^+#*K?:Y*'4,F0>+>-X0VEST+H_`'1@U M2`AK)819 M@IY-NX@20D@\>&B:6`[CDJCP_+'-\V(1#Y4(RV%&^'K1081;E,%#I^70`65' MQ;[KA+`-O(^+9)=:=&?1AXFW%EVHA.U%6(3HX"T2HIJ'5H1O]"R"VM6?6:X7 M%IE$Z*0*?')(+^@)GV=(UDH^?&P!_/J.1GIM\5%ZHG6'5!X/M3<6>;F1,8=: MT8V%D2`3O<'"!5JT<8$_P\B61R=EI2:2,AG)=EH5\JW$0A9DM#%,AQGH5*(-. M13'-@9!.X$DD"%`Z(N05#T;2MDAF>2QQAQZEA881EAT%M=4JR2VXGE`4O7-( M%UT<0LE0>@F19AX0+E*50`15`<]6GG43J)Y8#=<-#WH<8AEL_4VH#&0;#0C1 M1"P=BA`J6+V5TQR+=&)715MQE8$>;!JYT4E%X81-2ERF*N95BYXU(`]B(J>' MC1150L4+V`CQSDEY#)O%1%=9BM":;5;T`K+*,JN7-Y,M@A-%;_3W#GF$BC2' M/Y60H\E9Z[%+:U3#C&8R^^^>J[+Y-;^`-5LSZT=&G^'E>->M=G;:3V MT!TTO5%B@!^0QY9`G1R0YGN@JF0@3I_J*!`9SQ#\UQR:DK'>+,MK(!H?4 MK$1DRHA*%FH-1X8RB]BH4HA5Q#F10%XMMX1\,:E(D%&J+3(R0B?Y4$4GKE9$ MQLIZ]%31!\.1Y3-"'BGC37]K'DC&$&I]G$<*+>5&[J@"+3$,N!N]T1(EJZ#B M&FP24D+>RWF@,XRY?$&"49D5Y3.,0/CQL(0@=LVA1SEU-9VJFT#G\8:$'XPF M)K^=>_XYZ*&+3E@^Z*GHK#(?:?J"'E48V0D/\)12=QX"5Y%U-YI0Y\11MJOX MQ@&GHCW:"_GTYT/KFE:BAQ[O?'#^=S<'P'-()1E(S=4'\%"T@S^:PL6=>6IF M-,R(Y'1S4-H\Y`.)$`^Q0`ZSFO,@!"71730_R*6\0),FL;]3"1D>1"SI@(<< ME!`(2>!Q-V=5(A\%(,$D8*N"T`J#UGXB&R\D8+,^$!X%[C8 MZ-*HQC6RL8U.ZD052H0-+++@`"SXT#`.<(>M<$AG6QG<(OPA!">TA`<[P!)) M]&"#/&C^[FJU.T!95((SZ9T$&Y"\@`0I!138L*`J7&G#&ZK@CWP$2A,X<<(' MT+6(`Y!PA_[`R`6&,8SAD`,K_LC"*LIQ@&#U)Q^0Y,%PEI"S&L9R54B9BC_* M,11(^(,G35L-#SJAJ12\4@\7N(`RTI06%`IH/?ZXP'XZ,8S6Y*$4S?3D!_Q! MGO!UXI5EBMXBAN%`=/#@`)73Q"NS(!O8J04VRG"@=%YY`2R10P\'X-PMU%F. M$XVF)7',XD;048E7!O(0/C@$"YJYB/XXP99"8"(\RG&]=U#TFLKHAD#P>9#! MB=2-+GTI3&/ZTDHL@0P9>,$ARK&#(P(M'_FX8`8Z\0*I4:+^$\/!:0H@DQ;2 MO*`275"2LX1`!4VM(A^5D%!4J3`K*TVF4J+T#D<@48D4Y.,%FIK5_QKHTTIL M"RF4&,(A#O$.J4'B$$--2"=\D!TR=*,36'463CO1!>_A%:6Z:6!V"LNJ-PCA M$)W(!ZO>D9'3B>4-+^A$Y/+QLX)50ET3P>E?VS`$(51H"U00@FPD6@GO">*T MI_M)[WJU(42Z8F!1TL@U;>$?9%G6][RIF#DQ; M(QE\P`(;M`$5E"@'90I#!FRPX!W^];UO1J#%W@$3N,`&/G!AMD;9PWS@`%NB M"&W2@V##=*,<3%QC)0Y`K\GQH#*$><$!F"85'A1KPB8^,8I3[%*<=9@QP"LQ M0H00/!4#I@W7N?`:NS!CBMP"C82)'C8J2G,AC[#92][DLIF/C.:TYP0*L3U3S@V#"JZ MX(,4O."I:B8P)$SHU!A%,[K1CGXTI",M MZ4E3NM*6OC2F,ZWI37.ZTY[^-*A#+>I1D[K4ICXUJE.MZE6SNM6N?C6L8RWK M6=.ZUK;^OC6NQA$[O8QCXVLI.M[&4SN]G.?C:THRWM M:5.[VM:^-K:SK>UM<[O;WOXVN,,M[G&3N]SF/C>ZTZWN=;.[W>Y^-[SC+>]Y MT[O>]KXWOO.M[WWSN]_^_C?``R[P@1.\X`8_.,(3KO"%,[SA#G\XQ",N\8G+ ME`E[8(*9F6"$=OAZ!A'8P[MK,84U@($&HW"!),1BA"E4HQK@V$0$$)*#&2"$ M&D7P1"UJ@8,BU*(Q$=B$7XQP\YP701Y&/WH1<)#S1,>A"#ROA2>.CG2K^<<#;3J,'F`08!V$(U^"!%U,,'*EHF-(`?.`!7M,,9W(OL12%W48,7_L49 MX((G](4DK%\.$D8$F"%@-((C],/Y*088.$(/)@838($M!.!&:&`3!L8>X*"Z M44,_<,$7B$4J6&`>S)\+F!X+3L0,T,#Y;5_P+886<(#6#6%?-((M3"!7V-RB MC8(MA.)&.(`"4@D3]`,-;&+%@<$;^@4-#,`)ZD4<]$,#S.)@-,(#_D7X(1Z3 M)*-B7*'^&B@C1>Q!%0[&)B1@NFD!*HZ"7AC!\A'`)>9!_3D@!&HC13`!!]A" M&"Z&!OJ!&G2>7T#B,(H%-7!`"#G"7 M.C0#%^@D8'3@)/9%#=@",!2&"W`!(IJ8)S2@.TZ$/0`=8;2#&ARAN3GC/XJ% M,X:B)-``+#1`,_!%+-@"&."B)#3>8!A!#V8"%W3A7[AB4U+^A`,()$?4PAG$ MPAE4)4?L02;$@CU`(T+4@SW(0T4P01$891$0)N+A@"&$WF#&0A%4Q`Q0@]`E M)4(4`0%D0D]6Q!;2Y41(`B?@8A[4@CT$)5[*@SMJ`37L01',HCIXYA>@9A[, M@`O8PQ2`'!;X(09^`6%RW1[<9F[&0=S-HB=89C0V0P[`8$740PX0P!2P9AXP M06RZP"Q*@@O$@@LT(1-\`0U$0S]D@@O\H0L0@#V`7!Q\@1XB!#C8PC'JQ0P8 M(E9>9W9>)I>D@G=R8A&``P$V@PM$@#K$`37@0":\71S8PP-B9]S-81Y(@H$B MJ`[5PQFN`!*UL`7-B`- MZD4"T(`MC"!%("`7O.1>C&7/Y8#I0:=>%.(A4H0Z@$..;D015,,4U,,><((M MZ&=%.``XT(`+[$$]J`%6SD`L](,M1$.&GD$!E&D><`(6U,(>3`$6W")?1,`H M@,&<#N`:L*`+Y``'X$(.4D,0V@(NW*=8J,/Z?25"<`*5(@03<(*>`N=$K$,! M&"!W;H(?X((WYH$TEIXC<.9$B.=Z%D$C9,)';L078,$9R"8XX$`#')\D%$$. MX![?,<'^]C6`+5S@)F2>(Q`CW('#&N"`$=@#+ISE#'S!)N`>5M9")(Z??KI` M#53DZ=5`AN(`FNZ!]GD"%JB!#C&!&M"`EW+%$5AB;G[!&0P`+B0E#H2K(UQ@ M/6B@&F#!R!D!8@8B%EB=/+!>LNXFZRE@+>0`&.3>_$F"[(T?5X;D)AB!"X!! M/R@@$T`L+KBI$V(!)QP!->1`-``F)=H"%NB0`U3#+U)$!(`#,'B"$7!"#MA# M`9BL*^*?`QPI%W#`)HY"`4#H1(PJ&*1"W!DA;@Y;6/*%/6`AH.9!G>KI'6[$ M%48#B1YF/X!!S?+%%+SJLX)!O7)%2*J!=VIG#J#B2ZI#+,S^*D5LG]A11"U$ M@T#^7S5$*">XIQ)"7T3VPWO6`E!.!`UPI=K:(@OVX];F01$&)3?:0SM,`1=X MZBH2("=HIPM\P1H$+$FN@6L6K`Z-(A;X((`B7CWTPR:T`YL"JFDF)-;NJ;22 M:E6"JQJD(^1"81[0P"8`83QN`B<8@>S1*CBJ`:UR@-$B;DKFP;]F0CL4853F MP3K@PO0BQ"9$PQ#&`0>H@5X6@:OZ13-PH0^JPV]RG`OT0RJT0WR:+`*^ZD1D M@B/48/J^:YE*`@?XP2_^'M!U(CC$02H8(454`T-V)A<`IA;T`Q;4;"Q$@]+R M;U^('S@L8B.8;#0^Z41`WB"*J@+^[YZR>L(>&!\+UJ+N->DZ+"(G%*6R$0`! M7B]'-()'&N9APH(?-,#C3@273F-%&$)HP-\-B\4FP.PZI%XUJ"5J MD"XRW(/644XP`N,.G2YF\>&$$U1.'<;N?ZS:<1 M-.!\K@,7S*)(1H`:]&TMT,`# MU@`76*.+^.CC"1>X!%PNS(R`>#?BK(]QA'*A!(W!B-4Q?/=A"%.>!XO6(`U]WHUH)O.T\$0>;@_,U` M_HXML57D$N[%(=MBVJZNGN9S113A-A=&!'#`>YKR$',%,*1B18S"#:?"7-;L MV4[$-&.!36;"&?`!14Q!IE)$+)PT#L/L`]:##"^F(4IK$GKM-]9#-,_`&K1? M`JR?47($F\(H`=SE1M0`W3+S].IQ+&C!_R)$)V[=1*2TM"HS5_JL!:\SVDX$ M^!*`"V!E-H_"FHHJ*4*?,H,>!3=5\$8SQ2Q(U^01P`0Z<\,@?H4#LHX2_.@!]@0?1B'#48)BOK;@)S M@-P&X/RE-&<:0O=B90)(:S5.[Q<4@*LKA_8@FGW,3HJ!C@0 MX_9A;CX*HP%:W?QY@O$^<@.\<5H"\2A8+_J]*_Z-8@,89BHW0@]/A.6NMCHO M7U#.'RN[P!088"NI'>Z$1-`!7VG1#X'%T.H)ZSC)" M%*%.'D&%#V9IONM\VD,#J,$XPR?O(F$_^,%,`L98V@+0,0$-N&P&<\'=3H0Z MD/@QRF!;5\0TZV^0-B#T;4(!1.4,6.X;%]LA;^5>:,%O$BY"X&81J,$`T"M% MG&3S(D81@P,8-$(C@&Q?\T4F8KD`&N48P+44FIX7R@-* MUOABZMW5!CE"LB$8^,$H`&HU]O=>JD%.5@0.3/E3PJ+B"35"T``'K`&M8FL8 MUF>S8J;^>"/$3I]R(CJ"=;XDF])`$QZV M&J`[3_/%^"(J1;3#+A*U96-M(T2#IG+CKI8FP+NC/'1I113^<0FGIJ>KN1IH M.JP2X"S&P0#``H3GYKM"G_B!02S4P!1\0:5/1)VJP=:.(I\CQ"$+MX:Z.6;. M(/YQ:C0`*5<`>W]7(-OB)22?H)X7^D0`0S2(>AYTH*>6>0-FZ$^^L1&P(PUX MX8WF/:=R@6__Q0Q4`Q?,IM!#+E1N1$IK:C6&>QZ`0VW/W^C=XS=F(A;$`NHU M`Y8>6RKG?AZT0_<"0Q-&`#Q?\$,2NY2&*F&8HU%2O9%CH"$V_:@W@*N/(:1# MK@B&=XF?_";4-D>4X!]2A#V0[ZAS^?$C)",;WWUO!"HF/4#D$3A0H(-^_=H) M9&+/GJ-Z!+_8\A.!8#U;X`;6X!+^BV">/5C43!FXSA''CIRXC"*8P]$:B+8X M,!E8BXM+@9)HV#KC($%'@IML89$YT),CE0,SX:JQLJ5/H#1Z"HRCAH8ZGU=K MJ5%SI",!6S1F$'2!:QW!6E\E$6S73\V>JP)1XB`8IU\T%P0E@8QS%8<:6U\Z MCN)2:R!=-0_?)AYH1$V_'.#"7J76>"_!/6JB(18(SI;;N6K\#'5@+Q87SWFF MU(R35G%KUZ]AQY8]FW9MVXG71*O&^BJXQ@D%UL)X];(?!P,OJY%[6^`:P!WK M-:;V.OIAUTPXV+I+<$8U+IL&@MOH4TOE/#BX-!H8J]X:-7QNVB,8@4.#Y6\) MW4MB(:4&--GU+K9]0\OE#C4+%P M.4H@H#@XCKDTV*<(!1QXUY#@P M#<&+!C7VJB6!:FQ1-H\9@-FCAFB84(BI[D6F!8L$%,+EJ2+B=:-QD<*E: M$C),/K-JF#"QK!HPT:>(.(`R#DZ^:&"IRL;BR(C3UCA:('MJB0,7CB*H=YT& ML$A7("/L$=/3Q1EOW''96-QOH`3^``3&/*H=]4F2:JP;"(QH>A[(`7"F,/NM M>J*Y?*`<&@.W-1JBL=2U#&/,HQ9'@%GU"R[ZF4(F=3P!YT[QY,I$I+%\HV&O>JAH18MN)8'3DSG7OM#5-8D,0!PJ,,>]7):Z,[2 M/8NL01*<\,P9;!&2H1AA%&43B#P<,;:9I*2"?CI"FQ2VG!JH@0,/80(!1`(& M/TAB$WX"DSI<0(#6[&$`:I@:JC1$$*>M8P8UV$L$^H$%G#UG!EAH6V*J)@\F M3"$L-L+^@I[4`3L'I,)#C9`<-7Y$D"DXPA-39$TC0.,"JS!A$S70DV)2D3G% M@*H?!G(!.!S0J'K4XSD^JH4#UB"K[J0N#_8`3S-PL8<(<,(_9^E'(RHS&C`` MYW&5M.0E&<<$<.!B#=/)@P-/+E&>5S`@22TD(G8O5$2 M>;-%/VB`33\19$J2,DG5.#&*AS"(`\],@`NB42Z?/!!C_F("MH-32-0G`@I-HT`PKP:L&GIQ"`>[9*`ZL(6E%L$7^`Y+(`<+4@PO5 M8*A`=M>8:C@F#_5P!`VFP!4!%F!JG"#I2G#!@4:,B@DT:,`U:>!$%5FI`-8B M$!;6L*9&K6$30[)=!M6P48XP@853V,Z98`$.'2;FESD)83MT5`!X5@VGB*D% M+FBPL)D4H'P#R0D-8C$G3Q2@>WF(0P;!8:!_QL(0"8@##=RDCG^"@0!0`J8M MN("%>Y4N-JF(7FNT4(T&5(\#8*"(R^QA%4ED!PQ&+%8_&D`#&BA+/.MP+%P> M2A4G4A&3G?7L9VOSA4;X`0R-``,X!QQ@.+!`M+"&-=S)M0X&CB8G'"4# M'TH=FR#`JOHWBO0*9`9G``88UI`#/26@&?9X8_^F8)X(@`,8/\3!B=?A&4FL MH\;%X@0P?'J5"&3"'LRU!V(D88\SF`T'8'7=##@!AIF>A[Z*^0(-7$R4*G-G M%.#@D5ES$(<] M]O6O@1UL80^;V,4V]K&1G6QE+YO9S7;VLZ$=;6E/F]K5MO:UL9UM;6^;V]WV M]K?!'6YQCYO[X1UO><^;WO6V][WQG6]][YO?_?;W MOP$><($/G.`%-_C!$9YPA2^<8UOG.,=]_C' M01YRD8^=:E/G>I5M_K5L9YUK6^=ZUWW^M?! M'G:QCYWL93?[V=&>=K6OG>UM=_O;X1YWN<^]4Y)P0PG,4`(8Y$$2*H`-'R:@ M@G00)!U^[Q0?[FX&,ZB`#Y)80)]G(PF[>\#P.9I\Y3DE"1A@P`.P<<,"W!!Z M-Z#`#3`P&^`%S]\<+8#THD^];PP@S6`$`'SE$,`.QB%XAX#0P0`8#; M#R3X`,#`IA9PCA@`P!GG.,,2IPAO!+@/`%A0!6P/`+)O_V*O^!X`+_+``P!@[UXC M^&+`!W>0^3RP-F"`'81/_#K"&EK`-B2!^U;`F)`P"A?G`>@/\EPC!`!@"T60 M!Y?/\-)@"Q=`-GAP"PT/!A00\VSP[8K/&4QG`J;O-20!"9TA1S)E`I`0`*C0 M)Q"!`&O#!6'P+0"1!3UE`I:O`V3C`:]0(`"1!OF.^ZP!"UU#$:V!-ZR0^=8P M[D!0#*_^0A(&KR,^3Q)18`L)\29@`/:NQPWZC!?R+S$DX?QBH!5]`@.*D.]0 MX/'>(O#R8!/'D"!@P.]XL2-00`+YSFQ.,0_<`!4'@A<>3P4!H`ECX_R*@>_R MH`6VT/CR``:V4/SLCIGR,`<'(AVN40@S<>VT<0L1\372H1A"H/9*<18`4\``2NCQT@#R$5 MDB$!@!UX@Q>*X1P\H`0Z@!VF41Z?KP=Y<`]W<1<\H`4X$`!DT37$`$5@Q>L4`3^D3`G&Y(U^&#Y M(E$@%@`=\X`"KU$2!T+^MC`E$V,"=&\,)6'Y>A(.`0``-Q$<\P`LQ7(;!P(& MK,']\N`D+5`2!%`/5Q(`*I'O=,_OG)$=9$,Y`@M'#YA-(GT\XJ8\`P._'ZR!(*!>(,O M>Y$TL9,O.R\MRC#[TN(!"S+]=C+^.0GB)BN0(":@!!00`!Y@[XJO%<\Q'4&P M+O.@^'P0!$TS0#M0($`0.^>P+P5B%&,@#3JO!6!O)UN1-GO2-:(3`(KA'\XA M#=(A)0'Q'T``-;?0`A.#%Q3P'0UT"\F1.\ON'.=3,CTS3ESS3% M%`!Z\5G3HC4Y,0_D+PXSE!C)W^$CP[(@0`$`G-5"#*\!/%@!@O\QH'CS6`4D-9(P0>8#O?U>MX(0];4B#^^``$$-`R!<(U MBW7W\@`7&[(^)8$7;"\=%]0AX90@3C(GL74+J7!!;71!^;%.I30=T@`)TX`/ M4`!LHS`=S@$)_\%LNW+X/(#]`*!MQU`1L9(#K6%IST'^HM#O%%$D.\(+$_,M M!%0@FC;[_!%5)W8+/=`?BX$UY%-(>_;KCK!$,0`%5.`?G*$GQ9$M09!C9[3P MD/$:VY1)M[!(YY(=TJ!J3Q/\S(`7'.]D!\(:J3`,4=8JG>$?0K,#0`#VSB]W M0[,8>C8O=^$!YM(9TD`"K;)5Z3,/Y]28JC-+MQ'VI')P MT?`:S6`!TN%9@S96)U?L^,`DOS/^#5JT!=CA'](!$626[Q`A!E9`!"6A?E=` M`TVR`WQ0$A[`?B4W,3P@@*7/?OMP0LR`'4"@!!`!*U%@%ZS!`N$P!AY``R-X M@LL2^BZX0:W!&MSS@\\!]F"@`WC7)WBA`V*@&.!#A3N@%U'@$#6G!!+2A#O@ M`8)V(-S`A(LT?U>8&'EA!9@S#_C`#(IA!6S8&9R!=Q?`;'P8$6;U?+/.7\_T M)B9`,I<1A5T#BUOC:7FABHGX&#L1\IXV1\A8,OWU-,%8B[.8(%1P8#D%B]=X MBZ6XCL'M`=35CO6XXMP`$8YUCP%9XE2@10.YD`V9Y'@A'#^$@-@MF2K3SC38(`'`@/20)*K&`;4%I-#X)-;((H/.94UQ>ZL$DL[ M8A/I#P.X>%/2EV)162#^\AIY%@0)L!C:\C19%:/'=*!%FC9"H!CD MU`/'=RZQ$2_2(1T`;QAY`P8\8`P]X$++T@-:&O*N-!UAH`3^L+(U#+"CRU#\ M=KHC2--&P[%$IU2&*TX2&L\5J>^647B.;TVJ->6IF0F+R_@FW`X1].X:>Q%% M)^!F`<`P4>!]W>`?(%'RTN$E48`V)5IS/6`"%AH5=[():=,:9ODJ@J\4K=(/ MG9$L!8(OL39K5WHG!?OA>,$DI6\7BB$C&9`//.`?Z!&3B5B="ULE'X"R'P`+ M4>`?'B"T'\"&.V`%0EM%2>VL=X&0"Q$$5D""G:$$^&MH-]L9*AH$:ML#-I)U MRVX75%&7!:(#LD\:G1E+%?$M)8$#5^"98<\$\[%R_?`O)R`=VODJ8<,0.QI& M`Y84.Z)P=7@+%;?X.-;A>`$$EB_^>EDQ7/EN)]\Y.Z]QKWW"&J>1^]20#\H/ M!#`@!#Q`$<69U*P2J1>'#RC0MIF1#DLV@GO0`'-P`;AO`@Z:+MG.#=R/2@%@ M\,P@"F%47"VZ%XNO)Z_O'SRT)E]16O'U0%UR]U3@1^V5JH.;Q"?Z>&_B)2\4 M;.-P=F&<[_+0IA=.!?)P@,.P%T,3M9%U"YV!Q4W7-$/@E/D4O"?D*7E;T=Q` M7/]2R#7%#:YO!7@C-`$7:@&``&'`#$[1]H[/#$#*)=4$DH`AK?P`$L`%X@$TW;-:TR!9@Y$;)X9- M7"!X`0!<77*ML,9#730)+]#9[K'GO`(54B"*KT"I%!KG<@\-\$LKTO9X5B!H MTQG.LLM?`R@E-UI;\68U.I[Q8EG'64,?3CZ%W+Z3EGHSY2_A6Z6;,"U@8.]& MO;,F0/ZLVC8L>FX[HM5='2!#$V4!$67?KC51$?QB-$-]+RWX,MI=O10?&G_S M@"]9NRU=?=RY+]+?@@>%-"W`MD"M4@W+%`MIG#7.[\D)+EJ]O8VI%!QU-B=1 M,V[!M",6H`6*X0%$$`,4$08MNQI='Q$&)%D":6_Y8N"4)V#H'V#P^$"F.78ZX?CN'J`8,GL@6EXR830' MOUP!53X;J]G5'\#OF%%MQ7FQ%WF\IS1^A5=HW6"_,4`2SJ&_CTX%]O`O'7+1 M75TH\18^KI3$B;B9!4(1N?A*]_XFS]PG0L`9E+$%X&-!Q>\<`?>H<\3V3'0N M-5KA"+/3D[HV\T#??9"N75T)RS+E8:#B#3OF7_X2V9(/TJ!<>8''7YV(\Y!C M,6`7?)KLU<^7QQ`H#:\14;'XQK"5]1`N9_#X0F`&43$IA1815J"/79VU5=KT M!4).&1`Q$Q[F8]X1W<`JQ[L%K$'^MKW3]$%@%U#@9H\O'100^%S]Y8>N[JGQ M+R4P+6Y6T8W6O"&<$0.^NUT=*P%"4AX5``"`R).G14$/$_@@?`BQA+40*!:H M0)3FX0H`Z1`J!(`"8IX0!5N(S.,,@`>$9@J&/`DSILR9-&O:O(DSITZ<#PJ" MK-D3`*]_#]@5=)-'H(>"(1YBL+8"8<\8#OFT5"DP)A]K!6-T2`F@Q$F2`,[E M>9`FS0,8"$$`,)-G*X`'"-U8L^801HRW"'GM[8!0TBX`NP3R25,00]8.`-@Y MS/.OH`J$B-D)1+'+,N2";$\B\ME49,N]'26Y*?B`CT!)*%"K1A@9`%*$GT,7 M:]R7,=O^I0`PT)Y+ENK.X<2+&S^./+ERG=8F"R1Y\"'8J`\'6YM@!@37``75]:\-Q4O".DE6QYN[!5='K<))],"/IF!@0>W@?>0 M)$;M\D]'$*5#F$<%+9#48#3F`0,`,73&FWZM`8!(=0!,B-`$>]$E$`8%"MMNJ9 M(VHU$01`,6(I65:I?VD$)$*,=9"57[W2%%L,64JRPJ0/H5?E0Q,LE(>1?"4$ M`)P/N='962XA=$Y!+OZ(9!YA?EL0K;O0^!EUY3J3I4@_=GO2M045\U!0X8I+ MWT,_9I3MN`CQ\9)"1)8PY$LBQH`(C=+>2G'%%M<*0PL@9+=2'BATMH#&9HQL M1@N=27).,;Y-@$@Q+EIEAIBE@E#,"N=,=O#(7V+0`0CUBL3+QB23W-^%_[3P M3]%Y+%""T-F5,(%(,!R=],567[W^4ZZMUN06`-'F42X`S@W4+D*\JN!&,3'0 MF@>P^LDT7:EL0\1KJINQPPL&[.P2FEQO]VF49J<5%#6W`(0&-I<''PEFD+FF M`\-G:4R,$+#%BL2PP2KBFZ)1WLIX.&4QGK3Y/T,!67@>+;%#,-:NOPY[[++/ M3GOMQ.F[-4U@-<5'X.^%_5*YUHSLP<^)9RB3UG_+="6A<7H],LZ52Q83KVB" M]?E&,10NU^>%[L6O"ATX--K&Z:0.D^4"=EY0ZR(:!-'[J6IOX>9F091D^RVT MH+3V*-H.P``*<(`$+*`!B347K5A(7][B5;7D0B3!>`U!@]&,3'B3'HB@8'EF M4%!_?C3^-Y88["2Q:0K-"A*=7%&G;>U+"K'.L8!/&:LQE#N)UF26.6>\IVO2 MRP,/'Y(K4NFK=1!!S[^$Q;D#*G&)3&RB$Y]X$V!M[R3EL1!O!,1#%%CH1R"0 MA&\\)Y)7#:Y:I,O#9P@CK1"P)RX>,8/UDN(&+DI-=4O"7Y8&$P/5:2Q1ZBH) M&V,#@X\]A#'L2`VQB&2M&FX$`";)"H;8\:^4.`LBD@05;T(P`13PH2`KO-#Q M_L4+"Y%E>5`LI2E/BKX$J#^AY%,)P.4\-[N5SO!B,,T#) M."32Y2&W:949!`(6,_12!6E82>8>P`O3F"$-%@J;TE2)T8QJ=*,,%E`!?\AO(.* MA#PBJQ9KC1P:C$/!7^J&"P@U4!!C`PV8HXA!Y3A$7_59K^+2"]_XRG>^L@L!5.))6OKB9`(KL$9W&)FM_OZ7J_HM ML($/C.#BE"L&+7A7@G/"*S.L(#H1=H;='HSA#&O8P(@M@6(V;!,5M,`#_Q(Q MB4&,XA2K>,4L;K&+7PSC&,MXQC2NL8UOC.,J,YSR_N9=\[C.?XXP3/;MY=I+HI:#M M?!,[U]G0JH%S8%8SZ*1$^M&"EO1[*!=I1S]:-7Y&=)\+7>='!X9TAX:SGT^= MYT8;.M%X/K6K#4WG5W\ZUI]N=*AA,@,MZ'K7O.ZUKW\-[&`+>]C$+K:QCXWL M9"M[VUG) MJGNP*'`#N+T=RGB'$@:4E2P&0N"!$N`V.QNKM@?NK6]K__O^LB%(!U&*@?"$ M/P`1YT@#"/RM`AC(.]X3<`-E*ULB?>^OVOI.QP)XP>A73US>[Y9W(,'5$#^3 M?`+B)C[W3\F[`HP*QD/P9R7JC@M7*?N0?P[8&:[R\[8'U`S42Z@@ZX7=I% ME[;CS=Y0B?^9S]L.M\55$(*`,U8M"C<\PA6/=FF;X;4EF*CA=^J,G:Z@&!B) M^YS7WNJ5.=W3!@>,13(Y!V^5UW)N((*#E7D$%W2$1W2^=7T> MH`(3(%F!5%DH8%EHPVTRZ'3J5&W79EG[EPXC`P+7!E8,EPXJ\`^(9P9;AVT7 MN#\@D`9G=W9IX&&$Q0L+8'ANUW#_,'IRMW8%]W<8\#$5EUA\5W/I0(:O)8!F M]P"&EQG^NY!Z^"=[;W<.C#=[Z:!ME9=W_M=RXR9N*I`=^U-T*;-PK%>%';!Z M:8@1N&2&IO<5(H5XBA>'HZ=OG(=_ACA[E0AW&^,!VM9+,/!OC:`&_0"*H2B* MHTB*I6B*IXB*J:B*J\B*K>B*KPB+L2B+L^B*`]`/`R![<)>%+/ANO#_,>`_@=^ MEG5;_/9P-N=&LB:!"OAMW5AY;D"&*/"!W#9QWE<1F.4!#P!S`@=X'%@R+=A] M(NB/<81YT[A^C#5T0B-S8@>!O)!8B5419O`/&%!QL.=P0VC^!H18#,"4#H9G M!HC`ALW4`E]!B(B0#BES#@\``FBC3G\7=!IS#F@7ARR(=[Q0`F[(<$4W>M,H M@WSW;^VV=SE8AF5(CD17DHC0=2,E4J!GB=88AV#U6PEH?NG(""`"(2H>HGW`-E8,BSI>0GWAE?H6SI#@]V1 M#A@`#&K@![2HEWO)EWWIEW\)F('9BMCH<"4C=_SHB]TGC^5F;A=G$90%+CU7 M?O"X#Z%1G$4.&XR*%F#52*!IQ8MZ89=F8;%T`%? MN7@/YYE-8W\G>J*L%X?]YI`MXZ((9X6ZJ'\Z:!'Y%@)W*9@_"J1!*J1#2J2J M:(@,AX7^YH[B9G[O)IG^&(R.*:4?HX<]1YDK]W]`US366'MQ66U*5W"?*9`E MPEB.-X#^).-QD]F-+,>ADI5Y*`B)@Q>;?39Q$XB.W'>EJID.XXA9$/B+5%EQ M6&>.-W=MA.5NF21A)?EO#W!5E]4! MNV"BN^!UN]`!YR!2_X">:<@.B&!M+5`S3?@`WV2>(!!X#VAQZY=O9`F@M:1T M*6=;;N=P(W:#%N@!U'9MFB>IUI:(#EEX)QD"_W`IJ0=ZLG>2\Y9[M!EO=MJ/ M6(>(-;IP7MIW>UJ2;9F&:NF#L&JB+YJ6FMEO.3ASQYD.QQ`" MGEBD^\JO_>JO_UJ*-KIPP7I<2VJE3!INS"F543JE3R>"DIG^FB!8=\R(-"U9 M?4GJ;Q;AF7T'G5D7@`4I-"&`-SI*[5*=Q]J<+D8H+V* MH6[0=;YU7"%0C%'*6UZJ<=8&E`DZ>+W5A#CG`6FP`HCGAK-G,H7V&HI+I^BW M?1.P`.Q'%&E(N92+?^\*K[BD?RK9@RU9N4\8EX37H.^*<#6YF3I)"5S*89*?HZ(L+>*7=MD$E8*F7MW85 M:&X`9XT]FX]`ZP&XQW,`B:N'6J]V1Z8%NK0VNP`ET@$A]0_8!*II@`&($`/E M>0YF4$&8`E;LT`$$'`,K()X/`,'XYV$>\`\]PX5*9W499[%IT;.XYY3%:IC. M2XS+.+<8ZY,):H:)V%MIQW7<^94UZ5L,\6>ZIW(EYZ3[FZM+V:5IX80F.KN% M66W85G!8Z803&I<#R'@T^I4P>KIB:K2OM;JQ2\55;,6P2ZZ/:`8DYH^XZ\7_ M2&Z^2Y7^_^C%ZFAYY[;#1QJC]*IT/1E_]8NT@;=OVSNROGBK65=Z!:FL!0B1 MW8NEWO>PWH;#.L=M[)@.[;:_=BMV8IR^)0!68MMW/_N30]ARB9QO?R>0^$;" M`[FW.@BEU(B>I1H"')F&Z9`&,>!6H`JA,;`+K=QP[&`S(:6-]EAX)3-Z#_"0 M@2>@\]@"`VN3=0O"\]9L(V-V6DF3OWQM]Y980>B22[DQ2BR47GFXA9FCD?R3C**O M5VS/]XS/@HFYK%>8ZV2S7OS%4"K&8/RP(=BTO7G&ZXPL;24)KP`:S_4:Q1U7S_F,V9FMV:RXSVV=;3C;Q0`-R%!*T%-)QN*V MF^/VCD1[G&:0,E`;KPZ=A!B0':;^R;'S)]A\3*4("VZK:<[2F;V$G1TK*\B] MS9Q6.7/PFYC=AIN(.'\>6KZ[.8_?U'"[2'.IBUM$QW4'O+[.6V_W1L(>*WC$ M?-'LQEL9*)X$S(:X-%)EN:H/`-5%L0)IX`SIZ0SKF08M4-19/3+9R*M>C6WI M@'!QR;Q^*KYPG'4$.8"XA:34]M8+!0:I5K'8`/ M>,GYUH-,V'4/EV]M[6\^JV]@58EOIX+3!K@T>KAZ&\D_:W,E<-F;K>,[OMF& M1XB@ATM>"-I@['VZ2]`";=JA'4ACG-$R>()%G7AN2,Y=*%E-(]$"IY))>UR$ MM9Q.ZN3^`>B#KAF`9?=T!!XPTM*K!_IC(X0V.XWVT[I:[(>,,+5-_UN!Y$E9(Q;">\HT((E66 M5]6_I"IM)HDTG:5TPIC@3?.I)GF3,Y=M&*V\T'F<95=[#!ZC\[IQU;8_'CW' MTVETHW>I$;5GC0N"DPG(5Z=.][:/*+"0?$MX$W6:Q-YZ.8K)U^;:+6Y]T\EO M30C$P(J\'*OG`E@"/LKCW>[M]JR5/^YV;O288WSD#XONNSO0IWVSY-?;Y09_ M9+E3*`J@_D;EQ>K@>)[M=;G;O(W-3DZ.*$OK`X@!&IZ[!AW^1[`GMHC>BR*] MD0UU64PGC'6IT1B`E5ZG[U&,-/^`[TWS@[K9M!7!A23LJ"K,L08>2'UNV)6^ M,?/-G5['<`/H8ZEK&>@P7J@^L\G>_DIR"GURT+@L!K@4R'>9%;L,2NK`DJHQ''B5>8HX=: MEZ8,[10>]86G<))]7'E>T4K<`CG^[7>/]_X*5C5#[^2NP;Y[[F`LQKQ+Y#N_ M;FJ*VFY:>M0>V68?]\YK\4ROS$`I6K8*O,;=J*+9]C*=H'T(D?-FY%`:UD1I ML$ZJARC0-'$X8AYJ@K?E<2IY\>/^6..=CTM,:'#%D`84(968%X9:6(QN:O)E MF(FJR=K)NZ)>*(,)2<@;6F\S1_92:8'WIM]5*,&*AQ9#R&ZE'7XK";BB5VU$ M@872/C3>O*!1'_6]A7-,VK+=B]`):X$=>F\E@FW.'T?V&;5K<06'C!F!%'"`PH^O";T1>D=7,UNF*[R_E(XI,8^^,%=I%BT)CF'-DTZ7$V M_*=BJ=.B/S%@"#WZH,!_!"G^0S2Q+4$`W:(H0+;N&\@]JZ)3[KK+&KPL*MV` M&BZ$^81;P`T8M/)IKY^"PO`Z%=(#C+3>!!OP*T30$P@$MPI"2"&&=DJQ++>* M:^$?%!^`XZ.:>O3Q1R"#%')((E_*Z)P.5F"(I_G2TBTHII3^ M*,2`*#A5\`"H)[6"@-'HM4>&&& M&W;X894P^@M M1@]*;V::(VHA!$09R\O+X>Z\CT79G`4AG787TVH^H)9*9P5VV#EG0P\;JY.O MH4,H2^;6(C+HK-(,2L.A-,RTJ+2N$(*TM-10O=!;S5X.2MV>R:;VG&(0:6$N MZ+2+;M&EE#6U!7LC8E->:N]U[>:BALOSH'-64!*$4?T6CEG1"C(PHO0@8BPJJ>2#DDIUAP*JJG2W9!`&#UBN,;4]"7Z(Y4DMQU', M))5TZ#RM!=SH@23/21ABYIMW_GGH2;(4D9SJ-L,W^8`;BF/P_'ZR3JK(1:TT M#Q!$G4[^^CP``>7S8)31M4GE4MP\%'='\9S01S_]*CKW(LY9@51D;("C33K< MH!@4H.9EO8%="YQA#7:D83B;2K+^@SVPX6LP!F[V$73C,B. M0A4K;.E(#@+)(RQ[):D8_W#2DY#FFTIE!$_XV2!9-+?%-:W(=]D22'K,<"H9 MIDHX68)3LGX2&A4&!VI[Z0U:+M24#_T)!2W(8;Y(0R_1V,M^Q2.0>8+H#&=T M`"+/$I!&H/"5#1AJ>=&C9"4M>4F8?"HR.;%8;Y`&G+=E*57^$0(.FN@S'S3Z M9C@#*L&Y'#.UV["O?0M9&5GD59&TK,8\"@$BP#R3&SSBA6=\\=F*!$@V>[G& M@!-(X&A2J8)9_8,=UMB%&11(OKFXH5$""AT&,K<0L0P/?V>9V,H@,BFRL:I3 M%TD-=9;#"VWR)H[)LI.S,&=((1)QB(A9!8<24HY=EI$A9\$ M3J5`E4VZ6.9/V@2!!\TBSW1XQ9>+U)<]Q;2"?RJR9:21VT9^BHA)8E*I2V5J M])`Y)KO!D#ZBVM`ILX!B0OR`YG70Z0XO>D71=HXJ/KXJ6\TN MNCOD58\_1*Q>C)8$*;>>4<@ M'"'/&>R(@356T)^^Q@:#..J7(I/:5``'6,!!>HL9D%>,RB\JR7S^L&^$^JQ_C$`9/ MQ17,2KU;2I-RYF9Q6I#13&79X66*HBU02(I$*#C/):3)NX@!`&+@C`>\IE+[ M1<0)%.)?D`Q8U[OFM4L"A*1BI('-"_:D6@SCJXOXBGS$.0O^:?H"FPJ78$54 M)(KDA`-7AV3;?KP,<5N=I((2P`BS!-U)&@)3J?+%Z;Q*766C+;%[!^?=A@,:K8PJLL*0$-B(L)%@S&O>ME"OI*Q]XJ6I>T MX@&ZA=HM^FWOSXDGKV0"#ZC6````V#'%_+Y;3`Q9@?)RW6NXQQWNA+/L%$]U MRJEZUYE<*0[?'441TV2D(G&A"%C^[Z:L#5_[:R#V<,I61B-<;LAJ80G>#\F7GCV5\5Z)B"U(.@?N2EG2$LW&D`:[:`[WU6%S#AV(1!]W9LFR<%NR MW/DHR^'G34K5K6@GXC@(:]*9.1$SY-&ZBKBY]FJ\_+L<1.B`^2*[^FJ[VTDN MKR`"Q[FO_Y([#_Q`3+(EC6B(ZVF2!B.I>S.1T2@-`<$(;MJKU,@NP0L,.9*C M"D&-Q=O^J;0*M?4")3,(BPVTO,JZ&9*2%9/#0(-P-A.Q*'-S`TE8FIZ`,_51 MB%U8@7\0G07(*0&)#$3(*40Z![H'LR:+R0"PZ0+/A/R ME.1@)B]#E9AR,:((#:IXCYCIBHZ3+NB3B`7@@PD8C@48#:1Q@^L!&M(`BK:P MKI M2"$;B9QQ62.U*"=B++.OFY<*\8D2B*T@S*RP`J7C@Q`(NQ-(BPT:2X\2<`,^ MD*82&*O5$),ATC>JN`V.>H`IZPH)A#+#.`=K<(86D$86L:P-'*)ILB^!@0L; M\8O"@*;$2)U3RC@Z<;'>V,.^R;'->#Z/D\>P48'H<(/@HY#%*@R-*!_7\:23 M4INY@*N>.P]/J1!2Z1Z-J1/.*!C/N)=0]$/WN:P3NZ$@1"2M3$5:>@AQ$B$. M2I(.$#9VBCH>:J@*;S>:6]\#&%`T:,D)B?"YBV>IOA^`=IC`&^I"8$ MFPBB,B$DF:]BL,9L/$S$'))0XP_^B%JPO/,DXHA!)#X#'M1(0Q MU6NX,WJ,$A`1\P`J*S0P!#N/PDB#C/S!72@>RT(D^HJ!LTL11PM,RT$J$"OH3FC.DD=+0$4\2@^41&*^J"-3PRK M\O&0*5G*I6B4Q?,B]J@P,)&K<0O"?`P>?A(+*5(9$/L*(,P)LDPAH<0XH'A* MA]BW[NP;^E"]N-RZOL`(]A$A>4F'D7&.1FF'X M3`G<2DX*FV^#DE?BB[$Y#@'*(C#QC,!:@$+YK>'P"B*:HC=9*/PIB-4S%((! MJ_),`R32RUT001]Z(&8LM^(I,"RC01C8#NY@#O'XB<)+O,D)CCP#2Q`M,!^Z+,?1 M2E6MK5.LGC0\,02MFY0)'IT('=6819;*$G`C"(A8+/)2"MU`KU2DD1(:#1'R MQ*U9@%UICND`N`F$H"D;26N1&2BHFQ>546S-5I2X+1U[S,?^/)42:216ZBN9 MI`B<(:85!!R?/`RZ`!^[T@H#2](0`TP!.;9ZW`H0B%)^4J+)^JYR"=:;^Q0E MW`RRB:]+A`$,.#N!\XJ#&\O60X%T(`NY>0`(*@9J\4/7&$.$:S*6*9@'0M$. M>B_?*1/;=+^4,$B,:6:@BB(2`D=$FDFLKF3BK`-.''7 MX!@=B.4EJ58K"]UIBLH^V+,,K3LUA?W!F, M6[U%],`\R@6<@@%"5575XJ2;?$K-?16H&U*(_^TG(KQ7&8(3\NA(LFB!D<&+ M\[FZQKFM3+F3C-BEA>B/$.C>+0/4+&Q.(ZI"684B8%5 M3TX64"-BCGI$E,9C8_KN!SQI<-Q0N^8'1!X MM3:V6!Y+DBODCVZ"(?;"#YEIJ\W(N^Z"(Z09,QUK,,+3"'%#S?UMNS)JLH$" MJH(SY25.I-C2)T7R1NVQ$N=8BL_$X/*+$W!YS[V@GHH9$0OV"@9]@'WC!93% MX[WIE6`-^9CQT$NPS+]S6RE=39\DEMH-1+#OD]!Z3)^YO+L;I)>,L.+K<0,F M,Q@AXN*^9`+,9IM6A]YO+]>DLZ"S(-"GML%@!S(*#@)"H&%")T2JYK,"XT; MD>.),&):O&?>4#[5@-3%R$(`C:\&W5]8TQ>]3)*K1:2#0R)5Q2$)9.7R`T#] M[)NU4+6U1!UPZ1+=\`"*03!'(PAI`XMSV&!A'N8_1:#5:)Q_6FK=`3I$,S=@ M"-QHSNO$?*.D](?EBV7F)**'ZPEZ9P( M>D%@54EHJ4Y-PW7BKSTNT,T8_^$+@C&H$$@^,%9-,'0;*PD!1"@4^,D44$2B.J,2_PR#!(NB=#2W.HA=#J3PAJ5ZM@R%YI+3N&@JMW?#J!7 MRX)5BS9E?D*DAD!F$8:HBS&^I40]'^H/#X"*6SZ:=*`8TR7`IOV:8%-6/V5K M6&D.6Z2>?1I+V^@,]RHU,'QFO5.#P'B#["X-5!F8L;;G;"Q#62Y0ZV`H_)I M,=105A?KBQ;!EUVZ/]@B-,C9C@YV%RY9``D\AU%1O7,@#L]P*V9S*>YFDVCI M#=9@"#`$'&_TB>K0#BZS1:+J4GQ*Z$[HA.E1,$GA&I(4`2;W%[ZFJQV0) MZYN8HKN)90!72293DG/*%VKIC/8^H`5G<.9((`,+0F,Y[)H*V84K`0S7<%\/ ML#42BN.J;&;#&&5S+/IX(Y-Z[-UX.=C$F#W4F%ANC`'O((#^^7*L)B6^Z`HP M9H=7W7'\(2HM?8MGI"H;9ZF<(AZ1I^ M85#4#"@G&[3A&9JY8!2J*)I>>4D,@:QT@`Y+W9IP"YA=@HC,@2W/L+$\:.OG MW9L0(+C?U0T]+XU?$@T!S#%)7A.%N$3.0!XTG2DG-"/$0K$R0M!^6V M$R#`$9-7)-!,[Z>J)J*5#Q6E''CY/)(4,8P$[AC@P#TT#JEMKBDSZ--8SX.+ M1]E91R]8K9N[^0ELRR%6Z)UTZ/5?'WNERL\`U"JN&+'I,"$Q#>L8Q("[&/,Z M8B+O-(R\<@\\BBFLV/@GTQPPW[#^LM)4O6R:5_V7`KK%)>CU1@(D]07T,TS@B0U$>$)BPB<8]5?@$HB<@O9T*$,3RMX)^H-#%F` MB@!8C1B:WP3+-G\M^P$!BR=F.E^`!XB!79BB4<$]8([8U)[+$E'7Y56/6"L- M_CBP,K*-;6'TTO).*YMK<+)H17*YSZ>EH3O%`)XRB0PH1<)]C(.:DB&FV++O`( M4L4$&##^8I8($6*E"A0ES'AP@\$#!A1N4"!UHQ3&A*8JTG0H)O7!@S0@6H3` M<'+!UJ$@09Q;P6Z7LQ51J5)-\V_M/Q!LKY80&3>K1IT8[NKD:&8M!EXPC'+= M"A,CAG1F0L9-#)*DUA)J_Y5H<>Z<6D0@TJ4#D28-HLZ('A1;L<+9KK'.3HLV M&[78`Q!!^?#A-0$%UP5N)O!:T''!WQ(@?IO9"\(,2,Z>)W^FG.;<<<@3)$&7 M!)L7];__4!ZQ)50R`HI7%H#-2D4;6@XB8D1?^41F]I$((B06' M%0H8P?024AGV%,(_K#V`R&24#<=2"/7Q$5UT>=`8'1\UJ6"&>QWP^,`Y+7@4 MF4IQ819>","H89&22S+9I)-/0ADE1#I]5&20*G5(DDDH1?9/&B'01IM>(-!D MDWZ7A?!;4>1Y`$-A'ABEE)Q,-34;"#PFZ&,:0%VXE0I#_?3/`Z61M<)45"'R M3W#\K112D2,!>=>?'!&U44D;_62&"K+)B11M(7(50I4CR>5!9.F\U()59OPT M65M[?K4B5IQG*BZ7 MHG+I(;*G&S("*QL,QV(`@C,=I#'^E(*0G5-,&N&)!Y*7CZWE'6O#@7!@!Y2= M8T91$]AWGU\>M+B2E]X!6):/BI8DZDCQKI9@:*BE5M;"IYU6#"(MW#6222!J MV-&C8'XJF%$=(Z7"B:"IZ&IP+<%H8XS82C?!41ZDH>!4B;(:F4@%8D8"28TD M*:7//P,=M-!#+S022VO53%Y;*G5T(0:^J<@Q;4]35J:;FJ6CPF\]F7$N"AZT MD`X*VR[E!IW5M<"CVLL"Q9A6&'%$WCD=L&.:H2BFR&?!'HGZ46(A9862J5EK MZ/3@"P1KDU*?A@FWWW$!":1A)="F&7][*4I>V/TIUQE5"0:,JX2I\?@/!KBM MW/)12F'^<%A1*CA&:QHAT6[<<K2R5:3&R$`>(Y.[IT;\SDD M66G8>55U*;"[BMGF9),ZR:8$/")=5;`"DDK=!6Q=0X18['8H'V6/,.>; M%&9.2!0ND>1/'M$*^L`$FYK8Q%-)08%6.&*TS(`-,XI:``K^]A(VD#1J)57< MR[0^\SG0A$9"N2*==JA3'QD%[R;D<%)*@MJW_MZ&;%BM&!26;%+_L['QJ/L+RF+,\JVN)*VZ4UF54`QX'V: MP@M)Y`%;O!`$#+0&A?@<1C%-JV`Z="8D.6H0A.I<)SO;.9'-S`I:F[E*UV8' MN,*48&XL)%NJ8EB3"7@@11A8P-864(*)A:!K+4"!\,SV0]S(YI(!,U2B2G"7 MR!!%)X;1#"*<4;="G24MA+O?0#_^9+#]`(DP(_%`X9QF%S=\T2;;\M]?ACD2 M-!*'2%=YR4HQ12257$DSNK,CHJBR@ETX"&)E8>&O6`8L/L"`7SG)%$O@`CDS MS"I%B%J1/.%Y+HCZL4ZS^0@B=M$!RNF&;F-Y`%:HI!)5H:4S*Y+*[.IY&#-\ M1CYL#)/_##JAYP/%56/_"4);%IB9?X\R>'$6J"])N/XM"9#K=:=O;XG:= MM%*8CW[CR,*69"2(`)<*^/F]8H!`AC4I03%8B`%%N<0,D\6J&1@J4YE:DSHA MP&54JG7^&8P81G*1<0M8F@C20V'/8")Q";>"]!LM:3$G*A@<%W5"D^ELBVQ) MV5;?CE@ADGQD0_-9@%T*PS126;">SWL6M`8EFEOIBJTHN*;*$L@'@][U-^;Y MZWZ8XQW/I:A:'E;+(UL`@^#AQV4H`$%I8N`,,YCM0RT(S3G,]Q'R_$8SH-DJ MI2G.$/$`_05&)%R%YAFTT9^L8ENRD4S+"T*R1I>RV-F M5]O<`CK0@H82=]OQG,RORG&:*$? M+ZWK+1U2E6!!+"U&/I*'LDGQMD1MC5T\0&S(#%5PE<:B'"N+-9[94;74D@Z. M+`AYU:28R$A_&(2D!C.OW^+D!'9*I)M[[C+..!8`62]@!AK?90L.8G MW<%9;X;RN2>VM"4LK)XXHE!-]AYVF5\2[(A=*DB7OFT*>&`$]E\LFU&,E:0G M_S,U>A"1$[X%Z=DWEY6B4BF51EI%;'3*KA__"!LW&.9?]%)Z9#S,R/8@RG/5 M6IH,4]R48P4X9'S3SV'61<*WDB??3T0TP5)BPI:+M2GM#NR^_[,:'P'%RX3A M%[4;A)W/*?R\C"U&NYI%)5'913![W2^=/Z;[8Z6#KB1$%4K.EQ48I`Z_#B6C MJNB&U-FC):Z,[$S/?]XSHL,__O!7JL3?DYP!(H8E3L?`3+F"5Q"TC;6XT; MD=A=_@R?7;!1QH``C9G'2W[$?-0'?C33,;UBUVR`1UEB+ZG-468BBOR#)X9B M4SHE!XD.A.U*BK!+5:U$S)B+2W#^5K=8AE:"ER&Y!P@(6T?MB644%S--'B]: M$M]$WTO@Q2&>Q664P(E$"#(BRIZ0UY8UDP1"SIYE%-]LI4G\RB.*8Z?P3XR! MQ&242=F(9%1\"5Y02:"@';QD6YV$T9]HCUB%U3Q6GIM`RK.M!YYA55$MRS]* M#'.H8SHP1;>X$4@,Q:5X7`^MH(7E%O`2_'!HBB`W798=FP"!:YM[I%1@@NJ`'F,&"/`!)8!6UD>)4 MAAC);,8/[F5!?N9P#!-@ADP+K*$PG=1; M``>0W`8UZ4N,Y,&`"!@,)209M-NZMULS"7`&*5D:56]6.&E>)]D1)FN:!UG M4%R`[(I*LIVL7$^ZY1A*^4N@;B&8OL=F..'KM5S_61:7QLIPQ0``6**=NF=2 MW<,]B,8YT.=])YH)VJ+0J`GLM`H00Y%FA6A`S^CBG*0*'A>BS; MB$!BR<4<(&;$B/Q)9A2?@MZB5!P52>)-/ZX%A6C/9UD*NC!&WP0>F?Z1[P1/ M-NJB;):<;J2(:H*1MZGD]&"%]^4:>;6(Z\S4=>'&C/""0VG;).F+FY`3SAC- M`\2`);Y'HA)5B/W(B?DDMXA*&6F%-GX(84BBJQCJ4;9&.)&$#&%3C:S,G`D% M6(Q/I8:4U=$=6PY3LL"/9#57&@[1);(/4IT%4?%C([D*VH6G6IR,ERC6:>1D<,2,921D0N6-?1F%?IS^$$9(XF%816)SE@!2[Q\"W'*I:,0Q6EA4S4]%`J@H6))V6(IS&5<"K-> MS$&Q#X#,:[5X!K#::<]^2YZN#=[X(X/=CJP4WUD0+T`BDC36)A^"H1)9H)Y& M2-V`;_B.1522Q2X@PM`:;?JJ+]C,T^4LK7\"1]?D8T>\I<2T54FU3J.P5$+= M%87H#TS^H.6\@0@`<]EK^D8M9A+QI4C:>JAGR&I5M)QY;H2D9,B&+.NQW<;+ MX2W9<+!88=>LB5)UB14(O)N"%)&QW9CBCEV9^HY]\&8V;4L98H+Z@5Y8-*>ELX4?5D0?A$R761L MG%S#0%9^$B_V&`X8LI$PML_K-A>?L:G1D:)41IR>$B<>S1Z*4!QD1=G=[.'? M',U?31!5L41`TN%BC<:MB._:104(((GZ$G(A$T2M@1.6\-D`Y=A?C1!QV!C, M-%=;;86%KH1\-236V,:_'E,A<@4UBM$G^XTD(K#IZ$@07VS^Q$:29D@,G&P6 MA"'2=62\PQ*YW+N-7>N-;R;UM'+_6T*#+"$QW$99H)*QP!*&I#&8F$< M9+ALG(31CQY+9T%S"#!1Q!F?G::9^0RB&;%7CH2&8^%)GRD+'X<.Q.#*SXXB M_265.F.QQ/6QQ>D;N_"9:-FQTAK2K068(D;O%R%)+;%1P)BKYE#3/E4`O1NO"5RX;^-TIB6>%UI.ZP MA5]XYX;U95`U=-!(C8P5CFG&WHL\[VMR)$*(;5M$(>450RT.@=Y&MMSD1\Y_26Y06LVQ*+%$_W&(D&O M9TQY(%JYG.%&EF_YNX/B?+7MJX'Y`-W55!%)+1523AS;ATS-2="9OK.7=<6Y MA8A'QRFDTNB.](#C46Q(VQ;:S'1&YG`2G"A.$L^712/&_GJ14]DN9?-B3>2K M0=7+V\:$#2X'Q__B63\*LS5*ER!-D=3MHG,/FI*Z/6+5"NSL#EMSJ[=Z#)AO M"4S`K$M"/>(P474&B2-YSF*S#_?^"AFE`3N\FZ/]*#U2AT^`4T>5AM3KK&PG MB*/)E"R'36(S$H"T7^#+GX9,.V3,41UW"*L`2D@G$48%SK]^2"?WW119GR7%J MHV[G6W5MRRQ"_!H#<5+OG[^.2"'!BZ)L9U:XW,L!3[Y.7O"`W4W\7WR#;1G] M!B/NY&+(KMV=Y].0%Q^>[E+`]:B_W+GNQ(E(_5VO^E[SO,]SKOE*CL,2+R:V MO1_735[__#9_"4'=M36\V+!<)#;6&?")9&GD-;/G(9XN5+6"!'$D]HZ9?22! M:?LP>6/^-?':2QR2.[3/;GNE`L2*%1V*%>M`\-R_!\4>M$!!5D6+-`T-$N2+*.^YNPW/I5,1 MEBP*R0ND,E6(*(V9$EE#+(#!JZ,DT1\_@IPP=D)J7JM9AX2QX-^#?^DP>,5X MT0,(BE5#&+VZ>7,ZJE&]NCD=(BG;BA@EAYW0NJ/'T:)-JS#^<\Z9-7;6`,2( M`0!\]^[?PY2$)'#/HR(R'/^:&&KB\#Z+#J1 MNJIM@490ZHG**JV\$LLLM=S2IJ[,<"@-M[!*;BFGBOIILXI"B(O-K4A2H;FQ MQ!J)I+/0@@&%$G0C4RG@VFH!4+OR8LBA8A`I`861-L1KKX+X$FI0Q10SPTW( MW$BT+#U!.*<@1$#8#,F_GHMNNM+^4D/MN=96.PV%35NHS384*-.SA!!L/4HX MI.82KBJK,/@,!0^"H\I-YIQ3-;12)0EI@18>V(X=[]([SSO\K`6O6O7(NY;; M^P!DB)U=.MAEA5?AY(B/UQ90(9VDW"K!C#2*"9$HMFJ%+$/K9HNJA'\:$@@Q M1,8EEZ`3431XQ81KM%%&&'7<,4<=4<2QQ0[<(VBO%39`3"BAB$1,L4^3Q,@X MUB9`X2=;*SJ)RY9=?AGFF&6>">4OBPE3N-^2V[,%#[HRJE=;>[6(N3COQ/.K MDIK+E"D0_OFGJ;;,@%HI$`;[L%&^TDGTP`K/R;I3Q?`*6;.*P,HPT=?68O"@ MH4#U0%3^Z$KM*+735%,UI),YK.TB.(.=:LW?XM)UKKBL2F>!TU*&506B+<)T MHU17DV[ND]/I3SOTM@VOVFX]_QST&&CL`+Y=K`G0*Q@ZRGO5.65M_*@2/,`( M`Z#!(4DB1*6[*BR MP\%E)2N^L14&)!,5LY#$?%6Q4^3D5CD8>&`%VHG6YJ@(.BM>\3[T$5>TK-&! M$G@&-"`!S71,L5[D?,@IK"* M6>QB$J2CHP"9HNH5II"&DE3W&*D8HBSG+&/11E38I*OTO0^3F=3D)G6"`6=% MZ)'V&YR[W,(;H`5N..93DK'0@A9,7:J`E&E!`A$#-84D!F2$V@OTHD=!61UN MEEC;H"WO`@+:,&-%J!!`V#44=K33/H+A4C: MWU4`!2C:4%)-_0L:T>KT2K*TTHR80I/3%@*UP63P(;J4H#,TVH'&K"N=_L(J M9BSS/4I!;E0A&0F[FEFH%`!1P M"N<;NFRF:H)RI%(8:Z:CTC2>K*'<:$SC@?]L9W/7RBP_.7N>7=P,$>(JP84( MBH*DJ$G^L/)ZCU=W,\2Y&C%1OTS36O9R4<-P-7H8]6C&]AA2D:;(HXXJWDF% M6]SA2O`>/?(88ES*R+LXD$)FR^&ZHC*/6P7*##KUZ7:YVUTM$4]"(J.DRN8B MN]HH=;RPD(8@%O68(4Q;Y%@HP]8\U8#M/&;C&K?#<*;)KT2MVF"L!S+= M-+9/YRU.,I^3*A?2;0(EB(^V-FL>^W266S6V\>F$,J_&/,;""WB`1KF*6?7X M!T:'&E!O.K-6P8(J#0]Y@,4,L@N"&4:XA9IR;_MXL1L=K+C^6)U7A+1#54E?E/ M23E\;YV:&A:Z5L8N02HI'E%4(SJ>(P0&I)T9)/(]R\BT9Y%$L$3-4(SXBKR3DH7S:^R0\C2[@$BCBLS,.8M:E;@\YC0L MC.$U5P<#,QBYEHYQ/)XCAOI'G)D$&@Q@+CTTIC$`N@B"6PO+9[+= MTW4\-N6!..C4#!:SQ%8:(Q/E]B!B;G=A^()?86IUS:2+GL>\UT!<%IPI2"I: MXX;*:H7\(\]]EOC$][S(+$T4$5J"OE>_M;+825%-D..1N(0 M7FMK2$ MA^K:&'1RO$@'?.A#]K+'`$#_F%WMY-IAJ^GFJ@SA:,+"+&9XIS2E!FD[QOY- M*#1K<$C/_9I#%'.">64/4@5O;EX,X,@];64R#']Z;RKDKW^PC.*I5_UV!X69 M[W6&NA8Y+\=!*#3;OS/1)&]J;">S+L'Z:UYR* M%T)@!>:C[B:0`O,N2=8"*FKG.A*"00XC8QIFD,`+JP1ND(S+N'[D488D(G:I MWSS0\R*-(1("^)0+9!9BD19"(F3*O/R&NI2J79QF,$``]5:/"(OP?13KS1`' M_?IF]FJO?VHCE63O-FZ#T=[K=6`'@P2.1:PL1_R(80CB'\;O:-*!^1(KNLPB MOD*.:TKM1HJ!4J2B*,Y!`84$U*")J&K%5L1GPM;J3?IF3:+^3NI*M/N*C10 MX%GDPQ3CPQ"A905^KG%VIS>N@[E.Z,PJK4>"2[A@9+>P2A>I;+DD0I:YFDL@U-HL/4,X&,@8E*.B;TV[A4%!1',8`B-T!JO\67*RM*#&*R0S1R=;.RS<> M(S!ZKCT6$+$JI%.RQ]^&`FJ.@D(&BYP>YY=L+YWJPM<<:"$*14:FR!#I"#-F M2FEBZW\2+=;JIOQ.PXU*(`VF*)_^M`5;L$4E-Y%SK$A:Q.7GW("@0B,/8``1 M3E$G3[$#TJ!#*B0N6H!3F-%BSDSQ2,IZ/NIBL$P7#2]"B@27\FO*R$P&*63] ME*)"6,%W3@HBTN`$>C$&Q49D>)#A;&]M;BF[I@0;UY(MK\3Y'NA[;LA\U"L< M(5+%8`4O\]+HS#&)?I`=K4P^XG%&N'!A>O)5(LH-R/`>3VQJ%O(ML/)/:F5= MG`5&^JMIXD4!0806N=+Y&*@QRR9H?B/KG&]L;'"72.=!`A!`NF_8.F,C5L=N M5$5R6`,&^DKV<"H-=F$`QXTE-=$ETP[OB@$$Z/$U)2$/\D`2H`@P=_(4/VM? MWJ@H^L7^(/S-ZJ:RWDZD^*#'>$R0P:83*B6ES$)$0IZOT'IC3*CJ\C!FF'#P M'M\,:L[P=:`1ITBS!:JQ+>\3/VU"(@6%*-!I]#2L36YO+B%R?UQK0-4/7H"J M':%%,*W,02\K7!0P,VZM-H1R,0&%P"[33(!CL&PE*'!1&`7&W0[B'+0P(&/0 M]6)*-_PD*9IB*1AH>PB#MQXDW*1%BZIG/"FD5F3/<1@'_:`0@>",J*Q&-VNL M)3FG`'_SVO!N%4-M`HP3.6'@\3F/2&3,[[^0M""9B[HJS[5 M,C\'E5!=(K$BC0/A*HCH`II\PWY0R3<(:U><;E?.,\KV"S#K+ERX"D(E,!XC MQ*S,A$%`9NA*SY96-#C^%"N%4N"(!S/LXGARI/L$9K_4K-T*CKX42P8%<18% M@D;%;0)I=%.C!Y&@APLW*C,R%`DUH]?.81?$P\:^XTAY\SR4E`#1PQF$TP-* MIC9;(+2T@TKCPTK#Q6`"Z3*U`0)(BS;$VM,S1DH M3Z;(1AL>TD!M[XTRPSX+%6('M6JHZB$\J*B* MJK&*RD]B1V/=I2T^]F('"[$4M,C^[@D]Q!45)=`=O;0&.2@L,P-#%T@S*C6N MID8A\+5$-@@O4),]#H)=540PY_`I-_)JAJ0B"8,04_/(:&S&M`,3;;1&;4P_ M$NBY!#%DZB(GH15)[XXE,[$WK35:(61"EB+*LN/(J/0_K)0PVZY1?,32#@:0 MA.>B0NIALM,6'\7?:&XQS@Q+=?20P7^TORH&M##U;.RI)O&*=Q MA!+/!#5B)_<^&VM3IG.#-/33\M1,5`W%7M1,R@3%>&9J.&4+YT,U._5*H^=W M"`X'F4M4&9-9_>0M+B/XV)7R&`4^(C1N&Q0>981>0:8I3]-8N8@[\FE:U`,5 MTT-34='^:\TC7+SJ:%OO(7;U6;066VKT[HZT6L&V:[4C1S"K:]<#;:G4TE9D M;=_6;0?.W9(G8NP-.Y/RS+**5!FEQVB$+SA0G`"7P_#R@OQ%Y1KLN?[A#_8$ MB(2("05T"DN"&,#)@2*.XK`;8U]X3+TPM M4X&57,?U6$N$*6N+X.JP:5[8FTI4@L,-,6,-%6>'PU'ND(S-:7[JH% M`*-M/<07/>KN/3?59/7)G\HW?>%Q M;<=T?7\'B)>G%L^X%A^%7JL7IAZB&/!W//M3.+S1'!D.7AC^!$?ZJQA=5&0! MY1@6]2UV](B6QHT>6'(E&)&)$,42)&W9EKEPJ2&8JX-*\W6]AR*_$X)X5HJ9 M-D(=A#!KL4PMYBDG0M7*JGMR*;^L1VLC'F;MT&C=PMI9%-1EER7-URD MF-PL47.0U&F[0XJTR$'H@UL2T`2)MZ.4>#PH,&KM`P"IQ7MI#,F4-K,\T8O? M<9;#>'A\Y/H*I=+J]MV2Q]Z4,@5A*O#>.%M%9-N$R!M)+BI^L$%@1!!H(36:`ESD6GIC^`^1`93]_H5YC&*C'$S#`,RQ9#I)8THT6WAWC^N?,P.%`W+C=\)U!9J=A&=Q-L:_IDMU"7RP-<'913 M>QA''K3E6+#>Z'2XOFQ,902J/:H-+4XQ@F3*\-=PU_EO+^XM`'8J05D]<["DG6:.3,<2ZRZ%6[#2 MXA&E:0:%]6S;0M;I?`(7L^84Y_[HX*M8R*B>$;GZN#JXXZ(3_LJ MF$A'0D/X/05ERU*S/-@!TU[IKE,#!8`B,1=9%:6AR;7(JA!%0'!O[!JB>F>#P0OQ)QLQDES,JY:M\3"!3C5>:$MF'=2`#='F;BJK_3D M&(I,9D"$0Z0Q_'^[DI/>&U-W'C# MS;8-7'/2(T+/`0.>=`$$YEV'YU$TB,+O.$8_)G,Y.+W7-*.F):?3V2!2&;>X M2B`85'4)O)>5=]QBNJB9EY:?EP![>)87]'@SYV29V[ES)(>QNZ6^IET#"7,IS7A0K`-PC#P"\(CE0\]OFMR85UK7W1`G M,%L=C";YH`562K<2N[82W?ELL+D(92A&K&HGSR)34US8]C#&[&*VL#UPF,0) MDY>7MHH!`+*+U.[(-;C/SLXAU$K^]QR76?T4[4['7?+N@I6K;/M:_$,P%Y3( M&<^1;I:7Q#B_BE5ZJNY\6YIWD_+RK.PI&^Q3Y(*=H3WT_A!@22=:.@O;N:[\ MO@YEDF+-PQWJU4=0\&*_L9@WDW?6E1S!X30?L:K8L6PECHKL/ MWPA)-H*DTCD*U6]YN=?=/AQ[/1Q$6S1=>X<_\9T7W:5VR$D*YYEY[<2-L^C\ MEE$>(``('$@0`+M=NYPI=+:+W<$5Q1X\0)3F'P@09LRT,).F`T-KUB!V6+&B M0S%$$B466]G!I$>$"V,R=`B3Y`J%-QDF++D"$8@6)8"6*)'.0X@0&%0L6("B MZ=(%&#"$*&'F'Z(.[&(4W,J58(QB(=S`&#O6C5FS"SR4:*2FG]NW<./*G4NW MKMV[>//JW\F+'#R.6M.?=94YYA!XN_#G6)128@;@+A:> M\Y."I`+ZSSG%.&/?>)S2J.EE3^K'3DP;.A-1;1@M:&(ZZ3"GD*,KX,9D![,1 MJI*%9^;DH8`P*=00=1S>5$Q%"9)(E`M!K5:BJ.O#/^TV6592- M)8300R>ED>O%)R9M1JI9@5=,1JB>U/*<%^)$DK//=DC31]E9<[5"Q;R7X((+ M&HW!4]NBL(`*WF+EYUYWC@AL.2C+D2266BA&Q)KA4%:,>X$5JL1!3!AU)+?:99V'H- MVK!]WG M((]:P<:(1JH2*EQ#&.+.\*`>0L1\(2FO"$ M?5F=!M/'E>M)J5/C`5VT=(*=#I0`!:&1A"1X41K5F$TWA7E0L$J`K1;$!C>U M:P[N:+.QV53,3[MKR<%4TB1B+2<=\PO*/QZ@FH^`YV".THSS^D.PT6%G>IO: MSGU62+6M%",=*9+@62;HM\`%)5#[V@X+O4(PJ,F-41`1U,6P=92H&-(#B("4 MW,X1`A6$P`PMH]"AUF.3G+0-?X^JS*1`DI#=;,U:#S2*MIPBP?!)I5<89*-^ M('"N='T0!D882UJ`U!84VO*6N#3^X4J<(1!5LA`\,R*8IA2E&>NL#6'J`0%H M1*/#,9$D(L>C#X320$2U9$P^A(+FQIJH+S]UDU`>HX!KD5K^ MX1&2B`=38=.,%RD%`/6$;4H(O%)V/*4Y5A'D`1Z08+H21U!W>4MIX%K!=_;X M0I#\C)BSRIK\]!:5=`*N!`K=CC/^\;UT6.5V_VN230:TH9LH;U5?3&#=+%*M M-H6RD4SAF]^Z=4%$\#)[Y@K+*W6D@J",,)=`#:I0CR3-3C%T,9?I968.^"SK MX,EDF]G%/Q;`"QWJD(-I!B!%0L$^!%F!2K6'6- MI8Z.M.8#,G74R:BJ7UFR5?P&B91TAN^B3N+.1AO9HA:\Z7CZ$NG:.+0>1\W, M/IN9%42TEA%=*4@C1$R13)T2N*K$XZ::8P0?1$&*!TRUS8K(IR*G M(DSO+&3>VG1$C!T053J0PI0Y3E"N)=BB3:YVU^SH]5'7B<$N_!H]+:GQGKY4 MWY7(\\8%F"6QC.6#AC7,"\>BQ9&].D<&M0R"))ESU8/^\;39]%;4L^G$ M0#K2P+S&C#:=,P;I1(XU,@T-J#(SNRXG2;(FC.`V*+?MWEL!MQ0YHL""Z>"( M3=/')>+VB(YG08$'SB&*Y3[WRV!F[H-^R<_V[82^M`$BQ>CS(':LP`S+M"H? M4#"HEGGL.%WR7HNB'+(%]B8VM^D???^W.@7:1D8"*@9Z82I''?U7!1[@2*H< M%,]GJ4=5;P-6?1Z%4O"\BGW]3.K`.N`E"6(XPQMN;&,?BP&U="3%9:::;.N3 MGA.G!K8LIJV+T=FM&$]%Q%I1SS_>VNHZJTG-3+*#.8JU=:XJF9T=2I<_PC9/`T_0_`/:D-_61[0/,N3<+ M[XA=3L$`53JB$-38)Z^BDZT!3]RV-H=-2K'=9X03TSD88H;4*C`U8S,\\YIW MV&\R!D$QVAUK`&&7).W>BM!:0-K2,&K!13;#KM%I4?&UN@5IR&`,-GK.J$3Z M=M!D36J4E;R:R6Q1X%F/K8C6THW@=LD1+*6OH\SME7ME(`CX!TP_"[X%/-(] MZ%ZWWO>.KZ.VG"O^"LE)WE,G:5\D9-A$WJQ`$!9F\F$"*$A'V4Y3K(B`H"B\ M@BFD307^GSC9YL[&4_--?`*"^M@:$69@],4=[8:_K7=0Y_U',=ZM8(_H9#V< M_)"S8?5'3CL4I^^NKF3>C`%3G]KFC$VL!V?J@=*[?2L*IF2WH:_@PX6)#VY( M`TV"4QNE>^_%3??U5T7LYC18N]C'TVK*N(XP$%WM0Y6AY+2,_)K:[M>B,K6H MBZHRY58=1`8C$`,KP'A.9T@X!@)KDG=\MX`,>"1'A1U\!'WUQ'T(DDA$9 M(V@(40)@(AI\P`MN`&FR9TD%4A@3ARU8!$?BPV>>=QNN,Q';]":3]``7L2\E M01NI1V[MPCB/]E6GLB:GDBAR@Q#*0AGO\UIAQ!_.DQ#GD3[^+O0TSL!X`G5\ MR-=A!45',H8(0<[I0($Z>&1X,B4@$N M9J"`#3B)E.@7#YA4,`1XS@"$]$J-B=MU# M6DR6D$TWC/P'CH7#$VCE5B$P#TK#*TES<.@%#+54B1S9D7WQ@)ZB1XP!*GTH M%!:)@KR"1:'X42#@`8`C1^WB([(W,G8X=MW3*]54D;((7QY#3F%UB[HQ$L7P M$V;`)&D@BRX)5SO((\+X+8.B$/C6.=)Q'=0A,Y;Q8'/C$5O8+Z(V'IUQC<97 MA1AVA;P5`BW0`9KS*+\">`.C1]O1`]%\`]@"BB7+;E1);&$-G9!FS4DYY,Y='4Y=2(8\8 M0QC=*8\()6@KPTT6$IB"22L\4S7;58'VAW8Q17?B@U`<$9F*`JT)F@F:$:"FK9@SWPMF`4@5OM"(^-F)LMZ9+\%EZ2H*(JZ@8Z1Y.V&:)* M1HSOL1%*Y),=$W!AI2=P:2(;1Q&OF!04M)1G`17+63X-TB'^A&D][>DLNZ<9 M$>(G#MD^][&'*+:=C?$GQ2>&5&AS9!D^4X$(SR=O=(*!_S".`6.8O+.FGM1` M]#.?=:F?=]0_Y_"*^FE:M5@L/>DG/1:@=@4TLK52AR>BW_,W+%*HA*@6&P&9 M:+H?5G-B9RAMY7-XMJ%T1K$`&*JAFNJ1_;%'*S1UK3%1<,IT47&7U&84,!"; M5J6B5L4+B&0RMR=1-PDH+*,1:4!YOHE$G3>+_5,2734_1U$"/]%9_>5?1:I. M5#&IY(=`D%$I6H&'><@A"_-1A-&H2-4E',$OMN97;1D#^A9N7-JE-3>>D/4C MYQ!AU0$1<&)D(9,YDV)K,&B@%X/^9+K2-844IW=) M-<'A'AA139V%?Z9T2B7"*_RF0QMF5:/A;PAH,CMA$J(B%"&#.^ZEISE*>(?W M9X;BJW)YLIDW2C"998F:K+*82*2)/08&J\YR,JXQ*/T#7*[2`>D`.&>Y'K3! MK6T9A2Y97`2EC>1*B.;*1E6CKH07)QA(8PBV&MW'-?)Y2-1FDH1TK^]8HGKC#8WU*L%?#H0*I')7Z0,2ZD+#XL'<$!3+R4`GD'C%XB^?P M!S>)`1K^Z0<>^[D,*%M;^7::TQ,+Y'V%Q&2"R)A($Q1)JNC"T.(N!`D M.(`>I2?1BQB@LB:VJQPQ0EEM^6U96UREV*4$E2--*7G1BRD0X1X)-ZBA.!*M M0RW7HH;PJ$YU.TAWBZ\_LC2[V[=^BZ<`BUI4!+4<QKU:HV3*.U/<8K8(A2TJL&$N M#+,?N``!UC\B)1S%Z3'9I!Q_MJ,^:V23VANHLF"71T@5!17^V/)BXL:\O?6\ M-D4X7R0S,-$2"V%.S8&=K5)[6O.]D>*5=:H4B)4X8NEAS>NO4\,8RJ<8C!L.9>/\D;/OS#IX(H<$E1*0)I<#Q*S`L5K8;+ MLJ%0\.:,8J03"=$;+C%F)6:.0'P^GD.=#]`">_/%ZC*NRC>>27L.EI;,K',K MMORS+05?N5*_+^:P=[Q>+44_X&?^EYCI)A1QDWT,F4N4$A3RGR.ES(>;P-IC MF&M2+56'3GCQ0-_'QT+;;)(B`R9IK2>LAJ M4P?<(6@\&^-,SD(AK'XXM.\8?E97M_,SEXHQ,1]K(E\.`J^'@B9,U,,T;::H$E'&F;H) MV;])0ZQ^X],&]VA%6L2^.L0&.#=D, M'CD&!0Q)U"LMRUWW+I&%E]S$J]J/-JH<8:02;,G1C(2TAZ[ MP5*&AX&B6!]C9VWX9W#C'7--]EG#K'##L@*]S9;0TS91NW/^$CXM?%N<&:U4 M+N<,U/2=Y4N%YRO=X^,K,='5]%9X[#K6#A36;\J&IJ2H=NN(^H?'#'K@P=&* M%2G7?]QP`BM`314>L=4L:!*J;SRJ^FV?2U,^4)`J`=Y+QLCBAG<1,4(9(]#8 M'-O@_>`'B.ZY7Y;HE-@>&S/9TT62N:+6%K>#F_UDX^-J]$$\$L$Q5B[B)V$; M\J7,V_5$\7K+%S&IOI$JMA;;BMPB*ZLW2E%WOF9$MY$2"PUX7L$9[],>8]H3 M%N'5&`%[`;G%"M;%&$[53WZ%IP1)QT3E8I7=PBMM>$/'XPU^W>(B\:G6Y)W' M5<%%H#+$?"D;:JYU%\+F;5Z5'8+^NPQ7DA+960:-DOUM)Y">G4==6Z6"@3'B M"PY1#!SPN M'*R]D_GX>8JW?<^T1)[^LZG>MKNSUT$ZXQJGY=E"ZQ8DK/8FY.T3*:/C\,6@ M2HJ2:T$M[&3C5[WD!*%LL>W8D3@JA(DUT=<&I\Y65G[5NNR#15(B9K MQP]LGPB-W$+NP#AS@7&K0"'_/"9R`!0V8-0=.60(>X`[/ M0'`41V?^P8-Q9;:HU$X&0E;2;J;DOE*U$TX(5K,QW8*%E]#[2$GY172O'HMY MQN*-7\73VB"C.Y;#>1ECV8E M:2*!K9]Y'(I`K)6,&!0L0"%&SHPRYVUJRQ(XO66=,'4=.\E?JO:E:1#QYT6)&W`Z(6(6ZJ`!PX M1(N9+4JD\Q#";\ZB@&]Z,!,2T>1BSE:P6^DRAK64+56>=>:U`V>5*4%W:/MV MZNJI7$'2)/S`66:3I6.L^)=.Q4Z?$V!,`!Y<>'`8*#"D,X.(Z8H.;#]"A2L7 MZW2K+:RWJ'Z]Q&$/B?WB#!P8@X<2AM,IOIE>_;4ZT5/NJ@+$L_7.LI-*G2RK4'MTN.0\]2VB6- M$G+BJ_ILR$RBT]I\,*-NNR,^PPQ+S[BU`5QBN/N^_68^\H MI,HC;*MBF/NGA.[N`Z&N_?AK#B\`!73F0',1K%/!71M\C29M)YR6VF&QXO-: M&:H\*0;^3<-URBZGTC@Q116Q8W$L`A&!D4F%%PYR`!IFF&B/&!FF&"$UP-FQ M"!\KYKBA/*UU!C-\1VXI)IK.6VRG6&/U$@4P&7W/#)$FBXJJ8-7$$"SE$,D0 M3DE1,I!<$8NA>536=.Y*W!4>`"'1P!HSZBK8(DSV+T9#,)0KHC]"Q)F2IL0T MK4SG/)!KGS-3Z`8!1K'#^Q1;+?7'BCI=? M'L<<=IQB8^875L.(B20!`Y;IIX<.+)%6V(5NDD=FYQS*T=.[)R^_=-DQ;F>N M.4V8IIBF"$$1`F*^GH# MG!EV:0%8DT_AGM(KM]B,.MF1VM2XTQWT*,M]UG$6M*+5'FI=92OZ28-Y-">Z M_?2G=.-"W;D&%#1UKZU#8UF*FT4'Q1(>QT+`T5*=$ M($QYV\,CDSA@B(E$X$=Y7%(T.+'^HTQ(#Y`,>TN?)K,A\8W/2E%L@0%SHK*? MQ-!EC9G;N`*^E>B/7`MZW2;G%Q^17`M`GC.@HJ#F@9O) M3D*.84]W6D`XGH5D+)XR2P;I1""A6>9L7=/B&O'4/;>QR$G_,(\"BZ&[56T& M-[J9),MZ0RMN_F0!XP$!Z0R72#0E;GZ1.92QB/@L(XX'.[9\UN68N#G)N$F* M%_*6O_HCKF*2JVS$7-W^`.1%V!D&B<8REHKVE"OP-1(EP00A\+I218\\J%C; MN4Y\'D"$`27OD!^=D1_4$`M"6@2D0/*#0`;B@#^>=$E0H1E4*H,9*CFR):VB MW*!4QC+^2[X,:P0KFOS4Q+C()-(N:1#EM<*G1M>)4"J*NPZ&PN+*O'CN7>D! M#%&6I<"I/0X\N21/F837K0VE)9B9*ELQ[_01V:1U:#OL7H:V\L5HAO-G=5/) M+LY1`IS`4)LU[&9Q;A5!*^X0+O\#UBKE(L1C2>B`DO/`.]]EN0=B37-.[)-= MSO%&C)+I6^'*2S\'1$R`!O24>O'B:Q8W1A(<:TQ.%$M#\?HA$*(F/]]B$,_< M%=TNWA`PEPZW(:(M!X[`L<=B:L1',EC1YQ0[G)EQ*ZI,)0LI.F,35GB M#(!%TB_IX^F7,"DXH$YPL<0:5LZ>.-92*94SH'FK81=;.WK^MA*U#\@6LL!# ME*+0$IJ(]%J M5?%/IRNF6T%8KM(.M'\FA$V2$>47P=%$H^ZM&ZC4U49]5E2(4=7H;^,A7.EV M&18TD,1$XM#E&0DR8X8D\T8\\M02EK4LF_D:G&O:H14@U;MYBV%/>EH41I$' MLU&IBK"BFK.PV.5!9FPH[]X:UM[YW<1U^G:4EK6[5HNI,3$ZN-N"[X#?+ M"-:@0+LHP5SUD\$-BJEJGGBFN,G^C22:4WAUKW%,/UN>&2RQ(3 M9I\JZ$$'L-`RP2S^WEM;_U$%O>F-#)P8S+-(NGB_6J4E""Y:.9QL.F9B\=RG M09U6;_?O;'AI7:11W38!BJK52E%A-6.@U[[DC3?;_/"'/7X<^4P4KM[[G_P" M.'(`4Y;^4(]Y;O M!M*+OA\7*7V,-,\D/T2C"#L:A>DKCY!FMFDY`7TOIN;L$FM@')KIL'J>][RL M&!<5T"0ON5:0MMF4)UI3+9GWO9E#4UO(8HQ6!U.8%!$1Y.V16U,,#/&\ M$]W(1E^DZ5#[NAP_Q_9.J1D#'37--&ZF`R`XSY:R7NM*HD`%Z?B';WD.'@J[ M8-F386,@_<(J9/.S!#PVQV@[SKDMC]`YA'(4PJL[?[J[!=O^-KBZB&C` M@E'@!$X`AG[XP8/8PBFAH)5ZYM/((P+M: M%6MP!O.Q";W9/ZWSD@6@I=N**1[^&B$`6BBI8#$:PZJ>2X]&@9!EBQP;@P_) M&!WK2Q'\\!%`\)UD(<(R`,^J(<OI!>& M8C#5*K;^ON*O$3L98QN4\>@.6^P/$8PM(%,P51PH-OHQYEB7I1M`Y(S' M&`RW2[1'\"%3,B# MD"3/4?!"E=T9K-NA`1+4MV6-$S\2$4K4>Q6#0[6[+]&HIO M(J\ZQ27BDY8Q$8D'89';R[LX+3J/2)H_[5/,I!D_63QSG8MSB!(XVQ[,12)`%"P2`!=BV.$Z34PX@.P<86;VDY`(` MC9@IR($PZTA'1=!^X``_L`6E'3,JC(97[<\R[`VB`(QR`8PCA&B`UXL%6S@(-8C//+"W MH[7#BJVVP@*7WP(FBM.@$)*)230NL/2*JO8K@N$V*:35$7!K3`,17'`6R??U`5OQ7@%7:R.[LN%C3 MHI4]'&P]I9%-9@:0,1:C5ZYM,JIWF>4 MELPA#)TKEA:+)X\MH8F"Q[:809G[K;L;IM,BLF%RJZI27V'9#A*8-F?B(4B, M1"`[O[T;J\1ADR?JWQLTU@">B(?^O`@_(-!!FM116(41XU MP."!^(*-:;T=S@,C",(&>)Z!2``7R(0O^(),P('K\67!G8@$L#\XB0,K3BP8=X>'_G;WG95!V8Q#B_#':!*@0,A^'O3JA6&)L)0]M?6*U M_*2W8Q`J'MF9>KY)[#M;9@VV3%TM_3NB>%C^1H2XO/!?']Z\:!#@&\3F])1K+?CE>8:]9G[F/*B('T';#P["OI;K M](P>D5J#'9E/-7C5,UCF=2`]28V]/\J1'=%E0RU&'/V=?8;'?J9-%8 M]:#D)_$3ODS%!>O1W17,.K;CVD8E`02)]D(E@SWJZZB9I M9B*54OF(N%'`RJ*0@>%,8D$1+3E$:A,G>#3988'J4,:@J>Y+L;EJ8\(OTSW1 MD0W>KPZ9L%Z!L1::L58_$&0SW/2>X%:0M6;KTVN`MU8>'!'^8'F8`GL@@`HG M`'O`\"G`VF6VX*[-Z[TV",!F9Y<\KH&0A#.(!0N_<`JW!S"8F"%I0AJ`!0=( M`!IHA/*LY@;`F*MM:WH>B!YF:YZ>#]105BO2;");L,[&,]!^U]'F,V?#S>@1,79+9X#+_7Q.#1.AZX3V.T..^\^TR0:ZO&.HS+" M&21"#*M1#.1XHB*?8M1FR_*3;[12,'1!WSM!*A&,CCTI%5%AT`WQE)U=,+4: MFA`D(:2Y/;4&_/5?;V9A'HAF`(84)KUP[F7TS`&3.HAH6.99-U:>9@K+$*?U_E%_&LXT MF%8]*T3^8F(_B_*A@CRF)+S^V+'TLD8^/LMFD@XOKZZT=HX>ZJK%8`PR;Y89 M6R<:+18R^6KX1M\W;THZ;CS,G(]U4]RV*3'805=,&\3P:@S!(5DA;;]?^VF@ MA2'` MO)324;XL=1JZKBS)4H*3.3=QFN7JQC:IZQYM*(3?\)Y+1K=L%PF14[!YP!Z M-V,'&0C'HA=PMDGZG>?%DAQ4KG+%LZ4QE!XX@0JA`X>:F&Q0+5*A8X),G MAA#I6H#X]R_-/Q!FS+1H4:*IF:)I$"'JZ+'#`Q!-6RPM>@[1U(\KL"(ZA]0H MVK1'T[!-<^Y!RI_9H[G-:2^C%8/QX:P_*TSWE"L(TTZ@@[J9KG7QH8LN729Y$E'3I M/T3%5K(K;_X\>G:1G3TNOTL]9/7^G=F[W^7R/X!C/6#66FVY M154Q&Q#!DDJB-`)11A%*.&%&?C20R4`/2<0!$P(E\"!%!RFTQD!YU`)A/VK0 M(,E`F=B24#2>#$2-06J,4F(1HEJWPGD@E67F92@#*-==,->&DTT\][124;40=E=1I3347U8$=C02:<-%U M]<\YYQQ5S$OT$:B6408:*%Y<8W%$69W0J9D77T!Y\%11TRW%E&!1&:548ITQ M!AFF_K5$UE4HP00::?4QUA),5G(':FFG/2KI/V;HQ1I?/LTVJT\+8(!=5:+= MUYMO2+'^%=QPK^YEG'7*V?84FTAM)1U3Q!E;&'-$G:/=99AA9=ITX8WW7GK= MPN=88]S"]VU_+XGD)FFBC93?;G#QYYZ6\0I(H)]M2KF22N>`^"2__4[D1S08 M"K0O0@"[D(13!!9,)`1E1-3/,Z'`_*P[TA9%^J"&C0-3T`V0<)4YA"Y,' M^:$QBA]'8T^)HZ3>,[DJ.56GJJ2F-2JJ@,M&TP$VS MA=D34"$L:L9::`86Z7.*C09:&JO.6591#ZA$'UMIA5VO6U]9QN!ID4#O=FZ5E7VD;B:QOO?N?0:^%5E4IJK;\HZ2S_AA1E&WP\6 M'0HT!1<#(`2+&FJLHR%"U`PD"0TZJA$-%BP*E(,C"G%1Q$!&1`.1&IR4J,4: MMH0??@/`88_H^8%'>8A#1`!&@('(PT@1R5^)4N'`Z5$P([G:EG]^QI$K829+ MR!-41\P0*]F`B2>U>IM02M`XNZ2):G3R&TJ\H[7IE"TJ7HM)77Y3H.75J4Z` MPE>5.$.@NXBN.)^[3;;(UL,>^NK^*)8*5Z;8`Z[)7!!+GQ+E5GZJRN;Q89UA..U9SI$(5TXD.=9`2 M#.KH=*]J?8V%:7!7\7C7K!9_C288('+'3 M#MMTM17<(U\$JR`J_X4%-7Q!(.H`1C\:5K`@E>@+-#@9#:9@A#R`R&`B,P@X MP,$)]^5!'L!H1#_``0R&)"P.X%@#&/H1C1R4*`&96`,PP!&+6N3!!;80T<<: MT,H\Y*`!X$0(S/*P!@(V(!4E6L<$4RG/A-3':^S)DWV"AKBAF>LD=!%A3V@E MN1-BH$S^53.+J@`IJ:G\,";"4=5"$?J/&Q)J;'W*7`_SAK:T4<4N;*,C:Q;U M'*-D5([YZ=54%@/%O3V&BE<#W%@"-ZA,:G&*H+J7X2J:%#3UR4[I(!;D@`+4 MD*I05\+;5:'.PI9#G6.8ERVIB4T:ZED+':BH3UU%\G= ME<<:_U%7HS7.>`(M%'HB9AP0D MP!!8T%%"@F3`P3I`"P*1!`$@I+$I]*@!'!!LB8Q`@R&5J"``LP=F2Q0!<$0/ M%M5@$0U29B&6(9`B:MCE8]/7U]GV@WGN8M`&.0A3!C$(A)3^:8%Q:@6F@8ZI M3'0JU.(4*A6S?L'04*50 MBHE+35FZBQ7XC5K[E*E5")=>+NJ5,5_TC5I^]8^??@YR0'U68=9H5'8E=2U6 MLY,9VB:LD![+.6'7;WP6+S3)\+M+C+M88@:?)ND@AGG;U;D4`Q'`C=Q` ME;83ISTE/.5%RM26M=R-J.0!L7-4W9(Z+>K"D8?8;9=\OS:H1R>T!7E1SNC$ M.]XW!6\W)?6,>C'5`<6X%\.EFFEE*,-3_+J?4&`Y:]N^% MIVCA_WM@`^#\S&IHC,Y/*K+#&L"R@93SG/N>'I])A94_O]>^YDH<981MG+XD M>DPI;('^JK]:ZHA>Q;ETHQMPS/*6E.@IVYYF'GY"?2[N?B=-A"D,450=W[\% M3XC,@W6LW0.[X0$:PVFCZ8OGNC=<278/8K.MMI+EYU]O+Y-BM M+(9AEEXL^'B318?-;G?PM*/C4WZ\\P5KN!J\Y_&/J8&R`_'1Z/O5[SQ/3PU[ M.%]J/5]!G2.BSRBFEJT_")J-(&(UPSJC"7]24.:8(>9G>6ZRAE>,A]8-YV6K M$USFDL.?N]%O6?*M$%O5*+8AZX5PW4B4FDZH^L!Z\)ERCZ7^J5YRE%,ZK8KG M]3ZWJRO]V*D%PY(['@'9QVD->.W3MVU'&,JQG=K<)9VKM448206PX9<3\1VW M+=]2Y1K17(I[@-BNE9M:B9A\G)RMR1]GQ!=Z21Z`P!MU*5%>=1%[<9[LK6!& MA(Q`+`D+\HL:@$.)G$CJQ6"3Z-QML564P)0'3>!V%1IQP`KP`1_HC([FR%%= M3,JC>,7P6-K-B0WS,)?T,=NO`)W;U5.H=1T89JR1$97^$Z%7/UEB?*A'5Y78>9A5B)5+WV7&J&5A M7"$>7:$AC)W+]-68\KFA,R"""N*@+(;3)I1(DP6(*+I)[T5;&JV8%TJ74],V-@2V1%3+7T%@=6+S%>`!13&"B M?W#+R1&>>7SB)VY@X/0:09;A`VP`!IXB2Z%-19T#%)3-\`1"(.R3,\1#+/YB M#'+(0+3^EDY>!"Q@@93AV4\^"?E5Y,BYX28:(QP6FJE%VU/9450)6'LI#J9Y MA4P!;Y= MF"1RE$IE'?S%7]"@&&68SE[<4>A8E:,TQ2&!G_@Y74=]VJ-]X6"H#K2T@/?I M$$\UVQM-9/M)!M=9&D;&G]",H'S08TB&F">2)DD*"DQ-4KI\G1FZ7[FLU'I\ MC=-AUT8$@EUFR0/D9%%VGH50TT!,@3GMYI'80BW:3"_>H'!21':Y1%)6'>5E MGJ'U(_Z]"JI)E1)&7Z%Y5%>XA4=`H30"1Q9Z)8M)9#U%";K^?*;(/=Y=(2!: M*,:\1:0@V@=W;=M2$@U+/$`#`IIFSH4ZDL=YS.'?#)IJ>B9_`B:QD!W2_>/- M&29;KEMY3:%Y910#1M@`,D&$8&DB?J-0'P419#,^@U><6V=1*%AYI MINBN!:'KY-:ZA"B"$,],093@:3_F!<9L8W%EHA5N@A1I6D5`7T:2,4WES5V`B&M^6'B M+%M\AI^[%8YL"M$"]HK;@5)/=:.ZE&5GVE>3:J-W=";B["=^:@OQU".J!.BM MU=<5<81IK`9R%!NRI`93Y`::JJXH743?38&?\(@AJIY52_:3^&EAX$U1C^JFDO+8 M#-H#L-I#-7B/DJI!(P2K/?!JKR;$CMZ3GY7J`&@_UW%2H"J7(P&6(AH M?;+5.30%X)VH)*V+2=3A!E4=:,@0?Z&0HA+F:3AJ#XYGG-++@SYBJ3TFU!@* MJ]`-JW2JQH:'O7Y&B#YI![E$?*R7T)!5BJ:LX:EK>]T4&;HEDW*B+^S-!IZ< M:JI+@OS^*;SB8N]4H2CAAWW(7,XQIA(BB'N-Y=>83<@6 M(]'`SE/\JVM*DFH*ZNX]*<%Z1PMX0*(H+-DM:FHX+-.!#:2$EQ.M(@)6+%3< MG81-2A2FA<9"3>T%VG]T0,@J)93RC:>@K,J:YM*BY.^T&JC-*CO(`*;,J/%P M7=ZB:_&TA(\B;0P6*>W>+D*LQ^"Q!-.>H>[1!_B91H9&;;*<176-*5BT:=9J MZ(%H!YGZEC=>TD@T4A3-!VNJ77N!#9J4S?)47QNB!&7LJ-_^\9^^[JN`I`%7 M7.Z[V>J5W!J^(0X<`F;PB=VS["%TE6>G("YAP-S?N=I%59O62)563*WD>NG- M!<8:.6?A%-JHRFU-K6CDC6;HL@,/TIY\_@T7UB4GGM]K`J'K9(D,?.(N),)* MZ`+YX"X*I[`LQN;NCMR.3EYZ3NF[G@GE.I];0.)E-L]EAN5(O&?.M6(I8M]` M2F_@V:A+^E#XO6_/)05#<:,Y?F^&7:Y].91X3&G)B=Q?3A0%@J(HDMS5N2&J MV$G8+8#2%-3"*NCBEJ?S$HKI6&A&"8^O<._Q1>UT5)7<,")@',:C^*E=+K#5 M^"`JND=F;#&*JFS`#L@DI%3XD6K^CL;L(W'P)GUHWX&$"&O*[*HP)F?RQ^EN M(\E8S#:&%`6(].$KV;#G`CHDT)FN&O>PSLFI\P[*5IWDN9+&V=CH[7@R\[35 M?=E%6F)4>2U&%*,G3(1OH45?*%(7@NC-:W8Q!E_=*+D5%):`F-@$"H@=5/61 M(RIH5(;>X8I$0EP#6M-'ENN34)1CS;P"V+L6ZWE=I`$P8YAVW*TV!;/>A5:\VA&!^D)*-4=2GD:,,MCLSH#1^`0 M,(>B/,;^%1I&\J>0W*@1X\UF33J("4[8"H-A*=Z8+5O2!8))YND::L0NT3B7 MLX)Z(?+-T*?B"\F6QV0T\`]^V/N-+.B&6`R$]4:`X M,UMN=$.#)N^(!`QQ55>A-"]_1:?YR<[A"V9H24POGS%;'?L)8_7F-`:_:!4Y MGM\>#6S```KT%Z,A2U'C;WPAM5T&F!O$VX:>2[(>Q5TF# MJKC`]99$'K>09@R`M>&!4/\BIJ?DL^6HI&O2JEI'T2T#-"7^6P,$;.`EUS5Y ME[==DUNY^4R:\G5?]_!B$*3WTI\B]Z`5=5"Z$5(H;I1'M^C(2N);"S)9<.YF MOA$+*2ZVM><.#LUZ;.0\]EHL6\5>\[6`GG99JM]VB7&LV`0,P(`;6#,_RK9M ME2?^OE%2..J]Z#8V6LZRF<9CO M-+9F5#@(KF0ETW@_0\93(S1Z8^!(>VCA_"XL"XC:S5\6UL6T M-//(8AA'Y][)C3D7#;$/`DZ>Z%5S4[`\.N"HR-L2GD;CT!O=:)7>[$V:4X:; M8PF+AG3K*C8R"R^3GKX@4/EZ)I8K*I5KEY18K:QT9IL;MHK7'= M];&8NU@@FV_0OI(*`T?CG-#Y4F@5%$$2*$I?1EJ=M1!:G]VRX`EHD,-H5FZ& M3PO736QX->>A8;Q0_U5?JZ.KC/7O<3\>BZO.5AB;_58JFR#"E!0R:>Y"FVO> M2H5D9'/$J"2WRF[2O-B+'V;T0*;$5VN@=M-XRH:W\?B"",MN0?>ZRN/NKSO2 MS_BN9A;^34>@7.GFAUO0(8F26YK6E#%*XN'XX`,FKQFJJHQI.W'WSB<5BK5) MAX8.C8K/(B)M36H^B[XH:<\\")E];J+V\6/[8!H_+ZS MD;N]!W3#=60@0#^CZ`B$]0BL+$NHJO&,]\IGOB9SH)2_?%V9-KEB^6&OYD6. MAP.?ZIO`IC&^^>U9T03>ZT--%ZY;@W^`2L7?CBHBU])_.Z;_0UH_THAA>6OZ M]X-3N>ZN_G8(>6B4AAF$P'"%/8=7,]FO!MI9^N4\J*NB%WO^N;)>S=@84>M" M$KQ@L$YXK``[A#7ZBW71#Q+U`C]\S-K3WU-RJWK>&UZ- MCQM`.!,H<%?!7>RL)8RQ<.$(:^QV"43X,.(*9P\:J>FWD6-'CQ]!AA0YDF1) MDR=1IE2YDF5+ERR=K9`IT]E!B,XZ%"MF,>9`GS$[!-7Y8&?,8@^0Z@S:845. MG4<1(4IS;B?3F3P-5LS)E@CZ;TI50$2+-:*=#D886CHAR M4)J[5CPX%[HT9T/J)K,^*V@NTXIPCZRF^SK'JK+L&DHPK MO-XS:*`1-[/,N)F,X\RRM00#(<8"([.1/L@@0JX#T*!+(XW`"&NA,,1`4(RQ MKAQS[Z8GE7M`L['".JK%$H6L\<2AHDK*OZA.PV"VU5Q[+3;5,+`MM]5`4&HI MTH)C+BG^]0ARIICAW!1**L`":ZNM%JS#S3OONM/.2O#>8V,"T$5B5H!1_?@VY=?+`7+ MV:U_"HO18*7?4Q$ZHBKK]C?C5&[]O52..9S2S,L,I;7%065?^CKZB)G+5Z'&ABPNUGM07N'0I/WN!3E^B MT[S"&"9T1:D/Z9##%]0!"2E`*IY9S'(7[X%(*!>C'73^H1O:#+%.NZO-R$KF M!MX\K$Q025EZ*+:9)\UL5D@Y!^@\Y[Q(>>!G/K,4>`[3&TUQ*HI:84J0V(,N M'>%$-):S'_ER93[T7:T_ZX-BV'QEGH1`8%2X@F.P"N00Y`2"*6O3R/\0F4A% M]B\L,&/'0HPVIK0`?+_,,<,[8R4^RD8JRNF(6M7@=20UF M4M\YC"\?H*G[[<5<=6DDNT2%2IG-QR;XD5K]$B8:K,T10%!%S5(:" MT@*AXK38[XHV9K7F/-V>C)`RI``0;,$#QW849&(KVG M"?E#12`"+&?/PP[UID>8=_Z2EG0!D[4:B<8TVC0Y\YF(@?[^.35]Z6*.9B)* M06?'E$#.CWYQ'!M"K<'']L0`ECLQ9$9!&UK1IF2CFG*0IP`;TM9]#Y/=^J9_ MO/FC2[+)A:?4CU%\8SE4J7%B-C7*%7WY-*T0R0PD.\=,\Z,O?A&5+E3)IR2`';9A^7WOP'[WDOLY2=+0E-O&)-[J+7Z&61`;LEA2;P\`U ML4DT*MN:!%=TJE%2S"E+86:3?K+^N$LNRFDZ9>D#L)B.$/1)P9+9%W,9M\8[U-"'`7@H$I M57C?M3]DBPWW`%P@&,$X[XPIB#)8.3AI*(&:O]J:.KG9`QB@ MC0<&-I7^V?FE7W_IC1E"8`9NW7(Y_I82O_N,PTB<@=A,J6Z4 M&;>B^[K;[JK2'":C,WYE:G;0TTTMM?#Z2KZ"!Y?:XZ@FQ(_YLSG&? M^V;ET')HZZ&T<&W)O@J]DKUFTZ*/EM6D\RI=99(DTVUU;`[N"ZHG;-35WR)N MJ63I+8"&_"Y].94">J4I7&]+VC$&W/FT'4K]7LY.W$*S?B`XQP`+@36C)IF0_^.Z#9P!P#1;G.*2P]58V<`\-TPH`5FA2T`;*\, MKO'.CGE8:#HFD`+#Z/T4Y2\J3B"4P_(Z#W&,0N4XQ07OH]$^J.7N9W7^!(<` M98X2BFB:DK:0LE:`/VB2F?2H3<`+>PPY>": M39421O#"47F`*`W.:*K`10S#3:<\KV'`ZPBURPP\(`3T4.]8@W?^L=Y48#L& MT2\"PR#^58._("5/2L`<0>>+]BK\WFYS>`FI+)'RKL27WH\R[([9+$=M-G`@ M!HM4=$+%0HXA($(&FJ+C-JUT6!&\?J,Y8B467[!L7`Y8R(8A-(MHI!`'?7$H MB?(C\ M&J4$Y&PYM(\M2L`#!"XJ^@5G_B43S\TDAPPM6T"I1B,D1:=;WN0B07'N>DRV MH#$X0.`?`W(@#1-W;`,@\T00%0[OS$H%KF,[#-(#WF)*I"?`$,,B#PXC>4F7 M#HT,P\\LV41*'@@YI*(3.T^?D`+D+FUJV"$GQJA\?.%NIG#^*5P%DU!N4!Y) M%D70CQ(*Q$(P%WW$&70A(_R@*)$S.<]"@/RJ9BK#*S1H*ZX,!:G2ANJKQO:Q M[:*1,_0##ZVDFR"F*TV2L"@L+)]L+-/!2,QS^R"%$9_,J#`Q#M>QV@X%=`#0 M+JOF+^!BOC:I'@]N@A;V@JNK^RR[/$30%+"ZU M4?!RHPOS<^S,A$4`)$K,C:`\K46,T3_2P#H4$W<&\G9$1C$=%.WZ16="@&,F M5#O4:Q']Y=#>*3,]DC\\=%+1<#Q:DR;(#D MTD:&48+.!U#J=$=?C_9LT=*PQT>%E":.I4B/M%=U#XV4='4:(Q_[]$D)R.?8 MKTUNZ!E!)6_&XAS2,AW2*D5H(F$&)1O)Q.38[9P;[R+`,I?*QH*392!)4@PG(RL\O'J!492XBCJ*O?$$@ M[@$L<&@#*@E'2\Z')"O"/"Y"+LM4:8WVRD,O:()(??5F?_560,A,VD>--$@G M=HJ`3,J9*"=EIY!$@"YOFB9:V6MA?F39QHYA7/5,AH);#Z,+F5`JG,=(VF11 M6.A?P(,TYU,MM'9GS*!6P,4NM4QB230Z$C8S&P_AS%)X_./^"A+.%-2K`-)0 MI1536Z"L:F,!!C8M[>W_/.=2.A-NP2P,WQ:+0A02\U160#$Y1"A%#P;(L5]U346N_27/)&/BS5@G0$:-8B;!;^9V7WYD(DN1Q- M7,2GJ?K4L&[079S)SI2)][H2&Z]E:6^C!,P@W-S$_+YS;`N'3UU$.;`HN*8R M_00&[80#I[)M$-TT>L^)9`CF3A>-R,S2)L\31+6-4GGI:F.+9?SQS?+O,`M5 MS:15??^V-M9L8*W#W@2W>CKGN2C5:6:%<1,6?<%/,Z<"5I251*C/I2[78YRCH9WG7GDSJ#.0^T91V$SAG,Y"2*Y5B=X5).;1R M%UTH!VFZARDE(V@EN8:I;BIQ^.>NQ2(.J(=%!C?T*C'JS3:P;JFF*L%8JS[! M0Y`;IFJG1&$M-="NY!XMXLS8,S>ZB8ZXC@*5UYR\,:\DU5^&F#$MT,Y,(XV5 M3%`'=7[UY(W?;3?DN+_VES7L6)?6=U++UYP`@U$R$QT;=MO,33B<\2F45;(, M&N"NQ,*>?,$=- M$&"42SFD+>J4&=F$.&^5.\,XGK`Z]2QE:'*UG+5&4FDO_L$@"U67=<8@:R,] MGR:855DKK"M+"$;4CMFZKH@T`ZBD4F$@&D13JT_R=WIQ&E8.9R6:6*W>B2F)7^+*)B'U^,89RU M6HNAIN,7,6\#4/<0`]22VA;[1JAF*$YC,9#X-\+04I=K>P?Q96C'+YPG'&E& M<[[0.I!78<,P,!!QG?"82O)U9-XQG!SH[@KR']=X0?<6K9&7KO_VIJD'KD.F M;^>P.`MQBFIN#%EHTWWHZ(,/..MY-77%P5N.]&N)L6B;D17!:VJ/[743S2:=L6=`A# M>8]/2HI+G:H[@;T64M2)9#`Q(Z7^W*W--)D"!0_3^#H*DS7:6C&WT"U8B'!M M@[>Y@W!O!]_R6+[MNFJSY(XU$K_3,9#Y+:[T+4">@@J'A%_>+Q$8!`)@)QL2 MNVQ6X`1J!4=]:`,8^[&"=Z;(2#+N?&$X^C$FIT#=9$A3N,,YW6W(Q$3`1,0I MJ`HI9CH=C5EE)GEA>Z6\DI1^#H/CPQ_W$+??S%#3NC<<>RCJB:2&@BV(NS(" MB\;PJRVG`_RFKCRG&L"R[P[%L,D!DLT'\>RD7)VT^XZQFS"/MXS/>*I]F+P% ME=9%)HNCC"SA#=^H0\WC3-P;5VS#4FLI$`(=!<#$6+_#<#.3N8HP)D6KC<\2 MN)"]ZT_^"OU!5D!C.1B:&MUH`P&YL$PH^*T_UB.@8V(#J$O+^'3#._WBF45* MD?8H5!GB.T.WL)(XC)`LW.T?Z.;%"B4K=!C97/LTE$S-1B:[GUV7N\DJ6BJ" M')PM:EYEKK%`AQWL/C/B:J9KV9,PHCK][OGE]21HI+B[]Y:+$#?>R1OFL_B) MTJ>5?'A_O2J;]!#-[YO<_0_JK83<]3:+H4QQZVCK@N@['D7.PWB7`YG?B3VM M]JPO;\KQ'LTBPH:E_ENQT_"7+*S@&7I/@?4A[H%%[CQE:L(7B,W:1"$-)B$S ML=8BBI-7,?[RDT5*M1%W4=O5R60:3V?DNO9=PV`M\RN(9^V(M=*ZMH4;"$W$4&`.\8 M4KH^EY'W<,?9J\(]ZYSHA(((K;W\MMO8ZQG%^0,2,C.4[!&S?HL*[`"15JU:JBE3.D,8-J]$A,LT4ZW2J*8PB1[K3,X&XQ+$`!W;B' M%FD45B99._=Q#QYT[S9^O/=T$#`!#P\1HOAOV-J+JT#>@K!(F/+1.DR8IH6' M=*81PWY=&F("MF`3295=-]IRPI7PSVRTJ2978VF0MQA"E9G$ET,0[1(#``#$ MX,QEB1DTVX$5:1C11!5=Q!4[=^543$@BC?1`!RLA`!9+'H%6V$ROT?2/`18% M$B)/4AW^B6222B[)9)-.,J527BNUQ%!D+7K%$5TY9J2262-5&=E:Q:110CH@ MU!CF7G1YMV)QU]@P^VV0*CO)4>>C\VI@((;JJ*P`&_I M_,.08R2)I%]O(71'''C>>3!8>?IQEYYOP`F7ZWN_V30?3%\VE"@(P_U6)GK3 M!1=@F?PE1IY(K+VD8#K?11!QQZ:$V(!)EYTW6A MG?A1-NS.]I"59+449C&B_<.*2)E))N;`RP%X6I!H"F3DDQ+^3TQQQ19??%1= M*VU)98TG8;G1EE%RV>8#RI:T64+_)/;/GVINK%%7'57)I5Y[?38A:C91I'!P ML3WVTJ,0JA6C;`^(A*9)4\IIE<"QAC23<.ETJIQL+@$]86"G51W:/P&>]BEO MMTY=I@>@0M\]=9;.KW&)-Q^ MP:[G:7>[;4=OLH0)VF^,9G0'K`K/T3TU=YISURF%CV/7XV&:M_`T3(RE2&?# M."VDU0I$W-]:X^(#!.V7;9^"-I3-?0F=R%G-"&%$I8S*XA3(52WILQ495.13"0,,SPD5K M/Z8ID$(,U"/!:(I`(X&:6];S*5OM)W/$@0ZK1E431@T'57!K(=S<@($2O(]2 M>9I).@`7GM[\S588H)>O2"@>TQ3..\=!#K+RMJQV'2TW?7,;#"8``U:%2HJM M,E8):J*^#LXG:M[B3@E6ESY(6<0AH&'$%4&`KH2D*1`3>AYJ#FG!AP@$#-;CGB,?"1$*'E)"/KS(YM8D: M;*(FQUM=,0U_9,NR%A*_/KK2E'.(%PAC.*1WHM$43<[! M+N5E93;9V(4U/GJ7R[A"-W/48+8F>I\2[5$R?;%1FQJC,#&&J2\Y,RE]DCB\ MZDERISSM:23Y6)<^P@XC($N)53A9EH$$<'<+F9P,X;>5E\7^#)4S@PS)L+)` MA)S##"O,9JONV1I;:HV>@)M.@Y0G&M6H<2M+6V"8.GDTPGA-CB)\)BCI5%/! MZ(=4A,%->GB#*^\@!S'>(HZH1D6@4B&3A0`-:$`GX`854-!LEEN`;\+V-_?\ M#3U&%.!K8CFV>4:+L]*B3K*T!9D=3:Z)3WPLW!KK6('&3;()32%]<+FY=%3G M,H\B$<]J4QK`0%1I.G(:0SKZ%8%,Z(;%R00%E;.^4.HQ5G^BBD?&TB9`"M!J MFZGH+3T'A)_%19GWTC-)BQM[L(M5-?]':78_VK%G^42YK M8A-MJ'L2L7CF:"U(3ZH,J@+!;1'^GB3DK*W,A*XI7:9""<%D_C3#&92T)(Q> M\Q:HQ"8X\@BJ-J01S'"2@\7).<>RI)5G:0K+3O@,CB#18BPO^(!C/@@TLL=! M%4'=L`#N^$VSQN&L#.OT8I*&UC\P+J*"1[/0U-*&JXK[IFM;>^,^:B$$.8W1$&&`K$VG!**(T0G^^!GQNG0R9IF7@=^#GL[M*:4+$>]! MWLJ2#9A$)0GK$6&H^\H:WN9SL9H-6R*6WDA+>M)*6>]'DYM5BUR)O6OA)/IH MC*TO508$_92A`N4$,RP)Q+IFERGF<)9=-!!C]2Z\X"&ALW M#N'^('2/.]YS^<"WRQE M>M#T:V_-5F([J?'U2^>HE6](A^KYL2E&K'XO5AI3K@)_4YP#I5M\:DI/SFI. MEVADH$!D4IUA:]22.V((\3R^-R[?10@>^NRWO.^M^,>M^_+E*8T M(?AW0('LA@DLON`&5W>78:-!Z+U8B`T:R-0X"#H;(D>W__A6=28"<^)1J;XK M7!7:+NN_4/89Y[&+:F3(\FK19)$U%$F?PK^\Z,<=#=(^[[[W>[J6]8:L@1.Q M4=$G,^@M(8+*^X'N2/XQ-9*6X!SR2XE7G'&TW=$L1V+Z#'!+#T[C!&0]A&^X M)78-USGH0CSI,TL\8V%7L2\&8R-LX37<1GFI-U"W9B;K8RYXQT2(TQQ^YVPX M-"W94F(*=5L_4F")MWJ,)UNOE67^..8&V!0JK2(J@!,"6_-BFK=DT8)#'"-MAP8:;N@:>E4M_G%+BP$" MW/=]?PB(VH-A'Y-=_7<0F]9>Z;<2'4`FA;4>@[,@WD9_4H427]$1S,00)C(6 M9.@8A:$?;B-."%9.H?-BP.)P!,*&?!%&:>$!XW9C3MAZXM2$!CX3$^F`A*?G-LWHA.:68%CD(U1X?351 M&:LE./)!&GGV*B7`*G53$ORB/(DF1R`G3D80-P<%'[\79W4(&5%%5)8(%F,R M$^^C*-=QA]RV:])"04#2`GX8B!\)DA(39W]F76,DANY"%OS7%\40?)6L]9":"Z76R$2M6DE67P0BU0I".-4[.!F'`=QTP M!V@M8I,,N"?+=R=E1E>+(T(D(!BNX)$AB9NY*14\\B4YT1?*5V%7I2._&1E_ MZ6''T2G4PFW`@0B(PE9!!6QF.2N$H4"<"#7!47H$U4+-9EF_L1A90T\4=$:J M(1$30IT4D9K%\Q?\D090R55[%XR0MV,J0!VUT7##(G;9Z&_">%":18!&4R)E M66+L`8!KV8XZ-G!.B`)=-44G)#;3T47UU$X'V&3@N#8IA%*\-4OVB83AU&PP MD*"2<)B)25OPJ)RCIX.!P8>Z,1[^E%D"@2,X(="/U)&)54(TOY,?8<.$.>9: M*%`*.0@_IFD@*!<6[$`[]G>)$^E;#,F`Q/)AK9),G@(,C:2;56JE3/$2H,))+ MVS&>8!)7Y_DFKT8GN/$;]`<6ZY>_%F#K/)L M][5\TVE+-'%M:IEC!_JI3@@#*U19)@2E@T5$X'&7&EFAR'E&/D(>]C%E_I,= MB0=9J6>@)#IR4L@P>MB+$R)_"V<>KO(;LT:`_P@FB3(PIP**/"I0A)E@O`13 MDX(61!#^%AY%.XG`%;M0AAA:?9_3391EC0\Z(!YPFU>*KNGZ$PERC-JR?-7' M0&1X0-,C?25PJISC%GOW-6?*(I0$%B:3._,!&"T#J.G3*)QJ8):J0V(#;>6! M68@U2T38IVEW,,1S0*XQ'/.WB0_`56?$5$G,SELX=53WH7H?9D5SH# M*PUA,LH1326@`@'X1)^J93O&8H]XH@*"@/P1$R2%8JCA%H#%'9830VSH.[`& MGI37K)$G6T$IK7$VI)I&%Q!@#3E"%L5P`N9B!G\@"J+!"!3^8F>60PSDVDHB!]AS8(=2X/,;$\\[EK\2#+IK'_VK&]4F")2G#J MA@$S@0%/A'!F@V*8%[;"*#>KTIW`<5(5*:"F8F!/]$+-]GB-%:JMQVZE&KO( MN8PN*T4[Y&1:FUO)J3-60V8-$TV""5LY6[5`R9WDJH,"!G-IPT$6SX9:P(==#NLBT\Z&9)8#;L<;N%$S2LW@-6+T2N]01."QS=8RYMN/#H!/:2V='JJ M-T3&X[NPKCI6]NL?B'1FF`(I35>\,4BUC7=KU2@=0L3'YZ%D=?,/P7(M<:=M MS@%8\9$9^B(1/),SG[(`@RMP6Q9%OF$W8]2)VFJ68(;U M',.('/_VDVE81>Z!G/^A@MYBE'>EH8N1/LL(>V2R:^9=R`+`]0`>:#\>F+D%[:T,]9*%QTW:)-!&U9L M5OCT*+5R6%8`+1F)`;BLRU'-"J7^*6-@%C5[HZ<-Z!BV\7X%W=$>S0>W>I"5Y:HF M':%*1CE<);92J3C^E&`"N'ZX.\H0)0+=7GG5[XM&C[AA\3N1B:<34$08]1*7;UW=19:+8. M\EZ)F$=]1EPL1Q*M]HKH*=<=\B$S\$A+IP!N6 M;"'.,FNJXMQ\(%F\8'!;!MEF.3G^^!R`4$0W";6<7)/9%/42!B/@H@NU-^N. MWN)CX!3*M^(&.M:C[^$WVP2X80RR+\L@F9@S\J'A!Z9Z!1>JCLUEE?6@F[,Y MH=5%P@V^_%%85M!K&AU*FK$!%*$+K5%CM*9XL07=,*&BX+DW,&W=RE-A$$@1 M9,*B&YHU,>D!SD4UY_2DYHW>?=Y3BC*DSY%T7V"J4%=>411#8D58Y*Y-([0[8QE M/.X&Z-'^V/,L6;#=VK#,J;-FO0=E5G="$[6M./^4H([]SHK**J9*OJS:QUJY MC*-"W(+50VDDAAKR.YU(+#Y9E:(911YPCN,1N*+R%A4K)ISYFU#PHL>!ZQ$G MA:/'JWK^'*6P`'SNYP\/29QAPYG$Z>S@)K:!&:1,)UFI'#LX=GW3E5QK(!7Y MI^CG0)TQ/-!79_[SW\'C/826S=$U&X&$1Z5<)_3DLTH>66;2`F1K<0(^)IKB M`<61'->&VDS>[-#V3B^Z=:\E3I'5[V%%(3@E[&?K0!#GOC@;4%"X&[A:;I*' M`1,0XHW7ZYGS7+9%&D./JUP&TS=A&R%AP5C^;P.7V_VYHTS^3IC-VY_@T7ZV M!2#ICASK_F[N,NE_-JV@X86(]WC/G8$A,!,LZBEMP\W1BG)\X7S5-_`Y2-7> M`FTG55,:K`W$\,$03_H^]3%?P15S'0-U*Y%3?Q]A]2N6;2V4TQNB]77K@S?7 MC'YPZ%8S52X6CNV[Y.]24A7&=3#6)2O![L`UU>V5^F/OF+E>1RAP,A`T.Q)_ MX0%BSW@S",;??6#->Y!E:QW8<2_]LLR18Y)BN%48@*LXB^*6,[4ABF-0^.S/ M&&310W-YHXS,N&503\4S`1#_SJ4Q4Z)$"Q`M%DS@PV?"`@\M6H1PPTO214D3 MW*!P`\/CQ@4A56#P4,*,P(%F5$[^7*`BA`X#HW-%_(-)A6`!C`B]#O'CQX?41A4N)3$G6Q*!B`0JP"T*`0!14Z(H5 MSIRMZ%`T38NN(4R"^&?&`\D6`A'M/9>TQ=(%;@2[`::FWV'$B14O9MS8\6/( MD25/IES9\F7,F35C3LLN!@``UMB-)LVS6%^Z=!_\+-K73(N[J&O?7D6JCX[!)%,5$?\AZJ"VY]&]!!'6+8$"HR0WTFGA)!!68NXK MZ3#H:J3^B-(@;[SQ@+)NPN+*,^^?$E2`02JI&N)E@NB^VK"A_ZCJB,.&'$+! M@Y.2`N'%?_Y)(T:52L``A:D\A$&L=,PH$(0T4I*)KA(6D@J%=(#$4$,^+N)C M1Q$_$DE!NJDWFFRB4B>>V)(PN?".0N]&IPRABD.-VO.` M!`\"2["KD*8LP<'AAKM.+;9:@\LEDU2R:Z0DL?P)D302`HRCC@K;;%)**[7T M4DPSU;2R^JP!#;08V-EEE[5\8C1&%Q5MC;^[,!!0HH-F6HJDVA!ZZ\:.)I@` MNOC(`HJ\"=-:X0&6G/MPUX\P,*.L"OTDKKP_O2-M%S,MM-#^+4=OHC*F=&B* MJ2`5KF+QRF*<(;5"1D'0#5R++H)!P`(-_>LFEUZEK=N\F&W60@JML]8M,YI[ M*L4400SLQ";_D^1)P9QZZL,5@QL(51G3F)'+IA)N"$1"!T3IG[\*3:>I7:=# MU8R1'88AOKN^N@JG+P\2B+QS7ANP2Y=@*BE,;4,PHX,RC\,NT//T:V[$-SET M0Z3;G%M:0:A5D%I!#X);3;SKA"6*T4%#L)Y@$2*KB`?F)!?XCO_54O:'R9Q85Z6KCSA//Z;(+X0`G/*C4=T;VW6R^05(ZO'*OOXZW0,5!(-()H,D8O^K[.OR5D#=3SI'T=-0 M1B@=+WE@'CN[#95:4`Q2)0,/%F,LSGPH5>!`! MLIE()#7S">'W2D`OW.6/.39Y2;=\A+*NX"1<8$$!3O84H6?Y"2T/``%%=/7% M+T*'A>3^,1ZTAJ9`[4BH<]M#5?"NTQ:DQ*8D>1%>M4SEMX+8Q#9,6ECF9@.K MF<2$+-H)H:(H9)PTEO%7/SPBR7)4(HWD*F&2R$,EG12"E+`O.A_D"\5D1*-T MM$]\.GI9DO:'/)C(A#E2>PF>W/,:YI0D#;%KU,SVPJ@@J>H`"@^N63B27%-@M90HX*ED&8=45QT1E)"$B0N[_(DB_G6`V:3GB3.>;. M1BU)QRR'4D16M;(1:L-A.]WY3GAB1H?6L$8,1)/`TX",)KIQT?[RXY>[2,TD M+K(+$VWR+8)0+E?(PM[Y(,2OZQ0C#45RV!_%*R#KC>5G,9A:>YO).9TFE%CC6938$BNH_ M'WB3L*&*-[CY36%QM1$J"@8%/N-F480'42YZT7+*^Q!$?.53X&[4<5H<6EO4 M%:N\).63LS1A4EXS$[-U1#`,X4/^@&9JD#!5K8X*M!9/^^31!Z0!@$+MT"29 MIZM'5E*]T^:E"9;$Z1Z7IN=)WII(5I)#YX:L^"<(*_ M&@THOMQ\(UJ1=Y#\_<6`?+K6+4]C6=XY`M0T8]5GY!5#7Z0"ZX8S;>(9TJK^`T MBBY]04FCTN,5YV1P0\TK7""YXK,P=[1S/(7&1A&CD4P2JXW M#POHP&?^33B0_8EGOA;KRWB;U-SHC M/,5P+W@*63J93(["->%6`7L#0@CE6M+Z@6Y@'EDB$U&/KA[(Q+;F:*@"Y>>2C;,*':A?&S7Z4JQ06S8S:UB&;&=CTL%T)]2%@'AZ9#5[&'[Y()=Q, MYMZH>D3UN*QRO%A1M^@=%^I`:Z.'+$XBK_6/0$ME1S&I$](^)#ZD)M4-"#17 M"1_V!!6I\*\'6FN-3,_VU4TYY,N3JU*#MI)#(S^;G2>M*6.(PTA MMD(V\UE;F-[H`N M5JHNF"PK:Z\S]RYBX`P]<[JT''V5&51E2CZDG6]9=,=?6L1[5AWTNW M8K8-_@;&,GJ-CVC<46>7'.`-8PC$-BV\9WD\UIOM()W:)8#_^B+JI20O$+$6 MT);^Z@]^BPH80M3R]K8%6"=(]62K+)PBPD8<%!"GB_Z93UGCO?MN=M^<.Q.[ M1%V5PL1-U77=-^3=Q`JVOSDE)3'^"RCC]!1.WW# MOQF9B(@XA_KPL<"+@17(.[[;0`[,++\C/,"3%L&CEA?RG>^!.YJ0B9B0",B[ M$Z]P,@5A)>"(%S/@IJ`8FQ]:"MO3%>@(B3G3B!#@--'[%]:X/R,\POMCNUVC M$ZZYHH[KN`?HJSMV*`8-[$!=W$4;2JMR^[%1"<9$ M;)0#.PHU^Z.:0HB)8`H7[$.H.9CR*9P:'*Y?>0MZ@11QH0FF<)^Q4$3IL\3I MDT-Q'$=QE+0A*&YZA$&W`7Q:R*3H,!= MJ"=#Y*&[:;\X5"T!J1.QH#55DL*;0`%&^$8C_"'8.)M-G*1*`D"(`35)"R_: MB!^/J2WD$9!9NC;MT!(?<:YTI#T6$:$S@KX'R$5>?$JH9)O^X?A%JORQMOB> M)M0K0R$LMS*QJ%D/G``P$Y,+$!)#@5S!>QFH3RJ(FDB4)-R+5V,[DZ M@ZRDI>*FNEPIE%D`E/.0.T2!97E%_6&U&KJB:+1J^23K.!@=R,2SF, M!T0P`/OY-Z$J2"=Q`P^8&")[#>,<*`#]H8+(E^'(A@TPCP3]`X4+)'A)*:'( MAH[J@'/(3NY<4S:-#+K[SEK$CK82"!A!C>X!F;+H2E=ACAC,$[%RI=J;IA*P M4("1L/KXQ6HAFQ@QT6WRSYC#2_Q0$W]BU`"%5!NTECG$`!!)KKU)CQ2H?GN]&Z.5;7+"&04D*6FBNAVQ;:NXD`"="\W,9-=%*,@($@A#3] M^*/2NJ7OF1EGR89%7`TS53=*XY\;]!-R15,U;5-XC=?#@-/O=+D8X3`B@S:K MF:BQHY>("PPJ6H^OR!5MM;^=0\W.*(WW8J-1K%0YG%2'G4O4*$#16HH4!9`Y MXDD?20@;>8X,:I@'59D,@HAO?=C,/-4+[2XL,P\LV24-:9>DX<0\X(4BA;G^ ME#T5:!?F4YCJ2@=?W2EDZ@^/0)('4,UC1=:D,U*X;%:;8)W^5A$3J)$+F[@2 MDWU8_MC&-"PT@RR1!4@NV1NMM<-+BX&"_3$.T:DVP.N)#NA2O)H0(DA3;Y-7 MN95;>BVW\&RN^7`-X)&1_9D1+LJ]9Z1'2`'9$)&:K'V(/%RUOJ&OM+K1SPB5 M8:FE*['9B*U<_,!+H]B>YUHEKIN>ZXH?\_2WA1I9E^&(D!4C"9-4U5U=U<7< ME\M)W9P^GJN=$'N8HZ*D":C9"-$UU_``VI75@GP2X81+"]42W]V5KNT`3SG: MUK2GT?"AU<7+)XH-`!,3>H&:_]&>![M MMGJ<-\H:(`N=Y`@$H>R7%8#;N;W^WWA%U#/:7\5ZD5."$>_!NL(*)*@=6-F" ME*'-PC3,-)]-PK)UK^4%23B:7,6U.LJM7(EE7:Z:EX&%)@F;JHHIV[8HJ?;Y M(NS)P@[.("6#-DH;LOIZ86-\POJ*WHC=I;NH0ZIXT("[.3X@47!,GT"C3/.: M``S0B]?=N>;0M#1PAASE(=$`SS2)WE,R%/:9PFBR8MQ)./[,)*R=N#N\PUVI M(DZB2\F%2_85&OX]6S[+AOI]5_Q]8UU$-_X=GC2:0W;+5W\42).(3A(CS!") M,])5D!U<$2,FU`0;#52C)U%IOU]!0B5DR+JDU.UE737Y'O49DL9ANZ#H#M-` M!+OH8#?^V%/`Q<(>8>$7/F54?DZZ@#9HHV0:?JIPH:Y((LR'D005,-&7;)3Q MZC_FX65>6``$51-Q)&%7^0?E9=[6#)IFN]+^C!>*B,%J,INQC(BVDN2'U1(= ME"X8.`4.:28PEA)3`CV=*B1(B[0RR]`P_`DS]8DVCELX?F=>/*-^\9-U3;CN M<<*[5!<"F1<2:T<%:8J-<#PF11)VRURX_-7]!<]Q!L?,-%%ACCE7EM06KF0; M%!KP1#?0\HFGJHG`.%!/(B@52V61SM=.]4N*7653]I[H)8A&PB^1$]P4;AZ) MX=[$Y`NA):]CX>&'Z*4V:N'\L`U99`=D#HVD*\+,3+;V@6;^F)$:H2N)U:#I M$GT+*W`#(WC0+Y:*"`"C#%*!1/$[=&-D:V';@]L`L5;G?;1?>$YK742CGC(> M;$&IN@@2%]Y;LK*-`OI*E\&)\F$*HX*!JKGGA[;0CXK#&H[4B*;H%ZWD)^1; M_LF:J0S&4H&^$0D\R"RD1;IDLZ?C37ICP;L[7$@&1,1J<">J6'& M#M:<&:;I+!E(+MNM@:D*KOYLE);K=:,/NT/F'FJ_`.6/<%'JL&3JK2#6Z_S9 MA2R:3R:T+T8''A0$,&JHX"B77?"%('ML\!0=@]L` M;.6JK4V>)]$@#50CC4`QH:X2$'%^EM80\!8F<.=:"<_6G0*\[4A]OX"R'ETI MG\B+&J\@T1@&88LYH7_K,F1YF(;Z;$^JKXL\M416Y*+>WLQD::W(PN%F)6^Q M*X.NZ9P8DT<+E;NCK8M>0;(8;8*C$X\V>O MJ<%R>=P>$AW]36-?Y]]`2(ZE1`09VG)CUS&S)+T'*8HO)X@6T9W)'6T8SESA MDS:._@@C![CX;//#YO03'_`Y#W=Q/V4E_$;BZ$BD3:`.*(N>F)QNF<@2;=1) ME>A3II@ROW=$;R/NU1)^1A!J@IE:FYVS@V34V,D46J7#!:,P^JLDF6B(5=J9]VN=SO5=MM'@J5].]/2>]VS@YM,O_H=,5+ MC@VE*?D2F1"<%R'&AXW`G>QW@L7TD(V8NE3$>9:L+994+DGM*`K+:8:#M0"I MIAM)WJFP7J+Z34=.[A#J8RT3(JCRRK?.N0MV/ON#F:]YSV^G/X(,*7(DR9(F M3Z),>;(8RP_<@W/_COY+0[/#"F=. MG:TH"L+#`C=N4(0XYVQ7!Q`A4%AULZ!$TC1FSZ)-JW8M6[1(R[Z-*WQ?1/T0KV,4(')C=+J@RK0&(P6X%7Q!(W<(M:_8Q9+IR'=<]>_3LW33_ M0)18H")$B'0M0.A]^8"F2Z6(\'8^ZMAG.@PH;B_`0#H$!@PJ5%2%(;8%ZYO% M5:N6*1/^^6I$SIW#QFM79PC1OQ>(UDW:=P@/(Q6RUE35#$F:82\6P8PUA'31&65*/.8GC7)Z]-=MGF$5)65Y' MA::"!T&!0%1-3'EH$TL]=C;96=3]%D()/8&@$XOI\`;<`NDH]9)X>_+9YSFO MP:977G:II1,&V"%*8G>[8>`!":;9U6>?NK`VJ`'%U->>>X3^%;:"AX$T=1]^ M`RFVGW^G]F=3368(R*"KK\(:JZRS@F2FJLDIU]QJ?^Z55UY`O1EF<\>M1IY- MSE74X0X(5(?0NL165@' MX3U0F%-,?K96MYK5]:1<.EX6IV58YAB:FSV=@RE33A46;3%1`:H9E9JU0%IZ M?SXWZ#]FM$A:"V+J*>FW@Q+J%I4PTBM;"79:IYL'WNUF6E!"P;;G"1I#T;*X M9#J5"'OM#3F"DINZQQY4@:"*Z@8.%9-3P(RT2JO22S/=M-,:0=A2U+N^ANU0 MKZWXIE"2`MJU5$D]X$P,HP*P&"+^H)'%*YK?"FJM=!P'RAG':TG75G1=\RGN M3'F-.?`N1.XGM5.>%H/34->R-?=F.2X^;UKVRH;9;,A2_E@+)9Y&5%-;:>K, MV6DDE/"]GNGD03K_"-QA0N'EM-/5?$*\Y]P*2_FQ;+*E\YONO75W\FY!_90A M7B=\"^C&?3X8$YG\#QW)84DV<[J%VVDXL4.^\;5[F]^H#RN[6[N>PYSO.:\4.UL M!9B2B:?*A).VU4TM:6H2L/$Q]TI/%!,2%%H!\7EY.4Y(4I6A=C'HCRIYC@Q M.9+8YC630@Z=`27$F$WGC'9AT@>(ES?UK4:047P?XA; MV.)LE[C954:&&DR#&3Q@!J)DBCWN(5(Q&N8!ERQ2,D@LI$*:HD"CZ*MM5$*B M#8UCO,JDL)&V^TPZ@+B;6Z+,48YAD;+0LD@)RJUX:T.$`?JXI_DTL8FJ8@D) M3U8"WK3``UCD(C6K:4T&K>Z+:S2*"MD7IS)2+#TT4:-R:&;^#<',+P9*ZE3A M^@BN7M51D9V1)SSCB4>(V5$O!,345GH&%0^])HU(I"$PY:8MD/GRH+=#2@OP MU$)-)4E)1$*$!U#0`OL%$X`TP92G2OE"#Y5/0A&;([%<"9W'-9(R-LJ)BUAD M2R#6LJ6.F59<)F&625#P26F96UYB9A91())'=NS12$EZCF*Z;T-0J"0*)C`! M&-S&#=.\)E6K:E61:#-7Z9N<^EJ4#C!1#`1+U)O`7OB4FZ&5/66:B1]?XU:\ M50M;<84D9U2Y,;?-]8B>XR MZ"CKR^'H$"JC>1X1J/2<4%"+>=0YGL,G(>`%'_C`BZ?"8*I772YSKPH]F(RV M27':R4Z\RJ+3K#".Y$R>K::F*ZK%SIX1-")=M657ND)2LT9)(5$.-KA33@Q] M&<7M8.-Z0;N9-Y)F:9&&."?9R:J3'1WP@!O(PKC[X2U<976A"U>GIS02M;3( MT1@^?86X$%6(15Y]+763@J59VM:F,K+M3BTLWI81#Z_'B]B%,`"#XD(5.,IM M+HUKK,5<-7&<3TH6=7M,76^2IA>J5O0>LJ+S"#S,ML^2;[*D1&#`%%K#SU=9;-NV2$IA8N8=;IEM[2 MDS%M\IQGWME!_@$<['Y37TE!Y9K`"4[4C%0\"(;=9\XMJ.*LT4$.6N];8@-E MU^VE<"3M-%SO>NFW93J)`?\3\?`N!P!E&64^2.M"(`:7^.N(2C]5H'\SJ MNQPROJC3Y`B)8CB/^S%_[Q3J$?.,."2BG%[>6JRT1ZS#E0H;I95#BD\T?)I= ML8V@]J5TEU,89Y4^;I9[G&^4?Z$G^?`9L7UTC:D/,\V)GYO&%I:R'G%`.BFKK9?M)0FW14B+KF MSOV/(U?&AGY5][@-UTG5=M*I/\G^V*B!6&=E\J&BR*9"-.3+G(]#Y+3WD=78 MWS>_U=ZP?XAMVWT'`\0%;_[SDZ2`?BX/1PF&HK'!GRL1@K#^LC[P_='(Y8ZK M(/_OE-K5 MD%7%29BN_)&DT-\`40KVP2#7%,57%W5_FUC(Z-TAS1F;V6G<7F@?GD$, MZ7Q3C[U)]"G+352;3R2%A&R)M11>QKRA+A0+$6Z(#XZBD&F?A*@?<]C$LC1+ M$BZA$\JB+&95U'@4@S50Z9G>%H+BQ8V34!%5W937KZFE%U&!4%@T$G'`R"@:$4()2G?;/`$G"B?\M$%0*H4Q,4#B6Z91C4$Q9M7'6WDS>^^!34BE1'&D?,JEB02;3 M,L6$?0@&.OE=^=%1N8IXQT:S3*5AW-(8@;!"0URE;C=CN>- M6TY,1T.5@)Q)F2,B#^/1Q'J9!1']!+*(R1::"0&V!-9%F.$)H4"*U#A]ERLE MI#/&1`,Y!0(D@GT40RQ*9%L"WA?I8O1(3]"PH8-DS"_J3_]06E%VXJ15&I@M MEMW`35_F2$DF&4E:F(HE9N71)-"Q%V+%7%SXI(;,Q_ODQ"*&F^10SCA^V&%Y MWCA=CS@)9?[4!*Z$)2+8V5/>X>&5Y6?]E4)R85=Z81>.%2F.DQI!86E&#T9V M""*PI5L")ZK)F][XV6@IY'%&86G^.I'Z^,* MGEB_L+UE=9!LA^NC$\'4$\'G,-O!F>$-M>J46@: M\>"`$I\=L],38 MI6,LJ0GC[$@$II+YL.8SWLHTXLN5W(Y/6,F(HN&ZF=0JFJ:X&(O4C,M7!B1T M@9V#$&%Z"B%YV.8?62B%.NGXB`*$2FB85I4/VE!)E6EE8BC7&-QSZEIZA>BT MP<@)2AN!CDJFB5I0,HIHF#6;,(T))H;D<8HHVHF MGGDD)E8-+/E>C4X,OY@H!.Y(W7TE6+:2`J(B\3'I(>&%+O@*=%'AAY#/:6ZJ M2"'D@);BEGIJ@B;'$]7$@T(D20Q`1\""F)K$KAJ(KUY$KF:$L.KJ2``KK`0$ @`"'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`#L_ ` end GRAPHIC 16 y83222y83222z0002.gif GRAPHIC begin 644 y83222y83222z0002.gif M1TE&.#=AT`(<`O<``````.BP$)"(.!A08(B@L`!`6.#HX$A04``P0&"(F-C8 MX`@H,-C8V,B@((@`",BPL%!XB`A(8%AP4``8*#`P,'B8J%!XD.CPZ`A(<$AH M6$A(2-C(R%AX@+BXL*!`4$!`0'AX>)"(B(B(B'"0H"@H*#A88"!08)"0D#AH M>%AP>)B8F+"PL/#X^+!8:`@X2,BHJ!`0$)B@H+"HJ,C0T*BHJ"`@(#A8:"!8 M<,#`P+B`B*B0,!@8&!A`4!A(6*"XP#@X.'!X2$!06"A(6'!P<+!H)`0(!A(8-BH&.CHX!!0:.#8X'AX M0+"8*("@J#!@`A(:$!P@$!@<,"8H,"0F'!X<.CH\`@P M./#PZ*A06"!8:`@H.!`X4("`B!A`6)BPN`A`6)"(D$!H>&AP:$A(4*"HJ``@ M,$APB.#@V"A88,#0T("0F&!88!!`6$A@<``X4.CHZ-#0T&!P@*"8H%AH4'!X M@&B(F%AP@)"HL(@`&&!@6`@P2!!(8.#@Z'"(D%A88)BHJ!@X2-#0V`A`8&A@ M8&"`B&!@8.BP&+#`R,C`P/"X$*C`R+C`R%A86+C(T$!H@!A(:"A8<-C@X/#P M^,"@*`!`<-#8X*"@F*BHH)"@J%!P@*"PN&!@:/CX^'"(F$!@6)@@,/#HZ*BH ML`@X4!A0:(B8H("`0)B(.'B8H&"`D#!88"!`4!`P2#A@#!(6``P2&!P2*BXP"!0 M:``@.)B8D'B(F-C@Z&B`B.#@X)"HN%!@6.CP\(B(@&!H8$AH>!!(:("8J!!( M<,"8F%!H4("`>#`H,%B`D*"@H+B8*(!X@/BX$,"(F+"XP(BHL%!06+BXN.#H MZ'B0F%!04-C0T.C@Z,#(T"'Y!`@``.(`+`````#0`AP"``C^`.,)I$$C'L&# M"!,J7,B0H<"'$`=&G$C1H,6*-`YA`L:QH\>/($.*'$FRI,F3*%.J7,FRIC;@TZ41:)\3TG$JUJM6K M6+-JWO6X6*'>OPH%*,2(LZQ7@"K-NW<./*G4NWKMV[.LGJW/'8/M*GDQ9\-*,4B%KWLRYL^?/H,-6'DU:;V%6 MH5.K7LVZM6O&I6/+=CAP6N;7N'/KWLV[-\K9P&4#-CC-M_'CR),KAQV\>5^( M36D=6DZ]NO7KV&\ZWRX6.E#HAK/^BQ]/OKQUO2O2HS_HB\8*@NJY_Y0Q[;#Y M^_CSZ_><4,;!]^[]MX(,Z0$X8(#N%?A>>KX`F.`*[17XH(+.T6???AAFJ.&& M7\4''X(?"E@@@01*.&&#,A#X('P*+F@B0@Z&".)8]`W`X8TXYJCC3.KY1U") M-#2HGB]"2JA>BT@F>22$*R[I7X0C^M@7?3M6:>656`*CY));(ME$$_FD%Z:+ M#BK8Q`H==/#BA`JU1YD,*J"6&S=9=L3-G5/1J9.>(]'))TI_]A1HG5J/X:JT>M8G)8 MK+<&&JVM(.VZ+*\7S.. M)#?#%"PKDESSJIVG*FQ+P\+"&C&J-QQ]C<<:BVV&(HAP0@SQ+`HNN&97(2D(XEHJ]]QTURUWNN/*2_?^'W\,T7>E],Y- MJ>!^SSLI"'$,D7BEEU**,*H6&**/*Z[H4TX:DH3-*B8HG&)-.;*X(DL%F"1P M#Q_!6D#`*:2?!<(/YB*$I`D6"@P M1"Y(T893`:,-I\A%&MH00#N5SAK^N2#`J5HAB4R4XQ6GHY,=;F"!5Q#/&K:P M@QU&T@H[;(-XN?#!"(CA`^+)0@KB:]D(AI<+6QP/0P>#%29L@45X0(PFK#C# M"+J8BR3.)%CP<`4*,F:G"*PB";DXQ2ILV`92Y,(0,`M4!"3A1#,`XPM?TX<< M6&`&A0%CB?#`8CG:8``&AB2>%HEQQ5S(PF9Z*@`$Y.!&L1T0/W:+I=PP M-2_&U;)N#53".>9E-P?6;7"UQ-3;;$E+80(34_)*09\B4`P@)J``Q,)$`3*9 MBP08T&JK(!X!"L`15K!,%;EP'Y\6,0[B48*;)8G`-9RH#TR6?^S`\FDL%#'Q)#%@3()TRX68XZ\C$FP8)`+N`A/55%(`%`A`X0,*B`>.3[P3!?H@'NG\Q`>% MRLZ5KRP/W'9:A9WZU*<]!8&CA-I31PV5IT*%FU&-"E2F!M6I2XUJ%?+P5*(2 MM0K*%$G+B&='9A6@G+FP0`"IUT5KM**'P6I%$!M*/DK,%'_',>"-N\.$6(_C$1Y+%DU;(P:`X+0DF6E&./12`3^2CICAS58!;$.^F M'(F`((K6Y58C$2&X0TTR\,*;Z MJ*NJ8EH.[=J)#Z2(GIZH!]9*B@T39YBK=SGB"N*1(@(W>.A>B958K]27*L$Z M`PNL.3Z$CL1KA^TJLU:""56PX`9#XXC78NJ*D7S!#C$%!Y\,RUII\4$5!&`K M'TQ;@8:>:K7Z"%0FB'>*T7Z!&Z##+8=Z.X0N``YPZ`JFI)HKS#\HP6V2I4%U(5G[F6JSJK+&*&)O2`"?NG!#^NP`L5[*(CQN=#LRK1@6(%A04, MJXE9.IT6]<&4^4#'#J_*KW0UWX:.'FJ'EO,\N5>*BMLO)8F3$^K9>\\RRS M5M-K<%A'((>FA)5\B[<(>)#1%9C-;#%DH0]9`%$6/+/:``;^8=(*+((`0/0! M?(L!SC8L(@'M-:7L5#OT<@248ZWP@1Q<(4\YW*(5@3[5"%R1!GFZ8@0QPSZR MD`2')0L`>"IM<`^RD`GZD%'<\`7PL`T,Z`IPEP!E9W"ND`D$4'-$)$-PYT,H MH`JR,#S6<`HHIT;70`KS-V+Z,`Y_HFD!)CV?I8(+6`ZD(`LGR"J+E`LL`#-] M!&=K9V:K172HQH.L90&]UQ&_MV:F1E$@-EBAE`9I!`PP&$X#!WCC,01-EE2S ME&3C=D'H\D':!GD?8'D_0`(D@'D4@(9H^`,U0`*6!WEK&(>,EWF3QWB;9X>, MQWAFF'F`D'G<]GD4T'AWZ'E!P"K^?$``7F02\I8+E"`]K2!/6+0'K0!PN4#9X4" M[:4/'ZA:^@!%F`"![D4LD!2#'-&/:?"!I7A@CC98X"1AS)*)Q".%)$%V\_0^ MK1!3RI,+X^`PIV9W=.>$Q--:?\8-;I=A?X()PY,&`H6%UL$/F764H>6L(AVA8`SC)AB2`DS5I>6E8DSLY>99'`35`DT,YE&E8AFW8 M>&7X`_R@ADWIAC60>:+P`8`P,D-G"`*%"3*4"ZJ@,HMUBJQE,[<5<,%W7K>G M#S;$"M^G=JW`"N1C4:^P#:I00Q%P3UGT/BN%BJN&">VUC,"P,19`/'29#"9% MCYA@4M;@`SX`=YA`1WL`#F"S1@7X*\>718MP)XN@#O-F-5<$`2AU*F0D6PIY M!M)3`,C72IB03=5D27Y5BM;P@7S0!L0C49B`&F=E2&8%E@JE"M#$#=U(F&'T M#W64F20%5JD(#&V'6`E7/-*S"+IX`Y?X$9I64%HY6%VI"E?^2%%IX%X&I%J2 MN)$9=6*Y@I%X1SR9<)NG0DX;N3$?\0E7%)LE:9++09/LAH=R"(>1YY,YJ9-L M2)0[^8;^F8:1%WEPN(8X60.1)Z!%Z9-(28AGB).39Z!Q>(8?\),[20&L]P.' M2'#$>4A;V977:37<8%I8I`I/DRMC=I:*17SE8`$;TPI@50[,PW#>^2N?`$C+ M2#VUR%?DTT5\=RIGH';7P#(6`#-\`&=F\)L%1X&]MPCW0#RI&%,E=B=?0)NG MI3!;!9C*1T?6-``KM0>+D"RJ1#Q:&2P<]8VDI8OR&2R_F`O%H%%\P*8GB`G= M:4:M@J6`>7OBA4>U22R;)CU&('%'@\6Y5%PH<)@.2593E8C:J=>A)W M=(1%I'`Q?^)7'.9AN"8'$+`Q9V!:S%9M@`!"V<8N'Q1Z MGM>JCL=MDE>&^4EY=CB'-FF4D==X9CBA/SF(9/B?R!$U.-6!-`&*U=QM9@+&X,)6*JFU,.F<.>FQ%,,$.-7 M9F!O);O^56K),2.P!_V$"=M@#1G5206`I6+7-8':*N"D#WOT!0YCCCW#HP\9 MDI'ZJ!S3G5XY4M;J?%@$C-OJ9;:66JLEKN0*1*Z`KC?SFL3S;_>5JKUA.-4F M+XCG4Y(B;<1U5,"`M(6+NLR!.>0"HZ79*X:B!K`+GZH>110 M>4[YE(SWDT69"N3`>%=9+:$THF;VH5^9*[NB#K/(52F[HMZZB4"DEG:``AK7 M=2*S?#6JJ;F`D$,D<@70"E(PCTZH/,.(B?]:6R(S/-M@0%Y[L`IV!NW:,J4$ MLP;O>Q`H0$$H9U4T]ZSNS:PWC<`;$>RR:"Y(<,W232Q*,2F+`)E@$,)'S MA%88.5*X!@X4`[H;5[1\,+NGL)UBNQSN1F/!=$ME*PJ[Y&0,S&)O,U0G$!@O MLBC>(`)QP'IDFV-:J`0BT%/\D&2ZM$"IH&V:]P%#D`J4U[A4MK+`Z)XD04;P M"Q)\<`T?2CQB15.:V*+J]06$52T-IRQ1AKI6`[+;(`ND`$@O^V'*0PPC13VS M:UL>8;NN^0FUF)Q+5P'CZHP/BRI8"KP1(T_%P$W)DL9J%+*2)KTL2[TGF[G8 MVX[!`D[<^V<NVZF]4J9W;I5K+R2)33B= ML19#48M9IAM:G)IWB=8GGX"7!QRV":P;AS-,A^,VH4PIB?-LSV8X7#!MEQ)C M=^,N.98'-(`#"I(/MKP"X7)5/E8%8>@VUB9D2R94U59MJ7`.,.Q#@WE1'R@2 M7C.+LA,US/(PV3A#T=NMY@7$Q0=J\X6))H7$JVD(&H@"]7JZDWH-L"M\!4P\ M5MP16$Q36RPR!"`'I.!&#LLSJRE3[?L1\M2$Q_*\U53-TVNR<"K']I:ND,9K M],L-XU`.VP`!!<":Y?M(YYM9@Q!*!@:`.%8%5"/,6TE%MS6]8Y-2E2[, M>$,P(062#]]R`B?0!V5C-N;@MB,\7$]%*3V58T0U!.[@#DH0;VX7IV:&I??: M$7NP7EZ&?)VHN=<,TFBFS66D+%6&D,%2BJ3@5[[3S:^;I7_BTNI,+*S0SJ3U MSA+3"MV)A&),//:,I=K9)_+T7B.SQM"+B0&-"=4[6M0SQV$T=,E)<,G@"N5@ M"RPS,W]*)ZRPG)SV,(/0J&%5M)^0C1-KOF4G5F:F4*9T,"6Z*N"UD76WJ5:+ MVRF1SH$$TS%M'&4#+D,U530M54W=*%'M-O6RW+DT>\6YL`U9_,X&RO;/]F'6#A0G9R*790TU75IZFM0?L75:_MU*#0WUX@U*_=W^X2`2HQU3KY#9'@%AN9`$:10!LM#:'<%8 M.C0TP+>YV/QW$;-\?*5F`'XJQ'F[4W0#*XJZJG7.*U/%M?O@HR7E!ULZHRAH M>PE&+C=TCC4K=O`)$+`'TDQBGS``/4>S'_NF-L-VP.*!"<0>AR;^J`Q!B#>D(`ZU4`)L596H4"3I38@\7HUL"[(3$`\@:YF``. M\`UK5$A\(]KD=[?;+&T2:P;M55X=30TI]:[GP_TMY&WOQ"T"[G!5;[M;T`T" M1"$FV`TF-``"W%8%Q/;FUD8O[E(I`'$H_>(Y.,#YZ$J@*Z$+U M!2@`1`00FBHE3^SH\[R>,:PP18,,C$+3$9*8!*&X];>P#<*2C0Z]GKJ8"Q!P M4('<*FF`T7654-D\$B.I51:@/$2.*W3R5P:7@R(I"Y_FZ.Q"9Q MF?8][]8!-UL^PA*?Y14?U1,/^M]-\4JM`N2M`K9\W6C^^FA.`Y42+I*R0:+@ M8G:^Y\K-[VP#U4H=`AJO@QP?/<3B4HJH#]%W*C)D"+%F']+^U$6R\!&+0$=A M#^_7`$3=E4^PA8H'Q9YJ.3&NOC%20'ULGP`)L`BW9P:AV1&+4(LIVBO#XP/K M?WX\6$#U!@X0``S64ZY!=`/W$"P`82C70$/J1NS)Y8,/,&Z?*.5BD4O?GA$5 MTLBY`4PC)ED2X7%K9=''0$FM6F%J,U`5L%:D4&`J8"97N5:?&$9(,%#BN!'J MTEAK!2S"B(&RV@!KH\I5Q!'7"`##=$-.+@*+-B8!!VPAL`(Y]T30&%;L)X0T M!XC5R(V/A8@$"F`*^XG/.(F#,'$+BRE)KI5\TFWD0RJ7(;0%3@VL8#4L'Q01 MY7"#BU9RV(ZJ[D[&G%GS9LZ=/7_^!AU:]&C2I4V/K@*BB@@15:JX`]&:]6S: MK5V+.&'[=N[;LW/'R[=$S7`U.(@/QU&%'[\AKD$HJ:(DE:@AL7'[/I%=A8H3 MW%?CSHT[G&;(JP0:@M<*9`*!I,YP&%`3*Y90S,FIED'(&,B.H00"TA@4([M$IC041RL6:!`AD MZ9J.$FKE!I"(*A&"H%JY)HV!MFD1DW]TTB)P@!;:X59(18-4^$EE"!%` M&$()$+X5MK7NNILF.]^0/<&;\3;#!!-X5-%''W#D)<66"+[`"RT?U"N&E#1< MR<2:-(B!:B,(S-@CX3UNN<6,0R6[H8)[?%#8!P)&F`P3",:Y)6&+V\!DA'$4 MWD-3/HH!QYIR)N7CFI1]`":9B1.^Q0>,H8+GGHH)6,4.A$G^'L'=>SI>F`"0 M;R#%&D`3^`23<5B0!0*;PB(@96N2$%(R3!)01>F)3LJ7H:TOE<.':Q911PY* M7L(7I22L8:2">Q.@A&0S7M(H`OV4SF0<2J%JI6N!X>$#DVU82**-EG]>>)P$ MH"+E%D/*T<<55_8H6#-,!"/@D[#1PF0`]N)U1=Y3V@#KH1 M!C@+*@L8WX-B,]K@1IV9/;Z8,W=S22*R78]'/GGEEV>>U^]<2^W;ZJR3K5?5 MH.=6-=:V6XT[$52@(9]HQY=6C7Q44.(#?D19?PCJJ/ON.O!<2]9ZL)1)*'S@!@K^4-"*"("E4IC@0P0E&#I"14""$6P79C`A M%PG>"RH6Y&!DX#*@3[3M!D_*VP4+EQ<+3A`P?)!+TSYX0>-A@D:8<"`F&.3` ML$3`#@8"QM0D$P$;FHJ(DXD`-TQ50E&M,"_`6.)&6HA!T.G0B+("QA>LF$&- M,$B$%Y0A,&[0M`2B((B=P<0J@$L$TS-6KZ(WR=9\2Y*\J8(*5B"^XI"O M?.?;5BH^H`$-K`];[A"%$J!S@OCYAC4GZ(.YB"6"$*A@%M`(3;N&Y!F\<)&` MW`!F,('^N1EA#I.`8BEF6))9*88P,RW+5"9>AHG,8$:SF@\$':*@`LB,<5-K MS51FQL#)$&%J<)?=S"8UIQG.;8Z3/'P@0"[@X;G,#%.7G[$GE!`%37+R4X.M MR,4VL+A(@A;4H`?U#/124TG5@"N2"JU"=2+)FMAHAP:;S$=&QZ?1C,8C-:(8 M9;6LM1Q1I&(Z2I#H_2`ZF]Z$1P33V`[_$#I3FM;4IK3"!+R\>5/.<*,`JI`% M3X4Z5*+6:J'F,,>VM-+!RF\I`1\_`"L_ M2(DMDY)U"-V2Z%,MZ52H%LLV(4A!4>4Z5[HF4D^J*$!=, M!3O8@T:T-M"KY+::TQRE^DHU*LAH5*KP`05GBXD*&`)LM@5N<)7W MG.II3UR(#4$E)_K*64SUHIO$P56ONH*LAI*4/Z``"3Q;2FP=0+2D54)I4:M* M$/"&E6Z-GFQ8J8)X>$.VPH5O?.>=YB M-;0*W7EN/I@A+>$975'Q6G&=*8UO6E.V_3`NO%>L7J3!^W$0PT, M0#4#\+SJ1MSYSJQN!`-6,&C0DK76UR*EM:K3+4>RYJS9>Z7\Z.S*`UNZT\=& M=K*5O>S38#+8XM+-G&GP:ECGF=6J9C4.1%%*1&=6K&-5GQ).\!SM7:\*Y@C/ MKW*S[N[^;&=[VX$KL^4];WK7>].L9.IY5T/IK7*'!L99]7#^+'""$R>CB+@6 MACE,2E&<]JQ*G9]Q3Q""6'Z'SEJ.1\:WRLHL<^?2]@9YR$4^#1:'=VK:G6KYR@IHD>[OE2&^*GK+A9[N<,=+6^GWRO7>+]C M$(QX0.,O\M:O9*).JYTHYYM^4:9!D=!]4..)\CFU4:T$`%URHMAWEN MK>>D8?[^F?-/!!L^D8QW'$\,ZGC[3 M:4[]ZH^'O"'[O=5/[UL[FHPUJL4A#E>D&MNL[F0^.E!V&J3^XM#@#>\YIE,= M;WT/Y9<_+]W+CN!X9)6]%\5[=FZYF71@P/>_!_[O%R]<.Q1B%]HPQO#I:'SD MYXH;A=B"!-JA_((&/QUXH7[DM;_]78V+SK'I7G>:"QP\H[K\GL]\JX>341EL M/'V`L%:4PXO2DJ*VV$8W^[C!XU%-FCWC*J"%C"N[%<`XC*.!:6BCR9``81`& M,F#`!X1`8=`&^$J'*!@&>0@`,"B$S*A``8"%4=#`7-&&80`#>B`##*BG[-L5 M,>`&(-"!,B@#83`&#"@$(."^&\1!7-DXC[J_[A#`LN.D(>,SY,@'L^..IQJK MZ2@M4"BM^7,?1N.ZI%LW.ML.ZB+^/1^C*VY@`VV@!QU0P;3``"`XP^O+%1.0AE&(`C'`#!V0A@R(PUM)!V-H M@%$0``D8P5'0@080`!3,P4>$1-'8JN_IGJ+3.)?SL_*#N57[O$ZR0A7PABKP MK@TKJ53JL%][JMM@+P'LN!,H0EHPNNZ(`:.;JA7`OZR:ALT0`PPH`U,0@%@( MOC1L`&%(0^'B!@P0`'H`@F+,##88!GK0!F:TE738A0"`!T:Y]'4\5Q\<'Z^9Z5,[L5^)X!U+CM"8I+70OR!0;B10%131 M_HQ/_,Q/(PT+#+"#!I"'!Q71ZR/^2M^DTLX`'YO+OZ2[#3NC+DXJA:G<1+`K M#O%9`NFZ*A%(I1,(KU2"'U'(GJB2M$?PMZPZ,/:*`>KZ0:U*ET.`R\F0!Q-D M4&Z84&%X.I^D02!@P%U`4F`H!&/(`&W`/B#(2&Z(`B#8S?R,`FU(R04T(+'` M@"A@0$`L!`F024;=@G:0`&"X/C+8`D.M06%H!UXT!4"G*[Y=``)C4%6Y M%(9=2,D:E(8`T($,*`%,#54,R`"*K=*2)8VG9+EV\YY^(XYX[+-&D+EJP\IY M9#4:2`V4.BOJZ!9OV3>ZN M)0-MT(%V^,#D$-?%0!YD%1Y($%IF+I!'`7"C0`#YI4'`4C)CIQ>"2`#4Y`'8'+!UXU1UPT`4P""W@-?&'7; M=$!>'0`"2,!`"6`#4,7`43`&-C"&/\U`F>2&8?C`Q80%;;A0UQ6`=AB&,F@` MDC79`_Z,LD,6W$.Q@IRJ6`UHA( M!NC3%`#7%$EI4%6\*`0P,(6H5>5KU($@<$.]-($EUMIAZL6/C#K/A$8&]5`Z M+`,@-8$=1LIU@&D@/4;-39SA=J'`58F$F1'`5ND(`R*(18D(!> MEM+T=-LH#@`\SLRT@.1VY6+$]-I;!0:+9&;CS8!VK4RFC6-5%8!18`(,,`&& M*$2*EP3@C`<98`1K:(3^C!K`((2Y<0:[ M@8NN;\:XK3.6+-LJA:3"=ZYG;PA/AM26$,`%S?#&`!CE"Y7,KQ8+1([:_,P` MNESKKE[,=FA$8.!7C=AH,'#K[I6&XP8&'=A#&OU,=<6^C1X%[5X'-_36:#2^ ME,Q7[=9:BY3?O_#M]5:F/$1)567D]]8(9&S)=1"#^#;-'7;)<05-U(QI%I1# M2T9!&FT'N+YU&,B`\].9J8\A#E>Z,L[9&T2S'NA2+#^S)_%1,"[=6.HS= M,?Y(.^@]S4T'P#9!ZZ;!!GA<'6`"-O#&[@92:6@``/_4H:;NNBV#40:&XC;D M_-1KEQ9J=T7!78!O"8-@`S`@"T0@`SXVK7N2)?\;L:&[Z'&U7UN0!NE49M$T(XT MA9C6B`S0]$TO6%6=2TQ7U<^\8M$4];!M29?V\9O$[@#X5U,@27BU5<*K9-"T M;B!M@*G&S'*$;EQU7>BN:L3$@&$PQS-F"/Y63VXP4+,-ZF(58KTN1CL``[#U MO2C@74?6"!77`4A@`[E\PT+?]@+O\<&FAW8`1F`@Y#*P`Q84@RA89@&(6OIV M2485Z)G^E,QVA82_J.HCGVR[8\B&S,>F9*4A:#G.6X%8$[(A/`[D'!\K_V;2 MTT[6<`?P$`$CO$*DLVPM-)>M4L$=!G4:!8)V0%(_ODEE6X#UHA>5/#1-(7P-05M+,U9#TVF M'06N9E2O/4%&+G)&W=AEE'=-OG4@`%&M+8'#[50_/MQH)'!3N$;GCM[D(U!$ M%H:L1PL@(*!(AFXI_4R/MD@-3$D:?4:DE/I10$>C;,E*7<1A"`)').N&9D,! M$'NP=T:S_6MI``-D]4!YL/8.1]'8%-&QQ]47EP;^BDU*?:?2HBVZ MA11]V.Z.V/@W5&,$1E"U/GM9A(?]9R%"F[-%\V(OU]Z.I(J-H=/3VSO"$Z"% MOL.,6AYN]A3-*(A>]PU,K[WEDF9H5(_,7B1R8MQH:;"#E01[#'A1QD2+6Y_4 MT11KZ!_7U77;CBQ7`&C`T9A\#2 M<1-@2D#"E"J!%=*QDENZ7:,"0$)82-JH720Q"#.((:48B:.BB('9SA2LE.ET M!"@C0%@[$QB*7L0`)("T0BEAC9+^E](.SEUBTK4;)6V8`"!!TOWT"&P=4S#& MBJ;+$*"!1VX8-`I@XY9NAHEE5A(N;/@PXL2*%S-N[/@QY,B2)U.N;#DQC7B: MO9WH3..SYLR=59P0H2*>B!4,&%ACA*,##C5J9C1J)%NV;=RW=_.^C0-'/AH@ MJH@0`4)$O,\T5(B8)R*S"N6GXYV(WEE&,#&%TVT!DQ-B0NTIU[4+(!?\.FWF MB=85J'5[&7ID!!1*5\B[L5T'$^ZE)Z!C5<*89TR`#OFETE(;6312(;"`@9=2 M8Z4SH7;I1#%*`R94I=%#;HVD@RF#I3.,0^!]:$J'Z6@$1"PR03@23"0"T58Z MVIA5B'C^W#0P"CG@B:%-`V>5H4,[ZQR6#CGRB*>2C@&T,Z$$2/U5ABG:+!AC M`+#DU=]^P)C00``98(`!0MS`E%""_\'470`2^$66*5X!@T%(.HPYU44C)50( MF-ITI)=&PAS8I`3K>%0(@7K9.$H&)E[V**212CHII95:>BDMFI&F`FFA+1?/ M"J5U>AIS)Z@ACC@KT)`/;K6YZNIJ#+PZ:VUJQ`8<<#2<0%P5()R@F68KQ'.: MKK\.JX(O-!1GW2RU8%+8.D`@E5A[TFBHDCP;=<23?PN^Q(8`=]7$$D[D##,7 MFO$!8:A>&7!5QD_`B$&E!"2M)$^5AB;TU"C#Q'N853X5`JC^?P#"E(%`48S$ ME\'M@4%40ESI9,>..@&3`;E#D801B1QY!&=2"!HSC#!1%$+F87H!(4UA)D@# MAE;KD/B?0F`V:B8&0`9`/Q2%22<>"E::N]-MMMN\WVL,=R&AK=*W2: M'*>D@:#""FKDLT(^K,;6FQJNSK!;;='X%CAP:I3"]S1#5-%9"-,=^RMSIE&G M0A63_QI#!\$X>A%G:PI'$^H@04\9%*+^S>CCZ4!/.X6@E(X$/A&-4`/`LV$"&]G[ MNSTPW?L)TX40CBC?(F20@<%1\K`AC%8Z:KSA1L``46$&II`1"YF*9IB%:.1_ M*@D81R)FBB<)@!LN"P"+V$(&89"('!G8!08N!`9N1$$8")''74XV)FX,8Q@8 M*4_(/D2/&>4%3,:0`"1R-HI1S&A,ZY``+#"6CIX(ZF,(:T`Z@&`,.CDD%D"` M1"R&82><]:10QGL;%*,HQ2E2L5*9R0S>0$4#874F!G-C#FF0(X(JJ.`W^?B- MK7B3FU<5CE9LK!4.5B`LXYS&--4I33RFL2L:!`)4PZH.%@$WC26A"0.!05XL M$+.0GKS^CPUL`()_@&(,@=AA@#P9!;KDI2ZTS8F-!1`%"#"E2'^I`RF).0N,>`77VI#.RHKF%2T M@122I2,C!B%#O9"$%&`&8&QSP=)9M+$%,?RK,&+HVDD*L0Z$2&LP\I+)PX0! M"3&(`432:$<[RD`&8(!!&MH0AE0@68:1$0A[,Y&&,,@P#(`BI#\>LP\88`88 MLTP0(O@:A0Z`(`Q8R&,M$0N`Q>8D#!0!`7KSDD\[KD*+^-D'MAZQ6DP:C M&E56C9`5#@[WFQ,,83CQ(,ZR:*HJ.0HK;\*B@0Q.8"(Q9$`8#:AG`P0@EL20 M01HZ$(8.Y/&D\=BH2X79BYK0!(MA>"LE)BBE>88"SALE)AN.'+NTB@ MERA"&F*^U)5<>D0,+6G`V.1QKK$:0P>8%89FC>&MI8RB)MP(BG>&D1!PT:,! MD/#+.LA0S;["XK'VLHI`Z$&/KM`O>D&Y'1!@(0UYE$&XPC`F,(PAC2RUPR]B MB,)R[V*E)JEV))"8H0X@^Q9MX&2W9B``987&M.(6E`O6!B$H"R<[W^`M"L,(;TQ)82N,`&/K!DXM''Y)B&4\N9 M7.9D2D>!-:B0D&EI@HU#A)B@'0OY2IKE M=;4?%Z6$,P:"9P-`#VFL5<8G8T,ZC`$)"1RYFX%VLX^J?.0#&:-12ME%!MB) M(!,09(BQ8TDE4\*-.`.#'%'HYEB$)Y9N;KK(%ZE>-]NQ!8@@JB/MT$9&$2SK M6=.ZUE_^I,YR3J"KXQBG..;PZ1U5L#?JG/&,OUD"X9*M;-X,KA1J`($&E*"$ M(?Q44Y\C57)^!;A`K*`6`R",CPB9&#;@23+BEA=B?HR@QZ1#W-'SYKNY::0! MAT>8C5&W4A:C939+`XCL%"8'052&=^=)7F,JTTK$T->4A'G+CFHW83[6<,6< M&^*$43ARM[R=@J.)D%0Y>*U#+O*1I_1NH_%,<5*N+!`H013'X?409!H/-6R1 M5:\2ZE-?=3C:N,H3:7"J;3BL!E%\0!2BX(?D^B!3SY!&-*O23#ZF\2Q(T;MM M57_;U35=F:R_A%NO/1U"P"`/@C>&ZY$Q.TO13O*UL[WMDOG^8MXVM2Q.S4($ MTBX-RZLCBIA7P5:!.R-OF#&XW]QJ<+:ZU6V0?9M:R68%0S#ZM)5P'&UW2E<0 MIGL5W*YY*.I%1HD\8!2$1O;-D[[TIC]]%4E5G;R-L?7)J6H5\'8")7!A.)(# M`:M60/A6T2JH3P4ZK&(5]*#;BAGYB`<(J#UM,E;GC[HZ,6I.$`G44U]20=D1 M$.JCG4*L;$;5_S[XPR_^RFC*-#+E''%$Y5,',Z<*FQ@"_%T>^S24ZE>?T3T: M=6.;$'=X][L!#A=UQA!LP=Z,GP,ZAAB8`!`0EP[H0`GA M4C<]H`9N(`>:7K8A!^><``@<1^?^%,>O=$8>=,XF))^TQ8$H*,%O)(<<&=O@ M-`)M;-CPO5'AK`:LP!'CJ$$(BD`?/9_FT$`P)`*!W+VE"L0<<_C*W!@C&9'^!DZ!0#Q,&R,D M5)FY2 MH=U@FTSY2DQ-WB_^D>;X$74DWPF(@@8,P6K@8U/]G%7BX(9Y`C_:854*WU/A M0(5%0CR$0VYVIW=^Y_?)347Z2G6D7*_0#7$D"]_`5(6-$=(QP`6,Y$C2Y$O6 MIWW:IP*(`THB8W7B1JRH@0ATP:[$(G@6J($>Z*R-1CSD`:=D51@1QWK&5'00 MR].Q7(6)`AGU9I5QT'%\834=FY(,W`,+RX<)P\(,:,,)]HLH8P.0^ MDF10[2>J5$-+4N5JP.1,DB:LR$`)<-QCG$Y>*`:]&4_6N468O@23#)"::EW$ M+88AIDR;*@2;IJF74AV<4L;5E:F<)L:;TNED5)V9HJECF-V97DJ@EIW6>8C: M$6JD*.JJCYFF:4FJ=NBEC0&BIA&#<]!0@19\>.A@-/%[+P=\0\(,& MG(`<*.E+6N>&`>22SB=,PN1TMDKA^%T31$,P\`$F]*JO_BJP!JNP#BNQ%JNQ M'BNR)JO^LBXKLS:KLSXKM$:KM$XKM5:KM5XKMF:KMFXKMW8KMD8`L>"DL'"; M[FW1=.2#+Q!GX,#4:52!.VAFA54!(3!"?LZG\(TF\-U[=G: M+=[NK=[:+,_^+>`&KN`.+N$6KN$>+N(FKN(N+N,VKN,^+N1&KN1.+N56KN5> M+N9FKN9N+N=VKN=^+NB&KNB.+NF6KNF>+NJFKNJN+NNVKNN^+NS&KNS.+NW6 MKNW>+N[FKN[N+N_VKN_^+O`&K_`.+_$6K_$>+_(FK_(N+_,VK_,^+_1&K_1. M+_56K_5>+_9FK_9N+_=VK_=^+_B&K_B.+_F6K_F>+_JFK_JN+_NVK_N^+_S& MK_S.+_W6K_W>+_[FK_[N+__VK__^+P`'L``/,`$7L`$?,`(GL`(O,`,WL`,_ M,`1'L`1/,`57L`5?,`9GL`9O,`?^=[`'?S`(A[`(C[#A/D$8/`$*I[`*KS`+ MM[`+OS`,Q_`*G[`)R[`-WS`.VS`-Y[`,A\$.\S`0Q_`/!S$.#[$+T[`1$_$- M)W$*,[$2![$1.S$,2W$.^P,/^_`+G_`/#S$5/_$1$W$7*W$8>S$9JS#P>@(: MI_&)IK$:LW'/L;$:G^@:H_$PW%1Z;$>R_$>]S$>US%1M7$>PW$= M\_$>$]4AN_$<+_(@TW$C0S(?1S(B5_(?NW$>"_(D]_$C6S(C__$:^W$H8S(A M)_(B7W(A5_(@4W(@)S(JE[(G;[(KQS(@P[(S.(\S.9>S.9\S.J>S.J\S.[>S.[\S/,>S/,\S/=>S/=\S/N>S/N\S/_>S M/__S.-\`)A0#SN[N-1"HC2:T0B^TVT0`//2"[QXT0T\T15T1W]T8F`T1/T2R,H-Z@T22,T*WR!3=_T%]0T M3N\T3_>T3^_T`-QT4`?U3Q>U4=LT4=NT3G]!4M_T4A]U33]U3ONT3C?U43/U M56>U4ANU56NU5W\U6&-U5XG=F;3-FB/]F.3-FE_-FLW-F>_MFH'=W#K=FVW]FKS-FT+MW*7MFDW=W,3 MMV_WMF=/=V?OMFGG]G'_]FW#MG5'-W(K-W"'=G?_=G9?MW1']VT+MVP;MV-W M]VR[]F7;MGI/-W"K-G2O-GD_]W*?-V0+`C*LQ&$;-$+?@2#PMX$?.((GN((O M.(,W>&<7N(-'N(1/.(57N(5?.(;^9[B&;SB'=[B'6[@@H,%*.+1&YVYB`X-[ M?[B*K_B*IWB%NSB+Q[B,SSB-U[B-WSB.'[B(JT2`;S1"%\%PQW:*[S:,5W=O M6[=[WW=KDW=\\_=X@W9^.[=QH_9YVW:13SE]2WF6J_>55[E]N_9Q8_EZ:[F7 M&_AXA[F1ISF8I[=\4SF:PS=U*_F12W>7'WAR)_B=8[9XS_F$CSF6.S>1GW86 M`/A#K_1*-(-OM[>B+SJC-[JC/SJD1[JD3[IX4[JE7SJF9[JF;_JC)SJG?SJH MA[JHCSJIE[JIGSJJI[JJ.[JGK_H"#+JF872)X^Z)-\.JWSJNY[JN[SJO][JO M_SJP![O^L`\[L4/ZJX]XH<_T2J!!L3>[LS\[M$>[M,^!M(!N(\[N9>[N9\[NJ?[N:,!NZ.!NA>!N[\[NL>[O->[N;>[O>>[ MOI,[O:O['.P[O`.\P*][OP_\N_^[P2>\PB_\O!<\PS_\P+M[NSO\P0,\NT,\ MQF=\QM\!MR=$CYLXN-^!Q%]\,XA[,TP\O(\\R5\\RXL[&IQ\RZ=\R;]\NPN" MS=_\R1=!SC/[S0N"R/]\S_M\RH\[&B"!SU^\R^,[S<<[TK/\Q/-\T-N\R+<[ M@8=XRC\]N\,\RF.]UA,]U=_\U&-]TV<]U@\]U!_]SI.]Q)O^O=;#_-!K_$70=4'_1W`_,RC@$'?.'C_=/K?.>_?-+GO.!?OF#_N3W MO&,[/>'#_LCKO.AOOL1/OMW3^\0WP]\OO=,_OLJK/M.W.^_+/LVWOL1S?KPK M?]:G/$;A7+L=,:C&["CJ59)`LPMVXQP>LECFY=NW?QYM6[EV_?OM

Z\V*#J1!';[(%F"184@.:.[,9J9AO34C!OIF8H M;`^]P]8P[1_Z/#RO0S3P$`R8N.;RR\4788P1+\!45.U`F[*XPXW6;A$$"20F M"":75]"Y(\S14LXNX=Q2D`'#02*UCN*$*-!.NJDM%P!M M#/1.9)#Y*4<;Q/1%$!^7K"T%.^$D25%%!<43#2X;]=)3DPK2I!9!"CI$OCO^ MQ*_+WVZYM$M66\M%B`D$4?4V(YLI00YK%#$R4U?QY')40(_^_?3.#5TQ;0U< M#47%51SUU`1#3)'A5-!I2P(568JR2$A*5#"]D:8I5(R+$1G9;=?=NF@4C+!L MC64T6T:SH/?+>NO%UUAE\T7C7GR5Y2&37,I9)J%.T.!!GURL$:*Q7!3(L1,> M]JP%"62.$3.7-;3TE[$L2F@HVV;41,C?;#]%YHX??1L8WZEJ500-)`S-)%R4 M>'B3L!^-)"S'8QBQQZ!_?U3VTY_5Y!()*)A#`N6E$>+P4YB%_A1EJ;GL!(EP MJ-.2RYF M]]V9ZY/;OIDXPM1^D^][ZY[X$.?^D%@N%W2`7MK8K7W^;9]<;!"[T9.%>&7* MA.YX+!=-M$1""(F-A3E3IAMRF_;-U2Z,0X*3SC?P-_W>&B%0]86\[H,/9;6; M6TZSTW!E&V=<\+P7]_KS7&0=FW!&^6;L<.H1L]=XSGVO&OC%_=U:B-;()1[? M]^TM_TM[-9?9=_GI93E%P5A\U____Q(8>1F+@`4TX`$1F$`"6L\T,_#-YJZ4 MBV#LR31+0(MO+F*8CID&'<\PX#*$0`UJ<*D9-M#$&K(@A`,B(`OH", M<"`<;O#^#`!"%780@Z\9W/'@`(6EN%!KX$M%U#P$S*:X08L MH%"&S3@&!UHBA&6`$(P@1(,>_4C`9IP)&F+;W#+0D9"$I$`3-GC@%U]GQ#6, MT88EF(05N:3'U\41"I@D80D%4H*8\7"399E$S[(`1CUZD8\%?,8:I%0+'U;. M-#;H!`?6H"\.V4`@"B.AKL;(@QFN[W1>LU8N].'%$HCP&%FX!#(8N0P>'.-D M65A#.-`1+A):$PM6],TRF/"Z9:2FE>$R(P=0F.U$#(,C21@A0JT%C( M`U#/0F0:,B+@&"_L&21?QP0T'`.<0LC6,_IYRH0@X7J7,F+^,Q2!!70,3YU" M<-,DT[A-#F#!HL*<(2@Y(,I\D9()"5F#0HWUC!)@,TRNB2(]81K3!**+?W(! MX$UQ2I=XO04/,O7I3XW5G]N\-`O/L%P:."8ET]C#F\:BAL?60%1GAH-]'+*" M*PYA#WWLXQET(R$ZEF`%YC'"DP2\!#%!)XAFQ"<77!6"(4YW"2:D(0V'T,<2 MW+0,H5K#%53@T"08084TZ",%S<###1FQC?A0X1+/@-IM+D0Q(5R"![=XA36" M$5E]4.,2>$``!Q);BW+4HAD\>`863!,*#_(`%?HX1!+2H#`>(``*C%!`,*SQ M"GVX@@/,>X4K#$J-?[ABA,:ZQ#+^6,!!&1HPCJ[XAQ42:ZQ@L(`%MY@.PCSS ML%Q@@84V<`4+,E$+4CSL%ERZ!#7L@9OD[@.#J&"!-?81P23TC*K68($F?*,) M%D"ACNA`'B-7<0;3^8L MP3S^CI4U/+H7"4@PJN<`41U0$Q:_`X M"U30QS+"A04JNT(!;K@$`JYG"PP.]Q"R2,)DLP`%^_ZC%O&!KV^HD89;!$,! MP)7QYM#^J]ZV^D8/#X*O?`E(B5QLPPKVD(-KE@M422.0IF_I7TXQ_:Z=NJ6G MD_;T`:GQ:"<]PZ.FM8)I(O8,-MH&%8Y\,E0-6T`>B&D)SV@2%)!LVK!PL<\RW(V8(RNTB#^A&-J`@$(8"L4 M$-",-?Q#R00L>#`N<0RCBH@'#SZ4887MDNL:@TN6RZ9'N91Q)I@N%\UVP=9- MLP]!&$KL#T;'!*BA#T4\@QH'6\8E6I/DMH-N`K59`F.NNP\$7,(&2^#0N#/Q MC&[+88274$`N^CJ=)&0A%TN8%!7LX60%&BR+PF2R::C0#1RZ0D#([&FS<@%F M)`0C2Y?`H2RZ88M-N'`,ZS9__T4BFE$AJ("^I;:+[4@A_]H/S4R# M!2QN_&9+\82IVR[G&73O21RF,GJ.%"#&XEP@/LJ!&CR+>>2`!WB@-=)`$%S/ MQHS/%@3A#!'`!71O!K(``6H!Z+1PM@;$"DC-$$W##U+/-!B1"9++$`3!ZEQ@ MZ;JN&;S^#_R^KE;,C`>^+KG:JAN$L!3':@8EHQM.S14&D'F>),O`00]2*;DF MX1E$SA6?(1BX*PL>@PH$@0ED01>80.3L881TP07,#P\HKXW6#QJU MZQ:>0=A.90>AH!MTA1(08`KLP>*R`(E.1>2VT?A@$&R@T(L.1N_2+A?^81J9 M<$3@RA4FP12-P1G/3P_P4!"(`4-L+,NPYP]-0QU([6#4H;1FK?$NH1.?\2$A M@`/0/(3 M:PD)-#$)IJ`"'Q$!^F,F-:XU0M`8LJTA.1#Q*"&RM@$/Q&0%IX`)J`X!3E$3 M<-$T?M`%^@T+UC(7?.`9M#(7;N$&^RT4D$#YEL"86"`?1_(D"5$0FT?WO/$=#6$*WG`(,^Y*RH$)HM+X.@@* MML$&ED%U4L`%$*`/D:``K4`$(TB>6,PE/Y(`)7']'!%[M$@2?2,4ML$8C$'8 M+J<0,;$Q/?+KN,X-7$`4*5$&D>`4]P&+EDH47>!*7!$:;8`SA$[D\L5*.%,0O`DD?+^);T(B9!I$H#2#B=3NT*A/K7+"H218BB! M/).,"<2$$:8`'<(S"Y+!-&1!O#!/$-#13-K0!=[Q'\[K80RA.3N30'5!/[CD M(T71-%$3KK"'-07R4@HP&#H/2[Y10!FR)%WT16$4#RC2TK`/(VU4+[A/#V!T M1WGT(_7@$L#R)J?@%4V#%`3/&)0R&_1`%[0+';(!;@`2.=GO"V@-"&U`NZP! M'9H3).DRP9!(`:'Q(_&@*R\'XY*!NK:K&Z[+#[(!B?1!#ZXR%T@!`>K2'CIK M!_\!'6S!#=S`+"O(!?0`X_0@&TY1%^*R+?M-+45N&YXA0>72!7#0-%!P0[<+ M0G/A+YO^Q15,0DRS@\PSPQ- M(S,?9@8R#@Z9X%:'<`JR`1U=(!MXX#\CRQ9^M0^?H0!K04DOX;'V@`,8Q1$FSP7)2H#>G50^>00^H8!O.!!WP(!LL4$N1LR/'E!29\T<+$'30TC2D MX!):10&'U`6\CPF]!.@M](`'$B$E[;-JAS0EHY8'LA9:57)(HW8*$F$*]"!LKS9K M&59L?T'W:N]K`]433*-G0R$V>R!J$2`9Q,06LH%%.Q50IU9K\0!*5>&\?H$) M(LL5Q=9K?^'4B`ZN-NMP[;!A:P4=?D%H"U)-.2@;'B,3`E7([#(;ZE1?P4X6 MLL$9?Y5%R^$+Q%9'LZ$8)+51V=(%?B$'77?1/)='@+#?/)!2X7(/_%)&F\40 M\.`7W$`.&.$6K&$;OD!&X;0`76$/`-4.J58/?D%UDE5'QY9A)W<)CP_C8-4` M9347!O8+:E570W,*?@$T1?,22#/^&VQ!2O`@S7[A$@2R9Y%525,2B:PA#9!T M;*=6;%T`-B^A!ZKU;;'5"CK+%EY,?CE(8L?U%W14)1N6Z_S@%ZBA5T4DXQYK M'\[K$E)`/I-,1&W!@77T%^HQ4'>0L0(5B9M%%CK2 M>EGUNJR!"2XA&4)!#L<6;!E6#Y`G%`)X61D.#QS5$)Y!AF$W4!TU$^P!;`4'1[M?=\V?GG6 M9[T7@,NR2J.6;=F8:J7V>L66:OM6B+7V:JMVC=F8C5.7!WK@^BRR:9LV1P\Y M$0[Y>MG^F)(EF7^'>)(GF6$O&9,SF8WKE7<[-1MZH`^ MX!D,@0505V]#V)/O&!ZS`0H\,':MP1I0]WI_X13]X!J1Z7HQF7*[CE?7E4VO M"QT08$,S`77KLABRX0Q`$`$"542E(!L\EYI%E!B^<7"S(0>S@5.W(97)V5'/ M^1?8\!92>4-W.!MT%P$*,!FFH`=@[A)BEPJ,P198^9Z'^!>(@]DTP)D_LV$*>!<5-)$4FOKK7.!S7*$'IH!3H6"EY6^I5CI0B1,+ MN-D80D&A:SB@T4$7$$"5I40XI20)>F"3]:`'D&>K$R$;V*J6#R\70H&;DP$* M%/H7(JL8OEH/0`\*_!KHC`_HH`8*IR",B<&B'^8?7GK97*`6!K4'V'!@A_B6 M3\7J4IEG4]H`LR&,24%?>Z`UI)J2+1FF+[F3.?FU^5>2(YFV-_F2%[FFUL61 M'9G[XMJU*]FU@QJFA[BXC3NH63N3&5:SD_MSNW[!#_:3 M5]=4H9'(%KI!"L1X;$V@-9+`#8B!NH?$"K#@'Y)!6LL!"HRA%HJA"'/!4,_@ M=6.W==6YJ1.T'`3X2JR`,R5!!O7U0G1:]?2!">K;27K`!`KA#*1W;.L5M:#2 MMBFY7MM;C$V@I,OR%FY!DDU`2I*A&Q1M&\RW>\/WT9*@I%?V%4Q@HZ^$!<0Z M$9HE-@WE'QS#705XCNMW;A/A"Z1D@N,ZJ.NU>WT@K9^AIAVK()^!=>74#<+: ME`52$HHAA+F\7N<;L(UA914@A+^`4)7:"?_AE841"US@HB61"23!"LPZ%U:A M&_Y1%8+^6\H[5:'K];&L@1@2W)X3X6!<`6SK=4<`^QF&*QO\.[56^I+!5JGV M87"91Q^P(+#[S1JD0!>6P!CN.<61$I0O'&%FO=8MN(T6(1&N9`:A1A:^H,NE M1!_\H&[?MDVWH0=\5G+GMEX-117<0$1U(?UBV\>Z[I?=Y+^=[K/=_GVKNGO=_YO=[Y/6PE(0E< MX1;VP!720`HDN=(/\V M@12:_-[C.AD>1A;0`675(1'F%A/F]@PH01\LWA7LP7E>DR$1^``+0,\5^#R802\)=.&Q?4`?]`%YK:#BDR`9OF`; M+!YYU8'FMSYL0T$6#&$;7$'A$\$$ML'J?:#)3>`6BE<62,$8-AIEN]`:9.'# M[ST1P($85MK>ZYT/F*`67$$?TNOA7]WEI\`/_D$6;B$3?M[E9SX3_J$0B@$< M,D$6]C0-*EX*](`/KD0.*($2_L$::N&>>P`TI<#%7*,'F&`)K'X/OL#+[JH0 M7/X+%D$=P($/3-[?I\`"4>$+"D$5K)X2OF`/K!X5F.`+X$H.L,`6L#*NOX!Z M77[:]2`9:J'B]2$-2,'[BZ$'?+_^RV_!ZDFA!]0A#9*`"OZ!$GR?#Y)!==3S M"[`Z&5!AZ&G?Y>?Z%]0A$ZZ_E`'BERYPN7+)0O*5)I_NK[\ZJ&GQR]B^@JF\?,RY)0T>T"& M[,&'IDTWOYB0.KGG2R(FV_3=?^&F.A$?/[8*)?Q)V\]UV5_\)!NN6F;]9#)[?#%?'GK._>>< M"0+^Q]M+MKD4$H$$[O9+;=WQED@A:A6$82ZV9)-0(JJ<49UKO24"W&WX-!Z1Y0TW'#'J+))? M:WPD,UTB1')CI`D]NC12E$JIF-%W,Q+HFW\]8.*@C+\4`D&7/)*8C`F+0*34 M>NV]]Q-O=EE'G'TG@L>$2%O:1MV6/93CAW<_F0#>B[[QUIC^1G[@-EZ=3%BY MFJ.0^F<>>A`"EQ&%)M3TSR^KK.*2:BZ=`0&+3?KIXVQ"2IFI@05"A)V/M,D4 M8FRZ[BHB:L!F>:KJ5]^*6:#R?VTK'\S2BLML_DI^^5P"5E+ M9G+#C6F6QW"(:'[)1]\Y%OP;ODB.:.*AJ@C!3'$C'!++L7XL4>R\F,9-[,#>40+#(*2"JK*QZR>F< M7L3UHMNMT46WG"V<,N<[H])(4\S^;XKMKKSOL@R+:2I0-N,KL[3=.OSE(I1L M4[*TXOK'M+Q'`]QNO=P"G"Z/,7O;-2;<5)6$>@_G1R;68%?<-+QY\RS2Q%I# M_6RU)E.KK+/33BZWJ;X":VSGGG^^&;*HG4QZZ::?CGKJJJ_.>NNNOPY[[*,,B1G!S\##?")\(NA*F1HE4K*(2,>&PAPV`B/CB M8@H%1K?A#8!A5BRC&8E'G32>\7U,#!84WU@L*0)CC72LH_L&``PO)F>+0<3C M%O4H.R+BT8Z$+.27_,A'0TH/C^0#(1P?*2PY\O&/E*SD(?=(R2\(\H^:S.0F M)UE)4`JRDXFTY"=#N4E2:E*5IL2D)T&Y1U).TI6>=&4G90E+6:[2E*A,)2Y[ MJ4I=EC*8N^1B+TMYS&2>ZSUY;6L9#5A%AUVFB&R]JHGS2E(<_K4O(+TMK=EI$OOBM/,DA6+ MJBWK=6!KF8?A%J>3821G4P-1BF+QM;+-+6H8>=O:^A:OM`20=NG4G2VS,UB>Z\;4=W>]KBO[>]XRFM>U'AWN_$E M*8#QVUKC9K&X($VO?V'+7]62%:0$)N]J!?S;U#ALPKCM;7#-Z\?;DBFZHUMP M@2-P2.,$ISK!VT79@#^,E,;C)$,9&,6T"@N,EJA22NC(+DH.`6@SA-=I7L9,JLXLIDMD68 MF?QEG(*Y,JK%A"3V<(/[.MD65TZ`)+H\.BM?60J#X`9WX7%E"\BYK&LVX37( MW(I!]W@`W$C`"(A1@1&066.23G2*S^QD*G/W"ZTHQI4'`5E,T!G2Q)BTQB1A M"SU+(AF:QK2:+4P)=2@ZS)>QM''/D``[KZ*X.;*S)':]Y$)S%Q,5H`2:78UC M'9^6QTS&A!G4<@\(#((8AB"%*I"-[6Q;)@FYL(8=!HT)`A2$``]+@UG\K&V! M2@)#9N`&NM.=;DR@P,_R+L@M^)!M.U0`0_I`#3?XX`,,^>#^W3C%!`0*(HM6 M(WL`2R@(/#Y!<"=SVBSW((:Y,2Y>W;*I!WM MY+O'6LY+\$\)V_ET_#O;(A[+8OX M!!\,`8\(#![>_[8`*0!OX<*WPAK^*\=]RD>PB$6T`D.M"/X(EI"-=>=""A"? M?9-G3W"#6X,1*"BNX'/_B1&LA>R%;T-![H%T;GS"%N.>.DZ=3_1KZ.,54S:[ MWBEC]:L?-.MH_X3+1U``._BY\("%%@`*I@+IX![OS("[@8,J[""('4#%<`'VF=S#Y.(R<6#.!A;'DB! M@HB#O_)_J$$;<.A_5%:#L_8%KN!WK89%!3!WE#!TLV@!WX=O@"B!J[@Y#R-: M9S@XE/%CU]"`)"B!2.B'#P.(M-9$\C=_I5=P<]=O`C4`\&`'EM$&%2`%J@@, MK;`**%!]5E8,-_!S%B`)U4<9XH@"9_`)Z,B"%R@)Q;`YME`!$$`PP'`#X8@" MK2!W")8!`14`#]S0D>1S#2N("7;`CZT0`1"`:J?!#2]I<#/) M9L"0`/>("2!U#?S8C\`@CFW@9Q%P`_`P`@D`A^C1"H:0"ZX@CMS0!LEP#:T` MCAQ9>0;9"I:Q"B;Y*U4'#^/@?9FW/O^@?CV'A*=A`5ZY/C>0A1%X#:5V`VT6 MER/`@M_(C]S@DN*XE7Q0AA;@-Y_0"HYVDNMSE?,V@E5]9#,2@CIC0!@2A"@@)?R@0DE]I&0+Y0@5Q M"K*'&MG(AABBCOH8`9HXA5*0`"/^N9DCT(WK@Y6'MI5@V`8,B6=X*8[`<`U) M^96MT`8(N94QN)9W*9F24`'].)U)B"%[L'D(6)*K,):V6'@&5P'BJ8O0R9&8&F.F9\LBF\7>@_64`X0,'XU(0=SR0T^0`I" M<0H/>1E11XLUH0_<,'QI0*08<@\1<'?60`GE(`O5APE[X`K$H`KE4`&RR68K M61`L^`7^//>8XW`A&0H,^Y8+2S`.O)<+\.`WF+`*KI`$%<`(AC"7UQ"%UR:4 MUK`'OR()>4H*&,>"K<"A+``.=#AZ>X`)A^H_US``-R`+24!O/E`.>)<&'20`.%2`+LH`L;ID+6EAX%?`*XZ`/X-!E`Z4. M++`'YD8`=84_H)?ZDS%6`(Q/`/!G$-D]&4!3$('`IL`L4'C@F9;`8/ M26`&`=>CZ],Q!K1ZP)<``*^(<"KJ`**D<)\G9QUN`*D!J'UK"C M64J3*K<'!*`*O.>(:5=OL:AVV6=ODNH*B390(R"H)D&GP`#^#[R7!&/9A*U` M"MN@#KQGJ@\IJ;=P"MRFKS<@J6S:"AS1/SXP1XJW#6;@"G*0=5&:"XP09P1: M%O=`":*KF:QKF*J!'0/WN0#0-` M$"S(!VZ:!L"@?)G0!BB@%J2P/BOZ"B.`"5$(J37'@I@00#1WC`SHS=TE` M`$Y)#$&3"P3P#(?:I*^7"W+@C_UC!MD0D8";I!))I4[)"$*9!,"P"!&9"4_X MF-F@?6GP>#F;#06@"N06?62:"X7^.WRYP`()(*NRL'<%T;M8F`MI`*TKB@*> MFPN&``Q\0')K,8$T^@F#8!`Z0Q"&X#;8P'?BZ:O@`(%L`V#``Q5X3'KPW'%D`TJF`DW4*EOZ6;%F[K^ M,U#KE@;9(`69MPBC!P^+0+VY,*414(;P4``DIPH%<`-JX8AV4`"K1PH$H!;6 MZ6_7.H=46)M-6@#FY@H/R0<1:0@$P&T),)8)\`S,HP]P2+PH$`$U0:8 M0!#ZL`?^V`'[(9[D9H+W\L',I>S=E<6A&S(4XH)$>RXS6K'*D>Y`?>]VE<,SP`,KO#` M*G<#V6`+.@"NI$9?M&9XM3=E!` MWBFPC#B%@LRWSE80%K`(M;@(LJJ%W[BBAL`'$7`C-]#`#E<`8PD!V<`\Y>"/ MJEL`AV:GF>>\Q5MXW*:YF,!MN6!PXT:E$6D&/\=M_78-YTN\'L,'Q#L"RCO% M$;D'`S"8*&P9N%NXX;L6!1"X!CRPI%``P,!QX$#$>`<.-R#^E`YW&J(ZOPFP M!U2JBMC?:F,Y*:`(M("D1T#>(+#ZZ;"_);7!\$JJUP(>I@>?=9 M0!F*"0ML#0F)RW07SV^9R9.;#6/Y<`0!?M>P0(/PP=`O,T".'<(LH"7S@\1P&F0*Q2EHF^LC?IKX$8RX#>K8<"/"/7K%0(L%P72M MD,P:FLP$TZSE(-RK]\"K]P][$(46;,_'.+=D*939B`E.&-Q M6!"NX`,)\&,QW='==@8PO;QU6!-IP`<1G.`<2@!G`+1GD)"?P-[#_'T1<*S! M_`DWX`/^#&X&X@N9?`#5,DUV)OR8^LP*!#`..KFB^I"-$<#<\6J*J]<&!<#< M-V=N#.0#O,?.XOO+S,T3XRP)UVP%8N<[(

I=3Z'\"VM4DRC.J-TI_PK61T!`[#.,.280+-Z M1/VYUPUZ'S3+T3U"T^UOGU!S:4#512S995'3HM=SX;UT\0PXYIWDW&T69U#4 MB#^WP9D+`19>&1"< M!%BQXAEM$`UVVO?VS0Y'"EOY"6YJ!AEY[QX$#[?P>' MYMFZ\JLP\!S'"''.W)CH;I6WHO.,=[(PEV[O0FT0CE\PTMLWP$LG\>)IMRSZ M#(6/^SMZ,*]Y*+=ES]^OEYVYEGPO$8`OVO@KF M^+S^S$[>RPC.8^*M0VM[Y/R=!G!MW:+D+)&Q]*"B%@$EL:V.=Q?CV#O)?K[T!]-X`E*J90W=";U\!9VV:-U+4OF-(H MO,;G)J8OUUB<+%D[E]&O@Q,H')$R9ZY3$12;QBD2!>G36ZD7@)IK&WF%:0H$ M+ND1J:PO'AT.8I0+V/1<"2974"BI9.%<[EE$'8426"2A7"#P:K+3'EHI%W6, M$XN55E1I`P((VN!/(9(^(3`7>$J"+)=Q%JG,`A$58@B3$>^9ZK/**O`*K!LB M:,.0B#S#)`&D?4$HB@5OA(+9=!2CICM]Y^`\\T*$O^>Z@7<:JT\DHL ML]1R2RZ[]-++:YZ,,DIN(O!!(0(624PQ\BKXY(QRBRF@`)L"?%>`X?EHS(( MLF%5,LH:6\0G.3S;3)6I^&@M03'^3=,V--=6TU82A5999#A]/*+-MG(QD>26 M,VQII8`O[%A8(5+XX&,`8C!)9ME%OFAELU=LJ16>0;C9;!L^,#DCJG*EO"Z7 M[^03ST?TGCLV%RD*6`0%_[AA2I8!/**PK3V>V1`>BZ`%L3G1%MG00*Z2^(*/ MK>P@X#-@-I)WN]/XJ$#&DB(`YEYYORB/`)UM07,1QW-AG*^TFAZ1<<4P8;1( M/B1IA9A5UFL-4$KNM@,M`8-$%;8BCQQM1Q]B+G*U,6N/`!XJO]1]=]Y[SS+, MVH/_(BX?!TLI@2223(1`B9[.996[\Y1SD1%+'#J7-)!3&OO!<&2AE44VMJ#I MC9)Z>8_^NULL8#M,SG1M%0AN*7(X:X!IQ2H(W-_C,U;-:'JEYR(0DQK$- M$GYD$9+X1P^U!8Z<.61[G(0H#5!JB@&*9&(<`27J3090#>,&,TV1; M8PTIE,06;3DC)N[!6$-4[0N%D$,Q).21+^S!DM@Q[6F!,0A5N&($!HFE-Z^1 MV<9NPQ8.:84/].&#@'[J"T@M*@2"4X%,*&2R.I)">#D3HJNJDA22:&Q0SZ"* MJ'X!'L4*ZIGD``\^7`.^CC7N1TBX6W@D8:=I\%Q\<-(66;3!;>KP3%RA^*G/ MD$PD"N'^[U,,L9QR%-`AN\)>F#`!6+]LBBC6\`TQ5$H*6XB)A(MM[#A6`=Q6 M;&.GCB0`;E$0'*2F9Q7(24!2T4O2N)2C`BAHRS^*Y#8?4.(4+#B%'?"B4W#X MP,GOW0P+:E&2/20A"5DFQF^OV@JM^@!ZIUF%5J-+E[X9:AOJ*$<:QDJ:CA6K5%7(+1*I#L+>0A7C0(X/TF"(+&\RJUNEJV4E<89_['0< MG9LPA=%7FI'Z%TI3ZFBG/0VFCETUI(D-RQ<&\`56A+1L#IF*+0;1AL]@U:M] M&H0?VH/5[=B!&[[:M:^`89!6?,0.OAYVKKEQZCZAH$A?P"K^KP68ZJLF>W;` M*,1'/H4)/\R.&WZXR:[EXVV/Z%K8BO%J(NV`@C-LL$''W7%\3%WJ5A`[V,$^ MS;"%36WYV-LCLCD."B"P[*^>^@M=_>I-SO`=Y*`[$0:VPT2G4NUZF_JJ9[BJ MJ4DH;76K.M6M4`S'#>QN.T#\U_2^VS4@D&[PT)O:\9F*PDD3EI:'R3C(3L8U M*$G2-1D[$==(QIV^H.Q$#"`QX7ZVP$G*;*QR7#X>-W`KOD/)FB\WB2WN M7Y_FC5B?"JI-S6R2EKHT#L'=IXU__"I]]"._5[7%D?[[RE,]$7R0NJB9+4"R M6]_YE1?X\Y_?_^^*,?'/`` M/^TP3?_W?X^<^?.^^J,_KQJ]8Q,X5<,$\#L.D"`-_6,_^W.^\Q,_`6H/!!Q` MY#BUHT/`\0,^5EN-"20__`.N4ZM`!=S`]>L\\!L_!B0I]KM`[MN^[LO`%20] M$K+`&*S^/)PP!'6PHQ&0`DJPAB[+'/-[/PBTO)(@-^`K"0,3.@X4P/D[OQK\ MO?++OPCDOI/2,P5$IOYH&M)`/_$K&R8\MB54M_H#/_'+0.@;J9(X-6!*O^,( MJ3>D/_0[#L\PNOTS.@-\PBMTOATT`Q\$0FMH(?^S.`TL#8Q"/D7L-.5K/RA\ MQ##L0.]K/D@DP"FLQ$F41.:#PI(J1#[LQ`&$P1Q$0TT,0$SD1%0O$3FZ\9;L`9E9$9GA$9M%#\I*;Y%[$??:<2*"T:!'$B"+$B# M/$B$3$B%7$B&;$B'?$B(C$BLVH8T.*QMV`8?L(6%DTB.?$AN0)!;^+R.'$F2 M%$ANV`99L$B,U,A\?+Y]S"A_C$E0*XV2K$F;O$F),C!X`9;",I" M2(2-[$FC+`0_2(9DR#:C;,J&_,F@E!FB%,A]9`29O,HN`4BGW$JN[$JO_$JP M5$B=:9JPQ,D[(4I**DNUA,3I(\N!?$FLC,O?Z9BUK$N[O$N\S$N]W$N^[$ND M$POB@TFYC$NM_((>\+[#3$S#Q,3^PUQ,Q43,1U3,QF0VR7R^R9S,Q:1,`<3, MQ\S,S40ZS@1-R_1,*,3,T81,TSS%U-1,T61-A`Q-2.Q,QRQ-U]3,RJS-ST3- MUJQ,V*1-W9S-VKQ-VR1-V`S-U6S-R`1.W/1-QE1.SSQ.R`Q.TAS.Q[S,T3S. MVX3.U(1.Y.Q.Z^Q-\$Q.Y31.YIQ.T3Q,N!S,P=3*'FA/]WQ/^(Q/^9Q/^GQ/ MQ)1/RZQ/]Z1,_>S/_G[!27]A40`TAR= M@B5ETA[5@T3PT1Y(!"7%T2(5TB'=42^]TBC]A2EH4BQ5TBG@TB%U4A]%4R\E MTBZE4C7%42A=TBG8TAZ84R6MTBE%4QW%TR;5@SS=4RU-TQWU4R,MTT"]44-= M4T9M5#!-U"UEU#(=U$9]T_;\!1=8!$R54AX55/<<5$%=TT>54C;]4C[=T3T% MTB/E443%5!<04RZMT41MTQR-4DJU4E%UTE!5U4HMTAZ(TC_-52+]U4S=U&`= MU3^U4T\5TB+E`U+-T51=55IEU"D]TC#1=)"@`)=L%=)L`432`03X``IT`4_N%)T95=UI=*-/=AV M-==SO5.$1=(>F%=^E00WJ--VG8)D2%DL\`..!5@D18>'E82)G0(LN`43R-=V M14MV#5D]F`(WT(6'_0*#300F*`9ZU85D^(4KU0-;N-A0F%AX#=F%!5F$?=E^ M-8:"=5=W[0$JL`*?I=FK]=@[G0);H(1MN`5[T`4F@%J135BAI=F/M5&7?5BX MS=JSQ=J/[5AS!=M$2(9Z?5AB(`;^*4B&7ZU1D.W6F^!'<+W*:TB'TO!;Z`5:SOU; MXA5>>!7>)OT">Q");7`!A;V77`B%Z[5=&\V&6E`(6_@%CZU;O[5>=#6&^C"/ M'ZU2)LB$6PCOU77*L6#9*"&,2U9L14)0U#?&_V%@5`(8IA9]JU2 M:AB.7$@&%["@6\@&CK7<@.V!!S$&/+A:/]B,7&"$I\W1WC"&X@59C\U: M*/!>WTW^UQ[(A@])WZ#EW/']!6/XAUQ(@DEP@WW@E7U`X/Q5V/U-6L`E5Q[. M!710WXY%RW4]8K,MXHW%`I&@A'W`$5?0!?6=82O.!2R`X?4M5Y==#GW0W*2M MWBIUV:@=8[!=8>,UV"G8!GU`A_/-A)YU8Z#]!298`NR!@J*UAG*P`@2>8X6` M`B.XIEU7Q5FY!X`3$Y;7N;M&#W@`1Z8 M`E(^Y5,>951>Y5*>`E,VY59>Y5>6Y5+6@VR0@G\H%FOP8!MU`2@PA,THAQ[X M8%+VT6+^!5NP!E=@`F+F`1R-93F]T5(^Y2G(AB7>!PQVYF?^J(44P.!HME%2 M]ME15E1G!F=73F5RU@,\$(@O0&53U@,$@()_J*HF[F5T^(?X-0;O+69RAF4; MI89L\`EKL(%?&))0V.=RQEMH3N=L.!-K6`8\0&4]>(9]D`OL&5I;1@(91 M%N=IKF5I7FB`KNA(;(48=] M=FEP7N5G_NB?MN7S96+U36B%#N=*E6:?E658)F478()@88)G>`:WN84/!F`Y M*`Q+F8\,(89,&>C#F>C5F6VKF47"(54/9'@&QETFYMUWYMV(YM MV6YMH=:$-[*";':!6]`%A;`&9CYG%T"`;'"!UL8#!&`"/7"!6#9N!(AHTG8! MZ([HFH;M7Y@!ATE;G;+@$!"`>?%H!HVC9LZU8(>\CK2["%/<@&T#;P]H[P`!_M4C;O M9[`"A9C^A+RNY@#'@]5& M`&J@!@@G<`2X!.9N4FJ@`/;0!7WW-F;CR0<=CF@4N("[%^ M!C^V`6)^;2+WX_#-YAE&D(-V`1;/!0X0;BHG;2(7[E<^T^!6\/+.`@8W901@ M<3=XABW_;C'%@^^>;55?=59W93V(T=3N1X!L=5JO=?5&@%JP!;=A!`%V`72X M!0NR!FK(`E>^!!O0!"FPA2D@=CQ@`C<`,;L`$F<`$.P`(WJ&DWP`(H M*.XL2(%]2`%BSP)JX&%]2$KY1H!]T`0H4`@6,(8LR`)C((4O5P@;:&\7Z(%0 MV(>*/^=+8`)-V(#9U][-QAV8TB&Q`?WU_9R MD:CX^29I?9@":L!Z8_AV0*<&*-B'<*!Y5V:*-,@"*)""HR=RM15ZXO;TFH!W MI*<&+-!X*G_JN6<")F!M]78!5%`(3>"`-=V3W>#9/!@6T__ M57_UT[;*6%?MCB'R/I]_^J]_^[]__,__^>>!;88":A`)@,!R"0$5=&YRY;)& M+0N>*3Y(:7*5"]44/'BH_4.([A*/2[58U**4RPI'%Z$0;DN!$@$/BQ9=&$)H MA24>'@3^)S7+@@7A/TIR$`K4B=`0E9^YL%B1F(L*QRP\_KFJE6L)#Q[;$.9R M]:^E2Q[/=.V[9`VANF8(K(2CAM6&BXYN]-F[6JOMI5#E7&'9)@NAL4O$$-YB MZ>*6-2N997%,A6NHY>C-."!\M8Q'S%RU,N:2U7**1^]I1G+T:*T6%?0V1>9RX\*%#5=)-&5* ML["C5%3!$.J3!F,\D;8,(ZB,=]EE+BRS%ET'(>3&)5<==L1DT2:4A%RA1ZH(*0-:Z0@D=L^FQCST@NQ,:(.NKHDX1P"NJ! MA":Y>'8+-7B@8X,-R2C(0S/MY9+&CQVI%"$25B!$RBW%9<+A)5@&DXD^Z.!8 M2R::;&.-.L^$PQ,"NHR52R8*N/&8-6XXE:8Q652DH)]_`NIGGX'BH0C7:G1)[D$UNFGEW1G MQ6@,/4,%3DZ-Q0(4>"B0BP(RZC'^5CDI9*&4M!0NXVF+FDP@%P)XW.;*J'A\ M984@\#%"&BD\-(B0#9>4-A83ES27PC,V^"N($,WE8LPS_=[23#-243'!8]0@ MFXL-@MBH4!8(3#8PJ%YIA@0UAR'$A"*^/&/1>2D(DM$^H[TLR`RYZ/(,-^Y,+$!,MD$IRS/""Q#T(&\\`(4)?;BSXV="/$6+4@ MD,7-/1?^-],Q$J4!:A6M2,$-.A9/)TUH0"?#,M MYC(#Z`PU`V$N''2#Y4C/='.5/M0\L],_@DPB)VO,3B#(+51T$W79%EJ/3NIX M-$=9%DC48D7ZII;J+/[[>YK(IL!$8%&7&B`!"VA`267J?_KC'P,;B#4DJ",< M@JA2PS01#$$*!)Q2-B) M-80P/Z<%C3.B4]4DEK%'&UHO!2:3V@R0\(P6E8,:LO.4UA#"-5`A@(+H$,1C M9EDE*X3P,/M`@H'TL0P\2,T*$OO/M^B'$$4(`DOZ.(:KQ@+';KG"*_#YUR7` MLX8XWN(9G3!5,R!G@YQT$RN50QL6!-&FHPBB6V;T5+?2$!D$V"@3UR&2$`1! MM-_!#F#5DF3GEM(,J"#LH_7$EBM< MJO28)DO61.>'AAB"YQ!(V.;\J&`P-+#0'CDQHI/2V@QDW"833(.2&VB)$%3X MHEL:RUU62#5%'K+J'[=P`R^Q4H*A-T>):+86R2+D8_Y MX(!#]:1B'2U.E4R!/$75X%P8@J+1PPHR?WM%B4'H$/U*@R^*\\%^BDZ463@& M2D<[PNKRH#FZ10<5.CS4(X<*#3=%%#=RZM,G0QE3F@HJ&I!A961D`1EHJ+*5 ML_#5+(,YRU?V,I>O;.4MCQG+8T9#)[IA5"0T$BN.C;OH6E864*JJ]Q'%R=WNQY]6)J%.%BX-4I@LZ7< M(=MZ=<,V.O'E>&.9RU^E=2X.V\>-5A+`B!FP(!31F%]_N9W!)AXUB';%49?: M4[#3MD==88-=+Z/==_"Y/U7-.0C^X41(6$G"-J[9:#4CHX^6Q?B_`XZ03-S[ M:;.N\R&,G0M?+`/IQ[B#$/;R-"0H=RH^UDB'Y1N.8%PSVV06LYF_6N4M;UG, M_ZZRI\YL9C.K.O!*QBD\&!'EQT/^IU-&%)D!;_G+8S[SFM^\Y;,PMORR66HM MWW>=$;EOT[2\7U-UL\)C'&@BE0#NA4;"YOF-D&\,^*M(X$0)9GT,(=*^TFP' M?C-N(XY.",+3\4EO.";`6=HWPQ-9,?GE/>]JG]WA/'[F(>1ZCX;S7+L;:(CW M]\.S\V$7^]@;-;2GMGR'(:7!CO0<[56NW6S`>Y[;/G,_JQY^!PK-TO-56RX@ M$V?%VU7^()*[X9MJK8'TZ4KN?94@X%LWQ-T_W('M/=?];5DS=$)S:,?]]9'/ M:<+K$>#"Y4)W(80[D54<247'59S@X%HG#-]2P)FL*``JZ(,P!5Z9D2A0/G7-X=8(-A<>#8($2F(<'E"!@:M((D4J+EX0'CZ53D M:6)/`17E:6#F?6(EBB+^2>`DT-Q_#-'\0$@Y0)>B+0'??)?^(""?]2@"#]V, M6&65`G`6(N*`'&:>("3;VM49-`J" M.2T5%`4B$0*>.4&#+`)8XJ#!'`@!5GB2$C)+-:)!Y?Q')=V!_,6>"A%[DD>F$'V-6@*$V,)AS#,KBDWW$6&GB4;@&B965: M$8XC^M&>1&0@0B)&1>9"(L&.')[^1Q*$'!(41RU,0)6D@4N:D[]Y3AP^!A54 M8R>$`P]@)!%VBR MXJ8XV2:JY@%UXJ&,YFN*8KL<@O/=P3%LH>?%6B+99FNMP6/X@LEA%`'"F7593,4I?W;:.@R>)8E%+,)`0-8EXWK$TN.`(Z MML@,K)WG/88BA"7#4:4KK($;4$%=@4T:_&%SK`%$*A]AM5(^)ALJ-$,W)$%F#B:A(K`;4F,(P?&A2!LEK>L@)>$3AK MLRKKLD)KM6X9M4(KLU+KM78"!WC"$BB"^QV"C9;`+:3!N62"KDXK&JS!/\Q` M"HPI-&`#[2U#+:2!)Z"(EPI"$"S!6.@#S+AD"3P6--R"*VP#-*#!(9SK$IB; MQ.;6+7C<,=Q,&BC"&E@#"\2`()3^P#^<*S3<@;,N:PK,0'Z&H[/VCIC6YC8D MBS4LFW2:;4)THW06ARL$0YC8`\?6PA+\@R_\@UP"7FW:P[ER`AI``;^Z00D\ M;!J$PZ1AZYBZP2W(JB]X0A)`0Q&(K!#T;1K$0"=PPKG:0S]&@E+8@R(L@+MQ M@+TNP0S4HA'BP,9*IR_P!MR.*=-EA^&&[OA=9L*.GQ#,P!*P0.QIZS($P[FF M@8K.@"\\:>@*HB^0H/2[BU(C36( MU?B5@$2X0N\5VQ+0HSB(32=LPPS@U3_8;K8*XMIF10SX6S`D8[+^8@GX0N,^ M+-'*H03^+NH2;`.^@IY+AH->H8(03(`BH((G;,,V*.^^!B]BHL$='8*#"@XG M.)^U,JNT-FNV1NNSL*4\JQ3FNUPG`,R_`,TW`-QS`- M%D$G5.L"5*O)7:`@TN`""`'R\;`0%($@+,`$D$T!%L$$%$$)!`%$]O`%SH$. MVS!$H@$@D)H43_$=5#$-7J`.@_$7_[!E2F[(*2M$=D*[.3&TAJXE"8(,=\(< M5/$.;VT.CU\86_$"+,`Q-&@QFII;',QPJ!R=<[K?&(% M0@!"^=0F#MPQM+:C@81M#X.Q%X]?^<"P^S6B(B.Q$"<2M"*?+)9`(O$P-T2\.T2ZLT2T\R+/^P%V_M3>LT%2-Q2C\RYI;`X7B8T'>MT3+^T%Q>U44LN4N]T5$O^=52GM$6?<4[?,E-#]4U/\E5/]21;]0\7 M-0_W,S4G-5:G,U;_,!^C]$ZWM%LC-2S/="-G=4U/=%8?,D020N M``XTWTPC]DU3,V"+=5@SLECOPS'$HV@K=4W+=$NW=4RK]%Q?]TI[ M=`H[WDA[MSB4=&"+]WB3=WF3=Q-[%S38IBN8=WN[]WO#=WS+]WS3=WW;]WWC M-W['ZBW^3$!_][(H_B*LWB+N[A.*PP.+$&( M^$*$(A]AS(")K_6RZO.+^WB+J[A^1T(YB(,$-7B0ES>&#RN'=_CD'TWF=;SF6SFAR[FA]SF<'_J>%_JB M-[J;][FAUSF?<[F7,_J5-WJ<*_JCXSFE:_FFYSE$=F80!,'^,C0Q$LOCHUYY MH+OYHL>YGD_ZF$ZH[\YIA>ZEW\YF;^YE,OB(/MZ MI]?ZIUDS?Y_\RZI&-[MFO[MAMZ?\,ZMX-[N(O[N)-[N9O[ MN:-[NJO[NIO[7?LWET,SN\O[O--[O9M[-=J[N:/!DE-[L1[KM>=[P`O\P!-\ MP1O\P2-\PBO\PC-\PSL\%_)[OZ_FOSM\Q5O\Q6-\QFO\QG-\QWL\PD,\=TN\ MOSLY,'S!R:-\RJO\RK-\R[O\R\-\S,O\S--\S=O\S>-\SNO\SO-\S_O\SP-] MT`O]T!-]T1O]T1?]`#!>=X^\:A[^Z_]`?=1+_=13?=5;_=5C?=9K_=9S?==[ M_=>#?=B+_=B3?=F;_=FC?=JK_=JS?=M?_88WO28^O=O3?=W;_=WC?=[K_=[S M?=_[_=\#/MW#?=Q#WMP'_N$C?N(K_N(S?N,[_N-#/MD//N%'F>%'_N5C?N9K M_N9S?N=[_MXWF0I3/N2=0;__G+__CS M?O*_O_O^`W_\B__^*_\-Z#__`P0W@0,%WK!#$&%";C=N8"K&2%Q$B1,I5K1X M$6-&C1H]S4CR$21(CR%'BC3YL>3)&2-7BO3XDF62ES)ESJ1)$F7*G"1GZBS9 MLB;.H#M]AA1*$R9*I#=-KM1IU*E2J3=3`HW:%&K.GRJO+MVZ=&A5HUJY:MW* MLJA8I&AC9+[KCP M!MP/O>?Z(X\_[:1#K[_ZIMM-MPJ9\\\WU#3?W37HE!_A4$$9C>$-Z,5-$C%&FIS),2: M$YQH!%_3&`#!G1I2D9$!&CX8PMY&3B"!!GLUDIB$%>!E`(8JK!FCQ()E#5+= M(:H0H0H03LY6#14H4,'B%$66:.83#:B616M4("$>!AC`00-^7!6V8W$:X8<$ MB/01`0`0:(V'!!(:N1E('#12HY%21='X0ZM)8R`>`#[HMT:L,6)D!5'\)6T, M:Q[.)1[^)VCX]44&3@!`B8A%`:#BTQK96P9\SYF[Q)\U\MK%1K+^VAH0/LA' M#24`B`<'&FJ@H0H`3B";Q334"",CQ%LT&^?2GJ@5=5O/I@&`?'*)J%42^&GU M@QUR8>!7?F#/A^]^&A:7:^ M5@T(CB@7=\NQ5_F*K,G'^ELM;C67'<;V=%>*:H8=?.?%T31\<7+A)Y]B<96( MD-]ICH@.%,E511C1B,D="W?R`YFNQ`&Z@CWA>LFC%:]VA3=KN&(BX^O=K?#5 M/H"M``!*J3?"+F7 MBA7$2H7QBDMRC'/1M!@>_I`Y1"1!38`B,"4 MT@.G)J5W274I3IG:3*@REVE+=&[26\*KY1`MZ#[650QW[9P;!6W)QJ>%L(#7 M["4O6Z4&X=&`H-*S)0X*IB[*>2IN2O`9,.-1"HC@H`;)7*9&Q6&`5EFM8<)C M1!,>2D-HY@.._2KG.24R!+XM300S;1@E(;("&/##9[0")]=JE:Y[$@QM*75I.0LJO!7@DA\`X.5$ M6TE`HY0_TVHCA@F`'V"F@KXL8-T M[6P'ZM)EA7<``^$Q0!15.,$.-D#`N:$<`@S^4`42<-9WHM`N"7X``A'22@04_H`&Q+&W#U1! M<10(EVX9(5_Z_I`&V_H!!7X66!6D`@;2#4&'4_$K1IQ+!3M8F`@*S&$`\&L% M/\";"!A1!270X`+>5MT-M![^/2W%Y44#$N0B%QTH]T18A]Y&:$!SXD"Y MF_'Y@4;DPAK5S<7+8*X$5%A#`S0`.MA7D@A8AS(7D M:L4`IR:Y!BH`N5.'U=[-@7!SU9!(+KC[.@8P%^22(^*,?_=9#0!/L$9,>^;& MNX+.2N0"'Y"Z-7;@!"[#@%C6D"7:W.NZO:E![41DA-A`#EIKJ($$*89QTPI8 MVUR`X.RB/;91"VF-6>Q`>HR`P0?*P;H:Y`.?(*R7SD`JCB%(.:NYX%T\Q!%8 M$(#3&D.@`,A!"#$!7I1ZP@;Y>I]@#7Z$5O6:@QM(*7PL^6HL;!_0<7NE1\B7 MLTX%%%3^`^9S@=Q^<1;F@=5'+IQKOZX+J]O=`\`/#""YTS>BND>G>L!207O. MJB']2P<`X`D)^&,640U#J!E5YR\O9H"68/;.&E(!BW)A;W*I"F!N"%R'`$'N M[^0E'VH`Y/+!A;`J'F".`NQNYG;`5QP/;0RL^DZM]3A+70"``G0,Y8B%M4#N M;F[)!%$0`!C`B@"@H'9`!G*QA'E!K(AC`XH@%!X;0":(/=QP)?&J/6!8'=G;PBWYE_&:05HRH8Y3` M<2@@#"C@\V(%!YQ@"(8`!%*!!-2`=WZ($4B``FIE[\2A%,[^3W)TSKD\ACP;WQPEJC`&TS&=\ MIA!IP0!KP'Z$01J+@:YSPDBPH`@AE0:CQ^( MR%,^J]R\JPK4Y0?P+A*[RQJJP+K0\`,"*6S*Z2"[AY!GC+V`.#EQ$X,UZA?D&4(K.9N7(AU\H=ZX%`.4X$"4LI0C#`"&&[AEA#B M)@)@"&GR2B7H@(@CG:!U:D4+"6AOG``$-D;+ADX"Q4YZH.M7V`=M=D!L=,SY MIH56WHUO:D4/>X$19,EW&&$(9DOI!E%Z9D'I+.$>8<<9[5&N\`P2I6D`3Y-6 M-F\'ZX56I*E69DMR6,H:N&#^=LU=$E(E8>BM?(=WZL476X5I=*S6NFC#?!%7 M:J?W,D?^HIR`7QA@"*,.?'@'9J10%'RG)P>O.\%1OG!``5R-!E5@HQH'#0%@ M%F80JBYS6IY2U?R2"Y)(S2B``H;&$>_P5YJ,!EEGO5+E`HQN)WG0/_E/QSY+ MDF`G<_!F-1^Q^IY-ES)1Z"RL,1/K;C3)-6/1&AAMIB!"(WM!#F+1(VM%ON)M M(_C/JKQ%28(9T*WVF&-F'#KHQ;ZQ![.2/?9BFML:(>TX@%9C&A<)FHYPOKG#T4(PP MX>32X3)+5@RH.FE&.[ELZU@G;]`&"@4(!U3-**/P,/&32J7^1W)PQU/`<=T` M`.]P[T]1":3R\!GU$"(8H`84T>@6D1`?531II>O^:S4]IC6[BQ'^:Q\U3![) M1IJB80?FD9"XJAM3@09@)H-J[1\;09IPYR1C3FA(4CD%2QS*00EJ@%BE'>PZ&%[01S^K!0'8O5AZ5354*T8.1(&*+(&Q+`[&>$' MR-%@K2$.N%)F<<6IF/2+2(5)H_0/N%+^%FL'W,="=[!++Q,:XW%:O'!, M:Z$`+*NR@`&S+L(:0"$&Z48&^2%FK>V3<,>"Y#0>2'8B_,&46B5;>:4;]5'O M%+%/F\_#>#8:>@G^AJ`;HZR(Q`6$QHO/,#.0Y*^(SI+[:+!5'C5LN`5WZ$4U MA84U:48326]N<.<*.S0_I:?`[L<)0*[^TI4?G"`DW8=WVD]>E>PTY11BA>;3 MTJZJ%]G(9FG6`@ M?_5WEM7^/6DE&J(1(N*M>YZE5BYJ!B7JLZSFU&[G?GY@^'``A+KSHW[($8^R M:QL!!$!/Q^!%<2ZN=REPBI;TY+Q]YV M^,8+J_@6>/[,4!CA%E!@$)IX$&QA$-*@+L7'PK2HU6K`DZP!(VME^+(8^NSE MW?Z@@F&S5,;O=U1@8!8Q&D+ES@X-VWR/C3HT`9W+NGYO^"K^)A))P%=J`(LI M4'/T]9\6+Q4)Z8?$82B+"&J^-AL!\G8D5VKF9@?T6+3XUJED"HW[S;DH:0A5 M8'>Q*CS=9P@UH`I^P(5X9QZYCWS%!E=F$>U0"H0^@`&81@/*Z9!^1[X\"@"8 M$AJ*Z"6+!6!8IU[DE(7O1PE8H!O/KE1:<;P0]ES/!"7K@;.!024X,_4I=-R`17FSX!$ MX60I0-A6H(;))9(;@5QJ()>K`"O1+G]F-Y!(TG5`"`!P80B"*^8.FFE M>2?'<``&L)@&:CH?#&B-W4>?MY0?%G1:W`L$3N`#?HA\*`#:V&D(KY01`.'0E$`))$(4_-+E M_@8CV^D'?D"_T`TF&2`#6VOS&"`?=J`&3H"QAX!@U.`#^"'0>%(#L%)]CU%T M6LT)8)(.0'M+0Y+,YFO<-`!R2$"WXD$CLX98A1-8BA`^3A,":J`'ZP*%:_2AP9)T52F7_+M M<6C&$\L5EDOED%X-D"I,T1XVL/RZ!N)Z(I`+(]6@'%8`(T7@]!`;*U_M\*Y2 MIM9%T3SQO@6:'W`@'TH[&)=`L_DXND1(6&1'!#8,(C!-`QC`K79`!8#LS$1@ MM7^H3@'@MPW67(KQLAWVA[NJ&-UB#37EN-`M"\M*M`''#^:@="@+(U0`2V M-'F<2P/TNP:"`:Z]D!P4>WM*1WHP.Z?!>,[GJ5QM:&T4'$LSX6WER=$_B69" MJE@:`7**Y0(4YU@<'7?H)J0809]Z:9E^)4DKO59.5M6_<5'=9VTGZ&09(;-X M>"?'&J^622(B(2,P/5F8P:K@*4RG!2+6F)V(1:V:[I1FZ@E(1<'%E#)?_=`A MIUR;+B,@T6A:Q0N39]0%+^)4?9)TWUL49UYA"71 M">C?9ZK28:)[H;XB`IO@+ MQ8@!6$`%Z@5D5JCH2X."."3GS\;HI9ZL-<3FK_XT?@6+80Y7Q"6'Q.,%AAUN;O M-^+*^<&P13OK#]_QS\1N9JNH[(2U'NOQ3<.[4L&G(_[R.S].G$5/]L?S3\,: M7H$%W&CT4U_U5]]).(7U7Q_V8U_V9_]/&/A5>GM%;-](=!_S43]'?/]6<3]D MA/]&K.'^WDK#&ICG0W@_B7$?=8"?]DG$S._T>90`7V,DOT"-NA/[UYQ%/$>S)20+T[#!QUSO+O^(Z1;@]9VH!S9 MT%]CR&NMP>7+(%<5`(T,2VX(FG'"7"L`!%*LT75DSY%!,V(@JJY>1G(2VC;= M-:_OWT\:6A.5.K/ESW;5],Z(6YQMNZ`UJKZ.,8SJC*OWPA6#GJG8H-J,*!><>*X M@N.6UJ"8('8X-&+C5X;2Z65>&E#@4YQS?MF@E`LU28,3*_#H4'1:$E3H;T/` ML%=EN52*&85__A`2@XH25&)A81JG8Y(+@C=DI)XF&B5V2P:(FZ>1(F3-FW`- M:U->(M0D)5S!8%E#`@F[B<."D(RLX$1/NQ8D!X\%>IEEA/VE MJ^ZZVJD@B@@O2?1#IO%\($J#%)`03PT`3+<"/Q\TJ<(00]2@@JM#B)"*!@S$ MLP,`2IP0QE[QP`#Q"<@.`<('*EP0V8@5,?!!*BODHP0).&CP9$'^2%2%*!K@ M8$T\/VC^D(\X*OR`3XG_QB-"#2LHL<,[=_ZG`0C\_*`&(2=0(,()->R0J8_Q M\/,R#,\5=,('%>$@BM*-@`"T*,I0P.23,?'##PTX1%)#/J+`0(%2((`PQ`IH<0/^3!2;V\K M'&`S!4X,40Z2^23\@1)OS3!$%3_P,Z02F<-`@IHU@)"W"%:3,,1N*E#@CC4T M:,#/"L3#-!,`J5312/A5^`1"%0#;I`8B5:3R`X.,G.!$\??^>=(*2."$*MPD M%;4C@=^4`(#K9QU@Z`\P,8*"$>&DC, MI;#E.U'DPC0`R$'8U?S!`$@'321!1S["4%WA(;S8%3'*>!B0JI)=K$^JH54`4+8&V"J'U7A*@H=219!W::QZ$JH"C_Z1 MBY')5X&8>9>.:FY:?K-&2AD@AQ$Q[S0UF&,^XJ&$>-8TC\A-KAYCF$%<]330RP3ZDZ"0.9^>-8>S%L MYUH;Q],DBGV9[=T6^;1%OUU`MKF@0%;UQI-;X M$9,/B(K%(CF(>\;ZH_\^\I:,;*+`X4.$&;]XH9)3B2`6+6VW@9,0T`J^FTVMVRHF!@'`6N6$<>.R]%S>BU&2';7E;;M4'4.F654`,UX$!' MALIV@OBHP->C%#*Y%?R6J/[Y@3.6HQ/XG0^Q,")97_Q3H\?:\I#$G!EW MD685+XW^-0>E5W9YP<%&[Z*R@N1"=QRG])"V+0(^%00&)W@40?X8]B'+FB`5 MK+0EX[%TK_)[T<(2!QV;63"/Y44.UCB[O(G*DW*T%>P,?+;K\04?ZK_%VA[% MML2W#;*8C.4$:O@]J\Y-_O(+1QPGL!B`F;M=Z6K71\>N<%852\N^*$%4!DF- M)]/+0$-U-&_TMDM7\A_LHS@*H5XE,G&[M1[5`4,P$#Y8$#6T%J9 M8ET+EA=.E#<0=G(HY013]%_1XG)V`7,>)DJ#47-80P$P8!,^LG/BT'.G`1@^ M4GK-5D\G@`,?L0(2Z$-*IU5-YQ!/=RQ`J`+C(A$```"^\%#^#$1N]C41@!89 M^B,.4^=8J5%V?H$:',@3IK,7T\)[;(<%W1!%-!]9I,*&!A4=@&$@0(T)+']$YA^%#:/4#PN)HE1-UK@I#K(3U0!=50 ME#4$PK>P?:O6@P6R`^ZD'H23='WS%GVH M@7@Q;LZD8*?W7[\X5OF6=0U"*I&!-A=83S.W@MQ$8M7@!$/5(#+8<[%1B;G$ M36.A.O]A/07%U/W(^^F!LST4#25-PDR1:!5+*U5&E=(=OTR M9B5U3V^E M6.K8!=JHB_U!*!H]AV&HU%.AE*#/M%"]-&8S M.#6V5$]P61.AYUZA9&E'41K),@,%(GIQI)BA-`2W>!H^0A/S5`4K$$ITYQ,^ M,A%Y,Q&QAV0$,91C40.&HB95$!GME@>PH3B,Z9ID=H;3HD#^-/`#\0!C`-`% M)E-<#(0C!/H?`]8[`T8##B%HX%D6+/5AH]0("^%IXF!&/L@/$G$7N4!HD7BA M0[*)67>1,F,]_W&88AI0SJ5IMW07.A9*!^`$F644TX*F\*F*!L%9R3(O\4`! M:I`L/:$F(J`/'Y$W2Q4P-+!CZJ$G`*!O_U*)00$`#H@#UL0`U;11<.-(F=2= M^,=`D0!GF3(1!V-P[8%5TU9(!<%`E?A_:%9/=]93NW%*,VI)-%`O@P&!)2I`:3Y"`]CB$-_%#XT@7C!@L07!0>.F$#4K M#F+3>GUS5@74/TZ@+T%+,WX3'0\C"J>A+]XI@?[S:OX#32F5"FH0&848/CN@ M`C*`08G5ALS1JTL8/_BZA*=(KR*`)1.1.0#E!.MJ23C@KH'C1$`SL'`+3#!@ MK5-UKS-``DNX`TA'`AH0#R#`,`?1"ZU%`E5``S#P-L-4/.*0+(V84O>24@4) M08>I`@S^``(5=+.;*PZ)]`&20YT%DC.TP0@,M(14QR\[!`!O(P[\LE4P\`[Y ML`++2@,-=D5.L(31%!D300(511'?NH3!N$7CND76^A%86W5.VT`K\%VBX`D' MT40PD+.&,BW6FBQ86TTPD`JDN@/05*DK``T>60I[D5)+Z*G'VK[LDIWHZ'4% M$0]YDP^)(@4DG>J',>Y&Z9E%=K/$63:+-VIP7!B`9V&PK MXK'-X6$Q: MU5J]U5S-%B>39G;4U6(]UF1=UD-A.-]CUFJ]UF9=76'-UG`=UW+]FP0]UW9] MUWB=UWJ]UWS=UW[]UX`=V((]V(1=V(:=U^5LC6]M%8NM1T(2&1U=S8V=1W;D M&RV1>>K^,MF''=.;W=E]_03R8:P$H<+[\2/Y4!W]8=J>T0CS<2I]3",^A,#X M86Y-!(KBD0^\I"=NL0(J(+_ZX2`WX]D;X5Q0)MS&;==P9MOD-Z^XM!\G8(*- MK=D.D7XH\7C*P@`7\'<50P%A\#S)PCR931)`.'T%T0%H91,JT),KT5"G84!L M<1,J$%^SO1*5C:SJ0G((-=_'O=]B_62M?8T+@5;*G1#)1!)JH)\H$L4;,45^ M3!+/DGO1B,K1N'BPH3IO91H#D2X-LQ*UC1$I116-H-X<80WF0%V8M`G2G1&\ M%0]9JU=E,>`DT<)9X3N,UA\,GN(),_]S3I<&+,TOF-BT7I:6FY"(N9`X<0\Y>E*48/T("/F(M6DGE:"[H,2%' M$CGFSIRR3V`CC/X6?`[DD#WHTZ;,N6#F#8)\BJ$D3?XHUO#2I!X9".^0LS2`/,;NAQ(H`C\JQ!((=O=!)$P!,?2`3,U!+RG!NZ3%TO`[FG0()XTALY%OX9L\,%=$(T0"%%#O^)``SWO M-]+B#B)U$RL@,98S3RL@"B$@$_RB`B]*>$,@[P6A`G;3TBX$\+.`?I84"#A0 M#E-5\?BZ\*$7;GY\`ODP`Z(``L@BKZM,`UWO*7GP>()/4Z)`"ZEQ`@!/P$XO M@=CZ7K;^HR%Z@_4T'R0-WUJ3S#1UPP"Z/NRB?Q7-]HGN&GNGH0$L`&PB,('; ME`K\HNE6VGAS1E,4``CCAK%^6$PI.S<#=C0,=``]4K@,@%6&@O+VRF7>TML! M=2$-%&Z/BR5QT+#^@UUVX3`Q]E(`SP!=\"VF\?+I5YPO?J4$423Y0*\$WP@: M\$\4$#(%T0_)(O&Z!0)]RWL),4OX36GIAW]?OU$?10,`00%&/!K65`QA<,*) MB'SO`*0BX:01(W&,5CBLHH0"@"H@E`#XP8B1PGPT`(ABI`+`!QIJK`TYP2`5 M#!P*8:3:\6$%"0!JZ.1S2NNV.CQ!T>/($6JH+W" M22J1#6EH[FN-@:@53DDP,!Y>_'CRY_7KV[=V_AQ]?OGE&:DC@4,.@ M!@`&N5(!P(&&$W(1AP$G2%`C%Z^4\.\/!AI1J0IQG"N0D<`8L285A"!$:\(/ M&,E%%*1"9-`:T?*Q3XW\8`#`.&O^1`1Q"/XL5"P7E5;(9849<]&`/Q=%I$J< M)BAH1(U&X+)F!Q5RL7&&7&KXH!<3`0@R)VO\<^+**FI@4HUXJA*GJ;IRL88X M:T#DQXGP0J0@%XJLJ%@AV8_(#.7 M*C3H-!\`XC24$2695"%!*#4%,!>3<$PERPL8(&&%_/@J\J$KZ8KVU2K$)=+( MKWAT(MK^)=#*988QQ8&!!DV3.K1,11EA5-IP0V5RSHK:8M*D`441Y4%B8YTO M8XTWYKACCS\&&3U"RH1!!!`ZC" M,O,T4Z"3:@5T-)K0D#%V)`3<$3^_Z!(!XN(E/N?BA$OCT$0;\$'%Y\0^7>D@@ M%^5N!6*S!K)$TK57[&!K8?,18\1F%.89,8:-H(L31ABWN5&I;G?+6T5.P")J M&:<^^0/8XV(FKQIVT"YX@<'CR$?^IP?VI'(P"-Z>8*@E0SHP46IX4RKX1#K: M:2`?']@!1=SE,WZ8D4^QHPC35&6-&+!$1KM;59TL@A9&#(&$JWH;8%@%-^M5 M!'^9TN+T`$"#ZB7K1]G+9=>2Q*`IVA&-``B*2+:'J!5\0`5GB9^:RN0$#)7C M2M;@(][4=,=Y?:!-4UP>(CMX0#RJH4<#H4->"DDY@,7)8)!4BR4KI3!(,L): M*K`&OWIXO17VTY__!&A`U9FHO\0,/Q01P7_^8D-1X/`'(5E)#1F0#P7=0_,JE27AI(5^*$9@NY150 M29#)`HEC!>'!4#XV\AN+F\SL6,;_P0)P)S M@<"[8&@G`*K*R"9'$1BXZ\K$G`!"D M'5'@*0Y_D:E(DD@@:^`&KK`MDUU>EHMJ&.4'S6,$7]*2WGS^QNHHOP/JBVA@ M+2+UJ6*,\2*3_J/8K>FR";F0$8ZPU+<0.2$380H$2!"EAHK]Y4PP&$(N8"`6 MA5%.>X),$Y^Z`Z)'V1%P`[K`H^!)`Z3F17O)E5DG\99)1)TE&G5:7B8[6`.7 MB$,4XKB3YPPV$80U=,CZ.`F98H?$))?#*_PP2CX8]-Z[?&Y$[[@5@OGSUR!2 MN6=G^<#8&$.!9(W!9V"SQEGR<2;`XHPXC^] MKBH9BW4"GH`@V3N(V5KLT@@6W6P_((A:?(O*B#1>K2`D4(%>8"`#_Z`EH0]Y MK0YQ6@453"MFJ7BIFA)^^ MLEF4XH7^`OE>0L!BNA`:>"45*N`+.1JA=:BL1>3S,@E*Q+$12.:=(CV"+FUR M94AB*?%5X$..SK0]O(I\Y$NOHD#CB>@SCHB@!@L1QW_X\;Z5J&@'TXY\KD4_ M>M*G,-@/C8<<&!"'$^`E'D,8PF^<`#Z/Q,R@J:``:!(R!!!\5AROSYE1<(![ MW9^`]_G(A^9.X(ELXWYM?JO"0WEI'`,T(A53N>0)@-^2CH@`DCA@W0EPYIJ\ MD!0F40/!]_@&'`TIP1=185UG4D'6@\0^[/SX``[R(0H-D0:T)_@!T@@[45`" M$"@(\>"5[Z$!48@)&H`]%6``\V.(T'A`')"C#_B!$4H^V"C^.[W0'!&(AH/H M/1SXP$[1@`_PD@]`'!KX@8JIDR'X`0V@'.#3&7%(OO.3B1^X#H93/@9PP.#+ M*P/DIP(!OF!0@Q^L07U@@"$0!1`XK.V[H"&H`B^!O1K,"^O[@17X0>X#@3R` MI$90@A_@!T@*#Q!HO\FZ)'Z8B#\XNT;0@,U!HP^@BI3PIA,(.Q'@/1Q8@0=4 M`SP$`6:@B/33B>GA0SRL`LH1@0`$#GX8`B58O[P@P2'POOI;`1*$#1-$P7A0 M08JH`@KP#7Y8@9A9`E'PQ,4HO5-$Q52,CT7JF:KHH=2!&6LP`!>#(;_A$U>\ M15L,M8K(Q5SDQ5WL&5\TCDRXQ5?^[,5=W"<,Z9M7=!%?##618(Q0.Y-?I`AF MG,8A%(>>4A8,J8A7"L8SP9!,8,9]TL7QJ46C`,9FK,9C7$=PG,8>BL9W]$5F M1,ZL=@M,=_W,4G@*%7>D96C`]7R`N9#"B;-([K$(%:4P^3+OO3+OP3,P!3,P23,PC3,PT3, MQ%3,Q63,QG3,QX3,R)3,R:3,RK3,R\3,S-3,S>3,SO3,SP3-T!3-T23-TC3- MTT3-U%3-U63-UG3-E-RG1?)&@`K'%")+!+Q-I"3)C2'+VYR=GHD9;/0G;FP/ MXDR/W7S*C%PAY,0N:W@P!.R%8,P+`Y"#V52AJKA&<2!&^$#+]6#.O\2!>(@' MPS*L$V"\Z<(TQE$/?8`/=)$XI3N!.A*/)P#*:*@"*-,8"$%!B@C`;0P$$-"` M'QN)(:"`*K!.VQ2![VB/?"`'GCP/LY!/I&3/B=H\X?28"\+^S_G`M#YSD4W0 M`-5;`0V8+!Q(EP,M#_J<#WLR0PTP'Q4`@0]0@O=@&TNPT/$8C@@%S+48@MIH M)DEBCR;JF*1@@$=1(C$CCPY<#P9PI@L@CQ7X/",5!R1%21JX#1-5#^P@0PU( MBQH+"6O)B$SQBND+*&N8A@]HCR$UFC%`CWS8#R@%RJ0`P_Q)NI`!4A;C+/DH M*TFJ*260)#7XCT>X"S68BE"2TO(H5._,A^^0.=60&Y-@')\X,$7;RF[ZA2;])57]`0)FHB)WI+=`" M$W'!&`1DU5QEC&6LBOYX"_"HU7C^X%`$-#DK355:W4=C[<8""2=='8_N?%8% M,:21F9T:>+6PLQ;$^1LB>U87(R'ZA%9G/5;Q&`,0<3%Q7=98-1KT`!$F\E;U M"-=QC55DM2-TC5=Z%3Z4"#L\(M9NE5?RR(5SH`H>X:Q2M<[N++)9Q0L%X).1 M`1S$"2(`"(SJ]%Q'8,&@TM& M(`5)&(&7?5EB<%.]Z;A#Z48B4IC+;[XS5OST4"F`J MO0``:,B%_!@?-0!:<7@%8&T$<9PHRD7`R3$*3-K;IG(%WQW;IOVA3+F?W]P5 M'4D]#-F-Z5$C51+;SA(SHSW?OYG#9WW>;90JD7H95?);\V$,Y.U&T9@^[1#2 M4++9(,)?'"J7A+"S5H&A'@NWQ(A?@,WKQ8BQT``1F8$)B`N<-2 M@P^H`HC@*+H(0+Z-AQBD`9ZH&)S@L?J(@QW@&W_(X1T.0,8IETN:O?M;"1"@ M737X.?PS*!UF'AP@!!`X.Y_Z`#/]FQ;&O8I80A'0@!_@VP(1!9RI`?V+P2CM M`@KXDK_Y.0V@%FO`I'Q8#GXPN=PAMPQU,<30'+YC@"W!ISW\%`.,!\T3GC23 M0I8)`Z`C0/\Y@3A(87\@-Q&Z/+M8+9@HT$U3@D3\`.BE`0S,-D2H@2:8DX>S MI9^[/MLQ&A7P1%+@K0\NSF`1Z-LK4F-^`(^/(`'A,:`JN`T9J,:;48(:H(%$;HL>49<6 MY@=81L"L>)FT^(`:$"W5@9L5*&42:$KC:(0,+F=>^J'3<()BJ1-;!C8=B8%L M$P7%$-1KJ8(5^($"W2,-^!(8_@HAE`US"$.N[!D:*.4:4"(27!DGQ&>0$,)X M^`/+4X*J@(TZ9MJ-D#JSZ&;:(0%^L$`@TP!(R@/-J8$1LJDH_1K'*!`04E:D M[`5*P`0[X(:E!H8;F`$414`=F<)\D$$#@)TLB2E681M:88N_F@C:V1IQ(2)Q M^`B6F$+^$L`3-2!D6-('_*&`4)04#"$!&&"2'0`;6*&BO*!2)=F.E\&/:\$F M$>&;7@!>-YDY\Q&1V#@+Q,&?>1$/EO@T`-``#;L5:W""R08`M!LC"X@4`?,"7F%@+QNN@>;&6A+8CP<@%.EB. M_'B4PTJK5].IR9,#%<@40]LE8JF!>&"(>#CN,#7*W]@,1$EEL^D>MDD0A)FS M\CN02UL.X3")M(BO)9F0-L&?6-$6$@`T8BD(_2#ORPN;(HH41'I6_&$0`_JZ ME>B.B(@-UKJ+UB$T-2'1F%ML.K"03DHK"AB;O]F!!`$8N='^EL?I($NJC)"@ MG7GI-QQ8"SN>0@J(%C2"TD*")PT("C1=,W-JE%?A`F5Q!3X&@"N1*>V8.1&` M:`"8A92XH55"G!Q&BFR;O&#+CBA=:1?YF8KX@`P+D6:A, M8$J(`&X`ACH'!FYX:@K6D1:N@F(3"=C#)ID2EYGB%;L(K#HEA14RBR'@W*+^3!D'%1-`-EN?X@AQ89(F-Y M%0&*FC)I$_!0`<01FMW:,-?6;-G^"B0&8(&DT+:.J()*057RB>-`U1/5Y9?T M0R(@*Z+(4;3W#`,WI)RS>,_+R2M4433@5JO#72,Q1!F/33(0H0!^^'9C23*] MXBL*^*-&8"#;,$1):819Q(M(814N:_1,40'9B1G#VE?T1I[J9&]'R2`P*B`8 M"(YI@0%@/A0-\(QB83)CP2FCP!]C40E@E9=^$U__.3&1V!_C6!XTFYSR2CC= M&B"*>-J3$86!^*$!,7`X>?00?Z3I521/&P(`DD)F8PS-"734(815ZQ,G*+`< M!U\0`1V?(J)R@!L8<"DYT+[KZ1W3VKD?NE6R^0&3:1IKD_+SYI/KL_JCDSF" MR8>TZ!K^:"R6,SF+P^HN[7ECC]B!>1E@I4`D#;*+]OK*HXX`.Z]S.YB!V MS!K[]+D`'%\_.&$2?D`=F]HCAV_U&L*+5\"_&@*T%&_"6\^FO&%Z`("5_E`I M%3&2!0>*:QGQW.*7#]``%E#3>W28[*+81C%N&9&XD4F,4<'V#@CRX':>[#"0 MV%"1I0&BZR^2_&"H/T<*0N`,5QR+&NC^1IC3O+B`"U%\6F804@3(?C\34<\L M@2&!+\*IS+(@2"\/<6E"U`<(`"`8,4KEA`$C-0`BY1+E1!S^1'$P/N3B]S`A M@"K6&``0E2N7!A+6(HIC5$/#1D;Y`(C(!0.E.!PL&5G3`,.:S!6-U#1"*/-$ M.80B`#@!49)DQ&K6J@!0X\_:AQT$5Y[(]4,#`S5J&"`5EXN!$A`D:C!2``!1 M2@ID.8JRQF@%@'@TAP!H9`UNO(W60`#(9TU)(Z36*)"@R9=KR1HB(UHCD2KK M5HB-*8QDU`C`$+\'``W^P"63*"R.HQ)K?P'#1BXD4'999MF5 M)"!!I)EFT@\)ED;0"4ZHX`L,V% MQL\/(S+II#4_P(#=4DU9LY(*[3F12DI<;@2`$KF0Q-9JF)F)8T?ZT=53AUPQ MP,`0%PG76&'[-6(9F0T!*:)MF&E&@8,TL%`#H;>)`@`CI.'@I($D_47!G`)Q MJ!IN%RFTX8NAJ5B1IAFY)8(3\=```PWSB://1"DIU-)+(PE)DTTXQ;4F1#]9 M4TV0'P#^$&5PMS&EACA0255=53^0@"M2;^W`VP]2<03F;1_4,&9;;\5E6%UW MQ44'(?A6#?*&I@(`OW'5DX*G MI:;7CLR`X->KN-Z66VAC-3(0%1E#;GP6T4NZ8I3GC674=O0LN>E>A]"C)@#P,WT4<9G?OLQ$(83L4V6"X', M'DAHHP\RZ.""-+BCP@F-?(5;AIMRR+*D3/'FUA"7M<3(IZ6P9`VH`C/2RVXR M@%^`P;BX?7(E153L".%)^2C*B*V/\6BT3;Q#^W;;C>-;8N*5U M(RAJR?0 MN0S5DGY*5)J92919<]X*(/'GU8Z#Q^>6RBM84TZSQQJ)$,;=SY8DT M>;E-#?Y@#5=(AA\\$^#+Q"$'`=E+4(PX0&E0*`*9\*-EN:@"#H#GEH$AI'T_ M@!@#8%"#V^0B'U5A6+&&D@JY5*S^B4Y\XG!Z084;7*.*5O3$=((#N>Z<:4;B MR,<.2-"(1M1`(/'@1VSHHH;?+$I\C"!!5=@SHOR8Z4&,&4M,Q-&G7.SH/@#X MP%M@0(&=="0F\[$&HO2C(/TD*@@'EY)!0"*!3V%#,&0H6D$ M#)P@@GA\X`0";;OBK>(A@D.+804=HD(HAJ"I`U^(C?\94 MID8H(R/^\=#`ACCB.BN)HQ^+JH+W;HD:^)@&/A^(QQ!0B0,5"&9EC&#*$!@P M,&%FDD\L"R)%G-!Q08)1S,X&PLT(`3:+(H M"L2C"A^04DM0HP316$X%O\%1EG#P*+WI!W%%!(`9-4"_B#B!`E_<00W&Z$V5 MPB`:IWEG=?+R"IC)P#H[*8E"?N"D.^[@BV0322YPL(/8A08N!OU`EQ!YK9)< MIDS:+0@W&+U!Y&BP7=IT.0=B`#'T55)&0&P">SD>+O6:"MY M(Z2$\>P(ME'I,@/@`X`:3#4CJG+^!7SXH0+1?J^^:GB/?$%0W]^LH`:BB$"79@ M3K`<5PU.O@_F'G-!?IA+,$S1+$X<@VCE">8$NB;31OS#G3'2]P*I(,XZS%<3#+UU1R6^V,L:#;P7D&YG;:72BJAG, M:>09[PG^PGO2$W%4(3!S8D`J?OQRA*=\721KN,3=\ZA&M#@?31C<;>Z3CWA4 M'.(H1PH#<&"JHUAF!5QYU&FPDX\;P5SF"/_Y"CR!$_U*IA%6W\E&O)[QK"!< MI,2"ZX_3WO("_ODV+W?YS!-B9."<)A^/ZDK7#^[U,4)':ZFSTAYKJ*'4 M8W02#I[>"!S,DF3KL8M4Q<'RD0_^ZZ>A!0T0@IK.-\(3-(>Y2/F1<$TR/1,D MB?B(8CXG-81K<$:6.^'GM/1\,$^D(&CZQ%>`FI8?7NM!)UGD3U[VJ9]F#-%H M^^"]CAVKGP8AL%-5`1>>=7'0(+S8_V3$5\-RMF>\'Y&QS-;^G<0(9G"WZA`1 M><(CI?>DDUQ.Z`9^P?.O?XIE(NO?S]]1%%!-U91;%)`X9%%H%&!PY`]P9(+K M!2``\A+V\1W50>`!0D0N@,#)H`V.42!P&$!H#`<`A@8CU)X`'H7`T<0$?E\" MSI4%D@P%5B`"6MX8C"`,A@97G,;#O>`.2J`!!B`)_B#(A&`0-@L+\IT'$F%) M\!(11N`-^ML)1H0*]`S)Z`,A,&!$/('K;9]@J%\(`D=O&`W:-(((+*`"GN!I M;*$2CF`:DLP9XD`9?AP7;M\`4D<,OMKR6)XX^$,%7B`3ED1>#4$OB*"JZ$=Q ML&$3*N$2&F&S)")Q("+5`!?)CJ.$W"B"'@B=Y&B2O1;*4+1#_S`)[+@+&(B(TR8!E!A+OXB,`9C M:97#"D#)!]0<+@JC,BXC,S:1#8JB'-"`,3Y9,F9B-38C22C!!X`B-N[?1PF7 M"W:C.(YC*8J&?CP@.::C.JZC->J'(;(C-NK'-<+CQ+@C/=XC/D+1JXF#`N2C M/_XC0'9%N.QC0!:D01XD0B:D0BXD0S:D0SXD1![D/(;B1";D,T*$/H2C$YUC M+E9DQ5PD/)YAQ'CD+X(D%)ED0&ID1*[D<9Q&Z`5C_ZT`V3UD&-``-XJ#`31" M//3C23;^`M7XG"BZ9*28UEO,)#S*SPZV)`.46CJJ!`TD96D5)4G."7;)2H9(@NCBD9%=[$5= M"-!^=BA!=.@)RN-MX`622@I-#*B(WF>5ZL>`BH:4AN@25B@=V&>-_BA.:&AE MM`R!'I*67E)W@F@A,FF!OJF3?&F8AL8%A.B;'I+ZR4&(]F@R]L8!0<[7H&B: MDHP<0<3>*0O?9:!U4$F..8%1DJ#^DFJE:*`I(&[I:=3I:)9HE=(G,WZ/J?$# M@$@C`4&$"&C@=:`&".#`"6S!$P!H/HP2L7@/"%B"6N9#&4D24N1#)XF`BE6? M)*U`HI%99?+570Q!%3"%3)X`1S$`)3W56U2!$N3%=C!)JC``"%RK)8E@(YS` MM8J>]T`K$XU(V)P11(E7L(JK3G(BWZU`%8B""M`!#CA8%5C2?*4*4P`8%E,C6+271!K."+O>9$J=UT,4/W*_[8)^J8D8^%.,?V835F1O.PYHJ#05"<%XD#:8#)$YS1::YN_BF%WEC-2L1&+JA% M8?:)-:03Y5Z->M!`?A`$;D4>&0&`HFZHO_7&_X@#+%4*3+P"(IO)-5\+:P!( MW)S0CB"$0N4",[P/05P%`-&$0G@6SPZ'B[#,:.R50OQ&+BB(ROR/-8"55T@G MBD@GIOC*[];`"FP=?("OYF`$<5D##-10L2C)7@P6J)2$('D%4Y1"(2H$;U1' MF;"+1Q3^RTM<56;DC:->560JCA.HI:U4Q6%P"X#H49EP%M&M!`58!0R(GJ18 M"8K(Q%*?!\L$"&5,5LN\$VF<%$`%#T>@!`"!D&M8=5YIZ#_7T`?0&.=@ MRCD<1$#3!+_XQ2LM*04P-(5TYJ#-A#6?Q(827#5CM!%$[`!B.76P.(%I5`,C*`4( M*"9K')!T/E5]N<4T],4]CT=$J0!<=.*Q`F>_+(D1O^7ZL`M*<"_/6(,3X$,X MD1VR^,_(7$:3+$PFK81<,(*U]-VB%DY=>,I2OTFQ'(8?'1`2GT!X-PEA[`H' M78V,K(?3U,=(7/>.Q$;`+$XFH4:',$(^)P0#%"P,N$9]ER=VK'$(< M8Q**+S>_!(\HR)6!;(6^Q@I?1T1#Y)3ABH,3F`/!U$7)H$1T-@5$)/9(7\UZ MCA$.B,4.@"#E*!E?KF)>%<6EM2+^,E-`JB1C@;N%BO_S#N"$$[B#".1!*[ZB MMIA2(_CK;3RNI,PV04AC&(C4N(1CO=R&H.GXL7:9BS3%#5V'T%1)*87W-#A2 M7C29A(HN=$?W#Y"%ML!ZKQ,$N_E2=J,'9LV(7"[.=[@CVIR.I*A+2=B,48_$ MO2#$>>CJ\#0-@+31?%>$2.@F!F4[KL/`9\*5'6%@IY2$LMTSRJF(?E`TNQ/$ M_'R&.:+-@8OSV4C$AJ_/::QB2@B)A\>OX_!E]DT)LCCZHK;WY%E.E1R+F"B. M-9S.;5B)H@:&D>X)6P1(#=6[*W/0=F>2=K^17Z=OJO8)::BEDO>0H%C#.61( M0=R:@'C^NY4K!("(1BY$0Y<'%"9)1IB#A'T'(#\,K+NG.08&5WG:"G'=!D6+ M-)W?N[Z/!(:;]!!H0(PTIK\/?.P0.EQXECLR0A@DVQ\51Z!S"4U$2RZTE=7H MAYFF,GI4I3@X;FQ+AJ_,0&6-L&52@!.P9K'4!Y:,%Y*BC7;T5RK@83Y'M$?8 M_)V[!@@LP9?(VUKN>BH&^Z^7?8C4P$P7^P=%?%/LP&@9J?(@A/#1N*30>$3A M`"&`V]N7^FV<1QKPA8/'=QOYPSXSCEYP%'Z+*`WL``BC;SK5(,6Y?M;!5KR3 M34ZA&X-3]&DHQ`H$0L*KA$_V"[Y?^+X+CF)@A_&HY=4/A8C^4P7"TP\GZ<6+ M?1'#1PN)MX#R8SZ0X M$`#0`M7[TTFJJ?D`J##Y8X:LFJG-2+!P`<88H$ M_L3J"+N%JKLRGJQ^R@0A44ZT!@;@3L/-FBH*,DJI7,SA2"`:XOJA-.,H(^'$ M7&[*Q;'^'"FCR,67D@+AP1P9R*7-F4A:B*"#'!2GAA\>U"!"OWX`H`H.XXAG M)$49^<"GX)RP1A\:7WP0D)7B40(AX+3"::@I6>7'`);0?,VHX'Z8:@=`%FI) M)B?=TBK9G!##*Q=K")OJR85\Y/#)$VL`P)L0E<@GGZ(J211V:@79G4&H(13]IMI!$GG!#A M-!)^`T")F<0!Q#M'`4C%JM,`V,&W7.!4HHJ/@CJ-"W'R<8+^/,=^^.D@&"K& MX0.Z&-$`KRH^X*B1[C2HXBX2B&O(B1UVP(&%TX80`8<=5A!'A!H,4&&'*NC% M+1\8@H9!948:RD<<)6X6Y[03&$FJ!H,(.H$%I_AA0(T=9&-$K:!CSF66GD%@ MP$6&&:G!"1`$RQ8'?1BHX>%&/AAS(Q(,:B@[O?Q1*Y6?G!)EIHR'$&>%#Z*A M*J&93A9>Y<*FZW1BTE0!"''^\RCEJH1$&^%;#.$8Z%4P$&(J" MLZ27G9#\1A$((H$&\XOKFCBP?^I:\&S%AF%-<H;W-^*8_#7"(`DZH0A4Z M51*V?>IP'$K)V1+&+D^!X&PG8,#^AW"P%T8\T'\RP8$3&):/'WB0/;$+S+E( M,`9VP8`&\B$!;KHVA"K@SS&P`QP`9G&NC74']F!,D!` M@Y:HS&1KT0T`,*>$O,F-)&712R.$MH)\O(\$&BB*.&C@A+@Q)B4,NV+WI$80 M]HB1#E*#`9I$;1HAB""!P#U"X5@4\99`1N62`*%;P$:IH0!1L^:4&<,``28)@ M"#]2`3_^^,$:O6Q&%!\0DM1.D`H0>,,H.,#D"=00CP.NP)M5.($X6B(V)0YD]P<((JB&`% MB#2'VW*#@U34LBB(Q"0.5G#`0U9R"9F89CPF*H(.F3(?.#@@.`,ZRBH0LRCB M-"2?*G,"$"A!)A9=9"-U`TG#B8*2F)1)/O:IAE?FP5O[1`\_>/1,K)V`F#(Q M"`Z4\($J2`T'[D1D%5AS3!RHX9O'$@%+.<0,?HBB1_RXT#[]*+6OBJ(H!H%/ M+9T:@W&6$YPN)0X,K,E,I.WH`(U8`3]H8%>ZJD&N`A6'O*K^B;C&#(&6B!L< M/X['F$<.P::,U*A`5I`*:WHLH0N-Y65 MN]PV)A>Y0:EN*@-$+G'(82$=,@DCY("K[E9W(5FY;GD[U-WD?G2M%PN9[GJIFQOEWO=?XR+$K7+W45[WQ9YX%1S=(E(- MHM@:F6!R=*?LX0>75\L`WO)U0:QA,.-FQN?M\I2T6UPUKYG-R6'`@7^B`#@S MP(]P%@>N<)C;XZ.*_02:*`<6(6+AG.@#U8%JQR' MTLXSGR_CYSB[>D$4V-->]LQK6J<5U^)0`*J+K6L[*\`5J]Z+J/="ZS&46ARH M!DJC:1UKY"`ZS\DY]J[U_!$UN<75M`ZWGO5L;58?A]8J$(&ES^T<7F/:W,9Q M=348`.W^R[SWP,X&MEZ^W6:!#YS@!8].(\)G<.#9$!*HJ=PB4M\;TYH M[<0Q7O#N1)#@D\[XQT$>08(WW.8]]_G/@7Z<M&1+K5Q)9WI2D]STZ$>=:E/G>I5M_K5 ML9YUK6^=ZTDG^G*^WG62A5V09)]F<3WJ\X8_G;A32CMRS*YVN)]=Z7,7^]WQ M#C*,O-PY4_%>W@,)I#8+7MY_'R20!.(QC"3^R,59>G%-8O@K\OWP(`D*`R@/ MW^VE_/%@UQ&O_^YWH+@,.9('_.E1K^<0U$`ASBE./"@0D=3^@]W-*B"!7];< M(Q(L13E&(<3$5!)(HPRAEHR])7U2D8J%QH,N#*"!*%*QR('L`)[$O><.WHO' MB"`Z[L^)!PG0TH@J4&Z*"%4"##PN_)'UH@HP@`QS)`H#MDC6.]:@P0\Z]GM? M0U=JCJG^Q[IO]@0PY#PG(M3@"7I)`_@A`)]C#-2@@+Y'!:IO MC`0),*2B1P!`-H[CX3JM`:%C+F!PFIA*4YBC$;2F$2+LBD2`-7``!D@@-^)A M=A[P)QKA"4.F,09PZ^K"QL2A'-S^1,,\IKD:;\O2J\O0\%^<:R^LX40,\'L\ MS"A^@`&XBP2"Q20L;,L8`[]ZC,GXT.D<+PV]:[Z"H@U_8E>V"[F>0,'(L`^3 M*RC4X`>T*\=6XBS*;\)Z0,XUFJ@3LZ M8A2%CAB];"5V0"HH1394"+T:1474L,LZS!EA@E9T;)K\,,QRP7*0H[S\H5'@ MY$>N*RP880SLI3AR(1?@,1\BHBS<,1!E;"\8Y`-8P!^2"TD<*`1,D$Q<$"% M1F(I[-"B1@ER]O(]E(E+A0X@#$$Y@!7[@`X*" M?20J;7I!#8#I0!4E'A!!M9S@(JI@""1J"J=)"2@@'X:"1+2F"D3A0_Q%'#1@ M.+0&-";CD;)S!T"#!CY$!,;D4D2@:R@1-T"@-PE&+)V``E("+9"&)6I@!2B( M'T1``3:(M31@8]3B!UB#*BCTEP+^"P:4``CYH5-,J0=3@01`1`5J8`>8R@EP MI)H\!4A$08G\!@B'@`LZ13;BH2Q/H(7XX0.L1GN,`A,EBTSYQG>4`*I@@!8X MQ)T"=0@"JP)9!P"")S"G`@3)TU.6!P"L"9&DL+3X(4(G=#.F9Z;"AT!KH`;X M)"5DHE-^X/B"`A>";WLB*A6^]/\V@W+"*#ZJ8`&_"@`H42!.X`,R2G_2:I8B M102<@`1.``"02VX`$T! M0+'4X)V^;RDDU&;:12QK(!^4P&E*J6=4X$>(+Q]$(6T,!UA+]5E/P`FL@E:/ MPP5Q@##^&H%GAL!<"_)#O(TDOGF`DXL(:;"9*5"8G@H4G.B(75++56&@>G2(?*J)".&1+8$0M M8.0$7O!<&`9M]M+T_&8>*\,DE`!3I@(3*6,'@D*7C$2D@$^+("29X`1O&`$3 M&`)QK.$T3JYG>@UNQ:(PU@-H@V1(V!(H3N/=]G*$<"-; MGD@-,J12>N8-UQ%2EL(:2``&YC%:0C$6&8`T3$(#)D1'(L7^*6XF%U3G`"EE M2"?C-,B#`::')"JQ(5PM."8D%[*U0XRD0K*6U/RG:U'#,(CB#6EP+QP#;W+B M`^81G^91!8+K*")":GLP%TA`4;S72FHE*[SU+0``&CSB>]5BJM0@6XJB!DQ$ M4-#E<#4U@SAB'IV@(Y(B'I[E!'8`7UCW@ZS5>WY@?IN5YQH#73I7!?2C!P$H M?6Z(-?JDFY9V8$1,'%+"F08H<0``'\PB89>''R>B'$W&?V,$-8HP92<.'C^` M/QX"`%QA(\@#4G+Q(6"`)R;D(Y9`V-!!B=FJ67J($:1B@+RA$F&C^LF5=@CJDBOCX05%JP'KIPS,]A4.`UTE` M@S>>@E6`8Y:.]HV8B0L`:R2`=D%DY"K4XTAT\ERG@H\;`4R920GXP>7<)6MN M`X@4FC)#5`*$VFY]T\#3D\82$;V8%/ M@U_@A!;^'IB"W?,GEI81W#-BGB(7`.&`P;AWI'"4ZHT1)N*3@N^*)9"%?PY: MP$(@-!DP!&.!41#XQ($">(\4NZ,H$FP2V:.%=*-=1FA*=H6Q7"0N7`2F28-X MY\A&6B\H@%=J:L!/@CIT*/&8'`4,]%V(C#/<#E&$E6CDWQ,$2AJ`EKHE0+^-- MUF(E]@/)CLLQ'#B*,>)S@:^M*C`;L;4RZ."4%=HKNF-W[7>3T`66"=1_%"\F M2BLK&D(#RH&->8UW`2!F/$90-."9)/A2,+H)JIWW1W9OJ;LK'F1Z,DFW M8^[CCD@CNSE:Y'XOE3/S/`"C*)V;*2@(?"SC([;(CS\B.:>"O578*.!D<:;I M)K)"9W/ZB7EZ=A#BIU>"(*2)#DC`>HO:M)%ZJ!R97OM3:E%.KR_^SM.0[Q+"P#.H;Q-^;S?UL4^(H.RXBX8 M_%\NVG[9@G1EK[Y]SJ,Q`B;\9%Y^`@8PI5'&E&>`5E!Z1T'G49>.12M$(1-6 M9+_)Q/Y:I687!;S>@2)F('\?7%$:;8'%W$F`MB'`RZ+S\%`H9'[%F78C(ON& M(\CG$3?^*F/9!X1>8(!RBD-HL#9&1(7`H\0J\.@`%N)(J"2>>0))5BCA1:"W M*%X#`O@A"B,7.GU!L.-$^H)>JJ'%MQ1J%F0@7$96DNE92&E.>,8@S**/_`-: M_`1ITT1/L@*OBN1/'Z2%^L2\5C*0)Z1>'`-K3T!]!8W,L8O7F,%->)[6JG<> M>\,DQOC`48-"+@)5T&Q6LD(GRA%K*(,!@V)ZON-`IFI.&@6ERW$'\B(I++U1 MU)J<'_;.?;I(2"`NU.)8:)CD)V2_GV5Z&@8908A,F&%O`<`V<=XH%""A"29-9CUKN^`-U6`(&&`)3`+<@4+#*>+^<54#-N@;V4'N M(<1(:F/?1;K:G-\C10\B6SY``TC`/>X"+Y3T(>")32](8036\0#C!_+A-)") MNWL>;D^"IPB"`O@3AO:E*2CT/N)A(8W8)-1B3-2`;VXB8?8V@&79"3X`FCX@ M%7ZD.[Z9`MCI)*1IQ0'@H2.B07#!OT%D)#H&?.+$,0`"A#5&%``PL'8"``!^ M%#186P%`($&#N30`H$%#!8!4^5(!$(6#`8`/UL295&!-"8`5C!0PX@=@1ZH: M57)5<8*/'[\/51@Q(@%CA8H/$1DT`N!0W`XG-$[`V!'OZ`^,UG;`$&=-Q,5< M:BCDLZ;Q1$FKC!BD&L+(I%I&.';^]$Q+HX8*1A=4!!7'J!&,*M8.PE235BU6 M43VM_;!4TJ1A`"KBD0!P(AJ,&HRR`HCW"D?,C#4@,UB;#X"2@3MVT%B12D1E M"J,_X\4!`^D'"HU2`L"1:P7ML@`H^(0X))=&?OE$;523,%Y?"JJM&<=-@[:U M(1?3J@%`(A\(`#_RA185#\=140,U\)5Z@0$C#?%\TDPL6'%"4?E@BFJTG49? M$G.=W_9I%5[7\6.--10PI4(N'N&0UPZ]\;.#>#_4EH\3@*EE#0E."&7-!TXP MD,L)/\1'8HDFGHABBBJNR&*++KX(8X,0:L2C4SSB M,#`$#!^H\$,5C9`HBGE#?,:(&C^0$`^9-JHQ!#\@J&%-/AKL0`%+)Y1)XG04 M?/"!!HOZ%,\/(`RAWUHXH(6A"A3`P$\C#.0($EM*^(D75DF*)4$.G>JJ`EPB2!FD-G_R(J6=X-9#`DF"$ MY*6$$E4,`5)?C'00CPA55)%:8#2(PH\(/`IV@0@?*#'$$/'^L44!"1F1`((* M.M&@QJA_,D(+!6Z-6JQ:C=3(K@HU?'#R!U'&D6@^'ZC92%J,@,#3CF4=BB6K M2C"X[([0JL%`%1\`J9Q:.%?!12,7'.NG)^GNH($:J=#+""[`XB5SQ"KTU2VQ M>`T!I;Y:FIC*#F(VY"G.0-9;'#]5,'`N`]V*\BT)1^*`L`A##FJQ-8U4>666 M@C$2UY%IQ;FO>C`^#GGDDD].N8J$&%:#X%CU.)!@);VI9658:3F0Z'CE=9!B MXKPI!XDV,Y*)3Y4%5B"&IX^>J%&A,Z)/6K7CU?GMP?]^N!HU%6A-+D.`GA=> MKMM;CN\V$S^[./K\7J`^P--N32;^)D6/>_58=2Z[S>'[#M]:P:LN.D(TY%)@ M+HU@ZCOPP"=6?OVOCV][S8&)7SM_Y,(;E8I/&/KBJ8$00GU&V1R&UG>XO-3& M=3[IW$!^)SZ?;,YTZOO?Z7R2P!)IT!IAZ)\&%8._X+6.?/5[4_H^!SO.A>YT M8=!@_4X7PONM!77I,Y'TA+>Z&JKE`L-+(?Z$%SQ&E`,K2]PK7)4 MK*(5KR@Y$'T@C&^"@@CKF( MTP6M$;`INFB-;H1C-4QBQC`*)HY@5(!:7!''$R7R3/%QC6MV\+7:@2`?C%AC M?"RI(@7^_/$DXO#>(,/X&;J=0)%JP:0XS.@],2)218%4$0/X6$92HL@5+:*E M)P6)2W&8DI%M[&6*=MG(5G[R<9^Y92[GF$L2+9*,QD31,K$(S6A*$XN-<-#" MIHG-;*:($?FHP0X:I:-G:G.<+[J9$QJBDQ/HD9P"\L4ZV0G/>,ISGO2LISWO M63D:B$`$9L*G/Q^7%A4,+!\7^*=!L:(&@:VJA_)\PCL/"M&(2G2B%*WH%2L# M08M.%'D/U6@V,U0584BUNM.P3DP[!2M1QRC)`!4T"T8GFPOEQ``:2(QR>1%!OL29308< MZTU59,00FI76P[8(K@PZG`I2(=;4E@@L'V@L`$20OB<0J3H)(8%33=0(E0RA M+Y+#`5'V2LY&&`>VF(4H6TRS3C7`Y&LFJ8%`_FJ1I!W4MROQR0<(A%B5"&21 MQ84F`_*`E-LV4ASQ<`(,%HNB1A1*#4[X05!="R00VHKWOA0UYV> M`T$-5&O/LX%1F#UZWB:K^CP,U4#^";E`''`_8PT:`,"=&:)`8KJ;EXCPUGFN M22."%XA'``1VF.(PY(K2TMUVO7;#A^/E6DZYQQ8]045I6>,)Z:26)%PEGYBX?&1;K6,!,!NU9.)FB4FJD>4]4$T,F+!I=AJ%;^1R%N?'0-'TZ;SAH%M>$&.7<[.FR0=)G^8>E<`<)>OY`0_E,/1)*6 MQ-)A5#'57NUG=ER[\H5[ARY,JK)IMSI@B\,`K3N;X!!77?#9KE8:/HCN;+:3 M4%NZUCTV$;(5H[_=U08&23FV409R$!HX@4'6*!+YV"UO.11<'+GX@)NWET,< M7@XK2N"B8C9=DM+AI1$37&UMML-9'JXEY`C4..Y*ET1>C;J)6*E&I;%2,PD# M5QQR2.'MT,MH@![,:.9@0!SP2B;Z"91L#)(MC:QDLQ-1C M[^H$BX@#`X(K6:)F.,"9G6`@"M?5IPH_4,+J9,6,-K=6EUD1!=Z-W2/\5`$0 MF"H'#0RK@;DP8`7OZ@`)=J#.7VG`%0:`:]4\GN4JU(`"%_+1E3X0DD?\X+0[ M^,H*:+2F=HF`][&K@N(S0H MV@]6H+>HUZE/E&2+GZ`TC?842PT M\`'$A1!GH5TE$25*<'Z>A1U5L`*"DW@4(#'<)'90\DYY@7T:T"F$$`]KHC+9 M418/@7UI0B"6Q'U`0AP/T1E2TB'^.Z`&'D<_?))_^_(%EXJ`Z$W-/!ZC\4(\1`E#S@V$$.`9],1J6`- MC?`20=-=4(!6"$"J9`+\<`8`^%-E7$HE=$9GV%_B1@1N4`C\",RUI`: M\M-_C'`DN?$!UO$1)G$=Y&$-,%$;IN83A>8KER%M5G-L*D`"![$=()`+.,`/ M'*<1RE$0@%$GJ>!^NG@9PG%XC'``N^6)-1`&\N4$&?@1R=8/'Y$+$J8"T4`4 M2D`#BKC^6W*P?"0'&2RV'@GR'8DXBX;7'EK!=_EP('2E$7P1#\JP%QWQ$?$0 M&A]0=-V7"QTG@\:A?_R``W:B!KF@$BN``[WX"@F1#[D`$PB%)31"[LX%@P&$5YR."OP`R#R%YIQ`I9X M&[L2$?DPD>WA'`[!"$31`>)`'1)Q`N6X'>X@D'WV"C]P%>)0`R/R&:F`&YJ! M%B30",+1<*YC+?(SBBJ1>A7R`SZ1#Q%B>-B%(613(*)@(=PG8@=1)%50'/_! M`)V2"Z$A@3#@!!"#*6ST`SN@.T;"%:Y6$A]@?1*V6W=9*Y[^V`&J\ M4A*:.1`J4$`]`@.PM3JNIB!KLD\CD1M\J20)D@KPJ14?0(P)*6%TXI*N&94& MTFFA:YJ/_.`$6$$!B*@>(CISLRD.TCB19%HD'`>AN>`._%$%3E$#*)H\ M/12#@<$<\N,$FXDSRZD$+TF7IG;;1=N-I80?A$36C!(TP9CT"$?5R%,%!`DRIKO^(%T"A M2Y'W$R"QL("B$2L@D(&J%AX*J&=B&2.F&'"E$C6A%:7%<,38JQ#*6ZY0$0[1 M9(+SC;3XFHS0J0.A%1FC*7)E@#09@ M#3!702KP)*_Y$.#ZK3SV#C!0&]^FKNP*1E789Z4VC%_*L<3J$Z:6"QWPD!E" M$H*1!DPQ/;ZS`DI`?JZI'@=[L8JAB!-X';8XI9R6=S[B@##^H!YRF@H4X"H$ M60HY.1(3B")],2DEJQG-0:(9QIZ,8*AVQY:&`0.YH!6H@!4>QS4`$`(5`7P+ MBR0>MTZ9>G(1TXRY\`-\B'"84QD:4)SM*0H:2AF?@0-.(!J-(&T8\@&VQ68` M<#/%E[4,HA7P&F$?PCF)]AD'ZX;]>HJON9Y`2Y#BL!T0=K=:EI25X1$"TF_: MVEF?HA`O"1'1)ZX2QB!SI!Z+PEN?@;[BAAB@6+>V9VC81NU00MN M1Y[>&[!\X3F/,)MTVR6A)CLHD1#HR1>,<,`?9'@6N[$]DI0*B;&&Y['68`XD M(!X(JKG_@:;Z.;)"&J&ST;ZZ\K+^EL$@,ZO":<'"GLM-WR@C/FNQLN.SS,4` M3L`7M;(Z2QNSXN"!2@*U/CJU?>$?I_:^LN,Y*@$Z2CJ4])4A)#"V;B>[C2!Q M'IMA8L'#-2,**TFVQC&W[ND1V+L2+FN+"5$O>2LXK.$<@>K`]GB*E>H3!A!# MI8J@C$!@!"L7':J?CUL@@,H6*V82E8L52L@@:)FY(UQQ5Q'(U/(#[]!@C%!# MJ)LHIGLO\5`#6;*Z[/L9E`:[!C*[(H&(&_H_#@D#I:48%5."U/$$2@`#=.`3 MO1._!?$#%Z"(@*&^LWH1)>$/SHMJ1JP2UX&EC/`$N8`(!H$5V7LXV^L?8;Q= MX$M%$-;^"!Z"PC8IKIJ!B+HHCX"2%E6@&=B5&Z?F(P@J!ZEC'!-X%*,A#M&( M%M-A$"'&K[0S,T,P=-_Z7")ABS]@(:4C`A1,`CN"%_K,S>(`6Q5K$X<7N,&Q ML;&"S#T2&@EY'2)[>"%,B6KZLJ=D&PGI$R#0"#-[$%60HIQ"JB#*9['20A0$![IXG1B)5A/#`9D*(``\FSJ%';'E-;&<'@G>>V$"41SK2C%:<& M$>_#Q(K!B@4+*83Q)]G*`#!@6]69#RJ@$2#RQ0:18<&Q'<QF87^NIEK`1%:W"$B M_*PS\[G48@DKT6!9@;-Z=#FFVYY8VJD*>1NE$YC_]<1?Y`0O2#4R*\4RK4]).M%KPXL[4`/J\0,(J@9#@6]>@8N:_1%CTBE5(&H+9C?Y MR`C#&*:A)LJ9V=Q(`A%-4"!5&K\CP5",\(,!"1'DH1&9'':`/9';97CR#9F4 MB"1'@8CM`@,!F0J!FCP_`)9M/8RI;7B`4A7*&=4[$)6**%HQ3"]68XMC/.`, M1KF;B1!]YA.K>V8%E60@;L8(?_"-7?F/:B`>]J82.Z*2 M#'`.4$L=-/`**B&&E:@96PF37R,2-:$45CN-WBG5?6&4G[$#/R`_FI'9-E@* M+VF5S,!-$Z,9%5DA!"+,(WI>%8?8[/4!$S,O\$.YUK>H:.EF*I8@$`$#.PXQ MJ5HBJ1JU-?'>T9T/RD4MF=@(FF&+TPBXK,M%68$D`FER6"%AI@@3XJ&["N-\ M2E(9N?!_TOI:R$$2!>LOB=H%#;9[A`X#"6(B M%81;&RKQ`^[@$1P=Y:L'`W>A&&UB#8)&`[&A`1[Q@"JA$!H0&+T<(?_C[PM1 M%AXQ)W+PJI.$)95A'"`Q!(5X.-7T$1,)2>\^JTY0`U_QJIWJ$1^0IQB2$`I! MG6?R`]UAA6E17AS<"#"!W8K(P3A0`TPAOFPG\VRK7@JQL]1!*ST"$PH!#8)C M$>;`"/$M?DB!(Q]1*]31)$0Q!">P3R2@!MVN$-_^0EK!*3#!#RM`%/VD%@2[YR5G-+CE; MRJ**ZP^--1<<8S-THP*.`Q#B&.$XD>^".($,XIUH9$T5'/S9U"''5&M%&=-C8@3."I:2^6$H`J?-SD6M!:/1LJ5+7&(Z_64AL*L M-N407%%3(",5)VC49.`1AQHU'L.*;0F6Y<=\#&HN5(/2;B.;C%:<*"PNKTK! MBP6K4%-79:-^>M4`7M%Y;,6%C>08;8I#Q,JYCP/C]"6B4:.Y-4&T5*."GUN$ M8?S18.QPH(C"*E;J!5O4FFG4%34+;*03[4;>XABH:%11A4:!:C)NK(LQ-@X: MHA`G%G?=6CX5EO/A!2R8`49Q7W'C9``UGUO%(AAL_EA<(,&Y,A&+-`9:6JDB MN<[KZ;_^H.BP*1X5GBA-HNH>:@DA-5:`JC&C\MOLONQ.P*HFB*#R";3T."). MNN7D>"JJH6KB#8>ACCL-MOG$888VXI8C[4<@@Q1R2"*+-/)()#NTQIKYEGSK M)B>U8M*H)?%;K2@$LME17^2BQQS?16;8'L M,\QG?R4T2G\V=;;;2>MD1!\'.SS6V23CE7=>>NNU]UY\@V2`'R52:2O??'/A M!P"`"S;X8(3GM8:?'8):P1M^:$IXXB`9">0$BC/6>&..._;X8Y!#MO>#&N(A M5.2;5OB`A!!0=OGE@H>HH08*AJ@09H`%PWEGGGOV^6>@1=[H9)A#DBYHI'V> M4M2DFW;Z::BCEGIJJJNV^FJLL]9Z:ZY['J/KCHW6%^NOJQ:[8U?`QOGL(ME6 M^^VJY>C4)D+Z)*3(3(_^\FH]XP673S77M#9904/N&W`DB3:2CL`+9B18TA2G M&'*;_*%TSGG_!EG4:CJVQO(C)8?^>W2D45J!AOL821LA.L"CT:;7%'CMIC$: M88"!1F:(:\FGBBK$64S"\A`[7K^/AU5-%/`CMS&@EM)9IM%ZH$E.)8II?5K:#`"0RZ8\`5AW4@$,;Y*+>/S0D[E` ME0)Z^,(R0;5O6OK2T`Y75"7%*$I]`ZHU%`#0&DS)"?S8*?8808%3R00`T=@I ME)2:&!H`$B76D($*H'6X2RW-&GQ M7I6+Q((H,694*`[F9">F-24,4[K`#C[0U[8>[EO+ZJDKA&G,2042)4T\\`&`(;BF.2@^JU04(@H6 MB4<$/P!!8N*A!%&`^"SBR*`2FG>3>'!X+"JHP@E"LN'*,.^L,!"!+QA!W$9H M0`->14@C="@*5H(``$8\(WX"^N!0X0``.SB)-"6F&!"DHLD1#K1$:5&%ZSUE M)@^9H`;^7P,"<\*Q!D&)CRA"D@DC.CAU^;CQ%7&"@_WR0P85"4\UAO`!"#PTHLMJ M4/-)0%!GZ:Q`/`*A@1(:?!\&/%L)'99W(R3$"`F;BB[RKN]]G^A=A!L)FSYT M+#J=$.M&@/`'K\/)>L=%T[&&E;PHQ*48A:(&)Z1IQ!FJ`1(_0($C[H##-7`" M&N6L0G)^()\-QW-.3:8$Q\X"`-=NHF`2.P0ZA-671XRU8S[^$ M&*M#XQ5JH"U#B/77`H@I(H8,2###XNCDA_8@@KXI(H5QX0DVR!M82HCSP)`=L MA+!2`[#R(J>XJESX(S;LBB$!J!]BDQU(**\;"X&AO[.*!U1!*";9@23*!3D3 M#"HIJ;:@2D!O\T*H4?1,T#,-B_R).**PQHX M'1PH.0;^T`80MI`#5*J<5P($1PP$5Z*)2P.L+$0K!1.L+A&H(SV2$S\2'5.C\,*CL*$*B- MJ($=V#K!L`8'\Z1&`"QKV`%*DJ07$I@=("M^<(*FP+Y_TD8[;(Q*S(4E,#T: MP($F`B(8J`%]`0!:8))I(B\]L\:FTBD],R=Q@`&9VT0$8X1*7)(C8D,E>`>R M:@3P`0`$6T1#O$.P0XA<\+Z1_$%Q"*^00D&71";!8D'I>,$QZ8J2^X"*4RPJ MH0#3.X'3*).$'/X0C MB1'$B.PZ'Z(1,4H%#DD,/2.O`-NY7.@"B=FK)1DBM[A(1LA(W/"CK-,3.:N. MX4J%S8(!K52!](B<1ABE7=PYC,`(!B`WJP0J]^HB0$RL+^J'U'/*+8H)^K*& M']"`A1`1&J`[DE`3W%F\4-P$@@$O:Y2S.PFK;4R^'^`(YTDUQ@*`&I`8,LPE M,LE#)O$A9GBO?`"!^1.(N,3'O=P(A)*D1,2(N$B?@83)-:P(I\RK/[H>(2(B MR'2L:@!!)CFB\;A(4(1`YKR>C?C^`>(J#)<2J]+SC5VRQJ#\0MQ[200=DO$B ME&G"/:-QB($1`=^J02C!.#N)B9RB3&",!PJ@@<0ZRM=K"BV"#I#<"*7<"(`$ M#B#+!0F:H[M*!?G"%3,9)<'PRET"RW[:)1/LH1]`#VR$.L<8F(@ZN+?43CWL MSH7QP^Z,2#TTPESX`3F2#A3:N8N#`9E0`YJJK\5,HO9E$*T80 M!7YHA$?^S=0C12NVLTQ,6E0$Q!4Z&"><`*7T^1+'C`D-L-(_,J)JU'/9*7[I%-*:D%J*D).'"YDFU4J6=*\_%0F) MC6"D9<6)Q#K"L$*P$:O1%46AHB"?2)W4'^B%LY$>WJ!7F+J@,8G*3-5+7H+1 M?RK5[7RAIO"&;TP%;3J\$U"5\X`A;`HKQS(:P2B*K9V*#^BG7-43Q81,21<)ZC`##50:9W6A'M/J!I$/>6' M(_2)L]N(/^*QK\J_-B&$D=09`/@#1CTI'UK4G/*)>;4H73P).NVLPUM4/9N' M37P@1KBC7<)"Q<"]47I$R+M&*&R(&N@Z';H>80NP/-E$'"B'::I`<3.379+4 M(,G',I'.:Z6)7$B%97S?C2!$3^+^A^MI!%)1PRMI.4)A@.VK#K$T/YS81]F, M1X&03VN`(YW!B0X`24^"I(T`P5S0,QAHBWQ(A3F-A^)BJ@BJB9)CI49(A48X M/"1CA#@@KT[:1$!<5=]826MD!)I1%6?%V#BJ#@7T"#,Y/*-Q!:H@&)/]011* M"#C$I.)RQ^(D0RIDDI/\05`[CF8%10\,`R7HVSQ$E<,K#"?0`$_Z@&7L5"[- MXDN2N7X0$[$<4EE,'T12*53Y)].`+RZNQ[[U1#/1`$P<",6R2-Q;8$[48XR< MLZZHCOG:`08(!"!0`QKX@$VEB`_X M@!5X#7[^D#F$."(/G#L84#O2T"&-2*SC#"L2J((1\V0QP@Z0@P&:R"D4J^7B M"SMO`P`2Z`DQ`H`M%HB<`@`8:"1K2"Q-EC,2"(SX6K]=&L?C<3U>=LKZ8,NC&!`!C#J5V MH3>56SL:V('86`$7"KL:&QAAQDG!PH=>U@`U."(E<`MEME7SPAC^W%=Q".;/ MFP8L3(-4N(TO.3R4P^9Q&Z.PT@"!$"--UJ&(N0D]PT$/E3?^B'/%_=PYA.#/ ML+L-)CGL".\PO"AB9;)T80_#\4EG/`A_5C`FH`C M),,\M((C)<@$3#)H<7#HNC[HK)LO8VP$)HM(AL!`Q)AE@:#+E<#?BICE+OH! MA("!R)OD::T(EP,Q+&&]++LCFZ!%S:2@%N0-N3@;]+@.-8R+^U"!5)B+?=-L M;XX/C+A9S:2,Q9`+Q4B%:_L_G1$!VL8/#E:"/SN!!\NWSUB!5,`8SP:?XRDT MWS@!?Q&'*E:(S:Z/_:H"0J"6(`EMX?@OTEZ"U^X(V]1LRJ"!N!"*)]-*$:`` M6MPO$!"AQ%B/, MURH&BNM0`PCIJIKP[:!([YOP!/`.38P0`:D`"JD8;<90'=R&L!=W;;8"S,@I3[1G@;W.C'\B>5LR:&S^1&W'!GF5Y M%@>Y`-@2*G1Y+C#Y\]+2%:)J%2WQJ4%7]$ZQ$R>YDC+I*2()U&<9FD6W]&)9 MDB"'TX+^:..YT0II^15>J7-2/YG=L@8'"?0]ERH[YRW3A9$N9.Y"JH?JZ#FW-V'ZF6-)L>ZF;; M43>L:G=[)PU7D&&_Q)U\$(5MNW>`#WB!%YDAV+[MO;*!#W@_HE>:204G3WB( MCWB)OQ>'<(G3G?@39`0ZV(QH^'2,_WB0#_GZ6W>1?\EH*7F43WF57WF6;WF7 M?WF8CWF9GWF:KWF;OWF[WF?_WF@#WJA'WJB+WK^HS]ZI$]ZI5]Z MIF]ZIW]ZJ(]ZJ9]ZJJ]ZJ[]ZK,]ZK=]ZKN_ZGWEWR`9[B/\:L2?ZLO=Z@"]V MU:$2TX(5K2+Y$8+[[_)XI9'[^KMXFY@MN:=T;U%0P,&57`>87L![>Y%1R;%[ M5K_V1`$6R$J8;$^7T>D2M4?ZP1!`$>CX6FKK*O!FVW&,:/O',-BZA[<:!D`W MRL$7=4L3I.&]&D,EX?YW(FF$$P`%T!&29':\/`B,CVK!0B4-SF[!%9`!&B@? M7R"<>U$(#0ZBDV8>%:B&W>>VBEF[^<"?\HD'T?`6*OH`%5`9]2X8GH`O.J#A^J`6\J M&H`0)W`@07$,&`AD0.*$M8(.'T(<>`+`AX81+V+,.##-148_AEC42#`?!0!J M&(D\*"X>@!TH+S+XD(H&#AI#2,0+*4X.C1H7&^W(]U( M/_?JJ`;&B5R,&%EK!*,*ZE0P3%O#\2&3.&OY`-"PR`@$CJ&6(Q)Z2'CXT+H# M&3$05=#^J;5S)P5:1G<;Z_?!!G1)L@@EPB3 M$,,,K99KB-!<'VJ8-[A#5*[HC'*EHH1.UKB5DT.$6#.1@`3E0@$%ILT'`$,% MC2%65;DH,16%VQF746`[,.!?+C204)`U*U#$2#79,0``#'7EXE@CN>2"`P"5 M.>2$"*:MT`ABV1$ED'<0:2>.*ZB=I\]Q3AQ6D"M/#01&:$$``BP M[7:>05!N%J:88XJ%"C%FF*&..F;4TN%Q%-20"U7KM9=/@R`BQ\@)"#&"HH'B MT/#(2XPT\IR)R.DFUEJG/2$0(VKXZ*@XD`YEC1HGH6316N+^T,:(!A1HRH`: M"C2TFQ,(^=,06X^J$9VB#)P&*W=JA.BH=8N*:J&CD+H*)"JU0E?H=$B*):M` M/VB0"W2YT@'=E]&%>)!OE!)$:EX^PEJIL'F>X,1)10`)R!@$`JHF%6@@M2L:*\P0CO658%VK9`GP:K9KF:9!E MC#0!0#Z;&F1-%8:*)8H&)A%F#0C\2&B-=PD"T-MZ;O5VG(T,K;:T9IR8B$-U+IR(R:RQ,4,Q(AZB M>`P(\H$#T*6/!.MK'Y_BT3P*B.)1H>E#YI&5.,#3Q-%\<0H=FM!CH)BYNB"MF,BTR&]H`0F MN.%,;@#C!C-H5$$0E)<_#80!3J#`:=RB(UWU"0!_&A1)K,'^'K5D,R\4&((* M:@"`%:BA)*(0P1#$@0\[1J`C4L$:, M62.D(6G$"E9`@WSL2JEJ`(`PC[-51L"`FV>I%VPRA+ZS[&U&&UN)$W9P`H)R M3!PDV!$#=D#$@7142VIH3UD:48/^IBH`!A^0@V-J\%B0]84J3\J:!G12U+K^ MC4`.ILUSE\F-' MXO@`/FO@$FNPA`8,V`1%3B"*1H!`H/*R6"KZDXJRW!(`YQ"5$D1J$-0I2[2, M<-QJ`*FT%O%'N!1+)H?-MLP(0!,8(K;#-!UR0'&&19OV$LL)<+'8L&Q,%2!JBF"E6`QL9PAIZD! MJ/H4NKC^XB87Y`"`0$;TSA]KZ%$`J`)/N9P:+6VX$;7,!8H2]X25K@PU.+"& M8Y88,BKE@A\F/0A]^O'.ESB!'[F81LFBD]2&)#$ZC*L-4/&Y5X;((:DT:@\^ M?^`^EAK0JP`M][FUE8)$1[RTTV6?*#:$`GP#0ZGHEH MP)^HQ.U$`"W/`)!X+V,C8%HH'U:%-`""$9(&^RN>6T<#W\V&@NR&CH M9,733BS9$1E9P`@G)"L?.W"4"EAC#?!^H#0X^)DVFY20G`+^]-_CS@M`-2>" MT3D!)#_8:=Z(_8'U-,)'%+!70T\JSOXP8#55B%W)E+"#2'GO(6&0H9)W$`C4 M*$':(9J(G1;:'YTPX`=01A$(W=3AHR]&;92(@(B;SHT2.PG+"%;/-C75.1=Q M3<8/*G)1%=+[3B?CX"0LL>A"Y<"(A2X* MOS7\\I814@ZF8L@)!($!=U,A>#$G;DA&7A]0$Z=2Z8%LV%CN?13:Q1U"@*`(\L=$.`$(*,K(G89S M>1GZS%X"NI'1+)Q>]$V"950^],X%4(#Z,5?[B9]#G%0(HIG1(5T46L6'A9B( M/1TU,:"Z'<=>)0X.V%][@%#O>8D(.(&$.$6+J)LUC)RSU88HX-^PB$4^1!X7'AAGD,"4#*F#7$ MK8B%"D@%;FF``8K%#K06``*66C"``B`$Z(7(O$%@Z+76Z%G#BGP`/ZS=G+60 M![(>QPP,R)"`)RA/[,4A;K3'283(%8G:4^D>[P6.NOC6AF'8M)W`3"1%/!"> M;L@A#20%#5P5=!3;E0R$`3``!0A(P;P00[&$+^2"]XU?79P5YZ!?^RP*+J'C MA,&?!M0`"9@6L0$C\V%B(_Q`/$2C6Z"1!H@`/L9#7E@2M?5*W0"`YIG11I4B M+$8'\12*A#Q49&D@"%R602#$STS89_W;831<2)#*WCP'"GK^##"BG]/H20W@ M%0H>5[Z$B`W.GD,=VPT6FJ00RAK!0`IU1-:`Q*KTH3EN2;N8A<4X8HL4G102 MY6+T`@%\0M-9X=P0B;P4AZ@98#T%B01W2URIQX%ZQH`#Y% M1X3PHC4H06F6.6<9_9<9D*F1].\M-E[54$N1\[ M"H4(98IC;`E"A(CA00<]P<9[Y20CK`ML1(<8[5SG1<3ZL6"RL`1` M/=I#/H<&.@:9_0<(&(T$[M5.>6"!;>1`="3':)-:[,93J12(V!C^^)E#B8-> ML-3W*1<,A1.4O>3ZM=9_T,`*B,4%&(6[A`U$X.2`\,-E94T$^>1RW(:=X!(4 M%F6-0L0R`4,KW,`-Z&@K-`+=/$0UU`!_]&8^.`$MG(960,AUHL:3L8")T,). M>5E=M,BXV8B=]!A*J(:6#$]XU),Y[8!)E804B8!2&=7$=*-I>-_5]<8:H8]; M3`J-38S^-B5+C<``0*W1:60-F5$%R91%>[2=-:S4"HQE=WGA5]&(4?P-=)27 M70D@L4E;)$+91+0*8`E:?:;&)?8%R.#5@)H&D_1'>_C($/B8:Y;@4YF3!H"% M/[PCRL%`4R56-%A1I#Y9BI'`RW')5]E8/!BHPY24:4!7=9#`!!+6>]J706S0 M2?@]B+-;1+?]2A-12?7>A4?_P'R.R,'SV< MO(A%GN4&>/[BG'%>$#Z$-2R!0Z['\?P'I4:'!EZ35T$#EC6"W8%J90%`'PP/ M@X(JBN#6:0J$A0+@>N1%B+07D>Y-&OPBZC"/DZ$?2RB!.'S^:3CRAU.*0X98 M$(JLJT?X5CZ<0)&)@+NFPK"B74#FI0F;*HD&.4QD3,@TK8Z,]J MA`*DP=!ZPM!R1$*@M&H$`WT$/-0438U ME@BL``4DCAHH4-L!#NY13$0-?,Y748[=)@<'P8I; M).\&50%;:)`3[`GCEH['.!:O]H76?A9!O5Z\SHX2J,`__@`(((<2P,#@#(1L MW&Z+W>]`5*T3R!%%S>"B.L3E`!P.,$!'/3`0S6!CP(#N2D7U`$`-3,9'-<8V M]08S2,6-"(3C%`^T\F,!GH`->^%`D*T+=TOQ_+`(Q-@:A6[1B1<_[H#T6F8\ M6,\,T-B0MDW^J@.,R`+R2PA:`$__W0$OQQH5P*UH:HPCR7!/5&GXA4H3!RL>SP MK.*Q`--:*/Z\S02QR*:SS.K-%)L?S/*,HI*A!*4R*&@C^,SYK,J'L\HFH MDD9?2K%T,G(H,TJL96R(:#[[,$A3="FC9T<7RTD3(:$4].",3SXH+@,TP5JL M\M]4,C]K*4[C\J30P$^HM`JI00+#"B&@PB:S2#R\AHTMAT5D@A:!=3D,BFZL-=(P1Z]H-5BKT/C0];!P]4#< M\4!FAU[71J\(S+!H4A[9E]94< M=F"[]65C!+$T2UP7"9)8HV=_]6+O#&"_L55GD71_=W@W=XB_=XDW=Y%^4J4>$%R5EB\EIR+9DEW6I8+AF-/9QA'B`ESB)5X6&5S4C M0(V'A\F(;_:)'Q.Q/'B-7P0(V-+N\,D*T"!G\#C:(,<)L--O%/0;']U:]-]S M]8*;;/<704HCH`(@P_CT.-!*-`7:`%C,"82.*_@J:?ER_*.1U\;B]!^V/$23 M.\23+X'^E(OY7V1YFV/6"6`A46[6?=LX@\?L$+P"B0#C3Y$?8`#5V1!*USE& M7PU$>[B+XF4X(E5!9"B!!DS=KOP`E0A'*A7'\/90$YW/<(2@&NQ`#7S`<9() M>N(&863"\#HH@LN&Q!@Y@1B7AS"ZHT,ZT-P4%%X45R4$IH.`IA_6AM]&N66$ MX^!'CMQYLB<$=!3,TOBL<&S62SR[F/Q>*CP(G>V/[UD,UMZ*G1^3 M'/"#2VF;%8G"*WC'B0'[\7H7@WP`#/@'R)0;J;>*&@P!5"$3!YL(6,(Y=UN+ M('<$RIX&S^D,3-PW6HA[MGV`]%7,O@K';>""3MB'NW?3\HW^R:(J^GO:8%6$ MR,KN.W)*%+(K.W>CQEC+@:180\DC36THS]&\C'_*.IU,16_B=G3<-AT,A=T)-FB__'3T"FF["K3X>=,, M]EC'/7*C1*KLMF`K/8B/#UG?L=W#?$A<0`>>!>5"?A=3?"^=4O4'P0]9GQ];/2U==$4%@\.+S?=]#A^1'C:8TMZ9TX`4-N]+_ MO<]GR@J\"&3O!(;??4,@2,'@C.+^#[;AESR-%S[D`S??^_[@AWQ![`Y1+7!J MW-8'.%B?W-9_O80Y@$#U:&D5E"\_4``.!5+.[U`\0)1HQPY(%10X0*<83$ M,8KGQ$F5>-9V:&CTX0<-1@P8K0`A*E4C1N)(BE,#`L3%C!L)@HB3:L5&'*)H M^**@0#0+$JH"A#\0)`\.>3L"5&YE6#M^;/X4*Q'DS87ZA3JB:GBC%K%JA5K0QP@ MAFB@:U2Y(>*BX3L&"'DM'D8:H:4P<:H("Y6-3J"-@;@TZ$X<:RBH821&F%GN M-(*4.(&9O)BQA@88``!!!057$Z6*)YARCK`**0!A)&N4`"`H!1_\0",70="@ MBI)0*JW'S_@98L:.7@QDH&CX^R"FT;9C#H+1B@`Y`<%S"B52LZ<.)'23ZX+&!-)"/314:^2K!QGAD MA$T2&)$C%2=,`H`?:Z`2I9%&0@"`@I$:H2"F$]H41Q0`/DC(B1_R:^A41J!2 MXBPU=J!@K)W6JBZG&DA(J`88DBN/$:N8J@*`7>,A`0:.<*``-3978"`52A.* M#BBN&*$!`!'FHT^-3-4HZ0F<&@%K6_JL$06S6>6@RJI<&'ESQ6UK2-%C!FA,HL!0`6,4!E`$:(DZ%GP\8 M48*&7%98,1=1M,VGAD;TX@4H&AD4RX&GJ(G"8>T3%M&:E"A%S4 M@(&?KTU]>H<\^=&@)!2SK99;;X42MV9K%.#JW'1G9G<':][]%X1M^^+L7">< MEEFD'4_()=J<<*!4:!+ZQ?8#H(X*O(8?W!9AH`T'FBE#?F`@"P"#$7:4@5)7 MR$D#&I[N-$L#=`8`I(_+TW%1:-7()1**&:GH:0`6A]'2&F;(K(I<&MGA`SJ$ MRHVC5)10/I7=':D@8<_*$&D8:+Z=]$4#[R(6:LSU M`2?$XS,[X`=3")&+/#QF*HS(DS7*EZQ3,S^313YGZRPN((? M5"<7P&.<$QC@KK:)2CZ=Z4H2@_*TZ57%5T]40Q2S5YVA6$,#5\SB%O'&#YC$ M0U2BL,85_?8X%31S*4[09C,-4Q4G0$8M6?&D./#E-\]!4Q0KH`&;P$,I,N8Q M%XXQRKC<)+3BV"J?C]204BKYF'Q2"8NF,F78QC6$7,#`H:!DP`Y4<,BOT(4D MF5&C.(*FA)?%8V)LH^@A`45%\9T4I2GUG@(Y5!\@J:"B^0`UJ8--$BL*"Y33B80#`Q53JLP/UJ0`'W3,* ML9:R5CTQX@<<&\`->,N)CN)E*0X>XU7,!P%Q*J`$-8(K%GYD*9DRQ1K08 M((>A_0>9R@2`61@Q,2HRSX9.B$%UA=N3RC%BK]H-+-PR1%AQ&)8?B%4L`&8Q MGUX^-K+:K*)E88J#"\QH!TH`:475\*]OC=8;;]Q(.UG[F(;X8KR8#%Q11*`$ M<;JSI1#^77`\<`#!D>'3D@VYI7*WA+N,BJJC`$B#AOA!W8JNH"A5*)5#=Y0^ MQOP+IL$U#$_4`!':#(0$-:XN#AX29"P.6:51EO*4J\%21A!"0_]CS+NPM12A M>JXH^#J@PGPJR$JE!UL$_$,'>>LH^OS@KX-D+E1G-F>B/FN26WWBR8"B('*% M57/:-2M<-5?>ZHPK:`/QVYXK%S-T;,3[G'$ MEB)`B0A@$.BB_``I(-`,#!A2608NFBF;58I.QJC`JXP6,S_[0"/F86%56D.$ M[)0/WO:H58O@Y"E1@]3;?]E1T0,QDVIRMR,C,O>Y1M'^\W9KX"Z_S4<$ M3JA9?K;+(T>#5\]$'F]:\3<0](8[0]$^3Z6#^,3'=;HDGV9$$PPVZE++"]5_ M674U!DS$5:4R>8]ZU[T>#)5O,GS">@*V;<71JY_1Q55M@:`VD5L#H`C/78SY MN#8Q%M`A,\`Q;]-2`9/S2%R8>P>I\/:65T`"0Y%+'*2FG0W-'6U[?V4'F86! M*&:>,DGY;/(LQO*F'1GU(GBX*<*-4?PMFTAZ[]3E:&O M>K:&+,@\:'4T#MBIITA+"J_::EC^,C/%@'XTY&,B*0[9+(>ND`WD!\ M6]JJ;$5+LN[L&$%[ZZ$]7%+D9"?)NV!A&,PL$V<)FV.LIT81FGQI;>MZ4=O, MO^EE*!\X&,(B"QJ4)UA##;=4`U;/;NYM.R:[_AIAZDB[+6MLPMQ#"^9VVR<4 MO)KEW.[^W[^29Y05"+W10,P2<@.U^0-T_INDYSW43S!Z+ANQLKID!T1K(U:` M35SGTAYNUF9OB"#.*"9F-H8B(@!HM3R'`1*&$?1A(^*!`4LNV1A##4KJX#*D MD5IN=\X!C(R+*!RB$9Q@<2`(/#*$^^(!*AS*L&0J/Q@C13R.`I)%)V"(:*IL M!3"*Z8K^T`B[I'P\[@&+A?%$`#PBA@/SX0,80/P8:`7.J8_:AV:"1E3X(2B4 M('F&)B9R(0Z@ZX\H@`*4IV8>Z&3$)H+LB`(TQQI0D".*!F6P:HAVA-S^)6C> M))E(Z']VPA6VRPFL80P`D8'^!0?*IV9J(Y[6HR(2$9>@HR%^R(+P2CZV"P;F M8Z@:0E8H2-&'B+O6J"%.B`+>88B@`F8TQ!4CIDAP MP`MUA8&@0Q^8[),@*)+6\&:P<$>L9K0L2QSB`3LR\:&H*J/^(F4JGF`''.A= M:J"NU"UL'*)?*,*"+E!XQ"$?0H(?/VEJ#DY!9F7+W@4&WFL&2I$^]&ZJ4K$P M=,(H6E&"8+%[2L*P=J0P*D0%\.H#,J10WHA_T`08B8(D=J#=B.J;'F<(&.,' MM+!44J$?*F0B(FCB>FE']",>6(`"W00EVV8GWT44'"6@1+)TOD75THQ_JH!D MABB78$5%1$`<<``?0NE:,NM^RH%-/F#Z5*TG_C$@H>P(R](L34(E<:PA2@73 M:L"T5`0`G"!(IF9U^"%!<``&G(#Q[N6OTB33HD@<'(-)&."6.!`'(`(U5@P$ MK'&BAFYUG``&<.`)&(`$?D`-:,#^(@QM"AOAEB+IB6`Q^5Z&$11@:/22JXB% M.Y@!`';@6TK%*=4@8C`-5OP.(%>S-<=+06K`(N"$([I0[R1'+9FB+RJ3Q*S# M3X#B`TC@GV;J'X=`+R/C8[B``60%?[B$`0!E.CB*4\9")?-!'.YE-XCE!X8$ M`/!!5"B@)K]"!3*!`3X&TW#D.KOO7L834'`#4!1B)_#R.06S*A&S(\0-TQ;' M,3Z@"@`EGF!`!$Z"`C+D*U*!/+/FEO#3;#`M,DE("1JL!MX*&+GC`JYP""1C M-V)-*T0A'W:D2*""-8DJTR9B:'8@4R3',X53#8@3!XR3[*Y3.7>".4\@,)_3 M.6QG.KO^TSIO"=.BZ+K:B%@PXW%J`$;ZA`;&0#VI0KKFHQ]4,B[ZY"/SDO': M,],JY5^B)CXQ0U0N9&Q$8`:JP%$F1A36A22JS#$P!8E0@S-')0R@`],Z)1K$ MK:\`8+I(X$+C(4.MX0HS#94R2@1J0`:62<"^XDZ3`T`!X!'&ZBPGU0A7H):$ M(A[*HAG[PAV&(+-X(E-%(!^FPE(/J<%H(!YRPB&4H$7Z(AY0%;)>E0:H\%(9 M`"6>P".4(V4F(D:*`*(J$* M0FDGS$$)AHLLJJ!%FJ1$A4M>GQ6+O),.]L-3>T%D:7!<7]58>>)'X9ZMW?%57[%J7?!E##MC4>OTF]X8H$ZK7?%'G7>[DW^$1N M>X>H?_&W24AWB)R'?JGW>4?0>J<7ULSW=K_M=_WW>[U$@'/W]6!W*FH7>WF" M>VEW?U]7>"?X?(EH/ORF-3QH)Q$8=P78=DE7@M]7>2NX@AT8=&O8AF\8AW-8 MAW>8AWO^V(=_6$R^BK%.BB'*4F_=0R>A:S*!F(F;V(F?&(JC6(JGF(JKN"B6 M+R2F>+B8`B\0U(J_&(S#6(S'F(S+V(R7;CK'@FJ;>'>90HVG[XSC6([GF([K MV([O>.D8(0P4F(J'BH_Q&)`#69`'F9`+V9`/&9$3.9!+29$;V9%WHHT?69(G MV8F+]BS]QI*9CB!457PHJXP]F8(?V(,: M(@=SY(G(MP@[`Y-;3)1C>97!I)>UA#%^618IF9B?&`9/^0A7X`-^PBQMM0KB M<(V[9"A.8%>068L/M5!E,1XHP&9*(H;^H"SXXQ$:P9JG3#+^INN/*9@&8G(( MC!4^_EA!4J$&J&0])B-F=>)Q18%7>:)$AX!OI\RP1.5;UEE/LJ013J"0R@4M M:B";P>?#P&1I=G4'HB&=M>M>A/FD*KJ8-WI&0*!*/G=H3,T(H4GF\#*8Q,0[ M&8!8M`6CF[@1'*.ALX0Z!(PD%`"^VD0-F"R:M,4L&T%U-B)\.H($^L-4*'*= M?:=+2$`#/(R_H(X+*F>;66FZJL)K\L&RCF)T-#I,7*6=T]&>9/I>3KHH[B6F MO>>%-!JR,B$$'R/XP.11&5F6FS%+7#=YA:)#.#C>3H@3 M;1EX5V6#A2*OU9;!OC!72@- MKV>W208B#(RV),2W)"X@@A-;N\JE0X;W7;R)$V';;U0);^Y%EO/0B/*W=//# M'S);)QIX*K!L:!#0L'&WIIXH03\IW0[Q7XAPK[5G>T3K<7)"D,"C@B`I6=S' MH7JI,B65>W7"CTW[@RLQHS@OA!G@`C"Q>S,$KZ;!^TZY$\F;@=XW2XI&/L@I MZ8`W2_C"A#:U@><;K_=;L?\H%=S$>F=9'#:;KC]W)$"*G/6N6^*FF!*+HXQ5 M06!J!6T#LW+$PB/)4AB@*S"*,:(5!%'CD,3;(3K\;C+\(_^)$>@@'UQA8IL1 MPL-(K'K^A+HPMBG61RCR87W@>`,-956$%2PRQ;U]/$<@ZUK(1R!4 MX*.'W&7C9L*G<_I2%K/"B*.H/$>HL"/XJS&"2$<6"8($:UQX%-).DBGD0`U@*O1*08VY9?J@#Z8@`RB" MTPDJQ1-7?2"@(E)IL$,H"-4@,?3$;,,PS$02ZCZ/+C^<6#ZGK;!)[4O M^$$%$#IP0O"1C-JP]681Y0*!;4@&F8`!A]0,ZAB!B)HTFEJ]5Q8HD1N0$8,!FSD1G M?B`Y4H$&E&`'E(4FE$`9AC@Y'$,ZZ"@M:(`<2``'QK;42L42JD6EBT4$R'U% M,%YX!H(9SH$&1&$'*IXDL,XB&D)Z-H)52:VNX(P6*J*\:J`&'(,">N''D3X5 M]%T*22O?LSJ`JN`$(G0JPB(>8JY#4D$4"*-NB(WBJBHJ,`G?]7T@R@)BM@A% ME,`7;HK%,$BXU=EX314TKED/?BA?9!K M9I;P60'`%SHDYL8E<(S"&]HM.TA`'2D>V$1QR$2`;52`!)*>XN5`]EN&)%[= M;ZB9]GV!9I0`4%9DUKO/58`F[#^:))RS0;Z3'U"A5.!;'%+A91"H.-0:.E*! M<^X%3B!SN%8@[Z';:N<118S+*W:`:DC&"2C@6_0!:D0"JSAA)`H`%48 M-0*@Q-J%'TH(NE21,/A9`*.54""8C_=3<4"-,H2:/O!V!UE M[F!DCG=&D`A=(B0KJI$:$@#46--`@ZC/1E+;KV"P69P:?CO$@Y@U!N6#6'^; M,1)@33M\8`U0)\1GT&'B,`*#!HPX04)-WE&8$2,Z$70A6SO^G`14%6L!\`%! M3FA@32,4C)>1$_S4I"*+C#6G@1H;'91+6P(`@D<_.,$?@:,-,013 M!_E2`W,#2626-55L:$V&-=(```4KJ8'@H8@FJNBBC#;JZ*.0+IJ3H3,RUL5" M2;Z4BT/!,3+@"3"`,`0(_/S`@`H"TD"FC5QLFHM$6%DC&2,1`5#?77-:8Q10 M-?S0D$3Q%(677759(VA<53HAYQ"I_!!7KP_N((JH2GR@`G[BX'#;"J^04`.3 M&>7CA*C,_N!AA5SF-A]-0!F$T(C^GFYV84V.!6D-/TX8.^ZHI5Z4471E69-/ M%2_"H(2A/SVH=Z5!RL0.I*0P>0I+ M\6E(R+3GNIP("#D]8\2K,-<0[CW'/$Y%YN5 M-;C`R]ZL;2@T6-YNXM$+5U2H(:51%JV()[\X/`ACWP'`$'HVO6YZ\YO@9-2) MM@:4'Y"`B)GJGA/K`L7M:<0F.^")9+QW/#"Z#TGMDU]OZ$<[$F@@'A2@)/QJ M4#HJM9$1U.0/`SJ"0"[-B3]C:,28EH>6>$FE+^[JV4(WV"5Q[,`S9>/2:$3( M3>H\TC$B0*$36."2RRC4=5!!7EG^0%`A9N"%;-!Q#PSRTE*)A2E\4KD(?Q@2 M5"$N12$D@Q*(Q@8^!D"I)NL,7Q2I-)=$+W$S>Z;FEBI`#\;'4< M<-VE;K;2J#C:F"@%;7..:FMK/B!#I528R!JB<`(CN"0@-%+R3\3$1!@IC``!`HA($^-ODGQL8D<:&<$2)*F8MY!'&H,,V(Y;:E!`:: M[$$D$(7B'O$<(^Z2(=P3%FPUHDA9(4E7Q;RFDT"``SKL1K7@NTB5M*)::J[O MFF3!`:Y*&L[F.O>YS_L@P7@5G%W1DVS.21!9^/'%(3@T%[;%+OLD@A-9B36? MN]DF/XW^5865)$:5.'CF/`UZ$$]QB0)^J0)"H"6.D3"#(/&(AU&(DES.T2I= MNZ%`3'+A#@-19S=:PBM=2H:IQ3"W0O"J%ZWX$9+F=(PHO#W0!RF@@B8.AB>Y M.,$*."R*WT%[*^2@0.69&G>(/3R@$1=4IT MR4"VVUW5N'@[*I`(=SU28UB%]4]+*ZNG',.CB>07!VITL!UKD@D%@2LF%25? M?QB1"7XT`KPHZ04-Y):+'T"$$13H5'/\13O<%7"OBV,+#`Z`TWYH2`0.Y*N@ MQS:?,'TR%U)B"V875Y/=T(`%CQ.4C(M"N0^I04,NHS!QI)+^F.:LA3KD]8A" M8*LI)E-Y9C$1YE6=0XCSU``$#=FC$\R2"QJ<@`%EPZTX!(4068T'*"(8W&[D M"-UF._O9A[+&!]ST*A)TQ"#M=<=$U'"7$O9G+B08@D`RM`,<.+(&%@%`C8!" M%ECN8#S8#$8NH@&SH+B8`C\8@A)$(0JSB")($N/DQ:9XS=OL0`EV]M21\@:` ME_!#K$81`0Y\(O$=_E0H'^^/[K%3GBJ_)& MCMF)5"S3G.7A%4,YT5)E)C($"JRI/])>(QCS4A[OGHFWJ%83#1A@%/GL!A\U M,;NX"5:L&HR'B_&1WU(N9I3#M*OAHL"'6%70O>T@$R\TH`IRV/*#O'`)(HJ$ MMOSGW]Q4K$P4E,.7!G"0YWR(X`-7`3;XPG,5XD@DL`)#L`,B\']7L5?5H@1O M\P$?T!K^#X@#5?`#_%`8_+`RP_91Z4,"?7&!2M`%HJ!(:O"`,,4(2@`#ZL8? M*B"!\1`3(D!0YJ(;/Q`JJ@(9&U@%HI`;A,>"J1!_:@`"'\`/Z1<1P`$"5:!% M)R"!-+!FR?8#*U`%'T`.*^=S)Y`1J>`$#Q%M-``1U'%**G(1:D`!.Q4/.Y`* M\4`T68@@6_@2G&-_(-`(#,@D.#!M&M`G[44@\'&`3917`95G7I<1*V9GHM([ ME_$A##"`2M`0?D2##*%S`TAV)_@!$!@/,%B)P<,`(/`#HI)2'[*"+:B)H?4O MJ_$!H@"*4)$/YU!Y\15STD0=RF%.Z?,!_*$/C=`[&B!FUB#^`J)P,$]A@:(P M0V]4!4[@+`#25RAAT,0)/A1A*]!?QJYD=WT M(H?!>&63)!ID,6_T)HH8$]"1:V[T(=#Q3.)`"&76DK/$`'I$&8QPCW^B1"?P M/VIP$0:P&?K@0A<#;*TU(-`QDDGB*4C&`#C0$51"E/U1#>(PDQ^R5XW0"]11 M1VZDDE))D@\"%-$6#_51+$>9:RG^F905HD719I(AV9(6HY3Q,I)G^91V(91G MB1&T`F,FF1'E4)90(0<9E%^8K%XA[/X1Z,0!F'XD90)6)S$YA)R7B,T)5[Z8C^X919^90WUU8) MSF9(.Q!_EL)(L299MB2Z:62&H@Y+*A1B. MR9'2.9V10I+4V2C&4@,QX1&-``+@8YWR!Y[564?-Q0#]\$#7F9[-19Z-X@_L M611FC-%JC-GJC.)JC.KJCW=2;//JC0!JD0CJD1%JD1GJD M2)JD2KJDT2,'@*@JA$DT"4"O5=BQ>)_50`"0,8(O1D10X`B3)DD M*X`JZ3=`I?5<65-S;?4>#OJ3CL((M*`&1R>@8Q!03QJB-)"(:MJIGCJDT7`F MN-0?P`85'W`":JF>C=!4UN)`S44'*Y,+I4$Y6*(P/=DG<='^+C"0?BH@$`_2 M"/"Q'S&G31:K,U6#:(PEI]ZK=AJHI!:GR]9 M)7_WFAGQ"J)00R*FE<$9FC#V-5Z)"+1:KD!YG.@Z-S:5B/D`/EX!;Q4".4TW M$(G1C0]R/YI$F;@&KM$E#E(I$YP$8Y-%)4FR';J7$3$9E;K"K](IGM89I?K@ M#VV5KJ&IG_":)!00#6>:K21;LO3W)\*CB/G@E$94$R^RLC:)5$/Y9SCPD1DT M'93R(1DA\22DTE$C7@K6#H'S$@DOC^(B;ME6L,L+*5^B]*B;7_0B6-4*]/D3@2 MA9=GVPB9<+-ELP(MPS5O*[34@0,U0)C':9MM&Y(*Q6:%RYQN66OQ][3%C6R%$2PAQ>`+-,CQG^*A"H->"#-&*,VN0I]1B_OI(U\<0_ZH:3#5P%#XP8A,`"&_@4RE%: MC:`<*54-/+@"%$`!3`)0'\`0.'``\2MY):,!+JP;/0B22I`'"`@Q> M@K<=1$-F:$6`]*_+EDA+DPV_*!(>%8D:[,AG!,'9[$4!?'^=S!0`W4S=+F` MOKG0"*O<"#XA'YWS)_&@6BD61G5A,`\":(34S0`']:*+H32:VHBJRY2R[[@,5*H&DK< M"`81),[$`&-M?1DP="VED)B15[5.>AL,%$")_)T?%V9/@4SCE%!)2,2Z. M&%2-\S\P<(_@/3>G]2'MEF)&81'3M3M=:X$UL!SMM5BC704I-$"X!$0I6`/G M1!:\$9+^\9->RTS@AA=N5>O."V1O:(1K$K8_,KT[-''9&K[AB)+9(BD9FY)\ M!HB9;M1LLI3$=X97BF6([G-AP32!B+[YK=T&QBP4#JB25%Y$\PXT09_*= M"/3CNH$[4AD3[B*2>67D<<5]6W/)/^$>9ZD5\374H7F'.G'=]J8`-(4O`U,3 M0[09XMUH%#P7>'0Y6XU$_!P<;_3>4"%"G`@H8GE-IP$UZE$%68L<*Q`/]2(" M:A"U,J7B\[179X)Y]J1/UX0TK279#R*5W!M&,H5&ZJ7;0\YLN^,9E,WAF+[A M'KZ@F`-GN+;&$3(&BA,L4<0(:F1W?T==JMWB+V)?^0U,#"'^!VJ`T.+A%S@0 M#_F<"W3@%4^0/-,$`#)0RSA1-CNP/$+.)0XR0$NN[(1-)3"@6C20 M%T09#%M#Y:0:DLP]-Q*1"L0A*,[B*:N!8OAA#6&^D*UNM:.6?:>U1S`@'[VL MBH!&IT>95TJ`%+=A"=3Q:;B[)1K25Y%-`MZY1SO@@RB)4*DN$KW!$'0@$7-B M7,LN$J+``BAI#0<0,2\RA\[!`*_0+`DTP7NGR+@S!FO#2=*:Z2J_NG46$A72 M'+BQAJ,1T<(B(*61A"`0%_>S'`JQ,TW( M;3`PQJYK[`MA(,=2$S/!'/&$?3'^O3P%-,U*Y%'EY0T!DR!J="4>L7:<4P/R MH43GV[#X\C7#^T4M$WK6EVMUCS8[L),?@!6/01`XX`3D_$7K%U2EM%`1DO,`,$]6\340KBT?W? M[RFWD<38FP\4!(>W\\!F8C`,\8ZB4/UQ(70[Q0`KM".E^0,3>$C60`C_`0,` M<0X'`W'^!0M:6_$!1#P1J90P$L<(A\,3\4#\4,.(P0H*.TXT,FB0A`852E*% M-&AMB`AK#*R!2)6K(",0`&Q6L29N2(TA\5*MT%A#PRR3C-1H@`&"`0,23O@U M4FG3"4Z#A%Z2R!GR`PZ(C'[$RRK.V@E1+:W%^Q%6HH:N:DB`+`A`24X<-5+Y M!.KU@PH0&I:*@B&*02,G-:K$HW""CC4E`!1$/.'$)DMQ##Y\57*B9148']3@ M^`%#!`/.6R.N@.$R'H!\$%&^AAU;]FS:M6W?QIU;]V[>O7W_!AY<^/#AT99& M,\BHT0HU.0N_3UZ!A#-EX?N-496B">C@LP+[S5"&!F0!AJ@8H_!?&C) MJR`UQ",()0;RB0>HV#(L:+"0C,H'0K$:X<^U-`C,)R<$^V.`AOXBBL_$D%RI M@:N00`2/QQ#9@VO'D-0(J<1,WNONN\IPZ)!!3_);"H`A4(2*$`,:R2>YY?I1 MBT`#R8/.O!FRTRZ75(9P+DOBUF2S33??A#-..>>D4S?7UIMIO:Z2$T>].^\4 MQY^0K`G+@)G>$T>?B`B-C1%&1\0S3T@+"@/1@]0ZU+4G8'-43T$SB71$0D-= M%$]`.;6&U-L8#&D,L<*:*=5#+37^5=6S^($5)55S4S0Y05/*M5,^(V)`RESP M?`)/4`64==8C,Q7G2&ORXO$-EMMM^6V6V^_!3=<<<=UTQH5JB!W-D:B M`2"5ENA4HPHETZ6W7GOOQ3=????EEUMK+K067P;RT"`5->?, MV*`4IG^KQNB-7?$Z;+''EE,?-2IQP(%*-F@Z6WWZ\2)M+]10M(4C6O#`B"/* ML9,&$*K^$"'P1MHF&S@&,]Z-D7S^#ER$(`N'/'+)9;N@!0?BSJ$<5[LM)P=G MXFZ!YAQHR<$+7C+?C4F+A@#!P,E_6^&$%=Q4@Y;507C\==UW]_KI2BKYO!]P M#8#;F=]+*>>!4AZX>NO$Q:D"A-81YWU$'(;`7D]^J_!S_F,YXP&$VQ8C M'O"[X!%'?M,+((W\QX`3@.`$/G)@%?H700YV4&(7>$,!M9`N(QC/`7!`GW`> M2+_Z&45>L?'?FOCG/0_6T(;[TL?Z'+"WU]!,'(1@`"%HAL#^@O@PB!F\T`.-D"J MMQ62%[QH01V,`")]L*,%1&A!)B_9@@,6<8'`\X+P8+,44D:D$3C(QT`BM4*( MJ($9U6D4`U")@P6UBI1+,66)(')+7+8R'_GH!Z#4\,L8^@>51.(4>&9)D('P M:9C5F5&(>,F>:"02[N M;U6H`I.PAST1S(Z.\\.!"":Z$%TU@B\3%0'=9K*"AT)4EG4L4?0@"H+9K4"C MV*M":\21CY>RSCW6.\$0E,`Z%?C(*!7$GP4A:(",3G0(5;"H_%8:CP.I-'KZ M4P,(6"<]Z57!%8V(Q$-!(%-K?A1[0I7I3^.P4PM.L)S)44--HQRIHP9%P)`X2)4&ZW&H"F@`U!<61'52C:E4 MI3H:![W^5`1Y6$D%J>K2HYZ@>T/0GCCBL1+TB$"J)QC1XHY:(C6H8(.96(%G MPS/<(9PV1C3H`_94L,O:8N^T!2$05=&#GLK0@@8:S-^=XL6Z%82'!MB3Z7L/ M0P/CK@2+9Z61:1NAAA,HX;MP!7"`9Z.^\K6O()6[G#.,D"B!EF*QSF#H3!Y@ MPARP0!P&X$4E`IHH%DP8E(3@6TCD:CX$0L2X(%#!>Q2'/_T]\`1$@HAS_P8B MU?:'$9GXZ'^)U3W-GK>Z71FN]%0`EZA*;P@O!MLUI9KB`YT@81J)7A<,I!S8 M?L46H_3^3M%M#06?S(#Z M!K: MI?7?$]C)5HP098$"I^<[J''G8&+S`8(HU"<":OEJJ.5FALJL8P(M?K M@@AB77'7A//+.F:$#+#GC9#HXWK^FEVXN*L-'B/;&3QW+FV''+2"SGKO?D.8 MA9[*O)Y^H%I`VRY(? M7NWLY*!">K\6(Y:K+1'6Q8&%\*%JXJL*41RG9&/=^]TH==@<<+3'MRL5G77+W[[6_@F>\U8+?Z$@\= MO+BSY\0LE)_DVWX@$&`;V/$YUVPW3OG*K_SAV-NS??[.(XW@8+5&/BWA1RV@ M(H.@\;S^U.;GBSV3G4_>CLD!>I$Q#T?R7-^T1\=S-4H-6Y>3WOX>-+T!F>Z! MNRJ\Y)\DM-A+E`>(F\4BM`M0(MPK.Y1X&B\(.P2B,]8!ON@1ONZA'UE;M<$Q M")JB**#2.+L[/_1SOHC8N^B+B%(H+<"K#!\[,J%CD),#,^YKN5VY.<@COQ%, M`Y]KOO02![63*OV)#5_`K19\/SHRMQ#Y,JD:@@[PL_MS0LG)OQ>(M_7YG`T( M"1#".GA+CG*8)V?PMX1K/=DS.`;%(=`-$'K&8(N MB#Y:&,%RLZ-F@@@K;^:KS!1)RX6=$'H(M).].(/?PN.,S&4SO" MB-*(BY.JH>07H_B`'5""?81*;RD'542;.KB9=_HW9X`#GLDA$_*_`_.P>KB` MC*"FUDT4ZQ"0@C#J2PP56$`,S5IL/!J`J&WL[[P./4JL" M3[B3!Q*]6"FS9K&&Z^&R*_J7OXN(^]&L;Z+`$V"5N/2UZ&"0&/E`&7,'ZV"5 M%9@=R)P>B.@`[+N80%P!.M`(&#,7^`H+P/1,<5B!8SRY%Z+'XM,X0*FC:`(< M%6LV(.07`^"RU0"!?(S*XX03W!NA$:&%N#$>#VB!$JHG+6`;@YA%+W0&#R"" MJ`,L5*S^'"\@(.P$3RTLHD&#/;/#GQ@@5EP!_\*D4!B3@>EPO+_I`)*:'1K@K2.C M`36)0)[JCBI0@A0S40G5+113@1)QD/E\$'$0`240`73JKV-L&/*PAEP8`@W( M!;!!SBJ%$U\P@=P@$/Z4B-`Q7IK`<8"SS:M!#A8 MCX1<*+ALN'/!GZ.R*/%;O(BKS2IHH_1:+YL2!Y3\JON8JI7^XKR^1%2-\P;6 M62E6Z[9'73^2@BFN@+:5`(DK^2@EV*DDU2-QJ`8?X]2=&K(E4BZ=XC)/"(2_ M@2T:PYZ=8JN^G(?)9(]XF`>=VJF8,@A"7:Z;.RHL81UW0-0LJ0+?NM.0>AA_ M<`E1H`$YL-)G?9-0/$`&9(1^2!JE>0`&2"&4Z(&IW8WE7>Y7T903,=2BM=."$>+0!/7K#" M1MF[Q-MM4=YEWN[UWH<9K'YP7#HAA/`-PU$ZU_2UN.]EW_:%*S/2!P,P%.YU MW_JUW_O%W_S5W_WEW_[UW_\%X``6X`$FX`(VX`-&X`16X`5FX`9VX`>&X`B6 MX`FFX`JVX`O&X`S6X`WFX`[VX`\&8>$("``A_AI3;V9T=V%R93H@36EC GRAPHIC 17 y83222y83222z0003.gif GRAPHIC begin 644 y83222y83222z0003.gif M1TE&.#=AT`(<`O<``````.#(D-"@&$AP>.#`4'``&&"(F!A08-C@X*B`$`!` M8%A86."P0$APB+C(T)BPN``P2&!0")!P$.CHX`@H,,C`J%!XD"!8<*"HF*"` M$,C(L(@8.,C`H,B@J,#0V,"XH+AXB*!(8$A(2-#(J("`@)B@F)"(B$`P"(B( MB'AX>/CX^+BXH!A`6,B8F%`X"-BP&/C`(("0B`@@,)"@D-C8R*"XP'!P<.C( MH'"(B+"`8)B8F(B8D%A(0)@X6.#@V("0D-"H@&"`@`@X4#@H``A(8.#0L(!X M<+"PH#A@<*"HT."P(*"HP"!0:)"HN.CHZ,B8<,"(F)AH2)"HL+!X4(@`"!A( M8!@0`."H$(!0,*"@H.#@Z.#`D*BPF,#`J,B0:!!`4&AH:/C((/#@T'B8J*BH MJ*"`<("@J)`H2"A(6,C(R-#(N!`X2%!X>.CP\(!H$.#`B.BP&-#`J,C8V#`P M,/#HV."X8+BXN,#`P(`0,$AH>&B`B!`P."A8:.#`@'B0F(!@2*A@<#!@<.C` MF*!P4.#8R)A@0.#0N-C(J/CPX#AH>."P6-BH&+"PP+"PN,"0B+"PL`A`6'@` M*."H&.#@X+#`R."XF"@H*,"0&``H.!!(8(!@"-C(L.C8V.#8V'!8"'"(D."P M.'B0B("8J-"XP$!`0/#P\-#0T)AP4)"0D$!P@+"@D)!8.%!`0-C`P&!`*!`( M`&B`@*BPH"@@`."P4.#HZ,C`L!`H.-BPB(B@L)`P4)"8J!A0:-#0P+B0<-C8 MT)"0H``X6."X>."P,`@P0&!@8(@`&!`P0."X<.#0P%!04."X:+"8@#!8:/#H MZ/#HX*"8D!`X4-C8V.BX&-"PL)"8D)B@L*BHF*BPN/CXZ.#(H"!8:!A(6"`@ M(%!XB."P&,"(8)!(8'"0H(@@0.#`>.#8T`A`8&!H<"A8<,#(T*"PP*BXP#AH M<&B(F$!H>+"($+"HL&"`D'A0.,"8H,C0V`@H.("`>'"`@%AX@*!0:!!`6)`8 M,.#8N%!P@+C`R%!P>.#@\"'Y!`@``!4`+`````#0`AP"``C^`+,()$,F"T&# M!!,J7,BPH<.$`B-*G$BQHL6+9/QDVL6QH\>/($.*'$FRI,F3*%.J7,FRI4*-*G4JUJM6K M6+-JW^D"-+5H@P8D;'F#-KWLRYLV>MDT.+WFOY*9// MJ%.K7LVZ=>+1L&,_'%C8M>W;N'/KWIU2MN_81R_S'DZ\N/'CKW\K[XNQ+?+G MT*-+GVYSN?6OEO\2ILZ]N_?OTO7^/AH/60J91PG17P]:&[S[]_#C;SZ?_M$[ M^OC/C]]/4#UZ*>KIM]]]9``XWCO7\+=?@@DF=$U_L)DFWX045FAA3J>I](AY M"P68GX#C`?C.@O<]DN""]/$'HH)D/-CABQ#NU=Z%--9HXXTPD1?@B?WIN)^" M_OTHY)!`/LCCAB.2U^./DOEQ`(Y01BDE=QFZ1"205V:YGQTAJKCB(^HP69^2 M!!$XV2,SLL9$E?&Q&9>;JC%Q`9R'T3G3FHSA^9*>GVGI)WD"Z:`#"802BLJ@ M-J1@@PU@-+IHHBB8<*A`1+;X)WJ8_N0BFB*M.>*YYFJ>(94+$1KKAF54L2NHF6B3R@7*PO1L)H'PT\`YR8)ZSF>9I()P MRW4=`$G.Z73#90#)P/N4$K'3-',%,"2XG'U:%-NFDTU+1YXB"B\*?H8`" M*KID(2BV9*-"0J(I:-OHVFRW[?;:X6[[;=NP/+JHNB3`TFC^W8RNO:C>B09N MM]\V!+%O`V90HC@E#C3N>..*MS/T6P=<0(L**AC`M6V9)%(#+0B$W@8MN)P# M"9T;X7)YZ%H\<,XYE'!T0"!FI+.XXKB$(WL@"*B@!3R3KY1/-^BH`+H6'L!3 MCA0&$+&P8IF(`Y.\V"].PG4MSN`#J/0Z[.S1SUKH(HIQ^6 M"268UT"P2MW4T(8*'LSOV=MQ]Q\WN.@*8+<$.,!S+2`9Y#J7N,R%P&YY:X#$ M*%<$S<7`<24#@2'1Q@6Z40K,>2`<8PAA"!V`N6[HCRY5.`?F5#"&]JEI5P_P M'3R8\"3:J:`-&@%)%7BG@GD$@B/^W7!`*4"WN7,$0GN8&\,N+K#$Y:V0%MJ0 M"1.(@`OJP8IV0U0!/$[8M.?!)'@R@=D*P^&\NSPK%>$H7N;*8:<+G(,=*U0' M"$4HBGE@+A!/8L+T5-`$2)0*B0XH(TJT$0XI8,X!F6#B_M[&2$+`D1X*A%!20S$)<3VD?.(;1LKB2%XMQ))G#Y`,4`HP';$!B*R&"`GJ)2'.2Q&)824$]TI8" M$E"4HA.EJ$4K2BB.E&.QI2E;J44"C8Z$19&E)4 MA@02JY1"&4?%!`4@X`$*<*A66*6OUFBC=\>L`IN8`(EN8.X!@LP$/#`7#GGV M=!Y:"-8_,32=,C3)UJ.3L"B3$`5:@G8:H9FA!4GFP$ MC&^J0BJHU[U.O8]Z"LO0KTKAA^[=%:]Q815B/_(L[2$2-1C=Z$4MZLF+6C9M M]BC49#5+4\V:]+(=39MD)TO11:4-;1555*+RUBF<8DX*?OS^""3,\("^,C8E M<'UH1^C$VY:X:B6_]1Y:'3K%&I10GKN%A'&UV"HB+!=X'R$"/,[*D6?!DYDM MRX0"X'F.J%UMKRI`Q^:(AH"Q=J0*M.BC(FWB!%P@][8F"2Y\0S(JWWIQJ2@Y M(U\7-D5[-H^QD)`C&W<;UP+3)+?S#4DF[/C8SYSV49U4%^%,2^%'Z>ULJV64 M:%/0J!38P[1GNZQJ+4O9#(_R;G(C1N`ZJ6)UI]5X50\%NZI`@LJ_&;"N[L]`)")R^96_;BZ4YZ5KG)& M/2Z"A`C^]?02P8Q,QIJLT;FJ6)!W#.52-VUR--05;Q_]8U;OB\'CY8RW+MA` M,(Q+PI^DZ+=$RZA$^;I1W@+#!460#!$X^X(2G""XDN&_;B$;7>8*UP4).#>V M=:H<,L;O+KP[Q9QI[%F)QG2S4M&`1,`J0Z_[[3GF!*=RD+,!%RB'-M!WFE,E M`LQ%2\0/316(5"#4U)`(A`6Z(3%6(5JW7X98('+EIHDEXF:K*O@YP/@L>\+V MH9>;I;[^G3M&/5>W"6PB&]5#Y-<](25B7:LT.4IZP@1PK'%9VEC MN;@@PGJ+%H@?YJ/@N\UX`_CA;F!J0QV8,T/*`$UPC6T\W1S1=SBHWGFKY@OP#$VL&RCR#K`NW@B/-2D8A3^_EAJ2A'(OCZT'*$&DX' M**JI+LYCHO]0TN=HQ\'WG,BU,\%Z'N'8!=R]"WW3?6CZ7GK#4UZ.HJ/UW1!; MV=>;AFL$WX6!*N869E6[8KZI%A8'7(`(>)`,4I`"@:28PPGF,`<1\)[WI.#! M'&S/;%XWN_C.+CX"=^ULVE/[@,Q6]K,/N/SGQ_BUD(CBLQ+^$8ZS$P&7H3.> M%*X.$C,@0`ZKTQQ'#/`YT"GR`J+P`"UHH0ZN5>P!3@A=*1R`@'(F$A[PPP\; M\20-$$-F``R!P&5M8`8G]"R!4`,_10EMX``6D`K=T`V4YU=,\`!:@`"7(P?L MH"S=,&AC(`2)H$9M,`9'-=!=31,(X>"!L-*%'D1^ M1&,!'E`*")"&X;!?P@)JG9:)ZN<1%F!J8P#T`+'7A# ME#!Q/.A89\<5IN<1YJ!BJ>4W`%1MX`)]M3=\OV<)EF".Z(B.<\".,U04,[)`.[P4_9L`1 M[7`YM!!G'N$!3M`-L&)(K.0\JT)";;!>1"`]AV@KW0!EI@.I!P72H0.K18*^W0B3#YB5UV5XGP M`,((#]"4AM=@1Z70F0IV M#KUC`;MP``UP/W*@+]D3341`0A[(5<%"!,N$`#]T`?:4.63)6**X1M4E!$U0 M56M2<@!2&'"QT'7:P&7BA)>8@PL#!BK:8P`'"9P)68@W*U M5%UAB78\9I\JH`VHS4&P+`F"K"D;#1%@V8&"F"E/[D]WE2DF1!# M1+I]G)@L/86=1TA?Y0!U-?"J^\27"G,S9D4)Z7!UL6A>U>0[8)=U7&8`O1E= M_C5U3-``M/""''$S"`PN0$VA>#4N"BNZ``6:@"DE-C,,I, M#M`$5\=ER@@S3N`$DL94X*652>I4>;8FY9"%#N"K!K`]F[-@([F-=?%[_9E[ M_3BAYWB@"+J.)\`-"4JQ$+BF#9"0A5*P MJFM"!/-@7I"`G0+X*X$03:8#*NB*.8D("9]("X.(?1:#9X%4)420A##9.3K( M5%1K7'`&:=5EFRO4=<+25FP:-9D0#C2).;2@/(F6@V5V$N=P/XEH73L8B@FX ME\/T+.N50O?C7JP=R]I*V750[8""97;F:+8/%!KMY@6$I=#"0.F5U35/LI%50K@3U'+ M1P.F#<+D!^TS1=R4BOSUFTX`LV>(MT0#7O_EAQ)9HU0+IS#^>0YU:6?)REQR M1T*E8`",RE37U4+Y-FC$R1&*6@J*%#WW8P:QE;JY&I,=)+.D=XA2B1G`YFO, M1GTB0"[+]FS&QPH"R:$12H^^UZ`$^GOR**#`9[*_EX\FZXX8J[+`9P42R@VW M1X\KJZNK5*SMD`B)P`_I%5O]%91C%@B.>PZ29D>PVS2)D`Y*!"I%:SP7(+>E M!PF&5`KP\#.W!)-35+DP>44=%`ZK*G>5^[20,&A:`!*]0PGW"S,=!%N"!;8HP4FU!$'T+%BOG9)%'91-O!AHI52)K527J-2HK0MBI("V3(N-A!!M]?."'1\S>8M`.EL MO'?`%]1[#NRA*BM[MG>0N,"H@RP$\/``>L;'#48T2;C#IAO$36,T;`6T`)?. MG/:H[?#^<#IWQ%P#Q2PD2-_'R4QE7$'+T55\IQY1#MQ$1B#CS%`$*Z:[RAU1 M#EO,,\_B!VT+:UC[9M:8=$1@`5'(3%2GQHCU++*J!6.0;RR!RK)Z38S&Q^Z% MI]^,7(F$<0KP1KV3N4V#S>Z[)DN=AJ$3U^>'`!I1R<`Z*GBF!5/O-L4:A@%&0P+0$R-BA@`\[&SAG^QBTQE0+)`$#A MJ+\I2PHVL`!H0(\LFU/M"3,)\RO\BMHY?9Q;B)T@/;LR3-(\>)]@AYV/F@@G M5`XLO68H3&A,],,R3<7MW3L\35]$<)RKS";:$')=1[:JW#[Y5M0B47/7U)YN MFJ[4Y9N[H)%/!7FP0M4I\5=W_)9>5%3/TE116`I7Q[Y]_(QCK6!$T`X0V'*) M/&[[#<[E$$-IEIKZTBLG+9W:1W).G"'XS==+.FKQ_AS+=(,P=CCGFM0L)WMEXJMD%B\IF(`?S0-JM$H/H M#2LBJ5-$8$A.T%WBUA$M3C2GDSW^"*#,&[F^\NT9^QQL&3;HBV($:&,/')8H MYE!1?<,HWS(W$[0`JT4"9'`'/V('FJX.GW#<'48"`'0V"P`&EA5)VE)1QW8N MI/!M,H96BO0LN#I>8YE3%@U8"^-$-5V_B*1(1!`(Z4"HHJ`_^<#2BDQH&1+3 M54E#;1S(4[1W6HMUU;6[JDSAZ8,Y,A?4`P;E$"X28][@-&=/.%ND^-54-(GB MU.3A'PX/=J2$5EE=KHW+N[";[%-D8%UHXS;62]4Y#D`+4I`(B%S3+MW64)Z% M;Q[A\+-R19:Z00SE?,U4@U;G+(%N9N`$E+!%J?SD4<[$OI0L^4KB)\T]VA1J M'K&M:'7^S(*T["YD\DV3EDZ@#I3MS,AZVIN30M4\,%BJS:79OL5;B;3@`/"Y M"^T[WH'>&1R%`C&06I`26216W1HUSTT?2L)&"@O`T#;P)8]@!]>""MCB-5\3 M`S#%6:*%Z)256H1B!!*UP=[3LE),7UBVQ&B%PTE4ZRK`D,*"ZR5]L'C:Z_+. M-?!P/R&8,O/0!I)#$M(.56XB3'`&U(>===ON/;_I926A M/C[[IF%NLY7[S$V#[BEQ*@9PADX`QN))BXRU$>K34$6:N-.,[SP(1PXPEF`' MW_>^R!R!9VFK8%#;.^U$!%60A=WG$9MX>?02SO^O"K.3)Q3E-@: M'\NXV]IR"[W4[IO^M?UC]MD=@?(S:^8L@Z)M<*FKPJ_=[.:VLL>@0D)U=BJ!$/0SF]MP@;`<$0,`@0(5"A(%4Y"(@0+%P8(-22@D^+"AC8<1 M'Z9($?'@03`ZR-BY8T?D2#M9B(&QD?*B0%0#=>AH.7"@0(@%%3:L!VO73IX\ M(>%2H4)*.28]>V8*5"IHHDP](4D)V@Y2HJ"TBAIEPFX7DZR)0X:%I)JHJPMW=JGBI8ZR9&E3^U89XY]E4C)MRQ37T*L^SD%48(#+WLXIY MG$4C+DID%Z6@#S`C1CIO-6LBBR,W/7"NC0I&P; M[0"QPE%`F[/:"2J<,JDM->HNRTOWEZ+ M[38`9X.-IPMH4:&)WZQ38(./TD"R8Y'4$F&&&*260`,/=6<24V%8AIHSYA8 MTJ/$=TR`Q`P%SUSM1W?5F&W5,I,SHZX!,NJQMN.);^LK;!V,:=$#'( M:K@K$SEZPXR)`[@U`.)H3XPZ3!IAN^K%&*D[:[8!BU.!K>KX^5$[(8G<*3DC MI="0PZ"Z61A5!:2`YT'HLD1XM@]WNB#++3.1E<`R!R>\<,1F0D4'B"85"*9' M&Z?I(H8J,@@C.;,@@XQ''B%)'3O(2$$$$4@XU%!$4;))IC0)>G3-2&G22=QR MS`B*;7][\CDH!!QK304_8B-BOZ`,@*0<(B!)10MJN1(^$83U6_)!!=21XM2& M9"LRL))D0G- M5`CW-FV6UD)VAL,J"S2(1.78#S_^XE8AR-0&1+/IEYB@H[QJN64_9%$1P"CA MG-6P2G@"2]ARJA?9!D2,M@`#`NQ00H6L`!B\#(% M-F!4I![^DC@3F+(B+3&!/50$C`<$I0E""%,7&T3)70#C9U%DC6O&4C(O3@=` M(G)`(G81"$I00BRT"(3SFMG$:DU%!7(XP$ZRN!?JE`-8X:#F+A2PO53 M;(,#RDD)=8S!H#P35W)@1(MS.*<*P.!-BUA8&3;R1`%*XA^)HO6_"7$EGD'B MH5)PP;O@J:`4_`CB3AYZ'X')LX#O-**8M"&QF#+3,E(T2L*,=+!R5-`Y1RL+ M=(R$@+:H`Q[`T(:1GNF^H-2@+>QHCTD3`0]VE",Z1&4")>`VFZ!0@ILHRLM] M/#!02I@A'&.`QUF*,L]4>(M&87O`6;O4OZ.\5`O=V$4B*('^`)%J`Q=^D1`" MB*#$3!PMGZYI0SB>"B,,,2$1'S7*`:H`B4Z])I^W@<1L/D%-N<"H?#X1$3S4 M9QP$\&,7J7"`:\(1B)%25@7H(%%3/`L,^W6H%#4PZ)"Z01\B.,R/(J(%/,99 M`[YB:!=2R`X1Q$*)-H+2N<\5#0GF1">#L&YU,W'(#X29NHBD:2!9`$D:Q)N& M.XP7'>0E03*201'I@H$$8.!E+A^'`NW&Y$PP.2;B0B&:"YQC>\,+!,.F=LES M:(,=I7#`!2H8I'-HLT,UX$PFR.45FHKEG9AL)K8"X5@$.($I3+A`("Q,B7-< MH+\91D`BVG*.0'1)8N=P%CR4TB'^&G<56L!)Q(7NRH1`-!-??#L'N>00B!4G MPC5.A9:_OJ.-9CIAM1?01C>:B0#1FH5=;8",.AJ@C0LDHLGS*8HVTJE-7!!9 M3'U[9S?.P83%3$Q%=X,,`IY\#@-L145"48@':Z:XM M1#B1GGDEXQK?="Z!<'"C4YRP0"SMQ0S32XV?=#L0V?`Z&*J,2?W`A()99LU, M.(<9FQ6D=EQH+:6@Q7TD9@'!L=B,M.A&@&\#8QO.@\BHQI034M&6_IXH66W1 MIE(#W8:TRMH`;='&.8(][![-F,9C2%&TN>.5=K1%PATRD@.NY:F$8;1&?X9N MNI\K$7;^STF^J>PNY1CR`Q3`9%+#1(4=R#M>6:*CO+QX!#%$L`!$`?.7BK)< M*NN1N,39>W'V_@0J/K'@%8GB`>EXP,73889NM`]`!N@2+1`PCR=!%D#::`(M M2M&&E.&4)P]8#@+&D`G`R4&Q0I2".BCA!"<@``&4`%F/I)#QB^.B'8$P`]'3 M0;=,6$`*&"]Z*O0)55Q00@Y7E\,\CIP]%24,%S!"@!P,0Y\0X0+J2Q\0/)Z> M\8W3531$:$<-M-!S+6AA'EJ)8V;&\"1^/$#K?-5"$P)!GRH$0A12J`'1:X`+ MK;AQ%^?PP`,`[_.9@PDI#T!*.%*+`%H$E(X]*3QO2O$`(K#^-O$7Q^UJ?,;7 M-@`=$I"^K0"1,J0V-*$O1$A$#50>4`O@%"F!?P#6KUY<+52A&VN/>EG@[H`V MP+H&B=C2;>I'B>8C`#:9X`X"=AN.)A#]`6;HKQF@GO%PG%P*6BA%*=01XE)H M=86(J0(\Q*_X!]@J[T'BA]G9+H5F)9WM36`'S]"_C)."CCL'!T@_.1"M3/"B M>>"+,?"^!QB#<9J_C&L"`X@GI-BY4G`"2F@'PD,Z[[O`CZJ!Z@L'M*`=+8B: M"X!`[QL#3E.W&"035&J(%+"'7WHWUI&(R9$N]E*(EW@(Q_$(D)BE6:J%-+`# M'0`#4BB40K$!8GA"BEB<1_F!@HC^B6**$U1"A6+:PD_8E$PHA^(IAS"D.3$9 M+!8;/)?#G1`#F?N#$!;;!?H(!!9R$;08IT2@%<@JHC!4GPP40R>:C.,90R-* MF&0)(IK+!'UYO!(4DP/0C71B%<[0ES\(?PXH4BE"4D5!Q=0@/1:<(%J(>3<"]4>(@X MF4)&B;='>0DO%!<>`4H>&9.Y(,8PF8MY-`M%O(IXXK0RO)V@!".HC,JK*`\><,@NIW(JOQ`I9Q$M- M&DJU-$JII$RZ'!A?7$S#O,R>T)>]W,S;4<2C>!G,S$BS/$W^A\B(D(P!RY$N MAY@(CZR(C&@)C^"H'SGD$,L@"F\0(6$B& M.5#09(#)72*X74H)E*B'D+03$JB'"JI M1'"`>OG0%671%LW*[:$$?C@+FF.?71'E41$@`FB(@!V,R( M7P)2R?G(@W@EW%Q)\@J)1U"'1R#^`0==`#0X`045`5+04E(0`?4JSI,PAY3H MR(:0DYM@KPDU@OWL4!_]T-_K$"TH)P=P`"/9,S:UTSO-R!/Q"H$2J#AS.SP% MU$`55.A*@5N2B`F]B1\84AJ4S<7)`LS1',X)"<_9G`%=B.`4`07EACF`243) MTBXM3C`P%#&%!5A(@2RTR54*25(B`1W(`FI0ID%ES^PQ`TNSK9:3U5Q%S0]= M2P!A!W0P$AJ3L_=ST5[5U6-%5C#Y)1T$4IQ4'!*@MSQYS<31'-WTDWT;KVR] M`]!)!E)04&^=`R;<)?7R4D0ISD)I+Y1`"3VQG$*EB$EI.)AXSF3U3D?<$'C` MURV[2'K^Y5=`/4-\Q5=G4<-^S55C)5@6/5+D5(@LI!SY2H%\.\+QX@7Q\I-: M4$F12($M55!.]4TF/)3A_-A>,D[\G!.4&(AZ0(%%?=@L<#@N;(EY/=C3G`L= MVM<8--B8Q5FSU!>:3<^<]=F?E80T,(6E-07Q:MHT0(>) M5=JE':\4X%0MG0-SS51$42^!ZU);RB6*8(B-$,EGK3?%01Q2`2LU5)S35R"$YV! M"UN$2Q,;N,%W4YUZ\RZ"T"[GI+B-:Y?71T&7>Y\53FZS/5!VF1RE0F""#\A)DM5RV79+.A/EK5)/I%7Z(5>Y\7?_>7?_DTW*^Q=-JF(`HU7 MS2FOJ77:ITU@\A*)1[B&1T4%0QE7+R4X0P&#=;63RFU5^H4)EGV)ZWT)5WW4 MZY7?+/!)7=5?_S6<%%;A%G9AT:U-5!C2@6`('2BF#[Z#U]U>[D7"!LX<,M"! M+^6E"A:X!2C4DY`/L)3'=$Q/X8"#N79;(@E8=4!'V""G6G&HX9E M963^B&O^==)L38.(I:4SL9-;-I1"$&$(AIR7$)0?3AQ(9>;X MS9P!]0/@2(74$`4ST&@I&`-J`3T#D`*--@,I"$`RH3,;0C?OO(!P,`-=^G2"3DA=W7H^"D0-XAMMUWE^?7MX"K;<@].`1/N#`]06G9679 M%=P_>0<@GN=NQ5V1A2]B`-*.U!.CEF+[S;?,^>"'+@$=.&4RT`5FIFC1\"\+ M"`0S4@=QLA<_\"*O2.GN=*Q4L%6K)*ZN*I9Q)ALMDIJTJ8]"4P&0 M`6J<%>K%+DV?A6)Z2VC,R0*F=67+=N4W9EI:BE\=,`<1Z*7^1*'2@+8E.\%/ M^_7@VA2(/:'?LYUG_WP$EB505W5FQ#@`]7$-#T@IVQ8"VGD`8.C9GA"")KL` MI(3.\^$6P$P?2/BO`6GL]7@B)[M1Z58 MIP7IOH$?Y!>Q`< M\EB+O"[-LWGKH20"J,".S>W.#0$-H,R5F@GN._5'8MT*=OD4TDQG[N;P#A?4 M)XYH/I%B':"&.^"%6&I2[]7AIO5>7A"4V"X(&Q@X=?W8CA3;4S5:Q0'Q+"AF MV;;-2/5@@5A3Q$@JPKX=Z)`8;QG^G*Z8']#L3J2HBN$H<@Q1YH=0AS38G/`JKP..73@.B3^YS49`@?-%A3L658H@ MAE^R!X.HSQ#&W@'=$U?5A; M47MQ&ZO^J(\,H_>S4,>3.PO0VJ/)L[/?DPJR$H15(T$2: M$S":XZ.C0A*X%'C$8/@2^W>^I+G0.`LRRHY;!_F0'QRPIM9'".'ZE>(2Z`?! M;64=GH<5UV>JC=A!B?')O>"*\&5=]T\"K08RN`;%R1Q!D6((OJ\A[YD348=\ MZ'0?L0NC(()NH`3W*`4$>`#%]HET)Y@FD%,'D)<#\`-UD%-*@)9R2`3"Z#P' M`!++F_=.)Q<*08M`D`):D(HQ$#E:RXP>\[E2\(#R0R%B;`#"N*)PX#P$D`*G MWYQ&GHC_CAV4[57ZB'!3!G M"3\7WMAP`/&#L3BZ;K@0'$4A)F>8HKCKC@M(R"B%AP\'6BBSW*N=;@P:K_B/ MHG"U!P`(!0W2J2@8"%=!%5IV[E3-VQ0X;,(SMW MTG!.8\J4G,^B1W_VG*9RY4>.LZ!(08*$:U2"9>M(C$*Q#LR7+^=^1*:P#A(V M4)A8`#>3G()2RK7=5>6<"G60S&;BIZ+4A>D*VA5LPGP7DW)25#BY2::::JY)IMMNMF7:H6A(AL)BJU&!F*V/:)" M-'=0=MH==]12&FFE<39:9Z8%&J@=B`5'`@JRH7(;*BF@0()@F#5J9Q9XDE&" M8"C\0`(J]KP57E%.-!<>CTJM"LEX3IS#UBY8H>,D$["25]*3\ZG@*D.0Z/3> M24[(`4ES1#10T#Q.JN6?1QB5DXD!);+#U9"?C'2!`@>UD\DY3NC'GX!^%$1) M/DP<`$R"*CBPR[0")=2-4^=4U`U_VD!25`WE7$!$@NQ`HLW^25H8N,L!"O`8 M)'C5%62`3`U!\E63)U61W!C(@J=L017OHH`9YV8R72875'1B+;J:T';Y==AL*4=<3 MPYPH_%;";HD]-IMB>%:=Q0]R.7@C$3-I,>%9-5I$JP(A.8"KKN6QI:)ZN)8S MK'EJ-[$+F.=H4V1!B9CT['_7(8`..C&ZVT#9&XM%'Q':5%'.`9"(8M#@#%T@ M;H$9`9R5-C+E.IY1+2)4RCF9\UUB(/%]A<`YTVE#!"Y8@E?.PAI"EC^;,S12_]FRM-;?[W,,\MYVV6-U49-8I:2 M<4(8HT>V[+^AIE@GV2&V7_J"8;#A+36ENCG9:6PI0089/Q`42 M"+%(1@ZD`C-HC#K=:!V\=M&-&-V*+7&[P`%Z51#B@4=86;E`KAZ0%01,I82E M..%Z"!>M5+##`/#`2,1R92,5?(M6F9B'0M!2COR$PU^02!`"S@(M%:##),E! M0`:I`R1V\,1<"@D'C7:AC57A;B=/XAWD5I4)X&WL)Z70D`5)YYWLA*P-@RQ$2[5:R,;TF[B`JT06R,3G MP"C$3)3C(`B8!P7M%BL,,D0^&W26!XF5":;@X@*!^.4O^_:6(=*B(40XYAKA M]3C;/2D0+UG(62`1,A74('(_7)L0DZ.%`Q0NB&DC73J8DPF=C"0<#7D*)'(7 M/"P:P'=0X2)#CJ?*ALQ0C>$I(QBA$A(USK&?_ORGF^H(4#=I+S'@R]1OLO"( M/]+&,9%*PR0FX1L[)+)00?-%^BPJFM/$KS)D0`6D8)._^=T)%8>Y$QFBEAM4 ME*`: M'"")_2D<+=HBT-O-$$O-@5)!%I*R7#V.$D2X0#F`J$,@9H([%G%J!_FE,8<< MSR*I\%T5&=80=M9TBV1QT@44ITJH+.NN8%U>/M.8S($2]BQ3;=-A]3+5Q/J% ML86%V6J`8Z>9X8E^LN&-G%*@@T>DH6EVT`PBV[?11!F*,Y71#$7OL%EJV`!2 MJ#`!I^3T&Y4ZZC5SRH(N[*`+N?0D(>>P$0?/DH^'H",0"N`)4]X6QET%U5=# MS:5YD*.2B)GE`*I#2Q6@REA(+#-B6%5!&\[AU%SQZZMAQ>93B/"3)IE5;D\I M1U$>,)U:AF5LOT)17'6GP"P&%9[^>2V(5>?6UUO=\SIG#.H^!_O8!3.XP0YF MDZ5XW+7T)5:SY"I!-9`IYYA9RZ+`0YS@B8\V1(C`#JKSBKTS"Q&X M"!4)E7Q[,HD/*Y;6[CE'O.DLR#]^O&/]24% M?E!7B%`EV%K"$^64[5`YW[D=8&=T7F]2!X=,=-X"&T@CA(07);,Z\WF#E*LV MS[5W6I2SKDST;:C,D-ID!&]@_VSH@:-)T`0_^)D:TZG;%.8WI,(P<2:EV4>C MP`98P_0C1:S(0HVZ4(F4I"E2D`PPP"92NW':R>F'21.30;=UL6\@T,J0[+ZD M!DF-3R:P\K9,S"ANJ7M2>NBC,9EBA18$\T^)'L!*G@`#'LI=2W8]@NVUN+K=W!$]W309'^#\/C_C%U^7"B/F-`*E1CZA9ZE*3 M]J,.-(L8U"[JPYQ!A_M,&WK.>)[THD^!",``!AM06C"U<7U)%6H9U=#1@.>J MJ5DV9Z06=<,#+Y&#`N"!)5T5,XE5T+T<8J(B#W2D<]DAIT7"T8!NC*?*:7&R MS+7NJU3,]R3Q#H<"VE*. MX,N\7I[4A@!%C0>F5#V``3%82N7^#8=LI(&FK(]G^(+Z!`UI:)QH9-2(J0\Q ML`(Q$$,RM)8)1(HHU8;7M)Q@V($?S`AOV(!Y:,/Q MP(/H)&%!M($#Q$@B3),6/(!X'4!^C$4X\$=_J)D*C`&-,41^4()YO-$294(^ MG(,'M,$I-4>\.8%2\,1X2`'N`S"&%""/U*"&?!*0[!#T:$#`CA`(C1.2::#/Z(# M+B0"3,KD.5*"*,RC*BXE4S9EX[&89%V*5':*#:P:Y*F>:[16"E`4SR`-#,;@ MI9$::ZM5)8K#81YD<:Y1*7617#37^63M8@($D4`/D M85`M%5H005[NY2XDPEOA7MDT@`4T0$,(VE)1R#`!IEHP1P/``SR<`Q$0H04! M$?W!@P$P)@5:F38,Q65.2_4096$:@`%\RQH]IA"=@_#5E63"V2[P@V<&0HN\ MD6M2QVPZI6_^)G">A.M!36*\1J3\`#5,6L/%(@DL@`T\YPABBB]@V&U=1E?^ MHOKXR48ABC`>3=/@$2K8P`)HUH0U2OY@UF`04%T<0!K^)?1`)F^UR%].56^R M3%N@4F;6T35Y$S*=V8X94W[6V)/T)QVQ9WMR&8`>:'#FQ2DNJ(/Z4Z>L6'!4 MBJ48IZ)5S6N,)^O!@C*"0:!TBHG^@18B;2>B:)1GE(]HL&!V^F(:3*C57,:D MN%I"X6G4F#^F==_)B-_BB0/NC3N-IMI(!KK*4)3HIPP(8-Q("J M+8#JD0()3`)E="='(8UF,!)8DMJED66I79H/R.#/D`K.@)1FF1B,Z8!Z]M.. MLI'7H5>0QJFBGEJJI9EOB M/9:=A.>%HH"J!8<)MH8)OD8*+$!K",=P1`.5BL9FS&"*^NH+KH^*NN`CO&C# M9<$=T$_^K/&H39UJ7/B2KRQ0(-BIL[8,M58KMF+/:E0<"0RI#:""'50*Y5D* MQ!%#,V)88:A>%DS"::&&L)9E-`PKI\D@B9D&E^IJ1)D"NJX&K27KF@+&M1[< M`9S#&$A!$TB!P8[!SQE:P/IFPV8KQ/8%*L@:2&%*_6`2NH842U6<:T1C)XFK MU5#II6%41.EJ^?@,F,)K-/@`RI8/R[)L1*$L`I0LS48#ACG-ZYG8OT8L;Y4# M)/PL))#J7CPLSQ:MT#_S1#D9-MRI4G51<8GAH*414F*JL MRGY&67JM*9!EV*9H^7`4I0(*.OQ&]Y#!#XS/SOH3T=K%M4+^&[0-5-PRWMT> MK=ZFB=9(EM_J@#U`30`]QI+*R:.E0!:L'OJ$K=B.K:0NTN..GL:%6-)05*/\ MQNO9`2SL+6)QKN=^[@7"WFRP!FY0)ZM9DLXHFNNA@KEF@0V(0!I$0RTH36AA MYVC$:VE!;D6%F*0BS2-8RB?$0!;4*.@6;RKFK?%F*_TH!JA$2@`YE#,Z(XNY MFD+-AI&RK@C8`%GRPKM&@QQP[;"6J&A\K_>")=>&I2GX0C]47#UD@1XD+_S& MK_S^)LY@&/3."<1="N+>#*3PAF^$2B[FH/EH;,`(G\`&S[*6U;,J> M!I>F`0K80ZD(;;8B[_QFL`8/K9G^X"_I0AQN*.EMJ(9#Z8`4=`T0I@`85!PQ MD``U+&[Z)*HIQ"S,:JT/A&DGP"MIA,8\^((<-"Z]JH]O5(,.O,-FN.[F;C"J M*O'\8C`3EXD'_Q'##88']L;T3E86V($.I%YK16BV\(@`" MI.S)3L+,+K#+OK&IQ2`9&$>SGIE`T:UAY6.`<*)4Z7'=@A$[(B$W(?#S(>0S(B.W(BUQ$F&]:JK$H>(W(>-^LF[_$H M,_)6[;$DGS(I%[(J2S*"(N@?=S(C^W'U>#*/=O(;:7(JT[(MTXHCU[(O3S(H M8_(OSS+^)9?R8:ER(=MQ+8/R+M-R(D,R)\=R+_MG+L>R-/NQ,2OR*=]Q,=M4 M*4NS+)\%I!1&I$SHMH(4C,TEF38<&70H+CYG,H@`*A#2!$34/>=P1GG&J#6P M&!>PS[PLJ.6N=]J!*>C"M"Q5BZ#28S:T0S]T0R\T0_.$1$.T1%T1U/T1HMT2&,T1GT1Y^T M3H\T2_U3_^T2I-T4OOT3COT4[]T4$^T3!>U21NU M4&..F(JJ[_1U`U_WM5__-6`'MF`/-F$7MF$?-F(GMF(O-F,WMF,_-F1'MF1/ M-F57MF5?-F9GMF9O-F=?]OE,P`2'5_=W37]WQ#^'#^Z[=Z7S=[B[=Y5WB&(8[=O3[AV&SA_IWB"SWAX__=]V[>,MWB,US:/][B/_SB0![F0#SF1%[F1 M'SF2)[F2+SF3-[F3/SF41[F43SF55[F57SF69[F6;SF7=[F7?SF8A[F8CSF9 ME[F9GSF:I[F:KSF;M[F;OSFY[F>[SF?][F?_SF@![J@ M#SJA%[JA'SJB)[JB+SJC-[JC/SJD1[JD3SJE5[JE7SJF9[JF;SJG=[JG?SJH MA[JHCSJIE[JIGSJJI[JJKSJKM[JKOSJLQSJ@PS:MU[JMWSJNY[JN[SJO][JO M_SJP![O^L`\[L=MZ,\@ZF\]XL2\[LS>[LS\[M$>[M,#.EP[MF>[MF\[ MMW>[MW\[N(>[N(\[N9>[N9\[NJ>[NJ?[`\PPLJ[O=\[ON>[ MOI/[`SA`D#L!.B!U4P\\P1>\P1\\PB>\PB\\PK?'L;^[F3<#/!P7PU>\Q5\\ MQF>\QF_\8P;?P_LXP#_QIT+%`WP\Q(]Y,S"1$XO\@T'%)Y@\CX<\R\XS._\C]8\S-_\E^?\R@O]8_%8T=-VT"N]'M?*?5[0_5O8?7K!0]//]M//'`O\/>`'ON`//N$7ON$?/N(GON(O/N,WON,_ M/N1'ON03ONH0?:R+@2(HPR&T/9GG_%E4P>2'ONB//NF7ONF?/NH#_G5M_8_W MO7/(`.S'/@50@`S0ONS7/N['ON[G_NW#ONWOONS__N[;/O'7OO#[_NSW/O#K M_N_3?O(O__(G__,//_7[?NX+__3S/O-OO_4?O_$KO_$[/_3C?O-?/_A'?_%_ M`9=-_=ZGN@\H@R+,@N;[@-N#N>>;A3%H__A7O_:7__![/T!0D$%!X$`9!PLB M5'B084.#!0DV3&B0HL.)#BM&S(C^D2-#@1\[5D0(4>)%BQ%!DAPX467(A18K M&MLU,TFY=2YDZ?.">AHTJQ"CVA1HT>1)E6ZE&E3IT^A1I4ZE6I5JU8I M(*60+RB33`]P]A0[EFQ9LV?1IE6[EJR/.HH4S9I5)ULG+6SQJFW&C@B3H&NR M7A4\F'!APX<1)UY*84U7FV'7.@$:=-=0Q9B\1RH`[Y]:]F_=NQI0?XY5,N3+187ML#3N^Y_ARYLV9 M[XDNW;ESZ=>5-[=.O3IW[-NA7Q<_'OOS[].ICU=^7OQZ].2[3W=O/CITZ^[O MMP^O?KG^_?3;VZM//?:6HP=H M')&^[.9[<3_OIJ.G,00?0X"MX2BKPA9;C*G2RBNQS%+++;GLTLLOP0Q3S#') M+-/,,]&\TI8#9TIP00SAC#/."%>32RX&9JGP0CG%VBN3#6?J,,U!"2W4T$,1 M35118Y1T[":\?B*NBD4IK=322S'-=!O*OH*,ST]!A?`M">V\$\\`.OEG3U!K MH^R+3&&-5=99:84&N$>?G"RH2I5+9#$%EEQ9STUVT&6M9#?-9@O]PM%F MG(Q,5Z&6S5??98GL=QAC]@U8X($)+GC?80@>!A-,^%T88(,'-@:3AR&.V%^* M*\YXWX41'I9CC2$VYMDV%?24VI-1GL3:N$IM35L&0&%@'&Z]Q1!>;7W^PP[AGBG[,3VFB0.Q:8'DR25EC)HX=Y^FA?Y642U[4BC3)C-)A!`PT^ MF`F[:Q:F+IM@/L@.>!AF@L@#X6'0N,&.$\ M[F%&N37RX,?PP)>M(C234XX<5#'^1KT6VY=?CGGF;OEL-:B\EP7;:[!!9WQ? M:/KN.G6O31=8]-3#1J/UUID1^%_"%U^[[;J19B8/(C&R=*0>"33_Q`1X5[AF&!>>B'_1Y\Y9T/OWGFGW]^_/'59YX% M"-#1`P*RH8=FF`?D\$,%=89AQXE/5"`'V7VO?>(C7_*&H0X5/&!^!S1?^`JH MOC6@P1]:*`4M/J$.!#R`&4+P'O@D>#[GH6]9YV/>,/@@AVI08GMH4&$_5-"- M[M4O@@8D(`$=%Y2226XVW?+A#X$81"$.D8A%]"$M:#&)REG.5)C+G,QH%J>; MS81^ZN/^@Q]*40HY(&&`]?,B"=%GPANJCV[,4`$EX(&++,9/%Z600@,):+XP MAG&$<7P>"YBAQE+T`QZ?P`4"2C'`"!:0?/2;(_G:%\+RQ5&$:$!`%YDG!#3, M0PH*A$<"32$*%4@A?30TX;`,.4$G;&^&G3R@",6H/.'MHDFY(LX!OA!+6,X,^<$."# M"A:("8C&\YVTY"K=\L`_3)AQDS+`Q"<8N$R']M.KT5SK^[RI`ES(0`@00(,# M.EC,M[H5`GD(ASL#NM5G;A4""H4',&4I!`7JH1L+!2`'53`/9'Z5KPD=QA<< MJ0)^`#:8SN1J+)$Y+^'<:R:PA"@T68!+.01S&]!@!C\\^`5>>E"M=(,`;>^I M00A,5K:WC:;[9,M/Y7P!&M)\7PW^L(J$V`83`@Y0`3H@L`XAA$,%3F`!V(K+ MR\YV=K;"M*4#YJ'5Y"&AN-^3[675>L]A,&^[P80&/6E1A6'<`ZOLV&WR8KE> M8]:5GYY%IV^#*82KJ@`>0D#"@"_9C@`#F+CX98$0ENM58DIT%VYJAD4YFF&, M>E2DG3CIATOJ4I?.5*8WQ>E.<_K3GA8UJ%MP\8MA_`89R[@/-0[&.(*1XQP? M@\<\5L:/?UP'(0^95!)*JE*7NE1A.!49G&N0GP"UBVUXU;58Y9]#AUE7V@[3 M?4)`;S'O>=_D#?/!2"`O-.+:!-IV8[+WI&V#Q^QE..<7M\.(<#&%D`>L5J-[ M:!B&XI#^:;_=NE6]DQ7"-K10#4P(TWO#)?/W&NW>VQ;3N+0(8'\?C(92J,`/ M$&@'_,Z("2X2=Y?-]-XN)XM")_AAT9(D)WOMMUQA:IF]M!S9\.C%EJP%Y0", M]O6O?ZW:?`BA'4CX0A4>O(U[P.-W^6CFLI7+@FT\H)M\R`8`8UM=$,/7W,VL+^00JQ*@;;.9H;VYL$,S%*[#7E8YKCA407 M#Y-'.^#=1CD_NH&&@`H8'OY6^-&#'M<'M'O6$F]V/A3.!&+?(Q_=EO>X?T?- MD6^9T7E>-\`3OXUM#)L/>H`'.6==A8GS`1J=%Z<4F(%LQN<[M@I'.3.Z$70^ M,'L;3#CZK/DQ2LVV.^:;E@+#F2&'Y\J;]?#@AUZ%P`1X=(,)M4>".'&1>\-? MW/#I[L;O]IL'ZX.-&:MG=,#G5;S^M.SZ<\"VOS`1'4`A8$(*+P\Z/-"A':A- M'0"O"M!!':A+%+*I#:I+'=C!P.2`$OA!"YI@V_*!VFBA'7`)'81`#M2!'RC) M[WPMZ,)!`U6@#8QO]:K@`2S-"1Z@"L9`G,[HY?@``2HI`[\`\^3@`33I`<-A MTVA!';JA"L2)$JA)G-"!VO9GVZ;+C:BK#1#@`;?A_>`K'S`!`U%.DTH!!.MI MY="!$G"A#?1`!*5MRI@`'=`A#Q!`'8(N#V`H@#ZA'=YP'OQ@V*0@"N4J!_5@ MT^!!"0-AV^[/URC,PBQ*95+#Z3HJ$:7.PZ8NQ*KNI:X.Z[+.$%`LQ;C.Z[)A M"S(1[+;^0.QHC.SZ`,?.#NW4+LC8#JE:!NXP!Q18D14E01+J[NYH@R^B#-E& M\`OB2AW(4-HP;QX<@!\V:.6JP+EL$*OF80J%`![:@!(^(8L0`!=V,>C:`:LF M;PJE30C8H0V441WR(1_:P=)$@;HT2P_637LZ[A-DL!O(,.AD3JXPH0IJX/VD MX`&00`Y*P0\.+<]HP0_4H0U>3@G7\-/@H13"(1QHH<"N2_J$$*O\@`_:@!W0 M$;:L\?V8(!S:L1\.;P!P?4-H4*(.J"P&,;2('L97LA3C^I$SUD#(IE7(; MJ@"7:*$;J.T/\R$0L`KAL*H;("$?6*C;L(H9\"FR`"X?Z*D=9$`*.`T2INN; M'H#:I*"Q1$$&]&#RJD`I.^^-E-#CYG(;FNNYA*`*($"3G*`*(($(52`?O$D. MNI&>JB`1JE((G*L?("#HM,P.JO2"%G=E*0VS[_)2 M]2Y.>W!3DT0!+9$KAMKQL*91!0(!$UA(%+9-*05S0>62*86@L2A!!A3H`:O` MTN3@CQ@TKAQ@!6=N&^@)'2`A*06S'2FA&^9!#@83&Y\+$ZBK%(R/"2Z(1E7` M`_K2TLP``OJ3%M`2EY!@V+3G&064VLCR`0KL/RVTCX1`!E-S+O,!1SL.`O1- M>XS0&P-(!G!!KB"`*A$`$[[4"/F@)H%TP#R.K.2@"E@(`8*.VBA!U*JK2"7T M5B#G+(YG5ZJ@3_WT3P&U*55`"_A!"DKA#S/A'$8I$!:TP*;Q4+5R'I@`$EAH M'BZNL0[^-2T10-\TB<`@@!\@H5/5`>$"5=_@X=,<?X(!,6E#-ELS_/,A/B"A^9`!P#8908:$$I M`0(2X1P"KE0#]0"`(SI3XZ(0D<,^"J3(@1&Q4Z6TT3YED2WR;B9*E5QU$5`AH1T3049I M0?,4"`$,K+[^$JM2MF7G%5"Y=('ZLD^!52;I:1X@(5T[4L#^4C9!=;04^``" M*K5F=;8=/[`?$%,P.]-EO[0-_DV3*#,0;%#`1@D7*I/:'*`;G6OR@+4-^O3E MZ&FAJL#:`C43/A(".A-G=380-DT4^I(T^R$?($&!'(`/6(@6A,`L=5$#Z59N M.VXP"=?C&)/3KE!5\T&<=#%Q\1)0X\^5)(5>Z1677!8"^B_@,H$/$B%[L.J7 MAA-2_912(TLPM;!JOTEU2^$<+HY;+:TCU?9/.U<=VJ$=`N%LX:%9(:%5JQ16 M91-X2V$,PF$,1($)S*"ZC,]/@94R+XY8OS83H#<9L0JV%"HP.W"3FI5YX2L3 M("$32O=MVP%\J5>N_,!XD4`)ZXO^XUY.,U\N^,*<:V,'<9@#'8W<4,S M$\#7<@.U*RCJHO25.A.Q7P&V$0>68`O6.P]VI\)3/#%Q8N M8IFHB5118^5N[N:N8^WN'_)"JD8V<=5A>ZO`^/1G,]/2A6EV01^0XP(!:<]( MA9F70K>7"3;0?L>`'588EYI@,#-!\+(U9C/5N>9!:2^N'7$!2U^P3[FU':I! MG%K7,9\K'\"7?YE@:[-2>UP56,/85ZN@B-]V"0,5$KJA"1B5)JMKX2>"@W M2OP74`_^`'/+N!T2(1,.8"KG`1W:T;XZM9$/H`H.P'0M-5175PA25Y6_Z1PT MN92Q%JODH'_[M)3AH0G8(1S\X$N?"Q)&N7>S>%*G%N7,4@50#F__MGKS890# M-%B7N7FU>#++EQ\"S@Q*`1<4R@&8F7:E;V5)N98AX6VI>5(!*(8@P'NGRP$H M@1)^D1Q5(!5D=#,A`7+EER&%('%_U'N_%WY_=I(E]W$*D8`WJL/^-6`36(%) MS&"_,V$C6((]$133TX+9$\A.$14O)SX]&(0U>A$D81:R81)(>"U,.%#S`85] MF90A00H"H9Q?KH5GMB-OEAV^UP^"L+'DX%OK]68?X*2#^(S^@!0M>WJG#V"3 M$Q2)_TV):9F4C5A[JX#[^C2X/B/NUBNOA>,^1>,NY%9F3F> MM7J;2QD7QN!\V8$C!=DKSF%N?]9N[Q@L*U,(,D'Z$&"H29E;-TV0JR`Y"WD, M#GE0_YAO2Z$;D`M"M]E/\53^T&)/A<*?2=E>,5>3(YM;&9`)SB%;+[3ON-B4 M*Q-3`T$!AG-34;EU-3D34L%Q#C007OF;I4"?*U/Z-C,36*E5:1L28O4<%*"% M'T`!("$56@^KU(Q_E4Z:_W@R^7=ZW[8!^#<0:J!X^0%\F7F4_[B;=76ZP[EZ M;[L='8`(((%1*S.\YQFK7@Z`5C;^$^@9O;$J'"#A'!B0%K3A9[&2GRL#LON4 M,@CQ$`D8ZOC;PPYXZA*8.Q4:82^QH`NHS5:&)2` MPCF:`3XZI-$B9$7V3_\X<6O@9Y6."2QU01-!`11*"R:U9<&UOKZ7"1[@?KN! M?Q.[EE&;&B&A,JJ;O!4@$X:0AQ!'Q0@$4Z4I_^X'<8@.-$R.3?UC^4X MQS.!C_F7(^$!&-3X*ZZ2KIN;D/LRD.\9JP`;N;1@%VSY`U)Q4@ M`+D^P7N'4P5<>5*E`!HA``$00),)?1>`@1TFSR\FM84IJVFCTQN**7 MZ,$Q-F-;<<(I7`E47@E>$<-!>L/UD]MLO;EP%#"!F81V+?1;I MA;T=V:VTA)U8,Y"%2H&YV3P5^&$,5A@GX2%>JZLR1\F5(8%84;3=T:$!((`) MM%?L%6MW?1V8"S=1JQ48)E7ZLIWCVL``'H!K%U0.$J$!PH%;U\W?,KOCA"`Y M`[V>;)G`JL#HD5W2DRY!(+DH7TGLC7+2`X$=M(`6$,#?<@A<&?#UD="5`\$< MY2#??)P!/<"5S\$!'(`=:,$,:/L`6%`+9GQ2QP`=EET.HELHVF$>YJ$;2BL0 M<`&):&'RNP$!7'\($X$EL]\KVD'^!N6`M1=3MM%A"#-A((.5"7*7%M#A'-Z_ M_%F0%@3YC+'*!>U59%>?^[5@#``BT(%=!#/AHD4K7":"5 MRH8VK=HM;-NR?0,7;I^Y=/L$NQOLF-Z]ROKZK0,8L*+!@V<9/LP@L>+%#$`Y M?NQ8F&3)DI18OBQ)$J@`D_X%_0PZ:#-V1)CL/)`ST4A:"'")$D6IS8-,![11 M0@=/BY3^A7P)5-NB)02Y<<%T0,'9-*- M%KC@8MY"@7A`"SKK94*)`^%(X4!R.AF@10V)#,1$*I0@A``_NP1'BP,;=L1: M-[OD$TX;$-4P4";LT/)B2N-!A$L^\"`TVXZTI'/./*SQ(X0ZQ:F@!3L+[8+3 M3KN4`T\S"(1&)95.H.-DEEH><,XY3#"AS3D7V)1)(*E4`+GG1=IDTHX%U.UTCC87G'-1EU_V62C^F(@JNJ=I"[W9 M9D$'O#F@G/P,V*@VGFH#YJ%?(IK)/$>J,`8DINT2)JA[(JH3G[`R!"B<1&B9 M7R+P!%*.GK)Z^6M!B:2")T&RKJIELLOU]%-00!T%K5&=^##M4DU%A2TY5FVK M5;=>>2566&:5I5:Y:+G55EQRU=7'.'C=M9=>?OT56!V$$7:888SMVQADH$PV MV64"6R;)%9M-HD65HI&&K):0:A-(Q+/6J6L@>;)Z@:/'0D+)J0]<'"N?%YBD M4YFI6&PLJ%XF.FJ8CGH:*J$BKWQ1)HD$D@D1B;1#VRZ9:)-*(I7ZO'//"W6C MXD('7`"JIQ95U$T#F2AG[*N)\NG^4 M>:H*9FO)!!%13JFPPE3RO6L4WXA^5WRDC4+7A`1&5U$$]4^W^ID%3$B MOK?/-6-D$>%#![[3T#3EQ"29\,R32CM!=U-*JJMF:NE.B3M9:<.L$T$1XC<- ME/C>4Z^Z>MYX,_NLL]'^KA2UG61+_+95=:O5MU^%"]:XY)J;%KIOJ?L&N^Z^ M&^\Q\RI3KV#W*I*OOOPNYN^_``^,&<&+*)%-PE6.5AK>4P\^?^:PGVZ12C6G M(D0OMT$(PNL2>8V1[B"+(0Z@I-4!"\GJ5NYCG,^ MBV!!,++^-YO0CB'?D1VM/'@Y"2:0@19!34TRT822O$DU*L"9LN36C+K5;0)8 MTIT/?PC$(`IQB*X;8I:8``DIE"(1>FH`)2Y@Q"A*<8IP&T^SAO([:$UKBTT9 M'O&@8KSC(6\KRC,$\\;B/.A%3WI;H%[UZ!*,Z\$K>]OC7KV^![[PC8]\D`&8 M9-`G,$FL;QR$J!O\BDA%9<7M/@W04R+ZX\%$2C*(B)RD)2^9K$P@P`':((@V MQM"$2.H$AW3386CNALE4JG*5433``PYDAG!H0W&LK*41J>,3+!(EB]*R%E.^ M",8P4F6,R"BC&9GGO+.H\5S2HQZ[VO6NO,2KCMW[7OAFLQ7-LYWPG/>$IQ:6-XI1G&``]1+BM*IJP2*N4) MT(`:D0B,RYE`#ZHEWA'%=[R4%A>]"$QM"9,0Q"QF&<^8S&6NT2UN9%] M>77/7M;48S;+YT=A>%,8X?3,4!1VR(`:='$<1*A-;ZI*V*D0;W&;6S]#PT.< M"A6G7QHJ4:W8NX;V$BG#@^@7)WJ5,1H3HVE<)AO;Z,RZR'&.?-E>-4N:KVSV MZS$I52EF),%2<0JEGZ.)'4"+JB>CRG6N46Q8)77"!"A)Z:>@^2==_PK8P-95 MH479I5*%QQ2G/A6JQ)PJ,C-JU6;^9G4NT>2JO$3Z57Q=\Z0H+6MF-J-6ODX" M?H(MK6E/ZZ2>[E6TDPBJ+1>EI[L&=%&PO:1LZWK;D,`UMW.-6RX7>EBF4`NQ M$74*8QM[T<>.2Z/98&-'X?A1.GKUCF`5'V?[Z,?,,"`;8G`I:V,:10ZA=B>F M*6)NX3K%VO)VO%/$(6N#XEH?UE1W^8`$)/*1"?L>[C19FJ\D\WM?`+LUD6@" M4S[R04L'^A#`"5Y@?2'1IOLV^(0+F3`\?7O%9QW6H5TL+B$D:KR*&O.88H%L M9-'UW+I$MZN8#0P>3;I'E')3"9+8+L+>^QGP`G$@^$44A"VL.__^L$V1=*%. M'@P)JN7^=TDU9?`0_VJ8)"H9,SZ`\D! M'%<[$&)$&]V0P@/L60,_%*O,8F92Y\1\9OV!$,WZXQN9Z9PX)O###&^6@BAJ M,(9$)%EOE%OAF/4F9CVO*!#J%`4NN@$/-4\MTH_NM*?#\>:WD1DC3&@`+MY\ MH'3`8U!U_O,#',3I49/YS`R,=*WSG,#\E9G1>$4J<)7*1<0J=K'"1*[RJ+I< MJS87Q9.=RU:ER>*^C+2ZB+FNOVAL8W+B>+3F5)WL:J<_2,!#'6.(90/X(;A- MVWK/#%3SHVF#9LC96B65^YQ"]FQDQV$D$*=^0!/@(9TJ`*?^!J)H=P)5PHXW M\ZS6)FPUNS,RZ$+CH@8&<.>H]ZP_U.A[=;3>M7)B'>E7B[K"51!YG=TM:913 MK=,&UY-[O]Q#U?UYYC2O.4B2"!%9LJ,43A@#@FT.]#^?>4`J"OJH(7$?%3R` M"=U`@`J:8/2HEXD6ZFA3(A`PCSP-*!%"RW/0AXYTB/`C'UX_^AAPQ`0C(;2U05];C+77$8UN6&A?U+#T]4Q,DM<3*5J4;G-INR>`$I-:E[+QC'V%_" M6$2VMQT:'6/G^3'A`1,8^^\\+/S_G@(CI,L$'=#?$^'D: M?M#)2TJ89\GY-4=B.&P/"2'``T>8I[?WZ8T:KP<_(]J7PZR_/_,#0((?.!*" M$`)Q'4JD7OS@U[CC9@\)EB1""$P00CL9(`KIP`<-B'Y\=H#41W<*M5;!I12)-6S9`E44)55] MYW?)=F(<-7AV@3W212^(ET>*MR_^DAFSD`TW!GF1UVU]8W1,4`JT$($'``%2 M,`;\MWX(D&<66';!AT1-=WY\9H#A!RCJT`T_]X0T!PD/H0)CYSCB!@]",'M# MEP_LIP+^W:`J]F>!'$ASZJ>&9B`$^>!T\W`[#`B'43AT<=B!79@?8U`#&W@` M12(%JI()8Z"!>SAK?3AWG/-RK`5F)`2"?P8)UZ<"EY<<3N+B)AD8_:)]84F#RB&0M",9):`;U<%IN($H%B'2X9? M$+"*8P8,R0&,*I$)XPB-E3AST/=;=[<4OG2"V')<*WALRO4\+Y@NS599-%B# MWH-'-VA=)R4,DJ`(/:AM/YAC#".$09H#J:8#U(P>O=% M'Y4H M!)@(#\`(";ZG`E)0AX$0#F/@`4`""8'0!&_&#@CW`(D`D[`7$0]P>?G@!^H@ M!>D0"&VI$K'8?OWG!Q#A`#@9#N'@`)30#L"0"(7Y`.P0@*!6F6-FBQ!!"P2( MB+W!F38)"8F@#KA`"01XF>=0`Q3^@IK7F`>QV)M"0V;`\(#A``&:I`+H`)*% MR0YI)P>)T`T/D`X]605N1@EFX(DE]VILJ(Y"UVN_!1KNZ$O$I7?%QG?U:(_W MR%R"IR[6,PY;=0SCP!"F6QB`;X9H^?&E#\`/8NH`+VIT M>!6)HA5?.K$-AXJHB:JHB\JH7&F7$5B7$#$/[U<*E(`)4A"E7`D@*B`*U#AN M+:D2V[`@I\!B#JE3M`2\T`DVU`%HI!S[9`/@7!Z$*!YM$@1M"`'0C"!_%"K8@G`F;@FOG@`:6P?A"AF('P$"&R?Y;'?C6@*J9"@,):`T22 MLJ5H>4@0I=N0"=TJ!,C*J=2("ZN9@)\@!%!ZB#NYAA`@B]T``5`JI0&H!:A' M(^,ZL:B((_D`(+2@I':H`AZ@E[3H=$R0KNAP8,P:$7J`K+3`!/FP#6'+#,M9 MBB"K$D[0#4*`LS\+#]?Q`.U0!6;;J57@=%6`L_UP8'=+"Z)`(YUYKQ*K.(/* M5W+)`I$KN9-+N95KN=L0J2J@!Y"*B;2*B4*@>2K`#%_`M7+``D+@!QSK?JO+ M`A#0,>C`DCA[JQ!P?3.YNJ-HM;/^"*EJ6`K;H(;,<+=U6P4T0K9U::K;(+F8 MBP10VA+A\`6YVPXLV3&B``%\8;`!J1B.H0S\Z9\"VU8-4P4&G+P<6J"GAP3YD+U1 M6H<3"=+'`?#O`%7_`01,L'PHH+F#"\+H$)9Z?&;)R)$.!TZO`% M`"3#+H*<]6`J78,7)PK4N)BMWP!0%-RD4B=JDK!)$+#>VPMWDP@>CPO`/` MDU(,$?>0R\L9@<3K!_.@!3.YSFI(O>['OJ?[$'(`#:N;E`*,QY10O2ZRA/2J M`NH``0^AR%]@"NB+"1VMM758O\@)?Q!8Q->!G*:BU5#JUBH\R+Z'`%M,T)%[ M8*",8(+J4Y(8TL) M#5]@R&W-#W4K!'/=$GJ`"53\!%1C0G^@*T/@0[#4`7"*@4L8.*5?;IJJ`O`O=Y@K0+TS0+0\!`.(`163H'2 M[2*B,`S^>.P`33OE63[7#M#9L`V_V.W7WFR_7UZ_[KS'0B#/Z.O(NRK)"/#@ MD]W0`!:"#.U7L=\``-+F*11FW.HGO<$+#GF=W.RD[9[=W6SB[# M\8T)IH+:IXOHM`#C^CWH@\ZO"#W@X2[N.E3@!EYM#-`'R*#@`2YY5<[?X)T' M4H`)R,OFS(`)OB?6HYWAD7NZU$*`6.] M[-'MY,X^V4)PY7(.WAVCR%KNUJOMY3@_V^B;Y0^APS^MEVB]W9B0W>Y,Z=^, M"?C\Y:;R`$9OYX;=\@[NV#DD?:I3\5FO]5O/]5V_X<4-$?Z`"4$>\,,P#+YG M"C(`(&V`!FO``FO`S:*`"56^!JLKVL.PQ(Z,!M>!!C)P?5(``6LP#$)@]J-] MMW*/">D:VA!P'TXP#+JN\8>>W8-QC7;^?(`.F?,5K M@+V1_@".+`J7[_7)S_67_P5KT+@`/N[1+_U"`<$'FQA]0`CK+N`631!OW_7( M#^'PBPEK(/AM,`]K8-/S@-T[C:O@#?FKCZT07^/2K<):P`RVS?JZ\/30@`DR MX.I&`A"FAJ$II4+.&DS,^*R!UM`A"PAZ5/0;QL+A%P0J=,F8I\(!A&%(5*CP MA\G?R#P0Y'@<-DS=2%&8\OBIV!"B2!5^,%FT.?5"6\-BU]]=3(C`:S;)\&'$B0\[0?>7">`J:R1/IES9\F46:QZ, MK,8,GA-3_B"PP'1MI#K3*JI))FT:C3',$*J=CEO5SQI:6M!<7L-N9#]F_!`@ M@%<1DY^1Z&:WS4RZ7ZG,EH?-N">@592P0D$F/F/-P@A MK`*PP#)YH##%,M1P0PX[]/!#$$,4<4,?ZE#D1$5F47$6!ACH@Y#Q1I1QPV;8 M(>(QP/:#Z`:)H]J M=/&#!=@L8T:/3^"1]A-F$*(,EP?X,<8/=;)JR20IPJW,GS6"4%<79N`%#U^`'6G/^C$%B7@#_)8S\>H=7CM36,R8/D M((9:@U]NZ0$0#5&ND2+C97M>8QL*!;MP1J*+-OIHI`TK$<4369SE#1BU2+KH M&F^D\`ME>5R`!3]$$>43F27C=SL6@B`YCW9G?J`;8^!1AVVQWS:7GP?4"6(8 M8_8<:6\5S$%C6FJ-6;CN[1"M;)@@6(84"77\X(,/C(WQAV2"KU6'F9?U8$9P M-+*XQF'#D9!77G/8[?1=>/3@X\%A]*BFFFZX&Z@I4?*00I26)3/&]6KNELR? M($3!)E@$1IR@L6"K,&9\ M\LLW_WS^]`7'9'WV_R-_&/:-69\>'O.000]SH$I_?/9S7Q]^V*`/?NS#A`PP M$4#RQ:]]S%C`6A:@O_/10WZ8@)_-R$>/_\$&?A5LF0;7)P/N3'!]ZLO@^P@H MP?(-D((7C!__"FA!`+6O@_NC8?J`!A@F6(A84^-A#WTHHZ4UC0%/B]H/952U M8'VAAN-KR08!.,,6L@^%+CQ@"T7HO_X9@QX/0$?=KB&K!Q@P@PBQ8OK6,$7R MG?%_`\0;`3U(00RN,(8%#&$*3V@^%>*M?`3LU*5R`L(#=I",Z^L@!@W9LC@& MDHUJ'&'+,!''0K:O?4O,7K"&)2-CA8^2FS3?#-&GNW:-KR#^S)#")CV91AKF M[I3E`V4`U[`@4NJ1DZSLY/Y:&U[&4NM0F;M:B@@#(@IQR4`DQAG@^4 MM_3D.GW)2U?:,I5,7(,35$"75<)3G;Y,8SO-Z$U]IA`:VR,,)L%'(?&E4Z%+ MW&*4F('&A48T?2_I!QH@*E&,9E2C&;6%7RBD0VF&5*1'*Y$SL^&#&(WT0S7* M1#5W`0U;;%2FYJ,'&M3Q`#T$00]^",)%9_I3H&H1514-:E'+9XN!4HA[(\HD M0FVQ!ZA&5:I3I6I5K7I5J=*#'O7^H@!6O?I5L%95JUP-:UG->E:TIE6M4^WH M]I"I4KC&=4-B4,9):2'7E=HH6-"@QUK]:E9ZR``-"V!&O63P5\0F]J\U+2PS M+*I8R(+59@3=(8B:"AFMVH(>MM!L9SV[6J#NUJW0]2DT!I86]KA%O>TO"7O;\D;W.+N@9SD["MXEUM; M\297OL=U+VV'*]_P]A:TZUWM.506M M1EC"$Z;^<(4M?&$+:Q;#&^9PAS&L80^'6,0C)G&)33QA"N3#K975;HM=;%WN M`L:[)Z8QB0-<8QSG&,%#`6,?&0D)UG)2V9RDYW\9"A' M6(7AUG,THSQ7]:P6BVG6^9SG_W\9T`'6M"#)G05ME%H1"=:T8MF=*,=O><#6)*Z M8Z9TI7M89F0]6M.;YG2G/?UI4(L/?N?"Q4IUK5JV9UJUW]:EC'6M:S MIG6M;7WK5'_9TKOF]=&0B&M@!UO8PR9VL8U][""#N4.717;^LYW];&A'6]J! MT76OK7WMO%IMVMOF=K>]S6W!U#E$S/YVN[$8/I=,=;WO/N M]E*+=6IZYUO?S7;IMW,X:7<'G->_CG6_6VWP?2<<]OGH:?!]WG0\\YT(E^=)P;'>E)Y[G2E_YT=#@=ZCN7^M"K MWO.J7UWG6>]Y-%C^]3'/8^I/U_K8J6[VHI\=[6MG^]*O7O:V6SWN\RC:!.SN MA+O;/>].P+O>_=[WO.L=[X#WN^#^!]_WP?]=\!-`?.$7[_C`0Y[PB$\\X^]> M>;R#7?9AYKOF]_YX MSI_^\J-GO>ES_WG7^_[WM=]]ZA=/^M[?WO&O9[WHD__\S1<^\MG?_O=_W[XQU_^\Z=__>U_?_SG M7__[YW___?]_``Q``1Q``BQ``SQ`!$Q`!5Q`!FQ`!WQ`"(Q`"9Q`"IP_J1&1 M"PRS##R:#021#E2F#_2A$*Q`!NS`$>3`23C!`U1!&9$:%LR0%_20#8S!#:$! M&[Q!',S^01W<01[L01_\02`,0B$<0B(L0B,\0B1,0B0DP8#S`25\0BB,0BF< M0BJL0BLD0E\@FFC@`"[L0B_\0C`,0S$<0S(L0S,\0S1,0S5<0S9L0S=\0S?L MA/63P_W3`AKX`#C,0SW<0S[L0S_\0T!$PP]0`RVL`$,\1$1,1$5<1$9L1$=\ M1$B,1$F<1$JL1$N\1$S,1$RD0Q%I`T_\1%`,15$<15(L15,\151T@O%8159L M15=\159,P10TP<.X0%N,D90R#!.DP1#Q!0[01&`,1F$<1F(L1F,\1DGD`$*< MD6A`1F=\1FB,1FF`#$AD\,>`-(0B MP,>!3,B!-`0?F!$:^$5JC$B)G$B*K$A$5,9"M$B-W$B.[$A,;,AQFX9(``22 M+$F3/$F43$F57$F6;,F6;(%]+$B9G$F`C,>"W(=*4`556(9EV,DRT$F=_`"A MK`2BY,(X:(%>``%5:($6<(2==(1-T(!ER`$@Z(4`()*`$D,?$B/_$JP M#,N-Q,@9Z02Q/$NT3,MGM$8/<8)IR`5$P`9$F$NZC,NZO$N\S$N]W,NXQ`:_ M_$O`[$O`',S`I`/#/$S$3$S%7,S^PQ0#QZ0#1'@$(S`",+`!$@`#,*@'S30! M5*"&9R`#.^B"#[B#6EB&*/B#>NA)5:B'S+P#4UB&58B"*,`"5UB%*;@%KA01 MKU1+WNQ-WXQ$LI219OQ-XBQ.XV3+99N&,S!,QVQ.YWQ.Z(Q.Z7Q.QJQ.Z[Q. M[&1,,6C,Q'3.$IA,&YA,,#`"S:P'$R`!$BB#9;`&]NP"1^B%*5@%(R@#$U`% M$J!,53"%URR$09A-+"@$W&S!W31.`I7$.*B`+CC&`RU00PS.$1E.!HU0"=5( MY!PYY=Q.Z&P%IMQ0#FT!7IA.Z*2#YA31$,U.$SU1%&7.$:4!$YC,%*!,([A/ M\IS,>B#^@67X@)[\@%[XAF\HA"@@SS*X3V(`@_SDA1S@SU5P!2QH`3J8$5]\ M1*%DQ"Y8@0F=Q!6@4F%,4$4<@2/X@$-01(@TQ`]8Q"-(T#&M@`_0T@HX@DO\ M`"P=RV44SBJ=4SJ-QMQLRPLET1%UA`TX`S_]TS^%`A"E3CUESA0]5$2]SNT\ M3!:=T?&L!R,84AB-T9T$`9[,@3KXABD8A$$H`TLM`S"(!R/H@FBPAB@8A!R@ M34=HTA&QPS!EQ!6`!6T(!"X8@2X8`1S0AG4H`35%RS,%1C[0AEYUQ%]=Q"]5 MTS@X`E@8@'O``30-!&T(UG70TA'X@5V(`5NM@!'```5@@T/^N`Z(6IS(%O\`(@ MN(5;($J1!8(<&`1KB(8/F(*K+`176%4G?55%[()-F(%S(`)8&`$T#8),"`2= M35"=W=)#[((X"-I#'`%X!5JAU=9$--JC/<1-V`%J^-*E3<0%'0&GO0=_,$2B M=5JL-<1-B($9.(1;==HXP`%8\%*C#802H(9^F0%KR`0D0`(F"(*@W58%P(%- M6-`50()0*`(<4`!KJ(!,:(>:#03^#,A6IWU:1,351'A3IIU(>0T1>KU7R[W< M2:S0#7'+Y131?FV!'@@!?,@%<3B#7`@!U&V!177.ZCQ89UA,9WC=Q)1=QHQ= M1&A81$4$&J"&R:S82+W8BR6&C,V!,KC*;WB"D3V$(C@$02!*DOV&'%`#-<@! MEIT"+(#95AU0G77:6YV!4-B%%9@!-AW3$5B!$A#3,5T!#$A0#(!<#&#?**V``3;$&+W:(TA<]&5/;:4&!M96:\"`8ET!'!B`($C<0_B`76"# M4'#3#;;^ACC8!#V8@;LM`04(!0!.Q$/``2*PAB[8A0%05VW]`/QMWP]XWPA6 MQ`-UWQV67#7@1<2H7,RM8BM.1,W5$,Y544,EA%$8!4,`A`T0!T`8A588!4(P MS-NMSKD\S+MTXS>&S#:&X[ETAKGTRSJNR]C=8S[N8]I-4410`T@E!N`M9(S- MV$[UV"8@EZ@`55`U1Q8!2!@U:Z$2%S5!EAHVAVP MA@%0@'3%@2/H66V-@2#8`2:(@4.8`2;PAU#`69T-@E#(50PX!`S0AE`8@'.` MA1YFU@%8TT!8A^]=AQV`5O%=@76`A4"8@0H8`#Z(`230!BK^S0,BN`<,6-!8 M2.90"(1`8%]88((=0`(BJ``<:(=TKM4/:(=`6(%#@`5_N&=#'`!IGM9UZ.8C MB($!"(5V<-I-Z((=N(<@H(8X^`$%V(4=H-H%]8=?'8$2(`);U@9_V%9M8`,: M+@<@%N*PO=9-X()`^($!L(=-P``^".A,N(>L#5=KT`:6=FF)G%P0@=`KSNDJ MSN(,V6+/3DVV!?)5!KTS63-B% M3*C5H]V!(Z`&!1B`$IB!%6#E$>"#0"B"8.52(AB`33B'<]C?O*T`!;B'3="& MV">E8`+NB""Z=;*,Y(G2YQR^5IQ?#I M@WU,QT3^!*'>`!`0`T)H`7PX`SS`@S/`APY`!$((@3,(`4`(@0W(!60@!!#H M`7'``W$(`28=!4#(A0W`<4!HA6GP\5P8!;^D`T`PW:3&AR27\C,.@5SH@+>. M:S.':\/\8S5>`4(FY&0`@XN-AV3X@S\`AT%@64WMA1;X6,)&[*M\`L)^`D&' M7E6`SZMT;(>$R"Y`@G((A&(]A!WXYG/8A:U=Y?.][A@(!2;PV2,@@B`X!-&N M@#C`@%"`A99&;B88@7/E@MINUG/`@1&8U4U@`_-F:!N6[6!&@BZ@]0I@:.@. M!=PVVB[055N5=6"?`74\]DT8@%V@9V:O@%L.`E@XAQ]@@V;^/]`>5H#I;N\0 M/EH3;H<@.`+JKH!-&&@&`40T/@-T(>`!8%1P(P'C2A?$9!X%6*/,S#WH_!NI:B%3,!`-BB`>EK_-3G8+JS0%>:(86H%[9 M+`2K=_HHF`)`]W/C[86M%%"(?-\=6`%XU=9(+P(]R.%-.()=0`)M_0$D6`%R MYM),^/1SN/1[N(=5#@+J1F%_V('^J%6`'_C:"KC[WS;OVK9AU2;:HK5V@\9M M[9[NZEX'G>6#=3#7/?A#Z=W(O@!?G=WXZ=T?T=X MKCT$/7#7(.YW)#B'A)=3AK_^*G5XQ(!XQ,10%T?Y&*<#1P@!*-#J'NC35B`$ M*"]=T4WJC__Q)P<$9.#3,P"$#F@!(3^#:7"$CP<$,<`&@&AQ9@,@.HY"M&CE MJ,>&$*VP(4+D;"+%BA8O8L2(S50]8F#`)$O&(UZ4**OBK9J2PXO*"2I*D8F' M!4NA*5/^_LB,\@T(D"GEY`F1+ITE&CR)->E0+#0X5GE88`17J"!S4-EEC MLF*$M7)\*AQ1,*#+KJ]<%+`9L4O;H1T0=EA3X&]3J`&QN'P8L:+L"FLS*JP] M-$#!AQC`=A0)HB!&A1T5!G\(=;A(J,4KH';1%@BL@E!%<`"C)O7#KE";^`09 M$6?`K@]',@7Z@`%#"07M/I2H4/G'BGL?5F2R)K4"ABZ;IJ[@@R$4-236XHSX M`6M3%ZHE@`5)S*3""B+K-@4!AN%#N>_4@.$HT0(VY'2`3"LM%)E+!]A`E)&88V:$ M#2]&?)2,*_&@%$4\KIS@2DI/>)$##TXT\L_@Q0 M07B9$%$.#IN4T$X[/X"%Z1$XW(/!#O?L,$(7L`1RSQ%=\.HKL'KEX<\1F&E6 MPCTX/!7#/:)U,0(&_L`2Q%.;M+/^RU8EK-..8R/L$(@_U'"7Z@HX8/K#<%$! M.`,.`P1QA+`C4,/%O%&5$`0.L/A#QB$8!*''"J'<4T(L]^C1!37W,.8JP1@< M/"VD^<8!%<,E6*-QM\]B^""!BRX:332PT`J]JAT"X0\ MV0,ASL1(=-$S6DFFVFM/;<='Q+@BITFN6&+%FC0)!00'AAS2RR`Y?%/'H(/$ M\\<@*D610R5`')IHS4HURN`(P\V[R2%/235YQQ5L(M4AE\?1L6I/P?)#":B M5Y`[O=E*OLFS\_X[U>1Y#==Z5,>Q+A7LE%>7O>O^C3![[.7+'.#)CRN58/KO MPQ^__//#3//C-X.X,\\^KSA-".+\2&E'LY$^JM0T9(3`2-.`2-.J-J,-Z$,? M,Q+'BJ`P$$"TX$8KZD`N`/@CJUE)(FP;X46P089D$",9EG#%'Z)`-U>PX@_@ MX),7@%")&]Q@<4#XQA.>4(<4K#?K`(7"`&G]4#XIB'.-_UM?$HZB,C&I<(QO^VT@A^]4,?SK3 MWXE2Y`@Z`")%&!P%"(SVM5Q`J05->YK2H`"FIDV#(;D`00L(XD`< M!'$+GK`D!Z,9EBG)SJY%?3 M!]T4G#HMF3;/R,V=`C6H0G60.!=%SG+V[$>.Z-H90#`-1W3P#$BCI"`C4C6E M]<"2/1B%(WX4`D>&8)/D@(@CK"8.0)2"')1T1`?ZB+8P/3243JL'*UC!PL.- M5%!^FD(-@6C#2G#@%D^PR11X`(8[F`($-O'"+8%8"9@V4:8!JDX7^M,?;%Z6 M0ID-ZF975ED%?78JH7U*9T<[H9XVT7U#72UK65O4#1V5CCW#`QY6U%4<#<2# M2#M#(",2HCZFZ$>U18:/:$M;(!$"(LAX$A[$8:5Z;J"YO-V:(>/Z4#.9@!@\ M(,;A`*?^Q#IM5"C?4$FA!%$)P4ZA$"=@Q2-\H8KP(I$EMX!L$YO"H-:5;W*S MPZ;V*!2'_@8UIRQ#GX``++M_&;A[%D(M^U1;,@&W-L(2KA!]Q^FA_"$5"KE` M"!T(`0*BY0(?(,!'"#J0R1!W(")3$P,(0H`U%$L2!$/+&B!&,1&)M+@'@$@N M(HC[8D"T&!]?LNYUG5&"D'2W#D%A24V$4B>_(K$26P"""Y-A!U^L(`J_?,+B M@%GAFDGV/[OZ00S*'(-0(.^:1PB%8RC4*0PXLYL+BT%G,;0#20%H!&MN+4A)+%)X.J0WL4"P=I3&`0/D7B# M0P#A#]3PA1IN,=XI[*0GCRUTF*="E]L,`#U'"`2<-VO:R9(60I85+:,S<8XK MDI8K)-ML7JX3!.[E6W@))ZVF,;/P?8/6/W&8077.<3R%)US3$!=M7NXAGCAD M5EO:(`):GG($)E"#50<;>P:4;% M6M3``1)$`R&7\V'F$)KTA+HP@'/^,+U"L-@%G-\7]6SM8!?!FFS#'13U_^"` M"Y\^8VR1JF(5W]BWSB`'.=!>:X>>G8$3@6O:?>M;>M;BUW9W=ERQ80=B_(&P MXRU$(0:QT4$58J,_*=0-;^"(%=2B!8M#H@]YN.YCMILJXTF,`JA1A%@<(73) MPYSG,D=3TF>NO[\;O?4.`9W?U90/ZV#>Y+*U@D!L97C4TS,1<+#?[N4W>:G/ M'NI17]/R=:R_T%$=3?^UB1BTHW/MT(:"H^)Z`BO/^@=&?>LVH09-!`QLPA^[H)4"EF,-\UMC$P-@0A%J4W4)V;QF./\/[P.1.5\AW%X<01%X MWP_\'E7^_,M-,4$@;$X"_L?!^%Z`"-CH4`6X7-SJ\-]_0(=_?$;[.1/U3,4& M4@7`4>`FS(!I;%;]+<8((,]-Q4$0/)IJ=%;U4,X1P(*P8&!]W,-TM.`'TIQ_ M?!ELB1H=O1W'`^^'`7[@<++`!G-D@+%1,5%`#$02"8[0#$^S` M`%1,">``-`W`"@P+*W[`Q(6=+$;%#.Q@**#9]_W`+9)/$>@!??`!'_"+`L`B MY\!"%52'-IQ#/.(`#D9(_J',3SE3''!!)B`!YO@*Y5@#$0S`$5P.R9"/-8R' M06)`\V1&03Y%">@+H\VB?W`!$]P#HSF:7CQ+'&"`<(`D<8@=5&@*:^3%$Y*.=S?258`%]B>-44%%^3&)?K+I1$'R6#`+E"+]=CD M#*Q@''S`+`X'&V@#-[*@5(:@3'+^8U3()%>>0ZMPQTM:#P9D0BQD#D3^2\?, MP'C`9("`FH&4W4.%2`F4`(B,"=HUC0Z00-N)"3;00#W80=.4$B]P81>&4M/8 M03+PB1B681FR2>(,2N+T`D_<@B"8E[<=`@[ET"W98639UX)T@7TH@"!JBP)8 MPPXH0`EL0AXH``Z<`^YE0@GH@0)(3"9TP3KX0W=0WPJT2FW$P@]XH/"49CO` M@DX&`1)TP0'(BV:`1R:,0+@@3[A840SPA[H4@3_D8V7HP7X!!Q^X(IM59[XH M``,>P:V<8F4$,YP(58C``LC*9D M!,MEA>8Z'-S+Y:-3ID5>(,&([D(^4H,"W`,_0H@_+HIJH4O23=H(#*1%:DL? M/@5K,L$HAM$(0-\/S-X*K,L`(`'R\)R>K8.G_`420%\?QL'WM0/%M4,T$N0( MX$L[^%X0,`$.L,'Y244[``L?;`<&1"/N4<7`_``U;L(/[,*TE$,H3$X0M`.Y MB"GFP.DF&B@UB.@Z;$40W(,_:$4%K`,L((%IW`,3U$5PC,""#L!0!ET@D&,Y MQ`""WL,,:,,^)N6F?L"OS,"7#H?+12.GT`6^K$,%Q(!W4,/^O.T`IV2/EU9' M'"@HOLS+[6&*-N3F@KRE4I`3F:C=V^4,'60!&=AEVHT2+]B!79J0#ASKC8T2 M(9B`&C1-+8`!81HFD2&"#TA;8\X$X9G$&6[4*F!!XCQ!E'$`!]Q0$60F#IW7 M+3!1H7WF@HCFA\:!-=PI#BC`#R1&GN(`$7!C;@0"'Z!*.52`OD+D#&P"!K1# MIXSF[[S&`&R":V3"/5C#+B!!'&C&(?S`0H9+^/G#\8S`:QX!$NS"><)"$73% M/)+6.9R#\'0!R2*!!P!<(*>/!8!!A`!G0(H98QF>_Z`8IB* M:.W"`+3..JQ?9:!?"1#!P75!5WC^QK^N``8L!F!$*(=N12;X0V*40U]T!HR. MP`P@IYZMZ,2YZ.2@;9^MZ-FV;=>I#Z$5FH.9(A'LP'ZY'$$:)(\*RP#`RB[, M`(R&YORY)+H`PPJ<1^'RG/SQ01&TPSG$12B`"N7$@JQTS@`0`37\P`ZLZ@A4 M1A?$0.?E1\IB[28X;1S\*VW`)-ANPBY\A]:FANRRWPP407'>WPC4Q@`4S\O- M2FN&!>B=P[MDPB849U6TWUEX1FW\`'4\!7#HP3Z@9@P4P+Q.@*!]`1R"< M0_:25EN,)@8<07?\0!QT1@40P3T4`7!2`_GBCO=&!6IVP74\!Q?=@\%V0>_! M*(`$8:C^?4AA6D33')(4$C`]%:M='K!#F1`)+*$SF(@4@DD!&QL43HVUTL`$ M"W"VJ@TVJ`$XH`2?D"L6B&M)X,0JY,#?%,HM%(&Z%@&[?DYFGM=+L1L>-L@> MCF;V4`,K8JAZ9,*S'`(;_/`&NBPU5%%/@FTH5$=;\+`EXN@K3LYY#L`,[,!$ M?B)TP$)=[`)#ANQE:(81S\8K+FPYZ`'"948[=,P'?/$1`RTG1D6X[$`TZ4;[ MQ45Z:"T.Q,'0PD+O4?&QL&:20@5I]$X@:'QH+6,L;2'L(* MI&@H9,(.(&\Y'$%MQ`",KH"W',*SG`,\.J5I=#+K/`L?E.C^"M(M@,CHAG!3 M'.0O$Y@E5<2"WT;%04+%"GRCM"A`'M#@#!!!T#X%-82"/Q!!X3)!0>)C720" M;RH`H&I>.=R@EHK+(&C:`6"6#3&^N)S=[SH[*IQ&3>0ARD*]_$\+=M`6#UZH',JX*`1^=-K)`J@$QVGGH`;%141GH@ MC^!^0!&LP%8,1@E,3F5\0(N6`,1.[>60QCJ\\"DC@6#0G_JM@&"TQG.Z!V&_ M'!NHH.]=EC;T3A?$@$17IHLEJT(]#X$`7[6AF.`K53@@.F$YB',9M;NZR'T M!S^OPSVLP]5FPB$\XU:LPY]ZAO%8:%^?EMUNDW_HP"R?>/5IUE&QJ?D`@&#%P:\/LO6;R(,^_]@[F).2LC(#ZM6#(Z@MT MA().'H&L%`%+7C/R?,!@T&GXP$(>J''T8<"4(9.?D9K4\Z))_>)WR#G MZ*LEOS$X0\>_"K3U.N7SMJ`FJ^#SONH*M,-7G/;+H@MRKH,6385BP(+6AH(& M0,=KW`/T(BT.'CGKU"R<2<6IL(X>W(/`F';Y"DA<(T5LP32QVL!'D(&QW8$) MK'G>)3`HV8$1V(`-F$`&T\$C$`,QV(`=@`D9&&M$9`$)U,-'9`&(S!6U>C`Q MI`":I(`=8'56LXV9G`()'\X@S,0J&$$9@$`OJ(2?#,(@H/7^+=S`"[]P#$L9 M!Y`#N\VU@/!F)JABMBA&*)2NMP@N8@L/:V>Q;*PHFX7F#I3VHW9&99CS.(*M M<+KB`(2"IBS@[1&N/V"H]Y6#J90`;(2"O'Q?(B8[5)Q<;"![(`#[(=2%=NO9 M?+1B%P1!.5`#,&_T`I9`,E?'@&8QJA1C.V16(.S"#WR`R9**WC[?U.Y+*-#; M.3SORZW##,@N[\K%/0Q`L(3I,DGSO`3!+NQ")A"H5/A#$`S`\U;\Q3OJ8W"\ MO%!(*Q_(H4'8:F2"OQ1B9H<'^6;"7SPJ#GP`$31X5.1+%P0'&P0T:#C&BB)O M9T3E#JO'S7.%BX8>:U]&/'[D#KS^"S"`#'9(Z&(1B@<0EY@`##` M0G>`(GQ2"Q$@P29D;C"V0^=1CMC/SGQP`1?,8EG8Y`K\`'9TP0ZH.S`()7H0 MM#PZ9!$!PYT@6UDAE;$@;Y;`Q?`1P5H0Z&RS@]XAHCF,1,TY0J4`XG; M>A&DJ'8;1Q!H0[;T;E1RP3H<#YJ6Y%8`QWR[)=D-H8B4T!T804Z3@0W4`D20 MP0*0P!V8R)SS`AB8`"_<`9Y/!`T,=19H(3;0I=Y10S*@`B^0`#%DL%\>5M/P M0C*8PQWP`@K8`"\`&Z6O34180QD2%AE>5*#X2>*UE%!LP;>A^@N_-:L7VB2\ M>H`<0?G^DODP3^3I=,']P^0R`<2*"B-6[)A1`6$7@0FI8:B@PR'""BM6'.F" M<`29'Q@('K%8T"*U(P@;#BQX$&$):BO(?)`XT:-+DSM*Q$FX<&`7:CL0'J%( MT6*<@D!EEOBQ8L21$CLNOAS:Q>=/@4`ECL"PP]J(+G&.[/A0L8*U0&,#[;)6 M\>=(B5$I2HQS5BM;G&^1OK1[]RX'-9/X]O7[]V\TO'B[!!D0*L;($3N05`R% M`_*.$1\&X+`Y,%006#]&4$."`\/G(T'TK.BB!TF0BO=PP#HRXF60=ABZX`AB M[?(/)/XPQ(EQKT2)>Z$0Z@G46O4,UCB<\FMG3?8*X3^@EQ[^\2,0+!S`+W>^ M%T,BF0'K0G4946)='J850B%AXS`4<.4_*G2YE\=:U1)(AM_C&02)$MHK8809 M`BD/0`S:X\@\#%BS#H,\V@$O#AP"=!`RF08J(9,C;-IAG0%F&$&/`>*800$B MB%"@G2X&T`,VO#H!C,:^G)CF##H0H8-''IWYT1ELJ$F!%SIH`*,$;!`A`PQ> ME*0C"S*<0:0$&\C!!ILL;*`!$6Q*J$<,1(+,H@0ZE*1F2VQJ:1++(^_HLA9B M'NF2!AM0P0;(//7D@P0P4#'!!"016;*>*W?,(HL=H9X:&UY2>-/+>G0.1^QXA,LE22#D MR1*R<(:.K;OD!?HNOQP[R[(1H<:$*^E0NTTPP'[;:D3DIOON^NT'LLM6C"#T MT,"_Z:514_A#/`@HJ1PX0G%;:%P1#B&(+1P/>9/0`N5V5T$+7A"#&;15%P:F MP=*A+H)\:9<'25A"$YZ0A+[#BS5VL(.(&"^"RD,:\W@D/Q+^A(D.O+`:&:[W MI"A-201 M8$I9`L,C?-&E+.B`B>B[DAB,V#ZP\2(9[N-%TVJ1Q2W>\D]XJD<\5@&I,)(1 M"ZY`XZ(DA4#%60IR<41D!"DX2&<^$YIZ[&,$_QA-:UX3FQ6$H.04N4@>B:%* M)#`"":[DC$>0\TEDT"0VZ!#.%-3^PTE!JH41P$!%(F9A;#I`!=K$`,\V&:&6 M72.&#>I1#S!LSY:X5*B>Q/0,+,3C#Y"2:!1X(,S"%(.8W,&+W@QI1W900=9..*/GJH#)R&"J6.K15+9:8R@!C(\HPM*7>A:\]3(>+B"@(4CX%O/R#]%&>$3(%BC(RSE49"&4(+-W.E@ M"1M-E::.I=524&)4^('\2&0%,R@!!C!0@AG0Y@B4Q8!`>F:-S%+6LG7Y`&4? M.]H2Q&3^7(55;1Y#NJZ?`E5'4\-?0F5+U:G==K:UK:U3\?MJJ$*9X!JH."!?;[$%#E2WIY*KH^5P=\WNKO9VE?ON=ZUY M6,DE]B7F^8$_8H&!=;`!7@4*!&RZ<`@8FV.G?% MX1PX*,(FCH`#^H[`'PH8D7E$4H1[**`$19@!%^R,YT.8ISR;V($"U'R(`>`9 M-@/8128P<(@5<,:^[1#SABG-.B77Z$:Y^*881$Q#&^^IAD$2@P[01@Y4'%%, M=)C2I]F*B`F0(1D[?NARZSK,0M4C'92@A!2,8.1*W"+)@-TNNMK-DS:7:%8!T]ZIO2.9UV5F=P4B$SA`2E/BP(4!9&(`V+HS MO.LS@CN/""$X^,`A8D#H31C:SUW^^4$Y^/"598>%"-2N],@Q>&D:T:(5(!## MREG>:>:5>*U3(P,U>$$#&I##!+40`PU(4`MRD(,7.1>##A/*:ON)J1H+,&,P M'\KWSP.,L^/N$+!0`$WJO:1WSB%6?#$4*QBWL@9`7"@P^;#S3X8"17?NM,#AB4 MJYSE*P_^JLN39N.ID6`!Z"/!(U"0`A)DP00\)`$)B%$/J$V53T4W^FR78`[E M.MW'6,"H$9(P]5Q3(@N(4YP;N;ZN8=MJ5CI#`8(`5BHF*8@@"+IE,J:,5KY" M50)P(BI@$WY`SFJE+F"J`A@0SG9!(";C`FUEW,BE8X:%!+T%"59%T3X@!%,E M#EQB,I)%6#Z`"=H![;)C9#QF55QB7DH@P%2E`R7"OH@@*SP0-H+0(AC0)#Y@ M7F!!"*$M@U`/5/P-739A/S)!`?R!7[@@%(I`#_0+6LQCX6RO`G&/XA3@'N)L M`&ZP^+H`"8C`'R2L/K1!TI:/#EFG_VJ$%D8!$**/#ZGOY6+^SAET@`3NH`2, MP`10@`QTH![&SQSHB02H`0Q(@$O6[^@0@1(,@!AF#?[0B+FSNH2%A`Q;NH<`XTO0`"0IK!+W^$L\:FJ4$SF$7CF`3;",48&$7.#`A'$X! M&&X@_*$4(%(`--L$:(N\A"Z(< M]LXJ%*`KB*`+8`$8MA`68J$",B$&5N`BJ4'.*H`(F`+1)$(;.!`#]*L(_"$3 MO@(8?J`+@"$(BB`4-C,6O/`BSL,,#T$;](YXB@`'@,'`M&$=!N+@>"\U,6(= M)K,X+XO^T(J@!"PO#HA@\03R(7$@(K&S"#1SV0*!"7QS"P?@'(K@'!*N/BSR M"+@``DYK,[\S)S@"#`@$Q1B MV:;LSK@%6.ZA'$H@OA"L!!J&.TQ1#!%-Y2%U*`&/Z`2O^@+CGQC`R%'=(A'4*QZJY!%)\!<7JA M$E*Q1H9M!8*3"3)L,0:P7B[B""#S"(C@'NPL$S(C$^!MR@#^;RHF8A<"@?>* M8-!&!"DH$`-(08`<"X1Q"0%2_LS^Y4`&XH!UV80HU,S;1&*,@J@B#T!B(Q/T#0SD).(\].2V`%/N`BP+`)3X4) MV2`6)E`!?J!9K%8E`HPB8HQ7AQ4#8E(!8L$:`LQ8 MZ]4B$B(($]<>@F`&RH$S0RXFB>`(LM6SD(()_5.:]@*P)D%`\<*Q,``'0H%` M5H`:F'8B@J,DPB(X3LLM5B`R8L$FE"(XN*`^NK*]=L!W$R(_SL,F#19Y2T5% M;21A&=;^>?L08I7&;FC41V@42*C7>C]-U4AV29L!`?JA&JKA+<67![`@"JPT M"HP`''P,HSZ!2T-1%*]!%_(R"8S@%'JV=)M)8UQ'T,2.*)$`*LR0S`12+RA2J`#^;K`S!U`,I!)XRS;V\S M-T]+OP0&LM2N"/@4,XS36"NL`O*`"-C#.'VE'3*A58'!&F+!@&^U"[`3[>B5 M.@EM(C)A'88US_QA%^(``PQX'3CW$&:`63//,G/S"%"$,T&O"-IA;+MP&3'@ M`S1/=/,H7/_B=/$BINX%`&F*RV2%7U[EC3_F$):EOMC`09/^%X_M8GGYXD;P M87E$3+@"69`'.9"YUY`/&9$369&Q004:V9$?N0T0`&?#5Q=P(1UTH1[*H`Q@ M]A1(P`2R]%#N4M=`\?Z2X/Y,X'ZSP6`8,PR7N`0FL(=D4[!Q: MY+YH(A#2,5GN(7$=I%[NBS-PF9GY89JS&54(=!VLX;ZHP4">,0_.H=D&H`NL M81W$C0WQRQIV0QTQES&H80(#`4;VF0^$]B5@(1`LR_=*@`D2#@?:03OFC2#\ M@0GN@1H.+!!TTB1)%[!2$H/(RW+^F%@R\IBD)6*/DV<:>H`0Q(`06MJE7QJF M8_JER8$0R.%YIQ*H8I2&;-H/>]K3G*$9]*09YN$:JD$7?@&ID5I\C:`,C"`* MP`$<%G$NG:L03*!+*;D:BGHO3?D7HF`0;F&5`A,C1-`DZ"U9+,PF M\H.9JP(J2+!7XMHNSB$YO:TWS4,AM$(F>B5SY&4NS-I4!)M8?O"L868%H&S; MA-`T_-H\N.(#SYJO^;KA/H`,OLPD+O!;,:B,_<*CL0D)2YJD3SH/Q2$73ANU M4UNU5YNU6]NU7QNV8UNV9UNU>P"UQ0&WGL#\("X]8&X M=QNY<[O^M\^@%6B!CL;:=/2M)QA3HZDEO3SFVW:!#[!;^3P/&&:`8&&PRNQ" MNC>Z="?ALT5;O:^)M%LA$@H`ON-;ON>;ONO;ON\;O_$[$O#AO?/;O_\;P`$< MN-\;N`4@0!QNO`.PP<_/``HZP,\+`!`@/00V``I: MH0-R80/R'`J$O-,+H`=`0!P`H05:H-"?_,@[H!40/13?/=3U$-)[H!4< M(1*@8!I&'1"@8![^_+W%H0-&H06@H-6;?13J'02:`=*;P=\GH-"5WR#?B;P'\&$:6N$,(+T`Q$$/GWP#6F$:2)T<#GT: MC81^'LE5W26\'6+[T# M]KSGQ[X%5AW'"8'6(;W&@QO4YV'(`6$:U'T4?AX*M![KX5L7P>P*$`QK[L`W_$TYZ9(%Z/ M`"[N`2G^[]&X;]5S(LHMP3:[W')Y\C(G%IC@V51K[_L>^TMHS7T_U[6>$)H! M'_!!!5IA]J%`!3)]&E0@ZL6!$YHA!`"A&3AAU$$`U">@TEV=W\GA#%[]QE_= MM/D=(#KD"H$O$IY1*CI$PN>$X`1`XASUR#4*A#AQ%*%$`M2J!X@.&W)-"%&@ M`Q0\!2*I7,FRI"_3#@QXA-H69L6E%V1)>B1XEJK=!E M5[M#5K-:/=0ETP"W80,+'DQ8,`/'D"-+GDS^N;+ERX\[*5;L M9!3,SZ!!%\#389ZX,YP4%@CA#$0!*,UZI.PP0=P&9QWP..I00%RK48!`D`/4 M89HXDP4*X",WKV./:<4!12H`HAF@`KE:08$R*@1%Z2`XS>MP!M`\,21&3VM\,$'*PC8Q0H5?###"D*-L,(,7`A% M8`7_]13'?T?T],%/,Y30TX$?=#%#AD-U^*&!([HE8`488*"4B0%N^($U*ZP3 MB(`KKEC!BAA8\Z%/.Q"Q`UT^Q:'@$4*M0,T1&T*E(`9(?;#+``]"]5^3(U@S MPP<-/LC%E%9A)F98AVFAWV;1C*G^YIILMNGFFV]J=J9-G=EGIVB1B-.#2KF( MDQP>/?BI)TJ1G+%G)('FF8M*/4`D#B#XY+)HG\E%$@(4@&R`*`B`+%K`!CUL MD%((@$RT`:!^;@`(%/C@@4<(G(IZ&J.RBG/GK?C-B1-_@8V`PP!!(%%!"4P@ M@4$[1ZQP3B"A(,&$-9LX-0,3.&PRPY2A$!'$)M8$0@T2UHS0#A,,MA-$*(%L MF`<3H:RS"XD^F=OLAN/BX$\FU&P"RRY!P)()+$*M9ANB:6IM-4 M5VWUU5A')F?4G=%WZZV?XH-/"#V(W0-!9A-$MMACEXW/V6.CK38^D,(=`MIC M`W+WVY#*#;?8I<)M-]UJ%QYWVG$3^G5HN4:=$Z]472AD!0K@4,0]("-902!, M]+3T)N<@400??/A'A#^@\[')#PKL@,$1F[!!Q`<[E+/")KO<4P0;"BBIP,MT MC9`ME[D7X0\1L6P2B.JL_U!$$+/'0$07(_!;1"B58Q!*!=JL@]<`F500@P(E M7$_^"@K`LHF4ZYB/P29UK;.)C44$$@@&E5L3[E+M[%)$_UW^8-__=A'`3.#@ M$.D[`C!*P`5@5"L0HEN!7\*4M!N M*$RA"E?(PA2>K84P?&$+9;A"&M*PA7@H(>/R@T&=\"0LAPC2/7"`!!QT11L1 MZ\FR>A*(<\1A!:'`@38"8;H@'((/@7AB(!3@CQ4<0G9=N$Q-<`9C>\L''7!"#-&'^3"UWR?G!KNNI:A"$,8X`CZ(3HQ=V($"U+@4,7X@#GR0W[UN)\<*W'%\UICGAKIW MO7*40$+::$=4VAB'&#C4?-8X0CFJ]8&(%@$'Y7C?!YB0ASA,D2M=,201_K*4 M'02B"X4DY2;&Q:)RJ&\$3UQ'**RA@!C$84I%D!+3:.E+PR`&ES318%&7RM2F M8@:8*PO`]H-!0?``8F=Z&-"O"4:;M@PB%"$8KZP>)_"CC"$3#V@4SL M`+%0!,8.F&*-3&!`@M0PGEPI.0#SQ>`0`V!"'"I[67P500_``%Y=SH&!"OBC M'$<(0FJ+`(L%8@`8VY*@'R$9"@$1P8_M[.T,=G#82_(E0;_M0EP+1`0DC"!A M9+0L!DJ`@P7N`!CJ.QX&]"DLIY+IJ$C5I7?'2][R$B6$N*2%$VC!WO4Z8;WJ M=:]\WZO>^KJWO?=EKW[WR]_^^K>^_PWP?^$KX`(+F+[ZO>][X9"C* M#G9L%H/"@AI(B=DZ=G"A=N!`Q#.(PP^"4((2P`+#7-`##@8T@'NLX`AJ#I$> M!/;F$>L!03[!P3I*L`-CP3D4+]9#A(YPCW9LSQKF.@*P=L2//(P9K^;]R2UQ MJ=1(6_K2O80J4C?-Z4Y[^M.@#K6$T4J5J'"E`J<^BU#LUR"Q1,4H>*G*56!V MB"Q?I2B'P'5>EM*%+Q(0+B-@G8M.#9=BCR#62YD+3H_=H%K'@9L50/9$??'# MR+QEI$QH4EB(NN^T^H3?5%D'$<(5HA'4-@9-\[=@B$I+@`]EE)AQN+H'4V[' M57KB&,_XFM@M[XY[_.,@'W6]);.",N/9@Q\HGVUJ-N]RHG#[WRV=.<\>@ M-^0XS[G.E0C[K4IT[UJEO] MZEC/NM:WSO6M1V/G8`^[V$&MDP]T/>D#.KO:EYYVMK=][7"/N]SGKO8/@!>7 M/N"%WO?.][[[_>^`#[S@!T_XPAO^\(A/O.(7S_C&,_[F8X^\Y">/DV@X_O*8 MS[SF-\_^^I'O_K3F_[TK7^][&?_>M3;GO:Q MI[WL5W_[V[O>]ZSG?>ESS_K?%W_XKC^^ZI6?>MT[7_BS!_[R:V]\V#=?]Y3/ MOO8E[WSF1S_YK8?^]X6?>^#G9/JX]W[ROS_]V)>_^^KO_OF?7_N<$%_\NT>_ M\HG??NH'__K;%X`".(`$6(`&>(`(F(`*N(`,V(`.^(`(:";V-WSA-X'F9WL8 MB'P8N($2R'N]9W\6&'ZIEX$=>'SG1WX3:'TBJ($AV('05Q,C6($0.(,T6(,V M>(,XV(`^(`8^T(,^^(-`&(1".(1$6(1&>(1(F(1*N(1,Z(/^.?B$4,B`,D=T M+S=N5`AY<_(/`>`-2M"%7OB%8!B&8CB&9%B&9GB&:)B&:KB&;.B%R.""4>,+ M5#B'=-@3M5`!O,!I2%>'?`@9(^=47Q@-D#B)AEB)DJB(EYB)FNB(F,B)G^B)F\B)C!B*H]B(GW@%^P"'NM)S M1/=#?]B'F&9TNG)QLGB+ZL9QBD&(2N`-B.B+P!B,OR@)B"@)+P",ATB,Q%B, MOIB,R@B,B\",RRB,S0B,Q]B,C.@-Q[B,V_B+WNB-RZB,SRB-S$B-U8B,TSB- MU9B.Y(B-BKB*(H>+\IANM#@G4SC^C_A87KJ8&+00`%>`CN)8C-F(B-MXB.!X MC>#HBR^0CLYXCN%8C(LXC`Y)C)#XC8XHC>IXC12)C`!9C@SYC-/8C<$8C@'9 MC/#80ZZ8CRI95/5X)K:XDC#I2_N($X1HD0'YD#8B-1H MD-BXCN7XC93HC1%YD3DYC.J(B)48C>-8E),(E)/HE,5XDAB4DC'9E1S4DOKQ MDEXYEAN$A6?2C_]8D1QIB0\ID45)B3YICL)HD$!)E0*)E>S8C2#YBQ5IC`[Y MEVUID.Q(DCP)EY9HE,FHE5$S8639F!4$EIMQCXXYF50SDS=1D]!XE&\YD1[9 ME'MYB8O^N`BB*9K**)5)Z8Y228S'&(U8Z8Y^.8X;^90"V8FFZ9-3Z9:XJ8[9 M2)**J2M:0&^4&9Q4`YF*(9;">9QB8IDU,8C^V(M7>95*69)NJ9M_*8QP<)V9 M*0VZ*9W3N8Q+V9`+.8W1"`<$:9%#"9O3F9X-:9CA296&V)NM&(O(.9^509R+ M09_X.2:!U292>N9#N>9/H*(T:*0"7(``(>@D*BJ#1*`#N0([L*)"L^8VF M.9+HV*`/NIO>B*`"P)H\*8XE:8AZ*90C.9CP>2:_*9_YN:*%89^5QZ(P*AG* M61.\R)$>^IP6ZID,R9&4>`D1\`JO<`)NX`818`6O(`#>(`O^`.`&TE"7$DF= M.QFA4.F+T;@(5@``$M"D%KH(<)`!1NH)32J8Z(F1@VF3FHF()ZH?C!FC;!H8 M+GH3QMFFBR`-[@```!`!8>`-TB``0W`) M2;JD31J5WTF1HBFAC[B(``J5%6FE6*JEHUF1`O`*``"FM7FF4+J.))FGU9BF MF[&F<]JJ%?"F&>2JLOH3=;H9=WJ.4SJ.5BF89EJ27)H`A!H!CRH-&7`)B?J@ M$^J+TA"F5(JHTF"8PB@-J@S6BMSQJ1GQJJ6KJ34`FBU>F> M"6F)JKH?*CJK+`JK-1&GNP06'23^K^PJ&#-*$[RXG1WYF:::FR,9J,!:J,^: M`:/)H`V*H)28`>Y`GL28J!(@`0*@I1R:L`M;I4TJ`1D@`.39H9.*J`+PL!'; MH*`JJKEZE4L9GH-9F$>9F*PX)UQ9K_CIKDE%&-1C))!AA7+!)%:1(?2*-?[Q M3_\T)OJ6%#%YK\RY"$H@F"AKLG")ESP*FR+ZJX3J"6&P""ZPB'#@#E?J"3"0 M`$;J`BXPM4T*!Q$0`5K["A)`G@D`I"YP`H3*I%RJM6YP`E9@K&L+KMY0MEZ+ MMAL[LLRZEPGYBP@9F/JZE-Z0KHG!J@\'%T-+EHT[&8];5)';;6(BLY,`KROP M`^LP`"7^('&1@P/W@[-0$03^H`T(IR'^4+K[4T%!,``0Q`1'T+.2$6SXDA<( M,UDK6:N[Z(\W*:X#F9JMZ9G8"+"$Z@(9,`2R,*V4"*K"N@B@:@4"$`$`<*32 MX`8`<`)AX`G36Z7/*P!A:P5<^JE6D+W7FZ@C&P;6ZP+D"[[>\*TD.Y=\J:?P MV[2`.Y*(BQ.*"Q0OA@3WX".-F24V4QDC\"4!S%0?<`Z#-!0/LS.88;F2&12+ M145;`11K=`@QD%H)]Q/R.@+9)&((1SWSI&@N(KH37,*"$3,*@`&PD`CGH#FE M1AAQ0#T[L`MJM"%K-`(E``RA<%Q3H<$^3!2'8`V3]1:RVU3^^ZDK^2J1@]NO M=^F1[0B5+R"U`&"\R*N\`G"E$0`#5URHY$N]$@``5@`#TGND<."^72P`,*"] M)R`-EV`%PFK&UBL+8@S&2.J^8?J3(9JC,,SB=';,W<27D0NP["('#QR],L(55!(&"!U`[2)$B1 M+$K!!0Y'S>V,TTZ-P[OP4#C]U5X=(-I@1-^V%%K=$TAP#I7KRA8'%26P#K`` M%!>2"=WU$X05++'[`?X`"WQ0+:Q##5]$8CY!%GK`!D;$%IEP#T35+;M@S]:@ M4WE`UD'^$"S^T!2!P`4S$`@Q,,C^H`<,O!0Q,`"_PB"P@`2GS01<(*\/DTX5 M``N!<`2QP+^AL`L`$P=)`[H8<`@(@P/^\C)Q$`KW,`#"XE([L,@XX-N'4`+I M_!8CH,(QP#*ME`=ZQB+8W0Y<@@-LX&4C(#N<>RQZ!LF9YCC,>07.V9T@BI`Z MB92S.96B.=#!JIT)P)H(K<4*K;U'BJ@9\`J>P-\:*]%A0-'28-'LFY1V#`<2 M\`INH+W0Z]'@:I5.J:_P?9X5GH@G;1.\,@(QP-K6S-)9`0O^8"\]<0_KH+DW MXA](0.)V_2-'P`?\DB'^@.*_#;HST$:$IE,0E.-,$,JH>]G^W7,(08#B.U#9 M[8#+][#<,7!)-N-2L.`O/\`M`M,%%L8@&-!FF.0?3%,!1;YEK71FS.(@`^`/ MUV+F@1#ECM5*+6YPK#T`VH`D-1($;$!GJ-T.0.[E2&!)3,!/;)#9-F/*CQTN M]X#B:A0L,0`Q2"+>"U+F%`(+?7;7F\,'<:V'/Y$PY0`\%H).>XUJ*Z##E*,[ M!K,)]X`$JY/"*X`#1#4"]\`$18`!(?5'9!T\`U5/_K`/!L/!"F!'NU#

/+ MW^'+O`4^O6@LO0"0`3``C.X+`U\L"^LKLA,^TH@9N-#)EDILD!O^.#SQ1+N0 M"9G022A]+BU`P,0 M!_Z06->U`T?@3L].2`K083B030:E`*ZE`.$2!#OB4)\.[!VS"\Y5%W[4#F-D M4N]$!(=%6'A4#KY"!.*2"?^3"1]P".U0#D,3"OCS%+O@/8WU2)+%4Y8C]]/= M.M!=9J'^W&NH->5(L`O"0P0[(B2G103OHS05DPF'4%LE<.[M_O6KIOFUY2L* M$"'+4^F;ID%Q,`!$8%G3S.D_L2'4$`,XH"V@XUQT`=P@,OR01#&%A#U?MJ=(P$:XN.II4UJ5+;L1"]03#"E>O=+T)@.I&R4])-X<2#;HS ML&#!/(6*?7%8TCXM+1VOU$*#0\(<\I>I`N<2*XC`^MQQ M!)O2FS8-V!7JWBX,1Q3`LE8\5#E8.+)[QS%"V[H1']9?W]4%`Q%_,<[E]H=A M4[M=,;9C6"&4'0)A8H5#L/O`.@S*"26.7=HYY(,'B\!!@2.L40"'(I*+HP1@ M?JA`&P6"`*VC0_0@PAH*R^&B'6W^0MME@")@*<>:0Y!@(@9_=ED!!R)6J.BB M&2P:H0(D"`IPAW8RL68$U$R"\B,.U'BL2I6B^:C'$N+X*(Y8,EG'1`P:PN$> M:X@(XI!S")+NAW)P.(>)#S[2!HD1S@RBB%`4**%(Z7;\()9R]-!3`0SN(>*( M(@_9L[LWBZ1F%R8_8Y1/^"K8TQHN,CS$HT-P**>$%3&HX,']Y!QAAP%B8:*= M32H*I509*YQAT1(8+"*&56,L8LA0HAL!@W6L<;&+$4HX1P%J7DVVME"[,';( M'S8I*-E:H\0V6VT[0LE*EEZZX@7"Q*V)KYV`RBDPHGHJ2JAR+XG@E5>&<$<` MF[QQQXK^5US`5]\3%CGA%2LR4,(J`%QP(ZD(I$E`7Q<6&4+@!+R11H*Y#KZ$ M88>E,1CAI#R1)@-](R!L,'-U.K>P=',JJF5T&?/6,5\FJV"$6'`@@TN/4AWQ MD"XVV>&(AQ0-Y!S=B/B@-6H.6:$=6`;0(PYJ8-$C%-4R66&$<\Y9X0-C?U"@ MU@^FR^0#YIR#KL01=LQL[4PP*+$"_F#IXI`8%/@!VCBL>72]S][#KHLS[^EB MSA7\J1D[:[R.@XMU,$#P$/[F#);!4B&4L!T*%>`"0ZLK&"`(?TB,8X4!1O3S MTW+T`_6(=IB`44984MQD'2:.\'H$&H\($B.\.SVR@J:I\9'^"R?9W':D*6-^ MK!.0#O%S9T'/`6V%0&*9`0)JO+NGB""`^16#.&*@K:(!_!PAB%U>)4*_4("Y MM@)C!_C1R0'V"8()GMFXLPOR2_`0+#8!B])EHD\5B,,1B%"<<_B#0K3A`C#T MX#,3X0`8HM(#;2I`A'44`0G*L08P`PU'"P&86):B`!9TX@R[``AB\ M`Y_O0C&G=7(S$].ID=9V(<60+$^2*\'21^+FD17\8`#^P$$H@M`.^=P'`TAH M1V;NP83^>\P@#J%HQP\^X(]VY-(C_H"%/WY0)!P$-7H?N$<[,'"(6+2CJ1A@ M*A,&P)$5("$/)7!:^NZ!`QQ\)%4#L,<`C(4#)%!C!HDHZT>:FA`<)&)[[;C' M$:(:"^LA`7*!6,$.UA$*:^3A'EG;P7I",9Q$A.((@7A<.P"[`[AZI`L#X,,, M\H>!4`Q`IC_UATQ!$PIMY`%$745"+$(1VB"0U+7;ZA85P4681&)1+"WK2\I8 MELC!]#9E+FN*RX3;LD7``0Z+*"X?;2O<1E),&KD%+AS$DMSEM@M=AASN86B[ M6Y8%!68GG81D5!J2(^#`L#'UQSUJMMH@J+<+,\7`#QJK&P7^[&(7!XA!=(Q5 M`FT<]G!\N`=6@;I4^<$W!DC8`5AA\1&H2E5GL-"&/ZC1D16TUB,":4>LJ&%5 M+@S@L",@[0^N>H@2!"(0>OA`$`[XW@CGDA]\(!X3*'J//%@CF8TM+.&(=8\/ MU'4&U(#K)BIDWTR$`@,9O@<9T(>B&,2@'0<,0GNCMK<&'J$+]]`&&R`*BR<+ MMD$K6(=?#S>`\N;H!_T9,V]>6P&3@G<2*872*SL2AR(5M*#2@1;ZI!,]Z>`N M>GS>\YQ;6#,\9\TC8_-3'+J@*)!\QC0[DXY($HV^.D?/6/*+=,WT;&A"9_+. MG?9('.:$Z8X\NM2;QF07=&;J-;?^FB2Q9=YL^>5+PE M`8V<-2V=#W":SIG&@1Y^\(,@@+)+<6O/I4&-0#W7#)-SYO-G.(U`LPIO9UP: M@]SG)O3X8+%N'&AC;%:.WJ>(P-=.CV`%YC;K M!\;F\$3+K](U"[?:`$W2-H,7SJZ&N4CNC:V9ASKF-Z=YEW*.QK%UV[A40VMM-E:ZGONEWJRC91G%XR7?\V7=VF(B5Y MWI$GEWO^!CNH^=C5OO:1K&T'Y<9`#`1MUN^5X(EL'WO+3^H\O/?=[W\'?."C MY'-O`=WHOL7VO:0MF,1@O;E8]WH7)<%%1/HZ\2H+HZ\1J5M&)A+JGC^,M2'O M6\M[-Y*2%/O8`QN*4&Q)\*_'N=E8;]21B!BBL&^UWB7)=]SWWO>_!SY)?'!2 M<,G$\5#W-18;OS*KG_'JC2^D7R8_]=!OU_%3CWRMS=7KQWO1UHA'F4[895WJ M@YV*WQ[[*\4=?/9G2_TK-^LEVP]%W5/QY?/'?_[UOV;"6ZGXW$69KM.ZG>"B MHLLV[!H]HJ,)+,*^:(.N!D2D,V+`XY.\J!.Z!+PZ+0H_QAO^"O.+F=3;OQ#$ MOY4209*8DM,[J?LKP15D01'LORH!EY6AOG8AE[Y8-F*3/*3#-NB[07>AM0<< M0.J#MD,*C.6S/.RZ+:G[(O%;-D6:M>T*P"SR0&\!P1:TPBL$OOIC'A7$PB[T M0L`;/DD"%^D;KF0;#&E`PS2<+0FY#0>;^441*1,9DA))']!;>4\9GA,:1L$3'B,%D MBSRM0ZZ$`8`32(`A.!A[F<`^?"2T,(L,2(I+6*1:J\4CU+Q:XT`9'#W,XZTZ M1"-9\`0!T!=T](L)Q*W-,SWP.L9H%$AD9$8KB<2!1$A)G,:6P,3LFK8[0@JR M6(2Y.(%!O,$%)+9E@P-SQ`H7L`)P1*XL:L(;',EC6S;=ZD$;),GENLBB:,G, M(T<`<(."[;FY#L$!$H3*FPM#V:)*//Q!E\Q*A4'# MK\`*BE%%7Y0N`?C$!`B9"+@$=^C*5W`#>X^A%"9`NL?C$#/`&>*F73W2' M17`#5H0!>(D`HF`]#PNM,!.3Y``H\!.5AS$J?L);[0" M"3B!#$A#5^2NSNNUG6#,QPA(DQ`U(&*T"O`9+@`)1?NQD0A1\IIXH_;V01KF($( MZZ6[4S_H,;AU,)`CF+`]*Z@=:)MYG4P[^P!\K;0_VX18@(BEC%?0#%A* M9J]>`95C0E-!\.X(PX5>*+5A[/02+=;7>C+7? M[,=8K,N(C%,K.('\'$Y9H,EMC*/I=`-/&)C"/`L\@HI+J`JE0,.SC`"+<0,8 M^(J/'(LA@`%S!(`,@($$\,I+2(H$,*ZE702H=C0]YJF/0D"/@.0(@";&2@" MSB!<2IO71A,WC&V/$=B.K&E*H_S,.3O1SIS8D(!,>FO*BTV`1`>;*J`(J@(-CB. M"E&ESJ!,^J,2-YL$9ZR`RC6K$I@!/5``.QF3(CF"\DC-C["&4("%K$%1##B4 M/NFJ3(B!%<"`YFB/&(`%:LC2$V6-&;"&()"[CLC>[?6X=?J!K"D!6(C?"HB! M4/B!A`TU%`4//]D!_?4([5W-]NV"$M#04)H!D:.&$N@Q7N+^`K("C3$AW^W= M&6JPAQBX."*:`3-)M=.LWEBI&6N`!1,.I5`8(8^C!@SH,6I0M%+3!FV@AK'1 MK(0@T0_HW^5%3?CM,5AP5E?STBIJR.0+SG))BX,9HSB*22M(@.G,"JT%58HY MRXQ)&*R0AH2I5(Y)"G=@"HKYBA,`6IM\VJ0@4`&0A2'P!FUT3F_PQA,X8P!( M`!BHR8_TAOF$@2R6`+.0R?Z\"RN0!6E06UF@&!=P!U!U0\6TMKEM"1!<@0:N M4,L",2+8JDUHFWKR#)TS'23EF?X-@JP)#R[8@2!@M0Q]X$A6%`$6'[=9`5)V MH1>FC!@(`B[`I"-PWX+8'K(*"1[^A@6C$N`F6=Z8XM77T:Q<^IF86EY2L8;M MH>45Z((?8^8;5@A8X(@XF(&8R@Q_@(@5Z-X=,)-#45\$F@%K=N$2P(`@D.&( M*H=[H-`8P(&WVXP@V(0CV(5SF)/*8!*'P)M>09UCU19S90G>2MJ!EP0#N M:`<9\0?^).@"OTEK)@@%2RX"]3N"-=F24-C5_BB"`6"0&AZ!TV&W#`&;]`#H MY%%9;[$BJL3)Q%N7X8R*&VQ;KD@`/1K/QAX"5T2+LQ0`L[R*K+!LS,8*)?Z* M4L6+J.#:YR);%_@*.A;$.)[C.C8+/!9$:?!3"="C!+`7GR!D`$C:T%:*/JYB M>/2\L^7)DTJ]+@C60'#6:8)@J$`7K2]\FOCV#OV;`& M#"B-V?'FMPF"XLB#3*`&^K'E.&`#HB&""FB-HE(`-I#O/`'^YUS1AB/0!L=B MDGO@I>38*`4ZAQ)@`FT`JT39A%#@`PK_%3X@@@U+E$H.@A[C`W7(J0&B;GNF M'K(KAXNP)1QX+,"2I>+-%H%&J8\XAUTH!UY*:%Y:`3[(!'\@W(?X@$/0!FF2 M#K8RG=*(@W,(!)JN#NKX`,$U%`P1,&]^C@W9A2Y_G3B@B%&R*PW1_`93[1D]79CUT`L=6AD/:YCM(0.3;@$5LB7R+P MC&KM"&V0D8K()5Z!C;C1N!7PG+LN\Z^NL`&PGI264A[YN!+8@1W0CR/QF1CY M`";@`X<(E0J(!8<@@@56%O3VC,#^WI;!+CRJ7$+.$XHR)26$*]IR@1)L67IZ*R7"AI3UC@BN)8CR`0C MLM;QB&_.H`8O;PXT*0(L_XBCN1#"19;L=8T-*1L%0E(^0()-4!H,$"$*Z@VH MOAL`(8_3K0@!^P!D*2\^42"_&IL\$'2P*8%-Z#`ZPXX*X)M0V(16\1EM"`2[ MR9KUJ(!ST(;Y>)P$J1`N<&@9X0]&61WU:(?*T)_7$3)`KX@?F)$1X8W+RIJF MKG&Y*6G^[VGG&+CFLT/UUP+R*]F9Q%(KLYK>8]F%!;KKTN@-=S,1%E;SNT<. M'L';ZFB4P0VX.QES[,B:Y%ASO6K\(L#SVA&.FOG\_MTH6.&SIJZADD;OW$""E/:4W0F230@$;4#] ML8DIU`"-HI&.S]^%>[!]@B#XH,*!I1J:.GN(2'8-Y\CUF"OBE)`UKH,^H!!V MHC4V+XZ*BIEB`)CL8-OBS$X++;:*BF1V>^F+:<=',Z;:J#WC5YC:+P[+,5[M M^#\8&*AB0'4!:;!C=+PMW08(-TI@2```X)4G:>X$>)/D4%+^PX80&RZ*"'&? MEDD:-W+LJ%$+#0X5*L31PP36R)%=?HRH4"+(@!T?1L3"D>@%80?:[+R$"9K&T*DK1(RPJ,=S%/Z?T[ M>.\'0C^O^.(A\V,1D0/;.3#;=V_4ASCE(%.'/+BL< M,H!_F\2'00D*!%'$2+$0`4L1"'Y01#M,Q'&/-F#Y-T(>C<41B#8C0'A$)@]: MIA=T(\20R4H*<+$"$>L`%D<,KNW3VG#K[,*:747@4$Z/3+18V`K[C&19#.JE MQ,<`13180F91(L%'2GP-N0*3%=('X0<#!%($$CB-4&9X(YYSR`=,C%G$"IT1 M<01=WG9A7G@__!'"%$MY$9)$W%4'TZ"+29&"0"](L M`E%%`EA!Z0F>P"'-$`#(`H=#D49@T"7>2.,"`!F$$:H[JIX*`$.21!JJ%=(( M8%`$813^!(`$8TB+SADD:T3H2L)1H,.&E)*<73Q%E4C_33")K!\P`4&.YP#&(U! M;%*!-;!TL4X><:R0R0]%($7-/C&4LT+`FQ25G;WM&";9#D2L0(UK`\+(15[V MS37#9?LB35)Z!Y^SF>N^ZBIS<.;$#7!5@QL,E'*#/^['($QMKL4D(> M3(G&1Q<:#V<=+"O8W>1QL,1P1(/^;#)`)B5@L$LH(^RR"P;ME+/:/>7@\,$. MY>S6)#]$Q'"/`O[DUXX"U,`"#`Z;V,W&#E2>M4,>AA$=O'5*\0[:.9G0654F M?.R`&5)006?O#DQPX4\[AUA38P7G+$Z5/W;M``PLFY2022`[Q!!+)N=@()TU M7?!1X'HTAIG6^&,'H#G.7WQR'&O$`!BA(%G"]";!0/6M(X9"U$3.I<$,*FH1 M[HC`":HE@5K9"@Z7.($5$,*L2[B@6JFJ"`M#Z(:*>`.$GAC"LFP%PA-DH%'> MB*$++I&`$$9@$9Z0H30N(0LK!!'^A=<"XB6.>`(W*$H`$4BA"QCB#0&X((77 M\J&M%.6));[B!!+PA@26Z`)'+6HBEY+(HQ[5K@IV!%X3[()/8-$.'-R##7_Y M@,3:$:=[0&`&U@D$$O10@4/D*`A'.(?`4.:/W&A#*"GI2R!Z,H+V\09^(U@' M$?HW&@PP@7(50`(10A$#MXSD"+O@0QR&ESP%=&B2,8!JPQ M$K88[0@8<`N",/"#$DS%&CB(Q1%"88TX?"`45(J#2WT#E])8HP3W?*A-NV!3 MDLQ`#U0*#0YF,"2C"94:*_`I2(^@'(W:ZP@XP,H(R!#2]6#`-*T\:489"A>. M@G.K<;!J*'Q2`AP<@0P2G:I8O;."MHRD!'K8@;Q.>L\NZ#46&(#I22TY4+T) MRJ"3,%1%S`5'=5WJ7!U4E33@L`@:/E:RDI`&ICYEV0Y^2AK8NNPB&")9'TH# MLQ%91&I:&D6IM:S5;D=6^T5*1:M1L)^M9=3VJM:_^O>UM%Z4HX3Y* M(MB:HV%!(I+!-H97C>N,I=/[*?"TK%0AX+^HS?,%4?C6F2RDQVN8_\,1EO]^06*]?,+ M3MO!-Q*:T9@2M)]Q^\8_1WK2DRW5I0G=00VZEK>.@G1%*,W&AVB0N'!$KD&5 M>V(K4X75^6G)][9\Y"U?.6\Z=C&/9SR5*+.YRR2Q<9I[G!TGV_C)P-YUJW\- M[#]!.52\D4Y\.TOS]<[WS@T> M=:M$W5W(@S8P`)YKYW>-+M'<'..PC[A/5`\2A!@7_[W/K6F\'+K7#O MT)F.%U2"GA\":`Y.Q%R4G?1BB]M&=>&Y5)CBY4$U'52\\WWECMT`/_AV@`SWH]IYOT7N><'PC MO.GU[GG/4RQN%D.]ZD/'([^M+M`/="'K6O\ZV,/N)Q^H^.$<-Z[(^8PN1@UW ML3;?(,Q'CF=LV9PB'J^[#XW+1I!77.8.2?G$ZY[!D->B[WQ MCG\\Y",O=JFKF.J2OSSF,Z]YS#>\;W9&E.`)KZA$/_;L(^?MVTWNJ(H/NB&` MYVW+VVYJT2->XX[%>ZG7;G*-MQWUL0>C[#>HYH>_>1O^(Q)QQ&]#*B1_X$9?AM1_OG9[+N9[- MC1I$*-;LY5GO*9H&@AS>P9]$H*"[J"!XS%4@L`$7<$$[!$+FC$0V54T%L`$& M!$$@0(75^,/LC$`PM<,.!$$[<('^(\[`.B"!3$"A)CJA$%80N0$*7[!!.4Q4 M>OA)53#!VX1'$VXB*T*A%)J'V:T>_+F1%DE6I/E0:.%BGK&?',J<"-9=HN7B M%6J3!>OAT%,-P#C;6&-JI5\52% M/\P-$[H(4P5"@619(F0"):9/)L3)=ZQB*\9CYG5BWQ"A2HS`/;1C7.&4.WZ/ M(PI%#^L7=H)7*%EF!%=3*S861&\B"++B#I;QAI"1`I7`?VIW=&E*<&SH$ MJ81>ZZG^W*DI7G+AX3MV#ZSQ@3H^5RBPC-EPT_8P@6I`QG"TAAYLPDPT"'Z, MT^(D),%XW4)V9>/1H]_\'#YF0B@@02"L`$U-TSW`PB$<`1+<0^VT!>(48BC< MPSG$3PRT0RBL`^/80R"$`ANP#CQZ)6%"7D-VQ.>A'47LHA;"P+8`"V8M@B;( M@D(HRTN.80;&X?EE9J2X@T&X@V4U%J9(0P)8YI])G*G0BJDU%AI&(VL&&A5M MIO>]GQP!I6$)97H0Y4P<4_QP09/XA#]P@8(04(.``[D02H6)G9:'5@.BCW"!3[."!$$% MX%7U&!@1B"<2"$@H`,,/K("#Q%AV[J?C':8%!<`B)$K>81]%2(,;&(0$O*2! M1HH$G-&F06`8,4LQ?IR$XJ(D2.BEP$&#YMF?2:BM2(IIWAY$",`K`$!",-ID MP<%H+>:*5M:E+0(,1,`06$J$[AW'!8]99)). M!,$A7,Q/G$]9',(QA4(W,058P,B"D(63:JF=6IU_)8`'&K^HWC60OC6:D&$KBR$A((H`"3`99Z6@8I+ MS.GD)5P"C5[6J-+H;)UJI&[+3*K*J8Z:C3I@HU"C>?C"W".0C%E,;@.@##`'#EG5;KWG"IN'DIKGXG M[03/(?C,0:K%F2*!O,2!A#P(%V1".SABCLR`R+2G:QP!+M6IM=;KB>6I1E#A MG;UA&4:J)AB$JUQ"!+SD2LH"IQ:L&^!*JD#$1;I!&6E1P4J`PDH6:@37091$$0I34IT\Y$[V&K>`""KYJQ)YJ(-SYJ4%XP@D-;&& M+*=R7Z2X@:(:Q!"0"H.N+K'X"NY&0*(XBP!,B@M(5JB<0$44A*M8"PR0;"_6 MH6T:E*V"XB&\#QL$;B`P#72L0)'RA4TY8MLN3DN$A8%40%'^?(\VA-)(M,,/ M6-4^W$,F#:[@CNUY(!PL#(!*Y0%+5,!:^L,/;,(1\,,]L,P(S`!U6L,`!$$H M^$,,R`]U3E+0M`,U0`X.N*\$SUG9'8H2X*3L=="G=HLGO(+CPH%G`@OJKJZS M#(&JL,H):.[H>@,<2&ZPE/`)FR@,'.CIAFP&P,#FEF[M:NKK$J,GJ(JSM(JE M2,.IO`(5)8#JOL(9<6I!6,$B_`JI'@OG%O$2RYU(GDO0=L30@D=,#0`LR)MW MKI0F*573!,'LA#'8C`0.^$-=!H%/?,`,W(,_P$(HX,`DZA(.,"V63G!VPN]! M29"U4<4*D%BMV0Y8?^5O*Q!!?N85EP]F5<[`)L&&3`!X>P!(SP M)INR(HF@SKHK\RD M*5.*BDHN`$SQ07A"!*BL2TJQ9X7L+TO#"S#:8FY@%G/$%JLBEIY;G"6DDPZR M?N[8L-G+(.^Q(Q>F'W=$=Q[=NCW=T27=TZ'S-]LK)#]D2")>@/XI+$>J)G,R M#H\NQ5+N$:WP+M]P*I-H,H<:+6?`IV2`%;B!)_/P2W+HS%[D16X*`'3D[?+* MI_S*+R>Q`*BHS(;*3&YPMW3J^?VDN$5S.4,=TJTS2E=`.'/$.*>T2S=>X7[> M!<^B%U;^,F12&@A#K@O?LPE_:@JS2BGOM"=[P[&\`F4-]`S_L@I;+ARX+HU& M:@(DJ*(XYN):BLTF0%&'%FENRBMPK$'$[!;9+$<[ZE8?Q*CQJ_`U;P61]$NW M-=BM]+BYM5Q'7CM+,C`JIJTD=:LD;[:$\`W[M0K/Z"*4Z+60,@O[-4]?+J\D M4094YJ9Z`V%[@V'3LDNRT:ID-*65Z"L(0(RZBF1;06>'P6*6K05+,O-CNXBL'=Z6T%C[]V`NMY$R/9'\"AO!_@$ MX?8DZ+:`'[B?1$,%7\'/@B&F7(([1'B$7Z$'0;@[>%"$7T*B1GA&"X`;)$"C MN,$928*B*NJ&+\1P98"(LS"&1WC)@GAXGU&%3_AI17@":%&+0[@`[+@$N,&B M:GB/DZINB;(;V"P-];C-`KF/EVJZH-_$^?@J;]HIH&Z%EZ:&Y9ZJ9]+J:?A+5*$ MJM_B[;D=VD&YE%>Z@%NYKP?[2/BV!<_FVY7?!,[F_'GA8S5S3::A^W$@W[&= MGG5<2`8?V^4Z!_9=:Y(>GS8$KS>ZL#LZL(][I='/)KRL6? M+X8?8^&UW6%+O(,DL^==`X;TZXV?&#J[LN?HX@&XN=MVN1^\HVNY02&6@`XH MXD(DIL\=[NV[!\HJ+RHF&J:A'&:P]N$DZ]TD36)\MK,=R1)\4-ZJPA]XN2^7 M2+@\0:G^=,S+O,R__,S;O'CD/`>H/,VK-,S[_,Q7^<^GA,VK?-'OO,_S/-`; M? M@21<`=M?P2*T/=S'?=N_O=S+/=W7/=[G_=SK?=[??=S[?=U/EML//ML#/M_K MO=\;/MOSNAWQ?-B+[:W^_-$+?9C/>=7/M&+?MDC?=>+KJ_/ME7O4JK@5H/82WTON]K0.\#?P7X M?BT`?_$3O_$/?P4(?RT,?_`?/_$W?_1/O_'[OO,_/_;W_O7^:S_V`_\(!#_P M)__O__[V4W_U9__Y?__Q,W_QG_](3'_VQ[_ZES_\G__Y0S_Q.[\&W#_\XW__ M#S]`:*@UL-:(6@(U^)BTD&%#AY/^95,BC&)%BQ!`@2-:'AQHL%8%EP-M$LPI$V?,G3<)\N2)L&;0FS&+&OWYLZ4& MHDB!$GSI4B#3G%"7&L6IM6A,KS.-:J#)E>S!IF6EFKWZ,RQ7#3O?\DHYEVY= MNW?QYM6[EV]?OW\!!Q8\F'!APX<1)U:\F'%CQX\A1Y8\F7)ERY6/9MV;=NW<>>.K(5W;]^_@0<7/IQX M<>/'D2=7OMRW;N?/.?OHU,E'=>K7I5?7KAW[]>G4K6_?#IX\^/#2IXO/KGX] M^_;NSX\7;UZ]>?K?NNPZP\_`MOC[S[_W@N/+Q\(B5#" M"2FLT,(+,]>3-..=]48LXZ\#K;5:8)U=-MAIE]W54+YHX,#3<21VU6WKTM)3EGEE3&5-U0UE5A$ M8F:Y!?98;Z+EE=AI)5YX5YN=K=9A:'5.6.-K?_XUYXPA7O;^8IJI35A:9V?& M]MY@OT547):Y[MKK+2GM6*\GOR[;[+-!O8M>7I'6=]J"9Y955Z%UKI7663&F MN&VY?U:6:88S[M97:*_VM^]N_14:UZP]!OGLQR$?V62^R([<\LO9==DN--6$ M&G!]!_<5]%B-Q1?8N*\>ENVD;Y6UV:#]%M9JG$<_./'5^ST8]GN=93POQ[$< MX9`1HAR!>"N-?_?X0^*(0\ODI12>RQ$^J.!X*H^_7LKAK3]$RSBT=Q=Z22?? M"V7,T4^?4\WMH@5FT:T%?=C",R;X=85Q;35NT^=NEG9M/P>XI!5-;H;S7]!L MUK`#MLI8NEN$[_`"/"L=(11L@`7^!BIP!%B$8@78L\8Y=A"^XW.Y\!+6AOJYC_;H4Z M;1D,9SY+5;+F5K?^S5%O&"L:&#<6NEA!\"Z^V-J5#K$#8+"!>IO`P0ZGU(41 ME$`!.#@$"ZD$R4U]8!<;U`81@C@":\R`A^T@P@J(UX5#X``8.Y0DE0X1A',4 M`84B7`$F@S"`%4KIE4@H`BR`@8%9>E`!]]AE]%:@0D:-X`C"M%(HQS-23'96!SJYBQ7<@Z)* MA!()%1"*BC*O`MS[`!/:400]E;X3^ZY%(B;0&D%+FH]@8YT>`$] M*I20(-.D!C0.ZSC',M<%3:UN%4M:I`N]1A='=#9KG;`*5L]2QS_=44R-J5NK MZ13&QG**M6<;BQKB`"8Q,]KU5.^LB^-ZR(89N-1Z.U#`/17^N0,,'.('_M@! M"FM8`C:$L`(O?*$C8T##$NX`?#M@PP`X2:4C6#`&@0@"4E]HC77XXQ`QL"`. MG(>#3*QC!27P!S7BX,E[8#`&,1@`#JPW@%WX=AU'V$0H%#"#3Y1COMZ-K_-L\<]?L"' MJV(J;"3BZH4Q#"6OSF5MMK/?ZL;X.5^]+8^A^S``2376V`&+@7DS&,+D"K$& MVJM7SQICZ;A5.K_.Y6-;6P$3B+#^BR-$S[#W1*EBB_`#8,#B"+W;`',0[`R,(&29"#O8A"!7(,@2;&(`FMB$E8%+!"10+]$Z58`U,*"`=1RB!$V$TBO7480@`.,' M5I8I-3!)3")@(-4KS02!8QK=1MYC`!@HI36`$8,_3S2B1+`&(S^P@T]V01M\ MP*J%,YQM:*;-+F!5U8<-B%?>"+=V-4ND<2&!>QS=Q#S1O(N0JK0`?/&X-(L"B""IG.7)+<`@-SN`>1)@! MFW?Q@4WXX]XK7MI0/@%)*?`@$E,X1B)V;?`3"[:#S#^'R M)T,\R\DU'BQP@-R;6_^CRO2Y-7X0T^3'$*9LV,0*`K$+)!AWZ1/]##@`PB+_:KG>D8`E+3G M$#Z`S(K'&BRPA5X*HQ;*>AXO\E`"K)#F;Z`FF[!EQM1J54JG88P&(S^)WQT+0]\"L`>2I"HX0.BNG(+J8RWI.403!*PA.*Z(" M@0^4S@'^HX\/\D"KB/`AP(K$!NBN7LQ4T*J-ZNUTJBFL@,:M8,7%;J=?:D:! M2HQ87@".="=72E):5%*LP/`A7*_,JB2?M"$(9D`?FR<4F"`&,(`/?*D$SH$? M\FD7_$&[%NX(^&`=9B`0[@&I0.H>8B#I=N$'!NKDSJ$$8`$).L@?S@$5XX`? M[@$6VD&1J`$HH1$M,0`.CT"V<*`0[XD-D``'8&&^8$$;8F`$8&$7!H"#BHJ@=@`H#(+,"@D`;9F`' MM`$6:C#Z&NT>C/+I8$$!`B$A0TB5<&L$8L#AJ"$3_"&#G&_^-$NS`:,/!P)A M_@9/W_#"&ZND"P+A'$3)>`9@%+W$I7@H2@S)'J4$?*#$>93N!Z.'#)$G2@X! MI%;*'7?`S_*)"`B,"+@@Y+3!Z@*A>912TZ(G%#*![$)J2D@(%C8!2H!R$W8! M![K@A,ZAD8H@-E-S%Q!K2J#S2A!O0`6T>&J2.E_*\;J$V[;H??:E"0EGK+@E M"C?R@,:M==#JC=!I7YB%8%@']`;'"W=GC5",\S(O8/0E)AV"W_XH>+J`UX00 MJ9!*DB!)D58@^1PNE,A`X$0J[*!$IU"1/I$@1D7P1G=P'UEH206N!I,H@[:. M&OUM!&(!`Y2(26OPT`AKA:@Q>9[^E!]I%$IZU$?)U-\J``.,B29K=$U%Z@," M+DL)\C9!2LH0O.<1L)SWRB9T:;-`@48*,Z M*@Y24$TQZJ56H$ZM9P44J1.52JD"%4HJC0N>7=`">[U(Q@/FO"1Y%V*@;T0*:`:@>8 M("CU+O`^L.5DF\/)DYYR89O/>ID(O9FBDI6`2 MZ)N^+=_^]F(F#X]!JR3[HHSH1&A`T?1Z$(T/#+0F&79++A8^K[,"Q"4@L>=* M%&D=`L$OP>1*A3`.!@"1N`"XP@2H.(4;?[-XJ.$H]7 M%6`'&.F%*&M[A&X7=&D&8D`=:$D;`F&4@FT=T(QX5N#1B,=Y/F``).F(;G(O M0=,!\XL(_&$$@"@(""D.U#84`H&Z,(!628D:9B`#\9*8D&#^'4)!&]X6"9C@ M"%)I+`F)3-B5(3CG"O@E9^[5\^`*]=:J6!8A>9.W7M/I7V;'8I+70SM25T9/ M"@W(QD*,7^2H1%&%11M"82.%A4J`'UQ62W20&-?A@%TI`#^J0"*@K")02RP+Q$+!Q!$0. M5D'JJ4:@';2AF%B(=KVGU'9!^O(@$XBI'(P(0(L`XH@.ZH)@'X(@YPCM/8O' M4A^0:1?H2Q<9 MR<^T00*I85WUP@@]+W'T9B7K:E>Z*7FE01K@``[VN%3L1W[02%A`5('V6!I" M;XU&`IW1VGXZJQTQWL9PD4Y99Y>-F.Q:`0JZE'`9PS-AG[MHG)FL1QV MH7USMGT_T82=3X"_6'A4#L^VKR^18#:U`0E:>`(+C;VLIYX>;4^98!V@)!;R M$0XW00\RH;9HK??ZTBDM"J:`.+DVH1UR#GG(8!S-*Q;*@6^I80!N=;RR9P!L M2=IV809^%J%N>!,4L]V,L]@95JLK`5A]0)\ MS?'Q&$5^%06H):=0J8@?]0FHCD[91`I*C@#B-J&5*Z#C+"H.8F'EB"<6`M%Y M+`KDM#,[<^YZX@`#SH&G*H!VC2<4))`/+!."^PNV8GE+K<'^D*NG\J":D:<( M\D"6*@"G3.T#@F#,H.YS64@`^6`%B@"9";@(=/"EH.SM$I-X8"_:GG0%9C-Z M\N[M9J`B2D0"XXK$Q-*AC.5/BG^[RB+&BR-E\.D M=QEB;6`,"BG2]/`8157:!0`@`@1``-P``$Y``";&)$T2=V1%&GP;`(Q[8PJY MQG):@$3TI%GG:'R&DA?"DAJKX7'<`T<[A$-JA'(QK`':-O4AW4@TM_P(A!?7L M%K\8;3_PJ.*/&G<@2N(@:,T3\`9Q@HCMI7X@Y_)`H%5.'PGW>M9!U3!@!\Z! M",X!%G@X>@9@`&YJ![)3`79!`2:,%"GJ\!&`*-UN+^@)!*P.3BY4RFR4[`Z78\-,1:)\=,90B( M&P9^!09\VPH82'E)QQ)X&GD^L+RY9+$SJ%$"3DH@W4J6STLFG9@\==)59E(?I=(9!;WI MHG*T)!3R(/QB(.!TL]7N(;[G44]+@*6BY`C$&0?<=![;CB#U(`BL_4[Y MX1R`:`5PX!SN07YQ(`/MC!\,$L(`:@=B`:@R6P]V8`!4Z`B"X!Z>=`3.'<+> M;Q>((!/^%$`;4O`>]*!ZN@"%,$`W2]4@8P$'^"'%_6%NH`5 MC+M5:+[-]]B/#]GG9=[EI>%P:#KU!A99_*9M$GW1L0<>F0`TA9I`<8`)RA&* M'6E,S#*F9@FEJ,%G?\E*`@'*GT<#OT]4^>#N*KY*0'U1;NJ@(Y5,CF@ROS[4 MB;H;N\1[4E&B] MX9,,I6=!UQLZA02B8Z)7[7B_!%>S\^W534W!;!"@```-P!#I;W$E[AY@5@$5A: M`@0@`EQ``N"`5.!``$0:N%D%#BX!I#U!`(S?YG'>&[2?^W/>Y27`!4"Z^3/` M#5K:N-W!#3+@(]DIC3Z2].I-IQOG16N2D4K@!P)7.0&B@L"!<48,K#!B1)<1 M.Q3LV%1AH;5`.PP:/'CQH,:!(S"#8IU(P&.GM)S+^O@7X,H+2=XDF2YM.C7I MTZ=1>RO]6K5L;XO@N`,`X)4`VJ07O<*=`48$W"Z&X$X`QYL`*R<$`+`B0)J[ M5R?@G'CESILT3[FC3S\A[?JEU]Q=++("0):;V\\7N9>5@/?KV/-+CXZ=&C]I MV*87X>#%$1?65""2`C.L M<$13`HE8`F4(?2!A1A56L$*%'W3QP8H"S9#)#R-84PX.'W`AHF(E$C00!EQ4 M\.**&)C^R-$,Y<"R25--C?`!!A-"*&53*W+Q8`5'[!)$CT3^>**4%AV!P4HR M/CC""F*.&`<7N^!`))$PROABG#$BM(*$!6UEXXHR6HC!$6"U-1:!ADZR5F:* M+@I8"3_L4`*CDDXZJ:.1\G7A#H^N,"BE@?EP*%J@7:%$;"^XANI\IZZ&FB2+ ML`J;:Z["D0!NNL4JP&\`2``#=P`@]UL$TDCCPJ_2H!><++N&4:LLVG&G&QS* M9A!&!NE)AYL[890W['``N".-`)Y(\RIKJ^TGVWZMTD?;?*S1%^"`H9YE(()A M=7$/$?Y4@`,3.[13SA'VX("#-A@N2)G1(IZ[/[OH(L0-6T%*T+[J9ZI^%IL2Y]9EV7ZOHFFO\N?[-RMZM M_BFG:W#0NH=>!#!<`AP,&43@#7O^"6B?K7"Y+8+]K^`#<$FMYGLK`!R7_.8" M#!(D0.YJJ[[[ZO#ZP>O:JNO&JSJSU.M>A\@<21IR#\3=!`=Q4``;BK`#8(2B M"^6XQ]44$*5S5*`A.^B"`NYADY.L`"=BABSLX M`C!*8,DG`MF2HE*1ITRE:3LG>I`LSQUM09`O7$7 MK/CS'^&=!S>7@$/^,S[HD4`8 MBB6L11"K.V[('__R0[S2E(M=R$,7+F,CH%!.8H!864A#?@!!S14A(46)F@4; M4B(B6)!B)#N$#?.)$FL088?M`,8Z/G`$(K0C%$C8ETPPH,,?($$;.X";0(-0 MA%`H@!J;P)$>1J`-)'AI'4:8?P\D",U*" M4`2!"%=TI(:R6%/$*`8)"G")%'$VD)SNU&I*^B-1N'*1.*S^0QMLQ$E"+CF# M&!!F!;L8@#5.9XU0X""%%X3G3O.DN2YJ(Q3^P)N7"$46=99EE*RLJUWOBM>\ M_L65\QH5@&+EKOD\3W^R9-=@:2,-;TF`7+4Y9@3@L)UA!@L&ZA.6`+2IOF8> MYYG=V^PTR>4"*WC""MQ#K/IDL5C_C!.7K#)7:_6W/W,"4)V^L!=6&.<0"):# M&E"JP-".D(E[>N@#`^UD.0Z&D(9\:*";..3B^*4`DZ9P!'%X*Q(J-@.%2H0( M5(1I28CP46VL(RAZB.XF_+&+D]YCO3A82$HK$(-RQ)2G5:0O1._RP:,TQ1]Z MP%%/RV$-D^@1)VH\R"7O81*46*C^"_[`P7T_1H08&*0$.O2*QK01AS;^`"); MXL,B.1*$X+XE#K#P!U?]400EF94(*$HK$IA`F;?"!93JI*M>;XSC'.O84WP- MU:B"!T[AF?-YK9FEJV!UY-/L,G[N$1]TGC5,](QKEU98!`R4XPWT?*]6558" M=ZJ<9?-QN3;N<($`QA.&=FGS!-U!U2WU][S!'IF6LFUM.M5Y(+;X4Y-%B($F M$[(#".S`)/[8A)]W,,)"4Q@)4?J`8<+HP(Z>A`M4%-DFD$"$(^U%(%TX1"@R M\18Y&D2*%M1H#*($C,4A,DE4O,L<$/CO"$:R:4M`!>?>HSFN.=\Y:MM1]]_",`9;E!&G"P%G1\F5C< M",`YQ1R6&W!C!3=$`%P2*&88AB,!R+)/&BV/P,N1Z9M72&#G;K@$8Y<)@"F[ M*K#G*O+#BRR\7`)VM@'40FW;L@-^V,AN/Q#($=HQ@%A8FVK\V`$&[J$CQ@5B M`'OY0=>_#B>=A"(68`^"-9(X`"3@`$D6.L)'1X`#.*8;["S^PGJ>^!$*+@1! MVC*)18/[V`4]W.,(#K,2YG^79YS6J=<,)(N")$[BA?:KUA`MX!]P M(`%#8`4NT$O:)`$GD'\Q1QO^%P'Q88`.>`(9D!R[A!NV@H&P,03NX$L3YV;O MXF:L14[>X#^D<6>AE&<)L@D6\8+^;((0U840A]`4MS.#*S$"32(5%Q&#/F$0 M!6$A3#$B!X&#U=44/Y@4(X80"1$*.5$"U/`UFW`4._@D,1@208B#09B#U'6% M`G&$/R$3%>(D%F$A3S*$60@476AA"&%&,V!N*@$33R(B(5&&"!&#/R%C<$5P MX/<7JQ08D>06G,9IF`&(=#$IAQ@6\.8ZBJ@8E5%^5W%^KQ0:J+$J^5,N1@98 M[,(_]O%:_L%QB[`;R50NVC0LKS$LTM`?R:0=(:A-<-`^JD@;D,6*KQB+[K$= MKR`+5K"+`#`$TC`>B^`)[2)+2;(QH<.RH.N$GAT<0!+`0"A6E M=X%Q!*%`#1H1"K#0$:%@;E6Y$5H)&!\0`[``"ZODCQI1%$_)%SEEEJVS`Z%` M=U\Q`X.7)4$Y$`=I*+!4*NF"'QTI9)MH*J?!C']E3K%2C/?^(5M*9W0FZ$U# MEW$1D`$)D``JYPTG1UKM8DN"69BY5(P*&7%&MH(!M)-RB5<$69"@V19QH'P* M9Y3S0E=$J2!OL@)=@`&A,SH:(8B0&(X?D`D:5)M,4$3/MD.[P&(((2$5`)P5 MHHX;,0)009Q_M!ALM"*#H1$3`FZ((2/8^(AK%$%:5)MN,1C6V1<1L4;W``QO MYYU18B'9Y302]B?6R9[A>%=TV1F_0RHDV)`*J2[_0Y^J48(H2'2O]2Z%:8Q% M!Z"Q\CR/N7/9\1HLN7[Z$60;67&QE1_D5'2=.2_02)H7BJ'EEYJA0E?WJ!4* MH`=%(!`?D`$ M;V$52HJF59H[=@6?G9&0G6`I%3]\`%"A%2.S``FT\$%Y:`' M&[07)9";8302$X(!<-D18#D#;S4"UQ4$:G,G,D$C%!%)H<`&>W$A.,`U;+0D MS"HH7!#^"C-`#7FP2!\`EA-454A5E3B`)IC'E#&053'`!5T0`R4@(I\#*:\J M%6-J#8?P5?>P`TUQ26QP).UP,P81KIP25F_D#]80E3,0"@.``3.0!S%073,` MEIM:5V^:%O(9/,<8H:Q2/"?(D1:;*H!I@ORID?_)J*E"9/U)?R`)&^[Q37O: M'WZZLJP%J/P!J:'RF95JLS=;5Y=J**P3!_Y`!+L0AQ9R2+N0HTFB`+%@0QBP M"065$S"C;P=0`>VP"V]Q#MKP50RR#AB44,&&24?`!$A`?$2%4)E@#5X3!TR` M`\FG$8U#!.NP"6P3"@<1"[L`MLDY`"M`!`SS-!&D(14D187^EE!,8`U5BQ#M MT`[#.@`UY6],4`&P0%5*,F@*8&+G<$-?&K05<`Z[U1!7=#9X<4.\QE&A`%Z4 MD2\))'EQ*!^ M25C`VWYR]E>6N:A(IJA"AIY^5*:$S:RB2BK/;R[VMH[,$ M,DKGX'@EVB:[0+0]LA`8L`X8X$@D03$K4`3H50$_T`Y7EUX5$%)'$5+G]6ZQ ML"3QFUYQ(%X)(;\48PVPH``8@&FA`&]Y,$':X*2%LQ%,T`[?Y7;ZLA5P-)5' MM47M,#J[4,%26P$SY&].=%0CT%7^-34#9'12*9PYTE85'`$Y4A$(Y[`)L!`P M*Y`(6843*:8YL3.F#[(+*+85,]`%NY`(:<(BP15(?%`$07S$H3.-E+*[H@(\ M^7D_G%AT_V&1N`22KP*2$0N&1E88?P:8VQT$9HJ]XD\*;O% M#XJ3_Q)<257K,-&2!`$&Y%M/2$7!B$2L*`'Y4`29',$A\!/C72P M]\L'2!`1?!`(YY4).U)<1T09XH401]0%*?4H.X!0@?!!G#8"-D0-&94)VB!M M,-$%3."V)4`$_'"[Q79#U#45.$&O`!".@I1B08D&``T>Z%1+6;D1P!"M`5IGS`UV@ M3V.2"6QP"#5!*;P`:V.P-[,P+GL`N.L5L5 M@,D.^S-1FPDEI$]2!;0:'^](P#@8`!@6`U,F>9(.&!##VX-F;`./4$V<#,#?(`!I$<44O-0S/P! M5;L"/ALHY]"KBX/2O`/:#F>3\_=F&@E_6CR10%=,RB$`)[<;Q3-T$0DKA/F? M':D:P1Q38`X.P/ZZ8@Q]<6 M,>#H`@'IESNIC<$$O(44U+`.F'Y;U.`/GF=1R2L!K!>744;S\0AQGV M`R&"%^>,%UWP[._^>N9>[.V>1'@=;X%0PX'PW]2E(^(..8PG*$9]SND6*240 M*1U!#6]1[0B!M.S*(NTN$.]>[=7>!;$`*=;M.E5L%A0+D1)GQ@L=9%YL&W0. M`_X!`SWG2^YQ9&!W(Z968Q!,R0>/DA2!P+C/ M_4,64:6]SQ&G?X\T*(112J2L-(E]Y7#FXC_]4[T>CY^H41N512Z7((J[`5G) M02Z^E!R7E8&O,BR0]2HA2!KA$AVD`4R>$`8E*PDP``,A&"[:I%K:,8J^3<:V M]`+&>T[6ZY]%CQ;06/P(`1#4%`39M`F)@A4S%.P84:'"BH8.1WRH,&+$#@74 M1L2IB''&Q(@;*T9\V'#$C%U'.$[^K%@ACD62$BU2Y%AQ1I%$-^6+&+3=2F@04/%LQ!S23$B14O7MR)\&/( M@;OX"U0B9F3,F35OYMQY\XA8.$+AP'%D1:![A%>T0\+%\VO8L3=W8EP[\;\` M5[Q)DN1M]V_?O7<+][:(]W#@PGLKE[0(3@(``"+`@.-ID>]+$5Q8=V%%`@QW MGMS(6X;T))!F$1*.0VZYXXR+<#EO7MAM'RUL$W$2&CB0:(8!-`KL M(@7NZ2(4)O38!*,=QAH`!W^."B(()$*9<:%-@L"!15B".&>'36989X<5!H!E MA!7\P2&/%5;09A=8CJ@@B'L&.&*$4/+`@`T^COH@"#9^6&<=E2I@`Y9[D-R! MB'-"J>`(-OQ)C8L!@HA!FR<_6(<(-JR9(0\D2P@%EG6X.(2JI9K*Z1XA&PHB MDW:.ZJB='P8@`H,N[DD-`SYVV6'+3`:`"(=[VND*%G\P&&"G'=C((X9#=F@G MAB"T*6&3&(@()(8N-AP+))`AK)G45RAMQR.3^+]F:,BS$$6V+ M)MO'L`)W7'++Q>RE+KIP:23(XE#77'CC;&@&\1:88`0)8(HO/D$@!<""-B*WH3(+I7Q@/`BM\KNO7.!#K9>((FB,8Q<=`!P`->I@T7L"P$T3''>XXF"<` M\`IIN.&#`H"#`*Q0L3!X\!4"D(8$)@@#%PZA9/F)0`I'6,+\>`(&)SS!(BZ1 M`!AX\`0MDP5\^,4A@`$L0P[L%Q(CM(BB"1`Q)7*(E9BFJ8X,I`A]V<4'!%(" MLM2H=RO^0,).NO"YIP6!#SLX!(NH434%S$!V03@$'W:2E$RZQI5-M$,;4&D'$Z!"%JNL MPU1I.\)6?K4)'!`A%'HHQPZLL9`*I.H0??&'16!!!-?@8`=!*(=5SN<\LU5/>^8S6_02(`&!LS,D(C%@ M"KK.OX`608.%X1(GV`T&'^8-.$BCA!'(P"5DMD("PZJ+EN7`0-` MLEM]"D:O@UE; M8S"02B`^TLB@PA;Q7I"F)V(8-5D-5\+PD6X0`UMO>!UWG$B>$@PCI2\.-LK!F`'B/<_JKT?D".(<# M\L9*AP`#AW%T80P$6H7":R$%"@?"]J:P_2S\F!7@(!`#"$4[[@JZ.LVH':%` MPI>Z\,DX@:E.'_@;!G:`A"`PG*@#T`:*UM&%'2S)'T>8D3E7<`3<#G4$.#A' M#-J"R!V$(A!=H;BQ;'>/7=AI!I/+$LJ]Y`\D8.!1F3P"-<[^H8C@1K'.('1Z<6$^*TI4`PQ"%\([B1 MSX$#:UB.(OY@0FJ-5((=/`LE_JA`.4>^&FW<0R/E;(=.7`3^[B4KVL0`^B@1-8U54KK&YV`N4Y/+4]XI08A(%VB) MRZ:L(!$_`$SJH?2DT4O*),",BZY-H"-SY$LE;D;:*A9;@"&LP M08?0DI:(!:CH`@M#PY\` M"CGD`KW*P.8:`2X@*N/"'3)?/:HCT<< MHK<)&0Z?<2*>,2!]6P3].P%K4Y#FD!DK6*]Q2P^#@0.*V3_VB@[_&##V2$7$`#H>`]O&+>/*;>`*B_C>+8"/*)C'(X#K!<%S`PBS#W= MRXS3,SW(J#R):(?(825)$9>VB"?-2+W(X,*'A$B"M,'.B`-Q@4A-2SSA8KS( ML+,CN2:"@(4#(,2T:PUDZI,#T,0^"85UH(@\X`,^VX5?X1M6(8(9.(1K:@>- M@)4N<8@\$+QS`"5)X9O/8J08V)X50;E0P)(*6(=`Z`*B++G^4!`R#(`%<7(6 MLO$'K10[<\*!;IH18?F!#QP!/2`"6*!)TC$[2DH[)]D$XT$"VM.5(&C)$1"5 M`0@+R**4V2$),-F%'5$*:[F'AH`%T6""$CB$$F`"PAPQU"H"?PB4=1"X'>B" M0,`2.Y07Y1N19,.7`LHW\`JHH`$:GEJVXK@$"3A-"4B`DSH.`4!-\[@.`3`0 M\S@0D7('U&S-TTR0WI"`^7`'D+)-"<@`W)2`]P!."1``=\B`_2BWW7"#^2`A M\M(I_ULV)ZJISYPP;A&@!$R:Z^H?/@L"#,#([AQ/\M0,+Q0@,"0,/AB`(G@D M'SLRO(LC#*B2C*B`0+"&I_DW9HDP(A4.HBEA0`+P*!.JIBFC" M-$D!IFC*`X,`L0\HARI>36(@/N)9#"(1SJ`@N M6)3>XJW+&0&P9%588(I`T(90H(PS<:K]R4P1V4SJA+;GR[=_"D"W1].-1J.#!?>&M"A+8)9_8@/$+)0X+T*6!_^SR&K26+5"GB: M&2@"`"7$`@TL6#!:('D)1/H`Q^PB0P(3M=HDN/@D4S/5?#4)02+;7\&`;@*) MN0E/,(FC37@)N`V%JQF`:6I12<'$:H,P M)5H.UY6PF_*NSE1&!X,^VIU'_WNV-5608Y398834B>W,>FN@-/V0[+2?G'T- MF'B-?FP7V`A3R^M(>&E>RY/>IGA>R>C9+M1(3@-()``E`&5/P9F!'2B?0,`! M8MT%5OR>3ZE7,1)2')BQKD$RMCG^)ZK07-XBTA)XL:I8)&Q"O?F=@6AJLD%) MM3R#A0_P,D]9@>6IVNH96->#!21KB-PIG!FPANI17R)`@HE8G2,P')Q$LGOE MV]QIG+#!@<;WGU)H)\YHMDE3>J, MQP:2V","+P>CV#"^D#%>H/!RW8JU3HG%MXD-0`F+5'?:1UQ;`;U"PPIXL0B, M0SWFBQ$T/9)X"D$FW<`P#>-Z"D.N$D0.C`^X3.62P\"P0TIVB.8BEX;`@!G0 M1$E)B`C^9*Q&)L*YX,NGB`FFH&+NA8R?K9>@%=IV(+A[L),=N(<9*(%[(`VI MB(5V6(<8@(A:SCB..(+"PV6&^`%;+H&,\3*'*(%$0)01H(9[L!LA@0B&D^:* M^`$]:)X@@(H0?>(M@9.NZ%`D8`AK&(!U"`6I*(%U0)00BQ,,$!)7J^4=>.C2 M*!+3&``ON8<\^`"*!@J)+A9;GF8DN(=HX8)V"`)5+I?4M0U:P.+@$$`P[IF' M9>,F"IKG$Z\S7;:"&AACY!?I8S`S3J*",M,(F]V;'D;8A<;^,89I-L;'Y#6: MY04X%1XYJ;@X')@!'%@'[ED!JQR`&!`XUA,,!WZ2W;K+(/B!6-9$J;`&-E"' M3\(!)C3K&$AK;JW+51L,SBF3L>7A$5B' MWJTWZ,LI.39J@4KC?W%4G9YIW@7^XS5.Q@$L:B^V8Z#B3L+0,(&@(Q8Q4(#% M@*?OVOV]M8M(!!=L"==CU<]Q M0@Q`@JKUO!"7"K0>JYQP09%H2(4@B$V@W$!P"#YX([<\F\4)BR-\)%#I)JM- ML[Q3"4'A'NSEWLX>D<_F1W#I1^WM#$O,7LZX-2)L\L&NH)BM M737&7?VN,/XF#!9A/1=N&KUZ9V#6HAG@B^AZED.`"B%3$6=1B3AXG@?7"+LF MBLKL\*;^H"[JT0M$HF%,EHA/0*!B?'.*]+(`*J0T*^RW2+$+*X M)()[.$)8R(3YY`.X3*6*8%6&*Y.+R(2L\3Q6V871"8(JF,\KT8,J"01E(72G MG)-U:`L,R`2]K@`(Q1XIWAZB^(!>=[77JUJP2#H0RTO9>+T1Z MIF_ZGJ5V>W%I>+].F'W9WD5JB87C9=-V;S_J[_+,IIYS\C+W]U9C.4;JH;[= M\KIWV]`"I,$,@#?:S@';I77W#'XNI1X)#!+=AV-AX\CBV`# MP"]0DD!QPZ^R+04RM.E/CZ`D,?LQ!H4J""WQS3F$OXF?Q/$D(J"&'4@M#2^! M3/!UUZNE;(T#QU$`(L"5%>AY7`N$^Z3]V!_Z%@'0TD)5I]<6I4?/W@]^X;\N MJ%<,[I)=:$3WBNWS-D_OB*WC.4?&\@J8]MYST*P0H*;OJG>@Y"]?1\+85$7/M.&M!OT35#Y+=W^!<8)BH)'++LN@7[7"S;H"KO&=*JOX(-*Y8K!S63SJ)-JU9MI[%NW\*-*W?+CP8,25+5-V?'GR9DF+ M&F-FG+FSY,&0'4REBA^8Q-UHA09-$F]XT00SD<)=1%'-JTXU\Y.!211U85 MP8I)!#$EFDD4=ZY8./:@$FV&:(O:!9:YPEEAEAG\UV)6J' M(099996]\.5BEFU)F6>JH>E-F%9FB::8:'II&I=S?MG9:7-:5MN2:FFAFU@% M`N//2D=HL\YVUBB@'*!LK-22<2O%(96@VPT`S`^'?!`(,-3^@4CIIBE5^L,( MF2H0RDI=C(`#,-3$L"PBWQ57(0$$3*-T(ZEC@[B0]-*B&F9F0N7*7# MDJR96I6K33PQQ)(US%F=9(KY&<.@43FFP@J7QC%J%:L6&6%Z%CQ)G[N%=40, ML."`P7)=@!M*$'I84X',-/?LU1&AT&PS!CC`\D-Q&`1!-`8K'9WT$4?KH;1( M0>#P@58_!#$#NGH,'43/.(B]0Q#^U(PP0]-QX-#V/4XY=+9(2&0=AQY!W$/0 M"F0';0T_(&HU0A=W@TM03C\0C4,,/U&CAQXS:#V3SZ%@$$?@UNB1]=:P&"YP MD/FV?!:_GI->NNFGYZ5DP0BKYIIGED4)FY9;1ODPQ5[*QN;)',O>&):7[>[Q MPXJEICO&H,7IILC+?\QRR[[`'-8(A]@;7(K4MX22]-AGWV@N_7+&PP)EQ-RABFIN%]C(;.T]?+W+(NK_Q0[Z$6]8%!?M-"@-UQ31A`2#WC> M4$+M)M9&):`QCG",(QU)9L,HM7%Y%P/-F-:XF#G2$8TI!&%A:E<[T"1LAWO2 M`O2^Z$BP6.Z1C\QBP3K!@4MB,I.:K``F.:G)W632DY[-I3WG^MJU[OB-:]ZW2M?^^K7OP(VL((=+&$+:]C#(C:QBETL8QO+U+)" M-K*2G2QE*]M5QV(VLYI=2R?4X-G^SX(VM*(=+6E+:]K3HC:UJETM:UOKVM?" M-K:P'>DB#\$`11!@%@38[6YUV]M9^#:XO!UN;W/K6]X"-[?('6YP=2OZU04N=X]KW>+BUKO:M6YVE:N(61!"I\^3+7O;Z][WPC>^ M\ITO:VF05$L2-+_ZW2]_^^O?_P(XP`(>,($QF4P?+1.:V1QG-QG6)H;!Z6%RJI>'NBDPB4MLXA.C.,4JYN<'$JK0+4HRQC)^ M)&T1C+`^!E*0B`&DCA,#2#OFN,<,@Z,:CT>\/*HLQVH$GIB0'$@FKW$1Y5Q2 M(V=LY2O^5Y"2^H(QEKOLY8`=&#<)GF.<*B8QBGWL3I2!C`G-'"4U\TXQ6"+, M"W#'1]YU9I!,;J.5%B8[*:6PAK:3Q)1QT\,O(SK16'1Q!!7MZ$<+*BDJ"?=]C`SS@8I&T7\8,,3EU*<]2,J.:PA1G3+?^:7UVK<8=J M,ITFAJS>G1Y9HVV+\5&&AK'T9-#MET.#90486/D,;!9)L<1A!:&(`09B$+F4 MER!H+/G`RG\])&O,0"9=64'.64+SEW]Q!S7+RQ&\QN^:!]O6^B*VP*MN]63? M9LP.?_4-D_>:D;^ZV47>]M8A8W$;-EC3F<2K5$,U^EOC9#6/ROJ`< M+#9I1PD2$8@C%/$K1`G".8BPJI6L0.A-Y%:\M-*A%5BN1&.1_!(K'\6M;,#E=H,@,%!*$(_Q']O>V7[]X,A.@_V$X%\E"<]6GE'($P MH.`.\7JAZP\"+=`"J80`<4^_!6!+%,%\V(OZ,,A*](^CV!OXY!L#[4^[C4_@ MU`_^!$9K4 M+8FZ?4`)W%Q+[`#Z%0%R(,$'S(`UV$H)?)[B"!U/P()+6,,*?,``9,(.7(3, MA`+D54#^?6``+!S+"+!!)ER$S(7"%GY`#(2"=>1$*(1"BHR`-2!BY%`##AP+ MA7@--<""T'5!*#SB0`C0T91`H1R'-13'T,0`%\"/->``J[#$T>S`SA&BRP$B M5\2!I1`%\S`X@PB#@C=$B`'&\R`/Y'*,R`@N3B%KH%#?J(#>+@.%J9#JY%D]S0F2$< MR%")\)@&RFP:$BHAM>'9\WV?#5&A$)K,JJ7=.FK;FNB0%1I:E55`K*Q#$#&' M>WS`ZUG'+O!!*"C`/1S!`1P-'VA-$`!(JFQ*!6#%XL2`-JS^P#J@2`6<`Q/, M@$U\1T:L@(GL0.M%W@@$P3I@P#KDA#:TY#ILP@SL`@9T7A'`PCFL0"*PP290 M@P*T0U$R"D<.P`KD`1%T3MKLY`YD0CL\!Q&('A_@0"CP"C5H`P9@Y55()("` MQP"40$@<`1-0PP`,0/[HY!'<`WZ<1RB<0R9T`=W@`!_$P0PPP1'P`[EHQ2\B MP0K\1SOH@:7@0&`^X'^<@TY>"Q\.P`YLRD<@`35D`DUBB`+('!_$0AC>(=$T MWEN`XX^0XVA^&=;=!NNHV=FQW9D1TFI8VM9)7.]P',=)VQ':CJH9V3ZJD)K1 M$)[,6MQA1OBMA9_$`7;L0B9P@0#^-4<[A((NK@02*$0LK$`[G(.X-$41="%[ M=.$.%,'_O0B*^`-QQ`$?!,(FQ`$3X"0;$`'./,NM/`VJW`,1A$(LC`!/R!PP M<$$>!$(1S,`.?$`F4(1`',$13,0F:$-YGE\)%`%$=HYP',13B)Z)M,-3\('7 MQ,$Y($$<0&<%($$0?,`NX&0[9(+5O%X7P,*O"`YS*(1-**A-_$`7Q$(7TN*J M4(-"G"@5S<0NC,<*,(%R8$`7M)YP,,%/[,(`%,$Z:(//:,LFX``7_*<_%`$2 M:,,''()]ZH$"X`!]0B0O`L/F@::P51)IBNF5F2.3D)&GF5F:EM&I)5GN&-_< M,884PL;^G+*F]4%;F92&G37,JM&IFK"0G`AG6J!<$.Q""%Y(%Z;?OND?^9%G M<68""SX$=T9J=V9",Q8(#I1$,Y(G2^C?@*QG1F2E'L1")*U`("C``%0`'(:J M-=0'2T3$;RSH0!P!EHX`$QP$1/8'@PH.D88$4(B>KQ+E+I1#(NY"(,1`V\Q$ MYH#$(<3".;A''&!%$AIVBA`##P*B@7,R57[6BWZAH12`$0AR@"G5:)X1TX7?,;!'TX0K4A+($@1]>*!(8AS9` MZ>LABP)8PSZH+$L4QY6^BP)P@=%^`'3BK+H&Z*\0*`X<0J%T*WK$*HZR+``Q M04B82![\1!>41*;PP0@4P4\@P7@4J4O`)-$&03FL0!'$0>0P1R;82E6\2%6H MQ$-0PSX$QP^02"B4`WUJQ8?.*[GN*AN4ITB.BHY&Z=E*Q'BHX%`B@4]4J8>, M`$3NP`\`0PDX;5P$K%]07<&:+A>9IE\`QB+\V,91#,2R7<."&L,6X:4MK#ON MD9S04*?A*<@U8<;TT9P]8;8Y1J#^IL7X?86J#,#-`043:(U([&0H6&1-`$,H MO$CU%D$08"FA[((UY`%Z5(`V:(/,[$)Q^$HL8$>%Q@#@+<<`*`T?K$#ZSD`= ME@`1(,$,B(H>G,,'K`,_\&=$_J=/F$B%^HJIM`1$9B41I"MV!,(*((',W*IX M]*>N^`,&9()%'J4UQ`@&$$$@S"\`(L%`!`$PQ(#_*0#:U.0N[,#ZKH-3W@,) MVQL7V.\BVB]+K$`':W"E$BA-\H%"<(<"P,(.8$`LE,.$:H,/AX`Q*=HP'LL$JAR-@!,ZH$T]0A2R@=#%J#("MC"I MC`?!*6S"\<;B&9/%AJ@I;.U8W,BV#"-%C\#H&E[,GN7M".GMGNS5Q5P[D0.5 MLUH,K%+S-9%H\5G(F@#(MFQ? M@@!(@S2<$60(@#LD7#S/-L/1J>_^Q!V;Q//S[6.9<=H[RMEEYXE`4M5!EW9T MVT5>I\5>2_=UOT7J[N"9JMVTZ6,[[S-9S]ING\`KO$($>,(0#($$))\WR`(` MN($TZ*EGP$$"6,$K>()\8XSVS1IP\V-RK]V>%L^@R7'Q.O=M0#=V*[A1_]N" M.[A<_'6"G=&?SIUL[BZY=1L,N`$``$`"P,`B#`$`#($`.(85P+=\0PP)XP*'9P`EVBWL"#(AYCK^.-,"!BM>Y%43`A\\Y'/PSG>?.#`$/7DB''A["#MB?2T_Y%SGY0AGYDO\)!H:%35NTYU2@ MZ20047\%I_]+O^V(=JO%F`7A\.[C8[@=\[FCEX/YF8!V&=6Y!"1`8GN#`+QW!-CY(C![8IN=!+C#(I!XE=298<>Z MGJ6C;T+<$!+T!U"A@#>K_W0$?GQKG3GYQH'Y*R>ODU-45_Z-XIV M#8Z%RN'QC\8%!@3=6[A$5@K=WJPRI,]%'.P`YYQ.%MK,)6+^0"P;I8M@Q;!E)PY?KNGQ+0P1PN`O`@'WC-VY'0`38MQ5(0&(+ M0(N?@`N8>`34>8U;@1M8P0E`A@MPN!6X@#LH@3L$_=`OPI@'O1O(0@+HMX4' M#V9LVA2V,VMPMEK_B?:<-/EU`>2-`#4$PO3\GTV[-%!'-`FZ#_P<`1$`A\\L MQP[X[/O@M`F2'_FY7]Z_/4MX,`!9CJ?O>U>4Q8$+K%O,@`(O_!!I)-KT&H\F M2Q`81PQ`0*?H!<8_T87<`Q*4Z+U842`H2PE`P%HB)**LI3=>"'1L/ER8'J#4 M"\LKOOIG^LS@`1$`8;/@)"#\`O`*QGX`T7`*'4SV9 M6T$8?'D$\+J;PX`W.#_TNS@,&/TEA($+2(!\UQF;0HG#?IR9Q`Z?`0^YK[57 MS`PCM\T1<$'6'"O/7;"WO-X/#``L()!;PL+,)%[_`\2'4#@^C%BQ`Q:;%2.X M$`ER:(>](Q@RG=M!#1:.(ROL88A3`:2U'?=@51@Q(TB0'9M0JAQ1(<:](!\J M#"!RC\N1(!E!]O3Y$VA0H4.)%C5Z%&E2I14XJ)GT%&I4J5*C_7QI]4BF=5=] MCCC$=817DSL4S`C+%>39"A\V_5!@[<@1D%U^K(@3-LY7DV'37A7;]^6F4+"* M=*GP]>K^79.;?NX:$`?#8;Y]#_7=2_FCS[LC,I_5:W7$IG7:0/Z0N[=RA16[ M_!7Y;%*OP74]O?J=W'7RYK]IB\Q0L`/MTI^=IA:'^B_`%6^2)"UOOMS;\A>+ MFC]G'MWZ=>O1N6-_(6F1-$\``&20%GX\`%G2!%@!$"&,&P!68(Q_)0".@%<` M/$GS-@0`%V"(`(`A%G$!@%>\T8\_::0AT$`$K8!#E@3=6.02;ZASCKE%.-S0 M0^BH>\$Y[#0L\3H.F9-D'RV,>W$2&C@@ZB0%_!GA'`4FPJ&(`73LXIQ`CACA MGG)*P`$8LWI:@0D<-@FD'+EVT>80'X\XA`\D-MEEG4-B<:C^""2IZ4*;0%8X M8I=,Y/)GA245B&$%8$(Y9!<<,(!EA#HQ""+,7>((9(!-]"#BAQ':66>%>X1; ME-%&'7WTJ*9@A+&3GTI82+-8,D$"J`]FL$?)$:S!(905#G'+K!)*Z`H#'&*@ MJ8(@B,"!JXE6\!2#(V`!CHL9+NUB!FOB^"`&6(8D-A2S?B#"'VO6"B44#%[J M=04N<&BS@CA*V,7,302*]J416@WE`UR[P&"&@HYPE8NNK`U%'8."Y0(6)6GC M`M31*ICH-&N@[<*@3/Q!R2.0,+)FA"/.T2;=$4JH]Z49<-@!VYXP@#;;(V;0 MV-B>0MDAE-]&,`Q2XB:%R@?DKE#^HCH3H4MQNQ.YDX1$#U-\><7FT"//O)T# M9,^]",YSYQ)/W+LOO_WZ\^:$`J4!T`HW/(G`DT487!IJJ:GV1@+RWCMOQ):A M<_EEG+%CCL3JU'Z.Q.A:/%DJ+60L:H315O"'B!AV.&*3(-3$,9"\[B&B`M^` MJZ"+0V`AXH@B[OD[R$T>7P@'6#!@(I`1ON0SAG)FP!()K]P*A0MJ4EOKGAV6 M#6(3)!2`Y8,X7(>]`CX"L0:)3&!2H(0B@K#Q-$B%'Y[XXGV2%.ZIJDI+5FV. MR,PD33GUZ0-MHGUSDVTQX':3&,K:)(_#39IAEU'/`4E6'&B;`1C67?_!'QU7 M^WL`#`[^02*('YBHX)YV,&AG!#&X"1=D=P\T[:`(9+D'&X!1@I%58%M"JD`@ M@G#`!#(!`T08`(YT]SMI62\4K$L+FF:P`R:TZ1Q$V$$[,E&QA.UB!]OC0P6X MH(`\%($-2*@>`%<3B!(,SAJ;\,<`2G"`C?"!#]2`"1^LL0MJ<"$3L2"B7]BP MC@\XYA`8*$<@9J"5NPS`BOXHA_A*EKRGJ(QE:2O;D(1_R MN.$\)7)9BFS&H1/E3$5J1%L<6>0B,TY";C,:"L!"P2P,G(/^#Z$PR>"&%*3# M#.X#9#D

5H`L MU"A"R,8$46J4!0/`B`D10C&D&O*(+!@H0CNT(2YFB8MD(-E%.Q*H`)6V@P\C M"`1-J;&2=O@I%.5PUB[X<"G:L,%/%<@$GWXZ@I!)*RW^V$4%6D>:*_I#FCC(9W%*6G.JT[68I^H[9-N1&$Y&R0^"I8WG@H"'W#"$Z[7D/ M#+IFA3#89Q&.7%K3/!$&!)4'!M)PA]64EMK39B"U[A#`)6#@CLO"H;%KVP[; MNJ.AQ,ZL9=J!SMO>.;>B>)6F'@S+X.Q2IEF6HPL?-1WB1H"#MQ2AE\\K4X^( M<"O6%($)6AHKY\HR`B:L8U@C<`L.#D$RAY5E!0I0WPR*H(=,<$&E@^H""[M0 MA'8]M0+4R!X1[,5.`Q\XG>Y\9SS5RX1VQ#5;4)R>:C"P"5WAP"$C<.YF!&B3 M&_6$3*'^L\9--EK>M/23,`/0G?=*<`BO#H"?F\`P+&*@!PRL(!#:K(`6"6/= M&6R"OWME+_36PJ4BP()WA_@IF@"XF9]6P+H5ID8F'NH7)&BC"ZMI1^N8,`)8 M"#4Q>36,OEY\B#C@``=Y58W`[GD/W]SC!WJ@ADYGF)5V_,!5AR$[H,3J,&"S>53:=L(6*C)F,&,Q0)USJ+J`]Y$C!)!,E" M`-%9Q'[@4R$K7*)IKW"'AD@=AD4D2`#22`!YK)"!J;&'/!%(@`!F/1];"^T$ MEPB#`+YFL^".#;BD1+;9SD8V#1'WE,9=997ZB@$D9$:J+>[^)4'\486+92(4 M7/D`H'&P#C4=8G`CV<6-,^'#0.SB""5@LWU#L0D5DVMDYXC%50"FP"ZV`\=X M#L($=X"#>V1O%^>8F,.(T(XC#"`(U!A`8!%<<8LSJBFF7'!7*&Z2K"#A*QO= MP15#T85R$"9W?"M(2G_W.9#\J:$/+0*+_?*E%$]5HF'Y':U&\-$?[..:0]*# M36L(T92N-*?]9&]@N^#@FJIT'><[QR[8$KMU,$'&Y>#"!]J4"*I35ZH?62I` MNXP#K?M%JE1%P@RO:N]`M.X<`6M-6$OZNB)X:X)Q[\(ND%"$(M!07)D80'M! M,@`M!2)S=WU26O<:@WUD](&0\L'^*57&;$K'T9.>A&.EG^,A`;CC!*]XA0O< MX((32,!#H4V`%48_6=+GFCVC'X($(F`%=]S1#?L!P`D\!`<"O><%E?0:[^%P M@M-[PD"^5>/8C"WJQ1Y;;)@W48B6`^WDI?(H*R`9MK+,=9`8]58KT#XZ$4>- M%?AM2!"4B_@%O:H5E*`+Y1I_EA%G5)"H#RC6B(S^LZRJC[R_!#YB9&8`JN)` M_RAL3"Y.`1=0*13LE"K%**B!"+2!&F8@%#*A"W8`&.I%`="K!(@@$*@A!JH+ M&"@F$YB@70!F6ZP!%@+!))"L4-+BS48`"1@'20I%7$YH+@(A$V*`GP;@!ZSA M',Z$"-;^(0"1P(!@J*;N`2T$K=VR!7_01*-VH!S6H:>(I"Q:#L>.(!0`Z.5( M2']0*!,^X!Y,S"3 MQR2(;#*HD38.(0:8(`8F"CG24MQB5V^!$@08(+P@D`)Z(?>Z(@G\5RQ`7/L/%( MAJ0+!H*<#C(R?B+>2B!V*A(''$@%\R=V/F!BWB\6@"448B"P-(=4AB0AY;%= M:*,$@F`>NV`CNZ`$].`(K$$G/Z`?226F?H`F7V(%]&!5(,@ECJ#@J('(!39]13+X4QLBZM.RU-&3?Q1!"++%_& M^I+'%U2)`=-Q*3;C,A>401/,*=[I*2"P>#JN0=>)Z2P44BAT+I)"0PW,$F$$ M$Y61$]%F+2$KTD24^9ZO&1_+.T&)1>7(,*\C;72K1&DFV=:3+=G21LWF&#=O MCKQA0.'^1AHKE$B+U$@Q\T$A5$*/E$F;U$FSTXS0J-ENQMEZ2T>M=$5"\?)6 M5!,W";$^B44MK41R:QFKM-G.DVR4S;%BU!F?,3&']$GC5$[GE"F2=./H%$_S MU$DG;RNW_0QC/%5U+M!G^C4U+>S79T-4_ M\5,_NW1*)[6-?#58S9)#EA5&/G5;_Q5@(\5.3XE:C4)<@J#`B"(.N&`=S`)5 MB0<[`U9B?2(:*(\[*74P,_9*-V^-;G&1/M8O[35G_+/SP#6.0LLO<51#7O%> M%Z%F(!6.TK1>TS0[$HM?C:-9)U9G`U9:)Z5@B0)@0HK0'K;?@('G<@5Q'I91 M/&5GFQ8D^#1YI!33%)5FP_161<0=B)$8)8!K)2`!;&9#-%5C1817I\]#+H$8 M,X3Z0LO6P!/S##-'IU9%R/5$511F;K8XI6&&4;"NU/(4Q/4X@`23`#0`DU$3M M;!@5.^@S+,=T9=T!]L)60\BC/Z@O^JX43/_>& M*RI#?O-B(T9H![C`=86#)!NR`24W>4Q5*!@3%BHHF=@@%)!@!!DB"`:`5W8" M3QYF!E9@GG!@!F`!H2K@8VH%(?S!I%+"'C"8)WKN'IK%RVPH779B)E[W7V.W M."K//,G^M78)DTH32QBEX1*<-PQ>41I<0&W5TC[15=* M+Q"VH@ON`1CNH00"H0[Y)Y/W9!=*8BVH`5"N0E?6+2PV^9C(*$/'!P+\`8Y? M[DR*HF=AY&>[8@`$ZAYRRLZZ(,KRI.Z.@`T"X9)W+)/M;=T*L01]9Z(T;,N, MK!UTB`FC^9(AH[MPH,L^,`BJ:PPK*&)Q6%1U>"J^]2LCC4?^PW231,V/EC?4 MB`:)<6LNJ>.=XV@ND9CYWMGS6BMD638O\;*0?,N?IW=MFJ]C.39>@4M[IT(: M@R-Q?(-/=(H(/$5DE-,T01/RSB*C7*,OJ).B/P)1PN4SBE-P\>(UU")Q,"`/ M1C.D0Q?M?NP#?@!62'/$V`LW.`-@&O$'*B`6TB*;@HBJCL`?J,JZ0F$??*,U MK"L&BF`$$H$($.8(EN7#SD4/$:9VVF$?,&Q]$]@DE;&JL4$H!SN$HP1G^6L59*J36&SPQ9I#-$\=3^BI[/=?Y:[@F M1`2`&&\O`R(`/[PA`30A`HK1&[(V`V8K`BYD/54KD+1X0?;##2XAMKD#;3,@ M0U#;$R3@$D(M/!(@D(B;7J>6&4V.*15UR151:LB9(:H][PJR-XY;3HB'^R2W,SR$V(1;*`0<^RDXN M1<^(X(2.`$QZR7/Y(92I.BV*B1JRY"-^1QOL(@C*01L^0*JH(9PJH)_T@#-B M(!.(X#$A.U4E.RJVJ*;H,7NR&== M9JB)?&@$@@`)MHKO M2J??/2>^^&0`UA`/1\P+ER03#HY+#BU[/.?'W.IBRF(?Q$_(-D&)]NXA^MC. MN=6,7O5'DRV(83UC.\^SAR#W9`$.)"O5W*#V+D$^Z$,^D&81W$,6!@36B%@] MXD.1.)WO[^.V^0,&`$0"XD,"8"#^`PKDLWZ&^LJR*Z6C9;[T[-T(NJ$"^YPP M30R8-A0H`UGCT,JBAC3J<6KB'/J]H'2I7EXSH_9!HL**=2*'+/PA%MCB<3[@ M?LY'#^.`+$+!`.=B!)`*V-MA?SBY",8J!@Y!&]8A^9?J`QI.PYQ?JE:@>VP* MQ*'\$!(A"%9C'?I=PG'S'J;JY=D`Z.O-,!3^X%6#?Z7%NO@A!KC=)!;>1PYN M25`<-_4`S`P0Y65EHKH`()#@.))IP*9SVHI@4##CB((?18)DJE!"P8X1F?QM M6I'I7I=,YV:LV!2$R(H172JH7+F2@YI),&/*G#FS$\N;*T>4.$<-2:A-&)@, MF+$NR(C^"A+]X5C!)@BU/!5F[&(S(A21($+7A.KM\\,$NZVQ249@4)KC.2C@H<,X1 MA\092A%'Y1CG#Q7P0<1%*:VPRP`H:05+.7WEJ-(Z@<21TP>PX+"+1CLP48)$ M1R080T3E'%'1#A\0P<8F!/E3Q`Z9$/%32=;$42%@+MUW7S2%C;`"-;$<]<$* M7BFJ^ZZ[`[6F*S^,DEVA1*?C7;>"Z%YYDUZH;TG'V:H);!: M!#!X$T%IM]$&&\+>2).!"]P!)QQQ$83!''#2<`>;)-+`X4UVU=6&'74PN$,< M`+*@QIUX&220P"+YVNO>:*2!9B_-,R^"+[Z2T`?O3%K0H!^%R-ZT28)!:,D' MHA65X!`U1;"Q2P7M0+C)!QR6H$>#`LY0Q`_EK'!$.7IL`N0(7.A$Q#U%2(DU MF15H68&`)11*X8XKM,U$!4@$4D0L#\6QRY<$#5!$$;;!(+AB,<4N7H'ZCDN`)W4I,) M$^9V,>G^)BDY#N%1<6RR@S99K517D1UM@M0/.W2QB37E_+"/1!195$'R''FD M+%R'/+A"G0/$CE.L/]-DDV&OLI0^A7YMV#Y+KG)Q``X7_04L^SF]O_Z&^[W? M[O\`#*``U>6#\L%$7O1:C[[64YK*P"Q?\NG,S2X3L('AYA((@X/"X/"=RC`G M`6Y(SL180L(.(*``6MRK'.J@QHZW%0'\LFH'^-7:AAR*48!?6 M",*$*E"6'2!E0#L0"4@JL(Y,J$A`]\@4,(+`!6`,``.[T,8'J`&,>[1O!4S8 M0:7H)""CL&04`P@$!E:`@ZLDZT1!*%T%/@!+K,%"`>W`U@Z(@(3BK:`="HB! M2O`2R?:-8`;`8$,)B#`A6.PB%#@(Q1$V<8]UK(`/60H%,*2)RT,,:0!<",0* M8&&J.,$1F("Z"?F,")/S#7`PM/3(.^=)SWK:1!G(`X`88*'2%UA'`QZ@C M#0DH81&^&0(,?*,=.$@@/?O:(4#^*Q,?S.8(VB*A5X9!A(+$KP@2/L(!0E<%070D$- M9EE##WRJ@+>.JKX=82`&==L0!D+Q@](=`0=LI88>9F"K$CAKJBKY`9^VBH$* M4`,''RA!*,3F5_4=049'.`IA<2*D4,3@!V10R4^!6KP*;-99XO+6"JBU5I44 M5;1JC:RC;O+5+NA@1C_8A6QYB50MD)ZWN:3__,?>YT(UN=-]5/GE=IJ`]9$],0?,O?=FT7[?)0'=PT\#;K(R# M'.,.1VG^`P`)?&Q@+`0`=F;X"C>XP1/"@2]SY)M?UL#`"AT5`$=A<(F316`( M;E#H>3SSP,P\L%XSBV![.K/3\@5M:(*ID(;SM]H-[V<38MIPA>+@JM:U+W@E M9E_[#@&L0X1X?SEBT02?%-6+Q:(0.(Q3A6 M,8!X#"P/EQA8JZ6L5TSLC[Z`90`I\;"(F^R^%>MJ+G])KA&7*]TRF_G,:`Y@ M/G\6FD"&` MI3&>$[1&T"=(0&4N<8)7O,(3J,F`GA^MYPPX;-.+B$`$/"'^ZD*[8PA6J"]Z MU6/35E,P@OSDHSZYMT80!,*&RO`3CL-+,+:TN*`63_ M%XL/1)DE8C:@.XU-[6I;N]IKAE>;YR53"2YPH##EF0^'V+".==`RJ#&W`SG8 M,`[>!C,PY&`.%8H:=^L0WCI,MS0\`\.8/D5%C\WK%1]6(ZQ?][KI>VC6<'AI MH:ZO6/,][`>7LQ#_O'#OQDPS M>I_POV1*ZZL_/,,L-G'_8A?B)+MO/[E?B8O]Y]S(&Q_-C(>7XX_/_.:OR^NR MVF>W15-3T"NPU7-.^.DA;-#6LQPSF/=AZ>=^<.^2OKMW5_M`,T_V!E\F\/<9 M?&".$(-(X0"OCCJ"_4.!@0^$(@@SXA;0%%GZ9UO,T@4X$`08<#\[("W.]X#0 ME7RRTG'^$%B!%A@8T'"W.5^ MW,=RGM=@=^=`;L=J-*A=L09XM69`\@<8%@(,_E`!#[(#AX`$U$`Z/N%'"J`Y M%7)8AR`H06`-?T(UNT`$N["`O1((+?)L%]B%[2*!L^*%8BB&DQ=];I:"12=A MV>=Z.6A]LY9R##90$18:GB=3!15$<8>#UT5GK^=ZL[=Y1<=`H0%_]W%[/L@@ M22,H@4`0D[,1,[`)7!`$YY`)7H,!;50C=\($]V`-U*`!H5`.]_"$*R`EYC*& MIH@N8&@?RW>*K`AY&6@?TH=PFR=A**A^-N@OU3=!(HAV_J3^GDH MAW1&?IK'AVZW4*!!B(_Q=!CF@Z54!-:@`$&H#1BB+7*U($2`.];P1+$@6S$P M`+]"8BM`!#^`$M24"2O`A:W8CH'A$CLX9NXXCXI7AO4W4W/W9F0WBZ$'?G&6=SC8+[DH>S'UBRI(0=I'8?'X,SUH/P(R%.O0#B=1 M`DR@`$1@3=X$$4&@`.M@B:WS1PIP#XXR8S_`!S@R`FR@CL5'C_28BH^QBC:Y MDQ7WBH]104Y-W>@N';K/7B\&X&44'_UX?4(7 M=NRQ",SX&%`'&#DB(/Z@6[HR`D?^((DK"13U4S5&>`A'T`X[<"*>I!)+I#PY M,I.ER),[B9..H9-Z^9?&YI..85TW>'ZFYW*("6[HD7+=!X((IQXJIXM[AW3L MD8O:AUUZMY0S&'MYB'1=21,725G1*"YQ4%0TM@*!<`Y"4C^HV2#^H`VD\R(; M8@\E4`1<("TC<`];")@VR9?FPYO`B6T&5'F?EWFRQB^Z:!YI6#.9N9#L)W=K M]X&PIW2@T8O9U88!E8(0>8+V`E/:Q945^3.&B!/.PTD$DF76$`A84P2AL#B6 M>#5"\B<1,34C,"E%@`.9T`Z!T`ZRXP\F49/!Z86^.1-^&:`&6D^"21-@QW9_ M5XRR2)G^PZB=:M=!6#F=%GHS-CAV:W>"6SF=V5F=G:E3X0DOXSDMDN(/ MQ1,'7(`$02!*]R`MY"0MSH,#,>`5]W`/L,`/%,$'"+$+L'`(4K4.?!`#$W>@ M8SB@,D&!2-JD[Y2@,T&8VZ6+X8>4VEEGQWB0AVF4>MB&[Z%Z-#5]5EFA"XFE M!0>A*R>=[U>BLG*B-[$KV.*`XC)+C44LHW6DXF,KYL(K*2%+?,HK3IJD5G=U M!1JHAIHN4!HO;M9WSKETV\646'J,=O:!KO=`,(=]&5J"HK*BD,5&HK!JKAY&HD(%`99>E/P3^D'&8@G[X:J3' MJ<6H<.*GI4B9I6)7,T:)`&5=P!3#SLBT+LRPKLS+K M#2];LRR[LS.;LXO0LS_;LT(KVQ()B[$'V[86Z[9HR[`< M:[:)<;9Q^[9E^S\DR[%WN[!WF[>"8:TPX0N$6[B&>[B(F[B*N[B,V[B.^[B0 M&[F2.[F46[F6>[F6>W7D4`3[8`C[T+F?"[J>*[JA6[J@>[JF.[JAJ[JKR[J& M\+JFV[FJR[JI&[N?Z[JTB[JN:[N[V[JH6[JY"[R_:X_:AKG&>[S(F[S*N[S, M:[C1T+R-F[)7-[W46[W6>[W8F[W:N[W<:[U:\+W@&[[B.[[D6[[F>[[HF[[J MN[[LV[[N&[[=&[_R.[_T6[_V>[_XF[_ZN[_\V[_^^[\`',`"/,`$7,`&?,`( MG,`*O,#^#-S`#OS`$!S!$CS!%%S!%GS!&)S!&KS!'-S!'OS!(!S"(CS")%S" M)GS"*)S"*KS"&>P$;?#"`_S";4`+,?'"M'##-,S".KS#/-S#/OS#]D$+'0`" M1-P*.=R_M-`*1`P"'4##\]`"'=`!--`*1FR]"$"\0+S!")#%7-S%7LS`25P, M5$`%Q4`#1\R_M$`#8DS&58P/((`/N7`&(-`&[.0$9)`")(`">FP*3O#%]>L$ M6M#'W>L$ZH#'>HP"IN#'BKS(C'R_;0`(9$P%!9D\"=$0#9V0RN?0=R(,C"_=HU MW<>F#=NR/0G+G=J3`-UQW=JGG0:JC77`_:K9'=>F0`*E;-VD_=NC_1C/G`(@'#0 M!^T(4%#%E;W38OS),I$&HCSF*8`"J'W'UGSBKVKCWHT"68#^`L]L`V2`RG9@ M#RF@`V00Y2\=$Z$LRT">`K!`RB@0#61`!C[^"22.`A5-YCU^Y:C`S3:`S3&1 M!38`Z\A.RJCPY!=^Y;V=!CK0WH]@S=5@"J9@[;3N!,:^Z]:L`WV\[CY>ZS#Q M"*/\S%E`!O<.U,?NW?9LW&Q=RH]@[F1@S6P^\"1P[[)^[75MX[0/T).`TC!!Z&*,#U/=Q[*>ZRU=U?1,RF`.U-R,"K'=Q^&.QTX^";KNUD;_ M\*BL[MQ\ZF3@W;4>R-:>`D:@`[3^+.:S3O1=3LHZ$!.F@`IVT/,,;0/P[/!7 M[MM5;>U\+.8VX.YQ'>[3WL>E,.XVX.=Q[03H7O%0C^M,;]RE0/=!K]%LWM+C M'N310/9FG_#4WNKMK?0VL.TM/0D'_^<8G_F:;]0AP-/EK,MB#`5.T!B=T`:@ M3@4C7?,Z$,G%(-B$K0,^W0&17.DR`=(BK8HH8`14#A-)CO18Q\V^W=)[;;MSC?NI)7_G3;\U@/@'1C\H3T-VG MC.YW4`H]K_R3']?7L.K1W/>HK.7$/Q.$G]4#;P^4+Q-`;MSN[?X@SO"_?^T` M$6W2P#3^=P8>1)A0X4*T^A!A1XD2*%2U>Q)A1XT:.'3U^!!ERX!DJQ:BT M:#.P#8B2)5O1.KBRI,EIM#JUZ3"S)"!?;9PHQ-E2GR^%3J:U/"-P83041E*D M^3G0B1T;*6S<^1F-1(JG"$U936&*H9,[1NRA2/B5JZFH8J7JL&-1)3LC$ M185P0MD4*)06O2OWIZEZ5K&FG:25:Y9'UZX](@-6K)-K<;/0=9(E[MR#OK:& M+0K7QJ.H**QR]OH7H=W-=!.3J.IVDFD;J-@.G"!2]V[>O7W_!AY<^'#B#DF: M[`!S$JT00HD>=)*SF$D0*2=UTC?39#$0RA$&-3E4(:U1TZG^B%]J^JEKM:.S M?H9Z\&OLHD[(QD7KM3#HT*VA4ZUMM5JX\JN^S%J[+P4CT'%-*K6X@I`K$B8T MR(E'XM(%,\T$.TB.SV2#3C32)FG/C@87LN]`#@_2BKZZ[@*+C&A.+*Y&&V_$ M,4<==^2QHN.HJ&D@6GX\HY/5IIF..NN"THX**@`!2KKSGD.(EE;,*X;*A)AR M*CX6M^)0L?7D@]"4W*2:)(U'=``S/S+70E$TU.H","_H!NQ+-2>BN8,,5+B2 M:X($[?%RM30@-"@:11=5RHEW+-/0OX'$!/&MN$8\U"H3'=HS#2G^/,VU%OE+ M#)6JK(KAL!Y79;555U^%%=8?.XC^BI9N39=9[]T<5+1K/(W5H:-:HV@"DI6)H^*X%G>2QKJXV?,E8)WV,C(G89)#=52#%PB[K0WDC! MI;3?FL&<4R'1=&!ZZ-<2_FDO4R%,@V*UUV:[;;=#&K(E1ZR+3J?D8LH862V6 M:P6?5IS^:&.4'XN=!+PIQSLJ/)2CCKG0?Z'=VV:ZI.5O/A)F),NJ;4D,NM\Y MIQ+W3J3OLT&'GU3D3.I[%Q)M\X0H@Q2A?"?G]W41HQ+MA['NL,$(.R=I6E38 M2+U#H)_NX%K@5^V;I)2WGX<^^NC;P*XPNL",J!3!>]&I MJ"65&?6C*C:`&G2D$AC3X6MH-I/@\YF4*+?:Y4%_$*AB3!C+^9"%&9##(I,A`,+P\HA&3L`,91$.">/*I MGW%AJ#L?-*':0$@'.L#*OB"J`S+H@@1@(,.DE):"+-C!#EF`S6'FDX)Z9`&E MB\2+%!YAO#R2`)(IB.1`"X8*,M@!9G%)`4=1"@8=<*XJ%`554'5@!WC*LYUB M00$84%"\-*`"#)=;F_.(H1I@=M6K7\T(+6BPG6*\Q%C8U*:3]`&":*0O*/HX M)C.M>4WM!`N(+`(6%6C%$*9410?U>*`-;"J5:IRJ'F"Z`R].-2&KD"8-Z)KG MOX!ZATG6XY)M^0QC]Z=($NPG+##J;!]-]`B&D53$J!B>/A)V]K20`I4B!*LWP5O>!<2-Y/,+2&T<`(-.N`(]G8@&MOK3!9H M0`,=M'$'=SA-!(XE9;/KE0';H9.OXU.+%R@? M&6?%%/.0@XD/HB:F1D51\[BQ+W*\&E.8U,6N=!"*HU*+1U0(P1Q.IZ(H>^2V MO1``JA)OEK7LU1Q2(03I6TT0A>=*B?]\8YW%+4IT9UQ&QEO4X7IX?F(1SCNK3H5->: M5]_I&;?#8,'>$L99HSR'+2L.9?+UL5_&3E\R&=K1Y,ZM6"X<6 MXYO)I<;(6V0AS:)B2-BFP00`BOR*;G2TQ6;V][W MQG>^<12"8L#U;C72@B_.H`]]-+,A`(S0'/6]<(8WW.$;\8$OR.$+*1:G$Q*G M^$/*F0:.=]Q;#P=YR$4^]]SG/P=ZT(4^=*(7W>A'1WK2E;YTIC?=Z4^'>M2E/G6J5]WJ5\=Z MUK6^=:YWW>M?!WO8P1L0`"'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "`#L_ ` end GRAPHIC 18 y83222y83222z0004.gif GRAPHIC begin 644 y83222y83222z0004.gif M1TE&.#=AT`(<`O<``````,#0V,C`H&AX>-BH&!A08$!`.*B`$+#`R%!02*BH MJ(``"%!XD*B@D"`@&-#8X#A@<,C(L`A`8)AX$.C@X+C(T-"X8&!@8)B@F,#` ML`!`6/#`(&A0"'"`@-C0P)B0@)B8D,C(N#AH>``X6/#X^$AXB*B@B'"0H-#( MP!`0`.#8V&A@6"!8%A84+BPF(B(>("@J-C8P#`P*#`P,.#@V-C@Z'!P8,C( MP%!(0.CP\.BP&-#0R,C0T+BXJ-#0N,#`J$!P@'A@$%A02-C8V"!0:%`X"!@8 M&'AP(B`>-#0P.#8T$APB.#8P,B@&$A(0*A88"`@(."H&'B0H(!X M:)@P0'!P>$`X"-C0T("`<+"HJ'!P<,"XH+BXN-C0R&AH8/#HZ&!84.BX&!!( M:+"HF+!@<*"@H'AX<&"(F/#PZ$!(4+BPJ-C0N)"HN.#HZ-"X:."P("@@`+AX MB("`B'!8"$!H@("`@-#(N+"($"`8`'B8J)B8B*BHD'!H6(@`&-C0L.C@V)!P M$*"XP'AX@,C`L-#0T'AX>(BHL)"0B,#(T(B@J`@(")"(>%!P@%B`D-C@X$!` M0.#8R-BP&&AH<,"8H/"X&`A(8.#@T/#P\+C`R"A8<,"(D*A06,C0V#@H`,C` MJ-C8R/CX^#@X."!8:%A86"@P,)B8F(B0F!A(8,BHL+BPH-"@&,B8&'A@"%!0 M4%A("-C@V.#@Z!@8$)@8,&!@6,"XJ)"(D-"PN.CHX'!P:*"8B(B@L(@`$*"@ MD+B0$(B(D,C(R(B(B$A(2#AH@+BXP+"PL-"P:!A0:,BHJ&"`D(AH$%!XB*!` M2.CH\.#8N.#@R*BHH)"0@*"`$.C@T(!X<,#(R!@0`,C(T&B(F"@H*&AH:`A` M6."P&-"XN,C8V"A@<)"HL"'Y!`@``&$`+`````#0`AP"``C^``L)5*"@$,&# M"!,J7,B0H<"'$`=&G$C1H,6*"HP),L>QH\>/($.*'$FRI,F3*%.J7,FRIC;@TZ<1WQGI*G4JUJM6K M6+-JWM0L.*=7A0*4:D19U6A/JUK=NW<./*G4NWKEV=8_/JW4M0(M&C M18$J<%&(L,&H=Q,K7LRXL>/'D+_RG4RYO7CDW+GMUPH+$KL'/KWLV[MV^5M(//_GOXM_'CR),K9RQ(N//) M$)NR74Z]NO7KV&T^WQY6X#NB2`_^:\Y.OKSY\]3SDENO_B`Y!>_AQ^?>,(]& M]/CSZ]\/.N'\^/^MQQY![`%8H(`!(BB@?`KZ)YM]X_$GX8045MC5?`AAF*"" M",+GX7L+@C@@APWZIR%E]AUCX8HLMNCB3`42*!^!,38X(HDXAGBCAPP:&.-D M$+XHY)!$%IFCB$>2R,=Z2R+IGH)\-#D@@PZ21H,Q*JHT!4M;'C=%EQ5^^65+ M8'HT9EMBEEGD2&>N>5*2>N3C)Y]Z@J,#G@(EV2.' M'X9%SGTFC7G%HQRI"9*CC[;Y49J2FB/(%9FZA"F;8L)42RUW8?II5\?HHX\$ M$G"*TI;^5Y#Z4:RXM:4JJZZF%.&$L-:RJYLB<2AEA_,5HP,X>_IYP;+#*+LL ML\-`.\RTT3Y[03YZ5*+#0#/"QVU?A13S%XW$(G3EKR'%.L4:[+(0JSF=3O$H M"VN4<,85$G"42T>;UB*!OZW6RM$59SQQ!;HK'8/OJ!+H([!'C[(:,$M7Y/(% M(W4I[*^_JG8LP3&=2B6O/YE4@,`_E#Q,DL-KA))R1U>(@T`F*F,E+PLG((#` M%NK43-(9*[(>S2.E2B9RG)^BGUU%17+?6SSE8-*+9]9BOU MUE_WB>V>>P(J-M>RE"3O%0P$T(@KKC2"Q`/WF)/KK"(@<`O^.P^X\@#-AV@C M@;SJ:*/SX:'\4`*G5QQR"S!+[`M3+IDP)76WZTTUXP M3#/LM_\LM=/"#^W\U$I+/[7PO\_#!2290BU$4#H$/,%NYG@"`H#1#X.IZ0KH M>)PVS'&,7-R#".P@@3;TL:4IL(`!)##=+=;`@BY=P17`"&$HDC0ZXL$S1(\(E"CA2DXHO<')I83^AS`=`S-Q`E-$#PE;F$*6KE4]K8C,;GZ`62$6:C6M\N@`V MTB82`:)#=X?0@,"NH($G`N,0+!P8)7:G`8X4P&$5`*,8.3("1ICN'Z6$V1:$ MV`AAR*069P@A$N0EDA&<`!AKB.4.FU>!&(!H>C*%8*W+W>)P!7L6$/O8'8& MW3U@CEC^8=Z]%#."<>)QGM^#FD`K(=""%I2@I;!30@EJ)X4.-*%0:VA##[I0 MAD94H1+-:)W`@5`\++2B=:@DVTQGBE724`.S5*:KIB`!-]["'P*35RZ`L<$N M"?`?IOM!*#MR"$H@@`32-,DQ<@F,1L1+`D$4!T"Q^*BE=D5>+SP$IV"%0F"$ MPJDKF8(^0K%&,^GCEQ7(5<5RX51Y^;.<,$/@5JY0@J)N3A@P-8D$7$E./69% M7A609V+DU=9_[E$D`T4H1 M94OH`$;"@BI"(X!5;`0+-".,*K*#!9?2Q\Y6R5*ZZO2!(PC^13]H-ZF4##6$ MM1R)/NX!C)>])*@X`2Z\:A%566E5&T+<)TWD=89_@DF`;@S`PZ[0Q)!=P9-H M-5-/0B;`3!35EA`SB2"F4$73K5":E@J)<"=5BR%U$@$6UX1]=2X-[69D]6IF"IN"%VY* M-[Q9E4ZZZJ4RCD%RW;IJE\AB9K+^EJB\$4EI=9;0B*\Y).#=9P(#G`&DLIK/ M#*E*LGG/,JWB>W]EVU@D:FY%(@'> M^E9>^O"'"#@B@5P\000UBY4(_+&KM9VA!&N8,RY1:XXSE+!-<`V5F011;G4\ M@:SX-1-Q30=*F#U!B(>(\;37,&[OP4P?9P`:+@\H@3.4[I_@-8`C&9G^D MW/!F0;GIK67FE0#=!`,)!]?PA'OEJA9K0"$)QEVFP96@!+D87,J37`MZK8$2 M`IR5/E@@#HXD[]P^6YL(OJZ/-3CZT1^A7S.PM2Q&*AB0$KXT_$S=C%>\`GZO M"(80@A&,<`AA\,%X13C\KGA*3[K4H^;[I-M7ZE.[S_'Y2(2IPQ&%R4^C&;.> M5)F!\5(L^N-Q;TR>B%,(#':T0A][)CJ\7MQS,`F"!16X!^QG)8=&$.$!2`A` M`,)H76T?U=NNBMD/V%$!#4QA"R$DP?0^HHY9KK'JZ@C``Q[^<`LD:`/Z2O7' M#]S6"$8DCW-;>``1&H$.VC$7`?UX`.D1,&CU#OR3[A\],*XXL$SX+7JND`F: MPA&;\@3_<`M;X$OL``P(<`^Z8SK>!`T_,`*9``VN$'U$D(&9,#C4]0._9SP/ M<`*7,GIHQ2FML$#9A4#:\('`$(*O@AO_\'M5Y(+F9(&H!PU$``U;$'`A]T0G M0(&FXPHC<04L$`IS0P2W4`&N4$V-$S%#V-L`5$1S"9\'N/\@,/6`$99TZ\ M,#=(P`N_Y%=PYQ%Z,`T$AF"%)#[^%48^[T-J@?<*AR<$^$`,0N"(^%")^!`, M<(`/AQ=XD+B)BV=J@]=WC6AJA?=WCCAXC:=X?`>*?D=XIS9IDR(!R-6")L%K MP/`/8I0+T2-$6Y!UE41[K^41MK1[(>=*(DA&V[.!Q;=C(X%4O85C/U!5Z32# MJ+>#\B("6X!Z<"1+)/`#+/!Q=`4,Z#9G900,7[!*7W4\^4(X""@O3X!"2.!C M]A=5M2(,JP<,1``SN1``GX0;GA0`77(&C%!>/V!?0I0)+!!$;W0&E`!3N2`. M9\"/_7`&XB`.V$,P5YA'YH`.IE,!LX)=Y]P0'G$/-$#2ITB"#8$3((@"*T00F'% M$7)P1]*U/4_8D3%U!<@5`.R6"\D$B('($7T7#JTV#*3FEXOW>(M'>'YW>()7 MB9"(#W"PF):HF'"0F(=WB8E9B82GB4+PF(+WB(]XB93(F849#,V0>).(>%H` M!XIW`:^0".F23&"&11>7EG;C#U5E.HT@57K46C"&:!#37,U';N9P"\0W$F*) M6WGX<[Q%-#6D.TM0`=Y(A%N$9_NBD-=';K/4"B-@2B/P0NC^=F3RMY1:)@*F M@X9;,E.A<)U:]00AM',E<7^M$$OZ(`[:R$:I=`_7N6+J$$(!H"\R^3@($`!/ MX%TD<`8CX';*Y#":<07(!#D.(S#;@PXCL"6=9#JHL$DF-YYR:68=$3SMR1$1 M"@RPR2;RIPZQI`$*B0";U$KXF&8Y>7"9H`_V^`6F@P`[16Z_=`_.9PXC\$3C M:`[LT`BR@J"N@`!B=`6\T`B5@AM5=2_'H`&_1`+^T"IVHF$EYG^AZFG=UJ)CQF9EHD/K1@,B$IX-M")D^BH MKQ`$=UH%=!H.H)DN%]>:0]BIF_1\7>BA(M!LN%E[)E$+',D+.#8%*,4(-RH2 M.N96S=ACM?(H\H<$)3"B'-F/L%*.<"0O;EC M++"@G,2/4#2C`O="H>-!Z"`&NT,J+/5+0M@1PJ`!-/E&^<(I540"P20!\/8H M!OF3,--Q*Z4/WJ6>D:):!+>.)"@P$G!6.":+#)0K6I5,Z(!?6N6ETF53$H`* M;\=2-;=>'`=4`W-P*70&$:)5;O0#&H!:\O(`\L0YK:=$7_)5Q+I-O&6=334" MLV@*SFK^K"DTCBPE!PPH1JZ*`'*@8A[!`KH3"AQ$./GZ<@M$`H:0"PN88AV4CGB9EYG6)WX)/Z/&/LV0`$<@>)69F:WX"HJYJ)8I!,.`BIAZF:9):0;0#)QJ.IXJJ]3ZMZER M3EUX"R?P,*>*M.OI2:90"VWZ!(>[C+3*;;8*,_+W!1H`7@2CCK_*N7:S0-,Y M>W^XH^:@K&P$LL"`ADE+`HUP=26@#OY&K2W&)EG:@KP0E,"`!!60@BADHDYD M.O;*:SQ[8S[[M'8CKS1415W@<*IJ.JRJ9?YJ3G6U)<*[4[7^H)!+@%\5M(`D MIK!_")MO]ETIL;E7=6\%L$6*2YVYRP`.LW$G8#!D%*/O4F\T(R_\>`_4]KI/ M0%<[9Y05^Z]_>`(.0SAPFBZA<`M2)0RN"I[`@`[>FJ4!8%*EI:42(`POA@3& MQ%;W)6P_NFD)P M,\=^LWV"PR;L*0'B(`+VYK@P0Z#^+58FN?"`X\AKN%@FC6:\'`<,K9G((,81 MQW!ZI'^LXH$V`82[64ZRDA/IH/!]PIGPB5B2("C^J`!^I"C M04AF418*X@"E\0J\=>-P++"`1$#'=?P`'OFM_TN`/6DZN+`&?GP2HN,PZO!" M#CQ<"_2\'<%K@6P.T=,/!0`Q[XI5:Y(U``9)^2`+8E,MW^QIW:Q?B54*.@`8 M"T(064)=V:FC5R3!3"P/-@#XTQI:4]O<@-C!N(CUR[ MD]-+K-0CQ44F5*'ZP&R(3*T]HR;A"PRA##-;)$]?XF'```U#I+!8/L@`"O MQ\#-[&30]##2[+@&^;>)_-.!F,)'`U&!(E!XX%@I[%@(15`=<&!]`C56@)IU MNWAZ<"A,8BR#1Z(`IX`$`@40"Y;#H%.X04 MFX\=`8EJ1`HS66A)C9PK^7^2[NEU%2&"QW/8#))`+2R0(TRW&GGO= M:Y3=&*K&W6W2X(W2X1DK,@M,/@-0-FZEO[C>'ZIE:`K?5<0(S=;C*K/(8*95 M`^WG,$.M#K2OD;*O%FS57S"C.DT"WDU#_VU>MBY_4X=CJV?>3<9\:*0JK-S* MS!V@X20O>GR7D3O2YG`"#_@`[G*T5`S`P0PQY9926CI/!,-]);"@!%KCB\S8 MB*W!125[IO[8YN`#@L)17CX&0:Y16+Y1=I(MQ@#O7`XU\`Y1K5T,-,`'95#: M!%\(%P#.?++O@G+E2G/EQ_+N7=[EE3`/FQ6+=/4%Z2T!5MVBL+($:0PS*4W* M0PW@:_;^GL;#15ATT`H^YVRH,HD^,-7MT=B-UC15P6==TEB]K,P3GH[K3UL0 MJS2T!DA&0S)]I324R,(>ZZDD[#PMWV]7RT)M-YX4KO0-#.%:R2@_,)BLD`]` M9OS8]91K.OUPZFY9*^'KX">Q6_MGW$PF)NZ=OD?/W4G/9+60"W,TK$K@^8ZV8B?YFDP-7#YOKZS#@^ZOE""5_DW:;.P2W2\%B^\`[? M-$>Y;$/^\?"^;`O M**?0`9Q51;=`NA_!:[P0<@\0G+ZC._V0)8F;YR#QW`[9 M<@70(*1@\L4:K>BI)_/7-ZM@3[W.&.D=$3WG]9T\;PXZ2WIKT+,>I`'H\,CL M]61L4EXIB-16)4;Q??39C,C(2T$`P0(),&!KKIA#:&X*$6!;]$TQ=Z45074' M%4JD>/"8OUL$*5E$R*(1,$8/$YZ\4::4H"Q"D2M@!K).SD3I0/ M7+D\*>$005IC0/!>+9YA[P&[Y4_I%4H$T9$-BP`8+YA5"7: MH6F7P@V.]KQ2A10H($=.$1_BY/@H*!4N')H+S2XT'Y9/3^W5JTOK3JVC^FO1 MX`94OE*BXQ=]"A."U<`([QF05_H1N7(,XMXG)(!E,CFEUC^"/R1;UN>$`$RZ M*`!@3I@)O!((JB#!\X31`)V"_C/G`6`0D.P*$0@Z8:J(-CQ0K2MX(0C#6K+2 MBJ"T$!H1F``D0(BNK8"YI[Q:;@(&"09JD:`6?!=8<8:X0C+"3#&/D3@E,(8B$IQ`:X:Y?R_,L6VVW MY;;;SG+3#C;8K#,MN]=@NVZ,[&PSC30?5BN&..+*H)?>#([3(Q]P2M&C@V&& MN0!@?DW3[MS6JM&.7=-.^8XR_<1K2!^0))@5IXKFBV@)%\V1F$5]0@'FTY-& M`!D8;4;`3+^)#M'@H"L$:80$I"RK21NY.C9'D%HTP-(AC+/^LO`+KV+TQ[X3 MAI9`SP-1C@A+@E:EI!54#(3UH"GT48^$'UB8HI4'MN@HE"G8.T-28);(Y(2; MM,&V,GTT7AHS$DE88^@1DF0;HH-&"H5I*Q^[4%,$A)2@GY!//,G"6RBQFS_\ M$M(@SC7:CIRBMA?*41QL1[A)#@(I$X8A),[8_*83/A^A"V#88<%(E"0PD'3* M!-''\)"S6NL+)'+!%BI@*LAJ0VU:1DB?K4H@ZPJ-[7M`FQ.T:20`J]DBB)$K MUL#0K!*(K^H6UOV\8JB0US"'$@1<,347;2C$OD`F!X2V!V"::<8Q5`-NA(FFC'0C"\&6D(KYD%"T6G&&7%RF%G$*Q1%S(9@. M8:PRM?`5`DK`M3.T0C"F<`D/7T4"=521!;G`D2M$D`MAY*)D,!(^5J]MD\F%/^3`QT8\X0R9XHD@6&"X6]RC MCDG:PGG.X*L#Z64G#,F1R23PQ*;T)Q=G8%$N+(0$=/#09J%,R"OAA@!_5%&7 M#/*'H%+^8B%VM$(8_N`/(PJ`F90D1@RMX*%ZT)@0%OACCZ'PQQF\>!)QX*). M3Z@B3W)A+8+P8@VYD`#(2'`"?TR!$HUH!'NN0*C?/8%KT#+%KHQ%M48&X"1H MXJ,@[S&"5OY#FV?0&`-]I4OW*QP@950S0MGV!KM>`,$-;Q,5EI1`7BZHA%$0,`: M:B$?GH1BAV;T"1%NP0LY1(1%ZLC$%N2ZA5"$X@=096CQA"ZZX!1&(T`A7(&!:RXKK7+=P`D&(XP>AF.L_&"`";4CV'Y%!B`1: MT0]"5D`=(WA52ZPDC@#@A]3N8*Z+CL7$/! MB$RHEC('.8&%B/"`"I1@5VC2!F;E&HI,**JCO+A%(Q`4GN!.]P?5O8@Y,L&0 MY59`K%8J@2F$JPWDJ4.]<]4&7J\@C/$BBKE/Z*UEYOL#AKCBOOJ<9V2GJXVC M3(8%C)#N<$&[$[5)%K.MT`==*T!$5X#5'\E[`B]R&U+_'L(ER\P$:?_Z`[?N MY1"(=86N:B$'!'2A$4@`;`765)G^8^2B`K<@P0-:(8$K;($$_3"('"2[A4R, MK;M;8,0]Y'.%7#`"&JX-A3F>@(10(&^A*,5REDM:&PHBD%]U<*JX=#.;!_*+ MRR]$`SA@J&8%8+!>;^X@'XJ1CUIU,:ZX0+JMJ)H#>\<>:%8969 M,#J#"-B#L\ETR4?]FR./=I(5BNG#TA*[,C6/(;%$^P-QG$'5%?PA`D5?@=$H MN;0^>.RQ2B/.1S[2QZ=9A*8+9^55?6)12FJM$$\#Y1@S.0-[\NM;4Z=:UI9! M]!QY[,5B5]I(![DDC,QQC&)?&G0>4*\#:TO&)B(^1B5N$`^3*@#V("&SZQ)&$W! M(0D7]SKLO6W\\KNO*+)W/N^&;?3["LI*[N?]#YI MJ^T=15J/NN,=WWC-1+[$5K_ZD3+O=\J3E>2?!SVW:(.&`H[^N11HR(U-'_A` M%:H^-`ET(7#DY69ZS8LXA2C@!7A>5*.&,&``DXX!:;KZTG"97*,I1@="OWSF M=T8_J>5Z\Z4_?>I7W_K7QW[VM57Z,:@+YF+VLNE+T8$R0U#-OC$.[.0 M0P&%(#IN4!@,^C7DS#:H]B_E'L@EL/`"VRIEM.!AJG`(?0,U#H+$1@: M(E3")63")G1")2P%?4DSF[(-HMO^P0\L!5&H(!TH!-\`#N,8!SYHO^!0@'VY M`.5X!2'0`A<,!QH\`IY#*N![CAR4!5DH!="`JIHR/9XZ/Q`0PB<$1'$X!$%R M$0:`)4!$Q$14Q$5D1&\9&)72@SX;--30C7FPJ='X0MKC("/P(*!"CF9XA6`0 M@E`,ACK[EQ!*`*2*0X")@@O(/>D(/I5+H%+`P3_;#JE2OD94PNLY@4-`!W2X MAWL0$ETDQF(TQF,DP@O$`Y5ZJJ)#N5G4`2;H1*#J(#@CCE)P`Q@412$(!]VK M,^@XJ@M(`(`!OI0K!3P`!^E8C16Z#2Z$H3[3#A#(16240%-+%8J)/GK4QWWD MQW[TEGW^<2#:&`V%J01OX`[2((=O((6%W"![F$9[((4EV*!2<$%MC,-P"`95 M=(Z>\S\S:SDM_#[2@(T78B'N&(UY],<$O+N49,F6=,F73`BHZK(U.R!T00,7 M*H1OD(*=E(*%]$E24$B%_$E2D`)RT,92C$,85$7E,"H58BJG0CDP4R&D"PW2 MX#.!/$F8U,JMY,JN],HL$TD9JL(N.T@%,(*A_,EO6`*?A(&A+(,SU+\H:(9I M.$6F!,5FR`<=B$(#(K-*8+H#F@W7:!>25+,70L"O1,S$5,S%5$PKY"DQZS/X M@R$%R""?U""&U"`E4(++]"#BN`"Y/$6D"ACEN``<[+]]@;W^^(,I!A(-="&- M0BB&+NS"<'%''4!)QL3-W-3-W61$K"P%/PL-^$.^8@".#L+,M!1*#BJ./)C- M?/B]$(I#YPBZ6,2-U3`Z$(1-U8#-%Y+,%XI-V1P-V>0"WB3/\C3/\U1`%WJ- M=:2-8H@@[BP#M+3,:907]_N-8@C'@`D8Z32J*`PZV,"-.MBS<4$^[7B_[8Q- M&.K"`TW0T1A/DUI)EJR[`)K0KHS0O4//(_$3Q=/'"^5*R80_F230\"0'HMS) M,$!1GI0"7AA*G+L7^U2`83K0CX@!1CHR854T9[<25*(L^,03CH[`J,BQZ`+.CR; MAAS\LQ=R`06`H=3$O9DSU.U\OT(%CE3XSMA4`&.`N[4HCUS`$U7C"53)A1,8 MQJW,A'O(1V:ZATP@.1Y1-0F@&`WXMD=9OJKX@05#-KXH,I,RM5I@@5PU-5=U M0E,S!S]JC_(`5I0X`5-]57M3U7F;#'%+UE'=50805=TL4JR$H>_\C3;K(`[* M5@VB!Q(\#JEJJIX#&!LD5^G(L^!K3]F$O]8HS!.\UO!,A45]/TD%CDE].BO* M!3E8@J_^*J][B(A08(\I4(=0&`A=T=)CO(*2D0->);PK:"6LT+(I*%93^(&* M-05&8`134(=8.=B3@AM9A:1#F!%,\I:PT)`MZ`=^Y850F!Q*&!5$M"P+08"V MH80?L)`EH8J''54`.H96,`4"JUAM,(43L"Z%.(%_J-@?^`>\PHPSD`/#Z8=A M2\QU+8:1W$[9[""(E-/+;,N%O(.%E$AZ(<,7JH1$,,4:!#Z`N4`[;*K:^$[? MJ$T\Y<[P]$[?0`;NK%=CN%?+^`'["`5U"+8U^`$DB!Y8D8`28(2'DI,EW-G- M8*0*^!S-V%N%D(`9:83)12EQH(09"9FZ:BC3:EP!$H1MT_!M40[2 M`5D(&/5]CFFX,UET6]4(SX+!*;R=.3834MDT!C7K`.,]#P-Y@*Q(4FK3F(NY MD@4>0K[H@NO5+TP-719`@**MBB;ZO"D8"9GY"KC@(Z8-/5$+B\NH"6A186^Y MGHY@!)1)TA\A@4;HV`A,C-ZUNJM@TD06Y&X)E9*1'KF;`G:XXXX-B]T%'FF] MVO?SABXD3ABJN1$4RLV43Z#$3/(-#MR[0*."Q>;(,]R0!01B%W@!!UXN!A=P MOP0UU'HE!V383G#P0_"@71)`GJR;)SD)BS9Y$PJ\&@18@LA]4L\0!GW(!'8P M$H@#/6'^:.1A#`L+`094D%J2B[ZKX8],[A;#$!D_T0=3N(5%1.4C88C@_2<' MG&3`(8$(1HFX0)!1O@(#N>7<),X#-50NE,T"3,C@P*!OZ-8.6LMA!DKR+<'B M`(>@TP'G]-/IN(`ONPUV\<[)=#^H2M!C]L+WTP$0T%O?6I!^_F>%,![\..>, M4-(-[5(,U="H_C>'(;LCT06SONNZMM*TMN0K(%XJJ;I:J``28`'^?U/KL+82CDZC MI[YKM!YE(I3B%P*.X5P-R=P@\+6'M13*H>Q)&.@'\(W3A52`"Y0.*QB`/,N7 M?!B`<9$J+OP-7E:`/-@73.3>0LC?*"X&_CVN&G2 M2SV686-Q8=`;CF.!WH(1/$FCK7/^M#>ZO)V0F!$'\JN(7"F_%??.-_ZNBHNH MBDJN"U3)IIH85?VP%H)FD4T)!3"-B#N!\DTU;2MY/)1X\_-`E5R%[]6FP/O$ MQ"&5*JA:T&(H@Z\5YF'N[:&TA\V\S);6('*PPI0K[@KRSO>KUT(HU"$%A]\0 MPP7EW@(MACKP+1`!AAFK#!:`I:8&!@80XMQJA`K`M8@X@U``+'9HA"[`JU\; M)U?H"@9X`';0AN01`5=W!<+]`DE."#D(@%]_`$9@@:?+!=HE""0(`%Y``#?/ M!%1`K`?XAV.)D>M!@$^9@BT0@P"0ITX5*0=A,D8@`E>`A@J@7HB`EF@)@'<7 M-A88+8C^W@OL>8!&8(>PZJW?X@5H.'=3^`+>NHP+=VOA;??=X3&7;80+@YX' M>`*+D`!*^(('4*L*\->+.`-VKH"-9P2W"`]&V'AM,-E1:H1T9I$2X"HB@(9[ MP&1,(HM_6`(B(`%>.!6:T7"">``ZWHE>.@\).(,M\(FU*K(,T1!3J"0-Z'5X M^@)8>CIM\*I^\+"$F(I66((RR0536*Q^<)2=$`1!^`%44*OF:7)SD'*'CICY MH!1T./8$H0N4]Z=:8(!])0)>B+-0*4NZODD>?A)NX<`^*J9 MKU64:'-!N(5N[^D"Z$\^,&H58` M%+53,<0%#QI*%NUB8@9*$C2",B"'9YR-UJN-$-5?]X/;>+'/X[C6[$P-$*H+ M"9BD'#%A\&"1-J$$3X_K8;R"*2OY,WB"&0&M,X`>#ND+/GH*$"8"P(U^@D#@ M6'H/'2J!D2`"LKD'!F`(7@!&=(@E7C`G:QH(5SB#I]LK@FB$%N'=*?@'0LQN M0?`'P`((=?Z>(`#6R!R+>^HJ&#QT[QZ+*9E<`0,62I^YC.8D:`-FZLR94!5/ MU,IXI:,VD"=(`#M44B-,C<(:`2-QYDI&85<"5*R@KU67BL"F?!$:X,J4*YF` MX1)QYE[%`"QPFCO#$Q@T%C']`4/^8.Z8N"VW*JJC:G(+L`J4SIP`Q@X8DER" M3#XA@D#53CE2V-[OE;PY/$(>=Q-R"!!1IXH(&%%*)#,<7HL&`Q M"RJH8(.%D"/&+:3PP8<""I##1QG?B/@-*:1(42***98X8AE\C,,'.85$"$XI ME512XX/^$CI8##@1%N-AAQWJX&$>#193B1[@G'(!81)0QHN`!5[!0$4_])/) M&2QT9!%Q"-&DS@CFE-09E%6)`U5T`=Q3$#!G3/%6"1IL9!HP2YC%P@.W3('1 M"*U4A`!.^NC3#S!=C'#%2U<\\(`$.&FPQEA03K&&"/'ULT4H;7DTA0C@`7," M<=ZA)8Z<5VB`0".&73&"2`\(6A(+E/AI$4;=70'>"2,<<\45G9$@PJXB%!JF M.1H\T=)+`TY!$PG^'#/%GJVP!(PZM91P!D.-F%+!(6\!>D5;/CGZ!!+`],/7 M1OZ46R9^(B#A#TX@+5?68-YUA(`^CEX&5RX9%>`/":%H@-/^")IN(1AWRU;9 M)8)77&9>H/Y8=T9&3A5TBS85M)(+MA5E\D`H69X0*4["R%IN*`$$T(HZE`$C M1[)$\))OL>JP5,%YM_FFT6[`]/:;.(=4M$673SQ!$R^,!*!.+B+P4M$3H5TA M=`5R[KE&1=H(0_&!N8SUF6I4@IJ;=VWU0W/!%:&C&D\XZZ8!>(VP,%=&^AR' M\V`2,-(F1B7%UR;="`H^..$'"A)C@SH\V".%A2BP((/@D`.,%&60$F(9F8M( M"HDJ?J/$YBB.J`3GF6?.!X0^5`+.@SKTJ$,IX%2BH`(;RCCAXPI$6`CKE8`P M`&'M`7,?@DE1*5LN&NPJ`:'](%7^RZST)H46._V:HX_7-;4B9R;W:"`T,"5( M+9+D-3"9='G-&14C4:TY\@/+EW5)/,"S!50P0C!8)^.I3@C98<`Q]".M3 M#(N/.*X@C*2L03SFT$E1'J`;DYCC-A(P"25D0Q7O`.8>O&K+1;2RIP"4*Q[J%")!B/IZP0X2U*,A48$*36YPA<(ZU+-[G+$]SHL28:90"\I4`&%BJ@`) MM'(8GAPE-V<82R5STQZW940"T*GB*MV3%#DR0@/UTH=>B#;&PA&SF(1[7"%` M8"0;.4Y&B7,0DLA1AC!(@1PF^H;F1J1-;683FZ;SYNG($:0>@:.<>)"$XL"A M.\<)R4@38E`STUD(8WC1)(`A7L..IPY]S$\"_W!+OZX@#I9$<8$_-(CUJC*6 MB_#%CY0@@4V>-8410*<1Z/+:KU23"5Z<@"K'B)\I30F12+I@?@ZC2)#H$J*WV-9S!"&(*MZ"J2?95%I,< MQTX\.Q\N!<&^!["`I"05!J&`<0^&'<8?7Q,C&8M:$V#!A`5O`48"O0.^@FHD M/E\8@1715,2,Q,.FIA6';XPZXF99,V=F:.G9JP.[PI+2,U>479)*L[ MC_3-%;#VF9=X!SIT MGA.?4,L<9BNAZD*?)NDBX>OE\#CEJP4Z##+,//)*(Q\-S&!@"@PBL+C%[$#" M+;J@P)6Z8I%>C2FTHEL17H"F9%7-:4RF0-IZ=>80I>65U'1["U/XHR30,M!, M:B*.,QVB%5%,EG?`$Y?:$'EX`KI"7D%C$D*]RWPG:(07&4PMI%PA@SY3XIYN MJ94KA/@6V&DQ$9``8Q>.N+=AY"N!DL(3(@S3.VQ*GTK!Q]O&=D6*&Y&LH^,3 M"E,JMB*F&,&Q2(!G%K_X%K\=+9<6J4B>\4:U!>G'=KH##9_!%I/(THU@;RNX M*P"F-RK^78KX",.`@/IF)<`(K2R?"VLY!VZ6;"84-#;=B%O<(BO;?3:T-8+, M9*8S2+2#W'=G1(Y^2.$68BB#-$6T!/=NKKWQ?:_I."2*U=$('.S4G>PD\;@? M=6AWX%5<'HS1%U%EAG!J7JOY'HR?*Q#G!*AX`$5PF<<+_P#0)-;L"0*`+F0S"U M+X@1"CNTD8O6GI!99Y"`!&I1"P%E&1BRILN.S]/3K/FF;![CIP0>\`/1&J_! MHD33U,FFCW]63TP=J0#'/AYR?S2W+U(]&,;'DXMR630FW_G^$W&4"K7SQ.]^ MD&;T%T*ZFK$@(&V0^3A(E9Q MR:,KB(!;7M7B"5MX`"_&`FR3"'ODSLR# M`LKY(QUP(Q7UW).F(CIK?3H8K"9A@2GL0O..-,)ZQV"XPZ_`@G^H?^MM)])P-\P M.1&+K4'^,:)%VQV1U=F<26C;1OIB<$6U)PTD>=+3$"""` M3R#>ORF0_44AS]A?UYU/F>T?/FK*Y1D(KP2A/GI1+;A1+0B#/BB:69Q8%Y@2 M$E;$9,$/EXP816S!",C!W+6C;7AA%S:2;I"A$BV>TCE>;^FA!&C`90`*X>R) M7A"!/A0%;03//VT!AZF><05;'YH>O(S%/TAA(EXE,>4.[40(#7@(Y&!` MA?#(=_%.)11#&=`#B&#.-G%.YZR(\BW?BH!;C-#(C-">#\C^R//5%U[^R/3Q M`2T2QE]4A%M=H#JD&`P&'%CE4+F<@6\?90E6GFB!<$@S\8CTN8XS*<[S MZ<`IH,'SY8-9HA=Z+4%;FDB)(!^.G@B.&I_Q)9\4*$&(>),.U$$=S(X/E),K MZH`XD8.4.A,E.DZ^+9AL?49YRL3W`$I2J)59Z(/`T68I"21"V`@S=$4/$LH:4"F\$I01`?# MA&!$51K^,"BA(.AI2=*G64A:2.$F,$21(++#352J!*R!*3#,J,6D@,XD@69G M31[H+C*"*>2"KAY"C^PS'PV-R:PA90 MJA:]VG#ZG!8N4CZ>P78DA::T$J`^3;=6IU"DW`M.HSFL6EHT2G>,`%KHYES4 M[8ZI%*]@3P"8U`7FE=0B!=D,Q@C\`VY@8$5`PR(59:/Y'WQ"H7P^:WVV;E7Y M2=Z)$IL0`6/R2J.XAEGL%%,Q$FJ5&H*>6JI%&23ET18@@3Z,@/..@-?.XX`( ME%"XJE_,R@GX4K$L9V@U47+!&GCZ;D-,(L4L'R50CCD0S[H@8V*%X6X M0(0HP(-\B`N0@_=-+V6PP]JHKS[^("$2K`'";&M%@/#;@(<8P&EL_@"BB`," MO$4@B0`ZA&.Y:,,(C)'P9`+!44(+P\444`(Z?$_UGH`ZJ,,_X:(Y-"M"M5'V M!F%-;$$KK,$]N$(2;2I:J&X]K09+[&H>-4(7*$]W<.J;J511D,`:C,`::`-5 M[)2;,*>RQ)#1)>=A`,;V0`L! M`8-JL@>AE$]?2,"^E,`%B9*F=$4N\(H"*2Q*8FG$I5C+J`PO M!``CE,4]A$**\T(%F$+79L*TT!&FC<4#B(,_;$$`I'@_5$`FC%$MT/@<,<"- MR\9DU<(AD(9LB)F)^8.I-D(A;<03Q"9<*&5MG``"\`*77PH/M9DI+$&*!X`3 M(P7HL<0#!``[#-5YL,E9:<`99,R+?T&BHBF;P`4CM.9QND)\-(+$-4*`*$LF M_`.7O_@6_,!N'L,A=`&7!T`_A(*\(H4VO$5K0,--&6*.63"EO=X!?S`UF@[+Y#[%?B#9JNYGC';USR`NRY8(^!+ MVAT#"Y@J,'Q!SJ(44IC[BR-`D&?$,>0"87>%>SX`$FS!&N`'"VP!K%?`3<^W MP?H(@^0W]+F;`NC!`,R.@.6#+-2(*9;"\$E3-RG?CYI(\O$"*%80PQV/NR"+3^`@.<`<]=8?!H M?<4HT!H[?.\9'&X60 MTRNNC@X8@PY(@HW^"(]4PC#H@?TK].Q(`8M"HH=\TS>,&T!\(_6M#"F#!Q&6 M4?B-(<,R?,@5*J9#AYYAI8H5*T3^CD\A'84**5"0L1`(+N90IE2II4KU]ENM1:H&M4L$1?MDP;52K8*05>;IVJ5BO2LV_H"7[&K%+#0LG^!KD7K5W!GSYY#Z@`G49*.4J7` M5:H$#MQ'BI)47]23+U^="_D4AB3'46$9AJ3L#40H?+A`@5*D'$Q.RLA#/KZ+ M51)=R(4"T>`TC@SY;L!G[]_!AQ=_67QY\^?-DT>_?F?>+Q+4UXS/?J>K1OJX M3M'?4I_^B`>YZ`LKP*`&+%`ID5@#H1#L3JND%#WT:$TT'_2HI(X(K2AE&-I> MJ20,4GKSS2&"?'O.H-\,0HX4Y%AD,<46EUN1'.DDFLC!8G;3H9B13C+0QQ^! M#%+((8D<,J]0KIBOR)VN6`,88!C)I2E]J'Q*'78>6U+++0/3J!#5HN,F-7`> MC+`48U)3K4)P\KG`S&8JX2.,AAH:AR,^%(!H(8.60!$A)1HBY0X8BFM.H7%& MTC&D+T-2H+5"WC%&$"XIK=322S'-]*=:CAQ!4Z66>/(65+;X09L?0FD$F!,X M^]15(;W4099'1=,#HTHB%.W!UGS`0T,R<8U0B@\/$G&)X9#^E:(?9)F]8R"! M2.$%VN3(`4>DC!0HI`QR<"1'AU?!#5?<<\NW%%@E=L45F MBS/.8N3"Z%B)!7?4*"(%MNT1WY-13EEESZZ@)!-&3#&%D7].P!>^)S+11F<& M2,*%6#LFL5G MM&91A3#&[CAL5\)P!6RMM3Z8G&L_VLWDH.FNVVYR7ZI2GZ?P54N"O?%K]>[! M55K8.NP\LO;+?'0P1HN+EDH,!ZX/Z08X@ M:.E<:*1L"\E#!Y*Y$)SPV6FOW<>6]OOY5=QUMSWECS(*7OB,(CRXE*&_K#`C MBB@JI9!\]!`#ZSM`/S%0%.G,7GN$?LO^H6\Z&FFB0OCHSO?ST4]?_?791PDD M+ST"N<;6HEL-.QU6^^A]'6XK1(]POB$%$O6F(2)JR+&4LYSM/>L@W3-.`7U# M#M0\KA#F:]\%,9A!#6Z04MS2B$9\8!K@D:DU=7C41!"W$9"8QA#\"X<>>"$% MB;UH8S`BCD'L`:W/D4)TG;N8/62XKPX4H@,<-.(1D9A$)=ZE1@>3")DH$KG4 M.&]1J\G^PTA&MJ`(5:(9>I#"YMA&`8Z9C8QE-",9T1:V877N&T;8V#?`,0`= M=$!V2[3C'?&8Q]I%L1`^R`AK/G@=[$3DB2%K5$=*D8]]74`ZTEL1*>8$R8YE MK6-7&X+7AA,C4I0N1;S@WMN01@[?^,^">C3E*5&92G'Q431)TX@@=\0$HXT& M)-GB0S'"`;U*7,!IS?B&&,Y8R;#QL&N7]%H:RQ8&8ZZQ10113AXN("";].XN M7:%F4JZBGY5K\SDPNLTZ>H$>@;JEG?'`WS81^,Y[>K"?^2E;S1QW12".M MD<[K%H0_X.U(`7JXC9L@U(QPZ$`,)26CBVZXL6!RCIEJ7);U-$80/O#A8X&# MR4UQFE.=[I2G/?7I3X$:5*$.E:A%->I1D9I4I2Z5J4UUZE.A&E6I3I6J58UJ M+;+S-@60@QM;%>56O<2'/*B0?.&3R)$"9YL0"J*%EL3`[U M4H0QY1CD#KA8@SH`&UA6!):PA37L81&;6,4N]K"#9>QC(1M9R4Z6LI6U[&4Q MFUG-;I:SG:VL8ST;6M&&%K2C!6QI38M9DX;!I":E0!BN08&2`I.UK*4M,&>; MV]RNE+>]]>UOP_"'/^AVML,=KAC^CEOZT35NYWN2O=[U*WN.6M+G6]>U[R9A>YV@4O>\TKWO;*-[[S#:]PR>O> M[DI7O_2%+GSK>][X7I>XVDTO?).[7@(#.+P%%K!^^VM=!0?8O^\=\':Q:V'V M1AB\!W9PA9M+8`-_.,,@_J^&]VMB`/\!N"UV\8MA'&,9SYC&-;;QC7&<8QWO MF,<]]O&/@1QD(0^9R$4V\I&1G&0E+YG)37;RDZ$<92E/F] M]O6O@1UL80^;V,4V]K&1G6QE+YO9+\;OLZ$=;6E/F]K5EC9MH0R-9F^;VVNF M`"].$&YQCYO[X1UO><^;WO6V][WQG6]][YO?_?9W MOJ4P;^2X.^`$#SB+>NBUA"/=:E/G>I59_HHL)[UK$=@%!'P>M>Y MWG6PA]WK93?[V=$>`1G(0.UJ9WO;U1X"2T1`[I:P^]WQGG>][YWO?;<["@"? M!L$#/O"$%_SA$9]XQ2^>\8A7PN,A__@^3)[RE;?\Y3&?^5]L_AX]HR+BUSB)T=YR6&/?O&/ MO^^&;_SYT9]^QS\^#9'O@Q(F+_G^S,^?_I;G?!]^@?]W#TKT_<MO?!+#&Z!'JH"!5FP$1WQ$5T0ZY`O$F7P^;ZN!FD0 M$W-P$['^SP?ASOL\40CM3A2-L!2-L`F;P!(&KPF9D`FA\!77K_VJ4`LESPKA M3PNWL/[R#__PK_/"L//&L`R%$49$Q^#4L.)0C^,TSO0P;@Y)3N56#@'Q,.;V M4`(A\!I;[0]%H))<(8W2J(RZ$8V$J1O),1S#T8R&10S.L1LI``$6$?@>,1[E MU\T/NL;^U&D11-,2'%KQ6;,/$"#Q8A M\>D3(S93`']S$3H5+Z>I`JW>[ZNL\@ M$3(K4=,2MC()[>[POC(L(7(L#Z\B+5+^Y"\M-6\M\Z\MW1(NX[+_B)$N'<[C M-,XNXW!K5*\.%U`!3ZXY`9/FR"@P\]`/;?(PB^P/Z&$-M@("<`';6,L=3]`R MQ9,H\3$I*7$SH:\I/W,3!U(JMR_^^T+`^ZXR-;-R*P5/%1^2(6'S%=F/_;+0 M-B^2-G$3\[JP%SD/]'SS-T.OX(I1#0FP#9G1#92 M`OL0UG+/):QSR/X@%8[A)2C!K7P2/!EQ/%VT$?-1^23Q/,?.$L'N1M>3$T,3 M%,TN%.>3/K$2\.S.*UVS(<%R/]%/"JNP+"N2%@5T0'.3%_'O#J@4&!74_T3R M#!T4&=F02P]0"DCN]9RS)5\2)J%S`M$T`F.M)D44,7],#%0`'>#C"N[!.R.3 M187R1?6T^&)41C73$OW1,[_.*7.T1T?3^@I2(.FN[KX/2.M3%54S"8VT(9%4 M_<;R4@/^]!:=%$HUSPM[L2UAX`X2]$I'CQBUM/36L"0]CAE1[QDJU#F?<3G] M\CEE;B;[<#I?S3#ME,>P\PQJ01@D`!T@TXPD\P3S=$^1U>I@4#.54A^9,CT' M]08+=?L05?MVE.V"T%%384QC-4S^%7!?\3!-U?1# M72U$;_+'$"$5(&,*%G97R:A86S1BK=8H,Q,S9[0?R:[Y9A!0-38@K?4]0],J M1?$T0[84[S,)7]-D3U;Q4O8VGS137?9E>7$M0W7S:G9!T;!OCW%5D['B(#3U MP%0:@[8E-70Z"=-?^1!$!W9I>^P:8D_L/!'[2E,^TU8ATZ`K'_)M+77]G-06T;)NU15F1?4M:79OZ6TN"4XX M23)P)509-ZY"$1=QG3%Q.U0Z.=0/'W=$=TP,T$$?]"-8&S:8J/98-W=[(S$I ME6XI1]=&G35LJ_50J_4'0P`(?W3^=8EP*T=V%9T0=AE/-J?P/VD7"VW74RE/ M9CN/_WBWWTX5>(>39U7U)%7U9\5T+X]7>?^U7R>P@5^-32%7QZ2W%O2C98`K M>[=W@[]W8K>64)V24$UW6@?R4$]W[>(39-FW"`F/2"45+-U6?B=2%J609>G6 M(O/7"PL45`_T?_=M+@ON5'.V2PUP<"4N.1LP0S/T&9670R7P3#TT&ZO38&U, M#+@`/GI"!%R!BL](@SF8>SO7!9L5?-4S4#M36J&R![N.8TN7[1AU?5O\%3Q_&(X7&6Q+-%R+.U2-XY+$06:P"OON(Z;\!=L@5(1 MCPE_`1;"L@_V./)65@I_80A^(9"5X)K3]1.&8/Y^P9OO=BU_<5!V]]Z&X!KH MK=W6>!N-E[!5#&!=PC$X)(@>5Z-D%SZ8`A?^X!M[RXM34`:$,@*4CNU865F/CZ-]@:/[=.M\ M80]\0?NP[I9YF09E8!3`0!.:`(W_40A[A9<)TNYN.@*&$&W^A;G\`H]M\;,5 M4:`/3F$%1L$#BC0-/,`#0,`0I!D6^X`)+W46+?(70@`;%"&;!12KL8$)>!,; MYH$W,0\;\*`MTW4W.=+_U(`&]&#>[D`)U&#D'@_>E.`.A@`&E$#@$*Y!(^X. ML.$4EDELAL`(].`;]%EP]WEGAP"!955,E9CFRD`/(&GEDL-L6O*U.OF)HSB* M(;H8O.C0E!9Z:RRB<4<"M*&B6PRCB6\/M``.;""VX4`+8ML&JB`!9."CIR[K M?&$1#*`(%L%[MTX&G"`;CD`+M"`(@L$&X,``YD"6GP\>\`$`#,$#1CI'9:`! M#```W(`-UAA;M9N[V8#NSA8K4Q'^2-W7/H^9(4-`%0#`#VSACJ79`Y@@"@!` M"Z!9JO$!!-1`(M.@9=/`!ZH``+BAOZ]0P`&`#-3`%D`````@#]0`_GQ1"8:@ MP0&`!B)\G/DWD?W-"/P``,Q`WM3`"+C!!O`!'\`A`]Q9$;`!'YHA#Y2`08W1 MKQ,.!JZA$AS<"`9;!4BA$LP``#)`:^*0>$W29Q,X&EWR&4FA%-S[&\B&YKZA M$%X!'X+A%:SZ;&GI@#U:@"D1:MZ/N^&0@&0`@")J@8C=S%!8A&P!` M%09A#_;^(!N"```<8!!>.J6+``#P8!%H>A-EF=$3``C,-P(T`0"B8+Q-TR!- M,0T&@0G.>UN)^8X)CZ@](`K@@!M^P17)H!45`0"$(-=?40VX`0"F89G)TESA M#P5^H1D`X!T,G/+2X!<2```&00U^(0/PP0:4'?^,8!#T&@:P/1A0`*WO=JW[ M3PE0P`RJ@-X0(1]\_1/<&0:&0`E4H1@009[/<"3EG0GP(1QT%FN"`0#*0,CO MDEXKSE4+%VC]4AI%1P@`0`D*NN1NX0(`X`*&X!OJNA3@8),=V&P(XAJ^W,:: M`1_X`)7[+)1MK&FI5R8F>+4S=^EJ(.9E_ND\80[`@`VWL%'+P!A+Y9OTX&>@``JD#[%J$)M```;."E1P$(\'S3:U2$H_7K M%F$0`.`(@,`SOQX`$L"[K6\4O:[NTMT.KN$4`&`8KH'#80`.F""OZTTD<5;>16>P"TX,P@$`C(#@!\XNX;`DY1#V M_)FP56[@Q&"[(?YG34X*$*$4`$#^#VZ!`F_!#3)`>N10F4Q/:X!A&'3@#R@I M&.G+TZ*A/%'*X"D4YM!%18TNC7!2QB)/GII*+2IU:/\.WCNL=V;@`/!AR[N2-$KZ]$D#XY,M1-,`O%.C9+V:3T/HX\6O!`Q#N/?) M*&;@@8@:?2BQ7Q^_/,C@)Y]<,^`=V<6GX(2?P,`A#'>H<4V(%'3(815FD-CA M'=>``T`SUZ#(H0,TC"C@BT.$.`2'4@CXAQAB4#"$%#N&<8V00L)``2)BW/(* M`&6$8:08B"!2I!0J6&GDE?U-*<80*EP9QA]02OE'D%\&*24BMP0#@!)A#`$G MG%(@8A280"C``"*``.D0+HNBB!2UZ MBX\$03HIHP7YJ,*2E8)$J4.(:6I((Y44 M4PTN2'!%K[68`U17OD`554X[H42L#*OPD``/#115PRI%+#('(%'M442SV33E M20,KN,')'CQE,P<::&0S[!X?X`%/4#UDZP8>7Z&T`AA-";M($4$T`(`93D#% M%EN*N0677+XL@L9=FUAR,%]^K=7$*',DX`8:$<@`V"B+[.%'`M,,\E=DFWD@ M`QD^S`-/,AYHEH`[/B10!%V6)`./#PTT8#"*(!`"-E`G M8P,`<."!!PK749<,#SR\TUUXXX$D,H M,DWBBP^B(`PT8)/&+Q^8`4`X/H"@AN78*)%='T/0X`40>1CRY8Y_*#!,,PHTXR24@((P33/%`"GDE]U?HT0EPT2!AA1AJ!`&#*7P M@0@XS92"/Q4$"1'@:P8YW-"F-\5I@'7Z@Y&D0`I6#4$!.BA&,% MD$(E[I+^CU.0@P*LTL$PAE$(CU#@#J4P@ACD5XF"@&,8^5``.01R#5*4H@P> M$8,.3YA"@A0"',`@QS`NP(<>\H%ZX"#'-Z[1JBA*D2(.@0@E6!5%,2QA"AJ9 M@C[D\`=7M"HD!;@"KF"BJXU,@8O""):PC&*L>\G$`"DHFP,`\`%/;.((.IG# M73C1CDU4`1#9,```#"&#FP#"!A^0331,((,>&%(+0(G`!U21C45\(`4),('1 M#*"75=SE6<+Z2A.J@`8VF`<-9SE)P-A"L"H`QQ)L0"`^,-8P`.#A+$T09!2R M400`"$$P&FM`-(K`C2!D`1ZHD<`4`7^I45@'IMAPUJP ML1G7H`$.\/@9`*@Q"&R89QI%(`,L0`"'>6B"+-B`10:PH0H`P*,*.@'"+$>1 M```XH#260*`!+,$<:N#C`Q[P@7E.80MX+"X:V,"&W``'`B&T314T6([>O-.' M4:B""2C(9S)@\)WUV,(052A;,/A)!L$-@:6G`($!^/F.(8PB'P#(PGKP$%`# M6.$4*%B<*@+D.#_`X13<8!,:AO`+;@@!`-C(1S#P`3@8F*X89EC=XIHQA#NX M#G@P4A&+7!0\.-#@&F6X@-O`889\`D`'%"H#'$JA`&[Z`!%MQ6:08'"-"\"A M&#IX:?F&H`0A7&!\G?-2ENS'A"K^A(,<'Q2"`(M!EDI5KC$-?!3B M%$*H0A:^H<`XSJ20(5`"5E,P MXQ1M11*3H-$%L,I(&]\8$YSHY%X2!@0;/-$#P'G"%PW(@AF*L`DXK$(&9K#P M(I)Q%VIXX@/1D(H[XA@6;*(D7U%@@PSX>10V&/)9D=2"#8CVQD6L(BZ+D(T- MBJ*6M03^AF`IR$8#&I"-::A""\]:RUYT^9<(F,$`[L!-3FQ@B;"HPA#N8(-F M9"FR(_C3#=CH<@0R@\UY1"`#30K"TE#,`\IX`,_^C(8/Y($;-Y`!"/(P9`CD M89LJ?.`3B.8<$RP1@B"HP@W4"$:>9WD95<#A,K^@1C1A$8*H^D$>H_!`?4#P M"^4(LSI,RT(5XO8)$)3%%L?YJ"W\(`0UV(('SDW/>M*@AG<`@`;R^05,72=L M8G_B%]&P#ZU18*+V(((;`$!#@I0`;3.T9P@^&#:%KM$D$.2(+\'@QB<0P>M" M#$$-S>8/(IK$AQRI@:PH,BOQTLHZ4AC!1,,PPA#T``!5E`'^$10#QA!N48I* M_($4W]!TCL2@@S9-20GY+(,*_A"."P`#$<`HK@Z@BR48B,&0I%@23]\!))Y2 M=TKP[A,X5#&G6Q@AX*A=X`"MD%X=5*(2.GA%/K([A(G@0Q4*N`4I7D$*)$@! M&*4``!^`T:=@E`(8MP`&FQ3`*O0V@P^5FNHW;J$`54CI%F5H!G2O@=[ZAN$; M`)BZ&(#Q03]`EP]O'50Q`)"/'N%CZH-:+"+R"_@#/X2_!D&$/?[!B(X@Y`_H MJ`47,S*%)=BW5`@^(TIT)0B-F./!$(;CA&$B@Q"SBV5'\4""\B"-,: MQ1ZRD'LDOU(P;P&``0S@!K*HH@A'L;+#AB(;;D3,%TT@"SS<$055)"8P"0`# M9B3C#D#@@3*089D\WFP)?@Z"#?RJ<3'+XDVJ8`,9X!J#\&@>T#:*$`)`@`=F MD`P-P`W)@%5^T!J&I`GN8`FV,4NAAD":\`NA1A:#L!H)<`H?:`O@!`+.,3=] MH!K7@0^(E@9SXQP?A1Q5`#J_H!EF8`3OX1VV$`0V\`G,80OH]0ZN$P3!$(0H M,`2\=A\,H@5'U0=J\#>&0&M]8`MP<%0P8&Q!@%B.0VWX$!^RAB`H\`E_@P<4 MH`;-X`;^<'(-`84])7(B934\:&4\R",@)@(G(F=(E<`D9D`.4/0-V",%0V`& M51`D0U`%PW`+8@5N3L)6JE`,3*``&>!60E`E4:('0@!8MV`7Q7`-?\`7A6!T M8M!TQ0!=9O!S,"`%US!5;O(,"S0G`"=U>J`'I2`$/S>(T44._?(-PT`#("<& M/(5U%,`'JI`'?$`.9=P&`_;/<*/P('^/!U8F`$/!1X[V@JU[!?E`!%#2$%]S`%M>!XY$`K M`^$*?_`/C@=Y5_`/_3A&(I%@N>("OY(15S`%;@1A$G8L,!'^`36P"-D0!6US M+*7G>V#1-L%2%;ZP!RD`!VYP?2?)8]DP89[@`S;02AKC"T7@!OQT?)T7%0U@ M!GL`%8O`:X!P%M.W9&]1!4L1>N:A!T!`[5Y.M'^E)M]``-&D$]K98:Y688`4`F?`)S7<`=. MPT^*$%8P0&\D8F]TB"+'DR/?:(@<0@%WQP.W4`AW<0%,T"6J"`-FX``W0@-S M)08<<@W%-7!_$PY'$`[UF7&.E25!%P;^@U6>2(H`P`WM^0>E>`O"9HI"(@9L MXB8V)P6Q7;AX",L8@:&\'7P2*2D M4D6$)Q!_0`]GH`]JE!&*UQ`/T457H`X&>9"WHF"71P:Y<`9=>@80`)%O))%R M%$EN8`/^:%!Z/(%B$RD#9`&1D00`*V!C5"$46!$$>,0&-K!+43$'00`(>\!K M-6F3/+EE-F`#!C!59D`-Q!(P05DPKK0QG.,&BT`7W^<+^O>4&L,7;@`$*6`& MZX<8,@!GDA8-(',Q7]E-8FD7:.`._9>691&6EH!/_8(':1`!DXM_F; M]7I4QQD.N9D=:H!5@R`[NF20#`,&01`V:C;?`=F9@/QO*4U-GCMDE!FM[(Z?` M3ZI0"D5*MPR!*E:$16(P#L?@D%-*"08Q8)HW!;R`7Y67I3:)N&`11Q39`]%@ M`$*!>L>RIAL&%G>J"??2`Y'K"<'B!`)P$M0237LPD9Y@-`VP".T0!0``28@; M%F:0#4ZP!['K"W?*2G+Q2@03#0+^0Q<(5`7>UQ>'81[<\!>EQA>```3-YI3K M-PK)L`AJR2]:`!J)`6<)P`:JBD>P`);_QP-L4!I`0`V+,09=-$`+G M^Y3">DX::*R6``N+\P&#X`:?L#B:,`WP``LH8`G4VAW7JJV7*8,HH)E",(/A M@;UFD`$AL!8AD`&<,PC+80NR=@&T)J_UX:Y_XP>^-J_XL9M'=:^'E*^\*6O! M8`NZN9NY>@W%J03'F9Q#(&49$"+D\X;2^;#4F<+IA;$=H@+?4`49D)T7RR%# M0'<7T)X4(`5P>V_GZ0`D>QXGVX@9<`LE*P9WL",>8B4PNXI\$3L(U[/7\)\Z MR[,^"W#^'R>T"?2*JH4(36;+NV`G$GE9`"`-`!V56WE[PI@W=% M`B$&H7`&?=M%$E"027H/`MF0HWQ?9)20B9NX8PH3GM`V*!&Y1[&F1>$)O#:I M)]$.'S`'B\!/']!*[7`N38&L!L`)E"H#*ED$;,"\@!*2N:H<<$63@`$DY24O[L(?%0$E*&I^N0.AC0-L!`8[H`&JV!FT>0. M;R^9#!ENSJ^L-"6[6S^OK"0#//PE\/* MOL;J-8"3`-S@T`"@!6XP"L^QOXM#F?[;!P(, M(-2&!AF$=H:"L=-)(D*,31!+`_B`L=J)L6&PGMQP#=_@GG?`)D:0/Q=[#=06 M#(C@(6)07!D@!L(F!#&072+7)#4' MBW1"577@6*O(`^N$4QB,0H&P`VK84@= MW;Z%V38)`&J_P,[2&IG@A-&521WGBP+"E+]H`SAJ4&O?\8%FP`1Y,YK"9@:A M!FQ3A9O^MO`)34(#M@`#4S4/_!'F5(V:0[<@0V"&B)`!2F`+6F`&;8Y`AH`( M*SQS/@`GLH8&N7D-LN8#4?RQ5`(#9ZT"C@,'5:`"P2,@AO1;'*("UX`(P8`- M$XN'.7(+"6"(89`/W_`'2G`++/(-7E(>1BP%_`0"E4(!=ZH$+\)/!J"T^5`* M#H0EUU`HK\`EZ-5=%/!!*00#B/!![]">G".*?V<>JSB(1?M!4T0>5W$"_UU8,M]N,W]1IX03-'`N9[0EE4P,8948JNP"0&GDU%A-/W"3VA0 M%'<*%\VV"I0[+!I.J6"180``"#)I'E$`",HR2F3:EI>+%CWA"YRC!=L<,$)V M%VCP9!_0E@`0!8'A"VSI7$!P,++!T4VC"IN@S4V`0-A$DT,!#SJ!&DYP%V"P M&,F@"JH`#W-F`Z]`,A'@`71E6&T`SKE`\PH`1W802A`R.) M3A:G@%3O$`SAD,,GW`RD,`0OEP=!]U+D(`5*``<;.W,`0-IA4"@`X`>G,`S\ M-`Q)!!"%5`$``$<5/BE#I*A0D1!&%0##?#03`J"9'RD7`)Q"!`/1,`"5Q(0I M1#`?.!X0IY4)DW#(2S'-``CA0XZ<(B:E`("[)45+,#%2PC`Q*>4/.`#A2OFX M!8)@00`VKJE`%`Y`H9Y5`>@`YA2&X-"5/8\&'$B14O9MS8<6(QN,Q=H40AL8HSYC1K MIGQ+CH0IFJ?HR_3G\>DP8A!<$42IAB_8L67/ICT[V2HW!FP4:2![SY$45<`L M.E*E2(\5NL'LB2T#C)8403XL@BW#UPH'T3]XFNTI@2;KL#VAT:+*P)YL56QL MDM%#BPUJHV3+6&7``(\&X67L`6,_6)%D9!AE0!F%HE@0&X2 M,""!;!Y.5%D.@QI!77H$G!#H;!?,5;*CI@\X^F,"&T%?0,"(--9AX114X M0$"4#".4Z/13.+BQXA4R4##"!S=>P2.#7V"XP(Q7^G@UUEEK16$:.!+%0XT[ M8*!A&C>&><=89'EX9XA3\$DA`27><>"5#)2`U0U-8?#V6V^'4$(/?(1X)9AP M3KD&7!C,J,*0'%\A9]TA\+@@7CU>,J(2-]P`1PFP:`CF('(N:(8<&,!B(IPJ MJICFCI886@BL=X1(X94RC(`C&)O^F@DG'R:D4&"8<"X(60P%@@R"CV&&442H MEP@SHIAPPGDEG`3".2*<8)HA18Q*7FFFD*#RJ?D5<()*P`P_Z/J#G%<:SJ

RRA!S18QQKMALLU2$69PRP!M3C377:K/\\OD\\20" MVKB3@3KK0/=DD==D\\2ZTV>CSI?4::N!\_E"ET%V7P2&#C2*A!VQA M"PV2D$\GM,6D)N5!4]D"!6IH81^4``,UB-`6G!K"+Y30AY?`X(=`[,,G8-`' M&'S"B'WX!1(_\0LC)+$/3`3B)X:`Q"H.X0YW^(0:8'"-#WY1BVJX!AC9=<9K MB$L)2B@CNZ3@KC^0XAO7"$/"8#`$1(@+!D&1PAW+J)`^TA$LZRHC0V`0AFLD MY`\*:8C$&B)(1%AF"&5,BQ@2V1"])%(A(QF"7BH9LYBI8`C^?Q`#(O1"RC_< M`A%A4,$U;L')U"`"$;)#SHR8:?L`$HB/;9/8..8G;" MNQ[T&-H]`BT4>K-[4`1ZI-#9F2D"(>B11;NG48MJ5($A_=^9.&K2DRI0I1!\ M7YU46*8%-FI.$Y0@"6GZTILV2@DJ'"*E*+73-=KPAT%=XQ"#.D4;)G6*06UB M$Y50JZ3>`:H__%92O87$(WZK6-[^VN(9SU@LAJC`J^VJPAV'X"TII/5;"DE8 M6OO85K6J%09B39C$)E;7M-JU(0EQZUX!F1!1NG4(@>5K84$)2K6<^??M;X`97GOLD+N^*N\^*,L^@R5WN]9S[ M7.A>#Z&SHRY%K3L\-+'/3"E5:7>]^]WO,I"E$*3I3%]Z7O2F%[U%W2E2BRI4 MH0X5J?.E;WWK^XLFTK=6^QUK?_W[7_\.H0IP6!=<^_A6`RM6P8EUY%[[NI"] M.CBM+PG^ZV`I?&$+BQ*4SSALASO,V%Z"^"4@UFV)37QB%-?RFX53C!A844[: MFN,8]%"G:B?76^'F6,<[MJ=\?/SCV"!W>`ZM:)&;&UTD/Y>Z(6)R=9>\T3-I M%[Q3IG*5&=A`\=I4O5OF\GF!NL8TR%>I2CVJ?VK715"85$&&I0:QK"'#1VSS(X8F(M&=(H=_6A(/^8: MKA5'.,7)!Q@OSK9RR*UN;UPY'H=:U*$>J'%]3%`A$[F@#(5>DEW=Y"5/-T1. M)FE&JWQK7">0@0QTH$LCV&5@JQ?,7XXOF<5\9F3?EXEI9B+^#'ZQU3='^\TJ M,`((\(`'$'SCK`BN\YWOW,@\@SNL>P[LH1F280L?6MV(9O2B26S92,=;WHZ. M#.%BNQ@19'HS4^#%B=N)XU$'7.#WY*=Q^UEPY#*OU0MG]:L=#FOK=H^B3`Y1 M^W)]<8P34(5R,F^P/4["HM*IO4DMLWR'F&R4KWG9^VVVM%T.8!50H(P%CJL= M#^QM/(^[D7GE^;CS*NA0AE+0A%ZWNAF;6<0T>MY+9SIK!6=OQOQ!&[4(S;XE MP&E_\Q;4`^=ZUVEC\"";.N%$'O(_C_SP)$]\UM5=7XA"$`);2SGC

OKV6: MTX][/.0_+;E1RXQR9.-WS<]NHK/^\?MRQ/L7VC>W8X)QSG,]3ZS!$8;PA`>- M[G0'FNA%]S!DE0[*IH=>])&K]VMKC)A^.&[?M-TXA\%[9YWZ.]4Y&&&[U"M/V;` M![ZIA??6X1/__?^ZU>:.?WR#*__SB47^&<\X=X4'2V@-;Y[SASVZ9TD,V='G M7_^2)H]!1PU(#LUXL(]A=N]5ANR"40[)9.X MZ9(XZ?(HB^O`Y$N^79,3\JJI7X,^O6.O]R(SDENJ[$NVP>,^P:L5\)O!,V(\ M<'D\Q0+^-P9#O_.3&'33O$(3NOGKO':KOZ.#M_U+0OU[.LJXMQ;#A2N8`L4Q M!C%PPA+[M`1<0"W4L08\.`<$J(1S+N(JL@JT0.EZ,EJ+.XL[O@^<.SE9H)E: M/KPS06"3OJ-*0:/"OA9$LQADHJW"*AH,Q!L\L,;#P1W<.4>2O!U# MOR&D/_P[POM#0B6\Q*;S)JAS#$K0`!&@AU6B-P0H`,K(PBT\Q>`JN.7I)PAD M-5=T*.4R0]^[KK9;G^M2PS9LPP>:DP9Z/CK\N)!C+V-S+Q;<0SY,,_PJ%JF2 M04$,1/&+*T-4,#X3-T6LQF=PB?C#,*!+MTC\L",L0DO$1''^C+32HP1+2PQ7 M0`1C4(?4<(5'PT)4C,=41#7>$:CB$L/D6CA91+)8NT7BDP&XHZY<_$`1M`3^ MF:`2_,5@`[,P"[.3^SOX,D8T4[/"ZX-B8<9FG,&;(\1H7$1%G,;S@[#UX\8, M:[^AZ\8/TD$E$>;S"<'Q#U6#$-]=,7=V\?HPL"V MZ\>`M+6!I+M=ZS4)ZCB%Y+)@=$B2N\.(E,C[&KQF([R,=,9O(43R\S8)2S\= M1,1&^K,+`[KV(TF4'#%*M"R6=$FW?#1-;,)+A,>;K,OAJL=]TLDQC,"STSV@ M'!ZVTT`-7#NXRZZC1+Y=@\.FI$/^.Q1&^GI(JDPY*@+$K-1(\>M*G#._R*,\ ML+2\]_M,0`LZM(S$261)14.-<'Q+U62,TJNTN:Q)NXQ-?1HHG?3"O4PU6/1+ MH(PU6^Q-)ON?C#+*P[PX7E.^FG*IQ73*AOPRO[N^8HQ,-5NY*3JB_<+(RGPY M&\3,S/RYR=NY]-,S("PM'2LTU1+2EQ/$^4F332'*1`!%FU1%WU1&(U1 M&9U1&/23__T/24%T`1BPP$] MDRO;18Z;T@/=LF%+P?H2LY.+S#[L/B2"-@F5MF?LR.W$,T`;M_=#T[,,4=`[ MM!-]T[^9-$'@C/BL4SN]4SS-4SW=TSV50DI`H.%\'X.$G^9['T/E'T1M/A52 M5.>K4D=]U*;T@)?Z'DD-,P_X(0_H@TLM1DQMT!;,K^B"_5>#/5B%S20KO%>'?5B(C5B)G5B*K5B+O5B,S5B-W5B.[5B/_5B0 M#5F1'5F2+5F3/5F435F575F6;5F7?5F8C5F9G5F:K5E\+5A_Q=F#1=B<[=>> MU5F`W5F?S22;+5JC/5JD-;%^:%>F;5JG7==W35JIG5JJK=ID^@=]`%:MW5JN MW0QA_00]DU6Q'5NR+5NS/5NT3=M9-4F=2U/-4].R!4W0S$:ABS_YJU6\S5M; M9;&!4'YK71V)O< MNBPU^_PQ(4NHA&*X)#W#6^QPC% M)(P,=YI>ZJ5E;SNHCJN>< M7^F<(ONMSAM^L]O5SF^[4+WJ,QU<"/;K,+,T8"*V1'A38"1.)FU8XM!S3R=^ M8B@&,MO37#$DN\W=330$3.%;PQ+VXA,VR`52U#%F89UZK[];74^]W]C-+QM^ MX['*8=R5QN^D1@"VV\PC8%H-T6_DVR(.9`8>Y"NX!R:.M,,)`V.@A-1B)]A$ M9)L4NYW$WH;37N[MWEILLN&[Q2@+74O^8O%Z($WV13)F3A7^W-(\;%!2UJ^N M,F4XYK8*Q4$,C=4>=@G`$F*ZY>,^7DOTM&5T;.!',P,A#+CFV;SQ3(#=;Z$1%T[;$CW0N,8]F9DS*\C M`E-QQN'$VLH=IKP].T0'Z]W0-,O/=.>BPS^59#1Y5@QZUN5XZ^5[N(("J`4Y M@(QA_F>`IL>!]D+HXD_<9&81CC@`G9V`E&:'!J]JEM)-)F/5I93Y8MVI].;) M3+.LX]F>?/L4'+#5D;BB%N\V#1NC^H92UB%O#+FYJ7:.IYBLO3NYDH$H#^%U! M&`[E4?7#+\7?KG8C'7;5'0[;5N;!=>9&2+R\O37"P1W7*9I2#O<8U"< M*R"';#H,O=[K!:R]*+Y'#E8N6'1D2#;L$%Z?PJQDQ483]#W(%9YH2!TVJ$SC MYK3L9;O?9\NJ4MYL\@-K5=;,L/W(T3[)RP/OTWZW1(OIQ)CIN#ZQ>\A:0<@% M7/@#=^3IV*9@W%9`(\U)WNYM@C9JP;1%P:2H'MDNX3QN!6J47NPXYG;4*Z7J M8HLOB`QE4;9(_L+N4QX_[<[!'A3+"\VK:^Q0/39ME$PZ>`9<\PZ#MW;M$W,% M"I`"==#^`"G,A26P9W'JZ?K6PMV^<<%^Y,%&NTA6NV<&SO8Q;H=.RO>1P\=^ MJ;%3>WRHGZ0W736T?LWAU_.%KSW/\N[L3N\S^'J8.DH`1_ M5(8L=!A.4"87Y<([]BB72CKK@@U_7N\O6H'G07 MGDH43&.-1L:.EBJN3G:1+L0+E\:P].&>VZL\QKR2U$9;!7/`S?;"/5Y/A^L2 M.]XO@%S.(`P^/+QG6T:"7]7&*V=#1.?^A%=X;)Q;PDII3&_I>'9IBI>W8$Z,QJ]7 MUOYTU=+XMK"U@FXO)P-S'V0WM$=WY9`9D[JYF$#-FB" M9X:U7`-*V"%O\G\?**./7`"W8&=!9R#_-@QXPD>WOF=\$!F@!@U*L*B"#[VR!`X M,(+"A1$>0HPH<2)$&3(>)O1`ID@1,AXB7+080H:EDB1+HK1$TH,'()9"I`S1 MT@/,E#;^2WH8A*?FS9LHTEAJD@8%T:%%TR!-JA0IBE^P8*F)&M56GZ56T_2Q M%0(>BCY9MW95TD-8/N[%G*LR%#5)@^ M?3J,F#(@3*-.'3LU[=JVAX0)@QMW;M.ZAX@1\R=X\%NWP[CZH^W*E7M_OC*N?;FSJ@0\UT,@BN"*-7P MI7\___[^^1<1A`$V&+`*&(/D]Y^""S*HWR(K`!!-?S(TJ*#^#P9@"$@#%/HB MPQZ`&!!,$;Z,LI]`#$7@"QYP`-"`);Z@&.-##E%4(T46);1($0G,8P8`AA1T M$4@X6F13!);L`8\;KQB`1C(H1="`'P8`PLTH/=D4#0!^P,(3EI:@T$10/Y%Y ME9F6D#'-*VZPZ48X;AAP"BQF(M5'"(94`4`(O]R99PA5C34669.]U0<-AJS) M`S=&T%5H777]`L.C,-RA5UZ#89JI"IGV)841V)AAQA".8;;8-4KH$=U)44H4JTRTG1C``-'/^"[?6DENNNK8H2@9I7E%EHPC.(C&D/([6A<2C`A*5UYX<6IX(`I MD<&F@RM!CJ^C-L88#-]ZY8I`B#'OR7A$*(M;29Q\E_]40OO@,Z@A`#Y[HQT8V*21#<<7O M\R=##S#ZXL0B>`"RB!/P=\@B'HOHIT0RP-D@`-@QD96(#0E`V8M(QI`30:1C M-*H1R2S"D$78(!J6&$43,G`E"PI)(44R$AOP`(!IP,)G*`F!`Y@@II+4)`1> M$I,B/'`3&6()*55C"@I0DK40J$(5*%!#7#Y!C6#\(FM(L<7)W*:$3P0A"UU1 MBELF0RBT*,$60@``#=101;C)[8D^P,8GE""INQ`J4GTAU!W^_A*X/K1Q+W>! M(U^4<(U*&.(:@>-+'/_2QB&8H0J,6TQB8$"!=P#@%;>@@&?"``QL`"`?8NC< M8C2SE\Y@\I*;V8QI;+6:(:@"']=`#6ID99O,T(9SJ93";G@C!3&0(Y&W(`XP M='`!W[$R#+G436:4PRW&+0>8R+D%/K:E2^+EYAO*&55S-..\9WH'>N617KFN M08I<7&\*M9`#->UU#'SU9P]C&./^F^`@"UFO5```@C%)9'VC$).,CV[.LYH_&(=:KY//*ZN;G/@8YQJN MR(T8BCF=^!)OELDQSG&N@9SZ"AB:"GZ>NJ9Y+@JL00)3P!XKZL6]>^&'/S7` M@`2N4(M:2,`<>UB0#&P``!L(P!-.$(`,/A#/#@E@#BM`0X?TN8H5K$`3'+(( M&GH0@3FDS`F>&$01U!!L4 M(;4(S,,03*`I2^"QZ9+\X@-^*((B%,$-#U`#;,E`2@:X0899][!+:"@"/+!" MUJ3TX:RJD-E0D#*GK[WC3VGXVB"4#0NZVC6P;?L%#=Z1C'`>V&P6W MP`+@'8<=`C?><0T:6.$4#)OLA#XK8U#7FK0>"]^7.J<[-$0.LRT1W M-'^PN1YT(`7534<,A4!#)9A`G##^D$,13""',L/P#=PIZ%`-YS;M+UK!& M#,50I@Y>-4INZ*$4Y*@7=\=^"P540KW)^0,YTCXM_A8S-SJH!!_8_O:U\^84 M12=%U<-PBPS@0>W'63#CT?6'!K.+7.%!ASXFW)Y<],/"Z.D>./=3`Q<(8L(3 M%L:(%>2).=RV"JNP2/WV(X,&5`$0AC"#`Q!4@TW`P09H<(.3*80&+0!@%2:N MPAX:Z@`P``(`!H#1('@`LD5\Z&1:2``8-E$P+23#8H!PP/S^LX@H`,`-`/3% M(CY@!C!WB`=F*`(85%&%'E!HS9NP!#5^:@``4L,/X=>?CH(PCP7:0)I)Q)68 MC`'@P4;^)<"@`<("J4("'`$W%`1('`DU!`$^H('S&4!/1``06)I0I82F>0`3 M3(,J.$`#!$&>F,&FP<,6^4"7I$$3&,`KX,$T:`L/N,,HP$/1N,0HF!`^\,DO M^(`0S,,T%(TB],&O6=4H!-&>I`$LG`*9,(&)<8,:H``-;-$4H@"XV94:%!.C MT("/X$,&3,8O8`,<9,!;F)%@J4$?O,,K```V^(`6J$+XJ8$1^,$6"0$/S(-? M\<`K^,"W\,"EH(`-3`,UX($9O$("A$,&O`/15,(%W)88!@,^@`,DOH(*?,,% M;)$-#$,E7$8SA`,X;-$TN-807``^5`(/"`'MS19?L(@>/);^R8G!*=R6$61` M,SA9,>"#CPC!##/.!!-"SC M>4F!LV2`#D@.*/)!(=Q6,W!2&(1#,$R';XP*UY67?$Q2(8Q2&!3#%A6"&U9! M&!@!/KR"#N#B!5#+.P)`(>0#70%`*9P7(@Q#,.!C0$Y2?YG!-[P"BZC"VD%= M.`1D:H5!,#2##N2#&>"!N(C!,+B!#GS+,#3>2(;!XT5/MXB!*[B"YB6'*R!" M*M2"Y9G#%8Q#-VT>AN6++WS>];0'Z3&(#!#-;1F`"5R$?LB9*A@"2Z'!B5G$ MR5##/YE8P"2#B=F`\%6!#"QE`;'^`=&``?31C`VH&!O0C"&X`T&LPHF-WR(` MPBJT`SHU``"H0C)02#L$0Q2P@8/D8!&X@U@"0`+:ST:E3!-\S/W9SQ[L7Q-H M@ADX`1NX`\9$`1!,D"5401"P@0>X@T,EH-``02"Q5,^$$!#P7C),%?AIPD<$ M#0<"U2]@&E$9E5EQ0Q9$`P\D`RSD8!3`@D`LT`?P21H(@1O(`RQ\PCP`P`K, M21KHH"545=&PA"*DH#Q\0@X&`RP@H0D((8Y`,`Z("!D1<-W`(P!*DD78.+*H)QW$$5F($1Z`9TB9(4_($/```? M&``L`2(%QN&$&)(M$AD,Q3!*+8`=!.H`8W`(B^$C?]9&`>G&@O/CD3X*!C]R6&\"?`"R"&Z@"A_1`$'"" M11A`%70(&T#(QCP(```"&^P!0JC"_2'$!VB!CGG(B:F8)V!I$>@/^9W,AOC" M5#8(!@VG2>V!*KQ8^:G"*JR481*F_%E$TKP"`%E"THC?(N!#_F1?-MQ6FBV$ M2IE0-@!01S69H`E$(#%:2"0$$*B?_**`+4`B%D(M`&!A>9+^9Q=6A2U\2S)(2@@80-Z@WJ^@F\9 MP35DI!$,P2VHIP^LG(LR+@PH@2H4`@R4@0J`B22P\L)*4>60C`XKW\=AQC`@3&]':;"5S-4 MP3<9X+\*0Y#"OY]$`4S"$`F`'\^4(*!$$]#0F,C-@BK`(/-!FY)E\V4(@G MF```J*O%L)[\F*N0G:6Z[L\B+*4!^!,8K,#X*<@BY""U1M1$D9D+LT$R%(&) M]2M@_JOR"2S!`D&]:L&`V(`-P`$<#,(&S8B\/@E#>`#X`0)DRH#%8JP$;M`H MP$(V``+P?>P'HN:ED:Q1`44$^`I-]$P@AP`L0%+,>@`<.`!-`8%_XBS/XH-+ MI$$(%(W1>ER(**T6P`$W&*U2(*TJ9`!24,,T,(4MZ!\W2.?^U(IG4T!;53Q; MVV0M+;J!&M@"'OA!?&*1V'J1O@&`VZ8!+Y>":=`,'BPH(MD`D[Q",&B!#"6/9MQ"D$*D MSAE>(5P`B^2!&"""24]220,`.0`#[3@=;H`7:_@7WAG3'Y1M)6$.*=1O MI:Y*,N,#.2(P-$E3Y(6!/9Q!+<3^"Z[^0S=!6$S&BSTB5 M'H,X@3\-P@)I<0\\U']X0C80B"8XGPV_$P#8L#N=91*?D^NI-5@J:Q"O:XVYB"W+`RQ+$T8 M,@#(B1)&,DXX,BSD;'"G`23?Y@EU"9BPQ%50)UI5Q2^4\5"8,M6F,B2*Y]76 ME7GBE:#\`HLHPA`8P-@6BBY3AGH:`GL.P5BN!2WB@6G0XB!X$5Y$15_=;U]5 MG&]/,RW^HL&I4`H%E$$"N$$QT`[C?@(X?P(%V+1KJ<7CX&(&N)84M#,A)08I MY`DV_,&-7H-_9JD8^"WK&E(L#<,MH,XTK!?-(<*9\K-B7(:/%"Y"B\&9+C0G MD8*+(\*W*$%PD$)`]N[R1*ZHD(+\(HMO;%W761@3Z-PM0)+Y3H<*G*ZST`#[ M,BI,_VF0T@`P2'FUZ+0Q;?E_>2-0O](IS*$JX('AZ0``.!VWY/12.X\"1QX% MJ,,(Q(M[3`$I9'!X&$/EM<<42$`F[.KTX&1_.,$>)$,R=.M8_X<,K$+V512$ MJ$*WPB6BM]/I`0`:K%0-R\!K M0QE`-IS?R'0(-3B`#8S"%$>VOU:V%F.V96]V7]ZE18P"2D5$GKB(0'B`I;FQ M:DO@193?&P+!RRH-$(`L:B;`4J%$$S!!%;@0;M,4(+=L(6,,/,!"!F2!`SB5 M!PQW<5\5WTOBWI$C*$-"`Y-BB#23`)]P%-?N`?P\! M(NG!)]P"+?K`-RL-!7P"EH*`;_G57ER#1#(!@T^XXUP#+@[NC<9XT>#&AXO! M'5#`AY-XRND2:-@Y[;`N)\&`&:C^@A+D5BBQAHI7M.FDP--?0QG@@Q"4`2DD M@`'\QJC(]#NHM.\DQSD:N9;_Z9*+@6>(P9F#*)+.])3/?95S$99CJMDG"W#L M=)>G=-[_%PP((P`,0RV]+S*Q>?.PZ@+G1BK,N;S4P@GTKAC0PS'0^16L@8'] MS@;SC[ZHI8[%#XL@1)/Y`/05WQQD@UH'E3LEW\;,->B_'ES"'S5TR`K(Y:@# ML0[7D\5`J1M8>H7(0#*H0A;$'D61GXD]A,#H.JX3K/X$OQ;O00J80?'I!Q#` MPR80U1D3S3Q0I\,&WT>D=A6H1!Q;@A,HGSLX@0<(IP^8)I2@.P!H@4NY/PAH M@2![.TW^C<)N%_(A\TF340-U`H0',@"FP;(T"@`^#R&:6$KH(0T<`.]@A0@! MBQNW7RC2=$SC(8,J5:/Z>.R(PM8%`!I#R/.S$A8*&/@`&"DY4Y5-)4KZ_()C M)H&/(6GZ%#5:=.9$-4J&@`!@Z%.:3Q^>#K'EM-00-7D`"%$#8^!6W&BMP?JT,@`O`2"'2`\`]>P#/T1$!))&2&GQ9DLDF MG7S2B45XL*&=)9WPQ9-HM)#!DQ4`B&:3119IP`!/5@&`AW9D:"!+21:,``(!! MZEPR`AFB486:1=C(!@`WW(FR34O^9>@!``/8D($-0Q-@HPD#`-`BF46`&,2- M"'35=91"$UHD`E_<2<",3$>Q9+(F,LU4A@C&3!661=SQ\@-WCK4$VQ"P=0`` M)H#0U9(FY#&@H`@L"4$5.-+0%ETM/(@`%C``^,"#7]KD`198Y#&$((/0A0,6 M(&P92`A;8)D&@"H&@<6645[)`"*3TAA%I!`B]@@E;%;Z!)9?7@$@F4]D"D(5 M%&XBV>2=TK`E+CAVXNFHHI10`T\:EFH*@%*BPAF/P.+R(:\^)'*CCR&N`6&: MP-R8!IAK$$'DFD_`^B0N<#YAB@G"KAFB-@!T0&2(OW2XY0XEJ@"@&=`0.>4" M1#1S^9K^:X:#XSS,,),"M,::N:4SSV[Y*Q^YP\AZ&M4&ER_N<+HBY0]$N+G` M.8G>0>0.,8SPVKGA\+FF,HD4^(,4,>(#X<`+P@'FEEN`061(%:K3+QSGP@N, M=@++>T5V$9^[CS\(Y0-&C%N&B>T6,7AW3C_NE%`%`#W$0(2]8@Y,<$'C\#%C M03$*`0"-/\2HI#X8@-D^`S&X#<=#8!Z_A\#2(&;U)QG^:")/'UA!DV1@ M!C\MD(<-R-.?1N&+(B["#:EJP`IL`(`@S&$5[FAB-O[4!#S-H0&`0)@9X#&* M'L#F+DV$QR)&L:L(C*()D_*#!SQ`E0[V*FM9B%*S=F4))\`&&]P`A!8(`H9D M-`1;EHB`!QJ@"@H2Q_.I@<:7(`F M%RB%$;87#F[HX1I[25@XKF<$UZD$#H5XQS"8YX-O].TS0]#8!900-R640A7Y MR)P8N,(#LI$';6`+R3G#(80J&`$\Y#!DZ*0@!`,XAP*D2-C6*"!3.#"NIKA[ M!@PV`T]Y5@(<4J"`Z\"SO&+\03GBF=T0;N$4?%"``B-ZCDK&IM3+>4T!%Y!( M*0PT/!I,2'CX85TE*"6$<%0A=L8YFW&,(Y$%?:AYJ6L&/D)WB[T>:'L+%8(9 MOC$D`AX6L25BD3;F)R,1L0@=/L+1%42`BP+\B+*)+9&1?)1`("Y0!G,PQ!%L M8(!TVF#^$Y$(`,B@";+20C0^D:Q4?"`(<;-``)LE`MY2R03+J MU(,5P$$+JY"A+V2EA1Y<:H4&,`%T/VL)?*30B$5``' M./BA`<>*H*X\@(9H```.FB"#*JK@@R;(()#8&N0@#%"%_QH@&'Y(`R"I80@X M!&&5&3"Q%GR0`3*\,`')H"0W\)0%;-!0E!Z@!I[,@`U+1",!(`A!'S*0`.:9 MP1`QD9@EWL$#+6AA&H.8I4E^H;$\A0`;<,!#!E``#WQHP1#^HS""E\%,$J*D M00WA&,128F8415CARVYXAQ&8T`PMJ+D/BD@`/EXQB&,F40@9@(%@,)00&@Q! M";;`PV0HU6B7T>`5^!#".PY3SK/!`01\F`PX.O,Q&Y#E$]R@25>8(+5!ZX%Y M^%``/@SJ&;Q9IC+74,0KA-",(\#S'<[931G\P&=*EP&@P7C'':Y!#M%TI0R< M(Q`YA``'4.;#.DJH!#[PH8,[$(@&S1Z&/*L3!A`PNM%?*D,87#>@5X0(/-?Y M#G84P%!\5&+<(AI"(8+!9SX,Z`^5@(T0F/`.XA3"V/C(1QF&H``#X.,"X_Z> M1%0!N0&!@]K@((44BB&$=Y.B#,/^8#5W2D%K6S>#%%M#A`(*+039:!;EFI4? MC`8X(C$LX7\_$L:/S'$%N)/)LA&#SQ!W1J M3%6#'JQ0ADI:KIUD,`A"76H/3HC@U*N.WM^2R1,^_ZT,@[4D5J[P5'-T`J%& M08T(^L()9[2$+YZ^B+5[0%EH7"1Q\ZO?77G`%YL@0Q.`U2PG7*OMS(I@L\CX MQTE2(P)`P'"&-=P$(+B8#'\T2"!9.>)16&04'?G\L=)P$&SAG0FCD`YSX#L?Y&!-,A#F3;9"$>4CP(4 M\$27-'#^`R[;;!0CR`0L1E""R=QB,N[[OBTP$#1;BB;^402F+6JX@"*&D`'W MCX(&^#`$HK]2%\P@.@-J6*KVY<:;#"PG,<3/"+;&;D!#"?YO"`90V3S#U2[# M.&Z#')1`#.3&,DAAT%2`%#!P089@XJK'"`IK0'A#"N*F#,BA/H;`=3`C/"9. M-TC0!,&F-XQGA!!"K[A.:*P>B@D>RP#"3MD/:2`#XR@Y1@D M#+XA=`PKY]JP?1:KL4B$1;B@%F@.?ZY`'7`NYSB+Y\0.B*[^9,$BY>@@1>E\ M[NT@I>SLQ$[N(?P*\/[LYBL* ML&_\\1\!-$8%(]J%#=?C!%O&-( M9/*P#F2SV-`-?U)%5HY^2$0,["'F[/!&[,$G4XX//0L2GQ(JHW*!/`$/HL$- MHD`+H%*[)C&[NC*[6.F,0G$4/9%71-$LSY(55U$M%V]70L!<5''R<%$NYY(N MY=)B!L(/W"&0?+'TILSYFA$P`U,P7X8:KQ'-3J$*E@8?L)&9JL\Q'W,(7 M?L$M[H`=[V^:RB)J8*`2FB$@]1$T0U,T1Y,@7\TT#;(@4;,A>:,W=J,R(O(U M5]-UGH$U'1(C69-V4%`CJT,,1`,+G'B2+YJ;@"KA`#_=PYRA!*L-3/*522BA%%2Q%*[ER*UEI M$L$R+-TS+-\3/M&2/O6++1=OP?)3D+`E+NO2/_\3%T,`"!HE&"8)6X9QQ/Z2 M]A94,!O409<)',&Q)#Y!)3:#"6#`&A]30QUS'"<3*0YC,BFS#ZY"(LQ`"(0@ M&+2`HTB315M4-%_-U1A0-6=4-46P-B>R-5L3(S.2J6YS(WNT=L(@#S!$%5"T MWH9!"6[AV+3`.]*-.6U2.J-42J>T?82R.]-##.CA&)#2'')!"=VP*7MN/,>4 M3",E`J@!$%8`@J*2$IGD[-Z4/=TS%.4T/L6R/M$R/Q5/5_#^$S\#J3\!%%#_ MLPD&H0AX`!`T01B%L0F8\204]$$?-?A4AAI?AB=0`)7(HC$W5%/%L1P[U"WT M\0ZDIABF(0$2H!1*S453555C-#5I=$9[PT97TS5M-$=5X!ER7,SV917E>-Y4H=U3-9#!L@[IJI9 MGS-:;Q9GVY!%7`1&N)5!QN$*8DX[O30ZPS1@/&*MG4Z1'<$0"1``5EK(-C39I1Y=TQXKXW04P3)J MV95JS_(58S=VXS4"M,5/NQ9WZ7(8C;$)=M^(7$&/^,O,6>E7U,_C6;PV2-5]3<*\7-FU4-WEU1W?5-A57?!5W=M9M.9FU M$4@*%63EW73LVH M@.^4CIA%@64W@FQW:W,7@BD/085Q08$W>(-74M.6;4.4'2GS8:.7 MA%^48S^C>JUW5G&4A4%6!#>21V'8<,>7AG-3JIS4)9MU?7>8AQ\$VA.-88Z>W;U.X-47^-F1GM39M]7MS M,V4/MX9KN'R?5(=[V)`I=V?C$$7$@!(HX7ZC5'276)*/EA+?-'7I=$Y9EXH1 M^%V7A4\53P:T98N[F)03U1@Q9FS)EHS+6$+5.&W7F(W%,3(;MC*?5XYO>6-/ M,X7_%F3_%H][V2%I,W'#EY@#.9#EK6:GRF8/F9FG]'(5&45V!'2ALRDGV9K! M=3TMN3TU^6F[>9/-SUX5C-393]D<-UV1AV)C)]WQI5CR:LYDC.DJ? M.7-3I#2>-9*O6:.U\ES/U6FAUBS^6[=UO_EJ]]2D/?D44_J<(=CY2C%!+=A? MW1DPT=8C"/9XZ=F>VXQA^^`.+/-A^;F?HQ=&^;:._19P!5HV77,(2K8V;S.A M8WBAQ=CS>G.;1A'3:$@UJ.45A&=UED"[J75Q@W M2Q97=[5[#3JJ&]I\H=2AK]JRW7#E3J!X#H2S.]NS/QNT0UNT/YM&KJ`/Q1JU M?4Z[S)HK+_F,7CMJ7YLLUYJM]92!%TQKZW6N`_6+.<(8+?BN&S2O!9:OY1F6 M07;GP_RA`W;EX'YJ&'3CWLU5\'7>Z-ZLI'Y<2G[LL/[L!:K M#L^@%=0!O=,;O1E`O=M;'=B[O>$;OMW[O=U[OM6A%=;`'$X[M<5ZM=$U=6'[ MHS-Y+`W8=6G;/FN;3^5:MW<;4)UOEA9U;(/[G?4:IZOON)%[>0]#8IT[CE&S MJ.UXCVM5-F&U,AA[NW\TLFFXNR-7O%\\Y^3'1EZ$QFO/I0171514:ZGW-$?78(S+!FK?-+%]LK= M&9XM/&&Y7,.9U\N?%X[#_,.A^R"M=W!-O$;W^+%=6(;#]\V-^8:E>I`+N`#7N`'GN`+WN`/'N$+?K07GN$;WN$3 M'N(C7N(GGH=Q`0$N'N,S7N,WGN/^.][C/S[COY3B1Y[D2][D$2L7:N$*"J`` M!*'E5_X8"F#E97[F?43F67[E5YY^:?X89MX<8K[EO[F5@?O2FS&O)Y528V:-ZYG+(;8M&':?P5S4\U:7R]QC3?QZ M6UB/GX&Q9?C5%_J&RS?=T/?DW^<,?*3/+Q_S=?Q&A$&&!,#(/[]Y`W^PI?N.!]J%L==Q'5OX MLSO%'3_^AYEUSB>?@"K?')Y@#9X?^J-?^J>?^JO?^JO?1C@?]+??HZ7^=:>8 MB@U==D&Y3UF_]66QRAO"RF,_8`5V8.V6,8M7[]G80SNU,N56]X5Z>@D?U7T_ ML7D#()ZI&#)$Q4""`Q,B),BPH<.'#<.$B/($.*'$FR M9)@S5Z;P^B.FIO6&6$%2M#;-@(,D+(L,2VK=NW<./*G4L7 M!8HT;>VFV7OW[MZ_@`,+'DPXC9+#A@WW4=)G\>'#BQM+GDS^N;+E/K\P_]H, MHP^,7Y]!PQA-NK3ITZA3JT8MQ;24UJ]CRYXM6X44@[@-WK;]&O=N*<\*,E0H M?&'!@Q"35[PH<`!!88%PJ6_-5$&G[Y5=B#$`ZF MQ%^/,<988Q9.=N%E'%:6V6:-?2CB:B26:&)JK8TF&PRTM5B;;;SUQEMN-"ID M4'$+$7><E%16:1Y[4CFE MI2_R:44?5O-QE=^8_?TWUGYFE17^@B4""FC@FW"Z95<3322HUU\.1JAG88CU MB:%D&5;8X:"39:99B'?<\=F)C#:Z6HHLLNCBI+'!N)NE,NIVZ6O#(5?<03KV M"%%S0P[)').HIJHJ22A-L<1WJUHDAA3HZ),*K!9)@9.45O;JZZ_ON;>EL/!E M11574\U')IG^H4E6FM"VM5:L(^-:Q]QX+9I9C+,HN6?EJE.;):;+I9[>=+,[81]/@;HG^/RS"&(AO:1*`QW M#%WTYZH=+?K2\CZ=*8R:[C:$%#GJB)O45CN4]7-8AV2JU[CG;A'8J_Y!CPBU MF#-%*'^`MRMY<2>O?%,;*V45LF'JG>S>?(_"=0;6E^/D M&R:YN.%:B+[E'H;X(>>@=0[Z_"@>K332I-,;8[VF._W,;3G^PA&H5N M(>L;FLRTPC6MA7#>*]R<&(07N^BE<>6+T(02HQAPZ8QR[*,,T'XV&L\0D7Y( M5!&\[I>_V+P.NM&#=8./\SI60NAUB7I@4:'?FD6R[6DOAH:;$\SX0L@7,+H%!ZN(7 M5\DUWB'I.VNHQ13,48!QJ+$C&D3^WAMW:27F.2]8=336]+Z$1Z^8I4QY%-S@ M`.D]O="I03$SY+8@5Z%&IL^:CG2?-D&CF4HB$5+VR^3IG#8OIEEJ1_NZ(@%+ MJ1%4LO*="PSCD5PA!GM00I9GM.4:<=E&7OH38W5K#[%**,RMW!&%Q313]E2( M)I0%B)F!]`M;:"C-0YH/,8IDI&.P&43,&2HTH5&7-XMV24R*TVGZPY2,9/2_ M48;2.%4L)9!F>D"!P?.FJW+E&.TQA92<$0'%^XBNS+'!?QH5*<`4H9;F9L<[ MTK%C">W*L_ZVT+2TZ8\071F#P,<@&^*PHH+9H+TKT=2$@2[0T]4",.G^OC'+?;ID5P> M];%)`:9`F3H]CQTK>E&5ZL@82K*^1<"%6>W>G2P139F!]4$5,M\U%\G1CD+2 M9Y+T'%M)2AIWB7.EFX3:Z5@7TX>$"HL%I%WM`$M<5,F3L&(PK$_1%E20A(=B MD(VN48@%E:4^SSX@&V%^$,HWDRT4+:#E7FBMQ98%#9*BC;O3:AD&1L*VHZG&"+YS`85Z6Q2@?/L]UDSH4CBVE"3+@+IC^1H%B9GGVF,^Z MWD/%2Z!%>(`N(5B3)70,%P_@12Z"K-/XU/N7S7QUO9!)M;%J$$-F@'- M+Q35AR'80JWY;1>DE'A;W:*TDW-='2FIYBD#6VU@S]FB7QG,YI'HE#KTM`=. MA%<+=0PV),_%\'EDL(@^^UDL;I2!"38A`Z+(P`G9$+$(YZ8E/O>9#6QH!QN` ML(@4*VL4,FA`#RQ]GSXW@!K'[*YF]?A9&!(H!$U(!AGJ!!=4P^(7:?``+&#Q M%ED/@AH_/E`:8$9:QC7H%\D81!^.O*T^J$$>MOB$LI=M"\5,3LF5.ZL:KD$- M:MP7,YTS-@V8`.4LKPMIF&3BTK[^3*^4VNLU`@DE<1(R0+T2!&OO/N6IVDQO M-Z?D50^VQV'/>`4(2$&,_(2N>@;A`T"L`!`\2/@J>N`)#LH@&P```*&'(@,# M`(`'BR@/>TC<`$-,8P4)1_@*/K"'2E_%%XOX``!4D8P4@V44\+#XJE6,3!5: M(GOZR7'*WA0!-FBA"+#@,5M"\(M1&"(!KPB&&^`!A!NS!00)```\:'V@\B(( M3]I"`;`C/HA?^,7',_-`,O#@!S],X^QH]P&L?:C(UO(,!C28ABJL\`G&B*;* M[UAY!CKC;4:!4]S]G6M*Y^J;_QW'=3`U\YG1?+LUU_OQV#&;PJ@C!GKT=)9G MI`?``Z[^9_/L(0@`@`,:YN`&`*0`#PU/WL,C/G&A5!P`4^):=`'``& MF,?H$Y`"`+BA!TUP2LI7WG*$'KH!#@#`("Q!\[&@)2JWTOHR#V M@Q2A"@#XX10^X`.GH`5:H`;.!BZ5XW;DD@$\``!X4'>8<5]#D'>JL'?XU7B1$5D)F`R13`"PU>0EX(=X6#2,2N'-4L]13R,96&Y<`QZ M5@,XF(-$X03M4`0`4`1L(`-LH`D1YP.>H&%Q\W`F4&@4MP?^'\`EZ,%H3+4( M6@``R<`&C^8+%F<&V9!QF)8-@^!RET4?H^`.43<(34!,7H)I^C$*;+`"W+`( MUJ,5*;,66$$7$0`+11`$;"!T(0`$/@``@"`//N8![A`"9I`"R>`!(2`/AL!^ MOR!TW],6N_87;*%>'C`(9-`'?Q$"/$`^MF`#5G@-MI!LOR`$&>`8/!0NJH4S M&,)1[G4-W."`$&A$DZ0&[Z`(MH!?'X5EI>&+LV5;2=-EOU%N_E4I`S%%,85X M_A([7*1`\39O*CB-$L&"T:$":^!3$W8/S442C@44+H`!XBB.NO033K`(@""( MGK`'>^`)HN@`/0%H@!:/E084(>;^"4SH"S+@"1'P$WSF$Q'09U3A$_48CSS! M9_G8$W[F$U;!$VB1?`V0CS(`!!87#7N08K[0!(L0'U?1!!Y@&%C<7`1[`!DXG%Q$`!/@`!D''?1Y`A`Z` M%SHV"K``#P"@!6SQ"S[X`4"0!K^0DVTA:["`%WQA";_P:K&V%UC9;'OQ"7Z@ M!;;@`1XP&8F$&8/Q"Z#'#?>G=7B0BEH':VKP"XR1!GU@"T,`91<"E6K`&*48 M;57V"5"V&$-P"@XX!%6&F)Y!F)]P=S!P#9^`&D-P#4/0=^[R+AQ((^5F;L68 M;C;2;NO^YFX#HV9:0XVF>1*2MWDA\0?JH`\P>`6L<&?>V$\^L0=34`M7D)L2 M@`$U(!3GN`(`L`)'Z`N>`)RJP'">8`+)X`G9<)'Z*`.:@`::4`-,R&<]L`F+ MX(03MPB;0'+Y*(>)=I![@`8^L`<=QF>#$(8H]W"CL`@FX)WQ")VKH`F.MI&^ MA&D066C'(@/48`8`,`T;Z0&CD`WSH3@-@`:K0`WV*9(`T`-LT`":<(Y<,9&# M()T!.0J6P`W^V9Q.L!8LZ0.:8`D>0)-!Z0/+1PW6EVHIP`3;-U'X$)P_Z18A M4`4`8`A`\`O8P'Z?D`P@0`U4QQ:V0`T^\`%&V6NP0`8^P`W^`KH7L-`'9!`" ML08&`!`$&<`$&9`!2X%K>T$-59J60@``W&"`=JD$=/D+GT`-BK"CW)8&MH`" M('`*[[`99/H)1C`(E:`#B3H$P&A)[Z(BMY5;'M@T**6,[&9%O>5N>Z4U M*'B:*6B-)/$']Q`\9V0.N=`/JME845*.OK`'N3"K/<6;OKD(P`D(ZUAR1P`` M5>`+'V!Q'Q!U0:"/V1`$1P`(9N``)M!P)L`#JE`$V0`'$;<",I``_AD-$^<$ MHI`\E@`RN@"08`!R"W M`DL%%3*0GUPRD(M@<5K`GX:@!6:P%/QJ`_Z*KFB0<1Y0>F1@<0`0#1^PD2GF M!D>@K7"0#4#`#<'0?S9@`)H@H&Z0`("@"G`0AVMA`,&P`J_@`#X`!,K4%GFX MAVS0LR(Z"!'7LF_QAQ9G`[*6HYHP#1&7`O/@?B(Z#:]P`=%@!FJ'E3P@!'Z0 M`'#@![80`C[PI3YJ""]J!J\0#DQ@`ZH0#2``=B!0!?#`B8%QBF"J!BB@!H.0 MBGT0=ZI@"&@``&;`!+:`!E7``W(G!*,``QF`#55@`!GPI0!@`V2J!+80N5$@ M=V[`&$/^H'+P0`;>ZG^(J01H@`]F0*9#P`WX,`T7(`3XH`0P,`09X`87T(#! MD`%JL*E)9%NP08S\LTE.)!MY=5?I-+PE&#"JRJJG^4`<00$>X0I_\`]F,ZM7 M0#S3\8VU*0RS>C;`*A3""@"<$(3MD`W]!ZX-`'H&``95Z`M$NP+MD)W1H`J$ M-@@-:`!%L`D-8`:JX`9%,)Y36FA.J`KIRB55@`98N`E5L!,]$`4_N`C)\`&J M8`9N@`:^@`>XEW$R4`5\N`A-$`T```;P4+`2B[`8`!N<)-$JPI.D(>EMP("8*%`%V'`-B)"CPV!EAAD.>D`-(?"E@'JH@HM?50`"B'`--``'L`L# M<%`*KJP#@:RI^=6[F,F!FRFJA+56\[!0P\V9*R@MYUB@&?]`/O!`& M`%=YQ^"KM<"-U)%GNKH'VDN]W0O^%.>8CD'@`VB0CA=W:.T`G$?`!CW0`(O` MM@"\"*LPN7P&<5'0#K[0#@QLP"CGK>31#EJ0!1=)M(:0<9Z`!CT0`>V@[0!&S0@#S@#N0K`VG(!A8'!A]I<\TGB,W2N,WTQH)_8`]<(`S"(`+C`'`B,+T]10G.F\ZT MV1.\NKU7\,Y`\;UN,`=X#`83)P">D([T29P]\+\]T0/]Y\\#703KV-\`D`V' M)@-P,,#Z"`"@C`QX2>$(@=K8\.H`KQV.$H9\$=?8X'[H76=;`O76C( ML@@S'9&C<+4X/0A7N`E%0*-AR*!/[0N6$.!P\(:X9P!`_N#^L;?#5F@)0#`- M60#D0:X*>9RC00`"(BJT;/&S!@`+0ONS9GVTL)"C+.<.3`L$:Q("*:`*EH"4 M2OX*^*`*-F`+(("LIV`)L-`7:@D`@3T*@WT7OU#(0_D+U&``8"<8L/"EIU"E M3)``DYP&:M#FV-!L?=D'[S"7(,#`!K"+&6#:0X`"C`L`P3`$2F`&P0"!,(#I M@JIRE<#(@_J`L&O3I.&M^9`!@JD$UV``9A`.KQ#95:`*/D`!P^Q-;L5?)]4_ MH%HC)`B:QH&JIY)`".1XWDUX1#N MX%F@88(6N@G@G`+=P!SNX=`'XC*P";C'!D[`!G.0X@'%)2@.T_&!'PT'0LE+^AT&`!F`NHQZ`E"\ME6CMM'#0?3G:?COF`5]J"3Y(!DR@ M",G`I?GG`3X8>FK'(+``>G4^V'RA!L?J`Z]\`?+P57;[#I]PEUC2&)T+`/-0=W9/BTJ@!@Y@ M!IPS!,'^'''3D+&;Q%HWR MMNS+Z MF(YH(`-[4`6Q]Q/N,?'Z.1\?[088#.,HMPJJ@`TRX`X`<03`(!F+W`RT-"J" M##-FV!@`,&I1DR:6+"T:!01B,DL>@@&(X($BQ441.G*#"&`>$),6(S1)5B6# M19H6FV1(`0`/K!`U0WBP`2#!KU_8`'SX92G$KZ!IB@R$E<;^@X``1A_.?7XI&7)*YRW?QY]? M_W[^_<.`G'FT$,>4Z2Z:@$\:7$%3P1`T0E/CD13 M!K'06`1$&50QP,HAM=[C:P"0O!&.'7N4>P\9&EBE;%\6B2:(1:X$(,L;N8QQ M\!1ZM&$5>2QA@XTF;%1333;?),B7A=AH0)7`I713S[T-`<`0-B)P9Z-%"-W# M$FJ`@.D%P)]B>Y*%Q'EA&@<4H$'YY%C,T;$F&*T-L@46>4U:0 MQX=G1[&%&P`T(Q%#7Y9GV!^ M(;>J?*(L!LA-90(3+P/T)@IL* ME*W,92Y#CWIDIL6<==&+7P2CA@`DH*<5*`QK2-""IE`+8XA!#,;0Q]*F(`%C M(**+4?M0U?1(M7;0"!#M2)$3^@C^@+SU*'-F"%([6@0B(;FH'7MH!Z.R(:5% MP`$`-]J;;'SAB4VH0A.+:`T,#`&P`"$"L M8!4?&`3G(A`X`[#>*`E M+XG)J*A'DY\D0VX-^`4LOO(40WPE!.%SD4"?]XJO_.)0 M*5_"T17^%'P`(C8@`S<4@T$EV*(LP?@$#*BA.3A@8QIF`($:_H6':Z3A&GXI MQ37N,(15TE`19MB7"`'@@ZI:,@7#P`8))JN. M>+@3197Y)F17!*Q[VB.SF0DVC(=%;&)UEJ`!R><,@AB:,,)`B@)4Z`H0^*(4 M_'&,/.[1L[[HP2JXY(!5]"!%']""*H*P"1%Y(AM5B`8@W&"#./EB$&Y0K0GV MD(W4`J('>UA%-%2Q@CTXP0?(!(-M'5`%`P`B"#RPT2`,H-I-[`$-*3`#'HJ+ M!F0:@AI[2"=7Q#L--*W)MD5(@4C'%,X@%"$9&%$(-?"0@A3^X($:T^2*%C[P ME"KX8!'2584-P%D$;;HI`EOA"AR8)Y%L:,X-HSJP>+7`A(LDH`I"F$8"A+"' M)L"J5"M`E:KV^1-+^(&Y&0Y"$+CQ%8N@(`,)4(465N"&:5#%(AXH@N8`8`9N M,`L;5=#"-'B`CQ6'0!/"!<,H#BC,>;"T6H;P@SP*J"TFS`.9!AA$"$ZZESXH MXA4I@`,W]@(#&LA&%>%@@B7=H`@K@)D;:3`"-E)0!:$.@0R6C!T*F?!E-S!! M"=1H1@J"P004G*(A/NA#FN&0`#\(P0\H'((17B'>5[C5TA=C#G#DVK$EVI6N MTRD9=)[QC.^S"(J8DHV7OH@6F]Y(L/H`%):(HVM$V;[1XDP[9[ M0#:(?@OM/7#-%ZM`0RY#E.UD](`:XQX$-4`+;G?+P+?)T$2^-=&BVK:IW>#6 M=@]6]#?+<9".7FX(4 M3+)AB4U9`@C)\+A(%G+?!O@@&Q11E0R:0`8F-&^?_`2+D7T`#R;``@C4J\HH M/N"#GE,/%M3@!AF85:P,>"`9\/C``8W%!#51_5O-S`L*M/X+-\"EI7+)`-5# M$'84[$7^,.[*0`A&08W!3,8(W*"!+6R1@7?8`@74,,+:E6"$#!C!"&Q_:1_> M\0X7#B8#?3^\8S*``C6MR^\9"!>X0'"*#"05!K_(CB+>D8'<7-KS&"-B7#>- M'2DBIXF>KJL*2*U7E/G5U*I>]7O&`S/#RMKVMS\LK1U74MU"'L M._I#:L;VK`PTCB84R:`&"V&^EP@NHAHXOY5A:B64?ADVY3,_`J5D_O:[OWWL MRZ`=S65#^>5QA$FRJ?SB#]&A."5^2+WD;VZZ_YQ&=;KZ:YQ3%"^)A1!`BNN^ M__.`10@!$?,4#U`^ZOD)F[LYGV@"(!`H#XC`8@DH"]PG9HG^BV*9%@\0*&I) MBZGP@)/Z'ZL`P5_X!&YP`S68,FWQ#,\@BG!IH*KX!1D$E\BS!34(%QC@08(A MF,T(PM;HC%_8#1@8#,((#L)0`Q]LPB;TP>#XA$]0`24$CB'XA"'PO"WDF(TY MHM$SO24"&>O`J^-`&51CF5*#O=C+(O80+#>L/=R3PSD4HP!I+/G@!188FCTD MH\PROF)#OD`4Q$$D1$($)K,8N--9A"+@`2EI$_-ZQ,CA%$G4O\A1"$J<$_^K M1$WT/S41P/G+Q$_4N!!8N..Q!(V+P.FY0`<,EE5<112H"6K1.EBTA!?\.JWS M@`PP`#?X``>(*EO\.KFH009BH"3^S,'(B[S.`!?.,$9E3$9E+$)HY`RB$`[. MF)CAN$8N="NXVA@C`L./L:LP)!DG:B*]JJ(I.C6^6D/PT*(X;$C,8;;(T[F!AJU,:BI)@CZD+1^T8F(L.2 M$<H8I(H^483VJ7$=7:T?:<\=YY,IYK$?YN+7*RD=SR(5^"",.$01`),BU M9,NV[)3^!@`$7=$"'O@D*('(-9'$2Y2_B=1+C/3+BRQ`Y"RLK>S*X*3#G;E# M^?@#5DBCX$N%?O3'XVO+YX3.@2P(19P(AW0_$9%(_0O%BM3.O_3.Y=M(P0Q/ MY5/%Q31/\[R*8E')R,S,EH*%@&I/S13&S;S)^AS-^^Q)HO`,(@1"U63-U0P] M+X1-(09X:30>"3.W8/^#S$@A^2LD#,P MFK/\0X",SA$E44+$2\F)1(@,Q4D\%.[\3K_D2,&D/QG]2,,\SQLE292T"`-2 MR?A,"Y;,S,UD()ST3!K$SR/5SQLDBFND1O_\3];\P@$-PU`+Q]/SM.T@M=V4 MRBU-0P=-CS>DO0H5TSG\2OH0`)K3K4LT3>%4^QD$Q0U+\F92!;- MRTG$TQ>%45"%#]_D(@@=TUB%-5KS M&?KX`V.0``J9@BLX!CE(++1TTSC^%582Q14 MFKW9O]U"I)32YBC04JW-FZG<^+B&)<"%AOW5 MA_7<\!5(%#56BFW6C,5893U=U!7`P(Q1Z#N>M'W=0M6Z6NS6VE59NOT6ES5& MW>U=9>1;)9T8H1Q>XOV\`(U7415#4.LTZG`]?45'A`7'T]0Y9I7,!Z55?]4N#$ MX"N.#^+$#U=P!0X&WP\&8V.#1!&V6$UL4>U47Q3V/Q5>OAE=N(4XS)%]X<6\ M"HI85-JMX2`=UV*DSQTF4AX&8!S<3R4=8B(NHBX\7I%17E*=32G(TBK*356= M8,**7"O&XDO^CP"1@EOX@T[VY$\&Y5`6Y5$F95!&!`H(T3!693VZRUU*T4S$ M6#5V5HT8QQM3!W]T0+^BML\GJF:?$;_S=O_5=(8/,UL+.3B?1NAH^=N05Y%N/X.U&-O3\W-L"7N9MY$8CIE=.\YA\Y=*]BJ)3*UKJ;0\N0EIO]N8S.(9=19"2-NF3 M1NF45NF57FFB88(:@-@57=]DE>E]WF<5=N.<[F<;E>.`5MN"-NA&?=27[8S^ M_U!+!NFNE@\6T(!:8.FQ M)NNR5NG^6J@%02`%"O;JMG;KMX;KN);KN=Z/?\B$5,#KO-;KO>;KOO;KOP9L MO-:&#Z7KPC;LPT;LQ%9LKBSEQG;LQX;LQ9;LR:;LRK;LRWZ/+HX/+N9BWNML MS0X#T/YLW@MMSQ;MSB[MT>9LS&;MUG;MUX;MV);MV:;MVK;MV\;MW-;MW>;M MWO;MWP;NX!;NX2;NXC;NXT;NY%;NY6;NYG9NV*8`-[H&,9ANZ;9NZJYN['8C M[=YNZI9N'M+N[/;N\29O-X*&\X:&,$#O]49O]6YO]G[O\W9O^*;O^DYO^[YO M^';O^=[O^69O_Z[O_A9P]4AO`E]O]39P!)^/^_9O_E9P`G_^\`)_[@FG\+=6 M!TIX@@S7\`WG\`[W\`\'\1!_@C40!W)@J:!>6:KX.A4/1A:?BA9_<6UY\1FG M"A*<<:F0BAK'\7'=LJ+NWV9\QJ,631U&:DL]YB),4A]6U]_UX4TM32!DZBA' MX.5H340^8N>(YM3+ MI^8A:#Q&\9G2EMN%V9XL9G0]YB0E&&6.QWJ-Y*%E4*G\\BHF M\S.WCS$R!S3-1\C*M3V4]5@WAUS^@ZQ;5Q!>KQ!>GP)!@/-!QUKSM6>N+72; MEN49S%EI6EE7V'Q!-3N:T5KA?9H9T^VM?;V+-?.O,E+UW8D_HS'Z-^^(/NQOF80>[\ MHXRKG1WU>UUB:69B-5Q0"8[B*Y)[F"__NI\U.YS:Q"*05,@%#9`L6_/[V\=] M#Z;3,6[EIB]\A7_Z-8964`0(2S($RBAHZ2#"A`H7,FSH<"'^"DLH)J)(DZ:B MQ8L9-W+LZ/'C1B5*THQ,TT>DDCXJ4Z9R1T6H3?MU M[=RZ=_/NO;N@C-K`(P`?;BF"P(,#'S)O[CQA1$MIFDC?.!$D]NP?47)O>3(F MRYGBQ]]4B=/FG5_I:QIM[_X]4:3^\G=&K6]_+-:K4_%C#?L,[%E5H8566FP9 M>&!<<+WUE5UJ,?8@A!%*..&#AB&F&(5^_?'/%)A!0`\BE5V6V6:IF7@BBBFJ MR-IK+,;F6FL1W$:;C#':5J-O.>887'&Y#>F3>C#X!!^77<8WGU+VB=G??OJ9:95^_X$5%EEL"EA6@0?* MV6!=#-ZE8(9YZKDGGWH99DYB?>;%A03F7$%)&&*X(B)FFJWX**21GMB:B[&] M^")N--Z&(XTR>JHCJ,(1)UQ!H_YH20A#&KFJD1$UD89$%F&$$9.U@C222$^* M]!)+WGG^1R5Y.9FGTT[K>7GLL?,EU=2R8T:UWUC01MM?4RJHV6:`V;X9IYQM MU157G>`*.BZYY0YF8:""NB*&%)1((,RA*ERSEV57F..HI/GJNR^,+5Z*Z::X MY2;;P*$:7!S"PP&7*L*L.MQ<1!-)=QU%&MEZL46YHD12>+ZZ!"R5-I6'DTXW M:8DLRO#)QRS+SCY[9E9;5:M?6F.9!2"<-W=K8+C@*NB@N4$+'32Z&/+I"B*X MY'(%O)2H8#2C).X[-=60PF8I;##6N*EO,79J\(X^!D?JCSP*^3#:#45G,444 M8_QVQAGOVA+=W8$\Y7GFI4=LRGVWQS)]S;K\E%5H%CXM?F'^>96S@-AFN_.< MW]*UH)U#6W[YGD4+NJ&APM3B--11XULUZ:6/UB_`61.LFXTWM@ZVCF/SV*.I M`T40@G)IZ\[01155-RO<&)?$<=W@?7PWL%;R?;+?S0<%9N"#2W5X?H;S9ZW. M;&IK%K>0.P@T79-C/C[YBZ$[+Y^(I**/.4T/$;KH)9H^/_TMNF:I:EZO/MML M-\+>6\*(HS"%Y6XYN]-=1*;C.UD!+WC"0XEX?H6\8(TL2W=@GO,RR!2G"$YZ M6B'3S*XG+>R]"4[:RYGW$'2G%?:L?"Y\(5\TMR'4(4^OI2+ZG1KX>E MNQ^E[)<`*#/J1'@V:DS\H\.+T15@M-5[G*$)Y1LSAU+X4J9!">?`;#/?+1+3+, MDQ@Z4*@IF.-"@-GAZ'RH2'T!$4:I(QC7N(:C(^YH;$JLW7(&HJHGHDUB5.R= M1JQX12SB:E M\"BN/A*3?'^D4"#U,05"3H$>\*/7B!*YR&D^RGZ.Q-KK6B>PK7W--J\+%<)& MY1LF-G&3SVEB$Y^80%I53$FCU$ZN./8Q4T)0E:LTC\AZLIXMP3)E3UG6+*4W MK>K%K'K^U8JCFQY7H!+^\BQT^AE>*E?,B0[M?'FZ1@>4:0Y#A0(1BSID-.4' M*1EX8A$RX$P$J&F:A"&,,\`!#?^""+!),T!\RRDQ]I.(/'P5IHT2Z(D]L MPA!@T(0O9-`#E99F$PT8Q"!,(%D3/'8/B5##(D8[8-(`,U%@';Y*PJM47^,(`#IA&"G!YP MG;]C)U6Q&#>3A.=XW]DJ5\-XAY*Y,JS^9`I0RAK"$,9,A+QDB_8NUZF'1)2'V'*>05[O%,'8944@F``R!68`,'&&`%GG`"2E/*V,X,(@H` M4(4!$FP`&P``#"5-``!2T-FK`1&;H M5NG9*^AR=5@J^>I7K>O/E0%4NQ_42IG.)(5GR)%`V5NKSAI*.8A^J\SI/7.& M[LJ8/Z2B%AN](046@TC!HL@3!DC^P1Y\ZHD/```0BP"P#+*AB!')`(`9 M>EJ01:S@"(L8Q2#<@`9"<[:1,_6?-T&KJ=U88A5N&,1Q59&V&;FJQ)O;<\%C M3^2)3%CL(:.4^Y;&L:IQ*]+:+G<3JE`4^E+,>/HV"]$L;@JI>3!(2T6A-EI( M>\R7OH%]5`T&`8`5M&,/3MA#.XK`@T4(P`GM",*D`3Q@Q2*:&IV103+<<-*7 MDD8V+MI4;+86<9O2-`)-6$2H_6>C42QB'J8^<:IE5`4`)$.GL-`$BS^PVZ,> M]2`A0$[^"&+^X(DN](=IAMM:6]PVH.[M@A%&,(`]1);#/4VG1(TYG&3/4(6A9`8<*'NC5YA M'']@3+WN)=@:=.`,$+A[+L9`9\YX8A4`L($,:@#@"`Q"L[Y@-`!,P(;->&+A M!>E,XQ/K"<\\_O`,1ZDG]K"'QI<*-`0W`^5]D0R7$MKB34BL21]/*9_Z(@(F MC4U/+>$+2YC4I#%"/>IE1QU-R0`(,KJX;3S@\5./HFRC8/7-960&`"2`#;7Q M`'4\X..#2%^H'H`5&SR@"CBXP]6JAL5!?C%]Z8C?$K](`XW^/=!46$@__>P_ M?]!_`?XTL!\CL/B%)?J@AIMX@%9]L$5%V$(?;,0OV$(:%.#U=432X53!VRR%)`>5!W00OA%!3V"YK%>[ M_848+`$AO9D$&,/;P5U]>48-0(:AF(,$Z)UHR,`FL)@-;!YG[($)*)8;"&$" MK((O?(`--,`':('AR<`<+)@4"I@1NL$\,`*\(`;9,,F M9$,R"-C!]4#!=<;H;=8F``(/3!XU9(,!^(`,)(`7@B%G+((/))B+)8,,C,(> MP,,0]H`-1(,;4$,A!,6Y'@ MSPA3N)R7"H;D7Y1;8$B!"-@+?+%""_I%W$E3#:S!>W6(#XJ&)R0AHH$!275& M#V0#A!7^038T@`\L'R<$`8OM@0S8`!QLPAZLF`%LQ@<0I1L<`2``PH%9EAB: M@9_)0!)J@1NL`J4EEAN:@4^U@PRLP,(U0!+:P"(TH18PGQM,`U6:@1-PW`J8 MF@S`0XO)@!/,@RH`P#080!$DH0&L91,T@!G,@PR@P=\%QP>0V#PL0@0D@QD$ M`350`X/1HB^0(AIX`&WPB&UT6)Y%@#OP&0"HG`>X@0TP03((`0!@`QNT%@`< M`0^D@*D-P@>H0A6`@"8P`1!P@RKXP2@P`5'"`RQ0`QBP&!C@`P!4P2`P6`+X M`1T"0#2@@1!@@P$```_`0@C\@F*"@30B6@BD`3S$FAM@PX[^X<,OH``]5@$V MI`$W```<2``$([<`(`],!: MXNB\D12?V8"1LL&*;:$G&)A+[0$`!$$[L&$;'E@1@,$N4-=^H!)]>7IN0.$;8(,L`&$F24;L`%1$N(HJ`(/N`/'C=P@Q*EBXH%/ MX:F$0QZH>W`0LTBDRV09!VZ7!V)DX[3)";F5 M]SP4Y;30AO[K7=S5'^""''"!'(1!BC9&)F@4V[E=A,S99[0H,UU!C/[@*HP< MBP5!#\B``'@"57Z`&'JLJ37>Y*F"%H1A`T18,O0=`!1!OG@\`P#RP09X5+1B8%!C(K*$Q6`/TU!&D M8FY!6`.P@6)&;6)IPJ0=7JD)*L(E0#(X7ZGMJA,`P?"AVFZ,PLBY`6JBJB9& M`!L8@!;@`3:`P7$"@`^XPWL:P%+I7)[:W"@``5X6:@B,PJWU&1!XP*L.@OI) MWWM.@SSH8[%R`RR,PB\P6`:D`1#XP#3(7SL:J_SY`0"0@1H@[HII@CR\IR:` M7Q\,`AK0'P@TF"$8`AXPF!"$:T@Q![N^!Y4M!;PZ"RY9 M6W<]*!Q1:$::D+[NC+ATY-@!+/:&P1^QRV5$A@:L05ZL"Q_^H&0A20`7A.B# M0"P.NLL5M*\$=,#>>88E^@(88*P6I-0B4.6@Y1E5@J%19L-B>L;(?4`[Q.PB M;)[?%8%)$>7&"L#-F@&69JE8MH-/S4&6BNDK-MB?9;`A;#`;9(/;DEC4+L+4 M:NTB).$FR"D`@%IK`!_'?2UGRH`[1(`?!$,2'H$')&K:=LK8H"(31(`31,#B M'E6,88,?'#$8&,(@`$'*MB)MX$X$;!]L`0&$P0,0Q)P'X*5^`H'FI@$61^[E MPL**?8`R_@)K9@"-_<(G=*(;L*8FC"X`M&X(V`+I@@"Q`H#E5L0OJ`&SDJX? M8(,18X,AG`)![FXIS=,IU5-"7HG^R`3%NA;O4"A+E965&_%'&WW0?@P(]VCD MXW#D"GGD7&6O2,J0&-##&0S2%`B#!-P#^K*+B1J*"&2HBMJ+-/G"&-3!`.1R M'>A`_/J"YOF"`/C"Y.U8B9'4QXIA_I9FR/H=X!T<41*PWW'"`;,L)S1>T7(" M!;MA!X?&Y^6LZ%WP6@*B!H]I=T*F+TSB!["!@<$I"0/`)LA>.U]M$F9#:M7( MZ2T"#&B`/$(*B8#Q@4';0@$`+R"/+`!+,`"$+!!47EJ M*\( M@S--B/KB8`W,]5R3!A#B)(`!6#L#0N/I+S(?LR4"L`-07EMN`ID"@#0C,&(? M\"(401:L`!K8@'_]8%BVGDN!,]&.QT&8@2H<1XQD0#)X`$4['T*$`$93 M<8-I9T>G;(]I-`",-/69-"R@M'9F+@!LK@?A5U/7)49Q?@)&^\%@ZV67)6 M;'57LU6![RN9)4B"B[6&RA`I&$.'K)TY"`($N(4KL!G#OB@-_A7:78;C<;G MC3CEN>'0;O8&=Z<[**8F[H$Z`T`#^!0*PW,27FW15L&8RO`'*#`^EQADFD$T M`/0!>YCO=5PIE@I!(]^H"(00OT*?L9\ER`,>$&<3^QY"1#$ M7LY#.^26W\V!.Y2:6BY"`Y!8,ABI@?7`Z:FPD?K"R`5!`R3#*@2!40*!8OH` M&[`M'L\P5>[;M2KF*D0\HX+VR.56;!V'!Y`F#PP"$QB"#5B"!QP:(,QP%&F? M%H#?<3C^`![+0U"[HQ>[PW6.8OC)VPK8PBBX`WXRNCN\:@C`PGL&`:\J`FN2 M00;TP7%:;@@@^K6F`5'"`=.#0!#0P/F1&!R`0`:001"`@!IX^B$/X-PTU^^" M#*E[U5.CNE&\ZZI/)`=BW?5LV293J)=I

H`GB>JZGX!])P1^,@Z^OW:%0 M@!BPPGNQ'1^LI&#$=8I$0`]$0Q:XEJ`E@!EXI0/[733DH2]`)>7M6!0`I0,` M@AA&`%4:@"\X(E7:0.O-*(M)9S1P0@1S1M[Z`#Q_P%K*P-0>@>O^K9B'V8!.(UBT M)V$"A%JIM$:D8@-0(4=&%P:-%H`P'F5(!P`+3Q".!QH"84- M`'[2>&`R$4!+'VI0_$KFH&7+:6HLYDRC9&=/)7WZ_!3Z,RA1H$>1)E6*]->O M/DZ?WKD#PRE5&%>Q9M6ZE6M7KUZE7`T;%H84LV?1ICVK0H64MFS?OD7;UBW; M(7;QJABR]^Y>NWP!!Q:\-\R0,(41%R:\^'!CQX\A1Y8\F7)ERY90F[N"BT^MU%/^:J'[LYFR&'57!&&HX8MW;]^_@?/N86(/ M&AYN#*SH(<,W&!L^/*TJ`@:,B0B]9:PRX(9'-N:^3,RAG@V\>##>]QB8@]R& MC2```"WZG8TZF#GD?G`##%\TF0Z/ M07SY``Q#)AQ%AAY6<&.:'A89)0)N!#2$&QE&,<2`*))APX\$R&B"1$,,:4"& M"&Z,(((&^*.1FU$LB<`2&60(T@-NCO.#"8(&H1$,>(0,849#T/C1H`R*V`Z; M40@:!1X:YU$D#4OVHQ$$*6G,\(,T%?E%D6F"`:./41(H(@0RTAPD#6[FP3"9 M-'[)`!O^#Y.!R:)?0L`FG"A`P$DGBWA20M(T@#+J*$DK74K339]J"BBH?I'* MJJ](+=74KL8ZJRRU6&65+K/@@A6N6*48HBZ]_-(+KUP'Z[77PP`#UC'":"O6 MV&.135;9,#K[+#3(1+@B-=4HZ6S:*4A9MC';I-4MN&_!Y0[[-I]5X9QW?6%W47W>^M%>-U_%\;7 M7GQQ9%A(B1_&UQ(1([981WS9N'@1#YJ(H`D//``B2")Q++)D((!H(D@=0R@2 MQ458;EG()EAF@Z""FF"##5B`&-,2AF`!&I:A"P*B:%B$!K3^:((\6!KJI<>, MNF@4TB@Z):DI5>/I-%#P0`TU;/D%:XNPMH5L1Q^%-%)*A[J4T[DY=`V\,3,``` M44<QY1UK!YC(@LJ M/\?ARQ^>H8)"4+]\]A=:O_SXWZ?__?K+'W,ADE`H".SRL=8__^4$!04\FTX, M>,!'38HGE+I4W"IE*;K5[5-/Z0/^#/!V0XQ+%E+;.:BPJ> MT9?&^857DJ/JF98XI"`("GGN=MY"7 M1"4N$3B+0(@9#)&-36QB%5%(P+N8N#SJ\49Y76S>]KPGHNQ1;WAE-.,9T5A& ME(&/2&N\T8T80KXBW8^.=;3C'?%X/P&ZK`D%?)0"VQ9(00XR)V_;B5""4A1$ M)G*"<_-44^R&04ARD))_\Z!60BA"$B;N5G0AH5Y@U<*[/*YQ*WRA8!2CN51B M+H>M=.4K#[/#R(B!#T`,XA7(P4-M'3%V6?3E+[^5'8RT)`5:F(,G@+D\+F[1 MB\L$8_?^R#C&[*61FFA\(\K?3F-\$)0*PU`6T!!!LAT9E.G330 M;8S$%"(EV,BE>*I3>*L*5?I627V2BBQ8R:1:-AD73AK.A([+E2EW=[R-K!+YD<_Z@D9)*,!)EC.\4#*S"T^[WE= MC&;WSDC&:L[4FFQL8QMM.J2"S#&=1"6E(N"524DTE M2CSE.<]'ANH.&MSG5<$BEE7]$Z!Q^:1`/=F6%/8EXX@^ID,!IKG4%/FQT6=PR!Q)!&EA?UH!(O11L2Q'^VU+LR12F80S? M8VD:61W==++9;-_[>/I3S7KS;/WS(U)!>U2G*J6I49T@J"RH-[[I+9]8Q:H' M01JQ:N#JE"W:'5H*C.7.5;"E;C%G8Q<(4.*7`01-I3@:U\[ M"MC#3I>Z2EPI,Q$K/IE>#[+7FZ9DJ7E-;`YOO-ODYF;1B\?/NLRH:`OM>WUR MR)TP]:F9,NVF[@:5J33E*JUU[3Y3M:H/RE9Q7Y7+@44TS M4K:R.]5I>G%,Q_X-M0D])J`!X1O^VJ;Z!"EQ>RI4[WNW3F$0@U/Y[Y-5Y4\" MPVJ$M_6J5\VB8%V=-7*/>W"P&GHY8@W7PF5V:^A&)QDQX")U5U`'+T(LXN@: MUL1U-K%*69IG\6E/>MX5(QAA'./OB9>\;5Q(&W.<:!W[N+-@`V2005O:(S.2 MJ?>=9SV7C+=1/1G*@ILRE1%G9;D,=`B,6S"73?GEP`"WAA,V\ZLCBF;*4&`- M@I#6/UIGPQ';F=7?IB,;JXSWP.=!K'^T8UYFAHF55THG>,-J$"&=*1 MEF^D-&44))LVOTW)VY(Y?=54C66K4_XJ;5_UR<0]([R\^W4V<]& M+Y#SU]YJB]9M\[6O(A]HZ:1`);54<;)_PTW)M)2EW`0FJ+H1G#@6\G:4-=]R MO->ZUGG;F^A%ZS@2TBU_ZW8:?\7P2)S3, M*F[QBY-DJ.=,H,8WGM1#OM-2BZ2TR.OY2%'U#>4I!]PEM?KI@7*RD[25E8)G M7LI2XGPQ8I;AWWL>^,W]O(>O1+K2$9_%8+-TI0G_[K#]S/"&0UR\E+V1^6ZL M]3 MZGA;;I5^%_SOER7KRAB]E:XX?.*1O\1F8E>[Q7YZ-*?^<,OC%-&7S;KF>[KC M/AK$O6`'O=CGJ^W1;IO;:0_559[B>GV2&RTMY^K+JUSW=;N%K&25G`MQOO,: MTA#X_4=6LWCA#ZY!#`AP``GP``LP`1%P`1FP`0WP`!\P#!!ASI*O`I$'NQA/ MNQQ+\KPK^I;-X;YGT"0N9C(/^S9OQRR!J`[HT;YOG7IB["+(["H-]Y[.Z MK@6%S*E(;REDD`:GRJIT=(GF;(H>?(H':,HH1(HH?(QEO(GE1(RI++"MK(DO?(KP3(L MQ7(LR;(LS?(LT3(MU7(MV;(MW?(MX3(NY7(NZ;(N[?(N\3(O]7(O^;(O_?(O M`3,P!7,P";,P#?,P$1.6NK(JK1(K+V,Q'=-S(+,Q$[,R+?,RV7(-SF`S71(E M45($/A,T5_(S2?,E0W,T31,T:8`@NF_:J,V<&LWK`(FHX(O^-@>)!7\Q-W43 M&-O&#A6)[(*1].HK@CZ.&-%N(!=R(2\)A-*-RB+2P*XL5MC-+A0GM_C"U$PM M$;63MZ81S'[EA<(,PC"3Y_S!&]/Q/-$S/=%Q'74C%-WS/4/1%-&E%'UC$W]C M%5F1Q*[#\XT*-V=$]5S.F>" MJTR5!0`%4`P&\`%C=59G%5:OH58+T`!Q]5;%@`(H@%+.@H!))<487E6.Y< M@;"V3(C^;L[=GO%#3XGWKK%>)\HS0".B_H`>*"$5-NKX_#7YL$?/@&V:9I$# MG17B$C9'QBN.2M!A[\B/4("<8A,W*1;;ZDO;3D_D'JD8JPH'/993IJA?<]8"72J[4&S/C&T, MS4A(P0N;B%9:4P;S&K9:!6AIE71BMY6!Q&\XOS4>[4:_`C)KN2+*.O53XT]+ M2ZC=[`\PB%!E5S8Q=$X)T5:'8#;-6FEF(:`6:N$,<(%TZ+;^;G6V>3+P3R%O M;W_68*$UFZI.2!@6:3FK?WR,^U804CMNM$H/GHH37/<0*["6J=ZDNXF3,?F6`!!6UJ2C.I M:PE1W332YHH0=&%(K89K1#M#EII&'W.:W_5RZCD$(#IT*G"+YZ&TU(A-($!$ADWE=RB%W.K M%UV=DW$Z-WM/5=5:;5C$-(NUV%ELR!40@0^FX`I88(S+6,W.&(UY]&Y56&"' MS3^A"8X3]ED%EPWM.&D?=@X)R'@+Z7@;]&)O&?7L4=-PD)`+.>Z8N(DU]]P. M#'LK^*Q.C8I]I7LC3-XV@UXQ4WR1Y0^,X1MA@X2Y^(1%F=<`]KK^E&\'=4BI MCDA7.7]?.9R6-H^I#5)'3_3LRSU]N8?[[F!\]GEO';V#H(&@2`=P@;7"BZ9[4+.`)6;X.V\D1PT-+G\O+HLL+I M2'^J%Q-4#HV7@2"%THR,K),LD*MB7-/:8Z=7MM3-RJS7JX8P(TGID4$TN##' MH&6;,FA;,VP;KXYA'-(7,W@;>9S@7KYC/^TEP#]J78#C1O8@`D1*P)>.^2IZ MSV2@"8JD8!9A2*3G8EYFH].P4"/N>U)09'SWCG"FIW;F#?NWZS[/NA54J898 M.!^T@D@._9P,M,O-@66:(@O,MM@U&@V*O4'TO4$2ON,;=/1:Q`;`-(1('_XA MO_5[L)E(!K)A!5;`!PY\$Z[#R1W^(`JP*(MD0!/@@`>PR!,^(`JTP`'`(`'@ MP$92RIF:VIFNHP&RH0&XX0/D7,X;X,";`!X<8`4N1G[S?K[2OE)_?8JP<[$MQ>O=X&K9C.\CGVS*HF<.$J!;DX-^0FLF7R`#@@!/` MP`"J(`A6P!/V8!$`H27V()F0'0!4P3<6`0\<8`_V``YJH@@6`;A_"0.W"$<< M[SJ2(0&<_0B.P`T2P```P!#PY0@`(!I0A+&3S?)"T!+,``"B@`T,?7XL(0/F MH246'8_^0@`6L$$5(MVGA+<7':V]/."Z85#2B#.7+4WU+(@@PULY>3!D];DY M:\_NZD*UH1'WP#1,)PRV`2_(9WO(C86NC.&V&YH5`MN,US>9/,$&S,`7_J4! MX&,1!"`"D@$0T"#+F8CG`6$5Y$45`*%?.*0(`&'9TSRQ#@0-Y"/8(F`1D@$` MJJ!@7.0(%B$">H`'/F#/-[K/[?=@1>8#EAYI["@"W`'=F8#1[\@#,$(3?F'S MQF1I'4V!L,80N$\WN15J<5EN6KQJ]R;&*WY*>9"MJQ.L`M%DNVQ[]\[5K]B* MO]?D+PSE:<,5;L$8&#HUS@#.:`-G;8=WM#TX9&`3`(`3VF'^V?>@'0R!!XZG M7`HWR62$3DW6DL2$2$(42*F('2$?7PW`CR`[=V>CD+``^"A)0S@:,C? M(-`^XWAFJ+"U[B%"'C1!"^;>(@S"`Q*TVOH^_!X>8P&BC\"!!`L:'/CK5Y^$ M=P3^@@$QHL2)%"M:O(@1HI2-,#AVW`@RI$B0*E2$+&D2)>9R2$R9 M0VK:O#GSILZ=-L/4#.,SZ!"@08D:/8HTJ=*E3)LZ?0HUJE2I9ZY,62)FJE%7 M8OA<,0?6W#%&:L`!/$E0X"O M"#V*R'`K(_!>&3WV>$KLR5<-3Q$$R(B<^&WFMVP^``##YG"$R'I]+?*U1\;I MMXMD[*'6&G'L1:!"`:*,B%)]&H M)L@C1)#A812U"!YD6%_DP3@02Q%:7Q=OB9HE(-:?>[`TRA+Y)D"<.*$?@CP0 M`P"8-)$/8(`AP!*$&V;T]UZ`EOSB00:6N).&?&G`,DH&L/QB2826P)+=A!': MPH0907SR2QHHV&))!K^HD4:++KX(8XPO*D%C&DJDT8<2`NF8(X\Z\GA0D$$F ME-!`$#G^E%&22BY)D10=/>GD2%*>U%)+)E6Y4DI72O&,%#3-%%-)--4D)D]F MZB243S_U-)19;KX)9YQRNEG555F9Q14]7X$U12VI(.**66BIQ59I-:Q12U@2 MX%6:9IL`X-XD5@V;@0!`!QN'.'+J5IDPZD,*QA@@Q9S!&N(#08X8,.KO:+:0P.L MVM"##$Y$`:D6;AC6VV\R"!?-6Q$D:**L`8#@\5X(]1IP!"!,O/>+#PG84(4? MEO3APX%FG#O*+V`(\8H;TW#S"PHR/OWTC3?:2.../^XH9-9"%JG00C#\J=))+&EITDMCNH02F5_F=&;>:NY-5)L_S0EXX((/_E15 MYBQQC9L4D'*&(%.8,\45ZI3EYJ#F%*K7H5:!=06CC;KE"0^0JK*"+Z0-M@FV M05C+%P`?+%(#KC8D8,(J!T9AP!R`Y'I8ZGX=ML(3%'6BNC0Q:"1H6$#2(/*9L;R^:DCVA$;6M+ MR4HVLB647*E+=IN;F.@FDS+E32 M(-C@BW;L#A"J80-_&I`9`-B`4YTQ&6_8L#M@%1``@*%>$EMSH,.X0W3`8H/H M%+8(-D#0?&SHRVXBT"UO"8=T*RB"`PRP&EH"P`V+<(([$O"91;@/5\E8A'`2 MP(;;F,$,,H!.%521#3902!5:@(YGR,"&)NQ!AM)Q!QXZ*$]LN,X#0%AH`BB$ M0@`0<(66:`(U5$&&-(2@"@#0!(8^!@L*RB,-0%!$$7XQBA)^(@2VP,8@8)$, M,P#A$_+XA!8`0`9Y6,(O\O"`+>#``T2$0![P.`4LM,A%J$G^K8M7"R,9JVK& MK1$)C3"X`PSZ\+4WBI5):*.C6=FFQ[3JT4I>>D8?YS:F0`YRKGM;4R+;U,B\ MZG6O2'GDG8ARC2^@0QU9EW#XGGRJ801,> MH%`&;.$',V###W[`!DFG(8\,```?OPB!&DIFB`ZG**HTME$7!R)&,NHXJUDC M4M?`VM6PM7&L1*Y(2")25K.Z34ML92M:-T*F,$69D'*=JYGZ)A2\8IFO7.ZR M(OU*E#\L@1)7J,45]$$)3FY%#*&00%BF(`$Y4.Y-D`4E7"@A@2OH60(=L//G MG'`8-&S6`6]9Z.KQK3=>7(LQV$=1-,,5L!8!S]2:!I[)76YS?V/=]=$&"$U`@W7B<]UV;C>\33!-R?#K MBX06P0;^/$"O>MF;&.^P=V#LI8YW/-`$\>R7/9:0!S5X8`!X1D&"!>Z8@II@ MAJ5]0!,^@-3-`B0$`*AB&M1`V2]BZ!=XE.@7-H@&'@PQ#T/XP`=D@.F*,;3$ M`\'!$&EH6HVC9F.J52W'6.6QUHJT$*^V<U!!-! M`A*04<:;E7MB%+PB;KG+WP3FLXQ#&(EZG#`D@([#BF$)F83<%=8PISHW MRA@=*'H'!A#91IE*,\*"U!PB8VAK>6*!/FA'.^8`@%=I=W>:D'0R*RU,4<=V MTYT63FD7XQH;V""@HDLNJP^#:@"T&@#,#:=O@F,]X(QB#\7^P?4Z=?WKYNS: M?(O0A`-XL`<@P/?8Z;6.#)8]"C.D(#X$DT%^@3!M`IOS8I\5,('Y8V`!`2%H M@$B`Z7F`JY.E3#[_`D`*Y`TR,KP"4J\8$#ZB80M8N"/WL(!%&F+*8A2@H`\9 M0.**%5&B@\O(BU);.$%R[/"M+<3'0/9J6"UN\3AF7.,BL2/<.MZVC?#1)CD! MDY1/SI-#J@GE+V^_^ZEB%4B*`1?ZV-R;)1"*OU)@#7L*BST<*RAI\4F-4@,% M6(`RX&=[T0"&84INP6D```BG$74.F`!FP`G#%FD.R'5>1VF>%7:P93)D)UR> ME@4`4"V(H2HR``>SE!AO%W?`M&K^```,`-V1$?R<`-EN`O'>0!'B!1#0`+3<`-Q,-M M*>1M+`0+^&`()'(A\M"%,P0@$8(R$J4*U/`>'O`+9(`K%R`/))0,$A0">Y@, M?0!\&.(B:D`-X&4#R:=\,>)%"E(0E M*O%DX4=RG^A'=&-R)Y`*?V`,^I!) MD9,*<]9):7$Y"8A9G\,8?X$:J"$#U0,&D1%:AW:,">`+F_`JG&(ZD*9:U-1: M'XAI`"#^6Z:T"+65&!`4!>V0&-VX!WW!7'M@32,8=ZKV@C-(=ZT!:\^5=WUG M'+'V"H`77H)7,IO`!B4C+XH7#9:W7HV'A%6@,:(3#$"P"$W@#BO`#4U0A3[` M'JK@`$"0`0D$`%$081Z`AV$(,MQ@!O&QAWMH"4VH"4`0>Q]#4P_U`1\4,990 M!0X@#Q(E!!N2!I_P`?-@"S$5!`R2!OT&,K8P>QG0!X#$^0WBJ185UNVKT2J#`(V*:3JFL4`FX`E[T`Z5Z1T+]3]NT0Z>403MX)F[`TRM0SP- M8`(&L`+=]#N%QT'0&#WA=1KI2'A`5`1L``]V-PKJ5`74X5R^T02?=03OPP;P M5$_!9IRP`$]^``L1``99``D)0]DD`&OP`V?T`>?P`-F8(A& MJ7"*B#57I6.+Z)0%(9739WT/07'^5/E&9X.)6'E':_5]FIB5;C5E7Q)7@H1^ M:%(40(%(*I>60_IR,4>+?_"6`!.R4!28,"%D!($06!B`"`$/M``D+()Q:$)D,(-!?-0 M9XH/S^$;_&%A6!BIP>"&KT`&(0(`>.`Q(9`;0:`>`!("&<`?`.`'%N('!S0J M6C`-L*#^8E6`!]PP#57`!&G@`=P0#6?J.BWV"R2$#SS0!^]2!-R`!S=D<"!* M55^T<#[2(R-ZH@B!KV#S$&ODHBXJHTOFB5G"9,\`$WUT?N;7HVC")G?%/P#XG")[7`!8@0.'YII:?4`X/@"Q^P`J9G"*GA!(2Q M"FB`!A_@:!_``ZL0!5%@>A"$!PV`!RYK*=G@LCZP"3W0LB]+#7OP`3N+!Q]@ M*9KPLYL`3L<("#R0@8#1`RMP!#Y`2R_C"SZ+!CY`LDR[;X-P'1^0`&A07>BS MM5W;M0WPFXRQ"CZ`!II`#6"[6Z-`MSW0!-G``\7C#IH`"&S^"P_[]@'40`U= MZ@.#JQIDX`<\``__$0$AT`#[QF_R@0914`068@@KH![DY@/PD`P!T@1,@`;P M$+>K9PG<,+JD2P820P9@D``\``(ED@'*X'OPFI0UT!IL``91$!H'+#\'_!C709C!0IC7V4P(+(VJ$1N: M\;_-5!O_BQP:O,$:K)L2#,+MT7?^(DP=37#"+$P;WB%/M#8=M%8>5WB=X.$! MYA$!]`$$W?$<(0"1[4,=Z\$&;*`?"46%[0.?`-($OP`$#*(@'980'$*%'=9[ M)^6MO]![OI+1*\N]\)4JB]$J]TR>5:@2) MUY>]+QHE,2JC6VE'6>G'(%&P^BSPX:QE)N-!_G".7 MD?,/O"@G(-N_F&4?#?AGBU!ODY%LCY$`8)K)I6S*GP,<;W&#=^<6J]QW-UB/ MQJ&IZ%./Q1'+FHK"SI48M^9X,I`Q[?$_BX'$62'+5"R`7 M2(.\HV]ER*AXR$C!OHQLSW$"OT!A.4H:%H*PEX.#R:=.\)-IWB?^:E6S3<5P9 M-UZBHW#U1W%ER(8$I&9YSU'M2/''ED-RJTLT:I/82H]8!K2*-NYO=81S=L6 M+`+=T1(MB#3=U09IR\,WC\6TG2R$%9W#?M=#:BN35`H[D21Z,J)*K[B9(6) MX/VO,$[44C+(-RZ*"!O/[>TW*4?:/0[HK"C?2E&+]Z"Q8%$+9T`/^KW?`ZCD MCP[II4'1O.WDSG7+%RW<4T[E''WEG6[<%([27"[JSMU1&K[A@CWF!S+GY6G*B)?1R^0^`E([?4A0S//9IE.HZ*@8[L1H': M22$&](#^EX]S!87%Z(T>VY%N[;K-Y#>XVY8.W+6,RYONT71MY2"=W*:KY:.^ MY5YN(H'M(H2=ZE&3B#?6(ZY>KZ_^S0(!$1)7ZS^M$4@FU#3*ZW"C1P0KEDPM MBE6FW@I;5W^>[/"=ST9Q#:P@"%9!#I8,T%3:W]>N\5]=X!6MFZ^\X/3H[>`. MUR!MW"?O>"&`TJ&.[ES^UVK\N54BI<"6.YFD>?=\LSH_-HOL^V?X>WAI' MU)R81U0B?DM-?E5VXWNN MRDYN=[]]R[]]X"2_T77=Z>+NRP,#(.?>\LWMY0L3\V(N\XC^R'PU/^_UWLTG M.L>0"#9?0^L^+Q'EC.LO[G&9#7Y%+;[C6WX&6W()OW+LY_11#^@/3Q1B8`]R M0`'3'G2PG?%>+_I6JG>EG^UCC^`,'MR\C/9I?_(FG_8J'_=Q[^498LV$'EG']S#;>F:3O)UW`J7^&SG^Z`_2*#7=BZ;V/,Y_OSVO=^ MO^:RWE7B3/P7D3;?7F16$I3=\F*/X*_IO&\&'$B14O9IQ&R6/# M2ASW>4R9LI++EOMLYMS9\V?.OW[U$4WZSND[,&#\4MW:]6O8L67/GBT%AD#5 MMF\CY-V[-T'@!H,?+'APXL0A!AM&I,C\XO.&((=X=)AQNDWLV;5OYX[=Y91^ M?\2,)U_>_'GTZ=6;IW!+)T^?3.7/IU_?_M.H^*?BW\KU*]C^_.N*+`(+/,LL MM=0ZD*W^L^!":R\((Y10+\*:"*PPPPAK;$,.%WM,,LPLJVRS$$,$[40425-Q M,QA26XTV&&.4L;;6$-K--QP1`FZA'7G4<3B%EEO..8F0@PXZZZ)+\KKJNG/R M22BC1.F[4'!!X$HLL]1R2RZ[]')+7)[8J:?[RC3SS**<&BI`_P+4ZJO_#)1S MSK'22FM!&4)X\*T)^_3SKK[H0D'##@LU5+$/$^W,1!%3=/2ST42+5#479[3T M4MIL\^W&''$DR,?@>#1.N...:T[(Y(Y4=2,F.[I.2EACE;6[,\PQIX`KU%3`,6 MN,9./>7MT^)\(VB(9T@U$B+ADB-258VJFXZB)&?5>&..1""VRRRS;[;+33#IL27,00 M"9HPX(;;H[GK!JENN?,>2>Z]0YK[;I/^[IKNP0LW_'#$$U=\<<8;YW@]R".7 M?'+'*[?\>_?]=^"#%WYXXHLW_GCDDU=^>>:;=_YYZ*.7?GKJJ[?^>NRS MUWY[[KOW_GOPPQ=_?/++=YYO:-)7/^_TXV[???;7C[]]]>%WGR/Y\]>??KK7 MA_]]^?U/;P*<'_W8=S\"[B^`!E2@WN)GOP(>,(+^RY\`+L7P3[ M%S<")G!^]^N@`P=(P0<"$(,F+&$*4;C!#.Z/A!#\7P))6,(;3K"%#,RA#'NH M0O[USX4A$)E*1BV1D(QWY2$A&4I*3I&0E+7E)3&92DYOD9"<]^4E0 MAE*4HZ3D'OH@N*SU05O=8F4K7?E*6,92EK.D92UM>4ME.=M*S6?K4)#^MME.E:TII6LCA"*-X.I+0&,PA%8H&L,[(H%N\:`KGOEJU[UNE>__K6N=\VK M8`6+5\3B];"#_>M=Z\K7OCH6LGZ%K&(!R]C&#O:QFP7L81>;6,]^MJ^(%>UF M`YO8RI*6LI7-ZV1'2]K+1M:TK)4L;"=;6\ZF-K.H1:UC5\O;VI;6L+WEK6(# MZUO/IC:VG=4L;D6+6^6ZUKB^E:W^9F=[V=(^%KG9;2YKHTM8X"YWMI3]+7B% M>UKE(E>ZV"4N8ZL;W>L6%[ZW?:PC1@%7D+X5*'&=ZR/V\=]]Q`'``WY$'/P; M"P`7.,$#!K"!&2Q@__Y7P`:&L($5'`<*5[C`%_YOA/>!X`#O8\,85G"`#_P( M_QHX%B`.\8`1C&$)B_C##H;P@P7\X083>,4W=C&/!SSA%^/8P1T.,(QE'&(> M$V#"`$9P+#*<82(7.<4F/C*129SC&\>BP#`NL)-3G.(ET]C'_P4QC,W,81HS M&,LM]J^2%>Q@.-_9R7HNL7\?X>0;:UC)(7"Y@` M`9YTHA^!!?OB=Z@;$RE_L8#D,'.ZT0^NM9ZWC65:9]K&V0ZTH=6,[3T;VLCI M7C.Y?ZQM;[>8UK/.\;;''.-RMUO4]3:RCY<<9#G+N];&KO>WP=WH0!=9UN\V M<\,9GO`]&[S?"$_XN@/N:'PO?.(1Y_?$@7UQAV=U8FQOBXNXW MQND=XF8[?-[&MKBX3ZYPEW?+%EC7&6R[O8$5\RMWW^[FZ-"WWCY/9Y MM^/];0%#^[[[!2;7JBW7:S>=YT<7.M$KCG`]_USFV%:WPM%M<[-7G.=0G_C7 MM\YIEO<\[?=>>[ES?G:1IWW@8<T]ZY:#G.3L7CO1R5[RL&=;Z5\7>-$+ M/_=8S_W@BW^YQ1//=;4#'=T&Y[OC1XYXAN-[\.'6/-C=_FBDDSWS`8=[T4'N M[\(?NNY[SWS2X:[W=5O^WS-N^KXCG>^49UOJ^`TI7+&>^ZXO?NBHCWOOY7[[ ME8M=]V.7>,&!C_R#-__T!3>[ZC5?^]9+_/E`#[JV0X[]X'O>[)@N/;_9'6IP M]USQS.^\UT_^\\.?_?'K_CC)7;[^<)$K/^`+O_K3/^^#/_K;.+-JHKOOW".N73NP6< ML&6S-PFDP)%#/0*H01N\P1OC301S$P0PT/]'C.WA# M/]8C0B6SP>53MCBPP0`S0GD+LI"SOBI\0A]\P1TT/QX4/(V;0B'LP1TDMR(\ MP]R#N,V+P/>CPJ-3P\ACMS1<-@RSPC'<0A\\O0E4/,CK0B7[P)(3NQFLPB0D MPSW,0:\;.K`K0@.4L"\3NXH+Q'3#0[\3P,2+-]?[.S;DN1*+,9-6T.4$[TDP[_@T[ME`\9BU,8IK+5EHX4D M($8B),9P#`0VY#ZUNT1:*,9:_"]?W`==-$=J[+O4PT)W#$;D2T;)"P1>3$9> M],47S$,#;+X<(X!R'#M])#PP!,9DA$8!8\AU=#X=A,=##(2# M_+\&A#J4\T*GBTZ,T:#/(`)"`0[G$-*E,;^;EO*2>``9W`& M*(""JKQ*#IB$`P@$4.C*25B&&'B!&;"#7GB!"=B'=ZQ"7TP'Q'P!LDR" M2W`&.["#='!*F;Q(_HL#L+Q,*I@$95"&S&P#L4R'5:S`UBL]1UNVL'S+&]!! M9:/,MWQ+.XRQ98""NN0`+W"&=%@&8E3+T%/(3PPQ@[P!.X`"V33$`ZC-N%2^ MMTN'NIP$9NB&_U(&*,!*#F`&>'/,;A#+"?!%OF1!(-M)SZQ,Q,Q,DUM"#02^ MI6Q*2UPVTWS+=$B"^9P$U/Q$!V3^-H/$SLA4AN4LNF5;!K$$A8D,S)D+ORF$ M@K&3SKDA4FPT4E`T9I[ M.P(`!1L%```=0&6X`4Q84E``!4B(46>XR=&+P!X,A'1H4LA3T..<`0#`A`-8 MADL0TQFX!*>@A7T8TCA-QYK#P"8$<8S54@W3X1U3V#O`0`Z`9?3+9]N($>_= MB]`63,)WFT4STU!LJ;JMN;JYPLB61#P7W(=EJ%%YO:($-V`=,X(!UC%5\C<]`2-8#>$?!M$2))8`:30$OA;L-2-=Z4,E> ML-$76%-$9#X\]4$=I(5XR(*;G$*7M#MZ_45X!8!Z<%%X!%G^&_W1&@P$*F#5 M(86$I+U2&P4%IX1#OWS*/<2Q7TP'``"%C]V'#;@!`'"&8D3;7`5(M80Q*.S! M0ZM"FZ2%6(7:+?RO%(C12BVV#4C:4[U%9K#1C)7-8ZO!1HO;BNW&3'O"0(!1 M3/!2,DP"9:C1I<4VGPTWI]Q;`)@!O=3!'6728+U#G_W9204`*M#9=:-8N$7< MPSM.&W6&6+#3K&W,*4R";I#5?0B$W^U<;<5`TL73;KS9+-B' M3.V%(D,P$K4#9T#10$C:7JA=8*M8W&5$N)7:M#72(+W94P7(XJ1"A8L%BDW1 MX]77YU51;!-8M[*Z#LTZ8D58<7/^442=WA1EL&Q,535[P4:D!=_<`&5(`O$= M5V78`%"8WGT0WQ\-QP,-WF[X5`!VQ>"=R!JL15IH6+Z=2#AS45P%@!2(VE4% M`+)4LEITR'/+1AT,!&5(@>4]-QY+@C53AB@%@"*]25H06Q&N5:8!L=80Q6 M2=E<.!!>4KQU43LH8I$D1]ETT56U@S7EOAA#87!DV;G<`!XNXDLXXFQ<1\0= ML_X-2+7^P]_87==WM5$LIDQ9M8=5&QG80H#H0# ML-%>H&$M-L-:!$B\L^!EZ.,F%3=3_4H(KN!-#F0U$S`:YK-O9$GVY=58@U^" MS9JBM#;,([V^?&$;C66S(X!E&$UEH`5EB(=/%3!:'#7#9E:(,:!-!X-F=?C(=E>$=O!85N<-D.OCX7]8(^ MSL8T3ED:OH0)4.C/;8-V_L5E`.A`:%.EE>=VCN=]..AY;C%1MM&4O4EO7=(B M'>@;/H"_'%S4S<9?G&504(8U/>C1=.%X:`/>U4%PS8+Z7-/^;IB$8KQB`E9G M>9S(AA;IFRSGT4SIC[YG,<[&&P"%?8;E8Z9672;D8BQC`."`)+#J/%;H=QQI M4)B`)9GG8X'S6;)N[[J?3B`&^#= MQIU"SA5GXT3E7&7,I)V!XAUGIQ1MX,1@#LX"OO[<*>32V"7GL>[<#6@#J#9. MQNP&AZ9FSW/1=%76T85F4XW-`[#I1_Y%99B`/RU&K#;G99A"NVYA90`%JK;& MXD0R;)XVC3'8#S4R>N56EM[A'@7^`"@P4H&V@RS(`LQ<4BB@X73([RS`!*WM M!OQ^@8NCX=\^X$?VQ4`07U"(U1FHU0/`A/RN[V7HA?RV`P*(TA18:&6`TZMT MAI>-V1ZD!8KN85L.YW-^4P[(U"SH;X.,AWK(;Z_N5)*VT7K`!&:8\2RH!^Y< MAC[5<)Q+@BKMX-LT:VD%A1M66@YH\!X-<++494Q(3*2FX1N`A/SF@#;8V\*% MQ`9?4CH-WLF=;5#H46809@+`;\L4\#6ET2R`V6[`\BS(X2_WT;+.U!`'Z[)T MLE_..'([M2SG8'\ M+N))`'!43VL["%D93;E!?W),B/()J`=($%0[(&H"^/#\=EXXS8*''3A;GF]F M&-U2CFW8INV)^T50J(<9$-07`%`N!5<<9P:=-4@H6-(`5W4_[X42KD]7MH,4 MX(`4H(*AE3P;YEPLAM@D,-5)*'),@,^P38%>X(!ZN-*1IO`LUT$.T&]E\,QT MJ/=>$/6BSD@?PV84/,6#;;P*S#=[%/`BOUQEJUXPGP#.)J3Y>6)=VE:N-DBI@5?%>?^O#H'0[G;%R&RU7+0!]3D5MRLFP# MPYYUU*U%R=X'3;%MCER)5@4WZ!&P:%:36S M90-Y'`](I#5EV9;5QOSK.DV!6&C^@3J%A$K=[8?&7`)(URO-2S_/`L7LT5HE M`("8`2!=BTD`["0AL"].G'T+XQ"@-%BDGW++&:1"71U1"]NG3G+DJ57O$"T7EADUL*912B%`_$&4+-;KPFT M3@.H)S;^":3>@0*EF[3!,,,DW=S>E2L4D]MNI;D#6&:Y(H`7TPG4*[]A`^\9 M)LD#B$>@UV>RB4>[M4AE(5V+F/;EM==SY!U@4EOA):',7S5)9!$'A26QV`0; M3#90(''0))Q,93F$5H4'<<`=)IKMPYE;4`1BAS.!5)C.9IT!<``M;61A48&T M>,%,8?MX=,`&^$U0&G(IS(6<;K2,]$)&9!W6G(:TI#-#81P-:9I=?=$"DQV; MP:0D`>"5%`ANF"3QHW!M:.<8E!:9IU!SO23T97F!['.=@QN\\()8]J&EU@8X M7;0D6G7E5"*A,R3!H6/<;=E7>@_*56-J/P5%P`8&`<#!="S^6@1)F8L=$!AF M65A*:#=+CE56$IC(5R,`<&I4G4>7T$(+C.9EJ&0<-`+P&8^Y/0>*,[18.=`& M2`(P+'5#Q6)4JD3%@9123/GB%#1789NMMF%H1:T`77UE7ZJK*?H06C.DLP&O MC&DTJ$7N16A1;1%ABB@!=FQ(U)Z)+3;#DFA9:6P>J7D=`)_E6/QK@!`,J4:A:]687*RGE7((0"T$9@=!XV%EJ]I)LA MNQ#U5VCQB$)[M]D$B/W?Q)*BZ7;,F#X(]ZNE+5;;/MQED4X\&$^R(V*B2^EP MXH9U]+!I-=9S4F[$(N>>^\G-]4*814/._E!!<0B6OOM(:RO5>LJV"FA`;@GP M6UY!3%CXMR_6T*4FRR``ZP#@D[X1H3E.2=#IU"2\,(DOMH$6@'J!W6+%(0+8)#"7 MJ-H5:4$H2)BD:L816WAN8I'0"&]DU/M-]C:PP>=I2&J.X51/-D`G[2BO8!CL M46`(5AH[`8``T9E2#67DI%`5BW%[>Q4'O#@)9BPKA,J`(FV4XS:3R,4950N= MY;8T/RH41FBTR)EP.LF!+U[0=UE\SACM!D6R$(`;J&R(E.GB%T&YI]XUT($!]!8!#VC0JW2+*PMT8%'& M=1BYW"8+F*C'1-U"1@Q62'X;[`O@RN.,4&WN66\[H;]".D(4NM!@F7F1"@L7 M0TSRBG&*D0U-;YA#`!`)(OI2R#)*MHR#"7&3OM%(B8[XMJ]1A@.N(RI1(E+! MDKBT@UZR(@!J%I'8;?$@+:@5+3;P'K]-Z9\-$8EO M80J/2B3;'A\C+S_*JS1LDTFL`/:A>5$GD8*J9",#EY$33N(%-B%>CVCA))]D MLG'!F40+;--5H8Q+I:@1XD,CYPS^GM#O):5[I>G::*E05K58-%^: MME-1>^`0)5J/VUK4;L6#X_$25;FZ4C-!T!N*FNI*2#C%*S[>C,FQ:E5.Y[$H=FIC.Y**H8KI%#JBL6DS^)&83"CF.&41MU+UN,0+(T*H":VUPF^ADT"JB\,#Z4AL##I0 M]4XX(=;^:8X`PZVO6*P7G\:,-*40#4ZH%!8:M.!G>4$Y7/82E5V<-NY`_X$A M,AUHGV6XBE3.8HB84A*((XKV(*03M)RJ&HAUU8:OT3/7+H\&UKYPQW9VL&DD>LG;@(K> MB4R8(&Q)A'UGC>RP`?+HB-][LU*`N=+ MN?ZAMRR6>@$5O.H0T7AF.AELM:!.J#EH.?&DL.IRJQUZ9A!L3$B\O"7+<`$PP_F=) MA9)X'P*I.?OVX,+Y/!ZL)E!0]98=N2O^.[K?4V"<1*8+'=4C\6@!C*1D*8P]R.=2 M:B#W+K&,Q;S%Q?;9!\13LZ.WK:I37G!2+[S&.F9,IU*2@L)GY9)B)S-57]@< M2*W,A#"[.004W4!A_(E^;,J!',0DL(K>C%'\V=D3'408=55;P$7Q_(?Q&8=" MC`1EI=]G7!?"0($28=Q)&<>O9,$!#$Z,B=]&^-];>%7RV,J[A-5<\$:WT1H` M>$'1(14(-40@7%(LX93W@5\\F$0%@14?QY,0DS``'6)Y<%*!ZS$5GI$8+C`8FR(0%/I/_4%C.I%59E0@4 M594:^8?^'>;$(9G0:!`)2^2$1B2$JPC&>5Y3+*36;%($")H`<,]C$WTU"/=`4)!S`?,A&"J0#*`#C;*")Q*W* M1?V/?4V`,Y"<;#C#!)Q%$J3#-/8"<10C81R`+DK4)8B$;-1#.OS$7-R`1V#" M!&1!"O3")#20SOTB3=D!*"`1CF&AG?1"QZB%;$`"T`!=Y`2*Q"%)+X05__!; M//3";'#`0A;'"^W##4BC;-A!@:0#))#C),B$8.19-T4D1DK^E-"%U(H1`"1, M`#/,`'@!49!,C!VTHS%.0#+.0"_>2Q:HDC$"8#>`AS,P0SMB@HRD0S*VWY\M MQCJ27"]P@$F9!A2`9!9``B^FR3LM9#N:8U\!1Q;80>>`X?[0"#GU$#-,([X\ MG3JRHSM.`E#$AEW<0#FA&_/5@T$R58ND(SD&21)@2A9,P%02 M#LNH1=R\CKF``DC6@T8*)D5QP%MV#(8L9`JDP"2TWH"`BAH(YI8AY,D M"^\(!1-E03U48X>DPU3*1E(RAQW^,(-P:J5C7)4[<@!6%@[ZC.6XI%<;P"?%+,-B.81]KB>!9IB&S6=\6AK6<$R=H`7O],[$_.=[+D/O M@-@P$DLW%,A,:-B&`$P;<$Q,QB=?F<0-3$`\#&*'),@!D`WS5,P[ MQ2<@U@D*TH7`Z6&E$"E[4H=C&"BZ_9F*0I\#=<.R22F`4NDE-&B90@W#:.@- ME1!FH1O^3W&:_LF%D])"0CCIVACHU.#HE-H?`:AI&+D=0VWI>P(=`1S`!$!6 MX?RGK!$%E\%G&Y3I3$SHACUJ@F::$U$8`@44M?:/M>Y>M9Y:B?!.:<"0 M](0KCSI&8)158'PKN50**A4)$N7K M4 M%3291&7^4XF6(L](T;[*:\*:E1/BFT*P*R$>6+4R3)YRI[C"*U!,:T-X++AZ MJR"M;)[&9=":)UHD"LU:JV.0:PF]6-`N;8FL;*^&T,W&*8+MBV.L;-)6VO(] M;$,DZ[(>5+,N4#P"%+KN"\17FG!EI&WY!!,=:&@SAK;8AF.!>K$/%WL"*G]V%;GV=;6P.A1F92\J.7^AZ M7(2>49=BUC!=+NQ)C^_:K:+XK>[^MF[>2NZ]-EO7$M/P6NC`\FT\2ESD>BZ/ M5LK@BI6XE!7%NIY.^0_MGD7MTBSALKBNVVR*)"?07> M7IO5&6NVW=`JVBE#Y:VZ.@1Z;N>XO-D, MM%^:/*W.JN[_!C!Z/5!;/FZ0+:\26FZ0$;`"F^?XV1WS'N[W$M?95O`UU:]Y M^JNQWA?S/B"GEC#]YN\%0RZY1"@()_"S:J[ZGJPJMB4,<_`-ZU_LY2[4"BT/ M:_"V#C``YRRZOJLM=@CPWJZ=&7#.+D3[OJ\!D2T6/`)BC/$8'W!#/(+]&NT8 MHW$Q*8^R_]ZRQSDS'^^>&J-Q=YIM-!_SSG*S4.QQ-%NS M_S3+-#>S&IOQ*D\Q-"NA&^MR)\^R%W_QMH0Q%MCS/>-S/NOS/O-S/^-S8-!" M#/CS0!-T01OT02-T0O.SWN2I0MNS0#MT1$OT1#LT1%/T16/^-#Y;=$9S=#YO M=$>#=$B+]$B3]$@+].RQUSPSJP`QA2-8@"/`=$S+]$S3=$W;]$W+=#G@]$[S M=$_[]$\#=5#WM$X+=5$;]5$C=5(K]5(S=5,[]5-#=51+]513=57;M`6PM"NJ MM+;$%[6,PE>#=5B+]5B3=5F;]5FC=5JK]5JS=5N[]5O#=5S+]5S3=5W;]5WC M=5[K]5[S=5_[]5\#]EY3"^UM=;9T=5,(0&(K]F(S=F,[]F-#=F1+]F13MF-7 MBV57=F9K]F9SMF9?=F>#=FAW]F>+=FE3-FF;]F-?-FHW-FNG=F*[]FM7=FS+ M=FW/MFW7-FWC=E8/4&%C2_P.=G#^"_=P$W=Q&_=Q(W=R*_=R,W=S._=S0W=T M2_=T4W=U6_=U8W=V:_=V_=W@[=Q.X5O8\MAA_=YHW=ZJ_=ZLW=[N_=[ MPW=\R_=\T_=P@R=Y5X5YU_=^\W=_^_=_`WB`"_B`$SAZCS=^4T56[,%N,WB# M._B#0WB$2_B$4WB%6_B%8WB&:_B&0_8>]('[(GA42$$:I$$?*`&)*X$'](&* MIX$'M'B+J[B+R_B+IT&*DW@?U#B-Y_B)NW@?F#B+D[@'N+B-#WF+GSB/YSB- M%_F)!SF.>P"3GSB.'WF-]WB0I[@27+F0QSB//_F3*\&*KWB7R_B12WF)CWF0 M"_F7DWC^B4.YD*,XCL/YFH]YFL>YD]LXC3-YFM\YBKNXCKNYCJ\XE;\XC@MZ MH5NYF"/YG_=YGYNXB9?XHZ.XCMZBOLXC*\YI;/XD&?YC:>ZFWLYH4]ZBQ,ZK)>XE!.YG5OYFN\ZF[]XG]YK*?XDXNZJ3OYHC,ZJ4^ZC/>XFLLZC$.S?,M3O=0' M_M2C/(@G_.5C?N9K_N9S?N=[_N>#?NB+_NB3?NF;_NFC?NJK_NJS?NN[_NO# M?NS+_NS3?NW;_NWC?N[K_N[S?N_^^_[O`W_P"__P$W_Q&__Q(W_R*__R,W_S M.__S0W_T2__T4W_U6__U8W_V:__V__W@W_XB__XDW_YF__YHW_ZJ__Z MLW_[N__[PW_\R__\TW_]V__]XW_^Z__^\W__^___`T08@0,)%C1X$&%"A0L9 M-G3X$&)$B1,I5K1X$6-&C1LY=O3X$61(D2-)EC1Y$F5*E2M9MG3Y$F9,F3-I MUK1Y$V=.G3MY]O3Y$VA0H4.)%C5Z%&E2I4N9-G7Z%&I4J5.I5C79"$G61BZQ M9A4ST&LCL5;)EC5[%FW:CXW.1=(5"<76E8U0N(UT;JN46>>0]4$1M^*0,*[4 M2GU6&''^8L5&&RGIM&!!ISXM&]G+`3F'DJUO=KS!06<'DHAB%)2J!`XUJ:^+ M28IQ[5$,'].HP9%B?1MW;IA(WBRX'`F)8)9((FV[_`9KI%F1I$G3)3IBF4*% M2NDI]6VU;H]\=)#S>.V;`NK6;6LW?QZ]1KHY.AFW!_-.CFV=.HU#8@T%/[[C MY(X.4ZF4Z[)+SR(QRM`#P3(&U.@K`$LIC\`()9RP("0(B6R!-Q920H=2=)`")!@?-)+**M%"8A8M31UQQRL2!*,[44(6@T[533#1_%%"(D.RA%"A=)#2/4(SDM MB$V#*!6#`CAMO54G&W%$ID\QK"&$CN:DH2.2/L`DJ)$[@&W.,SJ@%*B16=X@ MA-IJW]`16A_;RR'(@Z3X]EM622F#CS)2A;7$K[[)@(]O$!)#"G+-71#<<,4@ MA0_5\*P72G7YP`6&U?S-@)1:,PUCW';?15A>*,TM,XQO^&CW7('X?7;?>LLD MI1+KO@'7XGH),RCA,FPS&>*$W?7^MN,I(9;8W&]6QI7FFEWR]4=ND57AC6T@ M,\YGWW3IDRYI(.OD,M^Z#0,)'"![^NGG5!!(!3IP/&?!V$KIH)*NI4/0NC&\ M(RC2,L`!NY1",B6EF.H0!.<;:`1*T;2N*XFWY7P![+H4[\@Y&\%Y^/B*#\"M M4R#3,G30(Q_KBL%X[F^:7-'),<,P&VP]*AF;X[K3%JASOEL4Z)OJ`CR]DB%( M"9#OP3=N&^TF74=R<02=5#/6R`T'L)!5;?X=>(Z0T`5#1@OJLCT<4+@#&:OI M[+/+;=ZX0]D%I%FZ$61T(80^I'69I8_^&MD%PSH+^F8ZTTL!I]S2$%1[R98[ M!J<0<.K^J$Z![/BXOQ@%)C]S(-(93R5DLR)P2$$!"@`<..;7I-/]37,ZF$>` M]*"@@11"#_138'5T0!"M:2Y?WRA&C,*@(CV\@Q2DP*`>\H=`_R&H&%]Q(>#R M)Q!R4"=`A1`/XJ3P#@5TC$6K`4_+R)%"!2#(=4>LA`[!41UP&"1W2,(?*227 MCQH&#XM9%-Z<%D`(,#7B0NW9TE:0@`+VM`=K<[/&?!:@"Q((1!J=6%H8&D&" M-6Y+!<=B6B0PM(M&L2H,32Q%,5CE*3ZL:'1XTC2T)!$N1F0_6&F&-64". MCN?`D"\.SNV(>LBH0%9X180YJ$W) M'!UIK*--@A!08"(5IC5;5AX8@70(%/A&&<#95*3@`&GL3[ M$;:0H,\?=>(-]D#"AMBRSSE"ZX[^VY#&U`)*)(=:IPX6C%2:2C&`!ZFJ#`/( M8$07NAH((7.H`[F&"7W*J@.M#Y]E2D5@28&'ZE@P38K,(3EHH`!RN&]*8J#! M^RQ9T^R0R*YJ`JPR`UG)B":653&UJ2))6%H]Z""A?WSJ;)T:U332<9QJG:,8 MD#&?QSR':D9#9PXBT:BNFM5.X\C969J1DVC0V""JL@3*9V$=YUD#6L9P')7HZ]W8-#TSE+6>%RLF!]*,2AG"9!W7Z M%8GJP765"J9]XQ=:F%).`16C[8)G&U5LT3&JSD*6-=!ION/ZMCT9,@@2>KLM MYJ['PPC^F>;]!BI9^TIW(.TEQ35>1HYB`&B[*5ZH=P,[MX>.MPSE]6"\_$?! M_*6W.B6.W.F8>K%G:19!W.ALC<-P!YS*JK\1HV"`WR6%\#B0P,ML+9/4JSG( M,AC,WXPJ,E8C3GE*`W+U1&$_3M-C1#4MBD%7BOLI MJ7!OF]P3N;M?_C(YO*_UX"A!*A!7;/*UU/SQ8?5@!%&-LIH)F:],EYQE&#PY M4U'&="(1`L%(FS9^K<53,MU&ZC"_&GBVE4N'MC49L&2)/NG\(A+N\`:KMF>M M!)$SD)*[7!'[P*XE'I(R^8RPNCZH5HV(*3@4](VW\;6[4$;^](T7K6."OD\U MJG4-IJE,-ABO-E.;Y71];0I:0^<20=$]-ZF2&4J>9EF1?X;8Y0I*)%C_VV:- M0%X;H2,&K[:'5V#9@3QS8(^MT&47*!!#(_@1U88+VZO$]E-:@]W6]2KU=-]@ M<;.IZ[+5:6Z293!$C/N<[5!O6[P>S#%B#0O#3GK6Q#,M2#()_2Y?=MJFG7LW MJZ*,S9@?Z4`<'8BXS=W:AWVE#/,F2C"OV*DH.=M#;+G>WRG<-?.%9504+]R MO.ZAO$+(5E>]2Q+U&#\.BL(X^M*A",%&""ED6XAF?C@%@RFH/3O-`#L)G4'KK!>E`!B/CP2PD!^3C!8TC M!V8A.\S^C)STJ+E6A)&L#'#@IPP2J#KJ0(>,"+,2R%W.)I,R2!)ZJA#((3Q< MP'02B*DLYK(`ISN\@P\4()DJH;)X;(4J(8%2"'4ZIFU`J1@4A&,09(G$8QZL MR&)J)VTFIA`ZQH).SC2F8V_$BQS(H5_<;W,$T#LLRPP5@)7P!'`&23PJ(1\( MR1"[YK5.IQB*(5^@T#ITZ`KS@=JL3`?RX6Z$HI?``1\R#P5G\20:H0_D@SZP M:FY0X`WDXVG4:@?63MC"3AJ29@'<*>'@J6=^D!G98ZHLYD;0*/FP$';<9G,. M+$#PX%0JZ+!$81XF*(B^`8A*`7&,P&U*H0SP"6% M2*$L0Z8M088M28$LH60NW3)`#.ATH0P92B%ZO)\ MM%()5N-;O-(MR9*]`+.1-F8O5\/^"-12\Q[S*Z5`,,PE7A;1+W]"#&#K%N"@ M,&U2-4.B]19%ML2@4&1K;EK**Q!"?*!%V/CH,EY/Q.Q'0/8O(UZEE7AD\803 MF&A%TSY%5HS3-EVC("]%.L3(XQP`=CL9C@.M9J+Q*C./LU" M#,JO"DPP0`_4(;!$2V("ZR[#?'J32,(/05GC82;40B/"MH2R%N-C/H9/-K]" MH!#A0ED#0$?T0N/)9U90)6BMBT@%7_C`02AQ-$V41FL4-W`@!XH1+UKB#H(E M!VI0TPYPZ7Y.)_)LU$B/=#&HYPZB GRAPHIC 19 y83222y83222z0005.gif GRAPHIC begin 644 y83222y83222z0005.gif M1TE&.#=AT`(<`O<``````-"@&+"($-C8V-#(P!A08-#`J%!02`@X4,B8&``H M.("8J#`H`%!H<&B(F&B(D'A@"`@@,,C`L-"X<.C@V,BHJ#@X.(B(>,C`B(@` M"-C8P&!@8*BXN'AP:"A88&"`D&A0","0F`A(8-#8X-BP&&!@6+!H>#`P*.CP M\!@0`%!XB"`@(*"@F``P0.BX&&AP2("`0(!X<-#0R,"XJ'AX<+"PJ)B8B-C8 MT,C`N!A(6.#@V!A`4*B`$-#0N#!@>)"(.$@X"+B`B)B8F*BHJ(B`>)@P0("` M>$AP@+BXL*"0,."P(,#0T`@X2."H$.CHZ)!P$-C0P$!@6,BPD!@8&!A(8.#8 MT`A`6"@H*-BP2'!X0!`H."!0:.#8V+"8*%A84)"0B-C0R$A(0!!(:`@(`$!( M4,C0V.#8P/BX$+C(R-#(N*"@D,#`L.BP&/#X^'!H8!`0$+"PL*A(6"@@`*!` M4,C(L,"XH'B0H!`P0.#@X)B@J+B0$%!H4/C`&(B(B-C0N(!X:)`0*)BPN,C( MN.CHX!!`4%!`"#A@<"A8<)B0@,#(R!A0:$`P`%!P>,#`P/#HZ."P&'!P<.C@ MT,C0T*BHF&!@4!!`6+#`R*"8B*A88,C(R+"PH&AH8$!`.-BH&`@H,$!H@#@X M,%AXB.#@R.#HZ."H&-#0P&B`D`A(`A`8,C(J#!08`@P.+BXP+BXN)AX$(B8H`@("`@P0(B( M@-BP*-#(L-C8R+"HD``8*'"0H,"(D#@H`,"8&-C0T(B@L(@`&%!04,#`N&!( M")"HL#!@<'!8"#!88!!(8#A8:.#8R&A@6/"X&,C`J!`P2/C((.#@T/#P\*BX MP$!`0#AH>%A86/#PZ,"@*&!P@$A(2'!P:+"HF"!(6'!H<%AP4&AX@+BPH)"0 MD.#8N!`P.!`X2,C`H*BHH)B8D-C@X`@H.!@8$'AX>,B@&(!@$*"@H#`P,-#` M@("(D'B`@/CX^,"XL&AH:"'Y!`@``'@`+`````#0`AP"``C^`/$)'#($'\&# M"!,J7,B0H<"'$`=&G$C1H,6*0W9)4\2QH\>/($.*'$FRI,F3*%.J7,FRIC;@TZ41X^WI*G4JUJM6K M6+-JWM0L.*=7A0*4:D19UBC/JUK=NW<./*G4NWKMV<8_/JW4M0(M&C M18$V-;CKKN'#B!,K7LRX<5N^D"-+#KPTHQC'F#-KWLRYLV>PDT.+SJNT\.?3 MJ%.K7LU:\>C7L!L.W$6EM>W;N'/KWJTRMN_?0'==YDV\N/'CR!$#7[X78E.H MR:-+GTZ]^DWFV(,:'4S8NO?OX,/^4\];`PX>SBQ4NOKW[]_`[#TD_7R%] M\^7O$TP/I_Q\\^8=E%^``?X'8($(U?"::?$UZ."#$'Z%X$'TU4?A@03BMQ^& M^QFXX8'_68A0A4,H&!E[$::HXHHLRA2@B1Z"V!^`]66(X8TXQIBAAPKB-Z-D M*+8HY)!$#HDCC0,>J20656+:WY'E;'B6$$+"$&>8Z M8$)2#R20_*,FFF;VT0>9`N5(XY("AE5#D!]MH>>>?/:Y19:`!BIH9EO.>9`0 MZ_1QIIH;-/K-!O\T*NDWCZ)#Z:6/2@HI)+"L@T\>&^XW4%GX"/'7AUPJ=*=( MTHA@Q:O^K](B@JNPOBK"1H/FJNNN<+GI::F(OOGF.K"86<^B:B:K[++,)JMI MI)`NVP`Y:*:3)J?*HIEMFO^8Z2V;W':+9DC2+&`)&DN@H:XE[*JK[A+L.H`K MK_36:V]/RFZBKZ30;K#)L_UJ*O#`DVY`J<'+/'JIIIA^D["CF9:0Z:,2-XQI MP@X_&I((9?2#AAUV+$#,*/WT$P@Q(CM#':LV+&JKS8\1:Q\K9CVPP"VFF/S$#7?^/6_?'6;;L/`S M-]MTUVVWWXC#\@KAAQ<.BS@@2?/,"!SM* M^;Q4',)-2"['%/WHU%:68#3?]3K)G%_B-W/6K6(\[PJ[<- M/.#>TWVMM>`[VZBWXFYPK='0'_*1\OU0`>@4X;^._$D:"%3$]"JGB(T<$"0' M'&">&NA`Z5&P@M;+H`:WXH4->&$9#_L'.M#1K6[%[UB0HH'\G(:^;ZCI4?_X MX#B6,8X:@G!A!H-4#AL5*6A]8Q/^_\@4Q(2X`1`2K&9`_`=*`*@YD6P!@8=0 MP1$^L041_,\*A_!&`P_Q"0_@:@M4H,4ACG"$9R!P@8K`H@H^<8@S8!/6H`381C')2-YT'QPDJ".+&4^0`D*4*#2%K8LF0#)Y8U1 MH.":BOA`R2RQ$0\L@)O]L(0/2E:R9-!BF"A8@C>D<0BMX9(CTO@$"KC11A]@ MK@T"?*(*B*H"*WC$"MQ`P1,;&(A^+."-'>O'4O')UK:J9!FA9-0WQN&%N88A MDB``-KV2748)'I*&%3HF MY.\6^=.`-&$0HY9(]]'`6'_KI^WHYB:_G0-ID5)?/11%*21'$EI*MN$X'A7* M<9#AKR+=+&;(?J.\I3VMG$'B/RI8@0HJ:#2$E8<&*U:.NOT8!1ZA>M0& M>J-D\@BWN.4Q@A$@3T\BN+`SAGR(;605JG#,L!6(2]W26N!;5-)Z- MNE'U^]:BL(?JOZT#,#0BR)?BT0=(U+!;LS"A$?2YB3ZP;1D^XV&21=H-2'SC MDJ8]"1/^;TPN,2:C#&++\P$QAP9LTJ*YVAY)NK.=1P2*`8'2&$Y'N(GB-/[4 MVAZA!14^@`9Y<(-D]L:WTC=XIJ8WG7S>\E[1CD6M>C1@A274H5QK3;=]#"%* MYLF%V.&@*,>E#Q:1^D:Q7,@ZG0T<[2ZDU"9";A(`0CAR'@C$5+OZ6PQ3V^7- MW88/:K,QG0J^G@:TP@)*1@P$RH,8C^Z(A<7>[?9C:SZE6S_]8O(<=W<@AA*\W0NP`*';X MP#WU-VNUERA?0&G1(P(L-C9Z8GZ8YVGJ=X/UDH"VYRL*6'NP M<'N)4GOR1S@_"#AH8GITXRF-L(0!F`O_1W885T1LQVH'N(,*."P'V"GQ((2U MQP_*-D`JMG@]5V%;A4LKYS')\VU;4V)[PEP?8$7*9'W%I2>=$PB1YVW=-`HX MU1':UWC*%39!-7TX.(CV`H1"`(3^6^@KP2(L9"(L/T@[\\=[:L-[>4,48=>$ M0U`/-?0*1=0H"=,M\Q>$M]=J/!B$B?*#B1*!)?%$3G5WE<-<6],RFK9X`51< M?S<]TN!4H^`-7N,J=O`Y84A4\N(U6%0&>RAY3M5RPJ1=_<`-7I5&SX!T8$.( MU%@O^.>#%L>`Z_`%I=B`H^@F1""$V5A[AR@L0B!VS(`&2[B.C<`,0Y`FBF(F M$I-#LP`)6"B$H7B(XOB#P_(%JD@2Y)=6#O",!D0+'M@/QJ@(1U!TVT4,/K`` MFH8YQY0\)%@RV\`-(:,U]*1<<8B0*7.1=\@1U3=C'Z%];6!.AY`,RX>0BK`` MQUB-,`G^*.[7!Z:#?_PXBK:7>Z'8?JCHC>R'#TZ8"4*9"8V``T+9"$0)"R#$ M*6PC/J/6)MIX@`F(*/PHCNO`%B1Q1[1H79_@`]_G$4#5#]24#'TGEBIP"`?9 M#\G@`].3;K=%5(PW+]+@`QU)5-R`>,L'02*PE=0D#SZ05LV(>#$YF"WRB'?# M:F9"!-]H?]EH>I%(>_@X++DPE$.YA$0IE'`P5QECCP.'?XO9*8BB@XQ(>V^" ME2)!!0ZP`-P0"*S)#P!-NP#6705=)@"6V@5.6RFJVYEH0GDBV( M`MLP"MS@#4`';RI9FV70>$YD!261.#>J M!SSREXV0J#NFXR9?\H/!TG].R([L*`B9D`M"\`^<@'$8IT_X>9.VYX.=4H5O M\IC]:)JLHFE>\S6W0BYSZ0-NI`@^4'-64*#3&#FQ-5WUY%4^T*#E1Q(VN$5L M67Y/]`R'D*'=.:)"$HF>B6J%(XFH]XAR8W&^<(JP(`0U$)3NN8Y"*9^TUFOV M^0TQ$"V=)J"J4"*0`48!!,# M%)PDNJ4K9.1N(/Q(`0LX(5<&JB".A/^;.,FKU!VCTB>DQ@[@Y,H+&`0:,J.N,`D MYX$/Q'(L,31@!V!#EX(QVB,XN?.`I_.=IO<%D#.HJ)JJ*E$LWV@[\5@L19BB MM'..`,B.1XD+3=(DL(`IW7`")O5(&65*!P,I.O,^8J(HJ=-J3$DWJMQ6)[0O`%G=)JP4D3B$??`% M1-`F];#^#D@@"$C)L)9)E.R(!KE0#YGU5_DP6I"THX2T:SE4=2W:+:=H?RU; M*E99>_$0LB/;M%O:!S&P#V+2B(W9D[#P!8<(!YFP"ER["C)+F5X[E/7@4@"6 M,%X@4DJ&<3:T/YPR"Z!*A!9WB.JIC^R'BD+`M$Z;MX09L&*RB.W7:N2(#YDP M`(0[`%W+M4+IM8?+M0,`!P#&21C3LPY30V'P#?CCF6ZR2+/&B.B)D[DGI'>K MMZ)+F');E8#;?D7;?UN[N%V[NHR[N(T@KFG;J2EU:^N`/JP&?[97.Z)(CE^" MGE_BCZ,[O-5(+#^HF/#:DV]BJ8@R!$C9NJL+MM$[E&(G,>3^1:<*4T.D=H37 M>*E5R8WPV@>'6"KX\*A(VRE(B[?$N[Z:-R:WRY]N8JD?>Z8QB[BN&[9;2Y0< MT"1'L0X00TH3RT,FI#:B&+>EL@M"L`O`8BKS:RH/`2>FDJ1?L:$6M(JY0L'L M*SKD^*[(&J-O\B7XT`BL"[T,"X#T(03#RF2-LFOH`RFQBB:)ZKNUYR4@C"A^ M82I?(@02;!-+&J4B(0:GH!-`7!)BH'.?,8,^W!5%;,1=T<,9;!W,:ZE\BX5? M`@>K4+AXD,6%:[B+FPD(R[\$\0WUN3",\I2X*[X^*,-S.\-#0+!$82KS8_`"&+P80*S'=GP5 M6^#'Z+`'CYP5>NS(E['(3VP;4UFFZDDFYIL+5\S%HURXHXR_8E<0M?P1T?`#7<`&CQ#(-1$%,##-U0P2Q)P$]G`&76#,C"P&V-P%Y@P#42#. M/+$%V=P)9_`"IZ#)/('-,)`%RPP#Z!`%BO#,FWP<+%![;]J?H3DJ_K>P,UN9 M1YD+0Y#`ZY`WFJBNDO(O6G<.^G.G,0H107B(54P?<&(0<$R^'5(E*A$`,!#/ M)1$-Z/#^"&?P"#_P`TE`S3\P/5MP"B]@#4F@SBHQTR]P!C>-1C/]`^]LTIGQ M)\0<#@&0!"^`#C`0`&?P`UWA`9W0"=;L%7X<#F?`!DG0TDD0#H]`TO+*KGL#R$#$K"3+`N(E[N%Q\E,R`!#7@RV!R`!+KRI!RL4H#.&0-QYZ"*`I= MUA`,PG$,Q^0V#]`"WCL`=_P!^",TU1!"S]@#5W@R!Z0V/:@SV!-'#E< MC@XL$5V[Q;^]Q::,N/]7$#A,#J-%*4&D,)*2)H#3U\!"CHS^B+3BFYZ0"@>E M8MSP@">K2--LP`9[P,\D$0V=`-YBH"?>S0;H8,33O-@\;`^/X-X?0 MMLA(#D&-_0.:;4!)##TG8=56#D%BT`6R;<0+M*%9GB=ESA'M_4<\0,S$?X+KW%S9>+SK'0'$ MEQT%FDW4>SS?_"SL(\'KX.Q$G+WC/2[>0\SD>6S'P4[K(:'D#SY!V^YI>HSE M3<[$T.Y$8K#3X9XGU<[CQU[$5(KML2[OSN[M$,[G.M%_@"''`I%[?:"U88>4 M!&_H(^RU_\>$<&"P9+H%DJB_XI?;$.\6#8 MI=X%Z'S^!O:-$E8-Y3..VN$0/=(NX,\EY,FAU%O?$:?@`3DOW\:N MU/@LYNONZI6-]\FL[-R,\U\_S$4Y\9]IO.;*):Z"T,9W*T[PEQ,RH2[N$-0 M/F@B#OK#+52H@T3AYR6B*,W[$-C]T4*PW2)%%X**Q`P,\,A>ER2*%&TYM:?+CQ=9 MV-CS(`9=$GMGNISRT.5,.(8I)<@;=J9,_[`']P0;&R2U).@&%T0DIP21= M'M5\NN?,HV@L36[I^.*44Y-B]CQBDT4,#+-G7M!"U^E,%JH_SJXLZ>$1S(=B MHH2SEP5=5H8$H[C%G%GS9LZ=/7_^!AU:]&C2I4V?/CUDB)!U0H;`$1)[':QU M^/"MQC5@E:1,JY"M`AY\E6[APC,=[[TJ4Z-,.."L\P4+$HUZD/[]@]5'>VS7 MM^$,L:U:2!_5N6#?SH.O-6LAXCH[[A3M%(PS28IJAIBEYIX]Z"^`'#ZAR M2*/Z2H+HA0-/8="ERQXZ)8I'&F(0'3:2F"NB`XNRYP=%3BE*C*S*@B&*)-CP MBRH82NSDDD*3%B')5"F<%[9XX1$7[XO&'C;V()`ENU[R4E$^8:!JFD<" M4&0/>SIQ4L07*&$CG)Y.4=`^&,D,`*(ZSPBS"P]08[555U^%-5999VW5-M9N M6ZVV/K@#;YTA\,!CE4;,RP6YY(HK[CCE@#,VD4;@Z`.2>M*1KAY8KNU#/5CP M<>V[/(9HS;SR5%.-6^CZF.T;SP*8ZDA(H71+C"Y<6*@+P4C9@Y:'2CKEA\%T M!-6CHK:H\HQW';N00`]0U`LB?PGSX"JJZ$I)3*I$PC"*O]1"+,$S?LC07T@' M3$I'#UI\\$,8V(ABKIT<'-B>1WRB)(H4,4LI@%67M`LO#&'^C&H/#\*)@I9H M)MT93`QY$@Q2AT3JL2=#VX(1'8$+!)-EEQ$FR:"H0";XH81:%H/#0\T,*1HS M3YK/(\R8'$J,4ZP6<*4D'JD4'5JL!-C?'D\^U&4-NY";5L,/1SQQQ1=WU;;U MA%`/\MH@YQ;R(9S89I5<0VVV*3KXXL--H,H";!/B>K=S;)&5(PM]@C'FA_6WB*E*)1WC!2M MG6J;S9/M6;LBDU**)OH>C8KB(A@)SIXJN?T%VR`T,URYD^D508?JN=TN4*V1 M53:8>IN3\(^^4L:2K"UM2?UJTM_^Q#(TLH4J9IWHB4/\XY#TO<50B'*8P71T M)@TZ95$ZBY"@YF>0*&`*@UZ[&0D-B!F1&(\E\WG)9?IU!DK\H&71:!0'GZ0( M*;GH0_I!#`459!/&%=&(1T1B$ED%A\JM0U>4LYQZ6M,')/1C`(U8!1J6TPC0 M+2M9H2O=<62@'"YR,1?P6`<+B)"=VJQC5^NH1Q^VY9UT&A$I**%_%:A\0111?=8V0_NT;8<4)!#"NA"GC]"E M8,8K6/O@$C@8E4]G;;K(SGPDL@U>ZD,@.1$,!M:V'VR%@@=\09.<]C9#$=$N M]2D9T%+^=)`.\HM`R#MD-*:$*(=(3WD!.Z51+`1"4NTL/V>(ION*"15F8@9Y MRF.ADAP"(!A00D?W0=B;/+:2#/ZL,1@#IQ+E.4]ZUE-QX*G<[K8%'NZT9C:0 M@$,C\*`#.`QGB\9"J.E`MT4N,G18WQE"'G:E'=;MPXGDB0VY'J?'UMQ&BMG: MAV9B9`_(0`8OW7P;)==V)O-!B&\[R=I4/$D32(&),9@!E34(@K26L,Q,1WJ2 MAH@8O*M1T$)4^IY4,D0WC7$D"2TSB4N2H+8_YI(-,F4)D_("OXNT[V2#@HL/ MN5*PKO$KEYV8AD/*5U9Y?>R0,UR)&"3%F!FU,%&1?!>H7/C^PB'"BWQX(8PB M)!0`67(E>^"$2P<#]K.;L`&L]H1L9"4[6<^4JXF[LJSL6A/'(31B``-P@A-& ML*SD)-2TIFWHL/`)&S?21G*V$L(K6/?&[G0T5_58!SQ"FAFX_`F''E`F*3=# MD_$5Z$39%,D>GIG+;!KD+H_(EP,STU:[G4&Y)CF:/;CBIIW-<'CH<`EAZ`+# M',W(E*MRF$YKB8X!;5`161-O59LT%-$"G3$ MD[(G1G&*YXE/<[F17.&1(FMVI1[^.-Q@`-MP0B,XT$5FA<['I\6!L01AQB'P M`Q:RC2.N5M,'?A"!G^2B7&O`Y:M=I%1XB0KAFT0JH4&=I&*$XFG!&E(7?ZTD M?5!"&W>'5,P/*>AYTBSF*)7K&!A$Y4'1Z.Z)A@KAITE%3P2"46.L5M;-],Q) MA_31B>0'SA)"]YQ1T4O`"'>2^VPA`-8H[GNGQ.$N6(.^B])R@7+998>\(`#V M*$L24.K2!:O:O6XA[JLA9%4,NDO6Z6S+W/@"09-XP#"5$1"B53QL8A=;5OAD MSZUP!;GGO%%UXUE')H#U'2T>"UF?'1WIR+B@23MDXVTA9M="_H+IR1G0;0NB35LSM;C='[?&`!!L["MMUY&$\,V[-M@4>28K!;N8G4S^U=)TY=\(LZ!".S[.RK>-[*A0,P#085IBD/<69G/":_N[;M$?0U;HK0Q_*] MT,^QA"'ZBAH3-,&IA:[WPY`-E1<`4J"7?V,ND-5LI#R__M)/%4XIU3,IM[G0 MQQXM&[C5T%\7'AFM"[:@#WN)XC4V>$!/#RDYL!/``11`\,"GU<`5)AH\VGFC M;&$R(3"C,EHH99$[9M&VTF&69V$BUH$ M:X@/8>.7N\@+'O*`/8B*"_$D0\F"$J$>D6@9JC@1RD.E",7?U&U+OB+AY&,+>C^%%,IG[P:M&BP(>?""\(:P@!QI)$(C;VH MB>FA"A/Q"/AK$[9XPOJ``0Q*"2'\CUUR#(_H/0D)!R^!$?;)@J#*`CZ`@3]S M,T_2/8K(-4=QK-_3#)`P%%49I&C8@RRX&U*`@?.!$"*)KY8P&/!"%)>8C/GY MJBZ(PXQX-P)$Q50<-B0P0&Y!%X[:%=FXJ-::C7^`0"[`-B^ZML\:CN'@Q5[T M1=%9#C)JA'68!6O!A^S8#BGZ#CAPQGQB(M78K<3X#[$0$)YX`:]PDR[(@APJ MB2BH1CFQAW%KYO8+IA!V*!A)IQT`S MJR:Q!T3^:1M[^`OP^HDZS"0)40DVC`A#.0.58*:42SK/T(AP>(1P(`BDF#.Z MZ!GPZ\.1J+4H<(DS0)5,LXN%@(&9H#PSF:%[/"080(HZP[B5HH5`.8NU($5^ M+(FC:4'-B((LL!`5(<(T!0"A=Q,#BR#9M2X3CX*)5J(=EP(XX M\I7.^98$A(UL<<;7J+*WB()!\H!IH(MIP#-"BHF2BPD/L`7`'"08(;HHV0.N M.\%H>('Z<<$TW`,T]"1">HL]*$I^T1C+C)?,+)R'$!JJ")_^&Q&(I22?R%R; MHN`/.NDUQ@.--$0'2O#,Q^0*SNS,S_S&S)3,NJB4%XA,%SQ-MMD"=*"YTBR0 MKA"0ILJ)`$!*2V/#S$C,+6#,QF2_?8F2`"R)S`21G9A!KHL0*5R>71-)\+O* M]63/)(H-U?$5U@"7.)HM[8"%?_`G(4@[]>BV,GJ[TP+0`)W`>AB'Z[`.*((= MVKF-VO"%FIRW1!YJ2T"RT-[.G0 MSPA1H@M`#<4I[D205W*+D_D("E(>D,0\"@HFSJ!05A&VB0F8'F$0!D.'R+ND M]C32(S4<97,BUO`5BM(.=8N!?]C^@#BB3TAXQ4QXC6(1#MWHC6RK0-$!1K0T MCDWHA@W8@&7(.S<*RUSIE2&HHSS(A5V0AA3SSJJLT].XT]'(4^`)C1DZ(>S9 M@@G1EQW9*\FRM(=ST?LI4B1EU$9%C??D#MGX.^Y@@3ZXCJ_$3R'8`"N%!1S0 ML*#1;@!T?55?8$ MJD%]02>AB#.)R,GR`%*`B4-:'U[;U65EULZ@G<<9C^S(CMN`!&JY#=;XAP:P MEKRKAV()J(;ZTN#`-MWXQ2W-Q=(BQCJJ#@.%!?8P%W!!%_!`%S]JUGH%.\?8 M-+KP@"S^`)(7X`-C'59#/8A.B$M5=;F:C`8R-TL=2,BM9O@(2* MG=)M&0!HDS)G+-5,&*,,O$!A`5?329U=<")(^(:T@YP:J"/;6@W:F4:%E=D4 M4QZ^8(@DP-D249-.<#5B<6+NI:4M8Y_ M2(<-^`-E3.BW= MU4U%RKD6KL2'Z&"=BF6=+Y"C:\D[2]U4UED&6,@%/$BH9]D<-_W68PG7N=.V M3!BRY4"#7(FB?5*W;(&'OF3=ZK7>Z\5>]HRRP56/:)D%KAS[-7?_>7?_HVL]XR6$%2W=8"$ M=4`".-*.\IVH/J#:M(O%Z\`'/!B6_NQ:RPT.&[O<`V/+#<#K9#XBZ%6V7-SG+^MG%=D6M;(#LHQ%ZK%!T@8ATPP2PE< MJ%!5RS`RELF=W$UV2^:`@SCZ@GW`!U$VY616YF5N3]U1'70)MT1&%QIX11FC M'"92C^I8APT8!TCX+.:@7#?F16OC#;7D10P6YSCVAVB!Y%QEYG>&YWC^NGQ" M6M994HK^)1^"PF1NB$5FB"!I81:.(@MEP? M/E7,S80^2(=UX(>-YNB.KJ!-Y5:..$U@$C/N)=_D7B6,M,\!8AJ`'FF&5D]NBB-NJCEA60=J/9^>)U M0P)SZ0,6@+%<$`*YS+N+789,<(*%5N*;WNF('EF*R%N*S'@`9P"+1 M&8+?V=,`1%WNA)(($HT[]20$`3#>XHFZ?HL7]>N]!NS0B.LE<5$\;3KA>QL^ M/>S%]NN\[FO&?NR_SE.ZYNO#OFO)+NS/@.O$9IS4+=&2\VS^SJ[3P=Z7TP6- MU`WMP'91T)9KAWAE:$O:9YZ-=<"=/>+;N[O;N[P;O\!;O M\2;O\C;O\T;O]%;O]6;O]G;O]X;O^);O^79O$;`!I,`U9XD`&-#@"%<#P#-?P#>?P#O?P M#P?Q$!?Q$2?Q$C?Q$T?Q%%?Q%6?Q%G?Q%X?Q&)?Q&:?Q&K?Q&\=Q&@]N/`BM M4=AQ8!F$T-IJ'_?Q(=]J(4=R)#?^[B5G\B9W']FB7 M]FFG]FJW]FO']FS7]FWG]F[W]F\']W`7]W$G]W(W]W-']W17]W5G]W9W]W>' M]WB7]WG^I_=ZM_=[Q_=\U_=]Y_=^]_=_!_B`%_B!)_B"-_B#1_B$5_B%9_B& M=_B'A_B(E_B)I_B*M_B+Q_B,U_B-Y_B.]_B/!_F0%_F1)_F2-_F31_F45_F5 M9_F6=_F7A_F8E_F9I_F:M_F;Q_F>70P9*=VN3:N;/DR9JI_ M`T=6:I9RYM"B1Y-F^;@SZI&32[-N[;KO9D>I39I];?LV;J^G9Z>VF_LW\.`^ M8POFC:.B5O,O<;3RR[^3< MQX=O[_X]_/CRY].G3P4F\?.%#[^\$^$_@`$*.""!!1IX((()*K@@@PTZ^""$ M$4HX(845!NC)?3"9=]Y@J[V$BH4ABC@BB26:>"***1Y(2$R`>:0?JX(X\]^O@CD$$*.22111IY))))*KFDC?-D^-*&',[E(4NH,'DE MEEEJN26777KY)8\1L/A2;!SN%Y,[8*JYY3QK*MFFFW'*^68!,<4E)614*I+# MG'WZR22I:JJF5PBHL MJZ?&>NJNO!J;:[#&/EJGADCAV6%4E%G9;+.X,OMKK<=NZ^RFW8KKJJR]L\\2TTTXV(.K#3?H@%=N^NEE@UXZYX5;[OKH66\>NMEOXZTZX5?3/KOEJ#S] M8LQ2*SR/U5SSCKKQ[=Q1/-G':^W^//)?0[]\](!#+[W7MUPO^^S0;X]]\U]3 MWTO9Q_/^O>SE5R_V/'Y_ M_7O>YJBGON1MS7G\.V#_#*BW[]7O@0WLVAWFX3LRP8PW^Z&,++1PAQ&2L(0F M/"$*4ZC"%;*PA2Y\(0QC*,,9TK"&+.Q%+VRHPQW"\'U`BU]3)-<^'A*QB$8\ M(A*3J,0E,E&&6G`:!Z$6//ZP1!8H[,5_%*```&TQ`@IHH@Y[T44O_L<3.02C M%K]XQ"Z>,8:]\$063W@+`-T"B?.(@#MFI(`A@A&&GOCB'E5XQPC4$84^!*)D MHA*3'/3^L9&.?"0D(RE));9C@RPI$\*$]Q)"G+`79,A#'O:Q"U#N0I3.$,<\ MW#')%;IC&G8@I2G%X8Y4,G$>XD@$(V@9QC.:`I3F:&,+>]'*4>;!%`I0Y0CG M80Y0YH$1.P#F"_E(0G=*SGD6TI,$X8YPSP823JL0&-F8YC3:(8P>,Z$<_N.$. M6PR``\<$Z!VP$5&`0K2B(_PG12DZT8I*E*,9C:@[/.J.7J0#H%BH(\M&\:HW!H2].Z5)J. M,*!M;2M7`_K3COH4KM_L1S'[L82';G26!^V'.'BZU'6VDREZHL)$8:K5C=9U MKAI%ID;=&M+$4C2/<'5L92]+5[J"%::4=2EC,9K5GX*5M)I-;%?AVE6F5I:T M&QHN)D4C2,S0N2QNNYH00-,$8%>3`.A>=`B&7:!5>N2M[SF/2]ZTVO=%G2W'[M0 M``Y'H-?QJK>^YNT%([C!3?NFMQ?^DF`$#L6!T&G0U[X*.$).\7K,D2YS%/T( MQ(+YF\<(V,$2$;@@#@*C.'V,J(%YEVG M7`I+DL..N,8VOC&.6R,,78@A9@E,9VIZ<GFD4S8S>5L0 MBG0X>!1+ONX#0N&$A#Y9SCN`=)RI*6@!.V,8Y97'@^.\@P>$68M^'B\.GPGK M*>]9RY#^CO6M'QWF7C@X&<,0\Z#'[.)>&`*A+7ZQG=@I8Y'0&,C.?C:THRWM M:5-[VD*^I(N*PYN$?0B]SVQRI]TA"V(_8!>2V,6E#1%.1IB#&TL@Z@["R0U6 M/].:SK"$(23MC'5S-P\/&*DA'I`,2=BAO,\\`D*30>N<6EK<+3"%,[A1<";8 M(AG.,(4AT%`&4SR\#&4`\`Z8L`-3/,`2'""P.Z(13E9/P^(?8$09_DOK!P0" MFR"OKCDTG%"%*_H(@2C#+O+X3%LXPQF!@'=U/VV*:3@#H79PL3GL8`N$W0YV:/$#$#H"9W!3%N+NQ1+$?@0<;MT!^][^P33"F0Y:VP+K ME@!Y+Z*!=6Z`O`6&"$31H\Q=;F#S`=\FO!W^3?1MJ+3@'RAZ-,RQ"V<4O!=J M!FRXJRL+PBY[QD-["16J+?K1D[[TIC_]B)^43R+O4V:H$+C\845*%D[@?*(@X0@'O9EN(7!XC4(`I MW!]E=\AW"<&7+UZE'0K\4K&%@@*401X\6>RYPP[L@M.M72@@E"7D@=,)DRV, MPA(0PC:,0I010NPIG2%$`T+)@]+^L1O5<5E*'0$3H(`\_-)!-4`+C`";'0&J MH<$1V(([>.#!M0%4H4$T/%D+/%4_1(,LH$`_<("+V<(V6`(3,!Z!*2$3\B"! M3<,V<(,Y],,(+!D&#H,#1)\[;*$=+)\Y:%H_6`*!_54Z*$!.#0`36!Y"I5CN MR5[L<5[G,=OGL43HR:$>[B$?]J$?_B$@!J(@#B(A%J(A'B(B)J(B+B(C-J(? MNL.UL42V%5E,H((L>"`A9*(FAISMX1[MM8"A[55*#4`.[@"J.8$M7%TO/-5W M)!VID)NJA4Q+C568E5\X>5FJB M58)E57*E6%XE51)C6,[>5FKD1FYD5KHE6H)E6G:E6IHE)I[^95M:I1R^Y5EJ M)57^)5EJ)5IZ)5P69B`*YA[:Y5CV)5G^95YVY5W*957"Y5;>9>RIGB)TT&SP MTTOD@#Q^Y@Z$)A-T8@N@`NV-)@<<@2&@6AGH7@XX6-4%)2&4F).9@P-0'ZHM MP0,LP2A8`@*8`ZI)0@OL@B'$WA&DYB8S+<(P?*@D,^U39, MWBB,PA&T0-JA00O8@A&RV3VJ8`XX@]:E5#^HH"QT)Q.L9QE*&D)M9]CU0QOT MGFDZ)Q.,IRSD)T(9`A/X8]6!9QDZ@/(%`A.89FB&9(O]%1I\`C&T0#0D9%`V M74.V0$J-P"HBU#;$)"KL@'P9*(+^AN9IFH,K:B@U.@!"$2&J!0*$,A[W18,# M$((2]@/W30,Q$$)[<8`=0-\NY`#C)90'SFA";:0Y.)@SM.(;J*7RF.4;FEH2JE3HFF:DNF7 M9JF6BFF:HJF9:NF;MM8`YH$*1/MB!#F.N!H(Y;,&M.J0#'I\=$,)R MV*K)I=W^$E"GJ:+"4B8<.^H4$^1`"[@B"AC"%N1`#J`"`G1G+PAH,L!G>B(` M(71O;#`QQH:#KK/7Z"+"#`O2;?>T8#XVD=L)IJ MJ;*J*3#",/KC$E(!`D1H0@5E2LD#M3YL#L@",")4.B``*GPHO98J(5#!$60B M$TR#SG$J4O4*5 M)61BKAZI+#QI-0:C<2KI@39KJ4+EE=ZA(E#!P)9JO0JLU$JMTG:HTDZMU=9K MI7(MUG)MUX(M;MT6KMD*K*=&UV;*C')(!\T^ M6`MLJR4:`@J,`A-P0*R.!ZTZF>:BVBALZ\32Z@!@(\::IK^ZWR<@P,0>`0NV M`#!FH',@`'26)@#:`0(@P+"J0&D20@YTJ[2"J[@R`L8:FFK&Y[KJU/-ZYWC* M+O#RH!/D`'MPZ_3J*T)]`A.4F"6TJ$Z5INPZ!Q,\@/)R[^V1*\-RP^]2*%"F M5!F,!R&4J#P8JWQQ`Q-D;R50`3<8:_%6@C_V7LD^`P*@[#/P(!I,:_$F\/AJ MZVC&'_EJJ^X"8"@0@NZBVO$Q`17^&"FYJFQ,&IJLZJZ2MJYS,&T=I@?H94Q,D?V.D<,-\3L?EDFX1^Z.3*2O&Y@"JD6[QGFOO54+L5FRX?H+O M`N7MUK!\A:L_+G`3%Z_*+@"2:FB^J>P(V`("+$"^]6(+;,&F+4#YQ6<0]H/G M?D!_DFLY/F_X_M5VVL$/4`FSBB+$D*25FA*L=D";$$+',$VC`#QKN@S\N\H/%W_@N*AM0`Q MT*'9]ZS==AS/.?PYVS-0P38D MPRA[I@\@5!G8]3"G'Q48X?R2L1'V@SR4029KKK9:@C/\HR@W\42S\[*IP0@07B`,P`!XMSR8PD*C-'5@K\=^=W@?P48S MAV<&`@J(,A400L8E0V\>MDN;I@HLP0@L@`-8'#$$-75K=R40Z`"HLW10P2-P2A,)0A<(2>!PQ/`,^3T`G[=S8.]31T<31R[K>1#E:BN0![F".X#7?9TM M].]L*W8(_O0S6`$:VX$#'/9&;T%C,`S%/DS!+I3,\('6)P#K#F04X$5?(!B@\4'>!TC/#DQ M1(,T$((/!()B;_27]R\C+(`=?`)/>P`]?\(#%+D*P'HE?`#@V0$52(,F3[HS M?("75T+^W5F""G2LMI9X*,1Y,NQ",C1S/5O!B7-#-'3Z;?+ZWREV0&/ZM3O# M%G2L[IIZ,GCF,W1Z,B2#'AL"N2=#)F]!IWN=JW]U\7T"(]@!,1A")82"UWW` MEP=Y)%9I5(8$=BM"`?`[P2NL`RR!PEJR[U(!&MCUE^\[P4>\Q$\\Q4=\9O?U M@T+\1ILD`MRL@]F"?`4UQ!.\8_\Q,^WRN;YPUL\"=>J)8OR M%ABA,W1\Q6NTQ!."9<_R^MI+@]BC_*Z/O>); M@9>__>$;?M#G<+"C/#R#O==#?M!C^N^VL./S/;EV/M@;?D.7_MM70NW?/0;C/;FV/>7'?>^__N'O>MIWON+K,.FK?D>;ONE[ M_NQK/HS]NU2^TTL4@.9KOA68,N0K_#U[@`,4?NM_?=OS?=PK_MX+?]O7\\V6 MO?J;_?=7/P*4K'R7O@\0PQ88/'WZ^0.4?0M7/Z:G%`IX`$`@H#*PA3-B`@=* MHZ)0X4`J5BH-M/*I7[\/"!\V=#C^L-*1BLX0$$+3;Q25+:/Z)<,(<:-&*I4B M;DRXQ4D_-%8X+NGG9(M&F#$=5L(I:G6HB*RB+2*<.<*SEFU;MV_A.OH@8DM916+QYM4K-L=>OW\! M!Q8\F'!APX<1)U9LE^RA`7`A1Y8\>:T3;M(8%_"[92"A#Q6K:N9,!8&'3\\J M->P9D9`M#ZRI?/(P].&63P\YIN:\)0?G'*4_1;/BLJB#B@["FJR$H%(!0L0J M&D*`T\HS;S!E=JR(YFFE3Q]21^3-.ZBTTSBU6R2T)>*G+(DL8#%/I98JA*=$*!O84(>48V_B0R#:B-C$(J(@^8 M4C"W3WQ@22JF#C)D"PI7:R@UCLR;[<&1B*%P+\;04HNR&_&01RX1&%/,QQ^! M#%+((8DLTDB]&%/$,1R9;+*RRY(,S#/0"-',H63L6``%;FQ9Z(,R1@C%`11& M>0:!+Q>0QYGF$'B@C&3DN6B!$P8H:(E5)"FDD`LX68)U!S:P@INJ)1),P?H7.(Z']!8X*5/REB@#$L* M2`\\*XX8`$X[:./(HWZ<:4$:1]'8,S]"*GG`F0?D*2,I:53^`'.!0/I!X8-: M%SK0)N:6:Y`W`P-Q(!`4G)%(56*X"82X#/M):J*/UO.N#&2JJ;CA!H4X M4_MRA`>HX&8$--A[YLT%+/E$&OKZ&<$2=_4JP*ZSTG)2,AWGZO'(B2FNV.*+ M,;8XR24=[C@RRZ2IRZ[`K/B,*BLT*\`*9B]R-!"<#JG($H(E[(>;%N2QZ,RF M$$#)!VER=B+:RS;M1P4$+9!%+@LPE4U>P(J[6M4ID!8&(!RG MJ!O-M3?#O\&.4'5*1IF,:TV"82$\] M0?`^E'1R)PDX-49"$_Z4A,4E*4I/3D)C5)RDXB`U]F,JE)&):L(N93Q!^EX8,'^"`9 M"#(@%:9B/A*.T0JV$<$SYFB)!7!#G-U$R4T"P1EI>.,#/G`&@J:&/BY"4('G M&Z1""I"SE]&S']XXX4>2,;.[/5,SCBJ4/0^9N+&-`H("*R/^KE#F#46X2AHH M68(=R.D,:0!2&K=*1@N&HS`J^%`^6WC`=QQEGR&J)!G-"B+3ALB=!R*@0:[[ MCC>X,4?S'0(E!>L)Y+I8$6]$<`0$E88+!>B^;";5@&GL'0+8J"G4'50:X*3C M`3OI2L8PS$;%Q`,?);9)]/51I%9ZYE@OJ;"E89*@ILO,,SDX2RYR\9)TK:4? MR_+'L:*/E7IMY##=2A9/RO.LRG0D7-N*6((*EJ]L767*Y(G+4,H2D'J%JUOG M:M;`BO*R:M6D8-F:UZ7QE:"L+.PH`0O:Q?HULB)M+1?)PK0D*6D`%/"JQT`6 MI<,.$JZ6[6#YNJG7DJ&`&&.S1$3^G$HKSOB@(B_K232;.9P'2K4^"WC`GCKH M@%&`RF;!O4L'(_@TSMQE`9R1&DPB&$?^Q9&$F!&-%9M[0,W$5E,17(`=%);! M7O6D)W"K:'>E00NFN["-*F-WHZ@BV4-:A&0P#!IM83XT9D;#=QJOFH8%PT,@4L45T(IU2(QCF* MEZZ;_2SSTN(\KX(U20IS[`-9`:S:..\9=\RUK=&;C*?I0P1,=N%8[=U6&X#_=8[=_`! MT1WQ1%NZOA53(;G=-`E*2G*72L"N8`WQP4*<.@JSL>? M..X6I":I]%J!4/(QT#,"N\Z*R(/"HQGO0RVR)['5YV\)@9L5DOA<'SP9608. MWT@#YY%1(`"'?[.P"24<92J<&\-F.:I+!T(?!UB!QFA<-\$B)3+J&FW5""K4 M5>CS12JH;\:]0]G8S/=BJ-)N"UOX&S$0Y.(=GT_1<$X25V\+,1ZEV2[=_,`1 M/W`(BG.\D\<`43A*_I;K\YS\SC@`QR6# M9U'P(JA#PR&R-/D.4E`E6T6)2G12AGPU2_.O-URSS,;E+421A!!:` M_\K"!W1B%(;._DQB8XAA&]I`'K2&`"60=4@.F^;H`VBAY?0.!1;``<:F#3I0 M)WY&`DEPMJ2!&^3A<-"`X\!.[,8N\/C/X9B%<'S@$#K/:Y)!)]K@6=!.7-3N M$'2"=M#F=<:F(J`D<3Q"\N["AWI')[8AWSH/\BJB#!R@B$;"?+PAXI2$8(@A M<52`*9IEWO!(!5S&J*3E/2K1=+9@&JD8LA^I$)IKL`!%1[P/(PALL9P_I[.-<\16W MH(A4(`/M0@6XS!L*\G7L0`6BS#:H;NY4("15X!/^IG(LYQ!\X",C,)J(P0[B MR!K=31$^80&,R"(Q`S=H(1#D40C)!!NTJN$C/N.R#4N(J M9O%O('/D`@PGK.[RC@(!%P(TV4SU2*@R.\C"P*)'G.J+8#+2*%+*KF(V!2TX M22C*%$$$*E-X\C'`TNS8`I,X;9,Q$+(G"$:BS$,)%8$6:&'R](P*ME,X)U/` M1D8[O2Y):C/7K&`D%$3HD)&VPH[^'V\$T_AOT$;&-K]S-O=/!&B!,Z7L/KFL M1^QS_SY3-+VLS3IO-4,F,373"KZ3,Y[!&6I0H\R30?M,-!-'.TW00+E,-/?3 M+#`4/V,S.#>TRT+30`/L%;\S(:)S1"W4RWK",\,G,!ET`?MLP"#S/#ON-Z\. MX]HO>F9+PU1HXTAM<3Q`$M/O"!Q@!,E"!'K2(A<068B!Z4*&%I:Q&:$T4F#K M=8KH"().YX3NY_Q2,DDS&4R3VIXNY;XR$K/3!XSH$'[S*XGA&0['"28LY6K0 M$U.N+$3@$)P2,SXA:;ZTSW8S06E$$3X.#94$Z>QTPLZ4\53``>PRSSX.$;.3 M4^2A^1S^X">+,N5L4.>BR0$0]>)$H#IITU`!TRQTCHN2]$S_YE'=U%`=8'/* MH@H/X1EF2P0^P2N\>*V*EG)55H5M%O/E5DO M3EJ_E1X-$QC=3S?!$#O)HJ803L@#;'%`&]@.("PU0X#9P;`0BCSL'M1Z_Y!/^6@IAZ9!VFF_' MJI%U`H$I+K8LE@`-C$-<1,!2G:%#@+:>"(4;BA!_8-+S2'5A>/:=7%$1\N\( M4**H8F]I:4<%1J(?RB"V>/8(1B`0NK'/EO8#`@$"7Z=?FX4;;%`?WW-8):-8 MY[%P#?=P"9!4Y`%_$+=Q'?=Q(7='F\>K$//BS*,B)&CR,HB._BDESLT91(!E MKPHEYHU9?.AI&\+%?6ZWG1!$'D0OQXSCHU3`N3I/!(R#.V)&UFPW048NS2I-<`<7!B,W M@S4X'(ES@SWX@T%87AN&T7.B[XR!0MNA%IS-^EB9#P@9T"DF4*7C7YNCNS@C(W6!R8N?C]A:LM` MY"SU=16H;A,G?I^F?-NQ8!+3?OMI5[O-:`A%3C1(-F:V#'A$GQ#@5I#C<&Q" M+R5S@$+^%B7,=R2XIN0JV((A@W!#^)-!>6%">91)V8-Y]#!+F-+\#5\5H:=L MV(>W#25>QI$IDA9(<]YN68>H[=IXF$,L8G;].'$.D&65M,\Z=E>3V"9N\MV: M6"<4Q!@#["@<[!FL>.%RT;B:[BI8C1N_F"EX,]?^9@O8%`UH["K8J`#!H/(H)VDA8LM2_O.$;U^%PXESZ*JGZ_UO/XAR:-Z)7)YM5"QG[?]H5? MYI9#UFM&H9B51)951Y;+M-U(;I,Y^2W\L90U>J,YNJ,]FN-.N9A2>8%QS`$H M4MG<-CNKYH=;N2ETN*3Z2X-R>1D=,<=XV(-&P'CF1?)Z(FO^-]8\QS2,^\R9 M,XR9P4B"H9D6I-G]:&&E->\LZ&,`0@:B_:NJ MO(8<.S$_(AI7)KH]R\*B+[HM,OJC'?NQ(3NR&]<7>Y0_S7,:89J?(D4$J@9W M6]J%!UC/SHV&A>J&I86T,Y<*G($F$9([BW`GC1F$\%B8E9DLX.N+G!@D]/DA M6DK6HHG&"H)FQ_=9;G*;$<#JAK2J&XZ+YOB%MVWB8)%V0E:-NYK9OAJ?;^(J ME)/9])BM[YF/.66?+VYFVT`)&]/^?:Q`(:T`KP69/KAFC%W:D6&%+&9027MB M),[HA9O(B2D:[DS%8L@6\0C4TA/VS.45TP`<\I+VGX@YSYP*IJ M&U!@.U'`/J#1(D2V(GX&\/ZT67HB?B%0!3;V$.8H$#X`7U_G48;C*KAA&U:\ M=XH-&^OC"%#G:4IH%*#KJ@:FF7Q`$_M8R^_9GA4(`?38^"XUS:R`8$+$+@PJ M$(C!$M(F@II1[XPV@YS"D8U"/HI'RT=S6IAK!,`O/=WVQ8GIO^&BL17\L9\. MY112:Q+^?(.I(,G;$_R0;M$'?%[U:*1SK:,L01[LP`$.]ED$JU]'X0-40![> M<+P"P6*)0:2<01X\D!N^JU_C1"'R=M:7$`PKH@THAZY.XEE$QLD^@1M&8130 M0`42$)N68!0N)4M3/1EB/=]8U@$I!=DC!?Z8@L$BEB.E@5B,$-DR'(14[\OE MX=Q7&V`LHSIR)DYBC_&`D"2(801&(1!,PA(B-E>/W1GNXA`(9@1Z3AZ,E!@#6V.(6'"JWLJ[K)\WG=![LES3(2-A'PVRN7O090O(ZL,LDSGH+/*!(%:%(-:,2*F(^6H7M?4`\LA5SF3PAG&'"'$VM)+GA0E&3Z'ZY^TP1CN`("N`F M)TI"1NJYGJFJ!(:+`'^B3,,'4G2="C^P"D`O&\[A]/*LI+1H;S=!?I%2_RA!M MSO9JKGHKL9!IK>9KTT8+MM#,K@!"48$"BJ@(I$)PH$""!A4Y;*BP@,&)#A%P MZ]?F$()D_?IYD^90T9:#`K=8%F0"D*]!K=(JV1%)5^^$O46'NA7VD2$?@,? M-$RXL>!#91P\\^;-1QDTG\I\^I3,2E>A"!4/I$F:,&2]`BM58LB:9N&18J5) M.PVYH.W^AP1W[_W-U[9BOKH?FEZJ>+3JU0@=VJ:2DWEAU=.7#P9.VK3$X5(5 MV88]&#?V\(.]6UD,/*?CKL.IHPUY:,#<^?3KVW?KA)NTG2Q72R5\6G52X7;8 M@/]-)Z![I!TXX'($CK>7@`W^)EYJ>IED"48^6/%)1X%8H9X55FQEA1W]>#"B M7H"!I)=P!:R8EQ4^H5B`%<]X=QI@YSDDXT^'W&8@<+`5B-U0_AWY7X0('A8A M9.(%R"2%0F[%H'\(DO;2%FHY;^DWDMVER0B*HI M88&-D@22Z7.2NNL49)' MJZ&U6K@KIA`*N6FPAL6481L;=MC/AP5(HP(Q'_CF4S\?^+!=LY^IVN5_IZ:X7PWFMH@D66*B]S66[I MJGUACJGKO08?W"N^BW#%%E^,<<8:;\QQQQSC%5_`(M<' M*UX>GXQRRK02BY$'+8#[40%HR//)$DLREY_G3%>6[8U-&?9CAS,H+'$$V\X( MW8(*_:#!=M#;F'22M"V,TL\G")B(^!9)AU9B/Y>+:")05'"N@A6^J<\_02N@`S4"_0P8@L$5$)%R'H``H[0$0>TP$3; M>,8%/>3^`&(00P4(`%=0TE<_TP6EA#Z:X#,^@`;PJ6]K]VL@`5VBI=SUCW=I MRX$-?PC$(`;P@`@46H>7RJ!+.QA4',<].`4B=&"2B"`$)\S MG0=61SX$]&@;7V2A[*S@`32,XAGIXZ+])JC$XB4G)#GDT@[_)ZLKX@!6QY+8HG+7.IREXVD@D5, MU[T]5F(+G,,>L@RQP?,AX'O]D`<56F`+1B23C&!TQB#!M07^+=HO!SH[`@*< MT(]D7/,GMA`E+\^)SG1.,E5U))ON>#^]SG!(_P M@(`^@!BFB(8$]:G/?')2CY7813("V<]^)G2?]10E/2-ZSTHP@A@.$&A`0_@! MB/)3H1(M*44K,=*+GC0:I@AH.?%9SQPDPPX6C2E),TJ%([0TH$>@0B6B\0$' MA.*E]!0E,6;Z@3I1E)Z!?$8H.OJ`4$1C"XR`ZK0FZ`P'6!2C@33G4C%*THER M%:PW5>D]B4C+5MGR(?S<8TGU>$^8AK6M$86I35-*5I/6%:QB)6M?F8I7/;;@ ME=)WI7V.83H1*5JVOMR,D$<;`B%2L$ZPG(1`%B,,>UQ[3A>E?D7`",IPA$\PK1\J M^,1%J$"([.8U!X2(QG$)P9%^>!.F"#AM/PQ!B+\N]7')\B%*FVN(A$YP,UNP MQ0?DP0WL]E.4A@#?-@(,G0%T)*0(<$!'HI%>C!+"%ME4KX<_W,]9II55:Q4( MB$^,XA2K^+>5,'`9Y"&/9!B"N_.$[PA,40;HNL8696CF)]++#?"A(!2:=`:, M0Q$*&'/^@[T\;B9^`P%C1N2@Q_((Q45&,&,HCX`1&5ZQE[\,9N,&5X?](ZY# M]'OB'+3`PO%3@"'&EPPF?)6>+0B$!5%!!30LP19=#JQOZ1P(4R#`K`N&;@M: M@(9^C`(5AW9&-&0AV]?^%:$M.((E(#WG?#*!$1WQW#XWO)E`NO6U]FR!?1_0 M@GJFUPYRWB<3C+8%)JB9&)9(M701(.$!'+3.IHL@(0Q1!FYPDM0(X(PLRKI; MP(Z:U%Y&ZXB[5&)YAGG:U)ZV*&V!SRUL(:),L,41#,K=]`9XT%J,1H#E[,-Y M4L$<\S2'JG,P[ARP&\_YG7$+4!'O>4N[VOSN]XG';,#5O(0N6]2'DO$+"#D-M< MS@8/N2Q6GN$61`,%:%#`L96N<50TW>:F[C33#W[H%LC"Z"S7N,)1T0O&RHGI MA*#"`E#.<4+H+!DGQ_,NCLWPI#-M!`9WN'*G<>RPI[?C0Y?SQ2^BYAJ+O1=X M)SLA"%'S%D`=%4]W>=XOGW=G/]L^T<:\YS\/^M"+?O2DC_O!'W_VBS?^X+*` M.^7'KO67F_[E.-=ZZU&!^I?;/NG^.[A][G%>^N`+?_C$]SS`$8<&IC@#BI\(!F!$,?-=Q!?.YN#$0\PA=!Q[H`\),,<8V=$ M2\WQ@$#8X?&HX*^=<6^'9'R`$>RG/2%:GW(]UW__9PX?8`H1QPB!P`A/=P0+ MPP@;]W]'X`"!L`OL)PM'P#D#X`"?P(`+&T->&(K9YG*=`LD*$=6B'=XB'>:B'>\B'>3B#;/B'O\=\IU>' M/&AZ:PA\@ZB&;=B'C>B(CPB)CGA\=S1P(5$)K:>'LM!ZF.B&F14*"B!:*(!, MAN`$#[`#3&,'+2"&(+2"'1$*)V<)*#!UHV`.-=@12W`XJ;B*R>(`3.`,VR`+ MIM`/YG!SS]<+\.,$3XAZO6`T*$""_5`&"G!:'R!:IG!R:%`&[L`198`*[A`* MG#,"#H!9IY4.'!%Q3"!:=F`..G-?)TAS02-?F84&B=8/ULB#+9`.&=0"O9># MNU",RYB/';$-SE"+O==\F\A\>V=S[L!K2N@.O1!?T]`"2S#^`A`Y"MUV.,E@ M"MTV"@/@#H&P#1^X:1UA!^S("`[&?H2P!.EP<@CY>`BIB9E#I)DV))E62IE#&IB9O(E&FIEEA9EFRYE$$) M<.ZD.V:F"*^WEGO)EWW)EGRY`YD5"'DP`([VD!EB"<-@--G8"]/0$1_'!(;@ MB@K`$Q"PHP19:9:$L@@B!&, M4'2[T))\.9?HN98/&I,V>9-RD9-0B9X2"J$0NI,;ZJ$?&J%6":)J^:$:NI`.\&,)#QFG M_&4+)B*@+0"=]\5X/2H+^!B=`3D-O6"=^^BCB[J=DNH.J,"@90JDO1`-AZ-H M:3JD/:HS(V`.I>H.RF4+#/F,MC";'<&@@4F"2ABD.V&<. MX%1UXO"*FAJJPRJDL@"'%3H7T4:LR\JLS>JLSPJMT2JMTTJMU6JMUXJMV1JJ M.?`2PB5PO1,26:BM/0JG4JH`0"IY=L`-$B8)*P>:"MH+[^H.X!0(TS`-0=<" M47JK74I95'JK7]H1DQ.JQ]@/3D!S/HJ@HP"JE%FPC'"OTT#^E`([:`I$*I"<[G2W0H]BP`PP*I#LP M#0_9"XSPGN+@LJ&J,P/0"]C@#@I@-/2)#2T@C)JEG`'K#!@;J[:@`+M9JU#[ MM%*ZLT'[.-M@"P]@#D`[KNY`H+MFFKMFL[I-Q*1P`S M7)7H$(1P!UU;KOT@#N?JH[U@#I*P#1_9#Y)P!_$JI?[*"-C@JQ$PN(8;`5[: M"_J*JT%[!'@PG7J[J6C*I^0J6@9;MPP+GQ&`#0J`#;U0C;M9L7[:"PHPITA; MM*K[J0IPJ".+L+$;`8Y:G?W``9;^2ZZ':@IZ>P<[\`!\V@N+NP-YD+ENRC2] M^[.9"Z2CBK"390MWH`!':PNI:PI)@=N&Q)PJZ-X*0MWP+_]Z[__"\`!W+G\4*7G M>@=`VPN)M@N\D&B)`)SZ.@WS@`V[R0@1D`@=D0[#L`/\H`"0&P$9@@:],`\0 MS+T9[`X-69C^_#L"XC`,,A@!C\/$SC``(_N_N3:\00L'IF,.UHL1.Q!-PV`+\)/! M^V`Z/7H'/28.X(L";[J;>>O$GS(_>L.[Z$(\8$\Z1L71\02CZS) MF\S)G>S)GPS*H2S*HTS*I6S*IXS*C8P*W;H6=NDW^IO*3[RZU)G(=9LTSJB> M#<"]'<$!NW`'^OJ]#4">ZRK%P!P!_"=P1DH`&>3`,J^L,_)4'+-Q,N]``\T"/W)P'T!S$W+`!]-B[_LNR>HK# M';&GUH?%_)NPTQR<_.#$$0"]"C`*VS"E"C":NQ`!W-TSGMR:N<%F3V3K"[4*]K[;$C@`81VP"6L`O`0?@?ZC=\ MSK^W\-\:ON$*T.'TW=_9G=\;GM\2WLCT7;=WX`G#.[P`K3M]!V]_S/=_4'`'G2N((WK_S8`Z#Z\O#2].2'#(N?#N&MR8.7[J`%[<#F;>[F;P[G<<[F_@OG=S#G=?[F M_!OG=C[G?-Z_;<[G?3X/[1#H>Z[G>7[H;N[G>0[HC'[GA*[HD/[G=1[HAS[I MAMX.\[#F[KOP[LP2[LPT[LQ6[LQX[LR:[LP*X%9=Y.E`BN#A'1 M6#J[^[F]^[^[^L^[]INZY6, MZR66`[R.[MQ.[=P.[^(.\.`^\0?/[]_>\1:_[0AO[IS^[_SN[N!.\2D_\A2O M\0J?\O.^[0#/\28O[!L/[.$.\S*O\CJ_[P9O[@:O[SL_\^,^#Y6`0_C[T^[M M#IY@XTWO]$\/]5$O]5-/]55O]5>/]5FO]5O/]5WO]5FO!0"*V1G^]5&?*I-\ MZ[C^TKH>$CG`]&4/]W$O]W-/]W5O]W>/]UGO"81P]*T/^$\?`/^9E_^'O?]_R3OTK/])0_#Z$_ M^OK]]J%_^J8_^HWO":W?^JNO^JO^3_H<_OJR3_JU__JI7_JRW_2H#_NW3_N[ MK_JZ#_O#;_JY+_K!?_RZC_RN+_RV[_NUO_O2S_JE3_G.O_R^;_W9__NQ;_W- MK_W![_Q:H`6\G_JXO_W?[_K87_H-#_EK+_G5/_S(S_NTS_JH?_U.3__S+__U MK_SV#Q">/,T;2+#@0($$YQE,R'#A0H0)!4:D6!#BQ(L&'R+4V/"APH,813J4 MR%"BR(,?/494"-%EQXDA7UK,R/'BR90W9<8$^1+D04**A`H5X35JU:8&K4KT^;/CWZ=6S;N4WCQEUZ=6S6I5&W M_GV[MN_<5UTO%RZ[-^O6SYT71VX;^O#5NJTOC^YZ^^W=X)EG_RX=*W/LUGW7 MI8J7`F?X\?$`%DR8=GCTP),'#S];OW38?+MO-_R,(X^\Y[R3[;SI:-L.-OYJ MZV_!^_93T$$(U0L0N@49_.T_Y3H\[C\'Q:.PM^0DQ*[`T2X;*C.DY-/+,Q$& M&\J=>=IIYQ8M=FQ'"R!O^;%''V\1DL+83^3!))'8E,4D<= MH50221[G,=+*6W+T<4W@W;.Y9)2!-OIHI)-6^N?,ADZJX:6CEGIJ MJJM^6&BG7Z7/:JZ[]OIKEYMV&FJPRS;[;+1;S2MKK0-+^VVXXXZ:9LV&]JP^ M16:=6>Z>]8;9;XH!5UIPM&VTD62VY2L:XUD!)YSQCQ^'6'*/*0\=?#![WY[ M[H'O_GS^\\?_G7S9O6]??//#C]UV]M,O_W[YOY<__OGS%]_[\[FO?P$,,;^@"'.^1A#WWX0R`&48A#)&(+!>$$ MZ\6G"O!XQB>\\40H1E&*4Z1B%:T(11]<48M;Y&(7O?A%,(91C&,DHQ:S&,4S MEE&-7OS$,P*!1+8%XQK7,(`!Z&A'.LZQCG748Q[GZ,<_]O&.>L2C'_72D)B\Y24-VTI/^E=RD)CD)R%$* M4I2-#*4I"\G)47;RD89\Y"HKJIE.= MZV1G.]WY3GC&4Y[SI&<][7E/?.:3GL,LIS']@LPT!%2@`R5H00O:`X,F%*$) M96A#'?I0B$8T#0M5J$0M>E&"4A2C&^5H1SW*48T"XP9)/*<^37I2E*94I2ME M:4M=RLYA^I,S`/UH36UZ4YSF5*<[Y6E/?E2D)E6I2^6G M3/_Y4ZA&5:I3I6I5K;K1H+)MJ.C^7&I7O?I5L(:5J<1T:E^"`8RKIE6M:V5K M6]TJT*RRC:@OK4,OZ[K2N\Z3JRG-ZR/W>HV_]K6O+:W#8%%JV#G^M9V(36Q7 MFUK6O=#TK9-E*%I]:EG+WC2S:=AL6CM+69[&-6MS;6DM@-%+/[`4&+6`)SI/ M>]I',O:/[P#&:1E;6]0&$K9S7.T?4^M2VBJSI3WH)6[="8S?SM*X2GTL9)TB MV8]+S44"9ZU>O> M-%RWK=D%[4]%ZS32QE.VCP1&.8B0RSK\01TKO8`P=LO.VE;C`&JXQFZ1JP[9 M^J$<:JC^PX'_"`PU7,#"UU#''_)*A'+\$<1S[/!^\XEA-QCA&JQ-Z1J(,.!' MUN(":MAP+H$A#`\K]Q*(J/%+8^I= M&`8%)T!!B1/P>(YJ.``O-)U+3O`"`"FHQH;_`(`K`(/1@ MA`0D7`UZY,/<;J"$NI'@!GJLH!IN`,4!-(%GGB*O/\T/L.+;\7KNV& MZ]"#4_=ZU;U<`S"N,`4+UZ(<7F"V22M\@5KW>)9UX,4!$.&%2'CA`*D5\Q22 M_LA64R(,ZD#$&P`PYEF2NP=]Q;`7A-'@4U^BMFD_K1J\4`Y`HQ08B.#%-=B! MB!5H0NGSK#"V#?S'NA+;"-M>Y]S^O0#C9@-@ZCL_:G.]K11P3Y>9`36#!``` MBDA``0J1*($;1$$',QB!%[Z@AAFH00TB@/R\,P"`!3(/!5$<@!R10,+E10$% M)/!B#.H0[TZ!80.7"_3WXH6"&B@Q@][?5`,KZ$`D_`"*;E2CU1&5P"62/U`- MO+K54+!!">R=UAY(H`0VX#A!H7`)Y+_X#H>8ZW"`@5>4`?$([%K*"P.F\D9X#":-"UR_"U?,S`*Z\$??*U: M0(1+&$(C`(8!H\FDK"L(4X?:$H:\&D=$8#IMJ[`ZB$?_`ZYN@\*D`#`!M M5`01.`+M@@(MU(`R=,8T,(-'^SZ!2DE-\`.SG$,-D(`MDTL_J#TZ-`-B8T.# MRBY-J#PU*$9,G(1D2@,EFR@Z*++^@)H$>N`$Q!0Y=;"!22`O-7C,-"C&./P^ MS5,#&UB#B/,R"5`':E"'29"NRK(!`#`""9"`Z]($.O`#:I``)(""P@+I245`@,4XHPG*X4RWMM3HP`GJPT$03!1\TL/X"A2REM2*DA#?@ MA+KJ@$6=HW(`!1![."`,`TKX@S!H.BF+41-%T?Q+*<>#0J]\@!I9'48H2]9S MO+@Z2`,_I802@#4S\((.,-$2 M6(-G.P%QY3AJ0#3MG(1,9<\8H`(,WZ$\-^-*GHP<;J$M'K0914(.2M8%Q2`%Z*,<.L+I-Z``C.P`B MJ(84(`)J4`,+>`,;"(,4F(*0@X))`(4+<-0.B$,O&+T2L#KR\[(8"`-$*+A) MG($2+8$4\`5:O*@#+9D$!890D(:\D08'O;!"]#5>2(&H+#AV,`-EXSV7U#!B MB[4Z\,$+$$(/%`5V2`$/?+XQX"W^1.@`=DBV5/0#7O#`:YB"/V`'=G#2`.0P MY"*RJ'PT>OC;G0M2A9PEH#0L8'`%>N@`=<`V#;RV*(52C8S2.G@U$ER!,#`# M`W0##.,%#@6&.]2PG<-(0_.#%:"'NC*#3!5`UGK15;_VW*;@`DY-+S=.N-3@!7OC;@611,_`%`"`]*.`%"MY5`%!7 M:GB#,(C^!&I`.DV(A7+XNM-+@1CN`3K8M?[T@RD8PTA(/2+0@(%<`36@!A]4 M@[$=*&K0A%H[10D8!]4;2&-MUQC@A%@0!1OP@MM+M$B8Q`[6KH0ESO![N#7H M@90[@4F@!FPK!VHH!UC=8E[80H(BAT0+N2O@!2,PLCK^O$2+A1>^@HA3S4V@ MAC5XM!A`3,73`,X#`+ETN`N(A5C`8TU(`UKKX]H[`&J`@BE8@4B(A$<+*&PK M`>1;@2FX+C]-`T)>#4`H`38RCHAS:5:>(->4RZ(M+M'$P8#?%U^1JX1 M]`-B4[L*6P%>,#1Z``5VX#!8([P&FX(3\#4_2#W+CGO(`_ M,(/4,[";I(<4N(8>N%\`Y,A!]8,+J+L5&\(80"X?YM$?9`D#,>; M'(,P$`5*N()IKN9//2G]];91S1EI4`%453E-4`.*([\2GL.QW;4#D#/6RP=- MF(2++4LY9#Y>X`70#"@W*P>R+@<)B(1.@X))C%/G8[T.B+A%92\Y-(*(2P$V MA(*,I0-J4$VZ3@->"(/9%(74TP3^44"Z_@PHD^7#O\X\*!;:A9L$2*L\006Y M[^(%0_Q5/$8$\BP'-TNTB%.'LE8'+UO%-!`%/-;.-&CGS!M(1$#K?'A:(B!H MM_2R@;R$T\,V-Z2&*W"%V;R""X@$"7!H^4QM[16%?HVOY8/5?P4`UU2'-Z"! M`>Y7&'@"%%0AG8IO`6NB`L[L$2J@T!3,P$3Q3 M,3PM>$;^!`J-+1G4MAV=\!,8.XP$9J1[4A-T72G-2!D,1T-[MN=\`U`@+BB. MM57+:4X8NQN;PRFK:.6Z84I8W&KX:S.H!GVFU!#L@7P&AK_V-4,;5'8(@S?8 MP8'\@QZHA2&LAKNKAC'P@BL?L``OR5/[LSG*-E$X`5!X\**4\/S=2JX$-RAX M`&GP@/M6:@!NO3;CNADVD!D1P@_"-N+^F!KV.@7*-!/74+K84 M\!0&;-N$N,<^83/0Z]/6+L^F@_"[OXP+*,^&`F4+]1603=+^%D[*MKQH/3\` ML(%(N(*M4P.G%NV!0KENE]5^C3,-<(4KT#A1L,!Q6SDJ$\/2>[4X@X(.E-5= MDP!J,&$U8-5R6$]H!H`R]&10B+C9S-)\X`6]-N'*%.\Q\$)>B[CS&N(QD#\U M"/@XJV5K7#I-*"P(FZ,@%W$G4X,5^$&.1#0>*RQ[/$?80G!Q7G"--0/3,JV9 M!$HU^(,GG?F:G[(KZ'!BSM%F>ZW4>EJ<9D?_9KHQ^%!#2\C=VCE#(X(Z!2Q[ M?NBCJS5VV'&M;]T<_W$:"_)E\P,B3ZTC-](&&\(EKS"T?W*6%EV7!(9JJ(-, M%09WYO*@-#0MMVST!4I]!H4W>*W^,_HJ(Y:2D]@Z^+5NPY6H:4# MIET&+UB&95`'4,G/-79&A*7E!:K:4C\LU=!E M]Z=.&`#JKK4%@(@NTUI-K_7P4PN8FG)^C!P0=0)`'6#O_!A$%+5OC[Z7O`!C M"ZS.8V`+5_O16L?/!<56:U^R>C,WL)N(L@+HT&/V`5Z(Z8$J76ZK'Z77'/.B MQU1=<*NVJ,VI1A^O((2[:<:@#_#_7!*$947)[J?M:IAQQ)O+6%O_0`@`2*,"7I MQPQIX%C8&CT`X(4H/7Q)$(Y@3L1HF#-`(4&D(+G5(DOEB`)%)$08NI,9-@!@ M`Q1FE'!0#QI<<84HU"$B"C6U9BF0&688A)!"#`$+D28PE7KK!9&PE&)'^7!) M220+`B-*;2J94=Q&]*0@`4%K=$#^78Q^B**)+]1H4*6'ZVX$U(;O$@7&A-EE MZP8[:RRU6G2(7;."0,(8`4H=9H`RA63`P,0.90"4I08`O#A831A1K0$:PP1:?6'8_->0V",1%#BQ\=+L4/>7$Q10@EDEYR`B!HV4R):4\#0 M$;*3A%SQM+U:)."JZ`",P;;K#%GAG7U"&887XX7-5E`HU6Q[Y+O4%/6L"I ML]H;;\SF,"?`V`5!==B#YIOWX%/G@@)@020:F"'*&J!4 M;`9Y%XC^8H8&D;#J1D6>CHBB5K'P"A$BH8DWY,,/*=J**$01J\B(8B&Z M>D@:.&6!2&G"!J"81"P>`H4$>B02:I'4&O+!"PE`@56:@((H#C`&AI$@.&!?@A1?^L+:4-0(@#(6[ MQ!0``(`I$(V.O$#$-8@PABL(HPX&.4!G.L`+.TZAK*`<:=!*&&9@!J]85Q&#^4@RP& M4.A2RO$8_%)SOXO\@QKJ(!K^3J@6!C[`">C#%/=J(KV(N<1_QEL.=:ACOB/; M63G^0(2$/@>]$?:E?0M[79%%\Z1L%UV'!4C-#7TEPCOIE4)8H1HX8_7.(:!T:;+]&F#C>J0[X%1HPZ MC'`!*?-+2NQ%,$,76J$+=3?-F,,I&,78N1X@H1Q(4,X#A.FB"#O/%L`0"K8G^&&F8]!9;/0,U=`"E;&;UG,_* M:TU4N@Y7CLP,U$&62>!(A1>8Q%BW6U%U&!H8Q39TI><\@VIKXE%F4(`'!@;;DW;&D/RDT<% MZ#BWRH9[GB^2VWSE`2>RR2.T\UK^[+PO,#]ZV(:N\WS!',%/9WK54UZ:CZN\ MS&*_QIDUGN;,O=GBV\V)PC7@]A]^<;N40E*=OLAV**!Z[6P/^(@4GO;.L3TA M.?%#X&D4I=\U"5TCJ@BC>$2\L>X]\8RW^^!S0CQ@"$?N@K?\WMG>=X*\[XN* M;S1'.%_YT^N$3V_&*;A1_T//^X$:.&J(YNYN>IVD"XQ?JGO@/3]WT>/=]01, MU[?GSGM1&*%([[_WO+X5RT(>H M1-L<]F3^\^\)WF*PAKJO'OUIU_JQ M&?XUW_O^M=_Z!2`!(B`#IE_\P0_ZR1\"YI\$CL@,Q(`P9)#:%>#S01]X@5\( MBN`(DF`)FN`)HB!3.-3XF9%$L5X$6IP`KI[FB='RS:`!TJ#<%2#SV6`-UF`/ MVN#R"2'\J=_?5J#&C8*\I.`;PF$DX2OB`8+N$.DB(CCN$D@ML,-M\38AP>1E_^')$9& M8RG"3YW\$/&$GA46Y2C:I&02X#(>IDWZHSA:8&$2IOM9I@0NIKK$)0QVH"X& M0UK.RU30@SFE41UXP0D8"HF)`WBE!J$01A@%R,R(S?R(_SX@02L`"?475X*9D%28D(FHV<2HC(. M).`AP3AI`!U<@@4,A#FBHBIB(U+NY%*6HB2Z9S$Z)1CV)61^R!K$0%`]IG@Z MGRZZ87#^KIQ]+(XFU4$E-9=O5LP:V1<]&,@:X"8OV-<;$`$P5$P8+(X:C`'< M$.B'"B>:$6=$?>=&!F10GA^K@$*2;&9'(B=G]L@:\`)#F&,^YF7[">.Z@.=+ M$F%@:F,E^HC<2,!-2,HG]F&3"$)AGB@,AF-2XN`62J=?@J9Q;]*4IA MZ%H3AN%5"BCXK0&^6)^8+@69=MQA1%V$C`=!`$!"M4R?T@&("BH<#N>($H4>&N00"B".9E<,K:AFXJ,P'B4#0L$: M"$)VSF=$=F0B1NHU1N2G:NK^/2-'+$IDX$^15J8#4D,);"G^J'K.8.Y?-68J MC$9BK>(?-=@`.=2EJXJ"5^B:*5ZBE^*A5BX4`EG%U-&%YF#=U*7&:"0KDJ4& M':0<Y=9`1J7]1"V.T,S$U&:8"(RS6%SB"&OZ@#TAR86_Q5;9SK6Y@%`.#+ MPMC2H,KK"1:JH0K%/>HC?D8)[7'$KQ"/[$W4JY"+1[!H:/K!EWR(I>0=PF*$ M13">'Z1+[.VKXFU$131$G1QLE2#).#9L0^S$JQ`/=ETL$S$>`5DLBU9L[/'( MQ1+?%.9>I=0)DC0)$[T/'42*F="(P_+>\!`$3?T/30%>E%!LQOZKX^7LQ8X( MSU;I*LX'^F]!:;<.F"T=0PPFX02QT3NS%7M96277U MZ7_>Y$1A97=]%T/5@1&8$B=T0)%5`RC\P3E5@QM<@F,@0C40S3480=T:0518 MT&"$`2A:'984`?@!R(0TA^<`"6PW%B>P)[^ MAI6Q;S"[@B6@KV2J$\>8*=T@!L<@%U5)VUB7CZX M0=UI@":4P"88`<$*(>ZZ01@@@AE49P=T`!%PRI`F%H%T4@D@$3!,`B%]$S!( M0.XF&Q%<+Q+1`2W-`"*`@A>`6U6:@2]4`R48`6.6@QLLKZO4D!O$@`0<`%3Q MR%A4@Q?^Q&]DV`0Y<$)9W"\1J`$GA-I$J8,7U)E)Q5H'Y$,)P-T,X"^.($R1 MFL$D=$`Y(5&GY&TU;,*0LA(Y&`'UU`']&E.2T($-'(`$&(%PP1WO=/`+6X0$ ME(`;Y*T$H-K'IH$1N`$G-"]9N0$1T`'>\$\-58,-:`(HA$&G<00P&,$F<((- M)!L4Q,#_GDLYK%,8&`&RP3`56W'K9;$;A,F6*B4FKFUWG>9"K1&>T@,]H,`S*B$F`];V-:0T8%:G``[=/(U?/)B$8QB]`#^2N0,@$H7B4S7H!NK!/BH#""G"$2'76&ZB#!#Q$94"!)M!#I]T$Q:F! MO[A!X`;'KUQ`&*C(";A"0E3Q1KO5Z@EQFY;%&AP.3:&O!'CT5WR2'96#!DA` M%5'#BS0O%'0#)6@`JR266Y3`NPG^`N)63ZNX71AX@8_4T:]^))-R%SLR%#NL M4R#EUPE<0R9ULAG`1VITP"4@GUEGDK\@AEX`PEE?0QV) M4KY<0Z1$!GG$!SM,04RKJ2$-&3!L1NN"LBAS!M11QPFT:54``WF$`;BZ_ MLHC2[E"T)&!F5Z5N121$PD)H@"@8!!)$0O&L**VX@>U`P1L\*DXU$3V8222$ MR25\R?+@"!TL,Q2,@>C$`DO0E(V(@AI@Q)-4B>[$PI+0%&Z@-BC0R?V9@5L@ M$<%,021HQ0Q$0NZ4"12DP$=(T+)X!5>903ZL0"1DP`H,;ZIH MT'*03R3^D,D'A^`THX(?,H`>75X.7L\9:U();W'4[LP6; MBP(H"/*94T(;72LI#U'`&01K],`5^`Z$!"H]+(:$=C(=E/(52'8=&#HH6T6= M>FU@&<$C>_:DC]WLAG91X"L5"N$E()<1E#?IL`3@34$^E$O^2HR5!B!OV.XX ME-#(G\2$!NQ&=5%<9\W`&MCS&V#$BQ3)#_F!:S!MCGT2=3& MUQI$BM"**T2"6]`OOB/"K@#`)NP;^ID%*.2N&Y1`":0(-2P5)U0,J0:'*'@+ M3]&*Q=-OQM?RHW;*LP='1=CRQ6<\-5@`*,@(-=1&JPZE&IHF0UWY&T2%'YS` MCM2$'RA,Q;#$^9J'']CRST2&P@S^-C@E1IOG-9NOKH(,O=,S12GCD\4HNM*O M@%>BAYSB2S]SAK0>B^E.-C`<"SA!QHDY]ABX$:7+/4-9^J6+MD!R(T?T0"VI MPZA_"7(GQ*B[]]ER1*IS!'5T0Y(@CP6H"WM$@FG]$#5Y'(R75OEYPPR?!A1`+[@EMLB9W@R;7'@G7#'0@%_?$01*E0.\[" MCP;\B2^D2X!P2M?:=^<0=`!Y`>Q`1*5$"1VPQ%8T!,"76L2G"2['0K"\2JVL MCT;('C7H2G4>='!D+:I+RY$<3^>$T$0P9N[(#OWXT!14`^U30R28P118]LPB M#V[U^FS^B[\&:/[-`^![%N*4`P0>@0,)%B08[%I"A0L97O,#Z@TPAYQX):P# MK)RZ:\#4`*CFIMS$BMHD)@0& MTXL?/Y0`U*GEY\J*G@O]5*/D9\9&/Q<`7`(&#%%+,T2J7LWJ4B&[K!W\-#1[ M%FU:M6O9MG7[%FYO09OI.GA]R_@-(-[_/T[Y8`H:BOR::!V M`(!?*%-.1/(%P(89.I-!4?.;!LH,`">@@!;MA9H@45XPDS.3AAJG*QHBA>$% MFZNFTJ#?<*(&Q<+LVK>I&0&@#DKL-U`"PX:LAIH$,VIF3*K^&DD=`"*>>87Y M74Y[K#``)D6GID;"N-M^)$!1-Z/'F`.>!:?18-V78S<`9B0_,46#OP!`;;`! M([&N`U$D&*R<'I+3A).6(JF&/VJLFR^-Z0"@(1:BVC/C"EDIK3YT%J4$DABFN*`V*-0!P@QHZ5GN#FBNF>*T]3=(X@3\H MZ*#&!@E$LJ:"H`P M@"GK`)XV`F4,-Z""4TZH#KB(EY0X`@`1J%`R`TY$1#'N@#GK^',IB0!XJJFB M'#KABK(68L>(!(6Z!A&)>-&SJ8K^Z+AF5*&JX44"A7[J;JFY9)V5UEIMO=76 M4M+"^AHSS&`#N_&X2*B9`A1CO>#EQ162%0T4Q429@I-(/H.-Q?[<(T\# M^[*;0CO!"ES+\T`,\& MQSH`0`(_J`'E2K_&*`'D-`"`6*`?G#BZ0P(;?IOWX,VIBF-FQ-;P04@TW(F&IFDAZ!("< M2.B(Q)7^$F(AQR-T9YCO9-1$*6<^)`"(P5BZ@10%B<184Z-P`P MFS5(D((61,)^+H'`V[7G6E!@4>?H$3&B5`,1D#G`)423#P3^!@Q(*L0=**:` M"$2Q*'"&);G&!.=J2H@ M(((:Y3B!!'I`#29=@!JB6<$,J$&$*X!&$)ASU@"C(TD>EL='%B#")+0$@$G: M0!1=Y(4O?,$B+\#G<49,I9G2AZ;*L041E/`"$1)RJFJLP!5_6$HMZN"&2,V` M$BNXPN[J\`.``1>`=/>8(%&)J(`24*53Y__A.@ M`7V+#.S22H,2Y%>.(XQA'*>!&*R`$S/HP!40H882E$!GOJ!$"0A(#1HP)H8= M0.6_-'`W+[C!",SIF@VR-A@SV$!YDX!I!S3AAA)T@&-IN,!&,P/3?,CT"C2U M*0TD<(D24.("90)-&C:AO$MXA@X'6,$F),`)VNVT!&I80P=*X(9U-34?T%GJ M)EP134X*=]$!%8"6A`;&$@QP$R MDTH(4L+^%2=`1+=B4((O28"KU9B!!.*TBD&-I<^L*3FCB-5"(P15* M8!K=RN\UU$""!590#2*$00UT8&A]0A:Y@^;EE6N9DTI\AJ@O%+A+E/.>UZFA(XAFN(=2=0K4/_^%\#70*?X2E'0 MZQIT?<)22X^#/3)E'-:9S@VN\8&`)*PV2.S!!1I'=`!^Z M?!((+Z+ETBI&/[HA`YY5J\!@X$&C[U=^7O"UE*K0A;+/R'\.]9F;,]U4?KK4 MG/[70@$M)LB!^M.L9A^P8AWJ55-WU;?6=:Y/[0?#O#K7OTZU^\1TZE((N]6Q M'M-@2N/FF"5;E:YF**U//5U-^SG0ERX(&"#=;6]_&]SAGDNKSJ=M]"7XVNE6 M][K9W6YWOQO>\9;WO.E=[WE#(2N<8+6]^:W@;)M;(`AQM+@)7G"#'_R_!`7X MY#+=;X<_'.(1E_C$*:;2P_.='9TO. MKZ'PA?.JX1N7^M2I7G6K\SO"&KZZNSMN;D,3?>DH!W?24SX7LI/O[#$?7\E) M?G:RRSPN;`JZAO'>]YU_O>(TYLOJ>[Z]H6^*FN(0'#M\KPA2^\HQ./ M>,0G1`*GHH,$:L%XPD?^\(F_QN0/K_C.,[[QD,^\Z#&_>,A7_O&MXORI&A]Y MQ9/>\[%7/>0+7_G7?][TL&?][3=_^LUC'IVA3WWP6X7ZU%.^\[1'.>,7?WS1 M>_[Q"CG^/.L'_OK8UY+VCD_]0IBO^>0/W/&F#S_JL2^#ND/=UG__L_K9W^[T MMQ_^?1>TU\5O>[%[G_&UD'STH2]^\&N_^7ZO]L0O]B:O^3"O^Z3/\%BO\@QP M])2/^6HI_#C/\6Q/\WIO]#)/^*"/^&R.\FJO]0Y0P!;0^P+0^B[/\:B/`/$O M\2SP`G$O]QHO^.HO_/CO`T$O\5!P^PI/!8M/^,9/\<#@_';E[MJ/V68L_J2M M?>;_MN4/8&K/N0+PR1#_P4;_<.SP4S\!HJ;0C1I`CY#C"2HQS:0^_> M3\(`#?SQ![CP[_4`(3\/IPT`%% M<"'L\!9K\/;P3^R:SP[[\/9VCQ(5<>"\T/]DC_?D$`3'T/EL4?&,KP8)<1*_ MSQCC$`#GL/\F,0:I,0(WD`\!L?PL;1/OHA/W[L'4`3+TJ`DK#@K;9YI*@'$L MK`-``2"KH1^ECCD$(0;>@&M:42'I#18/3!8?L`QY#P;)<`&?CP*?<1;)L2*_ M,?DP\\+T=#UJB\= M4U(1X1`7?W'_?@^=#%`N_5(28:\$LQ$13:\2JW$FW3(=L:\'BV\;O[$`"_/S M')$`L7`FRU$;T?'^:)$D,?,-.1(HE>_YG"XIX?$>_0V!7G'9KO(JV4JE`N,5 M\S$-(H&TT"4KOJ04ULHU=7,)2R,W5PG$_.(5STP4U&"!VD<#LF,K+4R:>H1C M_&VI'`3^-GGS+Q#HUR0C#7[S+R+!!CZF!TIA0![(M/(1+3 M/6TQ`]43)3^/`MN3/M?S`#5P/N&S/O>3/_N3/O/3/P-T#M]30.VS0/U3&0?T M0.DS$TLS+Y;2WPI)`M2AD+IF*I<*-,P`"69``YBCP>@@N((%W\@C.:A"$^`L M.F&##M0!-HSL0XGFL]CJCF:`Q#JL6U[17^C@"L(`9``-"N)E.4LADKKA`CA, MP1R##CJT/3@L1@LC.68@7_SE-YXD#6(4@KP'9`1A0&(A#9(T3.X(.R M(:]+X-@30!=43==T^MC43=^T/BDP3==S3A&0/^>S3N%43]'^=$]/10@=U#3# MA#7]#(%LRPWDYS<`RP)LP$'4`(`2J1J,`!0LH#VFR0M\8508!PHN`'-.*@TN M8Q+<@!ZFH`9*0P.(P`TV8040"3!>T5(GP7,V(;B0H!IBX`3"`#0N`13"H#W* MP0)H``G&XPK(8;60$TACICB\\@K68"H+HQ3X!A0TP39`X5-/X',>2!!NJ@1` MH3P$05?[REH31!.Z833(H;%F1@U.8`QBX(']/ M`=57LK,4Z/4[L?9J7W%?HB42C&.U@H%"0%O",[!=4^CE4R)$`3;,`"/`DT]/4ORH$>4B`&9H`&`*`;[DIH M]$@#3L`+RD5HON0R*$H"("-?9(9`!($7;'<\U"$2:`!H@O<`K"5KC_=JCU=? MMQ9Y[97^->E5:[5V>9,7>D67>IE7>9,7>9]W>[<77[<6>L$7?+WW/!=.8776 M9Y&6*&]V`5&698T6?BN6!*$68Y-V?GOV8]TW?XUV9]NW9I?69.\7:NV7:)?V M?8'V?H\6:646@!M8?9M695VV@8MV9A>X?WTV9_47@-V78AN4:JM6>[&V7S,$ M/)[*/J8@!6`C7CJ`PF@`<3AU$GQAF@#@1%=@"JB,.;C62QS#2T2!-L<@-U>@ M`R[!!JB"1X6S%$3A=(S%;V(@%H8KAM4@'P`@7U8F*HN+.3KFB)$7-#3WV$J, M&H2F1(1S.^M%Q;K#6+(C8BXC7YKM"GZ#%\;!6*Q#4;24:V3^IG@#B5""Y@UF MX&%*"(D-UGJK5WL%%5]%MU^E5WJS=E"IUY"7UWD;V7NM]Y&O%Y$)>7J_$V$1 M[/?T=W]K%D\U5I37-VIM%F>9-G])5F3]-X)%F6@W%C]A>959MGUAF6?E5&@! M5)9IUFF=%D]-.3\OMF@-6'[_]V)5N4T96&EA]I5G^95YEI833Q,_>"#Z(H0I M^5]$`2H/]S%(E!KR83G2H+AHTQ4N@900(4HT@%I`)H=U."I+E(:3PS8T8%QH M`!%\`9V9Z'BAH#=^(SNFA6^1 M&%NF8#?&8!E^`S_$`P!RZG4[&CS^48.,,",U!B1F)N4W.@*4U"$%4*(&(!J2 M"3E\JW=ZHS>3,1FGL?EZ#UF1+[EY;3J2]Y5@'SF1-[F5K+"409F5C;E^8W:# M89:7U1=GHUD/ASDDX1=-CWE^U=,`A59F89D'B=*4#=B5A9EFO3J5![B7F9ED M'SAI';"8:WF9%QCR(%AEM1J!E5F8,]$=J?8&)KF0&6B)/$,46M%A_CD6H&EQ*>QA!-O9 MLE.+>]19<=2+,9\5WJ)_WN0EV?#.Y>T68>YW7IQMY4`7UNBE9A)LWJ->R M"K-0?O=W/H$!?U/YJVG9EMDW?8%9:3%O3H!AJ@VO!X3"D\=ZJRD8OA5-)MX7 M@Q?6#ZJ4@C$8`0M/O7]6*&H9P-DC:$UVEU>9PH>6?9&VOI7:@>MW3KJE38_Y M9^OWK:-6:OL:4/^ZNZN;@4X&+(7$0VR[!_*6'/)%%.CF9I!F$LJ!&DZGN359 M%"ZCLM]Y7W@!@G@!M!T$WZ#PL_WY;X(F*@E;#72C2VR@=1^HATZ;@NI M6V8S#,:87BO:MM,@4'+[`F+A.5)#%"P@G%$BI0D%9,)32,/^\[A)^K.4ZPJ> M*(>M.[RIFZ>Y6[JU6[Q#.-`#>[LAN::S%[L1.:A;^Y*/C;P'#:EWEKTK%AAJ M!+XYV*FWNH`9F-+Y^V2O(09&![ZQ(E*O0H+EVGXKG`(O':>@%5(B0<]BHNH%#L>_+\0!TNP`90'9?U.H%'-IKM>JDG[R=`PM?QTW]5V0![ MH`XZH)O8HVGO>X!!')5+G)JK>9*SUT%\Y`K4)A)V-&9JW"-`IJ1P9Q)Z8!)X M-1*HQ7C#/%VHV#$"!@EHXP!X00-$`3*J(0VR%2RM-HG?@&_7YLSC90H:Q%'? MYA+:I@>L)(E*(8YC00*T%C9.@V'^R#2#VS2'9RK-?8:5D`3?#V"L9J5F=:] ML7K`23"?(@0L2!88#H#7/>F`QUIGI7IBL6(*^,/"-]8/L@(4MF?3U7<-B&!Y MLO`G3J`#JH$3%,TA+B`?$,$+3N`B4CW"XW?$%]AHNU2N'>(/4$(#PEJJ!?SP M>L!1U6$\0,=.;QF:_9O;_?3;P1WID;Z0U(`72D`":.`$0K<4[H@7-"%`8.-D MO!*0K(/^%Y`@ZBU$8'"?-6B@%"3`%0!`K=8`<^!H8!AYI*?`'Z"`46`#*KV2 MY<6^%*B!*+I!$(+A=A"+:)@W#;YF625C[P^@!,(`"8+!ZDNAB]ZY(ZX@XT^& M$MX((&)(J,8)"I1+`$Y(*$4.0(E24*;P\G)I4L*%#4M$*O%FDK\PU:BE*46R MI,F3*%.J7,FR9+F.NA")398\;>'+JW,FSIT^=-Z[1D4!G:%%@2),2-7K- M3P<`'?PL'2J!:%6K5*DNO9I5*]:K5KEJ+4I6PK4TB``@DEH62HZ00%6 M#H`-41I67.EA=^K@O5\5V\TJMO&%&7C#`JM331BPTF#[;@7;8TH',STXN?%S MK73LU5OOWEVM?/4U,#^C2Y\>_09,F6FHS=C4P57:(]:0)D:)"P:5!$4:E[17C@3VU0`%-6I4LTD-U)3" M7CD#%HB(.L',4$T,-)D$!1+V33+2AYMX`6`PY)DT27MJ"%*@#?39A\2"Y533 M@0T&N=B>)@BVAP0UZI1`!($[UM?>&IKXXD9W$=;DY)-01BGEE"3=1-V5/06E M'!W`:"($"_@(40,PRZ5Q!0`K&*7^%VEI^'&;46RZ:14P/=#1PVV-^>%'8D6E MD=112%4%C)YJYFFJQA1=F5YA!1YMVZFEY)950^25J6!%X%1 MA:F:>YDA%5&D#?IF<\"$QHM5/:@!P"6#&@&`)F98P`L=35V0Z%1XZ6GIIIUR MB52?QZ*:)YX:J',%G:C:^::I6`D[E9YW-N>')@!<8(8$=V+Z9E5^#KKEN>AN M^1R6[+:;DW5.I@&%*-10`]Y)P9R41C"B@/9=O=3DFQ(UD6BP8+U0:`#P@`M& MTN1)`!N\<"D]4-.O!C#5JP%$"W_7+WP15SFOPQ2G%,S"$1]L;REI:$!ODRI+ MC+#'HI3^LK#*!@%,37A4]NSSST"C9*6[5VJYG!\JT**((K1\H.@U4,1P`"<` MJ*&H5%:7@\@,I&'MA]9<2X!U&FK4`2TB%ZC#ECHSU*'.4.JP38M0:=:RP0MQZ"W/!6K=5JH9CY>2-5QHSV"TWG9?P?>!K"0&7&&V\,E49G7A!WJ1\V M7%".'T?YH0;?;M*A3AUK#*7)#$(1;[4ZB-1!FC!7O*&))M*3K4Z;PJB3.!W! MJTT46A>4#2P=D4-5QPQBUWU!4WE.,L,,BZ>K_[G/C4+T_]7^X1EVTB!`DJ3H M)6D@8)426$`#DB>!#U2@`P^(0`4R\#H0O$ZE,,A`!ZJ$@2FJE`13(D*80+!* M/0B/"%-$0/*(L"0)I%@'3[A""@;MACC,84N&!L#J"&4YP`B%-+:P!6F80E'@ MNH(FTG*`4P'C`BMPA1'>$)E+^($(HIEB%?W@"]'\`0"-4@,H+O"6J`##"+QP M13FXY(L3<,\(7D`$*`8W*#&2\01^XY(F.D"/-W2`"$@Y`"7D>((U].`2)^"% MKWAQ#3)QJ0X',,(%7%$",]0!%&Y`!#U`89;,1:\#@SS!%6:P*F!LAQ?5,`,B M3O"&"X0!=YI8U5V`T3JKF(F17%+^!P#"8`:)U"&7`."$[P`%$D2LH!JJ"T,F M3\`)I*A!<+>YP!L.H`%$7&$*%^@&+Z8`/3?0@Q=N,((Q5V"K%:8+Q(`2/>!%!_IE*R/T0`.<&$-1_(`((HA"#2?P0[_><`7B MT,-;HBA!'HLBBBM<012MHL0;_,"?--XF#`#(9!BX-!0S>.$`L5!E"40!*@F( MPE>(\0/^J-8`/%"8`30``(6BBH*HX:S!`@`@0@]FL$LH)#0-M;SG%%)P/EV" M0A2`B<%ETA*&O5(F#/T":SG,P(E&:6`-`+!`&CC+"Z3X@1<%F4$B+[`M`%!" MJ9QX`W]4&U@B'*`'OB*"FTZ@!E%$8J["H(<9OA6&'^)%`YU!A*EDM5E1@%48 M/;"5!281!M,I]+H2@,Y&&PHOC'KWN^`-KWC'2R6-;O==ZQ.;"D2P-!$XS2I0 MX,0E[KJ);ITJ5V_8C!D`&@#&?F?EWS@A@HS)6SH*AP!U;PAD:2!7)AC0NH_.2'*9S`L%NBI>L:(Y'&!M.24X#* M!?#8`22#2U8BHD,Y-G$-74:%Q/RE!B=20"9@I$"89NA&"HB7!M3JR0)O`,8U M2#NH%P/`"*)`A!^Y5`\`!UB#&=2Q!GOB3587X-1_>W"6VF%65C$`CCVO MJ[_LGK>'W26OIC?-Z4Y[^F!Q6]H>Q70T--"4ME/BMYD#^1UML7KL''7`#J&H,JJ9,P0MUD/;[E),& M73H;,*B:`BB03._$)G%7C])E9=-`&R^(479\HK6M&H>WN!`!`.E<0]2@(HHQ ME_G,>HIMF7E163_$-C&U-C"Y("V*:FA/=,_+=34`X%J\+2=6]I4`+S[\-TCH4-;`]#4T9B@:B&0=RC$)9R&< MUO]-#,PO(&Q?7[E;7>\:*(PMMK'_T@^VND0'QJ/L$V"U7-HF#K816A9MDN5B@$]`+`)#02NDFF):[N+;)E'!>HN!`_R7P"0[WSP&_+^ MAIV"!Y7^%B/H'1CS`JTPMP(%6[&V.$ZW5<1+#_&*EY9+&/P%4[R298;$A)#.@/?@5@??WT,\_;;6:N@9PK?>?-Z;G/V07THEO_^MC/ M/I2.OMVDGRLI?P)7.8290@';R@V?U8"M38IM"><#+G1-BSHT,&RH2=47?B#Q M":S=F&NDX`1NL#FQ8P/`808=L`9@]3W&XQE[U6&NX":ZU%1-@1"?,5>3QB6C MXR9@E086,`5FH`&(8D5R!0`S``5@I08%V`%F\V/VIB?X]BA3D`\Z=T\KP%A# M`7-Q]12D=!5F``IOL(-DL8`G@#%OA0C"0^C0%HHH`0K/5\T%<6 MTC=]1:-]=GB'>'B'W+=1WH==SN4&U&!+,\`+O+`&;0(*C#0OG!`&4$`9KS(O M%L"(F$$/4/`H=<`+GK4&8_"&$J`!4H50NP,`8]`!EW``!V`&"`$*;9)@';`E M9B`XCC*"*`A9HV$&L0,NI@$[4.4+^;4"4U`5H&(#=6!6`#`WLL(+1G`)85`" M>S58835<@.$G4$`/)_`MR@%Z$N$G50$%5V`9O72*>?(IVF,I09@/@*9VH$!7 M5"-AU%`9?F!C))@&1,`+A41:;G+^6KSDB&DP"?:X.9U!!&8`#&=B<`9%!Z5H M*J=E`RLV%#C7+<"!*)1P&8B"*XAFC7&8+I9&A]0'47G8D1[YD1BUAP[5A_N# M-Q0.,(P!0=@`^/@ M!E86*\^"%]&5`BPW2H,"&?3`">,`:+%T%"N).]5#)P>P`C9E`5Q3#HC8BLL! M.WZ$"/F@7+9"#P>08%<`(XED!&+3`;S`<@HQ:1(`EQ:@#N70EA*@9RMP"=>X M!IKT!D0`&WCC+$9`"9Q4%&N@!I00!H:44#V@#G@$`%,P"762!MUP!8C@!MUP M/G4P!6_^T`T7,`5K^4RM1`<7D`)78#60<04Q,`D\J9C5P''64PYG`@!^9@:R M<@"EB%/*H0Y]U@WE('%$0`^9]$]0,`/N!&T7>)'+,8<:*1W601/4:1`=@A+4 M.1/6>9T0X2$D89T>PIW5Z9W;R9W?^9T=DIT"(IX"TI[="1'7&2#I>9[NB9TG M89[H&2#UJ1+CN9\M`9[Q":#T:9[R2:#=&:#BB9_5F9[]B9_Y>9_JB:#H>9_G M:1`BR5W0QS9L4V82H`E(,`.:4`?J-P5(<`$VH(U0D`\K4*(G>AO+,P/J`"MT MX`MI4XG*`1MWD7\V8#J.\S6^P"-6XSB?\SP@2DI,>#R(D3?^;@.C3T<6IM0Y M:2,5/3`)OB!QES`];,,CI3J> M!0J?VTFJ^5F@ZMF>^GFJY0F@MMJJ`LJJL*JK#+J@[[FKO$JKK!JL\OF@J%JK MMZJ?NIJJR-JLSIJLSYJLP3JAQ'J@R/JJX$FLV;JM`1)J/G<#QO(G2=8G$!2N M)01ZMM:(*]:)MJ9B*P8,&51F7&+^$(XCKLJG%&WRKD7Q'7?"%G]")Q"DDN_X MKA#D)V1U+/!*KV3U'9MSF0P4*/D**`A;L/%:L.!79N=J+/.JKVVB.A<+?ERB M)V7F2`,+*(\R('-#)A:[0D/%9@_+)1MDL.)B+&W2B'CZ)P4;+B?KI?":0/+J MI(X4M`<;KA\+JJ$JG0=*GM2JK,8ZJZOJGKT:HXV* M"[N4>[E#"YU'FR5XFZK+2K9FVZJRNJJUVK6[&K9R^[3)F[5RN[9CRZO4^KNV M"K78>;P-6JQ96ZSTJ;9EZZ!,6[?$&[<5VK35F[3/R[3QJ;;K2;Y@:[4TP;>7 MYK<2"[FC2[0:>Q2(8`&@0`2R*T=C-+@?6[\F.\"CV[JD.[)#B[\?^Z_V6[^Z MJ[&.&[@-++&.R[B7.\!#*Z\73,'Y>\&/J\`<3+08S,!_.[LC+,`*++H'^Z\9 M#,*Z.\$.3":\V[L[,:IXRZVP*JQ1RZ#AF;3*:[S3>ZSJB[W^=CN@TDNW[0NW M2/RK#R[%!RT,=S"='S" M>IRZ!OS"S0FRCOS(B=S!!RS(,BR[^2O!K7O')WR[;(S)5%G#-OPNR&N]MXK$ M7HNJ3PS&U;K$.ZR]P7NMIXJUXSN@<%N]9&N\/DS*JLJURPK$JLS+[%G%\QG% M$8K%LFJJY;NTQ,S*=NO%.1S+X'G&W=?'JRN[FHS`+1Q\R++`N7O)A:S&)LO- M!!RY@XS`,SS)E[S!ZNS)BMS(B?S^NJ1KR*6;R71LNZI[Q^(LPO=+R./$,SRQ,R0&=S_=\S7[,TZL+T)!LTR2,R=6, MU;:[R/Q\R/^[N>[,(%'-`];B^\T]O<]&L<8E3,*I#<-T(-:]B]#;"K9.,LNEZL3%7+XP':M+C-<[ MG-RU'-%Q;>#0E\DUFS<+/KB;B[ID)2^)J^&WW=\^;>&E&]RA7!V.K=#=>3(3TZHH M3JK!$`Q0H`WY$LMJW=="K)_!`..!_=+%?3`'[GQY(8 ME]`-:E")%HOF=%[GK=SMJ=V[$)$4+2TJO<@A`/W8`$ M,6[%RVODRBSC*3W1R&V^U+D&'>#^!=]>TN&NW`'R6180`S#CQ)K@!7@VK&M` M#B7P,.>]UPFZS%4KTBLMO%Z.H6Z>%)X.YVP>?)VNYK6^Z<&7\&8^\1:/Y[GN M\-I<\6J.\0H_`Z!P(%3D>`O/\>K0#9Y1B1??Z0^O\9I>Z^6RZ;F>!IH`6%;C M>&>N\"[?\;0N\[<.\Q\+\2`+.:"2A4A0](ZB\`DO]-J,"+Q`#W6"*'#A\)H^ M\Q)/\9<^\7DCW$=+W"CMG6A!F9H@".K)(+ND#?OB#Z#@#S;'"[E,S!^]O>?I M*YR@#030RQ5=H35@CC6@Y%P\K>S=X]_+T3!]WJ7\4M=.MX5]W1-J'L&D#>(K M"`FV"7;^GYUI<0*0S]=:.]XTWM$"O]&O#-G3!ZYTKO7E@C=N8(CUNLU&$>B0 M%W#D<)E]\F-!B_%Z@>>SC^IVLD=2T>B0ES>?L@(J5@YN0.:S9/N=B!"7<'D) M=!1"&J[UBJ>V3_L&V_JZ+@&J!`"3P&;7OWNH;N9`V_R/8OUE/FGE`L>-H2DD M;_Y,J$M$T(CNKP$TJ^NM[[-X`:]NU8%2X5]3#_1+[_$`D4:@0&!I@!4Z$`D4;O6Z1"/#4B1(I%`*#+@!`$FS^*<:E08,B/8DU M*]6>7'M>!9I&6PQ-4GUJ!-LTGRMJ78,AH=$6+%"JP0@`<*/M M:,Y(5_)I0YL8I56K7;,JO1JY\4VPD='.O3J@XN:*-^@D!`V:CB@;*ZA!21,T MC1DHP.@$/?U94!H-4,ST^!S)R[A(!E5KB)VF8YK/Q&'[*0[%SVHSQ--$.G"@ MMVC:MG$++'Q%5(\>S072Z5'[]FSC4$@#N,2XAT`H&G"'MVV0_7IJSS`HUESK81(` MC*C00R(T(%`@08)R3[;4-&B.CM?^0)D".0WRF:*UT&[$,4?1&.*L1Q\ENHBQ MC(+)XP$C']AER#4``$4NQC`:I"TP!EG!@EC`"$:;CF3Z"2PMM=DKRXZ&%*4M MC+[<"PHPWN`$,8RHT2:2Q38:,Q(N2QD+*JG`T#(2J=X\S4ZSN$H)3CD!-0M. MJ;)T,!)M<`(#SD>I$@K.C"+!80H<#@U&TL>TC.4$TY**Y0`OK@2I(VW#%8R8XD=UK+*2KGA1V<]TU&A M&'AY`Q$;TE"#!@DVL:$'*"[IP`LU!NQAAAC(J48=*&8H`0`+;%"CAVQ[(,(+ M7S2881/^+^K0#PH;PA5FP#0NN%9?)*!`P@N2;)BD/_#H(,*-$@Y.`PE$IIC" MV@6!09@&-ZI!`K?7+MFD`R/0@P(1EO#E M`$0$3DB0'B0@AQP:$/EL!G+64,,+\QF@GIWPA9R_W\08A.7K`"FFDL>*(MH*1@$G$-B_E M@DNTF<&&-ZZ(1\"9C-C[],:P)*(##4FRP-WT&W@0C#30@AQJN<`+;; M7$(#2+`!QE0X$#KX81(I\,4:3L"+&=#&#:!`@AKH>`DS(`(`*UC#:WS!"7FE M`!$SN,(;UK`&2@`@#!(#P!5PHX$2A&$&)[-:&L)`@S5X@1?QTD`U.(%).JH! M:FEP'2\Z4`U0`.!N/="$*VYY@#<@#1%OT"8W4>8B=@JD:FY[0QHF<0+`5*,; M`/`"[?*!'C_T`!1AH$,'/@2%'OP-1!U:X."^`X7H2&"+XT+C!680AC>H@S:/ M:]SC*+?1'%GNB1\%$NJH\0!I;&$+TE#!Z$IG@2(&!0?MXN$,+O$Z-4PB$GH3 M!!$`$(/^ED*!$^0@P#AT"84P`&`34DF#&]MB@0X0@*)K",::."$G)'!B$DBX MPA4N0X!-,&D9]`Q0EK)70WK$P*ECJ`$4!`H*&FSB#5,@`!@:0PU-<*(<2%C! M"8)R,G)H:1Q>@`(+KF#4$TP!`./H2#DXH0EUK``4:A)$/HR0!E"L0!#E&`<` M?!$/*"A6$YJHDES3<`(CX(`<`#B!D\#@#P!U8Q*:N"DH_%&.*82AA%:1P&!] MD<,9Y`,):1AD"62BAFF6@QZH0;/_`06)J#$%7CR2OY$`T`Q'(ER%F`$4VDF#*.A9,U%D513+$0CO%-9= M_\YP$KPXF"B$$D=&!24&#DAXS6""$)1=2FM.2"$AJ4E1JE)WM116 M_@!`!R)1BD%,P4K:T,05@A(+\K+^D"J1"$,^8A$)#\4@%@1X0Q@>Y0\:.*H; MH)@UG>7$IE5UH\YT! MLH'M\&0!7SC*0S2(D\)J(+51:T.@<8G$/2R,L"[9,RDW M%+*]<3"<8!+4B(0KOQ")7&FC"IQ81L/7!(J>6M?F-S\B=BD=D>U&BPZ.>P-N MJ`$*>J`&UE=`UR;"`(HUE(,&X.SJO4IW``UD&8,D$@0^1>+?J/I`>(`$`):BZ!FQ^^TZF88)"+BS0MRO<$"HE!#"71?@AE(0,B(8%"6LT>; M;@#Z,UZN80=V>8$Q?+F@@$/HB(IS(GHMT<\U&FGR M>W3G(+7TDT;J.6G00G2P6JFG20=YHP1C"DVJPB96T%9R+,,"-3`+,!B)&#`* M*%B)4B`T:J,`(E`#;<@V(Q`,`V2)8&`3"E@#7B@!F`@AK0+&6#E1G`0'*8&0N("XR8@OU+C8!S M&A::"<#`@3'8`#?(P=+R)EHIA96X*0#P![KBA4U`P@VP`",(!E[X`L'0!@RB M%:L`@[&K@BI0F!/!B#=X@ZV*A&YR"4B(BC"DN`]#0KVQ@`M@.:.Z0S6@!@*H M@EZI.9P#1)S3N?-SB)[3$?7"KP$9.GHX&PTX@6Z@AJ$!LQDX`!I`IJH#`.MK M'!HI!>(`@&5P#ZXK#,2:C5)PC])1NV\Q.[33NNG[&0`P/-%[,;B#@JS2`/+X M#FI0AP/H'F\2A;PB$0V8/,@Y@3?^T`!?`!'>T80#((+3PHE(PYJ"(,Q*,4W8+V3B0%P#+79&PC;\S$`D,?R M,H-+,*P5B!!0+[4J(82L`$ORS/H$Q$S4)&1L"U)I`->`)'9 M:`_QJQ'AH1$HP$7RVRCS(T3,2;^YVH4C4`$5.`([X#260HM@4,DE(0>C&#!0 M,+@P("*,B)6K6$$`Z#5`"0E0*P%M*(&0<#N>`I3W89-G`P#K>9,O!,-&`=M"`9H*S>J&,+S@8TJX`AH\P(*.(IX](<< M*H6WD\'^M82-0?"0+7R38'C"-3BX$\NA1O&0>&@+;1`5I82LMY,)>G*U*M@G M'#`+CN"Z4MB$TH]5*R-%T.$ MV\0GA?P.#?`OM9-%R*L-NU,(*/`OV=O,&5J!%6"\ORK0 M!F>Z%0+`2)8(BINDN:,PP$LY`%Y`QBI8+7#A$%(`XSP!R%9 MDT%S"9WR!Q.DMBI``EZPM?TB@D?12J[T2AKLG0\9A*-8+8ZH&V_2AN<0*+B$ M`J,"-5]X4Y"XK$_L#9"8!`HXK36H`@^1O<$0!$05C"H0%?01P+?3DFY:RU)P M5%Z(JR>I@BM8`8)!C.T!`,E\L4MX4BA8R\S\`O38P_7*!\$,S5>EKM$DQ!MX M-)\;NB'S`VJP@/#3@)-Y3&H@)C3^FH(R^1M$"-'ZNBCL3(.L,S1Y,;MX],#3 MX+V1H(3:Z##C9#"%H)8!>45^U`!;Q$5!^-8KD(D74X-2X4QJ>+&3DPV,":"? MRRN9V$PGVR_^U$XU$`68*A,)L+YV(8(R20-*("H`T`0-$`574@>%4J\D90]Z MN#T9O(*JHX:360-1.+T"$=#48`Q-*(LC%UZ`Z*6H\>2(&BL+$U.`TO MBX3GP]#9-(/[^+P%LC-U\`*+]4516(,2`#_&&3IE35$5#886?:(7G0RZ`-6I MTHA8(`>_6Y)>E@#M*4)E"."+X@%4-"Q+!&H$X$?!7TK"8B$6,B6 M*D"G+XT%7["U+1*$;5N!3?%:(VA+U@N&4+D"D["*8,BZ39@UI['#-*"`%2B* MR[!4_Y*VH(##C1,$7KB"Y]!,K"P=U8WS#K)K,9B=2B`T&0XM<0HL99 M@S=8L=,2D!EIL?5@DDC0*4I0A].R`#60``_I`-;`-_5)8`_Q)4K`QR%\8WJX MFV\M,-JX`M0+6DAC4:+-'.H*VQ4H!0(X"B.X@DZ!QE&#LA6@E6"@IWS8A!/P M`G'3ALWD!2]8ABN`*I!8PT$#"6U(U4O.9*C*T\.@!E?"0"^8`O`!P\?=E#68 M@DFPR],J!W3U!4U0F$W0A)&P`)G^$#:=T`:=PL`#6`%_B`3^45/40D"GJ3/= M"`,>M;$W*`%BQLMH+H%Q`(7G.*U+L(%@L.8#N`(E`F%V1TL>H-)P%[M-6C&Z-Z= MH]6-.A%[=`45X@10(`*!*`5U2",,9)!4>P,OF(2'WFJ9&$HAC/(&9<8/UD(`8``50N(#? MVH])@-L24(-JG`3EA-LP((<5D"2*+@?`DDBDUL:E!@4UZ`!0.("[HH3T/9A) MP-R,&1#^`P2%,4@!]QD9N#T`-[@"(@!B@;A@4#`".K@`4."$:^G5KRN!`*J? MB#XC(M#K:TF(O3L!3HB!,!B1J@8%/[J$B"8""3`"O;X$9>(%4)@$BI+K30`% M+U"'/_ILD1V($[&!-KL"QU,:>C(CU+"!D<8FV-YCR@&&H?7C9ZFN&J`!"["` M#"2'#;!K;1"$W5Z&&DB#&+"`O88J'$A27EB&YYDK7Z`C5#*3+HV'TPD)Z6:2 M\RD%7["`;AB78-!N5V`!Z6+;%=B`&!B'<(M!+^C`-%B#?-AHT+H"%O#N,)@$ M02"'WHZ*Q@@&(S"L*Y@$'(5JY.EAMM(&IY$;.P*#,(F!`$?^RF"@`7U\7(XZ")'G82NM$C#R!,Y$=0P$8S0(Y&X MT@Z=R-1(#0GP4]60R"7WEE(H1<81COW@\HR02"R?8$ZJD-#V(3%?5L+IT-K0 M(XQ$#='K1&K0:08Y[#<'<]0("BG&")M)#9ANC]DPPRA/8/@FJ#`O&RW76$*_ M175H'$)G]#X/C1.1`$BO$$'`B&5M#*--(HP8P[W^Y)-7`8,J^!,H&,.<"(8JN%(P^4P\80JN MA!4[J8(2J,RK>!276,S+I(IHIX87ST+>0(*0Z`LFA14!A)-4L50SZ?7%;`S$ M((".2)4T"0G$<#<`$`0)6(-'@?9!5O>.&V1E?Q^F($L\&61JYPA";E2R%!+U M46-WD3:?F7OY%2!'27KW0&6?DVGXV:ST@<0?FRB7F2 M;W.8E_F='WD("=>6[\2DM_F;7_K2;OJ,CB]R),^ND-_ZTC?]TT?]U%?]U6?]UM_CKO?ZD`)]G$/`5$TT@VY2 M53O[V;?)90``%C!\T-S]5T7`KL*G%^?]Y!=-D'?]YG?^YX?^Z)?^Z8\6VX[] M6E<3$VIPN=+2[-_^[_]^XQ5_\.?^[5<3\]_^4F`@)CU_]!?_]I,-FVE8OJLNU*MRBJ1(@7[Z->MQ;9TY2IV*S%8 M7FT<.6)TO#%QY;F&>UH&B5-;E;TRX>B7,DX[]V>R($>O8V MT:1A=_/N[?LW\.#"AW\=B_LXL5X.Q;EUZ M7+B9J=<>S^M%=ZE_M^,^SQ.^^Z9SO[[W9W8:=:=[8E M=Y9NQ"FX((,-.O@@A%'=<""%92U7'GC_80A>=QHZ)A^`'+8W&8>+[4>B=)NQ MUU>((J57XEK:I6C33">6IQ^`4)0B(HSN]50DT5/.*9YI^!ZGDHH@C!F2BCC>8)!1=F'H4D5:4$ M,XDZ4(C)(!1(S""0!DU)T.2H:6A02CGEI"%*EDI1TT,YDR!!#1152K!7&J4^ M14T:L<[^0&L::ZP13)6;&BLFF9(:>:&C:093Q20XT#D1L6J@^6RTA>49&@MH MHMDL09"5XP^=!VGC3SGEND3-I02HRZ$V2&CR+KC@!N,/"_36NV^BD"I;%*52 ME3*#%P`8P>NQPE$3CR]&Y+,"#0CW(,@D!W"BQK"3<$).#)N00\-2I6C001@< M;[*)&VH(8@,G5WBAQE,BDTR.$2AO,DDI*5-3;,(].YCLOPPNNIK]!(X55*5_^1(VPS[U10T0U MK):S`@`V[*Q4)$8L,S42`"!"6"F@7'$Y%)RL0#?8-E2N@3;+`*`&XR%#8<$5 M:U##KN*7\#J.&L$T_KN"0!M^W-"#*TH#X#N6@Q`U+(11`S5N8Q0,.0!`[S:/ M>X'R1MB6(C&LGM]VM*/J7^A%4>=Y8]\=&%!+^RT4-0!0@MX^U6DC_B568<0X M@H1M/``I$JGA*0#FJ8$42LO:(H:W0``!JLDB%BXP87! M@-HD++@4:G!B#`2H51IVN(EJT`K^"6]`@A"!)T7>"(^`"-*3#.C4)AD,I&XB M*@4%5%<.:D1"$]V0#!2"08&F@6",(&!57`ZU5P5#2L10U8C$.[A6DCNP# M0RS",(E!^7%]W7G6!N'81DO1BQJ#D)_YW!:,M;5M('[4T2"0QXPWGLU2;=J1 MF^97/SLQS8[=6R38,&*I.5$-E'C\B!\)(H,J4*!<;+(C^]SHQ0#NRT"&0Q(! MFA+,8(8P@=200`1EJ"FPD2L-2,!5!U,%!5I!B0#$3`,UUC`)"2!,(*FR%`:S MN9<:R#`-P:2&/[:)L#\AH1R"X-4T22B(<@XQ'P>(A*M*4+`5(/.=1'`A-:!& M#EH)@@#^-O#?)`#@A:*E"C!M#;Y4%D\%1X M4.,`O'!3';V*%X+$P'K=26L-UGH3"N"@'&O`4RVG"E135D$3_NA<),='23X% M0ZW:(``%JB<(;:Q!KF"(Q!HT08#S$4"4;I.!9#2!A#X--9&6(@`8*``&0=!U ML0>A`#/*@8-($$2TI,7!&@P%-DW$E2!5T`8.J`8HKT+&4J[^I6ML>=E+*^J& MF-6,*4N#"85R&-,&^0A#*4IRA8&J@1/YF$0W>,$)!ZZA&QTXP!7N$*^-.&%*:C!"V]8P:>P&8-E&$&]H2+`)FA0@BGX@AKE M6,8*U,"+%6@)@\PML%*TX04;*(X3-?QG])@+@&[,2DK4H`0`B,`K:UK320%- MFN](C$W709C$!/@2-=H*19J^5$O#I#%):WQC'>?8G#N>Z8]Y_.,>WYC(/C:R MD(%,Y"`K><@['F8P;XK32=6IL`=8P8%3L`(DQ`,48UA&%63PA1.40!N"H,$5 M?%%'.0IBGY#X`@[<\(:L?2$?RXC^!R\V')%(9/6K-2B!+T`!BO?9Z:@'\,4& MKD`/IEF-"!M8P26TX0O*E8`P8O#>NH]2#:D*) MH@;C%=C7'O`&@[T4`;\[P=<^<+N;/>1[K_O7`1Y,O8=<[W+WN\#M7GB^^UWQ M96_\P`]O8X([OO!?5[S<#R]YPJ_=\8>'DI2G#+`\K2$?X18$"P"0CWA$VW.@ M>4,^YK2&F8,&J=30QA0LX-J"S?$2"]Z$)J#VC;ST^;#Y0`(X!K&"$YR/(-J` MQQMP,`A!\&(*>)E"/F)!@2MP#ZMSJR,]0*']*TS!CGV3(SC^+E&Y*L0#`%>X M!!A0/D=MY&,3L1@$U&!]$%GSHANQP/T*"$8'*!3#`,`;$,`@;,`F@`,XM-4< M51;]G,W8Y`,!@$,5\,(X:,/3)$TL^`(-3$U635<-($T,Q`(D`,`.914\5$%6 M71<8N(X_G)P7))\1T$_I`8"[E,(4T,#]\9[5`8`%3`(8((VTZ)NC\-LOF9-U MD-B_+:&*(5P"!0,U6,`4/!`O'``9<0(]4!,&#D)%V<`T#>`:A$J4I$&(\8HF MA$$Y0,$4D,/4G,`*0$$D#*`$2"$<2M7BH$H8:((@T(,17(`O5$\U\!``:((V M-(G!!4.I@5R$>4&!!8/<$$$LU.#^(::!T;B:^P41%-Q;[_A8B4&)*(P=(D+) M)J*8C[$=*1K%4$S;AP#'AY)68X.G=B_W;W+VBDP";=Q`G>SB!V!28W8&9C$NX5_^>J1F MS5*TH=D4O`MDP(.`D60I7*$VW`!*@L,!E!^?(-`71,)>=L1@-141T,`*>&5B M`<`FH$(NI40!IN9H@ MU!$+T$#!L`!=F1IHJ)^:(@$]`,`XU`"(0LUDY0,O<&C'\8(,X`#ML1\`Q-N/ M\N6A^%+0^!MW,J%S#F9A3B$]9)#^8BIB8Z;!&&!A,.P1$N#`"FP"=093,*1> MQ"R%M*C!"A38PX`F`*R!I9"F^L7`Y$`8BZ6 M(^Y,86F9@$5/#:BJ)0:#Z]1D]0Q403FAIFB#*):8[51/Q("<(JG->:BN,:G>SJA$XYG-3*AN$YCHGIG=38C>(:GHKK8N\)G=X(K?=KG MD73C(.@GTZ1C7@$`@`:#@-;2['W@@6I"@K9-),B1-E`#/2@H!2B.)E!H+'3# M"D@D:!#&051!YQ`!A(HHHUT!R(JH&A$!1O;5"I3L&VR:A'&"('2.+XC6%:[1 MC>8#/6S^%8^REDO@S1K!0ZE2`!7F)``4(1@LZ=QH;%YTQ_S,9$$\)2=(9"30 MDA9=C1&T#;ZE]^JW9:XDA>@!0RYC)%*N%"2:6R2\6<#!$HY[]% MYPK0BL<:P<-UP-2>:A6@G$\%`QQVE?O1BC;4@"_X`P`L@UX$@P3X`O[=*K:: MV-60D&W^*@&\D_H!@!NPBR]8#I?XZ:F1[@IT1['H2#D0P(D)84B50@D`%0!X MY7$)[^.2[D*=9WB6JWQ2K[FJ9[QFY[C&*_=RK]]V+[MJ[_;^5J_W8J_YLJLU MUJ>^>E_% M5L\D#`(8#`(+S!%!4(.?'L#T#<(>!PT%H"P22$8*V-\@F"R=@-$) M+K#,4D!,CH/-1@V.HB#80))H"=8R3!\O=,#]#2T%#&"25M875)8$0P8!F$]1 MMA(%P*!HS>.P:`,-:(+K;):2DBT"#EA:\D(5#$)"B27OEBT`G(2T[-0)Y.GJ MDM;5*&S?7,$5H-;,3:WJX&W>'LK>_@NB=B]Z6")@/6Q#0H;OC8,< MQ`(2\((-$(`$$$;T>`[0&8$&*3^EF.],HQ-5>S-5\S M-F>S-F\S-R.R^MHG^Q(*SP%`FRB?!=AD9<5`.9KQ_V45.0A&^W5P@Y[S&LSC MW,P)/DID+.1#WH31W%``Z;X!"Q!`/"#;:H$7W%9[EP#4@$(\J(X%1,0W MDJU]L4`CQP!=F9X-X`41H':[E9EY2R?("=1;NS%Q?6_WKH$:3((:S("EJ`$P M!P,1^,-RJ0$+3`+JV;DF4(,7?`'^$9`#RJS`%U"#N-9*HBOL8.XW?M<`.=3` M#-0Y"]05"P3Z8);$I3LZ:`E"HL-.*=1`G0LZ>*8!M)Y`+`L"/*B!&DA68))7 M*?B4/S1,#+"XN.Y,S6P"G&T0#MCY)%P"AF:YEII829S,%_B/P3WE5$YS=D\[ MM5>[M:WFA16EFYH.<##)-0``<`#N/L#7L0#S9GW4#'#),0*3Z6-FK%[ MK"Q6`$]"#/A"&Q%HNPLZ7M0`#=#`1-]$4SD$,VAH'9T9#4@5),S1#:"[/YC9 MO]\`,RP\+E7!)9`#/&`5$``#<0` MNT'"9JW^?`S00#PPC6VMZ"3H`-JD/)2ZA#:4`PT8P5"!`;@CP0V,>SEL^L.5 MP"7$@`T8R@W8P*53@!%\@0RDO#\,.[C'[)G&P$F``1)T^YT@`'A@!$N-[[PE$FKLH/GAVQU[LR.T$"KKR25Y$3R[& M_>V<_@8-_FT]+#5J`ZE=.^S'ONQ7MXYG.Y5U1+GD/EI%!F3D19M$AJ'88Z#4 M$AC<`.^W$06(EO'GQ;-$K#[2R?+/B6TE/S?2B9M1)BUZ@T`I MIT^A1BU%@.I3`FF:8IU*M2E50=0.`"`W21,\G:J6FV5N7:U&D: MMD_MTHTK=2H800J8\^V;5!Y0=HIGX,1[MQFS>&Z81>GGKOU[8S"9\?&WCWWP9=9N7W=SF_?2K`<#."'@N0,/++GG#\KTG5=%)S30&E;)(WH`;$TWO5E3!&.!2T_J,4EU.87[25BTS-OC+*X==]DPD)7[57@1E\_7^2%2A)AC!5[?4 M-=^<;^X93#OOU7-EH[)%6>RQR2[;;+Y4_EK&&G?V%]I_+[;9R:&?_&_39&$- M.M7L+L[1ZIO-7/KII)VL^R>N>4,:X;>Q;+9-MPE^5VABV]3X4ZAY]%IM&L_N MW///08\T[:>YR67S/CKH("APV4G>U8ZX8]5CE7Q95R@]T% M^G>D59_Y/*E7KSIKX0O^>_^LM%)-VT`3:>. MNOSR.47SWIGG^7^W8^`,*L7?[3TLP* M:*>IR4UW!!Q:^R`H0/1=[VMA\][^!3&8092!+WRHX=\'01A"$<)$A*H:Q#(` MX`L*[`8F8!A$6+Y`@?25D(8UM.$-<9A#'>Z0ASFDX,JRIT$A#I&(D^)@!Y/" MA1L6S4T[8IK<#B0#7]"N?5JJ`C-\48IYE<(7!*G"&K(X+P2.L8=E-.,9T9A& M-7X09.$+8A'A&$"QA0L`0#U],@B&]808\*'")+PBB M)!0XYB#^E,G,@FA#!L)$YFIT<,Q@Q`,'\>`%*)!0`R3XPWX$J($_1*.#-2"3 M!;X@@!=OP`(4?8$79$*"-FYP"4%PA!E?"%$?JT"`+_BB!LP08RP1FE"%+I2- M'0PB?73C%/H()S_"D>A$-8-1C%I4HE*!*%0T>E&1=C2D3]'H1DT*TI1R-*(D M;2E'7:I2EJ)THQ^%*$I9ZE&+WK2F,/VH1VT:U)O"5*43-:I(<0J:HW9TIB9M MJ5$C^E**1G27O,2#$D68$"2`P@8LN,(!^EB/>I+C#0!X0PVJ0(.QEO6L(JD! M*.)QB14L0X:^X$4W_@&`?-CU"KZXQ"1X$885T@``1-"!$>K^Z8MQ`.`$*JE! M-P"`!$&HM:\L0`(G`(!6'?AB,EYX`S(%X84OP,,"81C$#!F:6M6NMH_`-;!#=Y`#G#$H@85H8`@IG!6 M(OBB'_00Y4KHP0E!"@(`1LCO&U;@#W#\-QX'AD1D=1"+-XQCE%4@1V0I@(03 M:",6_;@"+V)!`U#T(Q9KV(`BSW?^4'H!2,A#'G*1R\0C MP]?)-&28E`OT9"CS[[U-#A"6I8SE*`=CENC*'E2SFV;8@E>JEJ$I;IN*7#5' M9:A+!>]*F\K4VFI7IM@M*DW7?%WHMKFHVZVH>)TJZ)'&M,W#):I+]ZQHIJYT MS[1-::5UNMSS:M&JIQE?P[K\WBN#@0+Q`$`YJE`*'>0#`#@8Q`KR$0LPQ"(, MD8W%%$`!CEE#5A"F1JL,M'$%``AB$%.(M0X._`8-RZ`*%IZ=?8VPD3=T0Y+, MZ/!"OA!9@KQ!L`08A"]LO8DK&&$3-.`$/0A@:G*48A`XD(FHF2SJ*+N7WJ`> M\[RO3*_^?-L;U/;6-[[[?>5ZW_O?H9[WOXV\Y7[?.]0";[*2(7YP?2]\S`VO M^,(-CF^`,QSC\$Y-F<]UYOR4ISSD/6[);6/RD:.=!1/O2AZ];E.J_YTG=>\J;?'.K+J>AZ M[=C>*]D.,] M<=)/F<@.![C"%7[Z,8/\6ME[#A"?[YYD`_1 M\MB'Y-QQN?>9?WSH3\?ZWC<_?KC__>F(__JU23_VVS_][F.?^LD7O_/A7_[Y M3-_Z5L?/_-4CZ?`O^:KO^Z2N_>@#ZY!(B4)OZUR([.`A[,;N[G#-\7SM["RP MUCZ;SS@T#D4L(,8,`F3 MT(5,[1\&@0!BX1MXX8_:;A8'P0C>X`9T8`H`S]MBX`T&(=MH8!9C81G>0"#Z M+O-TP,)PL`H:[\%2*!8*KQM8\-HHX`49;QPD:1MMS0BJD0+`P0C\@1ED0`<& M@;"0``A=\1WAT15_+Q[I\1U1#Q[GT1[K<1]E+Q_Y\1\!$A_YDZPZ=SCQ* M01O@H=S^8F"QB$&",7^?L[_UH`&+`#S1JX4)B$,C(!0;&[_;&,F.8$V4I+J M[B_Z)K$0#;`423'I`)`1+3(E20Z+0,$?2O(-^Z\4T=`2GX_3.JTT!B`@3X`7 M9DT:HZT*5F`*;F`07JT>-N(LTY("5B#:P.`*4J"3$`P66.(-8LT9]?(&RF$0 M\@$M<6`3`,`+/H87(DD;K"W:O@T`_&%VOND&X`$<((\9*(``RFH#XN$`#@`< M(($<8H'!>('9`K(T3?,T43,U57,U63,@"=*-LK+E$M((5J#^''"@!L;A#9"@ M#TW2*)G.$7\N%6TC(1<+'D0Q-D^N!H0M?I1SV"!R(DD1.?=/$$Z,''1@JI#R M`,MA"@!`*+E#$%X,$BC`/BK1ZN!A"D;S_(XN)N%/*X5.*#61_F!R*2V1$H?2 M$VVC!EC-'_JP^LJ3/BFR$1UQ%<.G%>LQ),"@&RP@'DK`.A/B"MZ@!.)A&?Y! MAK3!%2)T0LE!AD21$Q;T&\0SF%9@!28A-2B`,/.!!0:A!GAA"K[!FY8!"82$ M2&2`'*9@'"SO`*:`'`B``KXN'^!!$,9A1PE`!^!!V/1*$&(!%M[@'^*!$^*! M(5IS2JFT2JWT2K'4WHCO4@8`*F7^@!H&H@HB@1IL@R)\(1:`+1CRH08B)!@V M01!L3KK(CS;>=+I.4;G`P)PB\3=++KMBX<7@]$^=\Z*VC_F*:Z*<0_MDH`_% M0@?HPOT04OM*(19*8`QF*J```!*ND^6:;E*]0"Q=#CMS([N`D[LD,B%9P`A2 M3>7P%#LHJE`=T2#C4U0CS=O$\2'7K_X`43XM$NC*@T!)QT`/%)%J@`5P0$I_ MD1-DP+*0%1C!@%G'[(^*51!D*%`*PGX:I@H*2H:R":T$;R,$(3?@-%SEPB^8 M35LMLRG,U1>#09P$B3?AP5BE-$OIM5[M]5ZO-!C*<'.Z]/B"81<^P!0>X`/R M("3@`0#^-@%-!4$'OJ`<.ND+5F`C$@)0!&DW#DP'J$D&8N$+7&$C]DYV1+$V M!@+9)ND@5F(^!D(@4DXD$$D42\%'A^UCOLY^%.+`;".3YD-?=8`@\I":/D8D M^F@WK,U!,=8D*G;O1K`DTA&%7K8E=F,-,G4\SQ4C4%'5#@!4=2-EPVXXW+$C M8FYG,9:2CB\M\\$(=.UC*U8F@%`A#F)G28TD=I`A](_91K8\]#5IG^_`%`+8 M7FP-%J(DLF,4Z_,^\`-8^;4T-8D@&@8N@0/9,@^15J!Q^ZC?$O=QG`)BGS+G>2)HF2*@ESW9:20#C!%^)!!BZ!!@2A!/J+`(R`'+P@'E)- MK:8`>:,L'FC@`%C`9[7A"\CA&[X`"8(4#&K@30]"&^*!'$K@$JBI"I"`!L)W M-]F-,,/U1`&@*7QA?P.CU]R)0)!@PN(!1=;@"^+A('P!$DK`%QH"!\2"!WWA M"W2CG5B`-1)X@8/A93TPK<;A"U#7VL23`+2A!HR@04/E99Q=8:2<+ M'IC!"Y8!15B(",(W'L@7\VJC72%+M.9.!L!W&>:N%":K'!A41/97!C;A`.)A M$.!A&;Q`-(Y/&Y"`',C!"!H">B'^87KEAP8^TPB881!.3!`N(0QH@"`(-XW5 M^#4,%WM,LR`"CA=60'5!C1=<@8XI]W'C48\;!AGZ&''WV(\I5Y!EMY`-^9"O M=$LMI5_QHPH^0!JVP`.DX0$B0=7$4:^Z-S4$H09.X+/@P09:E!Q:5!M6X!MN M0!P9N!RN@![@P3B7@0;`0!S[R\5`01#^JZ_\H1Q<`0"8P2$V(0P(X+^.L1QX M(1X2U#%)S7Z3>=BJ(-M6(&O/PF<1(BRZJ!2"(0R:V$/!X!(0%E`=@P*N=IJ6X0!* MH0;HX0#^M`$'[.X`O'@,3D`4M8$SI0@`.,$7W.U5"[@BR@$=N\&8-X`7:H`` M4.@;:LT(P"T?:(`&RLH7-D&404%^\F%>KL`+3KFP!J($B""8 MSTJ,,Q424*@>PFZ-B9IPV_AKN(`U[9E[`VZI60"1H3JJI7JJ[561]V1\CL^1 M(7D+)CD2=*,*X@%)[[D/8X$3IB#P*`"R"@H>&BP>8H$">.$`*"`6+&`%]N@+ M0$$;%G8%``!^`2!*QXX7YH4"7NQ834V$JV`*5@`9\3=<8^%3 M3>4&R&%1YT,4WX/P_($`'&-`V[:2%[Y` M+6>VP;X@%@:!%\;A,GF!!4*S87,,`%0T%O)A!:2YJ`D<(8YZ99)Z-5L=!!@[V$B:)L)CA8UXLC#GA"@@E&)C!'[35!OR2 M[%@@LF-VLC.OP1)6$UR2^70@+%S^S0B"&XB)]PO>(*\_1"P$PNYHPRSSX3J_ M8,M_XX\\,$(4$@!B8!"@%C2]R8K)80/&@7JMCKA'DP(L(`6X@P#DF(H[#)_` MK09B01R1("%0R#8V81DQ!B81QF[&5_G`).8`5"UB'$K@;"8*``X!*8_'[MMP^U M`1120`?^:,`XF4_3:8`"2L`V?'$32J`<8`VUP5P'R&[,8:V0-F$#MC.O=<`# MG^.;!\&^%(P(Q')TX78^]#SS(LS`5X`7R!D`:`!C"UT'/)Z^K^"^P:"L``"B M&>S:.OW-G5&0&LP7''4W[/O`?EX;=&"]C7R?V3%D`04FM!T>>(&NAA>R.LP7 M">LA=8"Z;QW7"5S7T877B3WLQ7[LR=X7'2IP15=T%Q6+J$F+;N`L28W$T_': M!6,*2B#P"E,@J-L7.>$-",*:+8\"6*!)=8Q^"9N7*0"SC+P4JB!(#Y8%SOO> M\WV9[0?8#K;&[X/9SC)5P^X&\H$3U-$59BQ0&A7BNU/SRSS^&$Y@O%\M'XS> M`W?C!A83SL7BD?P[Z&5@-_.\G\V2%X3E!J9@"F#>S5T^LQ")".B!!C;!`H0E MG&J@H`3="("0'E[;*8(AT1%/A89CZ&^@Z`_+,=$X'<$MVD2#&2C#[C?"T\\5 M'EAMOD^LE[-^"D*6Z[N^*[VR[/$___4_JHU]US.?Z0#BAJ`PVJK((`#.0CX= M.BQ,&72#`J<5.F10H`$`S*!@`$K$T@%J!85!O@!L&GFC!(XJ7N`Q0S((8BD* MY``(&F0$@)>8!)9INW(EUJ!)`.!1H`F`@,9-26^`D=$00+R*8*I:A5K2`HY@ MVE@`J#&(PHI\L00"(,?P&X`;.K3^3;$`+AX`?V%7@(I%P0NO&S(&?;%9!0<` M&H-P\+IR,Y:O+U2?#M*[5"H%J+PVQ/('P$C;OTBT"3K@#\D:O,'`W*B"^C02 M`+[PEF`=4U")*JN_3#;]Y@"%&ZM],O\./KSXJC?PF#^//KWZ]>S;F^=R([[\^?3KV[^//[_^ M_?S[^_\/8(`"#DA@@08>*"`7[BWH'A?C@5<:+^,04`4%-KQ10T2<`,`"8U<` M4`H8.I3T30U,<<("&!MV&,P*`)RP##TTQ*()`*!XX04-1@C"EEI(5$&`BS"N M\$4LW;#^QD(89TU"P3)S1>3D&L)!]<4;,I067FD`Z":#-O``8$$--/"R`@O, MK*&3#E78,%@-Y+S!2SE$=5,#)(==4LIKY5"`PQ4V:'-##1VU51,OR^23#Y;# MZ;`AA:5<,85&1DQ!@`Z";L(01BS$\E*Z60BF/#X4Z:O*[3V6@VH MK<`+&(H^B.V#Y3'(;;?KP8=@N.*.2VZYYIZ+;KH&ZN!MNP-D:Y5`7WRQ`0WD M+%-#157`X\H5\+!P0!B^5!6,%V^$@<0!*_P)SPHGP*,#,\O^O"&C03H00PX+ M%(`A"`U59WA##-2&@8-35@4SR3+C^%)*%:6$3,,&P95=-1+^;#`..2M9``J< M<%Y1RK5%:UU"W35T\P:1.N!@MG)\^3+.,I,(0LXX&X16PC@T\/@=.5.\08YP MP7SS1C=(++.P#`=T0X,7FM40.@T$7'+`.%_`"[QXV[9+/(/@JHM\\LHOSWSS MSN/';O$,OAN\:;OA@(.:1,M017S^PNFPFU4Z@*$-=2(6'=_0;!4]617E'%"6 M8Y#X0D&%;J]?/M&GB2A<%;Z"[S:&.(4AV)D.MFYPK?%5P7SC8\OXJO*]")YO M@0.T'AC:UIB(/%!$"`P?>`#XE(@((GM\,4U;JE(^MGRA!."P"@5*,!VB>>=_ M?$$-U*A2H0TZ$(+U0Z&:PJ.#8$1$?$5C(/]P4"D4]C`8(*R>$\$P`.E)D3W' M>YX5KXC%+&KQ>=&;(A6?J#^^R/`IWB%5&8>#1AE>Z2FE(=4@+'`")H:%<\P0 MXQG)F$8U/F6,9KP!#4H`B0,(YT'!&",:\:A&/NYQD7I$I&GP.!Q%0O([9KQ* M?&38QD3^0F4*XUA@6/P!"0*X[8R)'$XF#5G)4D52/(TD8RK)>,E5RO*)U8NB M%V^)ARIN<9>\[*4O?UF?+N(2/>\*AC$)9LQC*E-QUBJ-HI+93&N]#9EO@Z95 MJA`/7O`"%-WH'<2N!,UG.A-"U93F#6P%`'K\2)K)5&8SK^7,9;X3GNRDICVE M6<]W>J>=[228/O_)S])H(R=OL$`8#G"`'Q&-G\BT9C\!&L^&!M2AS"PG-2.: MSW'N$Y]88JA'L63+84I1E\`LJ4E/BE)R"5.DN<2G/^-Y3(O.,YK3_&=-Y0E- M;1`@'C2@08HJ(LZ97K2CXX1FH+X`M9F&LYY$[6@TFQI3I\+^]*)/92=1OX/1 MJ$X3IEC2@2"^`(F@G0:<$75GEI[:5'V&4YQI1>M-.4K/K2[3K/MD:VE"RE+B MD32E?.VK7_\JGY6*M)A9A:M5_2E1FKZTJ!@];&DB$I,@JA6QD\4J8G-J/L5Y MU*5+76LYGRE1IUI4HQ]=:U'5&E.K$F\>FNO@"VN<8^+1<$.TT$W0`:6$!@,9,@GNM)M+C(>*5W3.,6Y M^I$N,J[[7>AZUS3.W:,,F^N4>*(WO-C=+GJU2UZG.$5_8&!O?+*+P.IJM[G1 MU>YUT2O$^N8W/H]LKK6X&]/X!!C^@?*I;X"%:%WOYM?!0M2O?M-;8/,>^+\- MYK!U30/AZAH3O0S&,($5'%[^DEC`!P;QAJOK7@*+.+SQ-@:Q MVZ1,'F?*-[\!)N^#G5OAZJ*Y*E3NQ@^$*8P/NML%74C%TPM_>Q([:RE(WI9QUG^)'[-/"`GUQ>&_MYS/-C^IKZUJJ'KMNZ5^-?S&;2P<\WL02L8@LW&=7V<+6UF[YH^Q,9UMI.] M;5TOV]C"F7.)H3WF;RO8V,U&-GZRG>ON&5O:Z(8@L-?M['7K.]S<)O:O6=UJ M*B*/.O8A.%N@5RZ##UE-]V%X@13.'PK&!^*R[@^M;VEK`(G('_#HBR!XI#SP M,;Q,JK8W^86#(L!@/@`5>/D/GC\/L, M(C"Z'#H.X!.QTP2SCLH^D`X*P[V%XP`,))T<,GZ>'_@P@^+WJ<(@9"`(I#/C MZA7_S\6]&,3_B`@6F)N"U&P#G\H\(^MXT<( MUH'(?.)A'0KHX$O?,#W#!_&E$IC>0%SP1PEX@03/,T\'6&\X9CBQFQMP`>FK MZ4;P`S2(<7SE^/@QB"^F$'E+`6`\T`VMA017$`,0 M,3G$H0,A:`072"`RH!;^((')XU7^4!$@7G4%&[`;,;A`@G`%)S$@-'$%HL)@:=M:$WH,:,J`8A"%#8LAR_Z5G63A>;5A=!O>'9V@D4Z`#_,<\#PB! M>/""^`$.&P``"]%P@[`"&]A_I&B*U$%P.C`.@J"*!R$_9>,_C%\ MP71D0#;^CM)%`8)@$4[!A;P@75ZG;``T<8)``,%GDFP!D?)Q@^&C M`P2@--_8DA69D8$%$?;#?),!%550D3>8&A3`7$ZQ&R330`,4&+'`"9:(10JR MB>VQ5Q2P"X?@#=YP"`_`?).C$,M''Q!Q$V]A>EXY"&`YC@0W"/7P!@+4DAJ) M#!9!<"AQ%%QP?*W%(V%9$KA('Q8YCA,'D:TED.=8E@(Y`!K^5)=\R1"M-0A" MP`LW,8Z#`!]<$!,LR7N.N8QAH9'9U!R6^9!\L8R\5YAY"9$#8)FM%8UY*0.0 MYPAE^9!K*9![Z98L*8NJITN0*0.KX)@:>0.9\'0!"1%QR7Q?UQ>KZ%5[Z76[ M09D"@GU2](LB4B<`<`7U$`^#("BV$1\T``DE@#`500X'\`^"``:P$#A"A`0E M$)U&L`&=8P3B&!]&\`8FH2LUP0RFTPW0`X64`]?$"N@B`/_,`5A0&#[N0DT``KT

@`T MH`-V@-?$#C^IL$"OG,#0W.>RT`.(*D7YE!3_W``2BH(D%"C M\X$$_]`-.)`/P[)W1F`$X]`-KLBCXU`#*U`"-\`"%A"=5"*D<`H1(@(/WV`O M)T`16*2)$,AU%$`,5J`(5$`+*L!\O0@+^&`2U9>8WP`)D`"6R-"HCSH%G/!U M\-`-OC"/V@0)-H.I?4""1@`)F]`-<``1<+`,F\`,@9>>$1$/&Q`#H$`#\$$2 MK^8`$^6`! ML#`%)E'^#\LZH#K``LOP#UX%"\`*J?-)'35@H#C1GO]`HG@'"23X!?50`OE0 MC!'S#?7P#:UH<+UJ!/E`'$-0,S7@$/'`?&QQFO\`#C(`#^-0#^"`!%ZP#**B M`XVP";#`$'U`KZ"0"Q%3#Q80@N-019>X"9!`HX.I`[#P#S20#XS!&]]0`LPP M#E-0#[NQ0/7P#QOP#5!Q@H]Z!>FY"I@:#^2P`D/PB_V'9$'+%ZS22:XXG0S1 M#>-P%,N`>X,P!-,'$TAP M`I#GM#>`#[S`#-()`!OP=$YBE/1`$3H0#V_`#+&PAD8`$TS^`0GPT`>0IWIY MBP.Q\"5H00'*YVMO<`74\1I(-!]5(`B@P`S]``>#`1%7L)C@T`>SX10YJ[!Q M"SZ0(7V$H0/U\!7@0`X;``YY\0^Q,`0:$`0]PXA2K40_Q\24; MV!<;@`\*QP)O\`9>0*]3"CYX"@Z#D`\KL*%P0@/=<`5@`(JV<1&1XA?AIR9P M,`5((+O.V8!6U*><]Z?$(`U;L`728*BQ*`,6@`RKP`MO0';CR`*"%Q<`8'P4 M(`3Z^WC4)P-?&P-"Z;2E\K4IR(4;.`AK6(R/MP)]L+``8*I1BP_],+A"\'1W MJ7`GR`LU$!T`L`P4@`3L1Z-?2P_^-Y`+)DP.7SL%XU@#O``'(>P%%,`,[$>S M[9<32#"\`)`]8O$&15IX9.L5K2<#)2%[7@L`N;`*1]P1,6$$W^`(O;B8("&^ M.@B$PI<+'T(<.7&R*]Q^'3RP!9L3T:>Z7T""WX`$X``)K@L.>2<#2.`BD)!W M\P$?S[D-5%L"_9`3@O")AH>W`/`LX_D5#+$,R]!:SCD(S``*.-`/@D($.E`3 MM,,+FCJ#2P@@56`HL<"L,2S$XRPPA9'0N1'`"`CUAVD&$@'4C`N^/#"_GP-\:Y`0\A79SP M#4^G%Q4I&`4T;"L?G"/5``_U0S"Q@>K_L"^`@J6"I`U/0!SX]EI9: M$0`P@K'@M+PW&9FQ#8("#Q#!!63R=&\!#N#0")F!P3X,#H)A@;6*EQJ)*,'\ MM4+0#W^!#^#`QP!`!&==%&JMNGW0#U<`%VE8$RRPU2R`U;K^;!-/U\>0.1&Y M#`N&=]49P]0`T'JR',8,,08EX`C(L`*J4@.#JRL`8('@X!(*MPU?ZY:(?=5? M@@_5=]2QRWNHR18%I7HUD+`R,`4L,`1PD!/UT`]K"!.N*!_^/`6IR07=L`S] M\`V\H`/;X!5#0`&.L`)7X`BQ(`B#T0]>8;/_D`_@4`(^R@(9R`L?W=L\LHV! M-;0!8BA?)WU?,-"&]SV*-PA>L0Z+'"RP@!W^0,+:1`XW`6-],Y!LJ`-``0Y1NZX6\1W$:R_T-#TX#N#L.*<`6%0C>F2O@7R`V8C@(D%,1V@H`0O`%O-`''N[A M,+Z4JR@H/?T7Z=T7=XT,X=@75=Z4+,T>U#&8`V#FX^@`5B`-TF`%1Q!\\!'! M-3#9_`L1>)"Y-8`'Y?$63TW!>1[4&TB$(!T33FOF+"[;H!C*23X7%'`P@S`` M5`L+CE`JZP"*]#,(@XN+(KOL%:QUV`Y`)6](/,6`37#``.M[E4ASB MK-6I_Y&EJC8F3".W($'`[`*B!T37ZN;OH[8V_`E1M`'R=X' M4>TDG!#^VO!AYH/9P&$\L*T%VJ8GL@/K"`.@[9+ZM6M,`R#L%;"@['U`S*\Q M M'V5>\-%^YB+;W0#RW5`QG0EA>.Y.`4HB>O00W310A%<@`]VZ<1OR!M-17?1M M$_9=\CJ`R_-X\E\2>048MP/>CT#!$(\7#^#PY'6)S0U^!?L;X4S^#_V0X6QQ MX2_$AOTW!7O\=!10%LU%`867+YOTN,3Q2"I>D53[LCKPX@Q1`Q\R!7#@=3=. M8$D.W/7P3DQT0=ATANT#\CR M@0>KL1,5F0O3UP^#+7HZP`MAL-:B-P#/D=527!ZKT=NJVPB7*.NV/NM/=_B# M`.MO1!&#">RYK@/<_PW]H*B9\+PQ$:JML@S??_`WX,_MAP>GN0&#@`?7OOZC MO>UCS!;++;=R.PAR<0/E#Q"#!&X`L(K+C1L#$.I8L4('PAL/!_T;UV@=@!HZ M&%H8I$,0`!K]E@&0?OX!0`@*XJKJJ3>ZZ2@Y(_IA+A=PPA/H MQ%PRC.@CU70$`))^RF+F(2YX64G+#'FA`1D`.(HHL)#J`6!+NV(`H)$!!E$S M+W`67(T&O%:S@,$!R/Q&H+D$T6@5`+X!)[!_P"GO!G@.&N0&'V%Y%**)`,@$ M#QD`V*`C?`#`YU&%(LKTGT$&&-41A`;)SY=X.HJ*!G!6P0H?<%I[:B>%%"SP M44>^N`$2Z\")<0@\=*!1!QRN[`>LJ58!!Q]F]N2"B[C@N2'^62,FQ6G#4''= MMJ<+PQVJP0@AHH`70^'+)2QP#/,"G!MBF:*$0>!+;@5!/YH"(0KZ\(>"SO+D M#JR(Y'1M$`NN&"06/$N*Z`J2=`"GC^-B`4L&<&28(A\*!MGD`'`$<:0?7@FV MZX1\8N%B!0`B`@<67KS:I.607>S8-!VX6"]5`,=Y"IYO;@!G'<0"6R:60?H` MH)NGUBE!AUA*X$6CCWB\"PDYG^J'8J&]>*-!S0!`BSQPEODZOB\R[@KA-T&'*P. M6D*X3V2JA_9!@FXU4$N$@1$1[M94WG#<`"'B#<' M<20PZV&A2_O`1/:-.'!$$\3$B&]P1,WR!O%>AGYN<,6AER/&;P65=>!E`Q+G MLBLB7FR"=OD`P#IR]H]XR,`_.NC'%0QU$H6`PW\4X$*`7A*5&CQJ6A&YP97` M<1`/IFH(`,C'22+",B'H8``;B$<_-C&U@U3!\$@]#O>%%X#@1,SJV M@MG5#A;]",P4F#&(7(P##TI;Q@THP((_\0Y>G_O<``ZRP<[Q!"$'\8GFPN6V M,J)-A&1LOBJ'B7D3CZ^03B$'8!PL=C$%)``!B]X85)K4]HW(`&& M<8BM"H)X`R^8<8,PA.4A'ID")V2`A"NL@P+Q`44,(,&R/NA@)'A;@05*\!;? M-(H9O'B#H)@QA3`\<@5`T@$[Q%<59$#`&D2$$R`A1U4.@,@K"$(&DG$*Q.!`J7I\#2(RL*;QKO"/C,"M M#T;:&42\,A)RR&`(5\B(#I2V2TT-@@`LJT$5;E"%$VT@(C7@10D8M0(D:(2? M]*#!!MX``%B4LW(+C=#EO/A0#$WK)E2DJ!5O@I4W+"-#5F3^QD&_(8-!,.<* M,9`:+^)!`9&2E! MZP8-3&.!=7"A-08\R>?4DYI,""(?DAK$B<8A"$%8@*HG.@!6+>"+05#+%?F0 M@2"N`-8!C.0+$KF(%R!Q`T'P(A]&@`3$8'&#D;``*[+<4E1`X94^OC4J%M@G M+W;)"R-E:DQ#6`&;=#(`Z>&#`H8AK`[45`_.#:`P2].L8;IQD)NT#A+PLHMA M#CN.1_FF,DVU:"X!0,P1F<:/@:1,LG@#'0`TL5*[S%MJ7UO(7(14,*"U:'&K M."V)2E2S$+40&!\TR'7TH0_P*.O^%_KPA4-.UH]],.%":M"(1=;`.1$9@A$V M`0DC.!<2!T""/Z2;0'CXPA?X@,-[96!/K)"#'/6`@^2>.`X:6#:!@X#'.(PP M#@2O8!G,\$4?$H@/^>)#5/_8+Q+\*X1QU(,+-!#"*KKRCV7X@UR>\\4ROL&F MZ`94$/'X@B_85&)(+*HX@%_:V8#A`0E`LJ`>%UWJ#(318"&\YB2#T"I$@ M]V'(T!E')LGSQ%8EQ2ON^0(DR&'A]>A@"-\8!U/CZPL6((,+@H@N=IW(C`V@ M]WG\@L,RQE$#6'R!R`RE\X,FQ%P\&Z6X/$$N%34;Y"\$U(0LN"XLG$/@<2PC M%S1@0:K^"JQH&DA8!BS^0I20`6)!K(+2N>@+'+Y!`U\@`P\W('0?:B"#=7RA MTGB`19,I\(\-R(`9JE['4ZS(Q1OT.`891(8CO-<'*[-@$+W^=;`#]ZM_[#JL MN5!UC:U8CV4XAP)#&`L*$370>3Q"72 MG+BX5,7"N44_2L=B*'23%-V>:)=<%:+N]T5VZ.E\KTD5R'7UHX=U6H/P`@Y" M9\ZXO0'IAS\[X8DN$).L1O.XC/K:]UYGT".EYSZ':,&1>^N)WOH@%'!"1RS: ME]8[HN$`>PGF'?6XEBB>[II5GM2=KA`*.,+N)QF$$YQ`P=TKKU3:T\CN^WR2 MU@LD5=X3F?3MXKU,D`A45XP^B*KN>BLJS[_@T)W3O\_NZ/?E]WT!!Q[4[_J( M..%V5]1>Q[AT^N_G/_^H?[_OG6#^^ALHEJ8Z"#R0OU+A/+2'MG+-^6# M/?0[OO[+%?GCG+YPA`;$PT7^',!&;,2*,L,R?#X0%$,!_$):K,5:M*PI0)U\.`"TL$5?_$5:](B# M>IH'08+&:31@3,9?#$-9S)R"2T/5,RZ-*T,%S(GCRKEK%$7^\\#4VSENW+E, M]$!Q;$49""0C@""%*$<`.$<_>T6>,RXSQ,8]<\5VK,;D4JYPS$1XW$!K]#.> M\\16C$9_Q$<%E$<^^\9P!,=6O$>"[,:#Y,-HC$4Q'$%EK$A?[`A_0`*"2SJ+ M[$B/%!7B@)!<0(*1_$B3K!QF;$9Q(<,-]$9];,EL7,AN;,>6A$:;!$B'G$=I M+$B>X`ED,1`DL#4KP@&@+`EK[,<.S,EKA$E_A,9WS#E73,K^A$1*G3R]AY1* M#M1'_DM*IN2S?LS*F0Q(4;S';0Q+FG3*T9-%BCQ)MJ0A3'H\3,K/S,>!Q.S?Q'V@1( M?(1)K:3*GJS&@]PSB"S,FQS,V=1&M!3,G51-ZWQ.[]1*A73-SA1(]-3.,Y1' M;^3,]JPHO20]W/1-^[Q/_,Q/^YS^S^`LBLKD1H%\QZK\SD[4S)<#L3_\D3P#]R@C%4)00B.W$4*Z4 MQB$ME=&L.B%M+2(%4=4$3:ATRJJ[4/BD1I=<.]>#S;`\4>YDS&D,T*A\S\!T MJB>5T-7``Y[4N0^=S1?US'SD4@Z[@1K^*(%,>,8(G=#K[-`Q]="8Q,H8-;@J4]/MS`1(B#+"5,Q]!-`W7H@3Z094T2RG M^HBO\="(\YXP@!!-:C=$)M4K-@@.(N132),ZM[$MF7:SJ MA,2)W1!0E%ANR5@][-CJY-@\A,2/U2**Q=C'$MF+W5A)K%B4U<.4G5B0[W=F=5=F430J=1=F@Q5F@K=B3U9!0#-F0Q5C^4$369-T`$FKA&DAW%>01('7`">@@#1X@+(:B!4<,#^J+5KUV\-Q`> M=/26T82@"I5#44Q$H:$^6C5%GL/;O]2);5`3>K7#[DS$#1*.+5'::.PN!_66 MXMHB1^D#B*LBP`T5)T@-#6JM62L60J$!)_"P:L1;XKI;4BQ=A`W MF]U=X:792SS9EZU=ZHW9G[5=VOU8281=UVU:W]W=F=5#J(U:?(5/#W0B^3-4 M,QT`@%%?*C(^1W"1KCV]07`_#'S^#!*QHI:8)':KWVG!@R(1OD&X`B38A@@" MAUL+*SRXG5M+";D-/T=P`G!=C3AY"2NZ7VZ-O]LQ(48"QF(5/@E0P\96WP=`%09HP]"7^%S4O5[WPA^2S,ED83(F"GH M-2[2'@VJ(N,#AQ406-9BH&]8"3S(!`_2GN?3'MJQJ/J58@7_O]/][S M$#75TO(UWSWUN8V"7.#M79MMV>W%W=P]7N5UXV]QVM_566]9VFWQW=G]VIH- M19C-8^)-VNQ5V9^5WMH59*>U"2U2Y$9^9-[-64"^7CCVWCCN6=S5B?%-UC(V M8W:;,?[^,E1,60<\@`,:&`(EU8AU@`5CM`!402Z?P(A0AJ(>1=BH=6&5(8N)IE@&P M^`9]SI1Z<`):CKE.@X5QIJ#)TL@^6`706&7NT@@*D&4NP.;^5<"4(4""[\(4 M.$BF3N;,UC5:W65DZ-UCDA4=.6Y>.[9DW9JY*UCH3W% MZ)5>T=-JMW[=1O;>/69K/(3FU5K\8W:"IEJSHR3 M#;``'%"3/G`"?&B%@!/5*?LMC(@F*&$D@!8@DI"X"#=3"I08B1 M;W`$9)B+D7:"N4B03%@!(VB$W7C^B[DP,0`0(`C"!^DA`E*&A'QHA!.I!T@(-^R)03@)^H6(>,&8U^V`97(A4G*(L1:>@([H<52`$D M^HUM<`+#4?-"N9UU66\\$81MN)A^\(MU M/(@*8+<41X`'4I$!-1$"5"F4;2!2?W6$BU&A#:B!B(^`*P`8%N;B)9Z40B$B M7H`$U+?L&$@,DA@$)#C]U#\K//`4FLC'>(`$1\@$'X&#D$&H?I@0>F`0)XB1>&!U6$A['\97CY_1E0]_ M\1]_\B]_\S__G-AD/LV9.V?_[J?^>09:!Q:B$2HV8 M$(`0!,"(DT'K`"#!XV@9KP'@#N;"XX2A#AUXWG0K^`6`/PH#+H8IV`<`,X\Z M4H0!Q^7-N'YP`,"Y(0,9'CPZN."\`:[;&YLZ>"US@@<)@"_]N@$01.&&DW$D MMQD!T&A;OG%X9*SBH@.`"%. MD`'8`.[&`)Q<'$)JBX=+/R$;XJVX0@'F/5#9O@ M-CD&)P1`ILTWMN(#,&30@$$K\CGI>Q-/)@"0X%J&5'`T''#T_EU]C(="[7I[ M;VQ;M0'^%CF8CAH-=*3S`(`!%>F=Z%N*.&_>_%YQ=LWRYL^C3W]^`/OV M[M_#CR]_/OWZ]N_CSZ]_/__^_O\#&*"`_5FDGH$'(JB>=UIY%]YXW@VRS!7( MK6"!6I)91\$*H/1S$!R#=#:%!;%IQ04>`A%D$$(*,32`(P&0)F0XXN%664"_%HQ9;F0R"PQOU]$.47:OD!8YUWP'6E@Z# ME+#"*OWDC`EFW0!7=%-#&,L,,@@\JNUEG0R?M>5$:C7^Z"D;"P#``^(@ MKN33'4ZTV>:$#KGM!@"G(F[#GIG%[34('+Q@QIL3T!FGDQ>\Z.#02$)`$BR# M#8KGH(D),HM>L`-"&ZVTTU);K;778AM@@!(&%,,5G%0>!AI%"P`^`+.*MM8<(5: M*T^ULB_;.+$-#3+X`L`__3CBR`9IZ@7.2_@4Q):6W4P!M)'X))?GGA7U^3)1 M0VQ#U17G-O?8`!3D0@X<0IAKDV7^^1S:3PVP]+,!`#I9!DK:0WQ1VS*Q;G,% MO+*9:%D]VQ`'``T%?5I#/R4``+4C3I`C4W1,Z=T/.)_FL@UT+;^FS&ZCLL7YY-X"F/@^P#B\6,*.# M9"8.\D8^X%"`5#PZL,#+"LS(UII`QOV+T"#;.*6#$R\9H4,\5X#:VN_@.+$1 M/'#(X`0OG(!S(P!];*/="8.XRTLW[:\\A1$TK)"+2<'"C!>#J`D`QM&^E"'I M"F^@C"#&``\*;(,N@AC$*MY0ECY88`..D($%OX'!P>$A,0-``N*&MHW`9`)F M8T""("3^TP=!W```=\,73OJ$A%Q,ZAL#$,(;KA"\QL!))_F8PCKZ@`\6JJ4Q M5_#%/ZZ@);)Q`3^#U!<81TWZ(/> M:K`*ZL0XOK,,)7&#&`:Y`@U78*A]M'$>&X"!0V[#&5KR8`CE8 MX,Q,Y#&..H##%'CQ#1:DX`KX8*<%X*"LK^5B"E.HQT0`D$[$D:,&XX@C7P;A MT'"VL2BQ<1L`IK`:/,"!'E.`!6MH:E-]ZL`I5R!'/BP`C[_X!0\,"0,S8'&% M:Y.L=+817X&L#!PQDD8P M`PXU^0MDE[1!07`A-J+[K&F5M%G-FL@)N8B);AW;V;X,4!"MC>4@="`(C8EK M$#)H1&PNA0?C;A9$C7A+)BQ;VP51C0*K"-B?<)`)E:B6LWP!3%I@*PAXA,$F ME1TDB<2+`_II3P;T[,4S6/($-CU@!"-2_5)#%_,8QC'.,CMN?&-ATSC&K(8R2\N[YC)2'Y/ MBV?LGBK^_UC*2TXREH_.8SOA3U$*F`8RS'D@W5 M:A*LT?DYTY/^6G.G)E?^2CJ6)C)6I?LC`?Z3/?$EGJ&->$TLY6'[&,WUYC'9!:RF<_<9G2K^\IR%O>YT1SN M*[.YS&]N,I31_>,.C:SN<`?^_-X"G[*3=5SC M./-;R4^FL[>;M6UFBX[;HFZ0R%_LYW#=6>3A&?2#"LMMW05FQ*X.N8DW.=@3 M@US4VR8Y[ICMXF2S_,[:1B3.\WQH\(!Q/!_)Q!5X,0Y(0&(#&^B,)KE=<[HB M5=,.\O2?5\ZWFP]ZQK9R8SE1!0!><&=/)DYVRY?5\?+X^\A*CKB:(UYN+$?9 MXOOF,<7GS6:+OSO?!<^RF?\]<+Q#6>-R7KB]$0[DC.\;[_5.]][!3/>+`][) MYOYWG._^YKQOV=W*?KOI5KYV3>8M+'/:B%_;F*T=6>/#`#'*4P`AN M27K89W[Z/!-=Y30W/K[;_8`]YONN]]_G/O MLKX=#W''>UF7&5R9,1G`]=O#J9D!VA^\!>#!==[!S=_A:9RYR1V:0:#>3:`` M8MZ];9[B_=WHD9ZW#%_*%9W0<1+(@5_R%=KUL9XBC8<3M(_/*5^XL-W.B8[- MJ1[RN>`--M_,M=P/QAX.VJ#2O04X;`/Y%-L/?ES*?`%\I_<=:#`16#\Q=W$$>"ZZ9OEH2&X-1P%6J#G>1Z5 M)5[",1[^X;EA!?*=`GX@YP'9`Y;A_8F;PHU;(?HAQ"V@!6[>BG%<"-8.$$)B M)$KB)%)B)5IB>UAB)FKB)G)B)WHB7I'8)XKB*#X()K9<$G:B(V:;F!D>`0Y@ MW]6;PZWA!Q+B(!;@&3(>_"$B(((>E>5=O.$;QI%;Z*4;Y1E>!B:>+0)>Z#E@ M+WX>_*6A!$[>,3+@`X*@*B8(*6IC).[@-GKC-X)C.(KC.)(C)ZHBY&U@,3(< M&7)9YGU>*S9<_<%9+0IB,AJ@_.&B`L;CPM7AEXDA'O*?_1&>N_7?-$I<,MK; M_SV>Q-GBNADDO-';0BH<-IY..5*BF`#A%'*B1GXC1U)-*%K^9$B*Y$B.XSG" MXL`E(.=5([[IHNC]H>1-7)2Y(B+6W1X.XAFJI#K^70.*WOVUHQW^8AXN8SLF M9$1J8-WUG2\V8.`1)>4A'$NB82-2I'F0)"1^&$A6A$=0@"<>RUA\13G:Q+$! M84%@956:Y5FB922>8S,*'L'!X2'V9`"^)%(J8RX*I-\-).;9HY;EI5X>8!U* MI#4*HP`"I?[-H]W]H@-6H#S^9$+*GV-BX.)='I]-)8*DI7?`P0%X@6YYAR/X M@DUUAR8RB.[`PA34`'Z%8]^L`*1TXP`XRB8X0EE>YFS2)EB&X+.("9^PFQTN MIJSXHEOZYF1JWDQ67+G-(R$*&S[^[B$"LB/I4*"Q[*:-&8O!_=^ZX6;6S6'T M^..2Q=)'^J5>BDO6]9][7*>X2*=*GAET/ERX>9W]=>?&5:9E7N8`I$8WQ*;2 M@0-;L`!G6J)6($.P@$-@((UL9F);*>&)_$YS`>$`Q`,`>$%QY9C2F2=6(@<-U,!7^"9_R0"B71I&2@0O/&B,4>F$NNF; M;J(JFNC^A_K>T,V>$@8?^]W.GLK@BMZHMI71,6#H!!>`!K):(6DA$;.#!X=B+?$T;U>2JJO*9 M4.RJ(Z`FU6#8&Z30KQZ*LFX#:HJ%0OC$`*AIK$B$1$0:G()KN$*BG&IH\]&@ MG4+AH/JISSGJ7/EHC2K?HK(KI/K@7!TJT(UHS[F@B=;H5W^R)*$=6'1>B**92JKLJ+@H:++OR;;O>Z0F::\.^:.+2W+[^W.+V MK>E9*J%";JA&+%7VIQ,,P14@@1/DPQOH1`Q<@6,MPQT-PA!8;3U\@60LQSH@ M142$T`E\PS=8T!<`D@64"Q[TS!7^P,(Z""]E-0*N.$',Z4`@68!_-8+P^H-$ M0$(^;!;3.-;*G,#QY@,OO.UH9D)@L$`C((%`7:]4C(20-(6A0$=&H*T7.`(% M>,'RA)0_**CZ/4JJ@]JG_*N$6QJOM)'"(&BZ+"JH* M:E_?[FN'^BW?XNOK<2Z.]ISPR1ZZ/N&<7BZ(ZH6F)-I("TE0\O M,$,,K<.T<0$O&,HVN$TF](,33(%B]`.>&$?G7`%A5-`4Z,`VC$8N?-@*S`_' ML$P_],RMX8D+$\D`;,-!,,.N)`[RX(D%S.\4@`*(&P],-(5-4V;`3\ M#`$>#`+^4&R##L@0KO'$5O[$YO""$.`:"_Q(-^[O'YME_\8KYL(KPK(@RW%N MAJ*KNFYN"=I.T$WNX*+>> MNPYAOJ:PLTPLZ5J/B5Q15*1=4Y1+/_S*6+C&_7!!;C`$,A`)JS#"JS`5M:P_.(!4OQ#(T`H(.-S6O:O!BNJO7JRY.(9 MHT:RAQ[?Z^5H0(NH/Y.R/Y\P(MM@!WLJ07>?#@H=GM;KAA;^<-U"ZA"^:T-? MG>">\@F>WBJ?QR4ZPF@,`8GLJF1\B$.`QA#TPS>,`?&(B%C4AA'X\OVX"&]T M2#$?S/T0&``0P8?EPCBL`[D0P8/MR%Z``XY@CU2PQD)PA!.PA%AX,SB#`Q%( MQ:%HM36C+3H[@<=.KU?81-I"AF0@5#ZK]5G2[?!%(:%"HL/F:_M):@L&\";O MK0&;8!3ZZUYCL$4GWU^7,D)[L/Z@.'=.,";*(:LB-WW_]V<`*3M.A> MI"MOP#;0A`SD@H#&!CBXS:VQ2X:(B%#<=$['YHL```YR12!KO5U>V-;`^YD+R&H"K!W,_(&YZO"1G;[B3+B4O"]!C!(.RX&K[<0 M$O8HL_<(6VZ']MY]1ZJ]PG=@,[#K,3#*=30C5;:E^83H6EI%C,4;\((_9,T_ M#`%T;$X_K%3.;``OR!>33IMEW,S!M,0-'$48.\%H4!9AYF(OYEJ\YE\,MF8^Y[+RYF(^'6%;Y;6)WBO;YGP/Z14[B@!.X MFX_Y6`0Y`)#2-ZB%@&X#'+S!CPP"4F1"9SE/3;S$!@C%"DQ!5:T#]DH$72`- MGAC*(-2`SU"SS^"#9"Q#]8F4$`C!":E&I(`&'&P#/+P!=9V-&T^*;@S;H_%# M'^B`9R\=`%@`.-3&%,`#/U34.C1"%]_%&Z3%*JP`TC`(G6?YG1^XEW.[)9VY M9;-YM[@'P=ZONO[OE,B MH8,YE].9]@A!/JR`Q\@7[M8#.2CQ1'GL%]R`86P`/*P"$93^;40TP@9P@A'4 M`T`16-3!0B9`_!"L`BR4;?!,U2J,@P4H,3Y4Q7A!PB;`PMLZ01^$03U``G7U MS@8X^,B7;2,YJ' M^X'#>TG7.YACO;JG.U7^?)Z[NY>O>8'CN99O^[]G>YC#N;O+.]BCNYG+^[M7 M*+_;_=WC_9<3NKK7.9Y7Q(?=:IFW#U/HUJ%4ZZL6:\X(Q9]$FNY0N>+_2=80 M:Z3]:OL`?FZQJD3@C$]$&E,`R?5\J^)W_:\*!>3;!.@/!N`71!6Z\1%Z!K"J MBKWO^;_3/IUS>]JCO;V?>98;.+K^LWG6;[VVO[G5;_GHT_WLSSN.>>'5J1SI:8RPKW?^3UAZ)/C":)F1J?1:FP MS3L1%INEA;\+-AJC+@3H&%A1H4`=!/`D/ M+E3(<*'#A`\+$IQXT*)"A`8'9M0H,6)$AA`=8FQX$F5*E1@GZN#2$F9,F3-I MUHSYLB5.FSMY]IRHTV=0H4.)%C4:%.A1I2N9-G6:\JA$I3:E3K5Z%6M6HE5K ME3L6/)EC5[%FU:M6O9MG7[%FYO7OYKAQP`W!@P8,) M%S9\&''^8L6+&3=V_!AR9,F3*5>V?+GQ7\V"-P?NS!ES:-&C29V?1MW;MV[>??V/?OU;^'#B1OSAU\>/'CR8-_!V;4VU&NR[=W_QY^?/GSZ=>W?Q]_?OW[ MNX.)RYZ_``4:H3+)!)7,D M$T0@:SO/0]HD>%.":^!\4\XYZ8P33SOSU//./.N\\\\Z_X1S4#[YE+-00Q&= ML]!!$PWTT#WI%-10.Q=EU$],)^VS4D()==132T---$[8.N544TE)[=344UV5 M-%16,25U54@IU?322%$]=%5=8;WUU$5!%?758A7]-54]>QWV6#QS+1786"N% M5-E@`=V3TF=UI1765)T+YD&W(H0-`WTP2`7==-555Y]4SI6BW7/73;?=>=F= M5Y]ZT=4W7WO-[3<5*>BU-Y5Z^87W7H(5WG=A=05NN&!]YY77W7;;?1CB<_7! M&-]T$4977H#7%5CB<@G6]^%S*1;^>5V))U:8XW@5=GE@BB%V5V&;3Z;97I(3 M9KA@D'^&F.9_T]6XY9D#5E?G?64^^5Z4]6VZ8X,S3IA??X,6VFFM!X8Z:7:+ MOGGIKXGF>.N6J8X:Z*]99A<#X/R#*\)W),"BB;SU?B1OOO7>NXE'_.X[\+\) M!QSQP0\W7/'%#Q?\;[\ES[N3PADGO/'!^=]B/ M5SUYX6?'7/CBG9?^^>EY-[UXW:U'/GOGN[]^[^^;(*6)"218$3VZ5[S[?,%) M>824^>W^%YQ^_.O/?W[^YU>B?_SC'PGD1T!2&+!_!*0?*3H10/UUXA$0Q)_\ MYM=`"E:0?A:,(`4S*$`,DD()$23!`1>XP/L](H3]:^#]*M@_#"I0?A,:G MPQT&D(88?`0!E2@_)0IQ?S_D8/Y*2,;]49&*6]S?!B6HP!,*4'`0[`0!=6C` M+AYQ@A%T(0='2$8:/K"%"_RB%DT8QQ*N$8Y.!*`9!1E'!JJ1@_7[H_V">$$M MIM&$6"PA``.(1$IN,7]NU&,,Q4C$4$H0?S!TXQ#->,(J=E+^?W"\H2LM&<,2 M=I&+K&0C&4&I/TRZ,GWKFT[[WM*#]^$MC$?\XBA?N<4&.K&`:#1D'$FP0A+T M,7]RG&0V36A%4+[R?EP\81?/R,(TKO&,?92DX!2H0?^QL)`>E",O57C':):1 MBFXL(CSM-\)E\N^?>X0E.O%'3G_&4I-[-"($Q8G.3MZQG!EL(#9E>,@^5I.= M/WPD$",IRG">$97T0^`;4[G'3FA4DIUD)31':<@;'I*77DSI-V%:PE6Z])'M MK.$Y\2G2,\;2BABEYP.AN<\9\G.-RX0G*M$XQSRJL8@X[:`9_^G/%>(QEG*< M*3ZGR$&-PE"*C#1G)P4JSIZ2()C^[`L76]9SS,`ETY=$O*+_?)G``V(SJOL# M*PI5F,$_VK*9`D6G4PM*T!5.<8TP["DS#_E)1P+UG'C=*$<'ZLT/IE&GI@RE M0E_:ST(BD%NMK&,,!6H$A$8R<;:EIP%=2)F MQ>A`J&;1A>K<8FT)&DN$UK2?OQ2I3\>820N25H!X)2-M-YK#TC+4MW@LXG/' M^%.RQA:2)F0J-B\JV[PJ,;?1S6L"IXM:.'(SC*FU(44=ND/M&G=^:1WF6ME2 M-_C5,K:PG*9<9:G0A7K7KOC5[!L3_$"Z#E"^\21I5UNHV`24\X1RG])-Z[6P5Q9K&>4)5CSRE<(U5.UAP8O.J0Q4@;>FG7Q/- M#4)N[>D3IQE6=9X4T<_D\3N/2](S/Q:*Y;1$T_E!28,9H^Y$I'6'Z$E*IEK1 ML%YTDBG84!6KUI84)">(/IN(W.>U9_E35`_;DUS5ZD\CN4=6LOG2J$XDL`&;XACS,\FS MCC>?+XO03'/8O-+EF_K8UR83_9>C$GZT)2'H`A(9MSAGF8O1@=XVS)Z= M(P$Y*5E.KW/9%;=XD:F(<8LK@0T6;P56M]M=2+/PKS7LYD[92<=':#SCUK`X M&\;+[)W>+^/UKNEJY4=T:QL6DTX?ZKH/NUDOQASH6=]@TG/;:PYRDI^MS2LC M*;KUE6-1H4-T02<"$/,YJM`%CTA`)ZP1YTW'?9D0M$8GYEYW*MJSXFS_N09/ M&O,$!`#OAMQ[`'Z^T0BZ@`V']SO^)$_;"3:NXWZV%#U?1P9>D\:/T,/WP>]\!LA!_:`A](Q+]^."`3.+P60T(B:2G"@P0?E@!76CHN40`_, M;Q&:@?'6"`M30`O7+HG8X`O/#P08[]P@R!X80!4$8`!Q29]T2A>:(007`03& M#Z,2`/P6`0@@8`SY2)`L,`7ZL)3``AN,0%$*-F4*P:E*8OVS)&JR04$``*>T(]0ZI92X!9Y8.V<"()XX!8! M0`QU`1H!`!J$L+QX*@`448NX"Q672W^JB0W:D)DJB`V:X1K^(4`7=`$"5`$` M@$`(W4F'J.N"X'`,;E'\RFK9V*F>'J$?`>`7\\S6.J$@#Y+N=G'OJHB^1,J. M7,`8`*`0=.$)KG$1=)$>=:$5].`:[:'%9*WW!-*6?LP8/:V,.F$;I9'8AC&" MZ/$:`2`(3\H%,A((^,`:%Z'S'B$`GJ`B`>`>6H''.D$.`(`'K&$1`&`18BRV MEG(FN]$F05(5V,`>`$`5N@@JWW$:DQ$`Y,`%$@`KM>F&Z(X5;K$0^`#P,`N< MV$XF?5&/Z`X$9E(7!G""5JT3KK$07>GCZBV,V``:HI(H(X@-CF$F%^&(D&C) MPNR;7*`7N9$H.3&)!BB"K`$"7/+^O8`KQ&1QAB#G]_XL^.P&;UK/!1ELTAYA M&T$@&UR`#_C@+!-`"8)-U:HIT6@3BO[N)24JT0S)!52A&9ZPU:RICQ"-(J,1 M#04H``H2`OB@%1*@(&ORVA!-F?@@_401B*0S+@-NHL*H%>YA#&!-]*Q!%Z[Q M&/B`-5V``8!@[U1-U1Y)-S%()B=Q-\N2MMKSD2!@#`J!W:13U0YP#)IA"),S M%-E3-JG,&HP!!,P3-6\1&K*!*%5!%_8.&L=`)(FM@O0-.X%MT<*M*'=3M]B3 M%(H3`.C00]VS$UQ@$52A_*XQ!:3/.9%R[^AQ"^6N$+91*(E2+L>R%:P1`$"` M*/$OCJS^`03&`!J:H2`!0/P@Z"@A`/*64@)=``12H$B/]!A"CQZ7\1&<]"$; MZ1A4(05(%$.33+A4R!J`X#$!``(BTR?EH!!N<0S<\$(1;06AX3\O3R#?33<[ MM!-"R)'HC@><[Q95P8Y:H1F`0";3](?Z,T[U-$?1=#WEM$^Q\T0-DT2C4SK3 M226_R_%8D4W@PIBF`^+>2Y"&4Y2R:1N;8>UXX$3EX`8_#_22SE4WKQ42;YY< MH!5F;MQLM>X:2`D(%4VS@9/T;E9-]$2MP5@9``"04A2YZ!'L03G7C@V0M1Z[ MTEAW=8-\X=>'V'\6),4Z@Y?(4_EX@Y@K2$VK:TB>8`//@_K M+@]?\]'R@.`@DS-90<`%`H`/H($56L%B*=0%C'6#2,#E\(X-EO!^JK60-(X4 M\-7+YI5>,XX$HC59DS)D,Y"*7$`/4+45^"`CD]4$7>`>DE4/0@A9Y6"J9/(> MA/`1Z#$%($@L`>!-2=,G"Z$3>M86DW5I'X%'GR#FVO1-`\!JL19=MY`-QA,` M0M$%P'8,%7,)'V$PDRY$9S6D0(HB6>$HL3*.6H$5U@]=?Q&#K*$5A$Z/""AD MZ8[6YG56=PGT],[]DNI$G\!ODQ7^.CM!%7A@&Z'A(?6N7VMUZ"Q/Z*YV+M'4 M_5AV"&\U-A\O`.BQ/#>H6F$.KH[.JGKIC#C5%=G*OT8S[#),]!23)0$`&XG2 M:F^R_8Y!%W@`>7E`#XY7%P(@`(Y7>1_A"3C6\N2(Z%@!!%BA>E47>^^A2D^J M3>L1>1_O&"``!.HR]70!!*"A$Z`2,WVH60M2!D`>6TR`+!7>ZW-'J"W_70!&H+PD=`V!>+1#>.R%7YV1-EU.>V!%8@.>05@ M@Y'W>+=.#_+W"1SI7I-751,`>F]0CLSW"8Z!!S0X>3N!@Y-7_%QX?$T8#H,2 M!)37A'7^0?P$`'KIZAA*K2!!8.^4(`!$\F,[`1+OH>T@R(9YX!BL@0>@(4EW M$'NAH?TJ"'IY0/\0V/7*MQD@8(8%@'Z!5P\"``*T^#@-*0"TJFG1V%^#T@0? M(6\GD3#S]A[VKC"!-P7Z1R9K,I`*[Z3*%'B]U@7<$0"V<&V!5Q=\\MJ4TI%C M3I'5]C&AL_M2N#"3M_VFEX%IB>Z`\"P=&5HA=)0-DNA.=(!!X'P-J1,Z&)78 M0`!8^0FV]WDWV!H@\9')Z41U@0$4$GCM]VKOX9?E=SV)[@EH>9X.>(-=0)=_ M;G33%(6!6%6_=99!0`_<[Q&Z%'@O\WOO(7M=N)5*$LN(R';^0Q-^ZHN$Z(=/ M?ZE^8O-4LT$/&(`P!><8SE0,>Y$0.^$QH4]:Y<`-U=!+=4$5YC`V;S(%@"`P MQT`7^.`"_9@!]/,FQP`(,G(1I"\`EA($>+$EC[.+G!5XNS&"MG$H[<$8@.`3 MI=:+'X&@@7<,U.]$!2`%('0,5*'],OI_P[='K6V>@?![O<@:*%@/LF&, M@9.E;50`;/%R):@0QH"8`8`!W%`FL_F4CR$`I+40UE,5&$`7>G&K'V%H@=<> M>!0`4N`&[:$70W&L`6`2%1DK&>`>3ID!)E$`D/61YVN/++9'U32$+%9*"W*J M[?E0?[9%=38%4B"9QZ`/YRKW3)>VE`K9&&JY('F2"%.@%?P7L@_R)E7A'GYV M$>;)N@&@0MO1(@EZ#MV/GR';&%I[1#NO@EI!%^2`#W1:_%Q`#D88LKGQ705` M%;#P2@'XU!+:E`&L(<;OVR5AB!\A>SD# MX#$!]!$J$@*RP6)5H3)Y-"?]50_ZD0>R86CI>4?O&P*.81O_^RK/.N8BZ6HI MF`?&LV.?J\DA6P](`3&)LK8M,AO0%AH>%+(GD0VJVF>/V^+\%\?Y(#WY.#ZS M872-@2@=.BZH?^]2C;(T"`!JW M-FK76[67DU`?_U,RQ,(5/.[?U&6I?88LL&ZMU"")E0D7S3&N9RO`SU^D?+/`<`B]^[,I;KA.9[`.1X" MV,!GD98H$YDI&Y;6V6"S]'1/>=[U'A9`>%X$/R%S66]M' M3U1:7=+60!HK"\%+*]KE`X#C(SLOX;V7.9XGZ:X74X`-LH%'UY6[A2YO3;NU MGS;@*.EPU]E)';#8!`A96=XV$313D>.C_?M"G6Q[*JB!\R=3]68ZT[[*WAL0&`\3*1 M#T;W!EW@L=L/I-]42#F^&]G`Z5T`I)^V9:55`/!>[D61=AG(!<:3`<:OV4W[ MVI64X_>XD$=9/>.8)JUA8"]/AY1`+*>6VPL_R1]_<_NX1?6HW"WN,2'?BX26 MXU'5_BV2Y25_`6ESWG42(``(A-9IC+U6$`0"2/#(&C2!A;(E!-"L5:='`<8` M,,C&GL9"+CIU2@$`Y",>"G7Q@?"$32=2CV)V:J6+@8M'<@2F<`$$!!^/`ZVQ MT260`1_^E`",A71!5"`//M!T/7(!8F`V'HLN=F*C1R"K;'R,`5AT,R<``5,+ M;03!YAC(BX]@DK@($V9N#$I8\[\:*3`9GP*J6)C]]%"P1A[5%7`"E`@#"KYTG0K6(!\`@9,RY,H`!`!&!HS9K(1T\8 MZ++F'/E%I@+)6B8YIAFT10(A9"L/A`T)YKR/Z9QLFG(G\@H=D]$]WE7VB'[# M6303;$_<="9KU.$8"#OGX'VQ`A"04*;2-$6&1 M`+#2"E!.\E%5;#-NA&1 MY1%'2H\I=.("4L&28HT+FEG6&5,,L.&"IP!`H,HQ+O08VX\@@,C&E62B!X`J MG1W[WY6LZ%>12-9,9(QR&HVQE5G^<3ZKD!QQOE1:7G91!J1,^9)"0E]_!7;- M8(4M9O#!AS4F\#N0-5$=D,G*%!,)G)EFW8J?\7$,`VU^1TI;&L$H(QNL?1CN M1"`\$C(K3^C"@RX)E"Q'FQP>.9P+;""EBBXMO_P(;-!XQP:8E4;<6\@0\"$3 M7/_QH8M M99,*1.!6Q?D[88@79@A1G?`I5.F(#"E1,@"/-!.CI0(QE.GAJRG4"0B'1WPF M3-;BRIFN!D%E))30*(A1NT_"YE.75@[$(6Q/):!1DEL1+69ZU/E[YEQ%"D`= MQF?)*5#^@]_=N2F:@;Y\BC&!V5*F0;\T MUW_W?,9A]Q19Q"*;VE-,>ZH<>GA60QZ6^@@?Z2YRJXH%[>HV",A:2R12NXGT MTL4O8=9-K*6ISSTG.&)B@(D6X1*JR0A=W`J9[69"HY+PS&4\L)-`ZO4(/XGL M?Y*[6)OJDI>8`,PQ`P,#PE9H,(4])C)*T,S$DG6HL?U/8B,Z%PA$XH(GZ($W MB#*1341"LJ*X)%W#49E`CL$'G+G@*+'JC/^@!()6Y$P@JG!!*X3RQ"MUKG5; M$E$)L2,;CP6)1A!XQ'Z$-::;O$D@`6@BAYS51IQL,#_[49;^#;NF$#VT@@=X M$LD].G,HA4@I;@!@G?]>G=%D MF-IX&4ZAY`FM0-,QA!6=.-F11)KQW?_F\@@V9.-*?N2!,;:YS3)V!);`LP5Y%N0C M%R!(40$P:P":(BH71*=H^HH)&6^WKT>(10[5DIJ7J`;$"=$I`&P(`(;H4Y8[ MALT\_+)8V?H8V`1(CTX\9$7?4A``87F(6EMQ22?N=LE'\J$\.'J$+OXC@$9Y M!Y/_@1;C/.DB@8Q'BMX"P-SRQ9G_56Y3N6I7`EZ)*UF*R`5:EA[[R MBR62PR(6P0JO?LQU(C4-Q3JAA#?=HR.=$``0_C,1M#Q"2RCM!,6D24C+L$%U MV:$.AYS^Z)*8J*(0@=T.$!:*%.>I1;@P20%\`255(C4%4_>-D+]DX@+P@:3` MGSFM)2>WO5:DRCNM,!$RN1O%(D9)(D;"V)"L@90J_HHD'+OBAT@3UP&CJR8A MX8H1P`39L96&AM7A MSR-X*AB?`O6G+AQ8PY1`450"::)F,G),6.23J3RQ$$,LT3%T'!,+R\$[UKB- MD]PV!AY8L1!/,=$8!-"*1T"`B5[D@^W`)(`<(`GA=(K/T2#PBQQK'`.8-I1?^H.(\<51/\([3 M0#(A:/#!H>DA12OT,,A'W*TS$TI`-DR4(@??@P^\T=)TF"00>[37,R@=(7N` MZ8*^306 M%.2;)'B]"&WPAYJWI!DY#_^0C&@C&]0T`UF5F4FHCA4J/FRVV)A!96?XL(@G MF+R(.T[MU2*4*9>;B*-"`B:Q0XL@1UE8*48UT$QX8)1X`X!W!HS6L427#=@L MPCN,'DOL9G(E^91G3:TXZ\<_RQ;^6R_1GX7H,AO@@T[:]D>*`]8G99BGT81IP`(K'!:R,9@C!3$R\`\`$+(MEOW8"+%\`I?UNE5$;4D6JU& M^`O`A![OO(G,C-#HG!`0H&JO957R'@$X!JTU\D/CM!G#KIT*^)##`%7\$#O` M<4$%C2&:]+3V"6B2`[A>G]%]5F7"FBD\6F#U+2#\K8?TO"%%,7.1P2WB+E&% M4Z)*LA03O>4N;*`1:-Y4Z:7T;?`L%%#'U-)Q8,K5O4MU8(<$5(X$O@<)8A7 M]O`M'PA;W#(5W.("XN<22043;P($\I0"H/$=?B(5F3(6+^)YO)%S,:$'&H%G M)=%`Y5%NFW$96T$CY-,I`%`7(F9X;O,A&/4$4^$I#G@HF?)QPJ0*![%\JB`' M#$!S%<0`BY``57$/_[$(8W`H9G(OU5%W2O4O?B%4*N1V+`1W#7-D!I(O%!,Q M6G$/A!P*:`\6Y$`A9!O MG*@@;``!#E<(/$:'8R`'EO8_]T`;*:`'8`8"S=49^]()$`#^!-RT+O4B7C`1 M-:J0-'M"+YGT!/BV"!$26(7@<#M39\>P"-ST!/?`34#0C`+``*_X0_:R%7H` M`M2(C4"P"&JX",`D6>LFB=RT"'I03361;V^(+-!@#-18"%XE>F/`"MI$C2[7 M#).X7$``3(\``MS$>P?29X1T$0:Y3;P7-9#W0"L2.:92,9UP#[[(32#``R16 M.-S4#%BQ38LP'2%ICQS9>ZFH"HO@AGH@(QA!ARF@"[H@DD\A@L63:A"`C0(P MCJG27JKGAK^X32'"1G+@BQ"@%5S1BPRP3>NF"Z2A"Z[""O^A?F;4%DL9E,;P M-X(CDLV0@D,6E-3X-R0CDMK17A7^13(\N34\J0OUZ)"F=!&Z``1+"0)L,A3% M)P`-N4U`<)3'H";N^%UC4$HB@3FBY@)ZL`A]H@K0P!MNDI'&,$AE)WE M14CXR2'^9;9>UN$LF"&=_C%`_S%0^TFAFJ$$E65JTPDW0I$`]G`3_R.AB-B@ M"&JB%,.?R-(0`Y05-F6?K.1$R`(7^^)$!HHS9T*=I&%3Z-()),J@FA%8#>%E M/VI7*XA8[+6>$'J(5+:BZP6A%743`E( M)=HF7C:E5$I@9LJBSVD7#TH9#WJ?)DI1-02A&(AV4X&?^/'>@A"$T,7Q>EDQ]E"0C6(=BI#FV%V]I9P<./^/T=U%XMD81RC M!$`4A1/%']_!+P;2H-\Q4%299%)D5)O!JY:A%Q`C,0NI3V@Z:A=!9;VGJ\TJ M7K\)0GA("MJJJR(B(H<&0HO$?DE&%[H:X>&=Q!3K*S42?>0 M>:Q@.6.CG^R7JS.Z--_8KI8!-^93=\-Z&7I4KM]14+]!*#RP)\)EKMUZ*@"4 M<`J7+Z-V4[R:>F7&JXTZ0V:"J_":&EZ91[#K7<(K:J1 MJNG:L,7*1JQ@1Q6[<-HZ8+D:=(5X*.AZL'LQM/<*?^Z:JR4&-VRC<*.VKN=* MK=@Z,:7GL?ITB'O1J@7SJHP1JY'^`;!-RTJ2$S'3>BI+55Y&:YBZ49_^HB/0 M&9Q*5J^J.D(X%7*R4ZOUBJ:TE5-(:ZR[2D,+1UM)]:P*R[)I6WK#R:YARK@$ M&Z;V=A>3,S;W:A=U98?]HCUF)S&H9!GS%`#:\H%V-[`YA7=(!KGT^K=Z]*P5 M^3_"0AND`!9\4+NS*2.'6WI@VJBT^ISV,JTWJY^S4ZN)96746KFSRK)XM[71 MFH=W2ZLW];+),K(591T)6V(IA[;5MI`:80UJ`71`.ADXE;6[6D*GB[6,>Q'[ M,EW#FH?6:F\UM!G4)!= M!*;*:[W^ZP<;9U%,\@N_A>BWJRN^,1%#Z]>H5+:TZBJT,XIE`)N[I%MWF1NI MLQ._60:]_TJ\*PR[6XNXT:ME\%ME\@K#^+*W>TNOL-44JG`/MX.YU]J\DJL9 MC3I1J"JT]R*,"IR'.T(92J`+*=##69.3,NJQ2`8Q=CA#3`RP"FPTV_N<"CO$ M6^R<;YFZMGIV'ON-57:LQQJ&PZVL=N"G+MUAL*GF;\LS#HLQ'?7+T;VRT\``A!@;&>KS0N=N@_C M,2B[P&130GQ+O!E=D8#LT1?#M6#YKNBA;S`!MRXMK M)BH'$ZVP15MTK?H9I?EKK0"$A]I,P.JKS'.LT1[LMS]=;9(CR3&89;6%U#VM MO+O(R#4KQTA\Q,4LRK.\J\8KT2/^9+EF1SBV1:,<-VIR]6YM02 M?-3N_-G^S$F^NGRKQUO8AW*XC6W`Y*L5,6BLU`;+Z7K9:E?3&LVWX_N=A_W3 M#/[5E"MTYKT9&#Q-J'K#-NS*G6S+,)'2M%W;8ML$7/O-AUQ>GRS.=[N[,FW:6O;, M]]VYRAWG_9&#;,ZT4ZZB>GM3ZDO(RMS$*MK?%M/FB3RPH&HT=%[.AZWE++S9 MXSW:=`Z\,;3(Y<6U^&JMPTFX8JS*B4Q",D[;F%SC-L2U&]S^TB*TW."]X8KM MV%$XO:/NX3%]2DPO8Z&>6-PS\^W9-=T@EL MUT:\WW9]4SR-U%+>N:B$P<)L[';-Z:7WF\7-W+9\P?TR7<_)X48MN,?-J/,= MUJ0]WJ\KV'N,O(RNN:;TOCZMNS"^PDK5M'Z,PJ&]J$8^K%8'!S+L8V-QO MG;WU'JU)CZZ<#.%#"\,MG[_J:[12J\(Q[[?F?;BGFLT2G-4QW\3INN+ANM', M/>C?/>8ZC/3V]O#GFOW?JU]://M+5T:HG'U0+TS!G MY\N;'+@@?+-9+J?'LE[=,:4_/<@(K.\O'L3V&_'?2,QHG:?X1Y]"<1$_6J]% MU9R7[\(5GG:HBW=U:_-3(=?'PO<)GG:%;:''R\3[V0JP3Y_2F:8W`:0:'[Q8 MBZ,&#H+GT1W=L:D8_,<%?(=$S-B3R]-::^T:[A\FAJKS*]+.2P)>>BQ\'70` M\8@4*8'^!0D^$NA"X<)'G0PB7+CPH,.&!@F2.&C1XD""!SD69!/11:N*CR(V M]-@1X<6!&C-27!DSH\>"#CMU2EE0(,Z,,AMV8M/*6JM6;&ZR^0@SI\J8!F^6 M).BP)<>II#!VM(I1X,5'5YO>A(ES:Y,)$MY=0_L.#!ZV;=V^A1L73YJS:25@ M:=)1*@F46SMJ)<5SI5[`.EL*>**+!P]=3QPKYF&O(5^$E5GZ):5DXTZO"`'W M5-E)\\R6")5RO.E"#P@0T`2T"B#`*$B:2PU7?ECP:FFK*IFN=/C96B<>()HU MTQ6`3P+94A]^W*KU48`GBWET9>J5X#%=W1<[=KQ8P"/(/"C^UI8:>*)AIJ6= MDG(1@,?Q9JR.66.C*[?GYUO]#[9,I_1J<^\BG)X2[;;-FL)J)>T<4D*79D!X M`JG:_.(K-(T>X2$QQG0YIB^;/NR0A]^XRM`OW)CB*30-!8"LNR<20(@ZQ6;, M;2;3J*)L*>AXTTJSF,[[+46J=JJL$Q<>T8.59@JQKQ47KO,/--*!@!@90P`H#'*4LMF M$DRZ1P2`)E``%CET)VLJ#M0UWV*-BD$C>RRI*S\/#O2)?J?3I=9F^ATP0#"K MVI9>+V%]"",2]I6,)Z_@W2H])04P!E!CC)-#76,R#GBP#.W,SMN!2Z6T(M*, M[$DLDBG-K*4SXU3K3;'AHBO-=^8,%CJ#.G,O6V]#!K8T-OA8!%`&^%#(6``, MA5HWK';^W@E6]_8;?*=5`Q-L(DFG4O()`)[`VQIK(`#`UYM:>6)IF%(\T#>? M^WY)*\Z+=1BS@X``M)E.AK+F&#D>/W2BQ/WB*;4$`%5E1XC5@!HU"O2_S+2SF^5^+*I;H3Y&(JD0@`PIF'@&EP42=(0QVT_1-^&NB6' M[%$%YO?>U3,IQEVH.P5K#F:@8?60?/C'+A5B0%H`0IR(*EXW+85(:GR[@U2] M./<0FS1D2?Z[SX&RP8!"\$%%B.J;N/HD$ZVUJ"_Z^T@`5(&MP8`):#5Q@>_D M<)]66!`$%\L82@*3P.5A)FA0<9#[_J8M106L0/92D4&^9C;^,+!I;$PN0G=0A6`^(Q!1P$W'!/:Z%D&.X0`"YZX3Q$J"$//+1C%TTS1A-HS-A M`>60%02+0_A@##DP[2E1C$HLF9C+=S6P6,KKTTV$E"J'N*!H3_EC*DO8N9"5 MZG8`2$$G*$9"4_(&+#@<5F!ZU;'AK(X5BWCAM&YY2UQ2\7[#BA3H#F<:%^@B M4!A+3$``""!1&B5#X>*@!*`)Q0E43%B"YI2?9@ M*CO9D`"JNB`DL\$D0@&@![PVA`_0@,9.AW,,N,9020&HZU$H24`7V$-)*PV, M-30)J!!-3@`N4%TH*?L3%Y""L':UB5VK2=:*`,5J76EUT MD.K``"#+)-;HRE3IR%8^&L6L1H$>;E0A`)1%TX%RT$4X(*H*N("NO;62X.5C&&C*QF(R!8J(6O%]<:P MUM0\0K9<9%4`%`:`4.7S$<=8!%**B=C5G5:^\2FN:%!L6)-THJ[:J0K.2">Q MC?SE3E,AJ9I,>E*Q)5%.>&D4(6MXVDC6ZSEZ@9_=CJL'%`N$5^DZ!G+OT5F@ M0$,50#!&(0(;Y4$UHQ7W&!0#9/,(,`_J&'I0Q1A8H9D`-"/^:>@]U$&OG.5" M:"])QAL#-.R!W4[P5@!XEH,Q'H&N03$G!6.HT"/LH2L@R`$:%`'QH"#PR3'( M00\HF9(Q4K`(542K&4P[R`"CJ3RM).#2"(%`(5"GB@JU]AYSQM62%KM"!HPA M!88JG9(F^S^[6EH)";B)*!O"!@BHPE-`T(-F6`$M!@`!,6%>!`\R14&IV(0- M_.T99HA#,!=$.EU\?00KPBP`$(QA#,T(6K<7,:A%'$.I/##&H)[0B5JC6S6% M6-<8VEVCH@%*#I:NJ2J,L0ACK!8HNC!&O'5![TW)4$G%?E:%'`*"%`"!@LZM ML8A;-61=GEH$ MWU02`.D!X-^R.2BT"&YPBU258P`P.$V(,^P`%.+*#'@T:AW:[&,4[=S6$,#K M`!R[B%I95U*OFM0`M*'E]8DW#\EQV'@LMA[$Z1IH.U*E+,*VE-PR\EF9J=VR M(8`QT`B,QPC4KHQWG7;N+1L\X#!^$,JN1TB+;ZT'%*UP=]O7Z8(/SH(K[W(#JF?(=*#O`!"` M5E#.\\O?+#9XH688CEKA`#/6AR*$"!@#CC/`#HA.H:@Z$R.1#H-Q*$/SX(@%I1!8>@#H49`\78,TT* ML6N#'24Y)!#@+U_Z,(2JP1!1`M2!@.6`)@[LA`UK/J,9#H00DM83@"4T&ML" M@MT[)%":$@!H!CXX!H41-"5!/7]KA@VC$38PN0F+*-0#(/QK"&LXI/[2,":# M+3VH%6!3&*0[F``H.4!I#LQ*G:[KA!>R!S[0)+)KB0#0A0W^JXX]!+\^#GL,0GI,;@D@R8]@`!$XP/4J:6_FA9Q9(!CR`9=&+KR0T.+ ML94MZ@0^&,.P(B47**_CN[5O/#F$>)UF"`EW@J9WE!8ZK)5H:@7?@9P..JA` M`0)*S"5K0"@0X`.$*@2%.!8@2(!L@(!%((GY,\=#>CU)DJQG,1YWLXF1M(8Q ME+;)@28ZLH<-0[]J/,%6F`\^<([^?0F4^ODC?$(49^G"2`2`B=1&$#@]HSF4 M3N!)ZJF;3W,!CD$TSB/`@QD#/6B%?I.VAE"89+&KQ9K$TOL?VPJG&N2!3=&> MU*@N:"HKWZFLZYQL@54@`BI.VF]@-*6RH:WG!!*C+DR.(@:01:0F1#P.4 MJ&Q%0-FBZ=BPU3HHB!2,FIBD=P("6"J)URF$H4`=(,!(0($&0P24#@M)6[&I M%%"=6H$`)9B@``N.DJ#!U0D_A8$`:]C"O1I+PPQ,@3JCU+B>:$JJ@YE(V42[ M;!#"`,B&<`I!%Z"<,5`.U+M$F9J4[O&;M2D3`K$*7#0B78R+4>#%.7&02DD@ M'_&/&VO^"L,X1E70A8.Y/QFL%>,4/F-)&8GRQT4@)8(8H,PLP<92&'AZA(-)`3I"J/CK MA`&22O$C2(2"I]IQR$"93"X!CI%CS=X!%*!,P^^CDED[+L+9,&,"%!Z` M1Z/IQ]1!+&>))FL()SG`KGYQ@1DRF3]Z MIE%[!+V["6M0OS&3%@8%BO&IC/'B@VJLG'M8!-Q2" MT#!;H2_B!!1#*=+-%)5$W##C_`_HX8M6A5"H/*LRC2:N7$@E$$Z2T#L]L(?) M:B0ARR.'`1B/`)=L,CQ2D$[JW,64P@N:$;RT^EDD\EZ3>M>\V*`P*LTX-6';\]%;Q(N2T((-`G/=#8T4&T MFRAAS9@!$H"(!)2%G%,_K*-_3$A112%_O)@:;2*@H*M.@(9^VTU`!:ON6JP8 MA$/"?,+02*%`40X-(\E3I1%ABU'^9V2#U4N`0O!'.7"YYW`(\1.4G5"")WBR M06$Y4E6U8^/#>9U2:UQ*W"G:3^&_<%)7?II"G3,>,KU*L1C3*@U90%R8%]V3 M.-U99*E3]=.I#O2OF?FX,1.U%)`V%RA4G9A"'@""D42(D5V=0WJ"G>+98XBR MSAHHC?C"U+&J-YPL56C:1;"';J,J'Z3544T=HEK:0-$I7Y)!&O12;'RW\>LL M2<(S&MDGU'A->"K8RY+`">7*$/M2$$3"A@6">S47+OHA*.J--[V0`M$)7+36 M:S4;M%$68`PB&?H@G0E0!Z(IMSVU8Y"-5NV\=/V5=MHPL#*)]U2"^(S2^:S> MU'A/_&#^"-7P'SDX38$(/Q"8C=LZNX4=V*,8TZ(\W83U0X8%J\["T)!`2VE, M0JBPB0W#S51!$HRPAI:!!HD7IU%E(-"T+>6E:)64+_^(BJ4F(U'0!T&\,T3-:OX M,+G'X0.[1>`O_J#5V;40*=*6M5%W&R`:B=E>YMH33+_9'#Q7"Q2DBRSI69J8 M74L$.<98KL(*9I=(V1DMQE5#_+V1*'`%L' M_,?543]#>=C^ZJOL1`@G#@SCF<3^U7E;,508'K"&*S;@=+:J9!:48IR\>!EC M`?.F2M*G3JB;10A5`G1<486>U2#<`*VR$6ZUUQ( MJ0Y1,?'^CWY3S*.@J0LL%#X@B4>#TKUA88D"5-OKK$>#U(9N(`E]!#&%6$5# M%H*H%C]X6I^)VI`A5;VYE'!LE8R3A64M M)H2*:G\T30?A061)W%B*R!`T2AARB-=92PNSW-,U">&TJW[#F+FI#J("5QR: M2T7)E\N+SK:R6BDSUQCF!I(G_ZB$^>C`:B&W\3"M>T!SE(%H0X3^5H MQLR\MJ5IA0DB00A7!7MHQOX:CB^G\P-IA;,#@93KPF8(UFS^J!@Z+(VR#$$I M85B1&\,1@H#501DZ="#'B:9L$+_KZ-^&Q9L!E_;X23`#XZ`V"<:`_VTPV M&(KXN%8(`*$,Q$(![")&#R299-SE:;RWD1![=`".IVG<. MT_=?:E3_Y(%%N(=9:EA5!ROZTLS^%P;MKJ(>0<&P"$:[>V"RHH%(^@W#0(H* MZ<%9R<$N@!V/TC-.WLMAJX0F4DC:06WNV+,@BP6"XI#4+B&=A\F?/%DI860* MW)5RM[A.O)BB1$F)PA#&TSBCB9ESL#*.?JN?#\?,7\8=/0!VKV.%;FQI-LAF M%1R_XF+Z9WV$;/[)H'@A5R2`=XWL"_P&"A;NA.6^&I/IE-:N80B"?]`Z^9>Q&8"$.IQ<4R50%5ZV(0,,&;,HB?-4@Q]^=*A"YP"F[%Q:(PF*P#&0H8L M.3(D&U8'`2QJ!H1!H0`N.G5RD=68KD5CGJQ]!"(BA$XR`20\ED*@G&./W,YD M$!(F3)&)%3]J_'1D8\>2(8^$V62"A'?7-K\#@^//04YR&81P!=("`< M6PN3S1,(/%SH28Y10'.,,,$*@`!!0%WC`D!`0^]4(TQ[//BPX0$-!"NUB#-F M'_H(O'>VL7$,!"#2CR"87(",)=<`K5I]$@"OP4'7D&-':9<#P@J,5YC)MY374@`@N=DC%&*^&5= M9([I4%'WL&(/2&YR14)]VF44TB/^TA'DXR,SKGE8;DTVEZ5#;`3`"HM$P00D M>.+9UI@`NH"G"T8*FN1;<9'R\"($^5D30*>-P0B@GX32UHDUS;!B#9*\V<@H MCRW=B*>)U-65YX@AVOJ(FLO5AN&A^`6@:$:NO53GIK7EJ:$N?)JT&%LN]'F/ MAJPMQ`[("P9(V%NN4E.U29FR%B[D4F668H79- M9Z.0MB^_H9VV&;ZJL;;?9'Q&9I)(KK$9)6).;<2136Q(3&(K$=<6,1LV12PM M1X.U@BV>4%ES)(@99Y3QQ!EMZ6/&(Q_F(ANMN)P;8F"Q%;/,\S[E@LNDD)@R MDB%9\W'^;2%MC'+*2B2@BAR+."T766L]_-B';`Q=L\AS?%^-2-M,I]#6S/O8$JD3/IC/T?^ M5&X98TRBVV<_$KA)&YMNDQ+2.H217N+%1EG<9'.L&%NYVW186SWS[-+F(]%6 M%>"CX_GL2]K2OM'E'[MP([O5%\V1S%BS-5MMHKOD]MJ.EUVRR1;*O7W#KH5, M$KV2Y0:9;K+!B_]EF0'<6;\"N*]_I68UAV'8NAZ&0-O0SUG^\N(;6R(HP<%- ML(*OB2!\7!)!-HV/@^.;WP4!94'\Z69Z&#S8G<87PHI. M0V2@8]K6Q)-L*80GD>`**R/!MGUP:AZD(FXN")D*'FR"C-E/#&6#P0:R43$E MD9\;;=1$%PJ)+<:*(0;U,@9[/*$0('F/9+H'R,3D!HH'5*,:/?C!.X507@F+ M)/8D^$8?(O;K'L'Z=Z]\";"6H"%@ MP%:32)>0H(=6W,WT-.*BAK6&B5'^RJ)L*`.\O<%DF`Q$4N=VJ;,OZF^3ZI(F MO8:93)KMIGHE/"8B27B2BA2$+0DH1`IXYR[G79&84Z*7_O)7S#>>*IJJ3&5M MC%6P"HW$F:WB90])`LP&$NPQ7=1G-*%I$A>QDV'$W%+=YCD9=UKHF+L1VP'K M=ANT$9,W^S%6$%N5M_LE\Q$0!:<&)VK2*1741TK0PU06T:(#GN2>5Z0>P=J5 M3#A.\8'=A`Q)EYBWW]FSBOA3IU(^EK8($'W*\HEKRVA2-OHQM7N8J3KL1]KV-0.]ME)I>^ M;;575[\*U@"*536D^`6"$ZS@!3.XP0Y^,(0C+.$)/U@)%+XPAC/<"0FWXA?V M^/`O.KSA#).XQ"8^,8I3K.(5L[C%*1YQBET0@%^LQ<4VOC'^CG.L8P=W`L"< M\Y#DCV M,I:S'&8EE)4[K2EKXTIC.MZ4USNM.>_C2H M0RWJ49.ZU*8^]:8!2.A^#1G5KGXUK&,MZUG3NM:VOC6NX*%Y M+>QA$[O8QCXVLI.M[&476]6_)DVKF2WM:5.[VM:^-K:SK6U%._O9H3$TOA@= M;$R/.]R7+K>D@XUN;I=ZW9X^M+O^KZWN3+L[WHLNM[TYL^M\;QO2_(XTNO_= M;WH3G-M`]K9H2G$-"0R\X0Y_.,21S?"(4SSBP1`PPC.N\8USO.,>_SC(0R[R MD9.\Y"8_.E.?SK4HR[UJ5.]ZE:_.M:SKO6M<[WK7O\ZV,,N]K&3 MO>QF/SO:TZ[VM;]\%"AX.\97[G:X@P8%3G#"*/+.]KWSO>]^Y_LH*E",8@2! M`'%'^2@(,/AB5$!?`Y!"!20`!@(8_N^6OSSF,S_U4XT[(!>UMWX=5Z+[X MQO>Z$S`!^@R\_N4H",+R,>'V($C!!(``1#%Z/^!&X`,?]8!$/3*A_>,'D`/K M@,/'*9`)>'@?_,0G/_SC#_7$*\/S@$!&S$F?@?H3``4&@$(:1%[E!=DHY!XL MU$/XC9_\A883-`(D/"`:**#&P=X!UL/[+2`&9N#0H8`)[%\&2%_,<:`'FD#N MY5T!'AY8#4`%BI\&,B`<@!\DP($$:MP-P(+[M2`.YF#.W4#I>9X$H*#*F4;] M@1[^;9P*(B`+QI\39,(%@L8`K$,]K,,`A)P*WJ`.7B$6NIS^$X2`!Q9!S16! M!X8`[&G<$2:@$F8"+#1A:*BAQU6A!68A',:AR8V"\GE>\XG&W>'!``P`%[@= M$.*!V^DA%^#=:+B=$[P=[XWA9XB@Y\7!'Y(&[Y%&&6;"9Q1@'O)+)-H2(?9+ M)C+@)6+B)^Y+)DJ@) M/,;C.8KC#?1>/N("[HU&[H%C+JC^XV@,`AX(Y#CB04*V(AYD0BX,)#E^QCTZ MHQ[>(VA\HPV&7S=6)#?J`&D@)/$UP@4&9#KNBRPR8$.*XP!D`D'BHDN^Y$7B M@`?>W[=Q@?)]WO*97C'$7>*5WO[Y)$TN8AP8`TX693$HH@Z`H>=5@`+^'@+" M`E1RWP,^H"^@7RS"PBR$7R/TP536`S[@X2H(03V0`R300!]DPE(%]>9%A^ MWP,ZYFG^+N$ZS,)JK@,;GJ1B!7.F%&VF`?X$,?("`D#('VY4)6"L$0,&8:@@;WM1\L`!\,]L$`#,$0Y&4? M[`,D]`$4AB9>3N8Z5"`D-(+VX4.!XD.`?M\Z,"!_[N!\"2JB$ZB$\#($-QB`_HB'XP4&(#L$# MGJ:/PH*$MF>!C@9M+N'W#4&&KL,_M"AO/FD<,B)W7F0'EI[^%^H+"A!`=68` M4[:B!'A@,;0!(`*",A1A);9!&LRD#G0G'D@I"`(D'K1G/0B!-P["[\%@9^IA M!:X#)>;>AM(>1=*G*OIIDFI?B59@/?2!C9*H-T(H`@K!^Z&B>_+I9U@F)-!I MI:Y#+GCCH=9#.K`@YWU?&I:@$T`H[GUFBK;BAC9H[FV#A^(#/Y;J`SKIH8+? MH/(C.*QJGKKA:7KC"_+E$V[JW0T`D3KH55HA'FQHA7HC'@BI;D(IM,K?*,2! M!P9![]'?$(:`$W`!'O3A=GKA(G*A_3%E=(8`MWY;!:R'J:N[)W@,N:VCL M)S]>9![,ZOC19A7Z`D6B8[3FK`X*IQ3TGI0JPP"VZ6\.(0Z,PB"FZQ`R'QBT M@00Z`=(^)QX:P$PF9BSV05;*ZYU^G[%.XAK60U:R82LVPFWV0<"&)KZ.Y*J2 MK!/4P,J&QB`XH,.*8LPRZBKP@]8J(/&5(3[``8#R;7@2G\J"+,3*+'JFPQOB M(;@8*9^-5(K5F(P-^Z1`>Y6=P00\. M(2`$P>'^.:VZ%J*6>BZ\7FW%NF=GFB-HD*;AKD+<\9X#%FG7(B#83BSD>N._ M0@++>F,BB*?C\M[(WAWRD!H1F]IPD(C4(!:/B`+#"ZCVJOO`F3B"BPD M]"HGWAT\!.\H'*F/AN<01"3FMF_\*:4R_&`E"FV_PWBGQ,N#QQNU% MOF5]NB=\-B!HRNM%ZFLC<"0\MJ*'9F_"!F\-=B_B/F!G2FKXZF:)9L('%^JQ M'BX>C`"]BJJQNJ\0&Y_F7NL<3.VWI0'^HL"Y1F?I#B'J,N#^_ZYK)0JPZQJI MU2*PGNKP`A]D/="`!0J87SZ@@7X?V?8N#S-@VAKJ\!9O`R*O$RXJ\2XN\\)@ M$+LM#=\Q0+ZJ]I+L"Z>QJLIP[DF"[.IF@LZQ#D=N&@_`JJIFG@XQ)%]>$2]B M!]J?Z#F!%.QO!FCK1:(`,F""YYGNN;;B%!>B$E]Q.1JP%A\ACFXQ`I,F&..N M-WYL'^#`$I)QV<)P#&^O\+;M10H"',^K>>+>QX8P#8OO528R)'YLR#9J\*K@ M`<]BXK(RXXK&JD)JX#(N;3)K`_YP^$4R./O=*`@G)WLCTOJ@@$EI4"8>)AB> M$Z2!<`*P.:\N'H*NNXYR*H,?">O^*UJZLKR2YMWBBL ML;_Z#NRZH>-"3R<0OSLF4"LCN0\IFPMCF,DA_!D.W8AM_6R-$ M],=V)C@4<\JFKP6.7XF*\/)(=Y5,NA1I!-( MK3*$@-O^R8-/%H&`<>O_@@$7X+.;FN(`O,+WP6K*LG)K-JOO3K8W#D!H#BKT M(N`)KP*]QD!$EF@,I&)3;L/(:NQG;,/NIFCO;8.DDNW=->SP*>1Q$V\>NN'P M\=Y_]H%'_BDLB%\DP@'Z72]4YQX'@/`V:-\ZB`..WK`W.O:/ZC8>T.MXE[=; MPNU]NG21OFQ&1F3M<3-IMK+0;4`C\&AE+WC'J:[G.34@2H'G[=\$]FC[U0.` M4B)7BF>!9N0Z["T.USB`GK!$#L$AGQ_ZY<(0K"HLU,#ZPOC^B,("@(9H:$(E M).Q":`J!$#CH7#Z@D`X!"\!"DTID7GKE0^*##1IK@=->]]'ERA+Y%*(W9:XE M^A%Y7J[#$&RJ'HXY?9KY/]#I#80GE1_HG`J!7,8X^$FH#,3I/]3R2C*I6PJ= M[/'"!K`O@U?ZLW%>Z08M(!(`)HRXZ9G``&"<$WSI]15E$X$!@!#$ZF53I!^=;#<4MP(S1O#&2W#.HH8.(!1*]F@H,?/\!"=COI M*ARWKDLPV?ZI$3B[!:8O+/"#W=;P6G*Y/P1N@;Y?:D+"/_Q#@0KYD-O@N),[ MI/JK:JK[`,`#[8EJH#X@N<.J5=?^)?'RJQ[B0PR(.[GO9]BJILMZZ&2N0L-> M9O@VZX+6^ED2W2H,@06\P2KHNZ57/*&-,YBR:=XA@^`-G@10.F@@`W;*0`AX M/""6(QBDO`RD?,J#=IJB_-'OH4>. MXUO"02!P/:3W0S?\@WU;O.+7DI0ZHB@>(@H\(JG>'1!>(R#J7=UY]IM*HB_H M,^_!XK/^P2+HHUPH=J(GUB)`FCX>COXKHGXM??XKGKX`Q:H3R#31J>(0+$/B M+S[O[PNV$C#'>>2SD3.;5JWG]S[8J6(_K(-D([_SE\81>UX0%/_*C;KI.J[Q M:_'S8]TVU,,WX$.J;K_X>V,F/[C,A?CR)2>_$"L8$_[X5]T`P`$)O__S3[++ MC8+^66>&BV*D/\94*YDV=/GS^!!A4Z ME&A1HT>1)OT8!U#3"C"/(BO2M`@8J`:=Y(($R:;-!D(@*A63.Y9L6;-GT:95 MNY9M0V1ON23E\A997(4#,N75FVE56[]_`0<6/)AP8<.'$8Z".LK)(,2/(4>6 M/)ER9O8<>6/9MV;=NW<>?6 MO9MW;]^_@0<7/IQX<>/'D2=7OIQY<^?/H4>7/IUZ=>O7L6?7OIU[=^_?P8<7 C;S@@`"'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`#L_ ` end GRAPHIC 20 y83222y83222z0006.gif GRAPHIC begin 644 y83222y83222z0006.gif M1TE&.#=AT`(<`O<``````("`X)"0B'@``!@8:&AP2)BPP)"HN``X4&!@8.BP M$.CHZ.#8X,B8H"`@<``H.(B`.%!0>)@@.$!@6,"0F*A08'"0H-"XP`A(<+AP M@```,'!PN-#8X#`P6(B0F("`0*"0,)"(.(@`(.CP\&"(F!@84,B@(!`0$&AH M<'AP<-C0V$!`0"`@:%A86*BHH)B8D+"PL+C(T#`PD(B(.#!@>!!0:%!04,#` MN*"@H+!P>$APB'!P<.CX^*`P2("(D("`B("`@)"0^#`P,-#0T"`@,)B(.(@` M$.#HZ'B(D!!(:'B`0"!8<)"(V,BHL,#`P(B(B)"(B'!HN+BXN&AHL%B`D!A( M8$!`:!`P2"!08'!X0%!XB+!@<+"PJ"@H@,"`D!`0,(B(@)`8*`A(8'AX0'AX MD``($'AX>#@X8-BH&&A@J("`>+"8*`!`<&AH:,C(P*!`4$!P@"`@()B8H&"` MB-C`R)"0\#`PF(B`@"`@4*C`R"@H*/#P\'AX<*BH^#`P0/CX^'!X@*"XP*"@ M^-"PN%AP4``@*%!H4+AXB+BXL$!`4.#8V`A`6$A(2'B`@%!0B,BHJ,C0V*A8 M:)`0((``"-C(T.CPZ!@8&(@`&&!P6*"@F'B8J,"XP)@P0-"PL,B@J`@(*"!8 M:*A(6#@X.'!H:"@H2`@(""`@D"A88"!0:,C`R"`@B.#HX(B(Z"`@2$A@6#`P MH(B(D,#`R"`@@/"X$)"0D!`0.)@@,+BXP("`T`@0()B8^%A0@)B8F,#0V"A8 M*BHJ,"@*%A8:"`H*'!X2"@H MF,C(R-C@Z.#@X)BPN$A(6#A@8.CX\(BHL+AX@)`((#`P8*!06!A0:)@H.&!@ MD#AH>*`X2+!@:%!82'!X/($.*'$FRI,F3*%.J7,FRIC;@TZ<2,/:-*G4JUJM6K M6+-JW6UK=NW<./*G4NWKEV=8O/JW4M0(M&C M18'V5:KQKN'#B!,K7LRXL5>^D"-+'DJXAN/+F#-KWLRY\]?)H$/G)>RYM.G3 MJ%.K7BRZM>N&`SVLGDV[MNW;N%>^WNWZKT$/57(+'TZ\N/'$O)-#AMC4!2W+ MQZ-+GTZ]>DWEV,$:/4MXH_7OX,/^BY>>%X9Y9%P@PQ";7CD7V>/CRY]/GS/Z M@^O3KT>VG[_Y__H1M!\,7!2X'H`(_:>@?PKVAY]H[WE7WX045FAA5P0>U)Z# M^0G88(/XG7<>?PQZJ*"!##E((D'ML5?8A3#&*..,,HF8H(D',LC%@3R*^.&/ M)GKH7XD]_A=9A#0FJ>223/YHI(].-H@((N91V6.("DJQ()8JWB<9DDR:A`HJ M8HY))F=G;I5FF".-R6:9,+F9DY,[%@FD0+SP`L2>>]*BYPYF[+!#&X0*"N@3 M3_@I$)``1ME?EPN]!]U'9E9JJ:7%79J2&&*41,PBBX@ACDUGBF.J-G+R1*8X M8@1'TZ7^E88TICC$C'J5IB#A*A6L9KZJC:AV\;JF8ZS:NM*JQM[TH94@9H@, M+[0\$2BA"51+"+755EM."]6VX.VWUE;;Q@Y`T/+7>3L.E%8F?^&(+D)@?L0J MJ/02(P8QG]8+K'!5B!.JO8N<2I(XO@1R@$AGSA%(#(&0H(V$+Z&21,"^Z*`# M'-K4BJHO.P4,1R!P)/N2J?;B6V^MP^+;S0$DB-Q3$K3:>^^^'<5\+[XNX]3O MO_G6.^JP*_F[A`4'S[4SISTOHC'0B(E#0AY:Y#SP(JB08(!.B)J+0Y[1=DT+ M$(":,2VA9)=M]MED9XLMVN/*(^BX0+0Q3*&#DOWVN($&:FC^W>/N@$E(XN23 M1PR$$Y['X87'4,_A+>,F#ASY&'`XX@?DP_%(XO3RQQ_5="JO+QP88('F?_2R MA$QBT%#-,R,\X_HS,40=B`7$Y.2+!9!L3H483*2C@SBH0"_]]-5?SY,%VR->>!X6:*$-]B_I$,T1?QP! M<5OBT)!/--./7[ZIO=OU^^;[="-U2$F`PP'8-X+\P21MP\B6N!2H0&PQ,%P/ M5""WO)4`<($K6]_RE@VX54$.$L);'\R@"+^UP19L&2`/LQ<\"3/Q# M/IX8%5`L@0J;^\,(=."+-"W!%WC``$T`L!G?R##I0( M*A7F@8ZV08`%-A>#19SD<1R(P0\[(@8#_"%JIT-%/?;PR):((P]_@(0O`E:S M16B!>0;^P"9-$*`#W7E.)@B(QN8T@0`Q@$J21V@C1Q:Q!%?.,98W">A`$1`2 M!)CS#Q:@J%1&!4,:4',1V]R94K7+5J4_5JECW]`2E)G6J3E6F1ZH`.HZ0*7NDHP+Z4$$,+4"" MI*@A!@F&R+MOFDID2?`%\WIJ16THU"7OU*,ONN@14"QB#G^(!F-)M;\_R'4F M=#TDYXI(ID5$LQ<2\L4(Y*A/52U"H%OLJT?HBEK:090F0OS^0Q7-M`A)_N&P M*P&%&.#)`91&!16+F%WM1*D%3\YU$9K8W!YPNY)>,!IDK>\Y+U#=]&+7O$B%;QANVHP@2`/D,0O&LD2 M1STV!TJ.L#40[WNMF`9<$P%W1*^;RX-J6Y*]XLHVOZM-"2K$D%R,EA:X'`A$ M:652V>G*)+.;L^%;Q;!7_F(OL*/-QV1W==J!KAA5B[@H%YEFX)3$EK`/\\5, MYTB2WDV8MSK52?9H8%GTM:FRO3!6_&8J8EF)Q+';/%V;8I(].$C3R!$^5HQ? M66.4").8;QO4W/:F-S.XC9A@`Q3^V-K`53,0ZKM0C>]2P6O5^=HR4&Y+6[4` M9M2._K1>$45,5`[8TH10\8K)G:JC&VJ)`CXQB*+K89EE3U* M.YNW/[/NFH+,:K?>6M;=UERMB6M[1<%L.3R"R"34W)2!$OV:^"/>R9X8?*&%BTU8 M7HOP117%L00X@,)6J,`",9:@!3BT,6<,;;HO\,>1/IK)AQZA`1E]0>A.P4'J M`O-4B?/P8I&PJAOC7((X0HJQ5-'U<3H8>DF`JUFRFR00&T/5F+#.D3_NO=2T MXCD!WL6.:(Y7%:NW&.!-L?B:T3RC]\20Y(@Z5^L*F6'<[ MUZ?-$6+0H.?`Y?KY:!#7U`/.P:\F9S3O"GCCHSY-8M`"`3G^EC)M=)X&QR9G M[T]7>SBH_<#=T*06J@"*7GMS\X#O?<_!+[(M:_(W8)5G8?$1Q:8$ZNU7M'P#J;LX9'$`,U8P$<``GL\PQ"51*Q90'> M5!*GXPMY`(5K&`B@]#@&X#K5D$[^O9<''+!&>Y`'AV5XEJ5:$T8#,8"$?]"( M4S=WQ+!K-]1[9^1:VC!Y#\5[J+`^KJ-'@7!8!".'^`92,,0!SY4KH;=%94=Z Mɔ_B$7@B&^94/:QB$O0`)S482L(AI MQ0<'O0"$^[`'(&-DJ-6&KG,]JY(/D``)H\4!CX0]5`!/6A!327@$`*P"!HJ`' M#+B2>A#^DWH@"G'@DD*@@$+@DA)H@!78@#Q)@8S@@!6XDB_I@07X<3>I@`ZX M@:Z@@F$$-&HX`B&3!&,W*DN@1@E&9'D4CKTW`LY%=-&4C%T9"%/'?'^P#X/H M8.>TAQQ!5`7D1N:4#SFF2:06$IPFCYC3#=$P4Z"(1?*C.S30#55T/GGP#*`D M28'P/[V71^OV37'T#&$W*J2%*J;T!V09/T*44+;28<9"8OM0#>>C`S)8EY32 M>)M%)J`@:ORC4,$VBMH`"II#`DD00'6X*B10C>)05#!T?PC38ELD#J`0*T<' M;:7"1'(96+G3/YO)1+()3K<82K$%!];6;=$$;_8E4-'P,#3^L$92V5>Z-X1Y ME$>0T'Z.MH/&0@Q6%D/.XPM=V%,E-G7=0`,E9@$T,'@#`WU(%S]Y1`*UDSU2 ME`=JYPO1-`?].7@"M4>"26B]P`'^LP2H50WB4`,Z$$>RM5==F$>I-'@A10+U M.76WV8:$MG9*N`36AEHU]58>F1,V4($G28`;Y($;:(`->(`LV9(N&9-QD*,R MJ0),12`1QP*(KD`A. MR8*`HSGYH%$2]6!+H'5"1#@D0`+,0P7&-P)'@#^+T$^[UQ%'T`O>-&&3=P0H M>@!A5&HJ-$>ZM5?/<#[`U0W,H'<$Q\\E85;`()48#`8,]FWA; MSA-12+`[-&1T!HYP,'=FJ,_?12V`-2?,5[M+:91-9,8V)/[=8F MDRI'&E5$,$2H_B6*G$4,>-I-;5EBF,HQFG.%J6@J>/H''K!@N>*;&>4O]!(J M"'"LS89@SU`%P;$(@GJ:BYD'"$`F2[@B=F^,+2A0_T90'$H-XR<6MI,B( M/:5[:TA%\JF.KQ9=\91M?W``#$4,4J0%>ZA-?\`Q$^.F_BH.GW<^T+>'_@)/ M;SIA>P4)P&(J83DJXH``A_26MK);>P"HOT(ZUS-UA[0/>=`+.I`$G$9$$M-2 MFP,']!3^BMHPK*6BE7!01`8K1-2W4`F7$TAJ`X0@HSBIDT7*HS6YHS)II$)+ MM#'9@%&*I#Q*I0LXM$?JHS\Z@2WIM$IKDPJH!ROYM)8@!"`G"DWY3?#1!-)A:XT`NTWJ=T0J17+L/R9/=V08$;V.'O` M?98ZJHRV1F1G0'>IK&;WM\_9:J/V,_II``CP5[!:.BU(#!5V6\FF;(N*H@:@ M8:N2._X8JIMSLQW65V+02;_R5\20A$18FIH5"-T0G%H0C\DBBLXC#FM4#\9" M`ZX4CIUUK#9$L4LP6H'`N!_AF[#3"[U0#\[KO#$`0S,&7$S^9+AD@KABD)I[ M%0.G2=I(?DJ0T,ZD:K:D"0R`'VV0T,^PR9J`W'2U-=5&6;0TDP=K$_M#\$ M]5<(4&+)2U[UI8G\Z07$"Z'$F]'`3 ME($7"`[@@(`@]Y(WN8!ZX`<'&)0Y6<1`&P\+2*,1*(%`FI1,7)-2ZZ,M\))= M:Z15^G`K$+8F(0X3"T!YL`=R=3H(D)[]E3GWRGL&2P/[H)RS9@"7I0U'L`]4 MH`5TW'0,F[CG$TWON@B'L[M4T(C^V),]BY`[>"DKBQM+ZPN*RA:YRG9(U?!U M=*P#)<:YLAA2E*P26+!&]X<*1\"$^W,$\F(!!K!2J3MDKW1Y=0P'2=B.O:E9 MSX"$,-0+'-F:NYL/^Y`/P$E7VI!BG+4(*"PO*^1\J^6;Y&,!QGS,%D`";=M% MT(./@>PON4-$W+LY*N9&DJR\L<=-@;";'9DKY:18$//`#V:OD'!#[EMB3J1V M^9LL2\"_2R>-G;P(5:!V%N`_D/C&]RE(2/@,S,,!^9`],)9<^T"$O.M/CF7! M!R:WD-QT%3:JT+.RQW5(GZILD'5E+RQ0AAL_:\A]VA"M7-81*8H3>"-QR&0H M>?->337^5>=E5D"`*%HU"FF3-V!@!M[B9RV`@"2]01@(<0E0@5][DWX@"@XG ME$!ZI-QB@%@JMGDJ$I>C.=;9:A8*JN=#3^O[.J^SB*&#/L002`?0 M5PV5C.=#2`;5#?DP6G@\$G>)J#7CN(I,5XR7>5/>OL$;.MK]E3T7MP`)`*,:F[Q0G^*W0TT$:+("%F M/`+C!-I3!-P(W1&:S-A;S0&F\RMI>UPHK,)B4-%AJ&P878-+0'Y!9P&9^<(Y M*]+4TC?3`F9UPT%C5G%\QF9P1EYF0`N`820$P35/D`(@-])JYF=M4%9F8`,) M=)+BXJ)!N0([T`(.F-1;O()D;5_$X`MJ!`D,6\92;2QT%=J8@T>@7%U_]5>^ MQ9VG@UP<<-D'I@U4$`-(Q#Z%;)=C!]D^!=>,M=8VV.ES*^E0PPPP^35U6.SRFN+MDRZFR954$2CDV$.M:LL7C.D MG3^L-5#`Z59F(@;,MF)10[R79C&8-'S#.,O.>X'.!LFI5/ M]DK!/M5)'.!&Q]T1H,`^DC4F8F#)>_",JA7=[';E8X[A))5*%<.8-," M`OY>`0Y5&C=Q'BY*("XUP!D-(R"(;6IBJY+BI<:KET@#0?;0RU5N^5YA(R4. M=KABT`.$%D"NA"SD&7.H^;.91)X\JGGD'"%$7,02D*<)XBLKM:4[BR"JRH80P>+Y.,\B^SK4^D9Z:`74J(;W"?5V^!FW&=,Z>Y\)IS-L'J$ MJ0B[U/E\Y2(1;-H-W?A)=XJ5JZ/E]2)1F4_.W1/]*^RMXJ$7]ZH'!_4`CMW@ MT=J%+\T\MD3X2^1A"$,[2C."H$\[!<5.U/PZ)[5++L:1*5F*9_M"A==.#/D24= MQ9`@J$,IJD71QK9,:.%/#+;:Q!GX\PRNMD5X]1(%')CHDR>TG@!!;`8Q835W M$#\&0OAPY,<[@`B8'-F,F ML0T;+BQY<68U/H):=/9>DU+((E4("IT%B$9Q] MU97WU,&3&-X_W?+D^7Z0F%3T'0\.S"-F+U%B:*MCYMNOHCJ?DXFC`IB(C)AR`2.%!K0+'^J&@^<73X MZJ><0CJ+(HMX6D)#P-B2BL3T`C/JCWRP0E!'!%JJ@H:C=EPNK+'*<@F2ZJZ; ML2V"-,%O0[?^L."[];Q;[KW[YD.EBNU2JK!!HIXI\$`:K%+I1E3`=&Y`ZE(D M)B,.(G3^2:9\^B.IP>.NXE(<<28J*"&@=/I-Q:#$Y$D<)?_P@!C@@*H2E*BF M\H6C@8ZX4)LDX*B4J>&&8DLLLLRR+\0!W<(TH::.L&NY\?*"BRV_,OVMUH-H MBTTRV'*-+;(G[K@-M\X4>V*SS8!H[;!C:<'!"6=1*XTT&*!P)8$$;&BAC6-W M%=8VPFPS#%@/>*4%$%OMDND/*L2,:*(10/'IID^?FZM!_[K[0P=B0%DNU'6U M(9,FY?HE1HN5]O*/H!B.D%'3'"T0!UZ1E+0.WAGKJB;GI!DJ,<]XG.I:X:"BE+8@+^,=#0=44Z4CE3D3JH99RS$=`8D2MV2XE"^.LH2U3R:(FK>>'F^B`Q MYDB+2;90A2NX/P(1`]XEC/SKH+Y@/;?X@W"CA1?)DD>^MF\+4]ZPR!I1;+?$ M-LO,#!R0008&&*`M#1DS&&$$B&NMQ;8-RR*[3=?#OB7W?<-\JU6D!+VRG.0: M=9@:@0[S7<12H),_EQVA&XL0@QC^%F&!PY7,0^(@!C$6L02.BW$:C%B7#@0-2`)%%!((@1_!%SZ@V%@R)PTX!],@?#G<02:'% M`$@3`UY&(!*[;(T@.]2&&'JA'<0IA%*4\Y"CDF`Q"(;<:%"-APH'$HNP M%W<(LH=`+"U!:D%=!U--':0)1QE'Q9`Q1*JP8&C0$(;^6@8 M3Q!`G7HLPJA'-:I<%M>216B02@C@"`(FL@\X=%!TGQM+-)8&"9X)1B1P.,I< M&"1!HXJ#!$:C*ROD`+%1;Q$).,0*Z#U0:8JMJ3@11$4B'A8CX0\)#M%`14Q$C0,WS1 M06+X8@\Q@(A9?UBIF#16DTOH!G"/("GA-240PU388O/`LLYVA0/>7"110O9# MD/+%N)BR&A=R"D8(!`K>^]S'V[`\)C<0*;#OGH>#J00"V>4 MV!E.,#&)G0`$&]A@?69H`Q#:`-#^?CX/?K'!56T4BCPDA!='O@!47N!`@TS5 M=BHD(B9#M+`$O%6#R"/4`EYG$J#<$7$F,[EN8)XQ`@F)(<@CV,*8TI7W8$2O^N=^ M0:F&)C316`XEQML>J.#GHNQZI,,> M[I<+,F8L+\(#I^P&*'R1H)I`S=.!YO.3E[(0A@"U)8"FB"]0084C\!E4,#S* M"$C@BR7^Z!FY$M;&HO9QE`.(`TR]J%*"U"WN-`N73@$[2C6*DQ\:=,/(N/9U M3R3R0QIH0PL<>(:%$L+MJ5S:)%7@VY6%>Q!-IVN[E?(%6,-=EIHR9+.$U0&: M<-VX)']N#Y>ND29+K0-\:4+<$_X-92BC!F+U$\2Z6HRO*HP8P]3&6_"4@C/< M8.)ZQ@+%;N!""QC1`FP1=*#:PEX[@<`\7'7+Z+1X`1)^4P42Y",0T4![(`Z@ M">XFQ!>]V,,>()&RC%P9:--JC$0@GKT4,YG'M$8`V\(3H-*-[X`#$FM1F M'B8D'T?8PQ&,N0@J[&$$ZR6*0O)Q@+.G_3R?S\/9C6D7.+S^&>T&J,:Z@+SW MM"=:1F:-0>`-T/9"^%:@'OD#7P@'9@^&JAOTPP#`?G< M$^IR^3C^Z:.A"=^[A`;Y,,#I#T""\`;"M<^`&(?"K!T2Z/#T^2"R)O2.=IQF M10O0S_[Q#0!4FU`!_FF??U("`&%`\GDB")``#LB'5@$."X`\$($9 MN["`X(NOQOD)X^,[M2B_^)N_AKO^"0Z(/$/2AO+3NRJT"RIPK!'(@^$B(I)2 M0O,[/ES#.0H3NL0`A(&JL7=ZGZ%[C(%"##!X`MKX@3PL.M&PIS\L,2G@A398 M`1LXGQU(`$2TC.6!'WAJG\D@#(2"`K'[#3]!JD4@!A&J@AEB$":Q0KNX1,)S M"<+R-&\"C`#J,[XHE,%:`B*#F1GRA23,/+*ZQ%I,0FY"JDQ,"%I$H`@##E*, M11&J1%34M&.2Q2[[$&%,"$Y<`F*H`A-!*C\!#HOHLY=P*`C*15\$C(!"EE'$5- M4Z3+$@]0H`$L$)-,[+.)!`X%.BI?3,>R;:$5QP`*75,DU M#(S=R+I^\HR@JS#/():?U#F#XH7O0;$_K*=Z<`9!+)86$`7R,41L,8,$:(,8 MHX7(@(5T>IYUHHQO\8!,\(%S21G>LPL+R@_5&2P?:QF,%,MPV@MXFQ$4DDNY M/,N4@0BZ)`IN<@^<^[:3\8G,,PE)Z86^&CNMD!"\S`K#M)6Y)$O$R91-3)2S M_,O40:%"FHJ6U/@!,QB&%5@!J9NZ%@LH@%(?,]A#G^2P=U*HY:&-AB+. M]63/]G3/]X1/]O0/..`+"]@'+8K/_-3/_>3/_O3/_P30`!70`*TPPKB#8@G* M.3069=D,-:C#KT:BG3?@>&,`!'+C*S9`'IQ0%4;`!J/PGJONGUE`? M!S668QDZ8UF,'Z",1H`">1C0&:71&N5/D:".9\B(L;'1'O71'P72(!72(?U/ M9'&?Y>0,.UQ$%546()@GU+"G$G/^@EN0`AA`!!@`@G\*J!40`B%X2NUDA!5@ M!!LP!"VERM9H#175N8%ZIQ<32EJ@'R*5TSD-T*U($'P!&SK5TSWETS[UTS\- M#!C[E29]IZM\#"AHTNI9G@SE'N^1@DVHTBJ%`>YI2O(1!2$@@J<<4VRQ`3'% M%O"T%C25!WG@C,.X2CG\2?FY`U[`@1=03T"%U5C=1MI1D`.0U5O%U5S5U5TM M)X+2N1W`#0_`L&))C*T+#2NET*,TL64],?'IU`]=`6C]U!8;4ZK[U(!*@`H; M!O4)3Z`L%O79.EYY`5QI!%XU5SY5"!(XH'-EUW9UUW?M463QR2,%L1HS`UI` M!#<@,2G^E5(G<`.D/(WQT*)8-(SKEP3#V.8S9>`(8<(8A<%EF=89];=DA M6%8S^-)H_51&`%&J,UBHU*=^LHSJ`4K*4)[(H(W`SG,<\#-=7DP0%G&(>N'0>7!=L2HUFP!=MQ@(&!15BJ2]L0)9\6`%JL M(PQ$W8$4&*A2?423?9YPY857E=J^]=N_!=S`I=.B/4]3S0R(#8V9)=NPA02P M58?%=8($J-86&U&V'=-";`-:@#%B44Y@B5@(#1;:,%G1C5'^P37=TT7=U%7= M]314^>E*Y-'0VD`&%`O;F5W68'"&8*!9$RN-:S%$:P4H[CS39#&G#=VQPO`5 MY9E8')"##.T59JF-I5W=Z:7>ZK7>OB4ZS>T57]'0Y*&-[D$QVU5T5:)YW8Y'F!B:6-V!7=#'5>5FU>)-B(((W-ZR7@ M'AW@`D;@/\4QZ3&,ZHF>_'6"Q25;F%W*TIA4[N$%,PW>]YTZ&*-*S8##U_7> MV$A?_&75VF#4##UA7G@!'U!+T,R2^HEAXZF!)'CA^*SA&YXPQCS@`>7A=]U- M/[7A^/3-NISA&56=6,%5&]9AG\C^S,Q$W=C54`AU1%:%@2'P6FB`!J_UVL5U MAANXIPM&!J?\5/!L@P08!AK;7#Z\2AS3L3PT.NY)GO3%8`E%X>X%R]](`@S@ M8PRPE3[&@`"NGU.8`'#@!T&.3T(V!$)`Y`DC!SY^9$"FIB$%Y$IN9%VM@3[> MXR86TE-X!WXH@!ZNE3WNX[RLY!HE94CN"$[64U0@9$+@AR:.9$U&"#XFY4L6 MW!PKEO>I#5YH7A$;`G48A\?%8BXNYB%8.C<(G^XEQ!#54E!5GX!"4[T-#62H MC>=D%B>=5%9=7D;MGFYF563P`$ZN@0GX@`_(`B5X!UR&B"P8`W2>`';&D`]8 M`V#XAP+^8&7@G+`"Z`=A^`<(P`!1Y@@L*``E&(-TAH`/@`!FX(=WL&&!UL]W MR((/&(,Q4()SAH`"F`!6%@R4D>$)&(-^6(,U"(%8IM,D,`00,(%96`.. M+IXDX(>+MNAWX(D:F&DEF.@QB.`>+3NR-Y>]F8_9+KP-3&E/#$IL.9Q,181 MM9:VIDJJE(=$#$_$X&;GA1XXOE+N00:MW9YPQM]&%>>//@5^Z(=9^`=#:.*B M#H%_4``EF(!3.)<:>`=@$`;(#HR?%H9^@&AM,`%@<`6DGI'^=_@`PUZ#&0B! M$%@#80"&-4#I'R5D$/B'61"&TRX"-``&$#B%C\Y+0D"#$/A1B'?U@#0MCN*"XZH\5?_B7KF1T' ML27F(5"!ESVQ&\AK%F:Q0AQ1A@4H9,$Z)O7?[8%>6D#K_M9:VFA>9.""_.T> M<:X5-C`$8`"&`B`'\<*``B#Q$&`#T-8&B'$\\/G\"`&8CMUCZ7GP8& M$V!/#)@`V^8'-BAE%5>`,=#G'@7^[)>. M57(P!)?F9!M>`P68`3;@"#8`@37@X^G=WTCD7QQP`1PHVRYV62XVYI M\A#8Z/6<FX>!F!A>W\0(8`S_&252`[3K79^5&!>Q6`G.W MT:(N@.?^;@D>SW;]K&=@P(1C-X'/WNS`.(4B$`PL4.UI`,Z6J('9EG4_Q8`/ M^(=R;QH,8`:7#F!Y1P/$0?1>]FM+SU!^;=FO)=LNEG0)EE):..-LT6!#]#D) M9QZM!9=2[VLNR,-&Y5_,V%NVU(8U2`8%"`$=KH&2[G$NL94QK_:.P`!"\'$0 M?&'=[(DD<.Z%=^(!=G7D7GH,4`+9SN^[A`@,2?%DT.$C+A2G_X<9@/=R1@.> MA_KA[(D:KG$,J7%4B&^U!/N.ANT9EQ`,"`%E=_N]AV'QXGOQ2H+T[NFB9H9_ M"(&GGON['.`D<(4U>.]^2/)R3GK,E!#)A`@,Z(?#!PP>1X/^*S=Z$/!VR__[ MU(G+1QM]K0>,/R_ZS><'!4`#@Y_R=T"#"8!WX6R:&,Z4O/60]R,H"U5E%5>_'6!;9Y8:_[P2<7? M)WB!.&HMHN MKC&1%*)(5#642L3P89:P4R8AHL+^H$0!L`DCDSR$2C4AT*<9BQ(5>A##*1-K M,/SL-^NF0H8SI394ZW;IAQ`;PV[%D`6$SX,O^T9LF['L4*^S)M"=66,"&F`] M,;X$(1;DPI@(:T`F69GK4M%&#;X\&[FRXX4;3?Q%*+!B61,>,69D+#%DT*%; MA[)5"K3&R]K*ES/_RPL9,APXD/&B)5WZ$R!/8#B#`4.*$V?APSN#-.0\^O3B MP3N1\MW]DP3R:+5)D*#^#B`)S.PP`P2(&4]D]P0OO.!0'3(P(`,$+0;*X9UT MT$5'RPL>N(:051`8,DLR+J5D`A846:10$H:,@057KDR@4%=9_#-#9>]\L!,$ M_)RBS2G^[TQ0P#N*G;(C/W09HD0!6OVTX1K#+:6-(1]\4(!R2;@"#!J?_9;, M+"`H!5<6$("3!!:$?#9!",``HP0_*/XTP0<0B'4*.#<*]9)*68&$`01F6MD: M/TX6D)QM.A9Y$!8_%C`!2?R@B1,6!5"T!C^(#B7C!X9@,(&5$FFTTV8S>056 MD(;R=HH2AE"%P3O,0*"$E87NV&-*4`IU2@'"9!GI00*A<2,YJ!0P1H\17=HE MJQ>>.HH\(X*@1=='H+[M#&#BD`DL`.2[?A M'Q@RTV(==-(]Q\439B!X'0P'NLR+"[0HV=@:&WR.2E?OV*K^)48:)9.LH\*(]=($2O@MC$(R.AX67&O\ M,TM8(X603&;)),-,280``X(A(325:43D<&NG4.2$`%;\F?V].SED!XR1O>04 M(.@',PB!NIN\0WYF>H=5.$(_0A4A&51J2@&(LB'EE0@-L_B'Z1Y&-P02P@0* M&)E;WE$YP\S"!*.JG$E>\HY^@`!;X;)4%@:2O)'40'S_(`0&.C<0N8!@3N1P M'Y6"%+V,C&$-K@O!/XJ0A!S:S6"HX-SX9C`2J6"A"/W(`B'\EL%WS,!Q"J#, M&.Q&0(V8H!_I"D$!H@@;A1&B-'N13#*\TH_3*(8/$$Z+A'#M.9T,QX M(8^_U$"%J'A'9B90&">RH70&>0<(7'$5+1V$')CK%#2SPAH,$")T#!,8(7:( ME@TE(XR4T8;LI(B1-2B`'[LCB>\HPQ"_33`CXG-81.A)&Y+4#8)TL>!`NT*P M(CQ%*@))$@;8@!E@,+0V8F1#7R8@C.2E+`E*^$=/@B(,_'7EHQ"@RQ61A"HT MP(\B0'3H\"!(*#3DL2%K$(9;DL`/&AT,(CV\W2E.X0I;63'^"82PU68T@H80 MH$2BLU@#F#"`B=`99GCEFPDYWG&[K@@,`IECPQC0@`EF``-$`N,'&B``$S;D M37FCPU`8'U*3.G8EC#CI"EH_0`YRL"&=#'T'K3(3I'[THPAH<,7N,""[`K#A M;'="(C`\,I/"&30)X0+L#!7@PH.\@YY[DZ$PBI":::1N=R52P%QJ-1![UG46 MFDM"-7=BB%[A**:.K5^=(+`&.RXED!;AJXLT1Z(R4<8ACK-35Z`X!L4.D4[_ M&`-&3P$,&+U5D]9MV8%><,SJX(!`.)##A)`!#6@,H3TPN($K?Z:S5.;L9ZZL MAQ.<`(,GV+*6_OE/S6@!A`/YJ`X0D>`((K_A+$N=3$G@)K M'%W$M]R038`-B_4)/:\71'7B\Q]9\,GQ_K&;I1!"L_TX!0:PD)(6DF@VO$D" M"-`P%!2=0I#%:PPT3TC;WY@P20E*$?X!Y:$HC(`8X+(2D&41R];3M'&$*EKX MD3ITSB5_0`:&@RTS43CC"82*201PA&D@-WCBUIE^]Y M$"R]@Q]K.`5;.422C4!7&RK&W(>KNY00;`8#8>X'QC"+:0`G>^0 M)V=#&`3XQDPC-J)\1M=M0'-N)FDAPK0W::IM.O?%/*I.PK^`:GYL:1$P:UB M:)'=2;LG2+9I@Y\UI(N+T1)F)=SS,FC@">!1R.,YN\4P9DIJ.861LLXJ1A@F M0,Y2-I(,WCB.'Z+5B)%FDC`Q?\3FP%A#[:22!,Q)&T0E:"4'%Z]'E'HR>[:ZEA@P1N) M"63,/%25]=L)JV<(5#P!.;T-S@)ST;R-_EP^1EFP!]/(+!B*H@W+<\/+Q#9_R'$0S`4,R0,!)J=A'5=1$``-B^9R99-!0(,Q@S)OH.4[<\!R5 M:%@(>,3J_8,A8)0V9`%J:07VG)Z;F-9?U!AAO$4!4_L,%( M?(7HW-905*$_W8TK))31308K:L,'*$`1;44S#03]M!M(]=2<8,`T9$;Y7`8O M.H1.91_^/Y2&W^P&.1@"!\418SU$`9R>W6F5YR"65""$W\P6AGC5B*$"T2U' MR+30(@(#BJ58$EG@QG5@!7J@=T`'@0A(UU0-S5#'='`!,@CD M=2"<`^;7A;`124`1"*!$/UB1^BDBC`WC)@*#_DD)XW55%-T3M[T(;6F$9C6& M["Q7;<7-@SU7M`A.",@4KXD(,2Z$76S>Z(U(-Y73'5Y1F,FA0!2AP"#/_;G% M5N(%\YA+3=)/CHU($OQ<\[F/7,#A75R$3@&52PR.-(E:7"K^@'")WDXI0)'E MBC"TF4[YF$!8#R',P/1DD$D$D69APHZYQ?&I#CZ5E45@P::`2`W4F`E,0*U- M#]75QIDA!D8$$59HPQB`)N]E9@&$@%S")F$_H%/(M!`B@5C]-HYF$T#^V)T1DS2(,T M2(`@@Q/LS`(LP#A`0GF4ARE!I(`.J'C$PGK\4C#1#(,8R,@5R`]T#8$@'`A. M1PG2@@OX0.-]0)&=&0BQ`3.8GSG^SMQ);*65J.:NZ*3#B-&.]0T4;I^+R"%G MH8%1AHRX. MO56(P&-B;(KD%>/$\!&8/15RA$L_S`":+`EOO(17[=OQ+)SB!?VJ@*_EG>Q$H1+J! M!R*#?PA(@!P3=60'$`R8A*B@`#S'U7"!A>2/H(JFX5B/(P)#`8IB\"E46/G8 M281CSFV$4>)A.+'-$[*FP,11'ZH?42YI<6T1H`B%8?@9VX7(3J;C':*3N-R> M7`[%4'Y$HFD6WWD(\B@BV\F.$)J+O/$WU4$4;">&R;$(8(E M#$&%NZF/&(:8P2SM5`C?#,P(JT):QQK/WQG?FWGAKBSM0MS^21R!0%^!IFA. M84-MK0H'5HES#1@C.,%R(@@Q18'"OM#,9E'"RM1WN,I'8` MR,A)1P+Z5X/R@DCNTDAF@AQ<2%QX'^(*`U5R:73.)*BF2QP19;%%TORYB(^% M1!-*6HV=J-9*UV95Z=SHG-"""?,LA2&<["PB&FC0A<(4T:@M#/-HQ'&]1%=X M%0@PV9"U:%V%BY?]A=\`FQ%E966D5+?H3OS>38O=3O&`78IM2K(I5$5UAKZ- MJ6)IFH>XCVN]G\)@2U_FJNF,Y5+^G((A#`62,`>K(=WV?5/I&>R-),$,I"$' MHTJ>65TR4,6F])ZPAL[R0(L]W2-3`>/NR(D8R29$F$!>_AG!0(!$Z0GXOD0- M$`)G#$SR=-:K9D&L8D%(>'`LEM7H4.ZW#04$_.5+Y>&)9IV'E,Y9L*C!4#&T M4`;F0$\!]8.,_B:7MBQ$V`^[7>9`#*+F^J/8?)(*_E)T)*@HS8S7P``DN(<4 M2($;2.2`:IS%!>AZ@,?J.@$OQ$Q^/`$MQ.MUS,RZ>E>#_(?GX@`B!*_Q=$[2 M8<8LG.%!^(WY3L09L8$A0)5="`H;U*W1(9LGRP(3C M%.`F.H7^$EQACZE80]!-",R)Z85%60!%B=C*&##9+>X13$Q`$3##*=-*2?QP M"-P(14`73!3`#$#1QO136:IAM,$;F!#J1QP9IGS)%`EGVN'4H>3M+#.6;M&% MBEDC$">*F0#1:)"3F;"/IISGC1(2)H"%1XB$`LF=\V7.F-Z)B_0#&V3!R-!3 MGCFQ:&D.%]JD&SI*/PE,J?94WXCG]C$#6%B$2!2`X?S(I:S!%=$1&\P`90#K M*:C53"3L:6!?D&UE/Z0&JCA1#*5C,GB&U)J)YHB$(;03:7#9L<9EE01%)&9? MHZ!8.MFM8!C@I.G;LB;7+!Q67]1`XT`0!%AJ-M<0+_K*2'#^]&O6@&ZD6%P@6LB`16^6IC!D@>%&!@2`!1,'U8Y``$64 MXHXIIF9H\U!#$3-\0$[K26P3!9RB@<@8=?85``2(,4R<9]P$-$B$2SMB@17B MQ//."T%1(I.=VQHP0P8I+YETA>Q8BDUMKS.'M"%,A49`D0E8BO%PV>8IB=^\ M3Q9\@/I,0V5@"1[7QN@Q@R%`P!7^1Q))^,VN7@_J,/@'R(6BOA5,O(,"9$%+ M<(5H9DJ(@`7`.?>E88`%>:=8>%.7G2W#7-T:--`$T9T#3F*$&E&.-62006T&-#:!5/X_4!IN[86')) MUHP"ZM?56#(0M$%ANR[/J-?%']DU/8.PIL84F-Z/!!VP%.3"##D'Y.^U%:@K2 MK9M`]LE%)U)%#9PG^83``!N.7)F0"7RQ"BF`L)/#D17165Q,C(U4?8NQUC6% MD]SH*4#&#(L69UE>#YZ;\9K65:#!#)P$*JQ!&8$`DE\:+!Z+I955Y.`.E#QM M5]*&DEQFW?RX,(S!5$@%9FR>"!_=O@T%%TI;]/@-<1:0XW@\^^QH1O!#JZ-! M;][U24!Q1G061P@[#W5WU$T4<./>CLOFY82`*Q2!Y57\&KC">'[`X?W#^Z!8 M8VR$$KD$D'G\!PQ%]P@\VV7C+*"G%T;61>C/N_.:.8^4Y1W^LZ9,0+C\@V81 M]$IR!$7U9&821)_[^<`I'#(02(%0QX)R),UXS=70C#P\1Z.# MZQ`$`WO!+N6[4GP-@1G80"X%""U(B(+T4H($4\UD9"A3Q8\`5H[<]5:\`^H' MU33(R66.;V5/V<`C_8B([2 MWC2T?E`]?VH82_(/O^U3)DEX,!9`1@U@P<:Q*4$ M__#[%*:&U<4581PJ+]"T!@T#:08$%M$TXE M,4@PR01#$VH()(CJ%*J%%PL^5#C^D*+!&J<,U4AB49M(AQ.22,1X"B$6EB0- MOEMH4J-*5(90D2.9Y-T$E0T-:=MX$2(&@?P($4HX="`YD/RP8*@!DR!+G1>! M3M"F4AM%J@9Y:AQ98X+/C*>X8ISV[E1;EC(7*G1E:%I*L`[1,5F9:9)T\L/P$"I`VMR;S,0);B9+03)V[< M.'.66G7KUJQ=NT;=VHGJU&88M6FSHXWCQ[0>\W+A&!EP&%)PP)##=.#0)#4P MBBS(7"',)-2[&B0W`*X>9(YS9H@AI!R'RB&LG))**;6<4H4LK\2R2RH3 M6"&!!&S8`0A:P``RLLF0^1$9Y'"0PH,-=\QS(@3[^8<0G5C44]!!"2W4T$,1 M52_111<-E%%'#864T4(E);322?-L++C&/KN,4UZ>V(T6S#KC)0$F@4C%"42D M&"VV&VISQK3:3+.MUME6UV6L<^XU2S<7%`9@=`@"AWLC90,`,(-6-;;'+W[)YD, M)\Y8XXTY[MCCCT$.&5$?0075L\V:A((6SAJ33+,6=H@YR73',1DX9)!!I%XI M@]G5B3''W)DV*6#XC98="`G-,2Z0\ZQ!6#@UO MSY#)Q`<\.7;.\^FIK][ZZ['/T;?-$,?A#B`PBQDS*#3;3,U03WU"#1N`D`*: MV&0]3@HHZ:W-[[\!5PWH764U[0;)G!:G=.'L"5#`@0ONE#T%+I"!#73@`ZGE M&UK(@VVC.A?B4!>^)FW&#"W`S+N8-`[::2E68^I=E_"U/Z!927]#4`&7K`2# M)^"L93AP`K'PMAP([I"'/?3A#Q6HJ2>H"1DN>((`=D`+1%3F,J83W67H%AK1 M\4(W.(#^QJI&XZHAJ&-XXU"'\("GPOQ="7C0,",D,B&ZX22G7*M"`A#A&$*09S3A):"C"D2*LV1-@0$/C<$%J=33E*5&92E4B9HH-@\P,<<`9-_T` M5$0"0IR,!ZHD4M$)>\"D)(<'QGU]:8O^&IR^9"4PVIQ&,G$J&S*<@`3HK9*: MU;3F-3GGF4]MLS%,`I49M!E+-37&397!P6X68,Q^\4]_+83?.UNXMW:ZQ@DW M<`9RH`8<*A'.!!=<-BVMCP^P0,$G0S^W3*Q`T8X8QS] MLUUL3HBE?VU)5UNZGT=;$XM:P<`RM/@!#B(74)6NE*4MQ12QP&70R@#GFTU" MW1Y]4[0?'8P6"6#$#O1E/Q?J*U]=[-NNQ`3&8P)S7Y`8AQ.&V`B4NI2J5;7J M51.SJ2?T$9R>L:49?"3`&4I&IP9%E2&`NH!,0F,5FL3D6^$:U[C^CI)=7`W` MG/$$0-`"$.+`ZE\!&UB``LDQ"JLEN$8%/E[HM&22>9K!VC#$!"@LG6)Z7S!^ M^58&***N8>R2E=3Q12XJU6^A'`Z]G(&#"X$)1+880DTX443*8[ M*.M2]S".PFZ>LBNH_(RW(%\)+T<,\MV%L.B\Z;U(>\&;&/@J9CW572^WS*NC M\,ZWO#F"KZ3XJRB,*-9DB*.I3-?D@8>MC*:\P)FOD!2S'=B`$;18P(7?&KPK M;92NPLVD)T'LQ8]2:7>DD4(PY$`,<:R8Q2UV\8MA'&,9SYC&-;;QC7&<8QWO MF,<]]O&/@1QD(0^9R$4V\I&1G&0E+]G(8B!.**%$2+PY`4J^N0$7V%@G?#XF ME@I;V1"!H(AT_C*,%`63ED0KR6#X:YUB=.&4U.$$'6B!SG6V\YWQG&<][YG/ M??;SGP'^'6A!#YK0A3;TH1&=:$4OFM&-=O2C(1UI24^:TI#&\"HPC&$SK@+3 MF5:KIA?0Z0N/FM0>-O6I49UJ:)":U:UV]:MA'6M9SYK6M;;UK7&=:UWOFM>] M]O6O@1UL80^;V,4V]K&1G6QE:UK5S7;VLZ$=;6E/F]K5MO:UL9UM;6^;V]WV M]K?!'6YQCYO[X1UO><^;WO6V][WQG6]][YO?_?;W MOP$><($/G.`%-_C!$9YPA2^A5M_K5L9YU=K6OG>UQ/8(ZO#$)L#<`&AIO^]WQGG>]Q_SMVT#')8ZA MB$KLG?"%-_SA%?YV"4Q"$@TX.^(A'WG)3W[>VYB$/](Q`DM2GO.=]_SGL5V) M2$SB$IX80QAA$D][VG^!'BO@VJ M^][;N)=""P"0`%\2G_G-)_D@C&"$)NS>^=P!71L M8Q7?K_;ULY_^[9N?_>V7M]\S\'C^]S<;_>E/_PZX/W_][S_<1PC&-2:A"0:/ M_TQM#Q8`!K#/_NP/!_*/`!WP`:EM`1YA$JZ!$H8/`LW(`'%`%!2P`QD0`T$P M!%6M$CSA\E`/`C60`SO0`QM0!%WP!4GP\AP)!1=@`U?P!GFA!5]P!S$P!OWA M!/(!)7C1$Z4`NSKQ`Q\11=3Q,7D:1X`1I\:1SV@![8\1SC(O!;/A]A+TVM+^ M3B`*!W,Q*:XP/Z\N[>\N&7,R(\PTR\QF9(S23/@ M/+/C5J\CF7(U3ZT7T\D2.I`6`K,T:7/?3K/B]H!*7/&M)!$&8!&N<.\M5XVB MJK(&6R`>B"`S9[,VF?/>;I/B6N`,X^`@]X`6/%$()//"G"$!A&"N<@\`)),W M;T`(@$N"31,WN"!:@0TWM0\=!$3#TK3241N6O[&I4 MKDYO%>2O[C;I1\THXS84KLSN13,.DRRTVT94_EIT2$G4U*)T/A&N/A_.))5R M`)@$2#T(D[`"493N"@A`R*A M`A[A\3SA&Z1N`=3A&([!&C+@$1Z!ZD8@&"K@#:SA'N[!'II`$2C@&R2U`8"P M$A3!&KS^X1CNP1KLP1/>2A$B(1*LX1@B@4\SH`(\8?A@=$CIH`)"X1`JH`(& M80#][QMR0%`?H0F.8!!R(%2M(1WB:A6LX1O>@`(,E0)"80O<0?XP[A$B(0?4 MX:T&@53Y]!N.05??+@@!V=[0@Z81+001*F#AJ.8`MT%1KF80M4-!UL80M.;P3N M81*V01V`K@G.`64500(&0`)X]!'.003L`>C281NVX?'\SQ_^/#42!D`$Z$`% MO&$+J&'S/,$"E;0$.4$1@"X4T,$=!D\1),$:1F`5!B$,XN\([N'K4A6N*J$" M)H$!&F``K$%%&\`(+D`1C(`"+!7HLN$'KFB`8O`$=ML!'0V$`0J'V MM$T=KF$`WD"MCJ`'!N`'R>X8T,$(?DZNI-8;!N`;A-1&U<$=ZM5>Y0U?'8[Z M;!('_D`6`2!@=Q(`<+(9`0!A,W!(XG!"/308,`=T*$!>$`1J&%:*X$$T2$,/-:,>(`"CD'CWF`2WD!(_>\<)L$>'@_I0H'J MCB`=&H`:1B`#)F$>:)02K-:,CF#^'DQ/?=/A$MSV](Y`$?QA$CR!!_*V"8J7 M!SQ!:Q?`$XS@$B[@`F&O?-].!"[!9>?!'S9.`B1!??NV$Z@AKD:@;44`>.WA M$B:!>",!'2*!!W94?:<42B\P2>5J\61V!,RV!^9W!-R!`IT6KC".!Z@V>D48 M1D?`&R)A'Y1T53W7W4`7XN"P=5TQ=5$W^V23=5UW`8:@#0X0B;EO#S*A$-[T M,/!!#9OM>]WA$";!"`9W`>[A`GC@&"9!!(SU]'Y.$6P!':*WY10A58$/';S! M""N!:KWA"#;/C#P5DS:+1LE8)LVHY8Y@&U(512L`'21`D(./&K[A\AI`0\>N M$MKV$B;^5TDI`!WFP8S\SA/&P0@R&1HDP&UY(`,N=Q]*=`0H@/1V-AT`\![V MX9"W8','>$B]]5P'#^@HP!/4@;-P>6SA2A'F`1TPET:IEOQH=&6OH6/?ZN;N M(>G8^.QNC@+.5:T4X9`C(1@$3Q$:X'=X0^<(/M(-Y.\D8H3XXKGU.V"X1"HX0VB+P-XH)E'`/JB;QN,U44!V`@: M8`"!LV_GV$8I`0!M&-5&X(]G<`'$EP>V81#V802H`9BI=_?"KXPIH0FZV`@X M05Y;>))W]JTJV`0'&1THH!,PF:W\C@(6H'Z/(9=7-)4O(1C^]N&2KR$=J.&0 M.2$2SD'Z-LX=0L$>_"$,!E@1.($"&L"I1T`=3M;IX%.-A3EEB[F%O8`"E?DA M*<`(K,$=ZA=EC\`:9%4$PB#S&D`2FNX;%*$)>L`>.,$(?-F;V0V<&XZ)`0`( MZE%,3_><S8">#V,1_.">\?D0%D"-H\\>*&"`*\$+ MX%?VO"$81KF+'T&A;92AJ>]_92_^\MC#)KI\E6L!*.`-0B$4KJ$'$O4;Z``` MWT"A0UKZJ"$#HD_VWB!:)3F`5WKC-@Z8!X!X-]D3T,$6-!FFTR&`/>$8!F`+ M+I2G#\$+;.$-!G@$.K@'PD^8>2#^'=#!'\9X`"I@'X3W&/;A'CJ!AM%AH@>@ M??EXC8=Y!+J:1K\ZF2]0$=@:XWK`;WG`'C!Y'X@69548'3)@'Q0!`*&A`="! M$SI7K\N-KQEN#V3G#X)+"I#XG.74L%U1'>WO"5Y182%[8A^`(Y_-_^X!Z':[ MZ8Z!#H"N$I(.?EDVN+M8`.4JCAOZ:65/:U/MM0'98YO`&JSA$/PA$C;5"RBA M?@=72OR\&JR'KQ(NN0=6#9:I@1*VH0+&P>^.045K^.Q"@1/4H8/O&,/W M.B:%,^C$&4V>RAG:0%]A,V#%-`[D69T?4@HNXVBRKP74<`&<`!^J>"&6(!>X MH)M/#<8M=0':U@A$@,S'P>;2P1LR&_HF85GE:@%0&Y,4(1T,=Q(B0=F-E(S# MH*(S#J,UVD(+/-6'U&PS.1VDMA+L&KEYX,MYX)"-`!UZNWDS5@("NGQI>A(& M`;IM%AK\S@LT;TAY.A@F6$D[N`+R'=#KSAV\@1,F`7.AP6P93QVJ^Q(:X`+L MH5W?"M*)6=+]F]+-B`%4ML)7C6H=O1+NP1O\CF2/8-3KSA/^WB#N6)@?+SRN M='2$/=;L?'C>-#SA%!8`&A$`<-T;`6`'QAG%S>@/#M8`5\T`W1F>&S`.BJ'8 M"6()"L%B+Y8.[D&M6)Y\*S"X+V!NH>$-T$$`UWAP6RY#&1J/!6\0W(&^#]Y# MY9.ES5T%-(NS"'E^:325)2%:U1?4QWCJQ`RJLY<:OGP$FN`>W.$>"ED1)CY/ MZ?R30UD%TN'R`+^F%[[N>-H>5J'EQ!L=)-Z:S^X;T,$>L'N8P?@:_%8=-%A_ M7?273;Z.QR](D5F965YXMZ'N8/GLS)8.OB&[19V-J0%L89K">]X=*^$0;'S9 M[4%=2U56@;8!8O5..=[`#BC1%U/([9@C8"VKXMUZ!5:F+$"!T>1Q:, MH##HR(@WZ-[PJ#1BHZ<1P<*@:T#Q"+4F#19`>PF31P9T\Z`=@?GRR#9/E6`> M"37`'0]H/)J@VZ9H1"1.&A56J#G"TZ1+Z2II#'GS"`]WD^Y52EK!"$))/5SV M0)>.Q[Q+E&Z^I-9@:K">+Q51^S8@TKY(`[[M:X!.P@AOZ/RZ:[#OPJ0MU+:A M"\4CF">W.26@V\)#$8\*1Q-NG71-GS;+W(V.30@08Y'T!%& M*)Z!%&`Y[X<\'^")V(P-L6P5"F MR)R3:*C(!;9,(DD3BJ@3BI[N+)G3(>C8\LT\O!U!P223N%/!`-NH,\(]Z$C2 M0#"77&;J.1FY!VRPP@Y+K+`,C&#-4]XDZ5W+ M;;?#+0!NN.#BM,`>$XH;+G#CXJ3'@>Z64D@ARZS`BYW.J6.//1?Z1(D*;QZA M0@,U*D+9$4#Q+,;^I0T$E%(2OBSJAND=CSI+_%[+$]6]ZI M[P5TZ&L/=YY0,)X[CZP23#`F"[W^`!TE^XL3ODQ?D"G3]HRS=-$@$]B$-3%W M4O,1`BO"TPDTP5N'GKJ48YYYLN-L\<.[KHKBC.(2+@'>^"*'/)+(1E>W^H%&WQ$);(O M@/I5LAU.N\[)V2YR5JO[!#OMP(TPX532,$Y M;U/P-N4NO/*R+?\22*I3)KY-MX^`IN;JK\_^<1=-(H(1T19WGC>M7G()X2/8 M12TUOZUNIU4`4#86`:#YT#>L;&VK?0Q*!YR'2(`'6X#?)41`!XWTSR?0 M:$`%*N"B!5#B'C4RF3T>0<0B0@-$"EN%L!1X.11*<5@+$(4$`0"$/41QBESL MHA>_",8PNBSI&S)UI.C(PT#N>`<$51P+"1E*RD)2^)26]5@A/6X($W M<$,5U*FQ"=MPHCK"8(1G5:M_''3,-ZC!`[R\`22?-$(H0'*!*F;3D`R/X.0I.LIC,;*8SGWG)!0QB'@1[Q.(FD8/^-,)DC21Z""@G M08%#T#$IA]#32*AQ#R/X"BZ@;%1<&(=&:'B##DY4I+:V",TN5O&*6<1G/O\) MT(`*%'/'"D4.*((:W/@#A#$DY4V28HVI7,(?WMC"_F83D4/8(QV<08=TU.&/ M_!V#!Z$0B+.@T81X)G"1`SWA(R.YS);*=*8TK:EQCA",:WQH$'0X!OS`J4V' M.'2;H<)?XQ*B"'_@QAN1^.$/*5"1&AK!0J%0AU$]<8S"$8N8-F7@`IR!S';&+)%*H\*C7&$E'`\*"#Q&'`PW(A@ M&T*IY39"P5!LL12MF=NG!/O)V,C^2G:RC-3KKQY7B0S`\1'IPPE=?9*.^`C=HC.D4BZN4[=M+):B'VNIVM[QE'_^\8;@WM7!^ MP#D8&S$T`G=D)S9)B01HC("22FR%`OM#EJLDEU>EBD!H6UUL;XEUS"M*@:S? M+:]YS[N<_9T#);_93"J-T(2A`&HR@F,,@+E'2,QS[N1UHT<$4KK"%@_,(D^RD9B^A!#T`(X+#-) M*`;!T"/8@HYH.X>KT#$`3KQ,=3WPAUONA@[.7JO!%V;.;3^G!_+V>,A$CBP% MB.B%>_S^JK\8*V+/0,CDDA$QQ>F@@&^R=H\*?*-N(EN`)]SA&T4<(K$,]FZ1 MD1->"8[WS&QN,V,'6+`!6L][!BQN[>JLO.(MV)X+=+-Q(.PN">\N=^3J'O*T MN3HT+0]\PBG@GI5''-A5KWW.6T`E8KJ*>E;,8)9N'J>+F^?GY61<%;$*I]ZDFD*C]C&LUFGFFY;+@;_;@:YRHIWB]%O*/W15D MY:1CH]SUVH5N(C"^1;$GGB`B/1ZG"$IL=-D<_@VX.D'$1Q#L;$,C3CK.C:0W M48#,?R,1'8*Q[4%T`L7'6X4ZN(.3I9U[$/2@E6\>EHZ';='^.B*#][EAHHA\ MC2T8\HYW)YIV;QAFZ@(![T0G5#":8%#'$WG M^L(\END"AL"+)SBA=`2"1LQG3JX]#"$_]8'Y$Y!!UG(-X03B%3).!JG.)O1$ M$??PACWLO8T,7,`3%?"&T-QF"TYXPAX4J'HP%'&,B&R!W'8;!"><9`]/?(,3 M.@Z.+90NG":XN`D&Z\$`#C$Y;MU;Y7;\1C#&X:5+6(,";PC#%H!#C1R$(N]< MRI/@[\&)-S3!)0Q(1VMU2JKS'/=.83%";*C3"4Y0`!K^>(,/IW(("H2A`@LX MQB!8EW`)S*CKJR?8!22AOPWN"#?^%!B'.G(@=G4H@@(NMOIP[@$:?`L'I^Q> MN7D?HJW5TG0/O'C7$TJW@'$(807(*,7U82(%,YR`$32WCRB0:8/@E&LH8J00,TJ82M,(1L\<`'70`G47\(#!X&(4\!6Q=!034@FA@`Z#X!LDT4*%DQ3W\"+?<`3[T"HB MH`[[,`C?P`.4$`8YU%Z M)5_#,PC^R5=K-U%&'NA\O34"7H`.,E93#W0"-L`([N($=O-^4O`'5K1F.-`" M!]("6O1`M``-0Q`'!\(+-/<2>W`#-K`,A9`+N8!;1J<\%'`,_]4#-D$'UK`R M_G`.U&4WGI`.(V`/_S4(7_$BR=4H$!$>Q:,(MH`.7D`-2)(4GC"!:N0-G-(6 M(4,BBI"!+D$-+Y!VJ0"U<@#DM`E>)0 M".ZR9NEU#Y2@69/P#21Q""Y16I=0`8WRBIPA1[^A`N,P`AV9/LDU%?B(<&2W M`$WP#<]R#_9R,-YP#-;@#Y-0AND0"=E0..GP#=G@"<$PF(GI5#F49<$P`B!B M$%YP$U3G(:%@"^YP$S5T"6]`F7=R"8N7%#&H,3S0CJ6$#2CA(0,O<@$-?`70_1`!<0$7+^M($J$&M)P14XE!7"V8,Z>)!$D2P+Q9"3 M<`BA$`890_?8`LM\1+'D`-;8`TVD0XE=0P7:5VAP9$1X9$O$!&X40'`Y"&XX33QDS?86(%Y.9I307>/(`F2 M<%E1X0G^<9%'E4`=YNB:P0!/ES:;/D$'AU`:BV$G#.@.^W`($?$&R+):QS*< M4I@3]F"!(W.0,"()Z[4`BK"%DLJ6Y/*+)5D<1\!U?Y$=0IA?=T<-*O`L=#<; MZ(!WJT`8P'06P!1:X<$#:D,-GB`K/'`6G61@%Z(XKZ<.\9/^BM@X$W7RI9?P M#;(W#\KW$O=0$;(W/VQJ,'1P1K+ICN'C#L&P#Z'"G`Z!-U81%EWA#D,BG`!9 M,.D`HX8Z(_<0"=8@&B_2D-2PA12P#_?9'\E:']',`Z\6`'_-:1K.UGC("-8VU5[8`FB MH$5[4+?&ZI-Z"P!&61]_L)0`(`3@P@6%,+B$JPVHL`B2U!RU8@^+>A'9@1ET M`%5)\1.70D.@$0PJ-VND^B*L[EX406W"+U16#)+H-DW`..40P MUI!$%/`LD?`5;&H3XLA+L1.G#D$!&=`R;+*:0D6Q1P"2L?J*_TBP#Q--6I7[%3C6`_N0&D*QL.-P#9=`HL0;2MA(A\AKR(VRBCYJ,.K022%A MFKV\"I4@CCBT`%=X2TGQ#8]\!-V)/ELAI+)A#UJ%D9WPR(^37*F$OOT5CZ`Z M`GERKIR\*9,AOSQ``7W!`PP\`H\0&:G1!#,A`0)$":1R+&'H)H.@P2[1R0/Z M$JO@&'EJU.E1";&R461+P65MI"/0L&KK?"I`=H!3$>G`4W`X+-.;'1']S.:W M`'^P!WE;?7;+H#$,$WM;+GD%K"M0+N5P!35LP^)PSLVQ`!70`&A2"3U0`9EQ M"2)2$>[@#VW3!&'@*RU]#QR[`(#^@0ZCH@X[`ESVQ@G@9###=PP@I`XBL@IC MHA-_U`FJB!M-$'8GD9*Q>VFQ$@D4<`F?"E'H8`\D0@U;`*N=<(;?4`E5VH/J M`$AE2`F, M-`#>T`2[8@UA?`SP:AWG4!A?C1,82<>_:S"V#6;0H"M%^Y84<"K0^T=*LBL9 M8"N\U)93<0\Z.@"A8$VO0MBY=@1J9PNV,`_SX%9NY0_S8`L6'BQ'8';>T%J( MY3=),0C^C.,-20Y0V7<".Q!S0&`#7Q5!@%B($G8Y$2HA3Y``G,.3X.35@!E$E*;S"GMH#^HE[P#3D@V@83 M>K80"2Z)$_3`[?9.Z9:>`>F@#K`2"5L@-^3B!5(BG]_0"1DI[*#"=@;#@7CG M";80"L$PF6*>:PF6/X>@<1?@#JX45.7AKM4]"/_HQ7T#%_EC"QI[AXPH06U@ M+I[#"W^@!Z6@S78S#D3'"'_P$A$4![P@!7%PB)SS!.-LPUBP!(6@!HB[+,7S M/!I1">-`Q"$C&XK@+_;B:*66/./S*0A17'5_:(O.:5 M<,R]!1`,1MR;)&)2@TK0U*D;T:`"-6@1%3%0%-'B18P9,:KS=\E(@Q'!U!W1 MB)$!@Y(I+8XXXHG3I$F<1JJD6=/F39PY,XY;D'*/,Q@+>D8<,LYB46A[QCES MEM3BN!%"'BS!HLVJ-BRHEI3)M$?G5[!AQ5I\4S;46+01%]P;1#+M6[3J,JAP M"]?N7;S^>?7NY6MRA)>"!X^LM3>"SKVA"T8LCC@"VA&WBA55K%0WXX(C'8T, MXO&X\9%QBEA>7,QXL&>-D"LM5N3)FQ%T1KZA[EO;MD6A.',_W4,+`(!%2ZQJ M72*NS`ZOMY6C/7(AW=#EJ55$[SMNE67JV;5OY_Y6($&#%"![NT!RE<4:.'"B[HZ8A@*G"P`H4J M"",'[(Y0Q)YT/+E'PDEB>Z,3Q[H3,;LA3O@-@$*J$&>1*QY8IJL18[P(,AEK MM/%&''/4$1J!`#/(DWV:N"08RU:YP(@.&PAE@$O0H8"'"B;^\>2(=,)`9QX5 M!KQH@0;>N.8_3C*P:,EOCE#'EH,J8>"(>]"9Y!)[1(C-B)D:2_Y"GS3B`J.\8_(C.8Q0H1M MMOAFDG/4\>3-#(X8(10DK0D1(Z$TZX0'T8Y!YYJ1&MJSK2,&,>(2?SBQI@=T M>L!HA`QB@^G72\*X1S0>*966)QP._2T.GO9(3EINN_7V6W`%M50$V:S9%#M% MYO&H!VI:LH<:=]!!9YLC>&!UDBU>Q4@%S::$)IAKC-@FHB,Z0;*"RIKX=)(, M]E&G@3HOZH2"!@ZIP)9+.I0D!X;^PGUT'$NL!0"9;3TV^6244U89K'&EW,>3 M(=%5=Y)[1A#(K0W5@<:=F8_1]R)%^AW,G3U[L'`!A8WP!RJ%_TN'I!&TW+(T MQ](Y9IX.PW`GH95E)+0%D1,HN6NRRS;[[$A;;F"\\C!*UR-/?N:!&@IL.>:U M27PN*6BXCZ@D@Z*/8`#I7Z^A9(2F<=5)546L\0>FV=#6CEJ1X\@)L\%(RCSS M&4O3#YK2N-8()>@VIY&FZPA>K'3,%ZBD$LPTDOHQS%<3/:/5&".X=#3\=I\@>MXAP;SXC."['/)H^_VN\`:$,H:>TABP!J)U/U(W^8X0<>= M?>[56Z/^<82NQ)K`!T^AIVD$=2I`TAOIJ0-99))O4F<0>]AC$!>`1CH` M*$"=06,5(TC'(=S1@'14@A(620@%K$&!)D!#$=/IG'R,\J].!+`3P:#)`M1! MPB/8PPON:,L$Z1!">W2B"4V@1SHPLHH36N:%`9QA$W@"JY98PQV>,,H)83C" M"PUP@,$(!J`L^5K;_W"C)",8#3W&4%@UXE?6%1EC?NA ML39?"]O85-*:<\0D&(I01RCVY(Z*'($2%3A'!@*8`4[D8`3^BC@"!<+`"4]< M@`(5X`2G+**.>W#B$OF!QCAR`)-C<+`DE;#'%D2S!4X,T!K"HM\Q]G2,!A3H M$EALS"&\H:]Q;&%/&5!2G[;4!%O8H@$7\$0D.-$):(S*"!F83"<>9PL"4O-G M_WK)-2CP#4F\(1@C\(0@LX>7^NWI68JXQ\'4H8A'&&0;=$@)!7Y%!_EI,H&* M9.B(%%$)HI'+>EAT3!@R`$?O(60E4<(4#RK1`R0=8Q\E25_?(B*!20SLH0:= MQ"$25KB%AF4$B,S;.AN*%D)5RUJ6`,L\T'$,6O&`:->@2RUM@8X&\``R]JK` M"!9PB`%P0E5'H$8Z_$%+B32A`K?^4L=Y1F`/08(H)9J<1SIXT`1T-*$S/#A& MOD9@,"/8@P=X=*4")6"$NB+.GG/MP0`JL`#1G,H?*FC7*,/0A)?MZ0*.&0&Q M*M`9:,RC"4[DP1;088LC[.,;`Z"7.CQR3YO(#R/4:,";B,2@C#4`(@N0`#JV M`-F,,/"@=:F0-T!+FYOFUC:999]!#L$#UT'C$=M`*M.I$FZ\%6) MAQYB$M<@X0*V&HI7F>D07_7(($:IP1&XHVTK.1*N2$(X(WC"B:3Q!B<68ZLW MB,9,XFG^"7E3F$*L5D)A-:5@/8V0P0483_NM&3_"@`;_JA(6@(;Y0 MP'<$W_!';+]QI8>NV`@7\*P1Z`!?Z*AI)&XA"25B]Q@SK3/`;WI:HJA#K?>:8C8S7;R`BV*H&,3&;/"C/P\I+F"?/.T1[H MN.@"B&:$>;@#=)3QL%R/@5MH9`#2DNZP(-M2672@>J:@M@S^)1ORJPLHM;'H MB/%#/8$.!9/&LK:`AE#1<0EU4.(_7N"$UBS4D`W9HL70H,0WK!&)>T`F&*%X M0P4^N!*B7:+)HIX$E$]JQY^5`DR;AI!J=%J ML@"#M1K!L"[)"*#*=6CT8$^3T&9"*N%A=]P-4!K&($Q(#3H/3^D1DI`$K]X0 MZ4DW9L678.$C.M':&*\I&$;`+TK^&C.J>5#B`F$X!Y3IX)$MG`K<(Z!`6BE! MJGEZPQ;[Z))AO:$.="",-/G>]Y.C#/`M=<*O^S"F"-(Q$'0,(AU/:&( M03!L`0:A1\:'_ONQ/N]Y0F$>;87OO!&(3C'0$_[S,)*["AT_+:*Y,;V`?Y/T M'FJ]8''O&Y+I$%#S`'!RW-?CK%Y"5L]DZ[%6;EH38J$M1!))&:C,(P1IC5#T MX'9'.$2WQ;Z-`3F[7_D&E/*'F3B";9@$?\@[T-D[:J(8-"D\3;H$5".-4?$' M:]@":U"'R@@&CYBD_N*!2!B`9_$(!<&:"%LL=QB`2$B'/8FI)=,WR.`W?X,& M*=.72GC^N*1*AU\QJR6A`'7H0=F:):':KA'`FAJ\/B7\O5[YE=M:0HQ@)$S3 MM)I(EY_:A\P:JGDR*"-(PHM(0`"\NJSK*E>3.M%1-;7P!O?3(-`)ABWPB$N` M.0];K"T@F,=(!S\9!/M),/@20!\##"-PE8>R)`/4B&)R%6"\B**SEJ/SO4W# MEQ$8ATJ0+_HR$U[\AO\B#6.*QAFYC/0[L%?KB36A`%=:`#7^G*PC<`>=J9=' MX,44\[!'>"M2:H+XNH<&H)C'"07`\L,FH`9(@Q._H8`]:0++@)J]:[&*@+'W M\\!'7`G$BRY*1#D3A(PQ+5L8?+\!4#/+!!\(@F8"QH@!"%1(<6&X%CL(;.4(1] M`)Q@H(:F\:]N:X*@=)7D8RLC.(>G(9Q+\"\Z")@*A(9M&`"@(C`5H"%F:$:"$ M>P,=@XK&(YA+\DM`/<(--6P8D*2O&1L`3PA"$3@5D;-7(M>4O`R`0-=Q"32F@3P="@>8@J@KF`2:!&PWN,)7G-&7%!=.`Y MF/`OGZH`/%N;7&,]?S`3*PF%1R"GBRC*2:#.)N@0]52(:QB`-[",!3B5:Z"' M*)F$%BO^L6_PQP23+2/@F"7AA":0DU3132&5'J3!NYKD"1@PNB'X3950AW?: M@BUX!-P[!E.\!Q)RM0H(!6NXAT,HJL=0`6MX@V.X!VL`.XM@@$&P!E-T!R*Y M`#7]AF,XA$,XA@K(-HM0A$O(E]JCAP!54W]S4U.,TW>K`":*A&.@AX@(!G?X MABV(A$Y(AS>UAIK+`$9%H9UY@V\XA'O0,WN@5'>C@W%XTLB#BLIKBSN=#U$! MPCGR!%/T!%;]!H1H@&V(!'4`I@:`!FLXAAR(A.RADC>0@`J(&&@8A!RH4B:Z M!U/T)"=EU,B++B[9!F^@@%#XAO)RAVWX!G7X!DY8FW*T!?7^'(1M>(/#L(7^ M&U)S/9NS4\#.;*AU38D%V(,%T`.1\4FQD,17\9RI84,ELQ!2TDG%&)[E*0VA M6`SL&($<\(<%495:4EBU6`S8^=?&`)_2.(_<@8[2(`W`(J57^=>AL-=54`1[ M>0,E(]@](]@%FL2I4HV`)24B.X(%T@]\#=CD4QW=`2+,05F6\!WB<0S5>!Z= M/%>@]9AT79IO>5=',MJ26#"D50FE<($[8`21&4ZT.0+OLYE)68`+\(9V#5JN M[=H1&=JMC90%0`8@8!3HV`,I*%ND6QYX188EQ0VR-=N4``,B*(1">(`'R(43 M24;).0]KJ"M(:1RL\EK"+5SM`%O^;Q&%$]&#M]T#("@%9&B!.'C;!1@"6E@! M`)""H1@'(3@1(7A;6&&$7!"')2A=X;B"WZ!7R7&Q2@)9P`"WW6"!2`4&]"#'8B#WVB! ML5D`1B@$X;@*JUB"*[`$)H5=\`W?LOD?>Z"'&1H$]!V$&0JCLLG=JW6&-EB` M/R@1`+`$1FJ!/W""W]#< M&1'FEAD&@OPMA=]580"@7D+QC"1S`WAR^"E00AW@`8C,^8TIA M`&H(T\Y(H5]A1I!M``FXW6]I8FZQA&34WRG6XTR[8AC&B!,PX(@@%"``XS"V M"C)&8T5>Y!T1B#(=)3?.F-(D54(A@]R8X.@1HL@J,:` M!J8;A(YYI38*KQ%JV71XA$'P,M*@S$?8RXCXI\D8APEB-T7^&`<.8HD,&:'O M'5'!"EM(J=P3>(+F-><]_HTV:&$LAF6U&()20.?E&>0],(.I.&1MV.$>SF5_ M_F?CD;4W+DW:N(=02(]/$1.+V((PF(=05`=.4!HZN(Y!X`1O8)4PH`"N.0(O M>(\W*+3S@*=Y\(=Y4.@,"`-;`,A5<`@ZO81SB`0&3(E1%EM&H(4_4`HGV(/. M3>'B!8#U8F5X7AY&X(6;'@?FC8@]R`1#SN$&?N!^!FBHCFKFB$5FA)41G#BV MZA`O<(R/#9A)<(?6:I*D4A@1$(T$_+"4G)?%X(0!(,:7P+6CE`!7J00O\"L> MX`&#LJ.?Q9UQ[I8_:`-+H`4S>(+^%2#J'?C=/=#?4A@"&<;BHX:&/TB`.!#L M)Q`%'$B.(QB"7#CD!KZ"XY5JT`YMNXCDJIZC(P&6>2((@7&+=/F5,/"$F.R! MR?"I+<",-T"22.`!M!L,]C%`O?*(1R")8,`?#>J(`!^>HWQ[BK27@# MQF=T` M"T(Q`Y$1@AUH`UYP`WC=/*2\T9 M"F1YDWGPAJ=!3&\8@&\($IB:'9G^=$I;`">0XD,I!6>XZ57^;W5LU_,FS)CW M?J42T[\E&Z3[AIL0L11>S,L%(I+7N`1)X$#0R9`%>;R,B;&+()8%'`'OZG2: M"'-%6H#.M186)N=L'WBIII+ORAMJP"*!D"]@(:`![X$3\Q[:-#E*2V/F`0)L"1VCP0Z4+ES@`UWP,'2$J3Y,H(W()A(F!.+GWBD*1;: MXD&E]XR8$&ZX$>V(8*B,PY.H9SP/JG M>8-S"(.U@09@4GMQ==$F\))K(-?^TSF"#-B&:[B&8/J9!>@!+[0U2;@&;\C' M;S@'2;`&.HX(?L\??Q>9@"][SH]JEM792:N$A9C$8!"(.1H,9H<&V%D(T#D6 MA5"'4`<:G;?\<8!]S5$'J&AYKW]YY[864RM^SA"K^BP`>@DG] M9M]]W8)VD6EEX9]^ZG>4RY>ES@ M;"!-*0;^+1XY`G-CSIT^0_8L&?0GT:)&CR)-JA2E2I8NERK=LX*F0#-[GDH\ M,D)=LH14I+,CV*Y?QQI=!18A@R,+;BIL^W;A6[AT&1Q\.W9!)84C&'15 MM!:A7FA:X;HU/!=:);1?H9D=,=:QPL(C!D-;0!EDX8-N$2]VZ'8SU-*F3Z-^ MV;1E:J)[:%$%4+#B@@MOWK@[QLD=:8RAPESH/?&((FN*%-5Y00(?^)YY@=A!_MVUQ MW3WZ0;/@-R-%=UL%3:C@22BW4:#.(-V]88U7#%U0P6Y]M9:CCCOR^-!J6/4X MTC@+#'%";#91M,!*VV0V@A<#5.!<1(H<-,\`GN"(T1'IV&($A@9E8`2('N'% M$)4*><().B)0R<`(#:`S"89^18(..F_6(Y.0L$(FKDS M23HCA-)`A@O88P0Z[BQ@S0`2!$.-.P/,0Y(BUT#YUPC>[+K*5QD,8$1\9BZ` M[!89)E3;/5(&F:VVVV[T([><+;#^!R.Q[7#5<,%<(^<(5"[00Z>KCJ;89)>! MMX"RDBU`R7>$C9!EO)4+>".!$:<@W!;%(0RR3QG$M;$)>/H1$FZ]VQ%C2=-&/3&`-]0 MHX@B/!PR`">&H3N).R-00P&?P2@BZPA*7W)!7Q08AFP&!!_$PQ9-\.#))90X MMJ4(1E!`#0/SH+/%/J)NHU66#J^*D%H6']2OF;9,,JTBE82"3@_$C7#/)->` MO9!6U/1]S%H13P;--FI[IO"WDU->^4+>*E470WO856U#G6^^`"(P\!';;!,) M=@PZUX#^*-@W@Z=#3R=->&7/(Y9><$\.%S3:!.T/#A(,/?901UP#.5`PUB!- M#**(._>HH.Q!;EHSN#K2&W:!I?;H3H=!E/BNCCTY-#'6"$U80X$BRE;2!/G[ MA?^@/8Z-\(A3!ZEDA!'E*W3$\WMF8`2KX)XUT+&R_DE@&WTY0M$.P8,&4`(: MXZC$(/2G*OPUP0BIX@$=1#`)+^2D`?J;7]V@%IP2\@EA"-G2L\X1"8FE8T_N MZ(O`*K`V='`B&#EP!V$H08$<8,DPE+"&.XB7F2&ZHTP)403:],8W'`).<-=H M3O_HD8-!)`XL1^!>#KP'#4JH*11-V%LPW$&^MUDNC6KD$>;^D+('9R`#20BY M"@Y@T+EP.6,(E7FC'C\'#2"(HA""S`55Y$B11VU#>H+QPB2\U#:A"W2\8U,)60U MZ[NF_OB76VN,PQWZ6^P6M#9.?E(`'5Y`)[J,L"(1',1U?-J7/"<1"FK0(;*A M.,0;+G'^C-VB,&IHD\%/;/>;09#,X)AFZ_0P:3PO"$8%4CM"%9BA&U$*H:7L(8WC*"X M!)-T;PQ&Z12G+%^_&2:+>CX&'<@KJ%4$6E#0L"0E^N8-%*\XW_KN%J:1,@0; M#&$/4I"Q)<:QAQWL^`\S`8`3B+0`V`!`R`\O\D+VT()"+*$*3&[R(H1P$=>9 MVDWOG"(U&L`2=ZA*+"/(@3>$&N8L4NG,%KY`#RIP"1$XMH(B&$>M*KO2E!W0 M<`NXCII`&^]!8W@?.?";]%;NMV#^4$(=BH@6.IA)SDNSY$SYRZ9G[$&)$1R" M#M38PB3.$8JOJ"[HL$XUN,D"!K$G"MS:'=1X%,[1TD]9?^5U MY5Z(F^I4;,,<%.]L.;<$SLTD:)2<$REC4B7>R2^`%Q0_RFN;_"1FY4/+&-^YD%]2X(D>X0&33Z[,03PL:3+RV MYP_BC4FH8`L>;DS?IH67,S\P;>J(LV/AO/,Y%P[KI$*49Q#""2-`0P7X&:#Y M&=(56O7^T-E7'`)+*$;5O`M#5),_E)^2]!9Q&$8&#$G8C0#WI08' MSE"94!DZ-![;9`:S-,`C.-L1J$"UA8'\[8DGE!EEC)3>+$#?],`J.%A*^9T1 MAM@*=ILBU`EH)4Z9J5\G)))```M('"&4GQ'1\`M(#R M09PA/5_$=8X<)EGU6=\#6(5%N$G0V-H1\,`@T)98"$8.#$`&](SC08.:;(&% M2=,Q]$R5H`.6^,,GKH2;V0.?0,,%3(((^$EFJ-\;7(:%I4/^``6-,7'*GU6" MSF3`/EA-/15@)Z@#H<0@!:3#I!F*V2P$-2B4/QB&FR@4J52:K[P!B'W($=RB M/QP!`_"`ZBBCWWD".JC:`JC#*'G!,UZ'9-2*)+B)9.`-SD#')=P*-;C37-$, M7CS0Y64)H"SAJBA:!N#%"$P;A%5"=FW0XB67!/!`07)4QZB#ZFP#-=R#%^R# M.L04#ZB)*]J#@"A$$Q$,#S`86/#`H:DB8@1#9%T`-'"*VAP"NJE@8Q":"M## MX(@AHN&;&]+D[>G>4ND!`#C#`N0A'@H$(R@?\P'B'/7A'8G"(J`"(3;9%?"8 MEE"`+7Q#$_Q4!:C`9`2#),0'`U#^(*XQI-1UV]D9ACV$P3E8PQ$(%2=XPLS( MUSE(`AJRY2-0AO^$P1LT0!/`(E2$+:M(HDQ%--:JB&WJ1K M2`$`)!\T]*3Q_20?0M\?&A)"+(,X*&63/0"-941?/(*H.19EE.0*#<(@',0C M((P*!`-7G(DZ"*E7*,*$QN@+"R,<@V,..Q@=7<_FAY'(%4>ND.YME>8L:@AJ?X,:F2 M/F@P(&G=Z:C4><)BR89%CN8$'8S1$71"E6[HK]9DA_[$`NC!'@Z),]PAB>JAB0ZE\Q7E0L0# MB[:H-BQ!(;Q`]L6HY/1/_^S%9*P">!S!M^*/?.3)*GRK?`@'B-&-872K9YQK MN()'8T`,W;K9O2$I2'$/,Q)N+XKP,)-YQ#L4'RK]-SK MN4*@M@*--Z#1O@(LO.:$PR9&`^)/AE1"45WLOUHLNSJLX6A1O>0%N/KIR0+K MRK:AL,*$P;5!`OS!6PS!`@@!\2EK\AG1%3% MAA.\$0!8`HD"Y4%4;9!A:^-&G-M"PQZX0"E4@=`V&0(L@T/(!1I9X%`!1W0@9OH!+L8A-/6#0.EPS=12^N2DUZP;G1]QDK9A5:$;CH(QDV(16CP MA?C%RU?$[O3P!>AT;(.DA"+@!5^,!8C9;FC@!7$TK[W`#6'L!=UM1M_RBSJD M`]CTBX.8"34FS&#\E;`<;_3Z+F/82^WVH]P";ORND>":Q!#$02G@+_[J05X@ M@R50U0K^(,002,$*X&\+.,%!"#`!EX(!*\0X$-D)7*Y9E=4#6$+#-403O`<[ MC:EZ+-8"S*8[M(<[/,LU6L,V?`,(WX,(ZU#+?<.-]D^:M=<]I`_.0(PBA&80 M`6?+B9%#=$(%>,.>6<,6',=>+"0G9$"NR7#YT(,/OT$&!,H/JT,#O$\*9](9\H0>W>0-[N`<,6N+!"%/$62`GWRF\I?PO]EL3^.`S!*K-R'TWN M./`",L#%.#A#'@U!+:]F+:\R+L]1"]!$(13#(B#``^0"(]2L>:F.:\D')1R# M5KC#)31A?5V"E`8#WGS)$0B.V'7")-Q*[`;:GVE&!AT>-&"RK6!(6ZB`"'@2 M-30$`U`#JEW"C&3`-BR`5EY`&%3*JJR"K@C("*B?*II>)]C"UT'4WR@"JO4` MZR[`HU3=6O03#O6%(OB*;_U)!KA>=AG*NER`/Y2//P[`->S6"`P",UT*.AR" MHD%4!M`0AB07J0!*HFE=#\P#98"=7S:&.MC"&^R#)[S!L$E3L%1SU9E2(YE, M2!S+KN@$-8A3/%.C0@U5[`J&KK3^#43TE"E;]>2@8H!.=4QE;#!5C# MQ1[@0&RW34*H@#H0R8)FR(#=$U'I8M]+.6.@D7KE"; M/E9D^:!G5)"79$F>9:AAC)1CCP-D%R_U6`\#)(\*I`XZ?+9!?<<(>+8Z=`UQ M[HU0T:`BA.*?1>9=ZL\C\`4%-$#?Q)(G'*8UZ"AA))!!D*`#-0"1?D6I!=T6 M!;<'7,$A=()7*(L,3S+^C-L6$HYAV-VN508='$,#%%`M:4IN!!$# M"*`$-/D(J,`/)8]_6_II`/BW6%QLM"U;(7@1*8).G8-^9H#^6XB3_J"E%IW? MXQF.8&>XF^0`A4-$B*_%2$7VL"&@(E!`^!W$H]026T07C+/X8GL#%5'=:W7- MZCQ+7,B(![U!3F2`(HQV7V3`)5S">NX%*NH-";::!M<-E(NQ/4RYT>"3/O7T MGYC<)7RXE"_U"=&J#'WY"F7&?C'3XJ7Y9>B,EW/?=TH3)WPK=`:#--V#9G#" M,>#T<2;2\%1R?PQMXD=O$ M38A4PK1]C5WR@+O$TK`803KP0)D\S6FOVC4XUQL4U+>;FI27Q=A0\5OG`'A] M1;I_>"5X05>H`)^L(LKC M_DYD^K8X<&P4N*=_^HM7F6@J.04IN#L>"L^3AGOG(#^EC-`[!-$_=DR5.-*# M]*[_!7$X_4VD@^XX\2`H-4L0N[';^$I8%SK10:@^@J^J-)Q-PA&_BMD;1'-Q MVJFQW=O^XYJK]:D_U[VXET6Z`,2A8^B,4!BA"%K"$0TF7;)W)"&T(\&.'3GR M9I(_2M`J43!BQ-T(!A$C'DEG1`))!B,JH),0+!BT$1(O7+JD[N2E=",R5`A6 M8=*V(^I$3!)!H1(T"9.^13KG#6+$2J'0<3JB:,2]2==B'AETR4B#F0F/7##" ME=H]=#T@'O,9:I(WCM;0R3U"X9,DL.0; ME>01>V#%DK6GPMTD(TT6&%8TV]/8X^B.C9WX,.%*:WP548#^2&G$&Y@B:Z9Y!`>&@AFJ''D0V<>A&@*"9I@'G2'AVTF.0>]B!9J"#J% M**C@$&LBN03"F8(I:@N1`#/)"%M48@F=;1;`K2R;@J'#B$O0HX8"3N#:1J8& MSE'-G2-FNT<%=53X:ZJJKLIJJZZ^"FLL:!:@YZQ@J*&++6BH<4?)27I8902Z MH&*`AT$XJ>"LOC+;D\\^_?P3T$#YK(0R?T03%%'`]L#!,\]..'2TTHI+:+UO M6HMD)D4J">:P!T9,BT[EJ@4[``K82]\@K-=;UO"E.1!$NJ(2. M1YIHXH)2,\`JN'.6725`B`@T8I`PXURP00]C5$>1!:Q1AYJ!4BIUA"8,ZO#! M>^J$L0>21J``1=R@.:8D3FA+:`&JA,IMI".(M"HB!BIIB)*HB\;P)6F_M+AP8NU5CEBODX:J.N( M$0ZI:X&.7*7DMD2EGIKJJJU&E-#*KD9T'$L:[8R7T!:CLS3GU#FG@IFNP;22 M@R[QHI+^(\3C9($1VDY'OQ',FJ0!'I)NP*H%DA6AO+;SHT1AB%KU!%;%84XZ M&`D0CXX'NJ[!ZB!;=JYDH#?LYL&>2=#QY`@>Q+MB=2Y!!UWJ.%) M]/]&DE"XG1*BI@$O8H:&A^#XGDD=6]"A@(>F%W"'=),FP90D'EJ28%*RB#1" MG6`^ZO\C%.E1OR+!`VK88AL\&$@8U*$."O@E(M20V$QXH!;")6UOC"/)*K8Q M`/%-N@2#$JUJPM&NH:>MO1"&,92AU;)FJ!G^\FDS7P,`:""5 MF'1P(A+J2`A6&H"I<;RA`L?PA"?>\!^(4<`6WJ"`)^YQ#`I1(@>2D$0HW%%% M2=1(4W;:QCT\08%O#$)A':*`/R3QC9BH8(V2Z($7[F$-6Z0I(NEX@R3\<0PO M6&,;DJ"01!I@BS=,L0*2>$-,+K!'?[CC2D-\A"TD(8%'8"4#YQ"!%XXPJU(E MJ0%8L49R%.$)2DJ@":9JB3>"`<%27<-ST%#'/;3XAB[B*0/$:X`DPN`.>KCC M`NJBY1;3`8U5].`<\PAFAQ(IB1P(L4/;>`,=$J*.+$IB&\5,607"H$1/;($" M"CE:;X8XB$#.(Y0EH8`6/;%+27C^8CF1:$!_[)&.;GIB&X\XC79JMZR(*((> MY_3$..@0"BW>HX''T&(D@$>6"X3!"!5X@Q&V$0QU^&,2X)R$)`91B0M(P@C6 M@(:U'O&A--X0I2E5Z4H%4\,>LG0QB]+AHQZ#0HMN4(B*L!`EVAF,,''D""OT MQ++495$5!",==*`#O4JR`'LTP!/V$!-@^F\D<=H@18#Z4(H_9/0PW<"$G<"E>ZOC48IH+&(R9GHBUI- MI5+*!J0R*E55`24:VD!H,A:LT'3L7/NG@BI!$T[J@"H]U)$47WTC#*Y,"%[) M2@FYFK;^?T>@!&('\9I>/54=LH-&)Q#[%])"MK*5/2HT2Z*"W^&D5Q.AAZD& M(54QT:$)$AG'(SJ;#GK`%+K1E>X+73K=Q71-AV%[*6(L<@31&C,W\3DI1\1; M$HL,K;LGK=OR!(->])+%N^D]J7R[&YCU\DPBLDOC>2T2D??^I;X`CB]NXA88 M=,ZDO_+]"YQ8!^!5_#>_43GOT/P;X*$]N+\EB4]:96:+)N`WOR'.#7UE-RD. MBXF]$6E:8/BKW_=>&,(&BV]3(0:D_!7X"/FS[HYYW&/(5-?'A,GAUW@89"-O M3;61F&N0!7^2/TIE\E<9C,; MNP>#V<,=B/``!(A#&U5X M0"G`ANIDOQO>\98W2@FEK#DC9LB=$07$L)R`/9Q`"!$9@AG6O`)<>QL`;=A# M*0*N*#Z401Q+T,;$M;&$*@#`X//^UOC&.=YQ0+W:=K+&@1Y@@`-+`R!LT%BS M%/Y@:B#4&@:\.`$`&(%K:%B:Y2Y']1YLDP6_4C7YVNK,X/KB""'K_[G>/\_A@'Q&+)Q>S M`&0,80]_8!0`=O`'*70&!BT'@!"*LX`_"('FH5G`Y0&0>-&A5%I&-("(E-`QZA7`W;@P(-".95U+'4_C4TO,$(_FL6$$F2 MU(VQ?E'^A/%A,AB8-#`P#5RJ8$S2A.].MPDN+'X#@W$!W*O#DW"B1/#A.0(A MCK]_YNXJJ;3O M`H)A'*;/M"B!#A#B^,C/`:E).8R/)"C0IDY*$2Y)(1RH`>C!0IROFOZ/_JH* M\"X@^)*K>(:"^G!/)@CC^OXO,+[O\*ZF$KQAHX(A5=8N5Z!A"-@-&?[@"3!/ M\TY@"(9PS6IN'/8`")20,Y@P(O;@!7RN]8)N"1Z@!=P-&G[H'"3APTJ%37H/ M&M[@&_PE$D(AF.IE$+S!%MRA"=SA&T(A'?+C'-`&^OQB2NH:]4X!Y$ MX!RXZ!Z\P0@>PE3&H0)LP1K8,!LJH'A&$6UN"204H0+.X1IRP`N\81L.X:3L M81OVT!-T;!C]H0$PS9@6<#`4067VIZ\<@S2B1!&\80O\I0)"H41*A1JVH#E, M)!3F\!A(\1LH8!L*I@DD()E$<(0J(*$T:0OX9LJX!YXAAH0\J>"X1OVT(H`PZ,X@1/@YQXD:GAFB101 MTA9<40<3X@(D`"1L9##X;P>1+!C^)"$HZH7Q&&/T`$`/H&$/3*WT-*_T.N\) M0V/(3*\SI&!29O(!6&\+*^X*7,'=Z`1AC"`,)HL.[Y@%F!(-L/F(>2N("YL$( M1$"O!,,;PL"?H$X;U2Y1>$)W9F4!QD$$T,$+]J$2%N`-]$F6;,$(?B9ICH`3 ME&!B`#=(T'M@!4\&@$/`&D`G+J%.$-.M%$ M*L`TTD<"8!,Q2$-`1B`2KH$:DH82YF$;2\4?YL&5CJ`"TF$?]N81]B$8WD!- MJ*('QJ+^7Y)C!`8!5,1R`3AA`+X!(E1'-2H`/ZC!($?@3$+!7=X@!WA@'%X& M1-QG&[9@=Z3G$GR$)*CA4]AES!;@4W0D*L\FEX;B&@QS'^B@,)&"Z5X&/EJ2 M:*")2ZA!K?. M.<1K>?*GOSC,2[<4-FH0OMQ43+:!0\A"7H:GF-(!C8[`2"/^`59*)@0<0QB%D8@LF(4,`S`OXPR$@0A'N(1(>1ND03.P@@A/FP6^F2DS` M]$I5("H+#*C@].T2\\3(8GK$(A//(3F:9)E6(CC`)")>XP@ZX2/B9Q#&@6;P M2'`:P"+NDW3BA"]6H2DG"D+BIIV*0P5&,B%4P!^<)Q(&P#RCHQ+287@4XA"$ M@SA4+%F&0V%6X:*J9U1\Q1-R"6`@Q"("!,3PKQ)P!SY,)3TFA1HHXS(1(BF. M`.X<5%""2B4E@0)2=3$23B=%U$/%!/2@<"='M"=-3!06`>A4M`N_L(=((QVF M8W[NJ.%I,<=L0CV%9*.`8K($>0L$;T`@:@.(:*B`Y@B$2$%(B MFN`8CJ$3MH`3`I8CCB42W@`ZJ-9JL=8Z).(/(^$;A,AB]C%*)"(=IJ4D*"%@ M]N$>!BDV/L)`24*;Y.4R+R`DB*@A@HD:2&A?(*J$!*B`2&.8JO.`;O*`)O&&1<&,E M%G60EN("8]K-,(7A4BL@2/"*4!?D18C^!,QD-#K$$1 M1-((#+7^`19O!+:!-0^F-KAR$N;4JQ)"7+=@-D).93^B6TU$*[1%86Y/(N3E M'O9!$<)@`+ZQ)-0A:MT!09Z!$BK5(7C@$-3! M"[#T*B0@=U_&('IG`/K&$]`AHS)@`+;!+ZSA+"B`FB2A`IH`7H+A$@;@D(K$ MIZR3`M1A1.A@`?PG=Q`5<<8A#-Y`'08@;=1!$B+!$P8@2GC^0GD\2;4>)`>: M8!M$8V02!L#.MR@R@`XX87C\]A+:Y0+\H7?W2WE9IH460#\$5R)"9Q*02C6* M:5'1Z7$GH;4PQ#+">:^!Z.0`2<#`1KD09%O428@_^H*`0A'(+%R$.!.-@\#E]BJ0)5IF0'!-4 MYB$F9F-P`0R&PT1CX(*&_?*&ARB'!R,KZ.!DCT$1OJ%RL'0$.F$`_($'0N%( MJ4$%D(,'/L4N3P(4J2&$+J=R/.@"!B`@H3541N!!/&$?%*1&'D14>)0X'D0L M289!.`%)288"E%H"AD9.?VJ/5Z,"+H=?-E=I_50@PTP$(FHZ&$21OX$_PB`X M2T(_Y@EET^&:[T.!CT(,N/W-: M^R8X.)4"4*8DN'AB)(("(`I4)""V$@(8"21CA3E7P\28%0*9[[,"O$$7[2%_ MQF4A0&7^,:69+D+BHNQ!@;@UH!5A>.C@2=PWG)L@<1S&'S0DN"3508P@%+P@ M#,+@'LB*4-#!/%WF>"C`/G@`=QAD`9!X0(6#<]1[5`1::A:@`=S9B<,@%#)@ MB3I!W)!A\T1!%(1`%(H#](Z0SU[.,O8`]$`C(M;LHI_`YO9`#0#`@Y>@#%Y@ M]DQDKBW"'L[!""2A(LB"`=S!%F`D;42DICUF2'&Z$GQXL3%Q-F(6'68V,$;` M"T#;823@'L1R.EH((H+/'0RX.7C4$Z9Z*Q2A"3*B6**\A;(#=S/@#4)!IS!J MN-AZ!"AAR(\!+%3Z009!$0H$G]TT6EPZ&'$]T M0F]L8B<^A@(U?2'1X1NPN4>H(6AB^Y*#HC@G=1Y@Y!M@IPFV8$@DN89SIK>E M`CJ/&7_OLQ.V-9;#1#]6XDHOP<-.XY4WTQR31BN:=U\7(@>0:BG"0`7\(KL3 M!R,:E7?N@2)#0;OEY3"70RY,9"!"H3@XP3!'8!S@YQ#H?"80-"D2MY!6([_U M.U':_0T>Q#M48Q($4,4,_&L4;O1*H046P!+V+2*<@-TLH0G%!,L"_@0('F(, M'@!RH>*X4!MR80=T6(0/(O'@7;/^NA,:X&(>$L0H]I)4@@1EQT)P@B'*:=6& MO[S,SSPL1X#<#Q]>BHA M`;,<\--&0>4]4.*&#LSH#>8A#/[8OGC!#.)?_F%@HYT@`7;`#$A""FA!_GDA MX1<`()PD:&,&FD&#"X0`6'AB$98DVL0]R&5FS\&+!D=0&+0`&H,1QP9\&Z'H MC:(%BJ`MD,1I1#!)Z-SQ2`G-I:(C%RX9:3`"VI$%W]2MZC$@$H^#(]2IPPA- MT;Q)#2H99"!ATK&>T'ADL-D$[1K1IKPH##^8,L(R)V2,AZD M"+)DN!)6=:P$M\>((VJWN<-Z$/6U2?=(+F"PQ6>%`:&H-8768U*HCL%>KZ99 MLX&12_:HX37BK6OK0^H6T+ET*5W-;Y,D^$Q'72GU"SS<%?YY:(`71<>#C$--,(?PL$`E(W@S MB2T7'3&(3IY(Y=$(WZ#3@U2*C."./4<,T$-,/'0R"2<\0+G^&C104L"#.F$8`1(Z%8S``%-XYJGGGGSV MZ>>?@`8JZ*"$EG6:(HCJN<`>C#;JW*+06'31HHPZIY)%DAJTAQD+=0I`+LLL M$T\;SF2*)S4Y\-1:#V_T=,TVE(39R35-E/C(.>>D,T)'#60`326#3(*.%R@I M)/QKD>DL\4%(X3"$Z(C!`U5F`WT3)8BXX32*DZV M1`:A.I<,8,UI=)A\E7&39$"W3U>.U<`Y7.]S&R<74'M,B5!^DX[5U]BCNC>$ MEF_^^>BGK[[Z=_HYSOOP_QD_GPLX48JG`)0BQ3A#*+*'I7C^&D0HOD&'UM#! M&BG+``6.<0]K5`!R"`G&-SAQ#"]8PQTLHD,&WO"&2%C#&L?@Q'#"8@U.?.,> M]\C`33"2#G=P<`OV&)`+WU`!:V0@`][8PO.@T80*Y"`8"TA'`\+2B0IPT!KJ MH(,$;.$)"D@B%(IH`@?O<809-H$"'"3+*K9PCF/\J@%AD$0%U%&)1W#0'5)\ M@Q,QK`.-"QQ#D62[Z"4_.,%'WH0!Z&2@$3.`-$0JY2$^L&B(]5:(2._1J5[(*0)5\ MSB>M\6K^T5)RF)NPZ$$'64!7Y#K7KAR!`2>A&UY5HJ&PE*@I@M708%72E`5\ M[J^!)0Z>SBK8L")E`92P:IB>1UF2G;6K:&6*;6)]?BZ0[+$EK8\I5H MK3'(*BC&D\0PY329S1?=+%NTSOK$JW0+TUMKDBR>+H"[#_(/A(X+5T5(1:JH MK6MX4W+87Z&6O4G-KW[WR]_^XFE33!5"RHY:7XS0%[][.C"AVN??!CNX:(=E M\(,O(N'T(3A/(VB`-Y9[8?-U6%#4R$`D%$JR#S.EPB=&+HO^4'P0R4[XQ3". ML8SS6[_[X4\*;9VQCG?,XQ[[^"`?:4`Q?[PG"SF/R$A.LI*7[-^EXF\'>X`J MDZ=,Y2I;.:_J<#&3U7+E+GOYRTH&,/X$#.8RF_G,:"[J>-/,YC:[>5`U9BJ. MWTSG.MOYSGC.LYZ3[&1/543*>PZTH`=-Z$(;&L]B]A29#\WH1COZT9".]'X7 MX`RF`F#.DLZTIC?-Z4X?>@^,8.J?/4WJ4IOZU*A.\AZ>$.`LZV0[^]G0CO:.;8WK M9DO[VMC.MK;3%^QA`WK;X`ZWN,?^?9%QK+K5Y$ZWNM?M;+WN`Q*WQA\,K,WN M>MO[WI+>U1!,0A;O"& M2_S@%W=XPR>.$(TC_.!W77C&,3YRBA?\X1L7^<0A0C[K4IT[UJEO] MZEC/NM:WSO6N>_WK8`^[V,<>]F\[O:@I:X,0A``$G=/"!@DP@W/V\/8$`*$K M*=M!&U9P]SPQ(A<(T,82!B^.I"]DWI.2`@YP@`P8.&$(C#W[I*%:<,HW'2/( MH`4R%L_^^I7S_K6NW[UO#"[Y-<7!T\E(&4` M1L80`&`#W'-*][SOR#@L48H]``$`+0`@J`LQ>&TXW_E+*`0`VA!PA,``"$_( M_A-H@0,I0-[$L\=3SO^'D05(00@)X(4T<+`#(`RA!8P8PJ.@L7ED..'^^,^_ M_O?/__[[__\`&(`".(`$6(`&>(`(F(`*>(`X('OA9SY[L`.,X`2\$&].L`>5 M=@+CL%3(L`=.```:R(%_P"DV@('W0PN9L@=JD`M+\'PNZ'RY`$1,,03W)P6; M1PO91PLN('\/&"@+``,K(`JBL`*8IBF\$`0@`EK"!??@'"L$(%J$'`+`"?C4$N5`%+^B" MT:<&U9=7%3<$BH>#M``#!=-<&%&@#R+!Y%J%XO"`% M3G"%6>B*L>B&9#B+M'B+N)B&-Y"+O-B+OKB%3@"'FX@^PK<`R`""0[`'-@"" M@@@`0J",@-B,`H:(C-`1"A&(T&!N0,!\6/"(T'<%AAA5T#`$.("#PCB,>3(. M?X`#3R`*'?AM/V@#C&`&9F!W>F?^`RO0@2KA!$_@#%:(A:X(`]SW>J;'"[;X MBPB9D%NXBPK9A0S9D+T8C`Z(CH-R;@`'#0H1@AF)DP`,NX=!X)5>:6 M``_0@MXH>`@@#4+')TZ`@[R@912I*0G@C%`F>VV``T.P`\X``V8P#KSP!'GU MDED(BZZHDW^0E$JYE$S9E$[YE-T'D5(YE519E;68?\!XCC-9/GL@"B<`>2/I MD1RID8`(#N`0/0'UPY@PXF&NGB1!OUP(XT&Q2)GOU0YC_F(6'F90H<`9G\`-_D`"9 MMP"\H'ES&)1[@(9F;<(:?V9D*>0M2N9[L^85.``1$T`KV M60:9`)U:69SR8PF\("E[T`(=J1!"\`<"*IL*(0HILRA_(`4+@6E[T`8G&9=+ MD`M<0&_B!P-/P`O\&2D)D`".AZ'BYP3.:931N0<=8`JJ8`5_,`PP$(I2\`>9 M%XQ1*:,ZZ0S;MWC9!P,[@`Q)Z0*N&)]@")]"6J12Z0RC``_^M;"DM0`/+Z"? MIMFAHK4"M/`'X^A4>MB,"?`'QX>@TRD$-V"B2+D'5O`*[<`-=?@$-2BC4O`$,"`%;?<'4$<+5IB3 M;8!]4D`+O/"C06JDE%JIF^D,-B`+,M`%7?`%G_"D1QFE4GH0$0@`HJ`'0F`) MU#<$I5`*R:@04K`'K.JJ>P"K3/('M```C"!:<7`%2]"-D)@$N7`#(IHG[%B$ MI\D+'&H^]4,+A:F?B/D'I.``!&`#7(JKVEF.?V`#WL<(21F*RHI]D,I]=PD$ MCME][FFIZKJN#LF+SE`.JF`'\EK^"Y\*I:-*/W:(/\FIG4WU@3N`>[GJK`#P MKP;A#`EP`G+7)LY[ILWJ[ MMUL(M$)+M/4:JDB[)XU2N)/R/S]G<*:R*&T%C?@3#S;0`BYP>0MX*K>@>[Q-*;JDN[S,^X5^*[1%:Z^O^V`I M8PE,)86B*BBZ>[%;V8D#@9W!BQ!$V;G0BKSFRY0WVYFH2XL/N;[-VXL,J;J` M:[3[.;W\Y;B>4H+9J[V6JY?UPWG$22C-Z@2;4+Q).5M`%&6(RK(=F)1:J)0I M`[J7Z;[OJXNE6\'N6@Y!N[J!>[3VZU^TBS_8:%3;&[[W%J=M`+Z;^ZQ'B9C* MR`V.L`-#\`1W^;D']#+,3^1OQ_-Z!_FW`# M0US$2>P$MU#$^R>+`%C$MT#`58S%_7?%1\S%_'?%FR#%!.C$]_?$^.?%98Q_ M8JS%_E?$0RP%14S%:9R%\ENT]>"Z'\Q?7*NO9JL^)7R:Q@@$.[`#W*MSB'LI MD9(I=1J,0(")9N#"W"`(04`&0^`!7`H-O(`#,`L-A`H-3UB.@LQ^M'"R38F) M`B``4'#*`O`$IYS*J;S*K*S*LOS*J4P+LHS*MXS+LAS+JAS+M+S*KZS*P;S+ MM0P+PYS+JWS*K,S+RMS*SAS,K\S,N0P%P6S,N$S-M_S+L>S+R,S*.,C+KKS+ MMJS*;;K,+[`"\=F'K`8Q#D#`"SA*@T*) M#+R`=R3J#.7HN7O`#;I0!RF@"%4*J/P#!`UJC)FXSE`8E6;P#$X)I!B\T47J M##]`"AW0`7X0!T#@!EKH!AK\M]&KA?7KSD65FDPUPO/.7[!\K@"+NP`W\0E%+`R8KZ!\[0R/S(?3"`#$\P M#NP(L\D+QQS]U9L9"T#P"4Q:"V5`*EI8QY_:NA[LTDF%B'R\OP),TUN9L8S0 MHP!$::)`PVVP`_QL`U.(#(1<#P;\F'KEF"8+P93IF(J=E"?[V)8I!>G* MBQ3,F9?^O8;.L-EN@+F;.<5I;0,$T`4.X`!?8`QH+05J3;]R[=85V09,)<]( M1<\U;09W+8H8,02TX(XPT`+IQPA`8`922]#]^)PM?+[(O8Z36JF97:E.X`P[ M8`/2+0U`X(]5Z02A*9K=%[_P^@KSJ@&I_;SS*[VN350P+<*M3:=T39'J*(%F M4+;EYP1Q4+54:@:B@`,ML`)O2M0L[`3(\`+(X`*I*."I6.`&?N`(GN`%#JI@ M396FFX7@H`^U(.%ET`+6?8:@[87PZ='X8)^M4`8\F=8IO;K@;=VK3=[E/52U M%]`*B:/^&L`">(`']#H, M%UZ&;L`%HCF:05K985@/3T#6]ED+)2[B&TRT5Z[:(S[>>)SBW`;;\=S':.?B MP[@`M"`$+6`#0C"G<$:4!0R06\C%-W#%7"R+9*S%3YSGZ?G&H[N9#/GC/HNC M#N#=K_`+\)``2:Z%0WS%7>@$F4`*]ED"9[WH&8ZI#K"IG;KE=_$7;W>L,J?BF`DR4Q@WD:`CE'(VCOV`'[6`')0`/2,Z%]X<(OE[G MP,@+95`+5:[K2>X,3*[=F(GE\FH'5A[>7?[L)A[MH9[>HZXG*^XI_VGM<[V[ M_$ERK0ZW>%ND@AZ&LH[!LHZC!/#^"C+P"KF^ZUKH!%R0"!W`#AU`!"&NVD!` M`';0!3+0"ENNVK0@Z?<)[1OL[)Z>Y=+.[!S,VM=^/A'*5(K87ZC^\`-,OK#. MO.7>A>K.[NZN`?#NWT2@`4Q:!HJ>UF"P[NV>ZZG-CTK:X58.[ZJ+\`:OT@FO MTM7^\%Q9ZIY2"JP^:68.YG6*\1E?]&38\2MO[&D-!,5`VETP\C*?\A[/\M.N MJ9QZVC4O`S1?]3:?]5[>UCHO*-G>*4[%[>KM[6&_CX#ZZCZ[\:1KNIL=]Q=. MZU.O]*HM]79PZ';O#%*_\IP^#$'[W5F_]0ROY5Z_TF"?]GQ2DA)OPF=?R!9/ MHBR>S_5:O_!^`0MT`+QYBEEWV`5?^V+S./`#];. M(`!#C@C*E6*%`/P$L"*E2:(8%\!X`F-H4:9-G3Z%&E7^JL8%3@0XV00# M1T2#7;U^!1M6[%BR919M6K=I83QR\LO/JES$_7)V!(?!*QJL2\!(4E)(* MKUZ^\(8!3G4G[]X2&@X;1*A0AAV!CZ6X26A'LT""!C%+;C@0\.>%#1]RI3A5 M]6K6K4,N`")$3XLA0_<@8[2CA3/;N'77OFA&%!!&0#8>@2:JT!+FS:OD`G"" MM^N.1Y,NI9Y=^W;NKZU&A(',F1/RY_7KV[=V_AQ]?OGQG`GXMM%." M[G@G0^P3;FR8(6$(;)Y]L$H`G]C@11>N44C%++;>L+B4OO[RH*EK(@X$6 M',Y$,TTUUV2S33??A#-..>>DLTXVY4"&BSSU/#,39/A@T)AX7#CS3P8UL`&9 M0GJN2R5EM+V@,'(<@3XJ8?@)ACV&*.4$ M6O?@(Y^_%-U_^??<]$P8SR@&XA3;Z-!1`00GU$]!)$^7%3TD9@X=AAP^M-!->D,'T M0E1YN;C4R4[EU$^/*=M8Y%8Y_$2-5&6EM5R7RSUJG#WV8';'/YSX"9D_VGBQ MJIQW?G&/(@%HX0]G`+!$HV7$R;9I;1;Q0USNPGVY:JM)RC6.-FA9P8SBG%E! M""F\=((6*6A!1KSYUF:[;;??AML)9W;XHA:[X8F'/_]^,5@4O?^#6$`"!6`0 M'@<)7'#2P_NS\&,*^U,&5`TR)##$#C4$S:$1G:C'Q*L_KS6EBL8Y`0`<_GCB M9YY+&8(6U0$HQ9DA@`(B=5J^A68$+I9S.MLDEE$G2ZI!)[[^^*/T,-&9%FQH M`0A>S$2R*C-X<4(KKM;"/GOMM^=^^[+U(0`/%DZMRZ"V^&:,+KL&8\PQQ-@O MS+*["K>,-,?EWW#"SBZS7#3/+#^-05)3/`*FR&=Z4`G/`*`S!4JA6`L$&@1I M40J@3*E*>X`"[WKG)'$LHV530PJ6BK(`$I*0*B4<80FEIL("WHH6HH"&&6!0 M$$;0`GK0.!L0R+25[O70AS\$8EKJD;BXS*5\!P$<7]0'&?CU17Y--`Q@Y@>@ M*$(F?YR1XA7]=Y#^[2\RFC$-1"0RP!:6T34R,X.P%K`'!3+P)U)((P3;N`#4 M`44/Z(+)#IBT00X2(7C@"J'41.+^A+3!P)`8&8<4D!$>&`S!)/):I"%I14A& M.L.,PH/!;';`""FT@1%/8(38R#8F*5@OB*<$RPU0J3U5]C`5]K%#._*SQ(-` M`7U*/*(SGG!+)TH1BD\\E!X4H46D\`3/$64( MO'CG$W"0$5WBP)'1-*!XAB"1<2C%73'Z3BEYN$J&^K"5#15B$O632XG24I=Y M:<>!@#FIC68T0%F4'#(OI,R0@M158IS(,P&Z4JR)(@'1$]KK2C&.H;EQIC.R MP1\6((K^9KT+$=;BXQ)R<3MUQM,DUGE>O+`S*T%ZYYWP7(J,\,C2[IC0JC^* M:MF<<`M30M2K$'TH0V-148H&*I>):U]'X^=+^IGTF&[5GUM#(U*4,=.95,4K M2796-(L`H5VOTX//Y`@`/0`-""3$0)/IE3ELC:Q M;4F\)9'J*BY+SXNDURB)3)L3/N)>9,@(L_O\\%0M@F3Q6&2@YAG'>2RI-P^/ M1$S@^:^`UQ)6,6O/&;Q(@1G,L`,=&F2("X8,;"&3.(^Z+\)IM2W$<%N9"?N6 M0WX.(W#)V&72RNBIF.WQ`H:P@QT\(:J+;O2[H$&+-NR@#5)V;XAS4HA"+(,/ MXQ@!EWY,$AEMXEF8?4*/C8Q0*/C^\\SI;2J3%T!3&Q)YOC]J77KGB0R+(".? M4H!&.Y_P!"./@V6$]LZ8;M#5KY`YMY.@2E@T8V7M@&ZS"P)=3DKFY0R):VKM1,JD7`KNQ./.$AU M2BZ++C'1XKP_:B1XX_UE_Z(V+=".=LS)4CTBA(\%K?B$@@VF\_2=]<&]C+!' MJVCN8*+;Z+Q="(4S_-N[QMOI4ME#'%TDA)FI'(3K'"''#6W#67%VLR8_4>NP MGB1%DHW^X5KW-5./`G;W0L'D/X+O$]"E`EX_O;W?X6J84RESOG//"5Q@!UQ> MT86<WF[M*SQJ4;1J-,_EGJ*>C[YT"U.>W14.8S,Y;'?.5Q9G(2X%NE1: M5*O;A.-?M^&9_ME.,UT$XR>GBL5C!`.WUPN/M*:%[(8`PI9V+ M+5X:NLC3OJ*[L/'3HG5300U[M]%C0/23F=0)L>1ZF8,3B5O[$=;+/WBY/W7! MK&?:/^P8A_G[OR#$+X1ZITYQI,O"@1Z+0812-N2+P"H4"R=(@$^H!7T0"&XS M"`V<#.KS@U:*A1#L.:YXI0_DH0G<:FRHY$=SC-4&T(>!XF7;I0ZBH MBJO(N[CQQ$\$1?E`A)H3'YSS`S((R$"_##0NKA" MM)HBG(ZI22@IX`5&&L`!C*1(ZL>`%,B!)$A^]$=#`LB"),B$5,B&',!,"+RX M(+QX>$CI"\.<"P]DD`(@2+",W$BS\D@U*)QR4"2-%,E)(()H6"0[K,;.FT%LM,&J@1=RK*PG+#B+ M>)X3>3CZ4SAB4RF:2<2,6`5?FXZ',Z\Q@L*HI+A>D[M,1)%&O,>F4"%^NS?< M@1?RP*?^SYJ_N)3+N:3+NK3+N\3+O-1+O>0%,+!(.Z"^>'@!KO/+511,KGL8 M)3I,DTM,_5A,7I"'0Y&&3."Z-O@Y#9C,RFP4RJ2%3!B94[$!SO1,4#&&T+0A MS^Q)T!3-1$C-3^"#YQE,!AA*/'0&/00*/K0:1;.ALR2)=7DG)V@9W52!,*D' MDQL0MMN(1')$];J(,7F7LG&G83.J2;M*083!6L$]WCRJ5&"$-MA)&.`%&W`& M,T@`J"R;5U.;4%3/]60;9P@&2`B&8$@0N4$$=MC`4R2/>JC/5<1/)X`$LOH; MOED\/PC07!RRQ`:LT2S['-Q;1Z;8 M`UJ(@S/A!4-(@$W2#1Q`DCV8.(U\0"N,.6?P``M,!$:``6E3Q;T0PU:Z!2[` M@V:XR#$TG^R;**YH"[-"0RCZ"W+[*#<[-Z2;D/J!P_])IOVQG_*3`J'44&0K MRAHDRRPI0B([*A;2/_VK+T$%5)!(0JI`5(/#KT45N?FK4:)(@!I!AJT9@A8( M#R,-MD@Y%RJT0F>;MB"*!?/P"B<`@VOC0@TH`Q<`+L#C4L"L/HG04OXTO.LC M4S3EOEXLP>W;,S\+ORYJMSJ\SCO^W:\\Q,;I1$K6HX@]%5:14,"T<=9G?=:X M#%$@\/=^M?,H\9E138.=9'J"M9;B4J3 M4S)E-5B;@+AAH]B*';;:F[]I)8D8([8=4!3:`((V@(GZ`#.7$U>&<@(7\`.[ M<8@%6M6('#QC^`)X_3MV:%7"\U)8M-"'$BB!4YG9EVU5!Y!9FJU2.V"#5ZU96;U7$?S;,S3:?L"F>6AO@W#NWU9_FPE,'15G@O:P+W=<..E6UU3HFT0I`58 MS%OTPA`4*A;VD&07'VNL4ZH'8.VU8S\U8T/4R!S19`/M4M3A=M'"" M_0S#+YC;>*U;\<5;>>59OJW7VA53Q`/:,)VS0]E7WD50I*T\\5M:8#5>XN82]J=A$)U@VTBU=:@-?P#3?V'W^W?%U73O`67K] MRYXUG^M3P\(Y4]\M7(X"7L1MQE]]P0+.J\AUDL98M6: M8['HW@%#A#Q&A'(E8GF5X"7V8R4^7[_564*.Q=P]9/C571*VU2LVJ>#]5Q/^ MLRU.834VHQ.)J1"C6C/:O7<2CS2VY.I@8\^EI^BM#NQ-OCM>B[FY`G9@!R*( M@W/IX[J%7?*MX/.M6_4-Y"?VX"G^;CQ^Q=7YS6(V'5Y)+K_-"^44$B298`EE MK0B44`1G*!W)->4MZ5/GK.;-G=XV=F&G^+(&SEX?/@LLA`>6U89DQI6!<@9\HQ+Q M0.AQ4&B/^""948<4$(5E@(X0$^,R`CE8*XEQ0%&F4*EQ8$[6&`+K]>91ULM2 M;HTOZ\14/J7O)8(N@&GJ.V+@4F?Q16+T%60*3M\CHMUXAN)Z3KP!%5I&]EWZ M=<,4Y-5_5FHN)F@@`R?8V0';X(4X>`)1:`.IIFJK]A(^'K400+/0UNG!=B$)90*1:O16M-.U^#*,H[.,J;8N0QL MP?X.<"YLL7`#1("!//:*++79R>@"QI8"\YX^UHT(]K[E]V;BR5[?*_U",*6E M,9WBW@UFVZHS_)$<`$_:T?!5.&6Z.NWK4*X*1I`9UP&`Y-K^@R#9@3^8$6G9 M`S`>DNL:!R5)@/[#`1LX@21!AC+0!N[*%G&(@P0/G8E3<>O(/_BS(1KKO^)N M"NB]B+/9[NQH%P/C\1Z'SB?[D?`ZOO1DSR+7,C-HA20G`DM0FU@HXLEH!_%M M\IK^@BEW["HG$75F1?)PQ03CCT0V!E%HQ;TQ4`4)I@2!!'Q>'&$,J0>) M'`C]D/Z)4`O5'/X8;=+>"*U5B5Z)K'&(`YL!,:6P!"/Y@\02%FC0F9GY@Q7( MJ8Q8AL;:(&ZY`P\E(.NXRLI"BA=G"F2(<2)\[GGB315'2T9-PL_*<5RQ-ZPR M6S(YM!R&]5C/V`0H9[LYY^FQH<+^1&_Q58/!I`5=_V,UP"Q@5^)>SW4GCH?Y M\TN]<-5DUTR#>4S+A':PE?;VD8;+X@5IK[-K?_;VL0%L_\S2Y`5ZX85P_W9R M9TV-.7>32W>4V8'/TO,16JXG^(.:X1$0D[N?X!%$=^VE.!K;#A-D**?'N@(; M:$KBX49#W?1P7*^K"O(D@88<\70HB"=0#O(<@7BH-`HIH!>7>!=0%IV'-PJ' M%Y>0CU[<2_62F.%GR=0L^\J%(&9=X'S MQF#Q'3@8B(:@;^\O*/JC#V29S83W0OHN%>\I=0$G]H.IEP(P2#"L;R*ZF/H; M`(*1K![^&+B!DX28!!C[LF?)M(=)M#>D&]`BMR=[G!0(N;\!GG05`2@E1,CS M>.^($[!P$+OWGS"#U;891#\23'Z"$&<)/3+QID$%!$BG,?Y#31_$*?ET=7%6&$"D2]U'2"REE5G1B%_X?L$A9U6OB5`49+!$ABXD'.(8 M=L$(K5!)TB<*6DO@HA!K[Q2"&`,"L!&E'RD;\#0E(W?^@Y`&4X"+Q3[B>@#& M)X\E\RV([[URFE7G6H;GPDM%R28/>P[3:1/SND#__ZCBQPN08A1A+VK08EY< MT-[B:1QHOS^)Q,(!$A)\"@<(``#,2!'8Y@\.@3OV0&NX1XC^C3\-&U:R@6") MMHP:-:)"L&+!Q)`B1Y(L:?(DRHD+8#R!`3)ER95/:-$:-]'9DYDXD.&@]039 M2VA29@Z!!H-F2Y`RG_":.(16TZ=/<$!;\!19PZ%/I(`<@HP7360PN#[UZ>PE MLJT@<3PY6]5)3EH[P2:MFM8F3AQ!84X<1W/(7KXB%TC1@VQ(BR$V6@#!P0L' MPP5.S&1R`@.'$RF:-W/N[/DSZ-"B1V]V(TV5'3LROGS!+&43(G;-9-CIPMJU M$RZR:3M@[2)S[MUV'!C[\EM*<-7#/_FYH3DY;^:9I:02\.N5C%O7^[-V?U]!FO11GY60IKV4?OW[\T>;??>SM MIYH,!`)XH`P)?O("<#C8)!B%%5IX(8894GA"&WN,LP<,!OV!C$!`."%B0@,Q M5-40`""S8D,+N((`*AO9N,05C(R@(8\9RN22CRS1-"$T?M$$PQYE\3*A5$!" M0Q>0DM%$59&\/.$$2'2=U=.25M&T9(Q@T3+$'B^)Z4Q50X&Y@#-0C-E06;0@ MZ)0JG6;U@`??>.S= M*MZK^97^5Y]\^=$'7WH`#JN=!L$&V-]_!O*7FH+.II9@L_DQZ""$R$D(*+?= M>OOM2'O8L,,?((TSS@D`'$2BB]"D>U"*+SKTQ`GACO(`1C9JM$0A8,`(+L`Q MLN3DA3(-Z11--7EY\$IW*G64G$K!)5>:,Z%I%%$+L-56D@D3>69(9R[0)\5P M'MG5E^,LW"6=1V:%X3A_]KB2'HPL8,80.ZQ`BPU"8/D6+4[<`&FEH-U2--*A M79I:J*UEUJEP3>,66ZFB(D0*+6`LB<_)9.#>GN%C3.%%5DY%;Y?G!#(D\DLA-3UMZEDBI7WSQ2 MO!#O^DDKG574.%@.0;QD`@A-=-+II^\$^^QSMC2HK%7VFJ>TV>8TQ)-MBDV$RAG!!`TET80K1B3)`O:BE*"4CWWH4Q\>)^4$1,"@CYV! M7X+X5[_X"3*`P[%:_U:UM>PX@#G.N=K77#4=6SF0@;JJ9*Z$5%!"U^F:#$N#A%WCX`A%*2*0WTK*6*G%"*012BEU^!!I[`,() MD"$*FSG$#,$<9E!6&(>1?*@%`,A%$#>"D3(DP$.V/"+!+*3$VBF,B4_DW?*H M6$8PT@(H)!F*7HR$.W**,8R$D9[)T+BR-$[(*FQ)V/&N"1,IG<\U>?RG:"9# MA%:T@@C^N?`G(!$YR-7P3S>?,A5NL#8<10*0:P.,E44U$XL#9O([F#3;KQ9H MP?:\[9.>7)`I.9C24B)(;VX8Q@;,@0M';3B=!8WL\:=E3) M!*]W;AK32QXVDS.NTWG?7!B5U@C/ZLUS9'_RHEJLVKWH9>:.`/WK9IRQ`WC4 MHK#&@,?\I``_J0%GD/?##0P,:2I62=1_E)5L`0F8P(]ZAZ,@?5O;.@D?3@KK M;2S%X&E)B=*65NNEK!"$+G1Q!E+0(A4YU2MN$Q?'W<:Q=&7^&LD"?@MJ,/5G%2EET;NF<8#[+^!.P_G5#(E31H/LE=K%6 M@]JG&)L_X4QVD:]H<$4%"*M(-K)7E#Q/1SWKG0B2EJ0G%2W=4GM*OJWV;ZT= M1@!T48P)@)$)5NQDN_%:KR55T=@Z M9\Q/_D9*?8_TKV82^H4"GV9:"HW^VIVKUE#)4C0X#W4DK##;J[%A>+.%WG`E M1QI!1:]-I226%FI+G$K\O#3%06`Q;5]<.)WVN-,[[=V-`6`)E7GZJDBT$.2^ M)!>=-G MAZK[?YJ]*(4!+84+EZV!AV;/$WZA'`F:=+3]#F6)50MI@5]0<':K=&R#,-L7 M:-J$I7ZX+8M[8\AP&N(^/G6%8G:NC1]OX^1:CRKV.0E'O]XC,;Q4U([ MQ1DL_VG^Z50NLY,CU0DNW\O)T\)O03=,94(#D5V02G M^Y#NKNRZ=_/@S&)4P@;D["7O7=I7V.$5OZ`F!8EETJZ7H`S*&N6((VT@$(JP M;I1&L8HQ[6(86[SNW/N0C6_<@N;:76`8-V)O&W($P02^='*,G;8-G_CN%=[3 M=;R%7]\\=*3)^>A,._`@%;Q'R2(2ZD\7]$5!7RL-9[W>^*X%'E+/FG_'QUC% MZ((#NC!"$3O:Q'UK03%80``6P`,?.WA[BE7F-K"41\?CC]N M/O0_7<6^"GWR`75#^PQ5FCIG:MQQYCY#(2N<\#>6\Y_7\V7^,PI)]=<#"N;I M^B\TD,"U=10,CF`"+I@0`7;TC3[ML`._&4L'1``!D@([H,!J00L'L=TKU(+; ML4<".$(:3"`I8,/!P=V*M9AM;5KT=2"@2)QQ088'^ETVC:`)N@ZW^97UA88S M($,BO&`BB$*V*!;X?8$Q6!XA<4KF60ULF%]$,5C4<8T0:I0`U((#_((# M.*`H=):^+5`9F`T03`%L"8(CM$+_.0#7>1W8L8<:;$`?Z$(?7"$"2DL[A$H9 MB%+N[=XG?$$9SAL*U($@S.$9=,`%IE@&TE:$%-\)]N'BU%BH,0+?'1_L^*$A M'DX*XH"AM`\C-J(C/B(D1B+[.,/^"Q"!/M3")9;!#@S!#=@<]TG-(CI##1K' M(CJ6;Y0B.VQA%ZP**JK*%R"#H<2"_K@*]CF!+$J6_-7B=T0`"7`#"9P!-B1" M]@D`$6`#.U@!$9"",$XB&%"A'))A,$SB$^A#$BYA&@X!^PQ!,^H"*^A"!+0" M"D2C$P1#`N"!,;(#$1P@)+!/,`R#!$Z@'V`#"F"CS:&`I;%8!VSB)M2CI2D< M*;S`(CK<(0XDJ-T8Z)Q@(0ZD0G(+/VD&+\``,D2D1$XD15:D15XD1DJ!*.0> M"[R2,;2!%$0D#'PB:\A)1")"@`U824(D,KB`(=W/"[`D#K2"+#B`+/P"/,02 M2V:"^<7^I%AD0KS%`Q>()%!RS5`B0S28012$X1AV0"(`2$@0D0F)2_Z8DTE@%VFR!`4NJT4(.)`BV$!'U84(F)F0.1F_- M41S!"%D92J*\@&9NIF;R`F=^)FB&IFA^)BUD0B+,#=?5@C$D@.Z8)J:T@[BI M@9ADPAF@IAU\0AD``5CP@@!$$D/IY@OPIA\08`3,5@?(9G#VIBH6!QAX)F_B M@2IJ`!%X9G""`71V71=\0CQXIES(0QIPHRXX`C;(X`O(11O^:*5XDJ=YHB4M$$4I.7^M4!KVH"ER:5]EJ9_JIC"84.`9H(-#*9< M\B=-(.A@8AH?9`)4D%=D]B'>!>(@-M]C5BAD2L8*)``TF`$TT`(C.,$.M$`] M\=5CP*(DMJB+NF@PV`!JR`!L&@/.L*.,3HMJNL`B!H,TL%(K$4$\\*@M>LH9 M9B<\L*@S<($C,"4N=$`'$.F+$0$!$(`#%$,N$`&+U@,B4*D2%D,9B$(MI@(B MT*1-?IT?+"(D",!4/J-3UN(0L&E:.D('2`.4\&NI_UF&ACJ/^/>I"$"A M"".<@4E"86#,2#,1JCD,Z/$R##+OCI!ASKJ"1"&G!#&D1`!YR! ML[K@M6:K,FY&;@PG`9X!$23"9L0"&+2I%3KE(Z6"H+II(CR2,TSAG&(A@-CK M,^(K>^BK6H(C?C@!!LKE'28<,-J-P,9E'2(L!LK=TPCDJ3;?8@I$8_KAAD:L M0B;`WIF(E[4`1(J@$_`"']A1]>GJ^^2H:JAF"E":-)A""#E(L.Y"$,16'70` M*3@K%T3^`%5R([5>3;36@2Y,:P+3O,Z]&T MQW?**[VNZYRZZWSD:=_XZQ5VK59^XQNZ`:82+/#YZ<&>;1U0ZM@V[/#1'<;V MW87>F"`>XL7&K6-*01N(PCB8@3/80`(L!B.(8)(]2G])GLDJEBN\IFKZ[??9 M9$W"PT$-D#)T(\_>[*A$Z\RR@LWB[,\&;<_F1@1(*Y0J[>=N0-,^APN<;NH* M"[O2Z;S.Q^MJK;!P;;[:;K^&+<#&61LHK`6>[JZ?RMT&0JST.IX>A%K% M&N+=AO`(3F95E,D>6*9^]5.NAF^TJI@@"*WI\J_4(@<`+W'K'K#5;BT"6_&^@NV]:K$S*FT MZ`YQ$.=&)-^O$3=Q_?8O%._"S@KP#4SM-\-N`E]Q[6[Q[:IT[HXRI;6!!*OS M&+/S*1/^KVR=\3KG(<,IKS_OU!XH`B(@0AN\\4+&<4\[Y@NS61[E,?M@7V!) MP^NQ``M\@3[X*G(H-,W6H4,G,T3;;`]+=%=?-"1;-/V"KC4G<0#G[T',TI3,3A?+3G?M4O'6:0";3N3<2O;X?'ZX]S-\U'#40L#UV$/1F(; M=NRHS#BTP3(4@F2G2PN1*ASWXJ5BE/<,&F6,(#B,,2K+K,XV_5!&F].IS%/8S(SV7`MWAV-QB)OSUY*X%^NU M[_XYBO/U="-2S$_R!&0"`*%B%)0``+32.N5M%NO!"'`WU MDG/:'O#!Z0"1-M1`+M0R03HYJ9?Z9H,OI<1Z*N?CV]4ZK6>UK8OY,I.Y(8\Y MSBIRKV.T$=.O;DLR7&^X)6NX2)-TLW,RG:4,RA"D2P)4SJ*[.P#T_(D```R4"W")PB+4"!#Q MB[S,L;__.R'RE92KSX$K?,*;L8$K,YC?NH/K.N6&=<1',T6C-;%G_&V;?=2* M*\>'JV;`Z\=[\ES?09XJRX@G=XD_!TRGN-W4P\"*<<*R,V"G=@>WV'1T>V&W M,0V-0[KK?+J(@KO\_,Z;^Q\X4RD\@1DHC$H,`3[@^Y$7@@LP>7T_/=3W'1V_ M*"0ZPY<[ZA#<@LVE?@?<:.O7.LYT(L'7[,TN(MF:N2+:XE@OLA_L?BRHN=!* MJ?!#*?%W\S+R/O)GWQ.(,_.C9YUF'XB3X3K:W/0#JO5#L#C^.@,8!Z\%#@%R M<'^C;C`]BG_<.>KV[S6F`23[&'YA+X`0E,)YI0OCF_OCU_^@%%>K#K40$,D" M<`%`%%JBC6!!@TL*N=@#C6%#AP\A1I0XD6)%BQ07P'@"8\%%CQ]!AA0YDF1) MDQ7W+%BP4&7#!4Z@.'&"#`PMFS=QWGQR$PK.%])8Z=)5YPRV%KQZ_@PZM.A1 M`;1^UA%*U"BOF]*D,B7%QZI-K$)9==CZPB:8"$-UA25EIBN0LU(W=.A@YJ9; MM''G=E7S5M<&=J*>TO*P5Q#V?JUT-B=H=H(&B3([=FZ=?$^0VI' M5UHGD2=7;G*!%`"\%HX[`4#(@B'3A4BG;GVZ*.VB_FAOLQ#:@AOX!AI4KRV7 ME([+X<=WJ9&C?/OW\>=//H27,V?(QI&BOO*<$.`_6G`04`I$$(%A0085O$&* M"9UX$(8;E%F*JAV<@.'"#*,&1+[QZI%%'PQ)!)!I$I,ADR+[8*5)`)X!@3#1'.BC20RA#2T(78IRL\0X@Z,3&SLOQ#.X M.M_$4SC^4@3H4`H8,#! MB1MD2C99*9R!(9%G$_'C#FD5@IKL=V!VENX#7$N;<-ERH],8G'B M%B>4R2JLR@ M9&;][(V4%^)%=-:=X]LC`3/^6`B&/1B9U!(`=OBC:%&X`P#^:$FK6V`%`)AN MR.4*%)H$5CGLK'_Z(\G3GC"#"`8`>(/6K;3 M3HKQJ5[`_#]V`."$(?:8>@?RQMD#B#*R/J@0&[S.7K^P7^4_`0Z0)$/8`2.H MQ8@G``$ZT'`"+YY`K6)-#F]W= M$$+&.6Y%]9HY?JJO=[8;8 M,23FSF-3VECO=A>RD16O#3!K'@BMN"?E!:M98WO>KUZWH$-&-YR`<` M-:K15T(``#2<`8`6D,>-<)1C1\:!*63LX02E&,)[%N",4@"@$-I8`BH,.9!" M9.<(9[P/`!T924DZ9`]/B`,0=B`*7MA`%$[HR!Z<00N93+"">+O@!OJ@BSZP MZ8/A,J$($]'3@7+W.8N1U^3E^F&U(/C4A$'@J1 MB4NLG<7^DFB[WTEQFE!,#.%0A! M"*)PYPJ&P)!QV"`!+4@`(.=9SWLRQ#J<3$`G7[6'3ZFQ#`]8Q"*N\`!\/`J= M\8%D0R$ZP(PPQ!GJ^R,_@W4L4I;29&:(0EITPDXI9_6;+ M7EN;+E;5M=2K!QG/V56P@E[,&X`=4L2"%8TN<N.<7CEQJ^'F M5O*M:DR5E$&B/@B*#EAT,A2_W08I>R M2+R]_*5Y@XEGU*U7I_#]J3)1%U]ISI>T$&.B:I>*:*8ZM5K:M,V`_<3-``O' MP)/6JH*][-7@5AD`7,ZT1+1L80Q_FM3,R>@-/&Q*,Z,YL2>>D$E=+058'^ZQ M*YY*Y%Y8.3IOEKR^W.R,;[I,/@/:=0N3T'N+7>C9*=NTND-MHI^]:/YNR\B2 M!B=5M_@GF65;C)@N]23CQ^GQC/K;Y>&/39A;;G6+!,P:'7-A5QWB$3.YQ(VE M-^+ZM6;^$:GX<2_.=64[=Y9>USG/`^-LGY')TQPUAID\)K3##4U4(4-[XM)N MK3[^:<$@]SEV=MTE3W]:;!"8PA2@*"%+UIVN4.DW75S!B*X MD'<'U?S,\M9YSMO,YGQCR^>0ZX"(_IOH4GYKDC`MXR=K&:I)OYNVYCRW<51YWN<KW5K(WA7"M[>M$8QKBGK[Y@N7H:-QXL.?S1L M9/M%X;LH3+(AONSP-_OR5M>O^5.+]2(?[\BCKT-OW!^STP]JJUW-O:RH7.62 M?[LYM'C[$W8B0<8!N>ZO[#AL0H`@%VJA%4J@%MA!&B;G@E##[U[MN@*OWE2H MNR#+BO0F[!_@I05<[NK=*NRUK%_W@!&:0@G@CP!UWN`#B<02;2\'+6L/'>!0?6 M,!9HRH?FL`[EP@7NT*>2A0YQ2F&2Q1D,/-^#`6"X5@8 MT:EDXF2@2F6"00INX612YJHN,1.UZ?U@Z0N?9SAP!EE\D`D5A6C$S:X^;1R< M80@2Q;=0<>[:K5\2X,R"H*DZ0!IZ#PEWH.^:Z@K:0`J0`1E@H!Q.9$^(T1B1 M45R&L1B/$5N>D1EU20!Z$09^3BRLT1@S0>#H;!MA@!>RKP-HH??"<1S+T1A? MX"UZJ$F*41U_1&'>,1K,`(FXH!BEH!Z+ZAZ1D`_`Y`H2`!'PT1_/)`&640KX M0`LC@!3^AF$988`0LL@@H;$('D M3&X)17+=($7WH,`-#@4<-N"PK,`/S*`F@0`F4X,=PJ#(1LH(J M=K(F?1(LBJ(H>])=AB,!@"`HF9(4G+(FV\`;6:$IG](,JO+[.*@#IE(KV1$O MOG(K/\`HF:$$4@$!],(H60BDN<;&IB&`R:_()<#(7(X`(4"`K@4#^*(4B"-C!#]J` M-FV3-W)S-VW2-H.#%/Q`'GAS*%O!#W8`")[R,.=D*(A`%/C@*3$I`@1A3NH@ M.K^G$:KS.G4!%X@@$;[G>W;`.N$B/+>S.\^S+ZOR+HC`!H"@$]H`&3C3,Y%#%5V/%4DT12/*9U:@N`!IJ6AA.5M` M%*3A6?S@*[^G!E2?Y(!QJ%4W;(!QHM5>U$E53M5;Y0`V& M-5B/-5EY#=5SI-5WE]5[#M5;M%5YC]2SGU9,^53D6 M8`0B;#K^-G-@%5:2%H`66L`&2)4A)@0E7V*OZ*Y"*!8&XH[ND&%C>ZMC*19D M04UD)0(9*@('3I8S<>`RQT%$0:U9*!9F7W8(RT-F(R(C6*ZW8"!G?VMG,Y9G MYR.>%K8D5"(87(`+IN9$AW9I">@E;.!\7E1@;]8_*%8F,M9C?TL*R(V?M'8B MFF-KRZ-K)\)D*>+VRK8BS'8B8,!KJ85BAT!JZ>YMW19N>XM9*-9N04&&"$."J%PR^"M]@]P%?>Y4F)Q'9<)5X(`(Y?N&I?NU@XB*ND$ MKB"1!N(!UFB/>LNX1!=%OZIR/>*X&A=3\X.W5N*X/$)U8Z7^=;VV/$;7=$\N M(D07D!YW=WFW(E2"&,N*DMPN>*UF>.UJ")`7>3&LDG+!D-1C":H``!*`%;D* M!ZSW"`>P;"#%&7;`8C%B`7!@-VGA]NAV)/?@4/"H6'RO8UD%!L!V9]1W:W=V M?=V&%["V.7*V(Y[@5"MJ'-;VN3AS1`78=U&",TG7:E""@#%"@6?7:P^8=C'B M@8V+(EQ7(B9X(BH8=Q]8[@))4@"@%$:3GQ(@#G#`$LR`/!9@A$OXA*&AK4JA MCTK!$C9V`1"A#$I%&[``(<"`%<>A?9"&%O2@>S9X49KC5UJ`:B+,=V%`"$Z@ M/YQ@!_0`PM[W/G"@:!@A.IP!4TK^X7]]UQ*>8(A7I6'5B&=3&&5Q0(T8`0=6 MH!3VR6I$(0'^P"6<@1$&Z@2*"P?:^&L6(!.@]F:!X(^6<`'^6!;YR0P`^6;- M8``#&0BDP'8;PH#J9PDAV9$98I(E5YTP&(^3&'/Q.#P@HGXTF=PR8@=^Y6;E MII3I3FY6XF8!D)++@Q<,.9!A>6]?.9%1DB[*`Q7U(`XC`,`2?JM'_L`9 MCF8\_L`&FOEK]N`'3)@6D,N<5X`6&`&E/W:E6SJEU9BE7?JW9IH1TKEG6^"` M5M8AZF=>'Y9N?[H-@CJ`?GH'BKJWVL`/Q"4&N'V(/ M7A6*I]CD2')^_L`,U&AZ\^@Y_@`(0.5H<*"PTP=\S:##V-%M#,I#O[VKQ)@!=1IOW,Y`1A!G3"L(P2(4@`9"AGR4\1"W<:A!!"-H`!S*\(7CAF&M:CH=F!=PZD&"@$DP\ MI6%VQ>F.%A+@"7;`O7_+8?>W@=[;86FA#7"H9]MAJ.MK^X`_8.<0!VX^<0(VT_(.=`;F7],(DNB%& MP`4$8K()HK*1:[6YN:/;NZ/;P))$X8_&(0$FW`Q.(`Y\90$@^HW5!\_GY@1$ M@2%$6@@L,Y#FW!+@J3FFPQ(800KPO`U4PADX7`]R^E?.>)B1*WO;@!:$0`\$ MU@R$P`8LR1)6MGX.B!$VY5?09@5:X)7;R0E6X`3L>[GE*#H>NKE]%QG:X&@L M/"-$00C,0!1*85.$G=B-'=EA8-AAH`U.0'R6>`>(_0^0P9UL(%'JJ7YH02NC M724(VH\"ZE/.B5*29@'XF26>6%*JYK<(FA8\>1PJ!8SQPQD2X%T3H(5[]MYO M8`G0!7`\B<#1[A'^()?@:IGP"Y'![*(5;BH3P!*OXA M[I3B/4'!Z=:`#-+>(4+D;;'DF?SD'V((VN#3,3YG69[''Y;EFH-M8.!A M9UC2@8`^PYJ?GKPRS2#6]QWH\WWH83F/&0+&,3SB17(#=V#^")B;N%ZE.^9) M>@^6:EY?L`=I!81Y![!>#]#G"?[@4]2[5D*\),U@`08)&:Q]O$,%H-^#4EJ` MY5E;:.W'":8>=`M9C6Q=?1;`C?;Z/L9A?,Q@CKVW^T/4PX4:\,.Q!63;IY'[ M_,OWF,,Q`_H<`$``"R)`%T`I"6S#.QI`V M0/88++@'1ILAC&`X?+@'V<2*%PN.R[C1XD-H((?8P''0X+@_.":>3.GQSPX< MR%HX&4IU@10`C!;L,0,``*\_:`'^('N2=FU;9%)$B2J5%D!#@WM>%%JB+;#@ MP>*6C;N:,6T"JDX8\3`">@P5"XIPT`2]"&.'/&V4D< M`$^@I5T@>H59T8SVA";[!ZX-MFV&[FF15NC5!7H`..$U^B.MT7^0DQYW`H`S MDU+V,&(-!$`-)41.0T2WPA-M_$?0`D,` M\0=T9'645';:%;2`*``(!U:+ZB%#2PNT(&,#4@L@LX,-4IC1T&$HXJCC#CT: M=&,;00[^:1`M3S`BQ0Y/[.%C0;0DD`!%+"9))45/C?1$EHQL^5"757X)E9A: M#N6A&2T`X<0*(RW@C)ILRO80G&H^(06=1,9I`YYEU0EC"W[:"$..,#RQ0XA$ M%FH##$"\%^4"C#IJ!I1$`@E#(Y5&BJD9FQ))2QLM.-,H5"Z>BFJJJF*U4@L1 MDM267&F]%1=;<>VQ0)K119C3`HCD`MA@@RWQ0`(D0O0@`##\@:M!0^"XFFQ[ M6/9';/F=,!!!M_W9'&>>[H`,G-`"(&T"9)EE[@I_F%N;61C-96I2C@J1W![+ M66*O=@NT5UVNT*QFPZ-`[)O64U")1YYYZ(TT1'C3SL1+="?^^+@?`+0,*!TT M]ZT%0UK.:`P`#MJN`$!_'4NW`+T;TG*1%+PP@A<.?SS(*[(`5%C0A>XQZ]N4 MR.!07"E@%O3'>*^FZ-:QJ[8HZ0[0`-'"?W7"8(8S.R00S)O(5#U*E5H#X4P; M7M?Y!"\+C4UDV5(D8,9P0.``0PMM7_5VW'./5+?<6.4-Q%7C[.!$C"(S#+C@ M4`U1>`N#/X1XX(K;V"0T3SQ>IQ0I6)V`,X16?;7F(U&-^<=3\"%7UM2+)?[K`A!)$5T.)`HBCC""IN+YR,E%O+O M*$H1!]OD5C99M=73M^+OM\F&$WW^$=J&JQ26M"%96=NB2^X?P*47)8KM?8KB M04,((8ISRA&X7!P$J^5\<6;\L0``MF=H&!E/>9)R'@"DQUE/0,H0$@`#7B## M1"RSC\7\`Z&/W>=B'2N%!M4")>N4#(,>S,UH6M"P@^R@%#B0S\P@)"%)WID4NVTA&7:O<@S/P\K_2H+(L.&G/ MQ4PSA%*4PGHVL(VY:@0;W.!."B%JWQ[,)80M?D=SJQD'?8"X!^1L1YH%N<]N M/"3"9(IE?P3D"W#Z@\#U^>L/0-A+4IJ##`#BJCC)M.!:QJ*_BLEL+'I`R'V& MER``"*ACE"E-=)[T$;38,#KI[&`,48,S"[X'(S"X6!Y)1AIHZ,$&T##AII"F M/$5F!4XV(:*'GO`1K,")$6V`":`@B)/VD:0E)!%I!`]))!RL@!?Q6@`0Y.&, M(XAT![1P(XIX41VMF&$%W32(&7:0T3K)@Z;Q&L<3AN!1D[3^P*2,:P,M)%2G M(714I+OSZ4%@D*&:P@"ESKM4&T*JT;2JE2M[$(6.<(`#A?P+/]FAC#S).1F" M(".EDGJ5S0#P`&TL8;"#%4"A2W`V,+]A[PGCBX(S?*%"RZ4&EQ8!0'>`D M])@0"I4SL$>+ZT#V+-IIX'AP1J\X\`((*ET`<.3JU+.BQCV2,=`>LE.*I\$P M7P`PPQ.&>+(U->1D4O,)-.@EBH?0JQ12<((3X#(\9UEB<#A1$6OL22YHB`:@ M]W&3:%@VA.YT1`^66("Y_O,1X*2TK0K$`5YLB!SCH"D.G2D()/_T$#V8`2$X M,9<^H1$=2Z3K(9:(Z%I%*HH5K*#^N(P3@@UX(4JK)@`90V@M(Y[@X"NAR!EQ ML`$C5'H0H!T%*Q5AQ!"<\"8I,,(,HCBK3_8`A8DB5B6A$4)5OO@9'"0`&@24 ME`UVL(*2OA@($UWH543!"%J(DD<\'4(*"Z*(L^0HR0=;@()7$*X4ZZ$%67Z3 M#6CD#!1[&<,V0(2IAM#A%3SYP&Q.JVOSDI8*W6YGH@G7G!-E+IEE1P^19`S2!D;PPAF,0*%3/26%)WC*L`(4%20!1QT$542]$%%4RE:1:(#<@]#170,A00KX$ M#5IXJJ'^F,X5+10LLH^`512+Q8&G4'*5(3C[J#@8AS-W<-1R`H%\[>,%3T5' M*4\U[#YF.'8%*U;N%?34,YY2,HK&(;:H]8IJ%Q'+"JKT!'4O@!>>0@9&LJ,Y M9]`"VV;PMP^%!!XI-!JI3K"!7=9]$-08N%<`4@(X&CM[R;76L\< MP098-KEG3&.#'N>J#0[VN;7;L-_EG5C5)EY>,)PPA,]\<0\FT<-B,6)M)Z`Z MB3`(=I!A+H7I/.J&>&3)"AH9+XK+757[+L4)[GYW2,%&M7'^,"=L],"+OA-$ M"O32"XYH[%\XZX$1.\A$2XV8Q>79)H_:LF/D23+Y*AX+?#GA?.8Q7_EZ%8^LE37O.E!-_IXY['+<8>?)>O.)IH;\'AF5Z>N!(]3/6H<2*IWI`P M!7`L8P]S$N%^]C%Y@H'GWH(5[P"J5XE^I?ZPYH)XN%*B&.)(;&"#'XQUS?M: M`2.H"16B$+K@QQY*$(,9FDB(*3+@TX[!@<9=6T](VHO)H$(%MVO5R&`%U MT)``I>*%K!6&/581%`$V5W&&*X!44+%@JE8U;@@#<(@3([$":7=^/I@GX^`" MHD`+BE`Y*^!,?MA^*N9,0D!34_-A,L4+QK1MT#!47081CPAD!L<79E!20!94 ME^@TAK(\1Q494_@N"!)IDG@0J$81$V$CJ#8.*Y941PB+KU-&PK=UAQ0?0!@R M;!>+N\B+1206].4Z/@2,1[@'F99(M"`2HSCN@8CBUPCNY3&W\0!SL` M.?$8!P?X//:(CQ,2CY:PC[>3**^T5*)NA803Y!TY@(,](%0F9/>_R/U+` M7,_H*=\AC432*&RA!ZV5D3NP0+T(DG/W$8F7%[41DB>)DJCB9#?7/BOI#%#8 M9@0!DW1GA+AV?@_X$"UP:DB2DSNIBP6ADQ>FBR78!J*PB432)D5YE.X39$:9 M?DDI"C?PE$W9&,N#&E8BAE?B%$5HI#;8F*C^F-.;5`F0Y'`EPEC3' M@&M9EFHI#;'4EBLVE$/0E-Y7)ZI6E'B9DGV92#\(A-A"A7[^29A^"7N%B9AO M@@-<`'MPTY@K5R>.*5+CP`M%=1#J4)DU-023IIF<*5*;^8H0<1Q0J!F-N%$N M0YJHN5%,`7NLN9JF""BP>2FR^2.TB1"9.9FXF9B[F2JW"(05Q)O!*9S#29C% M)T>S,YC&R1?)R9S(Z9RDMQ6F!YU:(9TB-9@+4`G/F17*"1'-J17<&4C$*9ZL MPEE`Z)7CB9[IJ9[KR9[MZ9[O*7>`"6?8`I_U:9_WB9_YJ9_[R8N^"6?`R9\! M*J`#2J`%:J#M.9*X>)X'RJ`-ZJ`/"J$1&CMB@8OT*:$7BJ$9JJ$;*J#%\9N+ MQJ$A*J(C2J(E^H(?(1GF":(FRJ+^+>JB+PJC7%6A6!6C-6JC-XJC$DHJC/PJD0**J@*RJD1XJD2:JD14BA@4FC2PJE42JE4PH[._JA5(JE6:JE M6TIC*0IG[\BE82JF8WJC"S`"&`-G%TFF:\JF;JG?QJ+8F$#0B"*!P%OHH*7"-$&HI*,=3)S2C,"B+`"N5`(N)A7 M8U1[9=1[1#1Y:$1[5*AZ'3(**FJ7#1[I/JJO]>JX>E5 M@&JK-LH\>5%<>G`"J-1EO.JK0Q%0);-Y=U`&""!859`+:?J*@<,+IID4.$`+ MU880H;;^5\H#)5VB:S.`#-^Z5\.!`R#B M!&+#6AZRKL_:KEUAB;VXF4!E*IKA!,[PK;R@.L*AK@%+"V:#)BT!.+V"*_P* M#6DWF+Q M7PF:%A-9&D1F,0ZA598YL7,[HG!B$;FR&M"D(BV`04FC(B;^DQ;HM2\)L!HB MZT-E<#S)NJQ\RA?!(UX'T3>WT5)%D[3Y`DU:A(@A$AURB91X$8X'H3Z(58(1 M=!]`1!(JP@AA]";.8`FCF1_*DBMBJ[JS@Q;&PH1>%;%1]!5,E%X)DY[DQ8UBP.6,)-T:[T9FBO6)EGEH3-\>S(@ M%1V`JQ<7@52%:[0K<`4F*RQ+@`#Q8&LX\`2K85M_@Q/T\F&XX@06X0S1P3*' M@1,P,#S[ZQ[I1R_E$24"URLON0@`E3;IN`(,KU\$^M[@;/1%` MHE%/>)2$*'("*WR]05RW]+(LP=6W;=`>WJL8N`($X<(?]>8,^)"XPX(/P9!$ M--$>EC`0"%*>EL!:(806:NH1'A(=$W<0R9*TQD4D2?&#_>3`>H(1-F8IYN5! M".'`)CD[H9(60[)O0F!CQ=$;D;%X.V`))[!N'JDCA1Q91>F10M$&>N!UQ>B' M'I(`O"`$>H!B*EQ*FV&[3^"M)I17".(A@38:3'4= M%OHFN33^P#38%EDK2I*196_\1?OK.5(8A`USQT8:&<>5'!NF&.0,(KPS:7A! M3,M1"JX&`+"&'[PZ#NWA'29Q$"H"#<@1?YJL27#1OTW:!D]P`C0;0J+E7#90 M"BT@K"($)JEL'F@171=Z!"-@T3IEA!5]T08Q`KER!!_]RABZ$C:@/Q.2%K6, MQ"?=MSN6.2=V'R'W$4#P`.J;N)!UQ4SE7T)R&(J*%]WQ!_0"S5E5QB1B/;#[ M%:702SM-+W`\B>V4,RQ[0!:\HL8L,]B3M#@Q6^%85W^0/Z&\,W!1QR@6'>W8 M6T5S/154',X`%Y5E0/`A65?=I#L`5B>0=%X=LRJ=5;UU0Q#^C4#98<8/>@2/ M<`_N<`_I@-$N>`3I,-CW\`@ZI0(-X`E-$`SI8-@AC4C/,`[/0)S*0;TZU[U] MVQKAV[=`9:FVNP>9$,S"7!@@9LQIC#27VC"N)!H$`AQU/!PZ,W&'P3L3/3LM ML$`=LM1($5ER[",$$2T$8;\DDGV_`02\@#LX`R?!P=7XHQV]F[KY`SS2/1Z[ MD2P*ET+C4"C%P=:^BT#C`=>4!$"K45DTO`7U,,QK4_B+*!'0`?G M,`F3<`[!<-AS=P3!<`W[?0YTH%,5D`$5\`;>D`$CX"(WPB-/(.%/>J0Z]Y?1 M$.$3/IS%*`0?D1%#1"_B:Q$AWK?^>'AE>&$)/8434L!)4TPLAHL1WOK"0W`? M.-,V.-$<>*&NMU(G.8,7D/(1PRI50H4H""L\TAL[4L^6.YO M+PQ)NS8>QO$'-`PGT;%``<6WR+LE?$W?,P;8%3`)`VX-(\``1C@"]V`$`UX! M%7T/GF`-86`+[I"=+N($+N`"1Q6'4!H-R/B7SO`SG)Y]B$D0O-K"04M,NN&0 ME<7J%!)Z"[`:`E+`HLJ!"*#-*D+1A!$"]H$`R=P?21C,+*[[7Q)3OT7 M0#IS35D]W=>M+^K#&M/]D3O:?^:=*W!!O1YQ'\&F0&;Q36Z-%G#='C*S!\5! MO68M9[AC+))R`F+#="QR3^:1'3W:H(E]#I=@!)*0-;"H#OY@!)=P#AOV[^KSPW<@*/5C&Y MF,30H")=WEFY%`=0%<8-@Q,/@B"7FA3$6DMIL0.BP5SL!<<_^"D[U'`*)!3C M4!Q.CA/NC0/MD1?U];!I$74)JF$-.@+',`F7,`F1H/(O.`);P-^3L`79^=&Y MKRJPMFFY:Z--1D>L7>)KC]U>M>.`V+&C+.R@A4O9MRX\0*? M9T^:H37.L5K".\P(O=PYK\<]H47+W+/`M-G2I\^&3KQP3XI%!(2*:C M:4&WMFFZ]$S>OSTR!"V:]5#AN9$;SUV<^UT?,QQQA$APTBE$O=HSQ(;9>)1 MQKQ.S'&/-G;([4DBG[2QQ!VS9&@/F)3[<,P`CZA@DDLFR6&$LQ9@4Q$XCQCA MKK3DQ%&1(XY@P"PY*_'SSSD9&L&:2428)!0ZW3)--1(+.VRE1?T;BM&V*$5K MT38MS53227O;E-//JC+CO4O7PO2F3X-$R,/S3M.43%@%.\(X-F.U]5:U%N#% M$DL4(FX'2_1`!M?S:%&)S)9X$9-89MT:QY8"FVCMB!N.Z<'^EC`D\,::8!P\ MZPAUCN$D#%N^J8"3P!8Z@H)OCMGBW7>_&81.OOPR`K`@=[QI"">D<()4)QV5 MT)E-I'!&MW'Z_;>U+O>5(IB5NK1L)6>DN`5@BJ60(J(VH>'78-T\5MBR?XF# MIF*#`?Y1WRU9WG=59VIL&*V/G1#*9I,_/EC&53=<@(&*_TUEYV:+'LQHI,D< M(L0-/68::8EL!37IHA>XP=XPTE57D4B,F&22>[V>1!)W$E4W'5N^%N$:=,;6 M>H10!FC[ZTG0&<"=$1192!$)"O2$-RG,4*,@)W#8X?`=[F@JX!0.<^()Q,W` MX;PA>#'C<#.><(;.EK(B*.%5-R[^;*FF8(#\\)J@D>)TS;@X+ZD=4-#LA1DA M. MM7V'*BEK&L>>B7.&]>&GIOI\]--7?WWVVY=I!"_0G.0-LZ'Q!DTC0DE'G2:@ M33.#^G$";!50APJ.801;:.T(37#',?QR"4E0@`)T2)29)G&.262@5C)Q!@Z@ MHIG,^0LKAR.>C5:%D"?@`'*7ZPA#I,"'AR#C=AAB2.$^F)+E)60BR#B=`,"0 M$(T(86ND^1BV1D(QWY2+>,8`L7G,06-EB)25[#0*@:03JN8:^_ ML80>"W('#Z"QBGF<0VO0.`(/!E$@?[S(+(.27P4DM9(^/N0FII$"[N((/L/0 MXF`KH6)43G25]Q"3A=>!D&&>0)$=M'`!AC-#"B"R$.4949@+&4)A=K`5;AIK MEQ`*AX3T0(T]P!52X71I90\8CPN>(.<-`;=D:S-X1I7#)[4PEY_K)# M-^C-%9$D3M.,HX\[V$1B.I0A*CH157LT'R0M>E&,9E2CESG^0BCD=X]:'2$= MY_`+@RJA-T54XDQT.=!"1D"!`DGB$0LX`CTHH#>&,.`(GHCI*A=2"0*Q%#,_ M?)1,OFA,$QJ&8S?))JM80IQ>?M,L0S#B5O0#A-W)\Y[$,5P*G%A0S3P!IT]E MB>'@""FM)J:;B#$K=Q9%U1U(=`%WM&=BS)K(XBD5+0&%U!TI?^5,'7.!S``!E%+!2OW,R1=/596*P%[YDM$+;>LR(+6RF;>'J5.*8YKG#[6UQ+R5/ MO"X@JLUEJC-OM*CQ9@>$&:X>\VQL&,+=I)Y;'>Q[36C8\QXNCM2EGJE,,]Z` M_5:ZRT.&RO3[9"A'64J&Z$)]'H#_N;!Y4%X&X)]S.5]0V<9M0?)T5%]K%/8)F7-7;Z,NM6MSI M!A5X=R`'\287&N7=]$W0F\VSK@4&/S1WJ:$-9!S)\WJ(J.^K#7YPA+-N"`DC0M>.K`+?H(:VOR_^1==,Q%O0S?P> M;;7($R+N7>]#3;8*V#&/:`GG>M>]3K4CW"]-#6()3^TU:T$YG"Z2H,0J M6)F."FRV$O:(-=LE_G'7+F"4=+%%QYUD*<.W?<5@,CI)`,H;J>&-NFVG%9CI#IO-;;Z;_TP.&@H)OG>I4E0)\SD$NV M$B=`_:)'`=+7;7][1:I4?AHD]F1K62NW]RU-6Z#3")J`CF]00Q$+B(O&0?ZB M)L!R'/6K!$S3U-(+U_8Z]=QVAQ-5;:$<07EQA90S=A".F6L8T#*Y.4O"31PG M3)ZN<=P#ZV_BU\TD1B*4OQQ!S[/^^LKC*GGK,)-QO'R3,78;BO>(*FFBJTL[ M+%8A#"2:F/C+/(M2$J;`/0W<0/<9@0RHI0H:I0*A@!&8DRU8$-EBB$J`K4N@ M`#E1!&B9!&](%+TQNWL)!CAYGP_$(%L*$C"XG'N"%,S3'FAPE"%HCF9*IF!@ M'L8:`EC0C'1BB23DC7Q"!NG8@Q$+(YO8`T/;I2O*G)OQ)EHXC0X)BD69"%\I M)JR*%&B`@:8`KP@Y#1C8,.F`AB\Z*XD8)B7!(^4XJC640\1[KJ@(0V<2K)58 M%8`Q"%0YIWR#I#VX','B0$F<1*.I!!OR^R]*VC49N0/<$291.QWB4;01DAQDL*,/ M:A%D.)@5RIR$6!5:R*Y1&\8Q8BP;X:[3H048B`;5009Y`H(Q2I@U.IQ&&",M M:AZ$"**'X`4DZB;442,T0B0;N4/)T9B!J*X/VZ.!B`KF0@88F)@O_)TY;`I\ MG$9D"(LXPYRK&(@VV(H/&YRX8AY>X`4I@(0Q6AXU,L8V>()_<09::`/$NT`< M6(%3H420#$E8.8)@T"2_V*P!@SM),`)T:$DC"(,,F#Z):X))F`=):$ET,!"T M6T58E`2?E(1KD$5OP1&YH`O_RKZ'R"'?69PE&QQO<@)!=,K^R^F/.=*,8:E` MS7""+XR*1O"W(>A*Z1FN%X!"1^&#(?"KI;@[JD2BTR4 MB4"(-FB#4?BFXX(B[OFFIX@*'#NFPZF2>ZJVI8BK'OF@O(RB&KJ>FJ@GWQF" M+VP$((B>'0@+(-`(W$F(K7.D/5@!F%@!HA-)TSS-S@@[4AI*=3D"2O`$=W`' M"FB"<6!-AE`'3PB&8*"`V&P"5C(+==!-X13.$UF`7%.S(/F!QHD9*8`!?U$9 M$=&BI>&2<9!.F=&8I8($&%B8Z-0B'_D1Z^21[IS.E5$![QP'O8$,YP08K?S, M51B"Y@09WD@8*8B&C>$-^'1.CJG^SNF<$6?03YOHSN_4C_@<)N*@3"E@S^UT M"J8YSSWYEX2IQL]\I'&P!&3X@R=@$M3<4`YE#,PZ%#B[B1*LA!!]JB.HA!(, MT3RAEU-ZGQR@I`HH486"(<1@P\ZPE%>)%4KYR$XQLAS=I8+CT;>PT5;I4;;` MIQ]=I'&(@V&RA-(TE5V*Q$HIN"-5C"3M&(PRGRNUT@Y%$)&R%TD01;7H/;<@ M4\50D+&SS;]S-AKK4C>=D#U@!"#X`R<0`KV8)EJP'(I8@&=#/1M8FAVH%--9 ME@7PG:@94BGXTX)+B#VH/2RME,""4KUH@S%\C_B[#H0X5,](`'BJFCX]N".H MM30!J:3^T3NL(;D>^<%/?5-6!1#(6(&,_*4AQ8&GL($_T`E("8_[^(T5X`Z6 M\(C>J$,D=8TG2(`_P*=?S55\6@';&HY%40Z::(.C>"LKO`GA.(U+.Q7?\)?F MT%5DG:M*\X_4R(T_T(QCC43?P`%&.-<0&]=D38\H;5>-9%=7"0\@15;D<(U< MC5)[W0,8J%$@G=;FJ$/]LL0"P<2D&8%(D)]C4-._JZU6C5@$D8A@I%+2P($$ MH+TFTQAL'`>'A#T<<(8XM9G2Z8IC*9RETAC]R"[7X(4$6".*;;*5[8^SC*/F M9%9(:<-[TDH^^Y*,_`,I0`8D:@,;L`PIF(KLF`I>$(6=T0_^?(S9<5@!Q*LC MGJV,JZ#8IJC3CJC9ZQ@"6H!*G5BL/AJC[!!(&+@G*6@!*0`G'!%:8TF*!2Q& M:."%R7'.`%6C/XB*IZW9DW%.7#U+N=VAQ#C;DZ'&:?J7,6I#/K.,(1`"G6BR M_Y2"^8)9I$!:*:,LNO`$A[45<%G)2X"X$L6EVEH6B2W=QB#8O-@#C#T*9]`# MY1$%)V"$S%R!DUC&.(`&1N@@.UV!-I`"4;!#NKW=FW@):-B!<0C4F>"%7K6! M)W@"7OBBXAV'S6@#9Q""/-U./=C/-N@FR8D#)P@3[X#>/UT!:"A6FL`!6A`% M''#(KR5?IJ)>/7`(JMJ)K1`"/M/^`R?@"2E@5C/`"B!8`%$H)/A5%N*`56AP M7:A\`AO8WZI8`0P-'.J%W1:@A:,8`CUX)ON]'&=(`&^P@?]L@7)]@C_(W1;`` M-3/`XZ+%@9[PH!8PC=R="5HPUG$0A42]56D-7VF]BM_EA3Y>`7PTQQ78@>Q@ MA#U>Y"G^BCT2_H,U_H.7'8)U_2)2+L:1H&&/!.6/_1*,36.+Q`D=MH%_M8$% M8`1N@@%;+8Q&W0.U#4T5TV5*7@A&H$QZ,N.#B8H_6&"M;($G"$U_38#]+5=S MS%TU,@UDL-4%$`+XY&6M)&-SW,P_<(T%?F;&6E=D,&-*30`VK@PI6X50D`2; M?(02'1-PV88P()>(TXVHLK&#M-@O+FC'J#]&CM.S=&=:2..HQ0$ZA08R?N%R M;6A&>&@Z%0H^/@I>$`([7F2@?8G"D=:YA551.%8<$`6/6('O2NE&981'5N7P MG9Z,)5_(^0,]@(&,CF$.7M?P=6#549WL;8$+;8%6%C"9=_&*``E('1R431:ALOY,,W70&SPZ&R#!HT1X3G*!=',GI)U!I MV3U@?(P#:1X'(0A(/7CA0,UI9'!M7WG$9%YJ%]:QW+7(%D"(W.5@%UX!1ECJ M'>!4/8"G!6@!NL5'/2A>3_:.'3!J3,YI&&!:7G#MADP)Q!."$C+N-OA>\Z.J M%HA:6B!L:"!:`%;@1=9E.6UD&]C^WO[=0M\A92D`DT-V7!SPZR?0`^?NZ`5( M@$->"%'@A=;%2$:@!4;``3U0B0X>BA98`1OXW@3X9EY@!%ZP@01P@NQ]`I86 M!48([`6P`='4GHJ4(8]PV:,P<0YN`9*>"1AO7-DF#(]D$1C`;<(8[<>(E"WE M<2`W$8U!#/B$RHW!3FX=M2SV;(/QER+GPF%QH02M&(RI&)/(1\:B\I7X5UZR MF1@QF+)=K`1="(U1'9^(B(V!\D13"D71$#W255?*@#G)43W7TT58?9\/R:'57%Y-Z+=*GVE=] M_=5,N=?KV%=>[U9<#[%XU7587T2R^HW[S)56QW4?#[%EQY1E7"I@;_9[A88= M1F*HG!@JU`U;-QE8QY175W5P#W=Q;S5C(>@V4:$2&G=U7W=V[U+478SU:'=Y MGW=ZKW=[OW=\SW=]WW=^[W=__W>`#WB!'WB"+WB#/WB$3WB%7WB&;WB'?WB( MCWB)GWB*KWB+OWB,SWAZ#P@`(?X:4V]F='=A GRAPHIC 21 y83222y83222z0007.gif GRAPHIC begin 644 y83222y83222z0007.gif M1TE&.#=AT`(<`O<``````-BH&&B(F-C@X-C0T(@`"-C0N`!`<``X4'AX>-"P ML*!X$`@P.,C`F&!@8%!04"@@`'AX:+"PH$`P`.CHX(B(>%!02(B`.*BHF`A( M8+#`R"!8<'!8".#8T-#(P("`>*"@F$!`0/#PX"A88%!`".BP$`@H,!`0`-C0 MR,"8&&!X@-BX0(B8F#@X.+C(T+BXJ)B8B.#@T#`P,!!0:'!P8$!P@!A`4-#0 MR)B(,-C8R%B`D-#0N"@H**BXN/CX\%!H4!A(6%A82-BP(,#0V!`P2)"HN+"8 M*-C8V("`<"`@((B@L,C`L'B8J+"PL)"0@!`X4(BHL#`P*.C@T'AP:-"X<)`0 M*'AX0,C(N%!XB*"@H%A84,#`N!@8&%A02("@J.#8R/BX$.#0P`@(`#A@6)BP MN"A0:"!0:+BXN#!@>,C`J.#HZ(!H$&!86,C(T,C(R,"0F*"@D*BHJ)B8F-#8 MX!`P0+!@:*B`$."H&%`X""`@&'"(D-"H&-BP&!`0$!A08!!(:/"P&*A(6&AH M8/"X&&B0H&!@6+AX@.BP&.CP\&B`B*`P0,B@J.CHV`A`6-BP*)B8H(B(B)"0 MD/#HZ'!P<-C8P.#@X!!`4!!(8$A(2,"@(("`0(B`@*B@D,#`R&A0",#`P,BH ML.#8V.#@V!A(8+"0$,"8H!A`6)"0F&"`D$APB.#@R-#0T(!X>+BXL)!P$."P M&,C(P/C`(!`P."`8``A`8$!`.$AH4%AXB-BP2#`H,-C0P#@X,+"PJ.CHZ)"` MD+"8,(@`&+BHJ)B@J$@X"("`@.#8P)B8D.C@X"A8,"(D*BHH-BH*#!88.BX&)@@,"@H(*BXP#`H`-#(N&AH:/#HV'"0H)BHL)AX MB!A0:&!P2'A@",BPN+AP>%A86.C@V%AH4/#P\!!(<-C8T,C`N`@(",C`H&!( M"/#PZ(B(@'!P:*"0,(!X@,C8V&AX2&AH6'AX/($.*'$FRI,F3*%.J7,FRIC;@TZ<1GD6;TG$JUJM6K M6+-JWO6X6*'>OPH%*,2(LZQ1@)K-NW<./*G4NWKMV[.LGJW/'7_M*GDQ9L-_"D#-KWLRYL^?/72N+'KU7J3;0 MJ%.K7LVZ=6/2L&,W'*CMC^O;N'/KWLU;I>S?L0$+RVB[M_'CR),K5PR\N62( M3:$NGTZ]NO7K-YUK%VL4*/33V,/^BQ]/OKK>)NCU\CK8)$[[.+S>;V\8S'#Y M^_CSZ_<<9QO[_^ZQAQYZ_KG77GO;-!&?@0-NXU]\Z$&8WH`4)K0>:?45M]^& M'';HX5?R(13BB!1&.*!["::87H`G,DAA?+Q<*.*(!Q5(5H8?YJCCCCS.1*!\ M"1YXHI`*"DE0B4@F2>21!_HWX(4F)C@9CCU6:>655RJ9GH1:(MD*>F=,N**+ M8'X9H8`*(B0C9;S4AF5/9KPI4IPHF4&GG%;9B=J=VJ6%)<5XB*D=\SMF-J!N5VI&= MK*KZQT;^.M&):C=ZQF6G'QG`>E>KO/):EYV7T*(K2<$..U6O(2%[E9VOIJHJ M79=D4%6OSY+:ZDIQYDI7EQ6N*$2R(4ZYXK3;+KKD8C,) M,9%D\0R31PYD5A9R`,;DC_VI^!0L M+1G0(NPH%J-1`\($%T)<(4$XR^%A-D^MF,#''`,3WTHL&J:3Z ME@X:[*Y!([\R0<;L&KA@_?7XR`X%R+8*X$(RR2C1.DD;J`'^ST'+=$D-7E1# MO090H(([^^Y3KX0.7-?D>BHNE*/&\/$00"/TH8WQR846V@#?`#;0$VV\3W9, M*-4&8D>]Y*$$"]5`!.\RD#ZM!$X0($37X.`EPA&2\(0H=,"ZWB4.+:SP7>AR M5[L>L"X5UE"%#E!7(=B@+AFZ2PO^-!0'#:-!$M&RM5+G; M'12Z,0ID"*`2O2@'Z^*T@0WH8'?)*$>0OZV,`@T.)"0M M4G8)9*"1"9.$T\/.>#XRDNIAE4"C`#S)$]J$#/-**$-L`GP;:%A?`.9-QAUN7:(0.SK?& M,M8`?.+^X\@?A/4]+QBP&P@H`OBV`;V.9&"0R5"#,4UR"3ZJ`1D%[<8^#YJ, M.2`#EUT1UAG]N%"M;*07R4!$-VQ<NX8`!U:00:=N>%3!9,!W,@PU40(`!E M1M0C-%4F`JCBNGDF0X`<&44C-G!&`4BK+M68`_[X=(F(^:$F:0.C%W8JDD;P ML@8W-0G:YI#$>L(E`?#06P*((=8$?$!OB1`K6<=:*+:RU5!KU1M9U_H!N!JJ MK':MJUSO:M>^%JH=='5K(MI:,"R`;XL?,4,C!HD_4M&B&F%$AJY<9TGQT(Z7BZSHU51:US5F@!R0JJL>J,'>@<[7KBZU:Y[;2MZY)C9D(?D#;B&,QQ._I(W*C+!! M@:L!$>/D#\T`'R,3FX%X:`.6+P;5M#RR@48DT)8S61\:MQ:2#"3P=L^BI'>9 M"1,;CP2_T33T(O?^?)WS6665^"N M*2Y&.K,599=-ZIJ;13)JU*U.C?M+)QL`*2UM&TWD'%9 MUY%*5'<*E:AL4RI@64QYR=IT:H`;$QA MK(#&1B'^'&5QBF/B`9A(><5A:'$<6G.$XA#$Q>'E+GA1_(2"Z+BC9.X`D;@V M&184B89I:34SF"^AS:`%@9O:TE71XL&ZE7`-!N`%XTH+86B0%I0_,O1D)'>LSQQZX[U]<7>E'%\2-F@U@<7:QM#>@X[3Q6MZB:@?51 MYA$R)'&30"[I)3EY=EZ'(T3B@`DA8`$A$`(T%`(MD`LMT`*8(`,RD($3V`(3 M>'(G9W(CF'(C&$03EW(4*'%"='+8@'*8$`U"1$-L\`!LT'.)U76Y5C#(`$:$ MH'2$!C[$!#UW@F#=\'25UA%_L`$N\(,@<0E,L#ES@`CQ,`11QVUBYP)^YQ'= M%EESYP6]X`*M,TCE4`T@<4>*%`_F$P^9]G=8$`^<$U)D(#&E\FH?D0$Z`(=< MA0ASZ'>70`ASH`%D0#Q,`#$(8P;^4*`&BJ@&+A`Z$H4,4-`YU8`&$%=@YE,. M`?AKVM!V9=0-&)0,.H!HX<-;VC``_P,^0W`[960&S`.*"+!+X*,&1J5AXJJ1!2H``S:`!ZJ"!GN8"J1E8A+&1S(U`YP9 M4D\D87^,)C)H!'[(W9` MERJY(W"4!5D]=EG/V';((';"I9W_\QRM_F&.RDD`:P$`;(':H("VNDT!* M<"K(`(SC6#`U`$:$=#*C$Y=S0&5B]TIT\CW@T0QGU`L5\P<-271()&2PX@*8 M=BJSE`Q0D$E,P$O)8%T<47<")4;-4'>7`(Q--'H;T)U9E2RT($QJ\!$RED0Z M9@:\Y(@U`%)?5T9;5D:7@$0*95`KI:-Q!/HY.D[G=['8-&&H$,:*!!0^`"7J`P&T"BF<@17`51E+4[ZT=KYF-==(((`_!'\30`L:I.&5`#&M1+6'"N'T%4Y;!. M1A2+V8+^J_%PKHT`8IC4#1(#66H@B,W`50/W!]]SCG_P!T?W1/MWL?C(KB&E M,,]U1@/`5*DP`"[VB(W6-IAU95Q&:!^+`,3U4Y(YI`76"`*UM+%FDB:"=M-`23-'2$@`!Q-V'3NKLIHVUA.`3X@`]#4,&A.IBV M9R=.]IRTTJ+VZCKWI%"=IE@.9&BQ%J"?6PT;X%*8M9:6A:S@$WE(I+V[9CX< M%B>-($S/DP%>M,+S=)O*Z\')$(^T\#V$JEAKV:H))DP.>FB":,)$5EV2:7!< MQU5:2"?-P%*\*[:8Q4?SVQ%<=9ZT,$\"H,"B@@#"Y,`PD7$7=W(SB`DK]``6 M()849P%".99Y&I5U:I6[()52&07^4YD+&*BG1-F!;SO(A`R"8WJF9\J!XN"! M7,"!8$J!$&BY$I:AA%HPF#PL_PI3PED.&J%<=EEU'82'AX4RZT,(/J9*EZ2I M$@:[!\Q5OPI:K.RZW7!&HR8T9$`(G49H2EQ^0:LKMMK%"55;3`92%#MW].18 MN.J_CB5V5*98^.!/;8EKJ;"B`*@$.]C!("9`V7(JJ5`.^$`J?X``WW.HK@-B MJ9!)+1Q2D3=/<\!UTJ.8`*I!L4O+/D7$MSN1\>H">;EK3-!I&0",VI`*6� M-;"6]JI.VA8/A'!(3*`-$LT$A"!VY]F7_\-`<8(`?!3/*YM&OK=*+A8M5R2< M:J`#%^;^6L?:5#Z#.]I0#D4`-*QV1I*&61_:=M]J(691JRP5K?\J+:%_<#3,0QAR4`=]# M"`:-T`H=I"X!.3,G3I$C5HJB7N_U5H5R5NWP-G9%30X`9PD0+NW2*(5`@2(W M<4"DV7#*KL6*?DS+&=:*U#.@]5;L<<1G;^ARIAE]3W.\0$ M5TFAHE),`%*$>MWQB%G!2:%'R$>'ZGR-@(_-QLZF')X>ML_XZ*(#[T`RD!F5XH+?2H!!SHGPQ)*IY"HM&@@5GUEE-ZO MG':T4`-%L#LQU1>3;_X?=^WZ,\Q$3C3U&=A1G+H8DZ0XTV- M`F;QE0"1$!@M$@>#`BZ3D')HK68'*`B00%8/D',Z%R\/B'(@.`GB8)66?&@? M^LLC,9@O#!(J==G@$]ZC[,I/B`;^JUS]-!*6;,':P-!WO=-VE0 MKZ,!'GM&WPUB>#[>,HS9[L9LN>52[6V,1PC?'A%P7I=*`IR8TH(JQ%X2M:>. MJ,LJ\ZFDQY8*2:4!O!2D&Y"A%?4SE0AVJ<"=B7F$R6WC"-L-`H`/;M%;L,1$Y^14Y;J8H;+9F>J9S5+K78[4)<1`F`W(& M(M\$>A#^7V^6."J$-^:"7E#.9NUP<1<771D7$D9C]P,!5"732U=N&O-TI*L"5RUPWL8\^7'TDZ6G4W!,; MW%.;]7;G4,?7"-]#[]P\4&8S`/&XO8TW+/QG,2"6ZB>#!;?(!,A@SKPCGK`N MU+)^*D@4#]!=SW=Y,CX5=.P4O'3R*MF+1O$@74GZCRH1G?29EEF;P7]7`T,P M`$J`!A16Z9UHX,2+>LFR\Z("GC$-A1Q,+(2@!O-Z,C8,K+0P2\H-SN#3VL02 MU`GV[LKEM9XU684?_ULIC=_*@Z[`(&3`!](<@;?$@G@4OUW4RAAWE9K ME6;7OU^%,@DJ0`PX"!+#M+H1ZK5P`%TT'KQ68TF9 ML`?2XBF3)E2M&KH%OE0MV1R,IIE<'FY1Y!]D?\M"7AA/H]9D3&QC5&C=--QD M19Y"]"(7S:B!AQ=6NW[QTMG"`LTT6DG5*F7+R5P@T$"&J^RRM*BKN20>-40: M98/!!*`E@TM:JTZI`&4B#2(RDAE`.8'^B&FF/VY*)BD+R^./OTT@B0028DY, MX$1(($GQ1!>)6='$$5V++%$$F-4<4=B6%$A(X@D:BJ]AVC99B'K++IDB!HFBVJJJE(" MDZ(/^;/^B)8:*EE(,;>82B:O.\@\S#3P(K`0N9N+U?(0 MRZLTK>(Q#H4+=0_,]C@+,PV M8FJ`C/Y(Q2&1:*%MIC_)74@#E[#BS-M1S,!*..*`0L:K9+0Q3:0-XGFL+&F' MVXNS9.*Y="!D(`W.+P3@[88[_>"E);RAR!N(0<V(^!,I@C5J$%JB^>^;[LR5"W2!)@MPQJ\`A:D2X1N+`_ M(1)8SH$*52ZH>WN-*QE"&MD`W@T0T(8)!9%]V+T,)%+C0Z:<@C<#A9+99C^L M)ASP(!=R:B:5&O[X;&ZSY%+CXY-3J]4M5W,]B"G)(=H83<2&I:6QQ]!-)O7> MT=3@,6>WC59@ST"K]ONH](DPI`QU>AV*P."%:@/?4(*HW.L@RLURE M/O;I3P>Q0]/&W-,QJCQ$/0PJQTR&EI&;+40N)5O9HI)1`Q,JT"/Z,-2#:@;` M1N!,.1"C'"U>IX3UP:LRU5@A2HXFAR5:*1)38AJ)F'BC'.%H1U+3D8L2D(4X MQ*$)3=C:&>*0`$Q@@AAB"]O8E*2B*L5H14M#&Y1@5*($B`0JJ?`(ZY3U'HE( MICREXIVR$*@/KF"E3)@IF!T;08@A<,X]:;KK;,G`L@DB!:5*-T M:'C6;A@WK8!-RR8YTU0C^E(-G2"F0QHIY7JTL1^,8*51/B0CM5*5`=Q'5XRD$3U<$B3&85C(4TP"&.AH(3`;F2?0D)$YF3"!"0HAQ+I4LA6/2L6@-:D@9@TY MD498Y:,#"Y8$YZ`!YFH`"J$3`%CF%I-.A6BDEYE+OD32"!D*`+,#X9,7.L>$ M.?3,#$Q(!0*\=U0$K*0AG_F4"P=0!&UX80Z(<,A(4\.$[YZR,\\,'W"0X9?2 M)F2"4'D=A;91WP'\%B6@2U='0RL0!#P5LY#LSF.T4=YB$0(+`R8B61J!CU#! M;W6`F<\T!U.SFH#3A=6PK4)0<8G^#4U%``HDPP`NXQLEH*'"XCGJY%SH`B9H M8T(@[,8?1DP86ECE/>'!S&:J,>$V>8NG*].6GV*X$#7HH!MHJ,8`/$(&,T`! M+#H\ZB5DJ`&B-,,%U?#*`-!`%):IYKE*&`#!KHP1'BU-BR9R8Q0AL0DY"GJO3YS2E.#H1$C,P'@U M<.R'S7`P$K-9+P'2<2^\T`P'8L&Q=.$;,JHE%U2@(9G#%%@UFK$!9"BD<%HM M#VK\4@-DF*$93$B-$NJR:I5^N&'-44TS'F,3VKJP"'6YQ(0R;`8=J"$>&;PV M=`[H;9RX7W3D8E&#M")0!H:'-&EDR:@=)C-N-UBVTW M]=!2#I@F6`,;0(.V7(`,@R"C!IF#MT%*BF^T?,\,:`#3`)BMP(A_!!D41X.] MLL>:A0PA7&8(CW,&HJU[SV%O%R%V*E*#$U^_!1FI0,Z]?"U5%Y;#Z*D0]\"Z M(4$7U*!S98("8NVHAI@,0!MH6/5:9**>&NS\WM)^2`:2GIIY\ZE#9D@%G_#A M](L@(U#W9C'?=BV`9N]%@FA)C%YH,8>$[GDOB[+RXA*<&C9[Q$R5R4V?DGF) MPI[H;HB(%R?/]BRK_"'/X=M($/J?-,']:>OC5'4 M0`G>G/XV_'3$SRX4"^>'_EEZ,8?(Z\1@TE>_C"F/WV,(_LL)<.L&OB.#>&#` M!L0N@ALAYZ(G^&&"]Z.^:B@")K@Y-=L&^)L^`0BMK/@L-2`S[NH%1!B+5(`" M]5,"SQ"`(E`_+\@@J1H"HQN`;9`NFX`"#RP"2,&"%:0^):@!%61!XVN&(+!!*!B5Q:D!?2C^`@^L!B68ORI4/S+(0B^[!`$0LUY(OH^J MA'(@@ZJJ@7A(PB4L'-E`!B1"!D)P@3D8OG(8`DA9&3#KA7+HA>([OW#KPP%@ M`L`X"C78'`%0/PSUZBTI8$\L#%`YR MBVI`!"4DA`S(@)48``-"!DI4/VVX"#*XC#DX0/XC!+"XD$MX0AM4`F1+HBS1 M(JF9!'K0D3<"M#[3(GK($BEIAR@1O3@0DK9J*TD[`SG`AA8`&["9!`?8QAKI MO*ZRD;5!-$@PAK-9$5/[/M-HAH'K)9-QB)9R-FU#1?7H)8OR)?^3C=02*320 M1WSBCP3^V8!UI(MI`@I:,$A@J@E[1$B!&(4,0`9?P\>5J8PY"Z:544B"I(R) M'!3\PXHBN"P%T0G_0P8=*`<$^1`T4`-ZDPV=L$=3.C[L4\C2*@^(VX!>J0SS M2ZR#]+]@:LFV@(H%08.:O(B6.LCCXTF=M`JB-*5+,#6+$"ED8$=6,8TY$TK^ M.$J=!#>E_"5\_(R@5!"H>$C$,HBGC,I92;*6"LAAFT>@<$B(Q*>)K*H6$\IZ M+$I6P1:*Q#^Z-,BZN,OG`QEMX!5?')K.L41$4Z1&H>1K,,S0@831I9*M&JT;^%A&'$"BC;!2' M1$B23%,:VW,BOOH\*;H'/>"ID&RHS.HL]_`2]F&8%4(3DUDA?-0J`.I-AGD< MOY2-48C(LA!.28+.F[H*=#&(N4$`%WA#48$/9^*IZ1S.X!3.>GH^"YFPARA/ MX%1.B>Q-]UA/^&0?]IS/JZ@)X^P&/[!..@&@^GR.^`2N#Z$8^_Q-P7P.Y%S) M!(V-JV!.9+N$`95._P1.@%9J MU8)H?3U%39*PP=8E20`G^%=C?!I`BX1VD(,LD(-PS=>575G&`3Y\&X!>I*:7 M2A>59-F;Q=F<)=.=F`HHT%EQG;UC=-,58:*QDE0;D8.$W=-'.[W3^X0Q>H`0 M:`$9D-H6"`%&K;2,952[T@('X!%L4)(@3=%]K9$X,H:B4=*?5=M7U8D-P`(= M@-N-I`PT$`#/P->UQ=N\U=N:J(%>L\R];=-+&T>GB9%.2X!(.`/5B[1C73UI MW((S2`!IG5H9P`1!R%'7]%$+L"L@W4RH41(JNB*#]:M/,X;^M`7)K75[Q7?\27?\;41 M+8$BS_.S)SE9-SB"]SV"WY7?57"#&_#=^5V%(V@"Y;W<'NW?!R@C'ITKVBO& M%9F$*9B]8FRC*$DT0F/?[BW?");@":;@"J;@HH6CV[O=W8V#^\5?X)W?^)U? M?'``K=U:`&[-J\6&2-A7J&D18F@'*T&1\TT:*6$B[&6B.K+@'>;A'O;A'Z97 MI?F\V?PJ$@G4*8D#2)/?1@/>1KO^`?KU7?M%S3,0FP=@@QX=F[LJHR3!UASI M*G]UHJ5A(I3-`CS-`F-0&M&-!`@&XC9VXS>&XSCFJ1-YDL,5XA4)5%!+VB98 MO2:6WW@@WD=$L(`8Y^%--3MHLP&@O$@:0YB)M2$]]5NF59NF67J$\ MYFB+?J*#]69&.U9\"-YC%:.B^0"I2=2P<0!!L%:)CEY3'N8J82(I:=@NFFDN M.EE`E8-'Z*(_16F7)M?V=-(/A9^5U6HR[6H1M6KI#.L]"]0H26=*QN35\^`C M8.+Y)8`F_@0-:(4F*&D6((9H#6<@M:M<+9M)/6N:5F,Q0ME[:.9+]J)*]J(X MJ&HQE=!Z"M^4%M?^S/YL.C&A!FUL M_K#LT;Z0RM[LL<:(&3`'STZB#WWL3K;A1Q"]81:&+"AH^.UM@\YF089JE,4& M3/C13=OZ' M?O!LU0;3?K`%9G@'34@R)AV!'_`&36!OD7CO^)[O>#6#,2`'>6"&,0#O)!-O M\A[O\<[L)!H!6R`'3;@`Y8@&^+X`*_CO)"IP.1X#^&8&;XAPX!QO,Q@!/]!L MM[PX1,^C^!WG0A'Z0C1&P@G?XA7>@\@OX@0F3!RI_ M!V:0APS]`S^P!7K]@_2>\G(AR5>9?IM8C?HFNH^D4G@T;!U M@*[=S!K)S*\:8TI.[$C.Z,3^(DHF1Q6X]8/X@V@X!&\(=?@9`SU_!7)XG#&X M@TP8`5O^-0,C``--&'=-M0AF`(-#N'!R\(9+AW,O_0-8_X,#^(%7>(5SSW>4 M./A?D`9;N.QOZ8=?.`1;:'A,/0!R``,<`&^+^(%4?P?X]H:2]P8KT'.,7Z$# MX'=TMXC*SH17*'51'X,`N`/_KNWQY?,`D'>WL(@_D`>>MX(Q&($QX/<]F'EY MG;!Z__2,#],2=^I@/EA`Z]TO*DVF]>!D%V1D;86N@01NC`1L&.H:<8`$1I$9 MP6$D_E.D+>,OVNV1#E1CT`8D#Q%[5WG4MG=-.(#ER(0?06:EK_\@S"'FI?Y`RCO\3Z`$T'C@<#;V#U M*XN&G"_3S`=%H)'S3'>+&3"#7[AWS3:U@[<",-@#VY_7.A^($?#T3"=^*#7Q M/=9C18N$4R!>%V?K)\[ZWL[?WCZ'^8T#8IB":TT`;H0K;%!&*?(KA.7U.`@& M%IP"(.%FR"&N214X6@0BU=6OH\"'$;F;Z,2OQ:LR?B!'_C'EU,>/&,9DT MDG0XP]:%$257LFSI\N&?=V"8_3$CL9^\0X=^@'S9@.#H^=&6JL]5/4K\2_S`#XZW?W)"9P,@[(/;A8IJ")Y=DR@QQPS\H MPU+NW#!.'#F1Y,1I(N=T)&*1!L9Y=&;5JGAN5AV!;1MV[=NVV\AV,WN5&W1N M\#5)36P2O023L&$C!NGY:=()FPA,&$P.)-!G#"84.%JTG`1+^WE[Q6A7"M.(,18/Q@XH`#/OB'.3'VY^`?F6BR8GTP'M7@ M@PY>^9B(^KTS7X1C*4F61%EM5=EB%U`Y5C\7E+"'4O;Y^%]^+8H)8IUWCO6' M']"04Q.,&`(H48!R.DG90*)UIR@DDR20`+'I4J,E2 M3#,)6E\_1LA#WQ]_]-.D6/TT:Y(YYASKD+1,=N-L?4Q2I2%59EC;[+7$_G#( ML&QJHA-/3%KKT+3P@]&2&KU::$R^\%,-; MI"V`_A'-*^AM.RZ*7&V$<`5H39WRB MZ6\$='J;II=:;A!"D*R:ZFJ.@](USPBSP.1?/^@S<7:')R1O)\:?(/Q]?4CRWO,)/8#&-H M\D->&_]PP3M&]'A5FV#\TC&1TIA-O/$\D?=.RIF-@;[W9W8S@B:8`8V:7:!Y M8X!>`3,R`GEDXA"O8(8FXE0335R/*"G)C"UTUX\?O.,7FDC/ML*V.VQ%@X)? MP@A+?.:-+TW/%MI[7O2,HA]R?`DM*,K>.RZ`%#!@)$F:.40`?&4?"C$(7M[X MA15Z,H.B]'`&-+-99IKRCHP03SY*V98WC.`_DARP?AF!(3/D4;`5XD`I)=P# M$,/8E6A8`0?(-*/_=70"D(:D((.<9BS6:$$A[!%-WY0E.\1)7T?W`A* M3,D9XLG19.:@(0HE8@X`?NE/T;/)_NYPB$Q,1!(I,88*G!1/]QX@`I-L25$>=,5)4D. M'+&Q2'!:3P!T$=/P`@&-[1L9<4:5FSLRQRNM6N9H:!FN!HD2*)6;FV-A,-;"9)C&<7$@6/8 M7W/;\HL<-O<7>6WI2]_"%S]8@1G^1/W!`2Y`U)`Q!1K,4"I9W5>]W7I/C-[X MJ(56I)E,[#4:\@`$7T)HA>865,"V-=MDJK,X5E$S.J-)S22:\(E*'*$)M.GF MYCCG&^&$+L8P_D0G;GPIU\6A4<\Q'3_;&9J$\&)6T7E`2`'\#Z9D94A+"-E&4-4I9663`RBH%9(8G@! M5:"/?/45%ZJ6'VJFES$$X!7M MAAC!"!/^\I*1FLR15\S''&GA<$VL!=6$9>(7_%5P1GG]+`T5"0?E>@A4U2>] MH>+((1?X@1\"<-=MH1G$Q2K17.8L M[6@&!_B%UBYFA$R,@#X!MFI3]U"",3RZ3X=@Q@421FDPV$*Q,IEB8@/P"R:M M.:IY^?>G]V.."T"#X-W0,D:[800X^;M"8"&)('6JTI(T$"SVE@D%>7H`X.7Z MS'>8DJ_-H.FP]#32?Y#/8L#ME<9\_%R:1`Q]S'1IO$7I#ILMRUNX.HAH&O7U7!EC-/`4QB>.<(1>]*(VGVK^@Z=D+/>Y?_-2 MU3%-.U7#.,@]YP/NM&>219.`2#Q##P;E,T6+%;*6+&992LH$>E/T`^0>;03X MLF'X=@FOCDBW&QMH/&)X&@UM>U4S8JO)6CX]Q+>86V)OV4.M?Y&).T#C`M&` M5EDJ)(_L'8`98^O=#ZAD6L\VE?1B^8.HJUVF$O!DI:)FQ@%6VA$Q-^1>A[`" MJ;=5I)#M&HJTWL,?9N`')][!^W6AF1'H8Y,1--?QW>`\8:9$=6.=>=7JIS7` M2>+$/N.`&?Y/TXH\SP%(A1'DA5=@V?_LP1W84`BU%9OH%X*8P4!=B!_(B:$D M2(4@H&8HV!]-3&$L7D=`@Q!5S3O^!$#5A(4?[$$0;8M,(*!-=);`C!YZX,_H M-9/E98*9E0E&D8QGY=[`(499R!I(0-4(F,C/S82N#54`Q!(JO<(A3%R9[)(M M`*$YR,2%O-_!1=^$2!'J-<5W398FC(T@64CTE<76+>$,F.%7$$H(K5=9-,78 MV`3RZ4Y>L)\)!M`?#*#[X-555$0.I+=SBD4U'T)EB M/$0*+N%&-0L!ID5\W-:*F-88(,BN.5U:S(`YO$4!WL0'[D??8(LM2(,1=)U& M%`MNC8'^-^".?G3,'VB5;EE)BE099Q75*X$6FV3-RJW%R36$Y>T!3'1;6(B+ M%&'&1.#`)9''5-Q$A?"$?B`%\TF9>O500Z0@G7F%)EA/](F`;/C:$2:*>+7#= M8&00EC6+-VX/B0P)OH&;1A0(NY4$A>@4((V!+IGB7!3+%<[>37%>Z9'(!8#0 MS+"%P\SA[K0/1`8)`EJ>-`3?59)#>\BAJ+D4CJ3(R@E&=8#^!PND#FA$3CLI M"D)@1R2X`:50QQDT8J>H76Y\#G!LSJ78G:X0P^`]3A:03D(T#M@5V7,8PZR` M0!:0(KEE`O'\P`\$W<*0A5>,$%9B MAO79@L^LI&-T5`G@`%VD("#PE(:X3$0`!2_EHDE,WZP%W"'PU(A$&&0$E9GA M%#?B36&XWQLZ19.4A6SB7K$X7K%(9U-%U:4U$C2`IL[48NN!([R\0PG,45KL M6@"HQ!]XHSK2)BG^`3LR`Y)0"!.*(QIYU@8A%#Q&V%P0B:+UQ$6^)3Q."7^] M&84VCS@&P*:]S`,YVU<))7ABU`C^!$#Z(88W[,$>3.&9`5'*J"08V(QH>=2* M?!8VAD^DV:8E/85-$(D)TL=HO@*XD254\-FV->'!D6(##0MM"HH9F!:`-84I MSHR`O,>\-+:T,@T@D%-)BA$&LC"%$OSM<\(Z8?))6A6*44*3A2@",8T M18<]58=`X-VBH$8"R$$3N,%V9`XL1*)N<(YM:`H^6,ZE^(:=1L(DJ`8HVA/8 M18(P8`?KC`:K@.)`M,(C-%F!I4^M&4%$/>9+F,.Y7-:2N"4T%%&"9N0;E@`:^J0T MQ%+F963^EJH4.*;'AQ91"JKJ6/SDR"C@5H3D3!A/K4V5E*5I+&$K`J9@^5%4 M+184S4BK3RIH2?0.L';#^G0%1D);=HJ\U,3025?`8>2WT?$!$;,P/EH@B:\6<(A)6,@"'GHA'E.;(-^%81^Z#L\ M(V#=7ZBUQQB,@"UDQ:!QFT>PY9Z(&FI.;%'-3)_U4)`H"SELQ?W1:.#RV:D] M6\ZJ[+/USN[TB5:4#T4(R>@%0"_^9>Z:8NOBLLDPVN:N&JQ^.:@4I2'RO0+S MF@1,^L[HS2=F9/#*^D4K0"U@/HX<.,&B@J)JQ%-J8$/7(N81&"9MV`9B'G$2 M'S%MY$81;Q.,1<(4T(,\5>*C1@)U-($6@T!T&$0U-?,E^.!'?VH3T"DEFI!32$902016_P4L:-TDT2(])$<57,`VA^,Q5%(D: M`XB!K!;%DD7X!$#)()TEI6[5A)?ZK8?3`F1.TIH;!LG*8>N1B(NG[0?)$)R9 M<0A)9/!95H0(QJH=9P;-W&>SP)SZ<82FAK"565+H:@3[*9HO_@`%J2F+`FA\ M^@Z\C-[^1038X@%.1^:%MT)+!IO;#[E'K-);3RP&@,T`+4IL,4/5EX0L8MUF MW;2NQK0)$!DP'`[SIV&S6"`M'"I1:)@Q-@' M(6_LFBQI/&:62M%I?& M(^"5!,X1E?P0KYZR)7WJ370$"A'N)2?L&)C!"(C?<#%U^\P'S\E'"5#N3+;P M.R!7HS7$&?9DH5F!WK0$C;(BRG5;>NW4.!>&9'RH/%:?1XS^`![IB+W8AS7+ M3!C:8HX.FYG]P0@<'(;@XON)GVFE8I,D%5XMZ]#H1Q:QQ6H6B:ABYWQL14T- M#5__D<:6Q/:M%HI@I+A$@UA%&J%\&T<0J%8,#T04"5UAHYALT*KM=0O:RX3(!!3F*$X` MF"5-'(=X5":0(^^*\%>02;18TBN8)R?O9Z4U2U"JS8KL#5BC:E`3\$2I,-9, M=HU8'T:DC%)#]0\T=&+%Y)72\&H"\&M3AM4R3FC`SCL]!SP]!S%@PXF!0)VZ MBN9HCC?A`SY$(N=$N(0/1^CX1H3^)P`F,,=RV).BM&EESFU!=.;2E"@(?1Q[ M[,'FC@P,@H2SW,OB36<1]6P$F4,&M45*>(5[7-KE)B5L,((&.;1$.( M/N'\F@%)@1+R:1%+S%\``PAVJHF4Z]X_@AR^CB-GH&-,80U90*P9O,,+EL`% M4-91K1`/R<,4YDZU-8EY-6>D4V,])@"P?%LL4T-M!3&'@QH`UWKQZTD M@J2I%G$+`_&$)3]%+5:9XX;8'!3HCQ0\P`;ZHU7_#S00"9(`U=5ADR4#$O,]E>$H:6IM2$U[1Y`D%P<,#.T:](>0L=9/P%RS=GS2Z=/EJX.`&&"U%(0U47_L(AOA]P M!+'*D?\4R2#/K#O)7"#.(5?..07,EG!]$@S>85AFM*4=$%%[PM7\) M][""05`8`30DQ4('-^L7RQUP%6B:`;KTHX906?38S&S$A;9M$HFK'RS@C==YJB_0'9<48W*YF@ M9"K=V,$_O'VRHAA,P]_9*+\XT!$(QY'`*YLKMN8/9G( MD7[HS4B``$;(';[\YX)!N>Y.^MT=*\\I:JI;?'K%&;9.>]-+\<^8=WON M9-+4+?O^7MK07K.E']I>.>BAOWZ8CR(CH+%BOAFLV".`\0AD1CAY<&C+MPO@ M$@ZB/?8P#B%O[ABMFV@RV4.>OAXB)X!,?NB/HGZ8`>.'?G`3CCX<`F#&C+YF MN"`3R"KR(T7Y*$*QQQ^U2^B^_#3Q`[T_JA/L$##`*#'!`S-!\J,_-)$01BHU MN6.QN,(;K\CE[MCCK2DS>ZVA/WYX#3L='_)#DQ0%,P*O?EB<49Z,["(L&AP[ MZH-_%!0LDSD M49695R[($<]91P*+I9MPS2*.21(@1E>PL'&GUTF(2>`,-YK^*&JH>*)J-JHC MH#UB%6B=?39:J:)R0ZJBSL@B@:RP(L;6DB(9"Y)RLW`B$A5`HE)!]]Q]=]9^ M^O%CA.,<_5+>;D:880;(^& M9/4HWH']V]>C>L=P^"/!0.J7XQ&HY&L$*?^E*-6/3T2Y8H8ASNT/>V>8V;^5 M^^GO9893]DC*1/U@&3>4A9L-(8\_FJ%H]`)^>&CW:O;H@'D3F"\S MN/[7TH_J[5SFO&$H)+YX?V';OP MPDE*Z9%SY2"&F'/5)08;D>(`X29Q)LG=@5ZS."*E2"+1M0DRE%IV%6:)JK9: M?(QZZI,SFLCB%.`G$2#CU.#Q]/%K46?]9/C0##%H?,U[$? M^SANO_W+/,TM&C"REK^CC/FWZ'P=RZ<_\P50@'LA()XRU@]-7"!B!33@1PZ8 MHX0`XAT'H,^`NG$!:60B?@Y$H`=!0K_,E4Q"':I?"$%8N`..T'_E6R$(=063 MDI0E`5MQG4J"![Q-N&YW69D$/:Y2%.$UX0S*^@FVM.6L)#JK#=BBUK.BDI,S M%-$-K9/^H3#,M9)?Z2H+[$KA%STX@VBTB2-@[`8YF%%&,YIO/F908":8MD8Y MSI&.=7S(IZ+#C-'9\71NK%&,<&.&R_1C#T:((Q\129T?@,&0B72D(^,0!QQF M824U+%;NS@438A#K6\5*@#A<$@)B5&(5G3#B3WQBE")F:XG4BA:TSO'$5SYQ M6DTH2TG`4BPY-*$)*(G#/<#W2$0>H"#O:*`'S4`.)@DS-Z:1QP%&L`3X$&.8`Y_$4E1;UB?=MT)(W`<)X7FI.=>QE)%ES7NM6][ELV M28`3;N(Z8D$"&S6!!#P>0(PS5.(I02'B&>+`2Z,TZXC*`XK^\EB92H2.*P[P MY)Y*2,*"0[:S?6ECI!Q'9-6Z2>@!)M\ZUR82\/D*H[:N/)GICA`L60G9WN`>6AQ)].*0 MUF`Z=E;QXFW[)C>@=?Z6N"#\`P;^$7M<0"&$7MHIKOR6MM'G(M(L9/$56#": MDM;=)'A([14((DDN>J@D#J0\P@"D9=5*6#44JD7O+`>PWFC)-KZRE2]]U6M5 MWT&B"68-'B_U(-WI#IC`!38P'V4UW`,O>)M.H!U,1@*3BLH.>)%H1V=5(MDL M\$)<2$4)-C[1"_NJEL36HM82+'2W5K^#Y^M60I9SR1DL M5\G")##^X887,^^4S"MHM8[`XBQ[N:%9=C103.F3)FSE'Y#HXILQG6E-;YK3 MO/U*K2B)V>`M^5SC'36$21*].7\K$@[`Q"2@Y9-FN;+$2SR>K5,[:Q+/\GA' M^(1WLY"63@^;V,4V]K'!B,N4E"0FP,-PL4@RX;)VKPG">`8E;4*,!\":';*U MJAJ@95]QCYO<^;WL5V-B5%HI):P43?JM9N M][C7+9D@U0'BJO*T5D'0&XQ8W*(X;XF[ZJQ80E&)_>T>+WSR9S37F^,=]_C' M"^SL1T`XM-)3R4KBT`IR:9&+9SC%`\*U.VV[0<3E7J_#I<7^[FBU-UHX/X(H M*E%?^KY7OM&ZP2=F'0P'.)>%3.]C@OO8=!4Z]SL>6:$+4?A`I\M&+ M8XC[6MC2M7IM?M]P\SSGCH[':Y_7BAL\HA&7L/WM<9][W>^>][WW_>^!'WSA M#Y_XQ3?^\9&??.4OG_G-=_[SH1]]Z4^?^M6W?O0S,)*$1E+5"DWH.\^P#:^0 MY`P]X.)(B)&(7$;V"+T(Q8A9*^C^UB/:O4>(1\[QWUIG$4`#J<#"_P$P``5P M``FP``WP`!$P`15P`1FP`1WP`2$P`B5P`BFP`BWP`C$P`S5P`SFP`SWP`S4P M%4*O$D)/Q$90MDKP!$VPYE90#5(P!5,O!F5P!FF0!"6A%R0A!W$0!V_P!DO0 M!X$P!7LP]'20"(TP!XO0!W=P"(&P"7>0")EP":$0"H/P!XWP!W6P"GG0"H70 M"I'P!8-0"7E0#+-0"9&0#-M0#!,1B%<1B)L1B-\1B1,1F5<1F9L1F=\1FA,1JE<1JI ML1JM\1JQ,1NU<1NYL1N]\1O!,1S%<1S)L1S-\1S1,1W5<1W9L1W=\1WA,1[E M<1[IL1[M\1[Q,1_U<1_YL1_]\1\!,B`%!,BB%TB>%LBC^C?(HD3(IE7(I MF;(IB;(IH3(JI7(J=_(:78`,JB$K>V`KJV$K>Z`KN1(LM?(KOU(LR;(KT3(L MM3(KV9(MSS(LS](LR](MV[(LN5(M[5(MU](MYY(NZ_(OT1(LWU(L`?,N]](O M`W,PYY(LO7(MX=(L$Y,P^1(R'7,L&],KXY(P\S(M#W,Q,[,S^Y(N/;,M$;,R M21,O%_,O0S,O-Y,Q1;,T[=(T,3,T-3,P^1(U+?,P2=,V,_,N+Y,WQQ(XX=(W M@S,W&Y,S5S,N8],O\7(OW](U6;,U'],V"],P@7,W:;,V39,R>?,S]5(P(Q,Y M=[,X3],R>P#UHG$`)$$':N_ZW//^/>$S/N5S/NFS/NWS/O$S/_5S/^TS`_"A MYM)3$E#A$KX.Y`ST0!$T087L/ZE10#-`02$T0B5T0A>,0:?102DT0S5T0SD4 MI2Q4&C&T0T5T1$FT1$'H0Z%1/5'A04VT15WT15_T#U`4&D.T(D;!%'`T1W5T M1WG4%("@1X$T2(542']T2(WT2)$42(LT29FT28-T297428\42J6T2JWT2G=T M27^42K&T2[U42K541[F41\7-5W;-5:=-5WI]5IIE5?']5QG%5M1=5ZGU5NS%57ME5SAE5]]]5WY=5Z1 MU6"7E6'C56$3EEDIEF#YM5D5%EW)M5D[U2,^E1GKU"-&E0Y(MF1-]F11-F55 M5A94=F5;]F5+EF5A=F9IMF9M]F9Q-F=U=F=YMF=]E@YD]F?^A79HB39E@[9H MD59GC]9ED[9IE19HG39J4=8$.K8C\($"&G1%/>()I+9KO?9KP39LQ79LR;9L MS?9LT39MU59MJ[8B/G890[8C+($.ZH$.EL%N\;8>[I9N^79O\?9NEX$(\I9D MEP%P`;=NEZ%N"9<(ZA9Q&Y=P[;9P\19R$?=O_]9P!9=Q(W=Q2S9Q._=R]Y8( M"G=T19=D]?9S35=R#?=N'W=U([=P!7=T]Q9P3;=S97=S(==T13=S*[<>$-=O M9;=Q89=Q"[=R:3=R'==N2W=T)]=P+9=P99=UFS=Z]U9QD7=RZ99U75=RH1=O ME_=U^;9ULU=R15=U)S=S^Y9Y[?;^=W$7?)&7>3TWOFV=ANW'LJ7"$H7@DLV>>WW;C6W M=,>W@;VW9.]7@#_7<__7W=S\W>?V7>YW7@_L6?%&8=HT7?&$7?VE8 M;ZVW>-N79-OV(=YV&4.U&RS!=XFXB(WXB)$XB95XB9FXB9WXB:$XBJ5XBJFX MBJWXBK$XB[5XB[FXB[WXB\$XC,5XC,EXC'NX&WY8&8/8%.KA"=SXC>$XCN5X MCNFXCNWXCO$XC_5XC_FXC_WXCP$YD.VXC06YD`WYD!$YD15YD1FYD1WYD2$Y MD@'YC-/^.!G7V!(P.9,U>9,YN9,]^9-!.91%>91)N91-^911.955>959N95= M^95A.99E>99IN99M^99Q.9=O68W<%D"C,8C=%$Z%>9B)N9B-^9B1.9F5>9F9 MN9F=^9FA.9I[%"0J&1F#^$:E.9NU>9NYN9N]^9O!.9S%>9R'F9I]^1GCUD:! M``A&H9W9^9W;>138V9WE69[G>9WCV9[C&9_OF9[S69_I>9[_6:`#>I_KF:`! M>I_[6:`1VJ#K^:`=^I_MN:']>:$)^ITI&I\C6J(5>J,'.J$'FJ%!^J$Y6J0G M6I_7.:-'NJ3A&:%3&J))VJ,Y^J,[.J8!.J4I.I]-.J!W>J7^>_J@<]J@35JC M73JF^]FF9[JH.QJ>_?FA13JG6UJG$QJJ'?JE@9JI-;JJ;1JK(9JI)1JC&_JH MD;JI@WJG,?JF+[JIW=F'WNSX_H2$`"T1SNN3_NU97NV:?NUV5H:T]EE:GNW M>5NN_:`&4"&X]2`5S&`4_$"N5;NWXSFY5QL-@AL5-F"F&Z$9A$$)]&$;4L'V MCONUS>`6@KNX:=L/FN&Y44$`]$#^``1`!\![MR]AO%&A&9A[%"Y!!Y1@O?&Z M&1+AN<];`.`[OI4[M/U;L9M!!X0[%9#A$I`!"_1`!]"@N;$[P&?;#RX!"]`` MPAO;PO\[PVW;4['V0K56:(S;N(^[:$A\Q$6\G4L\Q4>\:$YIO)V1 M'!G`!LY5/-"G7-7-@!""?`Y8W0_,H!D&0`!>?;O-H!&J(1GFX!(`/9_3G,I3 MO,Q7O!L:80"40-%-'-9!O<5=/,3-`!E2?;MAG-1#7=MC7=J-_,EUO,Q)7=1S M/-K+O=CC6=1YN9?;^B/42%[:G9K@G>D@/D=&X==38>)G@^SP M_="J_L0()` M>R'/#[L1XB$9XL'N#CYS+J-MY8[@K7[M_D#I%>\RRHA`70`9:MY&]_WB,WX? MT"#(R<#A*:(1F`#).P+7Y=X,+D$`G%WKFP[B^8[,N1[R^9TC+F'AYZ"'.Y[F M>;[K]MT,7%X`]L'?SQ[E!Y[$.Z*'63SC`W[T5Q_E.];@![Y(@+[PX_WL\=U3 MS_D9@YCCYCO(JWX4,J#V1F&O.[81D$$-7``!.O82:*'V.J+Y@[_YX8T6J!_) MG1_).[LB&@$->D$#E)\BF/_ZP9_^M7'>Y`E4^VF=ZB,=\6L@R"?>^A]TKQD_ M\`>;\8=_L.V\$;3!S;6\]AJA;0'B4J-]C0K2$D@KPZANEPYV>_CP4JIDR8MCH(T./$!L>%-AH8?/COV9,NP!L5JC2"H@Z;/L%V]/,PY%J(3AMA[M:(2;)4".":/HTZM>K5K%N[3HV/0J79M&O; MOHT[]^S^`9)097@-/+CPX<1+8J'HQ28:5`)JH"E"!LVE/ZD&))O3?&\-+T52 M?30L@(P2`:BTU=C`7(?$[AU3,2&C#6(J-HI$@-I5B*8-%&T7YM#4$1 M*I?8UP*(M)`V2G@A75H17HC,@;0`F`Q'1#'!H5(UD`$% M$P^B@@5YJ'#4C``ZL"41163T1<@&W?BQG`!)Z4`&1]U@(:%(-0@@`!JIB+?! M'P]ED,HVVZC7#4S)Z-,,&4Q@=20J^UURRS;:I"+D)3I(*1U;+Y4C%%&-%$&1 M=VFAP<0V!OJ!S(-8(+,-&0(.B:09:&PCP%YT3OG1)6A-PG6@#EZ0026-S=)BGC\A`X>=':)!W M2T0;Z'.A&:AXUR,6@"8Y2EK-<)?4:9"O%ZD4G$QXR:AW M";BO6I?,GPRAP6;*4LU!D0`(0.%L/)*)%,\<:"2C!JP##&!&-8AX=PF('"'S MLQD:]$*T`/4A`_,`?E)4CK;=Q$/^2&,U)E,$`LVXX)/-\8A6T27Q5.-'9-5\ MM&HR`S2;C`8'7B+:DLD00@LR00T!]]K=R,4U`JB,5@,B)'LQ6CSE"`G1I$&Y M0-,H,,_QZ"7(\&OOC93%-TQQY1,E;U4X_0V'[V=]A"_H=$+&4Y# MT5%DG5NWN$0P(P+%A/QV,X0+K4:$Q@!*F`&S%XW%-==%KEI-X.W)(`*]VRL/ M$$_0].$-O-L9#!YR1S64HX1H3/Q&*EXVA_B1&;0H4?7$S30"13D;$%*.=*-H M4,[X0"-3C;ETBUX$+"!QTM6N!";P7>@SH`,?F!HSW8L6&\A`IX:$%('@(VX( M4-3T&B'^%S5D0#1J`(W-M)&0HY0#"MH8@`Z.4PXS3&0T#;%9-3JXJEX@8"(# M6-;TD($`Q+FL)&T;(D10Q@0$."T9VFB$=:H!EJ-H`P$G1$"SDB@7H'TH0!!+ M!A;=YL&0$0%`0Q#(YY)B!MK1:(9#8`(BYM`^6C0+$20:0`T`-(!&3"Q_!Z)/ M/!H!+CZN:@X(F-@<,F`ER-&L:D2ACQ(00*`D$D)F]AJ""42C@09V8U)LPHX` M"*2!,MFL!K1@4PT0"JX3S^AN`%-`',W\[" M1XL`QN,A!-(!`@`WH0R(\Q+HI"!]JI2,JED3"J&QD?/,H(9RF!,*->A&+Q"! MA9G5H!&(VX8)FO5(P)$&@@QMJ$\0J,"(NJLWFG2H10DHP63@*RT$@APLDV4S M%QA&-(@0&8/@I(8-E"4996(C+G>W@FD`&(3"\84I0:#&!M`42$=!24#"@@`%QV?1-+B5*-K%GI MD7R%54ST&AFA:&MSU[F%6\?U$#S^L0EK%+%K!M(R0R6`2!_!Y)E*B=J()4YQ M`XV8H1=`)(`9EI0AQ[D2V:88P!Y^TYB7B*U*8=G3`]7+>"NM)HVN.;Q+O*H; MZKP.+=#9D68=8+I7758JO(]VI*,=@5,O7I@*1\'P,=;1 M!F(P5@D$F0$JJ=!`8O*)YZ0( M"O?"3A.76*ED0P/@"-%5KL),&R8`E\6@21$ZH6$G$9EAURX!A7$QMHQV2*1BD:E(KTNT9M0 MIMFP`[VRF`%.Q9-1FMV/(D`/`2K6)43;9ND$4,5X#O"3$#B=*!&@$]FH.F+7V\Y]=*0&YFG+F9!"&T8"A]ZQS]1VDG=MN"VM(TN M'6>"71H10#BB\^C*K>>XD5ORZ*(3`60C358B^ZC0C@D+6-`!FP:@DH(MB`D$ MT<'B+Q$3R.WEZ.=MB;2Q@GG!L";:+O&)M36_(Y=8F\>=IW;H=[00)YT>+L?^ M/&Q^#6SW"EM->M'+*&Q_>]R/8O?^NY]V[WF?>^#KGO>V7W;OAW][X"M_^<+/ MO?&9WWSE&[\;^VBM/KA]9E@23<((&`6=X[8/)(U M$M=%A#1#,M-:\3`*9+4?N&<&JA,55D01>H``RX$`R-`LVV`MF=@L7;,^YH0, M3=1:'T.$Q-=_R-=_J?A[T(>*JRA]K=A\S\>*K5A[QJ>*PZ>+IM%>L2=1\>5Y MKBB,PTB,Q6B,QXB,S"<6W\=DU`H%O\;1^+P4%>W8\^T`@<^`Q!WB-V^`93]0,K38AN&<8&S!C.5<.Y6"*F29B M09%P^_!]V+$-`74_L@%PFGB^;% M*O38"!LT!W0H%AOD18EE8!O`)@;Y4AE2"P'WD6(!(FHP/T?A-M5P<8V@0J010,HC=52X;.%XE"ZP#]H0 M#QM`!!J@!@/W4G.`E`+83:/0-DQ0$"JD!/^1/42`#SWTD]:!"-JP.SH@??J6 M,FBA#1G21;VP#S,$8UV$>/NP01J`!GNF!P5Q4]H`-P_#6/51#=4@?("4<#OR M&.#SA/@44!-1`WZ@!@3I=*U5$?&`!3%&!OJP8,EHFJ>)FJDYC+P(>[X84<#X M$ZHIF[-)F\7H!U&B`=B(!8)2#1K^4`W-(`RYJ0VCX(?QT`NJ09PZ-P#;P"EJ(`S$60-SP)T=H8EJT`NT&0@:^R1'$61US@"5S M,`"DN)]H$*(:$#IHH)7DA+` M=RRYJ0&HL&.70)TNT)S[H`0#T`L7)Q!'86'Z,`#"\*%,D)L3PGM0*J53M870 M$9SUN1?^VQ"F%H@,U*D!1Y*;PF`8R""D0I\-#H'A'*7`VHY+=H,B*D!+HD,(?J;^S"8%DY$*C2F7N]<,7"J(C;A[`K%["``$ MC8@/B#``:E`);,)9Y_>LQ)FM%MH(V[H/V]I]>U&D[4J<`SH0X5>NP'=^%Y@1 M"/"K]'H)0,`2O)>N?@&P%P@57QH5NS<0^9JM3O.ME2`P!`O^I6D!?=):KPA; M$(.Z%_J:K0BKL07QK`21L=OJ%_)ZL18+I`A0!@+XI2?;GAX+?(V``!I;L(TX MH*C$,Z-0!F+QI*%:8`!$"@MWO+MWZ[MWK;MX'KMZ8PN("+N(F;N(=;N(KK MN(K+N(\KN4"PKJ.PM^NJMY8;N82+N'T+:H0$B(U0!KV0"-W7N(-KN7^KNHL[ MN'V[KGN;NHOKMX!H"K&[NIT[N*_^>[B5.[G[X+IH,#3Z&G[560Z)D`J[F/&[V]"XC0N[W2V[R6T#:EF[V%B[Z;&[^,Z[JO.[N8J[H" M_+V'B\#K*[G-&[_6N[KNV[[L.[D0S+<(7+=VVRYXZQ*&R\$=[,$?#,(A+,(C M3,(E;,(GC,(IS,$(X`MJ(`#-`,,"H`^^J\(U;,,WC,,<;`DC(#4PW`QA4@;9 M5@G;0)PY;,1'C,0G#`0(L&?UF<1/#,5)#`26X`LF5@]1C,59K,5;G,*\*!L8 MG,&P^1#^0&`#96S&9XS&::S&:\S&;>S&;PS'<2S'J#'+X(` M=DS'?PS(@2S(9_P$-J`"VJ#'*@`$3_`$A^P'A3S(D2S)DQS'E@`$>J`-VL`- M4TS)G>S)D[S#OI#)B5#'GVS*IXS*J2S'GQ<;8)Q`8MP-IO`$ED#+MS-U5FMU5O-U5WMU5\]U6<,UF--UF5MUEHMUE%=QF?- MUFWMUF5MQF\MUW--UW%-UW>-UWFMUV!->MW0BTV-&[!L"70PUD10#X8=U8A] MV%>MV%L=SH?=V%0=V58]V5YMV)6MU8C=V)<]U9L-V9(MU9Q-V5A=V9BMV(]- MVER-VJ$-UI&-V7/]VJ/=V:`]VUG^'=NO[=J:O=>JS=::/=FF7=:E7=N)_=FQ M7=B=K=M5_=N,'<[&;=QF_=R+K=RT#=G-?=5TT-=_#=BUP4!D]@3?#-[A+=[C M3=[E;=[GC=[IK=[KS=[M[=[O#=_Q+=_S3=_U;=_WC=_YK=_[S=_][=__#>#_ MG=U?O-V!#2\^\00F$.`+SN`-[N`/#N$1+N$33N$5;N$7CN'N37I_H-T%/ANP M7`\F(`LC3N(E;N(GCN(IKN(KSN(M[N(O#N,Q+N,S3N,U;N,WCN,YKN,[SN,] M[N,_#N1!+N1#3N1!ON$=7N`:'.(FP.1-[N1/#N51+N533N55;N57CN59KN5; MSN5=[N7^7P[F82[F8T[F96[F9X[F::[F:\[F;:[F`^[AMZ'!4PS4=6[G=X[G M>:[G>\[G?>[G?P[H@2[H@T[HA6[HAX[HB:[HB\[HC>[HC][,UL;A3!WG&MQK M#P%9EZ[IFXX:F<[IGP[JH2[JQ.'I\E7JHTXNIQXO2%[@L(SJKP[KL2[KLT[K MM6[KMS[JK+[=KH[KO>[KOP[LP2[LPT[L!*3K3=W=Q:[LR\[LS>[LSP[M#G7L M3=T;ND5F!'3MPI'MJ+'MK-'M\?+MSQ3JX2[NJ$[NIW'NCX+NS)[NLM[NP?'N M#I5>\3[K]-X:TP[&O-&$B/$5_>[O_P[P`>_O_"[P!3_P!M_^[P2/\`>_\`WO M\`ZO\`S_\!-/\0$?\14O\!/]$FO M]$O/]$WO]$\/]5$O]5-/]55O]5>/]5FO]5O/]5WO]5\/]F$O]F-/]F5O]F>/ M]FF_]%D@)=LP!T*/&Z(0!G-/]W5O]W>/]WE?#'G/]WWO]W\/^($O^(-/^(5O M^(>/^(FO^(O/^'V_]XT/^9$O^8O_^)-O^9/^JFO^JO/^JWO^J\/^['^+_NS3_NU;_NWC_NYK_N[S_N][_N_#_S! M+_S#3_S%;_S'G_K*4`D_$_JW<0[(?PT[L/K2C_O4+_O67_K8K_K:3_O#Q`[K@TD6-#@080)%2YDV/`:BDH1)4ZD6-'B18SG"`ITF)!CQX,?03H4 M.;)C29`E47HTN;'E29@D%ZY\69`FPILOVL+`@C[2 MF$L]IV#@81?_=,(I*($HD0&`%\9#D*0TINCC@QBI@J^H-&C^Z*."'M_B(IW] M#"3,+ABBV(62!CU:@AXNIFA2N9!F:FXV3FK)H[20)-`B'0FDNZ(":BPXS]JA32ZN,*G""SNE*,.0 M3#,NBB3`I(O0A+ZH99YL)`"@#Q[J'.C!'V$``$:#EM@%@"4>+0\A"=*1H=$T M"17I6#0+TL4":FQ\"SR3D`"@@CV3->F*"`!P@EBX:HG"+VBU7"A8&4SUD:4* M`)B"6VM1_34]WY+HPU>.EK"`2.FND=0"56+"5EMBL]UVNMF60,_="0ENZ8IY M`&`4W($.AA```& M75KN=:QBX""G4;?X`H"<)@62@@9>K0G MP^:BQ.4/<(ZOH6)<'1@DHN6"5H730UEJ25*%D"`'>J16LR MKU3!Y`2WW",;(54^`$""O"A)!Y-^VX+-K:X!:*?1QITP%^Z!KE#%'0\W4CD] MFKZ0].&A"_K"B7GL;NBLLBC!9#A5YO089-BYHDH72)!IIAED(OD0H6*"J`4` M+4P/;H?@#"A&H.#N$VL@`H]CWF08^L7O++YXT(*1@8ZW\<.YV_:G-`+NX`O@LY3R^*$WOAV$@OC[23&R]0)5&*"#`SE>'CQ`2:`0 M%L!`$@KA'QK00`N8>$%HG*`%`%C`'1)(`SUDL`4)_&X74X#!%SY0"'=$`0FA MN0(`!`$'+B3A`V,97]`\20-W\,`=^?(D&]R!"0M4\`41V,4+YL$%3'@0!EJ( M9Q[LIZPK:$$0M=!"!3[P@C95P!U)8-02!.$."UA@"3A0(-:\$,+7-!" M6;Y0`9EB0E;%:,<\QEK0^[A*A,6H@%UW@5?QT8,C"%L"7 MAUT0UQ\;)0L2/EL+$/A'3H6`0QXB$,4ID+0+F-%%!`KA6;J=R0!+L*L6:N'8 M-%1`!ABH!0_2\`4,(+0%Q]6%.BU03SA8@!R!DB\&(@#=7EU#LZZ5P;Q`TPXV M1$`&2N7^#3V(I(4^R+4LZ=!3^_+KCEU\5R#%X(06W%$+F)7,P[.UQ0`^(3##B)@@6V-TP*$.XMG+2"(DNVJ M%E.X*EE@$-2K!IB=I(W`/)8`AUIX2!#I2(<@OFN!=*2!#5RP0%,*\DQHID9D M`Z'F)%@NB-6@V``67OP*<`D"H&J'$"S%"#!E)P59$9E#XD^./>OT9" MI/R1#G=P(EL5+R\/KK$V,=R;3)Q,5P7$HM=+1B!3^*Y`RO,@OM\YH9Y1&)Q8 M2CRY2!*<'.XXF014\>N6%P.?=^RM%0/-(3'DP;)=R*<3.-$':MC+:#(8&#+W`5>I.6AXF"A7,5-J`$5_DMC=D(;M.._N,5\:$!)]@! M87,',%$F?A@W1*.S;'&\AH"T2-L*4.&(2KNT3&,7^D"\X@.`$&`71JB%\E,% M5:`Y"XSS=`")=(#AJ;$@>Z(URDX+H^#4;>L)5$Y!!M\8Y"()[^AEJ7+U`F@7A,`!"?+RB1/4$)$BS!K)BT M:Z"F1KB$2V@$33N(UI$K.``!+L`7/=J%=YRB='$"*8@"I;,<4ZN@^_BQ5Y24 M;6D?8:N@N0F>#3*8"KB7@IH;&&')>]G"9JO%%N@J)'C.+"&(X8"#")@L%,(G M3=&%*E+*L:"$^I%#MOL"KH/\0&Z(@P]QX$]FOQ( M:N'-Q"PD`W`5*FF?*#@!@:.!PH$>N?%)+E`%2>([`!@W:9$H\.%00Z2]EVD[ M8=.8=.#^JN=$@G:X20"@A@J0B^3:T1Z5#H'@AR4@'8>:HR3@`?_8-58A'_+B M#^^,`C`93$'(!J!)D?:YE^:S3,O1@CQPSN>\A@CH&*493#.Q"?W``"0X./$1 M',()PEJ((LC"A`3E3TML1&F1@/39F[9)![/CI!#(HXU8@C2(+WP2(8+0T1<0 MB"L0`SWYIFMSF2XHPDCAQ<&4G%URRGSZ%K6@A*E,Q"E*@A(]T2\`&A4%`!85 M"]W4RL:[42A3A8;1%):)1^]0%0"0HB.%N?+9`2X0`]51TO3!RR_8M;W$2_HQ MM_L@GL&<-H0X`1XQ,UC1RJRY!I=QA_U1)N9!-)[PAUTPG4?^T\P+X4P#X`46 M``$08`%>``R!BX(/N++AE+8SB M#,+@X:0IJ(5L?!GOV)DB=,)<4X7E],9LP(]B""1E>8$0NP9J$,0O8`->(9XD M981?2Q$%6T/&*)$&XH+2R0UXO0(#R(/TO(\DP!(#V#5^$03-\S(:B"([K,_R M3"%)I(0KZ(,0Z(T^L%;1$1Q9Q#=ZT,$\,H!2S(9L(5GFVJ"V M%[J71]74LFH?_6O;ZS-5L9!;`*!;[W,"5;"5+5"%%$K?WLR+YUC"AFV8)6@H M&`&_'W-9!:,YC94%_T!,`216`C+60G0,(H+7@ZBH)0"!=A`26E%WH]&:!7"08` M$!#:?D7^N$K=EGL3MNAH*"VHI&S9`BEX(2V;&Y[I4@^%V(?=A8Y9KYHIRZ>X M@DV4`J/!PB_`3I#E`2FHM?R)4F+QG"@@!S;XK=-MV0F4%5T(8/'9FP[)ACD1 M!"Q]3)]UE>^B!$GLCBXI!)DJ"<0\3KYRF!GTT*>(VE\S1D[J,4DIG?8Q0`GM MM&][4`N[+=7%!$'8,P^JJD)08C8RF"X6QB% MF6(0MBW0A72(0SO+'ET0'$P845V0EM5C(Q^6`ODEH"2@!MQHR$+(!I[+.D[2 M1E5P*]F0NZ`C970=M$1=X-XS=(G2$XL-JALN0H^H),WN0OZ.3G.(Y09M6R,AE.W(\KL+J&<:[1,,XBA%B#Q.CV M^9VYX@%_N$$'X\OX)-;Y^!Q/')R&;8?LR+>#Z"^'HH<%.9PI0!YKOE8QT)3' M)%,*]E:"R,P+MH@,\9NB$,.O:X^!N+=[X3P-$1_]ZY=L$(12\<0DZ)=*)0?L M405_X!G($D#+X3GP,\Z)W64;'%E5N%SQ*=&;/MC?#`O*/M@\H94K MY>6"XV$$."2ZH%H]P"1I""8`K6=;P+;G(8*]JUI(0A M".:5\HJ,;#@IP-[(!5)*%`)K51C/>1"D#^A%*C.`;""'//B"\4;C).@-@6@= M`/!M5W$'X^:!*%`%@9`V1G`5?Y"`8G@!3-C"G[3OAG*'_"XWJ-Z%;BV&)-@% MZ7&5P[8L3%B"8BQN-R;L76Q:54F'`?JU%QA$4^-O[O6Y=,E!`XB"><&W>K+# M/I@/:DC^A_-]QA5OFH_;A3ZPP57UX%L%;!@0@PHR''Z9P#2@A/)-T2\8DH5R MNW9X01B803H);(!N[I>1T$F*[J&*`/ZH[I!&:8UUG/F8AWL%&O`;C8;RGFM@ MA"2(:(=R0[KV)3DJ-&">T&PH24Y86%9):#T.Y?:!@2#(#W7)!DT1C7Z=EK8S M-8".@!X,]?D^OQ MK$E;P79NU:W8*)ETT()KX(0\N*HKX#;"<7`.$AQE/P&S^[>!UY=@CYET80/B MX80:I7C'V@&:$\@HJ(6-^@@>`$89MT^$78+N4YH\Z(,(F*F=V8$E(U2%*H8T MZ`,QJ*=LH0&!F'5=V((\``!_OZ\\B'!^D`6,+'J#X8%!R9Y?BX((P"<>#99T MB`Y)8;)3/IGUW)87P/;VL)404+!TB8!KJ(`\B`[/J_KL(1]EO\\&PB=,F`)3 M8S?12$W7.K]Q:KRQ.`L>H`9^2`/^!+2AW:8&>A`$FIL"=I^6Y_BQ.A&^/HAV M92-[CB@&)!3Y>]F%=KB;/":'-)``R@(3D\'']7(I@R'\^1"^5^F#(`@-:7DG METF'7W>5E%_Y'6CYES\]F:\%@U$H"=V%>>`'3A"#5TF'+]F!F`N-CUBO=%B4 M:P`QXI&4;QD(2B"?7Y\'&:",76&#L0(`>K)5=Q"$NZ.GK]/Z/*@G)NZE.ON( MMQK(]'&"]%,:6[$`\1&V0D#\>Z=#5^&"!U0/CIAT2E\-@+BV8X?`:P4)(A1( M\)H!?DB0P"AH0,)#>DX*&ORRBTL%&O,D%+L&YV%$@\5@6*"!A.$.#`\_<+KF M$HF3);K^.&&B05!0+2<[M!2RF8:&A0@P=`F2*@1U(,%F00$FA05UP,&FY M!@,3'(HTE\!X".=:,3BU,&&@L30AV9P6:M7:Y0^#DX<2#`BDY"1EA:8%K2[! MJPO&"Z0[.)%,4\'NBP](*J2AA,G=V[C^"E.EQ$^+H"E2KR&&"/9A3$IP+'#] M8I#2"RTT(KR@M$,QD@\2=NAJ_?I%L2NJ/EC@"=X2Q1%Q(8X+955"&%]5V`#Q%8#`9=O+8%4@G",=#^-7IA@DE\>=%3 MRT>%8)#-+A7TI(LN$FB!202X*44D5;I<`8`%2-"` MW'D"8M!D,7O1\,$.+AFLGM->:J]H.7Z@2$K1X/1MN2/>= MZV0QT"*ET+3L&D`M)=Y>2PF^!`F\+27H+J2*.UKX`*TJ/M`#@Q3WYDM0,<6( M>Y"=RNF2:KJRW?N%`?%2HLH\\_AP[\/NR"BBN;I@+)"WL@E<[H7LUD`DL];S>LAN M6JVCX1Z\6K@PNSQ0,:JH1C'7._1L=KD[U#Q5SSJ+G-?`]D([-5EL^W,]+8+L\<\LTU6WH*__*]"-5=,]E3CULM0R$V= M;B[&?E?^K6+ML7M5L7N%_1:RQ9#2P!02#;/(A1W01=GO)#M@0M$^+J& M:;YYNOHF)[.3=!\4][K;3@ZZQD_[>JSWWX,?;+(8/:U<]-@Z.7WZZE\CA;;L MIZ^[QNNOSVNOT=-O/N?JJPI__/7G3SE?X$$>.+&$:\Q*)_&37_^F9S[Z07`U M>:`&!@ZXA`_0H$G0BR`'`?A`]+EL?5]``@"0P(]K7`$#Y'A!!+A0BRA<82'V MF:$'[P?"#N8/A_A;X`YUZ#^,^.^&'Z3*`A_H0/UQT(@R9)\1=3A#]"$1B`X$ M(!6CZ,/_0;")5NSA%-D#@'DDC8M+Y)\4R9?%,^)O?R$4HP_^!=>_A?PJ?'*< M(["2M40WCE%9Y2LBMB3`A714Z'[*2IN^FH4MSBU+=S0XI" M.KB0!`\Q98?.XG'[0%*%I6D1BT$849/;M*3(F++_MY(2"WTX01)V(4% M.*$*+0`@"1@PC"!IZ$8F0G&+A#S?$8E8OCQRDEF'A-XG6>E+8WX0BH748Y'L MUTIG.G)^>R3C&CG9P$U2I.-")$`!ABJS51F\Z#CE"@9(_G0 M)S83G9$TI`QAE@8,8.`*MP-B)\O^:$UO*C)]!_MHB$:J1Y/.CZ11[%4U^SD0 MU8`T#<682FZD!DHBFK.1T.2G(8G93"F.$:-WA.0S$\I`)I)OFU%58C%YV"QF M5A216#2H/#=+(4-O4\.T)+&* M+2IVH[O^S=O6M*Z@/:TZPUO6PZ:SNOKEZS[/NTAM#A.K*%5F43!B M41O>YA:9RF*-+(:MJ>`7?Y:[S07KB+EHVMCNMK'P%6Y_@=O9`7/VQDFM1/\4FF.F[R"W;-3^,9^3NQQF,:-I MF(,D@[J@5MUK&;>\V!`+3(,(V9EPJ8S'G3%38$0EKCZEVF1)6^A94^NLOVK- M9./.VL@/A-RU$.GHA=P+MPE)=H_K*4T]72AR6B->B/=)5.M^F(8^L["7SSM? MH5)XOQ*]<*+!S=4(O[C$=,9SIL.)9ADGF)WHE3=R#QUC;I]2K(/5,(W!/>%_ MX]C8J4PKDD%-1SO6>,^3'F^'S4<)&&B!24M\P3PXD3-;([4@6YA"!>:5$$ZP M(3!$7C!I\ZQ6;2]!"T=AY'VVH/+1<5/97ATN:M<,@QOU\I-VH@?.'VRG"!0B MN-VF83'\8P`,P`$.G,``")(.!Q;^5;K972TP^UKK[&W*0XPIITZUFN"M9OR=NR]N:WFA-OVGG=5[=H=F67H%=S@ M`*5T@"#2HP#P#LH@(5P$00-G_GF([>!0?5ZC4&FR!G4RB%GQ!#&F*G81,^KP. MM2";*P;/*MK),-Z'YS0/\]0@)EB?((HA777A1%E;K>E5N!78-YU94_'8W%4= MC:$77$4717+9MP%;^/W;U!%9VLT?KO'5ODG3WS&9MW4=6_PA(!I+>\6602'% M!]"#C!`,/U3`I41'TU%"39:*+O`#/7S';1!*!8A$X1$,5#$%/`# M3W$""&S!!VS!5`B(!1I`H8`1/53^P/>9S"B2A4M,0600T7FTPS4X`1STBUD: M14B,3$TL05&2!2>PS(RX1`1@0'U8!2?HR1*TPP5NR=;``0CL95]B@#M87%5< M0P5$S#7P@Z#(D(/00P24"DA)0`Q)``@0"!5B@$^6BBHHXWF`E$V\P-*9Q&9^ M``BP"$]6`$$L'0;\7@J!P!*PQFIN!@`(0D.UYN]M`4AIS$EXY+GB=;)G`B.3HU5)$$)`0``[(`$"(D3 MI`,[8BD`O,@N9-Y64`,`N`HED,,NO`"'(L$7;($H"H(J8&@Z?(`6C"ET'`T` MT`"$4 M>(H@X.BS8$(ZX$4$E!";8@(`2(`JG`8GP`$71(`J.$$?]`'^;GCJ+ES!SV$" M=K`JC8BB%E2`EZA>K.Y`2HR.XLD`%RQ.<&:>NEP('.0!#,#!"=0":WPH#?!` MXTE!(5A`:W`!;V#IA?:!!2@E%Y#IR+Q`%$!'+5@`/UA`.ASF>0``.5@?E[79 M?S$D>;FK'!Y5?:5;:MD0?>9@G?7G1/'G>H*=PMF;NP'5=\6GD/52ONE?'.85 MR?E9HRFL>W6D0:2D@@96P9::G7`!#60#(X3J%A1*!4A!BMKF%_!#.D3!%F2# M$S1>-A3"+B"A!`B"GHAB4R[!"<"!*D@!"3E!BD8!VV0#%_A#;E12&M@E#7Q> M-F`@#'P![T2!!(P0`'3!O8@@G.[^`M$P0A_D@<==""XAP0L(@D9(3#:X$PS\ M!IX.#>.9[1?T@0RH`C]\438$+0^HAA*Z`\9\J-DJ0SJ$0-T"P!2$2ZCF[`Z( M`298RRY0`R.0K-EBQ!=\0"TPX1=`'[N0T`=\P0I9BY:V3Z&L7C$H(]S`+1*L MC3M)0#;L@B"(@!2$Q;7L0A\@A13P`!>X2P1LIRY$`1=0"]PZ@3=2`A?0+4,( M@C+XQ:88BK$2C'!NGD&H`@^DPQ=D`X?R@V_6PA7,PQ700Q^4S`MDGNDZ`2-D M0^I5P,J2*<9@0`1DPZ/"0#90`@!XHLQ8$O,X%]Z=F?BUVJ;I849>UQGB5]DI M'*4-F+[^F62+$5@>::%[$2#;"3"P^5Q&Y=.X(5A6%9:9_9U%_AA*6NP.F]=($8((4N<,$NW`ZSJD8:X"GK4:$,6`H/1T$4*"_C"0(< M3,47D%+2#`8G:.HR[DD)70P)28`4>.V%I$$+UX+KD@7+3A[^/Q0"4D2QZ]9P MQRW!%]`#F::HY6)$#0]G0M!(L18$)43FVX8J/WP!!CI!NQ1#'VB>0#B!!+Q` M.LR#%Q="$KB#:O1!I!8##6#`%[1&8+`LTF3$BHJ<&&69W[59!4O:FAUH_6;A M69&5W\&?`I_;I0DB?#*65S&8_-W7%AHP&R[D70U3L`E=!?]9_86AT"7H!888B!!80+,=\.+GT17GP!TO*#*NQ"'DP%)4SB[E*# M!>3Q`>E)H;`!Y=W./$0`TB+QNB9-5Z;!M'Z>*F1H2F\,1J@".0!`#.D%BRX! MR"H#W*2>JWP!+@GU':L&([0#.3C^@3_(P.L8LAQ_01<`@/L*.=@.A282DW8C5GPP=,GD@9]BY7@&I<93I`+@V(9R\+I],<+R];B!2T!A)\ MJ#!/HN.A4.99W]"D7F6^M3*P,M*^P!44`D^IP@Z[DS=?"#B_%BJYVOX];+T. MF7()'``2+*!YF9P9%DW-+P"6V94%*'&;%8K!X4.>5+@%'#JOFSWEUN$YI&01 M'$(G])H1DRS;<#M>PUN'JG@N'@!L@3)4]$53(K74"`!@`K5XM!3<[D@_:CLP M0A0D0?+^+D2A#&=N]$$$,,+2-BU-BY2.+@%.QS(U\,`TNN>2QI!O@D`EQG)2 M4PM3TXU3ZX(%4,,52(%3N_4A9_56XP99\^17?T%8CW57;P$76``&[$(04-ZJ M^4,M.+@R.,D7D$COT+#0$L05*(,$0/'G;C(2*(XGZ\G#C2D-4(MA*YZ.RFRI M+)XK8^!C*Z^.P@"3:TP-MS3^[/)PKL;MP<'S^MX7/.KDH5`Z4`/,\0/Z4KB= MP&TAP("5&T`4&.X.\/@W>R6&L9RMA=A$BIT##RP>]G9]ZMP]6UM+PM:A[9ZQ M(;K9D5^[T2>?/]IO=]?782%"G=J=`9K!QNL:5BQW(]P1+5+^#:>Q\V[)!WPJ M%".N:J1#%[!W,8>(+BB,J,:P[X$R`&3S,+#%.`XH?0! MNN8`_UR!9,_X?6!@EU?%JR/A"R=X:*L&)8!ILDN!*E]#.H3H%PPX/1![+6QI MK'[!"Z\+GA<"(ZQ&$B0!S)%GCM7^5C:E)S"5UOC=7\8-;$/ZKSP_K,+>\U2- MEZ/""IAJ&H@F-GPS.KPO?Z0_L@;1KH>#HD01JX=N^,=SJP[P?L`M(4B@5, MXQ?(0#I(@+FB\`L4J120ZK4:@(*;+.47P@?(0-A21:Y+.2[QP`<(`C7P@Q2P M+!SDP"UM-;5P`35\KVT:0#ND@PR(/N^\J2I\Z-=4\[;`;9XJOY5*3=L._@0Y M007`005I("4HH6TB`0^DZC64*\9PP0DP/@9Z/P^TP]K4@A\3"GQ;!>/1@V14 MP.'/0QK^@W0ZM%8+?VR^N(_^`T0Q#``B\).@ZYHJ"_X07KNV`^*U+[L8/HSX M9:`6*0Z574M';0D&&0!`A`100=6U8C``I'-'CQH<*?,`4$,BB-H+A%\X`:#Q MY8HJ00#:79L"0,N+);J6`"B4TF'$'5&G6J0*<6K5J@^I6LTJ5:I5KEK':LWJ M%6O4JVDM@HW8UJS:LEO!.I0K]BM6LFG/=JVK-^Q9P6K[VA7=0L7*&79UZ%6G"^2,"49,J2+W#ZG*C^-:_/O!?3J<7& M-!4F\!VZ./5)U\7)1SBZW"6QT,Z"A"\[)-1*$N%*,3C=`5A0UM$A73"P+P*K MM(B-"^9>T"*)0D*RCYYKG*`F"AAVJ`6`*)S`)!T:MH@@"4PDP&"7))"0D$(X MKFA/1!)MNJ:=%"GY()UT8FL)!DK4^L*)/&+30A=EYMF%'Z8LR,."+7CD`H`3 MD.`-CEVHJ4"B#VJBAQXN(MB!P2GHJ:5(.**8DJLO8`@"JAW$)'.'7=*Q8`F' M*($A`M[T!:PSOOQJJ[*[(@MLJ\AB9ZO76=FZ]3"V7!76LUJ7!196N#(C=JVRX`+V+[1@O9-8 M9BOCEC-N,?.6UZU`0PW==-4-335:5^-*ER]>X.>+AN*5@),K>+MFJ1V6N.(* MA*YX"`,0]+UF8%T&OB:'*R0(>`M5=E+FA33JY5<7?Z>BQ.%X^5%R!]XPP$`7 M/N-D"L\=7@"YK),'GBK>-'3B+6&`3XYS*6664$:7E5.20,>E$%YB/)PSCC/@ MH8O&6.:`>33:?B3:GY$/;7@(3MPEJBAXA&F=`7MOM7%0!'YIG? MI2/JZ*O^L4]61H+QBJ%$"AHPT#$PB7B@(:6(_D4HSHB*24,^2EYP+>DKJ@+J MA9`=,N"++2*W!9UVL;^G2;*[#*,,=66DQZWVOL+0MWEW6DF7%`/,;S_K&P\#]D8]\M=%?^R3( M/P]&4'X>W-]TTG$%1IPP&QA``M\.M!>$EQ@"]$',TI4T8<[N*)K$*(* M">PBBV$4XQC)&#[GE1&-:53C&MD8K#:^$8YQ%-\9Y5C',&[/>WE,C1WY2$8Z M]A&0@1RC+B3@CQ-8@`8TT$(APOA'0<+1-1*(31]>@$16?8$?2=G?(]\821I4 MTI&<%.4H25E*4YX2E8'$HQY9.9ISI!*6I&Q?++-(J"T@`1.8>-H6:0G(:T1@ M'E>PI!DY!@<&]K*1<"!4*)'93&<^$YIV3)X=[SF=C,IAZWB4]_XC-7 MU?SGG00ZT((.%*$)5>A"PZ?/?7JOGPR5J#^/.5&+7A2C&=4H-QWZ4.Y%=*-Q MK&@I1_K&DF+EI"%5Z4KQF=*0NI2EG.RH1]4%TIC>%*E.NPE3G@IRIC1% MUS9]^M.BIO&H/U7J4IG:U*8R\)I"9:5-)9I4IUX5JX"TJE7=QU2N9E6D=8RJ M5//XRJ^"5:-_/"M:V=I6I:[5H$$E:VFH:E&XNI66_\'K7K%Z5[Z6<:QS_:A> MN.I7O=@SC,JPIV'5B%A8.M:.D#WE6A&;4LFB\;(,92P<,RM&>WX3IIN=)T,E M*]IH?K;^(W(5K&C,JE<&ZA6EL7VM:]WGVI'^YYBY[>IM;3M;W+YVM[B%R&^# M6UN4WK:VL#5N;'>;7-\&U[;)'>YLI0M;Y1+7N,#U[6^IFUWM>E>X%>WM<)OK MW.F6E[;*76YV93M=[7*WN\L5[W;)"USVKO>[Q*5O=ZF[7_GVEK;D=>YXI1L^ MZW+WO/L-;WJO:]_O#OB^#T[P=I_K7^$*^+T6/K"#41JD"[MWP-BEL'@+?&'X M.CBWZC5O>%?<7]VF%[W_)7%J5_M13K77NEV-<7^/6U_Z@M>^.):P!Q]LXN:Z MF,$A)NR$25SZ#08O'O2+Y3OH^B9ZUIQNM:/YN^='JYK#:V8SFBL\7RGSF,J? M3C2R2^R^_)3>6IRSN79<4S+R-M+SS?>DN[T"U-3:K MK(/<:#HKEL`!1S3!1XQ@8=.ZQ9K^-K6^!<-3G+3*?PUD0<]WUV8>MI_]+5X^I3O@UN9XMOL\XD!+NM)3`76W MJ:OGK$3ZZ`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``P!-3T19O\>S\$!5!$1?=C4:]`109^HA2E415?X`1D`!K34,FN M82@P(`<^$1OAZPJBX`2F4*^<``"0(!%G2\^&L1QY,1K#L!;H\;>N80NX(`DN M4(N>81=T@1X`0%/(41%U(9?Z\!K1<"'+L"'?T+AX)`K$T2#34`(LL!TF4D?F MD2,[TB.E41[KT2./$1E-XY7Z,*#^##(A,*06]A!F>@CMN*@C].H3E4[I.N+T M<#)(;JS4+(@2+E`52V8FA](U?*M^AE(GD9*+5(%"H+%^$$(579!M_B-C7$,* M6`(#G%(H/0[Q$,(#H.J".`)N7&@J&,$"TL&"'D(988NU;*\7`BW?M+#9/(OI6`7\D!K\F8>4H@@ M/E-]M3%\;Q/%V#-QZH(WA#/&OK"Y:@2+PS;+:C*0VR/4-F/"1& M(CJ",JE27G0!*U]1(L(S7B`B!Q1'23+F"^"3-^K%?;X`0R]&%3AD.R4"(2B! M%]R24_YS"RAA(_/18Z2C/#_F8MAS'"^F7O8E\;[@1G>B0@G%!2]P<>:#`'=B MF5ST!=`!*+^`#@D00'_T"Z*@'SN"$EH``Z0@56`@&_`3)^N%0?VQ9/A!1MD3 M-Q4T<*[(2/E!(O1'%\043#40*!%,%2BT#9ET33VL08`K8P%=?@`9X``/R(`JN``Y:`'`( MA1XB0`NH00^EE02AD>T(`)VH2`%TENI@2*_H!W4=1ZX@!O)D3WF M(0*H@1XX!@9V@1[@H%0\D2FT@`;FP0(`0!REZPLJ0`NFH`7@P$4QP`+H(9?X M@1+(509>(`K2H19T@A)`H&)#`!/^MD`91I22>.!-BJ1G5%09O,0"H@!HDDLB M,BD",$$0,H82^*$0Z,$",&$)QI$3:J$02.0$M(`2IH`:^H`YK@$.KH-$TD$+ M_K,=>``&%N)*;?5F:2!(GD$+6L"%"H$&!,%K=405I-0\ M`3)>4@4..)$:-(4?@#4K*38$EH`2EH`-IF!(])!B6W()/B`FD"`/\@!H)`(& M$BD)/J!>EH!>K;1RU+40@.-%J=(=UI9=1083M``&^N`G=*$0YD$+`)8>,$`5 M'!8)9("1E`$#0K<^^D`0*/.6DN!*IT`+W"%K,0%,ON`#M``)HJ`0VC1AJ<$= MG&`)Z"'^"8#F/[)V<'D#!$*@:%O@!&+U(3V5>[LW#4-2.$$U5+]G5(OA%C*@ M&\S@$A(!*+=/`EH`DP`@#SQL!S"@.I#@!0QE-[@R!GB7$;)A*+9#DFXS#)E# M`D:B8B/@4%;1'8A,K-!"SQ8%9R`"ZX`2P%@#EEU(+>`$8;B(@>279<( M``)&%W@@`AB!$G9!8>E0(J:`!Y0A&S#$9,6@$+*A+3%!"C@A#Z3V`X8B"GC# M*:RX/YCT++6@`M@``&0@!UKV2;Y`7;.!$6K!'XK2@O;1"23^4Q"DX`KZ``FD M($IK6!G8D1K:80M@HQ!@`(1'41G:H2:CN!T8(0>, MF9J16!.96"%V09P&DI=A0`RX``EV`1.R`1-:(`:^0!9(XAH&0DM98C=8(@\J M@!]H`@2^(`U@XTJ+5HL,91YN6)39L5*4P1]J81P?^2"*.02D0`J&@A-T@1V3 MH!W2X$`D8!Q%TGOYL!?!5Q<_V@S^P3<8?5&O$FZUE%-1S?<2S$!](0$H0X<- M[I@1NH`D+C"%:Z$/F%07WF0CJ/(:ZAD.X,!*,)A'VO$#G$"/LV$@8"`*Q#0=*@")N6`.81@`-E"%`>`9ED`,VB$;=.&@R1@M8X`1#H1U)8D> MI$`"$@0&0&`H7'$Q,8$'-N(::D$0LJ$0Q&`G,L*/^R!2O0@`4EL*K&0[OB`= M0H`18D#^DC[`H0WE!>)8"S``!E(E#Q@A16\;F%M@%Q@!85J@3ABA,7]R%Z+` MH=U!3^+EE7/`2KY8"C)BE/NZE\5:"@!EK_E!'*5@3'(@!N!9"AAA%C=0 M!@1!NEE"!K*!"S`!;U[@2A-\KQD\!^XZ!R2I(+_`D)1!"JC!'X"R*;:VJ)]! MFM/A!:2@%=Z:G/)`!ORX+>N$KS%Z*=@RC9FT'=*!'QCA!8(;K7U[(W09E[,X ML7<:E56A#UJ`$>0%`#X@!BIRHY>HB7\0K".%4^(,_W?!9;^0MX@!H8(57RF8MB@"4$?<;E!72QL`>.%&,03; MTP$3)&:YW]')23KJIWXDM3#*49IG6N$9XB`.GJ$5=O*A19?8G<`?/+B+6D#, M&8BG_Y(G5,6/]]0#:A,`>&`GY?R\.\(IN!V8]W1#Q3IC%":,66(#^9X5+SM> M*I$16`*V\80=;7A/I;FF)<+27]&-2S;45:$M?R)/KM0?2KVHLY+M&;D@V1X$ MHJ`=7AY^9QTMWR<-8'64><`)E,&W=ST=@D1Q?CVXE3H=>IE)R^FW=&$;V[`H M^\#9(9'^(7:ZZ0GI)*P=.[/=`H">VUW1VP'@ZW-_3\MI(`KZKUN24[XR(=H= M*$-`"W;`O/>$W9,`;]9V(Z:#L;\_#_J]EP%^;KLC"<03X=D?#GIY%J\!'6B1 MF)D4(*0H^P(G"0!J6W01-(A0EP=EUV)H`8`AQS4IA0!PDL)%QI=KU[YH2II@0`'U1=4T:VK-FS:-.J71:@R#ZH*I=,E M!08`.-`SYX*533;&_D70AP4H'^6$*C$8NV4.]C)X5%!2&+L%(V=:@"@2A1@'E%,) M`V!!:33$*L4N24BAH!;9J#+1#CN,3DTV$NQ2I+ZMX??%5QA(`0)0V>@2`G"Z MN).:#X4D\47)4<3PQ7?_^0;`8QD5,I8[L;I#B2X^:,'#%]9CK[UGBZ4!@`QG M9R-#4ZHDT0*^NE!CV179,"B%A[HP\MT',>201RUGXX:$T.[^^575=J$\^[U` M0CE@1&O:(84=],%.2Y""??A!HC\QHGY)()S@+'#!5E2&--L*H0A'2,(2UF4' MW0J7"E>HEW'!11=?F8=B%K.[W%QC"UR0BBYV%X4KF"4'$N@#`(:($EU@@APQ M^_,($ M/V8XD(:!,1WTD,)7^B"(0O3A!.Y0QD0*L00X4"-WDT15'_HPA1W\A@9+:,,&#>)[Q!;J@C/"NP2\67<%E8$Q"IKB` MB2U(H)^,8*A#>6`,`&%,7S`0@R"N\0$>7"%$;'P!QJY@D"HF(0KND,).HB`( M-@"`!Q7X#A<2LA-,!-*E2,A!C)``!QC`@0<2L(\,Z@B`*%2`8P`@AY4F4J,O MV(<>UXA`%`+YG20$QUA:,&$(&:G5KGKU+5QM"PI92%9PG0-CJ9FA<(2S&#@X M(3O".8W^$V!0@1=@X*T6@L%;G['6@:Q&"T>E1"O:`8@E"4U:*V`%CY`"+/7)8B7'R\`KEN=\`S[OA6_B)VF,C[PW)!LX;YL)7`%HJ0,$."5,75\ M`3J=.5KB(H%(&..F.^;Q@9\U:@M:F,<.X%"!TL``"8V%CS+^]@L"[+S5H:&U M"#VT$($,PX`>C?V/,FZ<8RZA5S')+<042FP1%D-$"C2@002T8`$+<"%%%;"` M9>@QCRWL%P.\?8&+89#?M[;#">UHQU.B?#AT/84?A1!>EV'@'`D(N1V1O<:5 M_0M7M&:8JVE5*R-_G.$^HS7/Z%V,G=7ZY[`:6M"#MK.??XSG\Q(ZT6Q-M%GV M'.GS0IJVA3FNI?6,:4P'NL^$3F%91^V7LSYZK7S^0F38JA!5((X2.8C!JE6M MBB+Q618'+@ZUI2Y2$[L3(E<0];7J\88K8L4V5QS*;*NC@FM8Q)9 M*0A-T#FP]K.!;.U!Q23/&'.V,F+^H!1:7R_:NX9,K!F=X5A?F]MG.QZN)923 M6F?X>-9AD+*%1NW4T'J&V7[WG853IIKT&4+#5O:O6UT37:!;U?ECN"XH@6Z, ME4DI%ED08WJ,'-:+)S^KAZ+GNA/TWV0B,:U8(V^]C3#FA6`WKM MD&;UG]$>:%2G?>UI=73=Q:[IP-<]LJ1./%],?>I-AW4NE3Z/BQIM-\H!`%&$ M"31(U&+^:,5<8_)K0>_F^[IY2WM@6FV'B-W:HA@/N.CM=CZ]IC^OF$=E(RM% M&DO@'])Z.W_>TI/V/.\'+_Q)JQ[1(7P([VF+7M_\:O7^_>=)2_.!SWE0[SW[?=\T MVN=>=D[W_\[ZIWV$MW\#QW8]UWATYW;:!X"!%W=[UU=MQW9J!X%XQV=Q%WBB MIGBD=E;/9WA\EW]PYW>71GR;Q@^U`$ECMW]]58'VUVD>"(#!=X$,:'^IEWV* M!H%B%X'G]5#IX`2.AX.$UH!G5X#Z9W9AQVX7>&N+MF@DV(#^;L=N=O>$-/B` M3#AH4"B$21B$$QB%AN>$![@#6C!*#D(PS`:"=[>"X`>"5AA\0PB$.'+?B"6+AGQL>'&Z)6!&EA6 MII9W#AB"A/=H;/B!X+<86_`"^U0:;T=I6DAW.'B`:$B!`_>)$FA\L/=I3`B$ MBG9>^.50GFB(IZB`'DAI?QB*M3B*][>"''](>$0HAGK'B% MF8B*:XB,0J@4^+4#&/=W@,B(#WB+IR9WSQB(@FB$=]>-E/>-P*B&N$B)=I>. M,XAWGB:(G1:,=-B%EEAXA]AS#BC^:8.H@'[FB(_(0I&XB#D(>`")B5OH?QB3 M`PCI=\0'D+HHCQ&XD!#ID-GHD&=X>+>(=PB9D`(9D0LYD7-8D=D(>$\(CA09 MCQ99D26I=Q2HD"C)D#&C_VH0HRWDU))D$,)D5!G>2=I&]J(*45XOO2'^7^(I*V)K(EXJ3N(0" M>(>I*9EL48^;&8BY^(JRF8BFF9:79IKVJ)H*F90RV):E&)=V&9CJV)8]VF(X#J(I/>93X5X/$^7>-PIB-693CJ8=]^8*&B([L2)JKB9(_N(9)J)XA M*'@B.7>?:8LB.8JD&8[)68R?*8SZB8F[2)%2J([;R994:(`FV9J-]J#J.9K5 M29_">7_4MY[`Z9QWB*%,69H?:8L/2H*TR7]26*($FH:YN9NE>)R@R*`.>H]N MZ(ND>)]4V([Y^)Z7V6[F25;_^)QYN)3;28^5^)CD>(.=>8W^S$FD(&FD'SB@ M[1F$/VFD4OJ&5>J3(#F1X%@8+WF`4!F>D4>9"TBER]B>6@I\\GF=H6FC>>>+ MP,F=]%B$2^J6;JJ6G@F9S7B(X*FGJ_F<"6JB5\JFGZB?VEB?:J>;G`F@VSB= M_/FB,IAH5-FC@F&FR3EAJBT!F>PIJ)A]IKDKI"5XFD;&FG M<,J;31JKLKJ2KEJ2HYJB43JK\TG^B>^:ENEZ>`>*KX6ZE9UJI<>IJO58B/69 M@@,:G5C(J!HJEW>:IVUJJ]Q9I5!JD4]:I/::@"RXI@FKG&Z*F@^KK$6)J?JZ MK-WZL"'+HB)XK=WZGB+ZKXL8J>%::H@:K/NYG)6)IH-JH0"*LM^'?S-HC89Z MK*NHDNZHB"?[GP)JLXN::?&)G[H9IYJYFY7Y>!MKJO3YJ'*8B.RIB@NHM>WH MA<9YA/VYA'AZM5Q;M(XYB'PZA8^WBJ$)HJ"XM6*ZL.19IF<+L4;YA^2JHC0[ MCV`KJE`(C`0[I8OYLM]RE8EYN(B;N(J[N(S;N([[N)`;N9([N91;N99[N1SI MLH0K+IC^V[F>^[F@&[JB.[JD6[JF>[JEJ[F;6PE'()2H^[JP&[NR.[NT6[NV M>[N.>PZKZRVMB[N^^[O`&[S".[S$6[R%J;N["QA'8+S,V[S.^[S0&[W2>[C( MF[RE-IBN"Y1CJ:G..YKC9F;V$Z;U(*;[E&[Q0R:`7BZZ+2[YA::#A*Y3N M6Y;FBZ^<][GSFYC5:[U\L;R"^6UCV0%*(9:Q%B6Z@`*\UKP08L`N&6L`?)@0 MLI`0@@*,B\`/?)<3?)@.#+P#@0(1/'@(W`%I%0,B_&,QH3S*9L'U*Y8AC)@; M#&A?T`$=@`("*<-?0,'$AP("C)@(/,`!3&XR+,`"S,"8^\+^D:NZF^N_9YD# M<+#"O38/#W"6K2`(2"#"5X`)].!CQ:L,+U`(`9.]5^`$%N#$"WD-(&`!&`9N MW#/&C(L.ZH7#=^D!$J`%<-`!9`QHZ/`!A4#$M:L,'<`+]!`"4R"086P!'D#! M%N``MA8E3E`((?`,7-+((?!-=QR3%D`#MM:K$(D.[:`%@.8!&``'((`.?*P8 M<``'6`;'@"9G%A!J'$.?NDI)(.'B:65=0K6(D"US`%KL$@TY$\E5RZ*'`%OY%2/4G#.R1$YLO+ M@)8#[Z05;M<@:)+)/(PQQI`.?5#^RDB)`EOP``#@!/0RONYA/-><5B@``CGD`3F`#F#4B)C@!#D`,:U@`1`=(VGLPKWV*EP`SP8= MDROFSD3L`:W`+TVQ=Y%35%MP#>*,,0^5SN.+`L_@,K/\E:22!!\`!Y01`L9@ M#)B@&_N-3D0]D0`O[P;/H(U1[PQ_5\SS&XG*G("*1CQ\N8 MM0?;BA+^"(WCYE/!#-;HU0%)L!TQ4`&6L7<>P`AL(`8'^0R\4"0=X`3K\06K M\0&QO02"@`XT?**F&J0.$0/MH&,Y@`%I''P>X-MUD]G-QP@A\,[@Q@C&PA.4 MC5XYQ#?CJ1B,("2N')R/C:1%0\I@>HDQH%<4D`W3X0XBD#^"4-F\:98QV`%( MT`IP/*&/D00$]--8.1H`W:$`EQH,57[0$WX@^'G,/YDVWYDV$Q MP`@8@\!8/0XQX,W-1FZ*`%2$-\"?&VD`BL?7N-WQP@OL-$"+"'^XS8.P4SB/@8[ M7/#!X$;"(K`3>HUK@U+CX^;@N$;"4>+!$XXQ-VYK?DQN$1=XV0`"2:`\,5`+ M_N!N`NYN1:W&#?X5]AQN('?50GSE$PSG4N['49`$)=SE[W;`$YX#$N[-NM`! M-YSB7S`.62<<-^[-$`[H5);-L=;#%T[B.(S`"B'AG*X_O"#IB'YO7G[K>?`" M%W35E/YGRD,!M<#<@1<#]$!&HY%A4C`%S.[8$$)N#"[-7@TA1&YGT\XE.AQQ M.2##18)D`.#=K-[B@TX?)9X:.7#^!;FT.X(0`Q[P-&0Q[3X,X:TN[""GD6IN MW:W`!;C6:QT@XNC5PQQ1WY&+W_RKWP.A`HUP"9?0"(G`*.@U#H)``QEA#&N> M&D+-B1S6*Y$E`1^``D+="EM0"!^@T`-Q!>W@#A]PX@Z1X5?M1S>\!1Z#`87@ M!':<\BO?\JJ<\A6`8Z2L-3```LH@"/3@RB@``QA0]$?/[4K/"U.`VQT`\C0P M(D"6Q_2P6\P6`Q@P!>Z@USE.#SG06"B?9S``-[8<(:4.!X50QU?-Q+\,`C'A M!&C?Q(`6`R`P!>T`-GJM#.T@`<\P!;W""QZS8J),)*`,!Z0,][?-)1V0]_3` M99GL]Z/^=,M28.;A/0\@(,+C-EB"D%B'1R+NP`KN8<]8;0Q>_Q1R!@(@T`H6 M`0(63_P#M@5;L/Q`A$534%@,[,=;4`$L?^(H\`([<5N\(.@'[%3T8`R?+O(@ M\#X@0$8^!4R3U?_]7D/\`\:+0AR\H,,@`\`'. ME1QPG'Q1UN$9$G=.(0DQ=L:0,,7^7=-K(."\R+$% M#@ATRJ2X`X`N1XXK)=V)U84"!HA6[HZN3(N")P@`@G3JRJ'KBT]W'U"@T*7L MPQ9C])1]N?+S`[I66R*B:^>N74$8>0`X@>.APY)V-"8'%OF!'H8DNYS"19U: M]6K6JL]5@AU;]FS:M6W?/C)R)>##B2Z9,7-)#\VTRJ)X>`8@1`?=O'.\P`3` M08LD`*B-=)*.2P?HTEM8YA%10JUGS[C4NN@!Y[@K8+4P`D$-`#T'M2YWR/$L MA`3S(?*R?,Z?=M")HH\K/&`#``LLD*^/+3S00D%,&GS0`9PL`,`=$=RII140 MN-#BBQPD\,>)+7C@X@H48G`'DRW^/@#`F!A:P6F*"'<1:3""= M#QS@`0`0OO@"DUJNH2>A+^"0(1TGC%$&+J\$<=$8+@#@!98("['O`PSZ2`>O M=@#89:<./L`D+PL&L\"?%\:!08L7)$B"GG&J1.$*.'CH`P9CI*C%GP\$J8Z7 M'#IPPH)68$A'$*?^"BR&=F3@Y:#+I/``DW:V"(&++3IH,@2Y.G!'BPXZ=:*5 M4-%9488DF.O``BVV:"<=>J3@)82Z=@%/*$$`P&0I`+B`@XT'`&`CJ"M"@*$5 MZCQP%0`:!,&P$"F>&=8=8]X*K(,_,>!EERB4R8&7,RV`0U'4.L"D$'0^2*>/ MG6"400K^=.!HX;*%0.AW2A1`O2H*'E`H=[XM7T"G%A!XX>'@A*?`_0=`1)!UCOHCA@UI>@"&A&(P)V@.P8.B` MQ;"XXV(3=';I`QT/AK45@$+V3(NE&.BR:R2>VN&"OW1:B.$%7]TI\AEE>/B@ ME2C2J6CN$'@!H0\+4`#!/A]S``$3QATOZ(HH/K6P8SYWB_LOT5,###"X*!V] M]-%?NZUUUU^'[8BXXNKMM^"&J]*K"MY&03ZT3`>-+@NN8&3^:7IB^$*&/,82 MW@-&P/I`A%U@&`>^A#AE5J+*)#?!0XI&.&ZG4F5821!#T1( M;E`:HV@EFZP?&&?^5AC)6HO\`>"!+MKQ`EX`X!DQ0!\`IB`"#*%`!'0!`2.R MXQ44H(D1-&J3"&#$"XCP1@1:2$<'.B"%"#V#$3GH`R:R02-ZB"`;?=B%%#Z8 MCAC$8#<1P4`Z-).-8?$"*FC*P0=XP8A:]$$NV6B!/Y!"#UZ(8`H6R,98`"`# M$""+!LR&7':#`L21 M/(`2-VD8Z1Y(`+?%/&#,.63!!Z3`H6H`0`#=8% M!?2H%2NR(847U*6:[9!"-F1@Q&SL;`N,J%(*I9`#CF6#E>E``07.A(YQ2"$$ M[6"$%"20(1$40@91E$(2N'`1T;7D(U+H0Q\\$!(9;*&;6HC!P```@WSNLQ!A M6UHKQ@&E=68C"31,3BNDT($^<"$&[(3H%_8)-K&=TT)7$$$!8:`OFBG#"<_H M(*7F4A?^GZN%`J-SD.M=*Y$9T?SF, M"AIQB4LT(A&JR%T.HO`,K#9I5\T)USX'I0L/I",*6-W%0"42(RDP-AV[V$*D M:$`#?Q[O&ME3AGK84$,:`,`#/)'5."00*4&XH[/K^P((L-F*89EO>Z/T0`P^ M*I0,94,SN[WM"1F!(0^LI+$FA;+`R.20`>`MJL<9.T9S"D.D(CI M%0ND0R3&W`5[W(("8Z2C8S'H[DY&(I=Q8"*\N3V3#[OY@7'^!*6]*8G(3=J1 M/P>,A0,!2$(&;SG)H2-`5%CD+4CX$,/<6D`,N4,O,?O4!RV86`:%D">7PG:%/K#! MS@[(F[?2#P-8^$`1[X8T4;E&XZ"F%G3_;A`U(H#MM"J MT6-3-I*CJI:*!`5Y2,<5QI'1X?+^@!ZMQ80,=&&!/#@E7815#T0I-]&P@04= M7'K89+C!*?$0`8#E4)DD;1P,,<@"M0(J2R1))?L,99[40X+ M5@&9#:[!JDHB#!W[T*$%T0#`MCP=BE4]H!Z[Q!S-M^54#G@@AFL`Y@M%ND(V MMJ"%"H`%`XR@]FFH]@6@N0-Y.\/I>KVBA3=S5\[&;($44,"(I<"A#QU[)CS/ M^@5$O=UHIH.0_:J:&""HP4UWH"LR'B:@R,)2A@EB)4'V`R-\) M*F$?T`"_:J\)Z6')Q@%R(P":8ASQR\\R0*@=Q>%"#2 M8``LE2XRX@DUDJ!Y;8G+Y5\HL&FWY_B=%#D&-X$#[*U:5*[UV,I2L"H&F!/[ MJ#;]+BO)`3KF8_8(C>0+:V:^G+T2)+UT$P,B.0SLSR0!$743U]F70GQST/8R MG9U+HR][,NMDC!8840HP>L&V#%TEV!=0?0X&?,+'\1&ATXR()MPGB.H`^S@* MGO"5%\B&I3DG'K``3D$7V'NX@,.+DSJCG,@!#)@HJ@$+%9'^@BM@N289E.W1 M%BY**[F8&Y[B$V6@`!!X`!C`$&@SDA@HLP1101J!@W("@"L(#%W`#^`#@#([ MDRO8";W@'P."B"_(@QCB(G8#'M!IPK:*-[4JP7FSMRJTC5!HJ[O*`21!$H+B M"4R(.@_X`E^YKK:*"(H;"NH(&XF;+(8;"AF(@FYR`D8X+100BS-B@W'P.&V) M@=(2"XM+@EUD0)9`3.:R0O2^Z?3 M:[@HB()Q^*S6HPLX&"$+.2VW&<=1B;81LJHRZSWFP"LIJ*WALZJF:+H]$1VF M<\2B:CX44#,V&X<@L9N,+!.)G`+?0I2`@ZK!(/:"JS8S!.>YY=>2:W*823"L`:.D"(6#"C*!Z9 M$":3`@V&\!4V>BZ&J2!=2P['^XJPZ(ET4,3XD4&W@H)<7<*,< ME()H*ZO^*&@!.*B%HG0]$.B9M-B"<2C(K3$2!]P)*A.D)"PKLB3,PC1,LJ1" M*U3,V)"=PFR.A`2!!K0;OB2V8SO#&`&SG_*D+9N5R=JPH?`'IZ,9YQ$!I1@V M0ORX#5R1B^.4=+@.1GB@#UB?<;@X$6`$#`2!;-@>=TBC;*B%6L@&Y>/-H!NP MX.29H1B6F?*`\)FP)*`B1GBRH9H/VU0&+4@^B^D`ZT)(]@*A12$A>$*!YZL% M5&)**?`'X!R'[A*AT2$4H^`J('MX8%@XH4^\"'E>RP6ZX/X`YKW0! M2(?RB(X!RBP%<0=JF$,:$3(Z]3TOY9*9B@Z\6%`>$(&L*83$0!,)T(5EX04J MH9082`[ZZ94,01AK02?VZ1_^'+'V'%L-BH2"V$O@4!"M@9 M&=E0^("7J"`)HFNWVW),UD+='B\7<#374`')^"".2J+&($# M93B3$Q"$0LB#%W@>M[F"#W$YR\R&23.C/^(!G9"_@4T+&3@!]N&%E@VFTFH% M,/,'8@$<,OO?$B,3(C^7;)LB9L@-N13 MCR0(F2+A"JX1,:^(`BZ@AREHAW8)FV'A`G>P`!X@'JMZ!F,P,@#(`Q;F@:'` M$'KHB'3P!PGH5G,%XG9+S'&UPG+]5C.)`@=(W>*`"1FP`'2H!4&@!TQH M!31EOUV(/"FF8A<9/7?H@]+;*E&5`3!4!B0HXV?@A5C386/8A5UP@I``8^NX MKO7B00G(@Q,HA,;A`5Y0#QX0A`\(@1[K$VD-9$R(JBN@AS*6`)'H@&?!A`_0 M@NO*#R[H`P=H'!EHBF=`B#X`)T5V8E[8`C:P(EB)&XG@@CRXJ1#@-@]HAUV( MRQS`$*BR@!/`)O-0Y<2[O82R`$3^:8>V".6_B!PMUHVY&<%3^1,`T!41*H0H MH`$69HB"$I<^2`)CP(`6(.8/D(%!;C"J0Q,V,L,.X(6/J@5ZR`-ZT$88D(\3 MD,WL@@%W.,OLK`Y+LZ$LOEVHD`%Q8(4%7A2Z"`%8"]A%Q@0)0`=_DA<)8&/X ML@Q/EH)6,&AT0&@9,`QE0!L':+F;SK`#PX!:D($*Z)," M<0<4N)1:V#!W$(,D<(*9*00/0`=`<8>QH(6T9_"GCT:*7.&"#\@5"Y``![BS+;!(K]N2 M2-4:%(@:`.*^=`&JR1#M="#M@/N"",F370##()9MQ!17(J8K(P97GI`+3@L; M4WO7Y,@,13&UB%@5S^1)$8D+[5FF<($C8T,7-%63[>04NMY.T4%3=-@SK]C- MO;#(9RS M2+EX[O<^\'[K_0 M'JP"C:`X-J=@B+R3[^BN/3O,NPL?B5(JL^3#CXOX-2E7ABQ?+QE$!TX)FW9[ MK@;[BP@7"B-?*"G?`EY8$;M9%+@0(2'4.L#X!W10FV?`A(*8[@2O[XA:$4M'N9!XY*+* M+5.?[5='@=JV;;DZ`EC_UH@HH._^"?(YSW5&Y;2QF&\4N`%.RVU@_^$H75>\ M`@!LB")A#XDS#+RAR#W=;%W;Y)OB_ M,'??=O:/CU*I$QUJ5W=T`7F2EW=];[?)\E$]7>P.N`%WUT6$6]>+N':,=_F7 ME^TAGO7;%GK'5#%WJ&[>/I,I6/JCM_41(9;JAE1,>'JHQ_JLU_JMY_JCOX$. M.),/N/K^KB?[LC?[LT?[M`_BY,N(7=""0GB`_U1[KI?UHG>=6N?ZY#L4>DC= MBM\"5J#BOI][<'?EUB*LERE\=SC\P6?\QG?\K<^*5^/[=W_\RK?\R\?\H\?B M0M""*;BNS+?UNK?[VP@%LL>J<3@IPSS]U`=]/UJG=O,C8`+]V:=]RU]]RJ_] MW-?]W9][!`(?5^=];Q7]T:^-TB?[G!_Y:;^!Y*]\92!XY`_^Z#=7W)?^Y6=^ MZ(&RA0"!QH<&".@PH7,FSH\"'^Q(@2)U*L:/$B MQHP:-W+LZ/$CR)`B1Y(LV?!""""2JXH%AO]?8@7+]%)$4[K8Q#P28`&$-!##?0PTY[6_SW4$$*C;B00`F= M4]1!)Y(H6BV,W'".,EP`T,)U`XUC`0!]*,.(,<\PPHAW]%!P3@P?\.($AQX` M$&,.%%38P0W_W4`D#RBXB-&6!G7I94-?:FF6BV+B]I^9&IF99EA=CNAFBQ3! M"1&;$M7))5=R,MC1B`Y"^"=+,N4PZ)@)#7JHH2@H,TY[3HPC4'#T/)=-5O^) MHN4X"74P3@<=9(6"I\ILJBFG.6"5J99*59;4#9Z.*1ZG6A+:`2P`/--A!ZU@ MT@(`O(C^%\,SM>P"@`>&*A.#=^[\5*B65P"P2PQ!528>(T9=&44AC'@E*T*& M$GIHM]Y^FRBBX8XIJ[CFDELNN`AQN^JZZ2)*:*'COBONO/0F>B^^Y[)K+[CT M\MMNOFAVBZZWZ'KY;[P*,SRNO`7C6S"SS,Y[+\(-9ZSOOPO#:Z[%$,A,"#.UHJ\XP%(#SEP0?N M[/+!5C&T4X@@A3@A'D&,%-('=Z`&Z)T%CUXI#AS.>7".0CFF%&!,M(_2DL^W+!^N,\;L.(WSRQ-^2[N^Y%8<\>LHD?][OYQ6C.;+. M"8,)K^DEIQLSS!=SB_/K+)<;L]!@$G][[K*[>SOIPIN.^LW`GSZT\:VS>W#G M!O>NL.H4>^ZRR?4^3[#-J9,;>O08[VO^Z:$/W/GO/O_\YQ'UUDQNT0`X.E#2 M@D`-@`-$$0,'"&(<'N!"Y(R1CCZX(PG4R$$ZW$$!8R!G'.T0`Q>T4(AA.8`1 M6^"1,1Y5"SA0H$@B<((%8M`!+3R``E724@?Z@*.!Y"H$'>!".JYPCAHR@@?$ M0EQ"1)$L&>WK<<_J$%3:,9\<6*#^$!10AA#U]Z@WI:QX>;*7]%0VM.RS3(O9R=S.1V0][&P.C\%`WNBY^<8M;$A@>.R8^H6UO9MT+ MV?#B>+T]YO%\?M28P(#WL#D.DG;*.R,7528Z==E/CURLW>\8R;LT%B]1\IO? M@P1%Q2[**G_[0UKF>D4!$;2`"^-H11Y:P0L/.```(/!!"`!PA1MLH3QP$$$, MW'.A6IP`'108!S4`@`Y&E,<8(F!%"SPPRSP`@!%LH$8,GN@$P\3@!0`01.-R M50LI`0`;HAB'%C[DP\.-*8J,*Y&*((?$&U#``C*X$"SNUJHM`"!P54K>QRYY M/?*E;F/^=)R8QUY6Q8@MC)-R'%GV0-9&V:D18M";7D,[N2_<+=1@QS/C[];W M4#]NJ[URU/D#[%8VA1P-2FSD64 MZZ(D0>2ZOX&D<@OG&$"./C!B*>.HUCAVP86M++85M?A`*P`@#K?F(6[X M@0%=G4D-"[#C*D?J``B2D!]?&603)Y+<4N]VJIO8#N[:8UU6C/SP99A[I.C M2[EWXSUV\J+']2+TSA?4TM5VC=^;Y&]U2U0IH]21@>PNR8ALT32V5+0X8ZX6 MS]M=],9TBWR,(^\**>3SC9>\<3'^[_`\IR6I\J^][VV!/RC0GF<8L`-7X(58 MN6`4Q(KA`R)`@3!C\-:M=``_0O(.#$10BW2(]UCK2L5``M]D1&!# ML,,`)P$3`HE!B`UCX<7!V&F ML)\TV8+^%G+@!->(X+*N62H*TC%#4&T!$UM!)W)D-`X9``!4%<9`T+%'E"<= M#53M*`H[G`"`H*P<`!_PK/:G9YQ]=A;1SXR=NP;.&[YKG>'[I2G M<._PH`]: M^(F-1"0*"M;"":&7@1.:`X!V=.`%2;A5!W9-CZ<,ZP0\2(<3?*`%'A2E$,'F M%B,LL%\511@6P7E&.ECD@3[T*E&7Z2>5V(4?+BBC2O2TP"[^6J6%UR\J0^@8 MO>?C+__YT[_^]K\__O.O__WSO__^_S\`!J``#B`!%J`!'F"^%-SFM40HW!^- M@,!>T,,S5,DY\,)>/!T(N(-V7)43U$(4T`-W9.`&?@4]R$`AH(`[M("0R``7 M[$4A$-K7M,T'0`<*T,,NM(#:6%8AY(4[7$P,!!ATY``OM(-V0,?9=,`Y;($Q M:*!F$,HSM,T4@``['PE#^M9@*$($+(["0",R(*#!"#'0ADCCB3C"" M*'3AH-QA)<[+.71BM9CB554B'X(*+%`##<*A+=XB+N:B+NXB+_:B+[:,',XA M7>B?NOU=)BE9<_$/!7@<3^A;(M%;OHB"W>3(OQ5C,2Z7:CGB.(B#$Q#1+WXC M.(:C.(XC.99C&@:C,#;@+[9"'Z0#+Q3@#DD@_)WC#;3#,UR*.>:C/NXC/_:C M/^(B.LYA`X*B`R***1[*0`V@>,6`B+#ABL`"/I[A0OK? M1JKB+G:DQ(`D`8JD`9)D`LZ?209@2BJDYZUD'+*D_KEDP M)5N2Y5N)5B*95,:95XBY%IV95S.Y6`29&):96`"9E'F)5YZ95NF MI6`*)57Z)586IEUR96`29EW"95.&96@VYF@JYF-.)6@B)FBNIE.:Y68Z9ENR M)D*BIFI"YEZ.)5K.Y63")6[RIFS&)F8.Y4Z6UV6>)5WVIFDRYF?RI5RBY4'$ MYF,:Y&Q"IVF*UT(*9G,FIESJ)5%*YVA2)FI2YW(>)UT>9F[^>F9D5B97%N9Q M*N=!N=I-N==8J9EWJ9Z4J9F M+J5GOJ5N#J9HHJ=HCJ=:FF5[%B=V&F=Q8BAA3FA?ZB4!A.=>JB=_>J1[QF=J M8JAO/NA[=B:+6B8H#J=<].1E3JB+4B=NXB2%UF6$IJ=N*N>/XJ6#VB:1[J9: MOF>-UJ:.WB6/`NAG]B6!6NAZJBA@GB>)7NAZLF:)IJ=;VF>+)JEO9BEX>NB" M3J=_*BB5^J>10FEH4BE^9B:;1FB1QB5O.FAW MYNF'RFF`%FJ88JFZKQ5ZL;Y2LRJXLR[:LR[XLS,8LS!X!RK9$ M*+=(FK=(N+5`&K="F!-$RK=1. M+=56K=5>;;\^K4I$+=9VK==^+=B&+=(Z[=-RK=B>+=JFK=JNK<.2K=":+=ON MJW5>;8C>*\?&;:Y>9=TFY=SZ9-^J[-]B[=[JK-O6+-Q&[(50P*4@HE[Z* M`@4P+KTR`@4HKE->"*?LT`Y!)><:)N8R)>0>[J;P8:AV@.76*^1*+MZV:RA$ MKD]>2%*>T^G*[N'>*^S::^IVY:94[M+R[LX6+LK6;L,RPCF`@!,X02M0`"P$ M+L*"P`<(K[N*0BM@PQ:$PKP>PSD8P_%NP9$`Y:8\@Q/(@0?^C,.`W$`K;,%^ MN)=3HH<3$%I0C@,Z0`*B,24%H$`6@,#@,N4-?,`]UNL63,*`K*Z[P@(]G$$, MS-XDO&\KT(,XM`)4+G`#0Z^\B@+4W.O_PH+UQBX*.($#.($$XVPH?,`F?'#) MAH+60JW&4D`DR``]W.\D/(`%."PD\%KWUBL!4,!Q)``%Y"^[CH,QM`#_&@,F M.(#F(J'4/(,<"$((M(/R/L/Q3<(6\#`%%,(#\$((J-HYW'`D\,`S/$!;!24% M0$(+M,,9A"HLF!X3SRMY^-`6D##`9C#.BA,`Q`%42I@#H\`QP0PO&H5`+0" M.X0N#_``$DXQ%QR3XD;!)-0O.XC#<\BR3U)``J0#Y)X#`!W)#:2#,?C`.:0# M$X?H,;!!'W!O[:*`].J/,KNKR"4``&#DMP[RO=**,83RQ^)Q)/2**%1:._@D ME:3#,[##.5B`,?1!/I\#)H0&\[ZK](8&`8A"%D!")P=E04LP/85(U(JG>[(7`<2CPX840K5*<`RG:<^7B="^/0^YZ;U(# M95"OHNL"9>4RM3WO\BIV;E;?K.F>+D.7!S9L(N*,0Q-$X M$`68G@,G)1*F`R:XM>G!`CLX0#J<`SUA0AZ(P@VO5<;-M%-V`".P0X!!0O=" M+H?X).?>K%8S=@8S\SES->5&;516KN1NBE3?[#$H,V-+;E3>[CGX@#N(@S4S M)1^&[ON^%]$F+OT>4U(*-60_]4[_,NFR=E=V(CM0T'D$ASZ?`SMX1_*6-GZ< MP9$H+F,S]#S7\'(#96;7L`\\0`*D]C@$]^M2`/'ZY'1_0&K^2S5H7S=$0S(% MN)X^0RYM[[1LM[;IYK97@Z[O0G?EPG%6&[7KFNYVO^XO<^USBT+'&8,^W_!Y M=QS'R?=4Z_>Q(:VU)Q^LXJ$`C7,(E-((>,`5\/0=FM\*`S#,(0$(6Y'8' M9`%A04(P0&4P.`$Z-S$%]#$ZD^\S0-C[/8HQM`/WG@,%4$,4L,.2H+-1W\", MU[B+K[43>$`IEJ+V!L939@%&;@&3J^\6G`$Z&+4'S+CJ)64]`;S7B;?3/8K"DJ`#W/*[$QC#OWN0$SS==C."J1\#"!@#/=W`Q!!_`_0XU@0Q0>A7OS8=[[S3W`6$O,^1'0F]_1RTD MK^2*>5PS-#_)@"C04SR/.K"Y]0P[03GPB!-LP@.T@]G6?`L80R3PBF*+0CN( M`R\\`!=0>CH0QBIF@0QP[R80/R9P01.T+J.'?7H8+Q=(T`W^3$(Z:(%>`T`2 M8*0Q<$$2.,$#I$,Z!,,DY%((E"*C.$`<1'\93T$Z/``QY!(FA#LV/$FO0S;S MIP-`0$H"`,`'"L]DI'-"\)PH3)-XA>`!2]2Y#IC<94F2Q)V38%'Z0`*03A2] M%KSM9/):QP('NENG#.F!0"V M=K!`,'4*BX([=W%V\;AQ0Q"`22$`0&(G:%(<&5IO.&AJ$H`#"L$*`7C0KI7& M/@U;\7"2I4\(4;S8R*5+@2Q"&4DI$`OQ[,/`+3H;-OD`0$:[+""X4",&(`D% M6"':(0S1D%<+`$[$#81D#%,?+A3^>>ZDD,`"KP<3>])[$,=='Q`4;M!+]T`Q M`!ZMM,@`0(^E2V*F`5C0*>X#B"2U1#USZ:#=%F-]>%#(LKU[52V\!'%YUAQ` M.RX`>$&./9]^??OW\>\,58E_?___`0Q0P`'ER\_``WD:YY9+S#`C`VW&$24. MR@KDB0(>,/'!,P`PJ4BV-EB)L]XZ*.="""REG1B$\5$?PB8CX*X#!(EDO<`*.0&G2A@JI6**,B3`E%$D:D5 M=MCYT!C^6.0"C@*1VJ'@O4F>>:"I<>CCP@E`VPF+G59D$(4='Y+@H@-VXIJ3 M`A"<\*$)&<;9M-,.9@/@DQ?3:0=0.8)L(ITDY!"E4G&`2S$.=H!L`1UV(@$` M!':"V84"0/U)0I16*(/%!ROW;,J'4.:3Z@98!J*(J0]X$2=0+MBAX)@^DNA) M'"Y$8.>9TT)TE)@X'+C!6G:XD"'$S=SI:9=TY`@QG1`H2',G4=#IHPE`U8KO MG!#(/(<=6K=@1V)CM"PWDA"@I```@D&@[!,'SC"&8PTY'#6Z&WR(BRHW3O-A MIUWNH@`L47RH]`PO`8A$PW8R]$&4Z-AIH@^JV-'QL3(I2$?^')EO4$X..;!A M1P:.@?NX(K7:J8B+/N(0@5"W8COT+G;.:,N'D*GRPP6JEG$EV9%4&:D(\ MIZT\94C"8G8[.JO1[PI=K)H MBT=8>`PYF(I@&2Y"=Q9.((GN0U!8)S,!X,)@"^,BQM"T")*$G*"@3@!HQ>V, MD4!C;($"<4@'%R!!C#YHR406,)3^2)Q`J/#D:2"3VPD!*."$/HB"`/AKAP\< MP(/NM:`/#(06-O8DB(JE<(7^J%B6;@@`6'1@)WVXR]"T(+,+(84=+>C,3N+$ MC@X`R1ANDP'TZ"$#+MR@`P`0!#M",:&`C8T"*.!)F-P!@(:$L"`^P,:.\F0O M&/*(=Y'`5PL*9B^W$&9'C"@8)M;3"BZT8!PJRPD%U%(1421!666+"7#&0:OX M4$`<$1O'0N*#@F-`,A04J$4(H$@-%Q&*'NS05`LP`<4DN`@=[=G30EK!DI?< M+FEW.<8'W`+`,U"@">WADPPP\0%WT&.4R*M%E"A0J:7-9SC`84?]^$0!)AZ# M1SIJ0CG^LD1%"K0@#\$#`*_*Q`5>)24T(BC>[?Y2*.%=,11`>L8QJJ+#!@(@ M"YXT$28HD`1Q)&`2D^!""-AQ#W:2\$(\.(8H])D%/O%`7W-Z5R'69JP]\?!T M#=W""W^,$*\,*D%(5CJ M#;P(PA:DXQBMF$0?=^%8H'H@3:UB(%C00<)QU$*'5=QF.BM6O(K8BU?90:D/ M>/"`QZ(@%/8JQ)[>9=+A[:\G74D*5`&GEJ:6;Q+`.4;(D(H)DF3-"7T,55PE M]@Q!0((+NX@0QI[1U0\U=8_!0QTUX$C`8BU2"Q%S'``&2,:8Z)-%5U$F M;XX`^^N3E@I42=X%C$V.L!;"NA( MK65*0CI*"`*#=14LY#7@,6#!"E9\(`$Y*2$%FM2S?XZ2GX'95LIXM!`G'-9F MBH7;"8V(Q9="EP+ZE`,DLCM-X[%U)SS"HXL(#MF"!$-08D.?N M;1)@`;[^?R:9D6)L2!Z*S!-1Y,M0X^UJ>653+%.KET]]R!!;>0C2(#'8`N6` M.%OC:RZ1\->4_PV%*(QV0I$4V)0(?AJQXYH.>#X8R_29L"4M#,(LK>393>1= MYJ:9!YV,.#8W2`>JJGP.=/AJ(M%.31XC%###1CF*-05/$FL]UH,4H=QQ MJ1OTL5+MQ%@<[L<#+KBW)PMAQ>0A012!ITT+48JK*A,E"@?^P*+&/*)8)=]V MXCSIA+;V@B<(P_AZ&?CY&#(8(8\V`YO7=X47>S*1$Y(QMTFEBAAWV@D7>#") M2%-@;FZD_I]P*`G>S9K"X1'Q;>]>")I28!?2MFVU45J.,^8T51]`A_#H3KXS3(ZHZA?)IO"[#!&"!!H$+!SCA!5_B M&,9AXR@@;=I!$GJB-<[AQK!&)"K&P/($8G:&S":A3^[B'"2A4C;/Y9P-YD1K M0ARL56!!$N9FI4!LVGC%RDRC<;C^@@*4(W.0"!LDP<5R:^FHHGS4BH"X(/.H MX6CRY!RF@,="I$^B0!2*0NOVY-)N`%OL)0'`#@!`3^T043_.;A'](^T2\4#& MX8P$H:LH(!3:(0'XQ#3N+IX$@0+P;D:!_\\*2%`R&I@Z$*.B*T&HA!` M0!!&HWJT31108'S.H15?<33B*3Q>9":2H1T<0!(\(QTJ1I&"QR>"A`!XZ#T< M``0 M0!PT)4O^J")Q.B-*`*:+?BY/.J`/Y"!5I&BAWFX<@$0.2F0?IP`$,(%LDN@8 M)N18[$4+SB$G+"2,2,0'!`%5Q@(4>TOK`"4;T>DL>`$$6@%]-$4M:,OMZ*$H MTJ$%8.$<0H8H`@4`/DY1PL="R@<3L"4NVF%('*4BV`&2NH@=1*+Y0&XDB.$> M:D'R3(00)0E(TH$8Y*`%.LE$-B%/B%"56.$&6L$'((;QP(,`8$%'>($N"V); M)D1%UO+T%D(A4<`EC&$^1"$4.(0=PH2%_E$4EJU<>*`0CD%N0-%JN&!/&%-< M/A!C(,@89,`CR\X!DSQC700A*5:L!>;D M8'A!)HPCPBP$!$)@$HR!&'(I>,8A`0K!`9Q@*3"A`[P.(?S!`?2&/KS#`@RB M;$!`.T.`.61#((Q!'!Z@0L8A"])A8-Y,'%))(PCB,.YG"PJ-H8IB("AC3K;` M)A(`2C%$#K3`?^+*-;!!#D+T')[^H5/DX!S(!VFH$)7C!XR]0;B0/0B82?DS`*T$QL*X:6V`#P3 M@`">0?3"=$Q;@=L:8@KV,58*QB?RP$,Q(1@&CUW-5$Z^(B%OQ@$6UF5AGW/*RHXYH'*MT&=;+*(A.J`)UNL<;A9F M878K&F(E>_9G8W8K;B`80$!E;\`-7%9S:DLQSX$7[J2B]H07LN`9>"0V".@& MGB$+4NF#T$V(+0*`)&*\G$@`2SB$8@H$7@&8K]/)@IG:6;B#^DH`6:5=A=G%V M/HYA"[26`!C(ZVZ@=GV697%V;&\7.'B!@6IK<37'>!D(IA:7=7V2`.)@3GZV M(O%$6-DV"'47<:B"VYRW<6<7>"VD"1!W9?6R=ADW:,NV;(1U M:V6#8355)Y[7=@'7M9ZA%0@7,B@`'2PW>%XD#HSL91M"6X<6.$`@#CY.?!LW M$$/6HCK68R<*9"?8/M"I$NFCJR!C,1OBXT)!A"MBA,DP//+V8$:X0#;7(A:3 MA-GJ@S]XA1]8ST(!G>Y'D-S5707.$?N(@^FCDO:$)T1814NGJWA8X(98,9?8 M/D0A;UFX=)+8B'LXA"UDB8_`Y-C^(4($;H6/H(074X?UHX4?&(9!.`@+Y!-Y MY!\%5T7=U8,/IA72P0V@9%/0(0$JT8VK.!0@Y8O=&(3#>(5G)X]S^(N_F$HV M%Y`A@X]UHHSE@T\:68=K6'-&%Y`/)C(A8W0/IH65.(:#&(R+F(6;&)!%&(8? MN(//F(CKT%M+6)`#F:W6J9TTN8?EXX8/Y@A.V995F8T_3H\SN*$JV((C"H-_ M>8*/@0O\@9B+>9F9N9E-IQ=_SYEW0A(^1/DXQTQ9FY%!,2LYWE>9Z9.=*`Y@&"(8E_&>3$(90DN'/& MX1,FH07^6D`+G&!HZ3FA%5J:O0X;,`$;T$&?%WJ"U7F=0>>;)QI!5CFC.;JC M3:>2V!B<^TBB#V0;-]JC43JE'0J.57J"G6*FC\"F:7HG;MJF M9SHV<+JF;UJG\6.G@3JG>5JG>UJF?SJI?1JI:?JGGUJHI3JGGQJJISJ+>9JI MJUJH@SJJM3JH=SJIL9JKI7JLQ;JGQYJJE5JLR_JL:_JMN;JKB5JKJ1JKEWJI MU7H^V#JMX1JMY;JKU[JIZ=JOT=JIFSJO`3NLI_JPS;H^`%NIKQJRR5JNM[JH M];JHT_JHO1JI"[NMXYJN!=NQ#=NOC1JNIQI;^/JPHSJNG=K^KHUZK\%:M'VZ ML/E:LT?[L"L:I@.D(@A;L>=:L3U[K;/:K%W[L^<:J)DZMBE;LHT[M9O;JWV; MM8_:M7':KL&:N#G[M;%;K8N;MJOZKXFZM)6[LJT[O,D[K,L[MC?[NM&[M1L[ MO(][M:D[L-6[O,L:LI4;N*\:O=M[LIL;N-M[NM_;M[N;LJO[NEL;OY?;L.4[ MLQ?[K`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`;_HZ[[NC;[L]5[N_S[QMY[PVS[N'W_I M@?[I]3[OS5[Q&;_M>S[P`U_I"?_LV5[SGW[?W9[R-U_S+1_^]/W>[$$?\+G> MYP<_ZD5_\>]>]@V_\M<^]5.?K>:>]4V?\4O_\]7^]%4_\L-Z[QL?]>U>^)6_ MZSW_]Y7&>G=%^\!\_^"Z-]^*SX.'9+``8[!#]:'?\,%_^)7^BU=!_8E_\^??\@'BB,"!1T(1%!@J84&" M!AL63-A0H<*'#PTBK(@0HL6+$"LZU#@0I,6)$BE.7#B2)$.4)UEN#(EQ(<.1 M&4U*/!FQID.3!TNZU`A29\B6'G-N)/DQ)RO`HU*5*58LW^4CPK%FC*(Z(JV;V+-Z_>O7S[5CJ7,2=/ MEUEO:K4YU.HY4:+.G3,(^,ACR:'.21+7JK&H4'_+)0!P8[-CB(]%45;X^-@Y M`-C8.0:,6BOD4(TG5UY\&W9IRI(+3O9=SIT<"I%%+U4Y4RY.AWY&2GGZ9WCI8 M^D?+PN\/$W=67:>>4N')9=A_RBG54H(]#;:=?&AQ5U^$")94EU\:;JCA9MEE MEUR$-H%W%%"^B4+!#010H%DOQXC2BR@OGD.!'.G<0$$H%.1HF3N@L8-B8Y+U M$@J.Q"G^1!Q@K$DB"CM,"H0B5*)(H.5B7;(X(P5G MI-.$:S+>8)EXZIUUE7=P\J??&9U'NA\CD6A*&R)ZJC[H5'JJ0+ M]K0>@8%AFI]]!F7(8:ZZ5M+85(M6&*>B@=Y7F2@W8).`%@_`(@HLD+3P"3U) M8+(8,7VPEL`-33Q`SXX^WO``%^*XT1@%D4SB3@B\$'<$!9`X@,TDK+'3S@/B MR&&0'`YL(21=Y]`SB0,A9$;C%N),$D("QD1"8S#T8"-#%BG^WM-"$Y!0TP(L M%!B3!`"%)`#+.0Y,X8`%K?SE:'Q>#7KJAY!6=>EYWH@Y[J"2A\1`\+9WQQPCPJJSZY"=U^ MVE']7DR$\6Q@=RL/2)W3DN&Z:]Q]F7;GA+$N%^G*J!W#0POLW)!."[VT(@,` M[H`0"0""$"?O&3>L0@P`#G@+@#CNB`,`#U-.PD,HO7SV3"6?RX`B-H;_S05H M*((PN6Z]/-#',97PT`=ML'!A3#G&5-Y$)<^$<(1G`+1R`R8`L"%'%NG40ESB M6=Q0R0.1N"8#".P**I*)LIVJL];^6:?MW]I"'Y8588^23S-R;WY:]=.#6CK@ MSV.G_ZNE06\UL_O\>=WGV/@I.B?QE2U[P-H>4P)CMJ2M!($-(A&%H@(A^UV- M/(@I'XA^)CY;+4@P`1H(W.0&0KS0S4`8(P`XY`*`)%*A$'P0A"1^TH@E:#-;7],8^FQ7*@2H[)`1%%#Y#!>UN>7H? M`O'6*!/^M25]"M2>U*)#JTNR;5,6RA31S%(TMCCM:9WJF7-(22%)^0\]HA*@ M)R>%ME"J;6T!6DN"(N6SK5DMDV[3R@=#B,RS%>9-]6.5*&=5D)`%@QAN($>EL$#&;`#%NG`!B2(`5%C2&)W34`1YL[1 MB]WQ`D7RDL%PZ&8J.=EG:XEJF7PT&4`1J:A4AF`0!=H'#7LB+7!38IEQ5Q\0? M4N!;C"$``"8APW6>0X=[W.$\ZVDN`/`"<;V`#91$H05QW&",5CH#.LN!#@#( M01*P`,`S?$`!*;*C1HJ%T44SND<*'*$2D+A6"!:#F*Z23X&-"J;-,OC`E;QT ME3Q-6065>C.UON\_=D-:]MAVJ*.YJH1N6MI7D[HS6)DJIM!UE?G.6M(\X4U[ MV;TI>OZW2UXVL)%=+<\BQ7O`H>IV:0[*3EC%NJL11M`Y\\'>!O'T$'&5@QTM M2,+FO(FB&\)HKHP)IQ3Y:BP`1"+^<>WH!1ZQ^9DM]!.*K2E-'GC@CM!DA0(A MD$4O?"`(`*PB%.Q(P"XFH05B5*(RZ<"$:Q8C,3WR0G2GU:AJ:'2.S[0N5>'5 M7U:QIU/FSO1K6(VN)K6F2IS5*542\@^3P<:5LDRP9?GS*E8K2")FJC7*PDR: MT(YV(#WA#)IZ8^`GRRQ2J+8RN573+8,R61[Y$3-3Z`65[BB'8WKA!``DP#4;2?`DDL$.+9"Q1C(X!IB2P:37`8`5W(3$)'P@ MQY.)<8G^DDC<%O[6#A8EPP(*?0R1V_R_+!.%>V$^[J6HC=+D-DB[RE2E65-) M/[0Z.<[`A2Y4K7W)6)9**%*F5-[4-TP??SG(5N;E]_:7T_6=M-TJ+14N[3=F M[BK9SUIF-[&$"^0\ZWE#9$54;2U(Y@+QCRYN2$-+42."UR@!B;$H;%/I*X/_N`"#^75#M.T8(^]<.,#)G$#+CC@ M'.C@P7!@\^9_F_M.R@7F]KJW[8>;#VA"V:G=967>!H(RMG;^.N#.MAWP*Y=R M@6^WMU3'0M^Y`YI!_=DW^-:,\)KQSY<:_#N@+G\=NW<09FVSK;[KZ[6Y(!=5 MX%'XPC7T(*;AKZJ)$M9+CA$'3&CA!EG`1!;.`-%(K.(9$,V"0+"!B28@1LO``=[3C$ZIM5Q.T`%A8%)("[0A!(5KA@#B@G0"3`"E%*K&%!V#B#%O8 M>25ND+`0J#^A]G0#\+&!HT\\%!)N:$)$"5")!(0`!*R-%S8D-E0"Q!R<`C5- M12D$2%(`DD!6Q5*R)1UN9C9JYDE3I3,_L2D1>&:PA("%$A54%C;%U&:;EU2S M-8"OI#\.!S^]=%9ID7A`57?HLRK^Y\-EWA-W?U9`A/<@M0)Z5,,R9-,0IQ=" M%R*$0TB$1:@0QR`)0"(Z+-(+4B0CDB`).0(CHZ4CO2`)*Z8C[*`E?Y$0YX"$ MHM,K!D$!B*8E+*)LD``)C:4B(CPB)D2B)DTB)E6B)EXB)F1B) MI@>$?*&)BR@9D:$;HQ&*#^$8"W&*71@93@$8:*>*K4@CDS`M+>`A/7.*E`%% MF+`%@'$#Q``)A?0:IDB*J7@;OB&*GXB,R:B,R\B,S>B,SPB-T2B-C\B)G:@7 MTXB-0MC^+L;#`UN@18:X6L:@1$G``YA`#+68C>FHCNO(CNWHCN\(C_!8C=:( M%Q"!CG)QC_'8B/?(&-[XC8C81VQT!D<@"72BCP<)B?DHB0HICPA)A`QICPY9 MA!")B!2YB!:I$1CYC/-(CW9!&[3!&""Y&2$)DB+)&"$YD@F!DBM9DB?I(23Y MD2EYDBK9DBSIDC3IDB,IDRF)D_U$%SCYDBVID@)1AGJHDR9IDBN9DT?YDCF9 ME$'YE#-YDU*IE%')E$N)E20YDR*IDCHIE4\9DUT9D50YE4L9DU[)E4Z9E639 ME5=YEA_)E4A9E4R9E&G)EECYED?YEC4)EV99EG6)DF'9ECO^&99?:99"295B MF9A@Z94[Z99;.9AX69:..96%:9B).9=::9-HJ9E;V9B8R9ETR9D=J2M`V9AC MJ90\69)G29?VJ)5V"11-^9AVV9FRR9<%\9JFR9E'H9=(&9%Q29-\R9JNB9FF M&9>4&9I]>9F!R8\\68NOR9R!*9RR>9K'F9M]*9A0V9M-&9R.B9B6J9;.>9/$ M"99PR9IHB9VV^9V?"9VGJ9>VN9GKN9SIV9WGZ9N&:9\XJ9C1N9HPJ99IZ9OD MZ9G/V99[:9,U.9ON":"JN:#!R9'IJ7+LJB(7JC*+J7 MEDFB/CJAE]F?'$J8JTFC`UJ@.^JA[WFB59F>,&FD&BJ=TCF8RKFDJ$F?E3F@ M,BF7@DFCQOFA-GJD40J9A*F9NOFB_$FE^XFB?]FD.^J::#J7(AFA'$*@?UFD MU$F6:@J;=2F40RJ:+5JA8:JBA0JBL$FEF4FA_ZF8;-J9'0J5@#F9D;F6)3JC M2,J=S)FB\(FC9QJ@[OFHY[F<''J?`EJBF+JF:3JJ(#JE7HJ@]0FK[\F62EJ< MF_F8FBJH#;JA&DJK9VJIC7JB%4J;B0J>PZF=QEJC=XJZI$)JHD1ZGU,: MK4.*FK?*H-.9JIY*IMLZGN^ZK'O:JIX9I.MJH9RZJZE9FXC:IESZI>UYJK.Y MG@@+ICYZL!N:G]I:HU':HW<:HG@:GY1)FXC:FLT9E;3AK!HRH86:L`:JI?VI MHQT:L=2*H<7*LL=:K9P:G=,JIN-ZL3%:KC:*H7YIJ;CJG=,IKY-9K<;9I_\: MJSZ[F++ZIQRKKTX:M4D*I0;;GN:JJ!<+M?YYEUD:GN19K(*JKE5JE4JZJ4_; MIHT*M***K!O[F14[LVT[M22*K9):F"7K%Q^+KT2+G?,:L%;^FK!B&[6LVJ-Q MVIILRK*0NIT2J[.>>K/#";BL>I?BJKCH:I5:6K.96K!H6[-J>[/6:IUN2J#9 M&:U9:ZM^:K$HJZH9BJ74:I_@&KJ`*IE5FJ`J6J8,&Z1E2ZDC"IH6^J0KRI]] MRZYY"K&W&ID4:ITDB[>>N*^:.Z<-2JRB";)MZZV!6J1Z"YVRR[N&6JI=^K#C MNI]'JZ!)"KT&"Z-?>ZJVR[4Q6KKQ&;9_^Z??FI%2B[D$^[,W&IJ]RZR2B9R, M*[E&^[8+BI^$>Y@2J[*]^KF\RJ2ORJSXN[&)V[2OZ[2U6I_)"JD'#+0CN;S, MV[!CFJ@`V[$1V[$#6[2T^[J&NK_^%WJNMXNF6)NAX8J.MEJF3PJY/,JQ/>NY M\VF^2IN;C^J\F,J^4LK`0#J]+PRHAJNG.[NLNUNTR7G$?1JXTMN_C$NU,\ND M4(JZ5MNY`TS#3RO#OINLFBN?M\N[X(JCNPJ2N+G!>R'`QQJWWRK#N?NVN+O" M^)O$TLN^P#G!H*FWY2F>3JRI?SO'XKJM2WN8V3O"=KR^^6J\90R[<1RG'S)/&N]`2RK;AR^H#JL1TJ\>(G)/AS& M;!NHEQK%CQN2:[P7@@NMI'J=/GN^D(NK)RNMJHR]YFFV\)JBE"J\^!JI+KK( ME]K#K#O^HAD[J:6JL!,;O)^KGX9+MQ@;PU=,RHZKQ_8JO-":G0[,M2!LJI2K MKR?[P'\LNRT+L"U\G/6,N%W[O;2-T1FMT1O-T1WMT1\-TB$MTB--TB5MTEJ\ ME`HM0B?-TBWMTB\-TS$MTS--TS5MTS>-TS:MTBO]T%X1T;CYTD!MT8]%-R-] M*Q(M$R:-$#GME$(]T0W1TYG4T$1]DT[-T$1-U5B9U63\HKMKU'1QTEN=CP\1 MTE"MU9?[U,:0SL<-F2G=E[ M6*E^_923C9>$&-DG/=B=/=)[G9/5[82A M4(:J/9.$R"N4O=M-:!=:Q-B,$==R#=%;T`1GT`IGL`K`K=5N,`G!L-@0S=<, M#3F1T`M@/='G8`ST(#NKX`##L=T4?02\@`V+L99(.3CT8`'8#=X?;1?&T`YG M\-TWG<84D`6%`#U/70F?(`Y\Q-?G=P8)S@O!L.!-$.!KF7^3`-RA``O88.`- M+=X)D".5,`D)0-TGF>'971?:0G[^9ED)JW`&3?`)Z;W11[`%V)!%+&[1JP`) M#4:GJ]`$<1`'T=U&.U[?<9!-X*4@B2X(<9(J[>O?`)O.`&T7T&#!X,.VY/ MG_#H[1E1`'J6-/$)[7*M<.#A`]"K;? M]GT.,H`-9]`"ZR+H+^1YQ="''0?#E)$12?\S^OZX1%`<0"0%^*V:=D^40`@`0"N402&Z`"8E.\^#^#7O/H$5=I_== MYUG?_>,I3V(O?P3'\`QQ\/`_#]8DAC%D[I*58$,`T`*+K7)R]$XG;_8JS_%< M[_157?'E8&Q)_\VN6?.ECY0>1!L4<`(/@/GM@@VK4`[+!@`$$/MRX`1Y7O%I MO/)HCN8F&1B-D?:T#@F+\1?!K_OW*=8Z0NEUP2*2CVN]D`R1T!JJE0YX7O/L M0`\`T`?!LS#)X`.\``#$`&M'(`C'T`L68`S$7M-F;N+5(`S;L`W"H`%:9":5 M@_M=,H/"31+"<)Y9&_#CWB$JR`C-:%'6,8*B_95>&9`KX8$B& MAK.&@"01H42L[)XVAOEXKB@?%&@._$NVY5**+0"X.8BP%B-F5HVUV)>(`BF= M!TR2ZQ/^4<[I!1,`/IEH%3?*0NJPTDP+B32W3I-DH6-`RDJF9(+A82B!DA$- M*YC@HTBTSCX3A8(D(&$'H54`D`$ME,XYHZQ/6N"B#X0V=*.%)-)9Y1@W5J'H M*WIZ.4>43_[:XJZ&9-1R2RZ[E+$L,,,4CD# M`'%,ZJ457GJ18Y-5#/K+C78BB0,`.2AHXHP*5SETE1G=@`027CXYAQ@`+#CC MDUZ::&*52-PX]-)*?&R"`*5$(LDDF;(@)@ND4CH#$F):F8TC.2`Y0P:=4@J& M%XO.D:.2+3[(<[10]@3AB%4876J@8'Z$Q)AS)I**JL*.J#7^$H%6F00`!RY% M9UM(-OWKDTB(.8,ECN+XQ(U(_CHC#DFR:.<3259YM*PT>TD``$C<2>*&,\[8 M5"FY,H6DG7-D:N6,+5#ZY%".LD#G"&+NJ2JE)AZ];<8L8-FB4P<`F`11F>3H MD\E'U36H%UXTSG+92K+8@B,W6(V#&$Q/"U"U&R82Y08*DLKBAE56W:BF3^0X M!A9Q`""FB2,&;4(48@H5D8(X`BW+.!E\HN`3$!KJA=UVL@CZ+^G@F^L!.0!X M@*6:LG!@VR;0K>09K2?J)0Y((AFXK&Z.9SK2+^EYAA-T)0P:5"K`U"6((NBX*:13'F#(N" M@14=T6!//!ABMD#WB$@@R>(,A([)0D(YN$BBB5;*.AZMLZM392_[[ MW_),``90@`1##050<0DS;.`2`I`)!>94)P)\``"8(,8#=*2W++0@#B!0C1ST MQ"UVG&-;"!*+:P+0O,+@XAFT2GV$$, M3)PA$GU(`#MN(`@`N.-]51-#"R#1M'0TP0$0>H"!4-.+58@A'5I812\L2(S] M;<0!K#A#"*C1LZ^$H!>]<`(/$&7!280@C3)`2"70UXH6\&`5-V@:/78ALFT5 M(A+H.(-J,.6&$Z8P04<0QR9:L0M=9DD@3`.`,20QR!J)@PO^J)#V_J(:`JRR M\`EW?`+"3NC9C(41*"=A!,',$[T2K/5^H'G8-,B[/^(VUI M839`U*8V309$H`(%$*<'WN@&`[U!,MJ6A7KU(0[E\$%]Y$`6,8AC(5NH9C*P M$8)DE...[^&61&"1CCQT+@MY(5+^2C[@AA5M:"0.6$D([I&,9(```&9K;C)X M`%=V.`"YR1DH4CXA,K(T#03E.$8Z5-D+"R2!MTT`0"10MY$YR>`,[&@'`+!A MDZG8U()9^4H33.*T9#CD*Y\(S9PU%.GM1#DI94Q!N0,HSTDFO;1$C&1]X0'(K,<%R MI%*$NP0`"&),@6W!XB'(]<$GL)$,>H@CN:)PVXV*$K,F)T<&?6B%#]P@LO]^ M,Y%3((8*35*)MCV`QR'SX!'H*)16?"<9O?"Q.RB0EW1$!1M7]D&.!"$)"ARG MH5S8Q2K^E5>.9(0,(;U(6VT^)(EC""0$1S"&@7MQ#%X@=RI-.`8["D$/\,+B MJ#[@PC/`NRJM)`"\[TT`CIW6"Q_(@`L)P2)OOU*9^A#CQKO@@F%N`$)1N*%^ ME=A7.VS"@TB*Q6V/32=X0Y`.@TQUF6EB!U8)I)HL\.V]QDB&)-RVDUWTH0EF M-G`RGL&%EOWB6.DR11'W(&DK3IEQ+J67Y M`%>;B$9THQN->*V[Z,0.@:2C3J*8DQ.200Q_H&M.OQV).,C^PE]RUV<2G;Q! M@P!0")^$@D[OX0A_:XV.!%C25`[PP1G2,0FP"R()'^A%(>K6"BZ(+QT>/(8"+BD^`!%(GKA/=DJK]2LC4LR@%5 MIA^#!P\8/@_4>4G^)DX22#+)$9Z>YEX8TTEQB)+I`;#;2AQ;E>S`%4%\DRX` MY*D7&>T3%\0Q?&I4LA<`]8G;D7/^#'JPD9E*ARFAM%U(O.!Y%-I1HALX@G3H M@W/HMDB(-(TZ!W]P@.%+@CH9LRPH"R?I`PR@!BWK'@GI!2W`-N_;A/61 M@T^X*0"`!;.@O(GXJM5XOF>@@,=9#;.P@#Y`ES[`!'80!6P``7;8`ET#$ZI* MDZN*P16)BA#PAXQ@!SCY6T9Z-V*[PBI!D(16#&#$',`8Z MHB(`.+G]XP&&R!'$DP1$ZI->.`Z;H$$?.#;)6I9CFX(08H>F685R:!HV-`EL M((;%HT)%K(VV:86"2(+J$H@DJ80S4Y\IH0!_4*5*0(=;ZX7N(;V04+ATP`3> ML(#QR@*^VY]*(*3T8Y2RH(UVZCX'`@`GD(0(;($^F"IB$(5DV0@YJ:80:DAC M8#X)6JM5=(>&2`=("`6BV0C74[[$Z85=L*R)<,734+-54(N928E!HY0Q9",9P^$1M%XQJ?2(8S<(!(P`0"'(C^))"!H90P$`C6-)N/H+7B`4'^`9O>$96"2(FPR.OQ@4 MOLL6'9$$CC@'=$!+3!B(]X$%.:B32HB"CS/$NB3N=BA MCO.Q..!"\)$$!U@C\^(!@!LOEMC^R<9RAX5`I&AY1N0`GR3`A";`A/%<"H$X MMDD(H7(0J\$KO#,X@L#1F( M@E62!62T0[.A`!_+0:&DBI'@"C8,%:7DFE6*A!-H@F0`T)28RL0SAD@(U!]1 M(AX[,QEP``_J!;%DAQ2513I%"DC@@F+,$6+P@3E=A6O*#KE,!PJP1TR0!`)@ MPP&#G!_^J0MLB\P^4)7^JP\)Z3;#G"H+6(@$\(=/H*YL6\+'=$+:8`?);`A- M4Z(+P\<1`N&-G^]U(?A+B[$$#1 M>\S')RR''I6UH=B758#*L'BL*4#)`!G#\+.L8F6XL.V%>ZJH M<9D$'Q@4W?L++J"'E<"5CJ#<]X!/'9R[3AHSKC2)!!@(EE4L&0@AD4FNN>,/ M:LB[8]6,F$`(3&"-7FB:79")]/J.=.0";L39!."Y51(%'MB%PGQP)Q(-H7A+RH;?PCEA\O:@LBOEYO)B,O,J%SF41 MD1+^#(HEH/84$1)&87EMSA6F69J=CSD9V;*8MHR(F3Z(@B:Q MH,'A!3>?H%=10.G5&,+0:H$3T%U*@80CJ`]Q:!V)9`@N*S(0P(3^&W/`,B/%S.V# M>?)?T<39)("K*DL'0H;%][C)-P,)MRO-E!@)'B`+\.0!FT*'6D`*3#Z7A,". MO_C6)!,92T7)J'``,2@2%DZ*%#;<;(-.$O[K,''AI&#A%X;$P1[LODZ*(S@# M?W&A&W""U]V4$10'?-B;/K`O;.@#F6*9A\.&>]#L.=@$+G"'2`@!7L@(L:J% M,X#L%FB>UJ"<`ZNE>3V"=DB"$!C45?0'5JD$"Y(!8Y@AA`!('G`'&9"!.*"8 M`MV"4N*J(P`!'H@"5C&&=$"GJUP[^'!'`!CNTL8M46B%$*@1XWG`8-21NH'* MVCT#3$B";K$2&1"'2'B`^%R%!"C^4`D)!6,`J..>[XMR`W&@AJ5+X4E`)QEX M``<+<`#@@CRI)?:(!$GEEH(0A*T$G_06AR,@+AF8!$@(@>G!QP8_,&W)OPJ9 MB'-Z@#GXA/PJW4BEH1#0/0J`!'^XRDEH%1%9!6P@03=X!EPIG-H.`=?>"'8I MPQ!T'\2RPRXBAA#P'5'(@IRXAXD8,P=P`T&@!@=8XN\&I5X@AC02`Q!V;NBN MA'L`*%;9%Z[:EP>`!>>^9AUR`SF0@7DQ"&R8R7GZ;FSPVP1`)]1CB!:0`4B8 MA`>(6GJP\W9@U/Y>NA3"8HHP\"0@Y$_0`O]6E%QJER.PJ78P0H3@XR28A'/@ MA4<'GN+^RY.0P>*Y*X0;B(3([NMLJYDR3(`M$)$X*,-(V(A5\(X6X*!T:`<< MYX'"@837W0*T8QL+L,L;J'$KO*;?RX)SJ/$G'YL6P(1(T()2W/$S6(4H?_*P M90QZ-6$93F'`+NQ'/&Q3YVN++$0G84\GB99(3XD*CY8;&(H_R9F& M?XM6:`('B5I)\3N#8,]52@9C*$6]_M8^"86CI,(3M'BN/()/4(NO.2;#0)8) M"57PDV(5?@$=%BE4+B1*D$7&19[;H2*4)@# MJ*@$M29WZ5?!%AIB0K$?(S9^/QU`46,!LEZ9('UL4A94;[] MWX]Y@Q\(=("%'O+`C$<3$2G^Q0>3W*]IP<=93"$`6'=Y9$&(AU'^B4#X`'4# M'CL'\"^,.X&:+5I#K*^*=&6/)&C^!Y-(%@]D_!D!GVAA^K68>O`Y2HNL"J:? M8H!PX^]&I2.5#E82)2IA0H4.%RY$V-"A1(@4&4:D"%$BQXX>/X+\F/%@1(8F M0W)46*D7PB,+0U6B8+!@Q%XL82ZD<#+AL3B1FF`R6')C2I@LA8K2:;#70PH4 M(LX,*:K7F71NDF%-=F93+Y<+5P%(X$,G480+F2:M%$HAV90-;39TB](LR8(Q MCSDTV/:D*+TT*TKL]0E`)!\LAZ[\"SCG3H1P9_IU6;?DW,8IC_1J`B!.N<,> MF791)9::EK+(L25%K0Y/T"],Q6H6R85?TJ_+C$2=-$B1@Y[5R0PK' M="_&*-K^,F.]N"52Z'4\-%L*L\TJA+M6:L-0@ENL8@F2^D/1N%66>Q!).%^- MGQMGW&U1^<;RSXGCYRY?X^KY&/U/%-=_%TU47WD,'0&`@EE(@E-=<0WE'G\0 MVB=@@0S!DL<)#]"3@`,.()74&0`X((ED!@;(7WRP34C41;L]>.&!%[8V((0G M>1='6,*M1N-\$CX4Y(#[3>9C@2JFZ)T<`#C1U4@[Q8==13`NA]V/1_XG8X\P MJDB@18A-%F&4=1W!3B0*\B!4F#4&V"9B3WYY)8#]N?FC?7<^:25==#Y9YA8. M$`2G?%H"9N-&H402"5-02@E?>W8V2F2A^5$Z5WU#TE5CC^_^C<2ED&P*J%(D M#GPB"6M42FBABZ&R>5XOJT"""2:"9-':0@00(XX@K=QH*YV3*A>L7)]MNF>P M8V8Y**,W)""..Y_0!Z"1<,:H:80F45?HJ76Y08\XD\!"8;0IICBH:E6V)VZU MQR[F7YPW[N?BE3:N@@TQU@OM<*6J2R^HJ[*D22E/-4N_>93.2O MOVZ\4#DWER/)L11T9JO)?"7;J7LB.8PJR9WJ*:;2)/72F;380ITTHU%N"32J M4G/<]*)\JOHP:VNR:["P0YL;,-'^4YKMJZ80'E,..T`3'/7`\8H)]=*L^NME MF$:+++2[ESXU)]K%(CUV3!5.6/2_?=O8-;8P@TSII=$:3![&PV8ILM7=76U> MW,).+32HL852^G8#EFXWW/3]K&V,5*:\ML8U&_NZBZIQO]LN< M:_U>''?'F6/.N%LJSSSGUZG.R&+AKIVN_-'K5HXBR=A+6^SCZ5(+/-HO]^JH M]^M*J7?RGK_>?JN611Z__//37[_]]^.?O_[[\]^___\#,(`"'"`!"VC``R(P M@0I^C#'P(QB$(<(A&+:,0C(C&) M2EPB$YOHPQDZ,8I2G"(5JZ@_*-(0BPC4HA6[.$4N>C&,8APC&$(P5 M'(`:T2A!R+41A>>J7QP_5D>%2/'($G3@&)'RD M5"!;@LB./%*1XOF?=P)3/\SX[PC'L"0>.SF7HKSE)\X!25>&I&FR_%\L M(;.%W>&GF?UKI2Y+N4E/%E`>G(W%*E("E3$=$B=,+ M'A@C&:T``"0<2D%1G$D.5KWD$1X`@%7$](*_[`@LWLF>EDR!IS8!@0Q429U/ M,'6KI@$!`"X:E5!@`P`O>`27BK(7D)`!81,R5N(< MH:L`B$=8Y_?-E_8B`3)P0V5]RLC^R((V8>4(`0!"T!7>'`0RJ8U19"0BT>NH MMC0=.4(YLN``4C:RM0@)A5)BDB"D*G*V+1FN3F";F*@T$B8\.Z=<9W.B7O!" MKP>Y0508DQ'DNI8TV-V+;$>RE[/L!#.#4=1J5]O;NA2V.1U)!D/!*MSSEN9K MQ"U-;(.+H\0<9)V80*1L#E(.'LC@M`8)13ETI$J]B&>1Y4A""]BCFDWJT2"@ MK&LZ:;LD7G9DE6K1;F3+88S!SD6WLI5M:X_@`T@`P`U,.48O9%*.)HACG)(A M3C*(,5F9L-8LUU%N06:>=24E\?$3,"&`#:$## M!K2A,\?^-"$$,A@L8(%4.,7UOV/:O,;F2),B`SI@L$UU[^NR9O$K%3^D%@\7=SW56V[^KF`-8[)K: M3@_6!WRT"63,#&2;E`/%G[AU):YI['.L>C8:7K,H]/QE&ZO^N,YV.8(,'J#O M.F\-OQ41-L2;5A!2I_GC#?\W8"5Q9LT\@R6DK(D;(L[G>`/YT('&>$E>O4YO MMPPS"SF&G6M>1,SHH!'=Z`8M!'#E+X?`)Q1NY"KD((,L)"`=25!4TY\N#BZ< MH;:"($8+$F!F<6""&*^\`382$!-(?,`!/%"E&S3["6QPH19ZI,`G=MJ"#V0A MR\0`IU8_8"\>$(,I,G%`LT#T*@`@51R%R`(!)`*+2;3@#.<\2#MR)0..6M@! M'TAZF>5@KQ9`@B6?@+SD,;&2425@$EQH*J_M!?:(1V*GA!=E37@ACEQ%HQ)Q M>(`X$A+[P)?)"80/P8$52WA,M$+^/`D@Q@/@N9(XW%X+#YC*,V[_@`=L?$1R M($8Z>""',D/"`<20@=E70HRR8\+KO8C#)!+`@]"+5QRIWRFB!4V,]K<`!!8[ M`]@_\8`^.,!0'4'93<+3O4HDR$(<.$$2)`%'A<81T$,[A$`(O%(OR('X/0"( M%`(`)$$"K,<%!/4`"M``V)$K`Z54"<($1 M&IQC0$+[B8-Z]((3A-VK)``FQ(%-A-_X3<'#I=@Z$8,1NH%7D=_VA<`#\$)! M;((#;-/^F)'4_*78$3C=,SP`%\1!&*H2_V'"*[&#'(@#/;3`)#B!',S6#[H# M&PA9.<""^[T2!20`^H5>00A"X4&&O3@`)C26!(H#AB$B89W!)*@`#TQ"03P# MZ%&A'-`#)I1B061B4NW0`/0"*F2`&9C!)1B=8WR":;D!!W[$#0A6"$Q")'"! M7AV!(`!`V/5!$S1!.L`")0+`7UD@59%2+SC`&;#7G"7#3;7,MP``#S`A&%#,NP>07#$)_``XEU=+V!#/R:# M./3!*I3#&AY!,NR4&P1<']"69N#@&0QDL^3!(2:!B:D@)L#^V4%T8#+T0BUP M004Z`4^-V"I$`6U]@@R<0SFT```@1&EU1@%60C)L&4-"WC'HY%>5P^TE@P^$ M`!=0@!O(@"B4PQ;(0"4@)9"=05.JV8@H8R3T`4_5EEXE`XH]0S+$7C*40SL\ M@#^V0$[JB%:=0Q+(P:TUXPU,$FUA`P\TS9DH2AST01]`PB?8V/=E1'KT0=/4 M`DVN@F")0QQ\0A6>5"]@PEI>VK8U@0RP3!R4Y5-)Y18`P%KJ""2P`P7P0!(( M0NRQ8R^H(-NY5!/X@&3>3!:8%@4D01Y$@DVI524D'9VMGDV`W(B^W2-8[&,E\$`_^B4Z=`47_&6= M05TKP5,R%.,D4("-M4`[<`$D@`4/+.$D9('%#)$NHL(E^"(P7AEM.C6$OY$$NV,09)``I35TS54)I`2D[T)-9"MDX]@&8\=Z$)8`;]-Y)/>0D`,`6 MD-(J<$'^%J020[4#!0``"#Q;'#!6+Z0#-OA`3'H5..85.H!2+W"!/6'&ZH$9 MM+$"`"S%8(@#.YB)7A668`"`,;!#@:V"#_Q??G$!)FBH6EF@#!R:6E&`TZW" M8?)"WN55%A2CGI;#,XC"B&3!S<3!-M$:50WE8(PE]ZV"5A!&,DQ"?C[;K8;` M-](I!XYCN,4D/7Q5/X&%HDK"0`9K"^3!H)%(.HD".[1`"Y0#L1;HB(``5N25 MKJY?`V:!/@V6@:5FF0"8G<7!1@$IXK4,#_#`S;##+J0#0Y9;TQB8=F:=:$X% MN!G&.81%,A@##YP!")S!=Q;C)1:CO4';F;1"N.Z3?X7JIF+^PE]B1A\,:1?J M%<;VP<;IR$P4(WKV08,.AA-L9;_V*&%P9XKE)(I%7#K$F(5M9R5,0HV6`S8X M*X*F6#GX*)!FQG8NU-#*`(GV17(27$*D8!_(Q/H!0,JQ5X$ZP$D>*['V`8KR MGG9*;&DU#8JI4B],PE5@`R:<0=XUHY:*ZAP\9#V^"CT45A!AQBTTPB5<0B,$ M8\&Y`1?(09UF8Z8=[9"Q6Q($64YAJCJ*9G+:&8K%03)\0#"40S!0E3%$@C'( M01.4@YL:XM*RZ996`L**4VJ5$B2X5.0"&)C9Q$=%(\.>EFO5)P"43E8F2N;* M@1OH".:IG([8%;X10S*HU$%(@F;^\"ZC1L53I8-9W"60G8D#0@=I)5TY$-BG MQD0?A,!6G4G$J1PDI(,<)(KF$M9,BB&7FB\O<*EC:-\2R@`7=,41P$+X M72;17J4#2.01`*#X1H(FHF=XMLQXX98;T*^B-"3-=O'-YFQ!I$,+),,#-RJH!C!#2:1F MY-14L''^TT"K1+8`_![$ED)&>L@E9NA(3E5P>%2%&&"#BO6"#&P;>+$#:45% M$J2#01P!4R7#%N#@4V'"#O>O(X)%D^9$,?+H(V@5/JF0!I!!*).!"T!8YSH` M);6?U$`5(@DU(PJ2%`)!UAKC*`4$=A"XV-&VU0/;. MI^@!0"V4V8CH9GI0U?=5PF#T(R/^9X&X5F`PN]8PVW'G+K(_CNE.<:X*KT*" MQ#4#RRYEKX1F?#-FK$(3C`AS*N4GK.O@WO28NM12J*`]S0&[L=Y*M(!55((N ME;#U8Y MR`"6+K`Z.D8+;!MQES0?'_9K=S%GN"2&O>>*:9/%NB[,$II;=4H3`"6`&;>4J M9Z.;&S`5\#E1W/XH(Z]3.FR;H-4:2:[U<-MJ-Y*66WKE(N?78*3)Q\TD)!2$ M`]@:0QE$,K1`O@;&;Q$%A@SC)[7JVE:XTC3>;70#KB87$& M>T9")7D0268U.5D)9BS?W&SK)^U"C86^]K:-5L44NMSCZ8# MY<&-T*`!82Z%)!I MABJ):R6H`4*HP2JD`]8=PT.O0AQD@0\\6S*#&TG>O+!>5"6T6TZVP#Z6-$=5 M?0M'[G2R\#F)6UW%;!)HP&_SH&;PJ--76)*K6$)6:#F$*DF.WZ&")9`M2=K_ MX?H"E3[.Y5>#+%B>R77.\<9OIQ2^DN!WA7\;$VVYZ1B*EF!%;K9+Y(CH>"NO M92]X%=HR)T/&_06?R3=CW_WHQKXJ;V-EBMO(P56 M0A;\E70_+6UY5;T[T8BX`T=H1G+^ZE$KK]TJ/`!`BWQ+`)@;"*16'02!/6BT MG<%5ID._=\5.U8H;],%*=02%8@,O:(8,2%A>8<(DN-0D4[Z"]($1-FX(&$0S M0D)_'L%,UDJCIX-B9V.0SW_TPX.9A>IVN^`J;)G"`\217ED`))GD(%TZ.948 M,NR%#<"S(^(>]*ITY`&`!$>.-.RU!0"D(Y%D')'4!$"(20GZ],E2CB"`='T@ M]>HE!X#,/I%LXI0)`%LRE)&.0)+1ZPP`HD8;.OS4I\69&R%X]B*6I**MG`1!+AC/+$<25RF%J*T$"JA"E=I%4) M*C)T5YDA1&+E(*6+FF-]#R)].6]$G/!-+SX8>,MW$#:.KK%PHP+*\VOI"9).FQ9 MUB*5L;PIMMPRRX%5KG*@*1[2F602S[!A3B:T6GA`KKDR>@`Q`#`!++$LDG&` M"[`PP::<^G+J0Z]*>AE.#MQT:Z@<.?JP\*QTSAAHL+F>:<$B`'W\$<@@A1R2 MR"*-;"H..>YQHZ$CLE`R$L`\2HH52*:0PZ)5[I%##B95K(3^F$DV^422NE$,YAHC1(HZ'$G!(#@<&[86`/3]Q M4HY(;FP(3CDR<\B-2=C`DM*#FBA1Q2,22``2[MZ,LR-1RFE"+#>(:<+'!IMUUHS0;6@T;2,Z01!2&((FV%P;?U!74-"$Q5*!.)WD@CCA$`K`7-[`! MM5TZY0B&43[G6B4K-U9Q0(Y5N)3CAD](':\)!QQHHI=CT*&6F&VQF40@.<2I M"9*X&+I'G%B/8^O(5E][U[7V?75O=.2L1^+3? ME_]]2=3^'T_ZTLE7'O;>8Y^?>F5:7X^.<;V&%)!3QGM?Z80GP$H@D%.G>Z`! MJ9<\YE6P*:<3'=\0^#SR`:\7+6A",LJ1#!/2+7:[NV#_RI$4S9UO>#V2X.L0 MJ,+_4>^!1T@&-B`6)-UM[W2V>U_N&"(#-Y#0A.5X$(`T2+H`5E!^"ES>_3S" MQ`N2#T:%0!/HN-A%+WY12*&0!&]>0A@P,B04H?"<&H'$1C8VY(U>C",:YUB) M.OXHC4,*1;B*Q$<`W=&.=0`O07>S_*`3 M7NPDYY&.H"`$[1.@Y%29&SZ1S8`>%*$)5>A"&=K0(]E$96IQX)$(\`F"&E2: MJZ#?-.UW49LXE$@CTRA(2=I3G_X4J$$5ZE")6E2CLI*?1YTF,A'*5*4^%:I1E>I4>8JZ(FV0JC+U MT4?WR=6L?A6L817K6+]X#F*(:DC^64@`,@3:`*`0&UW.1)IP%7'<-4B(?2A#(P$`&93#CZN`R"2@&!7W/!^%ZW5^[)$DA"@9=I0CMK-UB-02,-N/AH("J?-J0]Z[ M78:DCJ;:RJ\0U839_8:KOY6DZ4Y31^#@/AC"$9YJ.2QJW#>Q8Q51LTC8`!"< M593I1F#^J00[W)"%V]BL"5DH:"6VP(/JN*%$(5[%C#MR!#=PQ"-Q^-GSSL`# M'ISL!N>H\8T[0A89CSAFD*&=W+(P-N;>J&YHYBA0^J6A7,\SVU'N($HTERA&\QX/+:%A%#&W"D=MZO-%]ERA6:,40G_ M&="!YBG`4@,3'V?!`NGX<2]:,1P9M"->5FZL#)+A#GAA(@F?L$G7LH")DK"$ M"\2(Q#.L[(2MG"$)(5@+)/I`V8L\0-1)D(,HO!+J2#0AU:ON0WWE$%OWA"`9 MD!!$%F0@`[7,)1(A>`8VN)"%DX3`)>+P!Q##<9+F:' M18#BY?QDX0-3^(1L29B.$,CO"&TA(1<>>P3/?$=J#YC=)![KY93(3VX:20:H M>B>,E,"X.=RQK8>289PX)(,W[BC1$>PRNS/,YJ0GM>UVRJ$5M=CV[3L$P`B3 M4M_G`("R2+$,Q1G?>,?GEC>:2\;^+3GUSKE?DRR3[X--O-R"3U#8Y,E(RH,H M[%>6KV7R7)AI+WR^8:GC1"X4:`+&$-%ZO_I\[D4OAPQ4WXMDB*,%D0!5Q@UY MA!9X:!7H]#U$*D&!?AXN0,OT_'12IA6U6SG@L-X4(?_)J`T#X>``-0`$/'A4;G MEDH'\Q@"\TROYAHB&;J"&.JN$B""X3CC]$R/!Q#A(G:O`:-.YB""`*R',WSN M>7:/!]"LZ'H!^HX`$7A`'-S@#,Y`8``$[B8!$KB`1\JA.3I"!2E-,'JH%^+K M7[8B'2#^9@`*K+YN0CJ>+QW,*`GX#R9<*1GN`3W*147Z(">V`NYVZV8`X//V MKRG`,$96YS*,`TO.;0#34`W7D%X*L!QNJ4<2L!(6L!Q:0/4`[4NBAQB2(/ZL M3'1V4$6L[#(&S[KBZPCG"_%DH`\J).R2$/[@JPD=X@D;`BK*I?J:`&W`!!MR M47-X`VVZ4-/`4/_R3P$QH1(HBPM"P!8%BPV7D1DE;N-XX@V%<0[%X?*H<1#] M"B=@;!J3X<9Z`1'<0PYFK@'KL`%-I?48`BB2@2`>`.@BX>W^SO'Y>$"`$&]V M?,P1V4`Z@"Y4;(:,1@?Z=)#G/I'24(*R_$H(/4)JB"'J9.L(;8L5!R\9,@+* M@O#I_,HX)N'MKH)"AD>#>@$=#*RQXB\Q-$T@S(,L='!!1F@XL,G!FM$E7Q+" M0._B4@]^KFFY]E"Y=(CR^F_PHM`!;F(22*@7;&/FN(#"DH'EYJXSRB\2WHDA MPF,2[HX8GR\)*&PI+<(]'H`S)K%8`*`/^,1A@H<@YNP,H$)%F&\K*:T2S")9 M^H('#&DMQ`XG2(0L,"L*XR\IV-'KC'#?GB[L,(&W)$-JT&8,/T$H0@_T;N17 M>$/KZJ_#H@\F(U,R@40#4K;$[F9+X,'P[TRQAT4;[L9.:K5B@,-FWL23;%(>*E7@3&2XJE8.CB M$ITD4'J$`C340]6"57;##6Z@0[TL"R"&;];"Q+0L,Q#T0;^,2604-IN@79JD MH`3&;0;^ZD=G3&`69<1&HDOHQZ"V3+2&U$:+;!58X&>4M"G\K$"O%$N_ZJ28 MJ[FV-.^XU+FL2UE62$5V9TM-Q[I@AV^&SG1&QF;.U'KHJG=:!Z:ZU*M^9ZN\ M-._TM'VPIW/.%$[?![$@+DL+U5`/%5$355$7E5$;U5$?%5(C55(GE5(KU5(O M%5,S55,WE5,[U5,_%51#551'E51+U51/%5535557E55;U55?%59C559GE59K M=5*=BE5Q];=TU8MX=3E\%72`U25S(`V6(`V.%5F355F7E5F;U5F?%5JC55JG ME5JKU5JO%5NS55NWE5N[U5N_%5S#55S'E5S+U5S/%5W355O^E4&:4$`=U!5> MXU5>YY5>Z]5>[Q5?\U5?]Y5?^Q5$:VO5=_95@"]9@#Q9A$U9A%Y9A&U9A MU6$'!-9A)Y9B*]9B+Q9C,U9C-S9:`59B.19D0U9D1Y9D2]9D0=9CH\E=3Y9E M6]9E7Q9F8U9FH35ESVAEDU4=&B!G=[8!>E8==O9G<]9G@Y9HA99G=;9H>U9I M@19I@=9HA19I=79HB;9IA]9GE;9JHW9ICY9JIS9HM=9JCU9JK_9GL?9JQ[9L MR?9KRY9IQS9JGU9MDU9JV79MZ]9LO99MX]9IL_9M^W9JM]9NJ99GX79N\U9P MP39OX_9MT_9KS]9I]Y9NH;9QU];^;.G6;<.V;><67<96U9L'H9M-`'9:`"NY`"*)7>J>7>JO7>J\7>[-7>[>7>[O7>[\7 M?,-7?,>7>Z&!?,_W?*$7?=>7?=O7?=]7>M6W?.&7?NO7?N\7?\?W%59@"0:6 M>0-69?VW>9_W%>[`@.^@@!/X@!'8@`N8@5\!@A'8@0\X@AFX@2EX@A58@ANX M@BG8@Q?X@3,8@D>X@QUX@C]X@U^!#R[8@D^8A5T8A$UX@2/XA`-@ACGX%6P8 M@R^XA._^(`!H^(-MF(956(.!V((?>(.1&(19>(65>(85N(1%.(,]&()UN(F/ M&(&%6(9O>(N/>(1W.($K>()_^(D96(A3&(I/.(R3F(VQ>(U9^(#)F(>I^(U_ M>(MUN(I]^(U=6(P3^(I#&(>5V(2[N(.Q>(DCF`_RF(_/N(4E6(R]&)()68V1 M&(K+6(,/^8F'>)#A>(YO^(/5F(R_V)`G68$#H(EQH7^1%6(_EGF=EX,!.84- M.)%)N(N3N(\[.8)8-V9'O8(6'>)81>9+E>(IE685_693]V(%W.9%_&9GW M>(@7N(F!>(2?68:7N8+EN(55F($3N8%_N9=;V)M?N(@KV9'^O]B%QUF3?5F& M\3B']=B+:1B9[;B/D_F=V3F:&SF-UB'C1F2;9D/['B<%SJ*<3F<.3F)SWB$/3J,Y=F'7UB=?UF+6QBC MHYB0OYF'IWB0`WJ'LYB(7[F70?F&?WB7\SF1<5J9+QF#A;F0`SJ9&1B5!1B` M;5:`7?F6B;B2!3J#P5F;J7F*FWF:);J:FYB9V3BD_7F9^:"9(QB/<1B=,=BI M$=B;15F/'WF.@WJ.Z3F>?WJ7!YJ6_5F"K]BKM;JBF[J!X!,@9C)&X MJ@M8BY4YD(ZI8N9B[F9E+%YL6%ZJ3G;AD,YL:&YDJ>; MJ[T;M2FXOHT[F!L9J`,;H*=8B-TZD_^8C]'XH/-:P<':B+:F-':F:-; MNX^8KU_^&Z!9VHTM.8UKNL5#N+?YVX"%^,$7>8LG>[>'6L)_/(9SV9N?V8"+ M6I6/6GF3FH#1NL*/&YSENY-/NY<)FXKCN(U3NZ\7.XOC^K7%NKA[&(4A^I/3 MF<5Q^*^=N[!7G*.[F88SV[-O/+X/V[&7>KH3&I#5NX^'?*8CG+NS.K(7^IP# MX+L9'),C.YV)O+@)V[O_&_>;,W&-,G&\H1 MO;Q'V8E=6\SI>(D#/(N-.:]G/,Y'>I-3^*^?FK(;NL!WO)V1F:YO'<3=^HNK MFL5?H02H_%B3]XN6=X"EV8&M&(XAW8Y_:.U7='[7)?^,1CUK;;1G2?[NR"UG`43W-IUO"O;VQ6_K-ZWO;*]J4 MYSS683B?#5N:Q[G(MSV4\_K6*YO=>YVSW>ZWVD1]K;7?Z?E_O>1QV$`3Z'RYV[;UOE MAQNV.9C;FSC>"YR,;5VU0SW523BLKYC@>7WAS;CD6_ND][N;'7J?M?J#N[RV MH?U_KUNI,9Z'3?H5#D$:UG[MU9[MI2&!I>$0-MZYB_FR@3@`#F$07B$?4B`? M7F'O;?BK<3R;TU[M!;FB*9N,?]C^[3=^[0?A$)2]D*]8L7-X[O/A[^%^#Z2! MLLN[R>=^XVT[[^4^C358S'-Y[M^^[4/_H&/[_W=@0]A#\;ZX:5YK7>:\=L^HIO?O2W_P-'9IZ?[ATE? MPW%X#PY!IGW_]@MY[85`[04?]_O[X>4>[F$9GR%=[U]A#_)A#P8!\@-; M]H<^HSG>_=L>@M^^H.\`(`X%""`MP)V#!U\I1+@P@,)7!_D@O`,18D*&%%]) MVUC1XD**$B$2?)4BQ:M!KP9Z_`B1C\6,+V$N7,DR(M6.]+699V0[V%.AC-S M4KTCC=2Z$Q!(S)KE:4]!C'>F7GR5;QC7=0)3KLPX,>4WOUPG#(,P84T*:19= M5E7(1_+9A8<66)L`-X4G,1P$2M69E^94#ERMI1"]\Q6I"5PYW,68\DYEP7LX MP.[J=1;7LB$EPR0ML^I%G6L;'EJ3&BS(@PY3S"5UR*5#G2'-VI2(?*I+M3:9 M3Q!C;4_M`)E/3-"K\#I-VY-3H$X]P95(W5F'N9*VQ]J)!0*Y%!)R-GFTQFZR M.6000R2(\4U!,\$T5442'4+*?(F9QQX)J5G#`2F#V`&7>1G^.>16:F71)E4` M@W@&`0!P-;;'.M1%A)QPM)DE4GM\8;C98A"L`Z!@TIU`2DH30D?8@@YQUUV! M$0K&'%?474?8=U:YPA@>$]2U#G!Y#?>>2,6E-9%,'UWY$'L+^>14&D,M)>>< M1345%)Q0E?"*DY619A&+$P`@Y`(`%#J!'0N\Z$J+A0(`)G+:H?F<8!P4RH%& M`9``HRN!01W*W)UIB2L2=0R\"L-^"[0W2K*#^@RPH[4L#V?9G2P0:U%!>5P%@30#.QIN2 M-.G:<4A>@ZRQ0*FHFMF>-)46^DU@`<12Z00I$$2HO_$B-."5#!'T[@30SI2/ MKRQ]%Y.W$(75*`!K%&20-*JN6M`@PQ2Z1L>GYH/L:@$(IY80N`(PRP)[Y)-H MH2:I3)R?>Z8T8+$B-[K&'@N\"@`)*0T2L2<"W]C1P!?&.[6W?+#+4@!:@^6> M8!.Q6"F`A^2S3JXD1CI8:1>QZ^=>9PK6$9HS2;3"3W?&2>?B2-GY5%10UH9= MVH-,L$XLTAQR`JR8'S++H@%L+D99`\E+6>EJIRV2UP$+1G"AH*>=MFT#G4MS MH=8(A'K^1*4_G1*R'`PRB,^%`KA[7E8BWWMI>VQ^PBOK@.;)"1,/E#``06>4 M=NDS'9+ND;UW72T>$$)7[[CPV79("HVZ@OD@L9`B!M#\O[4P*)%;7^Z8M(N)/&>-:5E_2L9V#L$V#^SG<<@M0L M63(;Q`+$L+.#I80SQ@M?[<(4M>U)8V//2E)%WK(&W?5N>X#K$XN8DRX(B(9% MPR#!YM0E,%>5IR/ M`(*'GCM"<9<0&H0M;2,-X4&F28/80Z%.X,L]G!(E+"(4-;'I$.$I\X&O^)XW M?SB(:L6P@L[4EV0D@A[VD=$U"XC%H93)2_0,XA![LJRI4010=Q!V&N)INU3%4OGH,DU)B0'SJ\YL/Z6=#994F M5X*1/Q(<%3[I6;Y7Y/29KM,4!V+QP[<*3GW[G)DQ7^I3@TR-19Z`43[B99`` M0,`\OO1E5+E5&F^>-&YV+9$JL5F;?$9M0B^!I%!V0,E).@Y/D#O+J>:5#R8- M\8T.25I*AA@`^7"`HWY5B"O6X8G'/(T@!G543@[Q0;"18@'`+X(KD;Y<`:2L/;=:S#%>CQHBQ=89+K+L`. M#JF6&%S^X0KS2",%:Z#MD#*2KA20PA,?"N%.!](63PC)JV3BESMAYLLU?",6 M"TB!TH`+HOOFL2WQ)2X^(9)<`,EG#?D0C4MXZPE/V&=@`%P`'[[AB>6:R+Q' M.DA\'2/BE`ADQ;"]R75F*V'!7*A01\MP]BB"*$29AQ1:X\`"JA3?;Z1@`8/9 MTPL;!1;HS2(%/..+`^"46>[<1K58(P;0U6FPJ_@LSY-9UU M^E@\@4C#F-9HBW(KTMWOAC'#6>3'(@>^VAR+]7UU;.M M!A%8HX$%0J[(<(4#<-\20X@@8?:NF`[(@0!E["3/29W16;F.6 M2W]!K%%D<+=-!RHC&?OR(KA^!6>P`8Z3T8 MU!I;CQ5_<;7RGFN<81G9MT/V_41_!5UGYNP#CD'=I'`*B<]MPCLYDD&-4#,M--[R<**A$=?45 M:QCB":RQ#HU$?1B$.J)#[G88HYFDU#'7&NH9Z^(/^LM@7LU,HR8.NX+0;!9" MWMPL4D0130G>:&4!NA@TL_W9I*DP;4*<4)2];#DU&Y.%1&1-R@V=TW9,7WR& MN+::>G9!Q0+Q57H81OWUP_;[:@^Q\"[;MW@GP%_'=0BQH"W#$"^QX`D'IA(M M`5WWM@?^``08OP,CM-("'*J55 MJ&,]?1=&'%4W)^<7%=G1&HW$1-2V>DTW M1/GPBZ!$>>*X*ZN'/+S5*+E3(B6("-QIQ@"3A`>"WH$BK93H_((MHR5T_T#0*39[<#`.1C@PMH M;R2`AX$U"VKC8OLW"^DBA*W(-.X21@"T@=HBA%0ED(("&1BU*.X4C"$&C:Y8 M-?87,21@'B3`(G(%PHC!)&8)(<'+E=R.B,PWP,9+5E.SI*9=.$) M6J,LM+,^[0.-3;5#`SH(0L`7P[`.[V5,ZP*?JHFC+A-`D,%R[F6:G:A6++)Y MF0DC&J0U)/!FL&)MG-1H-_DL"8=[E4#NHT9AE`6W=.*64H M:<=ET$D=8U2`A-E6"=&2+JJAEQFBF(4P!^*,C=)P+DFG9.^VF*R0`%I:!',)$H4@B&,33@L@S@Q)#HKVRC'7SB`H! MIRTI&!JU#L-@4.R6IOB4F"9JCD5C#0O@"G;0L+%E%0,6,QP8HT=)`H05$AI% M`GX!.X3UE-584'3Z3R`&.UAI=#V*$LU9F:0D9G9@$JS8EFEW7&YU7&7T$7J% M1YFS5Q"2C0/[AF%Z)%HS3`*33:Y*>=8I3HG9I@^4$8D9IP5(1624/%TC>"@Q M8,,$&1&[A9BYE(2UHL#Y,L,02$_^JC:MX1(9BP=M649\5A:,1F['@8NO1&H# M%Y^:_N1;/\94P>.BLNH:#$Q#+VUH+YQ&KW)H$%R!?ZJKP: MFJ\:*ABN<`(G8+RK69.SRKQ`J9.;."KT)+))LJ>:F1DQRH46>V:Q-PN@J"XR M\Y1%XZ,`A`?OQU^F6;)3^Z0G$75@]`K(,E*[)!RX1995:@T":J73\F@`K+/H MP2S(LH3^K7F7+[5X9,E?&S.(1HM/2/N2E,>($^&\R6NPBSEV4N&86ZB$NH66 M?+JU@,IG(+(`$]#"+4R3`T8R30(L%;$&8@`!L1!BR;FV;H51Y/:]'B=`._>B MP/BU8-.0R^B?D%$S)]!,O/2G!&=#=KE7A:M.7?.1'=-,[Q)ICDNBC]@6=Y0" M-3,,E(L[/X0NQ4-7OF1MQO%I"M$3X@LG\3IU9NFKQ&.=_E'.53;;@OHFB>L,V)+ M3`992OB$3(ZV=4!#.SIW:K6F4B^%'H[6EJUZ3'R#,&)A-M:C*8U;JQ799RG0*W9+-+UF88R MM."#/FGQ2'%LGG1L%/=8`LP=:4QXA,@SK>A!Q&IJH\M0'Z1(K"IVJF,\!V;XH(4SK$2)K M(-,!A)7FRH5W"+`:1:\;Z'EA]`KI6BI[&C.U/,!B!\(#$X?2:&HIN0X]>1*: M$LD+H7,?9&+TZH2^Q&497-K)HA&MYCY0'+98Q)*WZKRB"H5X9Z>\K1#SQH2( M%YI02T1LV$P0#%M_MS_J6+2TY#7FNJ*&1982+;L%AK-`C*G",V`4_2[$]"(6 M:\*>'3%S!1;&-'TM@I%:`P'7_`UV1+B":&WM$E@[@R0[ MNKZC8DW^I/`@D#R?SZDCIE$"\AA).UW'C]-(4C,IZF6N/9K<88\A%S=@%Y,N1B1]782?4R7?4NV5LTY+:RU3%&ZV5W*U59 M`_-!C\'IP,>#IH,D@4(Z7M/$*J'E@F%,L1+(0(@LM1<3>3S^EZ.R`/EP9`%+ M<\(7YJ-".D-$`AD6*'0)'^ST"I[W)0LP1!/@7@JH$"FP.2!R-SA*NV+0&"VR MP*!''7=YPTN%@OFFFC(>,O0J!E\B6U>+'NF",5"[V,U)>^UC>XUBY3^W=:`7 M[7M3$P=1GG,\X95DQU2@)X5#(&N1%VL0YBXL85/A"05O!RX\`0)T"#*H2SN(1\+KQ\I,?:PH1]5'VN9?_B^SNR0!QIV$!='CSX[8?,< MD"DN+&0N[/9W11(=_Y$*\5OXM`=K4/5=*H1@:)-4!Q`'FSRH*X78` M<6*"G4'^P\0,V_,JP"$[$TZ<&)9"6H!7KSC,>OA-VIU7'.]PK%@1I,<52]2E M0:GN6B66+5V^A!FS$HJ3*9=0^<@'9$<^'3MZW'GGD#2BTD1^Y%BT8U&C.8WN M"3!()U"/'2D..K0GWQZB"D6^&DI4J%*.*Y2^&F0TQ3">;5_U#,G4*]571`_- M_;A0FM:Z%$&23=KUSL)77`\M#!#`J$+%C/E(&[IU:("/8)4F/I2UL=^0E2&? MU?DUK%&XB!LSWEC1KL+/35D7CJHP<-?1/N4J'J05,F6*$Q-.K/I5<=9\8"E7 MK-TY9%V[?W\G)JK[4&B//>\P3=U[]*'K2A^?+7K8ZT3%O=/^5JZHL_;LI34$I#)9FNQ)(EFJA4 MYR:D?@J-HJEV$BDQ,X_SZ4S>S!PI,:O`_.K+P2@:T*^\YG133:O,[(B#-6+A M@`,19UPNKS,!#$G/Y1BK$R0^U,SI4$8[I),W!RO#<\"@()US0+A^\@G/#IMT M\,Q0C[/413TEM0JD$1EC4]%5*T7^$\A6?T+/T$;39#-47$UE5-5*X0KJ+3U+ MA1184SD-5DP^CS*43S6G?2]1-IW\]4R=F$5U33KG"\[53NNDKM*Y\H00@!3* M3#741Z?E$]E#W;PUT3M+==`Z7663ER)MH742OD8]U!$`.ZS%EM).=5WXUL&( M!?"]>Z6LJ/5ZTZ";M M;+/6HT(%:D25JZJ6:Z!?_I9K3%WL+.#0ML;V['"1>O71MX"B+FU'(ZY7[/F. MPU3E-''^-7JY3]F.$^)%+7V;KIC''A'(F&&V%_"QS3Y[EIHG3%!&B3U>.Z@V MN:;.9.M"#CV]N7,MMFXH'3=;P*BLV7%0=RF'/.A7U?%E]3^*#T.66JUFXY\"9''[_8R,]NGFJLW>0('U"F.[TA"F_GPQ7+ M4*@<@%Y%K_1@S6Y?21J9V":COT'->0#+U>P\ M9RST3&5M&31=I%Z1O0BM(2$9)*'F0/4JL%4%384*&[]V517^PU5+A&\#G:]( M$2$`>`(JU7$@V$KF.?S-;6%W"B>TV9\03CC&!BB,5Y'RU MN0)^J7%TP96"[,`!.P#'5VMTV=)JE\`UIA$I);!:]$QXQN9)[("<(Z/D@OBX M!4;,D"F4GMO$^,BQ!:>/1BPD`E.(R=;YD9#QBQ@@W48^H>4$C7E,X\M@AKI' M2K*';5P:'\_XPTCVD)5B_$:@`G4P1K)1>J4DE0(GQ[]PV:V5P%0E&;^4RUQR M8`'\,J0JA09**>9/9$C1HL6Z"+R*=U\9SG/.4]'""&<\'1G/L])%'S^DA.>^`2H/M'9SWS*LZ`'-:@YU4G/A!)T MH>YDIT,1&L^",M2=`)6H.NWI3WW>(:,"I2A%/YI1@I:THA,=J#]'^E&4AO2? M[62I0F5*4:8,(J0#[2=,T3G.A![4HBWEZ#WC&5/L2,.G#SUJ.GGJ3B%DTTK; M]&+%N*0.JE;5JE?%:E:UNE6N=M6K7[4J/\`Z5K*6U:QG16M:U;I6MK;5K6^% M:USE.M>M\D.LZK@K7?6Z5[S:-:]\)2N5M@C5J`K6L(=%;&(5NUC&-M:QCX5L M9"4[6XQT5N+,[7O*6][OF1:]KQ7M:]7*1NRW)07KE M.U_ZUM>^]\6O9Y7Q7O[VU[__!7"`!3Q@`A?8P`=&<((5O&`&-]C!#X9PA"4\ M80I7V,(7QG"&-;QA#G?8PQ\&<8A%/&(2E]C$)T9QBE6\8A:WV,4OAG&,93QC M&M?8QC?&<8YUO&,>]]C'/P9RD(4\9"(7V[V`A'L0(0:)$R!+X>Y)>Q@AQK4+&8NM]G^S6^&\X/5$`QG M.,,>'F"S@]7@`7O4.1AB/D(I%@$*%.@"S^\-19P5O6A&NUD--P!&`0H`#!3D MN<%J0$$5)`V,&XBY#N&H0R`4$0Y$0+47<4@`,2"QZE50H-$PZ04%>B'@7K0B MU:N&Q"I>O6M>=Y@==2B`I@U1Z@@C@AO!+D`=U(`(>V3!$%68AC/80=A/9"$+ M"9A$`MPPZUY7X@R1:,*`W?",:V=;U]U&=[KE[($J1+H*!*`P`30-#&!X`!$* M\(`"@A&,0Q-VUL1(@+:YO>M>?&(2!]_"P/_[[X"?6]T/AWB!$0'L2-=AVA.> M^*23/6T*J+D7EH;J$0`N\%[WH@G^V9Y$$Q3^7Y&;.^(OA[E_CS#O`C0!Y')6 M`+V##6^9CWS;<>Z%&QS>DB-$(@&1.`*!6YZ`H]K50/$"D%H4+_%R)4(Q]V7?W"6EGOO' M8;)L-/<=S7E&A"$T'@B[7ZD7AX\)U[7-$C4.Q M=/G(/[[QF.]MT!.1@"-,?O(MT7PE3`]ZHA/#Y9"?M=[3/ON''V$:&@<%R-4` MCCHH8AK05H0A*AV37A"@]]`.M2*2SOA[U,'YSW>^`MBLAIR[F^30/>3 M"0'\!%WK0`440`+$/@L<.OX#/S<00=I3P5VC/IU[-Y=0@U``MDW3-$FK`F?0 M/7:SP1I\099`A$"0M"`,0F?0NE"XO4A;A)7KA3,(.&)PPFH[.'>8!$@(-Y<8 MOT^`A(/+MBR`NU60`VS+-D@009-+-2=L!_6SP/@#."=,@'!K@BP\.&(X@UD[ M`SC,MCB`NT^(A$G`AFR3@PADB:`SNDF@AVPS.J_#0BV,0YI,`OU,*C2P!0%,11C`2Q,SO4L%Q>/& M.'`]D^R%A$P`>I"#<[O$@)L$NF0)1YP$.1B[2-``U?M+@)N$GP/*192_IRS, M29"_2XS,_:M(@YRUR"V/6NW2'L#=DBT4&#*2*LZ'[P' MC:N"8/C^N":XA[>#P47@SJ]D"7:8.NR\DB-HAZY3N#W$2W%LN)C,Q%7(,[]\ MR\@\!I=8!<:4S%ZH0*\K3=4,1,-TR/T[.6X$1+_DR$I4@P%5N`#MA7LXN$\H M!\OLS\8,1)N=-30US3.52W;,@B;(1S_%1%USTPYET!`=.,7^$SO9/+BXY$E> M6+E5`$34XU`87466X,E4;-$G%6F(SXVQ<\W?4A\"#@:I3S6 M3,>"RS:2@[MX`,AH=4)B^`192\U";9,,%8Z13WUBP,G8,QE MG5.%9<5,_(0,I+\-!4=L%=%M)5'^N//6Q9R$<"6^(W"#=QS9]@O.!X1/;-N$ MWV37H76R7_3.>.5.0-R]>]4Z99RWJ>2&:QS2)855&`S8G=-5*\12GD586QV[ M^FS8.CPX2!C$B?W:F)59C`U$C7U(=#C6",3'EXP$GB39+7T\H,0VH24^7@A) MEQTXF`76M(7)!63,N)2)-WQ3NN79UWO`T@1#PR7:R#VR'?74I/S7,TO/2.M1 MU$.$(YA!G9L&0/374&V)/7-!\R2ZK05.6IT_G[O5^F39*<2'H!O;,X7=O1/6 MC"56U"-3CZV$/>Q0^9O4PZ-9FVT]A,V\BP0!OVT],.W616U=Y"W1D!1>M15' MQA6S@OO^V<63W.XE,C7846D+1/+4N3]K"40(!RE]2@_8Q5Y@!P7X1=(=7=2E M/HT+79GHS6S+TF-83&US-:]]S"\-W`PEAKW\A$(TVP!&VX?,W;7=W4#L6&1= MPKY5/7+E.D*5B=),8%CC4`^M!')]3&Z%-6^MA%,XN'_(O#E5T>$MU\"MA`2< MM4_`3!@-LZZSK8KRQVM`V)SM5^T.!^\RCKP@5#X2Q[\RGOCSE`` M.7;83O64B5!0W4`\.7HPVRX]V\`5S4B(/3>8`E_=XK-K8"W5T):0T[=5/0ZM M1'9@83=-TX]E5FPSWOWC4)%T4>O5XK;<2A,=@#G.4SG.3\+^[.#%#=P!H-:_ M5#TRQ>`1*PH.$-%RX+9RZ-53B+QR6$PS/;P$S;47QDPOGK]V"$/Y.SQ\G-B[ M)(9MT[PF"#>3:U9SKH0F&%EG;@G@5;F_K,M'ODE>_MUL*V?-:X4"GM-XE.'# MM.9`U.5L"\)ID,8A MO4I)V^BKDS2;.\\ZJ((:W,'I+%W^YK1&_/7FAG0#G(7#2/R$?,3$A:Q)8.3(>#R(/K0SDX!U3#S,UFB=+L0UC$U>+&ME,@NG*C;SD,1$9>Q#F\ M2,YLA6S[@$3`S-T<2`L(!'PN[1`OW?`MRZ?$M$6H,V<`A2,H M<98@@"RX@1NX!S][RI<@`!3`\1O`<1RGUUZ@4M(5/RP]@C-H@N]35^V;`XW< MO@S42$A=\B&//VY[6/;3OB;'P`<\@B8_A^VK\E68`R[_,;@VG M@%4@\@'DXX_UOB*7/Y!3.'LB^XFT'`3.P),.#L1EVAF&[S"<]^_$]>M]+(TDPDQ4X/_ MHX"LS>0"(+SU/$=S/KS"\S'9HY]YSUS&!#W'T#,+L+#:V&^(-[+^1"^Q()_B(EW@2HX!`P&WSE3,"^#UH M0P'#RT^`G(1[B/6))_F2O[!B)(!B2&VP4$!YE1<_%(3Y-A`ZDZ?YFF^RK,T2 M-=A/,1UYF_?YGP?ZH!?ZH2?ZHC?ZHT?ZI%?ZI6?ZIG?ZIX?ZJ)?ZJ:?ZJK?Z MJ\?ZK-?ZK>?ZKO?ZKP?[L!?[L2?[LC?[L\>R@```(?X:4V]F='=A*#8,)B0@*AP8&AH4"!0:+B@F,C0V+#`R-@0"/CX^``8&`!P M&,C0L&B(F(B(J+C(T+"PD!A`6"@H(&A0D$BP(,C(L*!H6'AX>,C(J%B`D-#0 MH,#`B*"PN,C`J-C0N,"XH(B(B+@(,#A06.CHJ&A@4`!`$,C(F)B8F(@@&+B0 M@`A(8!`P.)"0D-!(.``@,-#0D"!8<)@H.)"(>%!XB'AX6,C(D$@XB-C@H,C` ML/CXN)"HL&A@6+BXL!A(8$!`0*A8:'B8J!`0$'!HF-C8F,C0T-C@X'#`*#AH M>.CP\"A@<&AH>-#8V&!@8*A@6,C(P,B@J*!@6("`@-!H8'!H8)A(.``X4%A8 M2&AH<&AH:,"@B*"@>#!(8(`0.-C0R`@8>`@P2"B8*-`P*!A`4+"0@.C@X%A8 M6,B@D$AH>-BHF*BHJ-C0L*!84(B`<*B@D*A@4+BXF+`(*!A0:*!@4-C`R'!P M<(B@L&!(D-!86&!@4+BPF,C`R.#@V$!`.'B0F%AXB'"0H"`@&,#`R$APB-C8 MT+BPJ!`P0$`H@,C@B,"XT#`P*,B0@.CHZ)BPN$A(0.#8V*"@B."XL,B`>(@` M&!!`4'!XB.#@X,BXL'!8D`B(*-#(L`@("-C8V&!X>!A(:!`X2!!`6-C0T/CX MP+"P>!`X4'"`D,C`H$"`**"XP,#`P)`X,-#0T("@J$B@6.#8N`A`8`@H,!A( M6(!X:+BPR-#`D"A8<*!(6&"(F-#8P-@H&,BPF!A08(@80+!X:/#PJ!`H.%AP M>.#8R&!PF!!(8-!`8,AXB$A(2)"8H'B`H,"PF-BPL-"PL-BXD(B(<$!8:%!0 M4&!@0+AX@-@80`B0()@X,)"0>+C(R``0()B8@/#P\-#(J-#(R'"X:"@@*!@8 M$&A@8,C(R(B0D`A`6+BXN"'Y!`@``#H`+`````#0`AP"``C^`#4(-&1(`T&# M!@DJ++BPH<.'"A$6%$BQHL6+&#-JU/3-D<>/($.*'$FRI,F3*%.J7,FRIO6XN*'3OVZ%"G%1E2;/AT:52P<./*G4NWKMV[>//N),NWK]^B M`R/'7_]*GDRY+%*#AR%KWLRYL^?/H+56'DV:]-K, MH5.K7LVZM>O$I6/+[CNP7\?7N'/KWLV[]\K9P(-''-Y/JN_CR),K7ZY8N//1 M:2UR9$Z]NO7KV'$^WTY;J-K3M[/^BQ]/OCQUOSDD2#"T?G)[]MS'2BANOK[] M^_@_PR>H/L?^]^H%V)X$_@T(GX#J\2<@>_TAF"!_#$(XVGSY56CAA1C&]1Y! M!2[T((,!@ABB@P:&*&)_Z6VHT(?[MHT_CI!!4Z.N,NI/ M-+_:A>BP@A9[4Z,A1)N8G7)R2V(66:CW#Y\*"OC/N"PN**%_$])7Y#='D($, M"RQ<,0&G(UG*"3&Q31R20T]!##X<+-&><@'*U,0G8I@0 MLMLR3I"Z"3:@C>4RR(Q^10A-'#%\/=%T_N\$+)B02M=>?<-)&1!/\,GL8;`` MO&O?C"`^ZR"1X3`Q(M_41#3RDRZ[PQ'H0G@X<`43A$TFT4`=]*3W$5V%[PHZ MLXNODJ*JT,=TL#"-#BNA2T4 M!`L%0<,:PM!QD7!#$H2BI\`@A0C^WCF1BM@S#DX=H0NCFP8"EB&'X9E`$O0[ MR3+D5X9HA!`D_@B#\O@`J53(C%0P^<8$3-`%\DGB$VAD%=R85A)=+,,`)BB> M2.3@117DST8(X,3HT`"F:/3.!*_RB"YL($,:4YG<#C4@ MN!-:,PEN2!P-4JC";GKSF^#L9@M5R$)PP@$.BX/A,Q+>7!SC$D=/ MR*E3A>C^S$5)>%3`)R)@1KKPX^@P]:\T=:E5]3"!^[K$))'$3VE':,(WFM`[ M2>2O2@UUA(X:^`TD"A!4J^J11YJ``&)<81DTV^A'DG>O)C0T!,M(&B?H!Z6, M%FD978A`[Z)'IF5<(0()_5V3G#0CB2*Q;4NRJ4:[5-""3NT(U4O%/SE*AHG% M2*5-7:I!;;I5CE')2UHE$U=WQE"F-C1&WS#`,;F&2/RY5*E8PBJ9CJ!'`S30 M'T[]*UQ;6!&53I*AJ%4K%S-:D\+N%"8AB\, MM\&HH6IJM!^];IF<5>S(&-HJ,8#Q)]UTW#Y<6$[6KG:<*X3^(0QE*%O9RI"& M:1!$)6Z+VQC64!#KH&UO<3ONM!&43>SCEB5HS3J73X44`5HR4E'(1MF*F=3UB*30!J45A\1''B;3J03Z61%(Z'@E,ZQHD78QQNSP:(R4Y M:N%;D2,7]OTS4#E*%:J`VGIE5H M3SK<\W'P_&8Y<1C.VH)3G9ZV9^04=P!.1Z+5JDZAJM,`!WTRB@RC4UXN$6H] M?Y`A8,3H@J)40()^>>0(X8NC+LC`"60(4A)7`*_21,8C^>U-5ZG@``<%R*,F M(*-AR'@5CZQF[2Y(`E--F$8J'-&$?I)`=CP*01<:9J_;Z")Y'.!`PSB!*P+_ M]T=.:]@TH-DZ?WS;E7',K#^Z0`*$-[@)*HAVDZ#0L($ETF@=F3<)G"V5+*>B MXA(=Z33^($AQB.UY&8WD(Z-<99PC?.+C)#@F2#PV`2U(@@17X`!*KX#S-$$< M&?ZP`3&*88/P;!)HQ"BZ(`EH`W]P@@79)A(4KF8#,WA$>'3S'AFH[@@.L&Q@ M-;6:#:2B-EJ2(=FI0(82V^I)$I`@@Z'RMMOK/=IEU'6I$HV9"8Z99;[^2XP, M,SE'.6!@$DRC6&.FI2,F(+NJ+YQTP,1Y\3`YL";L4@"5]R[%B8$,0CJB>B8( M`]9`=80)%%[I'E';!/2-#.]I],_N>WT!RR!1,W3>$:E(12HWJ>M0$<>H7\F(%2I M5$K!!TR@)R$`"M",&(Y5L8^==R(`&(P-Z M2N>"O00E9#`"RC(-J=,%"-"!J7,%G-!T;66"X5,/#09=*]B"(UA(#61W!G1* MU?*':N1W,"4)(T!(!20/I#)N8L`):B,^'39+C?()RA,-3?!XJ4`"0#6"2J=W M'$`D+FAUO#<"G\"#T`-Q#L,"+,,UTR`&49@TI3.'2=0_<#>+?;8F1/@-XZ@T M7J0TSS("J8!&M"-`QZ9'.Y@*R;,WR3(Z<'=E&<0CQ"`/;R@&]9!!-E`]92`[ MLJ@3W2=_W"=_L<9]&(E^%4DX3R!^[>=]'YF1(+E](JE]JZ9--!`+BI,XV;=R MN69\:4+^/;EV3%-D`F7``3CW1\>T2=9#*"[8=!R0/.+%,0NH9$U`.VC`7G#$ M`EX7!OM#1G*@"PC``?7`/5'B7H[$11W#A%""E?;E#P7$":>D1_@#)H2!ZQ#+3#=R6U0#!E,@@@46T9FG#$`4JV#(AD`!G^1$=DA)PPY45* M]'C$0&'_0HMEP(C(X(_&^'=C%)AT!4BK@@!(E(:N]$A`TCL[Z3!*!#YD@`"O M5SWDV!$`%'*123$>4:`=4090(`>.0$=V)&%SUB/*.`%\X`]\@(R.(#]A@$D; MBB1\IE"$\@U>5`^N*:(R\X9A``7^,`)A<)T/571[I41:(`<=5"C_EW`P)3_W M@IDD2$S#(POIU02`=F(_L4VJ!FJ/TSB@%CF1\TZ+4P?9Q)+P!'XTP#@K*:49 MN9(8F7V1DTV/HSCHM`^,TT+T!&II`$_:9'^SJ$?216'?@'^;A1`LI,*<"1X7]*>6E(/87!'B1E'"/`QB-<%GO@E#O,)T0!] M%X53I"/^!_&6/--P?+WS3(X@4)@2#:$G40Z809BYEO[``A$P`9NP"4OH/F]* M1DKV#3](KSB3.P\CL#T84@AX>*%:KCV"!F6`78W&([2S,;K0M1U1#Q`$*DW` M`L2@"[L$:!]4$^N0!I6P#N(@0W5`0TE:3]HGIN"'IC0PMXXCM^L`MW`K#N+P MMS:46VFP0FW+0B#`6KG5M[-E0S+TM[553N0TMR-Q!`Y#/$9'E:.S2KRW1YS` M!Z`W/NR6.I!X=;TC7E86>V>H-,E82.0`+) MHZ)DDS\#NSS78+`]TU81A9T0.UJGB:KR4Y98\IX&8(NK0IMVU'>0R)//>H-/ MY`^39'1`PB,.409-BW1I M]R7=BF)W15D`,P'1T%U_YL`F^X*"9+.NQ`+YTZM\R+4X.KNU&3-SJ05&UKM5 M\5OK\#@LQ'WVE$+OQ&ISNP[J(+C^Z[`%6Q!<6Y`!II`!&2`.IG#(&;`%XI`) M@CRX?_NW@!RXDJP.@J`.:6#)D@M<@UL'@:L`ZO"V,K1;R^506@1H*37`(T@Q M8_8PRZ`%_4.NHU.6NI":$,6&,M>ZR)"T2/*_/-*[FJ2;H/*H8"RI4/*H<_D- M*=N+>N1!WV"\40)'NR*J=N0(9!@HDK+-!<>J&C6%D2Z MN.JNN09H/YN])P<%(T`"X,.^RNB^7W+/3L*M!+Q/!4:/52*3)]6_'3:N!?V" M/!E[/1/`CE:)R*","=S`#+S`Q7FOS,P"G86Y2B,')E-\LU%&"DZ,30'E9/1;%;J6T1-LL*%:R$:'C!50/?+ MQIKY4!.@3$R#QJ#%QL6CUL4T;8;RFG),%7!PIMO73?`D6RLDM[D%N(6\!8N< M`2]PR'[]`OGP`B^0`9T0V*:0"8;,R(XYL"0='O@69&T9`@;^BUAD8(.=97`D M$*XL&T"GB[W:>\[B*37KW&Y`\W$6Y3!S*2::@G*.Y`^.:<_PF\\$;"@R&6AJ M22PQ%W4@A0]#5EJ?_S;,,K7FPW`0C<),(@+,1':_:3=$CE3HMV)FA@KO? M4`QDD*UQ1`*GI2E1.!+`Z'FUOBH%R" M.\B47,B0K-F(;-BF8-B=D.>%7=C^>7[GBGW8II`/>YX!F;#(IM`)AVSHBG[8 M?EW8C2S(A[P.D`S:C)P/G9`):N[(3R*3H<V"X_.YXN.?!3N"@62H M!"P/ML,HX46_7NY=M%-T4'(-9I!(S>A%QRS,Z272MU$&)/@E72[-2,Y';+F\ M1[M,CK8P:U)+6(+=$10"J:TSV/L[LRKL:LMNYG-QU*)>U7.]47($5W`Q"IO@ MB9>L[BN8%O76$`QT-./$-F`#H_A)%8G`%?&/<6/;!RO:<"@OB%\\Q%%4&1`*;"WOB-_T1 M7(-$^;?^5S,\1C6M4>_Y">\M5=X5#=&6>`B@16F(U-2FO/=BQ/^BK1.5OIQN M!D\L-6DE/@(V45?PFEK$=U(&>R<'UM3V9\_Z)<2:EB/(`=7*DVD-MA*UVZ4G MD*9^2$K$Z][E[#C!R&TKV8ULR(&-R(O\`GENV'`/]X?N]HD=]X:-R(3^UW>> MYYU@R'6/Z&UOZ/D0VH#M]G@/V(M*],!E"@*Z"^2=Z5P@9#P7\7/F7T[J.?<"H_/!W+;G*&;O0ZEVF;NZ** MJ"C_)?)9[F8)SR3U.D7'-74$P*`N*R$0;,MJ`Q$(A`RWXP/^'`'L*:O;VQ'1 MU-=`5).ZZKHHQHT#6CE#2M6)XNR/*LHJ[$L/KR M#BH((`9A0.WAP[]7'.#$?_\SV;`1.?_/F;8`+5-T?+KICHLJR)0XC+ M0CARI*M)!!/$+&($&3+$,F0F3'#0\BVAB0D,'8U,98+3D8MB3)!!T.3;M(Y' MFAQ1T?$C2)4FQ.CZAJ"+B51R+HH$:L+`$5T8_86PFT;"1,V_)GA*"DG21-ZVWZKQX)A"([1#GZJ5V\DF2MC MRX8Q85A27SF.OG$R28R#HV@LILG^95'094B,(TN2H$DZQ)')$2]^XV"BC$"= M360N_3IQ6^B+,Y5ABZDM&4R]T&\+<9#X MK\`7\C,%P2WVRR]``!-<4+\7)DR0P@0%R4`_?1+LI!/[ZOO!NV668BJ$)C!C MZINJ,+*I#)U"*,.$>HCI`H&23""!DPFTL&RX,E(9C3N&."+&G^Z^L6F:JS": MRX0KCC`N`M<:"BT5(QTY(B'%&BJ)A4^NB,8F$B:0!`T31N#$+H*N:(B,'S_R MAZX:=2+^QB039#$!#;EL,(F$($%"@!@#_&%(%S.<7'(9/DV`XJIE/J&.H;1, MDF2"+@@2XY.V5#L"Q3MEFP@*DSCYA)B\NH@&THH4K"94:,()JJ!JK+2&`;Q=),&Y1;E)-=>5)!KIB:XR2T>E2HL4YD<@JTK[%* MX^N3/X4\M,C7T!`CR#C7"FZX*VS0:RD2_&D"`X@B`6TOS3GX$(&0YL0^8;?Z))460#OIPX-)/P)`$W8#G^6;*[FLGAQ-#)NQ"^G!T-%28@[40T#!B3-&0B&($8$L"^B`-. MEH=K`ETXR-H`3@2*!M-&;;!)#!O96U,I@W82CBT-BA&81]XR9&RJAX37 M/BFC_Y9((\,TYM<%Y'T%&;WC`!3^6#`[$D`A&AS(EP%4T)9EJ(`@99`$)R)0 MJ>_XPX*9,0/%4@$K%IAA*>8[`J3<1P(Q-`MMQF&?40P0!DY8AB@38$$$B$&, M5`C$$4V8QO)2\;(@&B`59`#B_%3VL3Q)3QYB^,Q7WB*;*X0`,B3@P"?.XKH0 M0.$L\OA$2%02AF\=264N\0>!&S_:D81]P MT*?<(N$&\M3MGGK#&PV28`@-:,`069"`!`PQ42(0(0D]2(0"Q+&VM1'4GX&C MP3H>Y\^1EN<\XM!/)#`$GQ?"A@QD<`2AA"07HKSL2M]H`LE*(QR6I,8[T=") MBIJPQ](T`2D_)(V1)H`\V/TPJ)QI2Q.^@M/7.&(S%`O!9I0C,-C)+`1+M4Y( M_L(9D%B$`]%8QHI@XPAB>"MYX\3I'E54&K@R9)Q2E8M4,8+^F[/.+`0R_0Y? MS:`6I4D6(BI'HE&DQ\UU(; M0A383(0A)(,K4L+_+8:$P@.7^2B$U!8E2&M&6J2`4N!P(V61M*5R#+N,97CD"& M"0R6*%;%4EES.I'I'I6H8J4N3FT;$KAJA#3*(6\3N"N7LUI$OZ>$C6'<8AVU M?L,,$T-N@'VV&6*D4YX/Q@CBYF8WO5$8;A2F02+8%CY'&;VPS'N,8A MU!"SB&A$_[%B"?3`;WBCI]Y&[`;^.`BB#G3#,4#E=F,WE*<\@@#!Z=(FES*B M3A?;28FMB%P&3FSK.RO"")2]08NDAJVBVEE'K3+\%9D^#A-.1 M]LZI$_OFF1I:SH4>=!GY[`@$D*%VC8ZGW@#GXKS%S<4O]AM"08KCO.D-Q\8N MJ-P@M](M1,(0.4AQBO]AT21<=-<7=<,3`I?08KLA$0-%W-X(BC=!X-K<:8EF M")"!C*'^F-O=[X;W@T-@@QZJ.M[WCF>=BXQO>/]9,)\V=S1V.`$27"%H_$9X MPA6^<(8WW.$0GO<0>91P;6.;VW_CM>#PMNN-\RT1&.?;K[?-;3@0P1#_*,:* M5?Z/66C`GG#[&PUZ4.TD]*.B-)\YX*R];<#UC08/%R-!9,1NH!==X2J9A@V- MWO"$267?2Q>>/_@T`N2^>R0\, M\VISO-N_]AO=IT3GN;6KK9%T1Z, MI7]#?JY[.M@ES^7)\YLQ!@@GHROO"#*D`O-VY'<(4H$&9-C^>_.G1WWJP:Z+ M(S3\VD1X/>(5SW;88QND(=\VCD=.`X<:0L4JS\(_#$$#^+AA\8K=ZX]5\^Z^AERJGGWRE]_\H6\XW=#^M[_M MW/!MW_BNY4_X]BL!#?B'->"' M%>2'8F#!%2P&-U"/@$PSB4PSFD0PN,/Y\3*)GK.><3MX2B0<"IJ&`XP?P[ MN2WT/WG@AVFK@TQ8A^.+A#1XQ(&ZML+#&YI;0"B,OYHC/(>++;*(-PA$0E#< M/$^LPW@215(L1<TT'[(X)@2+,'&BKB$AB!N;1XBH8NN(+1^`1NVL8I4N"7L"P$52`575+B\V4/! M8[]A`TABZQNZZP%%<*A?1#G_"SX):*@D*+8#J(0,`1UD)+$?8)Q].LACR\5B M$S8^C`47ZXX`$H,($`,2,"19JHY\1,2 M/CD;+QN.TVRTM("+FH0IKXM1+/N*.ND8@'L(WEP&0A$5%FA/AXN&&`E.J$,` MGJ@'7P&)+A`#J(.)BIBM,8J9\M/^!7\(#8\@"B@P&2J#-V+P42B;T>UA@518 M.`18E):(AH>0A9;X"NC0)7=;C8=PSHMH`A+0G^R;#EG83X1CFQX0Q`T\PR?` M&VV[/1HHR&MK*-]3,07=NX@R!!=+`_C(A/](3`I=C_/(2,FYL`/HL)XCS#WL MP/9[`B+0`"+X4-7@"S(J+!90M=7H49?@J73*4S'J1Z9LFE;LSMK)TY&PT?%; MC1P0BY<@"W]0H:*#D9/XEEBE4<>3#22U"A+H'9%@N+]ZB"D1-6*UNF5(F:$H MBP;C3CFK"E8E!I_*M.Y`UIV"E".MBFQ94GTLLOUA:>%Q'D0B_USA6ZUB&Z8@`4+2.;D6;<5M"_UP[ M7U,H";B$2V!!3TA0>9"'+:R"?Z"!!=F"2#4%<=B'!4G&BP0\`KQ871N//#6RT8B8,8M7,E7<6J"[E8Y!&6&3(P@YGY!`XHQY>0"QY^5MA=BT1QA`EX#8EH M"94((ZQ=!H)QCK[-LFO@8>1QU3VVB$R^+Q,.&.H`N!0F9H0+'$"M1-CS0!+L M`=B3`'XXAFTV6'Y8@V'(H)&($R<`WY$>BM0-D>892T6!WSZ5]9FB_2P*/T M@1<;"(VH:9&X:()4X(@(X,RMJ:2"$P/S<57HX`1.B":6G`;NB::5<$XS8`%; M6AT;R&!3H0[.))G1-HA?@F<1@-4P&I7YH0PH):37IJ;\0J("8,K"(,RB-)\^P3FB0G^-)BD4C$!%?AL MDXB9V4KV*6KZ" M,K@"#AB.%"&**W"E5!"#*T"&*_AC)CG7S?@)K&L),ZN'^=P$NO@$$MEN.B.# M,"6&UI']-+OIF]D0,<_+,_#>`'7*!P7`CG<.8'%M#F"S\&7)"` M"/%>Q@GQ^Q"'$DLV^8L$#,%Q>+E? M5UU1F7F(Z21DJ86"U2P-@)[EX83^E2OH`NNA#E?F$]1@$ED**X+PEJ+0"]\P M"A6P`0Y0X"MXB'#D`!$%N:/0,+AH M@((8H5-Z&Q45(8-I\0]>UP`TSP`PJ=G4T@'4.D/6M(`8T`"XS(>J, M"-*NT'([NR,SX?4X^G5LC8#_H@LQ>%)G1X-ED!=])E[NB&-1T)K'[4(#U6(PE_*(D_)XA<_@W^B:@@$Q@M.<`, M*1<#`W",90#J=EL-%)ENI*UV0K$)3&<(L/V&;0Q)^(,XD9.)>M$^ ML3CB:.(T$]&^-?G&PH0-D]]DF>#@:!G(5,L@+B-C`LVW$`A`V()!/(.GYS5$^D(W]9#R3IP5M#$B)) M#!7C=^PX/^/'DB=?;IP:\W__TJQ;)TA0=4%I!(D3EZ9.I$AP>M"@P;LVC=N\ M?>ON0:2'!B(:%&D`7CM)?-^Q)R(-T_?;!,18Y4]>DBS3!($F2,(7%"8@1M`W M=4$1U#)E&7!-"/Y,1+,])8EQB2;;73 M1!6IH)1$.&G%`62PZ9C*:!'41)4C9I*Q3%;3F.3(-U"0T5<$8G295RH@(@FF M(V6(`5F()I`933TFF'&-(TWLB2%%3>X4(XJQQ6E9-%2%0`R85S48QD.L:=$% M)PI!H:./DQW14H.(?5/1:2?9`)&&5S:QC(@[*;9:HH5R,E$(T?@#DD8TRE-H MI+,E>L4$"$13EITW:7E@HYSLA%J6CD)H@TY=,F3`%3@2!&4$D.D2C0T2F6F3 MEV1"!&!3$Y5U!;1EY8D56"F69H`6DF:UU17$I%)N7_R9U=+^2RPVH04'Q$9C M@@%2DJ"C@7CIU=$U"P.F6$FH.IA81336*!!FU%[QB;(@1<#30=+.*F)B(P#F M",*OP=8$L@@TP6RKQNH+'NDXS3+1D(#9-YRPL/CB$UQ#ZY57`9ZBB:5&Q6,]$V@^ M`1D<<'#52S8XI2-FRP#9*@(5LG"%F2@NZ2A$8I2Q.>>>Q^I0"-6JT%%5DZXH M=T31F"EM".="IB8"98D>$6OL`L7^?(//*UK3,J4]9I5BS^N(8N[U-`MG:2=6 M3PSPV#=81J5739#II`]&Y,^O8:1":HL;AV"EJ@;4DS.(L79QH/^>Y*(4(<4B MR&C)$0YB`S)LSG,YFXT<0I`*%AQD(,XR@"":VKJ#C- M-YAR,ME$L(L5?.#.C%6TWKCA/>EQP]C45HRF\1$YS(E.U`PA2"((0AU=$\35 MUM$U<0C^@@9U^,YMW$"#\$22-_TPFL_<=K;XX$<#4XL/)XF@B?WX@VX2&1!2 M%H2@`C%H8Q"24,!F:("A7&$TL=**5EATA%I=I7+_\>6M>*22Q"1F+G#*2DG\ M49H@FBXJT[K))R["`7]\Q75,(L9#'$$Z8A:S45O*G3>?&9$F#(]+O0L?]XQ' M$.25Q4"G65=6O@>^>B5J3VQBF$3H-8)K_*A)_D``5#[CD481@P^I(!P<-44I M%+9*BMB;@!A80`8$V,ARB+D?%5EC11^>)(`KVXH,!PA/AEB$#/Y0H#_FTKPX M'J$+94#&N$P@"X)H$(/0VB"U""I."*'I)@S)7%!.8B8FRN;^7"P4E`OO!4.D MSNI=T&)+J!#`EF*AAE[UL$GNJO)#LPAQ0A`J&`X1H-)BXFUB(8AI/1#GMZMD M5!=UX<`RB&E,V!R!$V6XPDF^"+G_S6J,_O#)&N&D1CBRL`R22)1`XJA81ZP- M.'CX1S&TP.QQ#!F=H@/2D!M-E'E/M9ABESFDIHI9)$?GOE$'TX.&(4JPEF M>*X9/@?&R*DH<"7Z73`E!](FY&Y)9@B,"LI`C"Z$X0J0\8=JLLDN%O@C*-O3 MQ3*N>2I=F(A#W+T*)[B8E-P=`:?^76++1;5:UZB\29W%,X%)4R(&2[7D$U!8 M6$U0R*YL30],/C%4W8YX(`1(H@RI0$88NB"W;UP8"O(PUJ30A\+>'5>P93`` M:!PQ.8Q-<6/?8(@J^:L"#DA55AZUTFK0N(Q1@256',D=J@(WF\3I!0'LLE.U M,NB9;*)&ISF+$Q&_<85I(,4`$7$K!D?374Z$S*CIPA*[#+!4G325JSX5`S*N M,`*OZK`>9ECQW/;K$A-LXF\J*4T$5L)=79A!!=]8QMYV@M8HKI7&>]X+=UNR M8SSW,R$DM@QW]PI`OR8,P1BZ=&`C`Q(2LBO4BYU-<()#GMT(AS[U^4=E<=&T MS5HVUL[^\81TYSG>^$XGMA"<2>+PD?0PA'/-DLHY2:QL1/BE( M"8`2E(;H1_GN%URM)@C2/49&"1T*)UA:988>#BJ$N'D2R/&ME[]SM^5P=920 M$.X("`@0:S@@H&C8Q,GK5DU0:XI0:N[H"-?L"X=#(AJC?((8A@$92SIC@FGP MCEK;>R9$[3'E64^;^8'^;Q)+D""64L*!FR)0+3-(H*X"74%0[XZXA*ORY$)?M%S=H$"X+L?07107U!(:A82*)X=$>7I2%,OS?YJFHB,NAB+#:\ MR]3[NI66(<1F,;5@575D$Y8DMGRGKHI]--"S5+=-D(;X1S'6D)QB*(TY2H.: MLF5;GNY8IVMI`$'7#B#LU8+GCFVC&F_>8S0)B-:VS9?/U!0A"4'JNA^RF3=[ M8V,E>8#&!B])1:+<4_X%QDM,P$Z9"8L8BU#D1:A,1%UPSS(\8/V,P+U-0)IH M!0ETP17,3F*$03V`"B?8P"=\`DW^087#Y*#HK(N.K`2<)&%BL(6#=`$R1(#@ ME<9EM!<"H`$+*-H%KD2I"851&``)*%H0@B`4?`**]-2EI96Q",;M40L;YI_` MA`&!@G$$/FZ$+"A4H3#*(MZ:$_:,$$H$%@&$4$ M/,:-:<4(0&$9C(@C$(,4EL]U@5L3'(2=D,Q!4%PAAF+%587$$8,5-A@&21@[]1%+4F0:9`,5-E,CW%(/\%$>R&%WSW0=9%0)UI$")#@ M\040#1&G%-$0#89F(+(R`#3+,JSC"0"51)32\^A,-)@("W!7^'3!4((<1$0#DAB`/(!)3>(2\4`=+N$2&GP. M21GDI5D$"W3!5Z"!B)713Y#`2F2E3=H*&?3A"!"#C82!05+^2QIAHB38@`U< M@1B$`5R=1H,T!$$,9G[!R4'@$@E@SS340P2H`!3,2$]!!0:=Q))XSS1$)JX0 M1$5TI5:P`%'1%`D00RF&D!F\!$)$0\B,4V*"D"[4HD"4)95(`CV*@70%Y01< MA1E\A58&!0=\Q>$T033415/F3D5$`.TQA1AP0F2*P9R<1%K@$OD0&BX1457$ MEU:@009^YDWJ"#%P%P?D8%95131`0:$(RA6DYQ68",5]0CD:9#1I11>8`8"8 M"2[%!$08)LQ<&!I\IR/DQ8F$0!.\Q`C@Y(`R#!-Q0%UX)D+@F2-$@QF0U!7@ MY,S82($*D11"P0;J')P4D%:(P4K^]$I=C$#(I,3$040%?0X]EH$,DAAORN=. MN05E@B$+.H@*B%!4-(%P?D5Q?D,!H<$(.*$D9%%$8.=:MAX+3(/Q'>0F^<;Y M>9(&S-IF22FMU=K3H"0H$4$=>,=UU,&O:4?7B(=(Q@)^F,UKOR?,+H_0>K=D%+P*(-=@&?0$@3<,*'.4*=PLF2*1.?I@*RQ!A!F`&EVL`2 M%6L6847^>GZ".<')L@`K%#PCL=YILC[K%42K51S!!)#`)\39J$;=W2Q#*L!C M;'!`5_#E-'S":@[EH]I`R`"()(S,O6T9B0UJ$]`I7Q(JG(1`X&4JEYSK-.2F MH_*E!0IJOO;*)V#+AY4=G.A"7TH"//X(GYH>:FA!7V:J82`+5CRJP'(L;!@L M7RZCR*K`JVRLG1)$G?+ECCGKK-[/5"(KSUU!%UP%OMK`@QELNH8`SJKK4/2I M>G91=^ M@X3!3U7`ES^@[E?YZ>DBP"?(@Y.!W8B1+A&&"1&FU)>%'>\N+^X>VLYXB[_W"+OYB+_Y.KTR*W/M^PP.,WC-F;TK=3WO]+^KZ M;U6!G>Q.[^YR2>W>G/NBD/V";FO^P&_S)B]!;/`#]V_\8L5C2'!<&02'5)7[ M&I__[AD4I&(#:]6A[6[OW&_[CC#V)@8`W]S^[ART"4=Q4!_U29]R4&0?-00@4POE73(BQQ$B9P@QR,(, M.X(@(@,4=-W7+$A%[WP#$BUI,/?QGAWA;&`R+/-Q,%OR)O.Q-[_R M-^/R)O_R$\<&_-6'LG52?0B-!/`#^T%?1<8S/U!#%Q\NU%!?&$M`&/?`=R3! M(P6;L:7!)-V1&SP!JYG-<$@-'LG'9%$;.D]-<(Q2.3^QP)3!"(C!NDXT10,7 M6-B`:C9!S)F71H\T290C')VF`F_*M!DC^M%)7%4A81*W& M]6SH@DMIA6.B94S;M5\GM22&1$0Q M*TF'`!`J2#<[MF;K]$4F]-G@KSJKM[JKOSJLM[H@K7AOG'5]Y&VJ*8)Y$(=EH0(J MR)IQ?+'^I`\[L9[M6_X.V7SJ5EY M4G\RM]-TE&OT)&_[MU\[2:]U9-66M/56K:NW!%B6&15#%A2#?1_#/4PUOA/[ ML%\"/AM"+"SXJI6U;A=T2A8YU42;SQC".%RS,)<[`231([7#;P)!NO&S@?=W?I:[2 M/=VK>J_0*=FJ^LS+=)9N$I1":;*7]6?3`!&T7I2).00#U<-&DZ/$`X$CB08$&#`K]! M,6'"0`B"WW0=E$BPR\*%)#X1Y%3^QD0$&Q$GFDFUL(S#B2=1IE2YDF5+EP<- M:8@IDX@&"88D:$B2A$A/#41Z$$G20T./6$2*%?N7E%\Q?D^?'HMZC"H_JE>Q M4KU7M9B$G#UHU`RZ<^C/)&YFYA1*9*:A6?VN&0P1#8V)>EVFC11CX]M+OW\' M?EJ(9IH*%B98<.@;C5-'DR^7L6"!P-\5$R3\/0:&(M"-.I#"14%G<7+"29/P!@H!@8HF`TXPZKZY[K[-EAG!!$[D M`,ZR",SXK0G'4@KAFRZBT0*A"7[,T9$N)O!M1T>TX\0`!%+Y)$@Y5#`!#7^6 M^4:.*U1P[R5=OHG`A->PZXLC,V"\\K80CK#,-5T>^\:`ZG24Z!ONPFC"SHF. M(&$A8OQI0D;+X#S4H";",`&9OD*(R(!/K%Q)2?)&D!)+?Y")(!I1L92+U(6F MZ92E0"6-]3;__#,DJ)X,(<(-GD;L9ZBCR'HB$D4,P06JJ1S^M,K!9;."*JEC M:%B'#C=HX,^0:UN4"2<)`/3*D%#&<7540G,,P1]%#?`-5I.N"\'=@M:5"-:' M?.SBFR9TB88C2=`[+H+'WDU5(#PGB,!0+(_@CI-[SQ-WLT#-'0$9!#AQ2,G& M#!CXFPGX@G>E)MP$;][L!BY(7Q/H)(C=DS1S-^`8);I&EXATT2(B)VT^21<# M%LKXH8(/%D@+*[\1-\><-3Y"()D-*IJ@F3TNVN&!Q+CH"(<2$L/5HI6&]YNN M':G3Z6LZQ?KK@HI6$LN^1M`:ZX=8_H8\--0]0K`J^P2;7KNBB6MI5_U&VVE9 M"5].D9I*S#4)0Y*H%JP1@SF0)Y[^PM)IJ:626D/#8SGOW/,UG'T*=!K$J6.? M2!#\K[^?6&?(3*7$;O MLZ_Y7>^FZU7N&Q])Z,O?/LO\IDR!_(E&C`B()YN/D520`[UWLR\S[[ZR_ZUK M?XXX0DKXY7^Z,S(@&O@(C&$,+_VMY;>]@87L"&5:WO:6T;Z"_$Y[J&K"G)RT MMNRIZ2'HT1Z;V)?`3C5P4M'PX`=!Z,&)-,C^E#_(8(/:>-!0#20#ISC`*2EFT09J^XTCOJBD97R"9ZF0&@=\^(DF M!`Y>1R`/"S#5G'I`X80"60;'#-7#WYBA'HCQ3=%<6!N!<#%&7R/#)EXXM<)- M4B6*6-U.!&2K$8W(5@=*0[4<%PG^:(`?./F'LJPR@@9=J"K*PLH(6*DL56*% M'VG80AK2L(Y([(H_.U%<3!;W#__\HQ_BTD[MS"4)W*$132$@!@EJ$Q=.$$,> M&.G:-*Z`#&3,T!'1L`&:_`B%5)"`!:T:&!2(009GCB`508.>";I@'275A01* MN]Z3GLF"*^#/$39P4QFN<`6.2:(N^KS"#7/4!6*P@!@3`!O^![3YC52P@`R. M^`0QH/"-*XR@H8U*!1J(\1IS<0(->LL20^@H/(4R5(D(02P&0H8K="&%:)"'&-<6#4F0,Q5D`-L#4>:W&(Y38E8T27.N(`EB(",:'.#` M!+0I"2H-Q`:24$%!MA.![T6`K&65100,X$Z"+"-,"XDIEA!`@N2$H`D$+4-) MOD$:$URA+TWH`AHXPBFL74$,T^A"*NYJ3BBP0!;PE)\-[LHO=_4%&<30JPI0 M-;!EZ-60!XDA"TA@`V2(P3N$G894[_J)(XRF+JDXF1@_BU%)&$`Q$R!&U=+% M`1]91!(V&$$])%$T[K"@3@7AV5[^^QB!N0K-$:DPP&F)4094"/$(;4T.EI`Q M@KO6YALD*$,$^'F>"9!`$E430^XHF=Z6^"1`/>'5K8@PCA[4(1)#H4$=>)(& M4;K!$[,(Q3^6PKD`-X4I3'E*,4"WN4M`Y2I0D4`D<$G?.E2K/]SJ#^-VU1,B M*,(-LUL5'D-`-GI^PP95N\)(]HH`NNR3#(?A:S=]1#>'Z*)@%3U"%\1@PY&X MT0P5,8$*B.'-%KSP0*:-T3+X=Q".7I5G M@EU&*D;^\(EH*&IA6$(%=4B0"C>9L`DV:*-"%56&4REI`F+HPA>KMC"'()5. M6=H+!UHC!KPQ&9X;LPMH)]!6-V*MQJZJJE5A'6NK3F09BBJ-6D,@ZAQ]HZW$ M&(]%2B(0*)5'>(J"`A^F\R9,N*+A'HA(1#+QD!MHDH0ZP($&;M@E#4XI@:1HB!H.Z@6$)'3^(57VXABP5%"# MI,("`@N3!JBCKQO68A;&6:LH28B%A[DS@C.2I@P5789E/S-DGF& M/W'_*('1Z$@!:R8'\@7)26(@AAQ^,ST39)37'9E&"$B@`@2,.QJ]X1DTX5>7 MC&:*`[*(U$GGK#)_L&`$;9?#D0Q6W;4G<-AFT$((W-0%1R#`.>8YI@E&0(9E M;!Z>Z'G@%2"OM*HI\61%2H@))H"`W4.IXG87@W408)FY$I\8)V3KQ*XS-*F- M?_P3P?U%4)60=(UK(>*\@@T6$BK^2B\$W$TX@C*K]XWIR-@XA:2;0*K&8'YC MV#JOK;K@:N1B&9)-[[I&.RH",[1@V"XE3TR@^[ZA,2YC&9H@^\2D"^2AD#@` M`;@#,TS-4HI&3SCE"`S/VJ1/!$T`%4YE`KYK7I!JK^2G&%:(((Z`-$QH4.C/ M^-RD^E8E2M3.!.3#7$;"U^0&=U+*XYQP(/Z#*/A#5T0D"7QEOG`%*-Q`$"*A M"S\)Y7`!*':"6'!BYIXB#(Z!!:2B&)B%*LSP6)1"+78B$@0A+&K"$(0I"11! M6WR""#1A=I9!F2*`J_`C8K\8=C"*Q6R$4L"T"'NKR6/H`F6H2+JX8:RCP00`%;^:G`AB<$`P$9) MX`_ZAL;66B4CP0UK=HNZ]"HJIR/ZFM(EG[`KH7#I?F)7:*!:W$!$1FDG(L<- M/@EU#H`&TJ`.BF$69,(K,$=#TA#H&BQ95HF5+J0I`,PI=&4H8F+I@H(F]./I M$G"XT(@#?')^E,DA)XLT@"H=W:1*9&_.$D+B]$4,3BP54B&@.&%H?$2P1-%A M*-$1)J!(T`,A[FEMJNNVBL\1_"5&_`$6KV8)PTL7"*G9_"%,NL]BH(T3'I(T M5&`X?^PAPT`XX849`T=)PH0$.O,S!>H9YV-PSD\U[.Y-'.'&D,LGOQ$]JJ9O MG@1WON%D%,,Y0D6S&F,R%`(-^(3^U/Q..\:M3-!I/@8BK,:JK,CJ>]!`K;CG MS)IM@PC#.OJO(XBA9NH"^G:M+B3M-P[#]Y80%\W%UC+*CA8"&>BM#'Z#-%@` MO>0"A?3DUC;4!,*`:/KBW\3$-YBH2DHP##A%:A3%[Q#B1&^D^ZP(X)SH)^WB MAFKMK2:%(R9R&@RF4W9&(]TD*,]#3QQ12;2-(7[#.7:T+ZHF%>1`!DO-*[%4 M(*YE1/HC*,:26KJPET;NY78I$6A`$.J@#K;`#61A#0VL*0AL0]B0&I#EYR`$ MYW(.3R5$`G8E0,XB+')``G@B5U[D(&ZG1`='L[A#$M1$\D8/(2HEH]*1(Z!@ M\Z8!/)TSC=33;/*Z50;QD;8QKX@%,3R!^:#`&%1Z8"#JEX M]!L;14>OH'ONSDJ@M3SO#CZ`CV@$(SW=Q`R.0#J.D]5*(8O'J-J.,!@?]-V>I57=Y48M4>%NDT] M&2(\'/`R&L5ES(`#G.-Q!R)PK[.O[LX;.=([.3(:W&0R'P@5-FU;!4,`$4(P M\J]@@J_2JN?.2*.=9/0@M$#\R.\;D*8@KF'@Y$%4:,<:=;7XEF0W'M+'DN," M%T+L4`S$5FLAY('WT(#B4M((;2C^457/,Y4C?>'I5K]W:$L71VKM!S^E_>1) M]G#$('0A015C?^I-GB[2!N*JI>0%2$$58$+R1B6@]&"R*`;BIO MWH"3-(135XO3_HCS:UB`;A,08YKS^?8(`2*"8OC"33A!^G;/!N)I8+$S=JE5 M`U,((Q7^A2M#(`,G%67NI3(/23!B\1KJBA/0SD<'L#1(@&XYKB7R!4AM%$O( M)@+2]68;]%TG(#-0]$TJ"L6BK]):4I+UI#J@VM!_J M2U"K)1A:F#]&Y"W#XE9,1P-D02DNQRDL1$_O-(>EPBJL`D)D(:3Y`2C8HB8D M@%BZX@]5A4:8E3:Y`S(=(7JW54F.Y([?N32P4T,\N,/7L$3QZF$@#&!BPJ8WZD>S2$.;Z6.",^9WX(>=I&?8BK=)T4`VC(,C MT`"K!F\B.0#02O)$VVT$OJG]!*TI,8-X+C"6!Z9JRJ"!*/`7:X_10*,K2+)Z`*$B:Y+KT MY,;A6LS"<0RA32-$AF5!AN]403!AP#$AP!=$#%`QI$-:01H(4'_KKO:<9Y(0H)W'ZC:O@(`*GCB[6U`H^Y M!$\%2J$1-J>JHCBB"[RJ3'Q$/FRG(D;`BJ+!`':V/2K"K,_C,.8J,GZD4=X1 M&3).&3&<-.K!##;(2BT"5+%DMT02/580?T"YM"NC`A&@/2R#47S2,O*6[R#3 M.)JH+S[17DC,S8IF(.-OSXC&.:K5/C8&2`U`!:"@"PP`';>Y9(NF*1WO$_PA MV4`/`\O^``V@(`CYM@FV[<<0@-E(P%XL?2%88*@,KFF&;:\F@#$6HA55M&>P MT>!\4N/*(`R:LA`-6*]LP*28S>!N2Q)\\L11(9Z&30PDH54@\=2%6BY(K8F7 M44_*H)Q.O:$<`3FFX3PP\%5U(P*(@=$QL!X^,PPD79+:6U9N9>E*Y(=#!+]V M(B@VR2AB@D^!HKZ(`"[K@<$'?-XSFD&$(^=Z[BH6!$Y;Z<"<(E?:8G&*H0@3V MJ0E"7M_@Y1,V:@180`4"MR`@2CBZP!6[P$T2`[+VXCN(G7#*#0B>%2 M!:+'A,/M!Z:\&*JA3FA)(N"WMIPVPD-N])$^RO,*CNO5JUYX`"TQ!()2ZH$% MF"\,,M^*!(($ZB$,=$B8L089ZN%/RL3T(R"X?D/B.:(>XCYTMU,%,$*%T,"\ M7.N0:NK08!\*&I`%EAV.#.#K)948'A[+'Z+K.:(,XEYI2"P"RL`A/__K.V;8 MXW:ZH4#$):()M(L$B$@,EOU%KZ#^'L3@Z*/AMXB!R+4KT'RCO"CN"HSQVYTP M"21!P^S?_D4)*&@@Y$)DE]R++`""AH8TD5#A.C;BV$&$QX[Q>\C/842)$"M: MG'B,Q4.*#XO]X_=/@R$B1))H^!?+DT*YWJ4JDE*U^L>[6H MU"4;`3'^$R94^%7YC6C;X"'\M0Y.U!_BF367&3>C]?7Q)LE).[*]EW1VX'QQ M?J/N2'EKZD=:1]/U^^4$$R2LGPXAO33D:$=P#YVMM?5]72_O(^ZIUS?^\'=: M@08>B&"""OJD@09$2-*@23T0X2`1/22AB!MN]#!A$AN:U&!):=2A023B\(,+ M/\6LN")$Q5A$34,-+<311A+)N%&.+A9SB00T7!B,!BDM:*`ND(EUX$VO(1D9 MD0<2Z$A\MS59FA9'.CF7;5C>)J5C2VX9U6-)-B7E$<00@\!=*O%QQ2<(P*1; M#F2X!V:8]B78990^+2F&"?5PH.64+'TY**&F0:6%;4Q61J7^GHPB:!^3=ZZD M)4Q:+#--!/W5.6BGG3(9J*!>&LIIJ:9R*@%)#FIP(0TF6?AC$K$ZF,2$#4H0 M(0VNIB%.)+C@X@E&ORKT:['#8M101*`T!,JOR^+2K+'2#DL-+L7T$$DL&KAQ M:K?>?@MNN.**VX0)!ICAG#_*<7+%-U>$,B:,8.^]_F(I M[R??D/#);_\>C'#"!E9HH8,]N)J$A1RZ(9!(V_9@R$BX&L)J)#VXL8ZOJ,@B M"RZR1/`KR2JOS'++)(LAABP&%%ORM)CPXPFQ*3[L8;\*_PQTT$*#^4T7O(V0 M2M(CC%8N;Q$T\0DA/@]](`*2\$;^`@)4;]W4)[SM"\5R7(]-MH))1+PM21R. M0^O'$VYL(1$CB61(2#34@6T:;A!AD$+'R,(/"RJ;K+(!F)0\L[$RSKCXL`HM MBZ,$',O]8HE#EHUYYIJ#N\P$5Z!A`!JI%-S4-"Q MR@Y2,KC^P3!5,$$:Q-((08A"<'UP2_Z3R8_",8PBG&,9"RC&<^(QC2J<8UL;*,9$0`%S+AQCFWTQS+N>$,ISGO2LISWOB<]\ZG.?_.PG-A7B MSX`*=*`$+:A!#XK0A"ITH=A4IT,?"M&(2G2B%*VH12^*T8QJ=*,<[:A'/PK2 MD(ITI"0MJ4E/BM*4JG2E+&VI2U\*TYC*=*8TK:E-;XK3G.ITISR5Z1)["M2@ M"G6H1"VJ48^*5)Y&)*E,;:I3GWK.0!A1%E(U8E6I*E6J8O6J5I>[\K6LPK6 MKU,%*U\+B];#KA6OAF6L7]=JUKS^+C:QB&UL9=-JU\1FM"$8%:M;(ZM6N$+6 MLFJE;&DOV]?/GM6LHEUM8"E+V+(BEJZ,#>U>03M:T(9VMG?5[5P/NUO?XG6R MO5UL9C'K6KVB=KA7C>U@O=I17(P`#=2MKG6OB]WL:G>[W.VN=[\+WO"*=[SD M+:]YSXO>]*J7O#$5PWK?"]_XRG>^]*VO?>^K7@-P5`RH4$%6F@#@``MXP`0N ML($/C.`$*WC!#&ZP@Q\,X0A+>,(4KK"%&QP"#J#AI:@@QE`N#.(0BWC$)"ZQ MB4^,8@D3Y0KFQ"@J;,":W9E&.O;)D[=L+&,\%0C'.580CY^"AM]*5+\6[3!I M>/PS)"?^V5&>ZO&,=^PO&H/)QDJNTS)8'+.,\M<&H'&RE[\,9JXU8<,69<'? M*FKD$H9YS6QN,Y%"<`06;W3+Y7&SG>^,YP6-^:)+1?-HU)SG0`O:RW"6\T9? M7.=!*WK1;=ZS17\JT30S>M*4SK%7#*U11%=ZTYS6G*-;:N1.BWK40XMSBRU* M9Y\D*E'7N(866OWJ5E_C.JN6=:Q=+6M<7T,7K-ZUKF'=ZUOK(M?$_G6K'0%K M7;\ZUK&^CK&+[>I;.QO:R?YUL*--[&4ON]K0CO6P;0WN:LUM MVX;:V>;VM\D-:UYGN]SM9G>M7XUL5W\;V=_>MKZ+W6N?C%G^R"F5-$N@_6Y= M)WS6N$8WL)_]['[#>^+L#C>RZ,5A'IMF-SS:TZ:VR\U][G*7?-G,,35'-M:Y[K6M^[UJ8==[%''>M6Y/O:O+_T! M64_[VM5^=;>;?>YP;[K4P_Z`4-DER!952)'_S))FP%WN;_]ZV\F^];H?WNEL M3_S@ZTYWR#O>\)*OO.4?7W:[3[[KS(`%7HRNT52S1!1+N/S22V_ZU*M^]:RW M.NI;[WK8RW[V5-?[IRG:9XH:7"7^+G@][7\/_.`+G_:^'[[Q(;\$S__DRJ1M(OB'W_ZU*^^]:^/?;O;GLP5'0'A=`_XE;@`\MM8@OG-OXVFE__\63__ M^9UN?N3'G_CSUWKZXY_V]S-#_U>O?_:USG_!%X#"IWPT86I9EE%(MQ)*YW6- M%WETYX!WQPR'AW9KQW82"(%1UX",9X%D=W">(>#/<@,N_"&2*"".8AV2[`-A$`(I`>"4H>' MNX`$2""&7UB"=K<$XI"&'1B$,ZB&<^>#1%B"+;AT?_"&HK"'E'B";#B)%?B& MALAX-/B!=%B'0MAYGX=I"B+OPB, MP2B,PTB,Q6B,M+A]'!9^O.>$NKATXR`+FJ`.P2`+AH`$?K@$FE`,A*`.XY`# MFY"%5U`/]:`)NR"+2Q`&)@".2*"+2H<$_U`/5[`$['B,%YA^>"`&]<`-?HB+ MY2<.:"".!D"/LL@,/R`+]4`(2R`)]2`/2Z"+VQ`!)J`.#FG^B^FW"]M0C[3( M#*+`B;DH#F%`COR8D;2X!.J`"O7P`R(YDAI9@"W!?`AX4:*W@"M)DS5IDS>) MDSFIDSM9BTAPA'WW?1,5:H'GBTN0`R:@"?.P!/-`""8@#]>H#B;P`_.P?SF@ M">;7E":`!_-X@4M@"!$PD?2(!!@IBT@P#YIPE0II`CDPCP/Y`.SHEF7)=@-Y MB(?XEA>("R:0"TL@"G;YEFYYC21@`H20`VC0`'=9EVPG"R;`#?,0#"80!LR0 MF`^P#7'Y`,4@"UM9EW`YEUGX#Q9W9[969W8F9O@Z9[R&9[TN9[B*9[NF9WVB9[[&9[^>9?UF9[[69T$>I_9[6R9Y+$`LF4`9_ M\`!]^0!H8`*2,`]7T*)7*`[@N`3(;LR)?FQXXCVI2;H)0P:@CS MH*-VZ9"E=Y[7R';SB)'N9WZ4*0H&H)?N]Y;HQYYGV"<)27KH=W[;(`J+V9B: M`)G[%Z7^>NB0N8FF^W>-4+J1&XD&86"DUSB!;7F&TLE^9GJ&:4J1:7J&1\FF M.NJ0E;FC2R"85RD*(NJ';/JD4%J=\ZBD8SF/^\>)6]";$]FE3(JD/!I_7[I^ M[(F@X,F.+C`3S'=TKYATX3F6FPFJW%F7(/JJL+J9K#JKLRJKM7JKAYBKN6JK MNEJKM,JJ[+FJOKJ=O8JKP]JKL"JLO$JLK_JKPJJKS.JLP-JLU(JLJRJMT^JK MVJJMQ?JLT[JKT7JK(`JF/UE1?N=G8O.ASZJJ[,@")L`"*8H$I'>4J,`,9.J4 M:?@`AEBCO)&2B` MH@![B-F8,<'@D'^@">/`#9O``I(@"BE*I=RP"Y(P#IJ`!T@0#/WPG)79#V5@ M`L6`![OPL82`LR#KA6)ZEO`J"OTPL.KP`-PP#C_PEP_0C4>+!!\;#(0@#SFP M!0_P!R-@`K(@"2FI#CF0`]S`=J*02)*@LN/0`$:K":(@"<70A800#/^0`^8H M"D<9CUSJC>-0LOLZ#E<0"^F(J).I"5?PC0Z)!T)+")H0!II0FV*;`TC+=GG; MM0YIJ1)YAELKMH>YKV)[!0,KC2I;CCA[MN2ZK<1*JLO7BBZ&J@L(IARINJO+ MNJWKNJ\+N[$KN[-+N[5KN[>+N[G^J[N[R[N]Z[NWRP>R>Z&W<7LK-90KT0SS M.KM4VYO_P)<2,)$P M*@LB*YL/<#66.@+9RY$/,`Y2B0D(P!"\O\O' MO,L'>]S'N@O(@?R[?TS(AXS(B0R[75*\*J6$S5"[#Q#&0_P`#0"]5^.;/U`, M7^/$#W##DKNZ16P"'+N85\`'@;BZ2V"UX/@`,)H#M^#*2X#"!B`*6YJ]#U"_ M!L`'#T"E*4G"KTRD7DBEX/@#O9F0+`N_);NE#GF4DF"4,;H+$9R-D&FR2#D/ ML<"E',D'T9QB;2ERR35D,2_`']5`&YCC^T//PKE?)STMP M!0T9T7\0P&XHQE8[D?.["4VIRPE=#UMIHV6`!_+;`(,K$L"@ MR#$MTS--TS5MTS>]NPTPO"J1H14%:1'UR+6[S8OYF;N`QFH9TG\LPX(9P"CZ MR41KR=ILM1R+R090TE$M"GS`HO+,!AS)HK'P MS/)XE%>PK\.,OT.,L\F,QGVR"6SWUDNP&Y*PK]),IF&PR_,K!J)0CJR["Q&Y MCX$]S>+\`&0:KW\0D88@"21PM'ZR"WQ`LPG9E/>\RWSP`T_+Q:B`HDUYHDN` M#"6LC20@#F2JP7PPT%&(QO);L[C^+,8/C8ZR>36?>C=-] M;,GB/=Z]"][:?=XWO0L[O7=\=F;@)S9:4+OF>)1H,(8-8(Z"&0:>_(9LAZ\) M^=3;K+I\,-5/#*-7^P=HK,U;S7:Q?)1L^9BR8(Y/;,GF^)AIO0M;_=5M'==. M?,H!3+#[NKIOG-? MK0GU$`PW+`F[;-I_0."/+09D>J(R;*)=.+_Q^L057-NPC90D;H[SJ\'`/9BB M?)5\JY;^9SR&[$O)6JX.Q5W<$DW)"\D-9(JXYDBF:(`,/T#@T9V\[G?>[G?P[H@2[H@T[HA6[HAX[HB:[HB\[HC>[HCP[I?2YP?'>N\/C,)3W@?&[@H\P'$[D)"*P.VSR&HL"B)Q[+OXS! M-[JO"SZ&J5[":$RE$QG"'KX+&WCVXSB38[& M?/X'+'[CD%VR9"H/^\JB<.V&?/`'DA`,TKBO3'ZBT`ZCA*#.I1W`&.XGS4"U M\;SK#S#0^QKF-_R9P'W/\USE7L[#2'O6:XG+F$WF?-`G$WG^-5>)!UV9O\!_5+#+N\&VS)Q3FPKQ$IST;^F#9@[WU.LR=^-<1`"#2K M]7]`LS8PS;J"8V@:`VB6XB8`R7C( M&VCI)T3;V<$0`G^`P,2`!\C0#(ZOCF??HF$_A@90!DP^#G_,HO=+I?=;[4., M!\'0#&FLQ4UYORB\Y8_)L6)PHM/^Z]>![^I=W>J(3O$T8:J']GPLX0(D#_S! M+_S#3_S%/_PSH0LH;[P=NO*&KL=;:Y578/;@S@?T@@R<0+&:L,WJ<`4D0`)Q MON>I3@S?_P>`.]:;`.[A3P@1$`:-W_W(_?YXP`WJ^%$2"9$AU>WZ0T*6C93C4(F11+.,":`F9`7CHXE$,4*[2DI" ME>-'&#&;4EY!-6X7'W4CRISD@W5$!&3$Y"'[\W`7GF)7_EG=I2X'B7'JB,'] MPX<0"U3^)&;N"I&VF%4^FTB0"'95DSQ)\D;^"`HT:DJL+,Q.IMS,T65'(8Y0 ME=79\V?0H46CLG$$\V472H&M9MW:]6O8L67/IEW;]FWVZ?)K]P-/U#^NNV^M^+]N59NOL-+O^ M@,7G>VOW"J_2G/\'EGSWKJ\V:T826'GZ4K*OJY7*"D&3_%Q+[SN%NA*P/0&O M(NF/LC@IZS4(`XRO*UA6^H^/#MT;CX\\Q*ZTHI+K<,DAX/E3#23)//,,M%,LT,VV523S#GAC-/,UMR\4\TZ MZ=S3S#4!U7.X'`OU56YZ*:K;M1+3TV20H@/OM\-UI MA[O07U^/O8]"N\2XSS`6""F#$$W^9LI43I"S/$TSJL28U4O2CJ`.LV9^Q=2^ M=OV56%YW7_:TYIL5MCGGG&5V^6:?<>Y9Z)UY-CIHHH6EV>BBE?X9:::'UA-J M28MSA%573P:-'UFUADZZE2_38N:IE_X5ZHC1MCEFG*DVV-.(R?;9OF9D$4.3 MJ'7F&1@6ZKFBF3Y?ICKN9YLI1I)-$D1)`1UZD'#!IKR/E-+S$)8AC.OER-MF>*:(79VVFNW_78*7!>-N13WYVY8D-OGGAB^\=>MR!]QWYXZ7__7;JI>^>>>-[U[[Z MZ).W&NO^UCW#!9?T.ZLU;$>T*']YZ+]GOGOKQ]?0@!!2@D$!@+'&#V]L=`"A8/>*MY8`1=T"%U$`):X;L=ZBY# MLBZU[S-B2%GLCO="&,90AC.D80UM>$,B MD/.; MY3SG-]:YSG%2\IWSI*N;3GI0D0S3PJ<]\RB$$'-""/]3Q3WJ24Y[< M1.="`;K.=/ISF]^XYT,M>M%$7JU5*N2:+;]1''5>5*0C)>D\T1F"$""T&15] M9T.]:4YTPI.2*BWI-RL:49H^-*6\H"@O0A#3L36###OU1S]Y6M-YXA2I*^5E M/A.Y.E3@T6[9W.,XK7I5K&9UG(3^(`8:1H",:%!TG/ZP03V(X0^M9I6L9D4K M.M-ZU6]$XPIHR$$ZWWI7O%Z5%UU``PM2FE?`8I47'&`!,11^UVAM;6U[V[R:,P(1^.LW>JH"KW(@L7H%[@C\:558;*(>)`"M57GQ MB3"@`0K-Q:U6YUI7+8R@'H0P+6N_88,1H.$3,@>`$M8A7R&E9``*&<0J6$(D.+$,]G"4Q_F3^@I9 MRQU&0X4CP.)TRN$*9E;L=("R"3E\(DK7\&F)23P7):-HRW*`0A?\,5H3J`#" MK>7$-,5SA`?&$A3]6&D]_\*$+#GZO/US-"SELUMCI7/;^D(W]#5BC%=ER MH*@_-F$"5&@AV6?^QIEH;>R"7CK%O6ZK3^MA@GZF>IS0?O043?OL;W"QU:#4 MPC7X<`4@^X.[?(8%!\J`(-I24MYCTS0Q0+39)*L@QP5U=59?W6YY1WNLUQ`N ML(MB`C2HVJKLWNPW>-%KYRY;#M2N[FNM?.5;5B>PQH;%F5EN5W9#.];(;GFK M!0Z+7S<4Y*U^=*P9WO!N#]?8QR;WD"_MCV@<5PXYB,`5TVP"#H!(X[QX>M1K M7E""4C3>0P=E"&R,DX9K]>6/1B>X'[[Q5U\Z!/Y` M4('^!`JOYL!/`QTE+?3])V1H0JK^S^[L1P>=Y^M^ML0+&@U4=($/%*UXJP>. M]#)P@@^\7G"P(WO6O/XW=:#&X^N*0UO;EGK8J%9U"&S@K6]PP`8V(,,G4M&% M;Y#A"E=(M>MASX$DRV.]^KY"%T+P#4)_X@HVD(0)W'Y5U]M@`KKOPI"C_XGH M0R'VLR<#%%+!"5Z0(162."4!`C4`@2T`=E+!4UXKO$[OA#8!!N``C(@AL]!OJ+2 M!#*D*/A;0PYHO^-3PS4$0QOXA*N*/^F;@&EX/3"RO1.Z%%*CT",XXG](?5"T9'\`=\ M$P/D0X,G0P8;8P%DD`?G\[C(,@!3M+$1Z`+XBS0Q,(!2DS$OM,A;&Z=2T[0R M0"T3R+!O^+$1\#$/JS`;$P-DN+/-80$3D`>/NS8@F\B4\K>7J(=H,#43*`,$ MPS/:BJL((`%_4ZT0P#<@.R>K"H$[,P"&C#2DN[,KF$`6T#-TNX)Z(`-35$@# ML`%>H$D2D`,5^`EYX(1O2(41"($DJT9_^#&>F$#$PC6J]#IBP+<)",EK^`82 M`S)\JX?Q.[?ZXH!S4P%*FS$.L#'^'ZRW:_@O+1I`Q2<`#FP,61X M@!]+!7RTL6F0@R2+NF'+.(Z#-GR#@FOP&SF@R6EPA/P$3Q;^0U;_\P>`5%(E MS2HHG*4I3)\J!$A]Y(51Y0,6B`!WI5-31"7+$KX(,?J[,U)*\RLT\#0`!]*[,02#`H M]51OY8`FR-@)V]@?FU@G*TZHW-5BU5%QU9+GHM-O$$4Y`$\3(S-40X`)M(&2 MA3HW;;.6M8&;+;%KD`-_TU$^4`%)#58VF]AH.+<()3%4`%CP+`./NX:?((2B M)0$$^#)_F$`QD"O:"U*PG1@:IK4B+^JMJCQZ2MQ;4JQEW2Q8>4%A>P"!(@W?"L&!'A$,D"`'R,!BAE4P?&.N M8?6'[I7^@\@JRP;KU^/LU\^#4V)HPR=;NQIFLW[=S&N,64<=M@C@@/F2SRX( MJT-[NF@@W];U7Q.8XHQ58`2HTK3%TND012T0Q9A=N]^L2AW].Q-H M`IQ5,!N88'QS4``=@66(!CACM"TMR"K],/)+88C4+#I6LL3\7=\-JZ2-T.:3 M2C%`/W]8,4GX7MN5RMTJ+;A%@.[%1[A=ANQ2U%HC!DZ`@I]P-$>(8=]%!C2( M@#[LX54U@_=.?'.3X)(&?G0:46CL9XZW,"-;8@U`9IC`O8['I0)UOJ.3J]88JMF5:WL=:%IM9%N$1GI5U M_2_(I65>CBP>U9)49B[#9#$8'M09-DM4/DZ#G6%C4P$#D$L??C(@!DB%++YS MTF!/K6<6F(`)'(%IH*AA?6(#L&)'S&C,P.@K)E^RUL\(R+@J58%E&-J:A=D3 M6H;1-6-)+=TF2.9SJLC(NF!:G&/^.$,`$O/)(2M=3C#!T_AFR4*`I-T$!"!G M4_Q7Z`7D?(T&E/+4%4O.^`P#S::.3$4&2M;D3':TTWXT1QB,2M:"&&ZP"!BJ M)@#BM2/H"JOI:]!EF@:PD@FU?YQEX)[EM1O(#8NK*T"`80M=+J8S"^8`T&5F M_T/C)6@/92A[N?*MG#MTTWSKH?I[4%5M*(/N&ASYPKY-/ M7>6Q^$4`7$YK;R4#`*Y/+B[@`R;6!O/!:)@`#R<#NP36(6NP)FSI"O9/V`EN M%;]I64K^G]@:35M9\9$1WCX=*__,;ZC+9T6=9QI^LMF^X8+\3:T\Y7ZMX66H M8>I@,_:][<:N4C1X8E0;,F^=`++VK9&E8@D'"C-@ZV$K:U,,`TE(A4S,#%&L MZSCCY6055U$T[/M47:`$JPIF7G(U#(P`S-Z5&4-`;T+[W*V[#^. M4`2+`$^]\\ZN,``U=.L;[=).[TEV!+BMM0A`A;8%Y>[=US)#JV4@YWDFAKF6 M\2WI;35JI!07=1D/`>0&6]_:3F'#.&CCXE=_\M)U[N3V+3PE@U"^734\ZBX8 M2UA/G3CF@^9338P#!8AB-@9#6-W<.>[;_DL!53,+G^['`5"&_XX64$ MPPF:5-$,CW'LG;&B5*,6@89(VTOX[3<*[-5-P"(?\1H\.^/^F5O7?H$:^M[4;!G MTQ(QAC-QS0QI%@,MV$Q)??JAC(:)_\02>^F6['DH8/,R@(*L.\X@$_;CE(6N M?TYGEO82.[Z?+:U'1(9OX`2O3/3^X]O[OE>PSI:#2D;HDS2S3`?J/^9[NT2& MH=+`;Y@&;;RS:7#M(-WX%2<];/IMCK>:$)B`XXT`&@L+#UW+M^:`:(A7$@B! M5$A]3MBM:B2&"!@!,C@"WZU&,F!,9`C\Z)2'>K#]IK\,VA\!)*[]5%M,("M^ M,^"`KR"&$"C^:.B""%A.+!0#8L@!3A"#:KR:"23]L(I),;!>D"*&BXP`_7.$ M:=BM+B@.'0\#&X"*5".#4DZ%M+[1QI*'XS.#XV6!ONM_@(CVK8L),1/(E#'1 MA:`8,OY(R&/1A=@(,]\F&(AP18LC8B;*$"/SS1');RHB1+!!1HS&)BPBD'`T M@>65;QS^#)@@0:(>F@E:0I`,2N)C*@[?AH[X%$&AOT\F3%Q142_5R*!6KV+- M2K()FD"ROH(-*W:LK&/'R*(EBXI85:UNEZE(R,*&HV]0(B"+V.0;&3014H4@ M$8%%$TD1Q'SR-^TC,H+(CH1`D]/&4QO?KAR>8-B`SQ#^KI#P!Q1KDP@3OGT; M86-9"),HI]D4`]5URFFOV]*V83OEMU01#$1C:&#X%4>?6"*;B;=MW50%222T M?&UH&,R\Y9E(NI33-V(11G`XOCP$"Q/$1G\3LQKKY8*^EW/"2S`1H:`1?F52EV,1GT"Q5TDR35#FD-%HQ1<4`I%DQHY`!O6-9)PT`45KCFC9 M9*`A0'$:24OJ"&9=$QC%%QE::$$I1T8Q^LDW'"4*Y$43'&J5CD<:F6.J:#;Y M30B?F+&E6WR1^LTUK^[%09W?.%5/-!,X>J.P07'EE8S'(CLC6Z,-&V@T$U;E M:J-5G9ECI)`J5I`C4$CYS:^MD='^V9UWH@;7:LQ>Q<%HZ@9U*I[>3G"EN^Y> M->^?7H9`QE/[FH`,HJ@*R5ZXCLAB0HT36/3G3Q/D6J>72J[J:JVH.2))$U>R M!ZPC9(QV9Y--A@J4392.%'*@NAKE2+4F7V14R"V/-`&;DW(*KY1U/?MELU:% M<,2+8B2++(U'['PC1R1I\2G&1>?)',566>G(TED=?15SPEYY96LCH?NTU#9N M'21)&$]=UP@*(7!UEW6I_35[1S\=M2-PMQUHW4S7Q5'567E=%](C761"/1SX M6W45M.)!KV6XC;I\:K7C5RU#F1AL,QMM561CO`PG+'R#S)-N+3TUV8&. M/?;I697^[K8_DA#S*QD!IH*`ZJE?M74(LIU;5^M^SSTY\"1PPD$7K&45=ENG M,X^[U)^BFWO29;L-==N1`U_2U%Z++#7UPO;\\^)IB4'C,H>CG[[ZZ[/??I!+ MU12]^^#/7_^LE)D0K_TJHS&^6+A@PG]@:9S\]L>B@0B.2TQKT17,8QD#HJ]% MDF`!L,@`A2N8X7O))!R;Q1C;D MQ!/EM#,H+&0:^[-)%VX6Q2^ZCX$K'")87`A#,*(QC7C3PC+^EB$\-<(Q4&U\ M(].$.$1^&%&`C4OC-^:8OC;&D6]M="/>^DC(_;'158%<)/A\A@J@D?$K9F0D M)1FYHTIBDF=`9%^QAH@+7`P1B6B\9/I(BKR1]8]\1"E?#<OB MCW#6\RI)DQO3_$&2<)KP&^ID6S7CN4,50C*2DS2H^P9B`"@4U!$DJ`@W\U07 M#(7DC2&P02J(D0ID=/0^%S7`!V?^]<8VP4X3=;M,3R87`A5X=&8[PQXF@2G` M8X`BE,MB*-.T8(8KI$(%3KL"&LAPC8E(HCE%C=966""/$%RCIQ,901XJE6>@:'-G&K(H5UE`1^ MJ";^R$%.UIH57DP`-D%)Y4/Z6D`M+$4%?CV@4TS@154V!8J5;*<`\:C3NO(4 MEX4-#;H2*P=D1(@C"5&L9Z8Q`7],X"DE-&M[XF("F=JO-?CC``(D`2+#F75_ MGN&$&:J66S`Z,J%D="%`M1)5K%SCN,@E250QIERHF?-K`O6G(ZY!3<@5KC7W M_-NGLEG^W&R:\QK[_-1VZ\(!%83@:,O8IG0+IX7D5M<1O/C$?:R+&O`>[;@( ML$$9Y,N!A'P"`>S5152UR9&H1M4S#11#".2`/S(LHPDXA)N!Q6F`+LA!9-L] MKD!Y\1-_.(<8".#%2)Z[#$*HX'GW7:_>I+8,!.C+L=3\U'6C*M#(C40,*I`# MVSA2N!D3-"C*1;!QX\O<(QMY13;UWR<9"D_5\A7B2I' MIMOBZ59EGTF+;DFTR35_>(08)/K MZ_<"V]?"3BZP,47L8HOWO4W1Q&F4309.;**[')A=IBKMC_-"]">SRQ$G/N%A M^6Z4$P[1-AET-(UL1^-';)HS%#C!)W\\6V9S`W:Y@30[#N#G/L"NRV+*D*5H M/&4"4$"OWORQ"?2.!-B><8XLHI&M_.5+23[FP!/S%HVS24)=_HA&MU?MB(T_ M4;Q[-4$JHL'L$A/;1SK2PKWM0A>]?4,WC17)O3?F(Z@V1=SXOHE"?K1M7FQB M=D+G8)2";6Q,!5O8[^WUTI&^]%_^5Y2R[F3<3EUM[%XS'>E8/[K1E?[KKQ_[ MZOL&^="3=G:$MXGM9X>":*9A`ZQGW?-0 M$)R.ZETF:*_<59KX(>!",(WB^:,)]]XYM;^!U4\L0]L_\D>CICUM(45I;C;N M]X2T,%].9'O>7G^ZV+=.[&$_?]A-U_KS[[_1D?]_'\8%S M5?W1A7K88`0L2-H$$D("C]0#&<0P$"?\<0V/B"$'LNGJ-S81!D(80#U`5'<4 M!&:8@&+^10-.2$+AI((!^(9#V(`!D(&)K-I[\8I;(0!H_05.I`*C65<3A('@ MD("A/(6)9,=[\0)%^(91)-O'.8<8)$UYL,5T]-4W+,8TD(`![-93H`%50!XR MU,,5D!A"<((!C,"<>00:S)\)0`&C62`9>-9BE$AYD("M7$,81``4#(5C/5PT M/)@<=,'_L8":@59V)%4(`A6($`13K(1T>%_W@5_XO2&K2=W4"4W5!<4;ZN$> M\B$1:'\`4J M5.(6RH/GJ=;&B<$5B($\"!0)7,$G&(!B51='I(*!C`"IG$W^&AH``GQ"/70! M9AA%$YS-"+0B5(BB>?C3T46&&$!!>?@*`8[`QAF`#7!"!!!.-(@!,K``@WF+ M&!`#)P@@FE4&`D"!04@"'U"&)C3! M@BG;Z$6`0'&`@0B5@4R`'"P&X0%C"X(8 M8T@&50A4`Y&`'.C+"/!!!\G#HDG^A@KPP34<(A_@A%%$0#W(@7.0@1PD85D" MX[PE#4YH`E4^Q32\I&/)`81TP0,\&+P]1;JIUC>@0D^&P!5L$^^LV5"D1#'D M@#_(QA7(031`I#X2Y#Z21O\,T3&`TA'A(=)$YF9&YEC.HPG\B.!\9F@TI1A< MVU.TW4=\)C%H$SG"Y6NEQP'R0=^AAFSL6(Q%PVN>97DT)11TD$4.G/W59,%P M7F&E!`FD@A;40P043D%DTU!8)&BAPC6DUC%BRL?9E@H\`)Q-&AAFQT7>I20X MA&1\`X3@I&3D)DX(R>#)P00@@QQ\`TY0I`E\`A_85CVHP!6P0$KVE1:D`OBQ M6V@Y&%3^X&6_!"-G(J@>6M^+/!-Q;5F"[N.<.0=C#IH<\!5C.@4J[,A2X"1V MK"1HA<%('@B)A6#]R<,(A$"&B"@+V.>(?H-*\L%0$(-ME<%=F8`D;)^WW.2` MHD+_14@3&)L_4$8$"$0T>"3`T>=\ID(#R0*`-J4SQIA#G,UM/H5#O.EK MQ2DOR$8]J!1'%,PTH.103"5Y:62^"2>$]N%D&DMEY9'_B%(>(FJD(AWO.6>9 MNHKZD03"FE[+`V82H/X"65=K623[LC<:D>80+(=C$4IB'AY6:D3+A@):!%@"E M3V;3E_8D+Y@LJ;B5/SPE(4P`(6S?9S:I'-QI#O!!E:9I3KSF:7$I'\!9%@*+ M%L`9-7K8F08M:[*L%K0ISZI6EHK^!*NF%A?>Z=K5Z4(^Q0)>`^^@9#&HE4]& MPVAQ0M3^*_==Q2]1)@M9II-IW]HBZ)M%2&MXV#<@Y<1J*E^QIM2:0)>^&0M( M!JFJ:=B:@":@*E?29K,>(-5J+9Q6!B$0@D.4H:=N$Z[J*J\:JVA8;';076*% MZ\)F1U.0WJV&0'3D9`)=9!AX6'DXY^@-#J]2:K?RY['J9`]]`]!]Q"90;K3: M%FH+=T2Y',A%+^^T-Q"[Z0.!1K0G=YZQ+%* MVH8:C,(BJW^L**]B1Q>,[^+Y!Z1=;(MJ+(S*(!_HK?$%QLR6[(Y21LJN;'DG6JAY M/&WF#N_CWJF/U*F>/FZ<0BY?@N;N M&1QD!"0-I@RH&)R*1VK!4Q!"BQ*ID$8SIJ!K0?""T3Z%)GPSFKYI+NL++\=F MG9DL\WX"QQC(L4[;SYK'`_!5*7/RELHF;B)IM%:I!$=KC#'*7FH!8X9K:T1' M@W7OKUXR+^B+KWC8)M-M)D^F#2L./$$-]TGT]FTTTG6T%FQR1S<#L])=0LCS M0(N!'&!'*<,"7PWJ4JBL0I9'*9_I`]"J&/`J3DS#=L89K_(.*-?I-62IP^$$ MFI+!)Q`",".6NH)TTC1#P6R"/Z#^)53\*MTIY#7+`K`::S!;);:&@/%.=2KP MM*]X9Q@@ZR>,LD+(@6Q8:;[``DX`JVP(!+5.931KXK$2`A2T:%UC2DG3)P=+ ML^7@&V4`,YQ-I/==_B'*ZHG7:8P859U??B)HWB*7S(/ZW-(K@)/!7^/&LM'L@5A$!J MU[&.,31E$T)"((.'-7AZLS=EJ`"0)T8(;#EL*ZU;I3=E3[=L$,,6/BML\X(D MR`(4V(`SKFY.($-N0F%4'"`LT"_Z&3`LX(\I?G42AH!R`ZLD&`"?6[;Q4;<) MY$#=H0(`CH!3JSAG9WBE<_;>P!+V5:]5:($+6#:H-P.HNT#^J9LZ99LZJ:,Z M9X,ZKT*!)GP"+*0W++AK:/,J!U!NN54N(40Y&1"".NS"+H<`M,%",\#")ZB` M.O"""H2V%NPZKE/NCNSZ5S<#,^IV,Z@#(:Q>@%>V0^=Z,U!NY?HZ(#<#SV[[ MK#]W:'/WLT_[F?-"MOLZR^7ZN@>X%F@">@5=H=,=XLU[Y>K=)R!>>J>W)N"D MOE,[+,B!'`2\'(SZ98LZ9I?ZJL.\RXLZJ%?T'37J.PV3J[4\JN]\S_,\RZ_Z MSL?\RA/]RZM[P6/Q#S6#"D#!P-_^,\=5L;%O@M*+?(!_0MMQ@B:$L0MD>[3O M>H[L.GL?'AFH^[>?.WIEF#IL`KP7^\MO_,.3/"^`.BQP@"9HO:R3?+BO7:[/ MO+$?W@]=O+/[NI"MVK`'O[_;N?9;?/1WJ#.L'?1\(/_JR?_*NK/-%3 M]KDKN[&_.GA#_JB[?=&SNL\'_>FSNNA?DXL\$J>?$=*D>NS+_NS3?NW+P2ZH M_,O?OAR0.BP`0R_SPN]3^.\#@PMXIT6>_,J?/"P8/^]#FN]#/S#PJO!#_NZ/ M.J3AONSW,O#__O9O?ZH;.X4;N_=__ZA;?^R;?"\O/ZH_O_3//>Y#?N3S_MR? M_*F;O/C^!W_T^[[H0H$!@OCF'!ABTH M!Y;2B`27>MQ*$=C%DQ$1BNV(4>FN75[M(AP;<>#)@EW1\DH8]BW"BTJ=,CR[ M*RW>AX(G[CTKT",L0I+D:%('2R5CT`0I/I2+%'5JE;RT"`UQY`HJ,3UIXQ2# MRL81H8Y.J_:-M[?CX$6;\9%D`DW:WG*;#4\:W/EO@DB;2T_^65TP2NS`54>_ MOEC[2NBA^9`P@OU)!3-OSH<8$TBPJ#_' MOI/.N^T,/"HZ!:?K;L'0H)L0-0>BVV^>2[+;?= MFOF#Q19=?!'&&&6F.""`>[7X(0)%ECA1W^]=R9^CH$82_P:)AAA;5G,^.*.P?*X4(YY%=E@ MCCHE&620@:'7$=C\A)@F%)?9C5]@;+X99UAPWIGGGGW^>6>=;=99:*"-[KGH MHY566NBDEWX:ZJB1!MKIJ8\F6NJLC6[Z5_CNE9ABH)`-.F>MS3X;[9NK3GNL MH:/>V&?^<(6&VVRZH5Z;;:K+SEMO>NV%N2;<9A;*!;T,/QSQQ!5?G/'&'7\< M\L@EGYSRRBV_'//,-=\<<6`>AA@73,(."C_.33\=]=0MQ[5Q/AZH=)?7+0?& M<-E5OQUWR)MQS67`8\YW-ZYR'Y[XXHT_'OGD'[]&*%VH]/W>BK54GOKJ4==0 M%,5%P6,3&]3A`Q@-89\<]O`U&=_Z]"/?7:C>H0\T^.S5GY_^^NV___&NH2_V M6/SDQQ^`UN.#.DQ@`CR@SW"B"(,)KK`$0A2P.)-[`"'P,,$"_@&!`4R?*-C' M)Y?-QG?P$PHL1%%"$YX0A2E4X0I9V$(7LG`7+Y3A#&E80QO^WA"'.=3A#GEX MPUU\[E['&,'HLC24'AX1B36,X0.R5\(E5@J%2VRB[*+(.DKQH8G9JNA$ MUS5Q%]B3WP.8J)<'!&@<#PCC^4J(JRI2,79X$$,%=W$%-IJQC%6$8A+YV$<4 M2FE$RX@-"'TGN/CY$9&)5.0B&=E(1S:2>4)YWM)B09-B($; M9%2'/^4AB0<@01UA,,`X)J@'";BQ"3&,H)5\^$<.QC$".E[!`#G0!"HBH`YM[M.1O.!= MB?8'/*'L`@E@5>M:V=I6=](36/O[4_]>THRTNC61LZR'/)9@@C(LX0_U0,,\ M")A24&1#&5)8@"L_+01#TT ML0O/FD#^#$L@H`FV\``#F.`!P7@L&9,Y#M464!2$&,<\'FB"8"RAH3_`@U)C M]\!ZX.&VUP2N`9<0`5DT8`GC4"H>I)N#S^(5D4@H9[T^6%8;#.XEN]@&$LA; M7O.>%[WI52]ZQ[M>][X7ON=M;WSE2U_[WI>\\\7O?OG;W_WJM[X!9F]_11%) MF,15KE>ZY*``[%\'/_B^HEB"8QL8C-\Z5A)+^($)4-$`)+R6&[=HJ"1N(=L1 M($&R8=!P`6-GS4W,0[I7X`:+16'-W8HCNCK51"QN6X]6HJ$>#7`L"R);V]N6 M02\-.&Q'E[!.,@'+T(`M^'472RB&"5[L6!+42\9(9SG&6\YSI7&<[W[G.XX4KS(Y!+$O:A\%X%G2$EVN()3"# M&84^P88-R`QKQF(>#;W"/&0;!A3+%@TK-H$XD&#-7)P@F<7(13!BX6'$MA3% MR.P\E%T,,0\:VO!]@%A'U%WHF36\S"#CMKG=;6]_&]SA%O>XR5UNE6 M][K9W6YWOQO>W$8"7+U6++#]647QUO>^Q8UB0Y@@#,P0!8JOP,!%%W`+CN9R MI!E(:1.,(+(FUG1KK;1!)@%-`_'.AL)_!;ZT)E!;0^2]=JYP>0N MM#UTIS\=ZE&7^M2I+G5Z0ZS/^'P)+YI>=:^#>QM+B,5T;_$'9CR0Q)MEP1(> M@`83A/C?)!Y[P)=P?Q@F]9$]83]NH5YF'W#]1!%`UI. M>!(T&:6XQGDRT<",$F_!/.+8,"HD3,`.WY;S#\`LBI/Z@[T7@^?_6,(VOMYZ M;S,#%F-%Y_NP[>:N:QOW#T"T[K?-:M[G'OB[S[WN=T]&X?/^]UTG/JN'CWO? M-[WYO3?^?O2-7_W@,]_WOT<^]KE]>^TSG_C3AS[TK4_^XCO__,L/?_+/3_[R M5Q_^S^]]]LM__-O+__O/MW_ZP:_^\&N;7IP'#>HMP>9#>ES"!:XO^^A/_:[O M_]+/^K3O_Y9/__(/^2Z0^XPOJ0R`U%(MR([C!Y9@%\H@HTX@J?YA[_J.\"*@ MU0KH!QC/MS[+[<)`$U(JL&)P&YAA&Q9H!$C-@0I('/!.$Z0+%7!L@7+@!&:, MM7*A@,9!',;!TD@P!\;N[99@LQBH`910')+0!&)APS)L"0HNTPIN!-I/^,YP M_[H/_>3O#"D0_2ZP_KAO#9UO_J`O]MH'Z0!'G=SLT+#/#__^$!`#41`'D1`+ MT1`/$1$341$7D1$;T1$?$1()\0'HY1KJJ0#EXP`=(0$CD1,[<1`_2Q-R(!B8 M+Q;&H1]PC!G$(1\0\(81-R01R8H:EH41TV81-^0!QFD1!0K`$8 M:A0U3!<)(0?#3LA$,=%R<1/4P:4D01V00!+ZH0%VX16Y011R,1>DZ157,1A: M2AT,81.801,D`<=4RQ"3.[O3.Z4S!,Y)K@SI.\O3/,\3/=,3-1W2 M2B"2?[)3/>-3/N>3/H.S3TH38DZS/O>3/_O3/UTB&@808N[M/0'M/P\401/4 M.Y>SD%)$01\40B/T.*WS7EB@D@I40C-40S>4-HM2#W'#0%D3DT8D.4<4DT9T M-U`4.$TT-56T7E#31:.315UC-F.41./31E,40`7T7G#!`$:G"?XS1X>SB%#T M/K+$18=4.?GD1F5S2%4T1Y%4.)44/-O#1+_A+@%G!&*.2[O42[\43,-43,>4 M3,O43,\43=-43=>43=O43=\43N.T3:^S2G!!3N\43_-43_?^E$_[U$__%$Y9 MP,\2+!`*U5`/M5!1`14"85$7-5$/55$AU5`;E5$?M5(?-5(1U5(O55,[U5$G M=5,Q%5$C]5,YU5%+=5)1=50]M5,K5555E54U]51;E5$S55)#M55M-5=EE5-[ M%5=I%51GE5)A=56!]5'I]$J,-5:5E5F;E5F)U5F!%5JCE5J;=5JK]59Y%5NW ME5N?E5:OU5J155S'E5S+U5S/%5W3%7`J4UW;U5W?%5[C55[;=5CJ%1=6P5[O M-5_WU5[QE5_QU5_Y56`'5E\'=A7\-6`/]E\)EF$-EF`#MF`?MF$AMF$K-F(M M%F,GUF$SMEX1MF`IEF,9%E]A)@+^"!1B0$$/4E9E5Y9E6]9E7Q9F8U9F9Y9F M:]9F;Q9G]9G?Q9G5^$294`8=,!HCQ9IDU9IEY9IF]9IGQ9JHU9J MIY9JJ]9JKQ9KLU9KMY9KJ588"#!8W!-B9(`!A,%LSQ9MTU9MUY9MV]9MWQ9N MXU9NYY9NZ]9N[Q9O\U9O]Y9OYY81E&'VY(IHNY9P"]=PE98!&"!I$_=I%?=P M'Y=QC[9LD=9L*?=QNU88)E=R*==QC39R"_=KY=4!+I=T2[=J/]=SH;9S37=K M5Y=U3==UG[9HB[9P&4`/`G=_9.!U=Y=WC=86#L$>CM8>#L$6GM86BK=WK_9X MD79YC_;^=XU6&(;7'F@W>9]6>J%W>&O`>0\!:8GW<(4!=]W5`:BW>LN7<)]W M>Z'V$+37?*7V$+S7=^T!>77@>(-7!^1W?MMW:7\7>:.W>>GW?X_7%LAW:WG@ M=@M0=_57@;&V!1+A`%@A>.V!%0X@$2RA:1G!&9Z`?9?6?A4X'1(!:1,!A(]6 MA(W6'A3!&5@A?Q>8?EG!&11A@&W!A5L@AN/!&7B`A$<8=,'V3[(.<`:8A8-8 M:CT@$S+!@HU6`3)!AY76'HCX#E88:3>X?0]`B>W7&;`@'H*7!^``!!3!'B08 M!+#`$CJ8A6TA$3+A`'R7%;#@`'"X!IX`"T:8!Z[X":`X:PW^.'Q]IPH(6(C[ MF')M014`P!1B.!,`0`%L`8=UP'$9MP:\H!,.(9%7UQ[N@(][MP8J01\`(`/N M-P/@X`!,@9,]V10.(1U,01$ZP1GLV'R;^`4`X!;N8`<2P118X04\0!D40`&> MX`5PV!02H1)`&73SV$I,]EZ`V(^/.6EY().Q@'M9`0```(:%P1;(F`%D&`"< M@7N=5Y$1.1%4^75MP1DR(9.?X)8WV0L28005X#^TWF0[U>:W=B,,^`0%MIT:\`28#FC+8$> M`,`2>```/.`.9)JF/<`43*$;*N$6_-@#=$`1#%D9O"`3NN$%3(&FTV$'`.`` MX@$`>(`!KCFE,5>8J\2'8<:8(1J9+:$2O,`+<#@1,@``1.!X60&"=<"CU3JF M$Z&CC_@.QE@'BE@'5-IT%6$':#H(;`$`YD`9.L&4`8`>^/H`#@``U)JJ8]=\ M:=@6O"`#;AD`#N$)`*`%`%L95.$6:/H`"KH3O+EJ\1B![9JKS5>:G<$9`$`5 M8CD1```+E"$=X`"-;<$25(&+3:$37N`0*@$$P!D+5*$%6N`6]*&-];<&#L$9 M;N$0L(#^LBU!HPV[!9B[$@"[&TZ[!TWH6E:%93!%,X9`.H8`#+AM"WA M$`SY$!3;:D,W7K=ZM(68I0]`N>/!$IX@D*M;%9SA!2IA!YY`'R::K-.!!S*` M%1A`%629%3P``%Y@B:M7>Q&:%5H```CZ!;P`#FI:!U![O.TAPG?`O:NYOY7A M!6[!%M+!J6_!%"Z[H@VY&S"[<$';H=L;F6T!#D0@Q%DA'6)ZMP$@'BH!`#Q< M'^+A``";`4"`!V[:$DQ!'PY!'T`9O7>7!PY!%4``Q9_;D#.:RA4@$6XA'I3[ MB(.XFN]@D)U9`;@[PK_;%FZA$Y19%9P9!*J::\%77CT;QLW^UQ+@@+DS(!TL MH9#=V0LL(0-N80>&>L97.Q%26!E`0*:7O*G'O,E9]\F=8;L17,*]@,>#6I#M M(0,R@<03PP?^NA,ZP:\S&@3F8`Z&?91%NW1M01'@ MX'V5F\H]>;DC7!GHP0,RX-G[V!YN?0=$@*B[>[6?P!YN(0-VP!+2X;33&G-Y MN#T'%6+8F]85V*MWH)`)NI!;0)_AX`62W)D301FA M!??>@U@8#N$`+/@67D`9$#R?Q9O'&>`0`-L6:@"P$7V+>UP9B%G'FF!1OJ:3H>#D$94%Z%A5@8=L"T+0&$]>&HD_K"TT$9`(#:;4$9 M,D$!'EYKU5LJ?WCE7[YT:X`'I!S!R;F0><`2O$`1,L$+`AT`T-F9G\#O#R&C MT1ZQ,SZ1R]<6%*`2G*$2AOVH]6$.-!R\GX!X+>$%,+^/#P$$%,`9YH`!5MNX M`<`6,J$3NL';N3>W,\'57QUP0UON65@!;!GTE>&TF?Z:`UF%'3EX'?D0T'R? M,\`#NCG^X`=B.UAM9?_Q)_`%.AAEI6A M$K!9@MPT7SK&.WN]E<&>_?6N`B"U8`?3>%&IZM8%=IG%>&2;[A0T9 MY5\`(`X\L?6BTQT="!,J7,BPH4.'MH(`F*A*&2M5!U3Q.)1(`99*MBP]FL!2L%("S94E3I MCKVJ>!-:HD(6Z)G MZ5#CA<(",1U-NK1I!XL_JU[-&F$+19;T*GK-X`DKD3PLM=BI6P0/MSI".?2OL!&-Y]A`%E M#X0+1C7@?H/UAR!^"=FR(6O"M/?>B"0>I5V%**8XX4*VV'-7=O\AY*(.-43W M5TSZW>=9B@VYN&*'"0GS(XT\1C5ABQ]2>-]@ZQ%5HGM.%2FEE-OIL-A35T[Y MT$E5:LD8EUXB%.*32>&""YE*41C^YIJK83E5EVS&*2=5[*%)6A5SYJGGGGSV M*:9H=LK"SS&!F@BGGX@FJNBB4M59J%)X,BKII)16:J6(:`[ZJ"PG6NKIIZ!Z MR8`RF&XJ2Y2AIJKJJE-]V-"8@>*"R::=LFIKJCPP$!MXK(*7FU8-\>"DJ4>A M>NNQEEK"BBWI5'+(';R&:@\K+=A2R4#T1!LDH,3:B1JRX%9UZ'P\/*&#!QF$ MY(&K\HW;F#TMT,-1)CLH0@^3"#G:;7SA]DL5@@R@6,,!G<5#KPA1X.OI7O_- MX8PRBCA#(:S=HEDK7N[ZF^B1,*)H"U8[M)!)#;9$L6Q0'4>HTI$*MP;'1JQD MTN(!+>#^RP.I%9_:6,!B:KP0`SRC%/24N>46FYK)P:M`=O2HTJ("-:^T%9$\ M,&+)N+INI>UJ#!SBC,2'5.*,9PH@%V2I3QY#Z*,74R5DBSY7BM@=\236K!O^YZOCN(76`EB1R8276NE#CS7W_-3RM,?O/[S+V9/)BW^.$0+TF4+9S@K M8SK(!`!`HH-*P,$>`5N,)8)F"7T`(#'@89Z;\!?!_?4O/!=I4-C/*,*$&AGBZ#1'IG,M*EO566%F5"% M5S(AN5PQQ'X*41W@\C>_/%7""SO4@>XD1K^G9,`4_',=`AESBQ?L@`5#X(0%GCP,55T9HP0$@8*B14IJJS0"TY#3P:@ M\[D.O7)&"8%GA%(#S#AU`@"Q\5HB;)%$>_!@!PH`@.'8&$,0?6R(W6C)V'20 M"&<@!#$MX,%M;.$!@DWK#GM95N$*1U&+ALG9@"B_` MC3#SFR/^N0#P`F6@4F8Z,.!`$G&`K(CE$/&HQ$]:T%<%`6S0H3!&=\ MJ%S`$H9(H&*+,>KC%CQ(1SIVP`HL@$"R^M"'7_[B3!Y\S0.JH`=Z#C`'<]G# M`PYD1%YYJ@I6H%:U/(A")7JG55;8A5PT/:HRT&%C1D0:`VX:0FYV`LA M4U-$=:3K3_#,)B;3DM_4;J-)K5F"BRF:SA,``(>_.11!K)#,(;ZX%09H[2]W MJ!9].`*`.2C"%%FT108,:(HB$E,'&J')$_1ACP,,,1.WL`4<\&E@2V"AM?K0 MUDYFM!.HU*`2.L#"$"/SA`PHP@N(>TE6V%A3';Q$H82Z2PX'NA!B%SBL5A&4(LM.H`R M#^(+Y5<^A@?PPJA7S$,M'G"&31M1Q05W0(_>3>L`!SG$[I3UFXE:(@I-)=(5$;.M(4"66$*?2@C$PIP1B=LP8I,5Z*NHS;%+>YK MZDS8%P`P1$AQ%&*V2([35,8-2G$`T(F%0(Z1>Q.!\2IQBP,8D3/&@X,7G/$_ M58/`F(+.1(3GX`5ZB,";<_*"/EC^_82;9*)X1`PH#UXPLDYDXA"IMC21/T-? M!5CPSG<8XA=C"NA#($K(V"L=N,A/%[??/]&$88(J1OY'DE:`'`)R!8/`" MN5#'.!/;HLHBBY_,2CO`PCH[(1DO=*(EF6B)'XT>#W?;XN@9,"7[2G=!&SL4 MW&LBL1MW$(5_!B$#XV6%,DS1"9G;!@#I",6+.S$VGD<%E2\`P0)-Z`53'(#M MRGC!"Q:NC`QXX0"FL.G<`8`%15R0?3'[>^#K&10V@D`1RI`[T0T,ATRT/*9J M!'6"`PK^4,R2]R9A`\`AA,B#@"K#]`K`["TR`8).#"2JE0.VVT)>;.'-?`B^&PKP0@N\8(E2<_;&(C@B*@\0BGW&J6L:]L!Q;'$'+_"@$YTX M/0">7EZF@/ALR<+C#P"$5Z(%S5%- M7,X)`!%X?S?@<0L\!G(U%7!+LT`V%D#:<0MO1'8UX$8&&'!B$,*%!)#](!$9#S&81)Q0A"W MP`H#80L@L%LS-W;ZT`+$9`E'%`2W\`0QQ7AYP0.EU'<`H%K^`J<@S.)&=U9J M$8)*(`$`((!XB+<[1Z(:E24"))-<+6!$%,\+9]J2>$'/$6*`,OF$+ M0.A[@=9?L6%C\R<2#(9K=6=7%H@7U@(>A8%/&9!@FF1BJ@!!6J<`N*<*O2>$ MY15`^-4-G>![6S>-M_8P$245%(,F.4]66%O4 M._K0"=^5$%X``/8@9J*V?;(&'/FF`Z-S:J*G0(?0@B]`?-1"CPWAA\55%5WS M;,K0(K!Q8[@G.=.(C"(G<-UP2:VF.Z;&/N%#3,?G>]W('@:EG1":43/QY@ MES8'%3'S!-(1-K`14R`00/"S+O2C:JGU`F4#F=;B!22A-P?@0R+P`G-@"9HI M`M'H19C^1(I1$1I"]B3SIA+%T6FKQ!F=,`?*`(*YF(NW@(*FT`UP<(,7Y))" MF%1]IH3O%I@I,I&9\W09L)MCEX=GYP$)*$#T\3XQ5QBIQ@.J8'>^Z`RW@Q!8 M8`H6V0*II@B_8P\]]#X#40FF$`2[6!5CF!E)%`]WX#60N2SI8`J"@1!W4`D* M$`^&15AEPPB9D`E944"5<'_V0!/ZV0*&U5R9L%]3`92%`HA5`3^)<`=>$3:* M9`JZLGIW=5)T`E>`&`" M%01>D`@D>'WZ``G.G"2\6`*B3!\`0IB'3I&G8`ZT8.B$@!?(B<"4C"G$@'@)-GKI*_F%'8TH5;_472X1,^"(@ M!+(C'E)'?_$BJPI6-,)*"_IKF](_7((EN;I&/3,_KN@5-2,D'N`7NE&!NU&L M2EA;'O!*\0`;3Y`;%5BLA%$902(FO-JK;E)DU6HEV?I!6A$;)U$NN_&LQZH# M3P`;+2`,9D&*:P0FNMJNST.FV0K^KSRS0>%JK94$)MPZ/W?1)?/*K?X*&KG: MK[C*J_\*+!_T2KF:K]#5J_>3K]M!FH&"!CI7*%4P/.VJKFN$L1FKL>WJBVZQ MI;XR.+Q2LL#B?;]Q%Y80"MUU/E8248FP*QV[L1O+L3-;)1R;LQ][LQT[-;]B M">6@/N!18;Q2@5HQ/#:[%>JJM!BK/@*+M!^K-4NK-4I;LU'+M%0[M5A;M57; MLS?+$%,;M5H;MC5+M5*;M1J[M5@[MCSKL3]CJX42`0X@`W1;MW9[MWA;MPZ@ M#,IP"'7+MW[;((?@``WB``^H`-TPMS+0MX?`N(2['PZ0`63AMWE;N97+$):; MN7:;`I3^*P.VP+B.Z[?*0+AS^[G*H+F:B[FHN[JLV[JKJ[JN&[NRV[J@$60C MHH&!$@'4D`(.T+N^^[O`&[R$R[NCR[N].[K"^[LGD`'%F[R]FP*GAH_..[W! MRQ#4>[W".[B^J[W8V[V]NQ`UX+WB.[[DV[L.J@/&6[[JN[[`ZZ##U2T1H`=& M,+_T6[_V>[_W"PCXN[_ZJVJ9H+_V"\#TJ[_8D`'[>\`'G!KE@,`,S+_S*\`. MW,`';`<+L<`2?,$8G,$'K"T\H,$>_,$77`[9@W,5BR814`QM\`B(L,(LW,(N MC`@J_,(R/,,LO`AQ4`1%`,,TK,.+@`U%L`@[W,(Q/,/EL"'^-5`.09S$0JS$ M3!S$CQ`M-3`(33S#0_S",5S%5CS%*PS$1N`J'R##6*S%30S$8JS"V?!8<&LG M92`".-S&;OS&S5P#=EL>T.S,TBS-S4RWUOS,TWS-T*S--,+-=;O- MXCS.U=S-U'S.S]S,#%'.VFS-Y(S^SN;LS-H.-KO2`]TB&]$"1]TMY[OMR+TBPMO`ZZS'92!5G).31=TT"$@25"2&P# M'FW;TP;KTQT+L#TMU$!=U$$ML$:=U%]KLT5-U!D+MDH=U3SKU%*].E5]U5C] MM;YFNS$]TS;]U6"M&A)K)[@;**<9UFB=UJOQOA43;&K]UG"=%V.-)M3`/6;M MU7&=UW`-TVCBUGK]UX`-MCA-(K-"*X%]V(@M/&G,S'B=V([=+W.=T:1QUH]= MV37-UV3^4DZ6O=EHGAG=JP'2J8 M_22:'=NV?2N>32)E[=JG?=N^/2>E;3F]#;8.JQ+#W2:A9"7*\SJMLZUP$C#L MLMS<,33XHQ+-K:G/31\!`TG8>EP>]"6#/2(Z72B&]-OF_2FS72)^#5U;80W1 MP@CNK;0*#1[GBQ+UC;DITF)SD!U,LDK5Q!#]P0#M5*V9DY*=DS*,(48@`2&> MD40^24N@H1TPU"FP!'+S`4O^.47_H54/L36L*M9<_=E&\=KG7>)[DMXD98!!"HCE[1ZP1HX=:8M'R-8F:!::T1]P_0"U"8?`+J6"@`',A+F<\9)P90( MQ,<%&/89JRWB25'>)O[HBH+B(R+3#E$#=E`"):`$Z`LL*<`#2H#IA4`- MB\$#U9#II7[C1)X"_(+-*0#-EWX*":J&8?"N02$T'GO#9P-GI!&\)&=Z`/U#88TZ%A$Q%A>5$C">$UG<``.^#^E=`Q+:034$-$XD+A-0*E"K"A#\M2>B=U M3ZJU$"&)3X/Q$4^@0.75V(M.(MNX@"!$0)45>`F]`#:=0`I20`L+@"F]P"N5Q"J=@!RV?`J]^"AM@ M#31R"F^P`3S@`+=^"BE@#1NP`:>`$$0_""U/J5L".;CV/LI@"9*#$[?Q74_P M`@HS+7<&,9]'@+?G/WM1'`8N+H>@8:;%<1'#6T M`QG0"2X2!&+'6;?@!=>=%_806J)*NW@T<)6 M"QXZ>-A2!"#3(08Z+%ZTJ,_+15OT`#@[Q./0`0`M="AD(#)#25L87;Z$&5/? M+1ZJ[ARR9.DB`P;";B5J:='6G729`%BR9]&>,)$O5.T0%E/^ZDMA@61=Q9I5 MZ]:KQW!Q!1M6EJVH4\V>19M6AX05P6)YBZ5)TBR,&H)YPQM,K4L&.UBQ4O:R MABW"0:7:._3RT*&E+FT=,KQ7,DR1(CPHJ_&2\&3.DAG8XO%D1U*,CR/K$(8X M,J++UB=QF@'#RIIB8%#L`!`$8<,XT$?``"XY0"R.A.*%0#T4>6`D%ZR1P0` ML-@0)HTL,C`1`"04R1D`TED-M4/^,KFE+`I?,G"@3#)09+^+#F%%@9>"T&$E MI$K3016=9K2HJMJ69)*V"9&D;R][-"`'+P%B$2!+;S31P1X)[LI2`&_&T5&M M&EC)()-X1-#1DCM8>7.JH0XHS9(##E`D,GOB`>&)+J&4#"(%7G@BQR1ML<09 M9W@@#=#.[.&!%:$L`:&31"2U*+-T0/#`,44.<,82/7E05-2*6E!(QK-BFZU) M)N=S29CI*X$$)/QRP([OH:NBNAA3@\Z,: M^$JPP[=3'!"V/26`E4]5M82Q)9T',^BRHM+H>:%1JCPPY3]S9W)FCDXR.9(' M$5A!$`#^H,SMS!85)4JJH7,3;$S$C5"SQ4)50MI!19#,!;>3A;UUU*B/#E%5 M&%9,>0)CA!-)1!DA]Q/&DDQ`V`%0)5UEV54'5%6WRYBAU&`%34))2Q)OPLSR M+6_(R6+*MZZ,I>@L.+,G$P4JJ20>?9YXTHL'`:C$XYB\N"6ISYZX96HXGESI MP1#(XTNQ`[6S(7U,2R6!C55KBX86I,V@( M7)(>_&E">RSA&,W_+$H$:G[-XD&VEFNK`C?=WD"VA-]^LT.'-W+%95?LF+/F MC5-\\V,]]HR50;=39&=6"1E.<8^Z\JBU-H5LN^,6ULD2%KS^$X4P$N:0I7>8 M'"-6C+J%'GMJB.@%!2WLY")[;-E!$2_T`?00>CH!P)0A+Q)F!Z69EVI$[4T! MX#]&C*+'L(2](-ONT@[HNA)U>WP0U&1EB3F`:R4FN0BENA:$)U%(&*VZ7%>^ M$L&L-)!*Y!B')"0QCG%HX$^.JH'.CG:6%>#%A%8BAR'L,8L2%DU+`I!`VD:*[8'@CGD1!42`9#^.&*A M.WA``=UX0M4RXHP=*$,!IFB1%,_"`WJUQ!(`@`,9E=$"56QO#EA("/P(=*:^ MD0I"1[*%*12@#&4<0!^OL84JXM'^P*D(0QD0I.!69$"Q3.G&#\G!G7M.\2P_ MD`X4PKA="=Y`C60I`3IVH(8U[&`=/U`#/;3KCK:HX9O=52LZTV$/\.(C/,GP M8`?Q()\7'H>13OR'D18YA(E,L;UX?$@9ME0``#SP)%NJ2!$SJZ4R$D$^?;3@ M-09BUUG=S"J#LY(SH>TK7E28=4_%1D360UB.&](@0QX8`U,IF!TI.N% M#F95C0TH(3K6*`$E(NF[:IR"$M1"I1)T0PD[Z&X\=NCD>&*YK5DB2:A88*HI M[!>/%QPU23LP!4ULP4X0P,U$;YL<#[QP!T)R9B2@@F)4()4)$=CBK!C99CUY M<,:)Z8"G*+NMHSZ3"31UM2RV_"A$.E&)'CI(`72Z2#,!,$@DK8R"7E'KR[0G M`6\,5'L:\(8&H$D?\.84)K,(Q@JR0)?MCN,N)A23`,9!T<[^&`@.5#O`VZ(" MKG^9P@/CU2L<+/&]F*7&0C.-KBU6(C"D'HJI&4C$'"CBH@PG0`?^L`E+F<0AJMUN\5$*F*+3H`HN,@[I%JU4H5? MYB8X;^#!:U('G!*P05>9BF0UWF"1#0#'#]>B3I1UD-COE,`/E*B&-7HW.O>$ M3I;1H:5:>""2""MC)@)+GBI*>UMA5"1Y]+-!"T\TH@!X;0H"1R,%![`#@M M/,BE,XZ)&GLX0P'DZRJ-#E$06U2U3.#R2/UV:HL7@+'!+UF)%RHQ["[IHQ-! MX8%$RGGM)`GD%J49B!&%ADPLB45=BKG9_VT69\(*OHVNY4U\E$C^0HAQB!-(2Q)Q MBUO@TR(\J(1%JOH26U;"WB[AP2V@1FZ7//$640#W+9KND/)Y5J09I"Y%F440_DK!]@6E`^TGH@01D`?&+ M-)H'A&UT^3.U?K.D?U7*FX,T?:CU8&J6(_%PM],K\9`GF$)@]9&]T3"%JM&; M.P@-!>"\R4B>DXDI/)FNEH"1#-@Y4^@$48&S?;F(KG&)[?'^`'T@)]GR`-TS MA6K3!PU!N`'Q&`-`_(A#QAG-FK+JM( M)(=3JU3KN\2["`'0"XO0`$G0``Y2PO1B"W((AE7+`@R2@"9T-0W@A%@HJ)^Q MB`ZB$O&RB"Q8`0THJ'&@"S*,!0WBA&#@A#%DPLJ;/DA+IA,QC*C(.@W9J9'P M@,2H*@!ID%TZO1U(FS"BO:V[+P"8`[T*M\Z*BG"SOT/$B%N(Q(O8`::2",[K MBTRH&GX!%U;0AR#3JYG0GN<3J@HOE,+LY<@@NU+`B*X"$6`Q1Z8!5PP M$U?8`$E4BXXX&570(Z!(*A,4"G#^6JT=P`+=8YKS@;8,<(9*D)#/H(>9R``0 M2$"D$;$#N!$%2`?"2(2=ZX1P7"ZOPC=32*!$,(6]J1=6,(@6L!K/>P%Q[(2Q MT3?.`(%,<(87X#0<]!=#!5,(H@2`Q_;(D+`X#>DL3%`8`,L"V,X#"E`1@2V8%$ MR`0`L0?^(RK+/&H^B_`"1TP>$]&0:^2+5=2QZSN+5]P^(A`8P-R^?TL+&6A% MJ^20EG!!R'")NBF-)_@/T&B!4`"0EE"$A^`(L1()1]D,$#B(1BF,PE"7`T`S M1H&4LF"`%A`5$G.,T?0]"DD,,O*`'0`D'1"!UHR)C9RYG!B,$TP+?4JD,/"G M?](NI9#(ER"'6*"+8$##S9,$`;`(B'H-[I(`>]`9[6D\)?0&6A,:"5B\+!`` MP?M(RPLOG11#>Q``3GA)6Y/#,4+&4.D]_G"(0YB#.:"GE!"J[]$'![D0`FFS M0X"#M^&\Q:$7W[+*NTR]6_`"D3`%?:!)#\DP7JP!2"2DA)G^"/*9P;)2!3=# M-Z`0&.4!``:+,8JXRZY*Q;32N\1\B5!PT5!@L!>%4<6\ML)!"T7PDYF#"=F" MB23L"3!,-;KR-D MSRX!K^M<`>E4"O`R23%5"O>:A2Q`4_;*$HQP*,$#/#'4@?$TTI=@!9Z"@QVX MA4Y(B@)!+NI".X>P!-84@:K*B?I\@@-0!L*HT(MHHAT@#"$5(U9XB$38(_BQ M)9+(&W821$FL`7UPQ"Y1!!A$DZTBF!I@A$6$C$$S$&<(&;1["$U-BK&:L%-D MK1/D@1Q;T1^ET5V=C#.)!UXU&R+^!=9A-1LG?5(F.4Z+2$[MW$GN@E.,((`[+4,R=<[<`;-"-9(!,N!0/N(,#``JA8AN%&Y"\62X^.@`O>(WD01!( MW2F^5"O#)-:8I9`YE=G#J-F;5<"\.U8F(23K-$L="(8DC%-RF)EHIOO(4>JH3]J@'R M61B7``#^E/V,8IJ:!]$LSWO;!Y&V(Q703NA8!8"#3FB(K>':_C.]A_4YG0"7 M)_""='@"?-0'^1&$#'#*"'_6`%IE%(BW@"8TO`>.@4O;J#)_#> M)XB'>-C0R`'?>'B"[97$.T@$52"4DD.8>%V4K`T[#YPP'6#'2O!`S;2$1##? M\'V".["(A?/>\(V'ND$44!$55?&"00+.RNG42"D((?\ MI\B0`./EA%SC(/K2SO%LPH'20G+P(#+$(+JH`4/HH"A\3N,=!_-RKPR:"W#- MH"80,;10T7[C,0N&XSB68](U M5E<1P@T^PN;XU16Y56FT3K>6;%H M+5:F4022Y0F^*DRA/498.9IM8U;^K.5?!N9@;E(,?F6>U55AMAOY169>7!Q) M9*AC[N6^7.9IIF9D?N`FP2X\KN9MYF8Y=N`G?>-N%N=Q'EU79A(-WJ=8)N=U M9F=*=ME$BH!9:(-'>(0VF.=[MN=\KN=ZSF=\IF=^[F=Z[N=Y!FA[!FA^+NA_ M_N>`)FB#=NB$ON>#'NB&QN>)=FB&UN>)%FB"WN>"KFB.SFB+'FB(ONB0-NB$ M/NA]]N>(7NF5]FB1/NF(WNB2[NB/;FF-EFB;]FB$#FF$/H4(2*1L5MUC;N>B M-FHHB>:7)>JC9NJF+F5,*&8H76JGINJJ;MEKIJ`(MNJMYFKTP>JHU@IU[NJQ MWNJD_B?^F"7KM.9J0<`G'`"![ M%MW&\",=<-Z.`&J0@4/X<,1,@;@:<1FPA1%'<1"/JT-8<11W<107\;CZ\!0G M\1I/`14G<<9F[!%G<<9F\1+G<1A_\1L?\A]_C!\G/\1?7<28G M\<5P\1,?7(;=F.<`QP M!;W.\$@W)V*^G#M.I%Z`@$S7]$WG]$[W]$\']5`7]5$G]5(W]5-']517]55G M]59W]5=']6PXA57@(-!T`'$=(G;<6U&EVUW``=1E/1D M7\@-%PO!OIP(P'18E_9II_9JM_9KQ_9LUW96EW5:7]%?>PYW&`3(VX`-D"%, M$H%A)_;89A,+]NWZ8BO<5L`9Z8D=E7>DWHMWG_1].H;4I:`.?_,GI_$1?XPW M5_,9'W@KMX4=]_(Y!W+$9/(=-_B!AW.)#_,2EW(XUW@R1_,4-_.`K_$0OW(? M3W,V'_@?CWB-%_(=M_(;_W@>MW,9G_@US_B)GW'(D',87PP?S_@D+_D@/W.? M+_(\WW.]"^?V2W<18&TJ$('M`+@:2/=%9W1CQVR9E>(=/6,`68S+=+NJKRY( M2PLF!B;^QW2,Q>!5U3B-U(`,0W1B92XD2N=ML/!+[F9O_'YWZY;N^?[NY49N MO'=N^$8>&7ENY.[NX*9O]&9N^[[O2.YNP0_O\XZ5X4;OZ29\R#?\Q&]OP*_O MXD;\S+_[]_;NT#_OS5>QC*E[\LYN_1YO6V)V5^ES'7!T0&=PO*:8!D8V':P271#D`'_R39TP']X6TZ7VG@D$JT%B40GJJ=)`4<+&A2OBO=]\;4;SHY[L!!K95=_T?UFHP=.NP*'%`@%&5CM M`F>K%`"'VV?T=A_=&IF:NP,('0)ML3+EP5(&!;9TU.#Q`@#^Q!<\=`BSY:S3 MPULM:@@3Z/$CR)`B0_(XX.46@Y$4#]$SY@61`!8%E9,YR4>P@PZ&!PZD#3I@4,=AW(5%D@6V+!BQY(%:Z`L MVK1@;6WEZO8MW+ARY]*M:_5VL!I9;15R0/#H!HUK($;]$;& M4&$U3KFK;!F#G\=\-PMD5`D.%BP>%H;TF` MCAUW`*@ZE)*S0!Z*;GD)>NBHAQT>[3ECM<.>*0!`:[1P5F/'$P"5?`,7*3,# M*QWT:MY9J%J5LD.L5MNRET$5""S^("IY$6%OKU?!@5D"!P#/SE'X.R$!:4,#*<@D$-X)RB0PIOO)&"6Q5B\"&(&("#H%Q4'>#,(JHLM%XE.[3PQ"%M*N-!!@#J M)0Q@#9+%3W]VEB4GB7WZ^2>@@0H*DC`+ZAE8%4.E0,D&(OAQBF*GB##E6SQ8 M>JFE@PIE"41>5%*80#]B`HI$R5@DKS'T,/)E)5GSE=VA8N.""[5A\ M:OHMN.&*.ZY'"M;);5D/!B6#A1/*0(DK#I"[F3VL5#(;`%*!1!4<`"028R4` MP.J1+4$>TF1NSB2RPV\!RDIK2"XJ=<<?6'):Z06$@`I4U MN$-);#_?54.;"`$`AU8MKIG*&PHDJ^'1\HDSY<#W0`\U[`V!95 M&51KK="''K-MS8[W/.4IY9_BRH606;X^^WUBGCE8B0Z%@37UUS!+"NU0&%1K MK>O0OSU:(T""D:8U+<)8`,?4EC$))(![>5(B`%`X@GF@$HGP```R@1/#)4*# M$:,=`*3'N[.-1!_%Z0@/W+8[9=`#`'/0DBT.$1U+[,Y`6D-12BK2-S`!X!8B MM,W+.$,GFN%I:#>C'`^L,0CT;4#^"7Y0`J,@@[KV4;&*=7D?_-07E`J)8`,8 MD(P,>+`!E33$`T]H0E0 MQ)D\,$6XU*L3'A%&86*HC("!S4K+$XC(J'2&5K33+:I1?M@`#RBA`QG4T".6B,ZR6L8#52#%%+/14N1U[93 MK(WIX!#^K6F2>0XQO$ARI@:7S)@]J#*JO-G#"X@K"D4J8IJ#U2"B3SK`+:HI M(*HDXC0QM,THGV`>MY$F>R@2XN+@=ZA*SHL'YNME$YT(S"=.!)?&_*DQ@R93 M6,"A$Z;0JB6\T(D3 MG4P57D`G*VZ!!65,-1-/2$1T$J$,.)Q$`%'G@ M;0(1@9=LL0-34(VAW1$&=C)@QB?$8PXM2!(:0@2.3[,$4`3P83ZH"2B^T0+UU M^=%L,E`)!8"M*.L!0#Q2(\=,4,TC#KD*1+SDRB=4HA*EW(QHD4*/B1PB8%Z8 MB"T\H(\S4BM9*=2',YR1";`]Z75/F,-2#E21[%*G1R5,VIJ^I\"H3.]!N M5X#;H.\-;;CB0JYQ0R8!"KU+)T!DP!=ZT=E8=K/(`7J.:I5RCD2B55@$*\()>[<(#9UCP9!8N:58L M$8\GE/,C-NHK/6(='BHEHA(':.2`>-!7#]`C;\:K1'F*TH(3X5H'K,!")9YP MLJV,NA+-8;.`VLCK6/>:8*PXP`'B$>A$%'N6Z"IBS8[(,V'8P7P.H(8>0($. M*S/WB2!^@@(@=``X6+"2ML@$%F3)G$K,1[`'LLBP]M8.=K+V6B-*UO?""(-[E$+F:G$>4<0?.4EJ!:Q8@EPN:*VAO M!ND$.X2R0V6/^+;(Y_9>NI^0/L!#QC#I!/MP7J[%+2:'#\DDXH$=BJL#!\B` M&J``A2O>4.5V)T8O8G.G2MQS$V"!X,M%&5YO.F(+^O1Q#I,VD"T^K>V9&*0:+,!CPJR?<`>Q`"Q6A$#FRCU"'CPP' MVLZ"'ZBM*%]38@]N@YP,+N2>(KR0`P4F,-&*)[*[&JZX,UW^I'4+?5331`"X M#W9"R"(>J"U+$^'4')YSK'R;/2ZVN(,"3!VPD`I;&(LSM$!?T9"K`8"/S8O7 MQ,EO-`6I*,=(&4H6]=](5`0W6<(.;*`.)%@0X`:PZ$Z]Z,@<@$`YS8;`L<*Q M!,%(`RM-[O;08/P(P5P83Q`=7(Q!3V"1<&&@@CV($U4(,# M+"'XA1\;S!TPF1_ZU847L)_HO8`^#(MJ]%-%*`QM',PJQ8FQ`4#?%:%;U$N/ MZ%,$;8>I,)C/$9QJ^`VY%%SS;(4]!!23F*%08%'F3*%=N,;+',(=-]U$L&Z`,A>H`IL,H=M(#^:2S$1?10)S@#/'G!':A'?X4>$.Y5*%I? MG?F'MC29'@X(]RTA$V("*$1`(9`?[A9+6Z1E'F?##3A M#K!;%)Y?/N9B2-C#"]23+F8A0U2"''VAX&&0:60"&O7)CT10WJA:P+D3#_)9 M'%ZCGTCC!MTA`SZ!*IA"RW1'-BH3^PA>M(S$\\$C3%*./.K),8!"D[E%#/%` M"RB"(J3^RI<)"-J5V]K)0+IA0DZQFQ_8P4O*!4%&%P%ARHX@SY,C4=:RR'$PPN$A/#1SB8U MA%F*"UI21<#0PPY,B8[(F>=9G%S6)7`&)TSA98/(RQX:XL0AG26H@C[@AC\9 M$)=!3>L4T$_^I$=`&2^=@ATT$112PC-MXUQI&3- M@*=P-JB#ZI@0ZHD8,([V"<2!'EGP(1+4S$8B'$(+0-8=4(\JS*<'S`$]V$-' M6`(<``6]#80E!$'"'9)QI=WYB,YRD=\3+65X>I)0'$P&M49>J`*-B42]M&9_JL9_TF:`LL6/X%R,J,U$YFF=ONF8UD`IZ@<]HHOV MI5@&U4`D%<43W((I4-H+J`Q,(`?^6YA";SP)'(@A*ZS>![*&2-C43<4=4BJ! M->@H4_+H:ED".B7+G$6!0%G3 M,\[+E::$/8@``$3!P=!.9B5(;V9.+Q37C#XKM$:KM$XKM5:KM5XKMF:KMFXK MMW:KMWXKN(:KN(;K#A!1GM2C[^Q&G.2GQ&2"/4"'*N`(#U2B#C""%]S(I:)1 M4?"`P,&.=7Y$$M%H+U79$UD#@]X3<2Q$44#B2090);Q,S.03F?#&JUK"+:"' MQB!C@23>"RR8IV7`R1Q`)2RL`HA,:J3,OVI*C>0+!?[('.C#20U:A5X17-9, M!,Q"-GS^@,[N+,_VK,_^+-`&K=`.+=$6K=$>+=(FK=(N+=,VK=,^+=0JK0A$ M`+J<8MD%A3VT)04N!VR"30UX4VK(A!>P!J5V`G1T*(_L4R3>5E19(YM+$BU$T2(B2V, M2I`P)$C;NO2[NWN+N_6KNOFKN[R;NSZ[NX"[^^J[O$F+_+V M;NH:;^_.KO,6;_#B+N]&[_).[_4&K_'F;NL.K^[*@/=>K_7^0B_W*F_UDBYQ MAL7,ZD#K@0"*+80B9((I@$U%>)-OR,0MX)!`9$`GW$1*U(!%Y)9)3-:Z"(,K MH(\K,.8T30X/A%I>[*"EP$1PW`;8M`#OI:R%%,`*F2`O!B(`' MB$`E03`$CPL*6X+)LD('C]2R9@Z5(!(-U[`-9Y0-Y[`.[S`/]W`.X[#R^7`0 M"S$1%[$1'S$2)[$2+_$29Y03$S$0,_$1\P`FI*]_Z"62V,L<.-N\)1O@[J\J MH.@=9B);/(DSO$#,*(("P`%;E)A)QJA(F"EA>J->#$L:V0B?M>1;"!Y3@$L` M#5-!\MF\4(K_0$L?4US-JN2#+C+^(P&J)52$\]#QI0P$OW:I M;2A@J*0PA-1PGY!)>=IE(]]%Q<%/49TR*[?RG*"O6@0JMZPO)/'9E%1?7V0` MVO)`5U(:7_2RJ(FJ*POGE]K9,!\S,L?%73:(U4:RP["")@;'1'CC1(AP)L<9 M-O/R5*#0R5')R4WS5"2S.#]P(B_H;XXS.H?B$%GQ?YPSE'Y9DXBP-4\%(UBS M7FDS-4]$J('S.L89':W%(=R' MFX%$ZGG^W9JM-$[C14D#ZKFB=$[_="BV]*&\]`,_`=@,W>XP0G/80SP4GR!_ MQ!U$W?019@;*1?!1E_!19`8*G_"E-'9M"2RGQ4G/LE<#M5DCR)R%-8.`-*$< M@A%`@)AF0WAU1$6LAV@FA'(4G(?J,@/T%SH!Q;#4]5E_=JX-M#$KLUL_P@SHP"`\ MPB,8P8,0Q"VX8`8$`20J`(PAQ!,\014J`/VQ'&?);R3",8(0!/\JP$9&3"*< M((-U3$5*A)4<]QQXF@+,`7`/R,.R)XHRQ,9XVAP\=SK@A"W^M,!G.&?ES4&$ M32DX"+6>$/6Z`((Q&$,1#`($%($QQ,%N'UW$+W,&76ZR0]$AILE$; M!='O9$+LJ49Y@\O)]$O)&0X(W`+^6\1?,^+'C=])3Y,UCTRB#+LL2A$N++1"N;2B"0=F#,CR!&'H-BIS,?&G) MH/R(592 MXT`D3K+8@U7J]K5!E)=Y\%#4@`=D@B^'A-A.S8QAZ7&DPPX8R03!%ARP^-F- M*,.X#%`I,-IFH)K540+(`46'!EV_ZT.5+ZJ&"G=/XT:]U"$B4PL/0GS`)+^A]`/ MGAU`'#H`(-TA'0P$`@"AS)8'`)EL"=,QD6)%BQ)9KTIM:G4GCJ5UK39%"E&H&&GCL5:-B-2LC%K"-.#"F7= MDS(DMH5IY-&,-C/Z\A@$N$WA1X-VM-!G*Y&7#+?29YMZ=8KVG@#0=_%0!F>'>!Q2`$"1O?"9`%BR9YU] M>XH(!Z:+Z').Z@/C0?1V3WVCW;K\CO'/KOGV*]#``Q%,4,$%&6S0P0<+Y$$9 MN@2L$*_J9)C!F`TY'`00#CD$Y!!6].'!&2]:,,44?52I)`,%7N#ACDK@V`Q% MT#(P!80,#O!"$54R222]*+SSPI866A!-%5;68]`6'FXQQ3F-;,FDDQUX>&&W M'5@QQ9D#G-$'@`/BT6B'2E39P3<(;U-FO/*,LJ032PY*B)4G#T&-!S8C3*B@ MZ8[T0`?^W>"$4!@**PP)P$1/(I#/1R&-5-))*:W40`8F9-2_"ZFK(1M$'@GU MD6QTX`$P41&Q8\1;>!A(3E4Z">*`("IY09G'GM`'!'WF.$V!RQ2()S7'G!D3 MB]&\.""#1!3@#(M#IC,P+V%LZ22#*2>R11$`@K#%'D5N68R5'%6\!0!3*B'0 MEM%JL_2Y8BUY21B!,M&O(0#B>=*6%UYHU]V,PHL/6XD.L00`!1QUL#]-/\(% M%X9#2OC?B2FNV.*+)V5@+HA1DJ$Z86J`0)I'$$%D!HEJ&(1D4*6QXTA5>/!` M%4L42(05!3)YXHDY&LH$CCE.S$2!%FC.Y``=*E&@$A`L407^N&Z5K<02.%1C M9,%#;&%@7GT.L+FZ2P1:BKRH M!#P=;NEZ38SA`R`1?W40!J'7(#V4X\5%DACCQR&/7/+)#]J8\9`XK>X#1+*Q MYA![0+?GD'(V-\*@YNQ!'6M;=M@!ZT-J.,1U95KH1!&&6)>]N=:Q;EUUWUW' M%D$0/)`].(IXR""3-3MYX6R^]69`:QYJZ`2`/2<2YLPYU*S4EGC@T`&\%_+- MRY[:L9_HD#!M42;,R26,;P=`;8&1^D<5OUQ_QRGOW___`9@@C2%*?QWQF'5D MY`%6+)"!#;Q#`Q?X0`A*D($4O,/^!1T8P0IJ,(.L^!N"M)0)+%2">L*P!RL` M``!GU,82IIC#$Q0PAXO8(@,ELL@+[D`X2:T/`+$*%H'F!8=ZI4\'MAAA(E31 M@B9!3ABL4(47YJ`(BEB"%5C`0EH4QI'%'0,-^XM6`,$81C&.L526*V!'JO!% MV_"`!Y9PHR78R(@WLO&-EF`$'=W(@SO6$8]Y;.,<^2C'/#)"D'9D8X,4X0$1 MZ%!&*V1`#:#C`4OH<"(,(.)!6#$Q6UA"@47\(M$PHBUZZ,`>:KP8''D0"CI- MI`6L"$_A$J=%CBWJ<@XP)1EQF4M=NHL'9CSC`:O#`T5DDB*MY,%ZS".HEMC# M$D^8)"G^>;#`VJPG'7?*%I)J4P,&.!.9<$2F()$934M\$$&I6V)%G%D16]@B M+M8YI[O6F9%W:B1U9(0D+".U,(XY3'^V=(\,:N"Q6^Z2H`4U:"5]6<`T5H>9 M'F@!\NCAT)?P()T,^)8']@0R5MQAE!.QA#,$11%%/.%O&"W<"5L0EQHP<(I/ M2,0E'V2)=*C'(@/-B$T/FM/VY.^,'/.G=6I0A5.T0P2S2`$^=9I4I0:PEP0L M8.:H(X)5>O2A%DD?3*M:$2+6X)`3(2(//MB"O_D&I@]"V5+1ZBY]]I1AE+1- M%3#@`[GZX`WG2`%.TYI7O28NH?J#ZFW(,D_;"-9`9-GK80W^RE.('>-AE^,? M1H3A`$HTHA$^*`0EY!H.MR*6LYT58%\O!TS/CI:T%E,LPVC)N,=>1`9LF.L; M4N``5\@5'%6X:VEO@U"X$`^B6UD1Q->@!B&F7M;)BGAD=43.4(2_J$71 M1#S3>SQ(Q!..>1$1(*D%Z8..,^AAWDEM,JO-8<54K^D,:UK$$D3K<`U:+&*] MN)>M!*;OC7'\,5G>%[^Z3=EE+/UK1T>*TID&=O4]G>EJ;;O2D#7T11Y<:J9I>=:>1^NA44]K5 MHY;TK1%]ZTB76M:;AC4^+RWJ8`-[UJ]F]:H-[6M.6SK4A<,$X_CI6+P*(P7M MJ*P/V%`4`(M`NCXP\G?[U\P>&K9P#;E%(G:P'FIY@%58NH4U>>`%9RAC!]E1 MXJ1X@(7^!Z=C.'L>E&2,AJ=:[:`Y^E"`O[V7))Y$4SAWDHBV;M&"'>C`"[1Y M>"4`7HDF':(2WR$G=0A=P`@X0`9G.T0*4([RDZ=@Y2Q7>;_.0]M[G/9]YSD^]\YRLWNLQG_G*AYYSG20\ZTE^N/N=5O'G6?*]WE7R^[TZE^]*ECW>M;_WG2Q9YVII-]Z"B7`7`9 ME=K%Y=&7!>>&"5 M-5O08][*"*]7.W'O]H3\E/G_K5M_[UL9]] M[6^?^]WW?O;9$($M!DC:U'%`7*?;/:O*(!QS9<-?=9GXMNQ+'V=K%S/%%A[9 M6^(0NE$/M4S!"]R%`:K%XPY"3%[`&9H$.DYO;.)!Q!.#KA:"J"`79@,O2#/8CO0!W]P!FDP"(5P"(5P!VWP"'6P!Y,P")%0"7DP"GO0"(LP M!XNP"J^0"F40![$0![3D`G#,`;14`RO M<`S?D`OAY>,@Y1!4Y`3K MY`)U#X6>)3R$)!X*QC12*`,L@H=0[&-`:W%&3@:$<1B)L1B-\1B1,1EM(1F9 ML1F=\1FA,1JE<1JIL1JM\1JQ,1N;<1FK$>_T$"7X;B7.H=LPX"9L81#>@`V* M"+.F*_`*2A$KT!9T`SCF8#C$IUCL)F`$1QFB8#>4072TI!```YL`5YZ4>[R03'[!K,A$BH86=QJ4!UX0!!T<5 MF2Q3V&JA7*VF:`W72(W63$W45A+1E@W2(JW5)&W8S+77A+9?I(F9;+9;+(H9?+50*W2DBTJ@:W2/`TFL?(JAU(IM5+8#.W9 M%B?:5`NO:L"U_@XF1""NL"TNJN`-Y(H-;F#S)H+U*"7Q#*L&EH/_E`$$QD09 M!B(?$V)P>$`X;*98.L%2+"$>,@``,F")>&!>XJT32K%8\,P#&K-\O&=;\F.L M#@$C\41(.-(6/!*LBFA=6.4Y6J`!A2L%0RO'8#,V;<.^-$7^[S@F',]RKLJ1 M(E+`%2B+$NX*=&R!#4+!`23@'PQ$`LK*4O`R(Q+//'3`8$SA(2$P]6:O-G@` M!#+!&83DX.BR0)JC,5?,JWBHA+XG$RHA(:_'4J@E.WC#,V&1`%&(-V@1`"S. MJ\#F.A].!!["%:E#0KQQ<6Q,-@DTQV@S[\BO+`%K'"OK#RE"!N#2!\RAB(+A M$R2@)69!%\C!'F:A*8OM/>S!$'1!$DJI8N#1(NRA$_1!7L)E1%1(X%:/8-IG M/(2/4C(Q.SQ`A[[%ALJM?5:S(K\3/!WB/35"//03QAJ0`Z_3JO2A4&R!/^O% M)`'F%P4T2">&)0(*H`IT2PUEQQC^ABSW3K?@2KHPX*=F0;K"009"=`_V8`5` MQQ#V(`L^9R*"AY1JPSG2#2$F3@\\P0'&RR[YY$3%IU3ZCP(IXA;JA6\VL#LH M$WF^!0">Q4K=@UKH(3V6:3W"PP,2M9+"(P"7$U*.!%)=T0*7M(@B+SP40`"S MY?)$P!34:36C!P6IE&,&U'^X:A!PU0Y.P1JTE$M]-4&.ZQO!L3K&U``F,E\.`02,I(AN82%751\@HE+8 M"&MB[UK^)()H?$VP8^]*'#T/-N:L`4#L`>T(1PQ@4+!&U!YJ58 M*N'-,B'*\N3TG$$!:$.KX,`4)DE2]V->K,11I*X$`7$<(OZ7&% MIJ4\)_5D&29E*8<'=/442'<#8%8)_$`)-N!=:[9U:RI`!>3^&$#!BZBC-^?* M%1Q@%N)*'84A0V.A"KQA"AR@"KY5&:I`%U8`3L>!"FS!$#;A"W0A%F[@>-OT M!C)T!71`%Z9@#S!`S`.`VWA"2HA?`FG5>`@$99(!)[`P;HL M4BS!12HA$6"B?C,`"UH`B#S@PD!'<<&3%5+S/3S@2Q)!BBK"&>`@ZAEG23^QELHR5M*ED]X[B9D)T]1-&_QI__@`$NN M@XHMPEN$YV,3AIE>0"#_\X(9)8,A9X,[F'0I`81AU@\V8(0?I9[:8IX(>6)` M1ZEL"A3QQTLU!4QO$ZC8`/V6]1QDX)C&H4TE0`(RV1`R66JG0'CQ``\,8@KP MH`HV80]F`8DEX1.F0!EB01>J8!RJ0`#V`#G52GJFPQ(2>(FD5-9T[5_`2FL6 M490)0NR+;ZJ:+42`^62#=54'J($:0`$3 M3D$)^AB$_0"V:#K/Y@01Y^`S,B!')8WC"G@B5&$.,`,.S%A!M$5+'B)>ZBQ, M]$$?3&&7G2$!*QAC/JH3[`9%=<"*)`F@3UB@.V*%'Q2@HL4!)HXB',`6Y-H6 MJB`BLH`8UF`6LN`&9,`X_X%U[F$6[('@7,>$9F&=:+J<4-I[':2-W+H"95I` M5-)_!H%T!X'D'``40*$;?MJ/E:!!/BJ%EC-/,J%U)K!02&G^6PJX_[R@!I0A M;`:GL?4B2X!&.-JF(@+0"_(F:S`)`O!^[9K]3+M8: M@VW[03C8`1P@IS'AOEM!M%'7&AID!X3C?MH8A7(T/%P#N"?B`#JA@"SU+Y1;.+%0[6T'U(LE50EI`6A)60!)H?!PD M(,=7@)-UW!`D(0MV/!3(@9:#/-*9K++]8V@_I@(G91#L8!!RNK[O&Q-:X653 M]X^AO$'VA^ M0Y__)7#*FEI0"`1TP)7J?*?NG*T_@N^2?`?T8-J7?2(T0`.J(!1LO`JHUA8V M>19FP6G!?1;^X1^F5M+1?1$IW2Z*O-P^IXV*:$XC970W.["G'13>8-3]V$%. M'::R_/3^E`%3+C!U#L`2$SQ]A`$]T(5BM$>F;B.S29>^J>&^"T&_@]KP$*3?V\)Z[B":K(?_6`$$:B/6*ZE@ MQ.1O*88!]$&IKV,''E`5]`,AA`3CD=E/[L8>M"3$`C=?V"2@!022(>:G7G[N M`VC(JU0OF$D!9L-JS.,1.T$!L%ITS.EML@5;"!EK?".++X('3D&;LQE7PQF$ MJ^$4VMTZ^CTOF^8%.F[<=`#9=R!MFH,`:T<19*\3A-U0=D#^`5)1TGA@!Y[H M/8#=S;/>[-R>5FU#3CJ!!"UBMJ/DF-Z, M%0Z81E8I?K%GI?+%$B!1\CS@">9I$#;`%;S_^T/[=`%YYME#Z>%'D<4@#`V8X[`((HLM0B@REA MMCP47'K(E+-##"IY2;2#E:D[#9O^GGH+]Q0E)73I^GE38^=$6R\`,%7)0(>] MA3IJM#@`!\X!+P!`*/4*QY8.'EZ\!-;+4J`'!9(%4Q28+A-9'0*=11V-.:=3 M@ND.Z1!V*(,7B0QN94"=6EB@H+Q[`ST84QC1U*\Q$C^./+GRY<69X^2QXZ=O MWC*&3S2*5.I?B4ZAHE5TR\,.'3L2W;)$/DHG'LI`J.I\Z$FG#)48=;9HSU*6[`7*VF.*71/98PD-;"2DSQWGV('3(#H!4)_HH MN!QL+;<2P(1],0APACU!`"*2/90(L`1 MI]MT1D[^%P$U-*B*7OQ4(DIF:RH4@W6 MB*#?*?XI0J`Q0N6W,=`J8,5J(,MF7CA%"NW M"&D=PFFMF6"8P0L>L%*),T/>"``<2]4(DT!(13&DJJ;4<-2MR16))D>X MX!)M1[T8@6VVVF[+;;?>?@MNN.*.2VZYYIZ+;KKJKLMNN^ZB*T*U)JF9J"4* M=')`"SP@J(@SIL"1J88&K79IBH9YV,)]F[5P2":=L))7HCS^B##(?CS(D&)" MC&RG6CJJJ.*,"`FU8,H+!QQBB0?.'"!8K#54H@K'6"APP!SQW,>B94@[TO,F#/9B@F9$L&2EWF026'3UU)U"S5L"23S3E$XTZ'N#:1,HK@N:\. MI%]DR^H)N3:JT_O?7/>Z\]]M1/'SWSXTL/OOCHE]\^ M^.=G+__WX8^O?O[WJ[^\]]_W#T#]S<]ZVML>^;A'0`*:SWT`])_[NE<__D$P M?N:+X/L2F,#1R0`49>#;1^BU.=[98X2MJXCK:K`Z555B!Z'#&>^"4Z,=4401 MZ1A.K#Z#PX3<<#D,V%&I0J=#P/AN)C<$XK.R5BU<8,*#?A..$Y\(181$<8I4 MK"(47V/%+&IQBUS$(A>CZ$7AA%&,7RRC&:6XQ3%F48UG)&,;W]A%Z!3/@R!D MR0ZODT,=*"`##2D54W@0F)0`$HM!3,AE+I,2*1IRD:3YW$Y2-L1(2G*2.\F( M!STX)$K^:G*3G.RD)V_2DSGRK8[(X8'F)C-('OSQCZA4)2HG$QA7,F"0C&CD M+#46F%@2IW>?[*4OGR7*2QH));\LIC&/B4SB\,`GPN0(*05$FT/&DBFQ_.$K M4TG-5-J2*<(89"SOF,QPBC.&2(S6,7J!27#:49WC;*<[WXF34#9S(S*`ISWO MB<](0JM:Q^,;,7F2D"I4X97Y+*A!"\H`90137O4\J$,?"M&76%)>T_+@/VVD M`U`H`PRD8$(*,`$*CD5TI"35I#"8.<^&EG2E++WG/N=YI$RV1!@:)44'8F"& M!@AA&(H`13=;"M2@'H<]"ZV6WX2*U*1Z\J4PGM=^QI8SAWVKHJM*UWYJM>^2E8BA(UL6P7[6,A6 M!+,4T6M=_YI7Q2).M(MM+%Z+RIMC4,N?['P-*$@1@`O$X`18S:I.&]`'3'0C MK+SM+6U0*LQ5\*`Z MH.A:/[LF4Y6\=JH7^$-M*=``G0I!"+FUA1%]"]^6GA2U1HK`+&:`W_SFMPTS M:(,:](M?_P*8O_HE<'\#G-__`GC^P0AN,(,?#&`%)]C!$#YP@2V\WP>KP<#[ M]:^$*I!J`#P_!"5M&KW@*@H`##H$9\GRS4L3;3`9T;DY6OC.4L:WG+7.ZR ME[M4`_HV%23AQ8@#E-&!"\36O$=.,@K>C()D=..]4*[S09M/4Z? M<_)GB03:H8.&H:%Q(HPECME(9:;(#M(\50*=DM46F6@25PO>._:$%%,=`*$3^]C@$"A\TD0@=`D2,J]TX4=A.9*LN>\$;]D[P#-,]KV2$W.ZVM[\- M[G"+>]RL+G<,\UR2[\KKJ16Y`:1C&P*L-H`"Z^5UKU'`C6"KA`<.Z(SG[C/0 M*J35%@+%D$1FD>J"ISHWMF@!"$"`A809R!D9F,./)-+P.63"&3R`ZR]MP8I, M>-68]$`1#YR!A!GX6YCW[$KOF8M1?I":1KW>9X.$`'P[@WG%.@[XIT91T<$L8.B+#"A-@C M"^N8>JJJX(8LH#T+DNG!+(C@@4-(0!&*T("U(&JVD)'B+U^)T<#&-,**924D'D^%PE2E MVZ:%!4Z/^M2K?O6L;[WK6Q\*I,L^-^5<-&\:+0P'4.'=%R#`D1V`"5OL`!3) MN'O($^B<8TW=P&8!Q&?`F^Z`KXU$8MI"!>E$9E^$%+]`9#R(, M-0``6.`:+<`*9&$+EK!X=]=)]M`O#MAXGF0+]*`/W!%WO*,,:A$G*_.`H\$` M.Z`*"I!U-'%J&.@2&V@!)8B(B:B(('B"*NB(-L%41U)1?--H.K![Y!5;1:8. M-D@;[?=F[P"*/8AOH&!$7>$&/?`"D).$>9(0H2`.Q<$#&6!V#@"%MJ`,1-`) M8U&!\52`P:(,]```.4(;!R(J'J<#Z\=+FV0+<,`#!/*&G`0;AL(A8N<03[%" M$>@!3^#^%1#X&K80#Y<2>BS8&U=H$88(@JGG@:?7@>JXCNC8CA_HCJ.@>A_8 MB(]HC\%1>T>B;M7";J^Q!AWP;K9V`OT6.CS0#?'@:SW8@SQX@")60)Z&@#!(@#H%X');`&(F0"2=#$4=!#R0Y&7NX M?\K1%U(H`,`9$[$O2,%^%&$/+W`SQ72<'J`, M.T`@7,&7AP`'`."3$^&'($`6B8.DRM`C-&E6"Z&&-B*=HY24U3D*4V`"J``# M!E`/4V`!4R`+73H)X"F>(S`)LE`&8FD!YYF>Y[D"*V`"5SD**S`+)O`,*S"? MQ*(I6/"&E9Y() M1>-+W@AQS-@67,$*#_DCM:;;=&'E8"DHIH:!Y()=[`KD!2(<]5I`>1@`J6@"]5J M`5RJIFPJC^=I"%1YEA80"R9@I1U(G\K!`W#0FAUG$;9P`(;2FH%J2`US>7-H M%.GP`B*C"GSD.R!W><&8+',`A1BG"K=@*<%"H+YC%(L1-0Y#3?TG*I;P`O<' M3*7:&_T("D^G9@$0``10?D6Q`S/K@++X$&R````J[%^E0G`GA,$/#&%[P,&TQ&/I@JRZ!;2E5 MI?D*I^$Y"9,@EJ.PKIM`IE=:#_4@"R:@G?6*GO)(KEDJI_+^"*=_ZX&A4+9Z MH4J0-W*)HQ3*8`G/B1":`@?QD(#2.AFO0H6-`9TULG=/D(!/L!>Y@BBI\@0* MD"KTT)HM4+A,\Q"`*('!XAK"\"H1<@!DFW0]QC64&"MHAHD!,`:]ZP#O!1TI ML+.B*&>ADUD8!SDUH"!Y(1F2$3%16DF:`J-@(7B8I8=6(_.<0A]\88-T2&B`2&5P(P]:GC' M2:1Y$AO<6B,@EPD_(I$2<0AS8)/^DR%V#NE>RH`4D[-)G@H`SJ(A07`AIH$> MTML:R$&JTS&8:!)>56!3F-B[O:L'5-A#8J0#W8`/PWM\?>!3E(6:,C"$5:`( M51`*'E`%#M!\(M!\BB`R58!P\8!P.B`!$O!U-YLG(')H,8!Y`)+W),`^(7J3M)TKN3T"H"'H>^)_,7-?`08OBS^R9Z9-42 M2KG`_+L"H0`#\E@*)C`*W^FN6#H"HS`")I#):VK`'4@+!F`"_.NE@=O`5_JO M,BG!+F$*#,B&EY<)Z.$42'%_3H'"M,E_@@<1!A&!BA"&$HF@KX&^-T.L.6$I M=^#"YZ'^.AD`PJO;OGKA:M$RB;&&JD(@"W5:RO0Z"L\@"Q;P!:O\I0LLN+`LR#K! M%ZBB$LN8"$=8&(%3"9;">*I#$$+BRQW%".* M]P1,?8P14;G^321Q+=<<(5-U35XS6\1[K>!]T`>@Z)B#[6N%#5C,4H6ITA"= M@3NX\U96B#LA#*"0(R%PA2'=EMW^E#1"X70((#.-D).,.,/(#VV^+9%0*1T4 MO:V!5FH!M#">"CP)XWD)'JC<[.FNI@R55ZK*Y9J.KIRG(2S!MJI*!-'6=1G! MM+LG$KTRG,)G.Z*)W@"L[G#/Z83HP"E4"**P%.2JP25SU3K8;H2%<))ST3 M]@`'PAE/]VM4*YV.WIFNEPX#I>R!F[#IFT"/F;R4FRZ/0`X#;PODFBT@L\P2 MRN"L.,,CM_`7#1??5*$`UZRY^A"1+3##>6*QMQX8!Y(!F++H-J$LRN`!K>D! M*^(A;S[^P\E<20+.&S\<4[$2LS2;UWR^X'T@V(,MBCV0V_<(937``"=2$QX0 MJJH1RAE.G(CO#^RO*(>O`X[_&>CB:HZL>QW==!(X'4?QW\&D/)"B^P MX1(+Q^Z]2D"K'-M!4+C$+"P1G0.ATK$6@HACQ,XQVQ M=.!E$3L@9."L[=ON[3R;#"$E[K)W\:,:XR]QMNR>MHNH\SNO[\32[R;X-[^9LF`"?'^&_-YCZN4'BW@ M:J/]*H+JZ)6"[Y7T/H_L6/@E^,#,L0-]D2H.40E!(!@T!#P9`(%[YRN'P`H* MP#&`XP7#JJ<.9PGC40D#8['BH0RS"SE[Y`R*`0*DZTEH6`D2^1"=QQ=8\'V9 MT^@YPU@?]>K6+P"H/H+[GAH\((=)P109HGA+;1JF4#/,N?J+ES1( M.QF6\`29((Q,8[%TH@IX`A`Z=`@[E.A%O'096MBS5PG`0XAP#C$06-'B18P9 M-6Z\*,S6$WW.6"E04$.@O189GCC^R\2#XTN8`U')HEG3YDV<-''ARMG3IRP' MPC0*$Z9'68``8V(L[=/GW5.H[VK52I:+`:@=+F-NY=K5ZU>P8<6.)5O6[%F, M#/3,_-FVIXR8]FA9&%77[ET+*T;0DK#"`+EZ7V2Q6?%L12Q#*Q0G7B%ADP1# MY":-F$+W[MTIH="^Y*&H10M%EBJR6FE+!RMG3RR9MDA/I#V3`BW18Z7#EM#- M<2TE>L*#M4"/N^,)LR>PA0A+R9/G-FN+QY-$BG[KL/?<0W'F%H4%S9T2(4@\2QJQ>QN\C&_H09D,";CN&) MR9[&>XDH@:JHPA8KK[3QROMTH&A(,,,4TE'$2/+*%'10'+=#\]#NI.2**&$8:/110B.5=%)*+^#,\U-00\W31#YY`+125%-%RU!,6\5)455CE7566F'B82U7-*TB((Y9X8HHK%C)AC#/>*F!$60`O5QEX8&!DDD46 MF8&3>3#9Y$95YJ'ED5,F61B344YYY9EK1GEGE4NVF6>8:W;Y99)+[EEGFT_^ M66:<>7:49:.!=IGGGAMU-&:LH2Z99J6W;OGFGVDV^NB??>YYZ9V+UIELGYT6 M66RUN79[;;:+?CIIN-$>FV1&=F`X6XEF<<8;=_QQR".7 M?'+**[?\>_?]=^"#%WYXXHLW/GC7;2)W=>:;K]3TY*.7?GKJJ[?^>NRS MUUYZ'5YF]/M'P6?44?''+Y\H\L\W7_WS1T9??/+C+S_]^=_G9 MUS]]_=E/@.Q['P#AUS[^Q0]_5WM4``FXO_`]$($2C"`/,.&J8WQL>QOD8`<] M^$$0AK!Z.W``"1UP0A2F4(4GW$$+5_C"%9H0AC.D(0IE6$,UX1SSF48][Y&,?_?A' M0`92D(,D9"&9Y"1#)E*1BV1D(QWYR)]($9*3I&0E+7E)3'X0D9GD9"<]^4E0 MAE*4HR1E*>-(1E2F4I6K9&4K7?E*6+K2E+-DXS$DD`54YTIE.=ZV1G.]WY3GC&4Y[SI&<][7E/?.:3%2/(9C^IN$TJ6"$! M`R5H00UZ4(0F5*$+96A#'?I0B$94HA.E:$4M>E&,9E2C&^7^:$H+7PQ5J$$%ZD"7:E2)6@&I2FUJ`IYJU:JFE*8VY2KV<`I5L(95K`:5 M`CLR@0.!6N$.F8@"%1:JUDPPH:AC9:@VHI").Z05!U$@`!"LNM>^#O0.?*4K M49F@`':`0:!`($`4T#I0>D0AKU:@0F-_,5>/;K6KFYW>5PO[6="VU`H*`$`F M!*J-.0#@`+YP*F9]@0,`X("U!]V;40)D`@!,>"T!`!"%V>)`K@G0AC820`4@P!8'V@"P50-L MX`RPPZ^%I8(OP```>O@BM;ZX`P">>PL*`X`*+\B$+^R[8/<"01L>!H`V'OP+ M7P``!"EFAR\R\`(J``#%INBP2L^+1O5Z,@(YMB(JSM$.*$Z1O>\EML,4O$!1P!^_Z@@E>N.LB-L5B&<)PC MR![<,0C^=SR+<\B"QU.,P#D&P`5)KT*;Q0BHD3W]Z81&(0'ZT`<.I/!G_$JA M$T`PQ0M\H0T`!($*5(#M+P@04"N\0`%7SBN@0>L+$.`W`2_P0H;OD(%;J!4` M=Z""*0AP@%OXM\A`R$!V[9OG##RXSR6FQPON\(+EVEBD6%Q%!`S`A0$HVHKJ M/<3IA%&31]Q2N!&CL)N`:``*S#YIS@@ MP`N("P1`O_;@O[WN'.[P"RK`6MB%33A^IZL`-X-A#LFNL&P30.T6TYD`LM5& MK:UPBSE8`0`MSH0^K*H-,S]6J^.VXBK*,(MYIWO2(#0`*MC^$'0G0&+HV%O% MO%_QB@&\0MV4MC347R$"?`.>-<_:X6"0_R[3"YN!HBK\:3"5@HUGZX7 M.KQ8`'R7X]2.0MTS[`MZN-G#7G`J/3(`8O=2.`,$`$&>([SL0'?X!2E'[0&X MKE%#3[$,;+"ZT*DX>7H_?0`+6+KU(C"+J#\=ZA7HQ:*SIV_-#V`&.S9`%0/N M==@7E@ESD&L4P*`,`L`<]\O.@!>``(9;@."G=[C%+V"[X@K/@0"*=;@4/IO: MA\B=KR!X[/31*H7&3I?(MO7M0[B,`Q`T5J!4"#\(1+S7O+(T\A\TP([1'7K+ MBW#R5A?]`-R]O7B+OOY.*+T(?1S^>LUS`CW(.B';NM@[P,\"@EDC*`)30/_" M`0##`?Y20.?R)FWX/:NZK4X+,&FC*P#SIJ`"`^W+0.T3LKOW/HO`U"A5ZH``!\N@I@`1VD'E18@!^$.OX;PM.K M.OT;@`JXMW\R0`2DMPUX-Q!Z/2HL1$,\ M1$1\*37$OPC8@,S[0SC\H#*P03U\A?O;()^3!CVL-Q9`A=;K(#]T0ZA;`#XL M*2E,1%3^3$557$6)6L3L0855T$11U+Q(7,-S:,,_G`%_`T5(H+\F?`4H!$4F MG$4G/`<[O*E39$5E7$9F3$17O)XRN,5*I$4EK)[YVT32^R"?T9K'(1'G,4W-,?D:3]4:(=X;,)[^T1&,T)Y MO#19,+WD"45YA#II6`5/1,9.8T>&;$B8.L%$S*J%%A$B'C$F9E"C_`@._`@*8/$#_ M6D#`2RB*3)Z?FT.,C#_LB0`VG,9Z2TD/,@#,8TG5PP5PG)[^E63)5QB$J*P> MDYI)K=S*B6JYZ0H_*=LO5.3`W5HQ,)""Q_M)<2F#0?!%C)S'["D#/=!$I'P% MI:.B;13'T1L$6;A*UYG*H>2"'?NWZR%$KCQ,Q+2J.U`L#_LN*Z`'%CQ$M?(K M7_B%%5,KM%0HM6R5]I.%]WO+)JQ%ZL&W=G#+DKPWPA2AHIL!O=PWOBP#C822 M:2*@S, MR?=LJ*HB-!65*:"2JI>R+7:`0>!,N-6Z*"M\J/;T*1S(TL4-@%6`!!&8`2?0TBT=2E($R7-BK#F``WK@+;%< M48IZS$PX`,6B`C@0-=I:JT$5J[52@"@X@"CHP):JU`10A@,X`&50J\NRJ!LP MJT2-`GK^L%2G,B@8(-LJ%,E94E=;*,R8,TEI3$^RU[K5<8A;@.^[.8LU=\95B!C=>"M2HI>*P%##.,L@)V M``!32``/R\RF\H6)92X`T(U8WBE;^I=U5A,!@;0BS--=8K3:JTU>S3O( MA%1/$^4X;;@%FZ,M;<`KY:LS+XBO%V`S?\4!+Z#46Y`M2@6!C06"3L@$^[H# M('B!3H!9X6-'VS+<.Z"O5"4^V5+^NU_P`B:X`R_HIDSXA6H;W(N-L3W#@5LH M.+![MA4[`"_X!668`^(DO!4C@.R%L]WR@LKR`A%\,KPR0_@4M8S]!>/#NP.( M+X-C!YU+`"^(L_R-`G:X!3#P,!#(A`ZC`KQZ,NWR`K_+```V!7Y5``!.81F, M*)IMBZ+S3.-5WB9,XI)$3Z5D(YME8B6>XC^L@)-T7CX]T1B;7H(BL0Q3M@#3 ML"0#L+AS,>+*`'JH,,5R.U_P`@7`.PUK688,-`"X+8[U.XA;+=AB@BN3@BMC M@BC0!T9P8^9RJ<(U!=*2NP<;+`L3NP1@MF6+`@!(@"0#`]@"@B3#9`NK,&@P M!7]E*;#^ZR]B`P$F2(`#KC`F@#@4(UU__3/U73:9P[@(BX)BBP(,LZ\$H(=) MUN4$L&5&T(<:NZ@B_HF@E&(J/N9Z@X3LE",>S-5C?N8EK4IT)1"NI:M.B+:" MDC`O`.,*`X)NKK!9@S!MYE?"JV,K:%=?@#G6[`#N`.UO0'$8^7XC*T36^2D"K0XPV63GF3[JEY]T.>,&N:>8$O3A&:9 M=DIID+0G?J,=PT=CGFF[Z)E[.M?"H9`U?J%3A@PF$M?(-`'!:`"8)XN*L@`LT['.HLPJU(`+^#? M#N/?=M8'Y3MN*NB$#'`L`<:H_-VST3INC+V%`RA5JX+7[-[N"V8X+X#`X*/E M`?/D*#!LE@*#54TK=K`V%>LK;0#^9A:4`GWHA!O(7WKPWN^RKP,P[-6^`P6( M,`8F3@VF929X[NJZZHERZ9I@2GG;:="&3B M9YVRR04\.3`8*!Q`6^?JP"/?R7!ZVPOT*YAE59920+<:J`NT*B:(V8&BM8(" ML%D+)[=Z7&F#V3D[\2:'68G&J)#BCE81T`W/;'K+!DD#I,E[SC>'9I_66C0Q M*:E"*C__[W5?_W5@#W9A'W9BY_4,&-EBWW4`>(%<3W9G?W9GS_5'I2TP M@'9KOW9H9]2$JF@0:'9L_W9PY_5D^*@-(H,MW?V9Z8X-:IPFP&!'WB"+WB#/WB$3WB%7WB&)W@:>[&& M=[BGCGB*KWB+;S4&5UR+WWB.M_A,".Z_"OB.'WF2+_A64\Z$$K227_F2Q_AU MIVRWP$-8S_>>OK1>N/`\,LJCNVR:QUI^PWF;X'-1'WJB__/^GXKTHR]ZI3=Z MAEIZIR=T37]ZJ0?T$ZSTJ9]Z0G-P5!@!9^[Y:94&8S2W1BI'-E!0K]]=:>C, M#\]B0FU[MT]'!Y>T>^3YL\]9>U/32?(W5S#[NJ?*;^SWH`?QMQ]\PB_$N*>) MH^Q[I[0WH\0DZ@PZQ:_B*W:5TBY\R[_\=H1Y`F%*%G#WNM\W?@=Z0X+-G4=U M?5^`$1A>MZA\S&]]U_^LPZ>)]HN`BU3\S`/[Q@\EV#P':>#[GJIV+>),A"!F;]S,9V!M5#]2C)*/7"%H#/]W3W7Z%G/X^]^[P>KY%?^ M=L?^:7V%!1`!GQ/^26K\#DU:YV_^A`&D=T3QK!V]6'SM48.J_YC4_^_O?X(* M?X"0)=``JE72!KQ*J'`APX8.'R8<(-%)NUD1R@C,J'$CQXX>/X(,*7(DR9(" M4959Q49:!8D((<*,J7``EP@1#)@DB:H8%2L)$MC98.J.JMK!FSZ)-JW8MV[9NW\+=JFA$3I.H M7$F4J?>ARPIA"(R)/>ZDDL#*#6QY MF+Y5FB?/C03H7''9.H35&49@X\)>>V,(6D;TSMQX'7LW[]Z^?P/_/??RQS+G M6DK6Z_+^E9-L@,N@(BY].G7#%\M@.A=N`>3(R1D.<`+)6;XU'95JQ4J9V@'SW_4S1G-9JT,08-_^A%8H($'(HC6<.5EA,H("[STW4++ M.<'%(,5<%!V#&W+884871=`+&^UP]TJ$WPT@#4$X;9A94POD<8IN]&TEV@)` M^#2C5#?=F>XIU'UAQ M\OF3GG_2*2B?A1J%:**;Z99CFXCJ*:@BN0FJJ*&-ZFCD@([^LN63+XU^:FF; MOI!**J&1)JJC@;XPFA2FEA8J*I-%L:JH%:66FFI^3G98!AO(43D("UD.UJ6Q MQS)8QBPGRC1`!>>61FJ!V+)#M`J?,MUDAV4JSP!!TGK(`(M)(8RVU M7+RF30LM,`*$;2T,R&-5BM##")%`M-`#(T0-H0B\"2@2[[LMO-D"/?BMQLJ` M"3#""CT/\]L#O/Y1(;&^]0G\KS8=`]D"#:P4_#$C]!)%!;Z,#-)3`D/0,W%1 M`0XX[[]I-76'`O1(T28.]\=HK M"XTP&],`LT2+K."#(Q8!&WU#-,`"O6BX968)W)GC*6L.`81[B`@*!#8W#I+' MN`D`@6T>V11R[9I%:<-(#R,/0<7JI25PP\@%]W!&"S]1D:_(K/QT@R(T/*%( M+#3HMD/R[&V6Y2SL-\\D^\1"QC&MDZST\H0T5+<3R1`*IKWX5 M$/3$DOP0Y./VDY'T&ED:R:H?^1/-/]'3`Q6JXRS%"W=$X1?Z(`"KZ`8"``!` M'P_[B1<0Z,`H^$(*#@3`"^[&&0!D(&V_J8\IBO8+4["#59GSPBT$E8D))FUN M``BA!P#^@+99M0D,_PM@)Z)`IP-.T!0Y`D(F3*&UX.2-0ZNP"1<0QY=S%(MP M2EQB3B)P#B."9P#ML(FQ,@.$!6"#-@#"!C;00:QQD:_*LIL>C!3^!DA=_!B8YNH,+'-O.^S5`A%H.D MT^\HI0TZ48$&+?!)'05%E02D;XXT4(1/>L#'S0BO+)SISY]$EIM(HAP?!D`0"8TZ!LKS`$`OB!``L`PA]=8P9F=V,P=V`'^C3OH`P"FV,P) M[^`+,*PPFK.R0@:\D,NYA3`!IC"%,16@CZ2![@7Z>.2NZ'(L5(C`1,I!(A,; MZE"0H.*)S:H`&P+GH&3L2->GK21250:178]4`13/?F3 M)P@UE/;[Z4\::05&M$8J3<$CP&`)A#KF,2W:\((7P$"`LO1L3[[``0!`D"@< MH.U67.LE$$+U`@`0D"A7HZ8U>V,%4P!`"O08V@\W@X,#)!!W=-JF.C<#V$R\ M$P`0A"%1]'&+&Q#@*FBC0@I]8@K^,&Q&`2Z4IW`,>JPR%,,)4)P)0Q_JVM%9HJO^"5`L9(86;`*@$]^T;SV9H*/X^()M\J0G`(9&3B80@*\( MRB4`O)`)@KH-K@%.5#!M:`5Z(!`$3+O;/`^H#P4$*CY6N$,UK<"$"N/@%T\K MK>"&*(LB^NTYH\2/3<67@$3VP'SW9:R]XZYH6DO):E' M=+=IIUXV2KSK#-\_616I1;'/$.IMB1S1K#Z4"M#!U8)8=<[^V`J:!L"`CP), M!WOLUL=:DUX@0#7OJ?.[[";U.WKDW4B(U\80;H=519A/7S:-A55N<'="?OD, M;=?ZQV19EM_!G1%MUKSO:-`#P6-U?:Z#'O;6@LUT*L#EG9"PI6@=32N`(1.A MQD$G,F"*=-X"!$3O32YG_P+?!#,OOJS MIL<<>FD%T>H0".F\.6^,;JQ5%`1"QQ9VT]O?H:?/A`M#7L427012*1/%%=HJ MZ:2M`(W]SX"@G`))98N@N$)(]53ZX$OP_`0K>%+PW(`GG5M5N$'Z1"";,0)4 M<4]N`($$ND&;!=4&*L(#\H[P],`0O)3^6`$#G!M4^0,_X$``8D-`C M$905G!`O)8`4\!P'$LW1 M?+#B*K:B5)`BB>6=?9%B*VH&6'SA+8[/5X".4=0B5GC/%X8%[N45!&7`"0!3 M)^#`I\P>$_C"+S0:I6A@:`` MD-'P',X=%F66)#AI9:/\`@B4)A"9ED/9Q`SDA22BY6P>QH])D5G6WWF(AK?% MA=4)HR+@AC'JY7">Q:W,C:W4I7&HAQQI6NI(JLE%]K/E09)!1","1MJN=(Q!9%)5MN/LTI<`%HN`5G<$$` M&L7',%7!$&=_NAY7:,,OD)]_+@J!=LI''F18HI9JI>=Z.BAFL($3U%9;OM9; MM@I[<*>!:BA;N.*&>NB'>D6"AN5@2`,;;.*#HBA'X,*0L0B/62B(PFB,RNB, M:JB(,A&%IFB..J2+T&B/^NB/`BF"V*B.$FF1MLAY!&F2*NF2,JF"D*>10FF4 M,@B/-FF56NF5*NF02NF6)IGNKIGO)IG_KIGP)JH`KJH!(J(Y4IFB)JHC9(,;#" MP3CJHT)JI$KJI%)JI5KJI6)JIFKJIG)JIWKJIX)JJ(KJJ))JJ9KJJ1Y,#ZRH MHK)JJ\H"+GA"K,KJK-)JK=KJK>)JKNKJKO)JK_KJKP)KL`KKL!)KL1KKL2)K MLBKKLC*K)PR+JT)KHJ+"M%)KM5KKM6)KMFKKMG)KMWKKMX)KN(KKN))KN9KK MN:)KNJKKNK)KN[KKM$9KO,KKO-(K)>)$BRX1OM;KOO)KO_KKOS[)8FA)KPEL M$D$'*M@$;@+LPC)LPSHLM!J.$0R"*V!(L16#*TPL&PR&B+#^`1OH03%4[,.* M[,B2;,GF:`1`@HD@Q#TH[/NQ`&14`"0,!A=L`!=DRP:\)V88`@V$8`\[45!E"SLF-E"*]YV!-#J M+9?"J],50T140"\P42\`"^"<0S',0L=:1%U`B2RX`0V0;=\J[4Y$PN46`^7F M1'1$+@W(;;_^;""4QXHB[8D2;D8@K1CP`T@4`RZL+BZL*#^LJG3`KD#4[C', M;MWB@N;:KBS@+BK40T<@+2X&])C(`;Q&V_ MXD(2&$(/N&]UT$`:_$,=&`(JK"HJ)($X`#`J_(,I',,QT`#0XH(AN($X]``J M"$(DF`#^`K!T"`(-!"\NP$$=_(,D1(+>'H/:ND'FDD0/",(_&$(D:$#C8`(J M&$(&H`(-K$,]4&]'X`(-F$0.HT(DI$$]0+`)T(`)$T8Q9(`A!*\LU$,:1`+U MHD(=U($-$\9.F`+Z5J\$&((X_,/[&L8((,<`A$++<@DJS(+@GNYEX,+Y#"']<#/X@#(4>'.*Q!/9A`(#?.(L.!"1R#"=1#$M2!*$]K M(2?Q*1]RXR`R*I\$'U,P'O<`!<,P)W.R`1.!"0B"!IB`&R#Q8`"O!F3!B=;# M/XC#)N."*?BQW=9#(.#"%LB"!-1P*Q#(:Q#'N^Q M"1AR=&0S1IBS1P#Q%J#""_.#%_CQT!:R"6B`(%2SW09R$A"Q-E>KW8I#,50S MO`[M22"R$FL$(HL#[KHQFAR.B3B!:ZG?`%0&<:2QY%IQY?+^@QLL-.IR2!K/ M[[XNLCX@\<]^;03W,>3^PRS4D2'(`A%H=`3\@P;X,1'DKR(302D?0P80@4EK MP#%L`1%$`C^4@3A0@P1$\#$003#(;0^+`S\8-1_7`2J4L%&'[3'4@P1H0`_\ M`R[\0P_\K]U*`!%H@"S<;U4;L`1,L`W7PRQ?-0`3`1%L,5+W@"P(PCI`;B=L M\>ZJL!R;@AOLK32KM2&\P"1GM4!`LS2;P-N.M4KW`!$<0V';[3_X=1)D=1(( MLF2O<%CKL&3#<#A'PEQ/[C^\-2KT0&5;KP,?@UGVP#IH0/#V0!I8MEBOK00R M#X#='[/=]'[)___<4\X/DXH)9XNU`\VU_VVX= M;[2"L^HW=\(6K$+_UH,>@[,)P'8Q=(($%'@.NX$$U`$_Z(.'7_0B-W4:.'8& M\'$:R`(":X`,)W0,]S`NC*U:D[()$`$20'4]9(`&2,`+@+B%_WA5$X$@IP$N MB(,A"+:-E[`&,S&."X(AV/-.2P`[1X(LJ#A0%W(2Z,,Z&'`:',,+W'0+^S=@ MVRV'_\/^#S]!&J!")D3S.I2!(#SS/_!#)QC"/P@"4I?N/[R`!-/Y%FRQ`7<" M`EBP(!?#"\A",?0O/PA"$IC`%B"U(.@R38]XB0.O M+[^V+O.#!I0M#$="/=0!#>3Z17<(+B3=`)@H=X?"#"R`$V#[`K2#'O!M+\P` MME>(-,"#:46`",S`#'!!NI\[%[06&9NQ1\!NO-OM,=!ZZVZB?&,O/]#Z\?HW MZ^,<'/KLC/KL'7L>Q"K\A[!+W_.](6P^=&!\OS>WP[^$%W?,9? M+ZO^+"JLPSKHL2-O@2$T1(?-&!'LB&H M@OR",@(?=@T#N3BXKS@H<1*8@B)H""9X?1V9P#KDKY)?-:_S;#VP,Z/O\3H4 M@^GK.&SW@`EH\0$OL$>$<-`G@0+^\_2G1P*N"_8/*_O2XP+L1X<8U(,@P'4T M4SFNZ_JDFX#_\NS!E^[7TD`I:X`I1#`>WSJH9P#K.WN+G,.[?\@J%%%?],4@ M3&($%`/,PNP9E\%!N$3]#\)VRP(F1/NT'_0_2&X=`82;8AHB%:3Q1((LA0IQ MN:%!@U^Q'@4CT="P4"&J8T1H%$S4@U^$C!)HN#'I!E;G(2U($/'CD>J5T=#DGK% M9$FN)ZL8['7+)_=PR)K&/MNQ(YG`54^0AF+B<'DI-G"BB4C%2J6H MQ/BL]V\=$U!!)0,BLC#%A&+6":0S"01YS80MOMIB+WYD>8$M7"9[R`1Q,FPP MP$B"JTV"$-V(\)@Z6',C"9,Z_.>I+:33"Y5(4/E'GQ.AZX$&61`4T835:`!O MLE#X$>>TC&;)H)AC:DLCB0AQT0"S=11Q@S33!MR"'R+2F([^0`U0:8PT#=)` M$;7%U/2IC$$&>&6`!43":($W!Y"FF%[8<,+.=M+DNEEA@$JZ&6A"-@8 M9(97'*U`!!$@F5.6"*3ILPR]^-%`@[%Z,,V0CB+9BJ&52A)1@XDZ,F2P+!XB MPI"EJ/(+.TX[LHDI$7$QQ!":>IBHAZ7(FHFJ%A^:;S"">M"@UXZ2P.C&6UOJ MLB^%)"A(@]T(BH3570WIIR`B5(OGJ+U-#.\:0@MBJ MUPUF>111+[YH\"NI58]1RK(TUSP8X8371(6()'3ZYSD-B#@&E\B(DH#)>C3( M8)U_9%EG"QI02<)-T5H'%W'< M,"2#8R(1Y!]3Q!''(F[%W6N='@3)5^:A;W,C#4&.DJ4.JW]*`LHM<$DB@P?_ MV2(H(OYQ@Y]ZTMBB#E2<1NOJA7I`4H(ZQ$4ED22(B,B4H+@4)XEUDLC.XS1F M.NK&OM.83<8!,?:[XCJ*]D2RR&DC0A;[GA6D#MHZC6XC,3%24`*UJ5O'HDJ( M()MS5&+IK<"/0T:%AMG:JL/"IM.(Q$D-*N8Z$ME[_*DFW*!+XBF%H)N8A=@5 M1K@,+NSD8C!4I*]@`"=^DJ6,8BIP=``VP$(E%#L':2V"[Q%-U(1S[*P`DTPQ M*J.=Z2G^A586'A/!')4(;JSH76!IR$.0MSTB5`0E"X$5+@8DB[>4[">XB`59 M>F"(E9@+%03IR,04(I9C%9`K&US(,1SV$U2@P2&)2%[`9G6S#/*.A4O[R0&1 M)8MZ7&M4XWLAM\8W0!HPL($_44U!X+474['E)]>ZR=<\-B!<["M)"_$7K0[X MK.WERV#/T^(6%38@BMV,5E=Q(BX09X#M:80A<6,(Q=0(,(TPD(QQ/`_B1BA' M7(P`%&3(X\9H95M3$A&G%@()_4`V%'4J!"* M[<:&BOP)&\EH2<_$L8/;VPLN]LC'4>(BCWKD)!G1$,=CX.3^'CCA9%Z^V$F, M[*:0GZ0E0]!P#`.P\2J;U"3^/.G*<;DPC!KQ3`<9V)9"FI*+BK&4G5P!E@AX M#WPBB,`J9+$*Z]E)>PHI@PC>)[X(A$($W%R(`13UOO5!BPW@-,P3'Y*\A0BE M)%?SX2O_0I9DMN4?X;H?6D2H$;2!A8:BR\BVGC6^:]&@!VJLWK:*F%#4N.0I MBBA(,:[C16=EI%XYQ(@D"@)!K/R+,#2$%RKJ%1>]V$20"RTI:J98JD@$XRC< MC,C]HME3GR8&-5G\:5!_JI!Z)$$<1-"`A429*,,(=6$)"V);#@;5G@K5JEV, M:E6)V=6B*H9/0#N2)!\RU9+^+`Q0.K*96_H3++2*``TAR-*"6#$CQ:A( M1!<;4G,=8X(UO*41TR4!7IF6*87$H2(F.M.%H/`A8$%+('XZG")6USC*@8HAHCB<9G;7.<^%[K##6OXK'DI.!T*(^T$WR#* M8,95A!5\%7`%3W\"5T.],U&S""]Z,?+$P-HSL1V!UV$'@Y;`'H.G`P)*01P[ M0L72B+*#O2RTUO`0SB)E0-MBU7YID(@UV#4,9)%P6@3RDY`J]"<*'LP^`4Q$ M61X+B8?^T:^&V]M;W3+%$,V,[HI9S$7A:E&_+9;QC&EH9?KAYRB6N%D/P>:OEVAC2/16#BC.RE\38$BE4O0Z-1.F9ZK4% M%%F-]*A)76HN3I<-.N9Q]B0:"B`/0,B)8@/VB@RG<`BG+4EF;Z6P>5XGT]/* MI4HT??T;V\'HA+^RZN^593M;,O_OS-#R1&`/S"YW)<&V`XK^\R"_G81"R.!8%PVVXI&J11I*"IVFQK?BZ'!.C:M9U-X[#`: M$E,;!0$O&F1`9$@YN,A82@3,7:7@`S*$P_-=<8M?'#&H!DL9"G5=%L"SR-1M M2QE&P`6S\M6OY<7KDM5[W5TS1%5S'J"@B9W8^PK7LB(Z#3_XZQ."SALI`0;H M@-MR"0/'32BC>J5G^_?M$$N9W(O=\[C]?.Y`S]?+M_4)#2>6\]O6M-+7;#1$ M,%YVC-S0"_!"CRGJ$>,QM5V_)D@#$00$+4'0O1@I[H0A-OV3O!^C$Q(H!FM^ MU?9UT/U:L9F1V1G?>!OOV'RXOBO^^%*]D#)DXWTL$,DU\>2_64RW`A_/].IM(;$EK8Y[03NPYV*.,V:9+F]:%8..*DDTXP<4:E&WV+*"<-S0].QP M7$C`),O!]G/8YFX".-`=0/K.\0:0`)WK MF^!D`^1'(::+"Q10%AAP?.*I`;VI%VA-R<0IR7"!I\;)3AIAGJ`,OO3L^(0- M(BCEY_)B]9SE9L3BRXH-Z(POZLJ,Z!:"]M;,PCSL!LG-LHP-6AAHVVPFTW+P M_?ILPZK^#+&"B[;\#H`>S=/,#(/$S?H60B"6B;%$RNP"X1C2H'9R"](TQA#$ M00-,@`:^4&V.81TTX!\ZH1A(`A7(IB)H@Y]L:.XV#1>&1R]Z@0;0(PS7@__H M+CU*0QR^KP`'D1`3AG[LIRUR`"7BS`V*L2G(!N`!0 M!B#',H(+*H#62M(FQTHAIBG('+"]5.7,^`$7``-;%"+O0J4BF&4W>`7%#,%" M5`6B1,14DD`#).#0.B4IE4N*II$FDF`:F(ODLXB_N$?-&`EDB3V2H)37N*RIA%Q'JHJ2"(A^K$K#0'@GL@@ M8`4O[>;U$&@EA(4&'*XEF#(KG[+^#GH`^P@F@P1-G:'([M08B(D$TB) M/1#D[C2D'@Q!'V2A'WTQ0EI/[AHR@Q*".CJM*F6!!4C"!/2&_\+0-_6&D3[2 M.(\S,2)`#[#'4=`JNXJA)E,2)S=``T'.)J73"2J/)@W%)FT23D0`U_9"XU!/ M5=Y"5*KBQ+*BL.*,!F+!R[Z"']QE#&5!'D3%SA[*/;,NLL@")OCE&6$BMEJJ MRCKB)DBB)FXBI$3$+T;@+51$YRC%`"QH*!R4@S+B'T2%*(A@!$+%RSH3^H8B MA]#2RS!K2CK"06UB)VGO0$6P)HZ!L-P3Q%*Q10!(1!"+\8[A!;;`#021Q3J" MI1)!-3+^0"-E8PPS(&TB(0,Z!W5Z9S!0YX:,9@OV1A!4RV@R0#JHTBCVPF=P M(@G&`7/$@D>14TP+$/+@9!#2)`(B@`4691`&@0UN<2'T1`_N003:E`TJQ2=Z M00_VE$_WU*]0P?0N\*_>"Q/^00),@])PH95P25$58E&/801`:2_L,@ZI0?#@ M*(\8%=-&:01VHY4HZ8X\M9,4E91*J3_"XE!5;`UMU)(,%4::*B-2PE67T>=F M=5P@]5-]8LM:0H!"]1ARM2U&P%4AR9E2%2S6D#H^J51_]6JP+R4.E56YCP9> M(`/RK52!Z"HZZ97DB'N:R8ZDB)1&B6*I4%>G\P:\_6JTF2J5NQ@8XQ&#G9A&19: M'+8P`@%B$8-@%S:[)C:[,D)A&V\X=L<$C&8TW54OCN'1@O!>119ED9/)KFLE M"\->$>-E7U9AI@L\/[">LBQE]`@X$B_9HI[80]>P%O.3]'`]CJ99KNQ8I0M+&HL=0!F`&K"KU<-9K MT_8X-6(YI-9B*XV+M/4\I$\HI4HDZ@MO1\AM?6)3U=9OOVH\92P"*O!16G:Q M\J>>0O9O%W<`QR1@%V-7L&,=GJ+^ZZ)IWVK08)@E1XL6%]+`%$1'J4"74SRC M@H@`;1$&%00A#]F5<5M738@L>VB,XZ8'JEST;!X",:/5=7,U#2/_#@F1!`_[M2%`!%"2`9*8#VV0A`X(G>_NA>M"C8NAC M*;`W-GJ@#J)D-1@I=).H@HIA[_#2;33``/1&`LCC/QHF??E%U)NQ5;! MAG&X7_C^(0SX`8BI@1^:C8:+F!#1(PMN!DD&9`WV;XM4HVDZIA[XH1*SAA_(@Q]0ABBN@Q\ZQQ04>&(HA#V, MPP0<8B8PYH[_Q6H>SHC_N`"A`A4"P7\`V9`'$166^"<4F3FXB#B*X07.(PD$ M`12:I('Y4$*&&(1;`Q7V@>Z>P!3N;3/J87)_TPVP]ZAH($&8HZ(,@4+^4$M3 M@C1XI#J(@#160@S_;88/F9=[V9?W%SV6R!Y/(RF<6(L*V`T0A'I1E3FF>#)T M='DUX#6KTC&'^`7P2R%`@F+T1CZZA.Z0)94]XZ@V,H[K8`OZS-@2((_F7YYF>Z_F052-*KB)*QX0(_)>+3N882/D`ZC`#T@`VF01H2#8# M5,&/(B$3#)H(B*8.(#@C>J!*/699!BZC-:)%QNN)H_) GRAPHIC 23 y83222y83222z0009.gif GRAPHIC begin 644 y83222y83222z0009.gif M1TE&.#=AT`(<`O<``````-"@&)"(.-C8V-#(P$`P`-#`J`A(:``X6,B8&&AH M:'B8J`@H.)!P$&"(F%!04"@@`'"(D,C`L$!`0,BHJ.C@V-BP0,C`D(B(>&A0 M"-C8P'AX<`@@,*BXN(@`"!A(6+"HF"!8<-BP&-#8X("`>'AX0!`0"!`P0.CP M\)`8,*"@F&AX@#`P,-#0R.BX&$!`.,"XJ+!H.#8T!`X M2!`X4!@8&,BHF(!@"-C0R/BX$!A(8$AXB.#8V&!("`@P.*B($)BPN."P&`@( M`,C(N-#(N.#8P*B@D%!02"`@&+C(T!`0$,#`L.#@Z%A84/CX^,C8V,C(L&!P M2"!0:,"XH)"0B/"X(%B`D*A06*B`$.CHV+B@*!!(:)"HL.BP&%!`"."H&-C0 ML%AP4'B8H/#HZ,#(R,#`P#!@>-#0P$APB+"8*$!@6)B0@*BHF+#`R.#@X'"0 MH.#@T'AX>*"8B!A`6!!`4+AX@-BH&*B0,+"PH$A(0,C(T,C(R&!@8'!8"'!P M:#`H`"`8`.#@R-#0T/"X&&AP>/#HV#A@6`A`6`@H,+B`B*"0,*`X2+C`P(B( MB#`P*+BXP+BXN,C(J+"PL)AX$)"0F("@J$@X".C@T*"`&!`P2&AH6,#`N-C0 MT,"(D/C`(`@("!!(8(@`&+"HD"A8<,"8&#@X,(B(@'!X2("`0&!@6-#(L-C8 MR/#PZ/#P\.#HZ,C`J!A0:.#8R."P(*BXP*BHH!!(<(B`>,B@(%!XB!`P."@H M('!P8#AH>(AH$!@8$(!X<%A86)B8D$A(2)"0D+BPH,"8F`A(<)B8H(B0F-C0 MN(B`B(!X@#@H`,"XL-"H(&!XB(B@L/C`&.C@X!`H."!08-BP**"@H'A@"!@0 M`,C`H-C@X/#PX.CHX`A`8"'Y!`@``)``+`````#0`AP"``C^`/$)[-$#'\&# M"!,J7,B0H<"'$`=&G$C1H,6*/2()D\:QH\>/($.*'$FRI,F3*%.J7,FRIC;@TZ41K$8#TG$JUJM6K M6+-JWO6X6*'>OPH%*,2(LZQ1@!K-NW<./*G4NWKMV[.LGJWNE$.+WJO4\.?3 MJ%.K7LUZ\>C7L!L.5->GM>W;N'/KWJTRMF_8@`VJX\*[N/'CR),K_LT\,L2F M4)5+GTZ]NO6;S;.+-0KTN>GKX,/^BQ\_?0;9&;1HC36O_B#Z@^VU-YQ!.R<= M.B[OD_>(?VI_J_KMUU&`)A$HX($O]4"+>0HRV%Y\Z:&G'GL$/>A@>NFYAZ%Z M&W:8886QT2?2?2262&))PD"QT4KW"?-/;>/AYR)+^/4AS(W2_`<2'7W\LV)5 M+L+HGXE$&BB7C#^B"(60"#:ITH<$40@?0AYR&"&%&X*(884=@KC0@@@QV!=] M4GEDXS]00/%/*FNNF8J*.8HD#!Z/X)'D26A.(88#=U;'12K2:%,-(GV.V$2..CCAS]\P\B?F@$))UV3I6BCVZFXBF;;_Y3ES"IT.&`&"?UX4`O'+>'6%'1B`1/2,!P)FP1%)"@\0T@QM17C0,-^2"-D M,9%4@ZT8@&JJ2,S:]$D<32$4HTW,:T2RP-R$++`&MD#+)8/^`[=@ZP;$J8@- MQ]\7%RY2E;_^JNM1//!0Q../E^-X#I/DD(,"F%M.^2NO2"X0XKTNSJ%8Q7Z4 M"AX4(_"IIX@(_@P>27NN$CJ6B``?9O>,DS`(CW'*G,-YH:Q,"$\.Q``)0K(X`ZGQ6WY4P"'A+ M.$DRA+#&"-X;;G]'&^.*<@\\E/-*Y9CSA`#%(04%"/"`XA"')Q+(P`0>4(`* MR$$1RC&08*&G@G[!!P\`PR5;[<\]A"B31X31!8H)`S_](94#\`6'3(U0&K?S M2#&DQ[N9"$,1:SAA9^@@C$@0#T7^8D/!SG3$PV(T+`X?H8,;IKM< M.8I`N4D`L("8RZ,>]\A'`TH!CQ#D(R@N9[D(%D&/A=/'KBHRD9*,8%CS"$%/1+"/W.0C6".9@T>&57.#9.LD<^`)4)AB MGB84"110AZVT=4140O!EHKJ@B"D8E2,R`*7V-B($(<`04CR$@J*D]:,;#4]F MZOH/C_Y1#$4(H554C50QNM"%Y(4@!!"[46<9=5B.D*H8C9+^!A2*(821A@0* M7!!"%[RAT!]RZQ^OC$,LA6$T7NIR>G!JK!5ARMDN?%887-!LCQ2E"$<5`[5_ ME49@.2+9FP(3/Z?-T7V*\9]BD+=M/KTB4,$($A?!%H8AH&R.;#1:1D6L6JEX MKW6%,`5[:E<1B#AL%,7&#_R$J[%9'6%^8^N1YBHB>==-5Z(\&P(U;O4S=LQP M.S*\@A5,HL,9+H(=(;>"QY48))M`/%D,LPBT\LXA9#;L,PSO'C M(B!B$#^.Q8^[:WOIF4^1/$T,X1*&UN+PC&*L3;;:B`,T1B"]$5A*:*"4!P(< MP`]L63E)$?/&&IQ0+A2PBCB(N!O^MI[!#S<\+T?JJD8 MA8)'\$,1PQ7"&J;<,'[<8H3>N$6?:RD&?#VC&D_N"!>XO.=G/*)OL!R1,-2L MK_1B&AK8/:X8SEW9#GTM M*;LA$D*0LAO<,`(_C+0/#GB$&^+@`)X.2+U'XYEKA1`):&'>A+C%#[=C)&6DN=TS,6+@,A+!$:=Y:&$4>0L%=^FTYK'JHTO($(PT="ZDUO M^Z@]C29B8_B`N'$3QM!!U9>]NK$3OA0\-[?$T8#Q?^@`+3@#W>V&UX M;B1N.486\G(%+#_E3A[712J`CI2CHP)&/`G,03+^=:3XR64LXI/+/P<;L$B7 MPT@'M'YBY0F$)'$M5V1)E`KA0W.)(@UW0W/$T0?%@"]=4"IG5"[0QQ&?A"_O M\GG><'S(5V'70GOW<3ZP]T3W)#,(D$:EA`)K@``Y(EE+%RFS%`FU)`T(\#:< M%!)=IH/XT3X.XV2GY0WXXBRW4&%/QVI.EB/_(`\R@RCP]30>52W]`@<.("J: MEH690GC#)X)2"%0\\TNC%T4E5$\1(X7:L(.]I7DYYRT4*`U_-:3-9/_=1VM0@SCU!TZH4(B'*/1L,G4#!&6H9=PA`'6U=) MWH`MA,`S//1*WF,C788"0D"#=+!EV(('97@VSQ`U471\5S@@UA(S4T02-Z22 M]4)X<0#^BO?(5Z0(!=[B*/V4"C@#:)L&=*F`7<)G6ZG0-S3W3Y:TBJ7T#]XR MB;+C!B#Y3-"&`L/F!GJW`+&31MZE@U`@!+`C>Z'4(H97?#`$,RC0AE#%5Y$0 M+JE`"$R40C@C=LPD/GCX:O@"+C4B`^5"???Q#V(S/@PY`L77!\.&A_U$!R&E M>;MH&PST!@\@!73E"79D<0((0'$%20H@#N=$#IOP`!,P`>='E@$58&Y_D!M`08$/8-Z"&6*#DEQV1"FJ6@=<2!XK^H`VDI0V*T'9I MR4,`:6V&J76*T)U"8#2Z]P]CI'6((DMB*1).H)'JPH/9%TQYB0`,&9$^66%W M,P(T!5Q[ERY9N)(CT9+8X@!JQS7Z64IQB0>I('O$1UI=H`W!ABU$QWS7EPHR M4)&#-Y3)Z5KT])#3-C;2ME?+!SCA(P92YPW>T`70(`]4U)#QID,X(H'/`#1# M2$]B2:-_B%UJ0W4XV&*E(W7:(T&A)G/")H38)K'@`.F^:8X4*FR0*CF:@J:I.F+ MOKB`Q(F<@X-"R%F4KH5>I!("#E!FV)58-%1]`GHTO;5G[;*J(]"J/>>CTL8] MV+*JK-JJ8G`C=I@OWN`C)D&),`0H>.!=G!2E*<2?U28-0EH-Y'FJ)UEN*IE* M6!@SF2)J3<1#?.4'*LAFM.HNK6H[PF!XBX<(7$AZ1)ES(MI7H:643GB M#1@^XW-&7+!ER"0[`!E::+8\@*(-:@9H,G*OLB.DA/`/7,"?/T@JXZI\D)*7 MHL2P,D)/T[.K2_4/1/DNM-JJ(_"48LH:G$D.>"0.SPBRB$JIY$"HG;FH+%"G M*5NG1V#^IRQ[!+"0LJ:)`SJPLG6ZIS.KIWQJFK!PIW1*LXCZICKP`*G9IWH: MISCP`N3@"1/P`99ZH#!W0E$T,>@H.]8B!B,P9@X3`A6H6*+$/;N#`&/T"(#" MCTZECYAU'U`P2W^#1F:+1C@H=-4P1+TZ*7XP`ICH+YZ8+]8FJT!W(WS5:4G9 M4>AR9+J8+GP%!R-%K68"2J/6-TX`!1!EMJ5T/3&#`L863%%4KL3!0R-Z)WN% M+0L`*(C0G/_R4U_I6MXPD?]!HSDD+BZ""/*`MT;CKV.9MJXEI`N@(H;W@U>E M?"#AL'NKES5H>*S&HA0)!6(S>F]K81O;&#I[FR5[#(/*`D?^H+,L``O<<`5V MVK,N"PLM>P0MZ[(W>PPL\`+9:[XX(+Y'4+/C>[TS&[,IVYFCR;*$*K-]J@,X M(+0I>P4LX*C'\`#B2&3;`E(8"HN;RK7E-FA^P%M$&0+*Z;7_\7-:-D9QH*0' M.IY[.4MS2!)0X`V"PVJ$$%KM50P!)P9=H((F]2,,ZZQ_VT/8(KA02+@'RFGC MBGJ7=<$<0:U$M$L(T#<=B"**8#0.8Z2E6*Y&^;GM!3/04`S@@V[)-+5`)4HM M4RTP\[KI4@QZ5@UMR*,KXJ.5I;LW8GA(*1+U]A'$.KS6)EM"$,+/4&TAH+PR M)DA&YOA1+*OZ8N;&8W^D9J_*7L,B%JR@RRGVK!9@E82V?&AT'TG"`D8JWD#$(SQVBB"5O)4B%LG"?%NL MV*(1,.QRI11XF?9;;-E,/B4,@J-ZX*52.G)M4@NBG`I# M]#1O'1&ZJ.J4=,PMF!I4%C*<-"C]IR[^+*[W_HM[EJ=!!:\ MKPBERSS.8A8SSNPMT9G+=:P:R'B99J4YE2-C`&AQ'5=C*&9'2<`Y,)9(\T+@F=EX3K!)#@K4FFE`M"RP":CY!IE,#I3LOK"@0)H9RM4RRI54 M:DC6'ZA,'"V)`A5V'PD$HM M)T(J!#]Y2RO,=0FMNLT,N-@2UM%,PR-AP"L-C*U2&@ M")$&0U!P60!ZQ$6HHE3SJJ'FDFKK%.]DWPI\H0"@D$@+"$PFA M:,_]T7:NS8JIH`U^H"*W0)+X&)\#@IS0AT(#?=:GG=;7ULSU0LM:^)-P!M>_ M]4ID*R[)\TKV/2#<+#LE!'T?R&ID/=];9I72(`^(R8,3TV0998Z'#6>?*R[N M/*31!-G0:L7NW8<4VTP(SE>V"\:<'=!<^#0ZN$4MHU!43=IJK-#**B.W@`AK MTY&71=9IZ`9+S8K@H[&RC6'KAW+XE]&:$X`6]TC("`HL)DF78U:`Q$#Q%P$] MT`L;(@MR3@O_HW'V=T@+1$?*2''^@P1`+':9EZF,0(V2:5@Q)N(BKR1$F@L% MZ8VV;2M;ZHH"]R5YTK.[0&F=>GU"/9DS]*(F"-`%2(2VZ`9?+IZ@FY)?]/,G ME]:@5CV@?R6)B%"&WPTURF/:6@W'Y9TSQ<"%LRZN0(0WJ<2$#2/#TA`"2_1% MH<9,L!/'@H,"78`F:^(-WB9;S+8O/'0MI&A%Y2H[ZYP*?=`'7"T-2P2!H^3* M1^/+(_3/I7A\(\X^8TC6<*;N>(VH8$IAJ9X'B!'J'!T(PNC+09=5`@U#E ME4+HMX.#!RWC![P6"97H;!XAQ\^PD5^,`$WX"*$M/0RU(BKH!U\LI/B6]6-$ MU5#@!'^S]JBCK!R!`.G]Q6GH^*GF:K>D+]$4^H*C920QKS?E!*GP9(--,8UR M<'KG`(FF(@"I][)%R^-#A\<%>PM`"&(SL$,X1@#ZQ?_@I'K^?R-XSY%*27-E MDPIG\[IS(G2/0`A%@U/Q_/":T48<_V-%(/&O0&,H]O*/,_YT-$'L7^?CC_&' MQ`,S(`N'(.?X+^?X8(R6L_&3($<`4>X5#Q[E#+X2B/#5PB)%&#:CDVKRY%6+L]&!-&$4)Q83@D*CGV(AA`G1J%$EGELQ1R`2%N+11D4A MBM4DE(H.12AXGL6,20C*4#JI%L1\QB\$241ND&JL5K*I&(V$BDGSY@:%MY(F M*7(I!BVFR@5X8D)31(>0QF==OOJLIO'F5V$.CFI4Z^0I'!35R)I%+&S!47E" M0M`1:%$T=;B!"1X,C^^T>1CK`N*J_*@S)1V!K"#KXJ0L&OF`QI M*-7"83EUXFV5J,WV*08'S[^AB,T6*^:6+AY$NA$C\KP247%I(:S*A'-+VUIM M=*+#T7:W&%@6B21R: M),43<\BAQ!2+*`>?0V:4I<8:WY&%EE<>\,23!\11X$4.-1QRH0[+L6/($9,P M209$%O"C&C&F?*3**OU@3IC4$'/`CRG%J.861$C"@Y_)'D$$`40RJL8EU;JH M1BU^XGC^1(BES!+&FS@GF:$2,JBXQ\P'T$A-C?0 M%(:ZQ+R)XYEGG%`D%6F<@&.-,6_Y4LI%(Y-R2BPKS;.:)B;SXY](4/!#"&'^ M5!`*1/P8H0DW^'%C!'F*V3(Q1<10*]A'NO@@,43VW-0!RX1YI!HG4("&'W[$ M<&FT+K\40\P^1E,D4V@B*98BTMQX4!AM%@"WFC`5P;6Z!5(%4QY$N%`-D4R? MT:8OX41A%((^XBW0M?ACEFF6>FN68%$RJ'APT[-+(@(Q'^TED@AXHXL:&' M(IJD1(CPZ:$'6FBQT<8>)B&'G"1\[/%'!7(PVL,-&3+RH(,<$D@B/*%(Y1^U M4V&[;2CJ51<*M?])95II$"&6U1!PXC?NN\^K.T$M]\8);ET#-(LX1,9TV:74 MO/$FA']H8["DQ6^E@[;"29H[E;=52YONSP74LAB\0T,N<`BY^$>8B\Z36T`% MA0D-$<`K16RT?PC7TJP0W@X!W1AC!]=FCZ@,'US=>F>NRSPU?[\_7]&=YP.R"6GW*32 M+Z_>9O__!V``!0BA%'%H:`H)6]C^A`:B#;'C%4G0$-ER]C,>U*@7KIA1!@_1 MBQ[D0`&OF$0.)B$.<7BBA!MHT9$6"#2>E2AL=C";6>3#%`'-$'K&898QQK6 M,8YXA&(8&Y3%`1;2D(=$),V(!J*&$,V%7X-D(Q722+(I[6L"P8Z!4B3`(D'_+(18*H(#R3H"PZVL)D1R0`)K\L`A/N-!#S2I00V6H1.RX($"7L`C'N7`$Q[E MVL["UA">"<0.`0T:DN#Y3Y:VU*43`-Z`KK&=%:UJ-V4P732()!5QD.RA9!!%6E'=9SG;6LQ=RY`-! M2%07#C5III4K1*S)M+U2%&JT\`,^KIHB!3!"![=]`%1)*`Y&D#`'H-C:"DS[ M(N*^R"%)8*8=3/%9YC97?Z%Q;G2EVURZ?HT=C8R`(T-(5Q3]=)$5M)$&00G8 MUQ9AM^*8`"Q8H`-R3*"P$R`'*4G8(P6`@D4]E21$3,$04YZ(H#"*H4V3>,4! MW['`B=0AA`ZLUCA.%Z<)=G!S)_'!H3FS1.5`;A&BZ2*B,71G^&":TZ#FBASE MB!9-`^$RJJ8#%AR!O?']47OC.U_^!?3HOJ``Q22$=E6P#=6%Y6`'#_`QC@#+ MK`\XK!D:CWP-F/4!'>@XLG&N@8X#1)F83X8R@X;2AVOTX^@@0^5:?3E""+7G1SF]L\Q-0>,`$='(/0 M.IC`C\:9VQ\INH0E))H4ML98GR9M$O:%D=C&D2'*0N@)#7I"?^CP!%)+`QTU M.P`J2J",9)C/0G2@00E6G:!8ET``Q7S"'&P]AS8C!LJHH`$-&&%J:7R:9D`( M\S%K+8`%O]K4=``V#5!Q`'KVFI?6-LFRC:WE)]A#/J0FM;?MX>9^TE6NEOQ: M0)]IZ7+^**$,-^BD(<8[W@SV0A:3V(1[63=6>.G-K8`-J MC-AYI'%T6LL'H,$BL$T1>R2##_"`QR($L`@^M%IF:)P#'^Q1@BTP`A46L@<- M!+`%5J0YVRL7`#J:+BR:&# M1C]`Q?'UH`BY-@F&"E>H.GMHT'Y&MLDJ&!-&,+J"T$&#+63^P]C*V$(FC,R( M/Z!B]$'?`J^+LW0'H2,9-\O[S+ZI.>#,6V.]`]>%"P/AB$K:/^B"?0P8D``N7C@]XKI#[(A#^P0N[3/?@[ M-::XAO=;!-K#I3Y@A!C<,AH8`U9@PUS*A#%@A"]+0_9#HY5K/@?I0S-DBM&+ MN?V;)\R;)898H/Y[J![X.P9$P$<$O`-,P$/PA!F3+Q*BP/A*-`4HAPESIJ(I M*J#JOQ$A"!`\13N8A`:A@_G#A#\H@0,X,!.,O5,SGTS8`F5`!V\;([*3H3+D MPV\+,S2ZOS\$HXHPB2<8@_J#L(E0QOK#(2\$(PBC(;+K@]V;@^VK""7\`SZP M1='H`QI@!5ML,"-"H^(3OE;L.:,;BB>@C@8K1Q^2QF-,$'N0.RLKCGALHBZB MPBV(.2+^E`8^:+T=?,<#LQ1JS)U]E)T^6(0LE)WR4\B([*,W2D@D&[5AG`@^ M8#\!@8=L""0&$4A&D,%PA$-X],5HI,>"W,<"NZ%RG,>7NBJ'0`:$.""@5\$#(0DZVK4C@, MTS)"/,&-5!![@(=`4#J*L+DY@+(GBS(OLR);_$;SD;EL@(<^"+,#>+)D.X`G MR(9,2$N=8[(E*TOL*SHODT%I.`!LE,6*,,LNTS(N(+/.S4O4X8Q@$)I0#[^6[1!SYR(:W!, MBG`RM:Q#)#NUUS0)M"2]%"P.=`@SUQR^(T/,!-G",:`^XV!(,QPS)W0RWVPB MWU1,)V-,R#Q+U$0V6SPR5@B`+%O.NR2V[H0ILNQ,Q30+((#+7K.RX$3-N(0I M:>`X*#M')AP7UW0^ZQ@$JE,&+Z,ZV)0&75,&`=@Z'E3^!LO\/E2@@R,5`+%4NVQ@N63(P\VD`67P M.3I(AF08EQL40QK(!%;02C1%A:5[O:'3RMQ!!U00TV2`-?#+M600`)R[ODQ@ M-M$`S62P-;I,/QDZ`)(K1.&4AC`K@4S(0R%-!EY[`F5X10%(AB>(N-*S.FE` M!4*%TBTL4P'(PVL4.I-P0S$5`&5P1WWLS"<@5%8H@28ZLCG@TU@KN7$9EV10 MU4&`L-`(!R(0V534^G8-D@U6./35,=4-0!;E%*($P,U6/6\\C?=(Q#-BAVS:U&P3E MO%AEF`-8?"#@3,J$'D()+E*H:2Z71 M8I&:A"6#"%&HE-&"`+&K?=&NXD=6T,%L&(/);#^22T$GHP.Q982Y'(1%*-83 M##[S800^*(&A8`5,^#0JQ-@_T#A2\[Y<]5:!E#9CNP8!X(.3JU84I#8Z@`>Z M[<@MB+TJ8ER/%`T!@%+V%$/12P9X,%>5^P.[9(0YP(0MV#K^5LB&T2T!)FO% M$EB$SLV&4@`]Q"@&>/B#.94B5-@X?Y2Y<-1=L8,'3#`Y4D,]5CVY:1W7(PO= M,1A;: MF$(%3-`Z:;@]M@3>(Q,`:Y6&$WQ3*5I">(!(9Z1=ZE73V,/7MG78XK#<3PM# MI<-5>%#",3!#>S@`1H"'6;W8W_VV$YR#I)-6LVNY.,P&/*6#1:C/B3#>;`@[ M/A#;/Q!)LX`]RJ6#P"1=9+.YKWB",+S9O+W#3S/=T2TZ'*+%08"R MH+,_<O^QSRSYHW!LS_==,,QT$U_AN)B MPX0O+C.!+`$:0",^V&=30SU&J,,^@#GHM=\_N&8G$X`GUD'0Q(1K#C-3CF:S M>U/0S$54`%1X=N+X2V4!R$OK)6>&W3V>B!@L"K&''1$XO*B`HQIX%*$!.R'E"'ZG'#E@O8B;::I[:8Y,768.#I@8G==@[DH9H2*9P0:V#JVC,V[/7.!G&;X/DXS=5<^5PXU?5@A#83?.E0-?ETS4S_U*.D!\ M4!:0:F9R*#SL)@_ZRI3P;A](AD4]&F`R(WPZZL:^>&?Q%;;V,*77B4MES5SA M-1Y,Z^51P'988N7#5!;+_=;WP[R]9N[VR"VV0/C@%48]\(6I]Q.`P90!L47W M:U1-*`''@R9@RJ:P:W,-SRYPF-+0)0)@XZ3"<;IB2#9ED5:K^FU^3$R6CHE1_^9\\OA[X M2+$?X'X`>U+OY\-GW^F0+/7F>2@@YTG<,@J((\Y_GAB80PZ3*#A)$>7@LQ\/ MY93#PROE5/B@A>'Q4$1ZM-#RH'[61"(,4!J58$1KZ/Q%%W>G_8$*$-J5A=)E M)1DUV4?^USA5PE=E!?+$1T"(E1$0C$A&EI%\Y/2$"/``V0='6&EU@%QH7?-7 M"3?9`P\FR0S""!"M9;=E<9DY=M-P?T0''`WH&+285GT8^2-?6J%CE%?>S<@( M2(/P\:,T.TF4E321P1@G0?8SRV52:.7=?'''^4\`0J?&3#V1/*>*J, M$K*FT)SUL@G<0GE7,1"L0B*+WTUZ_VH`8D M9AHAE\P>>?//Y;%\9AY2CP'\"$FC@`YXD6(2"1111 MWH02FB>AA.5IV`,/,Y370P\?GD?>AB7*F4E2)E:+'5!R_J'D=E7!(T-?Z.C% M(DC#K=B=:P>NL'2KH:T1;T_82@<\DP&'"CI]&"10'R0%RC9<$<%M M8BEP7LD:6(P+I&)REM,A`"9\V`J:V]E@'F>L'U7%ASV$E<`''S==,]A``2N9 M%!"1/9'1<5N@6&_J::,#L0#)(#O^%3K11_^26:7=%-I/C)_I-W2M$91)-B4D MH6]9J$N.8`1LE2MG)2.Z,8X2O9$8H/ M!P8RB5Q'(TY1E%J28CK`\C:]`2*Z<9VF8`'P.!BA`NBPR.(L4<`_B"JE4@CFMJ98)NRIQ&1 M9&^@"T/X#(YQ;D)=;1330CM00,@R*G^FXP(7);`P`C#@PHA1MD!*4/]G26&>Q)4AJ21)48FIU'[$'+?>"'>'P M87@1*25B5';/0B&D,Y)[VT\\N9><2"YU'^F6J!"W&3#]A7"N%-=TJ@65>2V3 M#D:0(5HC@D(P4K:RX`';>;CF(/1([16TZ(2'7+'&T<)1CG/$3QOOJ(0[OL)I M1S,0TG)0!$],(@<;D!J#7C$U#45(D@TRCPKPF![,EF,2<2GMV"--8!PW]"41"\RH=U?J!@KR]Z#IS# M'$*07R/0`"-U:ML@&B4`1@QB$5D"B6;PFXSS8B(3,;S)O/@P!R`)T8'[943* MAKH=:)>];>+F+LT;%C.K`$2\:,FYH) M.:)219P*BXNT%F6D110Z<-8[C4\::#)I*@6>H1GU6>%Q%?(&@@]8#%Q*X)(J M&BC'SN3^7`13(%HI4ENVUY9-3R7#-J'P6(B,/-`9'7^6[&0/#6CU"=K0>E`$ M4_@104[[HP)R.VP)#5>,/?#:)(JK'GS(XT/F"5$D%8<7PP"(H3!@A1D**S!8"@?$;X\0I;TN)43*!B@/P))5>9<5/@,!>R;0I M9+KA3@F&*8`2E&#G&,F14>X"U.1D,V#P.*^),Q&=`_S%OR_A2:MP*1&=VN"=$7=6I4Q]*\(>>U`H5G5-59%CQ*!X"?JPT MX+AY%W'SK2@^.@6W%,D?1DR:\*6JF'!8Y'73EG0&ZF`L7%(R%B'OO+."%;@: M@W6EL8B]"04>J@*"`.!1J@W"#NM\,=:9RD<7Y!W^80'O[U&#(A>A&RZ8%E$& M#:(<>E]S7V9@BU`D::&AFSF2W&&C$-C<43JDAQ\8&_B90DYH4:RT#Z8LX%25B`+&2KUEQQ.$$E_9 M0Z&!":%D475<5^\P@@(!#++8R@#^T<#S4(64P04&?DGE`(54>6",F&`VF55V MF"!:=<8(=L83L`U$_!NR-%$/;M]'',;=>=!68`8-^`M$_)PT,,)_R8ZI\$6- M)44(D!HJI.`3[!Q$&`'(+0*_!<45/@:O2,XRM8:I>,252=X3S`&^O9WG%8FI MH,]WD&&IS"!V%-5YQ=!CT*"&Q2&AQ`Y5,4(9#?`^0$$'C0S;U5P- M>E02/M!"$SP#*#`(U)3^'QG53#%^HSG: MPB1IB/V]@ATHP%9VWSKU`1\@Q1<69DEFQV):UF,RIF1.24I.2^$$C-QUGSW0 M63"M$SKP@4,59F@LPLDTIB]&)LR@YF2N)FN*9FN^9LR86X00HWD\"+!9C6?! M`3\IZ^-FU=*#;"-7X38'RT<`B0,`"W(!QN]'X(B6QLI:!N-5H.2(]B4!WF\ M0CNP0]9PC0I\FSAJ"'I,R&T66P3^X&>O#(=#=-8]2 M]EH(L,*\F2!4--Q3?E$IFL55\)J*_BB0!JF0S@QF55*&%&G-3,@A]0#Z#4`3 M-`$_`&<+"&>"5NG[+2A^C)OX6&H6*AH4+M2*:;%%H=WN16KJ`)SL$$OBF@!JJ@XN=T8DT9%:EZ6$V& MC`5)F@;*4$/Y-8K'-)P<0V%OH)^F&-M3H@?2,@, M\$".@J=$#JJKOB9$^6.,&J8T'(`_ZBEC0M1+9.6K]JJO_FJOC1OXV<)F?=]8 M+J=M\H#^A79",CJ2+`QGLP'-6P+G#=S'6N9'.8@IU&S6>=#EAC+2#/0`V6RH M/)!(D*JF%Z$KL*XKN[:KN[XKO'Y$LG(HL`';E@[7^$T"#WS6':'E@E8IE29; M'"#;#?CKL][`OI:#;&5-;1KI@Y"-L4D-M^&#$A#"]@G:J@YI1&9LO':LQWXL MR(:L9-Y,9IE'N'X(MXD'A:#C>)``#Z26&[&EI?I,<)K6LEGCAW2J>8QIL?VG M-71KS8Q;#[R#.ICK^E2@/2R@1OSHJK93SXFDR$:MU$XMU58M=VAJ?UZ(&"T2 ML66-A"`#^2G`RWK!>T!K?+Q'SZ!MST";@;)E&S$G@^31A%[^33DXDH?(YKZF MQPQ$0NC!FZJ!INTU'$+>9XW!S!,,0C.]I]4N+N,VKN/V:EB*Z]9LR(1,J(7H M*]9@8R0-`(*20AS(48V\Q)WD<$B(I0-7P@+Z2 MT;4VZ,YTPAM=JO8:PI6^WR20@P+XD=@&XWF^X!@\1 MSG?XA8^FZT[X"Y3\@4O,H629TO'^+P`'L`"#481T9=64T822A[A.`M(,4-T0FI6.1$]0K*>M2(X5M09$M2H;)R2OJ$P0#S(A%S+C M[H=74LC43$UZV!:':%;X,DCJ/FN`_NOGRI'02.NS"%K$#<4`R0($;8B>1-F*@R""Y8H((`C,$?A`JZ"`?/L<*)8F#/94D6 ML<(B6)?^K(0=*Z`8%0G`_EKED&'?$SQ67="&^ABR-5\S-@/KUE+(A'26A90# M.RB`+422(@N2M<7M`'"S,(:-]7;R?4QK.ROH'9&1A'BQOC:2"7OH]YG'.*AI MKS!"*3"%1P*'P^Q$^`S$+=_,;M02D"$4XA*,@3O%BA)%4)' MK-Q319O2=2C73]R.M(@&8F4S2J>T2@MI>O1L@RB(;N6?@V2-U(A#*(."*7B" M`AQ"+W1(^K;S'+D?Z&IP!M>'M4XQY2Y2.%I(,3Y2#UB#*J=+M_!!G]8=+%>& M2DA.=S70EH1F5\/^C8X\Q$K/-5W7 M-7A&Z"O8PGA(+X/4%@33=.K*EBE,0A\IP`04@3)6(Q8?Z%K6T=G"!WVH;62? M+2V4'[%!S;[2PH1PC3^W36.4``TT8EKX3AX/1W'PT!ST"$>H2A^@1K$T#JU- M40^]1%<0"N/$<*%DPS'5E\()KUW_-G`'=_?5IM1LR'A,C5]W*B+IT=3$5J<^ M0!'(`B0DJ"ND;WXH024SF]ER\0873=&\@V:=6QX-EV#B@S7,+E$:Q`K5Y!"A MA"FUA9/$B/`D1?!ZI#U<%(QLA9'DW9,\*12G53I5,BUXA!2KYKW`O M.(,W.'AT)2@H)S;J:V!>[E\C`PG^$':GVA\$#X`RQLM7(/B94/N@1=1G$9IVDF! M<\R]`%EI.A#4.KB3/[EPBPP`,DJN43A1,3\W$I.0;FE7_I*ET,Z_*/39*A^E,,&*+`R#@`_1*F'#^B`JCH_O$>LTP<_O+I[U'JMOWFLOWFK>W@Z M>]8PQF[^!-`CD;E0VA5PY?QP""O!Z9*.Y MT*1M^[7YSE`J&Y4!UPAM&?5"!-!-7P@*;H,&Z1A64XB+5G")AF6363B41T;4 MT[&*_SZ54*%#+C4T2"#'(&@18IY%0BF#H0P/<@R8PY2[R[\\`&LZ;\U\>$`P MA82;>-A?$72MA$P"/OA1$\#'^M6'4<\L%VOO<%;JE3ZK"7--`2M!5-_QP?#J M68571\':8105*V1?H'`$;=P='R3#=:S&ETGZEY#=IBC#0S?^1KN$AE,L`D3L MV.[%$#HT!@W8%\?"O-[O?;R*48?N=2552#IT%M7L%GI$B$[CPQYU`N M;UOZS`#X`L##GW9+(^9W@B$L*"VH;@3@0]1_Q"`$WS#=U(AFP];3!`@^M)'` MPXD.A!%T'55#1@P+Q:;@$,-EW(P(`%@42=@)76N/4SN:A>8-+M\?/_*#K/B9 MQP!62+@]K.K^-884XUAV96V5@R>00PZXQQH]=IO3AP;3[-JJ>;[K^R%@(PG@ M0Q+8&])BRF+>1&BK'E!<(E](CBUZX"N"1B$"#)A0(L'9/T"@Z@-$&BJ!TJ0] MH2&M#QV$#R%&E#B18D6+%S%FU+C^D6-'CQ]!AA0YDF1)DR=1IE2YDN5$?#Q@ MOGKY:E*YY2PR"1^^'OB*O.K1@P09(*"=J``5.Q M9M6:E9]4JU>_>OG*KY,A4E\[O3)5;H4PB$`(2H.+L<^U/A,'2@22E^[;NQ'_ M0N0K-R["P"T1)U:\F'%CQX\A1Y8\^:1-'OB0Q7QUF4Q9]>^G7MWBI;Q>1Y]V5;.S3V4O!3?\ZMW]V[?^U?W]KX*$GZZDXN<'J_A!T*H6#AEN!D:D<<@B"2E$2,*(+H3HP@PC MG(A##"T,$<0.-\JP0I8XI./##2OZD"(7.4IQQ(Q8E.A$&44,"<85FF(LIY*:ERT"SGIU?83!.FH7+P1`%/W4TT]!#57444DMU=1344U5U559 M;=755V&-5=99::W5UEMQG16*RWI(KE<5>J7ED!YFN`P?66;^P">T8U'[Z;(B MBN@L*/D&@&VJ_B`EKM#A`+0JCMALX&_;<7_SQ15%M$E7W779;=?==]6>605T[999F;H)GEEV]FV>:< M"[$Y9I=QUCGHEG>&&6>@AZ[YZ(Q[?AGIF9=^6NF:H9XZZ)B'+KKIFYNFN6JN MC989:Z"EYOEKHUM6&6F>K;9Z9ZS35IILL85N^^FUYV8Z[J33_IEMM?>&N6JX MI_:9Z:+U3ESGK=L&'&VYDR8\Y\7^(X>^..13U[Y MY9EOWOGGH8]>^NFIK][ZZ['/7OOMN>_>^^_!#U_\\(E&+3YQB%*5812YBL8M;W"(7GYA%-(91BFR<(A/?.,8K M4I&*1CQB$]?8Q3S>,8IGC&,9Q4C&-P8RC7:L!H%X-X`=^K&09?0B%!DYR#4: MLH]P5&(/R0A&2#:QDG7$XQZUR,@S^E&3;4QC'N4HR3M^DHZ8C.0?)WG*58[Q MDEDT(QVA^$A"/I*7<.3C)9$HACBHCA^%P`,""'0B"R=,7$@S"NY!UUKI.=[8Q(,:C)NVNBC^0R&*$CK\`Z"I M,^8_(II1C6YT(PFMIN[FR5&1CE2D=(!"14\G4)*NE*4.]:@\&=K/ELZ4II,Q M*4I/9\R!UI2G/;5.'Q+:NWG*U*=%-:I);CI.U*D4(ERHQ%.A&E6I3I6J5;7J M5;&:5:UNE:M=]>I7P1I6L8Z5K&65JD2""E.W--6L;77K6^$:5[EJU1)SM6M< MN:"ADQ9"=3J-R`EPP`'!#I:PA37L81&;6,4NEK&-=>QC(1M9R4Z6LI6U[&4Q M2]B\0B2M"UWK0RR16=&.EK2E->UI49M:U286!Y;0*T[+Z5>(5($#JK#M;7&; M6]WNEK>]]>UO@1MUNE[O=]6YO.>!:B.PUH+)]2!6`RP#G^E:]WW7O>^$;7]RV][?T1:Y]Y>M< M&42DLR"-*42JFUW\!G?`^>5M@0TL7`0GF,'P94!X(T)>B^)AIPA!+P/4BV%5 M8)C#&]:PAS/,X?9F&,2V%?&(/6SB$VMXQ2P&<8=?S.(3I[C%(;9QB4,,,X[O"/2]QC'_^8R#:6<8UI;&0=%]G(.:YQDYWLXR7S>,HJ9O*/H8N0_N8N MI`!^<9"/W&(I3YG(0A9SBJML8C+'V,HB1G.9J7SC(@>YQVX6"Y.9T96V]*4QG6E-;YK3 MG?;TIT$=:E$7.LO2V#+NNOR0#U!ZU*UV]:MA'6M9SYK6EE:%HR.T5W*2CJGG M976M@1UL80^;V,7>-!A*?>K;#14B'S#VLZ$=;6E/&]:W?JU2(TWAB%2A'MOP M]K?!'6YO=_O;Y!:WN,W=;7./^]SA3G>[MU$/>;L;WO6V-[S!8.]WWQO=YUXW MN_GM[W_W.^`##SB]$7[P<@,+Q/D&R%^K>A"/F`PQ^N\';G^^#SKK>\ M!YYQ@X-I]`X?E^^<$Y3O1OO_SHWFXZOL/]ZW?5N M]JB'_>AU7WK@\YYXP7<=[P=O?,L+?VX&\-Q)D#9=KQ%BA7J<@/.=]_SG01]Z MT8^>]*4W_>E1GWK5KY[UK7?]ZV$?>]E[7N)"=;O%&3![W>^>][WW_>^!'WSA MBW[G/5^JI*5AA>$OG_G-=_[SH>_\_7(V0)[-T`>BGWWM;Y_[W6\^Y1^BZPE7 M6!J6\/[YT9]^]:__!+M`:_4IGB'^+K"?_O6W__UG_P'C9YO\YM]%^W?A_ZH@ M``F0``>P_=KO`/^/`#FO`!?P`04P`*N@"A*0\RB0`@&0`1M0``\P`QVP\PS0 M`POP`!4P`#-0!"_0!!?P!"GP`S?P`46P`%_0!1$P!E>0`2/P`R40`!$0`D60 M!_^O!WU0!VU0!4]0!E70"'<0`AVP"3<0""WP_3ZJ[2I.&N8/!U?P!%*P`3VP M!9,P"1%0`3W/"$L0"W40!VV0"WTP`8G0`X40"K40!F\P#MGP"W>A#'U0##4P M"[4P#N70`)60"8_0!&=0`X%P`%VP"?\0$;'P"#%P")$0#"60$4W0"X.0"_5O MO,1IUT;^!_/*;P)!,11%<11)L11-\111,155<159L15=\15A,19E<19IL19' M40K52OYL<1=YL1=]\1>!,1B%<1A/,1,?#;9X#?DL@1B9L1F=\1FA,1J?\?UL MKPJY0!JQ,1NU<1NYT1F-$2'$#W60KQ*ZL1S-\1S1,1VKP`JH,1>;2AWA,1[E M<1YML=0LSW3&<1VM8!_YL1_]\1\!,B`%T#/ZH,"*N42(U](FD1(HFQ(IIW(HCS(GE3(JI5(K@7(KNQ(JMU(IO_(G?=(JI9(J MQ;(KR?(?D_(GJU(FBQ(7K:^IW'(IE](I7Y(@X7(GPU(HHY(H\?(L?1(OV3(L M]?(MG](KLQ(P"U,Q$=,JP?(I!S,O$3,OT=(R"3,R'5,GD_(PX5(K"7,SBQ(K MB=(LR7(ELRRIRNOG5,TE?<`'8#(V>U(V:=,2;A,V<5,W1],V8=,W=Q,W97,W MAY,WA?,X9W,V;9,VEQ,Y<7(YS.,U3.^US/J,30RL4 M0YUS0$&T0R441(D3.!6T.@?T-[?30OG3/:730UET-T1W]42'<41XU41XT4JGXT2)T2(42:=42,TT37-T2Y\439L42[_42:\T2^743:N4 M2^643;'T28.T':>KJ9HT3Z,T4-N43_443>]T4/>T3/D42K]42_&449F43=/T M3/>T3@/^-4FE]$TS=5*U5$F[%$R)=%$-]48UE5/S-$FME%3)5$GAE%(;E5#= M=%`%=4EE]"1%QQ.=ZJYXM5=]]5>!-5B%-:KRDPKE;UB1-5F5=5F9]5=-DJ^. MSS418E>;M5JM]5JQ-5O]5#\?@EJS]5O!-5S%U:V>E1-'!_F\=5S;Z@/45:K8 MU5K?M5U[]1LKLAHS1`;DU5WS=5_YM5IO%5K%45JM\`,(MF`-]F`1-F$5=F$9 MMF$=]F$A-F(E=F(IMF(M]F(Q-F,UUF!+S=38#M5NS^(V=F1)MF1-]F11-F55 M=F47]EE]CORX(&9E=F9IMF9M]F9Q-F=U=F=YMF=]]F>!-FC^A79HB;9HC?9H M:[980;8*K1!IG?9IH39JI79JJ;9JK19GIR_\-C%:8?9JO?9KP39LQ79LPW9; MC14CR39MU79MV;9MOS9K(X2B`#:G!-9M[?9N\39O]59FE7;90K9I]S9P!7=P M"==HX58:9C2V*.Q>"[=Q'?=Q(==LEU8B(+=R+?=RVQ9#[C$9\0"C!`-S03=T M17=J`4/9;"?5NE5F96!T61=J5[=U]U9S<35T/+%I9>!V:_9UN0!W=7=W7W=U M@9=F<7=W?9=X59=X@_=W8U9W>_=V@9=W>7=YBU=XI==WHY=ZH9=YA[=WI_=X MC9=YBS=XJ_=YJ;=Z;39Y9Q9]D5?^>9=W>Y\W>97W?>-7=;57>L77>'/7?G^7 M?;TW>"77;YF6?9T7>=N7?^LW?,<7?Z]7?._7?`N8>^-W?Q4X?-4W>IL7?B36X?+/7>T$X?_&W?>E7?]/7>@OXA+NW@4EX?1D8?"<8@DV8@7/7?Z_- M7$4'^:P0?M\7(62@#^#7A_=KOZS7>8W8AZ<5B7]7&H:8?)GXB0<8@R78B(>W MB,EW@%V8?E?WB9%8B'&7B8W8?A_8A9OX@WV7B:%K?GF8@A=X?8C;,W M:^'X?;^7@*=XC*$7A:-8?[?X?T_W;Z.XC^UXCM&7=]&8D`?^V(U3&([=V(?E>+.NV';EUXJ?EXN%&'FG-8_W-WNA>'>]^(KE]X5! M>9'K&'K!F)!?^97#N)4Q>8\Q1&Y?5B*&N(NYH%.F;X@[I4.:>%HY)9@U9;,T M19*M,)F;ZI?!V(?O@I'I^"$.PYDI0ID[)9B!N*D\13`,(XDA MXH>E.2)N=R)^N9T[-C#$61A2(17R*F;=>9ROV0K3F7*_68G#N8L9`I!KA]GV MN6,Q4IR%^(G+V9\+^IV?.)\96IN[F(B=^2^J.9DEY)@#&ILGVJ)#>EHM0:%) MFI&YN-0D6ILWFE.<61@<[9WOHI^E.5.8>:U0^H!2/B*H.X(+QKJL MJ]JJIZ`8,,*DB_I+HEJMJSJM@[F=A$$('``/IN`?"!LQ^-HC@,HBEY:H",JO MI=JN\?H?W.*R1X(+Z``/BD&A31NUUPJH_]DBGIJLN_JK,04AA`%=/HLCZGH* M'$(8TB6W7]LQ2#LR6)-K-2($O.$1X``.Q"`2G(`?Y"$$W`*YE9NY;P$:XL`! M@%L:BD$1^`$.GB$2BJ$8Q&"Y^4'^$4(`(8KA%N"`$+(,$1S@&>"`'YS;#<2@ M&+:;J$."KXM!&Z`!#E"`$"(A$L3@&=8@O[O5GDR;1A"A&I;[$1S`#[#;`5)A MG81!F-+%#QY!'CYKP;?#=`_Z;T>J&/``!>``&B+A$:"A&J8`P4(`#N)@->$\!,3`1EH$(H2!O(,Z%9S@Q+D@%?[ARP_\11!@`;2! M:34$`6[^H=$SXLN7.Q(0``&T(DY".@P-,9RD:$0=<=/486' MX=0YXK:1W-B?X1FV_*A:)'%+1X=?Y!^.'`ZTF[M-G!_B=@$TG0[P%2046$X1:B_9W^.PZDX1_`'0X:G0[ZP!+TVK;_80U&``$T^A]$ M^R$RI=[''%.<(`X$'B/K'!H(6T6X(!(,7K0WB]*%@-3]_1\"`^,10$*$H>`E M0AB('0X6`)U>'0[<0#`(OB%<_>"E`5/^@@M:'IF%X2X(OEO^,26O8'[C*6+< MM>'CN0`1Q,`MNKP8*ER9[R+D*QZX0U[D8[ZV^T#D0W[3U\Y>:^J[^<&D2I[" M#W[J/XO@/^OEW:+J$:+F&4(8$$&G$5Z?77WME[ZV<][/#;V9G>0?V!L.SBD$ MY!Q3QKOL:]N>G9[J,QW?_1Z_H[[LH=[?K3ZCECI7K=U#L#W,_X'-=1P.(D$8 MH.#>M5O$??>SPD*0@`/(F'(M4RYXX"K M8YX.'$"\W6*LSUH:\,`!"KH8=-P)N/HPA&'0FP"_M6'MTSOFA2`2O*$8I+OK MO8'-;SL2'$"Z8][Z>SOZ%4'*H:#^Y`GA'Z0;UJ$!Y$/``;;_S[EZK4V-K`E; M&-;?`=A<&M8:$4)`]_'@(?*_&`""CC=$B.A(HR.LF`,'TH1)>PC1#1P4D:!` MH:/HX0(X2@&,N!B&0H7`G%FP-%+"'Z M_/DPQ`!(1(L:/8HTJ=*E1)M4$V80J-2I5*M:O8JU*C\X_.A`<<`QDLN0?:0Y M\-;'(9Y(0E(]+$:39$RW>!R$<`B7(,2%Q1!)@]OWKTAA=>\^A((H4J2!WHKY MI//O%D<\PD)`@Q,')<$0TFCV>>FMITN5#H5IX[A2R.;.!%$Z$"+Z)<^LM&O; MOBT5BI_^0DQ[(^57"`^4K)`)<720*@04R7`>"1.VL2."TW`<0'T,Y1&<9X@< M(M3>\7FD+CU]6H;C!`$4)Y@;$G+BK1J<:@TC/8,#K1KR8F[\5$.A"!3%C("9 M?'"LX=Y]^450GC#L02--*M74]-`_"T"CB!_0T($(>P>*`9(3D>`!AQNP>1,' M1VN(`9D8T(`EQG4/>046')$@D$HQ]U5S$4K0W+*&&P41"(H+!` MD*%Y8'N%1B"F^\5WFU6Z2^`2<<`-'P!^P]XQ.')$'Q1H'(B##3\*D^(P#CSS#V8PHN"%-IXA,QY$0"#AX M*`+L.3VL4P\5?*#Q#='I=<+3`/U#T MF>/8T1[H$($H%,-<=S(06`T"@SIMZI]O.P<4>(0^E,K>Q;@EC43\R$,@(J<] MLHMVA"`@GQB48_9+6_JJF>*G\X:^Y7U,]5D M^0@4*6JSBV2>2\A1!(C("HWCDX6LW0BI@.7'+MH\M;"M(K\LK9S4#2WS`N5! MQAR$4[W"F/1)Y1##SD2RH5 M2UD7M"'^$VG(X'<\B]YS9.8$&0@#+`"*CB)2X37V!0G`X:9%'&/*Y12JVPK0:D8<.$O$#E)KC+XAD;3[@60,"#F)`_'@C5'PC M$(00X;FHN6&+'*D)WO3&D=#082MYVYLW$""/$I$1#F""B+CHQ!&X0:%:WJ@9 M$U.6(V_8KCF(2%$<$!`JR^&J(6>3SD8PV"G,,6HH_JNDI)Z"/_UI$C=;@88V M0/B<$/QC;S>"32.?-BAHA.!YFTK<^!"@N>X5+XL'*H8$A:$=6^$2,^$[#B(G M@HB%C>!ZSU(@`QN"$/?),!7>N$\D4H$W1&PE/#SCO?RR)6T4+".7HF.'V[A MF*D4(TI0.\A#N!`";RS`0Y01!@I#%JIG((H0A!`D>](CK1ENTV8/"IHWP]80 M+L*!$,\1(DN*H8U'-*$YSXD`1UZ(LN9$@J*4\)@PK%MS[)H$"H,LO,)!V5SKQ.BIQ\M8VFH."=@XPR MC6$;H-.^FL9(!NR/>8/K_KR#\&6B1IR.H19R5$OZH)OHQJ4SS5!)HKH3@:%\8\Q2<>D#\F2-Y96TI?^(Z9^.-H_$"?%&BW@FM!P MS#_D@X)NB=<[EQF!/`2+X`@MF)M.=6/)*IS8JH9,O""5Q@ZMQYE4X,&9YZ*C M=\0:Q?,\XFB<\G"HUHJ9M_I2,N:K*W4I-@"\_K:2I]NMCZ>R%7[\!#(6%J4; MIZK8L$G^)&^Q?&S*!#8@CG1EE[K,92K$5]-(H*`:)')""'([HU0PQVH0(2W[ M\-`VJ:G6J?"%&FSG"RVOU?:5\+WBC^]\F'KM&!+KU!>_A,$%.LC*"5!)H'5\ MT@5.AUN$GYX)-$H-TIQ+S(O"5`QV?*E(A1">=M%K:M2*Z7T09PR" M@%O@@0Y&P\-EY(&`&K6E#]I9P"Y2!#%AN!0.;3G/7".VDC"MD",D):**%,T< M>72Z"WX1_O%F.'W2&%D(`CUT.X>) M#DPWR+XY$L(R=\P/$9L*5&05AW_DMEM<=$`<1RHP7,5#&S*X3)$6\(A5XNJ: M0Q1[L!_2AW_@3":`!LM`XE",7;@TF]*"24P?X2?T(.(??;<.<[BW!C(_)-9H MNR(=B&3$WW'D%K=@E:GP4V9$W$>!\JB&"L'YU"D\9P"801%'IF")9J+-#V/U MR3/<<+A4<$%C(=M;71YR&3%$#"'^-7K1(\1RGSBH*F6BCV6^X1X_'&(EB%?GOYY"I.X1$`<(L9)X*>NE MM5*^!IOT!="/.;Z<2LY=]MWH>P4>KAMTMCXG)T,#F").`#71P0]X\`@,`GV[ M94Z^M6,`!'0_@5!"\`C0``V_5PU6D`2RL@9WX0U$$@>(8`D=X@9% MJ"'00`CB@@>K10<@98)X,`)ND!\+<`L7.``A@BQLPA(RXT,+0Q&A`BA0`88- M)0:;)Q;^4=$'&'&!&2@$AZ,J5H@$]=R@3:N(&3E`,;/5_ MSZ$(E\$GT/!_XJ(-BN(*AG%0Q?`(63@BL].!-I$B&')E5?@(47@2>%0DSY$E MSW`+CX0:);_./^;WWV$S*`D343 M-C53#"'`="%0$*FP;AY6;AY9;HXA`UR0D3)0%@XG04QG2RK)DB0I0@^1D7F" MD;;4=!(4-F5A*J&1(T(@+@V!"+`1:`[Q:=7'=`<1`B894*9BE'94;@9QDK9D MDU'X@:)W4&FB;BH)C[(7AP[AE>IV$D6Y2C79!QPI0:VREAW&&5"1E!NYCIZ8 MDL@D!*@7-A[)E*?&5`U1#$*@0C!9,W`Y!;(G0AK)=`B`$:X(8$AI&'KID3+I MEW'H%AU(F6.Q;HY!!QZIF2;)E)>(D8?)0;18BY%RBS;9DC*9DG59,RL)$2O9 M8:JIDBTIFG+)FH>9EC8ID:TI0GW^H)*ZR9OK^)(E"5(N>1!]&3;BX@T@Y!8. M=VJ;:1`>Z90'095,AQ+:@!#429U+N9E.V2V"DT=[F)(E:1!6*9=K*1,GAPB* M>")6'\Q;E.95_,97=69UA\YYND988J9+)V9H;V6$KR9^_R9^AJ9$9V8$U MB:`"2J`&RI\MR:`W"10]MV?!18$I"9H="&C]"6A1T8'B\J$@BJ&7&*(;&J(C M.J(G&J(?FI*`-J(>QA+BPI\PJI$B5'T>1J(KFJ!#B:,<6J(F6I=<4%"KV1#) M6:0G8:0JY)\M$6C]^:$F"J(`BJ$V&J,YNIJL>:,ZJJ,TVJ,[FJ5.VH%1:`E# MZJ7)N:+^!0JC38J?(%5]&9JC6NJD*9F+C5*:]G*:<>JF;\JBH#F@5JJCJ[FG M$-.4AU'M:B,AFE M>,H%EB`^V@`U_HF?'?JH*5JIEYBFCGJB@.JGGKJG&*JJG@JKJFJH!0JF+)JH M*3IDYM1\%NH3LWJEJCF@*,J@NVJE"!JHM4JH$=J?QXJK*'J85[J@?GIH-)%/BH>4JIA"JHN?JO*JJGT9K^JMUZIO<*FM7: MK>VJK>,JK;IJK#63+M$FKM$O+M$WKM$\+M5$+ MM0&;8P-+L-0EM5FKM5O+M9!J&GX@#Z7H``C!M(+R"-4@#]36M6O+MD_KL^?D M<\)Z4&U+MW5KMW>+MWFKMRM*M3IFM4QQIWLKN(/;M)WV`<+P`;+GM"$CDH3K MN%S[MA"85S\GM(]KN9>+N9FKN5I*M7_[*'MEL)LKNJ.;M/9`NJ<+J4`!K/XF MMUV*NJ\+N[$KNPGZ$W3JN8#[+I7^.[N[R[N].[@QF&?]`[3LY+J^:[S'B[Q1 M^P&R&!15>[M+`;JZF[S32[W52[38L1N2FU>MRP4?X+W?"[[A*[[C2[[E:[[G MB[[IJ[[KR[[MZ[[O"[_Q*[_S2[_AV[?/"[T%^YKUR[_]Z[__"\`!+,`#3,#E M6PFR2)%Q&[0'50D?4`D/W,`/[,`03,$5/,$-?,$0_+T13,$97,$:S,'>J\$. M[,$2/,$DC,(FW,$?;,$E',(1[,(2_,$DS,(RK,(;/,,Y',,<7,,VK,,TO,(O M',1#',,7#,0KO,,Y/,(P/,.=B[]*<8MS(CPS)D2S)DTS)E4S)3OS$2!'% MEF#)G>S)GPS*H2S*HTS*I"S(/_M;E&M'IS*KPS+L?S*]YO)1Q&]#"S+ MN:S+N\S+O=S*IPRW.V:1$/$!/F#,QXS,R:S,R\S,S>S,SPS-T2S-TTS-U6S- MUXS-V:S-V\S-R%P)F%S+11'%W4S.Y6S.YXS.Z:S.Z\S.S@S,%=FZE6`)\TS/ M]6S/]XS/^:S/^\S/_>S/_PS0`2W0`TW0!6W0!XW0"6W/X!S^SI!PRQZFT!$M MT1--T15MT1>-T1F]S^_,N@LL#99@!2#MSU9`TB(MTB4]SR%MSR&MTBB-SRY- MSRI]TB9-TRE]SS*=SRV-TS7-TC'=TC:=TS$-U/_\TT7MTS]MTCU=SS@-TRL- MTC+-U$(]U%`-U2_MTTZ-U4AMU%*]U$%-RPWMT/I[4#J]TCKMTB6MU5V=U$Y- MUD-]T_J,U$]=U6[-U#O]U"E]UDM-TG/-U4JMUG[-SR@-V'9-US:]TX1]TGM= MTWA]UX$=U(5]U7"=U$W-TH*-P*LKS/&\UY6-UG*]V9\-VJ&MV*#MV:2MUZ*- MVJFMVJO-VI^=V*T-V[$MVYM=VK7^/=JS3=N`%;N`'CN`)KN`+SN#O#`5;N$7CN$9KN$7'N"U/.`; M#N(A+N(C3N(6_@$_@=FI+($^80DG4.(O#N,Q+N,S7@4=GLE1O`LTKN,[SN,] MSM\G<.)A,LB9[=$M?@)'CN1)KN1+SN1-[N1/#N51+N533N55;N57CN59KN5; MSN5=CN3^-5Z[I-G04>SE96[F9X[F::[F:\[F;;[DNX#DWRSDXYU.$BX-5N#F M>:[G>\[G?>[G?`Z\K2+F`B[6'O;GAX[HB:[HB[[G,[HE6[I MEX[IF7X"@5[<8U[H'Z#IH2[JHT[J7N[HP0O/]S/I#%#JK>[JK_[JG#[H'O[I M8`#KMX[KN9[H#'#J6$/G$;[B$%$%];`-Q6[LQX[LR:[LR\[LS>[LSP[MT2[M MTT[MU6[MUX[MV:[MVV[LFQ[F?DOH-?0!Q,[MY6[NYX[NZ:[NZ\[N[:[L]7#J M%*KB'CWLQ0X&R'[O8*#O]K[OQI[O_N[O]\[OV]#O]F[P^E[^\,HN\,G>[_^> M\`1/\/DN\`L/\0%/\?Q^\14?\0R/\1P/\`J/[PN?\1^/\""_\?B.\A<_\@8/ M\25_[!//\C%_\A4O\3._\BB/\[(.UN+\Z0S`\"O?\!%?\#!_\"&O\3"O\CC? M\"Z_[`_?]#BO\4?_\DG/\O\N\S_]43?]?M^[PPPDH\NO!%([ZK``'>/]WFO]WO/]WWO]W\/^($O^(-/^(5O M^(>/^(FO^(O/^(V?]SJ_\V$M[HY/^95O^9>/^9FO^9O/^7ZO"G&/ZI'^$U5@ M]YUO^J>/^JFO^JM_^LQKN\9=Z)7^4/JL3_NU;_NWC_N<__DH_NN59.>DSP!V MKPK#'_QX+_S#7_JS/_MZO_S+'_S$G_S)?_?'?_S%3_S37_S/K_S:?_W4+_S3 MW_W6;_S7G_?>'_WCC_S?__S9O_[@C_SB;_SNC_W6'_[<+_W@W_[OG_[PC__T M;_[<#Q`,5`E4-;!@08($$2),R/#@0H,1&4RD:)`!%VD9,X88`,GC1Y`A18XD M6=)CDVK"Z&B4]L'A0($3+<*D>5"F39PT%<;4R;"AS(0W'];DJ?/GS:)''_[T M^1(GT)A)9U;L&74A5*P\A>ZLN71F585&(XZ%:M.J6*,4HR*E>K9BV8666-*! MXJ>02;S^(POA@<)26I6Q0P4/)ES8\&'$B14/#KM8<6/'CR-/IGP8,F'(EQE7 MMHF1)<>\H4631*F29:7`BS5OYFP9W+\L3.%1QX'"P^?+GT9T79,Z<^G+LU:-;I_X<.G?LUZ%?UT[>>7/KZ<&C MEWZ>?/KLY;U_S_Z>/7?TW;?G]]Z_/GS\QM.//_Z&RN^_[OXC<#_VIJMO.NG6 M"P^^^!QLSC.-0!MNP]!*6TFC2A9\;T+Q**SN01+'(]#`!%<,KT43[VM1Q0(- M;*]$\QXZ<4;U&OSNQ/)P3!#%^?P[\,`7(QQ,/1U3G._%&4G^E%%%'0/%TLQY$#Y4SSS8-7;//-MLD=,]&)QH4SCXQ)9--0!==M-%& MY]0S3D3KU)/0-\D,=%5(5V4`S3EAI9-.51D-M-1$"P5#54ZWN3/.1NL$E=!/ MB34T6#Q!-?53.H-%4P:_-/1R6I$\9.F#33V=%$]M/25U3SQ_33581_T\,])4 M2\TT4D1A%557--]\-]-FW90WUC)_-?5,?7T]E%Q,N55WSEK-+'?07#$UV&!Z M"^TTTX1-95/-.R^5M%0_%6:43'W^+_6373EKE75A4=T4=U4X&:C$K[H*X8=: MD8SS:V:::[;Y9IQSUGEGGGOV^6>@@Q9Z:**+-EJ:/J2%&>;2CG;Z::BCEGIJ MJJNV&FVRRE=[:RZ;)5GMMMMMV>^RLS_ZHZ[?KMOMN MO/.>F2-ZY)[66KT#%WQPPJ&.6VXPCRM\<<8;=SS:COQ&.Z7'*[?\\KJS?OEL M,%7Z$&ZK/W]:=&D^)_WGTS$7.W6=6:?9]=(U*B9RR3<$7&_8I4[]P]QM%IUT MWF.?.?BH3?>Y]]^\/MUUY),7WG=A[-I\:S`10+H/8;#/?OOL^Y"!^SZT[U[[ M\+_??;[]_]\^KD/??H+(`#' MU[[[$5!^"TR@]^S'O0:*CX#]NU\%R6=`\UDP?O,#GP4/Z#T/'K!^ZGO@"#_( MO^U)@Q1]J]UP_"&&OC`P?3*<80UM>$,$8T MIE&-:V1C&]UXQC&^L8QQ=",=Y2A'.]Y1CWOD(QKSV$4I3^F!QE*3L92E%Z M+<9C;-&;93G?'$9CZE24]]^*SF/LV9SX`2E)SO MI*8[&5K0@`JTF8E@Y'":888HK&,=&E-:1K3F?;TI3CE*4QU:M*;!E6H,LVI M2E/:4Z/:E*DG)>I*:^I4I%9UICS^?:E,N7K4I()UJ!\U@Q=:Z`8M[,.;:V5K M6]WZ5KC&5:YSI6M=[7I7O.95KWOE*USWD0@W5%0T%PV"&0Q[6#,4%K&+96QC M'?M8R!I6L9&E;&4=.UG+8A:QFK5L9SW;6]S3KK9V:%7K;9W[ M7.A&5[K3I6YN=\M;9B!7N]OE;G>]^UWP!E>YM6LM=QU\=+; M\,97OO.E;WWMZUAFC!>9S5VO-NN0U_^VM0X![N]="1S7`[\VP;/EKX$7+%OK MNKZLA3FL8<-^&,25U:_?REO@9@HBK\R8!5N9(0AF M.#?&#W9KBYG)XF@DF!E!H&N,92L(&R-X%C/N)C.8T>`;'WFM/G8QC)T;80F/ MA,*4U6ABUT':QIYA'1<^0Q0,NXXSC-BW49A&F!%;Y2\O]@S3\+*6@POF+0/7 MS6,^K)>'"V;'EEAN)ZXKC?E:AW"8`Z\8(`:3GS8:;3"#'&`@@8@01M:/9IU]$&$FS:MUM& M1AW:_=G":B(*A06!&>Y]VBC```-Y/BN?Y[H/;H`@MI3N!@"6L`X_KY48+P`` M!EI]Z"5@`P,`@(5LZ]`(6+!A$]UXP29`T&NV?IP;(N_&$F#Q!DWXF!E7```: M4*[-6:#A&`"@Q,WMV@9!D```FX`X7&>1AF``@`QI:.8LS`&+;J0A#4Q^>M2G M;NMU+`$`)_@".V'`0)I`$-RP``&P"P MC&D(WK'3X`4`NI%Y=YN#XI30`,!WOHQ<4/X%=4?M.G8`CF`0?+D&E[61>TWI M<.A=$&./*^]K#`+)^WRM=6#&QAMA:*"'`QSBWH`:(H[7=>2=$A!G`QLT<>JV MKL/O:%@',]!`!G`(.AK,P,82$,R,AMN\KDAVIM/3,$9!'&%A]N_%Q@%00"'AY.U[]NZ7BL^-F"&=<`&YQLVVOHKLPNVQOJI M.#L#"0``%A@%RXH"H9,V$?NN=7`$`"`!+4.#)7B[P*NL,\``<(B"7,"&(Y"` M+<.&*-#^,F1H`P\T@VG8A`G(A5%(@V-8!A!@/<@*@AT8P2C0A#&+J[*K0$A`.W]K@QG(QAE0@L*Z.P`XAC.P,"_^VZ@LT\610BP' MY+O#TBC%0K,OZ[)F"\,N&T'#TH!1,`<`"(SR(#$C&`C/6&X474(/,$REQ,X4A"R^4ZPSV($J?,>;-"R`G*R@ M-`-[#((&Y8S1$:P1S8#)!((9&((8TC(9'N\.W9*:T%+08*S1B^*]*;`1(M+$8>S5* M"$1;JP,U<+ZS9`9BF`5-$+5P`X'^5_.Q64A+XJ,$F\O+L\Q*07A$(S,\6-@Q M3=O%/M1+XFL#H-O$GB.^C3L&9L!#[^-#T$S-&ZL#0MLXFQ.$SFR#N!PP2_PX M2$2YN*-+[ZM$2B`^_](F-@"'3=M$33`PG`@2N@T<7B!@`X@B$$``!`-GR4 M5?X;/^`[P26@N6X85C8H-&<".JWK.>ETN%GH!A/@!;\#!7/^>X'RNX)%L[=- MY#YF&`50N#P5:X1C8`.\;`1P70(U.#[B@U=LX(4XW$5>"`:2R\=N8(-P$`00 M>(%H'3)VQ8:+7()E4$QF,H=][09S@X4K@-=@B,"V"H874+$K8(,;L\6'`P?C M'#^/A3$T2(,SV#GK;"9-Z(8K"`9>V(!9:(--X`42X(:K:X16?=5H=*MIK$!K M/(,(@(*5$`936$\8^,;,0P8U>(%&T(%)U*QIL,]&6`::JU,S.(-P>+]-@`48 MT``8V`1P``$-<`0P$2Z`9ND+8HJ(/^"2"!YLO;=8#!PA6W'6`!$)B&'7B_8^`& M&24!<'@#REL&N,4!1RBL;IB`Q!+(;G@#=CT&"8@"#V&M@T&<``%;&BW=5"")2"#'4#3 MX-T!BD->SOJV37C;(ZA3#3#'*%B"--@!6F6V*)"";D"&8^@_,^`%*5#?%Y@& M3:"$C)*`1BC=.G.$8\``4`!8)T6Z1FA6GO.R:=B`39C:C94]R<'*:64&1:4# M.FA41H17_0L&8Y4U6`#5,XA#<]"^%]"H.@"`-!`W[/2QH8.XAELT$%`#,KC7 M-'BZ. M!FX(AG#(L6`88FVZ3`#`!MB4P_\*.WC%@&@X03##S"#8Q&UKA'U]`6*$A6!H M`Z>K.!SF1'-@@T;0J+&D0EB`UT8(X6YPP-Q#@R`@!@!HA%&8A6#@!@ET)BH, M!V8PAR;&AIQSN%',RED[Q6@(ABN`1EO.AC;!.ZCN,-$QF,`!Q\6 MA&.`U77PXZG3!!;&AJC;V;:BP/'\B)^-`,\A6J-%6CG0!#:X`DHX`_M$A@8% MYLLC-FY0@RCXWB0=A6G@!G"0@%S8.&F32@#`J"-`@U.8AC?^V('46X9^Z(>_ M;(0&U0`+9S#`)ND`(AI+FKU<51X$E*.(6C-6=DP(%3 M&`5-V(11N.JLWNI]`[PSR-$KX(9SIK@MZ]P*O8(C$*D=8`,S\,#J4V"_8>!F M2M2^H`M'33&F!3/*&]=(3LYH:`3^IO-C:>UB4&0&B9TQ$2;90%R'=J7%-(`% M5PX'(HV&<&C`R/QCLLS"3NP\3=A#$8:XK/L[PVL$0:#B:)@%I>:&BQLV*EZ& MJ-N`__KAT=XTK0LP?-S,,`8`P@L'BGL!FR-7`"#N9MKM,UB"0J0T*N0^?'RX M(?/C;@@"9MCC:V7+(-@$,B@R?-P`!QQ#'F,&$_A@WR-&'@959C*!D/4^3J;D M%F-OK@Z'#9#CXF8TXL-.9K)%;`@"2MLY8CA9$]@Q6([E7YOE6CX.7,:HHP5' M'U2##GPWS[MH'[1/L=5F`&"&,S@"%FA18C9G*CS"'XR]*+@"KIV&-E""=;@" MF@V'=-W^A(L^`TJ(/7]3@A/\YXW3A%$0.@S(04>8AFX(AO6\UU'8."A,K+D& M40``A2Y;AG9>!AQ`!N:-0Q@X`XRE21C/QQ:5`LT*@F!(@Q:=AG1%!@V(`HFU MPL:"/`!X`PVI>[&%K;$0+1,56@TI4ZA<@!@PE!F((@F/^'TS]@=+A%/SY!V$2\5`-NJ#5JK;DKJ[0UY@7]8P9N((,`8P8U"`;B M)H8K6X>_#`9!$P2_&[]\][V6I?=C@+B@P$3:":,?63SIK]1G`60A4957H=>WN0WF(4Z?K4XQ`!3F]8@P$[63F'^[L4J MWN!*9K_U$\]9KL;&BH((J/5;7X%`\&5T;\N\3:>[DTZTAEOZ"7!H$M"`PJ*X*QA^RVK1MT5C M'_SPK`?R-M`[R`_Q,F0MG9>T3-,$&&`F-L2*N#6>@\\0OA M$5;LBE=_&/O+16/_2A2$5CV#(1LR>L?V2%ZT*3[F3LQM@(@6I!&`)8+J,".X MY`P&`(V8"7H#H$XT9FJX"8JF4:.@)0Z94=3(S!R`90A.6Y'U+`$ M<&59D+2"8(&;)8@7``Q!Z@CJUO@,K"O,TF+.G'E?(C>0/H,.+7HTZ=*F(34S MHWJUF2`WE+1Y]ZZ-ZB@P`!R;9B;*E=SK;G?3O7H:,@".HDQ[N8[DBS.[E0!X MD:ON\6F;@JF>9NYE2N@[<@6)(I[U-+E!=I,,I^',47/BHY``5S#7"P"T54N( M,@&`>S/6^:_#$%(8[(#<,=SD(MXZ4:@63!K"^=<0):#TMUK^%&@4-`TS%V:H M064:L!9BB.M(`,`;&IY!"0`[G*$!#D>`:$:`C1P!P`0!4<3,4K"`9&HCZS3TT*H3571181OMT]%'N)+$ M2U$UQ029&L`R\U*U,[U$`E6;D`'^67UH!'L%+.MP8P)'#1&SSE+=G.25HW41 M0Q4)RW33#;DA;>0K`%\Q(]9&)KQP:[_$I!%-J22:HRR^/EAJ;Z]!<QDT4*C&FFRR%D2)2^RI@8H%1H&#CC+" M($>1DGW^EV//R$T3^]I#4K+CD1H$T08`O$P#^S1G3%/7$N!--SA!E(RR`0!\ MEBA%+FH7*:4C$J@>I7&;BWA>,,OD$B<`9HQ25YU]>AX=WG$&@[UJ@,(,LQ8J M8T8T+^NT(5(=P;!1431C\D(,"<>H)1C!:$0TZI*&(`A"+A6IRPLJ@B%;F>P* MF\*0"3!`C&5L8AV317&S@+J,@B01T M%PQLF*,;#X)!,'`PBMZ90$_9D8)==!.%'`;#<-W8A'@<-(I2^D=Y(`#1)8,F MD<'EHAM78-`H*D.X4EXRH+LQPWS\LQ0T3*.?1WCG-!K1C6]&`2FY.,(1M".B M:6`(H:,X4B@)VHUL($-+.$( M+R@A,1")C=::@!>QA9<>/<*-3=0G#=G$#6N==8PEU+4.Q)"/7P7("Y1%0S*[ M10-0,-#^U6"H@1BC'9-?JPM89E!"#8U8`BSZE=[U`C"Q#\L8=KO*AG1JK`ZP M.`8ENM'`:(AU@%G-:F>J:F#25+)S/&4-#*1RA1U(@!(FN((CS""5%\#@/*W! M)0"D(`=SX"`8R`C:,L"!C!T<`PTZ>^PF-B"7#9BA-V@@`0M@,+GZ^#4-,6I- MT!KRUI>\``02J$DWSK"!8(3#$2\`Q8Z\"@`6R"$(&@#!%=+@"!_M.`J:.(*C MC*E6OU[!/<@`[]-6LT-V M(`SWED&7\^&AK,<)3^8V0X:<;<`4GS MK`112H0P;0W&)D"!/V3`$A2.V`3W,$`&56^"%X_3,)NB4!\6\*(F5GX)X/HR MP/,\]AAI0.0&HAS5J1[8-&X@U("C00P0H(&U&D$#",P1[8K4`0/>3=1(L$$N M,ED1#>'X(@%!$NUH$^/9XN4("+1]*)%0(AQHJ,-#4'97+Q*CL<301+[[U8AP ME#L:UM;$O,WQ['FG.]VC33>TUZV1N_);V@<)!S9`D!'I'AP-&H?,!T%P\/H% MP1P4M[B_PT$,+\P@(V1Q`0DAW5Y.,+!#7)MY*X&-X?'/2Y=CSM< M+<^NMCDT`5B1B'R.B1U).)2.&9[^9Z8-:%#WK`*+`8`S@RP,#WJS,<.R9(,= M-3V5JH)]I@DE\%P"YEB[.21P=DUD&G5OEP#:E:")[(#@4G*($8,P0(EI.,(< MNKDK-C!`.1EI``W(`(%P,'F>,VC"VV:@A'A@\'8YM,$L;CUBCAT8___`["(P=--'8MNT'.C"%4SR"<`0W8V,%`S5#MS;9A'3PF MNX8]!P*TF\,,;K=[YLW16!FI'=64*.9`"O1HU=#O[GT$"C2!= M[K2?10R`8!1O%*4Y4,WYW+7?C8_KG%3/(_Q&(*/OMYP[VC>[(3,T`C;(0;69 MGNHA6]C^C<95-1NBR%>C))8@A)%(>$H=D`&IB$2IZ`\,-4JCX`H$IH6CB$IF M."`'=F`8!195G.#%D&"_K*!((`I7Q)"GL.`&-N`+^D0481<(!I8+7LQ&"$)& M!%;P'<,R$,X9G,$HZ,O&I.`&5H0-SF`+*D8$^H0'9L8.BB`#^J`,\F!]=1VS M1!("'E@E.=[M2=5[*(@9+LA[P!,:FJ&&P8[P%=_OS%YK8$[L7%_0]$[2P)-/ MF0WNU<9[M!#LT!,?SMJCQ4Z5.-Y`U1-R%*`9[D8;@(`9*->:U)\Q_4[QF6$4 M!-0FVE\;IF$F:J*,P,[\X5XQ\10H`J(C)J+]R>$?JB%R,(C^!NC&@L3.X]"B M''(B3QFB;J24F;S')X9B2DU#>&`/)E$5&'Y&,W3A,FK&5SD2,T)C-$KC-%*C M-%9%06``IJ2!MU1C-WKC-VI$@2'C)(DAV>VA.=K9L:6C.M*?.GZ?'I[>Z=43 MF[QCB!1?5!F@.V*2'MXA/(9(FKP:+R;B@A'DL5T?K?7C.OHC/^KC/BHD/J*C M0_KC/=IC13+D03ID/69//8ZA,8[C9[C!^X#C(VT`-_#72*)D2JHD.)(%+W## M1:3!5JSD3-*D1G#&1Y+C\(WA'LJCZA7?/"(D3U;B.^[D1G*B0/TD&1K@)L+C M41[DV)&A/2X#+&##CFE:1Q8E15[^)?WEX_!MI4!!)5!2I$_>(T9V9#R>(T*N M(ED*I3Q>Y3["94_II$Z>QS&"X;)A54T^W&5PE5[ZY5_2)`Z"(&`29C=^'4[" M3(+E(EMZY5DNID'"4UIJ)5*.'5V2I5(Z)4.^)5/F8R7*)>XA!SY.Y%Q6IE.R M)69J6CS"951NYE#ZI"YRYCRV)F7:8U*NIEJF9D_NY#W:)1@J8&'*5V$*YW`2 M9W$*IS@BILN48U:NY5/6)E&69F2NHF5BY&QBIFFB)C\B)6XF)5H:9?U]I6GJ M)G5N)D3*)G5BIW>J)?%E9G6:)?%I9F.:(V.*IW0>X$?^IG'JYW[R9W_ZYR,= M9G(*BF+^[F9FAF5LSB50ON56+BA\LF-8'NCMF:=H3J=M$J1&.N9V@F>"NF9G M1J9VVN8=_F1M:J=D7F=7NN=SOF:$IF5JRF96WB`#@ILNB946J9N)F2!;F?9R:5%@FA[YF90HF=S?F9;?M]\EMUK!B5V8N5D M5JES>J5DTF5KFF0IJ[:E(9.".`FJ@!FJ/^FAI**9!BBB,CF53/N65NFAJ,@C?5&1HTF'C ME6ACSB'BR<@TP&%3JB:&CJ9/[4:B.BBB&J*DTN-"*AARZ,S^)7IG;0SCE\9E M3[YJ/RXJ>))J18HHHG*E@G5I7$K5FH:=2"X@!AS($FR`2E065:(,,V!#OG1# M3"PC,U!9&E"-FRW!#KG9,F0=".#1G0IJN(IK87YAH?XHC+HEHWYFH[YG@<*F M?X1#:-$33_W&!AS!/,&`O=;)@DTGGHS8.L@!!E`/,K01+W[J;6:DA]I&E3F: MAWIF4,;6,C3>49:F3VG")I3-D"T#)>YA&V`#-TR?KW)H>6;I.=)JB@ZE6V[H M94;ED=:3L()=FPY8$"P!.&!#&E#`<97*,G!#&M1(.'";BI273':=KY#!"X"$ M5)!*'2AMJ2P%THYKU$IM84:!N0;^B@VH)JVJ[$"FJN>D:T*6G01DAV00TZ/Z MS'[,DQ+LQTZQYSZ2R`9D&'R``(F04]D`*:Y*:!DLY6[:=($K(F\ MDZ>N+#Q.@V1,B5.44Y+FCD3L@,&2)Y>>Z==^:8DF;)@R)6FV[(3N),PF&['B MJ5,L@3"-`C%D:S8Y"B%Q6S=DXZ6`J\J,1+^`6T6`FQY)V]3J[NZJ)*%:;6@< M*N!*9#M6)/U`4:VFJFV\`=_X#*H>6RZ@TCJ[=!C:< M04@5Y(>NAAR,`B]H23M&`6T('SUV9STN".&R;R9UC@2@03<@`T9A`)AT)481 MB9U-J4;^?BBIGJB[5NC6(JR"!FFP(J;,XFD/H4$&`9B?SH1+;HHF#%,TG`$7 M.DI%X*#"K$,8#>8LY)`%CO"FT&E%%`:=S@).>+`4\NX+PS!7^.[O)J/6RFH4 M&*$PQNKCB4<>0LT2'$."9`<."PRLT;',,I:*(&C((;#F,K3H/38`X5 MRV(>K@VG\EA,!0,X!![^@,(H.`4)Y,(A\ACFP"+V#2/P^(@PJA],]$[O M``\11ZH9#[$LRB(BCNB&2F=9AF>OLFQW'JQ[>N1'SFC7R0?^HNU0`Z[#,I!+ MQ[P$`(23"[!(TQBY>3+)ER.?]1%R5@* M]9)`-X`")=P?W2"B!)36#GC/0UD.&L#")`8-".#6)MB8\/%"-RR#%(B??'0# M"4C`^F(2#'3#!H0?&J2!!&``"RS#!W^IY^'+&U2(B0A'.&@3X-",!.`+ON2' M4(MT-TA`$&Q`[?#(UZ!E%&##2$/^"HO4`2^,7R[',^>)'$2'!R@L0QK(&X1U M:N7BZJ^*:8AB[M:JYU)>'^B&8=&V%6Y4Q(T*G"IO1",TLU\%T.M!RAP@]B2`QLHP8>!`PX4'=$XCB-LCP9(Q1%L@+$"@-IH@M^8 M`]H]EB-H!QF4#3E17D)3B7&?@2/XE=A.\1+,ZT!]=/J*AU-L0G4#0#"8PRCL MP`LD]0M<09"D`9R"`!LX@AQ(R0[3*A8WM M<>_H``O^5,Y7)0E!!P$:L($YG,$FM)Z`IYX$Q(B"O^8TA+;/X``+,<8+4#9) M$&$40,KT14%U<\A/BES_F\I?R0#9U40]!9:H<&RS((Q MY]BRM-`Z2!A_R`%7!'@5C8(-!0AB)(IA$[D%1@.X!8%)G@'&"-$H"$Z27`$W MN#!F4SF@EBL-BX88:JX>YH+@=$_&E`B<,`@9Z,@T]$89HP$W?%A8```,C$*4 M1T$NY-`&C,(9L(%T@$]Q@$#3\$&#<.'[0R'866:``HM`'S/MJ:1"HR M26PN#,D;Y`(.&%Z$E<0T`(`K0:\CG(+R2`#AQ$[L?'`4.,C^$2H/&N3"I%\! M[H1ZSVC`8.2"!NQ`,$3N'H_"'J?Z,5Q!^*U(JB-#'6P2)?BZ>ZB>2H-?6^W& M]%+T)L&"&-/&[I@-AB!/1AUAT>R(4.[JBNIBBY[ED*;J@E(H;RYP%P:?6/F5 MM&K$8Y06SD5#&P0?0<`IKJC('`5!Q0C$R1"S!=Z&OA?Y&2Q%M@9?7?#"C[?Y MP_B%P51YPN^H9ELM9\_G/B8'``A?BM@%=<19>4S)-(##,0#/$JC!!N0++RS! M48'#"^C&;83Q.@S%GK@4G7A>C*.!E(2#$0YZH`?!)KW`-#&9R?JCEC4&WDS# M2T+',H!"OBS!7=3'R+,\I-2!=AS^P]/SU_=6X.]`"FV<@:Y/@R8\O0X<@R-X MAW.DKXP0%!]/'MUA`SA(3A0\UC((WFZ,-ML;K%FN1IQ4E#FOR#YW6"AI@.Y( MK*S#!/0B!0Y+25)C;KNN*Y-&)&2B*Y3"IUL;F.@^$ED,1$P"`!O``,>X2V<] M(S.P03@X$GJ=RCHPACG(001=AN[PNP6B/EKL^_0"/.BS-Z^4?HY,N<+;_GXR MO+D2*,ORV"A(A-[:1F=)#X@0_.!L?.QL`@XD"/"$$F_D1A1`!YU'P"5U\^; M0>),`Z3^V-@TZ/HCEQ=ZT__L`400,P#>3`L2Y`'=,D`%@VRDR4ELNF:4A):9J<8)MRC8*U MR>3'C1Y##N7X\:C`D!Z5$F7*M"C(HT:;"JVJ%*0-2%NY=O7Z%2Q7+='(EC5[ MEIDY<^L:;?()@!BSLVP:R37+C!LENV2940*`@=DZ7@#,&3`#ZXI<&`#2K(NV MN'&T.HP=3TYSQN\F9FV8-9HX:@F`.H&Y'=E[%G5JU:M9MW;]&G9LV;-IU[8] M.Y&;L+MY]P[;;.C2J4;-C'H#H,S!Q3M`J3Q39MKQ.M.N'-/^,&T9`!@RH\!0 M<@;<.8,-@":HDS3SS\F"7;J1@*H ML`(II"@T`8"$::`[AIN6>,E%@HU`..@,;TW$SV"%W0HXI(A[TS@`-)HF)1L!X$F"7%XH*8HK=,CE#/E>$`DA MD$;)KD$VGQ)*P?FZ%#<7 M;H*A9)1<,-C`C$;&(_*8?IJ3H,N*HO`HF(*FV0"`-M9Q\0B#))XXBB,`(#B7 M;K`QJ=1#$'C1<`8X:88(YI9(-CS#DM&F;TZT;2B-"0"YQ@8&#F MQA>8F848'.6J7'(Y,)=4OC2"B(8;7M9A9L/%HV'#!%]57YWUUEUG70O=T)[] M-ZN)"ZZX[#:(H@Q8PAF/TY708`.$*#0X(AADD!EE`@#48T.*:=H`X(B*Y%MB M/#784+[DH(%>!FX`R.D1Z!XU*%\C,S0``9PVTJ]33J6B>)>':5@NJ+*E,T MUA7%-D5O8FU-6@QE5]06FW6L@Q++.(-=`B.IT96%458E7%D"XYBNRN6KA7LJ M6,,E-@BOA5L_).8AT9+RN-G5[G:W&]3CF@VO7P&4!&8C MJ;K>AKSG5>]ZV=M>\K8@O%O4:W=SD9V#2'$C)CK6L8;3Q*]!D8D[%8KZ0&%$ M#7+W3=@=&]?H%$6O'16I6DO*@Z]6%=Q1D;L!AJ)5$#0-',!"`M=9GQ0DL`X$ MGQC%*48P>./+E::V%\8QEO&,:?R:%LBNQ<(:Y8GE`(N1D5;%00YRR`!PA>)Y M5\A)5O*2F]XRS)7L\S" MT*Y)5*(7K1I&*SHUZT+2/3IN7PL:K^.5 MP+K)FUXYL)LLUY:`'-Z][FC8>][WOK>]/9W>=K?;+`"G=[_)LNY$`?S?"&]V MOPVN;W_C&^#[?O>^]XWP@4.\+!'^YW?!.8YOBB.\X_H6.;L][FYXE]SAT9@X MQ5-.WHF?W.(.CWBH1U[SF-];W@6'.+QU+O.=SR+A+4\XT%.>\FQKVS>M-C=_ M'6QNI\^9UD^7>IM_'5]ULYSG`J]XPG-.\9QGO>3__OC(Y[WRK^-N6-WD/ MWG.1RUSG^2;YQS4>=Y&OG.@5C[>]7_[OML]B[0_?.,G9OG.=]YWL[;XVVNO= MT_^N>=GKO.YBEWP/6_\R;&:7J(3WN.-W[H<\K[]EZ=][)Q_>;T??G;@J7O38"7.B00V80-`P60H89EH MR9:48P=<"01$8A8W@!R6X0.7@0UPQ!&4R`PHP8A@2\D2`0:R0V&,0A/"H8BH MZ0UP8B,T`!32(!Q``11(8`/3X"?29"/(@X8V0!-VZZ7*$02*9?=V0`=`(2A. MXJ64$02@D`J[RPI!R0VN3OX:T0OG+?P,4.$0;_\H,?OF+NL4$A#OCR&M3_'B M30W9;?$$,./`3__DC^=";>84SNW^OH[O`'`1Q<[AOD_C_"\1]P_]*++=#`T0 M%ZXF^P_[7A(2`\XCL>__XDX"&/'H/!$L0-'6S$`)@D%(YN<85HDHFI(5'4Q! MY.`#44PC@B$8RB`*F@,4^B,<3,`('8$,QD4"F@,'?L]GCN&A]*<13N%=WN`Z MWN`%`@H`'&=BS$`?"4)'KLP,#&@E@D.`BJPC\.4ZI.`*@BLE5J(-LD,'I*0B M8`%6!,($2*`?D($L][(1?`QIWK$,3``;^@$#V(`#!W+%"A*4L'`3AU+BWB[C M6@X!#5#Z((X./Q+^W@[D9+,G:3+?L.XD:X[@0I(F)>_]XL\W;S(-,\[S6$X+ M[7#C+%+^(O6.$^L/Y3!N^C92X1:N)#\N\%)#]#(OV@8P-FGSKI"R`E$/%G\O M3]A3?A)DPBJ".HX!)A(!")WK.E9Q9W:K^"KB!3CP'9,O)K*2*1(!'*Y@8D8" M`(JA"#LH@%[!A`PQB&M3@66!-)#9!I:9A220@]<"!#:9!$Z1@%#2@O@"` M%W8F24K%&O'SMMX1]6Y+?D;!$50"L'B'#&#!28+@&9O0)2C$#'(!%$1+(Y[Q M#70D)EX`1$"##6)D&MC@2%G)+SZSK\#!))[T)4(0-3]"->5KZT023,-43,$/ M$L.4_2)P3--43<^4Y-A43.E-3>-43N?T\PC/3>E4).$T3'W^3B2W[DOQ%%#% M-!IN##W#0BF_BR7,H;749W[6"4N$2X!R3R2,Z0RJXTJ#0`Z"+U'!0P=@8CS, MP5$/PAGQ4PE@8+#&$0::D$"#$!RN1"0BHD%$2`FZ!`8HP2':8`*6Y#Q824/[ M(R)`X12F)T7:P"MCXD9T)B0TH$:C-(H<1`9A;3S8PPQ"S+FF(6IJ=#!C2PX` M``=B1`.6I$<`0`UD*A;1@`FA"5YV)@J4U!5-`!:N]`6"(0A%(B4^,PB#@07@ MU016=4L=K$MI!PL#54[O%#GIE&`!]6#3-&'-=&$%-D_;U&'!STW9KV$CUF(O M5F([L5"_8I1>L=O\8X^.885DR1S^-T%)-4`3E@`'-"$-V$`'8D(D2.`-0,$9 ML=)6!;?&PP9RH:-5`B'"$-6,`5V7-]&,0D_-$OA^(5 MOW()PH$;%(HOCT$*B"D8)C1`WD`*I"`BLE4@>(=;IT$(108$86)M::(,[@4`J*Q`H\ACM^L53[=T4;W=:M=V:5=V/=)VR^YV[71WX11W*8]VXP]XRT[M;O=W<1=X MAY9%W>&(\7>8VW=YF7=ZO7>O44>J.W=H4W>;.W>)=W>Y_W>'F7 M(=.78J\W>XV7>+WW>ZM7>:\W>(%78S>V*SHV$?:W]?IW?X-P]U:$&Z+@%#9D M.PCB%,H`1T9!$[B!0V8@):(G/ZHG%U)B`E@"8R9T&DC`2"KX68S&)?JA)[5WQK>7IGV7Q]^9?EM^RP;0+Q%Q+TMW4GN7\/HB5B MAA*.@42"(5ZJ13Q.-+@L-3V6!SK"8SP4>`-&86H;P5/+)1>:$AER(3V$9*:" MH09)@!L<`1G0`&O+P(#@8Y@FYI$-U`0V0`J.80,.`O4T`!FN0"*8<:%>`#IJ M]`B*8P(F5R1F`#',8[3V-QCR)8#^I9B,?68#V"!(:Y2=HX`QPABE/N\%! M1!>C!?F0&?F1$WF:I;::(=F12[>:&WFK*7G5;"#M<#E]@[*5:_E]=UE/A;>L M:=EW5SF8O1=]L=>81=F517F3UY>7=1F3YSJN)39W>7FML;>LR1I^K;>P0;F7 MT9JMPS=W\SJP[SJRZ7J9/?)^H3F::7B@I=IG4B(@%TOUY``#0,$$Q&,:TH`, MWK$Z5.8]8L2;QZ,\@-4O/MN&63$1)&"TG5)%-D%>%1<'*$%Y=F`'RD`"''H3 MX"-J:9K^#1!4)`PW")=%#D"!#'[D(;:EBE]`<<<6!@:F#8*!;5$O2/^H/D/Z M;0NY?V.B&X]C);:U(,@V+C>A8]1'/@:3IA48%H!C!9][LB1@,"8"MC5()##F M#:1%"8:&CT-7>3DY*$B0&6"P02@`XY5 M3\QWT5NF)TK%&"N;NDNFAR9$8DF\4L*IFIJ]>IH=.761_72S^LHU/`@J&6W$ M>I9?.2,E9:Y-K'=/V<:'6:X#.\J/O'NCUT3:=Y6/>=[*?<=_F5 M7,B#N:INW$Z]?\2_'RNLO*J[ MNIJC&$=RP6K?9EM)((RO(%_%/$;^5SLE!H4]K`4]8OL4/(.YX\,<%JL-L-8'"9EJ58^FNT$](11C+-=K8T(@F,=YO.5$&J(XL+8) MHS@-C,>+P;L9-IU_1:(Y@O1&V#G4?S9HXO4=9=HH?*1;U?-_%>HC4UFT M&\'R"1[SV;W&7QQ^29E-[Q1WF<&+%J?%`7[U!65:]11R-F#=.B,<(E_(!_O; MPWW@BW_^QY.\Q(.\\6G7F1F^X8O][PE9`QR8!((`!FK),QSA%"2@7$9A&I8@ M&)I!9M`H%\H@&,`A$2A>/<:C)3!>0!!4_6$X'-XC6'N$TDB)KE0*&/'B2,+5:C^&')CR905(VYL M`Y+GSZ!#BQ[]V48T.1+DJ$XMH;5KU*G1I`E&8EVT:.L:T06@9D>0U*M5"P?. MNKAPU,B'PT9.//GQX,]9KZ,$`(?MU\JAKV8&8PF`)1JBM7:^^C7PY%QS[N&WGQ:DA2CBB"':`%ED*)(TC2,F``!`,.'DHD0PP2S1 M43"@:+(2)5%`!8X2S5`'SC*S!=-(%$AMLI.01-*X0T_!++/,@*`$T0T`Y(`R MRI4N1G4**,%0(D$::6R56!E^`>#^2!F)[93&$1N8`P,H:BBA01F4@+/F2&8T MHP0;.45A#AOD2!!.F*-HAA1*V)W#`%OJ+W7+FH2;%#C;Y MNV&'V_6T3!3B37@PA1U2")_##+ZG,7;N<2<%&C8-S!YTK@53GWGKZ,"&@F9@ M``J&!EO^G+&#[('\\_AQY\T8!H[M%(0V*BN(G%-..[.2(C3"0X$@4$G#]9"(KVO@."2`DHH$CRVPP#27+ MV&D&*,OX>O4R4IC3C*"-=+,!-N`RI`0E7%."4&0S)++#!AN$4X8&B2R^`QHI M62IG0AH8"LH&0`JJMMJL!A'%#&J'G3A#V+Q!R:4;X,FU)FESG5(4L2,S0SBA M)K8ZXYMWSI`92DB^`2@DF(&Y.8RC\4ZK.X'@*T-(@J*5\)JT?IA(,F_/]/CD ME^]M$.0F32*ZSS&CB0KXX*/"##1',PH)\MHV'QIGR'&&JO/^^E=-UD&OXIB! M@,R10!`PA,`+K:-AK?D-,]:AH.T0L((1="`$)7`&>L&&@+]9#0AIMAT8^`19 MZTA@$`@X'C.L2S4N5)`#4_BO`ETP/R#,SP%3:`8YO%`.,71-!\<3!#D$H8>I M(6##/KB.()C@!10;C@9>8`(,26`=_;,@#5>SP^&X\(H>M"$%:3;`+$2F9&P91JCD`@C M)2.2H6`2E1+1P"E/VDU0$R"`F1DH@0%'I-"('$5#'0"D&NY4912,4]>%@L!1 M2BQ0`G*J0QT49`XYV5.>C6#&$H6SCCHT%`8>G"!'!RJ<*!`#`SN00$;-48>? M24`33?7A/37!C`4:%`T)QHMQ5;WN+VMJ]E#')35%P4J3:; MT(TNBK89V=%XD,HVJBH0%>`&"F&XH""5ZP`[7L-0A+ M>$,C7@`+H)IC4Z#@!3>^@X87@",8:%C'#HX1#`RHP44;("`)8+ΏX.@3& M0!K^&V`8=*-&47#7)F06C&XT,1SR70(;T%N@.GQG`RM)`P7^87",;C0"',>X MT`:"`0M-^)`$QW@H*);0"%C4MX*H`>\Q=I`&-C1"@FE81B/4L`P)2HG(5X`B M8:_@0P%M(@IU6`89NG&&1A06&P``QSTW@0Q>T,:#F^!%(V:S"=L()QIFK:(< MO`P.!?'N!6N&Q4R#P`LE'^$8!# M=Z8!J,<`0#C4!0[KP&`3`'B#)C3^09>]`F`3HQB%&M1@&W!O0$%D.$;H_+(, M`KX`&P1Q)QHDP`;[K2,-FNAA24U^0,8I& M'.,,J?1/&$VZC%%HP`2PL/<+,)X&-9TA#14]47$-3HSK7 M=5RUK??.][[[_>^`#_SX<(UWI>UZ!?^0AC2@X%W6!%M>05_-&;#!A@MM:!U' MV,09Q./^XB`$(PT:`&I_2#`*OQQI'5=J`S.BP`(UF.$,5P+J&?"7X&-@X`QU M4`,W7F_>"T4!!^Q6T'?4:`)"=V,)'0X"I^H0^KT*QZ2\<#NL=G"&#=2'&?VA M1%"P@FD)O*$-4SQ&.'A!)W!8WH=M&/(9-`'S,_B%9'(`@13:8&)*K(-2,";@ M)@BD+I@_T,2@@$4E=T5G0`DF``K=``JS@0W,D!2V$01BA6RH,44F8!/_\S*_ M-W*G$6IG``L3L`%2``K@\"A0@0$:L`Z2`@(6$28/!`*_MPD@V`ULP`W_PX+N M0T)7!`M7H%-^,2]ML`[9%G!U%T<28#2%ES1Z)WA*N(1,V(3^3NB$Z5-X-B!` M9E`$TE`,Q2`-$>!!OB)LD71^X18>+!5U*"4O*V1>,[4. ML.!Z41`M,V52H'<&Q%`W5[![=8@2$\0-1T!!!K$$#)<4()"(,/"#^'-N,/!& M/F1"]497`.!2382`F^)2-=&'71:`9G`%:5`'CB!7_'(`%!1FG!@.+`#]-)AYI"-_@0" MXFA_^<%Z.Q@%5]((M@&/[V1JT6'^A$=X-$GXA/S8C_[XCP"I35&(=U.X,437 M!@C9CL+&A4;T`O,2#6A44A(0#-;A&FU`'6]`,=OX!FV(#"LD!>9P0!)P88"I?(8HE@I"+X8Y;#FX@Z@'`,@PC_$H7O:(&OB8C^5B`P'9 MF9[YF:#^Z7>$1Y!UUY<1&60+"1SKP`L[0$FAHWJK$00KP3]HLPPFY'I=:7H% M*)EO&))RJ`:K9U[\8E([8&+(<`8=.(@:\)*!.(@FM03KYQ]1@$4@0`(P14#4 M`9W`X2X^T40_.0W'H`9G$`6PPB,U4004L M,`J.4!T$5'$=!0!2T)0:0(O[YT(!.G)EV8NV:$1^D09NYWZ-X!>@L'GK8`(3 M<`;M.'1FQ0;VI`.5.`H/M`1`F'0=A'IR\)?=V!^#B8RV`7$:``LFP'P$!`I/ MM4)M4!0*%60L<`7.@Q4,"@,:$'N"=9E%J)E(LX^A>:1(FJ3^2IHBHYEK!7F9 MJS$-PF:A5Y0&FZ!8C1`[EX<45X!4QT!ZT=((&+<$=&AZ40![`$`I':@&(@&2 M_+,E1W`&L-(-&H`&,T@IO?=ZW"">/>03'01N+\!1-68.F[!"HW`%H$!6-1$- M5=%!1.D05]`:F0@#K:$!)1=@5^07M$$)FU!OCH<4:;<#*]<:JK()E!`.Q_"( M!T8";:!L]?&'YC`?%.E/)K8!R`EN7[0.\9(&IZIG07!@(%"G-%8Q4?H"P8`V MTV"L!(05X(`!E*`#&U"374H)+]`-S09Y9]`?57>E49`+^G6(7;H#H'8&W)H+ MRX`#7Q@%$&<&8;,2Y'4&HR:!4#K^I$1J+D:ZI/B:K_KZA$U:76[PI/,*`L:Z M";@3F0<"`(U"IQ`"+5TB!?2R#DO0I>N54##@8-=F#CJ`(Q)`"5<`#D<"D@ZY M`<RK38)MPFA(0LYH``[/Q M!G(`9N"0!E?"#?1T13L00 MB]QQ!=)H8$?0"(6I,G5`#-Q`&ZAA!N:P$B\R+\Q@#G3!`F\P@SO`DVAP!%L[ M6'J+`0ID7B[BJ7S6)2]@!FU@9IL``^9@K![V`FJ`#=C``F'#L"XR`:L7GA@0 MN8[P1E?^U!^X0B_'P&"\H"10"A^96:]WQ!#"@SVOXRVMA"*M>TFJ>TRLR[J7 M=+LBD;NO:TO8P[NU*SRWJ[J^VTK$VRJYN[K".[O`&[S)>[S&*[RZ"[VZ:[S@ M[W2V[JU6[V^*TK/"[O?B[S/FSBTB[W0V[O*N[W"TZ_5!;!06E.* M:PZJH5*6\!U(">:$`U,A8U18%Z:T`AD M*XMS1@FA1[8%G,`+;`[1T+-,!401M0,IL1]U@*6EYD,;K+AZ)2=RL@Z.X#-1 M0`G$P%@$+%BF$V!!:A,/BGMDJU,;=;MRNE+ MRX\LR>J+RH&LR-_[R*%\3*"LO#7=R4-]U+^[O$[=R$H=R(;LRD"=TT2=R4D= MN^MKU=(+U8)[=-!7;W, M>]I9_=JT#;R*/-.V3,JD#=53O;H]'=1>_=.>'+O.6]0V3""_!D3>`*$MJB[1DLK=Q-7.9C-RN?-6$W+S^I]S;M2W=N$O5 MI4S:U!U94]C@W5W@/V36`9[7VMW9?@W>8JE`-'3E]VWA#:[@]9W=!&[EW,W9 MG3W@9"[9).W90691W0WA!H[@3F[,VIW>%H[94Y[=BEG?\!S>])W?9\[=``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`H0720((%#1Y$F%#A M0!N)$D6)\A`B1(<2(T9,-$V2QFD.*5*L"-)CE&G3+F+T^'#4J)(F+[:K$>''DS)P_29JT^)'FQ)`S1R852O3^(U"95)KY]*G4 M*%:H-%-F+8D59U202Z&*?3HUZ\.205.J/1J4:-:(-A;>76A#CAF^S/B:\?NW M+^"_,#:D(._4PFL#IXT;]O#CEFV7EB,0 M[W3J"!LR96I1NX91:$!MV.!($LZAH-LE/:()G=\)X&&@))F$ASMP*\) MJ'W\=AI1RB@IG9H9908,Z/K*K::<0BF[*,QP)(T=.F(0HC)VF*"-JRI""[NR M/APKHOHP>&,3^N@J"T4.!7SHAD;^-BDC)PW:T($$"D42,*>(S'D#F_50&DHL M\K(J`XU---D0Q(N*W,2+4D]$Z1?OM.3UK$]31/=>,T](U&V4TST)SBVY*4:F[3BD@0TJDF3(VV00$ M&!QYX0T$16*P#"D`V$`2H#("`8=E-(%!DV6.("&7,MK``=<;Q#(#60!`<>2- M*^S0=:XH8+B5#5,3!$I'5+%[J(TW`$"F6JVBT`06`-YYDD$A9Y5JURC*.`8$ M,ZX`P(S^HCRDU5J/0%`#@#*2S,@1`%[0M=NQ$BRC&P"ZR45?'94$\2$E7@`` MA!N%XC`*)73(N"?VG))RU+NJC,W.Q;II0XY17K@B"#EF3@P-"?J28.:]=&-& M9\%FSCG,*#:P=S.=(S-#3*+->%-GV9J3U%$['\6R34T]56[J0JM.;E!!JQ9- M3>1:"QNV3S?]&C@\2\MMMC;A;#MJR4(UN6[K%$X5IIZB:.8(;G*91HN-KL!A MPQ5/=6B:,G"5A`"AIK$&@'!.::;R4Y;9)!<"]ACW'7,KXAR`-G+)15TT;@P) M!A""40:&TDSKO"W MCIG!$\U`7AKF-SP@:E$34:`"F2""@\AW?`T8I.G ME&0/FK@=@9Y4$BT@#Q2]0^(T1DIRB$>[+Y"W;,XU^(&.+*IK+`&R8$)2=4`XD"`8;&M&(:1SC M"E'`QAMV`)FD;0`-00A"&[H!BG#L0'],NQ8VE@$*P6P`%*#`0!O\!P`2-$(" MZWC/,I"!P$8$K)YB@@$)UJF8&1;4H`=%:$(5NM#]T6V9=K-!O*81`00(0Q@( M4`12HID46`+@"#*9P0;,``IDN&<#RZ!$1X#W1,=%)!?&Q`89F7(#EVIQ!ANK MZ?Q(8LS^-&@N7E$`!QJE`A$0"*\1Z:%"&4"Q!"7T9!J:(($4,.`27GU'?B6E MQ`Z0),\=M"$*DOBCANI#`E!(`0;3D(`07T`)$&AA&B`(AQ1*>I'_*,&L,H&( M/(]PA1V@P6,BW0`V*D>)#4AA!WB%`2BB@(;T.)4`X2`G1$8)@,4VUB?(F%!$ MP!,..YAO&N_`@!1(@->)U`=749#",@:FQG&`8ADWS4A`WWD#F62$$J`@`9DT MQK=\-I4MM\4&[S2!TZ$F0ID/-4@S3=@&2G"##?BI)C@VP`MN`,`143#')@"` MC3-(8!.-P%;,^+?8%S@"8"S0US(V``-D!$,3CM`N-G80A#3^P*(-OUS&8N,[ M7S2\``2.N,(Q$,A0`A?8P`=&L`P=BMQ1170N$Q4&'>@@C!6<81IH.!A.FU%= M4&0BPT<(UA'F("J'+:)<2TC M%Q*1`!KV2@E'..((N&(#9=^`WO;Y606'+NP$`$#-*+2!!<@H`RRX46,AQA5D MU+J!)P#@"5WV2`(8"(8$)$&)"2C^P1%LF,#&3)L&UP(`%E?10AI(4(9E!,,1 M7V8#)22``W#$*!=2R!`:`@9C?X8*U326)1B#"$U[! M-*C0OA=H.%F..,6X=G`#9-S@6:#!`A9KMC$` M8.N4H&^`$N1@`R@ZTD;2N00B3BXR49`W@6#,X!1F"`8LHM`//&*@`BO>005R M8;LT5*#^#=#N,4_0#%O_+A:C1<(I<@&/FT^#&$CA/ MILT+$>6YD/EX)```*>SA'6X^Q1[6.PU8.$*0QMS!&S>Y^DT0TY@@.`4))E`! M,`;C"OW0KA;Z@>%?.R(899C&*?X(_`UL8@\D\>@IG$\[Z<^/N$/-MK:5V]`` MLB$(`;.X!Z/^*(O"*)%KGPDP ME_90%Y0;%[YIG`UH`P+8`1-`&)Y[(HOH&P"PAAN1B6`(!CBRJ8UQB*#;@:RZ M`=USK=0J*8D(JJ@CN@E@@S=BNYZ*`KC#AGZX%78A@!FX@AQ,!'0#G'8AP8]:'X>!OO'8 M@!F(`DH@'$&ZE>RA`AS@A@H8/!7H"`)PA#*8K/;``1R@`BU8'"GX,W!@`SM( M!"W0`N?K!BEPK1=`!MU+%9>SN688!^O:`Q;0@<+JADV8@"A0`6QHGG%!.7)@ M@8BA`OF9,UAX@<("A0F8@%S8A%S^-`-)^"6=&ZJ9"#\&&[^Q^:!CT)9H])+) M:+OV(Y<,=I:)]WY`L+N8@J_+=E0`-PT`%)@$&;:RD=HR>9(HDCT!91>@"AVYB."+IW M2*5=B@(1`X"#^;.G(S*IJ#$EC+I@V(0OQ*,HQ!@T0Q[M6A5PXY7;200O!,.X MFSO1T8)-.`8`D("KH`*,\2K"RQZGD`18.()IJ+%;Z1[' MV8-PX$C^;N`&01*U[J$"N#R%5*0$W8N)R2H#M^(&6)A$E[-$+="$9+F"<3@% M9""#&($(YI'!U0.%C6B?7V,#2V2+/ZN`&4@#9/@C:T"]CT2>WY.$I/,I09H& M<'@!S7DI[[LVHFA&Y'I&Y(A&-D@$:ARP:PP"]].`,M``"0@Q$^#'&#$86LP9 M,Z@#?0D"9`B8'7@\&-"7"<`!,Q@%LPR"=E0"#<"PDI*`<)P!@?3.[P1/%F*& M#"Q(@UQ&GH`)B)B&9&$7GV@&)R('C<#(33J&DD.]8Z""**BYFTN$53L8DY0B MVB1)G7L(^0NZ&<"BF?BO0IL!)#Q"G?0V-I`)+?#)+X1"Y//^OJFCK!>0T*0L MEZ5,@TDR`=]PH.@RB6F`F0?!NC3`1O5PA"_2`/@C@3,(1[Y@ M@RLX*_;9`#E`@P4*@BO8A%/`1PD8!8-!`Y80TFD0HH"3`];1(/:)P(D+SUFE M58%DAF8HSPV,%]F9!H/IAE/(GD3^N!PRH*E<>#8@:A\>8],7H)Q8LCGMD`0M MHH13J(AI0,D>')>FDJQW>(,URE8_A8DG@<,K\%.7V@0)Y1L3Z*F())?$?)8] M*(-5Q(%^^"-*V(.Q`X`=V(,6O5>#T5(J&#.8U($KX#P\0LS)&SUZ,I8]P`$= MP$H_.XMJ[(9@]4`(0V(A$8(-EF`8`B,Y<.(4=P`!S:0:7^]+)O!QRN5'-RYN9!8RKH*`/A(R)&P**3(![YDL^GBK M^FT#$C`!-7`$`A`B#9F&*[B"IP0'S-&!1-B#E51=)XN)6'K^@U-0@B/PG"@X M3.L!@"O`'!QHJ?98,3^3!&,*O-<#@$U8AL$]!;0M-(S!AAF8@6`X`DW0!.V2 M`@)`816^@KT#`3+@AAG0!$GK!L;TW$!=ID%-H1@!1."EA!8D6,X!GE4K""HLBN(P%[#@1V0@LHT M@S8F@0(,7(`%Q4`%=J1U8@+5P M.()PT*`+OH(<,+1PN($9>``=R(%$>`<`!C?@/Q,`,2 M>`%?+F0"P(87T.4VT(0T:$7':08IR#H5F.,`$IT"`0F-ZD MJQQK.`)P@!:/G`%),#0VH#4/89HVH"E4P$U8(,W``6:[DO/-:Z"M`$6 MFI<88U`0Q`8[=%!-%?1!S@($*,I^D>9`HV,YF.+\'202N MY@NJ]L?^/T;KM"8PS17DO/#SKAY"$&^#?34P55>$)4;J* MJSC&'OSLQ6X&2A0Y0LP(,Z@9G$*-"EC,`B MP?&)Z+YN77KKH=;`HEZA2@W',JC4R4CO]=:7!/H-\S;O($MOOCAO^K;OOXAO M]5;K_>9O@V+KMF:FMRZNS4XDIQ"0(GL(F2R/N=CLPJ:>BEG^<*^-<`?YD-B! MR"#1[%E1\`K/\*DH\)U($HHQ\.)A"@37;+E`\02/'@HW#[ZQ0Q6_MNCY"03_ MB$3Z\)U[ETTD#QQ'\2,FZOX&\B`7\H3Z;P`_B(@J9`$/$25G\K=.\C]]\B:7 M\BFG\I^J\F4C_F'!WIM)_IK7_F+)WI3_WAFY_:FE_J?7_>AA_J)5_=5GWIWIW&J'_=` MG_2M+W;^IT=Y5N?ZIH^"+Q]OG&?[ML__Y1&`>NA?T5)G$GO]" MO*]SO<][D?/[P2?\PC=\OB_MIK=KPM^Y-II0/=?[OE;\383(6*=\R.>;O*]\ M/[]=7#O\(E-[6G?[T2=]C-/Y,T_SS\?[-9+AQ_=[26@#:TC\.+_=1IQ]O(=] MV>]SV(\VN:=[WU?]I/_\/&\&%="0II<$)4!0X)=SD_`/N\_S5*F`,K#A,JB` MCN@CN\_TJ?_ M^F_WU`]^J5>56P$(4+D2:2EH\"!"+5&0L7DQT&#^LQF;`&BB0C`A M1BV)2)C85.&B1A+!/(+,:++@M),J5V)LUBP*2X11IC5+1`4$`!:22A9L1@!4 ML&4?6-KBU%EAJ(1ZVV&@EFG@BBBFJ MN"*++896FH@QR@C):G\U!]%WTZ&$T8"Q2:)%30C=B)$D5S@$9%,5(,.;11I- M0T60!U%A($%4L$&2E&P,!^1%0_)HH$:G4)+&'L5I,:5"&@&Y)D(ZKLG6F;X5 M5,$+,_RHD7Y1NFD@3,WD\H(28.9R9Y54<@F`)^0I9)ZA6DBB"0!+J=D3`&89%3Y$A1HL5%#&'IL$ M<]V'`\S^*.)B!!#`V+"=%0O9L8X)JRRQQRY+;&/).NMLM-1"&RVVV9HA+;;% M4IOLMF0=.T$5L_;921BT8M&$B`1@251`4X+_13Q@V2U*0DD]-)\HXF3G4IR0R] M&=C,E15`K$49TW7DS`T9UT0`E!'7?.8,FACTSA%P51G1##57P/*`7E)QJWYM MG%E0"Y(0`,([#!>TVSL&2=*&)@3L='09^KU#\]3X$?015DXUH\D,9TY'`*** MZJ?$#/-5N0,`E$2ID21OX#?D=#F[1*`.6[,`@`H5D.HT%93^`!!XE^^X"E(S MCELXG>.;#)0+-H2_VIJO]IX6[+($)"+LL*6[V^WIT)J.;2+N>NOZZ::O+GOL ML+]..^RMAVX[[:7WONWOJ'.+>_#%VZXZ[,>_KGOMQ!\O/+.K(S]\ZF8P3SWU MK4-_>_*]#TNOY^'3:",(+QQ#T`ZP+".)-6EP`P(W`+S?9$\';[!;,*!,4\8R M.)`3-P&DL`R$6&D3XP@&`-(`L5PL*6A:((`X[H<#.PQD&@1X0PZDH(-`H/8`8%O(`@R8"&0&X`"!Y3X$2A`00(=2*$,%(+%!G90`1`L`QDL M>`'$=H`#L_B((!%9QA6L<0P`J.'^A4[!1@^/\0:7D.`*XLF!OD`Q"2E<@5,S M0*(CQ,&&(^0G'%:4P@9N8(\<#L.$)6#CB1\B@ MT`-`\8X;-2-61S":)"I0@;^Y2C^A:D./')*(4^B-!!%JQL$@!+F#W281TW#< M,9PF";I-0E$Q$8SX$+.8U@6A64$(PK`2T4I9$B`(K9.E+7,IRUW>4I>VW.4O M<5G+6[K'>IB"I7M^*3KK6<^6HNLE+8\)S&4",YK-C*4QFUG-:>92=+X4@29:`(=.04`A*90)`!X,#PGZ08(7 M.&,/XT`.%8ZSAT*RX`;.J$!#J#`.`!S!#F@A3ALFD,`='#`895!2,`@@TV"\ MH!E[V```NE8!L_3#&8B=`0%>``!0M$$)`(`+31-K$;IYHJMIZ(>58*&Q.BKJ M"DH]Q3(H0@5)J"!24BN()&"C2>E8`QEVL$/0^,."!Z86%!K^`QP5",`04-!/ M"P9['$0X.1LK9NP4NR&!*5F"RHH69I7/')U[GJE=[(Y.=-?E+J:ZBZGK>G>[ MP@IO=\\;7NV6=[O@12_ITHO=\L[7N]E-[W?K&]_YCE>]_&5O=K]+W_T2^+W] MO>]Y\SO>]9*.ON!-,'?52][_1KB_";YP?`5<7_P^F+\4%N\S@1=BBE)71OB* MR4Q36Z4CA!*U`-!:/Z10MTOR!Q3]V`D;6-","B`6!+EH@V\G!@X=@+8"Q_#K M'AJX!\4%+1$V8`,;*H"JFE!A`U-LQG'XYS`C7@FTDH"%"5R6AEQ$!`#I06P? M8]NF4I'RB\&4JQT M(@G%J4`2+9".).8Z6XU7SI5X,-:UKWLI#&#]5MB_"@9Q@`.\WPZ+-]SP!;=]S]W> M_$K8V]PN-[;O6V[TRON]&3:PN>?-;@%/.,+I'C>##RQN=!L8P@,7-X`ES&%Y M8UOA\%TFB:L=HA-C=`]ZJY(:0IDW`&C$!N')`7%LP)^^_)4$L M,CS(V,,-CO`@:PP-R\BI@`Z.88UQC,,1UB!(2,DS4T,#B4#+,/M'6)MI9QBZ M`K"Q@PHHH0)K*&$/"DBLHV!QA*/=_=)L$XI3RD""#5P!!Z+F*D@DL41]:<$& M\?LKJUW-M-C2]2`MV`-L)E$F3PVM`G>R@:>E>X<<;PN1M M./'KNRW\[C[#T^>PB#?<_`IG]_JEPQ3PM,?[X>,^W;J[][_^$\R8@'N;W[I# M,,)W;X:(2QPU%%])(O8@#@!,AU:AK,#%,1(H$,=^Q(;*`&`PS,G^W4`->`2V4%R%*`DO9QR)9XD;(AX1)=TU1^-*!^] MU9NY;5NWV1XBUEO"'>*YK96%B35S?+9UBOC'B(4*,)EI/36!7++HBNU$B)(K.6GR;)YJB+AY?@+V$@]'; M)=(?(=[+7US>Q>4?B^5"+NA-_6C.RXU<+@C6"^#`1S1#;<`",D@;%1C)-!X6 M_W$,S>T&IPA6&I!!9I'`*6A!S=G)<6"9:/6$EJC,'@"%2[#923T=5CB-9`4, MFU5`:LU`F9B5$F"9#Y;$3$%:=22"F3&D:-D$I"!#H2WACR706CF-'9R"C.VC MWNU8%-)1IIT"@:AC!7BAQL2*'1E$!5`(".Q$+N#`WJT:-!Z$)*`*XFE!T\P5 MR&D!?S#^CDEYRF^Q@0E`TD42\"D'DPA%<@0,JQW31GD)MHGO<`"8F M@E6VS@TD0A240%TG`(+<(,BR9B: M-(-X2&=+7@VNAT`6$.9$)#>4,)244$_7.@`6L2# MK"--,N0$O&)6*PE:L;$*-ZL<>I`$;!,QS'$14EM@JA24!.$(< MZ4`CM$$4O`,R'`,.+`,(,*:43NDM;B95,@0.6!"5JN5BOL$FP((GZ``R:*($ MD``W;,`T&),6+,,+8(`.+,-BFL$TV!4)3(`C-`-?$FD46%%![L`1L(%[^"F@ M">!A:CW`#*1/H)@4`7"#&B"#$DP`'KK[3!&PQ@(OS`)%2( M5:#4#43J#KS#)DC!#U`!2_&:Z"UK,+2DXJB!TE@>$$X`"*@`"_01D+P`-VB" M(_#1:M'-,4A!Y$C=LC)J&4C6F,[`ZU'=!-*0%M`-"Y0!IR50"XE'+\S5,90! M0OP4`(2#M3(JRU#(,I3!K9[):BZ#-:H@1)J_RI@U&W`JC#9X* M[,L[K"\(5$=!G/#RIO"-S*M>-D,O.'"4-H<,T[".@``V4-U3/L?15E32'F(O MN((K#''+0`RDO$%PM75"DP2E@F1MAB0LR#92*B"DMD9O%T MS`Q73L,&::)?BG%V9:(D<$.6*EB_=.*Y-4>V;:86.$X:O$-A)<(&%%,NT,W; M6L^>#NK!',,T3,,+'($D=$U0-*K^)")JQ/@EHHZ.W)A!+FR"X5*R)6>QW-R7 M2W`?)+NQ342Q7XI.Q-!;%!R'140R%)^7&:"6)6%F2]6$*F\B`7PNZ%K;FGC) M4[K$F>S!#SB*10`@`!Q-!=A`"^CRG/@RF`17UZ1!UP`)+_.RH^R!YQF$#="' MQN"D854S-)^)(MDP-D/):I4K;%$SF/#R#^P!E"Q2XR52-=NP(@&)PWPSD(1S M3Y0:8N%*%AZS2GXS/T\S(2G2G:S6SQ%T-DL"GMFS#51`F1Q-^3YA-S.-<7+S MF=AS1#?'="B2(OTRD!AT-K\<-G^TH_Q`-E\S-A.22?\-( M3/]P*@7^\7I-0Q((`QV$@#!$0)HV`T[4!3,9LJ@\4%[JS`/UC5T6G,$X`B1U MLB=YKUKHB['!1,T^TS1(M04U@\%T91EA,0R/$!MPV MP^!()-U@PU-4R/Y,PS$8[G=91!M,PPUH9B:^PR`99N2,CB1,P"53`6DOIDN\ M0W:]!`@D,)[&)<9\ZB!=[E-L96K[Q,_.\N@DT"EX]EI(7">S24P;1`O^N%PAO1X;8,,U M1K-+?S>;"`E&%VTBE.!)W$B70`1ZXR2;H+=+-(=[,TU^M\0DY3/]W#?36+=+ M^&=]@[=)X+<1F53#7'=+X$A[0[,#VC!UZ_?I[;)+*SA+5#>.T+>`3[>`<_=+ M:P%-BX]-XV4\0($T2`,4),%6)W&9-,<>.'$FDH!>F(]J-P,VO`$R;((.;*;6 M;$`:A`,WD$/N+B8:<1&F:L(;7,%4C5'5N`<:>0(X)/F24T(P7($6H,$$8,`; M<,.=$AZBZ&\,AL,R@(,=6-`T@,(;4$78?I<`IP%5X(`*K,4&',$$A$S_3@#5 M[L`R8,.0US4VJ(&5F5E:3T-JX<#^F,UEW"9V7VQ+,]`-&SC"DT*)XA!7^E+( M.T0R`:1/&E#"$NE``,4/!M2$(TS`$8CV:6O-:2="J7.#)#M"&F##`[!`;[0! MX9$`"4C=F'Z7K5_!-JK`"_"1KH"Z,*8*-IB0Z#3#A&`#.1R#TNW`$A&Y$ERH M_T+;#F@B54(WZ`X`B`^)A!.2--OP#!R#KX/X1;^T3^B`&EA2B(?[?4=X3+][ MO'L[@+NTN\<[ND,XA'>W>\>5^TMY\[Q6<\P]=[PZ_)B(^.NZAD-6SV0V"_P1Y8`R+G@A*\P$UC@%^=P@1N0/KV:C_T0X\5 M[&2]@V61PY,L@XU-I"8P/1K!`ML,%8!LD@A+\*:I;]FA;MA*H@>$: M!Q[^B0FH-F)MPM<=F5^&%Z02^@RH@0E@0QG,55][.\1B)3^+?+L7Q/3^[AC%;WS%?[^Y M5S?XPS1,S_N^V_N^'_R\]WN^%Y+(WL#UIW]ZGSN^:SS&Z[N[@SS$._R]?SO] M^S]`:&FF1>#`@@2;&20HD*%"A0<+#DPH,2'#A1(16EQXT`LDCQ]!AA0Y\N.` M1"=1$I@6#PH=.L+P3"/0#`0`%L@VA-N`C1L`)=-F7'&4JTVP-'L<`0C7+)>C M,BDEP3HBDP"`-WLD7`F'#!DH`,OZ>;W13!*+J5E)_SQQB)M+!+(B3*2D488'X(2HHLBHE)( MBRKB`;&9&38`A8PW)$ED46Z040PJ[PSZZA0T+D1C M'$H<>4L*`-I(I!FI*J#D0DI&+3473QI;[082<@`'![)HO4&2'0#8`592;Z@) M#9FF08R*Y51BH;'4M#@BF#)28^,8I$!!](@T'!EG'$>L>:PV*LP0454E7CC& M*O!DH\TVW*@`MHR:@CVE,A(*0P^`&91#*0HV7E!L!@!(:&8:;/;5@HH)M@OO M.X?!H^(_@JZX`L1$RF#CBFG:0\;@UI3`+[=FK`&`OVEZ`Y$``I=#B8P'J/#U MU'?`.0*V*&X(Y@A)DMHAP)Z;H>+47BXV=\0\D4[:(Q7)A%+^RSHUVDA()[E4 M7T^FHYW\R21:FW-+/LJ;'VTV%E@XZH*67N`B%N0P"(GS!IRA8PP&$`1^H MM!ELP'%/9%4U"4:*9C8`YP8J+)RA`B@EZ0;51*:!18T*QO$I%]A/O0&\:<8Y M8@=)<+A+DKQ\!?:=W1.J`-AC55*VY69ZHG8F'&JE@M8V-G`DH2O>FVRR9B`# MI4`1)4PCD2N04VZVVLYG@P4JJ+`/AVFDD^*VVMD040N`X1*?<`0'83-0V"8: MUIV'*1`\DO@/;#16-#:`@V,F.Q3^R$9'$PM200<6.PG+#(2@?'E%"3K#S\IV MEA0,:4&%0?-0T8R6"!(9CH8EH@*6QF0UOY'M;ECRTMJV:@0B/@YTL`;&)9S1"-;([`@MO\CQS,3,3_`J:%@0WP M8,@YH`ERH\!X>H<[_U$5+!@%'BV8X`45J`DV+GB?E&B0/QSTX,HTV;+<$*@, MN1`'&PX3C,=]D!Q(N5"&+&2'H,GN0S$\VAI!^A$O0!%.@!NCW898-[-1H0(J MVJ$/K800^E&!0S?$$4M'69"9MBAH,ZV1#2I0@1M"B:62&)P6),$T)I[TBF\# M8]:T]B0E.L2(0Q+<&8%G0``"GT(K,J:`XQ M]R`7;L!00V\XA3%-IAC=+&H<,J&"J[AAC5[D@%)EJ$T%%$H3L,Q@$_W``3AB MDXO)A%L(4MB$2=@2=Z,52Y MO0A&SGS'#$#PS!\PI`*21`8(*C7^V!DT:J@$N;$2E/#8PG!%":\C2`5F@`Q' M*"PB0K4&`68$MB"M.&U;#J.6Z[3BNZE-3&CD*M_V]C2>ZBV'9>4RF=LT5K9M MZ:PD]HA)1(R27G@%!YHH@Q9NH`DU`*8,I3-*-]A@`A+D3I'+V$0&O>(:`(QV M!OKIB6O>0(4V6`X9B=`$&X+A/24<0=++D$0;4DN"20`O:640;:'.-T MHRZU)-3)!@2]`=2=5DUU@K$!):1A&<8\R6S4(+)FY,4U5VC#YR)S@Q"9EPV> M0,8$-G"%Y)SD!F_89AMP(R$V+&/81^CH-#:1!B7@H!O+"I&%U*"$1-B''&4H MPW$VD`C^6U-"WZ3FMZW1T&\`J"`15`!%,)"1V6P1H#5IL/>B5!TBKSR``$H0 M#<%SAX-WB.@_PD[#NX1F`CO,X`4;H,)C@J&&-RAA+02X`:?S/$,[TW``;[;Y MS7'.9>R(0S[EY3*BWIR(=QQG`G98!BSL4($65,`.+/@6"28P`0E93C)9!K04 MCC"#,E1`!7UQQ!%,C=1E@!H`W%`"KF%C!WR^PZ@Y=_O;X1YWN<^=[G6W.Y?K M;.YW_O*JX1P)4"GL@>?VS+C>O*?S^@2('9=@!OT1$ M!9:3P!K&/DE$V@!$+82,LY?]^, M'90^^000O"/\[/=WO,,1('#$#:+O"`+T_>^>_KLC$L%^]1<HO_`0OL3X/`6-( MYF9.:6I.[IBHJXB(;H:$"GJA"&0(!)NA!9"!:<2L'X#%#ISA%([##O8`,E2@ M'R2A'T*#+"C)*BJ`(?P!!!HL!8-A`OJA'UKC!L?A!61#`6P"UZC@'52`?6+L M[JSP"K$P"[5P"Q/B!S:P)/*,^C+^)#A`1"`R!%%4A4-F`ME`"5H"C\,QF`*(D-.H@4X1`_'\&*0*LB,ZMARH6@"4360*A'1D$_( M@K+,);S2$"[.:1#-10M6B1(J($3V\!$+R0USSZ@4:C7V<'P"!!7-T&!4)4-@ M8P^-:0\QXR0B$3_&QZ8P$0[/T`PSI`\IL>"H([QJ<7IV1V'X$!9AR&@T\`OS MQ`OB3F'H4,9B)!JG9"!LX`?V8,H!^R M3,LJH#**`+O:XPHD;%^4K@7V`!3^K!W9`##\84=^0`72X`=0:9LXA#9`BP20 MR@8.`U7^T,X9R$&N@(X+)7(B*;(B[!#["`8C@')6'!+F`X`BN!UI`,<<,3 M,WX*A8%Y'1?8@!U0O&(*![7CF*)8.P-0`%%B@.(1DZ5BE(BJ@ M,2=4,FWT1G%4[B@3K2P3.\$3-XOS.'^4-WUT.C73!B2A!90,-HBT-[%S-F_3 M29NT28.4-*=32L>3-'O3,V/S,ZG^U$O!TS.94SNYU$G!%$K#=$NG-#C3]$O7 M-$S%-$OAU#J!%$RO2B@VD(`;C8QDJ@-6.0`GZ085:JC5FH!](``?@H!_*@%)/X0HFP!EN2%"A M9"UA3#YQ`,N<\B$!X`CV:R#\80-RP!F28K8JH"_+JP7HRC4VJP6LC@0!8!Q^ M<"!F%"*%9!TG8D:<-2&@]5FG)EJCU0JG54JHU>VNU>:T55K?;!VU]5J=M5L# MU5NE55QG9$=++$^54TOAU#:?-$YUDTPQLVA0,U^=LUZ)=%^WE#N;O3,Y"S9>__5)H7--HU->:5--N;->&?9?-S9.OQ-D M^]1/1\(9H55*QO5D6R`-#G0&P$$'3D$Z2$`@>0``'"%#GZD%?@"?RF`/KD": M`.VXG&=?3B%W/($`>BQ&`$;I9*1IIP0[*L,3["`'QD$A!0*H5`![`,`3?J`% M;G4#@JHR-L$9`'(OB0/;@N%"?E!&@)4<-L$?#!.R:)1&4!9W=&'7=WE3>(>W=W?7>(TW>'DW=&G7=I=7=%&7/$GV1&K. M6A'7;\G6VIRCO$Q@;/NA,FY@FO:E:RL@+T#`9W6@I7H!`":A`GZ`-F;@!VR` M5E1+1J@`'%Y@+R571K##0ITAJ"2"?P62!-)V'+!Q`S;`'PC`'YQ0D5#T![CA M!>`@=\87=/W!#G!`?J45.^86X;P77 M7<1O7;U]8A@E7<7/8;FTX(=@5I'I4=:%7B%?W=!=B>$GW2XHX=DFW MB)/XB)^XB6\WB7?D=JL8BJOXBK/^^)R$6(J[>"-B-XNA%XJG.(S)F'6'6(G' M>(B7V(S/"72Y&(RI^(B)^(G%V([?6(K)^'?!^(K7V(F+2(L%F8F_6(_O^$ND M=WI+I'H!=UPGHGR/H`SZX0B.890LA`1```=$J7S'UQ[S8@;0=P]L8'TG(1OA M-ZGV0!,L)V"H`&#V\G#IMG_9LFL+@JW>8D=.P4+(@0X1^!0(0A(611S$X0=^ M('?\JP*<4!SZ\0?>X1C*0$6HH$;VH#';;EIY^&2_E87_]G(W5W-/.%M1N%RQ M.9QA^80#%VP$=7`CMUE5.(5?F)U[6%6M>8?!V6E_>(T^EXI;MX_%N(Z[&'>- M6(_3.*#^F9B.`WF0R]B003(#%J+O1B)O[C@0"00 MJ8"/FQB)#=F/C9A`<4V02SJE_YFB_9AY5[JDEUB?,7J-]3B1%;ED'/PGI1JG"%`3NP!3NPP`-*0`%'Y0"_K!P8Y`H1F\3=+*[@:Z]@5T8!P0 MZ0?'00UPP!I:(`>N8!-ZH0P>X`JD8#8@=0GM@)A/!198#@""00EVC&UG(-+) M80:(=49^8`:6X0URX,./005B*[,F@-3Y%WD`(-GE@HV;%A/-F5?=F9O=E7V"J!<@!`VK93]UZUM,EK=\BM_<:W?3?E M>'3AF#1A.A'V`!9H2;4I=KC;>,RIF/Y,CLMO?#3#G8U=-XY_--S'/!%F-'T? MQ0Z2#$3^A(9HMAR/\.6-Q=VA51BH[BA M2;I)Y=RZZSRQHWD&VN"M=.P-'GT&9D`)$*F\3ET%MBXA_JP%RD#FV45)M6#F M=P0$5*`7UA:5>%[F$^[39V1RP(.OFU9G]\#SK.$:!>(I,$9OD:K4NQ&:5&#I M$J(%-C>:563F;QY6G?WKP3[LQ9ZQ)3O::]NY"[$91HDSDVKM"9284SM&D)+M M6*L4NH-AZI:.JDH1&IUIYT[]X?9BE)K_CNR='N MY9>K=Z3MC1R,$V4"#'6A`S_NBRK.!?]+RGOIW/=T\S"GB+7^[>/>!OS!5`E< M[4496*>00[+8!O:`!2"<[FF_ME.?IH)!S._^!TZZ:&_GI.EG[],<[6<;D-5X MLUU[H-.<6.><)+`;LH4_1JC`'W(`!_KA%)SA^[UEQ+TQ5172?LM_IJ)9ZR,? MP`6R&WN!!":7?A12_9VV&_/>,+6>_E5D;Z?Q&T'>?@&"BHV!!`L:/(@PH<*% M#!LZ?`@QHL2)#G]`NH@QH\:-'#$.T`(RI,B16A*IR%%FF1V!XS:DH21)RSAD M=D`T:V$-V8R!+=.HD-2"0!$[B3R14T*%P$P05'K90=:FF18;.US^;#&RF9T< MRY!)331#2J(=FR91T=*"2AE0H.S^X,`!5&09$I1NI%DV@TJ+N2JLO4&J%50: M:W%!MFCV+@T`[+#18E(P-I>U2`)!XHU9DN3+FS^//OW4CNS;NV?O9>+4@5HJV`&`0\JD M\!M^$/0U'T4!TJ=:3FD)Z`M%-@"H8(,./@AAA!).&)%%[UVHT0!8J2?3=J!L MM\<;&VB!#`!%.!9,,&5,93PAHFOE7&$'2UL`,`QA363$@"; MD/,"`,$HT8(GBV4)RAZ;D)8#`)10D4@+>FK1RSC"@="+-<&HT,(QP=R`6#!7 M-%/!#BRT(5(S.X`3C"H(`6X^(!T.#]A0(@G- M@,`"&]98\P,)#P3+1AJ%<0ANN.#:@&&YYEX4WX..6?J"%-A2F%`+/P@$;[WV MWHMOOOH^:.&Y[WFQ87HMR`G`##=8HP(+:OV``P`$G`+F9#_^(..(,W8/[``@!*G9#GJ.!4<04X_ M6NS!33")V+#'%1,@W10`)/QP2AK!S&OL#S?0>,H/]W7MSPZ2_[#ADMQL<`IV MBYV",C)`F[`)Y1.P40'71_22R`\^?RMN[[Z+1*Z_PL,'83,_^'-*\A4TLV_S MSC\/??32/]3O\!U]Q&$+%;P`3DS^_9"#PP8*5$=.+S;<$$QT1951`3FPB$_^ M#5K8+-W4.U10LY0V3&U'/Q.P`+\WD`-1(K%#+\I@AZ6]30H.6Q(LCE"!IXU# M$HF0Q%N4Y#0`@,(?+X-%,/:BP>7MX1C'"&`:6@"*![SA`1N01"\T&!,0C&-_ M67(;`7H&@#2\XR8BT=X;@I$42?B)!/VP7#.:L0<0C(X`NA/2R,#Q@A\0@`I* M&)TDR!$,M!C+!E4D0=F.P8:;D"D8.,`.6D#5-^S8`'950P8!>E&$8'A+$B]@ M@Q8F9H(,;`,A@/!T]8W0_P*)A#,-%R56@!6RXPLRN8$?#9"N-ATG?#Y@G M#G=9]`=UK`\HV"")@?",=W\LJ7J"!TGK%;*1+&VI2U\*4X14+Z47P9YZM,<] MO10MC"6QS8IB]:H-*(%1=;1!3P\XOS>H$@"L3"4L^W>,2A[^59@AH8(.Q'2* M!]J@`L$<9C&A9(C-I2A%S.HZSO.IT'_ M^,D:SM@KGBJ@@H^VS)T^)`-6;/!"$M@SB_+RDSC1>I^PV@"@:>GB#PJ:Q1XF M='):4(,),C-/,Z6I306VAQ=<@73]S-0>J+`,\Z6E6J"@X,0`0,WG+N,& M-@B&_C3!5/S9K!_^.*8SD*2`"NS!!MLUZI*F!@*TO<4?>[!19BH`"QQ4#0`L M>.XIN`&+3);U::`XQ<..04H"[P'^K77:P![VT()E3+%L]-K(-X-CGAM#(@L>8X`KC*$.6WE$VB-J@B7\A03#( M0*@!`^`(4%;!%7KQ@RI&IP4V(,`5^/L`[I!.3WK*X`14,(,T[6`<:=H`H%X@ M3`L.N5C^[Q2R'5YY#%#T.$W2E42T_*&%(]"9F:-=$G@5<%G%J,`.P&L#`!XP MCAE$^PA:\,<&U'`8D5#A`1I40IW`H83[/`#$85*!%L@QY+"Z:EBP>(%RN`QP MX'T9S&8NN,$/_E(T0U+-'&H&)=(P)Y"<[PU?`\59)%X&*;B9U3>@.#AR@"=L MD.,-UK@!*,@A!4R_@YC8L`8L[-"U7J2!#>"`U4BHL`$VL``$.B(!",1!#A(H MA1SFO&.GN"'R-XA;U#J00@[2,`.ND6#DFL`.%=Y!CH9ZT9T@H0(HKG!");!@ MSJ%Z01LV,&^G28$08P-2N,'%U;T,G2.C79/)_`N4\`8U)$<3 MW,"!(\[R=3D2P,T!;_UN!XZA,"-\]K2OO;T4/LCCJN<'KRSKR'A&DLM+?&1; M'?[(&(^Y^=1G*J]D]>^E0Q+B^^>.QIM^]=U[44;=\=]347`ORG;8VJG[-<`O M3TS\8\L[GJ5LFZZJ^(U5@0<`%#^>R(5*VB"OC$2JK-!N608Z68L*$@2-JB" M+#A/M-9#_K`,P3`0.DB#!^5>(#&#A%4Z/F@82C@0+]B#6A2%+EB#,#A/%1AP M7H:!&()^'4B&96B&!/&!UO,14G%$1^2$73A/;.B&74B"==B&='B';RB'3NB& M)!B'=^B'>+B'<-B&@%B',X.($I=B$V!&?6B(<[B'D?B'?#@S;$B'DZ@%?+,3 M?%B(A1@I>3B'@LB)A'B)E>B(>?B)B0B)@_B'E@B*ICB(ACB)G=B'L]B)K?B& M8!B&&7B&O>B+M9>&PZ-FIPB'LQB'IGB,E4B*Q0B)65&*M>B)@'B,CLB)DLB* MK68')$#^`IMHC'+HAZ?HBJ\(CJMX1#8`'B2P`ZQFC)0HC=-HAZ[8BN]XB)?X MCO3HC;)XBY:(BX=(C7:HAX@(BJ@HBH$XBKJXB^TA>[^HD`L)7,$(9NS(CZ&8 MC_"(BM!(B?'XALE(BQ>YD=/(D:N(C%/!>PSXB>T8CH\XBO%(C'O(,[5C5)$8 MD(^HCUE!B]+8C/J(DAJ9CQ@9C0/IC]ZXC(((CNX8BQ!)@@9YD)'$D$O)E#'E MD+TU%5*1(`DB%?_1#`#B"U=)'P3!/%,Y%0R2A"YF`\QC$+[@E6-)ELP3E0DB M<2^Y(&)YE63YE6/I9B\9E7=)E3TT@FCYED=DEEW)>@"BE73^J99&E95:8)93 MN96("9A7F8(!\I=QR2`@P2!D&9D+4HY9F81_*98+DI4`PIASJ9F;.998^9F? M&9=]N2"4.9B*Z89L^9:>>95F69I;F83S<9H#D95I^9;SE""869B#J05(F90; MD9!-B9S)Z3Q/>2YJEH29V8:H21]_B9N">9E^B9BT^9N'Z9FA>9N%&96&21\# M0I=1V953T873.9:(V9?L&9GH^1]@Z6*:*97K28=LJ993Z9AT*99829CS<9[I M29MH6966R3Q=F9]?.9OK>:"369I?B9CS=)N>>9C[.9MNR)<2%X?;Z9EU^96T M"9[HR9Y^J98'^I)M^)*G>9?3*8?^H*F6Q%F(%3UJCDTJI#C*< M?$H\AUH(K=8"_I"H%()J@^H/-^`+],)(7G`*9=`"@'H0)-8#G;J!7)-_9\9! M![(05.`/N>H/Q_FHL2>IE0JLP=H0S;"G?,JJ""$=7#$)>I03INH@_F`CX^`/ M"J&H$%'^K9MVK0_A!4H@#L$0JJ=:!ITBK1#A#SQ0!`K`!OUA>P`3#*,E4G_: M"YX0#!ZV$%[@"\OP`))'"]?:JQ<2J<(*L`&+I<4:H]F:$/3P#E?@"=C:"SC` M`M,*(?Y@!T?0`]EJ/@IRL0;A!9TPJPK2`NSVK8SD"T&B`A#;$!70`T=@`\[` M;AV+<`+!`N3@'WIQ@&W2-P;K#TC232K"KQAXK`(+M#7Z2)C*$09[$%PS+,Y` M$!R$`ZLJ4D9;$%Z`?@+Q`P,PAE*[M++P`/1P9@/0$/X`>EQ;$+[@#,M@#:^4 M$)^KS^D;]= MH[=\>Q#E6[ML^Q:%,+P%`;R=.KSLNU4,G+_WFRX/W*GIPGN=,,#D>[_HE\`, M7!"YBGX>/!#'\[L02P\S$`RTD*O^]Z$$2MNX':QW15`&S@"H_RP.$_`._N$/,R`.DS`!/'`\2,*],S!Y,[!2 M,Y`&DV`'HL=!.3`)+(!M-O"G;"$.GN`+AIH#&V`4W.L+D$P"KZ`&XPH*"J`` M;@+`'6P-^J$#19"HO3`)$+4!KR"H/S`)3D<.OEP$:2"MO2`87>P?X_,`"A#" M-J``.?#^`*`0PKU0RN$SO),P/HPAO-I\@`P#S`[<&!PQ%#O1P'T?P"J#7-U3@"VPP`7IAMS,V`[[P#FGB M"=W:`BP`"TK+!MS`>]9P!;(`!PI0,,\0)+W@#.-S$+[P"F.LL/Z@`ST`!T^S M#,+;=,[0`@_M#Y#P`@^0J_)G/C/&`KLL!7`P`>+0.1,P9'W^2T[>Z@QZZPG. M2TQJM+3(\``;I@#BX`PO%-@V#0#X,*TLD`/.<`C"$=D;L-A1X@QEH`/O``=5 ME`-P,`F*[0^>X`EPL`&D;=K86[M"ABWI>[;TR@,K>]VT\`QQM&(_P,@_X-/A70XXT`LJ\`XZ MH&+.X-+.4`@O5`2%X`70P=HV4`@E@FK.@-OCL-GRK=C.D'4,#0Z@(,-*@`,\ M(-H`8`.O,`G.0*CY*QN%("]%<`S^]VWA`.`%R'`YF_8`RPLEJ$8Z-R*\P<`" M:/T#@@*]/;"W?4L/5T`.:.T,KA)U_I!?_B"W`Q'D*JNT/`"\`*``PCLU^``' M'S6M,9T&4\X&53X!#S#5FV#BKU8(#U!&(H[A:5!&:$UD9Y;6@0TPEOT#.?"V MA7`$*8W;2I"[N-T#S@`'63(`1^[)Q^,,2O`U_0Q[/]O7>YLX/]CZ[B.##%]!-3K'TW`;ITK M2@#`:LU4"&3[`$>@NSH^R^1214^.OM>=`Y[J2].:[9"@M\&0N;N:UD\."0YM M#<_@L-,JM?F+`\>@\'3K#S@P`=^>ZW`#`&PP">+[`SJ.\;#:Y]KN#Q,0#*10 MKM5""BV0`US[`R[MJ;B]K_Y0Y\_8='"2N@@Q^C^V.'@QN3?(L,`%UGZN%X`PZP`9^ M#M8`T+DA[_E>H-F3/^Z_*^\F2TY.?K[^H.-2H.\X`+&.[@^RH-]LT`,DAEUK M#25\=03+11"(>@1OA8;T<`3+``>0D*LR3`]B5\11]P.TP#=70*_9GOKE8`.3 M\$+E@`_2OO(@;<65>SPN+_/!P/-'RU`S(+8\W_/^#-`M/%R^0+Q(OQ"C[!_R MWQ#P_P/V;^BVI^C*O?4?#Q`__%6@MZ?"`!O^'@"PYJ^%#8CT6OS8`*"<0W_+ M`'3R=T6'OQ\W`$PJ--&?+!8`>CG^LP.`ED2!*(.5\<=F@C]_4E1B5-*KYLT? M[P`4\3>`#3E_$!$F1`9`EA=_153^L/'C2!IGSC:Q@50&`(ZB/WR]#C5@`X@K-G1`,XH\9 M`'BPM0%)"8!-_GQ!BOP*)`X<]-RZ'3"`U`]Z/:ZP\=("@`*0/0#@>S;!9=)" MY7RE76NCD!U?$]A4O5NF,B1K;(Z8AH1V;G]XM&/-&>@FV&&!O?[H1<`(51Q M118)3`\_&&.4$3^JH"O-!@_]0^B'3JX`IP5G<'*FEQR\Z`6`%YRQ`8YC)BC$ MGR,F<.8'UXJ`HYP9"BDI,#B^>\<9+`MQQK6UCH+#B\MPN*&"7AYHH9`KR)G2 M*SN49",-.$(<+2H`6L"II3)^^.&RND,(9+X*9E;!71H(# M#GP`4"&I&^E)J05Z6`(`4V=8@$5)^/Q!AB8X/@T1`$_@*(3^!(:Z!$`'/WEX MPR\DN_VV'`#((=::-Z(2%0X>`/@!&0+H8?=8Z*A8JA"S/('$GUQS.`6B4Z(, MLJ5#<%)A*F?$"8:>2[WP18D?G(%CF0T*&IR('9OY/)"0:`*Q@-\,35V&"#1!O(8>0-'?2T MH8(9TA#99:BCYN]%CJNV^H ML`A<'/3&NBI:`#B"%(3H6<+C(!EEV[@73L!,^HA=?TO`$IX52UXB<0Q1M7+E#!+7-\2/R M_V%_-N0-#@]04PO((04XD$--:%%`$S#5M=*$)!A*8%@+\N8YN9VK7*)+6>E\ ML3I:7,H?!\,!"=Z@+[=XS6M9DX_5.'8SB%!!4()J&8C\T1)D4$9J._2/TE9T M)%`XQ%1EJ"'4RF`-&#J(,!O`0584@(.G^<T0M9%$$!DYA$57IA!SN4HP5*4.0D-L#"7HA#`9BB!P\>\(`> M:":0KYA!"\H!25FR@.1?WF&'(KSB-%GS!0\,233,E>,!;Z"%YWX@307X28_6N-XK!F`79[YB M/%5YY28F00M0'"*%7:L,*5(WB;68A@>"Q,<-VEB9'I!``3E`!B2^:0-/I$$6 MO0"%<03UB@>`XH_D1*A"17/0!RQC>Q+:9^DHFH-7^!-LI0'^&SYX)"#6`R&2I5`A/O.(4/N1/5^L*HO>83D!^Y2R( MIJK%J?*0:CME[7RPQM&M<52%;L24/YSQ)']`AYWT*`0]0%+;)C2!83@!R0^> MY%NH$A=SQ\WMCK2DM81HR7/^"*[^WXB[G>?"D:.VM2Y.=F?<*1FW*%5IPI.D MH]P?E+>Y7".N1A'B#RV)!FSP+<16$R+`$<\KE6M;@&Z04XG1K7=-I:SL6H`HDX1_2D,8_(M!4PI2#'+8A&D0>H@7C MV(``+7A(!7RQH+@FI`7V?$=$WF$-)325*M:PQM*\\"&)6&,&[.0/:M[AA3*4 MX7,WL,9+C!RB,H2(R4W6`I>EBJE.O,8?9;`=BN)L@S_/N3\.4;,L<#0J:[Q# M-#9003#^-OF0,)-HJ'KL!9;9PF0VZ`#0"$J1DS_.QO:]^[W1C2($M@"O M][_1'>-YF[O%;LQILN\#PQQ#01IT@,*/^5,!%BBA75)@RP_L<`46Z(W1.EB+ M"I91#A:HU0:ON((G4I8#A4AA'$<@QV-DH0-DB.,(GLC!6L;^\7(6Z*`3^J$" M+`4A$F+8(JURG*\#VOEG9YXAC'!%XP M$26\(1@N7\TXIW;"<7!C`EJ0(B@>8`<^`JKS_[V M4QS\"<]^^57H_14B'*>SG7[^F>W^[/R3OOJSOO]SO_TK0&83O_$K/VFKL>:# M!(Q+`F'8.&'PN(BP!J3HA-CA#W_8A&-)"&L@@2%A@25Q!C8X!@7Q'7P@!T@" M@#*`@X/Y%5]@@PTP%&Y@@XE`B0$PE&!X`1TR(`#(`3OXB`TX#"4)!A(\A5RY M"".!#1M(#$-A`[!`.SUSAI2I"F1QAC?@`;Y(-!TBC)8`DNF8'E*PG1Q@,B2,PZ;HA6C1PCC$FR7Y ME$:*"L?^F!(V@`4`4H`ATM=(9>\2AZJ(@R6!R`%,B-X"IGJ(A>.`6J"(9E M*(E"N$<>\)LK.(*#;(@6P($Z:8$C@(7<2CN<8!P`F8XC0(TB*++'((7$4))" M>)Y$:8I0.I(<\*TTF("`I+GA&#C7P#D_T0NB\0A0>XQ)F`#^C# MT0B&\?F9I("%8'@(*A$D(%&D9Y@!')@$%@`%CYF.32B)+$0&2'%!@1`.C_&' MQ$N(@]E*/6*!F0P1N+"3!W!+LQB'05$"PTP1%6&^=F2C;5Q`_^L^^9/&QKR_ M\%L_`,0WS&PV^>/&[.-%7$2XQT1&8FR_]'/,#Q--`SQ-8RQ`<@3-<;Q,ROR^ M[1O-8YQ,\L/,SZQ-^,O&9HP^6;0XC,,#8:`#.A`&!^"0'Z`%-D"&9$J9OEDJ MN#L)M?2')I&%'N@!):BR)UR&E1&(<=@`QAD'R1D*,1%$/V$!:#G%0@@5AS_U02!+`B);8T`&X`A\LLQXHM5XH@@F8@!Q0 M`&3X0V=P'[[H*W^(#(C1+WKHA0D8@`HX`C68%WS(1Z%@!,U(3M"#`[,(&7^8 M@"N`&8'@`?"TB#@LCQEZ#6>(C/?9$/B\C,_32PA1S,7D*6T\1__KQ6L,1G'T MOG$$1S0%1GZSS5]DQM@D36]TTV9336(\S?W+3'0$Q]0<1OVSO\N,TUQLTV1$ MT]TLQM6L36=T3/U3P-*OL`5I8G>W1HS.T M`WP0B)C^H%2Z1T>@$!Q8(.>Z)E$P0$=,%74Z"Q1ZY,!H(=> M@8T_^A0GM(&"G($-G8N3LP[0*`J7E,,^T2U?"`:4(@H$]0JH`L$0J[ MN8QT>8S>8:Q!&=(BA0JZ1%"I)!\G+;-#8(-EL($<^!U_D(WW.8W(D((6F*8W MH*8R*A`N[5(:"4;2W,RE&,#8#$<`K$8WO:G6A#^;0BIH.S^7A=,^34=LU,P] MC3&3-4U%A<8[_=,WD@[S61 MU_`MF,0:PB##35BZ:@U"N?`'JWP'8+P'T&NIJ(_ZSQIRB!P"^4\A!8$IG>(8<@&*H&5_R=4K],; M.00%"*4T?<;\#52?W4;KLP$Z1L.;L@MQN(C^D\U(6&?3YRC#[R\81W<"^>Q69=%F$'^8%&\X06L+8K`CWM3B@[%5`!'9B!KD@+N5."I\8':X.$[[B"-R##(V@>$YGH M^SD"$OF!!Y!C'F`Y]:CE6]X8#'[@0EWF7&$!!YI:7^1-EL4_`\Q&/,LVI\P7F!LY?]$O0A2B')@!4D#73#.YG:@S` M\$/X)FMX!7+ZIK)5N-$P#?T^!.A`#D;V#B3B$7%2C[@M!P'GMAV!A'GR**S1 M)412`JQ4.!6W-AX9*-=QG8GP@DX`J:I0@E>0) D7>HIF8Y!&3HI0SCKXA] M!1X@!7^Z`0@'G_5.[_Y>"17H)14?H7X4I%=0`!W`&E;Q\LJX-G34\?.^J?BX M;,9(8AH@B/0@<]><7-\-J9=7XG+MG4B^&SWM;=ULL56YW2!2\"$B`R:8K\? MX(%><&T[[_17R!]0QUF>15H;>`;&P11(D`4U=_08.W8U?S?2\+=T9HL=@2P`2R-OUZ/F*E!DF`1_;XOT&'@]4G?(PD+U MX&_UK7=H(RZ%\_892G1M*[-[=\7'&*_*0+!MWW%#QT)_YR^"#U]OO_?FP/?1 MX&"J>'B%:X$K.(1WCW=Z`(5\]RYNG[8\/X_TIAX^EY%-MUG^]O6"X'*&01^L MW!*N?:&=3*$'J%^P(,':.:6O>?O?)YFQW(J8HO":A/"'!)IT6'&&V,*)L0\P M2)"NTDB4]7D&]BJ$Y=8:ZGJ2HG>CNL=@\GH&N6T"2*@JJ/C5("F-,;F"OI@O,=E9&^"MPA\`S#J6 MF#\3NJ>=YX(@L0=[X^JM"RNOUVH"<@EOH[]]S31O(B_R\]ZW>--XE.^V`(DW MA"`,O9@9:\`'*9B$;Z\V%=<1],Y0DYZ>;Q?^X0^UBB"#Z>DV96\+L>[YZ-CX M:-.1X7]94?_]:1M_Y_\WH&84?>/_MU_ M68"P,6"`#8$$"=KX`6DAPX8.'T*,*''A#R\6+V+,:/''CW)%E'#3T>1'BW(# MRO4X-$.6EP&T:!WZ,<#?(6239M@HXZLB1G\JBM@9(--?KU!29D8;-4%E&K='[04L'@'(S2-'SPH-$.4@R MZ?%`YI84SY8RP19ID73F#1)VK`$8U^0EK7&*0#!YIXG\_*/'`$4?HH,`ADRWY8)-$ M`IGB@/GM%Z:8#S%W7VTVZ%#$.YX$,T$A^!P13!$``%`&#L$D-$,P+_@#R0PX M6!,?+#?19Q$]#RAPPP0XM%#(*S@HP0,`XA2BQ`L`%"$%6\C^^*-B&IX<,DDP M5_0WIYN>6KE!,$<,T$01.,@R#@!2^&,-.0!,4HX-G4R@0@]7;/)#$R0H8%8P MLM`F5`LX3'*(#E>4\<-7Q\S`8F+.X`/`%8=<9\TQ+;3`3;,L7-&"#3D`0`X) M;P#`PE#E3$#+*\'P0`\]H"C0RQMLT`*)/^7HL!4LLM&F%"GH>O*,-<2]X@D+ M`*#%`UNOC$.0#B2\\\"VA3:'S`2RD!",-3\40EU"UAQ1'2D*3#K)`P!,$!?* M`/CBA3\SZ&`-/L%,TBD+"I1!#ANR2!L?+9.9F71&8S)M%X1/0QVUU%-37375 MA?C#41.M6=VUB6EE;:/74*OH+XG^8Z.=MMIKL]VVVV1#XHQ=]#AS]MM6;]>T MWOKQU+=2?V_4DC,/D`-'IVWV^7(YO>0`!W5".:.&#LX,$`PH<,#!<@NTR>3, M,C@\\TP/`"`#1[N8ORSMG$4T\0PL5T!2R"1'..-/(3B015`PY#31Q"2@^]/$ M$:1"`C/F$P3S`QQV`-"",\Z0\PKFM)!>B`E*8#X)+<'UY\PD`'0"QPUM.=," M&STX\PSS//CS#'5\-3$.#W"@VP(9%2 M9C(#!="#%',J!QQ(`(Y.04(6B1G)(695""](87,]4(`_2/'^/4T.```)4TMB MX$".(Q1B/+2PQC,>P`(2@&(#+^#&#S;P0!O<3#9-D(I,W`.`#3J#94)I`@YP M$#SJM(`>G0!`#ISA"]FU9:"">P$+*`F)'LS@!].IS@!&"M`6X$INCHR;!Z6S M`0#(Y`?O4`$]9"$%-C*/!%N+XA3MV!>?*@6/=Z2C'"\5?HL:$K<.C!,L9Q#%(Y MHY?.H)X2;$`*7]@%$DI(V1%Z,%#^.PX`E@J8!`G:`H<7J,$T_J">8J3S@F#< M#)4V*,0/1GM.N`)@&;"<0?[@`(LC!,=F3;C=&[##E[BQP*$`10P^/EO0/6ZP M"9J35D,!*04`J#);%7U/MD!!N:$<@06T"5Y);QA(@$XT!UN35+^:4$CIL$LH MXZE;\#:0@U=(`NRWP#5'4CWH%#VZZEY#AK4ZUT%D#7L0C`W@`P?ET.A=^+<)N"9$%KYC MPR'@0,I6Y76OL,7?6TE1B,".APV;@(,2,%4(7S1!:%YH0@[`409WLL$+A4`& M`'KAG+;^/$,@/R!%JP:`##8`8,/RA40GKI`#PE+S6>[1RC:YFQADS`<296## M)(B]9](C[:33G1B`$?P1/GR M^Z_]$M2J5*7C5:D:U.M0V"$%1MMV@C=L!)L-:M(:J-NDQ;4(0SO:TN;BA(/- M-,#U^J>NF=0S!O",(TS@&>X-AGR=\89@+,095PAW9UXQ`QZHTB]WA$3*>O$, M.-!B$EX@'1R><6Y(J`\`>AUE8FT0#!;$T\9L:()27)G*@U/^#LK/X!\UGR&T M]LVI#'4#QQ&D$$)O;,!L+Y;4J$]HQ#X&P<Q2 M5[R%N*YT4,J-0R.F%_0)+$*5-RQ9=N92&O_5I%E!Y%J`TD.$L9C`X.=`6"><$AW`K[&,3VC%TY$?Z7>Z2D%)-P*#H`"++S`#-#"HA1!KB$/.?0`"TS`ABW# M!-*)MH020=F,J!S0(]$#NAP!,J"+.-"".`@B*>`,#KQ"J[#,%7C"HO#`\N&` M#O2`M%"'&DC!!,`"#T`"RQS!*Y20.)!")QP!&^3`0N1`!K)!:^'`,=B!%'B" M76!5-EU!,#P`/MA><\U`-$X`*(`#*$3+>`3-8-"#$D3C&^"#">``/CS*!"A! M"Q#3,I1!$\S`P%#40-T,<>1>131!#[!!FR@`..3`&RJ%#;S*Q\C"HH0'#\`" M"[`/+8`#^HG2JQ3!!AS=KKT0<02#3JD%(KH$(IH3#I!#+W3^@B@J0`L<(@X@ M`T`Y"YV(@T+8R>[`R17P0!F()#,)7N#HFJ_Y%[!]8=K,U@1L`A&6@_:AB)<0 M"([8R(PPB8(\C2^PF:(5R#/43W^(S8')2!NJ0!!5Y1UJI>BUQ%/EH1Y&1!<* ME4W&%#T8T`2E0EXOXPB&`I#!]UT84`BF4`3VHAS^4 MP?N)X1FZAV4I!)=)2R=8&5_$$V9L&4<`YF(*B[0$IMR$TD+80&EH30M$"[.1 M!"W(&$5.1DPX0R=4VDQDIG(X3U+<$>"A)FF:9CG9A2\41%=81]8PH,F-1/'5 M36A$'J/)354-`&8-)UM"@EORQ9;^S00I7)),%`))'L)(5%4S,5P9A)90&">7 M&2=M*L=P"D1A'A>7>8&]E($JW<4`_%GY=`(=%N:N_93@_5?J@24&N5!]<)JP M!,,;P,%X9LUP=0JGV]^,6`>L5PR41+T(-=C`1!^,LS\)936L1L ME=!Z%@*6?(CMC%VK]$YP#`0(<5KO;$U77@0&T2>*UB=]:@2+#H2)MH2)NFA] MTBA&I&C2O&B,VJB*UJB.QNB+SBB/_BBGL:B.YJB1HFB1GJB1]JB/PBBG+2F- MINA7@N5#9&$7BN4S=L498I5_"873=$4A@(*@W5N_E0-PY%I!#09'C$=77$>6 M\F&;CD?^3-&IEH['CR[$E[J00@B%FM:IO]!'X.FIG,:475P'!@5>:RI$2SC- M@H(6:"6A:P(;HGZI%^9:?Z5IGPHJG[*IO[CIA15JG5[I56DJ?&KJ0.3IGC;J MDAD`*IC?K%#2#&"X#F>-R`9US0=72"S;R&'<0&#V@4&XDI3,T`H4B%5M@$9T@%))2#7M"> M0N!&5'1$$;C%6DEIU'0EE#KID1(IO4HIDT*(C`ZIK<;KC_;KD68$K=9KOPZI MO-YHK4)IO1[LDS+IBA)IC0ILP0JID!HIE5;I'-DD'_[:=&+^F(7AI`M]Q0&) M@S`]`*>4*K;Y&LK>),?6$7Q>V-\@:IRFK$]A59I.9Y]B!)OZX5BF;.'Q+!Y= ME*,4^C0LEZ<,&K+\J:8[6ZKV:KL1.[(QNK>@6ZQ_?6S5NN?.CJK/NBKT M*BU0@:JK8B]9*BWQCBI0X8?V7F_2+NUT1B^L#B_/9FGW5B_V!F_P9NSUMJH? M=FRB\@18@F[`NFCL!(,X&`Y**=UD'10$L<$5=((=X,,S(-)AX8!X04(O;``) M-0\<[!"VXJ`:M,`K](`-F,`$/0-^79!42`>Z(,,/^,+#W,"^/2$N^5 MHMX89UO^MJ$OS5(M3FJO^<+QT\*G^;9JU$*M%__L3[UQ\3JO^S;M(!>O]:(O M\-JO]PHOUG)OK&IMPQ(QA$AC#;U4M"1$-":$-)ZQL*"+7OV`_3T#,EB#,XR3 M/[3`.>&9.,C-,_@3-E$/X%:H,Y300E'/)!C=]M#"%3C4`+"!&L3B``@&=%&2 M[-S/NOS/O-S/_OS/P.T M'6EMZAIQOOZ`-/;.`8;2>]Q**)$!*W_G1/'M.)0#&SP`+0O^Q$`I``F4%K;N MD2?L91/H`'#-Q.BH`+,-A`PW#T?X@CJESSAX`@]42)]<(P#@P/9LV4'1UJ_8 M]%8],S47\31K\3+;+N?R\+\&=8O:JHOB;C??:!/C+NT>,>TBZ<0VK,*>+E'[ M,,&&\SI7:4"#=5B+]5B3=5F;]5FC=3T/=!*3;D4@=)(!P#NXAP&"ST&S\H@B M#REXES@$`SZPS@_<`!N0@)UA:TLO`R4U`;E,!CV,#ON@J$J_2'\<%!R\P1'\ M3W*9QE^EU7X1K]NUR,Q-_,VO7 M+HP.\;QJL[[J:S?C-K]2J%?^@R4_=VU`RUM:(W=8%W<^+W=RE_5Q.[<_ MSV?H2C/H'O0;;,V<(,->/H,.P,)?]6\\A4:V,.(S4(_["4O.B9LVJ<`S?/21 M&9U\]$Z1H0^0JC27^8,V]8(V]4#H)!<<=(*,I24;."!*&5,9"+CY)$Q6$[3! M1K5I"[%0/VR#WX=I%[017[@VK^YHY^]MO^OG2O)JCVY1\VAN5W.'#[6J^B[? M['/OE&H_QTV=1O>,X[-I4&6B>&JB-H(LB6$)!0`'$+M3(`Q MC8XX#,#^.+`!\>%,I36!&MC!,Z`4W_8""Y!"[US!BCWX4SMS[LZN,ZMV:B-U M.)MN;)O0X MS3KCJ`]`#YSYS-7SJ4]`1;WXJ.NS&.8`+&`6K-_S6G>N?.UI"PR?#N"#7)+" M)DR`'8A#:R'#*X94@,CP24O')""#1XEC_U(CH#Q*P`S%K[0)*)C9&Z)J+Y`# M#I!`#N#R>!02#O#`,@3#/[XBL1^N0.+`)H@?N!%[#CP;$.?ZB'LS59NS;@-I M3!TZB8]V;G>MKD.Q7]R[-`\Z:M_VC6*5;>-K5D_R.1?TH._^:=>N.(OGLQ<@ MA@[P.#\K12>\C!2]>H_O!(T;3'_$QUW?\_*Y],B_LY;9ND_U`G$D1,RKM::W M"YL?A:V/JZK,:Z,_&F?2`7\AOW MH?IJH2,;ZN/YU$R\P^$N6?]24G.3/E#YBSIU MVY#B$>F75+&P9NG7Y^6S:>*'OK_^8[Z).NK`9XX@W;[H(WY0H>CL]SZM=FES MXS/^\KW?R.]1^:6C+G(<*^I@_&[@-9-"_#VB3GZRG6B>\ND?]LFE9NWY>['< M`YA["/A`@) M*G2XD"%"@P,5&A0("6-&C1LY=O3X,2-%D2-'#J#7!-*S(SH*#?""LDD3A?Z> M.:,W$))-A3";>!G0I!P`64T&_/27$]*`'Y`*87Q6J.?2F"F=%5I:TY]2@3R5 M0D))-2LD..+(P8&4<.``IEZ)+G7F#*54F0/\'75VEFW.N#B?D1-G=@"`OTT* MT3/(=23^)!L`/#U3V]1?4YPPG?UX1HO-@&KUXO4'89++F8-T_CSB0^D0 MI2MT*1)MPX,4%U:DCK8@P^H5#U)W*;%\^.P2M3J<#CZ\]O73M3>TV-T]=^S= MT=P[###]BCKF?#E$@ M!SM6:@D2'D@@IPAZ(+$FATEZ6(J626C!R$04LRID'*&(:@*?2120@I2L6BBB M"%+(F6`P`>E3B:9I)P6(.GDE5=^DJ4(3][HA!X;9A"'3$\(NO,-`'2P MHP=(&".%2EJN_,&.29`DCJ*D&'/&IR(F$2>'KD@!91)0CPDJU=RF$`%HCH!!1\5R)&ED!XVR.$!6NC1 MS)/;3,.IASG'L0&2&&=L8H8BQ&D2(U(\%:>(I4AALI,')AE3`1\G48O#>C6\ M%R,+&23O00[![<#<-]]T8MOOH(#_*_@@0M9=)8+QQ)D6C@"@$XP.V824)L1YEY9@%(@I*%E.FH0%&P8@YXH6?IC$3''$ MN0*`<@K!AXU@)K'C`0`4(*$<'0`X!!)ZWBBBB1X`R*&)G6$I8AP6@FG!!EF" MF:",&ZX]KI,KDE1A593`?O`"E-/#IEHU#2+&MAW=V M_TF%!XIZ0!S'-LDUQW*>D06`*W;"YXVL<`4*`!X@40``B@;^D'M62)8FQ9E7'OB!%#A@`49P0#R]*<`9UDC;!F+'N1FIP'/7HAE) M9#8SCS&(9=FQ#WTZ%B A!$0.AQ0RVP8]MT$`/XX^^OO/!FLE'/0M+D`;_ ME3`7KB=D)Q.0!EW&,(VM<$'V09C"!H9"BU00B1Z9H/VJWE-X]PQ>,@0,<=*"&)I`"`#T8)@]Z`8<H0@;*)4G#J&B*^!`)@IH M04*A*E504!6-`%#"-]^1E2:4\0;^G22'-1,*@'?`@1QL2`HDV$".RC1TD`_` M051]Y`E`F>`!=P7`*S@E2=T="IGBT%T3N+A/L-$"#N70WCL`0*I);,`3D`2; MG3#E2S(HMBB;ZA8`Q@&'";"`KPKPQ.PR]X47ZF\2)_H0'[C-K4^&*@SW&Q#.:`=LA9/$N M9Y"#!3=&J%=R--:VE54SMI&%,^*;VZ",E1S!R$A\[X)78DZ1+6W\05WOTHO! M5D:2CED3]T#K#\H&%A*)?0:0"M&^,\8$+H4@`=*2PM_`*-8G@KE+^TI;0"$_ MXYZ^W-0/Z.$)*1R"!3@XBB\2M:J<@`(`K!6)/WB@*AV<\0BPS')2^A(,?XQC M'#X[@B?^S*:]Z4XS^""'->PPS];8$SQ-:-\K.A'*<@0C.7"."ZAZ<847Q"2/ M`C%))^`WV+;L-U,MW@A$;!C@$@>,IA^MS\>:';()Y939.)3^-LDX6$0!7_N% M0!RP2!ML;8RA;-L->XA6F)V>#>=4PM>&=XJ_16[ZX M$Z#JVA0O$W;+:6@)093:,[IP+P?/L,&/NX@W_0%@`\!4"BV>`39`82[<%#Z;5JZ0$/DA[-1:T;*@X\]@P1&R>&B,W_$, MO?UE`*:E)B3`$7T;C(4%;WD#&S[3A"NL]4X`L`/F`)`&\'NB##KI`0#M!LIF M,TS@#W@@L@!@&1!J`%8K7XZ/#*2`BMP'#J3.QCJAGVCB""8)?>1G*4RC"7A`O`@) M`"`A**3^`*&6AU[H07"XQ+N0P6V.L$D68Q(62@@VNP.%ZSAKNKA/@P/XV`0ZT3ZY^P!]ZH0>*#ZF0 MS0__$!`#41`'D1`+T1!YR!`341$-D0_QI0=#(E\B$9^:`&P>(%N"(1C@)`T` M(+[8`(%&HWUZH"V:`'XZ,93`QHO09PY[@`UZ`25B1U)HX0A(AN^`\1E\ MPK<49>ILH!"J113WL`>#`0=XH`>0:0+J(L;PY@=$!_K8@+#^NF(IUFBMO`P' MK&$2V(`->``SX,1HE`EL\H1>I$F;FD`!)D!W0`?Z@F$<4.T9=J;ID@(A)R`8 M>.`9:HD<=@1^7F<3]D84RZC@<&(/(0$'(*DHG&%G>`8'FD^>JB0'Q)$'2*&, MZ.9FV$`)JHL,/V/CD.\16_#X&G$1?Q(H@U(HAY(HB](H@[(1[R53>G`G'U%^ MD*&I>.!IDN9K<.`(2$`2OT8M[&`O8.P;DX*Q)B`'\TO^%L*2M?(%QG!`'%H@,!6`%EJ`!#QA$H#% M!A2@+VV'*9/B%023\NP`!R:@%V33#FS`$]S%$XHES8!L5BCB!]_`$S8`NLI% M-<<14^Y$'3>.%#P!!V`A5ZY),'OE3LAAKSKA&!Z@!6A!M>R`7CCS)_`K)S]- M!T:-6R"A"+B!',I@$J"3.S-++[_&2+R>W$B3Q M*5'STRDM-5%9-:-<-2W@44%[8`)RX!B&XB)\*55UU56%S5>!-208]4\#U2?W ME%JKU5JO%5LYI$\Q)%=UP3796A,DD8IY31:<142SS5@S34K>3(D#582QS4_[?53CT\S M(`T`_O(.$911$]1=N[5<]3-?A[3%LM5C/Q9D0Y8HM]5`XS5C$Q9:WQ42[Q4_ M)U1$`?$11>.54/799.;18<^95Z"\1A5=E39"DW9EJ11?AY1C^VN)!I1FQ+9>R'8084ID MD77 M=$O7=$\7=5-7=5>7=5O7=5\7=F-7=F>7=FO7=E/W:Y$H&O:!=WO7=W\7>(-7 M>(>7>(O7>(\7>9-7>9>7>9O7>9\7>J-7>J>7>JO7>J\7>[-7>[>7>[O7>Z/7 M/OM+#J*!?,O7?,\7?=-7?=>7?=O7?=\7?N-7?N>7?NO7?N\7?_-7?_>7?_O7 M?_\7@`-8@`>8@`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`"KLUJKMYJKN]JKOQJLPUJLQYJL MR]JLSQJMTUJMUYJMV]JMWQJNXQJMQZ"KZ5JNO=JN[UJO]YJO^]JO_YJKL6"J ME>VAR_<>`H$:QD`$QD"QJ4$$1"#^L0,A$!1;LAE;L2W[LL<@L3$;$P)AL1?; MLQD;L2E[L\<@$##ALBL[M$5;LA/['B[[L3-;MED[L1U;!"8;LW$;MS,;M4W[ MLAT[LW<;LWT[MB\;M:F!&E;[MS<;M5%[LD][L45;LT$[MS4[L7N[NBW;LTL[ MM4U[LB,[NC6[LTT[L6_;NAE[L;';LEW;M*,;N-&;NUE[#(X[N2D;$^I;M!][ MLD4`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`M_^\T[\=/;[K^=ZI/]^$GU)E]]2?_[??]\'6;^Z&= MU]'[WSL<<(#`%&H-)Q$`18P(-)(A)8,(Q$#%!'!A((,**#3,V MI/A0X4."%#UV7*@0XT:,$2-2-)A0A$.*&AU.A)EQ8L*2'R7.S#GP)4F#"R'> M[*EQ#$+^@@ECQ@Q:T:;0EB*%*D0HT6-(A0U!(DU:4^3/H5:M2LUHDFQ$LS)Q M!@):%6G)BQQG!MU9%J7`I5)QYGWZL6G("]$""QX`J;#APX@3*X8D9Y_@P/>8 MA#SK=J7%IQ(ENMC,>3-7CIC^E!IJ=.=#SG\RK]7;4^C1E!,%>M3I>B73S24K MBKY3JI0+MP3_H/;Z$*CT#OPJJ^KNY!)+:YSXJ"W(O7==OI-FYUU]@=#'>DDTW9] M/=20=?R-<4=+ICDUG4*=@44=:G*-Q)18T+6FDP@7:;A0:!C^BI15@)PE==5- MX8U$VE$<)4<0-0\>I*!\GI'V'X?CI.UEU.8QA3BQYLZE'+F@&@5]D? M86019WLW(A7`FGK44!Q35[)TT8!Q61D6AQ)ET<`?395B3!899/!%+0'\5M`8 M->@1AA[&0-7:=^+Y%UP-^21`X)1/457D7A65@HD>D6:03PTNI'8C2;+A6969 M($T(%(__)3!K@MZY9].!L1&4A1Z,"K7DF4S^NI9#F"QKJU@N_4>0FVVZ60L2 MF-1ZV81JW27A&'1F\$D#I9!JZJ7^H?6H+4O=P@.>1`GPZ>>'?'D4WY5;35C@ MP(OPB<1$(:K9[9MZF.H"2Q#!U1QY5L$H54K"&I/:=`JSR>]7$/XIT[9\NME` M+36$"]&>F_K)EWG:*E2?DSNA*MT8^2Y,:1@ENWEPH4Y%Q]2SF&3Y&)=?)HU8 MF(^-:5JQJT7E4YH-Z`/`U8!\(0H`$.23F43&7(W+?'0=B\O5$#`ZV7;?(:7' ME'=Q&)58"0#PA:M_!``(`";D4TL&?.>34@U;`_")JR/N)1W;`\%C-01(A59# MIY>JA1^+U36P-2X-9`$!`+@80[97![$65:_]`;H6A":.\;D)]JJ>H,7'_H'$ MNRY\<37^$AN#!]95*\85[MX`U-`L2]3^]RKQ7&<0"@"B?/'NY0G:9)!$`;@# M0!9D`)#!UI#W9'N<_E6$4P-7`\#[2]AK#T`!H^OU+-1";T@0C$%)5`/QHI1M MC.;IRYH)`!"*;^2E?"WB3FZPHA6/?$X?\&E*`CZ1/E-9#F'DHDY/],`\"#@/ M>M+[`SP*<+50N,!\OZI?MIP5LHG!)C,XJ\7GKN8.2B&!@NG+PL%@&!*+]7!B M0#':8)1&1#`YIFE/4X]WKJ>\H``C"^G#Q#QN.`;Q?O#'VHP0!,$8(KST`/^#3,##,`!(!]W MH!8#G56^74$$'MV#P,Q"XPX]S"=7OE)@=!X9:K%%";UD8)=# M(8%:)R0'`H`,Y)/D#UD3.0@8;WB[BY]?#-01-JH2$W<@WBLUJ!SJ!+)[?P1& M*:H(`'VDLC:\C-N(7'`V?93B>:*P6O]TDP`(W`E71"O%#%_9(BG60FQ;A(E[ M8F24N%&G(2$*2TI:53?HK5$BP(#CU0(`#$P\SVY;](E?B-*6Y'VG*5N#H'[B M-4`R6/!W,9.-6`J""5,$V$"'XA(72!0`[YH'";G6 M&CU\XII946-H]$C`K51ND&X)#2;T`8$M,E&-6`E21'H:"A-$I'!9"&1#[D!) M0,S'!7[,Q^A@2)U1[C0X-Z1<0RFX+X;09I3LWU1R)!JHI$9G@PE7@1 M?:`C6U(E.Q>B$/)WII4(7'0RQZOUCV+A^JDQ`G$'IA:/(9`M)X'4:->L.+>Q MQCO/RKK^!UC0CB&SM#'0E*83`&!F@+57RP!(:6@KH1'6O-&5KG/=:I5PA51] MVG&=V-)XP`P1ZU!"#,Q,:?HEI@D&IWX!4;0VBBN?5C`XWKVO1.Y@R<>JD9@*0`#EF9CXT;@\U2C&/0(YA'L0TQCS0!20(U6I"?\BB M]\))$*L!`!"ND@^CYG-%@;B`&B@6CG5`4JL@JZPJ>J[.&.*DGU((TR.U&I!P M=GSB%_^F*7<`'"J'[`)@/.C*.$O`9FB3HD!>T9.GL70Y2T'^Y>H8DB+4J._5 M#L=(_LJYI/`(C6YA$3W?.J;_Y`8K(QLYB"'C$F@FQJ4Q9O'O"H%$-* M@=RQG8C*G2(;0E7M/;RY+Q1YI"$F`["> MX+B`RO!X]&GZW5\2!=E2VB)(*0Z\OM"<='3X8R'[XA*J0$18IA1.FH4A,Q4R M]LM?+3\+%3^<&6!Z-0"X<(<[OD`0%X0!$("(YA?L%1H6U_!SHL@"@+X!@0)` M0.ES+!P9(."../W!>X")`!=Z(3&!"6Y%@HD-(#K8S=P*$*A>D>&YAM< MURT9R,#SA%X=^7+\A"CPKM;Y#5JU>)NA6?GNC@)HOO1^ZKW3<1&*165WAEQK MP!C([_<$N(]KKB1U!O@.^\)MS$F\D6_9P(#N#+D M]P7&X`[^9"`*SK<0VE<`@"!/WY83I:!=Z(($Z8,$-:!Z[J!UN""`"7%UHK!Z M@*`QUZ=S!9%V[$@ M')=@'__4FX;*)P+`WKC4& MHB`*KN);!$%69(`N8'0U\',>"0!,9E<*?F0"&:`'[E-<`?#^.$"?!0"X7C-PFP9,Z':]UG%2YP?[O4*LQ3"Z4PBUY04"DC13@!@#,`0"E\7`#]5"_/`B,"`C&,3 M"`'0`,#T#;5@*H4#>M\$`>%"0M_P2(6C#[@P0]-(%P>Y7_K(B(AS'@0'48XH MB;2R"%=C`C_5B$@P?<9@B]XS(#4@3V30`**#C+85`"QY,B\631+A/N_R?TE7 M-=!3$'=0@#BS-0?3/1W'$&@'"'=0`]WC#B"6/A#`/._R!V>#"]LX0]6S(F&.\!D<&-9CS M)(+ZH`?`$`":&1%O5BL'!C^&Q(VG)&1?:6GMY`YR=#8F%&E@),N%")7+,(OZ%J9!`*]J1%/T600P4("5$*+)D/)3DV3,4LP]2D M=S"G#5$*7_`-KQ6$599%3+BFIV0J(O`YF7@'))2)ESJC6^AESD%P.>I'HC!V M?H68]'1/!^,"FE0#I>`^:*EJ#3D/G^0!:S62P`J4JEQ/9;EG_/1 MC/.`"?0D46;E`L1SI0FP-05`C`SZL%=S-U.5IA$AH3B#2P-K020TG&,P0$#U M7IA@L[@3HL!`3+4P("QV7V/@/L%HKKU#$K7ZHL#@/A;X*EIA'`07"I+R#96) M+\"$CLEVF(9S0MP(/S@3DKWYM?#^*;8FL"#R1)V`=Z6Z^EWD)I=A)S;SD$6X M$``XYZP&\@=[4[8N4#@N\XK]`[)7LRB_-H\'JXA7DET!)"FU(#J$B)CHPG"E M0$D!)U&<-+%A180*HK/S@$..E[.1:D8I2V6?0P9_,%1-:[#"PZ0$-+5($`BI M,:I:-+170Z^Z8U#SD*4/!TP%$`"YM8_Y165;,TT+F*O_YVS*(RU<)#>MT1&G M2:RJ>5,VTA0:DE$AHE#->K,+$JWEB(QI0Q!A$`AZD(*1NJVZ.:@IJ;NXL'HG M6*X6-0:(!(OIJW.*"G^B<)(-E8(ZX:[<^1\$!SDH^4=X@'YBRLIJF<.>RZ*)F6:!<88`)/P=,X[:RV`NM5Z./(0JT-(0N/&NT+U$? MZ#J[4YA?-9(@@6P(7I"3PQFUA6_H>`.F'!@WG,'0($\J@M1 M=X!)1LFM%76$VZFM]S[NGL7JHR*+BQVKN:87_E6 MF[^!;G"*1DQJ4+^1(_!P?X69&F_6A(5C=G;5>VFW=NH82*`I4B%EC&06SGK@ M9CB&+U@,$<2E'6_+-1P42/)COHUW49DDB82&QPHX!B0$`;ZQ-4S)3CK'8GSE M87832+^I'1#JHFES99B`RDC`H3B\LSL,KCM<*]0*Q#O,O@248#"1M([T1L!D M-_TU+:J[6AHA,ZIFQ:T">(_*C9)7Q3K13F7[!UI\&@+9`&F+I;LC1PC;4,VV MI8Z)+NCV22J3`2:`!'Q;N#T)N-+^BM$L.\>]O(H@*%EDG;)B11`Z6QW$=#<` M"4P_=U#PH+.K>M(\82/=!?A(LH'_:("]PEDH(NS MFQJKG#[26J6&\R"U\AM]86"V[!`G%6>"J"+`^ER%):S!G!@2`+TB9QGDD7'^ M@KAVV[;X-`;-"V]5<,EQ4+HC?^*8SPB1#]+!-NMM@"1S?IXY>QX689X&5\JS;` M-98%((!75D6MF$5\E<)VL\+SV,(LVYFV/&AC4`M$Z0)K71$;K<.--XH[/"#^ M*$@"K(@41?MM0=7Q"V^2*ACM8%CW? M"E41*(M/YC)#I@+?W>?59*"V/='(9&773SSDPRE9AUJ&Z8.6,N'$X&>CA54]MW4FKVK-I.LGQ0Q#3<0HCW:A[&:.+4D M!H%8N7RK*\+:V)O7T&-UU)HWW8-P-7M*]@*G8YH[WQFY);09((6.W.HJ``ZF ME58+FZ)?:?8Y.:8[Y$,18/Q:]VN)N.1'87S'H$-J#S4/HI'^#UXG1!!H8\S9FX6?#9;*2Z*CLCULP7;C7?F/I8>1ESD+$FKC0/X(,1T@2$B MX=W]$$!MX7J,T\;0/6HW8PC=X<;TX9-(;[-=$>Q5*2"YTK_Q"?-G#)@4[_%CM:MVK[6,8P-"RG?V//KP9:;J*&:5 M&F?C52RFM"?D-=.!V;M#(&VX-MC^!2U0T[QX;A@V)29,\!0N53ZK\A_S\%-W M!+I<4V=?5$(LW9)MVA0M(D`],J4>J M"@Q@E`_S`'OQ(T(/Y,>5QE1J=ZA^E(F*GY=>F3Z.E36C^+=5JJK^6DR,$L_2 MNB;*-4!V?#%',5?=:$F^@?1'V%"%HVDF]CQ5YKZ5(AK`7@O\DS+S@%PJ.K%7 M5%*_"0Q[Y2!ZA0NO*/=7>Q>I3+41/+L/HCTJJIX0(.1#19W+N;$_,:-#A03` MT'2],?X``(=KX5"K!@Q"0Q"Y1AZ0[@[SL%_7F:1\DVZ[F?2#YI%9,+(I"T`` M`>`+O$#^8R```%!K'K!\`$*-P32O%D)`\_Y\00@@'Q)<&5Q@*HCI3PV$9+[E M(X.P`287"1"*^@,,$,):I<:0!.#.Q9@""/4%@#A&:,%YWS(&F!=T3"!,P(P" MR#`/)*8Q"4P`:`!LGCL`@#Y"=,$U0ZFI0O4!(",RP%51`4IA1%ACS)^>:+\A M<9<%&(0"=TH!"P6`*L@Q(C"130G@$S"((D+>08*P0*D[7`'4N.,2898L5P%D M&1,`P+<[C`$4V!D8@+X&>!M\I%:P(+")<8&)+'40`"[&5`L'`KZTX%#?0Y<. M91KH0C3FS0=`@AY=^G3JU2'):=[\7DCD0KT'3PY<-G"JQAK^G$48ZE,!,A"^ M<<NJE``2D*Z,&_G"A0`#:NF,B,C*H MQ1T(_MBO@3NH"NF/`&;2)Y]:,E@MGS\@.@RCF3ZI11]]]/AJ#/DH^N.M![/X M1I\O7`B$Q,W&<*&VTU#$Y`X2@<+$L>]".NP;4;JJY9N#<$G@HX(*_*)#G-`B M@XS^]+AC2U%J>/*S4A+0S80:"LQ@KBPRRD#,3[YX\HL_ZOLO/Y;>I*@4/1(K M`$FN\FD```B`&J,60!/`CR:(QDLTHP+&""R4!E#ZQLKC,-%C1M:,.2ZX3S+* MYU&0_ICIBQ;U,>9$8WQ4+($Q8"W^U058HX)+L4(!,$'6,?01!13$>0NM0<#C&D(H`W#_1`N"#%(B`Y#!+$,HGU+^ M"`P"8DVR,CA./6T`U+(P:90,/83$A2J&&_#Q(&(P\\V<:(UCOD,,$B.^:>LZYIIZ]3.IKM0I7V-_"^ M^UD$H%`++(X!-C>`R)WBP^ M:6#KX1K^^`2)LR?58I)0: M/LG@FP"^H@K#3SX!DRH]C+$V@S!VPN1LKYGZ(^>5@F))#]0($_HXB,@*X_(O MOJDR*,>^_AB>I:B9-B/G+RO%]C$\9]%5V1=!OA;5D:_AZUK"[KK?!-9V:_QO MA)+Y\5J$0L)[7Q/]@G'NVO>ZEAIDU\/WH,+PWNP`2/Y$#?!6F*W5`G^U`-7/ M("([[0VG='JX'-O\=3_O&2,0^/--+5CDG6\$T"8=3("``M&`T4&00EO[0P)D MUS/]G`X)I1`:[0+PB2RX9899*(C9D$>_C\F*)37(1P:0@`G^GGU+@5QCH/:$ M4Y!T?4TN2A()/+YQ.3V<"&@0.1SNLG>J!-"M%G_XQLT&(Q0-!G!#B?I?W008 MG$T9,'N@&IH*OX8$'HK-0_G(1P+(DH\LB"0!>DA`$&LH(`YI,!_&..-W9I;$ M`(3A@#USEP.-)AP.@40\QEF.TICV-$Y*!SM*NP<38L8=X1B'C5=SEPM4N"L0\OM``S0U' M:UI3"B:HX0)H4@9%XQDG[EQ0J%#^N,.?NB%-C6`GT%?*DD&R%,HX#ZI*9*K2 M7[Y$9FQ0:,M\BN>;O@37*FTRSD`H*6\(W0D]=5G*`0%IG,L4CY+R:4J6Y%*: M`EUE0A$*%F)2Y9LB_*928'=1'HW1H,GA:7'@,SW838]L1%WE0EU).W`&@I94 M"\HX54UJV-.F8ZAGJ,@Z4K_)[*0AC:5!A^(8KV7Z6)2@!#00J>5FW6FRVA(%G:%^;N\\PAIKS>-/K M.JO:TAZ7,-;%;FF)Y,S0:JVW@YDM):=[V^^$][A54ZQU+TFWQBVQ>("F7NPZ\[^^8^//A`J> M3&;'"X]U;&1!*4H)^VURV7SE$GW3NPA#-'* M6NPW2&XR;*=<66E2;3R0&NODKC:T.^4$$`[CD.2>Y5XO7U'^N:->-F6>,9QGR3%Y4UN&LY3?"4\_2SG+QXER=T("M"@K M69I,)O`KJ3QII1S:PX?^LBG_'&I)*\69A2:PJ(UF6$9SA[+>\SY`5'<,K9WJ2 MG]8SJ2]98^?@N).?S$XH?29494O8G'GF6M-O,53&_.M]4J04N((`+BN,"-!*M MVB2S[7!2%]?4B986F#W[9M_AFLW^C'Y$@*&='%6;:MI0QG8,.:X/:V++26",6&6XWGIH1G MO5>M%.\V\[K\MAK6H'U81XM`S3T/M-.!/>KD*E++A.VUJ34.'&XOS=N`\2WDM/,=;<7>=3?Q$0"5$_/+E=ZTXN__!6)'60E7U[8Z$XYT[-- MTO7Z7;')2?+5@V_D1U_-T)+L]A# MNBA[,1,;#"NKOB;#K6';OIN+,IISKP?C.=C;O>*2)/HKL+G0EZUB*: M-[P.VZ4-%+K,\J[R^[&FXSNHX[`I*ZR?4RPJ-+ZJ$SCUL[DS=#EM MB[RJX;^G$S4\K#[#,#FN0K19"SF+Z3Y5T\4FS+GQ>"[-A5,"4^L&R"#PBXS\NB[JQ M&K\T!#)1[#'>4:#:.\*:,RSD2Z2HPD ML.(H1`7N.TRU/-G?1%E0R:WZ-,D1NXQG,YBUS+],/(:K3- M&;1!4#.>-`2O^$E+YDH\-$3.I03.U@@H@DQ#%[,:N,OC'3O\`3 MT/3J.;-D.H$TQ(`,1R3$%K.RG;/.PC0;*[K1CB3Z>K3]B"M7]KM/34 M/)]!2,*$%&8SO]><391+N4>!SY",IXZ$LM"L.CKK4JJ:R92J/$RB>C0_8:M4JB+TS\SRLKQ?(B2YV+ M%N25JHJ:70A1F.ZQ=@E47)(];-=1#=;[>B[9DW%.7&S@J:S.J\[]R0Z$! MX:8E+,(+92G`.S#TJ;#HR[(6Y<5#1#+YRU*6.9>G(XQ;];@;9#A"XPY8'1S: MN55IBS4;W%'=(TU91!%S99YRU1<4K3]0);F3?,DN\[VHHB87\)=X==4YM+(] MI,I)`U=8_%6EE#]H:[(KA,L"1=!%C8X%/&P M,..N?[1'CFS"/AV#>AF3<&(\],I,'456944"9VFSPVI32>PW$,U8L&-2@AV# M+R`#$W$7T_H#IMW95OG&0!5;%1R#;PA:H?V"UU9R-FW3>-#JGDP)\Q5 M)(A8";G(O2C-41P,"?2`D<-U7:`K MM4<%N4E+$A5TV7E<7HJUV$=T3!&$B-_;>M'U'0F::"<3`X8,2&!GXM_XW2XB<<#VRK`&G@@? M.EL(2-O>4B[=LLM.O"3^U0CR35%153Q&1M,N3=5$EJ]E_@(3`-R(0(G-6N6X MN&0+-)K\2C&H"N4^&1`'SH@0LK#PFM-MCM$57K%2*)``H`;O`H9/`(3;^*ZO M7>;0BF2L&RUI:0DR".)58XG(D)2JC1`(6*;5&D7?,MW0"@N$J.&/M,E,336> M:TXEG$>F2%3FK=A&/4`>&\.8"\[^4O-$L[/#\ZQ(4]D4,$8(7-`4)OFFM'(E MK&JEN?BZ:"HIF\X'8`BGG6:09?,NO'J8#8&KG=*J%R.W>BHJC]/:C*AAJM`- MG`8)%T@*E`*.&H&FF<+?B]J4.Y"/;YB'E0JL<^PO&T%?Q3(,=X:`M0Z$<^$* M/6`,DU(EK+(2K**,HIJTG>[I,$F)B!"*M5:EC(HID7`H9VHH85U??'Z)SV2) MF-*FBV1JT/-I9)+L@@BLJ5JIQ[Z#KUX*/UF-G#((C6XEFY"]_*(GOQ`A7YS( M,O&*`6F0C##K:=@C96`%X&HA2%*R'[!0FS&G5O%@'HA`CX3@6M7IF@]OD`S^0!)ZR0`ZQVUX M:``7_P88=R`W^AX5,B`#"@!'#P-,"!NOH8I=,8$'/A#=,(;QP6`10D(7"(,Y M"9P[^\(QL.VJS6V$:)4Q0((^3P!*]YHP\.$`$/,^%QNPX-S'+2I:#1?=[M8B MR8#E-AL#>J$1`8V@R''MF2$*81!C"*+:O?,Q.'0,YI%C#I@XWZHBJ9#Y59"' MH9F_EILL^((L^+QYJ8%!;P#LI/;X@0?+J&%.DYFY\U5S7FH!94,]@^GQJ.-% MO>.IN=N3Q%"LJ3PK3D[%0IDSQ]$'U'D2 MFD<1M](9J""BC$#E;*'Q/_`1,@@$8_ANGKV;,OD$]-C[5_0.7+`9N,B".R,Y MV\YY%P"&&0<55T^,3($+?8`(##D+&BJ)80%8$LF`-T'E/2L2/IGXPICK88=D M^1"%&<'^A>-`\PQ8EP>NCXU^]X3`C_B=$5$(A?A-0?&FC8P@@QJH_?'&;20` M%CT`%O]E?,='E``(#!;!!?20KB*#\?!CR8>EXBT%B$!C!`82.##0A6@*%PZ` MY/`AQ(@2)T*2LV^APGM,#(X1$R/09#&R`#0`_3F%Q=>/Q;$Y"*HU5H-!K<% M@*L4ID!W(-Q$`BS+S0;`T`)H,,:KJ)ON,&6X^0EQ*4`WOP'^PT2W[AV_H0+\ M\8IRH%?32`JD37`YD%^M6_7.PW7SJ%G=HMP5!8"D!LX:P/)93>W"=P9@WYIC M,H$3$^+'-S/<^<-8;>IYH6IU=QH`JF&](UNZ$-6@YTXR+,:YYTY^* M!E1J;EUW`?!%:B-ATIMG+J`'0`8NE/+-)_.,,1,`^L`SX4WZ_%%*2-]M!E\& MB)'D5U&XW-'>3;;MM9)`F0'@CF`-U%(<`&\=*!H`W\PC7$@4AE+*8@`4`)8+ M58GRQQWUY:,>2MA!EF))867@7VYI98#)=TCPYAL`HA@SUDVX8/)D`>K9]`4P M/`%0PQBET`9`&!(6!!-N=]0"P8;^5=UTY)UZ_0&@70UTZ9>@_`$`B`M_^.9. M*?,@D182K7E4$*4&G>0:02!QM.)K!*G$4E\BC8%%-!)`N9.#?,`D@`U>UWV%UEC-*59*2[85!>38)7R[3R`E9E8 M2WX!UE,H_89R&BY,NEB#"]\1S"-F-RDGJ&&(N8#C-W\4>5,HZLZ(V*PG759* M`Q`(",!GL?WQ:)>P/1>9GR17II^.S!VJW8`NC`%F+:4@!W(I%&9[KIX-_L&P M/KD5T!K^M2]>BY-MEO;E0AA'WGRH?)C\\6XH\]20SX5M6;L<3F,`5C5E[NC% M(K(92EU?A5+C8DQ(:@;]I]E@C6&P@`%[)0*^?Q160RD#MX8;2RZ2X4Z_[KA8 M8VLGYWC'S:($XL)T`_ZAZ&^EJ(DF,*)!D+$(>+OPI%"W2DGER'LBR67-4K\I M674I`D/RYBXP'`8P8[3E,]IZ$#WB7Q#HI?BA>OB.G6\FB/#Z37JXH#4P7).! MRJJ!;!J?#V=G7L: M%S5S'@132/B/J"G@)*'4O2@<4[22`2X`:0%`/EI3"O@`(!3^;!O#S?21@0Q\ MQR[YW20,3#+))PJ0`,Z013WF^J!;L.*@[]@M M)`-#T9JR8C8;WF01^KD)HL("L5($@D(!`H3R7-*D0'C'+@7+D$&D=K/-;8Q+ M#4C93<@`#VJX0&:8^(*8`L"E!KF@.+6062VRX!5X6&=GV'%9B,!2F`;,(P-7 MA&"&)EA!O8Q/7@7(`E*X%#J!2.U=WY!9NT@F00J6L$@J'`-\[G42:H#/17I` M`B`J6`,JC<%M7M%-T$J2I7DPK(;@D]ILLG`'/>RM>H#CX9[_2D3+@I#"`R\*8L@%*/"HM!$^XP00E@5&*3[@#1[Q\TR']PJ'+ MM%%%I8#^H\-<5I8AE:U+*F6I'G3R/J_P)`LRHE'(+O,'M)F02("!P&%;JI.? M")6H8SN(O/3TA0SHX4FC35TG=PC*V#C5,:4<6_?\DJ8"?&%@MSD)_EP41+_0 MU$:*(TWC0J*;P[@):7<@4V;U8"YP'A.T"S016WO2S-_\SIDYZVLI*%.QR7I& MI6$(PR(>Y\W$>,2#O3M65D[S(IDE@"X;K44M-)O2E;84DC&56D^5J,3[&=5[ M^FTH_BC*SUX-1*`,,6A!+>*J^OVSHB[1F#V-NBN"_(K"NS(0A,\&`<*%PJ/W M@NL\PD!.,MHWBYB@C(9.M*$V<:M`JSQBM?D;8QP,*UO3@!1!8P(BBBWT.24UJ1+*BFN0/-R-#Q2Y=@%!Y\@^>!-PH M7XL)_EVF,X!(BL+^9BF8Z!8QV.FM`F\)C.!*K19M08)3:B&Q)PVKBTBZU4K> M6)LH;6LI99[N1Z%)W6E6LX'(!N3DD.27\?I/7\.KT[[$-J'3&$/%?Q!0HWVM M(/CD8\H]K2>$QV>I[('/GBT!R:S^6'(]7AE8(01%\*K6AQ&%\NJV'YG4B/A9 M*TJ1^L'SNUX44:F/-G4100J#M"Y2`Q_?-0`[34L>/-*B!X<9PQA0Q9D+:H`$ MB5/L6&]%UXLL5N/OW'C4??$T7:)C+]C.*LCT7&J8!);JD.#"'07`12TP6M7( M46FK.7*U"]#VO$Y%$8+/:]=4<&0( MNSC#ER?'L-I:9>F7.?_JQHKR/!S6X&\5;;6\8'WURMR!1Y*E[FVBU+OJ84=/ M8DL8R.YPH0#4((/*^4Z7@??>J>YYBL/;COVY;X0K"%J850<03(;!X165+^4NCC<$/Y0<$T!%< M9`;?H`T$O%0-X$(`;(MG,$['<,@/<5):!=X?4$;`&!X]70I,,!S#^`<\E$)QR!Y89"!>%$BG)`8PT-8\ M\)_3`=$\"`3)B,*LO50T(8'-M)4+$-)OBAF0%-=$-8'`227B2,5A'C<0=_OR!;ID5Q]1& MXD`,S.")7WR""2A(\\S#WV!"80R)G8Q4;,@8)>I(2$R&*%Q(F%7,'7")\HP9 M:K1.3K@`R8C-'X`)`CE(!AB+X>G!&"#!5X2%'OP(6"R-;]S+!Y)!&"`&+HS< M=T!``-A,&-&%*`A@`E"B"5K/0OG/_6"4:T!>2H1/O-4*O"D-^90*1IQ/^JF? MJ2R$1J1$NVE/_WP/]HC*J`U<@UG^6"`P1Q8`&R88464PS8N4WG3HP3PP1L6A M8B@D"H"TE3Y$"@_B1`'4PJ.H$"'24Y,0XJ"0I"@D)"4V@.7AQ@AF08R01-T#>\Q;;]!@0ZFU>@C?28U%..`3P41E[190V!H03=`7?`(RJLOIG65:RIADU<)I_&0"9($^Y&)KFJ5. MN(BQ@(6++,G35&/DZ(-.N``#B8(H2$4H[DD!=""NB`:;1%&YB`($($:YD!,$ MZ,,A%2%.E.RI/@!"`*B'&IZE'JS2D^I.Y@7,B/R)B6):#13(R^D! MAF9`&!SID[J#*F5!DJH(;I3HB;I#Z04"/`"ID'XEGP8`@UT/D>!"GLD++N@@ M(;GAA68`$]7`GX8"P6"IAN*HJI&@<+;@6>B#*.@::*Z9G5[H%^B!,:CISWV" M3OS!BII`!B3`A8Z>#E5IF)P+IIH`&3C@V!R<%`%"9NA#*##+L712LSI6DCID MO*KI%]#HA=+D'V1!>9I`MXC.%\C^:6'>2@)8*""P9EIATA_@C6#6EIRFCE\T M8*F6'KY\`P20@2@TH#MDP#?H!$;)"JZPFT^Y!#M:U/S=T^L11$+:A:\]3L^:;:*$!(<<5SSE$SE:+=*^1MB2J6!ZD5>XP(5$(1.]+?B05*)P M+=)ZCF!B1]S]0=<23=7"1/T`SIG="DBYDD@0;JV0K>6V;:0"KE]4C];"9=?> M2OU1RJ_^1,E+2,W;2DW?=FZB^`7A-AV8$='BYF4@,!CGUHJC24Q+U"[;>E$I M@$Z5IL[DP(-?F*Y`P@87@05.=@>G3"W>CA#<1N'4PH7T+LWBBLA)`&Z;1*W5 MPN574%2[QHM9P(/;$%!/_B2S_\1_>I&-,2O"DY%,^]9<$GQ(\$M(# MO]4S/G#J?@4'4RY!-@D(G_`S*A7__8PH9`$2L%089`$9+!P*-W!?$&&T$HRI M@M:\J?`S5@H(6X_<7/!>%+$-C^\'!Y]#P89K1#!4>K"6,13^/J4C/-))`[-A M$$.Q^T$E%P\Q$=IMIZ@;.8Y@$$/EF37P"6=,$2M5][U;S8$PZG9P^)4+%'<2 M+ERC'K!4+=#&6LG-6_W75Z4P$R^C#7\C;NB/%PLD7RQR'^E3 M"J8O`V<]LT;;BW7@@:+\A:WH]*(,8&U\P:O(RB+CJB\ M!B!^;X(S74CU6+`$M7=4B\[*_43Q-3PST\]5-[1%;K M#_>!M?5,-?Y,"B51$E:/05CG;EBCA%LG=?ZZ]9Q,=;D,G.3FKDSG+E\P6/A4 MM>3& M=4>X-KS2#6;58PYMOM_9*`/=H[Y/\F+9LMS6!^?9* M!X`[D,$7)'86W$=E9?5SB_5MY2R#26YIKP1?[W7N3K7R"J2FL'=U8^T`:S9? MY.\^\87DPE5;CYIM^[52Y\]>Y]A,!\(]L/3VW;9CL_5N,UU.G[=R`_:_'811 MQZ-_JK)$L/*K,`&(A[B(CSB)E[B)GSB*I[B*KSB+M[B+OSB,JWAKU$)/_N0? MQ'A(?$,^L$:,][B/_SB0![F0#SF1%_F/"U<63%`^Z`$3W+C^D3\YE$>YE/?X M&*PX*G.X^JAL-`P!EW>YEW\YF(>YF(\YF9>YF9\YFJ>YFJ\YF[>YF[\YG,>Y MG,\YG=>YG=\YGN>YGN\YG_>YGY.Y3V/Y*FNY!!2ZH1\ZHB>ZHB\ZHS>ZHS\Z MI$>ZI$\ZI5?ZI+ZJ(\ZJ9>ZJ4MZIF?ZJ:\ZJ[>Z MJ[,Z0JVLH+,*0NV#K=\ZKN>ZKN\ZK_>ZK_\ZL`>[L`\[L1>[L1\[LB>[LB\[ MLS>[LS\[M$>[M$\[M5>[M5\[MOMZK*[N(\[N9>[N9\[NJ>[ MNJ\[N[>[N[\[O,>[O,\[O=>[O=_^.[[GN[[O.[_;VZRSBI;WN\`//,$7O,$? M/,(GO,(O/,,WO,,__+?_M/\",,17O,5?/,9GO,9O/,=WO,*ED.\F7 MO,F?/,JGO,JO/,NWO,N_/,S'/+1+/,MJ@##?=_;O>'?_=XCOMH3ON+;/>,#_MPO/N7S?>33_>3C?>!+ M?MP3_M_^>W[H`[[D([[F\_WH5[[H<[[I@S[DNW[=RWWI%W[@7W[EQ[WG&W[N MDW[KE[[HSS[>.[[FM_[E$[_I+[[:^W[M,[[C*[_B,S_O@[[PHS[LU[[L/__> M4_[J8S[K1)AT*#453:"Z9-FTRL$E5:%>59M6ZE6M7KU]%0J/^\(LL@:O]S;)XZ'Q)Y\N)%#V(L"!HS8FA%N!1: MN42+$1?+5;C)6CE2(&C.B4'9994UXRP:;?0`1X0&J+;:1DDY1)9#2"U(T:DZ M>4>63@ZU05MNB_O!VFN;($46T"!9EUU(.MG6AM#`E>5=?SR%)-MQ#_7WW".Y MI8I>?3O^Z58@>8V-5UZJ2#'Q/FL77A>A?P]A+6.#_R4W48F#S)?;3CR&U>23 MEZKQQAP'\F+!PJ2%F8A?,$P+/=H:HXUE%&:#V>=?4/!"H!]FI<"Y)F2QKXBE MC^LO.W:F(TC##>X[Y!6G)\''4E)XF$2!_EXI^33.EDYB@$,D?K>^I2>9CI:K M^YM$EJED@3N[&2P]I)PN;&^*NL2;2\^KVCKN<,5?U\NH-%L]Z4I1ACQTF%'Z1$L,J M"V7:S M_B!?6&(37\'G%?MRZ*$T6:CFH8?!P1SH..R*2!K$5P;HH0>X7XD@AU>(Q/SM MQ*`D2'\J!-4A!B@.6KPGU6U]_ M>#`5#\+-?`*A17+LD\`$QLM^)@H1OKZ4'5IDL`?]\5P-BY#`\>U/52`+G')Z M$,%R**"$LC/B$6.B(.EAJ0D1\L"4GH("`BS/`VVAE`08]`LX""0%PV`9)*`! M!S,P*`4_# M$%)J@@.VJP@<*J4JJ7)`4S`0 ME]FA7P,#VA\Z^N.?Q8E8<]+1GT,\`U+YS$$Q-<.]XJB@E:61I)D*0LNI9+1( M!HD?OA+*P6!2,$GL:%@G#K%,FR'U\NQ)J,Y2$<@-WC6B%&-52(5 MR`[/&LFW-BJNB4W=81M.!!?70[D.:"M(%F#:0]+RI*=61DX@IPXPU M78VF]*R^&%!A%0HNJGW75`/HQ(<-+"1AQLN=#P0F>X$<9(,4[2S0D"^')4#% M>&#)F^Z-%FD;Z%_-HE8\`DZ4_A!<1Y7*=G-BM:U`Z@:VP7UUMQ0NZV\IA>&U M-NH&&Q92(=6*6-R"Z,<-="1=#Y5*P*+9EK"$\0N[#.B$_.^BO;4P<#-,E>'^NG4@I<,':!H++O*!UUL03JREXCK*Z_)9 M2W^.K;$-54I&]M6Q.QZIWI1['Z(^K6:0ZNE]PL1U&.=+P[ MJBZ72AGPWL;5NI#PQW@%XN+M5CC&`K'%P3W%GX$*Q`W6X+,M*8BX(TT%;3D& M2A/NA4QOSWPF/%LB06R:!VA"PG?/!(0RGQ+IMY(`5OE)H+LNN#]I6.S@@V8Y4K64BX@51MS<$[ MCD:I9._^6:7P%!LI.RYB/%.*5!@^),6+\]@?1+>#C1KNPX5B'T\LEN:-KXD2 MZT((:,U^JQ/L<3.''S5J1&*%).05:\,*\(<\;+OE2D:H6TDNI9P26]I!X1FY#&)IG./*K5?D0]C0& M85M$JDRK(4W]7L$/2.BQGY^BQ72B/N*IH`:(SRA-.4P1HD)TL#E->$8I95'\ MWK=__/[N17;:UW+L=R/;PST3ZQXUXX%UJ M,#L2*`<5X-5L;(C\+2@&X`J:8P!P@!06S`$U$28$HS%L)#Z.A0#R0`2)+@8& MX$&:P*E2@!1;H58B#6=",`0]`-,6YK*HA1VR`W06C7'D3KG89H#::@5^441B MZ+P09]%,[/G:@03"JNY((:S(1CG^OHK[!HD&\8\$5D`YY@8UO!#NXFI_MH-K ME$,!ON;5N`T2X(P#P_C'JO)`4Y/`7+ZD(`@A$]J=D?J()KJ`O):JL4&,L@7F+):EE+[&DP6^"$T#@$( M"\(?W*4F\E%(G=W(@AG(L*V8I.:PK`2:0#%(6%&8H MICR3'0AL/`VD M7F[3/>6S(FS*:*#B/`QCTH9S*G2P$PIA/O,C/@%T0"7EG+#))5+O=RY&7P8D M#QV20"$T0IED%%?1BECB/':%T@X%PYP+$$U30D$T1%MC>*!CTB6\@$3G+5%( M9D5))CI%]$5A]"+G@U&>8CAC]$9Q-$=U=$=YM$=]]$>!-$B%=$B)M$B-]$B1 M-$F5=$F9M$F=]$FA-$JE=$JIM$JM]$JQ-$NU=$NYM$N]]$O!-$S%=$R](B`` @`"'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`#L_ ` end GRAPHIC 24 y83222y83222z0010.gif GRAPHIC begin 644 y83222y83222z0010.gif M1TE&.#=AT`(<`O<``````-#0N*BHF(@`"-BH&-"XL$A04``X4&AX@.#8P+B0 M$!`P.&AH:)AP$`@H,%A86-"X<,BH(.C@T,#0T)B8B%!02#@P""A88'B(D%AP M4&A0"+BPF"`8`.CP\`A(8&!P2.#@T-#0R-BP&"@H*,C`L%A`"'AX0#!@>$!` M0%!XB)"HL.CHV.BX&(B`.'"0H*"@D#@X.'AP:+C(T,#0V.#@X,C`N&"(F!A( M6!A`4-#0P)B(,/C0(!`(`$`P`"!8<%`X"+"PL!`P2,#`J"`@(.#8X.#8V)B8 MF*"@H(!X<+"($-#(J!`X4-C(T#@H`-#(N-C8R-BP*!!0:&AH8)"(@."H$-C8 MV%A84`A(<-BP2'B8J-"@&#A@6*BHL("@J+BXJ$!H@!@8&.CHZ(AH$-C0P)@H M.(B`<"!0:*BHJ'"`B/BX$-C8T,C`J/CX^`@H.%!(0%A02+"(D#`P,'!H8,C( ML,"0F,"XH`@("(B(>!A(8*!X$+#`R/"P$(B`@,B8&/"X(,C(N-C0R-#(P.C@ MZ!`P0,#`R,#`P.C@X.BP&%B`D`A`6*`X2-C0N'!P:%!00*A06)`0*(B8J!`0 M$#`H*!A`6.#8T,C`H.#@V-#8V-C@X"@@`$`X,`@@,+"8*)"0F(B@L+!@<.CH MX,C(T,C(R!!(:/#HZ'AX>#`P*!!`4*BHH&!@4-#`B+BXN`A`8$APB.#HZ("` M@*C`R'!P8,B@(&!@8+B@J(B(@+B8*+B`B-C0T,"8H$A(2"A8<'A8")"0D)B0 MB)BPN#!88."P&,#`N/"X&,"XP.C@V!A08,"XN*"@F+B0&+"PJ$!`.+AX@,BX MB*"XP'"0F$AH4!!(8*B`$."H&)B8D(@`&+BPN,"XJ-#0V("`>+AP>.#8R'!P M/#PZ-C8P,C(J)"(>&AX2+BXL)"0B+BP MH%!H4&"`D+"HF'AX<(B(B"'Y!`@``#0`+`````#0`AP"``C^`(\(/'/F",&# M"!,J7,B0H<"'$`=&G$C1H,6*9YY%&\>QH\>/($.*'$FRI,F3*%.J7,FRIC;@TZ414&*+TG$JUJM6K M6+-JWO6X6*'>OPH%*,2(LZQ8@!#]BW<./*G4NWKMV[>'.2W1,K7LRXL>/'D+_ZG4RY\D*ESR)KWLRYL^?/H+M:'DUZ+\2, M;D.K7LVZM>O7C$O+GMUPX+-1L'/KWLV[MV^5M(//#FSXM_'CR),K;RR\^>33 M$*$B7DZ]NO7KV&F2Y>)`XQFHXHHLMOB5>_R=`81^#/:7(7XWAACAAP_*"*./ M-[IW(4)"LE=A?B**A:*+3#;IY),S2>@@D!OBM^"-&#ZH8)!<0HBAE2$JTYZ0 M-D;XHU\`3@?EFFRVN6:05^+8I9DW>@.A-3!Z6>6=&D[HGH((U6>9,D:DV*(9 MB#Z6Z$MF+(;HH^,L"E*CD%%ZDZ2-8;J2IFYRQ"5\?W[8Y5]&&/'*J:?V8BHW MI7###0/^L+K*ZC__J"H0EU1Z&62"2AY64J/1!!OI:X\6:ZRFT7BP46/)+KOI M.,FB=&RQ5K&2""O*0NM!:ATUFBUCP#H[TK33?M3L8]\^&VVG'\T)H9T^$F1$ M+_^T"NLL^,XB!0/YXOO``_[^*W"_LS#@SRN]#!2O>PK_=801@6GYYY0C0F+H M1V8$ZT,KK9P0#2L<[;):L(EXX(&UB:2L,K;.1O,,+"F(BU?&*$13LLDJI[R1I3EE;(8-L.CQ"R+1=`&+/"TGL@LDGOQW+1*W^;L0NP^,Q8-"?`DC5+.K?BS!=:F[2+#P/2FO#^P_/66FLOK[!: MBKVP%F[XX8@7+H6^]^Z+N*RN,L#-*XS$&GGALDK>:JN08^[JN&P[DTX'ZF"B M3A;1\*-"(DASMDL7O^@!2],RU&Z[#+*C3C,;;*1S`K=X12-/.KS'K-(N+LS` MNPT@BV1&%BK(3KOM62!BA@<[9?R%.BJXH`[OW[.!B4'RA M@BML=$#2Z['K8?_MMN>N?C2(\-[!+L#+2_BRT#R4["(+RF,#U%R""1P,B/S` M'DIVYH()\`X1'EA?1^[V"R#"P@59<`;O&LA#F+`M'9XX`"NB844@=@!OD7*! M"G@G`_4IQ@:0&&-)=G$"/0!QB$3\Q?E@D8@DN@"('G/4^=B@PRE^(7G%*^.D MHI$"-DQ`DE@)X%L4Y[C$&2YSC'@5YB)8,'V)\G`8?)PHN1%*6?F#<`P(I>4Z M)SE7%8P;(A$>[U;7D37*@`V>8-U'4L`95NQBC!X@VP/5D3Y@J4`=+L`D7*+A M/15(TR,'^`+OHJC%CD3#!^>3W[6L%KY?9!$G;&2#QWP0C5VHHP,R4(?Q.)), MY=6QFW/^B<8!_#B^DK#B!.`CF[7&H8Y+=N07ZKB9HRBI#EBTY`"MN.(UO?E+ M-C3Q+;OP&3ZW,KB.OJ*CI``H&UQQ@4@E MZ@*)L$$Z/+*1B;ZEJRS)6$39P`]6;'0-T" MK-V*ACWMF)CK=;&?)-&E^#S2**RZ0'[>A)9C@A4-3?Z*DI$\J[G&RH9?,+4K M9DA$%QH9%X^:E*:U''.L!KW5RQA&^]-2X/'/)_YLKE7KMYW>KB!%&L$"-@82@//6+W!#-P MKW5E(+1%?`$;E3Z4`7S"J7TF8N5'"CG2UH9YMA6+!,2`DSB4>&VR0B.A&*JO`Y4A6 M+2G%;BD66-5E[+`P9@9N%?EHS@M:-$;!J5Q*E;DBX2UX%2O=985KR%46LG^1 M&C0L8PQ:2/XRSA"EY#![4[O%'4G^=],!0/`FPA/^:S.0@17`<)FY6XF8(UW% M;*[UBEE8U[7SG:V*A]0;P`V`%[`=40!?/U@6T0>C!#I9RUQ6DX`/VM<&` M=7L6%7#L M=S)+ECS^1!8L@G\7N\9LQ1?N&D"+W[KD^^YW4]',W?.QF5NLZ`+OV,P1D&F\ ML047E[Y;P>\>=V3C>A99O*U&<6_N%20^[QBT)/OJ$WR\R_X>^3CP,/"5:\VL M'-O%`18-MOH.5B3`F_A'UJAQ:+7O"QG#6+"^D(*.-=R;'M!ZR;T^R91[O=5< MW1FDM]Y.CL'=Z-"J)!MB%N@\LV$7<&;#)7B(O8]O!-+)LGHKQF',6UM"XBXJ.T70^R'L67#*1`M^JX:]P]83KX0?,C>&A%%]/8QYV_+:^[X`SJ M$#L=,`&(0'9`;\\$M?<`#OMUSS1$\V$('J0#R7 MH%`=43YLX`('(`]MU`$N8'09(P]Z8#KID`YZ8'#?9`._9'!B-0.DHU:G0UC9 MM4V(%Q)K=G(#UD53M7$UI#P^4'Z]`S5QUP7UQP8]>&:8<$/+587.T'&0P'[B MHE=L<$]Y`/^-FA1!X`(J(8):M,1'F!#KO"!Z+-`6S<. M)&@#V91`*LB"PC-2@# ML)!F4\$(*492HT0P_`)L'P1MO8<"PP<#(V`*Q1<'(Y".(T".(S".OF<*PY=[ MQJ<+WP`#%7!\\QA\NR>.OY=[]]A\T18'Q@=\RF<`:L:,E;4+((,T\_9G!,0,2+4?6!"[1$7]@1)Z`"B^0"`)4.X5."Q;4S'>`*NW`M;R6% MF/",(Q'^5,P`5(6#3;01A*8>&+$.P@F$FOV M.Y\6/LZ0",_`E?]S"4`T>6PCEPO$#W3D$?:V"UW4`417<..0!>%31USE9^`U M`^I`-SY@A%F#3SCYA4IGA&UX`H*T//4%E7!%*7C@`W*9!1S1"C+VA]CEAS0Y M`4@#26>WE4`DD4`99\L2#7GD#$4V>A(U#DL)1`D7/R7)>%/9/\Y@E;K5`;_3 M/CVI0%+$-JZ0#FK3/VR@!RVC>!OX*SD'8-%04"\/H`O_ MHGO:AWO`9WSCB([MJ(Y#,`3J.`():J##MXX&FH[`UXYQ,`2_-WP8^J#G**&Z M]WL5<([B"`/?D(ZY-PLH<`,PY$Y`%#\W$V#0D@B_)`,ZHSXG<`&Z53LVP`_$ M@T5F8)*IP<38`/I=HP?\3VM4&.9I7-"&83F\F0^D"AF\#Z/ M-@YR"5AWU47IX`PR0&_4Q#O`]43JA#T;`3^$*3+/P#NP8(`"!YKH\YK:U'[J MLV/-B3UWU9,&YP/P@PC"E`A6!&7^4TES);%F&\<1!R"6;$`U'B-?L*`"\O`] MYC0.RH,(!]`H04I'$7<`-F<1RIP7["&SN(!O]0%/YH(C297?E@LB[F36V0&WZ,.6Q0- M8M0!8$HWT2"6.F2FNX"F%V"JXR`R[/FFQ.0!*4`\A`DM$34!.I-9WZJG42"6 MIY@QOZ0"F3H.!_!]%_6*UQ0-DYA%:!AGV'5,Z$I/X]`!O)A$771NC7(`.D"G+<+Q),%#[01>.`*'=!8+WH),IIK,7&AMQ>.OM>.OO>@"IJ. M$9J.IJ#^H`FZH.DH"@X!)LP!"6;CA;ZH!@Z`@-)CCD+?"4;C^2( M`N88!SD;!](&`P8)0^-@A$`D`_)PENE4KCW71@[D5HC`>7`V>7A64?S0510K M/BMY8_:J/DHT50<65<3S"_G)55(%E'EX/LK:$8GP5QZ!I["P1DWU/9.766+9 M1!E#>H`E6)<`I#=F5/*73BEP3H*E#LN2"(=T5&4Y8]B3,5!*@X9*$FN&""(# M>3O'HT":1VQ`2![@`_S@`XF01Y*+9UQI`^;:964!0>@9`?` MGM>I16M;BT>#GD?85%(5?S]Z`$9(-0-V2)C@BLHCFN9"BYC^X`IU>W9[*T;. MBK?`JS--I5O-I%F\,Y09XT?=FVZ\DU\+Z5N[U51RJ5'J*WG+X@%CY83=^K:] MJ'COBJ\"%HEDU8OAXP+H=CW]`[:(DF=E>JF%%#*8(#+.]84'P%B)8';=Z[9! M!+D`]3_1<`'7DY.7-162,\(/8``@Q'PAQ'S2IGW3EWS"!Z(EBWRZ4+0'2K.^ M1Z#$MPPH`*$"&8[JZ+,8^@#UB`)@,'P)FGPH\+0DX7YRN:*HPU6_]%1-I3Q@ MVVE^R@;!"UX`;$GJXUSG8[%PQ#^\HU<$54M:3-64;*-549EW$G8#X80V#S M-;P>TR@#1G;",XEXD[!=E+YF2F/^574]["D/0:--;\15-O`+:C-@[G94'.$# M[^2\]%JYG`N$-0<^,V"%KO`+)R!%`[:YK-IJ\.,,1ND>)]\2.(T/)T M3I>[G$=Z+M`*=9<"ZC:33I:'2D>O4UA/N#``8L MHN.$F?56"_1?^"M7[_0H[*1S4AARBJ<"RJ(]T11>XB,/XE>M(B/-E86`=<>< M%M58)U"Q#!9C[;DL!Q17,*$YP79+LP5BFR,X-K53KT4K,F4XL[`Y]?(OK_(` MNT=!)[S^POYIHM!V`S<,?,ZFCQ!JH0"#>RAJ$A[0KC*V2RT3HUUH15C[7\)J M*6?D75M7MN"9RLSI,Q=0QE.%>7E4Q=X$ON"\5J]Y`23'.C:@/(YLKI9\J#:'-U\`<*&* M9SJ'7I^F>,%D*0[MR+2[6\#CA5C;RK!,4.)3A9)M.LS$RERUA&'=@<<[B`S- ML%P=+(J7!6FFU<8Z1E8]#GH@B-<#S5H\R%;F`=;\FF`M-,AC?]V,N>#5L&OE MM7/Z$2=C9>@LE6[!6SJ3`ER)O_XK5Q&EB2AS`.,`/\0+$JC^-@-0(R[FY3\J MH)#Y)D:3.-F4G9@*W=E-Q94-)'!:43@6;2\/)DK;5C`CK&*S)WLE-5.](!AZ M<":E0B_<(&V2XP^:$SCZ\@\?50$2M"\3U)_/5GS<8-+2)V!`.H<]]FY[>)@ MU@JPH`YZ()=^_%;,D]N#'#2DQ];=%\Y=F'<(53MP/7-Y[;DV=U="!G6!+65/ MNDO8J>&9ZW@<7)BWB^7WU$[$\P5H:M62-'<"J`?*<\: M77;VY4T.:&0>P-JI[-I:'-N!1^/^F#!<4GC;LIO;X0PM?H3*TO5I]]N%QB2& M,W#<=I3<8!.OGC#IGJ`"4,@[USFES$C=UFW/\9/=CZX\%CL.HP#FOXSF'F%^ M]^=8/)'1M(5A*A9:KO)*KT31'Q8K_`+2`H-A_W`&JY`AJQ#L0%`O.P4KI]*- MKQ!L&@92FO,J)Z7L_R(%-QT2@Y'5IM`&TX\'MZOQ-LH M5PQ M>A`&OW"!E/R:G:MF2UXW42[8-Q9Y*F"U%<5XB?T_B^W*4YR[#CVV+;$S,N`* MGB`/];K^V45MXB\>JQ_3DVWN9C(>$H+UA]5>YW_>VN7[VM9L:/9["MX%/!ES`5T`W:?K MVZU@?NJY/\HS\8ZYT*C.$4&CV>MK<%5Q4K12+Q_%*FC@6;$EX*!U6[7E[*TR M"_ZIC]SP)<`^+[U`+V_?"S[U"@*^T1\V.9M34]P`4R\F$K\P>#K6DX<,+3[- M5=J>;]]'RM*K\OGK[0P+XMZ2`N<331TL`^E`-V>UQ@`?$F_><_)^QV>GXNUY ML:RM/?O.X^5;]-'M/`*?2#23#I=PMAZ01W>-SMNEUU<_+N3^B_%N%GE2;;L) MG@2PBRL.GIDY4-%.H0R")J)YJ'52H0I MHN%9>8GCQY_C&M)L^7(@JW$N.B#$M.OC5*I5K?[[U^O?*ZZE7F'`ZI7KV%=8 MMZ+9RI7;*SAIRY8JE3;;*Z\,C"A;56C5*F'']JXZ,HL1-\)OL_;JE<^($<1: MM68URQ7KV&P(J$:3T0KCS6CR$*;^VX7'J`PV$S8SG,%&QFF<_!"J(YH:]C@\ MNYYV<2F0%2*$F@6:283(%:8)SF;H^7+::D.$KI16%BX\-%7H$ MR2#\$$S^2,!Q+E`1D40NB-&BH2CR\[F/:F/#F41\"*\C,R[P@#TQE:/N/7E4 M9,,GZG"*IDTCHQDIR"-SE$>>B79D(ZFI//"!-#9P$]1)5ZU:##&S#I,5L;*V M*IAEE@H>8(!76G5M#*O&'NNEDUI[ M08,J5M3QA+Z/&L2R(-)0+.A$Y6JCR5."?%#Q39QVH8E5@3S`T+?W6IGA!#.^ M:&47C%IM\83F"/8HD22E?.:Z*K4;\1=4Q_$ANMF,*A.][!R5!P]``:0Q/(63 MRP]D\=@PLJ.*V>.OH(/8X`=-!AT4N"H)*;0P1W+9T/?^4Y25#W,><36" M3"11Y$Y52`2D\$""I2K,V(!E8A\\7-$'AD@UU4<@D_O84QQK;'*Y,I6T&J0Q.Z+SS.S4-`K#"D/VT1E1<7I9(4;9J]#M,B_"6Z.+ MK.)N0NRFLJVWS?#56SUY;F/E`A6>4WC%71)Q=`*/$P7.F>1T1,H#'.W+PDZ< MQI%;#SM?Q?TJ:XTPJQ?&=L*&ZH\F&&Z3\M#J`MQHYD`Y85HA#]I@EBQD8WY MQNXLG70FKUP79!>-?/EG1[\X0#3^3L**:+""@:\RV(H0)J6%#61+#ON-VBZF MHB[I9ARRF0AMRO0,V36J/1"2&Y9&QPH/>$@/3.&.FL`SM;\9)72@@6'>/D45 M'[AB/R^*$"LFE#@IM\]4V,11EA7*MG]"(/CH-2F;+@AHRP)*JXZV<6XP[$JO4U,O_'A#%@A&J8$ M)80ZS*`,!9+&J[$P$;^`1=,(YZ>*$:E2](G&`?3SR!DZ;H=328>1(A2-,*E& M0-71X]-P0IK8X4$=^(F3C"Z`AYW)8!<.9$4BNN`,EQQE54W#R*1^A%0I. MN0,F093^9ROR]:YWLI(,^,0WF)Y;WB/N15B\F&9%I%F!L`Y4.C4H92II<,G77!?(MPI$8^8047I MD$?3QG$`&YDJ&I7+P@$&D@B-1`0X-NJ`#/0P45ADP:(]HTHBRA1&)QU@89LY M0,/8<((%$50Z/T&:FZ3B`G7XL$+/0,0!,B;0<21"I"3%"896]`L79"$U_1%( M(M3D$@_D3P]K0D3Z>M,*%S2P<#2]3.7XLZ"I'``2/X2J0.3V/X$>(#[N4XI) M*T155IR(IG@H*QOT0%,[0D4%+N@")M"F(?E(Q08MI=`);&#^@P.0R@4*#2J& MOD"?[B`$9:T8QRY@T:Y6G,")"3M;"*V2"+A)EG0_7)`\)Q*-%*I`:RSU81-= MD((#/'4@!V#9+N8'I)VZ`!*7`,UF$O%4G#A*'5\8QQ=D0"D7[,(3-6UH5CTB MR5(!MJI7IDLHL3J$H/NQ`8(IYB6"(C M1`]:FXH93M!CPPIN3539!16S(%X>I]`9N]!:E-LUY;#Y+QVMR!_*@'PEE#DV ML?*P,I:-4F(B*T0@NY@40J[L@X8,F4)F*C$F/+R+3D[`S%19]H)R*KJUXMXMB8R MR1BB*II4+8*90=2$?@&I]@*S+%S!0%?*TLU:*#,MXK`#"` MJ_E?(#Q`%P]X%C>VF4U?>3P;OO,=R7NG\UY@N$57-@,B]*`.N:;C$EEHHT=4 M\!09:&V6OX"Z,SP!U()<(`LJPH0Z$(VFSG0!ZK]PA@IL0!$5."/JGD!L(FR` MB;)?PNV74&JA+IG8+)3]ZV%W056>\76H=\$'*5#!W3V1'!?P_1==&-W:FWUE MC;HB'1/_@B?,#G857`01=H?ZX#FB$QGXSQ6_"!#>+G_W+KC^QR#J:#:B#S6# M=/QXMI*/N@HL!:,LP#[V62@U0VP`]MAC%"-7EX[66R&SKO-=ZEU84Q8,CW2K M+Y^>+F!].MA.9R?A"Q/-=KU#TN&,='OB[BK@!]DG+W7LL"+$3\'$7YV!">13 M_,UUGSSE\TZ5PO.]"Q<8?=2[0'C#0V)T+G`\[;J:+W"%#H`\VPL[G[`!S#N\ MP=&)"?`\;/N35K"]7Y`]C-B%SC,Z/>&4PWJ][\,HAG"!\7.&+!`4@V!`9RA! M`I(!9W`\N9J!V>.D7V"]X6"[C\`7/>B`='`%P2F1'FLV%9@(>9B!7[@^N5*' M9W"_BL.=9!J+4O`';E(>9KJXXZ'^B^[!BL4HBR,8N3/(BVI:.5%8!2-@@&5@ M%F;AAEE(P[4P)OVJ%G2ZE7/*!Y^;"B1K(3,(%=6B*H+P`!XK"@6")?3Z"*8X M`7FH&$AI(`=*!`_`B)Q(A%A"KUV8`'E(H,V:B!C[A70P.*)HH4!D1*FY(D5L MQ$Z,I3^,)5%D""7S`4:,I4]T1%0LB(,Z@4.D)U)\((9(-X'Q#R4+ M(8^!Q45<0J,`1$7\Q!8YQ5AT/T)\-08Z05@JQ0,)Q%U,1%B"%`9:L@O80ZGI M15:,!A^@NF,D1J/01=:8"![SD<2Z@$00D1;1Q7*\C&5\H%D\"6J$16N\@%O< MHWE1K5?^%,51',82L<6*&06"$,:`S)&&Z(\CB2Y,&4:9(8H%NL>IP(-XY">M MT<972T:!.,0+")5U)`I;5*U+&I57VB6)@+.&9$(F3*8I[":O$(M=D4FO"!:; MY(IR,@(O+#`PI*;_&L-M>@`4L)XS?(!LF`4&8+!>*(M\J"]KR0=DNCA<60PZ MA!QC?$<82;K?0!V$P9MB%*7G0!W=F(%$VK7WV(6YN@F08,NG@9RNO)1$B92Q M+`BV'(AWA,NX=$N"&(6LU,N]9(BLA)2P=!)%H4N;.]YH+ MLNBF][J5N)BP,\"+O3B&:D*6O3@"-"@%!B!*EWLY!`LG<.(>G+RX_)J,=-HY M(^@6XG3/][P0-P$LT(RDL/LE^,3/_-3/_>3/_O3/_P30`!70`270`O5/NF`F M:9E*NEA.7R$+KW!*9&B>Z/G"8A&&Z`&",^!"!G4P&/#0"BC*-_BF$24,[ID+ M7^$5XV'0F0R?^,H'\S%0_WRH_5`!T\L)II`'&;B8&.71'O71'P72(!72(272 M(LV=5Y"Y62$+!.4F).T5R7@O:/K^BS`T%@Q]A1$=RCB(`QC0!10@2J)$L&]J M%J4DC)B\+YE,4B=]KRA\A5Y@)R-EPMJ@%.F8*#V0`1_2@\J$TSWETS[UTS\% MU$`5U('HSA:U25P9"[0(%KI``/H:EN9YGN@1AE7`4"#@@C/8IEFP'A2(@Q'@ M4ET(TRX%53%E@&8I4Z6,"T2EPN7,"C0P@B.@AC<=5">)A@OH@G$SK!EXG%GE MU5[UU5\%UF#MU7$Z3V[0"@SHA*UHBZTXT3;=2>CABV(1!1D8L)3[KQJ@G@I` M`0_E5A1X%IBK``-XEF\%)RN8!;J0`NXISYK<)NYITVV)E?84UD%L"$2PUQ18 M1<:\=GAB3!S6EF`U5.;%=NQ)=NR-=NI:%.W^)WT1)X).P)1 MJ(*XK0*AI5NB)5JZI=LJ``(OA8&-?0`K\%L0M9X'H-IH256LB$D(@XS'<"9K MX8-W9<^SE=S)I=S*M5Q>U5KUQ!6W()Y_V,F@Q5N\!5VAG5O^O)4!387:$15< M4/56!NB%[K1)*X1#K_B>"5N,+%R,%[W7=WO7=W]5/IIQ*IBRFK.!"QJ"% M`J/;HT5:YA6%"7B'"0"PO0BG;PW36;`"ZTG*,MTFZ63*0ZV5./P'E#T""459 MIAP6(\B'KP7>]G7?]X5?R\W)U[656^'"G'O6`@-=YGV'$'!>O:!4+C@"+I0" M*?@F!+/>,5U7N/B>K7A5QF",(^B$Q3C>Q7C5`3Y>\L6`*(C?#O;@#P;A?ITP MXM$*L1@>"BZ$T!5=:Q7#O?Q'0V%X2-0!B`(X@FS2B6VXSO&XSQN29SC MG?DR8R,PWU5XATO`XBN>V[A]AVK="P%&#.\T@)?[V*3<7E,MC)%[U3-@#.\] M@E8.?AR6H5L*(E ML%7`9&WQE:($IS$%9J540P9@!!/&8"X4'L_M9"[VG5F^9)1%AE$^`U0.X